data_1bmw_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1bmw _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 9.9 tttt . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.731 0.301 . . . . 0.0 110.428 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.515 ' CG1' ' CE1' ' A' ' 23' ' ' TYR . 30.0 m -92.74 172.06 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.374 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.412 ' CG2' ' O ' ' A' ' 4' ' ' VAL . 4.6 p -163.49 133.8 4.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.397 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.492 ' CD2' ' HB ' ' A' ' 21' ' ' VAL . 23.4 m-85 -95.61 -169.9 2.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.073 179.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -165.75 104.85 0.7 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.809 0.338 . . . . 0.0 110.505 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 95.8 t -55.21 91.84 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.179 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.445 ' HG3' ' CG1' ' A' ' 51' ' ' VAL . 9.9 mm-40 -66.1 169.57 6.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.568 -179.704 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 11.9 tttt -63.18 -15.33 56.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.193 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -45.95 -27.81 2.58 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 111.213 -0.755 . . . . 0.0 111.213 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -71.13 131.29 43.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.77 0.319 . . . . 0.0 110.348 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -145.47 -86.61 0.11 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.434 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -81.68 -66.81 0.84 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.923 0.392 . . . . 0.0 110.121 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.06 26.08 2.72 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.214 179.708 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 54.5 m80 -94.32 139.61 30.86 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.233 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -124.35 89.24 3.04 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.263 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.416 ' HB1' ' CG2' ' A' ' 53' ' ' THR . . . -90.26 153.38 20.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.51 -179.819 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 6.4 m -145.29 137.5 20.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.044 179.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -98.69 51.56 0.99 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.505 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.492 ' HB ' ' CD2' ' A' ' 6' ' ' PHE . 3.0 p -53.57 107.65 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.924 0.393 . . . . 0.0 110.19 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -174.46 120.75 0.25 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.252 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.515 ' CE1' ' CG1' ' A' ' 4' ' ' VAL . 17.0 p90 -127.31 19.61 6.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.831 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 60.44 147.94 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.901 0.381 . . . . 0.0 110.518 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 109.07 -93.47 0.77 Allowed Glycine 0 CA--C 1.523 0.592 0 N-CA-C 110.652 -0.979 . . . . 0.0 110.652 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -57.54 -173.43 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.793 0.33 . . . . 0.0 110.484 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.34 173.69 6.67 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.515 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.424 ' O ' ' CG ' ' A' ' 71' ' ' GLU . 0.1 OUTLIER -109.07 123.51 49.28 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.483 -179.942 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.44 ' CA ' ' HG2' ' A' ' 71' ' ' GLU . . . -115.1 -62.59 1.58 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.284 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -158.95 164.2 35.83 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.595 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.444 ' CG2' ' CD1' ' A' ' 52' ' ' TRP . 16.2 t -138.68 145.43 27.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.211 0.529 . . . . 0.0 111.335 -179.547 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -124.56 130.6 52.76 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.223 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.46 HD21 ' CG ' ' A' ' 54' ' ' PHE . 12.4 tp -114.2 151.77 32.24 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 121.021 0.438 . . . . 0.0 110.172 -179.058 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.423 ' O ' ' CG ' ' A' ' 35' ' ' GLU . 0.0 OUTLIER -125.98 -156.04 0.71 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.699 179.458 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.423 ' CG ' ' O ' ' A' ' 34' ' ' ARG . 14.3 mt-10 -161.57 -88.54 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.497 0.189 . . . . 0.0 110.72 179.711 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . 0.444 ' CG ' ' N ' ' A' ' 37' ' ' GLY . 11.1 p80 -160.76 -46.72 0.05 OUTLIER 'General case' 0 N--CA 1.454 -0.235 0 CA-C-O 120.797 0.332 . . . . 0.0 110.8 -179.716 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.444 ' N ' ' CG ' ' A' ' 36' ' ' HIS . . . -156.97 38.39 0.56 Allowed Glycine 0 CA--C 1.523 0.577 0 N-CA-C 110.914 -0.874 . . . . 0.0 110.914 -179.605 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 5.5 t -73.6 -76.03 0.14 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.828 0.347 . . . . 0.0 110.219 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 37.3 p30 -173.32 55.95 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.131 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 67.83 176.29 0.26 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.242 -179.784 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.481 ' CZ3' ' HG2' ' A' ' 67' ' ' ARG . 98.3 m95 -52.69 138.64 28.3 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.542 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.7 m -130.98 110.72 18.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.935 179.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -48.66 131.42 17.79 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.82 -179.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.23 -171.33 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.578 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.419 ' O ' ' N ' ' A' ' 47' ' ' GLY . 41.3 m -142.03 102.33 4.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.235 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.405 ' O ' ' CG ' ' A' ' 46' ' ' LYS . 0.1 OUTLIER -64.56 76.17 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.331 -179.966 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 45' ' ' THR . . . -107.14 -21.9 7.82 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.923 -0.871 . . . . 0.0 110.923 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.69 -33.41 66.49 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.838 0.351 . . . . 0.0 110.336 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 98.12 -42.38 2.09 Favored Glycine 0 CA--C 1.522 0.526 0 N-CA-C 110.562 -1.015 . . . . 0.0 110.562 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -107.32 -25.12 6.19 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.679 -0.968 . . . . 0.0 110.679 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.445 ' CG1' ' HG3' ' A' ' 9' ' ' GLU . 24.0 m -136.5 179.0 4.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.826 0.346 . . . . 0.0 110.467 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . 0.444 ' CD1' ' CG2' ' A' ' 31' ' ' VAL . 4.0 m95 -109.42 128.35 55.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.417 -179.423 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.416 ' CG2' ' HB1' ' A' ' 18' ' ' ALA . 0.2 OUTLIER -114.69 167.94 10.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.421 -179.964 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.46 ' CG ' HD21 ' A' ' 33' ' ' LEU . 79.2 t80 -146.72 133.2 19.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.316 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 25.5 p-10 -94.65 114.29 26.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.544 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -84.51 146.55 27.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.261 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -113.11 -40.19 4.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.403 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -67.66 151.55 97.07 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.272 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -71.72 -18.77 28.38 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.681 2.254 . . . . 0.0 112.494 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 3.6 mt -96.29 144.13 26.74 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.903 0.382 . . . . 0.0 110.662 -179.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -143.2 91.12 2.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.269 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -96.35 -140.7 11.33 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.775 -0.93 . . . . 0.0 110.775 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -73.9 166.38 29.83 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.527 2.151 . . . . 0.0 111.893 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -125.2 177.46 6.1 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.148 0.499 . . . . 0.0 111.0 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -147.43 134.62 20.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.494 179.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.486 ' HB2' ' CZ ' ' A' ' 6' ' ' PHE . 52.2 m-85 -124.22 168.52 12.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.253 0.549 . . . . 0.0 111.478 -179.072 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.481 ' HG2' ' CZ3' ' A' ' 41' ' ' TRP . 0.0 OUTLIER -170.86 68.36 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.404 179.741 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.486 ' CZ ' HG13 ' A' ' 4' ' ' VAL . 4.5 p90 -51.8 177.81 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.407 0.622 . . . . 0.0 111.544 -178.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 5.7 mt -137.96 55.75 1.76 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.045 -0.979 . . . . 0.0 109.177 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 40.1 p -27.98 136.83 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.762 0.825 . . . . 0.0 112.709 -179.015 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.44 ' HG2' ' CA ' ' A' ' 29' ' ' ALA . 14.4 mt-10 -50.78 -31.15 16.02 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.42 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -63.23 -31.68 72.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.447 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 103.18 62.33 0.7 Allowed Glycine 0 CA--C 1.523 0.576 0 N-CA-C 110.669 -0.972 . . . . 0.0 110.669 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 74.5 mtp -152.18 115.33 4.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.813 0.34 . . . . 0.0 110.313 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.68 176.75 5.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.384 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.421 ' O ' ' CE2' ' A' ' 78' ' ' PHE . 2.0 m-20 173.25 126.94 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.113 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 97.8 t -76.17 152.77 6.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.752 -179.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.511 ' CE1' ' CG2' ' A' ' 4' ' ' VAL . 38.9 m-85 -136.88 121.08 17.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.152 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -109.53 153.02 24.71 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.471 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.7 t0 59.53 30.53 20.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.675 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.423 ' CG1' ' O ' ' A' ' 92' ' ' TYR . 95.9 t -59.77 -73.82 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.19 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.426 ' CG1' ' HD2' ' A' ' 83' ' ' PRO . 50.9 t -87.52 139.32 31.65 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.416 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.426 ' HD2' ' CG1' ' A' ' 82' ' ' VAL . 47.5 Cg_endo -73.83 -168.1 0.43 Allowed 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.572 2.181 . . . . 0.0 112.063 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -76.12 -64.12 1.17 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.341 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 6.3 tppt? -96.42 57.7 1.69 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.282 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 40.4 p90 -51.77 148.9 5.15 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.483 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 3.1 m -122.85 110.24 15.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.181 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 2.7 mp -50.47 100.97 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.459 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 137.51 44.87 0.08 OUTLIER Glycine 0 CA--C 1.523 0.579 0 N-CA-C 110.534 -1.027 . . . . 0.0 110.534 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -166.45 -176.76 3.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.769 0.319 . . . . 0.0 110.345 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 85.3 m -119.68 138.66 53.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.572 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.423 ' O ' ' CG1' ' A' ' 81' ' ' VAL . 7.4 m-85 -143.95 107.74 4.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.168 179.791 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.436 ' CB ' ' CD ' ' A' ' 94' ' ' PRO . . . 176.25 178.02 0.22 Allowed Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.488 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.436 ' CD ' ' CB ' ' A' ' 93' ' ' ALA . 49.4 Cg_endo . . . . . 0 C--O 1.249 1.027 0 C-N-CA 122.565 2.177 . . . . 0.0 112.059 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 4.6 pttt . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.804 0.335 . . . . 0.0 110.281 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.522 ' CG2' ' CE2' ' A' ' 78' ' ' PHE . 17.8 m -55.06 171.07 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.461 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.434 ' HB ' ' CG2' ' A' ' 91' ' ' THR . 21.6 p -153.47 135.6 14.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.375 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.483 ' CD1' HG12 ' A' ' 81' ' ' VAL . 14.9 m-85 -100.58 169.38 9.09 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.455 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.5 m -157.59 112.72 2.74 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.342 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 44.5 t -58.07 91.38 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.275 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.404 ' HG3' ' CG1' ' A' ' 51' ' ' VAL . 6.7 mm-40 -51.0 176.3 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.463 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 61.9 mmtt -67.48 175.5 2.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.314 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 51.13 49.74 42.28 Favored Glycine 0 CA--C 1.523 0.547 0 N-CA-C 110.718 -0.953 . . . . 0.0 110.718 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -102.64 136.9 41.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.873 0.368 . . . . 0.0 110.452 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 3.7 p30 -172.07 162.81 5.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.295 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -49.11 -28.1 3.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.742 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.81 -28.33 44.5 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.373 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 25.1 m80 -149.65 125.22 10.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.507 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -111.83 94.37 4.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.222 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.427 ' CB ' ' CG2' ' A' ' 53' ' ' THR . . . -96.06 125.69 40.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.488 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.417 HG22 ' CG2' ' A' ' 21' ' ' VAL . 33.2 m -113.67 -171.17 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.003 179.765 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.402 ' HA ' HG13 ' A' ' 51' ' ' VAL . 1.4 tt -138.09 80.66 1.81 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.302 179.656 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.417 ' CG2' HG22 ' A' ' 19' ' ' VAL . 2.4 t -97.31 102.39 13.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.989 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.49 ' O ' ' CG ' ' A' ' 23' ' ' TYR . 0.0 OUTLIER -162.87 -65.27 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.878 -179.721 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.49 ' CG ' ' O ' ' A' ' 22' ' ' LYS . 33.5 p90 45.6 -171.78 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.724 -179.454 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -115.85 142.63 46.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.474 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 131.23 -43.88 1.26 Allowed Glycine 0 CA--C 1.523 0.541 0 N-CA-C 110.759 -0.936 . . . . 0.0 110.759 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -126.91 -170.63 2.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.826 0.346 . . . . 0.0 110.601 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -118.8 -175.32 2.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.514 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.437 ' O ' ' CG ' ' A' ' 71' ' ' GLU . 1.5 mtp -105.99 123.73 48.45 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.343 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.432 ' CB ' ' O ' ' A' ' 69' ' ' LEU . . . -132.16 -58.58 0.95 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.924 -179.776 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.402 ' O ' ' CB ' ' A' ' 31' ' ' VAL . 0.0 OUTLIER -140.63 173.6 11.33 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.83 0.348 . . . . 0.0 110.925 -179.778 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.466 HG12 ' CD1' ' A' ' 52' ' ' TRP . 1.3 p 164.3 131.33 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-O 121.518 0.675 . . . . 0.0 109.76 -179.847 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.477 ' O ' ' CD2' ' A' ' 66' ' ' PHE . 2.6 mm-40 -112.04 -172.49 2.05 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.843 -1.071 . . . . 0.0 110.476 -179.546 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.472 HD22 ' CG ' ' A' ' 54' ' ' PHE . 5.8 tp -144.22 145.16 31.89 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 179.302 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.66 -178.84 6.79 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.086 179.712 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -132.27 -85.22 0.48 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.574 -0.284 . . . . 0.0 110.566 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 171.71 39.76 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.823 0.344 . . . . 0.0 110.595 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 167.29 59.15 0.03 OUTLIER Glycine 0 CA--C 1.524 0.621 0 N-CA-C 110.817 -0.913 . . . . 0.0 110.817 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.6 t -133.57 158.85 42.14 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.78 0.324 . . . . 0.0 110.296 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.421 ' O ' ' CG ' ' A' ' 40' ' ' GLU . 0.4 OUTLIER -51.67 -33.48 34.0 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.31 179.907 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.421 ' CG ' ' O ' ' A' ' 39' ' ' ASP . 2.9 mt-10 169.19 -179.19 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.236 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.493 ' CZ3' ' HG3' ' A' ' 67' ' ' ARG . 71.8 m95 -62.14 145.02 54.56 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.339 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.43 HG22 ' CZ ' ' A' ' 54' ' ' PHE . 27.3 m -122.85 2.04 6.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.159 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.425 ' CB ' ' OE2' ' A' ' 32' ' ' GLU . . . 60.07 137.86 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.344 0 CA-C-O 121.301 0.572 . . . . 0.0 111.3 179.322 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.474 ' H ' ' HA ' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -62.51 -167.13 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.372 179.733 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 49.9 m -150.85 125.32 9.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.358 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 13.6 ptmt -69.25 64.66 0.15 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.239 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -91.23 -34.18 7.7 Favored Glycine 0 CA--C 1.523 0.549 0 N-CA-C 110.814 -0.915 . . . . 0.0 110.814 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.427 ' HG2' ' CG2' ' A' ' 51' ' ' VAL . 4.4 tp10 -88.34 124.14 33.61 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.822 0.344 . . . . 0.0 110.503 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -71.56 76.28 0.66 Allowed Glycine 0 CA--C 1.522 0.507 0 N-CA-C 110.637 -0.985 . . . . 0.0 110.637 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 154.04 -36.75 0.71 Allowed Glycine 0 CA--C 1.522 0.49 0 N-CA-C 110.633 -0.987 . . . . 0.0 110.633 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.427 ' CG2' ' HG2' ' A' ' 48' ' ' GLU . 16.2 m -142.82 -176.7 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.95 0.405 . . . . 0.0 110.537 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . 0.466 ' CD1' HG12 ' A' ' 31' ' ' VAL . 5.4 m95 -96.33 131.67 42.62 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.637 -179.436 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.427 ' CG2' ' CB ' ' A' ' 18' ' ' ALA . 0.8 OUTLIER -130.29 147.07 51.96 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.404 -179.958 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.472 ' CG ' HD22 ' A' ' 33' ' ' LEU . 45.6 t80 -137.43 142.27 41.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.239 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -91.25 141.12 29.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.507 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.1 p -143.11 147.01 34.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.278 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -144.45 31.56 1.21 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.456 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -102.87 157.26 34.07 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.228 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -71.1 -32.52 13.07 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.603 2.202 . . . . 0.0 112.142 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.1 mt -80.6 102.3 9.72 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.336 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -138.87 132.79 31.02 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.477 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -177.63 -98.78 0.11 Allowed Glycine 0 CA--C 1.526 0.758 0 N-CA-C 110.644 -0.982 . . . . 0.0 110.644 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -81.38 164.88 18.96 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.609 2.206 . . . . 0.0 112.083 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -139.36 161.34 37.68 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.465 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.404 ' ND2' ' N ' ' A' ' 65' ' ' ASN . 1.2 m-80 -126.99 149.51 49.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.194 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.477 ' CD2' ' O ' ' A' ' 32' ' ' GLU . 85.1 m-85 -138.83 159.84 41.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.967 0.413 . . . . 0.0 111.071 -179.629 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.493 ' HG3' ' CZ3' ' A' ' 41' ' ' TRP . 10.0 mtp-105 -152.42 73.18 1.02 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.84 179.352 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.446 ' HA ' ' HA ' ' A' ' 31' ' ' VAL . 6.3 p90 -70.49 175.2 4.97 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.384 0.612 . . . . 0.0 111.023 -179.531 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.436 ' CD2' ' CG ' ' A' ' 75' ' ' LYS . 23.9 mt -146.88 57.58 1.16 Allowed 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.972 -1.013 . . . . 0.0 109.396 179.789 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 28.4 p -25.84 135.95 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.872 0.869 . . . . 0.0 112.487 -179.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.437 ' CG ' ' O ' ' A' ' 28' ' ' MET . 3.9 mm-40 -51.96 -23.95 5.78 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.599 -179.498 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 17.9 tptp -147.07 68.58 1.16 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.644 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -160.91 -103.82 0.19 Allowed Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.875 -0.89 . . . . 0.0 110.875 179.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -178.58 -176.69 0.5 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.89 0.376 . . . . 0.0 110.638 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.436 ' CG ' ' CD2' ' A' ' 69' ' ' LEU . 0.0 OUTLIER -93.2 172.96 7.97 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.345 -179.858 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 171.81 137.17 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.603 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 45.6 t -99.36 132.48 44.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 179.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.522 ' CE2' ' CG2' ' A' ' 4' ' ' VAL . 52.3 m-85 -117.28 139.8 50.36 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.5 -179.572 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -126.12 161.9 26.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.421 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 51.22 35.83 14.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.441 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.483 HG12 ' CD1' ' A' ' 6' ' ' PHE . 48.9 t -75.91 -2.55 4.23 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.816 179.757 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 84.0 t -154.12 131.63 6.21 Favored Pre-proline 0 CA--C 1.529 0.161 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.482 ' HG3' ' CE1' ' A' ' 92' ' ' TYR . 48.6 Cg_endo -75.22 178.68 6.99 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.516 2.144 . . . . 0.0 112.181 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -64.54 -57.52 8.92 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.12 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.93 73.72 0.83 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.171 179.717 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . 0.491 ' HB2' ' CE2' ' A' ' 92' ' ' TYR . 23.1 p90 -70.22 177.02 3.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.521 -179.854 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 2.7 m -137.27 119.23 15.31 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.094 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 4.3 mp -48.94 119.3 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.547 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 105.06 59.03 0.66 Allowed Glycine 0 CA--C 1.523 0.533 0 N-CA-C 110.591 -1.004 . . . . 0.0 110.591 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -170.75 146.23 2.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.896 0.379 . . . . 0.0 110.639 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.434 ' CG2' ' HB ' ' A' ' 5' ' ' THR . 8.5 m -93.43 122.99 36.42 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.046 179.696 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.491 ' CE2' ' HB2' ' A' ' 86' ' ' TYR . 69.9 m-85 -108.12 -87.55 0.49 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.791 -179.592 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.464 ' CB ' ' CD ' ' A' ' 94' ' ' PRO . . . 50.42 -179.97 0.01 OUTLIER Pre-proline 0 C--O 1.232 0.133 0 CA-C-O 120.641 0.257 . . . . 0.0 110.432 -179.781 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.464 ' CD ' ' CB ' ' A' ' 93' ' ' ALA . 49.3 Cg_endo . . . . . 0 C--O 1.25 1.075 0 C-N-CA 122.45 2.1 . . . . 0.0 111.937 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 4.5 mttm . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.809 0.338 . . . . 0.0 110.355 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.528 ' CG2' ' CE1' ' A' ' 78' ' ' PHE . 16.8 m -124.85 -176.39 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.424 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -165.14 148.04 8.18 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.235 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.571 ' CE2' ' CD2' ' A' ' 66' ' ' PHE . 48.2 m-85 -123.34 145.56 48.64 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.326 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.403 ' HB ' ' CB ' ' A' ' 20' ' ' LEU . 0.2 OUTLIER -129.3 -176.99 4.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.301 -179.942 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 39.8 t -128.14 87.42 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.4 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.403 ' HG3' HG13 ' A' ' 51' ' ' VAL . 1.3 mm-40 -52.27 147.92 7.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.275 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.27 63.16 0.35 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.371 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -154.39 23.32 0.66 Allowed Glycine 0 CA--C 1.525 0.682 0 N-CA-C 111.022 -0.831 . . . . 0.0 111.022 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 16.9 m -76.07 105.02 6.88 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.442 ' ND2' ' N ' ' A' ' 13' ' ' ASN . 0.4 OUTLIER -75.92 -178.48 4.35 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.096 -179.721 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -62.07 -36.6 82.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.466 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 4.9 ptmt -124.72 36.45 4.6 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.666 -179.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . 0.421 ' HB2' ' CB ' ' A' ' 13' ' ' ASN . 13.2 m80 -136.09 -176.27 4.26 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.844 0.354 . . . . 0.0 110.563 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 32.1 tp -167.07 85.61 0.26 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.269 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -81.33 107.29 13.99 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.58 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.424 HG22 ' CG2' ' A' ' 21' ' ' VAL . 17.8 m -88.99 -170.66 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.163 179.698 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.403 ' CB ' ' HB ' ' A' ' 7' ' ' THR . 1.9 tt -142.4 57.68 1.45 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.308 179.67 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.477 HG23 ' CE2' ' A' ' 6' ' ' PHE . 4.9 t -72.17 114.72 11.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.463 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.93 164.03 20.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.318 179.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.47 ' CE2' HG13 ' A' ' 4' ' ' VAL . 0.4 OUTLIER 174.05 150.05 0.08 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.372 -179.995 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -79.79 -26.89 40.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.485 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -53.56 -75.84 0.21 Allowed Glycine 0 CA--C 1.524 0.625 0 N-CA-C 110.826 -0.91 . . . . 0.0 110.826 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -93.77 -164.21 1.15 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.794 0.33 . . . . 0.0 110.428 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.07 -158.31 0.82 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.415 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.422 ' O ' ' CG ' ' A' ' 71' ' ' GLU . 47.1 mtm -132.25 126.82 34.37 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.704 -179.76 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.426 ' HB1' ' N ' ' A' ' 71' ' ' GLU . . . -125.9 -44.04 1.8 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.083 179.722 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.404 ' O ' ' HB2' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -164.27 168.93 18.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.89 -0.596 . . . . 0.0 109.526 179.712 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 8.9 t -154.11 136.48 6.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.901 0.381 . . . . 0.0 110.975 -179.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.43 ' CB ' ' HA ' ' A' ' 43' ' ' ALA . 3.3 pt-20 -134.08 138.06 45.03 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 178.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.434 HD21 ' CB ' ' A' ' 54' ' ' PHE . 13.4 tp -118.24 155.6 30.26 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 121.157 0.503 . . . . 0.0 110.854 -178.015 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.473 ' NH1' ' CB ' ' A' ' 38' ' ' SER . 0.0 OUTLIER -136.75 -156.97 0.74 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.325 178.946 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.415 ' O ' ' ND2' ' A' ' 65' ' ' ASN . 1.5 mp0 -153.35 -79.72 0.1 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.696 0.284 . . . . 0.0 110.559 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 177.18 119.32 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.79 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 52.64 63.75 4.68 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 111.165 -0.774 . . . . 0.0 111.165 179.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.473 ' CB ' ' NH1' ' A' ' 34' ' ' ARG . 0.3 OUTLIER -111.31 -70.08 0.83 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.946 0.403 . . . . 0.0 110.289 179.797 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 25.4 t0 179.59 -63.3 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.119 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -157.04 163.0 39.53 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.344 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.481 ' CZ2' ' HG3' ' A' ' 67' ' ' ARG . 94.3 m95 -57.57 146.89 28.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.695 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.42 HG12 ' NH2' ' A' ' 34' ' ' ARG . 2.8 m -129.31 107.92 16.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.43 ' HA ' ' CB ' ' A' ' 32' ' ' GLU . . . -45.96 140.86 3.44 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.777 -179.546 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.414 ' HE1' ' CZ ' ' A' ' 66' ' ' PHE . 0.0 OUTLIER -63.02 -170.89 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.539 -179.72 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 86.6 m -138.8 98.84 3.64 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.326 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 13.0 ptmt -67.01 79.29 0.12 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.509 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -128.29 24.87 4.94 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.76 -0.936 . . . . 0.0 110.76 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.434 ' CB ' HG21 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -107.59 175.8 5.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.801 0.334 . . . . 0.0 110.38 179.978 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -60.25 -43.92 98.0 Favored Glycine 0 CA--C 1.523 0.562 0 N-CA-C 110.572 -1.011 . . . . 0.0 110.572 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -160.52 27.6 0.32 Allowed Glycine 0 CA--C 1.524 0.619 0 N-CA-C 110.828 -0.909 . . . . 0.0 110.828 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.434 HG21 ' CB ' ' A' ' 48' ' ' GLU . 14.7 m -143.13 -175.81 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.8 0.333 . . . . 0.0 110.369 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 6.7 m95 -109.29 141.94 40.88 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.712 -179.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -125.81 159.38 32.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.924 179.533 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.434 ' CB ' HD21 ' A' ' 33' ' ' LEU . 68.1 t80 -144.09 133.68 23.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.845 0.355 . . . . 0.0 110.511 -179.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -84.9 128.61 34.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.364 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -122.54 154.15 38.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.379 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -162.22 50.73 0.2 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.467 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -128.71 156.38 77.63 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.569 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -66.99 -28.28 41.95 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.897 2.398 . . . . 0.0 112.123 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -80.06 163.43 24.18 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.28 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -175.29 44.74 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.49 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -83.01 -132.68 1.9 Allowed Glycine 0 CA--C 1.527 0.808 0 N-CA-C 110.36 -1.096 . . . . 0.0 110.36 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -75.29 141.3 25.67 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.355 2.037 . . . . 0.0 111.8 179.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 44.8 m-85 -97.62 153.0 18.49 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.529 -179.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.415 ' ND2' ' O ' ' A' ' 35' ' ' GLU . 6.2 m-80 -124.79 126.23 45.29 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.026 -0.533 . . . . 0.0 109.913 179.581 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.571 ' CD2' ' CE2' ' A' ' 6' ' ' PHE . 2.7 m-85 -104.74 -178.25 3.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.654 -179.573 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.481 ' HG3' ' CZ2' ' A' ' 41' ' ' TRP . 0.0 OUTLIER 175.27 77.85 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.997 179.975 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.404 ' HB2' ' O ' ' A' ' 30' ' ' GLU . 1.4 p90 -84.75 164.08 18.75 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.222 0.534 . . . . 0.0 110.975 -179.653 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.42 ' O ' ' CB ' ' A' ' 29' ' ' ALA . 9.1 mt -109.75 64.26 0.61 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.283 -0.872 . . . . 0.0 108.861 178.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.406 ' OG1' ' HA3' ' A' ' 73' ' ' GLY . 0.8 OUTLIER -33.77 138.06 0.09 Allowed 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 115.552 -0.749 . . . . 0.0 112.206 -178.833 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.426 ' N ' ' HB1' ' A' ' 29' ' ' ALA . 19.0 mt-10 -49.02 -28.13 3.74 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.958 -179.543 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.01 26.64 0.31 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.678 0.275 . . . . 0.0 111.127 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.422 ' O ' ' CB ' ' A' ' 74' ' ' MET . . . -97.15 -36.46 4.94 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 110.381 -1.088 . . . . 0.0 110.381 179.67 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.422 ' CB ' ' O ' ' A' ' 73' ' ' GLY . 0.0 OUTLIER 82.25 70.8 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 120.85 0.357 . . . . 0.0 111.089 179.443 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 48.98 -179.29 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.198 179.209 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.49 ' HB3' ' CE2' ' A' ' 78' ' ' PHE . 0.3 OUTLIER 167.65 128.45 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.882 179.886 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 77.5 t -95.31 137.54 23.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.013 0.435 . . . . 0.0 110.525 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.528 ' CE1' ' CG2' ' A' ' 4' ' ' VAL . 92.4 m-85 -133.39 144.46 49.58 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.494 -179.781 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -133.58 161.49 34.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.194 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 54.02 30.28 11.57 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.94 0.4 . . . . 0.0 110.138 -179.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 87.4 t -64.48 -15.97 18.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.2 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 44.6 t -146.72 132.5 9.36 Favored Pre-proline 0 C--N 1.332 -0.19 0 CA-C-O 120.506 0.193 . . . . 0.0 110.565 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.461 ' CD ' ' CD1' ' A' ' 92' ' ' TYR . 50.6 Cg_endo -75.44 165.81 29.93 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.561 2.174 . . . . 0.0 111.899 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -66.12 126.54 28.98 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.293 -0.412 . . . . 0.0 109.989 179.651 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 24.7 mtmt 60.17 50.12 6.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.942 0.401 . . . . 0.0 109.924 -179.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 51.3 p90 -47.56 158.96 0.16 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.967 -179.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 29.1 m -124.04 108.85 12.8 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.035 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 2.7 mp -47.98 107.64 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.626 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 132.7 44.76 0.14 Allowed Glycine 0 CA--C 1.523 0.565 0 N-CA-C 110.449 -1.061 . . . . 0.0 110.449 -179.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -163.29 156.41 19.01 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.99 101.68 11.23 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.722 -179.78 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.461 ' CD1' ' CD ' ' A' ' 83' ' ' PRO . 32.7 m-85 -87.98 -160.17 0.6 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.868 179.563 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.441 ' CB ' ' HD2' ' A' ' 94' ' ' PRO . . . 66.82 176.58 0.06 OUTLIER Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 120.721 0.296 . . . . 0.0 110.578 179.653 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.441 ' HD2' ' CB ' ' A' ' 93' ' ' ALA . 47.7 Cg_endo . . . . . 0 C--O 1.249 1.056 0 C-N-CA 122.567 2.178 . . . . 0.0 112.04 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 8.4 mtmt . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.864 0.364 . . . . 0.0 110.272 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.525 ' CG1' ' CE1' ' A' ' 78' ' ' PHE . 1.7 p -149.32 164.24 4.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.301 0.572 . . . . 0.0 110.215 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.477 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 0.6 OUTLIER -156.99 133.41 9.89 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.516 179.775 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.48 ' CD2' ' HB ' ' A' ' 21' ' ' VAL . 8.2 m-85 -109.77 179.29 4.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.092 -0.504 . . . . 0.0 109.893 179.535 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.5 m -166.23 128.32 1.89 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.846 0.355 . . . . 0.0 110.335 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 29.2 t -70.0 87.51 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.189 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.446 ' CG ' HG22 ' A' ' 51' ' ' VAL . 1.2 mm-40 -58.28 166.09 1.78 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.436 -179.756 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.6 mppt? -54.53 -21.84 11.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.83 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -45.14 -37.43 5.81 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 111.269 -0.733 . . . . 0.0 111.269 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 13.3 m -68.19 124.97 24.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.778 0.323 . . . . 0.0 110.348 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -133.93 -52.74 0.85 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.516 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -146.72 -76.78 0.19 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.658 -179.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 14.4 mmmt -99.32 25.58 6.79 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.462 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 31.4 m80 -125.38 147.51 49.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.451 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -133.44 91.53 2.87 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.0 0.428 . . . . 0.0 110.366 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.437 ' CB ' HG13 ' A' ' 51' ' ' VAL . . . -92.12 131.99 36.94 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.16 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.424 ' N ' ' CG1' ' A' ' 51' ' ' VAL . 14.5 m -127.5 135.33 63.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.847 0.356 . . . . 0.0 110.596 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.3 tt -91.98 67.2 5.14 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.036 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.527 ' CG1' ' CD1' ' A' ' 52' ' ' TRP . 2.2 p -82.19 110.2 17.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 179.395 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 30.3 tttm -178.06 111.13 0.07 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.33 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 29.3 p90 -136.56 151.21 49.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.441 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -50.78 172.99 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.526 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 76.05 -84.8 0.91 Allowed Glycine 0 CA--C 1.523 0.557 0 N-CA-C 110.753 -0.939 . . . . 0.0 110.753 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -64.62 179.11 0.66 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.734 0.302 . . . . 0.0 110.344 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -133.08 178.65 6.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.488 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.422 ' O ' ' CG ' ' A' ' 71' ' ' GLU . 0.1 OUTLIER -105.55 120.42 41.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.26 179.963 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.439 ' HB1' ' N ' ' A' ' 71' ' ' GLU . . . -130.65 -50.68 1.06 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.823 -179.69 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.409 ' CG ' ' O ' ' A' ' 29' ' ' ALA . 29.1 mt-10 -159.23 150.51 20.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.999 0.428 . . . . 0.0 110.848 -179.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 20.3 t -140.43 142.89 30.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.679 179.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.454 ' CB ' ' HA ' ' A' ' 43' ' ' ALA . 1.9 pt-20 -148.77 137.43 21.3 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.875 0.369 . . . . 0.0 110.475 -179.759 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.485 ' HG ' ' CE1' ' A' ' 66' ' ' PHE . 3.9 mt -89.84 173.18 8.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.139 -179.424 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.446 ' O ' ' CB ' ' A' ' 35' ' ' GLU . 20.2 ttt180 -121.49 -63.3 1.33 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.477 179.261 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.448 ' O ' ' N ' ' A' ' 37' ' ' GLY . 14.0 mt-10 89.62 23.65 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 123.555 0.742 . . . . 0.0 109.961 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 58.49 -76.98 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.332 179.427 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.448 ' N ' ' O ' ' A' ' 35' ' ' GLU . . . -48.38 -65.24 2.66 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 111.119 -0.792 . . . . 0.0 111.119 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -49.34 101.3 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.808 0.337 . . . . 0.0 110.591 -179.844 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -59.79 -28.91 67.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.338 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -94.1 129.4 40.67 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.308 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.438 ' CZ3' ' HB2' ' A' ' 34' ' ' ARG . 80.6 m95 -66.39 141.28 58.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.591 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.425 HG22 ' CE1' ' A' ' 54' ' ' PHE . 35.8 m -111.77 111.66 37.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.969 179.706 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.454 ' HA ' ' CB ' ' A' ' 32' ' ' GLU . . . -49.33 141.54 8.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.845 -179.601 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.427 ' HE3' ' CD1' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -70.53 -167.66 0.2 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.121 179.767 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 85.8 m -156.28 98.24 1.83 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.502 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.51 90.47 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.107 179.749 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -112.39 -17.89 7.92 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 111.384 -0.686 . . . . 0.0 111.384 -179.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.439 ' CB ' ' HB ' ' A' ' 51' ' ' VAL . 17.7 tp10 -77.78 -28.69 50.61 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.852 0.326 . . . . 0.0 110.719 -179.706 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 112.55 -39.74 2.76 Favored Glycine 0 CA--C 1.52 0.401 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 -179.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -137.14 16.16 3.68 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 178.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.446 HG22 ' CG ' ' A' ' 9' ' ' GLU . 50.4 t -149.01 147.12 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . 0.527 ' CD1' ' CG1' ' A' ' 21' ' ' VAL . 2.0 m95 -89.87 111.78 22.93 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.282 -179.506 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 4.9 p -99.76 151.05 21.69 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.501 -179.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.425 ' CE1' HG22 ' A' ' 42' ' ' VAL . 57.0 t80 -139.33 151.24 46.22 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.138 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -106.88 129.88 54.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.714 -179.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 14.3 t -127.98 156.03 43.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.11 179.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -156.86 37.48 0.31 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.437 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -124.79 154.33 70.58 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.441 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -72.89 -41.43 1.43 Allowed 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.644 2.229 . . . . 0.0 111.926 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -71.54 77.14 0.8 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.49 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -116.35 89.39 3.1 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.492 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -98.76 -131.79 7.4 Favored Glycine 0 CA--C 1.527 0.79 0 N-CA-C 110.438 -1.065 . . . . 0.0 110.438 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -75.03 145.69 31.65 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.375 2.05 . . . . 0.0 111.767 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.426 ' HB3' ' CD2' ' A' ' 33' ' ' LEU . 56.1 m-85 -97.11 100.71 12.19 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.933 0.396 . . . . 0.0 110.345 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.429 ' OD1' ' N ' ' A' ' 65' ' ' ASN . 0.3 OUTLIER -78.27 141.33 38.6 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.949 -0.568 . . . . 0.0 109.781 179.952 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.485 ' CE1' ' HG ' ' A' ' 33' ' ' LEU . 92.7 m-85 -128.71 -177.45 4.2 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.046 0.451 . . . . 0.0 110.532 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 178.35 52.22 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.691 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -49.98 169.23 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.727 -179.671 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.405 ' O ' ' CB ' ' A' ' 29' ' ' ALA . 1.1 mt -123.95 72.87 1.18 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.213 179.613 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 71.6 p -35.17 137.59 0.15 Allowed 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.783 -179.201 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.439 ' N ' ' HB1' ' A' ' 29' ' ' ALA . 4.8 mm-40 -45.83 -55.1 7.05 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.951 -179.558 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 41.4 tptt -138.85 77.83 1.64 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.528 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -163.42 -91.13 0.08 OUTLIER Glycine 0 CA--C 1.523 0.583 0 N-CA-C 110.57 -1.012 . . . . 0.0 110.57 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER 176.76 172.69 0.44 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.892 0.377 . . . . 0.0 110.459 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.45 145.09 35.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.216 179.848 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -138.75 140.72 38.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.568 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.427 HG11 ' N ' ' A' ' 78' ' ' PHE . 95.5 t -85.54 152.82 3.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.334 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.525 ' CE1' ' CG1' ' A' ' 4' ' ' VAL . 32.6 m-85 -138.46 120.78 15.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.227 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 30.8 p-10 -117.26 48.37 1.35 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.676 -179.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 167.34 65.96 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.419 ' HA ' ' HA ' ' A' ' 93' ' ' ALA . 70.3 t -111.68 -10.07 11.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.564 -178.727 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.406 ' CG2' ' O ' ' A' ' 81' ' ' VAL . 86.9 t -156.04 131.7 5.58 Favored Pre-proline 0 C--N 1.331 -0.197 0 CA-C-O 120.648 0.261 . . . . 0.0 110.765 179.511 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.487 ' HD3' ' CD1' ' A' ' 92' ' ' TYR . 47.5 Cg_endo -68.74 -165.65 0.14 Allowed 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.807 2.338 . . . . 0.0 111.875 179.461 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -77.22 -38.09 52.0 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.15 -0.477 . . . . 0.0 109.852 179.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 1.1 mttt -123.31 74.92 1.27 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.959 179.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 24.5 p90 -47.38 171.02 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.954 -179.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -149.4 109.75 4.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.147 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 2.9 mp -52.69 122.11 2.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.526 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 102.29 42.67 2.16 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 110.936 -0.866 . . . . 0.0 110.936 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -160.07 129.64 5.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.85 0.357 . . . . 0.0 110.57 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 15.1 m -81.4 128.36 33.77 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.136 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.487 ' CD1' ' HD3' ' A' ' 83' ' ' PRO . 63.3 m-85 -111.97 -93.09 0.46 Allowed 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.876 -179.58 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.419 ' HA ' ' HA ' ' A' ' 81' ' ' VAL . . . 53.26 172.35 0.04 OUTLIER Pre-proline 0 N--CA 1.462 0.157 0 CA-C-O 120.852 0.358 . . . . 0.0 110.419 -179.661 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo . . . . . 0 C--O 1.249 1.055 0 C-N-CA 122.783 2.322 . . . . 0.0 112.127 -179.914 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.888 0.375 . . . . 0.0 110.239 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.512 ' CG2' ' CE1' ' A' ' 78' ' ' PHE . 35.9 m -85.43 -175.56 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.547 -179.799 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -166.52 151.25 7.73 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.175 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 51.4 m-85 -119.51 165.59 14.2 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.352 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.2 m -159.35 119.38 3.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.402 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 55.6 t -63.85 104.78 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.349 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.428 ' HG3' ' CG1' ' A' ' 51' ' ' VAL . 3.5 mm-40 -74.52 156.95 36.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.452 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 8.5 mttt -52.06 163.83 0.33 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.313 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 82.99 27.46 40.95 Favored Glycine 0 CA--C 1.523 0.54 0 N-CA-C 110.684 -0.966 . . . . 0.0 110.684 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 86.3 p -81.16 114.3 19.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.776 0.322 . . . . 0.0 110.346 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 47.2 m-80 -107.86 179.97 4.07 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.321 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -67.92 -29.82 68.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.41 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 10.4 mmmm -98.35 -44.65 6.45 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.478 -179.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 18.0 m80 -80.4 162.11 24.63 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.743 -179.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.489 ' HG ' ' CE2' ' A' ' 64' ' ' PHE . 2.3 tm? -155.95 77.32 0.95 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.754 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.402 ' HB3' ' CG2' ' A' ' 53' ' ' THR . . . -69.52 140.31 53.91 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.84 -179.427 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 24.6 m -127.85 -178.2 2.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.793 -0.639 . . . . 0.0 109.682 179.544 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.0 tt -134.95 80.42 1.84 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.833 0.349 . . . . 0.0 110.362 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.9 t -90.13 96.21 6.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.33 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 39.5 mttt -148.86 145.79 27.65 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.397 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 2.2 p90 179.0 159.89 0.64 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.272 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -58.91 -175.92 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.425 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 72.53 -90.31 0.54 Allowed Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.66 -0.976 . . . . 0.0 110.66 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -68.1 168.1 12.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.733 0.302 . . . . 0.0 110.348 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.429 ' O ' ' CG2' ' A' ' 27' ' ' THR . 36.7 m -134.68 35.65 3.14 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.925 0.393 . . . . 0.0 110.647 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.423 ' O ' ' CG ' ' A' ' 71' ' ' GLU . 0.0 OUTLIER 61.4 120.85 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.829 179.639 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.429 ' CB ' ' HG2' ' A' ' 71' ' ' GLU . . . -126.26 -51.73 1.52 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.09 179.531 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -157.59 169.26 25.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.868 -0.606 . . . . 0.0 109.737 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.453 HG22 ' CD1' ' A' ' 52' ' ' TRP . 3.2 t -150.6 139.57 15.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.179 0.514 . . . . 0.0 110.775 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -132.73 144.87 50.57 Favored 'General case' 0 N--CA 1.436 -1.126 0 CA-C-N 115.408 -0.814 . . . . 0.0 109.613 -179.217 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.484 HD23 ' CZ ' ' A' ' 66' ' ' PHE . 2.4 mt -121.59 175.22 6.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.398 0.618 . . . . 0.0 111.429 -179.32 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.451 ' HB2' ' CE3' ' A' ' 41' ' ' TRP . 27.5 ttt180 -167.16 162.77 15.39 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.03 -0.986 . . . . 0.0 109.149 179.581 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.428 ' N ' ' HG2' ' A' ' 34' ' ' ARG . 40.8 mt-10 -120.31 -85.1 0.66 Allowed 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 179.869 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . 0.402 ' HB2' ' O ' ' A' ' 35' ' ' GLU . 3.3 t60 179.8 -56.43 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.307 179.374 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -106.06 56.54 0.51 Allowed Glycine 0 CA--C 1.523 0.566 0 N-CA-C 110.616 -0.994 . . . . 0.0 110.616 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 23.1 t -130.76 -160.71 1.06 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.847 0.356 . . . . 0.0 110.386 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -87.23 52.4 2.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.298 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 66.83 -174.63 0.19 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.246 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.456 ' CE3' ' HG2' ' A' ' 67' ' ' ARG . 88.3 m95 -47.97 142.45 5.01 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.722 -179.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 16.8 m -107.07 -142.3 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 179.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -156.27 130.64 8.78 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.51 -179.77 1.14 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.724 0.297 . . . . 0.0 110.532 -179.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 89.8 m -151.43 123.36 8.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.505 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.476 ' HB3' ' CZ3' ' A' ' 52' ' ' TRP . 0.0 OUTLIER -83.62 97.41 9.05 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.363 179.919 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -148.1 23.8 1.42 Allowed Glycine 0 CA--C 1.524 0.601 0 N-CA-C 111.095 -0.802 . . . . 0.0 111.095 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -100.6 -31.59 11.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.8 0.334 . . . . 0.0 110.225 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 96.18 27.9 9.69 Favored Glycine 0 CA--C 1.522 0.525 0 N-CA-C 110.801 -0.92 . . . . 0.0 110.801 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 166.6 -34.47 0.23 Allowed Glycine 0 CA--C 1.523 0.59 0 N-CA-C 110.811 -0.916 . . . . 0.0 110.811 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.428 ' CG1' ' HG3' ' A' ' 9' ' ' GLU . 4.8 m -126.33 -178.38 2.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.875 0.369 . . . . 0.0 110.508 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . 0.476 ' CZ3' ' HB3' ' A' ' 46' ' ' LYS . 7.5 m95 -110.6 142.68 42.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.346 -179.82 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.402 ' CG2' ' HB3' ' A' ' 18' ' ' ALA . 0.8 OUTLIER -134.15 152.05 51.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.314 179.987 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 87.8 t80 -147.31 147.66 30.59 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.43 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -93.87 120.57 34.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.374 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -142.78 175.58 9.71 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.371 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -131.69 -64.66 0.78 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.011 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 48.58 104.34 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 115.982 -0.553 . . . . 0.0 111.458 179.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -64.0 -16.71 56.47 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.345 2.03 . . . . 0.0 111.34 178.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.418 HD11 ' N ' ' A' ' 60' ' ' LEU . 7.1 mp -75.22 -171.31 1.38 Allowed 'General case' 0 C--O 1.232 0.142 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.99 179.509 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 4.9 mp0 -60.43 -79.02 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 179.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.477 ' N ' ' HD3' ' A' ' 63' ' ' PRO . . . -175.5 58.63 0.11 Allowed Glycine 0 CA--C 1.527 0.798 0 N-CA-C 111.276 -0.73 . . . . 0.0 111.276 179.425 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.477 ' HD3' ' N ' ' A' ' 62' ' ' GLY . 51.7 Cg_endo -88.23 108.05 0.56 Allowed 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.798 2.332 . . . . 0.0 111.984 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.489 ' CE2' ' HG ' ' A' ' 17' ' ' LEU . 53.5 m-85 -109.73 166.63 10.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.133 0.492 . . . . 0.0 110.704 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -150.48 129.18 12.35 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.559 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.484 ' CZ ' HD23 ' A' ' 33' ' ' LEU . 33.3 m-85 -115.41 174.87 5.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.104 0.478 . . . . 0.0 111.097 -179.323 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.456 ' HG2' ' CE3' ' A' ' 41' ' ' TRP . 0.0 OUTLIER -175.24 50.34 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.704 179.849 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -56.44 172.79 0.21 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.108 -179.286 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.427 ' O ' ' CB ' ' A' ' 29' ' ' ALA . 7.0 mt -124.86 73.54 1.29 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.282 179.627 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 22.8 p -38.22 142.97 0.14 Allowed 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.803 -179.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.429 ' HG2' ' CB ' ' A' ' 29' ' ' ALA . 3.5 mm-40 -51.47 -43.84 62.25 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.302 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.32 -39.27 69.75 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.316 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 108.97 46.67 0.93 Allowed Glycine 0 CA--C 1.522 0.508 0 N-CA-C 110.574 -1.01 . . . . 0.0 110.574 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 42.3 mtt -136.5 79.43 1.76 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.823 0.344 . . . . 0.0 110.62 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.36 -178.82 7.2 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.191 179.722 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.449 ' O ' ' CE2' ' A' ' 78' ' ' PHE . 0.5 OUTLIER 174.62 140.0 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.472 179.893 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 88.9 t -81.08 144.52 10.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.322 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.512 ' CE1' ' CG2' ' A' ' 4' ' ' VAL . 38.1 m-85 -127.77 126.02 40.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.177 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -93.87 139.77 30.49 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.644 -179.655 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . 0.445 ' O ' ' HB ' ' A' ' 81' ' ' VAL . 0.1 OUTLIER 69.19 -77.05 0.05 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.593 179.756 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.445 ' HB ' ' O ' ' A' ' 80' ' ' ASP . 53.5 t 70.68 -54.47 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 C-N-CA 123.682 0.793 . . . . 0.0 110.653 -179.575 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.437 ' CG1' ' HD2' ' A' ' 83' ' ' PRO . 93.8 t -105.69 140.78 21.53 Favored Pre-proline 0 C--N 1.325 -0.484 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 179.639 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.458 ' HG3' ' CE1' ' A' ' 92' ' ' TYR . 45.1 Cg_endo -71.27 -169.68 0.43 Allowed 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.579 2.186 . . . . 0.0 112.107 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -72.07 -64.42 0.94 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.237 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 14.4 mmtp -108.03 82.98 1.72 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.099 179.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . 0.478 ' HB2' ' CE2' ' A' ' 92' ' ' TYR . 26.5 p90 -71.87 171.28 12.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.58 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 4.5 m -151.52 128.66 11.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.089 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 36.3 mm -50.86 96.41 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.449 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 132.23 48.98 0.1 Allowed Glycine 0 CA--C 1.524 0.598 0 N-CA-C 110.844 -0.902 . . . . 0.0 110.844 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.416 ' HB1' ' CZ ' ' A' ' 92' ' ' TYR . . . -155.72 135.62 12.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.813 0.34 . . . . 0.0 110.362 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 28.7 m -93.42 91.24 7.07 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.418 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.478 ' CE2' ' HB2' ' A' ' 86' ' ' TYR . 30.4 m-85 -82.77 -161.27 0.47 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.202 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.449 ' CB ' ' CD ' ' A' ' 94' ' ' PRO . . . 74.63 177.84 0.06 OUTLIER Pre-proline 0 C--N 1.331 -0.208 0 CA-C-O 120.798 0.333 . . . . 0.0 110.635 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.449 ' CD ' ' CB ' ' A' ' 93' ' ' ALA . 48.5 Cg_endo . . . . . 0 C--O 1.248 0.996 0 C-N-CA 122.648 2.232 . . . . 0.0 112.037 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 19.2 mttt . . . . . 0 CA--C 1.522 -0.109 0 CA-C-O 120.868 0.365 . . . . 0.0 110.251 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.528 ' CG1' ' CE1' ' A' ' 78' ' ' PHE . 1.7 p 177.94 164.06 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.174 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.471 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 1.1 p -157.79 128.36 6.38 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.457 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.432 ' CE2' HG22 ' A' ' 21' ' ' VAL . 10.3 m-85 -102.72 177.84 4.74 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.122 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.419 ' O ' ' N ' ' A' ' 9' ' ' GLU . 0.3 OUTLIER -166.13 112.43 0.87 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.361 -179.851 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 14.0 t -57.61 85.52 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.397 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.433 ' CG ' ' HB2' ' A' ' 20' ' ' LEU . 3.6 mm-40 -60.55 161.19 7.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.348 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -56.28 177.59 0.06 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.494 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 77.5 13.24 83.74 Favored Glycine 0 CA--C 1.527 0.805 0 N-CA-C 111.455 -0.658 . . . . 0.0 111.455 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 19.1 m -86.91 109.35 19.27 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.909 0.354 . . . . 0.0 110.051 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.427 ' O ' ' N ' ' A' ' 15' ' ' LYS . 4.6 p-10 -153.28 158.95 42.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.916 0.388 . . . . 0.0 110.806 -179.622 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 54.25 -85.96 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.835 179.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.427 ' N ' ' O ' ' A' ' 13' ' ' ASN . 0.0 OUTLIER -142.49 22.91 1.99 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.622 0.249 . . . . 0.0 110.745 -179.882 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -98.06 120.09 37.85 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 179.743 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.421 ' HG ' ' CE2' ' A' ' 64' ' ' PHE . 0.2 OUTLIER -113.3 98.42 7.1 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.054 0.455 . . . . 0.0 110.772 -179.499 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.453 ' CB ' HG13 ' A' ' 51' ' ' VAL . . . -86.76 138.83 31.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.027 179.572 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.444 ' N ' HG12 ' A' ' 51' ' ' VAL . 26.9 m -141.93 139.8 30.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.869 0.366 . . . . 0.0 110.816 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.433 ' HB2' ' CG ' ' A' ' 9' ' ' GLU . 0.5 OUTLIER -99.41 34.85 2.08 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.517 179.937 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.53 ' CG1' ' CD1' ' A' ' 52' ' ' TRP . 7.2 p -57.02 109.74 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 120.854 0.359 . . . . 0.0 110.521 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -179.59 77.68 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.243 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.485 ' CE2' ' HB ' ' A' ' 4' ' ' VAL . 25.7 p90 -84.63 -179.89 7.23 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.562 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -47.68 -68.28 0.2 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.874 -179.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -56.3 -20.26 28.44 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 111.207 -0.757 . . . . 0.0 111.207 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.479 ' HB2' ' CZ ' ' A' ' 23' ' ' TYR . 5.4 t70 -90.07 137.92 31.94 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.763 0.316 . . . . 0.0 110.594 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.434 ' O ' ' CG2' ' A' ' 27' ' ' THR . 88.5 m -124.63 11.08 8.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.104 179.694 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.413 ' O ' ' CG ' ' A' ' 71' ' ' GLU . 28.6 mtm 58.03 112.63 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.815 0.341 . . . . 0.0 110.625 179.654 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.429 ' CB ' ' O ' ' A' ' 69' ' ' LEU . . . -131.92 -49.06 0.95 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.584 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -176.02 83.56 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.81 0.338 . . . . 0.0 110.907 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.474 HG23 ' CD1' ' A' ' 52' ' ' TRP . 18.5 t -68.45 155.0 7.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.15 179.589 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.46 ' CB ' ' HA ' ' A' ' 43' ' ' ALA . 4.5 pt-20 -147.14 142.09 26.96 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.839 0.352 . . . . 0.0 110.639 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.423 ' HG ' ' CE1' ' A' ' 66' ' ' PHE . 4.2 mt -103.49 -178.41 3.65 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.445 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.477 ' HB2' ' CZ3' ' A' ' 41' ' ' TRP . 6.4 ttt180 -132.85 -64.95 0.73 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.591 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.446 ' CB ' ' O ' ' A' ' 34' ' ' ARG . 23.3 mt-10 92.5 33.65 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.669 0.788 . . . . 0.0 109.187 -179.195 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 3.0 t-80 67.54 -68.81 0.15 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.487 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -157.34 57.87 0.36 Allowed Glycine 0 CA--C 1.523 0.578 0 N-CA-C 110.595 -1.002 . . . . 0.0 110.595 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.415 ' CB ' ' HB2' ' A' ' 35' ' ' GLU . 34.1 t -92.47 -46.17 7.78 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.77 0.319 . . . . 0.0 110.335 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 47.6 p-10 -177.51 52.65 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.537 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 62.51 -177.32 0.14 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.47 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.503 ' CH2' ' HG3' ' A' ' 67' ' ' ARG . 93.7 m95 -60.27 129.88 43.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.533 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.414 HG22 ' CE1' ' A' ' 54' ' ' PHE . 25.1 m -122.76 116.44 48.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.125 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.46 ' HA ' ' CB ' ' A' ' 32' ' ' GLU . . . -56.08 140.28 44.29 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.47 -179.779 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.56 -167.65 0.2 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.173 -0.467 . . . . 0.0 109.953 179.787 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 91.4 m -153.62 127.15 8.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.864 0.364 . . . . 0.0 110.654 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 11.8 ptpt -73.18 77.2 1.28 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.03 179.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -93.22 -25.79 18.08 Favored Glycine 0 CA--C 1.522 0.516 0 N-CA-C 111.169 -0.772 . . . . 0.0 111.169 -179.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.461 ' CB ' ' HB ' ' A' ' 51' ' ' VAL . 2.9 mm-40 -86.95 -18.93 29.58 Favored 'General case' 0 C--N 1.33 -0.249 0 O-C-N 122.759 -0.259 . . . . 0.0 111.284 -179.483 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 96.48 -42.34 2.24 Favored Glycine 0 CA--C 1.523 0.539 0 N-CA-C 110.333 -1.107 . . . . 0.0 110.333 -179.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.42 ' O ' ' CG2' ' A' ' 51' ' ' VAL . . . -132.73 23.36 3.98 Favored Glycine 0 CA--C 1.522 0.51 0 N-CA-C 109.806 -1.318 . . . . 0.0 109.806 179.161 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.461 ' HB ' ' CB ' ' A' ' 48' ' ' GLU . 42.0 t -159.0 145.57 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 -179.621 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . 0.53 ' CD1' ' CG1' ' A' ' 21' ' ' VAL . 1.7 m95 -94.02 117.47 30.15 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.966 0.412 . . . . 0.0 110.607 -179.027 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 3.2 p -110.36 139.55 45.44 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.029 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.414 ' CE1' HG22 ' A' ' 42' ' ' VAL . 58.1 t80 -117.69 142.24 47.47 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.867 0.365 . . . . 0.0 110.611 -179.762 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -103.68 104.86 14.95 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.183 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -84.57 143.94 28.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.532 -179.813 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -112.35 1.83 16.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.122 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -121.96 156.71 59.24 Favored Pre-proline 0 C--O 1.231 0.099 0 CA-C-O 120.668 0.271 . . . . 0.0 110.361 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -70.85 -29.85 18.09 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.691 2.261 . . . . 0.0 112.18 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -81.73 134.1 35.41 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.42 -179.838 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -174.05 40.39 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.325 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -58.19 -93.07 0.01 OUTLIER Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.849 -0.9 . . . . 0.0 110.849 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -79.74 136.63 12.2 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.584 2.189 . . . . 0.0 112.053 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.421 ' CE2' ' HG ' ' A' ' 17' ' ' LEU . 49.8 m-85 -107.73 149.46 28.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.638 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -125.81 116.32 21.39 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 179.013 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.423 ' CE1' ' HG ' ' A' ' 33' ' ' LEU . 29.6 m-85 -100.65 171.11 7.91 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.29 0.566 . . . . 0.0 111.608 -178.706 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.503 ' HG3' ' CH2' ' A' ' 41' ' ' TRP . 0.0 OUTLIER -162.65 83.27 0.53 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.978 179.24 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.43 ' CE2' ' CE2' ' A' ' 78' ' ' PHE . 5.2 p90 -70.87 167.59 18.64 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.432 0.634 . . . . 0.0 111.045 -179.5 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.429 ' O ' ' CB ' ' A' ' 29' ' ' ALA . 4.2 mt -138.82 55.69 1.72 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.966 -1.015 . . . . 0.0 108.756 179.378 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 17.0 p -23.59 134.96 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.907 0.883 . . . . 0.0 112.732 -178.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.413 ' CG ' ' O ' ' A' ' 28' ' ' MET . 3.0 mt-10 -48.76 -26.24 2.25 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.691 -179.656 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -158.22 63.46 0.45 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.31 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -151.59 -103.95 0.26 Allowed Glycine 0 CA--C 1.523 0.576 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -169.31 -174.94 2.09 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.982 0.42 . . . . 0.0 110.561 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.409 ' HB3' HD21 ' A' ' 69' ' ' LEU . 0.5 OUTLIER -123.9 172.36 8.97 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.219 179.959 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 175.73 140.35 0.06 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.931 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.46 ' HA ' ' HG2' ' A' ' 67' ' ' ARG . 2.5 p -79.49 145.56 9.17 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.209 0 CA-C-O 121.26 0.552 . . . . 0.0 110.037 179.561 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.528 ' CE1' ' CG1' ' A' ' 4' ' ' VAL . 98.3 m-85 -126.14 143.86 50.97 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.033 -179.409 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 30.1 t0 -121.69 155.85 34.31 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.901 0.381 . . . . 0.0 110.803 -179.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 4.3 t0 48.77 51.24 16.13 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.654 179.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.426 ' O ' ' CB ' ' A' ' 92' ' ' TYR . 72.5 t -87.88 -16.49 8.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.627 179.782 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.431 ' CG1' ' HB3' ' A' ' 86' ' ' TYR . 59.4 t -148.57 133.35 9.06 Favored Pre-proline 0 C--N 1.332 -0.157 0 N-CA-C 110.433 -0.21 . . . . 0.0 110.433 179.667 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.41 ' HD2' HG11 ' A' ' 82' ' ' VAL . 46.8 Cg_endo -68.53 -165.73 0.13 Allowed 'Trans proline' 0 N--CA 1.475 0.383 0 C-N-CA 122.695 2.263 . . . . 0.0 111.986 179.483 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -80.32 -37.84 31.79 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.282 -0.417 . . . . 0.0 109.957 179.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.98 67.02 1.11 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.218 179.797 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . 0.431 ' HB3' ' CG1' ' A' ' 82' ' ' VAL . 33.6 p90 -55.58 163.88 1.2 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.644 -179.772 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 7.1 m -133.38 113.0 12.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.241 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 2.7 mp -50.67 116.16 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.501 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 115.32 44.26 0.67 Allowed Glycine 0 CA--C 1.524 0.595 0 N-CA-C 110.677 -0.969 . . . . 0.0 110.677 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -163.24 141.18 7.87 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.816 0.341 . . . . 0.0 110.527 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 17.2 m -90.5 112.13 23.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.19 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.426 ' CB ' ' O ' ' A' ' 81' ' ' VAL . 74.2 m-85 -94.39 -99.03 0.15 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.53 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.45 ' CB ' ' CD ' ' A' ' 94' ' ' PRO . . . 50.48 179.13 0.02 OUTLIER Pre-proline 0 C--O 1.231 0.096 0 CA-C-O 120.704 0.288 . . . . 0.0 110.558 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.45 ' CD ' ' CB ' ' A' ' 93' ' ' ALA . 48.0 Cg_endo . . . . . 0 C--O 1.25 1.075 0 C-N-CA 122.464 2.109 . . . . 0.0 112.044 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 3.8 mttt . . . . . 0 CA--C 1.522 -0.113 0 CA-C-O 120.792 0.33 . . . . 0.0 110.362 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.483 HG12 ' CE1' ' A' ' 78' ' ' PHE . 1.8 p -135.58 163.57 34.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.361 0.601 . . . . 0.0 110.359 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.48 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 0.1 OUTLIER -142.74 139.91 31.26 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.253 179.579 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.451 ' CD2' HG21 ' A' ' 21' ' ' VAL . 20.9 m-85 -112.96 -175.01 2.57 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.325 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -165.09 -167.0 1.1 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.145 -0.48 . . . . 0.0 109.945 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.3 t -139.37 82.42 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.147 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.434 ' HG3' ' CG1' ' A' ' 51' ' ' VAL . 65.7 mm-40 -50.9 155.1 1.26 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.457 -179.771 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 6.8 mtpt -53.49 175.33 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.379 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 64.18 46.81 90.0 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 110.585 -1.006 . . . . 0.0 110.585 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 61.6 m -102.69 108.66 19.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.796 0.331 . . . . 0.0 110.383 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 55.9 m-80 -101.66 174.46 5.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.255 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -55.56 -34.93 65.19 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.599 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.0 -52.71 4.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.319 -179.645 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 27.1 m80 -73.46 136.92 44.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.002 -179.434 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.401 HD23 ' HA ' ' A' ' 17' ' ' LEU . 0.8 OUTLIER -137.36 84.16 2.04 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.521 179.309 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.431 ' CB ' ' CG2' ' A' ' 53' ' ' THR . . . -74.95 116.91 16.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.896 -179.229 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.4 m -109.8 137.36 42.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.011 179.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.1 tt -84.78 70.53 10.84 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.521 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.451 HG21 ' CD2' ' A' ' 6' ' ' PHE . 3.2 t -85.6 98.61 6.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.131 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.9 ttpm? -167.14 147.56 5.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.484 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -161.78 157.62 24.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.299 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.91 -21.58 66.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.716 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -46.17 -91.0 0.01 OUTLIER Glycine 0 CA--C 1.526 0.722 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -90.83 -160.74 0.74 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.729 0.3 . . . . 0.0 110.428 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.425 ' CG2' ' O ' ' A' ' 27' ' ' THR . 32.5 m -123.67 24.35 8.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.038 -179.737 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.426 ' O ' ' CG ' ' A' ' 71' ' ' GLU . 8.4 mtm 60.61 125.28 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.013 179.402 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.441 ' CB ' ' O ' ' A' ' 69' ' ' LEU . . . -122.06 -61.79 1.45 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.259 179.736 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -147.31 171.44 15.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.1 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.422 ' HA ' ' HA ' ' A' ' 68' ' ' PHE . 1.1 p 175.84 151.01 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.28 0.562 . . . . 0.0 110.519 -179.822 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.423 ' HG3' ' HB3' ' A' ' 41' ' ' TRP . 1.1 pm0 -140.23 171.36 14.27 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.97 -179.564 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 12.0 tp -126.41 154.85 43.05 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-O 120.987 0.423 . . . . 0.0 110.088 -179.036 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.47 ' HB2' ' CE3' ' A' ' 41' ' ' TRP . 0.6 OUTLIER -145.47 173.24 12.19 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.892 -0.594 . . . . 0.0 109.534 179.371 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 17.3 mp0 -133.22 -89.62 0.4 Allowed 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 110.346 -0.242 . . . . 0.0 110.346 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 20.3 p80 -177.35 146.21 0.47 Allowed 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 120.77 0.319 . . . . 0.0 110.514 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 60.92 38.76 95.95 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.844 -0.902 . . . . 0.0 110.844 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.1 t -118.38 173.98 6.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.862 0.363 . . . . 0.0 110.423 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -63.79 -70.58 0.21 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.511 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -153.68 173.73 15.42 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.031 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.47 ' CE3' ' HB2' ' A' ' 34' ' ' ARG . 75.2 m95 -52.71 151.21 4.55 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.189 179.769 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 9.7 m -122.83 118.77 56.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.397 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -50.53 134.85 23.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.624 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.0 -168.62 0.14 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.217 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 30.0 m -147.4 105.87 3.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.356 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.88 87.84 0.37 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.209 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -133.88 21.82 3.91 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.985 -0.846 . . . . 0.0 110.985 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.426 ' CB ' HG22 ' A' ' 51' ' ' VAL . 0.1 OUTLIER -108.59 177.6 4.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.754 0.312 . . . . 0.0 110.292 179.953 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -62.44 -44.66 97.29 Favored Glycine 0 CA--C 1.523 0.545 0 N-CA-C 110.7 -0.96 . . . . 0.0 110.7 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -160.94 31.41 0.35 Allowed Glycine 0 CA--C 1.523 0.567 0 N-CA-C 110.717 -0.953 . . . . 0.0 110.717 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.434 ' CG1' ' HG3' ' A' ' 9' ' ' GLU . 5.2 m -145.77 -179.44 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.854 0.359 . . . . 0.0 110.468 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . 0.415 ' CD1' HG12 ' A' ' 31' ' ' VAL . 9.4 m95 -106.12 140.41 39.14 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.514 -179.769 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.431 ' CG2' ' CB ' ' A' ' 18' ' ' ALA . 0.5 OUTLIER -138.27 153.26 49.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.233 179.886 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 36.0 t80 -159.28 141.52 13.7 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.631 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 20.9 p-10 -93.52 127.94 39.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.27 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 9.5 p -94.96 143.82 26.17 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.36 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 14.0 mp0 -104.27 25.85 9.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.402 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -133.38 156.97 79.21 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.282 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -95.2 32.92 0.17 Allowed 'Trans proline' 0 N--CA 1.451 -1.004 0 C-N-CA 123.924 3.082 . . . . 0.0 112.355 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.491 ' CD1' ' N ' ' A' ' 60' ' ' LEU . 0.0 OUTLIER -49.97 162.82 0.17 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.725 -179.903 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -153.76 27.35 0.49 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.347 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -120.9 -155.19 9.48 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.773 -0.931 . . . . 0.0 110.773 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.438 ' CB ' ' HA ' ' A' ' 80' ' ' ASP . 48.7 Cg_endo -79.89 163.84 23.1 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.622 2.215 . . . . 0.0 112.182 -179.829 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 50.2 m-85 -105.76 -175.21 2.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.236 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -150.67 141.18 22.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.97 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -137.93 178.85 6.81 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.038 0.446 . . . . 0.0 110.885 -179.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.42 ' HG2' ' CZ3' ' A' ' 41' ' ' TRP . 0.1 OUTLIER 176.23 84.15 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.51 -179.982 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.422 ' HA ' ' HA ' ' A' ' 31' ' ' VAL . 5.0 p90 -72.56 -177.38 2.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.275 0.559 . . . . 0.0 110.995 -179.213 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.441 ' O ' ' CB ' ' A' ' 29' ' ' ALA . 9.0 mt -140.18 72.39 1.39 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.125 179.678 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.435 ' OG1' ' N ' ' A' ' 74' ' ' MET . 76.6 p -30.88 140.3 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.403 0.681 . . . . 0.0 112.447 -178.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.436 ' HG2' ' CB ' ' A' ' 29' ' ' ALA . 3.3 mm-40 -55.88 -38.86 70.73 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.809 -179.634 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.56 53.72 1.42 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.745 -179.739 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.423 ' O ' ' CG ' ' A' ' 74' ' ' MET . . . -142.46 -109.39 0.73 Allowed Glycine 0 CA--C 1.523 0.551 0 N-CA-C 110.853 -0.899 . . . . 0.0 110.853 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.435 ' N ' ' OG1' ' A' ' 70' ' ' THR . 32.6 mtp -162.98 -178.68 6.23 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 110.206 -0.294 . . . . 0.0 110.206 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -94.01 -177.61 4.38 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.074 179.693 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 9.6 t30 176.88 155.74 0.26 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.392 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 71.2 t -111.21 147.15 15.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.948 179.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.483 ' CE1' HG12 ' A' ' 4' ' ' VAL . 38.0 m-85 -135.87 127.81 29.49 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.453 -179.77 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 39.8 p-10 -118.86 158.01 26.5 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.126 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . 0.438 ' HA ' ' CB ' ' A' ' 63' ' ' PRO . 1.2 m-20 53.37 33.72 16.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.321 -179.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.402 ' HA ' ' HA ' ' A' ' 93' ' ' ALA . 69.9 t -61.56 -17.21 16.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.759 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.444 ' CG1' ' HD2' ' A' ' 83' ' ' PRO . 70.9 t -147.42 140.06 14.49 Favored Pre-proline 0 C--N 1.331 -0.204 0 CA-C-O 120.652 0.263 . . . . 0.0 110.356 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.444 ' HD2' ' CG1' ' A' ' 82' ' ' VAL . 44.6 Cg_endo -69.39 -165.95 0.16 Allowed 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.665 2.244 . . . . 0.0 112.003 179.798 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -74.31 -65.87 0.8 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.031 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.39 71.48 1.36 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.212 179.735 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . 0.406 ' CD1' ' C ' ' A' ' 86' ' ' TYR . 15.4 p90 -56.95 162.96 2.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.506 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 43.7 m -141.32 122.85 15.06 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.404 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 40.7 mm -51.54 116.95 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.342 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 113.11 30.21 2.79 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.664 -0.975 . . . . 0.0 110.664 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -137.15 134.36 36.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.794 0.33 . . . . 0.0 110.18 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 21.6 m -91.34 105.68 17.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.9 -179.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 39.2 m-85 -97.35 -155.77 0.51 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.0 -0.546 . . . . 0.0 109.642 179.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.435 ' CB ' ' HD2' ' A' ' 94' ' ' PRO . . . 73.91 175.76 0.07 OUTLIER Pre-proline 0 N--CA 1.464 0.232 0 CA-C-O 120.673 0.273 . . . . 0.0 110.779 179.762 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.435 ' HD2' ' CB ' ' A' ' 93' ' ' ALA . 46.9 Cg_endo . . . . . 0 C--O 1.249 1.033 0 C-N-CA 122.536 2.157 . . . . 0.0 112.02 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 10.0 mtpt . . . . . 0 CA--C 1.522 -0.114 0 CA-C-O 120.789 0.328 . . . . 0.0 110.187 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.528 ' CG1' ' CE1' ' A' ' 78' ' ' PHE . 2.1 p -96.65 162.95 2.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.27 0.557 . . . . 0.0 110.371 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.468 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 1.2 p -145.16 132.91 21.06 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.463 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -99.37 172.5 7.29 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.279 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 16.7 m -166.14 96.56 0.6 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.182 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.8 t -50.77 111.64 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.581 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -70.24 171.54 9.65 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.51 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.69 -8.83 51.17 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.191 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -48.38 -26.55 5.07 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 111.086 -0.806 . . . . 0.0 111.086 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 28.5 p -52.87 126.66 20.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.725 0.298 . . . . 0.0 110.279 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -122.58 -57.61 1.73 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.496 -179.805 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -134.51 -78.21 0.46 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.354 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.22 -20.64 14.59 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.702 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -54.32 177.28 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.804 0.335 . . . . 0.0 110.285 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 25.4 tp -162.2 84.03 0.57 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.312 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -72.83 162.46 29.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.232 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.437 HG13 ' CZ ' ' A' ' 66' ' ' PHE . 30.9 m -156.65 133.32 2.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.815 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -94.62 64.41 3.01 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.169 179.539 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 28.9 t -56.48 111.78 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.593 -179.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.74 168.82 22.58 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.12 179.769 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.481 ' CD1' ' HB2' ' A' ' 26' ' ' ASP . 0.0 OUTLIER -150.55 -68.88 0.19 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.094 -179.95 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 52.0 tt0 -168.88 -61.42 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.515 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -152.18 58.9 0.42 Allowed Glycine 0 CA--C 1.524 0.654 0 N-CA-C 111.094 -0.802 . . . . 0.0 111.094 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.481 ' HB2' ' CD1' ' A' ' 23' ' ' TYR . 77.0 m-20 -108.71 178.81 4.37 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 179.531 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.401 ' HB ' ' HB2' ' A' ' 71' ' ' GLU . 0.2 OUTLIER -110.0 172.2 7.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.893 0.378 . . . . 0.0 110.492 -179.892 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 1.2 mtt -126.18 117.62 23.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.158 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.426 ' CB ' ' HG2' ' A' ' 71' ' ' GLU . . . -116.88 -58.34 2.08 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.642 -179.765 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.42 ' O ' ' CB ' ' A' ' 68' ' ' PHE . 20.8 mm-40 -153.24 162.7 41.01 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.476 -179.843 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.489 HG23 ' CD1' ' A' ' 52' ' ' TRP . 2.5 t -151.96 142.78 15.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.276 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.43 ' CB ' ' HA ' ' A' ' 43' ' ' ALA . 11.9 pm0 -153.2 139.82 18.84 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.755 -179.603 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.414 HD11 ' N ' ' A' ' 34' ' ' ARG . 0.5 OUTLIER -108.99 172.52 6.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.182 179.893 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.44 ' O ' ' CB ' ' A' ' 35' ' ' GLU . 0.1 OUTLIER -94.31 -67.58 0.85 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.634 -0.257 . . . . 0.0 110.698 -179.685 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.44 ' CB ' ' O ' ' A' ' 34' ' ' ARG . 2.0 tt0 88.91 74.5 0.01 OUTLIER 'General case' 0 CA--C 1.51 -0.571 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 -178.622 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -36.97 120.82 0.75 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 114.995 -1.002 . . . . 0.0 111.832 -178.216 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 128.17 -48.87 0.95 Allowed Glycine 0 CA--C 1.523 0.55 0 N-CA-C 110.446 -1.062 . . . . 0.0 110.446 -179.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.414 ' O ' ' CB ' ' A' ' 39' ' ' ASP . 40.6 t -75.03 -32.79 61.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.745 0.307 . . . . 0.0 110.494 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.414 ' CB ' ' O ' ' A' ' 38' ' ' SER . 8.2 t0 81.56 -53.17 0.27 Allowed 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.729 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -72.63 124.04 24.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.573 -179.751 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.484 ' CZ3' ' HB2' ' A' ' 67' ' ' ARG . 77.7 m95 -54.73 155.19 4.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.036 179.743 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.6 m -136.54 124.69 34.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.8 0.333 . . . . 0.0 110.422 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.43 ' HA ' ' CB ' ' A' ' 32' ' ' GLU . . . -57.19 138.56 54.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.243 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.77 -170.14 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.232 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 62.1 m -135.79 95.18 3.18 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.444 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.413 ' O ' ' CG ' ' A' ' 46' ' ' LYS . 14.6 ptmt -74.16 90.98 2.08 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.97 0.414 . . . . 0.0 110.402 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -156.83 25.34 0.5 Allowed Glycine 0 CA--C 1.523 0.581 0 N-CA-C 110.729 -0.948 . . . . 0.0 110.729 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.438 ' CG ' HG21 ' A' ' 51' ' ' VAL . 7.7 tp10 -106.75 165.91 10.97 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.765 0.317 . . . . 0.0 110.265 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -39.85 -49.7 3.34 Favored Glycine 0 CA--C 1.527 0.794 0 N-CA-C 111.784 -0.526 . . . . 0.0 111.784 -179.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -164.49 33.28 0.26 Allowed Glycine 0 CA--C 1.523 0.549 0 N-CA-C 111.001 -0.84 . . . . 0.0 111.001 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.438 HG21 ' CG ' ' A' ' 48' ' ' GLU . 4.3 m -148.79 -178.57 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.916 0.389 . . . . 0.0 110.498 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . 0.489 ' CD1' HG23 ' A' ' 31' ' ' VAL . 6.5 m95 -108.42 119.1 38.52 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.215 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -106.46 -179.46 3.95 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.613 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 16.4 t80 -177.46 124.37 0.13 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.929 0.395 . . . . 0.0 110.626 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -86.06 154.17 21.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.143 179.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 52.5 p -128.51 126.02 39.56 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.463 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -86.76 -37.43 17.88 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.216 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -63.48 139.04 97.53 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.259 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.403 ' O ' ' NE2' ' A' ' 61' ' ' GLN . 49.0 Cg_endo -72.92 -15.46 26.33 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.574 2.183 . . . . 0.0 112.366 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -50.79 128.11 20.04 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.856 0.36 . . . . 0.0 110.522 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.403 ' NE2' ' O ' ' A' ' 59' ' ' PRO . 1.0 OUTLIER -113.78 61.46 0.66 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.263 179.949 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -107.47 -165.22 21.85 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.688 -0.965 . . . . 0.0 110.688 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.409 ' C ' ' CD1' ' A' ' 64' ' ' PHE . 45.7 Cg_endo -74.28 -172.06 1.07 Allowed 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.46 2.107 . . . . 0.0 112.036 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.409 ' CD1' ' C ' ' A' ' 63' ' ' PRO . 57.6 m-85 -152.88 106.35 3.04 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.641 -179.796 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 29.3 m-80 -74.83 119.77 19.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.269 -0.423 . . . . 0.0 109.919 179.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.437 ' CZ ' HG13 ' A' ' 19' ' ' VAL . 8.6 m-85 -87.79 167.87 13.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.816 -179.555 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.484 ' HB2' ' CZ3' ' A' ' 41' ' ' TRP . 3.3 mtp180 -172.68 116.71 0.32 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.581 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.522 ' CZ ' ' CZ ' ' A' ' 78' ' ' PHE . 0.1 OUTLIER -123.39 170.24 10.54 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.017 0.437 . . . . 0.0 110.538 179.785 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.42 ' O ' ' CB ' ' A' ' 29' ' ' ALA . 7.2 mt -125.88 68.21 1.18 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.341 179.534 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 71.4 p -33.69 138.47 0.08 Allowed 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.875 -179.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.426 ' HG2' ' CB ' ' A' ' 29' ' ' ALA . 1.1 mt-10 -54.1 -26.18 25.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.356 -179.697 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.5 tmtt? -67.12 -52.34 42.91 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.283 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 120.24 58.75 0.24 Allowed Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.792 -0.923 . . . . 0.0 110.792 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 1.2 mmt -131.92 70.79 1.46 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.776 0.322 . . . . 0.0 110.38 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.75 155.15 19.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.383 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 177.8 152.25 0.26 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.563 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 92.6 t -104.86 151.8 7.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.158 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.528 ' CE1' ' CG1' ' A' ' 4' ' ' VAL . 55.2 m-85 -127.38 147.57 50.27 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.759 -179.343 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 14.4 t0 -134.61 161.76 34.21 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.248 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 54.65 44.77 28.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.238 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.437 ' O ' ' CG2' ' A' ' 82' ' ' VAL . 60.0 t -93.34 3.09 8.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.238 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.437 ' CG2' ' O ' ' A' ' 81' ' ' VAL . 66.1 t -159.24 110.66 1.54 Allowed Pre-proline 0 CA--C 1.532 0.257 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 179.603 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.43 ' O ' ' N ' ' A' ' 85' ' ' LYS . 47.9 Cg_endo -75.58 62.09 6.25 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.524 2.149 . . . . 0.0 112.41 -179.741 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 53.86 -87.52 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.551 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.43 ' N ' ' O ' ' A' ' 83' ' ' PRO . 0.0 OUTLIER -87.91 56.61 3.95 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 120.934 0.397 . . . . 0.0 109.946 179.74 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . 0.426 ' HB2' ' CE2' ' A' ' 92' ' ' TYR . 48.6 p90 -48.23 175.95 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.854 -179.744 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -144.24 134.15 23.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.113 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 36.5 mm -65.21 118.44 7.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.468 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 114.03 35.22 1.53 Allowed Glycine 0 CA--C 1.523 0.577 0 N-CA-C 110.602 -0.999 . . . . 0.0 110.602 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -138.64 175.53 9.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.768 0.318 . . . . 0.0 110.383 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 18.5 m -126.52 101.23 6.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.3 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.426 ' CE2' ' HB2' ' A' ' 86' ' ' TYR . 19.5 m-85 -107.22 132.35 53.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.294 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.437 ' CB ' ' HD2' ' A' ' 94' ' ' PRO . . . 173.83 178.25 0.16 Allowed Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.397 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.437 ' HD2' ' CB ' ' A' ' 93' ' ' ALA . 49.0 Cg_endo . . . . . 0 C--O 1.248 1.019 0 C-N-CA 122.489 2.126 . . . . 0.0 112.095 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 27.5 mtpt . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.852 0.358 . . . . 0.0 110.578 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.483 HG23 ' CZ ' ' A' ' 78' ' ' PHE . 29.5 m -122.22 -176.73 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.21 179.695 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -161.08 137.38 8.38 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.399 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.419 ' CE2' ' CD1' ' A' ' 66' ' ' PHE . 19.6 m-85 -107.05 169.36 8.6 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.943 179.821 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 47.3 m -162.04 103.56 1.14 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.925 0.393 . . . . 0.0 110.497 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 31.0 t -53.22 92.57 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.341 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.408 ' OE1' ' CG2' ' A' ' 51' ' ' VAL . 0.1 OUTLIER -59.61 164.53 3.51 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.593 -179.859 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.438 ' HA ' ' CG2' ' A' ' 88' ' ' ILE . 1.5 pttt -86.03 61.14 6.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.286 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -133.1 22.61 3.99 Favored Glycine 0 CA--C 1.525 0.656 0 N-CA-C 111.001 -0.84 . . . . 0.0 111.001 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.4 t -81.82 146.54 29.83 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -152.45 -88.5 0.06 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.739 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -96.61 -66.32 0.91 Allowed 'General case' 0 N--CA 1.454 -0.235 0 CA-C-O 120.694 0.283 . . . . 0.0 110.3 -179.725 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.434 ' HD3' ' ND1' ' A' ' 16' ' ' HIS . 0.0 OUTLIER -140.81 49.1 1.69 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.627 -179.996 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . 0.434 ' ND1' ' HD3' ' A' ' 15' ' ' LYS . 45.6 m80 -129.93 112.56 13.64 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.075 179.555 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -98.53 81.39 2.71 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.225 -179.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.95 131.54 50.02 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.572 -179.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 29.9 m -135.1 136.38 51.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.238 179.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -89.95 75.53 7.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.686 -179.743 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 14.5 t -75.11 95.32 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.093 179.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 23.6 tttt -171.4 132.41 0.78 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.46 -179.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 10.4 p90 -141.42 25.8 2.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.463 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 49.16 87.75 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.575 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -174.08 -105.38 0.18 Allowed Glycine 0 CA--C 1.523 0.532 0 N-CA-C 110.755 -0.938 . . . . 0.0 110.755 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -64.99 -175.17 0.18 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.75 0.309 . . . . 0.0 110.364 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.407 ' HB ' ' HG3' ' A' ' 71' ' ' GLU . 0.8 OUTLIER -103.78 -173.95 2.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.473 -179.866 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.41 ' O ' ' CG ' ' A' ' 71' ' ' GLU . 3.6 mtm -116.69 130.18 56.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.636 -179.621 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.446 ' CB ' ' HG2' ' A' ' 71' ' ' GLU . . . -122.44 -56.85 1.78 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.641 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -158.42 166.49 32.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.287 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 26.4 t -151.67 152.09 11.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.927 0.394 . . . . 0.0 110.675 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.437 ' CB ' ' HA ' ' A' ' 43' ' ' ALA . 0.5 OUTLIER -155.21 138.84 16.03 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.364 179.963 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.489 ' HG ' ' CE2' ' A' ' 66' ' ' PHE . 1.4 mt -94.27 177.56 5.91 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.676 -179.53 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.419 ' CB ' ' HB2' ' A' ' 65' ' ' ASN . 0.1 OUTLIER -130.26 -156.91 0.79 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.664 179.649 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.402 ' OE2' ' CB ' ' A' ' 56' ' ' SER . 0.0 OUTLIER 178.48 105.25 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.826 0.346 . . . . 0.0 110.134 179.921 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . 0.445 ' CD2' HD23 ' A' ' 60' ' ' LEU . 8.8 p-80 -50.11 119.37 3.57 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.462 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 117.68 -32.06 5.5 Favored Glycine 0 CA--C 1.522 0.53 0 N-CA-C 110.565 -1.014 . . . . 0.0 110.565 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -78.75 174.14 11.75 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.765 0.317 . . . . 0.0 110.16 179.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -129.07 26.44 5.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.5 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -159.92 145.26 15.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.457 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.483 ' CZ3' ' HG2' ' A' ' 67' ' ' ARG . 71.3 m95 -80.69 154.11 27.5 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.194 179.83 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.43 ' CG2' ' O ' ' A' ' 42' ' ' VAL . 29.7 m -115.47 105.42 18.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.957 0.408 . . . . 0.0 110.327 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.437 ' HA ' ' CB ' ' A' ' 32' ' ' GLU . . . -52.35 136.66 30.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.394 -179.819 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -71.69 -171.16 0.63 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.804 -179.801 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 47.5 m -144.55 111.4 5.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.557 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.483 ' HG2' ' CZ3' ' A' ' 52' ' ' TRP . 31.8 mtpt -77.06 95.27 4.16 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.042 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -128.86 -38.96 0.33 Allowed Glycine 0 CA--C 1.525 0.696 0 N-CA-C 111.437 -0.665 . . . . 0.0 111.437 -179.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.404 ' HB2' ' O ' ' A' ' 51' ' ' VAL . 0.0 OUTLIER -52.68 -175.32 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.99 0.424 . . . . 0.0 110.425 -179.741 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -104.01 41.69 2.08 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 145.59 -10.8 1.71 Allowed Glycine 0 CA--C 1.529 0.921 0 C-N-CA 121.015 -0.612 . . . . 0.0 112.428 179.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.408 ' CG2' ' OE1' ' A' ' 9' ' ' GLU . 33.5 m -133.21 175.02 12.34 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.137 0 CA-C-N 117.709 0.754 . . . . 0.0 110.844 -179.627 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . 0.483 ' CZ3' ' HG2' ' A' ' 46' ' ' LYS . 6.9 m95 -106.93 139.94 40.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.572 -179.576 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.6 p -122.4 135.52 54.71 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.359 179.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 1.3 t80 175.05 96.94 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.501 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.423 ' HB2' ' N ' ' A' ' 16' ' ' HIS . 6.0 t0 -99.62 31.03 3.34 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-O 121.43 0.634 . . . . 0.0 110.138 179.396 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.41 ' OG ' ' N ' ' A' ' 57' ' ' GLU . 44.9 t 45.91 -172.93 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 114.928 -1.033 . . . . 0.0 110.98 179.574 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.41 ' N ' ' OG ' ' A' ' 56' ' ' SER . 1.5 mt-10 -100.75 -46.86 5.02 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.225 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -64.03 116.42 27.11 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.451 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -68.33 59.6 1.03 Allowed 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.724 2.282 . . . . 0.0 112.333 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.445 HD23 ' CD2' ' A' ' 36' ' ' HIS . 1.6 mt -94.0 92.51 7.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.845 0.355 . . . . 0.0 110.322 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -77.0 78.38 3.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.469 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -145.93 -162.04 9.52 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.816 -0.913 . . . . 0.0 110.816 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -76.17 128.91 10.9 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.59 2.194 . . . . 0.0 112.075 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.437 ' HB3' ' CD2' ' A' ' 33' ' ' LEU . 27.4 m-85 -88.29 -178.27 5.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.976 0.417 . . . . 0.0 110.554 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.419 ' HB2' ' CB ' ' A' ' 34' ' ' ARG . 2.9 m-80 -153.55 137.65 16.44 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.631 179.75 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.489 ' CE2' ' HG ' ' A' ' 33' ' ' LEU . 80.8 m-85 -121.79 -178.36 3.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.045 0.45 . . . . 0.0 110.97 -179.642 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.483 ' HG2' ' CZ3' ' A' ' 41' ' ' TRP . 0.0 OUTLIER 175.65 47.79 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.656 179.997 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -48.63 172.57 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.108 -179.245 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.403 ' O ' ' CB ' ' A' ' 29' ' ' ALA . 4.9 mt -122.28 72.51 1.06 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.446 179.753 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.414 ' OG1' ' N ' ' A' ' 74' ' ' MET . 0.2 OUTLIER -37.98 142.14 0.18 Allowed 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.685 -179.254 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.446 ' HG2' ' CB ' ' A' ' 29' ' ' ALA . 3.1 mm-40 -51.57 -67.31 0.26 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.725 -179.742 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.79 31.38 5.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.733 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -106.34 -100.52 2.66 Favored Glycine 0 CA--C 1.523 0.547 0 N-CA-C 110.655 -0.978 . . . . 0.0 110.655 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.414 ' N ' ' OG1' ' A' ' 70' ' ' THR . 0.0 OUTLIER 177.52 141.51 0.08 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.853 0.358 . . . . 0.0 110.361 179.958 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.401 ' HG3' ' HA ' ' A' ' 69' ' ' LEU . 0.0 OUTLIER -70.31 178.66 2.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.254 -179.982 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.466 ' O ' ' CE2' ' A' ' 78' ' ' PHE . 0.5 OUTLIER 170.04 131.79 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.582 179.92 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 79.7 t -85.18 150.61 3.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.111 -0.495 . . . . 0.0 109.928 179.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.483 ' CZ ' HG23 ' A' ' 4' ' ' VAL . 61.3 m-85 -137.74 128.33 26.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.882 0.372 . . . . 0.0 110.645 -179.835 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -107.67 156.54 18.96 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.214 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 28.0 t70 51.97 52.81 13.68 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.34 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 85.7 t -85.76 -24.6 6.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.577 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.407 ' CG1' ' HD2' ' A' ' 83' ' ' PRO . 46.3 t -138.87 138.56 21.65 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.579 -179.832 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.48 ' HG3' ' CE1' ' A' ' 92' ' ' TYR . 49.3 Cg_endo -72.09 -166.88 0.28 Allowed 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.619 2.212 . . . . 0.0 111.979 179.621 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.66 -78.47 0.07 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.044 179.67 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.411 ' CG ' ' O ' ' A' ' 85' ' ' LYS . 0.0 OUTLIER -91.9 71.36 5.61 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.001 179.589 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 19.0 p90 -47.93 150.48 1.12 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.776 -179.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 1.2 m -117.63 115.56 25.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.291 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.438 ' CG2' ' HA ' ' A' ' 10' ' ' LYS . 42.3 mm -51.94 110.22 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.27 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 114.32 32.33 2.0 Favored Glycine 0 CA--C 1.523 0.552 0 N-CA-C 110.771 -0.932 . . . . 0.0 110.771 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.404 ' HB2' ' CZ ' ' A' ' 92' ' ' TYR . . . -124.35 164.37 19.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.757 0.313 . . . . 0.0 110.398 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 6.9 m -119.68 89.93 3.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.66 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.48 ' CE1' ' HG3' ' A' ' 83' ' ' PRO . 34.5 m-85 -89.03 -161.5 0.77 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.912 179.669 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.446 ' CB ' ' HD2' ' A' ' 94' ' ' PRO . . . 72.26 176.96 0.06 OUTLIER Pre-proline 0 C--N 1.332 -0.173 0 CA-C-O 120.614 0.245 . . . . 0.0 110.461 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.446 ' HD2' ' CB ' ' A' ' 93' ' ' ALA . 48.7 Cg_endo . . . . . 0 C--O 1.249 1.042 0 C-N-CA 122.506 2.137 . . . . 0.0 112.071 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 3.9 tttt . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.78 0.324 . . . . 0.0 110.242 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.438 HG23 ' CE1' ' A' ' 78' ' ' PHE . 27.0 m -80.38 -178.26 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.509 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -170.96 139.71 1.46 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.242 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.574 ' CE2' ' CD2' ' A' ' 66' ' ' PHE . 29.5 m-85 -113.65 168.91 9.37 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.492 -179.81 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 19.1 m -165.57 118.59 1.16 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.381 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.417 ' CG1' HG13 ' A' ' 88' ' ' ILE . 62.6 t -61.65 102.57 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.335 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.432 ' HG3' ' CG2' ' A' ' 51' ' ' VAL . 1.8 mm-40 -70.11 174.67 5.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.502 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.4 mttt -83.17 64.48 7.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.556 -179.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -156.44 33.25 0.59 Allowed Glycine 0 CA--C 1.522 0.506 0 N-CA-C 110.457 -1.057 . . . . 0.0 110.457 179.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.3 p -89.82 114.97 26.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.873 0.368 . . . . 0.0 110.593 -179.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 13.8 m-20 -104.23 -156.05 0.56 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.081 -0.508 . . . . 0.0 109.933 179.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -46.35 -63.98 0.87 Allowed 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 120.846 0.355 . . . . 0.0 110.777 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.87 -22.68 9.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.906 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 28.8 m80 -48.84 136.51 13.81 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.96 0.41 . . . . 0.0 110.884 -179.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -129.05 95.79 4.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.651 179.629 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -90.58 128.31 36.54 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.683 -179.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.408 ' N ' ' CG1' ' A' ' 51' ' ' VAL . 15.3 m -134.26 133.96 55.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.202 179.627 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -83.83 71.93 10.42 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.384 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.424 HG21 ' CD2' ' A' ' 6' ' ' PHE . 61.4 t -70.93 95.14 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.286 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 5.4 tttp -135.62 141.59 45.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.41 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -163.36 149.65 11.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.39 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -76.42 -22.23 54.95 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.743 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -46.91 -50.17 15.8 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 111.081 -0.807 . . . . 0.0 111.081 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -138.04 -174.69 3.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.776 0.322 . . . . 0.0 110.304 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 27.2 m -121.65 54.68 1.13 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.796 -179.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.447 ' O ' ' CB ' ' A' ' 29' ' ' ALA . 33.7 mtm 58.35 -164.11 0.2 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.786 179.55 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.447 ' CB ' ' O ' ' A' ' 28' ' ' MET . . . 154.24 -62.59 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.367 0.667 . . . . 0.0 109.682 179.722 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -160.75 141.17 11.4 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.817 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.411 ' HA ' ' HA ' ' A' ' 68' ' ' PHE . 4.2 t -134.72 156.39 39.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.973 0.416 . . . . 0.0 110.754 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.439 ' CB ' ' HA ' ' A' ' 43' ' ' ALA . 3.1 pt-20 -154.15 157.73 39.31 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.979 179.775 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.6 mt -125.16 -176.54 3.6 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.457 -179.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.483 ' HD2' ' CG ' ' A' ' 41' ' ' TRP . 5.6 ttt180 -145.71 174.24 11.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.075 179.686 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -154.27 93.76 1.65 Allowed 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -40.25 116.07 0.62 Allowed 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.389 -178.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 123.75 -25.41 6.19 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 110.466 -1.054 . . . . 0.0 110.466 -179.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 4.3 m -75.95 -161.34 0.17 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.81 0.338 . . . . 0.0 110.39 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -83.11 -65.81 0.96 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.528 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -153.18 -176.93 6.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.619 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.485 ' CH2' ' HG3' ' A' ' 67' ' ' ARG . 87.0 m95 -50.72 150.66 2.73 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.602 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.431 HG22 ' CE1' ' A' ' 54' ' ' PHE . 10.5 m -131.62 131.91 62.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.139 179.718 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.439 ' HA ' ' CB ' ' A' ' 32' ' ' GLU . . . -57.22 147.23 25.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.569 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.403 ' N ' ' HA ' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -72.61 -166.04 0.25 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.993 179.855 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 90.0 m -154.05 112.61 3.62 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.837 0.351 . . . . 0.0 110.686 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 9.2 ptpt -68.92 69.55 0.18 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.193 -0.458 . . . . 0.0 109.97 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -90.47 -26.41 23.17 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 111.296 -0.722 . . . . 0.0 111.296 -179.491 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.424 ' CG ' ' HB ' ' A' ' 51' ' ' VAL . 5.4 tm-20 -78.45 -14.84 59.18 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.761 0.28 . . . . 0.0 111.222 -179.728 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 99.74 -41.39 2.19 Favored Glycine 0 CA--C 1.522 0.518 0 N-CA-C 109.976 -1.25 . . . . 0.0 109.976 -179.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.438 ' O ' ' CZ3' ' A' ' 52' ' ' TRP . . . -126.61 -45.25 0.23 Allowed Glycine 0 CA--C 1.519 0.287 0 N-CA-C 109.075 -1.61 . . . . 0.0 109.075 179.107 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.432 ' CG2' ' HG3' ' A' ' 9' ' ' GLU . 19.6 t -82.57 151.36 4.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 178.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . 0.438 ' CZ3' ' O ' ' A' ' 50' ' ' GLY . 4.1 m95 -93.05 114.77 27.4 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.996 0.427 . . . . 0.0 110.187 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.8 p -108.07 137.58 45.82 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.286 -179.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.431 ' CE1' HG22 ' A' ' 42' ' ' VAL . 51.2 t80 -120.34 142.79 48.81 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.686 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -99.94 109.38 21.74 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.061 179.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 27.6 p -89.83 158.95 17.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.558 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -134.3 -44.52 0.77 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.42 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -51.88 156.57 2.44 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.395 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -67.88 -34.55 23.49 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.795 2.33 . . . . 0.0 112.433 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 2.2 mt -69.85 151.45 45.69 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.835 -179.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -174.1 72.9 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.22 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -128.44 -96.76 0.87 Allowed Glycine 0 CA--C 1.525 0.687 0 N-CA-C 110.814 -0.914 . . . . 0.0 110.814 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -77.18 97.77 1.17 Allowed 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.587 2.191 . . . . 0.0 112.205 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -73.51 166.47 23.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.588 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.401 ' HB2' ' HB3' ' A' ' 34' ' ' ARG . 0.2 OUTLIER -135.81 122.99 21.64 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 179.227 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.574 ' CD2' ' CE2' ' A' ' 6' ' ' PHE . 2.8 m-85 -105.84 177.88 4.72 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.303 0.573 . . . . 0.0 112.081 -178.569 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.485 ' HG3' ' CH2' ' A' ' 41' ' ' TRP . 7.2 mtp180 -177.56 96.84 0.04 OUTLIER 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 114.877 -1.056 . . . . 0.0 110.287 179.45 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.44 ' CE2' ' CE2' ' A' ' 78' ' ' PHE . 6.0 p90 -91.73 168.13 11.68 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-O 121.151 0.5 . . . . 0.0 110.455 179.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.428 ' O ' ' CB ' ' A' ' 29' ' ' ALA . 5.7 mt -136.28 65.23 1.53 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.641 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 26.8 p -33.5 150.09 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 115.899 -0.591 . . . . 0.0 112.048 -179.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.438 ' CG ' ' O ' ' A' ' 28' ' ' MET . 7.8 mt-10 -49.21 -30.43 7.0 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.333 -179.729 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -69.19 -46.56 67.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.377 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 118.72 43.29 0.54 Allowed Glycine 0 CA--C 1.523 0.557 0 N-CA-C 110.69 -0.964 . . . . 0.0 110.69 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 12.1 mtp -105.61 108.1 19.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.833 0.349 . . . . 0.0 110.448 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.8 149.55 21.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.349 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -177.69 125.13 0.13 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.594 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.447 HG13 ' CZ2' ' A' ' 41' ' ' TRP . 4.5 m -81.99 176.56 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.591 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.44 ' CE2' ' CE2' ' A' ' 68' ' ' PHE . 97.3 m-85 -156.79 112.82 2.97 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.3 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -98.18 158.17 15.72 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.463 -179.759 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 47.1 m-20 59.16 28.53 17.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.557 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 74.3 t -61.17 -75.97 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.434 ' CG1' ' HD2' ' A' ' 83' ' ' PRO . 59.8 t -87.18 139.57 32.33 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.427 -0.352 . . . . 0.0 110.289 179.613 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.434 ' HD2' ' CG1' ' A' ' 82' ' ' VAL . 45.8 Cg_endo -70.5 -167.77 0.27 Allowed 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.595 2.197 . . . . 0.0 112.022 179.765 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.41 ' HG3' ' N ' ' A' ' 85' ' ' LYS . 4.3 pt-20 -83.84 -28.19 28.2 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.23 179.828 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.41 ' N ' ' HG3' ' A' ' 84' ' ' GLU . 0.0 OUTLIER -132.07 63.48 1.62 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.136 179.755 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 51.9 p90 -48.66 148.68 1.99 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.789 -179.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 37.0 m -128.18 113.27 15.49 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.271 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.417 HG13 ' CG1' ' A' ' 8' ' ' VAL . 3.0 mp -51.37 104.46 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.248 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 125.4 47.44 0.22 Allowed Glycine 0 CA--C 1.524 0.598 0 N-CA-C 110.707 -0.957 . . . . 0.0 110.707 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -167.48 175.07 7.4 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.754 0.311 . . . . 0.0 110.365 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 5.1 m -113.32 141.56 46.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.484 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 -141.51 109.18 5.65 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.33 179.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.44 ' CB ' ' HD2' ' A' ' 94' ' ' PRO . . . 170.59 177.49 0.1 OUTLIER Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.406 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.44 ' HD2' ' CB ' ' A' ' 93' ' ' ALA . 48.2 Cg_endo . . . . . 0 C--O 1.249 1.031 0 C-N-CA 122.533 2.156 . . . . 0.0 112.097 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 2.3 tttp . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.711 0.291 . . . . 0.0 110.35 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.536 ' CG1' ' CE1' ' A' ' 78' ' ' PHE . 1.7 p -116.87 163.67 13.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.232 0.539 . . . . 0.0 110.397 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.466 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 0.6 OUTLIER -132.92 139.5 47.39 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.205 179.838 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.545 ' CE2' ' CD1' ' A' ' 66' ' ' PHE . 32.3 m-85 -98.26 -176.43 3.41 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.298 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.9 m -167.5 112.96 0.72 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.369 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 45.2 t -66.26 101.84 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.309 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.401 ' HG3' HG13 ' A' ' 51' ' ' VAL . 0.7 OUTLIER -54.39 -178.16 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.6 -179.79 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -94.24 46.96 1.17 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.269 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -133.56 23.82 3.76 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 110.895 -0.882 . . . . 0.0 110.895 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 7.9 m -86.65 106.04 17.33 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.782 0.325 . . . . 0.0 110.285 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 20.7 m-20 -100.61 -158.38 0.67 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.371 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -45.76 -62.26 1.38 Allowed 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.076 -179.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.98 19.12 11.7 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.005 -179.824 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 6.7 m80 -100.5 130.77 46.62 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.826 0.346 . . . . 0.0 110.088 179.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.44 ' HG ' ' CE2' ' A' ' 64' ' ' PHE . 0.5 OUTLIER -122.57 90.69 3.35 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.452 -179.628 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -88.67 130.75 35.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.162 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.449 HG22 ' CZ ' ' A' ' 66' ' ' PHE . 25.8 m -129.87 152.3 37.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.555 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.428 ' CD2' ' HG2' ' A' ' 22' ' ' LYS . 0.4 OUTLIER -104.06 98.58 8.38 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.081 179.803 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 25.1 t -98.83 99.09 7.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.808 -179.55 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.428 ' HG2' ' CD2' ' A' ' 20' ' ' LEU . 0.0 OUTLIER 175.84 160.18 0.28 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.259 179.698 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -159.8 47.93 0.28 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.338 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 52.43 178.89 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.506 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 66.29 -82.06 0.1 Allowed Glycine 0 CA--C 1.523 0.547 0 N-CA-C 110.832 -0.907 . . . . 0.0 110.832 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 36.3 m-20 -64.71 167.91 6.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.821 0.343 . . . . 0.0 110.397 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -111.7 -160.05 0.7 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.275 -179.836 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.421 ' O ' ' CG ' ' A' ' 71' ' ' GLU . 6.2 mtt -121.05 125.5 47.46 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.925 0.393 . . . . 0.0 110.631 -179.878 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.424 ' CB ' ' O ' ' A' ' 69' ' ' LEU . . . -115.37 -57.62 2.23 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.4 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -165.86 177.67 7.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.143 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.489 HG12 ' CD1' ' A' ' 52' ' ' TRP . 0.5 OUTLIER 172.17 137.88 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 121.111 0.481 . . . . 0.0 110.251 -179.899 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -128.43 163.24 25.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.083 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.495 ' HG ' ' CE2' ' A' ' 66' ' ' PHE . 1.6 mt -109.49 163.57 13.31 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.055 0.455 . . . . 0.0 111.002 -179.543 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.454 ' HG3' ' CD2' ' A' ' 41' ' ' TRP . 0.7 OUTLIER -139.81 -163.39 1.49 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.688 179.375 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -153.42 -87.41 0.06 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.323 179.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . 0.413 ' CG ' ' N ' ' A' ' 37' ' ' GLY . 48.0 p-80 -179.22 -47.19 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 120.83 0.348 . . . . 0.0 110.617 -179.858 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.413 ' N ' ' CG ' ' A' ' 36' ' ' HIS . . . -110.58 23.67 19.45 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 110.735 -0.946 . . . . 0.0 110.735 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.428 ' O ' ' CB ' ' A' ' 39' ' ' ASP . 1.9 t -86.11 -7.42 58.6 Favored 'General case' 0 C--N 1.33 -0.244 0 O-C-N 122.9 -0.176 . . . . 0.0 111.285 -179.797 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.428 ' CB ' ' O ' ' A' ' 38' ' ' SER . 0.8 OUTLIER 82.43 -51.76 0.2 Allowed 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 122.447 0.299 . . . . 0.0 110.9 179.942 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -142.42 177.88 7.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.915 0.388 . . . . 0.0 110.882 -179.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.47 ' CE2' ' HD2' ' A' ' 67' ' ' ARG . 60.3 m95 -78.55 166.53 22.46 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.443 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 20.6 m -141.51 119.13 8.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.234 179.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -50.66 133.73 25.34 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.576 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.424 ' HE3' ' CD1' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -63.04 -171.0 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.547 179.942 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 66.3 m -145.75 99.46 3.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.574 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 2.8 ptmt -61.17 94.37 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.35 179.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -132.3 14.79 5.07 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 111.19 -0.764 . . . . 0.0 111.19 179.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.408 ' CB ' HG21 ' A' ' 51' ' ' VAL . 0.1 OUTLIER -102.83 -14.17 16.7 Favored 'General case' 0 C--N 1.333 -0.152 0 O-C-N 122.719 -0.283 . . . . 0.0 110.986 179.96 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 66.1 26.16 72.36 Favored Glycine 0 CA--C 1.523 0.539 0 N-CA-C 110.42 -1.072 . . . . 0.0 110.42 -179.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -174.64 -39.42 0.05 OUTLIER Glycine 0 CA--C 1.523 0.591 0 N-CA-C 110.53 -1.028 . . . . 0.0 110.53 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.408 HG21 ' CB ' ' A' ' 48' ' ' GLU . 3.1 m -133.1 -177.16 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.922 0.391 . . . . 0.0 110.363 179.87 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . 0.489 ' CD1' HG12 ' A' ' 31' ' ' VAL . 7.6 m95 -101.38 141.46 34.22 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.605 -179.558 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -133.87 147.47 51.16 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.471 -179.757 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 75.7 t80 -130.98 112.49 12.99 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.407 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -71.58 161.91 30.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.411 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -146.56 170.81 16.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.114 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -146.31 -50.14 0.21 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.51 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -55.35 153.09 14.52 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.443 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -71.94 -50.15 0.28 Allowed 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 122.659 2.239 . . . . 0.0 112.136 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -57.91 130.99 49.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.687 -179.862 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 174.92 159.31 0.19 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.277 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -177.27 -99.77 0.13 Allowed Glycine 0 CA--C 1.526 0.76 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -75.32 157.47 41.43 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.569 2.18 . . . . 0.0 112.135 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.44 ' CE2' ' HG ' ' A' ' 17' ' ' LEU . 72.8 m-85 -124.27 -177.73 3.88 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.093 0.473 . . . . 0.0 110.845 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -153.33 130.42 11.1 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.636 179.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.545 ' CD1' ' CE2' ' A' ' 6' ' ' PHE . 80.8 m-85 -114.07 178.98 4.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.14 0.495 . . . . 0.0 110.838 -179.561 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.47 ' HD2' ' CE2' ' A' ' 41' ' ' TRP . 17.1 ptm180 -176.83 59.15 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.656 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.433 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -54.89 178.54 0.03 OUTLIER 'General case' 0 CA--C 1.518 -0.28 0 CA-C-O 121.388 0.613 . . . . 0.0 111.492 -179.21 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.424 ' O ' ' CB ' ' A' ' 29' ' ' ALA . 7.1 mt -144.64 48.39 1.34 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.107 -0.951 . . . . 0.0 109.182 179.78 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.1 p -25.46 137.12 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.88 0.872 . . . . 0.0 112.741 -179.007 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.421 ' CG ' ' O ' ' A' ' 28' ' ' MET . 6.3 mt-10 -49.62 -59.03 4.15 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.507 -179.69 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 3.6 tmtt? -123.66 58.91 1.13 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.314 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -141.4 -101.63 0.45 Allowed Glycine 0 CA--C 1.522 0.516 0 N-CA-C 110.77 -0.932 . . . . 0.0 110.77 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.6 ptm -173.46 -178.43 1.67 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.709 0.29 . . . . 0.0 110.297 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.86 158.12 45.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.52 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 174.05 128.43 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.266 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.466 HG13 ' CZ2' ' A' ' 41' ' ' TRP . 17.6 m -68.71 140.72 18.49 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.473 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.536 ' CE1' ' CG1' ' A' ' 4' ' ' VAL . 79.6 m-85 -116.81 121.53 41.81 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.311 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 26.1 m-20 -101.64 141.09 35.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.569 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 17.1 t0 60.13 60.84 1.98 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.604 179.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.456 HG12 ' CD1' ' A' ' 6' ' ' PHE . 75.7 t -89.44 -65.57 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 179.695 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.437 ' CG1' ' HD2' ' A' ' 83' ' ' PRO . 60.8 t -87.83 139.83 31.17 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.388 179.78 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.469 ' HD3' ' CG ' ' A' ' 92' ' ' TYR . 47.8 Cg_endo -71.88 173.47 12.71 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.61 2.207 . . . . 0.0 112.071 179.83 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -55.54 -51.21 67.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.098 179.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 5.3 mttt -114.78 87.08 2.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.115 179.655 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . 0.42 ' HB3' ' CG1' ' A' ' 82' ' ' VAL . 28.1 p90 -65.94 164.47 15.01 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.579 -179.799 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 7.4 m -145.43 112.76 6.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.261 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 2.5 mp -50.81 98.64 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.457 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 132.03 54.63 0.08 OUTLIER Glycine 0 CA--C 1.523 0.587 0 N-CA-C 110.781 -0.927 . . . . 0.0 110.781 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.461 ' HB2' ' CZ ' ' A' ' 92' ' ' TYR . . . -172.6 -177.75 1.79 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.816 0.341 . . . . 0.0 110.398 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.434 ' CG2' ' HB ' ' A' ' 5' ' ' THR . 4.1 m -124.97 142.55 51.41 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.375 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.469 ' CG ' ' HD3' ' A' ' 83' ' ' PRO . 4.7 m-85 -146.76 123.59 11.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.359 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.452 ' CB ' ' CD ' ' A' ' 94' ' ' PRO . . . 174.93 178.88 0.18 Allowed Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.41 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.452 ' CD ' ' CB ' ' A' ' 93' ' ' ALA . 47.7 Cg_endo . . . . . 0 C--O 1.249 1.031 0 C-N-CA 122.488 2.125 . . . . 0.0 112.099 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 7.6 ttpt . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.866 0.365 . . . . 0.0 110.165 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.484 HG13 ' CZ ' ' A' ' 78' ' ' PHE . 2.4 p -74.75 162.99 4.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.368 0.604 . . . . 0.0 110.552 -179.85 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.459 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 1.8 p -139.6 148.79 42.98 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.133 -0.94 . . . . 0.0 110.124 179.672 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 48.2 m-85 -123.5 145.05 49.15 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.111 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.411 ' O ' ' N ' ' A' ' 20' ' ' LEU . 3.8 m -148.36 129.78 14.81 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.152 -179.88 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 96.1 t -73.21 101.16 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.401 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.412 ' N ' ' O ' ' A' ' 18' ' ' ALA . 6.5 mt-10 -59.1 165.15 2.65 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.485 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.77 65.4 3.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.286 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -154.91 33.44 0.67 Allowed Glycine 0 CA--C 1.524 0.615 0 N-CA-C 110.812 -0.915 . . . . 0.0 110.812 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 21.2 p -82.03 130.08 34.98 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 110.211 -0.292 . . . . 0.0 110.211 179.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 6.2 m-80 -112.44 -161.97 0.78 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.518 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -49.76 -71.06 0.07 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.145 -179.461 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 41.5 pttt -117.99 40.95 3.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.841 -179.328 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 9.0 m80 -113.83 178.95 4.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.4 179.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 43.7 tp -165.15 94.25 0.64 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.419 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.412 ' O ' ' N ' ' A' ' 9' ' ' GLU . . . -91.58 107.47 19.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.372 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.432 HG22 ' CG2' ' A' ' 21' ' ' VAL . 17.1 m -90.72 -173.55 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.286 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.411 ' N ' ' O ' ' A' ' 7' ' ' THR . 2.1 tt -135.11 78.15 1.72 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.502 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.432 ' CG2' HG22 ' A' ' 19' ' ' VAL . 16.0 t -86.23 100.63 9.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.295 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 17.1 tptt -176.11 124.73 0.19 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.548 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 42.6 p90 -156.98 174.29 15.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.251 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -64.21 119.65 10.64 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.495 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 122.07 -65.73 0.49 Allowed Glycine 0 CA--C 1.523 0.557 0 N-CA-C 110.921 -0.872 . . . . 0.0 110.921 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.411 ' OD1' ' CG2' ' A' ' 70' ' ' THR . 32.4 t0 -66.83 137.47 56.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.824 0.345 . . . . 0.0 110.577 -179.79 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.45 ' CG2' ' O ' ' A' ' 27' ' ' THR . 60.2 m -111.38 18.22 19.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.815 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.418 ' O ' ' CG ' ' A' ' 71' ' ' GLU . 19.7 mtp 59.55 114.79 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.797 0.332 . . . . 0.0 110.604 179.777 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.431 ' CB ' ' O ' ' A' ' 69' ' ' LEU . . . -134.53 -58.86 0.82 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.309 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -155.93 153.35 29.47 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.92 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.486 HG12 ' CD1' ' A' ' 52' ' ' TRP . 0.6 OUTLIER -172.43 148.0 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.386 0.612 . . . . 0.0 110.627 -179.713 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.413 ' N ' HG21 ' A' ' 31' ' ' VAL . 2.2 pt-20 -142.22 178.86 7.27 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.065 -0.97 . . . . 0.0 109.688 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.506 ' HG ' ' CE2' ' A' ' 66' ' ' PHE . 4.4 mt -122.87 176.74 5.82 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.133 0.492 . . . . 0.0 111.031 -179.559 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 4.8 ttp180 -145.27 -175.46 4.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.673 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.416 ' CG ' ' HG2' ' A' ' 58' ' ' GLU . 4.9 mm-40 -151.58 29.93 0.6 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.722 0.296 . . . . 0.0 110.81 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER 56.58 164.53 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.555 179.615 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 51.99 25.08 16.09 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 110.887 -0.885 . . . . 0.0 110.887 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -135.91 109.84 8.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.857 0.36 . . . . 0.0 110.356 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -61.54 -22.54 65.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.654 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -100.2 176.52 5.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.914 0.388 . . . . 0.0 110.558 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.483 ' CE3' ' HG2' ' A' ' 67' ' ' ARG . 62.3 m95 -123.26 157.46 33.08 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.072 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.415 ' CG2' ' O ' ' A' ' 33' ' ' LEU . 4.5 m -107.25 105.89 19.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.946 0.403 . . . . 0.0 110.504 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -54.08 121.75 8.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.771 -179.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.88 -169.87 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.267 179.729 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 47.5 m -147.61 105.19 3.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.703 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 14.9 ptmt -62.67 82.92 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 179.509 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -109.72 -25.45 5.43 Favored Glycine 0 CA--C 1.522 0.484 0 N-CA-C 111.067 -0.813 . . . . 0.0 111.067 -179.425 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.434 ' HG2' ' CG2' ' A' ' 51' ' ' VAL . 1.1 tp10 -77.57 -41.04 40.29 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.774 0.321 . . . . 0.0 110.458 -179.776 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 99.42 -44.19 1.71 Allowed Glycine 0 CA--C 1.522 0.482 0 N-CA-C 110.168 -1.173 . . . . 0.0 110.168 -179.487 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -92.49 -29.7 10.72 Favored Glycine 0 CA--C 1.522 0.494 0 N-CA-C 110.208 -1.157 . . . . 0.0 110.208 179.516 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.434 ' CG2' ' HG2' ' A' ' 48' ' ' GLU . 3.5 m -140.41 -176.81 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.895 0.379 . . . . 0.0 110.283 179.65 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . 0.486 ' CD1' HG12 ' A' ' 31' ' ' VAL . 9.5 m95 -106.43 134.42 49.6 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.837 -179.206 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 4.9 p -117.09 145.81 43.52 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.225 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.476 ' CE2' ' HB2' ' A' ' 56' ' ' SER . 85.2 t80 -131.5 138.9 49.16 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.329 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -122.73 134.08 54.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.524 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.476 ' HB2' ' CE2' ' A' ' 54' ' ' PHE . 0.3 OUTLIER -175.31 177.89 1.78 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.396 -179.972 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -155.79 26.88 0.38 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.404 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.416 ' HG2' ' CG ' ' A' ' 35' ' ' GLU . 0.0 OUTLIER -49.22 169.41 0.17 Allowed Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.636 -179.935 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.407 ' CD ' ' HB2' ' A' ' 58' ' ' GLU . 37.8 Cg_endo -93.92 20.09 0.71 Allowed 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 123.851 3.034 . . . . 0.0 112.243 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.6 mt -110.06 51.42 0.76 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.391 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 6.4 mm100 -60.13 121.19 11.3 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.292 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 169.32 -142.76 7.53 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 110.762 -0.935 . . . . 0.0 110.762 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -75.95 169.96 21.09 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.57 2.18 . . . . 0.0 111.975 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -118.26 169.65 9.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.377 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -141.74 134.33 28.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.005 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.506 ' CE2' ' HG ' ' A' ' 33' ' ' LEU . 72.9 m-85 -119.1 179.61 4.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.044 0.449 . . . . 0.0 110.697 -179.808 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.483 ' HG2' ' CE3' ' A' ' 41' ' ' TRP . 0.0 OUTLIER -176.19 60.75 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.683 -0.689 . . . . 0.0 109.71 179.629 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.407 ' HA ' ' HA ' ' A' ' 31' ' ' VAL . 4.6 p90 -56.04 179.44 0.04 OUTLIER 'General case' 0 CA--C 1.519 -0.23 0 CA-C-O 121.263 0.554 . . . . 0.0 111.16 -179.3 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.431 ' O ' ' CB ' ' A' ' 29' ' ' ALA . 6.0 mt -141.7 67.08 1.34 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.245 -0.889 . . . . 0.0 109.179 179.737 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.411 ' CG2' ' OD1' ' A' ' 26' ' ' ASP . 69.9 p -33.03 140.73 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 115.908 -0.587 . . . . 0.0 112.293 -178.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.418 ' CG ' ' O ' ' A' ' 28' ' ' MET . 7.1 mm-40 -53.07 -57.9 8.83 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.567 -179.825 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.09 81.74 2.04 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.506 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -175.7 -95.4 0.1 OUTLIER Glycine 0 CA--C 1.523 0.562 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 16.6 ptm 179.84 -177.53 0.37 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.869 0.366 . . . . 0.0 110.275 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.63 179.82 3.84 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.262 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 177.9 139.87 0.08 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.625 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 87.3 t -89.5 157.38 3.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.131 179.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.484 ' CZ ' HG13 ' A' ' 4' ' ' VAL . 78.8 m-85 -146.34 137.91 24.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.873 0.368 . . . . 0.0 110.539 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 29.5 p-10 -116.1 159.52 21.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.255 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 56.99 45.75 20.62 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.316 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.428 ' O ' ' CG1' ' A' ' 81' ' ' VAL . 60.3 t -94.17 8.08 5.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.104 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.427 ' CG2' ' O ' ' A' ' 81' ' ' VAL . 72.9 t -158.47 129.93 3.91 Favored Pre-proline 0 CA--C 1.53 0.18 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 179.693 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.437 ' HD3' ' CD1' ' A' ' 92' ' ' TYR . 47.6 Cg_endo -74.88 -169.47 0.63 Allowed 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.352 2.035 . . . . 0.0 112.08 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -77.41 -30.81 53.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.252 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 36.3 mttt -132.74 72.92 1.5 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.333 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 50.3 p90 -53.24 149.49 7.13 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.528 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 4.9 t -128.08 115.24 18.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.289 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 3.4 mp -48.93 110.51 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.616 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 110.04 58.03 0.51 Allowed Glycine 0 CA--C 1.523 0.568 0 N-CA-C 110.712 -0.955 . . . . 0.0 110.712 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -176.28 139.78 0.36 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.805 0.336 . . . . 0.0 110.395 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 57.5 m -89.4 123.05 33.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.284 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.437 ' CD1' ' HD3' ' A' ' 83' ' ' PRO . 5.7 m-85 -101.95 -34.68 9.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.636 -179.633 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.448 ' CB ' ' CD ' ' A' ' 94' ' ' PRO . . . -50.02 178.94 0.04 OUTLIER Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.654 -179.782 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.448 ' CD ' ' CB ' ' A' ' 93' ' ' ALA . 48.5 Cg_endo . . . . . 0 C--O 1.249 1.036 0 C-N-CA 122.661 2.241 . . . . 0.0 112.19 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.457 -0.096 0 CA-C-O 120.798 0.332 . . . . 0.0 110.977 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.48 HG23 ' CE1' ' A' ' 78' ' ' PHE . 29.8 m -53.52 171.66 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.205 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 15.0 p -153.15 127.45 9.19 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.385 179.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.426 ' O ' ' CG2' ' A' ' 91' ' ' THR . 45.4 m-85 -84.74 -173.08 4.53 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.938 179.821 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -165.03 117.36 1.19 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.976 0.417 . . . . 0.0 111.028 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.434 ' CG2' ' HA ' ' A' ' 88' ' ' ILE . 14.3 p -49.85 129.31 7.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.423 179.546 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.421 ' HG3' ' CG1' ' A' ' 51' ' ' VAL . 8.9 mm-40 -116.95 163.33 16.37 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.355 179.785 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -50.37 -24.5 3.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.9 -179.538 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.416 ' O ' ' ND2' ' A' ' 13' ' ' ASN . . . -45.95 -27.52 2.45 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 111.12 -0.792 . . . . 0.0 111.12 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.4 m -72.68 115.55 12.1 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 179.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.416 ' ND2' ' O ' ' A' ' 11' ' ' GLY . 5.4 m-80 -115.59 -68.43 0.92 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.41 -179.753 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -125.82 -66.91 0.91 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.126 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.26 27.05 9.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.139 179.759 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 58.1 m80 -109.75 145.66 36.25 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.391 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.464 HD12 ' CD2' ' A' ' 64' ' ' PHE . 8.7 mt -125.93 89.47 3.03 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.957 0.408 . . . . 0.0 110.272 179.766 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.403 ' HB2' ' HB2' ' A' ' 9' ' ' GLU . . . -82.96 143.9 30.36 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.841 179.723 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 17.0 m -139.42 145.39 27.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.772 0.32 . . . . 0.0 110.947 -179.606 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -100.83 56.27 0.87 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.486 179.659 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.457 ' CG1' ' CD1' ' A' ' 52' ' ' TRP . 2.3 p -67.47 102.94 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.175 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -165.45 135.46 3.59 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.328 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 9.5 p90 -156.76 35.26 0.3 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.415 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 51.35 -162.26 0.07 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.454 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 61.42 -103.55 0.57 Allowed Glycine 0 CA--C 1.522 0.529 0 N-CA-C 110.637 -0.985 . . . . 0.0 110.637 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 64.9 m-20 -67.87 132.63 47.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.791 0.329 . . . . 0.0 110.151 179.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.435 ' HB ' ' CG ' ' A' ' 71' ' ' GLU . 0.2 OUTLIER -76.45 175.02 9.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.563 -179.742 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.412 ' O ' ' CG ' ' A' ' 71' ' ' GLU . 0.1 OUTLIER -98.51 130.11 45.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.452 -179.804 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.437 ' CB ' ' HG2' ' A' ' 71' ' ' GLU . . . -118.32 -53.07 2.36 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.691 -179.884 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -161.73 159.16 26.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.905 0.383 . . . . 0.0 110.62 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 18.0 t -143.05 165.12 15.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.936 179.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.431 ' CB ' ' HA ' ' A' ' 43' ' ' ALA . 9.6 pt-20 -174.74 147.86 1.07 Allowed 'General case' 0 N--CA 1.451 -0.411 0 CA-C-O 120.805 0.336 . . . . 0.0 110.687 -179.603 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.484 ' HB3' ' CE1' ' A' ' 66' ' ' PHE . 2.9 pp -109.48 171.19 7.59 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.325 179.619 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.478 ' HB2' ' CZ3' ' A' ' 41' ' ' TRP . 3.8 ttp85 -101.14 -54.65 2.74 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.764 -179.514 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.453 ' CB ' ' O ' ' A' ' 34' ' ' ARG . 3.6 tt0 88.36 30.62 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 109.182 -0.674 . . . . 0.0 109.182 -178.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 29.8 t60 46.81 -87.7 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.068 -0.969 . . . . 0.0 111.469 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.433 ' N ' ' O ' ' A' ' 35' ' ' GLU . . . -42.32 -51.42 5.36 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 111.602 -0.599 . . . . 0.0 111.602 -179.516 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -49.87 100.91 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.767 0.317 . . . . 0.0 110.585 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -51.43 -29.89 17.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.245 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -108.39 164.15 12.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.193 179.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.481 ' CZ3' ' HG2' ' A' ' 67' ' ' ARG . 67.1 m95 -87.77 150.14 23.76 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.314 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.435 ' CG2' HD13 ' A' ' 33' ' ' LEU . 11.0 m -115.66 113.95 44.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.141 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.431 ' HA ' ' CB ' ' A' ' 32' ' ' GLU . . . -48.97 130.83 18.71 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.618 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.86 -169.9 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.145 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 53.9 m -141.28 107.51 5.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.325 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 17.1 ptmt -75.9 63.65 1.74 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.269 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -77.57 -26.4 61.16 Favored Glycine 0 CA--C 1.522 0.496 0 N-CA-C 110.627 -0.989 . . . . 0.0 110.627 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.409 ' HG2' ' CG2' ' A' ' 51' ' ' VAL . 0.7 OUTLIER -84.47 -169.53 2.66 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.824 0.345 . . . . 0.0 110.322 179.95 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -107.13 -27.37 5.37 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 110.825 -0.91 . . . . 0.0 110.825 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -131.13 -3.58 4.34 Favored Glycine 0 CA--C 1.529 0.948 0 C-N-CA 121.363 -0.446 . . . . 0.0 112.34 -179.496 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.421 ' CG1' ' HG3' ' A' ' 9' ' ' GLU . 33.1 m -134.27 167.22 26.62 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.132 0 CA-C-N 117.573 0.687 . . . . 0.0 110.629 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . 0.457 ' CD1' ' CG1' ' A' ' 21' ' ' VAL . 4.7 m95 -115.04 134.97 54.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.532 -179.689 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -122.18 168.63 11.77 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.721 179.414 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.473 ' CG ' HD22 ' A' ' 33' ' ' LEU . 78.8 t80 -154.04 120.13 5.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.755 0.312 . . . . 0.0 110.936 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -78.25 134.17 37.6 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.019 179.552 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -113.52 -177.77 3.21 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.905 0.383 . . . . 0.0 110.752 -179.662 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -152.24 -45.09 0.1 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.415 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.97 156.69 4.93 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.548 -179.797 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -80.31 -19.75 8.9 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.664 2.243 . . . . 0.0 111.857 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.4 tp -48.94 135.01 16.25 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.606 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -139.45 81.71 1.85 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.338 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -137.24 -148.11 5.38 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.744 -0.942 . . . . 0.0 110.744 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -78.93 139.61 15.48 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.572 2.181 . . . . 0.0 112.127 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.464 ' CD2' HD12 ' A' ' 17' ' ' LEU . 60.9 m-85 -115.45 99.1 7.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.229 179.72 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 21.6 m-20 -62.62 164.93 6.95 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.277 -0.419 . . . . 0.0 109.96 179.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.484 ' CE1' ' HB3' ' A' ' 33' ' ' LEU . 21.7 m-85 -142.48 -179.05 6.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.889 0.376 . . . . 0.0 110.777 -179.778 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.481 ' HG2' ' CZ3' ' A' ' 41' ' ' TRP . 7.8 ptm180 174.5 85.31 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.284 -179.755 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -76.95 171.95 13.95 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.134 0.492 . . . . 0.0 110.816 -179.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.431 ' O ' ' CB ' ' A' ' 29' ' ' ALA . 5.4 mt -124.69 61.68 1.15 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.406 179.783 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.2 p -30.63 137.13 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.356 0.662 . . . . 0.0 112.293 -179.066 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.437 ' HG2' ' CB ' ' A' ' 29' ' ' ALA . 13.1 mt-10 -53.56 -67.54 0.25 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.338 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -111.95 61.49 0.62 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.43 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -151.21 -104.69 0.28 Allowed Glycine 0 CA--C 1.523 0.564 0 N-CA-C 110.801 -0.92 . . . . 0.0 110.801 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 179.94 172.31 1.04 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.837 0.351 . . . . 0.0 110.274 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -86.59 -178.36 6.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.413 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 172.75 153.27 0.08 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.195 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 77.2 t -102.16 159.75 4.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.358 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.48 ' CE1' HG23 ' A' ' 4' ' ' VAL . 29.8 m-85 -148.4 122.96 9.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.403 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -109.04 154.2 22.55 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.295 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 56.61 52.86 9.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.386 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.438 ' O ' ' CG2' ' A' ' 82' ' ' VAL . 72.9 t -95.77 5.79 8.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.169 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.438 ' CG2' ' O ' ' A' ' 81' ' ' VAL . 88.3 t -158.69 127.73 3.1 Favored Pre-proline 0 CA--C 1.53 0.18 0 N-CA-C 110.09 -0.337 . . . . 0.0 110.09 179.486 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -81.31 160.49 20.08 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.61 2.207 . . . . 0.0 111.893 179.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -55.88 121.18 8.68 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 179.364 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 61.62 59.69 1.78 Allowed 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 -179.309 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 36.3 p90 -44.48 156.94 0.07 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.25 -179.347 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 88.2 m -135.27 107.78 7.37 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.731 179.641 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.434 ' HA ' ' CG2' ' A' ' 8' ' ' VAL . 2.8 mp -49.42 94.45 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.852 0.358 . . . . 0.0 110.596 -179.559 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 160.47 47.66 0.02 OUTLIER Glycine 0 CA--C 1.523 0.552 0 N-CA-C 111.11 -0.796 . . . . 0.0 111.11 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 174.66 162.82 0.22 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.873 0.368 . . . . 0.0 110.79 179.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.426 ' CG2' ' O ' ' A' ' 6' ' ' PHE . 87.7 m -96.28 141.17 29.93 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.02 179.783 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.419 ' N ' HG21 ' A' ' 91' ' ' THR . 8.4 m-85 -136.43 129.68 31.53 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.454 -179.837 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.449 ' CB ' ' CD ' ' A' ' 94' ' ' PRO . . . 174.98 179.28 0.17 Allowed Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.358 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.449 ' CD ' ' CB ' ' A' ' 93' ' ' ALA . 48.5 Cg_endo . . . . . 0 C--O 1.248 1.017 0 C-N-CA 122.549 2.166 . . . . 0.0 112.1 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 6.0 mtpt . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.668 0.271 . . . . 0.0 110.497 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.499 ' CG1' ' CE2' ' A' ' 6' ' ' PHE . 0.4 OUTLIER 41.15 -164.28 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 CA-C-O 121.135 0.493 . . . . 0.0 111.127 179.868 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.439 ' HA ' ' CB ' ' A' ' 93' ' ' ALA . 0.6 OUTLIER -174.56 -35.79 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.626 -0.716 . . . . 0.0 111.359 -179.749 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.499 ' CE2' ' CG1' ' A' ' 4' ' ' VAL . 86.2 m-85 66.44 156.17 0.1 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.204 -179.407 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.407 ' O ' ' N ' ' A' ' 20' ' ' LEU . 0.3 OUTLIER -163.58 117.85 1.58 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.568 -179.945 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 95.2 t -64.1 101.33 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.103 179.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.4 ' HG3' HG12 ' A' ' 51' ' ' VAL . 4.4 mm-40 -64.75 162.91 15.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.71 -179.73 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 26.9 tttt -79.21 102.57 8.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.144 179.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 178.42 -35.86 0.08 OUTLIER Glycine 0 CA--C 1.523 0.553 0 N-CA-C 110.858 -0.897 . . . . 0.0 110.858 -179.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -48.18 130.8 16.15 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.815 0.34 . . . . 0.0 110.646 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 20.0 m-80 -123.89 -67.2 0.94 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.356 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -121.39 -78.2 0.59 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.416 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.43 ' HG2' ' N ' ' A' ' 16' ' ' HIS . 0.0 OUTLIER -97.04 -24.77 15.62 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.698 -179.87 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . 0.47 ' CE1' ' OD1' ' A' ' 55' ' ' ASP . 5.9 m80 -63.07 119.26 9.17 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.147 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.4 ' CD2' ' OH ' ' A' ' 86' ' ' TYR . 0.2 OUTLIER -114.03 97.06 6.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.46 -179.844 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -94.19 131.17 40.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.37 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.407 ' O ' ' CB ' ' A' ' 51' ' ' VAL . 18.6 m -125.26 -175.04 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.271 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.441 ' HA ' ' CG1' ' A' ' 51' ' ' VAL . 1.1 tt -134.88 70.39 1.44 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.219 179.88 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 6.3 t -86.25 103.63 12.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.453 -179.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 176.29 131.7 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.412 179.822 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 6.4 p90 -151.0 158.77 44.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.265 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -74.23 115.53 13.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.404 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 155.49 -82.25 0.16 Allowed Glycine 0 CA--C 1.523 0.592 0 N-CA-C 110.743 -0.943 . . . . 0.0 110.743 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -81.91 -166.08 1.14 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.812 0.339 . . . . 0.0 110.378 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -121.42 176.01 5.88 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.465 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.405 ' O ' ' CG ' ' A' ' 71' ' ' GLU . 12.6 mtt -108.49 118.06 35.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.383 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.43 ' CB ' ' O ' ' A' ' 69' ' ' LEU . . . -119.38 -61.38 1.63 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.573 -179.831 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 15.2 tt0 -155.84 163.53 39.69 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.139 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.433 ' CG2' ' CD1' ' A' ' 52' ' ' TRP . 38.7 t -139.57 140.6 36.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.089 0.471 . . . . 0.0 110.721 -179.796 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -134.78 123.33 23.42 Favored 'General case' 0 N--CA 1.441 -0.925 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.271 -179.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.49 ' HB3' ' CE1' ' A' ' 66' ' ' PHE . 2.7 pp -111.92 177.08 4.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.213 0.53 . . . . 0.0 111.223 -179.395 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.428 ' N ' ' CD1' ' A' ' 33' ' ' LEU . 6.8 ttt180 -145.35 175.32 10.39 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.342 179.576 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.417 ' O ' ' HB2' ' A' ' 36' ' ' HIS . 17.9 mt-10 -116.12 -82.76 0.63 Allowed 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 179.728 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . 0.417 ' HB2' ' O ' ' A' ' 35' ' ' GLU . 20.6 t-160 178.08 -37.38 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.062 179.095 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -111.1 -18.66 8.09 Favored Glycine 0 CA--C 1.527 0.813 0 N-CA-C 111.007 -0.837 . . . . 0.0 111.007 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.5 p -47.4 152.1 0.68 Allowed 'General case' 0 N--CA 1.462 0.136 0 CA-C-O 120.847 0.356 . . . . 0.0 110.772 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 36.1 m-20 -53.65 -44.06 69.29 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.516 -179.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -162.76 -177.04 5.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.414 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.473 ' CZ3' ' HG2' ' A' ' 67' ' ' ARG . 55.2 m95 -58.76 156.28 11.39 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.205 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.433 ' CG2' HD13 ' A' ' 33' ' ' LEU . 18.6 m -130.17 113.86 27.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.315 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -55.52 123.2 13.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.214 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -51.7 -176.57 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.804 -179.797 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.418 ' O ' ' N ' ' A' ' 47' ' ' GLY . 33.1 m -149.73 126.03 10.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.393 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 15.1 ptmt -65.19 75.33 0.05 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.2 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.418 ' N ' ' O ' ' A' ' 45' ' ' THR . . . -93.89 -32.11 7.76 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 110.945 -0.862 . . . . 0.0 110.945 -179.825 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -78.42 174.14 11.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.871 0.367 . . . . 0.0 110.29 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -104.64 34.46 5.77 Favored Glycine 0 CA--C 1.522 0.524 0 N-CA-C 110.228 -1.149 . . . . 0.0 110.228 179.724 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 178.78 -35.01 0.08 OUTLIER Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.979 -0.849 . . . . 0.0 110.979 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.441 ' CG1' ' HA ' ' A' ' 20' ' ' LEU . 3.3 m -123.03 -176.31 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 120.87 0.367 . . . . 0.0 110.557 -179.814 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . 0.433 ' CD1' ' CG2' ' A' ' 31' ' ' VAL . 7.1 m95 -98.36 139.49 34.04 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.725 -179.587 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -131.13 152.22 50.64 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.177 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 70.3 t80 -130.21 141.38 50.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.546 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.47 ' OD1' ' CE1' ' A' ' 16' ' ' HIS . 6.0 m-20 -97.86 114.81 26.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.339 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -105.97 179.18 4.34 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.467 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -172.02 39.05 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.607 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -123.34 156.77 63.17 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.339 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -71.75 -43.54 1.27 Allowed 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.614 2.209 . . . . 0.0 112.012 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 3.5 mt -69.53 122.45 19.06 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.474 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.13 88.29 2.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.278 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -104.25 -148.37 18.59 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.854 -0.898 . . . . 0.0 110.854 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -78.24 167.16 23.58 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.573 2.182 . . . . 0.0 112.141 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -123.64 113.84 19.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.378 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 70.9 m-20 -86.86 131.98 33.95 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 179.437 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.49 ' CE1' ' HB3' ' A' ' 33' ' ' LEU . 44.7 m-85 -113.38 178.07 4.41 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.101 0.477 . . . . 0.0 111.105 -179.444 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.473 ' HG2' ' CZ3' ' A' ' 41' ' ' TRP . 0.0 OUTLIER 175.29 55.04 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.494 -0.776 . . . . 0.0 109.696 179.975 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 4.2 p90 -50.23 174.21 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.844 -0.617 . . . . 0.0 111.24 -179.307 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.43 ' O ' ' CB ' ' A' ' 29' ' ' ALA . 2.6 mt -130.09 75.93 1.69 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.194 179.485 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.426 ' OG1' ' N ' ' A' ' 74' ' ' MET . 16.8 p -37.49 149.46 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.6 -179.17 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.422 ' HG2' ' CB ' ' A' ' 29' ' ' ALA . 5.1 mm-40 -60.97 -54.18 48.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.02 -179.338 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -129.81 58.14 1.66 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.89 0.376 . . . . 0.0 110.795 -179.568 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -149.07 -107.95 0.46 Allowed Glycine 0 CA--C 1.523 0.582 0 N-CA-C 110.895 -0.882 . . . . 0.0 110.895 179.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.426 ' N ' ' OG1' ' A' ' 70' ' ' THR . 0.0 OUTLIER -166.33 179.07 5.81 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 110.223 -0.288 . . . . 0.0 110.223 179.936 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.4 138.38 50.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.447 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.423 ' O ' ' CE2' ' A' ' 78' ' ' PHE . 24.8 m-20 -135.46 127.93 30.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.298 179.854 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 58.4 t -77.46 147.59 7.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.617 -179.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.423 ' CE2' ' O ' ' A' ' 76' ' ' ASN . 72.6 m-85 -132.27 121.65 23.93 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.157 179.805 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -110.27 140.88 43.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.698 -179.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 70.0 32.44 3.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.791 179.656 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.478 HG12 ' CD2' ' A' ' 6' ' ' PHE . 18.4 t -65.13 -68.26 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 179.564 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 93.3 t -86.53 131.48 45.63 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.168 179.697 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.438 ' HD3' ' CB ' ' A' ' 92' ' ' TYR . 50.6 Cg_endo -82.79 161.16 16.3 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.557 2.171 . . . . 0.0 112.047 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -62.33 125.24 23.22 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.188 179.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 58.86 47.93 11.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.145 -179.829 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . 0.4 ' OH ' ' CD2' ' A' ' 17' ' ' LEU . 22.7 p90 -50.12 175.67 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.775 -179.814 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -137.23 104.56 5.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.998 179.736 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 2.7 mp -46.14 102.83 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.767 -179.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 145.52 48.49 0.03 OUTLIER Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.741 -0.944 . . . . 0.0 110.741 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 179.1 -176.3 0.25 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.931 0.396 . . . . 0.0 110.423 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.437 HG21 ' N ' ' A' ' 92' ' ' TYR . 89.5 m -118.12 141.38 48.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.259 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.438 ' CB ' ' HD3' ' A' ' 83' ' ' PRO . 6.2 m-85 -140.45 124.13 17.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.533 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.463 ' CB ' ' CD ' ' A' ' 94' ' ' PRO . . . -156.49 179.55 1.33 Allowed Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.121 -0.49 . . . . 0.0 109.93 179.533 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.463 ' CD ' ' CB ' ' A' ' 93' ' ' ALA . 48.5 Cg_endo . . . . . 0 C--O 1.249 1.029 0 C-N-CA 122.525 2.15 . . . . 0.0 112.059 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.1 mmtt . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.685 0.279 . . . . 0.0 110.63 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.531 ' CG1' ' CE1' ' A' ' 78' ' ' PHE . 2.4 p -115.53 162.72 13.38 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.342 0 CA-C-O 121.223 0.535 . . . . 0.0 109.996 179.503 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.468 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 0.2 OUTLIER -134.32 151.99 51.56 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.566 179.984 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 17.8 m-85 -128.73 -176.09 3.74 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.881 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -167.03 174.63 8.19 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.05 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.43 ' CG1' HG13 ' A' ' 88' ' ' ILE . 93.5 t -123.37 83.29 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.1 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -47.59 161.53 0.09 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.857 -179.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 12.1 mttm -60.72 -18.63 55.52 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.001 -179.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -74.05 -2.3 61.71 Favored Glycine 0 CA--C 1.53 1.004 0 N-CA-C 111.824 -0.51 . . . . 0.0 111.824 -179.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.5 m -76.54 128.59 35.04 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 117.216 0.508 . . . . 0.0 110.538 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 22.9 m-80 -134.28 -164.32 1.49 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.143 179.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.431 ' HG3' ' CD ' ' A' ' 15' ' ' LYS . 22.1 pt-20 -75.87 -41.51 52.0 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.466 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.431 ' CD ' ' HG3' ' A' ' 14' ' ' GLU . 1.5 mmmt -85.12 -39.8 17.5 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.489 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 30.3 m80 -97.61 161.67 13.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.596 -179.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -141.84 85.88 1.96 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.565 179.559 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -79.43 143.01 35.41 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.238 -179.609 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.429 HG22 ' CG2' ' A' ' 21' ' ' VAL . 30.1 m -138.71 137.27 43.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.288 -179.863 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -91.51 65.0 5.13 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.2 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.429 ' CG2' HG22 ' A' ' 19' ' ' VAL . 10.0 t -61.78 115.18 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.415 -179.811 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 2.2 tttp -172.69 178.55 2.63 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.189 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.481 ' N ' ' CD1' ' A' ' 23' ' ' TYR . 0.0 OUTLIER -146.18 -71.31 0.25 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.044 -179.923 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -143.4 -57.88 0.41 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.219 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -168.34 63.36 0.19 Allowed Glycine 0 CA--C 1.523 0.587 0 N-CA-C 110.759 -0.937 . . . . 0.0 110.759 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -97.33 -167.35 1.52 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.776 0.322 . . . . 0.0 110.41 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 29.3 p -119.67 132.01 55.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.447 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.427 ' O ' ' CG ' ' A' ' 71' ' ' GLU . 0.0 OUTLIER -85.99 123.86 31.79 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.7 -179.851 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.435 ' CB ' ' HG2' ' A' ' 71' ' ' GLU . . . -117.81 -61.54 1.67 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.407 -179.852 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -155.83 151.51 27.26 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.025 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.416 ' HA ' ' HA ' ' A' ' 68' ' ' PHE . 12.1 t -141.27 142.95 28.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.661 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.453 ' CB ' ' HA ' ' A' ' 43' ' ' ALA . 3.9 pt-20 -137.3 142.87 41.9 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.022 -0.535 . . . . 0.0 109.905 179.798 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.429 ' O ' ' CG2' ' A' ' 42' ' ' VAL . 5.6 tp -118.92 147.43 44.02 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 -179.47 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.498 ' HD3' ' CD2' ' A' ' 41' ' ' TRP . 4.7 ttp180 -144.08 164.02 31.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.008 179.583 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.452 ' OE1' ' CD1' ' A' ' 64' ' ' PHE . 2.4 mm-40 -118.56 -72.82 0.67 Allowed 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 179.747 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 6.0 t-80 -179.17 -39.33 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.348 179.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -136.32 57.39 0.68 Allowed Glycine 0 CA--C 1.523 0.552 0 N-CA-C 110.545 -1.022 . . . . 0.0 110.545 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.1 t -132.88 68.88 1.49 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.91 0.386 . . . . 0.0 110.486 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 23.6 t0 49.1 38.19 12.39 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.78 179.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 64.73 -173.37 0.18 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.653 179.732 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.498 ' CD2' ' HD3' ' A' ' 34' ' ' ARG . 94.1 m95 -46.84 143.26 2.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.885 -179.841 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.429 ' CG2' ' O ' ' A' ' 33' ' ' LEU . 2.4 m -137.58 111.46 8.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.85 179.531 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.453 ' HA ' ' CB ' ' A' ' 32' ' ' GLU . . . -44.71 152.13 0.24 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.105 -179.452 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -72.16 -169.51 0.5 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.349 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 37.7 m -143.63 101.26 3.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.181 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 10.8 ptmt -64.76 80.71 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.534 -179.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -117.4 -37.14 0.94 Allowed Glycine 0 CA--C 1.523 0.588 0 N-CA-C 110.65 -0.98 . . . . 0.0 110.65 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 8.4 tm-20 -60.86 -33.39 73.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.756 0.312 . . . . 0.0 110.351 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 97.82 -69.76 0.71 Allowed Glycine 0 CA--C 1.523 0.545 0 N-CA-C 110.774 -0.93 . . . . 0.0 110.774 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -74.83 -29.13 61.54 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 110.589 -1.004 . . . . 0.0 110.589 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 14.1 m -136.38 -177.49 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.791 0.329 . . . . 0.0 110.278 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 7.0 m95 -110.25 132.64 54.0 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.558 -179.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -115.3 160.72 19.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.145 179.826 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.422 ' CD2' HD22 ' A' ' 33' ' ' LEU . 40.5 t80 -148.61 112.63 5.17 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.555 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -70.86 135.98 48.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.147 179.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -142.49 125.99 16.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.612 -179.816 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -93.17 -30.45 15.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.01 179.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.441 ' HB2' ' CD ' ' A' ' 59' ' ' PRO . 0.4 OUTLIER -51.84 170.15 0.23 Allowed Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.253 179.754 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.441 ' CD ' ' HB2' ' A' ' 58' ' ' GLU . 37.4 Cg_endo -91.66 56.92 0.9 Allowed 'Trans proline' 0 N--CA 1.45 -1.037 0 C-N-CA 123.569 2.846 . . . . 0.0 111.761 179.339 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -47.44 93.07 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.78 -179.756 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -119.23 47.33 1.71 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.341 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -165.96 -165.19 22.9 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.502 -1.039 . . . . 0.0 110.502 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -79.94 155.7 23.34 Favored 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 122.55 2.166 . . . . 0.0 112.065 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.452 ' CD1' ' OE1' ' A' ' 35' ' ' GLU . 46.8 m-85 -101.8 -173.97 2.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.21 -0.45 . . . . 0.0 109.88 179.743 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -149.27 119.18 7.11 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.095 -179.87 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.408 ' O ' ' HG3' ' A' ' 67' ' ' ARG . 13.4 m-85 -108.21 163.47 13.14 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.423 -179.828 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.484 ' HG3' ' CH2' ' A' ' 41' ' ' TRP . 21.7 mtp180 -163.44 84.69 0.49 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.141 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.416 ' HA ' ' HA ' ' A' ' 31' ' ' VAL . 6.5 p90 -75.82 169.9 17.26 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.2 0.524 . . . . 0.0 110.691 -179.783 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.432 ' O ' ' CB ' ' A' ' 29' ' ' ALA . 3.9 mt -133.9 50.49 2.2 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.184 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 8.3 p -22.74 137.94 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.167 0.987 . . . . 0.0 113.037 -179.035 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.435 ' HG2' ' CB ' ' A' ' 29' ' ' ALA . 2.6 mm-40 -55.94 -31.18 62.71 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.166 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 14.9 tptt -151.14 70.28 0.98 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.165 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -151.1 -97.49 0.16 Allowed Glycine 0 CA--C 1.522 0.488 0 N-CA-C 110.816 -0.914 . . . . 0.0 110.816 -179.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 13.2 ptp 172.63 166.82 0.12 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.748 0.309 . . . . 0.0 110.288 -179.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 18.4 mmtm -83.71 147.84 27.42 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 179.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -154.98 132.56 11.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.804 0.335 . . . . 0.0 110.472 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.43 HG21 ' NE ' ' A' ' 67' ' ' ARG . 93.8 t -97.27 146.67 7.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.148 0.499 . . . . 0.0 110.618 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.531 ' CE1' ' CG1' ' A' ' 4' ' ' VAL . 41.1 m-85 -131.05 133.65 45.91 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.304 -179.486 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -127.14 31.87 5.17 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.368 -179.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -168.39 52.03 0.05 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.483 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.414 ' O ' ' CG2' ' A' ' 82' ' ' VAL . 57.1 t -93.64 -12.2 8.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.549 -179.077 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.428 ' CG1' ' HD2' ' A' ' 83' ' ' PRO . 70.3 t -156.76 141.33 12.02 Favored Pre-proline 0 C--N 1.332 -0.166 0 CA-C-O 120.696 0.284 . . . . 0.0 110.694 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.479 ' HD3' ' CG ' ' A' ' 92' ' ' TYR . 51.9 Cg_endo -81.26 -166.71 0.43 Allowed 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.72 2.28 . . . . 0.0 111.904 179.763 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.411 ' HG3' ' N ' ' A' ' 85' ' ' LYS . 5.1 pt-20 -78.15 -27.11 48.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.173 179.557 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.411 ' N ' ' HG3' ' A' ' 84' ' ' GLU . 0.0 OUTLIER -140.33 73.53 1.43 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.014 179.771 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 45.1 p90 -57.12 173.91 0.2 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.79 -179.624 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -152.43 113.66 4.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.035 179.696 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.43 HG13 ' CG1' ' A' ' 8' ' ' VAL . 3.3 mp -48.5 109.11 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.828 -179.645 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 121.42 52.26 0.24 Allowed Glycine 0 CA--C 1.523 0.589 0 N-CA-C 111.015 -0.834 . . . . 0.0 111.015 179.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -179.31 148.85 0.38 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.846 0.355 . . . . 0.0 110.794 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 19.4 m -92.77 135.51 34.05 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.895 179.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.479 ' CG ' ' HD3' ' A' ' 83' ' ' PRO . 66.8 m-85 -118.7 -26.47 6.11 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.635 -178.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -49.18 171.29 0.11 Allowed Pre-proline 0 C--N 1.331 -0.235 0 CA-C-O 120.648 0.261 . . . . 0.0 110.746 -179.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo . . . . . 0 C--O 1.249 1.066 0 C-N-CA 122.547 2.165 . . . . 0.0 111.991 -179.928 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.789 0.328 . . . . 0.0 110.376 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.523 ' CG2' ' CE1' ' A' ' 78' ' ' PHE . 20.3 m -73.94 162.97 4.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.511 -179.889 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 43.5 p -148.34 128.84 14.01 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.176 179.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.476 ' CD1' HG12 ' A' ' 81' ' ' VAL . 42.5 m-85 -87.13 171.91 10.33 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.356 -179.828 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.7 m -163.13 112.29 1.31 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.552 -179.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 57.8 t -61.57 96.16 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.251 179.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.446 ' HG3' ' CG2' ' A' ' 51' ' ' VAL . 8.5 mm-40 -52.14 166.29 0.17 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.351 -179.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 17.1 mttp -60.32 -28.56 68.23 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.685 -179.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.418 ' O ' ' CB ' ' A' ' 18' ' ' ALA . . . -83.22 69.18 3.42 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 110.98 -0.848 . . . . 0.0 110.98 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -130.37 128.65 41.85 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.702 0.287 . . . . 0.0 110.283 179.85 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 17.3 p30 -166.79 -174.96 2.92 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.618 -179.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -54.72 127.0 26.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.339 0.59 . . . . 0.0 110.494 -179.904 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.413 ' O ' ' ND1' ' A' ' 16' ' ' HIS . 0.0 OUTLIER 67.74 20.88 9.38 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.155 -0.929 . . . . 0.0 110.958 179.572 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . 0.413 ' ND1' ' O ' ' A' ' 15' ' ' LYS . 78.2 m80 -157.68 89.01 1.0 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.826 0.346 . . . . 0.0 110.549 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.404 ' CD1' HG12 ' A' ' 19' ' ' VAL . 3.0 tm? -100.97 85.25 2.82 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.937 179.851 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.436 ' HB1' ' CG2' ' A' ' 53' ' ' THR . . . -77.82 145.21 36.48 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.75 -179.632 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.406 ' O ' HG11 ' A' ' 51' ' ' VAL . 31.5 m -147.71 131.0 8.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.033 179.322 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -83.5 85.02 7.32 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.773 -179.568 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 24.3 t -87.4 88.85 2.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.194 179.669 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.437 ' HG2' ' N ' ' A' ' 23' ' ' TYR . 38.5 tttm -145.96 160.25 42.11 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.475 -179.848 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.437 ' N ' ' HG2' ' A' ' 22' ' ' LYS . 18.5 p90 177.01 174.9 0.4 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.345 179.784 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -101.28 128.33 47.47 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.453 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 146.43 -49.03 0.65 Allowed Glycine 0 CA--C 1.523 0.575 0 N-CA-C 110.669 -0.973 . . . . 0.0 110.669 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -135.94 -177.47 4.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.745 0.307 . . . . 0.0 110.336 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -116.13 172.69 7.01 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.496 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.434 ' O ' ' CB ' ' A' ' 71' ' ' GLU . 0.1 OUTLIER -75.74 -173.78 2.34 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.436 -179.934 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.441 ' CB ' ' O ' ' A' ' 69' ' ' LEU . . . 168.52 -64.82 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.29 179.801 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.404 ' O ' ' HB2' ' A' ' 68' ' ' PHE . 0.2 OUTLIER -148.0 162.78 38.65 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.778 -179.862 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.456 ' HB ' ' HB3' ' A' ' 68' ' ' PHE . 1.9 p 174.48 138.94 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.093 0.473 . . . . 0.0 110.384 -179.869 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -137.09 178.29 7.2 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.351 -179.634 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.506 ' HG ' ' CE2' ' A' ' 66' ' ' PHE . 2.3 mt -114.59 176.42 5.06 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.006 0.431 . . . . 0.0 110.767 -179.65 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.48 ' HB2' ' CZ3' ' A' ' 41' ' ' TRP . 0.0 OUTLIER -161.25 170.79 19.57 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.007 179.632 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -139.44 14.65 2.57 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.283 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER 52.99 25.62 4.16 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.613 0.244 . . . . 0.0 110.793 179.58 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -161.58 29.54 0.3 Allowed Glycine 0 CA--C 1.524 0.62 0 N-CA-C 110.964 -0.854 . . . . 0.0 110.964 -179.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -112.09 -16.39 13.06 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.528 0.204 . . . . 0.0 110.97 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 71.21 8.84 6.51 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.78 -0.191 . . . . 0.0 111.067 -179.81 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 26.3 pt-20 179.42 151.47 0.36 Allowed 'General case' 0 C--O 1.231 0.105 0 CA-C-O 120.743 0.306 . . . . 0.0 110.244 179.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.492 ' CE3' ' HG2' ' A' ' 67' ' ' ARG . 86.2 m95 -76.89 160.65 29.04 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.377 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 29.7 m -134.49 106.37 7.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.319 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -44.06 131.5 5.83 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.122 -179.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.416 ' CE ' HD13 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -68.55 -170.13 0.19 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.367 -179.983 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 42.8 m -147.49 118.68 7.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.342 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.1 ptpt -71.77 68.75 0.64 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.576 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -90.01 -12.71 61.61 Favored Glycine 0 CA--C 1.528 0.85 0 N-CA-C 111.227 -0.749 . . . . 0.0 111.227 179.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.418 ' HB3' ' HB ' ' A' ' 51' ' ' VAL . 0.1 OUTLIER -85.41 3.83 38.27 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 116.875 0.338 . . . . 0.0 111.391 -179.831 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 64.19 21.53 66.21 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 111.041 -0.824 . . . . 0.0 111.041 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 171.96 -35.21 0.15 Allowed Glycine 0 CA--C 1.52 0.384 0 N-CA-C 109.959 -1.256 . . . . 0.0 109.959 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.446 ' CG2' ' HG3' ' A' ' 9' ' ' GLU . 3.0 t -106.78 157.81 6.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 179.555 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 3.6 m95 -92.18 123.68 35.7 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.015 0.436 . . . . 0.0 110.945 -179.132 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.436 ' CG2' ' HB1' ' A' ' 18' ' ' ALA . 1.3 p -112.69 140.64 47.29 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.313 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 60.7 t80 -121.16 145.33 47.93 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.368 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -88.56 90.1 8.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.34 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -61.19 110.8 1.49 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.541 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -95.15 -36.75 11.36 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.303 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.407 ' O ' ' CG ' ' A' ' 58' ' ' GLU . 5.6 pt-20 -102.74 116.01 63.34 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.345 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -92.4 42.22 0.31 Allowed 'Trans proline' 0 N--CA 1.451 -0.986 0 C-N-CA 123.356 2.704 . . . . 0.0 112.439 179.669 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 2.1 mp -77.34 -175.0 3.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.229 179.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 19.8 pt20 -105.89 32.63 4.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.385 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -90.79 154.03 22.88 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.638 -0.985 . . . . 0.0 110.638 179.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -79.79 170.02 17.38 Favored 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 122.577 2.184 . . . . 0.0 112.047 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 16.6 m-30 -108.6 149.63 28.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.626 -179.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 6.8 m-80 -133.72 145.94 50.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.817 179.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.506 ' CE2' ' HG ' ' A' ' 33' ' ' LEU . 67.1 m-85 -125.36 -177.83 4.02 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.143 0.497 . . . . 0.0 110.694 -179.818 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.492 ' HG2' ' CE3' ' A' ' 41' ' ' TRP . 0.0 OUTLIER 179.92 70.37 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.411 179.692 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.456 ' HB3' ' HB ' ' A' ' 31' ' ' VAL . 6.5 p90 -72.27 179.68 3.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.375 0.607 . . . . 0.0 111.413 -178.92 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.441 ' O ' ' CB ' ' A' ' 29' ' ' ALA . 9.5 mt -141.5 77.02 1.57 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.428 179.797 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.413 ' OG1' ' CG ' ' A' ' 74' ' ' MET . 21.4 p -36.21 136.54 0.3 Allowed 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 116.06 -0.518 . . . . 0.0 112.006 -179.114 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.434 ' CB ' ' O ' ' A' ' 28' ' ' MET . 0.1 OUTLIER -42.03 -34.23 0.68 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.192 179.782 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 3.1 tmtm? -56.87 -48.79 77.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.476 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 123.85 76.94 0.33 Allowed Glycine 0 CA--C 1.523 0.589 0 N-CA-C 110.794 -0.922 . . . . 0.0 110.794 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.413 ' CG ' ' OG1' ' A' ' 70' ' ' THR . 9.8 ptp -169.72 144.49 2.88 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.788 0.327 . . . . 0.0 110.172 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -111.71 178.62 4.26 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.654 -179.631 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 176.92 127.87 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.045 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 63.4 t -88.85 158.28 3.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.705 -179.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.523 ' CE1' ' CG2' ' A' ' 4' ' ' VAL . 51.1 m-85 -140.38 117.33 11.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.966 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -103.94 150.58 24.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.789 -179.472 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 50.85 57.03 7.09 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.618 179.78 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.476 HG12 ' CD1' ' A' ' 6' ' ' PHE . 57.3 t -84.54 -80.8 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 179.755 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.441 ' CG1' ' HD2' ' A' ' 83' ' ' PRO . 60.5 t -81.91 139.5 46.47 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.438 -0.347 . . . . 0.0 110.53 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.441 ' HD2' ' CG1' ' A' ' 82' ' ' VAL . 46.7 Cg_endo -69.82 -167.06 0.21 Allowed 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.701 2.267 . . . . 0.0 112.031 179.546 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -78.99 -27.82 43.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.156 179.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -138.94 77.38 1.62 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.254 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 18.8 p90 -51.23 160.27 0.55 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.532 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 6.0 m -136.44 111.78 9.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.224 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 2.7 mp -50.41 115.13 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.509 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 114.4 38.45 1.1 Allowed Glycine 0 CA--C 1.522 0.512 0 N-CA-C 110.631 -0.988 . . . . 0.0 110.631 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -156.27 -177.79 6.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.851 0.358 . . . . 0.0 110.492 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 93.3 m -127.27 143.31 51.26 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.399 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -144.45 128.4 17.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.127 179.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.443 ' CB ' ' CD ' ' A' ' 94' ' ' PRO . . . 176.15 179.08 0.2 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.411 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.443 ' CD ' ' CB ' ' A' ' 93' ' ' ALA . 48.5 Cg_endo . . . . . 0 C--O 1.249 1.03 0 C-N-CA 122.61 2.207 . . . . 0.0 112.174 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 37.2 mttm . . . . . 0 C--O 1.232 0.152 0 CA-C-O 120.655 0.264 . . . . 0.0 110.634 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.534 ' CG1' ' CZ ' ' A' ' 78' ' ' PHE . 2.5 p -179.6 163.41 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.341 0.591 . . . . 0.0 110.627 179.843 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.473 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 0.0 OUTLIER -142.02 145.24 34.18 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.108 179.594 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 16.1 m-85 -117.25 165.8 13.01 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.14 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.415 ' O ' ' N ' ' A' ' 20' ' ' LEU . 0.2 OUTLIER -165.97 109.02 0.78 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.226 179.986 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 84.6 t -61.45 90.58 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.451 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.406 ' HG3' ' CG1' ' A' ' 51' ' ' VAL . 21.1 mm-40 -55.1 176.39 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.477 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 12.9 mttt -74.0 -13.1 60.82 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.036 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -46.54 -28.37 3.45 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 111.021 -0.832 . . . . 0.0 111.021 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.5 m -53.08 121.71 7.97 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 179.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -110.61 -71.66 0.75 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.423 -179.894 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -138.62 -58.29 0.62 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.783 0.325 . . . . 0.0 110.54 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 10.2 pttt -104.91 -29.08 10.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.548 -179.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -64.53 166.0 9.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.5 -179.734 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 44.5 tp -146.43 85.3 1.65 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.363 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -76.34 134.8 39.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.44 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 34.8 m -130.26 152.2 37.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.182 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.415 ' N ' ' O ' ' A' ' 7' ' ' THR . 0.9 OUTLIER -99.58 91.46 4.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.294 179.891 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 17.8 t -99.72 97.0 5.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.608 -179.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 176.29 133.21 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.44 179.777 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.423 ' CZ ' ' OD2' ' A' ' 26' ' ' ASP . 0.1 OUTLIER -115.87 -73.87 0.63 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.338 -179.974 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -174.6 -56.93 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.586 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -46.59 -66.73 1.64 Allowed Glycine 0 CA--C 1.525 0.666 0 N-CA-C 111.217 -0.753 . . . . 0.0 111.217 -179.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.424 ' CB ' HG23 ' A' ' 70' ' ' THR . 44.4 p-10 -71.09 165.41 23.6 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.846 0.355 . . . . 0.0 110.482 -179.832 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.407 ' O ' ' CG2' ' A' ' 27' ' ' THR . 50.9 m -127.29 45.32 2.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.229 179.837 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.405 ' O ' ' CG ' ' A' ' 71' ' ' GLU . 14.7 mtt 60.15 175.93 0.09 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.502 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.428 ' CB ' ' O ' ' A' ' 69' ' ' LEU . . . 172.8 -61.7 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.306 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.417 ' O ' ' CG2' ' A' ' 31' ' ' VAL . 19.9 tt0 -160.62 161.61 32.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.345 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.473 HG23 ' CD1' ' A' ' 52' ' ' TRP . 44.4 t -157.27 148.7 10.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.957 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.46 ' CB ' ' HA ' ' A' ' 43' ' ' ALA . 0.3 OUTLIER -148.6 136.15 20.51 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.978 0.418 . . . . 0.0 110.507 -179.81 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.448 HD21 ' CG ' ' A' ' 54' ' ' PHE . 6.0 tp -104.1 141.69 35.78 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.958 -0.564 . . . . 0.0 109.61 -179.599 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.479 ' HB2' ' CE3' ' A' ' 41' ' ' TRP . 1.1 ttm180 -85.25 -63.7 1.28 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.618 -179.858 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.459 ' CB ' ' O ' ' A' ' 34' ' ' ARG . 2.4 tt0 91.16 48.19 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 109.003 -0.739 . . . . 0.0 109.003 -179.154 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . 0.441 ' CG ' ' C ' ' A' ' 35' ' ' GLU . 1.2 p80 44.41 -89.44 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 114.845 -1.071 . . . . 0.0 111.207 -179.639 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.431 ' N ' ' O ' ' A' ' 35' ' ' GLU . . . -106.21 93.53 0.88 Allowed Glycine 0 CA--C 1.523 0.566 0 N-CA-C 110.883 -0.887 . . . . 0.0 110.883 -179.831 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.412 ' O ' ' HB2' ' A' ' 39' ' ' ASP . 8.1 t -139.86 25.27 2.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.586 0.231 . . . . 0.0 110.625 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.412 ' HB2' ' O ' ' A' ' 38' ' ' SER . 23.9 m-20 77.43 -54.87 0.54 Allowed 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 122.993 0.517 . . . . 0.0 110.899 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -157.75 170.75 21.66 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.33 -179.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.48 ' CZ2' ' HD2' ' A' ' 67' ' ' ARG . 81.1 m95 -63.67 164.14 10.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.394 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.411 ' CG2' ' O ' ' A' ' 33' ' ' LEU . 3.5 m -146.82 119.06 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.309 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.46 ' HA ' ' CB ' ' A' ' 32' ' ' GLU . . . -52.87 136.43 34.25 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.38 -179.87 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.74 -169.93 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.397 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 85.0 m -128.91 104.17 7.45 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.199 179.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -74.12 121.0 20.47 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.46 -179.858 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 152.41 46.32 0.02 OUTLIER Glycine 0 CA--C 1.523 0.534 0 N-CA-C 110.608 -0.997 . . . . 0.0 110.608 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.421 ' O ' ' N ' ' A' ' 50' ' ' GLY . 15.8 tp10 -134.04 73.48 1.5 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.698 0.285 . . . . 0.0 110.403 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 58.92 -83.71 0.01 OUTLIER Glycine 0 CA--C 1.523 0.533 0 N-CA-C 110.705 -0.958 . . . . 0.0 110.705 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.421 ' N ' ' O ' ' A' ' 48' ' ' GLU . . . -142.92 27.4 2.18 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 110.675 -0.97 . . . . 0.0 110.675 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.406 ' CG1' ' HG3' ' A' ' 9' ' ' GLU . 5.7 m -145.6 -178.43 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.798 0.333 . . . . 0.0 110.361 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . 0.473 ' CD1' HG23 ' A' ' 31' ' ' VAL . 8.8 m95 -106.13 155.28 19.59 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.513 -179.727 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -141.22 148.3 39.69 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.245 179.904 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.448 ' CG ' HD21 ' A' ' 33' ' ' LEU . 70.3 t80 -125.52 146.65 49.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.254 179.724 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 18.1 p-10 -89.61 93.72 9.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.665 -179.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.3 m -85.62 95.5 9.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.138 179.695 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.77 -34.63 13.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.729 -179.62 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.62 156.09 2.45 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 120.882 0.372 . . . . 0.0 110.644 -179.706 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -77.14 -22.62 11.1 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.546 2.164 . . . . 0.0 111.563 179.551 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.416 ' O ' ' CG ' ' A' ' 61' ' ' GLN . 91.4 mt -60.74 172.74 0.87 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.587 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.416 ' CG ' ' O ' ' A' ' 60' ' ' LEU . 0.0 OUTLIER 174.7 116.86 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.253 -179.975 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 178.84 -125.04 0.95 Allowed Glycine 0 CA--C 1.527 0.788 0 N-CA-C 110.692 -0.963 . . . . 0.0 110.692 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -73.52 146.62 39.57 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.427 2.085 . . . . 0.0 112.144 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.401 ' CD1' HD12 ' A' ' 33' ' ' LEU . 81.6 m-85 -128.91 -177.01 4.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.384 -179.907 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.434 ' HB2' ' CH2' ' A' ' 41' ' ' TRP . 0.7 OUTLIER -144.95 149.48 35.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.307 179.97 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 -141.5 159.89 41.27 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.964 0.411 . . . . 0.0 110.867 -179.736 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.48 ' HD2' ' CZ2' ' A' ' 41' ' ' TRP . 15.8 mtp180 -154.11 61.25 0.71 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.965 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 10.5 p90 -49.23 176.66 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.19 0.519 . . . . 0.0 110.991 -179.46 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.428 ' O ' ' CB ' ' A' ' 29' ' ' ALA . 14.5 mt -141.53 65.51 1.38 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.389 179.451 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.424 HG23 ' CB ' ' A' ' 26' ' ' ASP . 75.9 p -31.05 134.56 0.06 Allowed 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 115.606 -0.725 . . . . 0.0 112.655 -178.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.41 ' HA ' ' HB3' ' A' ' 29' ' ' ALA . 0.1 OUTLIER -40.5 -36.96 0.63 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.452 -0.794 . . . . 0.0 111.553 179.927 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 7.9 tmtt? -61.97 -51.51 67.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.365 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 131.02 52.99 0.1 OUTLIER Glycine 0 CA--C 1.523 0.569 0 N-CA-C 110.807 -0.917 . . . . 0.0 110.807 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 13.2 mtp -133.35 128.63 36.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.847 0.356 . . . . 0.0 110.433 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.471 ' N ' ' CD ' ' A' ' 75' ' ' LYS . 0.4 OUTLIER -117.26 171.66 7.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.043 179.8 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 172.39 139.12 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.458 179.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 86.6 t -88.25 155.35 3.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.296 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.534 ' CZ ' ' CG1' ' A' ' 4' ' ' VAL . 97.5 m-85 -143.85 109.3 5.12 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.077 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -71.71 164.0 26.76 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.004 -179.295 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . 0.423 ' O ' ' HB ' ' A' ' 81' ' ' VAL . 20.3 t70 50.19 -95.9 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.713 179.88 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.449 ' O ' ' CG1' ' A' ' 81' ' ' VAL . 75.6 t 65.73 4.21 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 179.846 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.446 ' CG2' ' O ' ' A' ' 81' ' ' VAL . 88.4 t -159.54 130.5 3.77 Favored Pre-proline 0 CA--C 1.529 0.168 0 O-C-N 122.196 -0.315 . . . . 0.0 110.429 179.319 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.497 ' HD3' ' CG ' ' A' ' 92' ' ' TYR . 49.6 Cg_endo -70.22 -165.44 0.16 Allowed 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.705 2.27 . . . . 0.0 111.768 179.421 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -74.46 -53.71 9.0 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 179.372 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 10.0 mmtp -110.38 79.12 1.17 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.004 -0.543 . . . . 0.0 109.982 179.589 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 48.9 p90 -48.12 136.41 11.82 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.888 -179.648 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 75.3 m -123.3 115.71 22.14 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.15 179.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 2.7 mp -55.55 119.18 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.557 -179.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 107.79 51.13 0.76 Allowed Glycine 0 CA--C 1.523 0.564 0 N-CA-C 111.132 -0.787 . . . . 0.0 111.132 179.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -174.81 135.43 0.38 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.799 0.333 . . . . 0.0 110.784 179.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 11.5 m -79.32 129.74 34.76 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.181 -0.463 . . . . 0.0 109.881 179.565 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.497 ' CG ' ' HD3' ' A' ' 83' ' ' PRO . 35.1 m-85 -114.94 -22.19 9.71 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.186 -179.138 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.44 ' CB ' ' CD ' ' A' ' 94' ' ' PRO . . . -50.32 178.35 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 120.713 0.292 . . . . 0.0 110.527 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.44 ' CD ' ' CB ' ' A' ' 93' ' ' ALA . 47.6 Cg_endo . . . . . 0 C--O 1.249 1.066 0 C-N-CA 122.633 2.222 . . . . 0.0 112.023 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.433 ' O ' ' CG2' ' A' ' 4' ' ' VAL . 12.7 mtpt . . . . . 0 CA--C 1.522 -0.121 0 CA-C-O 120.76 0.314 . . . . 0.0 110.288 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.441 HG23 ' CE1' ' A' ' 78' ' ' PHE . 15.6 m 45.5 -173.89 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.079 -179.852 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.418 ' CG2' ' O ' ' A' ' 4' ' ' VAL . 0.8 OUTLIER -169.78 130.5 1.03 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.518 -179.705 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.462 ' CG ' HG12 ' A' ' 81' ' ' VAL . 8.4 m-85 -104.75 156.39 18.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.085 179.757 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 57.5 m -157.48 121.93 4.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.877 0.37 . . . . 0.0 110.596 -179.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.478 ' CG1' ' CD1' ' A' ' 88' ' ' ILE . 11.9 t -60.07 93.63 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.088 179.737 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -47.62 137.5 9.12 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.757 -179.764 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 4.5 tttt -53.8 140.81 28.9 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.405 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 94.17 34.99 6.18 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.63 -0.988 . . . . 0.0 110.63 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.2 t -74.64 148.24 40.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.814 0.34 . . . . 0.0 110.389 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 -134.33 152.56 51.88 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.459 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -55.21 -32.58 62.36 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.347 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.13 -12.49 28.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.292 -179.83 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 54.9 m80 -132.12 119.5 21.02 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.832 0.349 . . . . 0.0 110.795 -179.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -105.87 88.35 2.8 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.948 179.681 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -84.06 119.15 24.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.981 -179.485 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.427 HG22 ' CG2' ' A' ' 21' ' ' VAL . 17.9 m -108.51 -166.8 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.52 179.23 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.1 tt -140.95 79.18 1.68 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.724 179.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.427 ' CG2' HG22 ' A' ' 19' ' ' VAL . 3.1 t -92.58 88.45 2.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 179.673 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 7.0 mttt -142.37 161.53 37.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.58 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER 170.71 153.19 0.05 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.208 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.414 ' HG3' ' N ' ' A' ' 25' ' ' GLY . 1.5 pt-20 -88.63 -25.62 22.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.515 -179.835 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.414 ' N ' ' HG3' ' A' ' 24' ' ' GLU . . . -55.29 -38.53 68.71 Favored Glycine 0 CA--C 1.523 0.555 0 N-CA-C 110.724 -0.95 . . . . 0.0 110.724 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -131.65 176.17 8.55 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.82 0.343 . . . . 0.0 110.324 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.83 -167.49 1.35 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.378 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.427 ' O ' ' CG ' ' A' ' 71' ' ' GLU . 1.7 mtp -123.36 117.68 25.76 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.368 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.429 ' CB ' ' O ' ' A' ' 69' ' ' LEU . . . -127.52 -60.33 1.18 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.74 -179.783 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -142.85 171.39 14.11 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.325 -179.889 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.493 HG12 ' CD1' ' A' ' 52' ' ' TRP . 0.5 OUTLIER 171.51 139.58 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 121.099 0.476 . . . . 0.0 109.898 -179.786 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.432 ' CB ' ' HA ' ' A' ' 43' ' ' ALA . 1.8 pt-20 -134.79 178.51 6.96 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.178 -179.777 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.494 ' HG ' ' CE2' ' A' ' 66' ' ' PHE . 4.2 mt -118.31 172.66 7.3 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.988 0.423 . . . . 0.0 110.894 -179.608 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.47 -173.06 4.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.732 179.588 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -139.27 25.54 2.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.778 0.323 . . . . 0.0 110.709 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 48.18 31.83 2.76 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.757 179.767 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 164.12 47.43 0.02 OUTLIER Glycine 0 CA--C 1.523 0.551 0 N-CA-C 110.924 -0.87 . . . . 0.0 110.924 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 7.0 t -113.85 148.98 35.73 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 179.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -50.8 -29.73 12.39 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.333 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -171.34 150.11 2.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.31 179.844 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.483 ' CZ3' ' HG2' ' A' ' 67' ' ' ARG . 64.4 m95 -51.68 153.55 2.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.333 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 27.7 m -122.3 119.26 57.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.469 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.432 ' HA ' ' CB ' ' A' ' 32' ' ' GLU . . . -52.98 156.69 1.97 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.502 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -94.16 -176.57 4.02 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.478 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 88.3 m -128.79 106.53 8.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.558 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 31.9 mtmt -77.98 93.14 4.4 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.283 -0.417 . . . . 0.0 109.959 179.773 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -129.49 -41.45 0.25 Allowed Glycine 0 CA--C 1.523 0.584 0 N-CA-C 111.284 -0.726 . . . . 0.0 111.284 -179.549 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -49.28 -40.84 36.01 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.872 0.368 . . . . 0.0 110.628 -179.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 96.7 -33.23 5.84 Favored Glycine 0 CA--C 1.522 0.515 0 N-CA-C 110.196 -1.162 . . . . 0.0 110.196 -179.693 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -107.39 -24.55 6.43 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 110.574 -1.01 . . . . 0.0 110.574 179.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 17.4 m -149.24 178.03 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 120.813 0.339 . . . . 0.0 110.352 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . 0.493 ' CD1' HG12 ' A' ' 31' ' ' VAL . 8.4 m95 -104.79 135.92 45.27 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.103 -179.304 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.2 p -115.74 148.57 39.65 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.072 179.725 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -120.51 158.97 26.14 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.849 0.356 . . . . 0.0 110.671 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -114.45 119.6 37.43 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.297 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 8.2 p -91.76 157.2 17.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.514 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -117.76 -48.83 2.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.511 -179.911 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.402 ' HB2' ' HD2' ' A' ' 59' ' ' PRO . 5.7 pt-20 -102.76 159.09 30.37 Favored Pre-proline 0 C--N 1.331 -0.221 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.394 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.402 ' HD2' ' HB2' ' A' ' 58' ' ' GLU . 43.2 Cg_endo -67.29 -158.36 0.04 OUTLIER 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.211 1.941 . . . . 0.0 110.021 178.337 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.1 mt 58.74 109.63 0.01 OUTLIER 'General case' 0 N--CA 1.441 -0.923 0 CA-C-O 120.872 0.368 . . . . 0.0 110.926 178.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 24.6 mp0 -106.34 104.3 13.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.475 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -95.61 -165.23 34.59 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.92 -0.872 . . . . 0.0 110.92 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -74.84 132.23 15.41 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.613 2.209 . . . . 0.0 111.957 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 30.7 m-85 -94.11 151.32 19.58 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.501 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -131.04 140.96 50.16 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.0 -0.546 . . . . 0.0 109.773 179.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.494 ' CE2' ' HG ' ' A' ' 33' ' ' LEU . 76.5 m-85 -123.56 -178.94 4.16 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.074 0.464 . . . . 0.0 110.748 -179.516 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.483 ' HG2' ' CZ3' ' A' ' 41' ' ' TRP . 5.4 ptm180 -177.33 75.22 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.497 179.771 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.431 ' CE2' ' CE2' ' A' ' 78' ' ' PHE . 9.9 p90 -68.55 179.5 1.67 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.416 0.627 . . . . 0.0 111.315 -179.088 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.429 ' O ' ' CB ' ' A' ' 29' ' ' ALA . 15.2 mt -142.87 72.3 1.37 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.212 179.485 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 72.3 p -31.39 134.1 0.08 Allowed 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 115.642 -0.708 . . . . 0.0 112.447 -178.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.427 ' CG ' ' O ' ' A' ' 28' ' ' MET . 2.3 mm-40 -50.02 -27.15 5.08 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.421 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -63.77 -41.46 97.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.137 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 123.37 65.25 0.21 Allowed Glycine 0 CA--C 1.524 0.61 0 N-CA-C 110.848 -0.901 . . . . 0.0 110.848 179.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 4.2 mtt -155.39 145.48 21.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.793 0.33 . . . . 0.0 110.452 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.461 ' N ' ' CD ' ' A' ' 75' ' ' LYS . 0.0 OUTLIER -121.44 -177.24 3.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.095 179.985 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 173.14 176.03 0.11 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.498 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 97.8 t -131.41 162.21 39.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.15 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.441 ' CE1' HG23 ' A' ' 4' ' ' VAL . 54.9 m-85 -150.92 130.6 13.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.943 0.401 . . . . 0.0 110.656 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -120.98 164.48 16.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.234 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 7.5 t0 52.73 43.19 31.65 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.249 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.462 HG12 ' CG ' ' A' ' 6' ' ' PHE . 98.3 t -88.1 -5.2 10.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.081 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.419 ' CG2' ' O ' ' A' ' 81' ' ' VAL . 86.6 t -156.57 105.71 1.99 Allowed Pre-proline 0 CA--C 1.529 0.138 0 N-CA-C 110.224 -0.287 . . . . 0.0 110.224 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -73.67 -177.35 3.05 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.48 2.12 . . . . 0.0 112.224 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -77.39 130.53 37.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.342 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 63.56 44.36 5.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.258 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 47.9 p90 -50.49 140.94 13.05 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.583 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 2.9 m -106.69 118.83 37.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.196 179.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.478 ' CD1' ' CG1' ' A' ' 8' ' ' VAL . 48.5 mm -53.02 134.88 15.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.353 -179.91 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 102.24 28.42 6.46 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 110.668 -0.973 . . . . 0.0 110.668 -179.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -142.9 136.35 28.55 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.847 0.356 . . . . 0.0 110.51 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 91.8 m -88.12 113.57 23.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.308 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 45.3 m-85 -106.4 152.11 24.03 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.524 -179.745 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.431 ' CB ' ' CD ' ' A' ' 94' ' ' PRO . . . 170.07 177.74 0.09 OUTLIER Pre-proline 0 C--N 1.331 -0.197 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.387 179.769 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.431 ' CD ' ' CB ' ' A' ' 93' ' ' ALA . 48.7 Cg_endo . . . . . 0 C--O 1.249 1.057 0 C-N-CA 122.564 2.176 . . . . 0.0 112.0 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 49.4 mttp . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.812 0.339 . . . . 0.0 110.36 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.517 ' CG2' ' CE2' ' A' ' 78' ' ' PHE . 18.4 m -80.09 163.26 3.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.338 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -162.95 132.07 4.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.444 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.497 ' CD2' ' HB ' ' A' ' 21' ' ' VAL . 9.7 m-85 -103.49 177.69 4.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.185 -0.462 . . . . 0.0 109.926 179.674 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.9 m -167.17 127.7 1.51 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.763 0.316 . . . . 0.0 110.785 -179.628 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.41 HG12 ' HB2' ' A' ' 17' ' ' LEU . 87.7 t -70.77 81.54 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.264 179.529 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.437 ' N ' ' O ' ' A' ' 18' ' ' ALA . 1.7 mm-40 -49.25 178.74 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.816 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 5.8 mttp -67.98 -16.52 64.09 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.857 179.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -45.11 -34.69 4.41 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 111.006 -0.838 . . . . 0.0 111.006 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.431 ' HB3' ' HA ' ' A' ' 17' ' ' LEU . 1.4 p -56.95 127.22 30.76 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 179.564 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.6 p30 -109.56 -56.69 2.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.685 0.279 . . . . 0.0 110.766 -179.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 34.7 mm-40 -130.51 -58.96 1.03 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.906 0.384 . . . . 0.0 110.142 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.417 ' CG ' ' OD1' ' A' ' 55' ' ' ASP . 0.0 OUTLIER -108.35 -25.55 10.95 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.218 179.807 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . 0.474 ' CE1' ' OD1' ' A' ' 55' ' ' ASP . 21.0 m80 -58.0 176.86 0.14 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.359 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.552 ' CD1' ' N ' ' A' ' 17' ' ' LEU . 0.0 OUTLIER -172.98 31.64 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.587 -179.238 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.437 ' O ' ' N ' ' A' ' 9' ' ' GLU . . . -18.93 119.95 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.333 1.053 . . . . 0.0 113.0 -179.854 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.468 HG13 ' CZ ' ' A' ' 66' ' ' PHE . 21.9 m -87.13 138.3 19.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.665 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.426 ' HA ' ' CG1' ' A' ' 51' ' ' VAL . 1.0 OUTLIER -97.94 42.99 1.08 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.387 179.795 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.497 ' HB ' ' CD2' ' A' ' 6' ' ' PHE . 2.7 p -50.63 100.53 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.301 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.22 165.08 32.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.265 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER 176.21 175.07 0.32 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.496 -179.83 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -104.54 154.82 19.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.341 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 94.64 -58.55 1.87 Allowed Glycine 0 CA--C 1.522 0.51 0 N-CA-C 110.71 -0.956 . . . . 0.0 110.71 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -91.92 173.86 7.63 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.778 0.323 . . . . 0.0 110.217 179.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -121.0 -173.14 2.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.528 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.43 ' O ' ' CG ' ' A' ' 71' ' ' GLU . 0.0 OUTLIER -118.39 125.74 50.62 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.504 -179.8 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.428 ' CB ' ' O ' ' A' ' 69' ' ' LEU . . . -121.54 -55.64 1.92 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.621 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -159.92 172.93 16.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.422 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.489 HG12 ' CD1' ' A' ' 52' ' ' TRP . 0.2 OUTLIER -174.4 136.83 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.373 0.606 . . . . 0.0 109.798 179.827 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -121.97 151.77 40.42 Favored 'General case' 0 N--CA 1.441 -0.918 0 CA-C-N 115.055 -0.975 . . . . 0.0 110.103 -178.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.467 ' HG ' ' CE2' ' A' ' 66' ' ' PHE . 3.1 mt -101.56 161.29 13.75 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.197 179.784 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.464 ' NH2' ' NE1' ' A' ' 41' ' ' TRP . 0.0 OUTLIER -124.65 -168.15 1.77 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.413 -179.92 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.425 ' CG ' ' O ' ' A' ' 34' ' ' ARG . 11.6 mt-10 -164.81 95.55 0.71 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.83 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -47.67 103.94 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.746 -179.589 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 136.01 -39.39 1.66 Allowed Glycine 0 CA--C 1.523 0.584 0 N-CA-C 110.785 -0.926 . . . . 0.0 110.785 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -69.27 176.35 3.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.856 0.36 . . . . 0.0 110.414 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -118.84 33.91 5.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.394 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -176.43 163.5 2.48 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.531 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.472 ' CZ3' ' HG2' ' A' ' 67' ' ' ARG . 57.8 m95 -88.56 175.9 7.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.322 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.9 m -137.24 97.68 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.175 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -50.76 127.61 18.73 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.6 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.426 ' CE ' ' HB2' ' A' ' 52' ' ' TRP . 0.0 OUTLIER -61.32 -170.12 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.115 179.914 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 92.9 m -150.78 117.48 5.8 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.156 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 2.4 ptmt -69.12 63.5 0.13 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.387 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -86.83 -27.81 28.04 Favored Glycine 0 CA--C 1.521 0.46 0 N-CA-C 110.383 -1.087 . . . . 0.0 110.383 179.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.436 ' HG2' ' CG2' ' A' ' 51' ' ' VAL . 11.6 tp10 -91.99 125.28 36.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.895 0.379 . . . . 0.0 110.246 179.847 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -71.89 66.82 1.12 Allowed Glycine 0 CA--C 1.522 0.476 0 N-CA-C 110.713 -0.955 . . . . 0.0 110.713 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 160.18 -27.55 0.33 Allowed Glycine 0 CA--C 1.524 0.595 0 N-CA-C 111.175 -0.77 . . . . 0.0 111.175 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.436 ' CG2' ' HG2' ' A' ' 48' ' ' GLU . 3.6 m -148.4 -176.81 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.062 0.458 . . . . 0.0 111.064 -179.692 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . 0.489 ' CD1' HG12 ' A' ' 31' ' ' VAL . 4.3 m95 -104.76 136.45 44.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.939 -179.832 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.435 HG21 ' CB ' ' A' ' 18' ' ' ALA . 3.9 p -120.83 144.62 48.25 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.907 0.384 . . . . 0.0 110.662 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.435 ' CB ' HD13 ' A' ' 33' ' ' LEU . 89.5 t80 -140.75 86.14 2.03 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.016 179.638 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.474 ' OD1' ' CE1' ' A' ' 16' ' ' HIS . 10.7 t0 -48.71 151.1 1.24 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.548 -179.794 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 4.9 t -121.94 121.96 38.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.329 179.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -115.47 50.49 1.0 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.55 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -142.89 154.17 61.8 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.331 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -71.15 -40.44 3.25 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.715 2.277 . . . . 0.0 112.068 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 4.5 mt -73.04 153.97 40.65 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.444 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.73 100.56 2.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.319 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -114.74 -152.42 10.37 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 110.723 -0.951 . . . . 0.0 110.723 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -80.99 149.93 17.84 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.66 2.24 . . . . 0.0 112.009 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.425 ' HB3' ' CD2' ' A' ' 33' ' ' LEU . 45.6 m-85 -102.57 164.3 11.73 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.549 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.42 ' HB2' ' CB ' ' A' ' 34' ' ' ARG . 2.7 m-80 -136.6 139.56 42.21 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.801 179.631 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.468 ' CZ ' HG13 ' A' ' 19' ' ' VAL . 58.5 m-85 -127.31 165.13 20.28 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.135 0.493 . . . . 0.0 111.204 -179.46 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.472 ' HG2' ' CZ3' ' A' ' 41' ' ' TRP . 0.0 OUTLIER -156.99 61.08 0.51 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.48 179.578 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.435 ' HA ' ' HA ' ' A' ' 31' ' ' VAL . 3.1 p90 -52.55 170.72 0.07 Allowed 'General case' 0 CA--C 1.516 -0.338 0 CA-C-O 121.483 0.659 . . . . 0.0 111.398 -179.094 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.433 ' CD2' ' HB3' ' A' ' 75' ' ' LYS . 5.6 mt -135.42 70.91 1.43 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 114.833 -1.076 . . . . 0.0 108.874 179.544 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -30.73 140.61 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.28 0.632 . . . . 0.0 112.317 -178.726 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.43 ' CG ' ' O ' ' A' ' 28' ' ' MET . 13.8 mt-10 -49.79 -47.28 51.3 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.935 -179.455 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.23 47.16 1.9 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.815 0.34 . . . . 0.0 110.844 -179.846 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -133.51 -108.94 1.09 Allowed Glycine 0 CA--C 1.522 0.526 0 N-CA-C 110.609 -0.996 . . . . 0.0 110.609 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 10.2 ptt? -165.9 163.2 18.6 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.757 0.313 . . . . 0.0 110.16 179.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.433 ' HB3' ' CD2' ' A' ' 69' ' ' LEU . 0.0 OUTLIER -98.44 -177.7 3.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.362 -179.922 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.423 ' O ' ' CB ' ' A' ' 67' ' ' ARG . 0.7 OUTLIER -179.4 -167.57 0.1 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.533 179.952 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 96.9 t -134.35 145.7 32.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.128 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.517 ' CE2' ' CG2' ' A' ' 4' ' ' VAL . 52.7 m-85 -134.73 134.64 41.23 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.522 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -113.71 155.72 25.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.444 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 51.08 59.21 4.78 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.445 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.413 ' HA ' ' HA ' ' A' ' 93' ' ' ALA . 95.1 t -94.55 -17.38 7.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.964 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.434 ' CG1' ' HD2' ' A' ' 83' ' ' PRO . 82.5 t -139.71 140.1 23.89 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-O 120.629 0.252 . . . . 0.0 110.389 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.434 ' HD2' ' CG1' ' A' ' 82' ' ' VAL . 48.1 Cg_endo -72.49 176.96 8.01 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.652 2.235 . . . . 0.0 112.092 179.877 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -58.65 -32.24 68.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.254 -0.43 . . . . 0.0 109.976 179.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.62 85.66 2.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.131 179.777 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . 0.403 ' HB3' ' CG1' ' A' ' 82' ' ' VAL . 16.9 p90 -52.09 144.74 11.61 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.684 -179.72 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -123.02 102.41 7.98 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.854 179.572 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.406 ' CD1' ' OG ' ' A' ' 12' ' ' SER . 3.3 mt -44.33 118.26 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.823 -179.712 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 114.41 20.61 5.8 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 110.979 -0.848 . . . . 0.0 110.979 -179.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -136.25 133.11 36.66 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 179.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 56.5 m -91.96 93.56 8.85 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.899 0.381 . . . . 0.0 111.01 -179.657 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 47.4 m-85 -79.55 -153.31 0.08 Allowed 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 178.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.463 ' CB ' ' CD ' ' A' ' 94' ' ' PRO . . . 71.58 179.48 0.05 OUTLIER Pre-proline 0 C--N 1.331 -0.222 0 CA-C-O 120.696 0.284 . . . . 0.0 110.683 179.525 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.463 ' CD ' ' CB ' ' A' ' 93' ' ' ALA . 49.1 Cg_endo . . . . . 0 C--O 1.249 1.042 0 C-N-CA 122.633 2.222 . . . . 0.0 111.99 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 35.9 mttp . . . . . 0 CA--C 1.522 -0.117 0 CA-C-O 120.839 0.352 . . . . 0.0 110.242 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.437 HG11 ' N ' ' A' ' 5' ' ' THR . 1.2 p 46.3 -170.98 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.544 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.437 ' N ' HG11 ' A' ' 4' ' ' VAL . 0.6 OUTLIER -177.27 173.12 1.8 Allowed 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.458 -179.996 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 60.6 m-85 -141.64 172.23 12.97 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.048 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.5 m -166.72 112.57 0.8 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.4 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 13.1 t -59.57 113.27 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.14 179.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.92 173.29 12.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.648 -179.661 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -75.48 153.96 37.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.402 -179.931 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 95.26 23.51 19.34 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 51.0 m -80.01 127.43 32.28 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.761 0.315 . . . . 0.0 110.288 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -116.31 -161.74 0.81 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.189 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -51.65 -56.65 12.44 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.485 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.405 ' HG2' ' N ' ' A' ' 16' ' ' HIS . 0.0 OUTLIER -106.15 -28.08 10.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.636 -179.763 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . 0.405 ' N ' ' HG2' ' A' ' 15' ' ' LYS . 14.9 m80 -57.4 112.31 1.37 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.492 -179.897 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -120.85 99.77 6.71 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.181 -0.463 . . . . 0.0 109.897 179.786 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -95.36 128.25 42.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.53 -179.673 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 28.5 m -125.24 141.89 43.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.213 179.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -91.92 64.99 4.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.403 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 14.2 t -68.15 93.28 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.367 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -157.97 144.73 17.8 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.446 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.509 ' N ' ' CD1' ' A' ' 23' ' ' TYR . 0.0 OUTLIER -153.05 -175.16 5.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.229 179.841 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -115.52 96.31 5.58 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.354 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 155.82 -59.71 0.37 Allowed Glycine 0 CA--C 1.524 0.613 0 N-CA-C 110.807 -0.917 . . . . 0.0 110.807 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.4 ' HB2' ' CZ ' ' A' ' 23' ' ' TYR . 0.4 OUTLIER -83.52 -174.79 5.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.733 0.301 . . . . 0.0 110.356 -179.995 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -129.81 -179.3 5.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.637 -179.786 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.433 ' O ' ' CG ' ' A' ' 71' ' ' GLU . 0.0 OUTLIER -105.39 122.91 46.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.429 -179.967 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.435 ' CB ' ' O ' ' A' ' 69' ' ' LEU . . . -128.72 -53.67 1.24 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.787 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -163.31 153.38 15.64 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.794 0.33 . . . . 0.0 110.653 -179.866 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.483 HG23 ' CD1' ' A' ' 52' ' ' TRP . 4.0 t -135.78 137.62 48.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.108 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -136.33 134.55 38.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.758 0.313 . . . . 0.0 110.463 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.8 mt -105.14 179.06 4.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.986 0.422 . . . . 0.0 110.63 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.481 ' HB2' ' CE3' ' A' ' 41' ' ' TRP . 8.6 ttt85 -170.15 158.49 6.95 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.946 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.428 ' N ' ' HG2' ' A' ' 34' ' ' ARG . 5.4 mp0 -117.29 -81.94 0.63 Allowed 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 179.81 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 168.87 118.14 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.459 179.31 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 52.17 38.2 48.08 Favored Glycine 0 CA--C 1.523 0.532 0 N-CA-C 110.816 -0.914 . . . . 0.0 110.816 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 12.0 t -103.56 -76.71 0.58 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.742 0.306 . . . . 0.0 110.459 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -157.36 52.61 0.48 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.423 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 54.69 178.43 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.073 -179.835 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.481 ' CE3' ' HB2' ' A' ' 34' ' ' ARG . 93.9 m95 -59.04 136.74 58.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.847 0.356 . . . . 0.0 110.161 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.476 HG23 ' CZ ' ' A' ' 54' ' ' PHE . 34.6 m -119.73 111.93 34.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.176 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -52.08 137.81 26.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.253 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.23 -171.29 0.05 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.563 -179.749 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 55.5 m -138.1 109.74 7.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.063 179.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.476 ' HG2' ' CZ3' ' A' ' 52' ' ' TRP . 36.4 mtpt -72.69 77.01 1.11 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.514 -179.754 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -102.66 -55.33 0.84 Allowed Glycine 0 CA--C 1.522 0.528 0 N-CA-C 110.473 -1.051 . . . . 0.0 110.473 179.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.41 ' O ' ' N ' ' A' ' 50' ' ' GLY . 11.8 tt0 -65.3 113.58 4.14 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.838 0.351 . . . . 0.0 110.065 179.806 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -61.98 79.22 0.02 OUTLIER Glycine 0 CA--C 1.523 0.57 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 -179.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.41 ' N ' ' O ' ' A' ' 48' ' ' GLU . . . 152.02 -42.54 0.69 Allowed Glycine 0 CA--C 1.523 0.561 0 N-CA-C 111.242 -0.743 . . . . 0.0 111.242 179.801 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 30.0 m -135.46 168.98 21.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.889 0.376 . . . . 0.0 110.806 -179.577 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . 0.483 ' CD1' HG23 ' A' ' 31' ' ' VAL . 7.5 m95 -99.84 140.74 33.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.571 -179.899 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 14.1 p -128.5 146.21 50.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.148 179.767 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.476 ' CZ ' HG23 ' A' ' 42' ' ' VAL . 33.2 t80 -125.04 140.88 52.51 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.535 -179.791 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -97.26 87.52 4.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.255 179.877 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.4 m -69.84 175.8 4.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.359 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 11.3 tt0 -161.67 38.49 0.13 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.296 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -131.29 165.52 34.68 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.427 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -93.59 7.26 2.67 Favored 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 123.849 3.032 . . . . 0.0 112.578 179.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 2.2 tp -59.86 153.29 21.19 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.782 0.325 . . . . 0.0 110.351 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.2 46.12 0.98 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.215 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -122.77 -146.44 7.18 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.67 -0.972 . . . . 0.0 110.67 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -82.73 153.36 15.18 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.719 2.279 . . . . 0.0 112.195 -179.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -101.16 162.19 13.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.139 179.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.44 ' OD1' ' N ' ' A' ' 65' ' ' ASN . 0.0 OUTLIER -127.14 113.11 15.96 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 179.511 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.426 ' O ' ' HG3' ' A' ' 67' ' ' ARG . 5.5 m-85 -97.36 -174.08 2.83 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.871 -179.298 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.433 ' CD ' ' CZ2' ' A' ' 41' ' ' TRP . 2.3 mtp180 170.21 78.04 0.0 OUTLIER 'General case' 0 CA--C 1.521 -0.137 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.88 178.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -79.88 -179.73 7.12 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.147 179.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.435 ' O ' ' CB ' ' A' ' 29' ' ' ALA . 1.0 OUTLIER -136.31 68.67 1.43 Allowed 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 179.642 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 7.1 p -35.11 139.82 0.09 Allowed 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.929 -179.079 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.433 ' CG ' ' O ' ' A' ' 28' ' ' MET . 7.7 mm-40 -50.93 -54.06 27.49 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.605 -179.672 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.4 tptm -116.96 71.46 0.8 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.498 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -167.87 -102.93 0.16 Allowed Glycine 0 CA--C 1.521 0.459 0 N-CA-C 110.552 -1.019 . . . . 0.0 110.552 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 7.6 ptt? 169.13 -177.09 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.774 0.321 . . . . 0.0 110.163 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 4.2 mptt -75.44 -178.08 3.89 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.263 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 175.17 136.36 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.338 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.423 ' HA ' ' HG3' ' A' ' 67' ' ' ARG . 95.9 t -84.35 159.24 3.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.267 179.903 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.431 ' CE1' HG12 ' A' ' 4' ' ' VAL . 86.8 m-85 -150.16 120.03 7.11 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.32 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -115.99 151.81 34.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.458 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 61.95 34.79 16.57 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.357 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.424 ' O ' ' CG1' ' A' ' 81' ' ' VAL . 49.5 t -78.08 -0.5 3.39 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.935 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.437 ' CG1' ' HD2' ' A' ' 83' ' ' PRO . 84.1 t -154.88 139.91 12.06 Favored Pre-proline 0 C--N 1.333 -0.115 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 179.271 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.437 ' HD2' ' CG1' ' A' ' 82' ' ' VAL . 50.3 Cg_endo -71.72 -170.16 0.5 Allowed 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.647 2.231 . . . . 0.0 111.982 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -75.56 -28.57 59.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.188 -0.46 . . . . 0.0 109.96 179.51 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 13.7 mttt -139.25 74.95 1.49 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.982 179.783 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 25.9 p90 -48.3 151.78 0.99 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.876 -179.63 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 2.4 m -136.9 110.07 7.79 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.828 -0.623 . . . . 0.0 109.991 179.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 2.8 mp -46.12 105.96 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.845 -179.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 128.25 44.55 0.21 Allowed Glycine 0 CA--C 1.523 0.541 0 N-CA-C 110.619 -0.992 . . . . 0.0 110.619 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -157.63 160.8 38.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.796 0.332 . . . . 0.0 110.339 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 39.9 m -113.51 102.04 9.92 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.555 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 29.9 m-85 -103.95 144.61 31.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.615 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.419 ' HA ' ' HA ' ' A' ' 81' ' ' VAL . . . 172.46 171.42 0.22 Allowed Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.41 179.701 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo . . . . . 0 C--O 1.249 1.063 0 C-N-CA 122.61 2.207 . . . . 0.0 112.082 -179.956 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 7.8 mtmt . . . . . 0 C--O 1.232 0.158 0 CA-C-O 120.767 0.318 . . . . 0.0 110.452 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.476 HG23 ' CE2' ' A' ' 78' ' ' PHE . 3.7 m -53.99 -178.99 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.121 179.866 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.2 p -152.54 131.17 12.3 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.42 179.949 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 16.6 m-85 -98.47 171.57 8.08 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.248 179.878 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -164.44 105.86 0.86 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.298 179.996 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 60.5 t -60.34 101.63 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.297 179.974 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -64.05 -175.72 0.16 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.315 -179.952 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 5.7 pttm -86.25 10.79 13.66 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.168 179.972 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -69.27 -29.71 71.86 Favored Glycine 0 CA--C 1.522 0.487 0 N-CA-C 110.571 -1.012 . . . . 0.0 110.571 179.79 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 53.2 p -53.0 106.11 0.15 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.817 0.341 . . . . 0.0 110.264 179.894 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 10.1 m-80 -89.34 -68.14 0.79 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.337 -179.97 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -135.8 -54.6 0.77 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.393 179.963 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.62 -27.39 8.57 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.392 179.926 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -52.24 179.44 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.358 179.987 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 24.3 tp -159.18 83.42 0.78 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.249 179.967 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.415 ' O ' ' CG1' ' A' ' 19' ' ' VAL . . . -73.79 158.37 34.71 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.511 -179.906 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.415 ' CG1' ' O ' ' A' ' 18' ' ' ALA . 35.4 m -157.55 139.17 5.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.347 179.845 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -97.52 57.87 1.42 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.431 179.987 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 18.3 t -58.8 94.47 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.359 179.975 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.5 ttpm? -152.27 149.01 28.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.448 -179.929 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 12.9 p90 -169.19 137.89 2.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.309 179.916 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -55.37 152.77 8.11 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.27 -179.979 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 113.91 -77.09 0.25 Allowed Glycine 0 CA--C 1.523 0.569 0 N-CA-C 110.736 -0.946 . . . . 0.0 110.736 -179.931 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -103.81 179.94 4.13 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.801 0.334 . . . . 0.0 110.347 179.933 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.52 -160.87 0.74 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.513 -179.813 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.42 ' O ' ' CG ' ' A' ' 71' ' ' GLU . 19.9 mmt -122.72 127.85 49.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.542 -179.77 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.431 ' HB1' ' N ' ' A' ' 71' ' ' GLU . . . -117.23 -55.69 2.3 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.58 -179.933 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -158.55 165.23 35.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.324 -179.937 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 67.2 t -143.64 149.4 18.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.956 0.407 . . . . 0.0 110.451 179.939 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.417 ' OE2' ' N ' ' A' ' 43' ' ' ALA . 9.7 tp10 -134.78 136.99 42.99 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-N 115.96 -0.563 . . . . 0.0 109.79 -179.431 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.484 HD22 ' CD2' ' A' ' 54' ' ' PHE . 13.0 tp -115.89 152.26 33.73 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 -179.918 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.474 ' HB2' ' CE3' ' A' ' 41' ' ' TRP . 0.0 OUTLIER -128.39 176.19 7.91 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.826 0.346 . . . . 0.0 110.543 -179.818 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.419 ' O ' ' N ' ' A' ' 37' ' ' GLY . 1.5 tm-20 -138.85 12.41 2.68 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.16 -179.907 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER 67.48 -68.77 0.15 Allowed 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 120.822 0.344 . . . . 0.0 110.519 -179.973 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 35' ' ' GLU . . . -68.75 -26.33 74.59 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 110.846 -0.901 . . . . 0.0 110.846 -179.951 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 8.6 t -50.87 140.41 15.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.76 0.314 . . . . 0.0 110.357 -179.895 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 16.5 t0 -49.38 -30.9 8.45 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.472 -179.999 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -170.77 172.56 5.65 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.431 179.892 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.474 ' CE3' ' HB2' ' A' ' 34' ' ' ARG . 69.3 m95 -54.87 147.34 15.38 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.262 179.922 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 6.1 m -124.77 109.91 23.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.298 179.929 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.417 ' N ' ' OE2' ' A' ' 32' ' ' GLU . . . -50.54 135.12 23.27 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.482 -179.881 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -53.69 -171.64 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.624 -179.925 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 58.0 m -128.85 93.17 3.55 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.498 -179.896 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 7.0 ptmt -71.05 84.57 0.71 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.403 179.942 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -144.21 30.21 1.89 Allowed Glycine 0 CA--C 1.523 0.533 0 N-CA-C 110.473 -1.051 . . . . 0.0 110.473 179.934 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.436 ' CB ' HG21 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -108.77 174.05 6.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.843 0.354 . . . . 0.0 110.503 -179.879 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -59.82 -31.63 72.36 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 110.718 -0.953 . . . . 0.0 110.718 179.968 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -176.6 35.41 0.09 OUTLIER Glycine 0 CA--C 1.524 0.595 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 -179.978 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.436 HG21 ' CB ' ' A' ' 48' ' ' GLU . 6.6 m -152.16 -179.93 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.776 0.322 . . . . 0.0 110.425 179.803 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 7.0 m95 -108.44 140.0 42.37 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.438 -179.644 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.413 HG21 ' N ' ' A' ' 18' ' ' ALA . 0.0 OUTLIER -127.69 177.0 7.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.126 179.809 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.484 ' CD2' HD22 ' A' ' 33' ' ' LEU . 77.4 t80 -161.77 119.36 2.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.403 179.926 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.443 ' O ' ' CD2' ' A' ' 54' ' ' PHE . 28.3 p-10 -66.87 -177.34 0.6 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.402 -179.988 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 59.24 178.93 0.08 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.443 179.897 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 174.39 50.17 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.218 179.941 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -50.47 121.41 14.12 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.444 -179.847 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -71.56 59.73 2.66 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.444 2.096 . . . . 0.0 112.056 179.87 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -114.88 1.29 14.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.256 179.956 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -177.89 124.44 0.12 Allowed 'General case' 0 C--N 1.334 -0.092 0 CA-C-O 120.778 0.323 . . . . 0.0 110.367 179.939 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.406 ' N ' ' HD2' ' A' ' 63' ' ' PRO . . . -74.23 -54.94 5.94 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 110.814 -0.914 . . . . 0.0 110.814 -179.881 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.406 ' HD2' ' N ' ' A' ' 62' ' ' GLY . 48.0 Cg_endo -74.85 122.02 7.01 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.531 2.154 . . . . 0.0 112.214 -179.932 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -99.46 137.06 38.49 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.082 179.818 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 12.8 m-80 -98.59 134.24 41.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.803 0.335 . . . . 0.0 110.343 -179.923 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -119.92 174.31 6.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.455 179.993 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 12.6 ptm180 -173.52 76.36 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.0 -0.546 . . . . 0.0 109.92 179.923 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -61.42 175.19 0.61 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.192 0.52 . . . . 0.0 110.809 -179.56 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.417 ' O ' ' CB ' ' A' ' 29' ' ' ALA . 8.0 mt -132.02 65.41 1.57 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.129 179.569 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 14.0 p -26.99 135.0 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.644 0.778 . . . . 0.0 112.633 -178.987 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.431 ' N ' ' HB1' ' A' ' 29' ' ' ALA . 16.5 mt-10 -49.74 -26.0 3.46 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.54 -179.713 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.5 tmtm? -64.81 -40.31 95.0 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.317 179.898 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 118.86 53.46 0.28 Allowed Glycine 0 CA--C 1.524 0.604 0 N-CA-C 110.798 -0.921 . . . . 0.0 110.798 179.938 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -144.71 145.61 31.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.797 0.332 . . . . 0.0 110.47 179.964 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.417 ' CG ' HD21 ' A' ' 69' ' ' LEU . 0.8 OUTLIER -127.35 -178.87 4.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.312 179.976 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 174.31 162.92 0.2 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.526 179.964 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 86.9 t -107.18 160.77 6.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.248 179.854 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.476 ' CE2' HG23 ' A' ' 4' ' ' VAL . 71.8 m-85 -151.19 130.39 12.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.525 -179.92 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -115.0 160.56 19.44 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.313 -179.924 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 52.32 55.12 9.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.355 179.932 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.417 ' O ' ' CG1' ' A' ' 81' ' ' VAL . 75.6 t -102.05 2.15 10.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.034 179.957 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 89.3 t -156.26 131.45 5.37 Favored Pre-proline 0 C--N 1.332 -0.154 0 N-CA-C 110.229 -0.286 . . . . 0.0 110.229 179.556 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -70.98 -171.16 0.54 Allowed 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.516 2.144 . . . . 0.0 111.863 179.761 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -74.0 -27.85 61.17 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.883 179.386 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 4.0 tptt -138.46 77.66 1.64 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.093 179.779 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 51.0 p90 -55.05 137.28 46.74 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.589 -179.795 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 5.3 m -116.32 107.29 14.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.12 179.717 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 2.7 mp -47.76 108.39 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.582 -179.872 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 126.05 43.36 0.28 Allowed Glycine 0 CA--C 1.523 0.569 0 N-CA-C 110.587 -1.005 . . . . 0.0 110.587 -179.864 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.485 ' HB2' ' CZ ' ' A' ' 92' ' ' TYR . . . -153.8 -176.32 5.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.796 0.331 . . . . 0.0 110.389 -179.948 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 89.9 m -129.74 104.44 7.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.669 -179.84 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.485 ' CZ ' ' HB2' ' A' ' 90' ' ' ALA . 18.5 m-85 -106.97 140.27 40.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.463 179.901 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.407 ' CB ' ' HD2' ' A' ' 94' ' ' PRO . . . 171.75 171.7 0.2 Allowed Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.389 179.593 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.407 ' HD2' ' CB ' ' A' ' 93' ' ' ALA . 47.6 Cg_endo . . . . . 0 C--O 1.249 1.032 0 C-N-CA 122.606 2.204 . . . . 0.0 111.984 179.804 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.436 ' O ' ' CG2' ' A' ' 4' ' ' VAL . 18.4 mtmt . . . . . 0 CA--C 1.521 -0.158 0 CA-C-O 120.706 0.288 . . . . 0.0 110.403 . . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.472 HG23 ' CE1' ' A' ' 78' ' ' PHE . 19.5 m 44.22 -172.38 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.338 179.807 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.426 ' CG2' ' O ' ' A' ' 4' ' ' VAL . 0.5 OUTLIER -179.55 137.64 0.13 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.301 -179.761 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.428 ' N ' ' CD1' ' A' ' 6' ' ' PHE . 8.2 m-85 -116.13 178.4 4.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.061 179.855 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 48.2 m -164.43 124.06 1.96 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.873 0.368 . . . . 0.0 110.514 -179.94 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 90.1 t -58.64 90.33 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.449 179.99 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.429 ' HG3' ' CG1' ' A' ' 51' ' ' VAL . 1.9 mm-40 -59.1 176.04 0.25 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.432 -179.968 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 5.1 mtmt -69.72 155.37 40.62 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.27 179.878 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 103.37 -33.44 6.58 Favored Glycine 0 CA--C 1.523 0.533 0 N-CA-C 110.851 -0.899 . . . . 0.0 110.851 179.968 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 70.9 m -50.67 112.36 0.69 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.684 0.278 . . . . 0.0 110.316 179.969 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -112.69 -67.06 1.03 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.937 -179.685 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -141.46 -48.66 0.39 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.643 0.258 . . . . 0.0 110.93 -179.702 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 8.9 ptpt -103.93 -39.38 6.62 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.766 0.317 . . . . 0.0 110.498 -179.944 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 13.2 m80 -65.94 110.26 2.83 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 179.794 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -107.21 94.87 5.33 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.41 -179.772 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.431 ' HB3' ' CG2' ' A' ' 53' ' ' THR . . . -95.34 120.44 35.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.381 179.987 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.405 HG22 HG13 ' A' ' 21' ' ' VAL . 21.1 m -114.42 144.24 22.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.218 179.899 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.4 ' HA ' HG13 ' A' ' 51' ' ' VAL . 1.5 tt -97.54 62.53 1.7 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.758 -179.718 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.523 ' CG1' ' CD1' ' A' ' 52' ' ' TRP . 3.4 p -81.75 126.02 39.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.971 0.415 . . . . 0.0 110.103 179.74 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.494 ' O ' ' CG ' ' A' ' 23' ' ' TYR . 5.8 tttp -166.33 -66.98 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.312 -179.863 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.494 ' CG ' ' O ' ' A' ' 22' ' ' LYS . 30.0 p90 44.97 -172.96 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.906 179.824 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -122.06 177.66 5.23 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.353 -179.724 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 96.95 -40.7 2.49 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 110.772 -0.931 . . . . 0.0 110.772 179.949 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -128.99 -175.11 3.45 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.812 0.339 . . . . 0.0 110.266 179.968 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -113.25 -178.98 3.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.548 -179.98 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.429 ' O ' ' CG ' ' A' ' 71' ' ' GLU . 0.4 OUTLIER -128.56 126.66 40.78 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.462 -179.882 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.449 ' HB1' ' N ' ' A' ' 71' ' ' GLU . . . -120.12 -59.85 1.75 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.393 179.957 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -142.8 159.0 43.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.291 179.986 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.449 HG23 ' CD1' ' A' ' 52' ' ' TRP . 47.2 t -138.54 145.98 27.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.038 0.447 . . . . 0.0 110.435 179.96 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.455 ' HB2' ' HA ' ' A' ' 43' ' ' ALA . 11.6 tt0 -139.79 129.53 24.58 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.891 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.454 ' HB2' ' CE2' ' A' ' 66' ' ' PHE . 5.6 tp -110.35 150.19 29.13 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.962 0.411 . . . . 0.0 110.049 -179.027 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.421 ' HG3' ' CD2' ' A' ' 41' ' ' TRP . 0.5 OUTLIER -106.22 -156.31 0.57 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.548 179.462 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -149.73 -87.69 0.08 Allowed 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 121.235 -0.186 . . . . 0.0 110.631 179.883 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 17.3 t-160 175.48 -56.97 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 -179.976 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -91.36 -25.82 22.65 Favored Glycine 0 CA--C 1.522 0.513 0 N-CA-C 110.467 -1.053 . . . . 0.0 110.467 179.607 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.41 ' O ' ' CB ' ' A' ' 39' ' ' ASP . 0.1 OUTLIER -50.66 -31.66 16.87 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.871 0.367 . . . . 0.0 110.327 179.87 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.41 ' CB ' ' O ' ' A' ' 38' ' ' SER . 11.2 t0 81.75 -52.33 0.25 Allowed 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.882 179.856 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -98.24 177.38 5.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.969 0.414 . . . . 0.0 110.753 -179.619 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.421 ' CD2' ' HG3' ' A' ' 34' ' ' ARG . 59.8 m95 -95.96 171.97 8.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.383 -179.946 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.434 ' CG2' ' O ' ' A' ' 33' ' ' LEU . 5.1 m -146.86 105.64 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.201 179.621 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.455 ' HA ' ' HB2' ' A' ' 32' ' ' GLU . . . -49.94 136.49 18.39 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.697 -179.693 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -63.33 -173.09 0.06 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.896 -179.791 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 30.2 m -137.66 99.97 4.08 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.372 -179.999 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 6.5 ptpt -64.51 80.38 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.47 -179.905 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -113.11 -24.78 4.69 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.88 -0.888 . . . . 0.0 110.88 -179.969 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -72.73 -37.28 67.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.894 0.378 . . . . 0.0 110.473 179.987 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 95.65 -38.68 3.04 Favored Glycine 0 CA--C 1.523 0.541 0 N-CA-C 110.274 -1.13 . . . . 0.0 110.274 -179.654 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -102.17 -29.9 5.89 Favored Glycine 0 CA--C 1.523 0.539 0 N-CA-C 110.42 -1.072 . . . . 0.0 110.42 179.734 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.429 ' CG1' ' HG3' ' A' ' 9' ' ' GLU . 8.0 m -138.49 -178.47 2.0 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.768 0.318 . . . . 0.0 110.273 179.773 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . 0.523 ' CD1' ' CG1' ' A' ' 21' ' ' VAL . 5.5 m95 -114.97 136.98 52.53 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.893 0.378 . . . . 0.0 110.772 -179.414 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.431 ' CG2' ' HB3' ' A' ' 18' ' ' ALA . 10.2 p -126.39 151.08 48.14 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.732 179.452 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.407 ' CZ ' ' HB ' ' A' ' 42' ' ' VAL . 63.9 t80 -141.24 152.79 44.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.941 0.401 . . . . 0.0 110.921 -179.634 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -94.02 102.06 14.12 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.106 179.714 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.1 m -83.73 139.11 32.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.712 -179.702 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -100.06 -49.93 4.15 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.243 179.823 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.415 ' HA ' ' HD3' ' A' ' 59' ' ' PRO . 12.3 pt-20 -74.3 126.46 88.97 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.313 179.963 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 58' ' ' GLU . 38.0 Cg_endo -91.97 71.28 0.78 Allowed 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 123.159 2.572 . . . . 0.0 112.066 179.627 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -106.84 -30.34 8.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.058 0.456 . . . . 0.0 110.375 -179.936 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 44.33 36.48 1.61 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.942 179.933 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -94.04 -144.71 16.28 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 110.895 -0.882 . . . . 0.0 110.895 -179.83 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -78.63 120.79 4.88 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.608 2.205 . . . . 0.0 112.291 -179.821 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.403 ' HB3' ' CD1' ' A' ' 33' ' ' LEU . 30.7 m-85 -90.76 178.4 6.07 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.1 179.81 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -152.78 139.77 19.17 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.936 179.81 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.454 ' CE2' ' HB2' ' A' ' 33' ' ' LEU . 11.0 m-85 -127.68 177.25 6.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.05 0.452 . . . . 0.0 111.136 -179.775 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.412 ' CB ' ' O ' ' A' ' 76' ' ' ASN . 0.0 OUTLIER -177.16 66.89 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.592 179.976 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -58.47 173.65 0.37 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.252 -179.277 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 10.2 mt -123.94 83.33 2.13 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.307 -0.86 . . . . 0.0 108.896 178.884 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.418 ' OG1' ' N ' ' A' ' 74' ' ' MET . 1.6 p -35.55 137.08 0.2 Allowed 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.799 -178.954 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.449 ' N ' ' HB1' ' A' ' 29' ' ' ALA . 21.0 mt-10 -46.71 -34.51 5.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.171 -179.16 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.99 60.03 0.59 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.776 0.322 . . . . 0.0 111.017 179.867 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -148.79 -107.18 0.43 Allowed Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.803 -0.919 . . . . 0.0 110.803 179.646 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.418 ' N ' ' OG1' ' A' ' 70' ' ' THR . 21.0 ptm -159.9 -176.42 5.69 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.846 0.355 . . . . 0.0 110.182 179.864 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.01 159.7 20.48 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.638 -179.762 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.412 ' O ' ' CB ' ' A' ' 67' ' ' ARG . 10.7 m-20 -152.43 175.06 13.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.098 -179.953 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 49.5 t -110.24 160.98 8.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.434 -179.907 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.472 ' CE1' HG23 ' A' ' 4' ' ' VAL . 75.9 m-85 -149.85 129.2 12.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.396 -179.922 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 15.2 p-10 -116.47 164.97 13.77 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.35 -179.999 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 32.3 m-20 52.35 27.29 4.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.524 179.959 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 88.3 t -61.79 -16.36 15.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.677 179.838 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.422 ' CG1' ' HD2' ' A' ' 83' ' ' PRO . 54.3 t -150.06 138.92 12.73 Favored Pre-proline 0 C--N 1.331 -0.228 0 N-CA-C 110.292 -0.262 . . . . 0.0 110.292 179.945 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.422 ' HD2' ' CG1' ' A' ' 82' ' ' VAL . 47.8 Cg_endo -72.28 -175.62 1.84 Allowed 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.592 2.195 . . . . 0.0 111.978 179.86 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 26.4 mm-40 -69.45 -54.87 12.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.21 179.849 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 10.5 tttt -113.9 67.4 0.67 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.237 179.98 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 30.8 p90 -57.64 174.42 0.23 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.676 -179.819 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 27.1 m -150.8 120.21 6.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.07 179.827 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 3.9 mp -48.96 104.31 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.742 -179.752 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 133.43 53.4 0.08 OUTLIER Glycine 0 CA--C 1.523 0.561 0 N-CA-C 110.814 -0.914 . . . . 0.0 110.814 179.992 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -173.71 140.79 0.79 Allowed 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 110.228 -0.286 . . . . 0.0 110.228 179.92 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 25.1 m -97.43 89.25 4.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.909 0.385 . . . . 0.0 110.626 -179.89 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.406 ' O ' ' CB ' ' A' ' 93' ' ' ALA . 43.6 m-85 -70.2 -156.94 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.042 -0.526 . . . . 0.0 109.874 179.56 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.437 ' CB ' ' HD2' ' A' ' 94' ' ' PRO . . . 76.65 173.71 0.09 OUTLIER Pre-proline 0 N--CA 1.464 0.24 0 CA-C-O 120.809 0.338 . . . . 0.0 110.69 179.853 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.437 ' HD2' ' CB ' ' A' ' 93' ' ' ALA . 47.5 Cg_endo . . . . . 0 C--O 1.249 1.063 0 C-N-CA 122.583 2.189 . . . . 0.0 112.096 179.891 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.523 -0.092 0 CA-C-O 120.792 0.329 . . . . 0.0 110.205 . . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.533 ' CG1' ' CE1' ' A' ' 78' ' ' PHE . 1.7 p -115.09 163.38 12.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.368 0.604 . . . . 0.0 110.569 -179.806 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.476 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 0.6 OUTLIER -134.31 148.76 50.82 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.048 179.729 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -118.52 171.79 7.92 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.389 -179.944 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.9 m -167.81 131.8 1.73 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.007 -179.952 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 34.8 t -82.21 94.68 2.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.537 -179.728 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -54.4 178.26 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.513 -179.921 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 4.1 mmmt -85.89 52.35 2.45 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.514 179.936 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -139.69 23.68 2.78 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 110.86 -0.896 . . . . 0.0 110.86 179.974 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 19.0 m -109.89 127.26 54.61 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 110.168 -0.308 . . . . 0.0 110.168 179.944 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -121.85 -87.61 0.64 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.471 -179.863 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 39.0 tp10 -117.61 -61.92 1.63 Allowed 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 120.826 0.346 . . . . 0.0 110.12 -179.79 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.421 ' CE ' ' HG3' ' A' ' 57' ' ' GLU . 5.5 ptpt -98.69 -21.56 16.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.746 -179.847 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 5.4 m80 -73.73 135.48 43.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.835 0.35 . . . . 0.0 110.282 179.926 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -133.44 100.14 4.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.243 -179.968 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -97.12 145.1 26.32 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.377 -179.95 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.436 HG22 ' CG2' ' A' ' 21' ' ' VAL . 14.5 m -139.83 134.19 37.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.579 -179.871 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.43 ' HA ' ' CG1' ' A' ' 51' ' ' VAL . 1.3 tt -83.22 64.0 7.5 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.435 179.876 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.436 ' CG2' HG22 ' A' ' 19' ' ' VAL . 17.2 t -74.04 87.12 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.272 -179.978 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 7.3 tttp -176.61 120.52 0.14 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.401 -179.966 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 27.3 p90 -130.81 29.06 4.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.291 179.99 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 53.91 -177.15 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.327 -179.889 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 77.21 -66.02 2.95 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 110.714 -0.954 . . . . 0.0 110.714 -179.952 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -84.65 179.27 7.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.775 0.322 . . . . 0.0 110.315 179.922 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.4 ' HB ' ' CG ' ' A' ' 71' ' ' GLU . 0.0 OUTLIER -115.47 170.78 8.15 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.275 179.906 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 11.9 mmt -113.65 126.2 55.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.739 -179.712 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.435 ' CB ' ' HG2' ' A' ' 71' ' ' GLU . . . -115.82 -60.87 1.81 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.223 -179.804 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -158.19 161.47 37.84 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.551 179.776 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.448 HG23 ' CD1' ' A' ' 52' ' ' TRP . 12.0 t -136.78 142.79 36.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.316 0.579 . . . . 0.0 111.407 -179.723 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.435 ' CG ' ' HB3' ' A' ' 41' ' ' TRP . 2.5 tp10 -137.5 122.68 19.25 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-N 115.105 -0.952 . . . . 0.0 108.911 -179.827 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.477 ' HB3' ' CE1' ' A' ' 66' ' ' PHE . 2.9 pp -110.66 179.5 4.05 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.254 0.549 . . . . 0.0 111.492 -179.036 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.481 ' HB2' ' CE3' ' A' ' 41' ' ' TRP . 9.4 ttt180 -148.94 170.79 17.53 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.141 179.417 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -119.97 -82.83 0.65 Allowed 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 179.906 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER 178.33 -56.98 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.311 179.383 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -66.02 -28.03 73.33 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 110.697 -0.961 . . . . 0.0 110.697 179.959 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -61.3 166.76 3.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.756 0.312 . . . . 0.0 110.366 179.941 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -121.47 25.66 9.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.487 -179.978 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -179.5 149.13 0.37 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.277 179.968 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.492 ' CE3' ' HG2' ' A' ' 67' ' ' ARG . 58.2 m95 -64.68 160.57 19.59 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.506 -179.983 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 31.5 m -130.33 109.61 17.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.174 179.796 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.42 ' N ' ' OE2' ' A' ' 32' ' ' GLU . . . -49.11 124.73 9.37 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.725 -179.658 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.04 -171.3 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.116 179.77 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 30.5 m -152.11 119.05 5.8 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.58 -179.923 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 14.2 ptpt -74.78 67.52 1.62 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.07 179.708 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -98.16 -19.95 22.14 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 111.21 -0.756 . . . . 0.0 111.21 -179.749 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.437 ' HG2' ' CG2' ' A' ' 51' ' ' VAL . 30.9 tp10 -77.76 -45.06 25.71 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.767 0.317 . . . . 0.0 110.388 -179.884 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 117.58 -63.28 0.4 Allowed Glycine 0 CA--C 1.523 0.561 0 N-CA-C 110.708 -0.957 . . . . 0.0 110.708 179.977 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -84.47 -30.01 28.52 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 110.718 -0.953 . . . . 0.0 110.718 179.97 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.437 ' CG2' ' HG2' ' A' ' 48' ' ' GLU . 6.3 m -132.53 -179.44 3.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.881 0.372 . . . . 0.0 110.437 179.953 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . 0.448 ' CD1' HG23 ' A' ' 31' ' ' VAL . 5.4 m95 -103.72 125.93 50.52 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.183 -179.823 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -118.05 160.66 21.11 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.406 -179.945 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 26.7 t80 -138.21 128.12 25.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.42 -179.966 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 19.7 p-10 -102.18 115.98 31.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.441 179.988 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 4.0 m -170.54 161.5 7.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.203 179.928 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.421 ' HG3' ' CE ' ' A' ' 15' ' ' LYS . 5.3 mt-10 -132.03 26.2 4.59 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.542 -179.903 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.95 156.51 25.47 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.311 179.882 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -72.49 69.42 3.44 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.641 2.227 . . . . 0.0 112.173 -179.942 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.7 pp -81.54 127.49 32.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.366 179.909 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -132.38 32.4 3.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.475 -179.999 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -156.13 -170.29 21.23 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 110.863 -0.895 . . . . 0.0 110.863 -179.996 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -78.32 165.75 25.18 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.721 2.281 . . . . 0.0 112.039 -179.916 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -98.16 105.3 17.43 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.464 179.962 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 17.8 m-80 -77.51 140.65 39.8 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 179.191 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.477 ' CE1' ' HB3' ' A' ' 33' ' ' LEU . 37.1 m-85 -121.57 -178.56 3.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.157 0.503 . . . . 0.0 111.245 -179.245 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.492 ' HG2' ' CE3' ' A' ' 41' ' ' TRP . 0.0 OUTLIER 173.95 59.09 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.728 179.973 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.437 ' HA ' ' HA ' ' A' ' 31' ' ' VAL . 1.2 p90 -50.86 165.24 0.11 Allowed 'General case' 0 CA--C 1.517 -0.321 0 CA-C-O 121.219 0.533 . . . . 0.0 111.054 -179.323 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.2 mt -115.9 63.33 0.7 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.118 179.671 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 12.0 p -29.95 138.22 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 115.594 -0.73 . . . . 0.0 112.476 -179.019 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.435 ' HG2' ' CB ' ' A' ' 29' ' ' ALA . 16.4 mt-10 -52.36 -36.11 52.88 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.364 -179.952 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.09 65.74 1.15 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.505 -179.835 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -151.23 -106.92 0.35 Allowed Glycine 0 CA--C 1.522 0.484 0 N-CA-C 110.58 -1.008 . . . . 0.0 110.58 179.965 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 16.1 ptt? -175.32 176.17 2.07 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.805 0.336 . . . . 0.0 110.194 179.919 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.476 ' N ' ' CD ' ' A' ' 75' ' ' LYS . 0.0 OUTLIER -94.62 120.78 35.39 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.141 179.924 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.423 ' O ' ' CB ' ' A' ' 67' ' ' ARG . 65.5 m-80 -112.05 168.69 9.4 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.727 -179.596 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 94.1 t -120.48 153.23 23.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.046 179.68 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.533 ' CE1' ' CG1' ' A' ' 4' ' ' VAL . 45.6 m-85 -152.9 130.71 11.66 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.576 -179.817 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 36.9 m-20 -118.71 149.55 41.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.178 179.867 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 27.9 t0 64.12 42.88 5.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.435 179.98 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 76.2 t -86.28 -6.35 10.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.054 179.827 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 96.8 t -155.69 115.07 2.24 Favored Pre-proline 0 CA--C 1.528 0.1 0 N-CA-C 110.217 -0.29 . . . . 0.0 110.217 179.795 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -73.55 -170.9 0.73 Allowed 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.417 2.078 . . . . 0.0 112.014 179.862 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -90.67 125.63 35.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.167 179.808 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 64.74 42.46 4.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.094 -179.784 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . 0.426 ' HB2' ' CE2' ' A' ' 92' ' ' TYR . 27.1 p90 -50.76 177.53 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.771 -179.776 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 70.9 m -132.23 110.01 10.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.939 179.692 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 3.2 mp -46.16 124.38 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.729 -179.728 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 106.68 55.68 0.65 Allowed Glycine 0 CA--C 1.524 0.596 0 N-CA-C 110.833 -0.907 . . . . 0.0 110.833 179.958 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -179.6 141.11 0.15 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.808 0.337 . . . . 0.0 110.578 179.986 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 8.2 m -83.89 131.3 34.88 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.042 179.726 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.426 ' CE2' ' HB2' ' A' ' 86' ' ' TYR . 59.5 m-85 -113.54 -23.02 10.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.937 -179.36 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.466 ' CB ' ' CD ' ' A' ' 94' ' ' PRO . . . -51.02 -179.82 0.04 OUTLIER Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.332 179.844 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.466 ' CD ' ' CB ' ' A' ' 93' ' ' ALA . 50.1 Cg_endo . . . . . 0 C--O 1.249 1.027 0 C-N-CA 122.579 2.186 . . . . 0.0 112.071 -179.862 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 15.0 mtpp . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.794 0.331 . . . . 0.0 110.377 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.479 HG21 ' CE2' ' A' ' 78' ' ' PHE . 19.4 m -51.59 -178.65 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.32 179.902 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 20.0 p -155.56 134.23 11.88 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.481 179.965 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.541 ' CE2' ' CD2' ' A' ' 66' ' ' PHE . 37.4 m-85 -97.89 175.72 6.04 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.15 179.87 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.404 ' HB ' ' CB ' ' A' ' 20' ' ' LEU . 0.5 OUTLIER -164.4 107.05 0.9 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.857 0.361 . . . . 0.0 110.537 -179.981 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 40.7 t -60.81 85.27 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.255 179.948 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -50.42 143.97 8.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.673 -179.773 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.434 ' HA ' ' CG2' ' A' ' 88' ' ' ILE . 0.1 OUTLIER -67.4 142.1 56.82 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.276 179.899 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 117.95 14.08 6.84 Favored Glycine 0 CA--C 1.527 0.795 0 N-CA-C 111.41 -0.676 . . . . 0.0 111.41 179.839 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 39.4 m -55.65 104.6 0.14 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.961 0.381 . . . . 0.0 109.987 179.731 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 8.1 m-20 -57.85 -164.91 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.602 -179.589 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -56.68 -48.09 78.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.091 -179.345 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 8.8 pttt -136.13 33.78 2.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.944 -179.391 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 5.2 m80 -111.93 156.56 21.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.804 0.335 . . . . 0.0 110.279 179.703 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 28.9 tp -137.01 103.63 5.2 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.684 -179.77 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.437 ' HB3' ' CG2' ' A' ' 53' ' ' THR . . . -90.7 124.3 34.98 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.068 -0.515 . . . . 0.0 109.894 179.574 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 32.6 m -117.45 138.82 46.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.827 0.346 . . . . 0.0 110.653 -179.698 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.404 ' CB ' ' HB ' ' A' ' 7' ' ' THR . 0.7 OUTLIER -94.64 69.59 3.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.452 179.96 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 18.8 t -80.11 90.01 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.394 -0.367 . . . . 0.0 110.246 179.991 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -151.97 129.16 11.18 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.504 -179.958 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.418 ' CZ ' HG13 ' A' ' 4' ' ' VAL . 15.0 p90 -154.53 176.75 11.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.262 179.843 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -105.43 96.64 6.65 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.358 179.992 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -179.99 -51.5 0.08 OUTLIER Glycine 0 CA--C 1.523 0.54 0 N-CA-C 110.594 -1.002 . . . . 0.0 110.594 -179.912 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -126.58 155.22 42.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.738 0.304 . . . . 0.0 110.296 179.939 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.16 -176.98 6.44 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.406 -179.984 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.426 ' O ' ' CG ' ' A' ' 71' ' ' GLU . 41.0 mtm -117.23 122.24 43.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.623 -179.743 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.428 ' HB1' ' N ' ' A' ' 71' ' ' GLU . . . -122.23 -53.31 1.93 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.276 179.922 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -158.04 164.2 36.96 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.146 179.948 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.456 HG23 ' CD1' ' A' ' 52' ' ' TRP . 12.2 t -147.26 149.83 15.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.633 179.968 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.443 ' CB ' ' HA ' ' A' ' 43' ' ' ALA . 0.3 OUTLIER -158.81 130.56 6.53 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.07 179.966 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.484 ' HB3' ' CE1' ' A' ' 66' ' ' PHE . 3.5 pp -110.99 -177.88 3.33 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.039 0.447 . . . . 0.0 110.998 -179.44 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.482 ' HB2' ' CE3' ' A' ' 41' ' ' TRP . 1.3 ttp180 -143.06 162.09 36.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.007 179.724 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -129.51 25.59 5.4 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.198 179.643 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 49.32 94.15 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.817 179.838 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.414 ' O ' ' N ' ' A' ' 39' ' ' ASP . . . 98.23 -30.13 10.07 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 111.207 -0.757 . . . . 0.0 111.207 179.639 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 14.7 m -65.2 74.14 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.794 0.33 . . . . 0.0 110.703 -179.7 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.414 ' N ' ' O ' ' A' ' 37' ' ' GLY . 8.7 m-20 46.62 43.3 12.43 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.937 179.655 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 52.06 -173.55 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.926 0.393 . . . . 0.0 110.387 179.887 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.499 ' CZ3' ' HG2' ' A' ' 67' ' ' ARG . 80.7 m95 -44.86 144.2 1.24 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.945 -179.936 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.46 HG23 ' CE1' ' A' ' 54' ' ' PHE . 31.1 m -131.07 116.37 33.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.124 179.757 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.443 ' HA ' ' CB ' ' A' ' 32' ' ' GLU . . . -49.51 128.81 18.15 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.25 179.991 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -62.97 -172.13 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.287 -179.808 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 31.6 m -132.5 109.35 9.73 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.446 -179.9 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.442 ' HB3' ' CZ3' ' A' ' 52' ' ' TRP . 39.4 mtpt -85.49 106.58 16.93 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.327 -179.999 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 170.99 43.84 0.03 OUTLIER Glycine 0 CA--C 1.524 0.596 0 N-CA-C 110.749 -0.94 . . . . 0.0 110.749 -179.902 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 24.3 tp10 -130.38 65.34 1.52 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.776 0.322 . . . . 0.0 110.457 179.939 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 67.42 -80.7 0.15 Allowed Glycine 0 CA--C 1.523 0.551 0 N-CA-C 110.75 -0.94 . . . . 0.0 110.75 179.987 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -146.49 21.09 1.69 Allowed Glycine 0 CA--C 1.526 0.737 0 N-CA-C 111.256 -0.737 . . . . 0.0 111.256 -179.954 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 29.6 m -138.85 170.45 16.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 110.159 -0.312 . . . . 0.0 110.159 179.764 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . 0.456 ' CD1' HG23 ' A' ' 31' ' ' VAL . 7.4 m95 -100.24 137.36 38.78 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.026 0.441 . . . . 0.0 111.032 -179.461 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.437 ' CG2' ' HB3' ' A' ' 18' ' ' ALA . 0.2 OUTLIER -120.77 142.45 49.55 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.546 179.31 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.46 ' CE1' HG23 ' A' ' 42' ' ' VAL . 27.7 t80 -108.01 116.14 31.41 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.963 0.411 . . . . 0.0 110.691 -179.547 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 57.9 t0 -107.49 130.2 54.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.112 179.847 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -158.26 -177.65 6.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.908 0.385 . . . . 0.0 110.517 -179.884 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -99.52 -26.23 14.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.448 -179.945 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -50.39 159.09 0.9 Allowed Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.483 -179.945 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -70.56 -20.6 30.87 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.554 2.17 . . . . 0.0 111.856 179.673 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.4 tp 57.12 101.87 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.519 179.739 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -173.97 71.04 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.35 180.0 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.434 ' O ' ' CE2' ' A' ' 64' ' ' PHE . . . 175.46 -158.07 25.07 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 110.762 -0.935 . . . . 0.0 110.762 -179.974 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -78.86 169.71 19.09 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.604 2.203 . . . . 0.0 112.086 -179.949 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.434 ' CE2' ' O ' ' A' ' 62' ' ' GLY . 72.4 m-85 -151.27 111.87 4.21 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.515 -179.968 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 12.0 m-80 -81.13 153.21 27.4 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 179.445 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.541 ' CD2' ' CE2' ' A' ' 6' ' ' PHE . 21.0 m-85 -128.75 178.17 6.54 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.14 0.495 . . . . 0.0 111.257 -179.769 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.499 ' HG2' ' CZ3' ' A' ' 41' ' ' TRP . 0.1 OUTLIER 171.85 78.71 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.552 179.864 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -78.11 169.0 19.0 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.186 0.517 . . . . 0.0 110.932 -179.295 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.403 HD21 ' HG3' ' A' ' 75' ' ' LYS . 2.4 mt -118.16 71.91 0.85 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.234 179.528 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.414 ' OG1' ' N ' ' A' ' 74' ' ' MET . 28.4 p -36.75 140.55 0.15 Allowed 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.742 -179.108 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.428 ' N ' ' HB1' ' A' ' 29' ' ' ALA . 17.7 mt-10 -48.9 -57.34 6.6 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.635 -179.7 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.43 52.28 2.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.441 179.958 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -129.8 -108.7 1.32 Allowed Glycine 0 CA--C 1.523 0.567 0 N-CA-C 110.636 -0.985 . . . . 0.0 110.636 179.917 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.414 ' N ' ' OG1' ' A' ' 70' ' ' THR . 2.4 ptm -173.12 168.13 4.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.838 0.351 . . . . 0.0 110.35 -179.993 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.403 ' HG3' HD21 ' A' ' 69' ' ' LEU . 0.6 OUTLIER -77.95 166.71 22.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.231 179.857 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -171.03 164.69 7.52 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.311 179.917 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 98.1 t -130.37 142.26 44.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.163 179.943 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.479 ' CE2' HG21 ' A' ' 4' ' ' VAL . 86.3 m-85 -134.04 132.69 40.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.602 -179.818 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -119.54 162.22 19.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.276 179.844 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 55.03 39.88 31.77 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.312 -179.871 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 47.0 t -86.62 -10.23 11.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.818 -179.978 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.403 HG11 ' HD2' ' A' ' 83' ' ' PRO . 98.7 t -148.49 130.7 7.64 Favored Pre-proline 0 CA--C 1.529 0.137 0 N-CA-C 110.301 -0.259 . . . . 0.0 110.301 179.782 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.47 ' HD3' ' CD1' ' A' ' 92' ' ' TYR . 47.5 Cg_endo -70.73 -174.35 1.07 Allowed 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.534 2.156 . . . . 0.0 111.819 179.575 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -58.3 -63.94 1.09 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.004 179.668 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -108.76 86.57 2.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.114 179.622 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 31.8 p90 -52.83 150.65 5.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.753 -179.641 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 27.9 m -122.21 101.67 7.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.982 179.748 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.434 ' CG2' ' HA ' ' A' ' 10' ' ' LYS . 2.7 mp -44.36 116.48 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.005 -179.673 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 106.72 56.06 0.64 Allowed Glycine 0 CA--C 1.523 0.593 0 N-CA-C 110.812 -0.915 . . . . 0.0 110.812 179.854 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -174.03 142.72 0.87 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.898 0.38 . . . . 0.0 110.731 179.984 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 10.0 m -87.69 133.65 33.8 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.044 -0.525 . . . . 0.0 109.881 179.561 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.47 ' CD1' ' HD3' ' A' ' 83' ' ' PRO . 65.5 m-85 -117.09 -86.07 0.63 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.022 -179.266 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.476 ' CB ' ' CD ' ' A' ' 94' ' ' PRO . . . 50.59 179.86 0.02 OUTLIER Pre-proline 0 C--N 1.332 -0.192 0 CA-C-O 120.723 0.297 . . . . 0.0 110.438 -179.714 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.476 ' CD ' ' CB ' ' A' ' 93' ' ' ALA . 48.8 Cg_endo . . . . . 0 C--O 1.249 1.066 0 C-N-CA 122.586 2.191 . . . . 0.0 112.097 -179.846 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 9.0 mtmt . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.767 0.318 . . . . 0.0 110.44 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.523 ' CG1' ' CE1' ' A' ' 78' ' ' PHE . 1.7 p -58.55 163.66 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.268 0.556 . . . . 0.0 110.337 -179.919 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.479 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 5.7 p -148.09 130.6 15.8 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.466 179.907 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -98.87 175.25 6.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.258 -179.994 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.0 m -166.47 107.74 0.69 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.297 -179.966 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 47.8 t -55.34 99.82 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.402 179.997 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -72.29 174.49 7.2 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.596 -179.836 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.04 178.8 0.78 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.385 -179.966 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 67.24 26.81 73.42 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 110.784 -0.926 . . . . 0.0 110.784 179.939 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 85.3 p -87.49 109.25 19.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.767 0.317 . . . . 0.0 110.445 -179.969 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 30.8 m-20 -112.73 -162.52 0.8 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.236 179.815 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -65.54 -60.07 3.32 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.416 179.997 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -94.6 20.26 8.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.905 -179.727 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 19.5 m80 -128.11 112.32 14.45 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.863 0.363 . . . . 0.0 110.462 -179.914 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -119.03 99.27 6.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.281 179.966 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.427 ' HB3' ' CG2' ' A' ' 53' ' ' THR . . . -95.29 132.58 40.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.182 179.877 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 25.7 m -132.43 137.35 54.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.428 -179.999 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -87.88 90.18 8.28 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.393 179.833 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 27.2 t -90.24 101.24 12.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.369 -179.966 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -174.41 144.28 0.9 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.343 -179.926 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.436 ' CE1' ' HB2' ' A' ' 26' ' ' ASP . 5.9 p90 -158.48 62.79 0.43 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.502 -179.894 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 65.12 -71.33 0.08 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.779 179.719 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.427 ' N ' ' O ' ' A' ' 23' ' ' TYR . . . -75.26 -160.66 8.56 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 110.796 -0.922 . . . . 0.0 110.796 -179.879 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.436 ' HB2' ' CE1' ' A' ' 23' ' ' TYR . 47.7 t0 64.55 127.99 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.793 0.33 . . . . 0.0 110.368 179.998 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.411 ' CG2' ' O ' ' A' ' 27' ' ' THR . 31.6 m -109.97 34.26 3.96 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.559 -179.933 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.415 ' O ' ' CG ' ' A' ' 71' ' ' GLU . 0.0 OUTLIER 49.25 -177.6 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.011 179.595 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.411 ' CB ' ' O ' ' A' ' 69' ' ' LEU . . . 168.62 -66.01 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.168 179.832 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -154.5 154.81 33.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.722 179.898 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.441 HG23 ' CD1' ' A' ' 52' ' ' TRP . 12.3 t -148.96 153.64 10.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.084 0.468 . . . . 0.0 111.092 -179.597 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.433 ' CG ' ' HD2' ' A' ' 67' ' ' ARG . 0.0 OUTLIER -163.37 147.72 10.89 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.896 -179.917 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.44 HD22 ' CG ' ' A' ' 54' ' ' PHE . 3.4 pp -121.95 179.94 4.34 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.905 0.383 . . . . 0.0 110.942 -179.512 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.414 ' N ' ' CD1' ' A' ' 33' ' ' LEU . 4.7 ttt180 -133.96 167.13 21.16 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.078 179.847 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -128.21 9.11 6.15 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.281 -179.927 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 3.8 t60 67.98 -67.48 0.19 Allowed 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.766 0.317 . . . . 0.0 110.595 179.791 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -52.22 -53.02 33.05 Favored Glycine 0 CA--C 1.523 0.592 0 N-CA-C 110.972 -0.851 . . . . 0.0 110.972 -179.843 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 58.9 m -51.02 -28.71 10.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.771 0.32 . . . . 0.0 110.487 -179.839 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 24.9 t0 63.26 19.25 11.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.822 179.981 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -155.86 129.05 8.14 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.871 0.367 . . . . 0.0 110.479 179.898 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.477 ' CZ3' ' HG2' ' A' ' 67' ' ' ARG . 84.3 m95 -54.22 139.53 35.59 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.417 179.94 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.476 ' CG2' ' CZ ' ' A' ' 54' ' ' PHE . 28.4 m -115.35 111.87 37.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.28 -0.418 . . . . 0.0 109.908 179.575 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -46.49 136.1 7.82 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.669 -179.617 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.432 ' CE ' HD21 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -65.2 -170.03 0.05 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.234 -179.856 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 23.4 m -144.29 103.9 4.03 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.595 -179.881 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 9.0 ptpt -67.64 72.43 0.15 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.143 179.683 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -103.55 -39.08 2.64 Favored Glycine 0 CA--C 1.521 0.447 0 N-CA-C 110.671 -0.972 . . . . 0.0 110.671 -179.852 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -75.86 134.18 40.39 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.811 0.339 . . . . 0.0 110.367 -179.967 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -78.36 74.65 2.04 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 110.74 -0.944 . . . . 0.0 110.74 -179.989 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 150.71 -52.89 0.5 Allowed Glycine 0 CA--C 1.522 0.52 0 N-CA-C 110.656 -0.978 . . . . 0.0 110.656 179.984 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 18.0 m -114.84 -177.95 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.795 0.331 . . . . 0.0 110.306 179.919 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . 0.441 ' CD1' HG23 ' A' ' 31' ' ' VAL . 13.6 m95 -109.57 141.44 42.07 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.709 -179.842 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.427 ' CG2' ' HB3' ' A' ' 18' ' ' ALA . 1.7 p -126.89 159.71 33.14 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.867 179.705 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.476 ' CZ ' ' CG2' ' A' ' 42' ' ' VAL . 57.1 t80 -130.86 125.33 33.31 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.861 0.363 . . . . 0.0 110.717 -179.664 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -85.09 63.11 7.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.177 179.78 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 52.3 p -57.04 147.06 25.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.436 -179.875 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.6 25.05 4.4 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.518 179.932 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -117.93 138.54 25.5 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.208 179.756 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -75.5 69.35 5.95 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.518 2.146 . . . . 0.0 112.164 -179.694 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 10.7 tp -151.22 106.68 3.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.394 179.898 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -102.02 62.99 0.9 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.037 0.446 . . . . 0.0 110.416 -179.92 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -109.02 -153.15 15.36 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 110.702 -0.959 . . . . 0.0 110.702 179.98 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -75.4 158.7 40.5 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.546 2.164 . . . . 0.0 111.953 179.96 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -131.21 105.28 7.56 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.668 -179.855 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 41.3 m-20 -68.82 168.65 12.99 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 179.432 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -144.74 174.69 10.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.141 0.495 . . . . 0.0 111.047 -179.815 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.477 ' HG2' ' CZ3' ' A' ' 41' ' ' TRP . 0.0 OUTLIER 175.57 54.98 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.559 -179.941 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -55.73 176.24 0.07 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.076 -179.377 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.411 ' O ' ' CB ' ' A' ' 29' ' ' ALA . 11.6 mt -124.99 69.82 1.14 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.59 179.598 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.411 ' O ' ' N ' ' A' ' 73' ' ' GLY . 16.5 p -37.86 140.78 0.23 Allowed 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.928 -179.18 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.415 ' CG ' ' O ' ' A' ' 28' ' ' MET . 0.0 OUTLIER -42.64 -44.91 4.45 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.355 179.988 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -54.74 -32.92 60.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.341 -179.994 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.411 ' N ' ' O ' ' A' ' 70' ' ' THR . . . 105.67 53.59 0.76 Allowed Glycine 0 CA--C 1.522 0.531 0 N-CA-C 110.757 -0.937 . . . . 0.0 110.757 179.986 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 5.0 mmm -129.18 130.13 45.95 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.771 0.32 . . . . 0.0 110.537 179.991 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.01 123.01 45.84 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.197 -0.456 . . . . 0.0 109.872 179.885 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.467 ' O ' ' CE2' ' A' ' 78' ' ' PHE . 6.4 m120 -134.21 126.16 29.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.377 -179.964 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 73.9 t -84.45 142.69 13.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.342 179.988 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.523 ' CE1' ' CG1' ' A' ' 4' ' ' VAL . 23.2 m-85 -129.38 137.02 50.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.52 -179.883 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -114.17 147.57 38.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.219 179.9 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 58.04 49.35 11.76 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.191 -179.867 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.426 ' O ' ' CG2' ' A' ' 82' ' ' VAL . 99.4 t -86.09 -4.75 9.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.23 -179.843 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.426 ' CG2' ' O ' ' A' ' 81' ' ' VAL . 89.4 t -157.09 130.8 4.75 Favored Pre-proline 0 C--N 1.333 -0.149 0 N-CA-C 110.228 -0.286 . . . . 0.0 110.228 179.77 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.478 ' HD3' ' CG ' ' A' ' 92' ' ' TYR . 45.6 Cg_endo -70.18 -170.85 0.45 Allowed 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.589 2.193 . . . . 0.0 111.923 179.676 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 -76.24 -62.61 1.55 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.192 179.788 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.08 66.46 0.91 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.9 179.655 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . 0.42 ' C ' ' CD1' ' A' ' 86' ' ' TYR . 14.3 p90 -49.45 154.13 0.97 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.886 -179.606 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 39.4 m -133.07 109.51 9.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.024 179.751 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 3.7 mp -46.25 100.44 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.908 -179.727 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 138.53 45.61 0.07 OUTLIER Glycine 0 CA--C 1.523 0.555 0 N-CA-C 110.86 -0.896 . . . . 0.0 110.86 179.868 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -162.98 174.61 12.1 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.825 0.345 . . . . 0.0 110.446 179.93 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 94.6 m -119.57 126.98 52.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.237 179.88 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.478 ' CG ' ' HD3' ' A' ' 83' ' ' PRO . 42.0 m-85 -126.21 109.39 12.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.391 -179.906 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.437 ' CB ' ' HD2' ' A' ' 94' ' ' PRO . . . 172.14 176.47 0.15 Allowed Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.257 179.96 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.437 ' HD2' ' CB ' ' A' ' 93' ' ' ALA . 48.1 Cg_endo . . . . . 0 C--O 1.249 1.052 0 C-N-CA 122.558 2.172 . . . . 0.0 112.096 -179.948 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 9.8 mtpm? . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.819 0.342 . . . . 0.0 110.502 . . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.473 HG22 ' CZ ' ' A' ' 78' ' ' PHE . 31.2 m -67.52 -175.78 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.496 179.993 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -171.65 153.87 3.53 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.31 179.849 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.486 ' CD2' ' HB ' ' A' ' 21' ' ' VAL . 51.2 m-85 -132.1 145.17 51.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.282 179.894 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 68.3 m -133.45 130.71 39.0 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.348 -179.923 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.444 HG12 ' CD2' ' A' ' 86' ' ' TYR . 84.0 t -67.71 90.99 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.276 -179.992 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.417 ' HG3' ' CG1' ' A' ' 51' ' ' VAL . 6.3 mm-40 -56.21 167.91 0.59 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.401 -179.918 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.09 -18.36 65.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.918 -179.979 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -46.52 -29.33 3.91 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 111.102 -0.799 . . . . 0.0 111.102 -179.846 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 27.8 m -64.71 139.04 58.72 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.727 0.299 . . . . 0.0 110.386 179.928 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.1 p30 -139.05 -50.49 0.53 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.59 179.965 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -147.96 -78.04 0.16 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.405 -179.908 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.18 9.67 41.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.219 -179.951 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 5.9 m80 -105.28 125.68 51.26 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.848 0.356 . . . . 0.0 110.358 -179.964 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -110.14 104.11 12.92 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.296 179.981 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.426 ' CB ' HG23 ' A' ' 53' ' ' THR . . . -110.64 110.49 21.19 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.29 -179.993 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 5.6 m -91.13 -168.61 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.04 0.448 . . . . 0.0 110.461 179.998 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.404 ' HA ' HG13 ' A' ' 51' ' ' VAL . 2.8 tt -141.46 83.39 1.86 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.506 179.905 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.527 ' CG1' ' CD1' ' A' ' 52' ' ' TRP . 2.1 p -102.53 97.68 5.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.007 179.892 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.483 ' O ' ' CG ' ' A' ' 23' ' ' TYR . 11.9 ttmt -145.45 -71.05 0.26 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.255 179.98 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.483 ' CG ' ' O ' ' A' ' 22' ' ' LYS . 30.6 p90 44.36 -170.23 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.067 179.807 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -123.32 146.49 47.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.272 179.972 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 133.76 -58.69 0.69 Allowed Glycine 0 CA--C 1.523 0.58 0 N-CA-C 110.85 -0.9 . . . . 0.0 110.85 179.962 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -112.76 -162.54 0.8 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.801 0.334 . . . . 0.0 110.379 -179.958 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -119.76 -174.72 2.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.478 179.968 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.423 ' O ' ' CG ' ' A' ' 71' ' ' GLU . 12.6 mtm -120.43 119.27 32.55 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.196 -179.976 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.437 ' CB ' ' HG2' ' A' ' 71' ' ' GLU . . . -120.72 -60.6 1.65 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.632 -179.7 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -151.83 168.59 24.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.589 -179.811 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.488 HG12 ' CD1' ' A' ' 52' ' ' TRP . 0.2 OUTLIER -179.01 144.2 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.986 179.967 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.418 ' CB ' ' HA ' ' A' ' 43' ' ' ALA . 3.6 pt-20 -142.12 168.27 20.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.472 -0.786 . . . . 0.0 109.915 -179.771 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.451 ' HB3' ' CE1' ' A' ' 66' ' ' PHE . 3.1 pp -121.73 174.69 6.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.869 0.366 . . . . 0.0 110.767 -179.791 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.425 ' O ' ' CB ' ' A' ' 35' ' ' GLU . 6.8 ttm180 -126.88 -94.61 0.45 Allowed 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.215 179.821 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.436 ' O ' ' CB ' ' A' ' 36' ' ' HIS . 0.0 OUTLIER 163.34 -35.78 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 120.703 0.287 . . . . 0.0 110.239 179.875 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . 0.436 ' CB ' ' O ' ' A' ' 35' ' ' GLU . 5.2 t-160 86.44 -16.5 0.42 Allowed 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.172 -179.626 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -104.14 -27.67 6.13 Favored Glycine 0 CA--C 1.522 0.516 0 N-CA-C 110.412 -1.075 . . . . 0.0 110.412 179.693 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -83.84 -159.1 0.35 Allowed 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 179.796 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 22.4 p30 -141.04 24.27 2.17 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.615 179.985 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -156.4 148.51 23.18 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.916 0.389 . . . . 0.0 110.472 179.909 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.485 ' CZ3' ' HG2' ' A' ' 67' ' ' ARG . 55.2 m95 -85.7 154.83 21.38 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.2 179.867 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.447 HG22 ' CE1' ' A' ' 54' ' ' PHE . 34.3 m -124.16 106.26 16.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.914 0.387 . . . . 0.0 110.146 179.704 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.418 ' HA ' ' CB ' ' A' ' 32' ' ' GLU . . . -49.0 116.97 1.87 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.712 -179.757 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -53.84 -172.06 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.387 179.909 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 31.6 m -151.05 122.74 8.01 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.423 -179.942 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 5.1 ptpt -68.41 67.79 0.13 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.083 179.698 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -90.96 -26.58 21.6 Favored Glycine 0 CA--C 1.522 0.483 0 N-CA-C 110.626 -0.99 . . . . 0.0 110.626 -179.929 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.438 ' HG2' ' CG2' ' A' ' 51' ' ' VAL . 9.8 tp10 -93.3 129.8 39.26 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.816 0.341 . . . . 0.0 110.231 179.946 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -74.03 66.25 1.84 Allowed Glycine 0 CA--C 1.523 0.565 0 N-CA-C 110.912 -0.875 . . . . 0.0 110.912 -179.84 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 158.65 -35.81 0.51 Allowed Glycine 0 CA--C 1.524 0.638 0 N-CA-C 111.085 -0.806 . . . . 0.0 111.085 179.809 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.438 ' CG2' ' HG2' ' A' ' 48' ' ' GLU . 30.4 m -135.81 -176.43 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.94 0.4 . . . . 0.0 110.859 -179.722 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . 0.527 ' CD1' ' CG1' ' A' ' 21' ' ' VAL . 6.1 m95 -101.85 134.29 45.27 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.494 -179.42 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.426 HG23 ' CB ' ' A' ' 18' ' ' ALA . 6.7 p -127.01 156.3 41.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.448 -179.847 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.447 ' CE1' HG22 ' A' ' 42' ' ' VAL . 50.6 t80 -137.99 124.32 20.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.409 179.904 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 20.6 p-10 -86.78 148.89 25.21 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.314 179.972 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -172.88 -179.36 2.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.482 -179.856 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -161.18 61.59 0.28 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.2 179.918 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -133.38 157.42 78.17 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.31 179.996 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -70.87 -35.57 9.18 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.529 2.153 . . . . 0.0 111.989 179.898 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -77.23 98.56 5.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.376 -179.974 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -148.21 48.21 1.05 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.399 -179.98 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -78.12 -101.74 0.2 Allowed Glycine 0 CA--C 1.526 0.747 0 N-CA-C 110.698 -0.961 . . . . 0.0 110.698 -179.973 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -80.69 177.36 8.13 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.63 2.22 . . . . 0.0 112.102 -179.995 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 49.8 m-85 -153.61 103.18 2.61 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.72 -179.969 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 6.2 m-20 -73.44 129.43 37.98 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 179.358 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.451 ' CE1' ' HB3' ' A' ' 33' ' ' LEU . 40.6 m-85 -115.42 170.87 8.08 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.13 0.491 . . . . 0.0 111.096 -179.333 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.485 ' HG2' ' CZ3' ' A' ' 41' ' ' TRP . 0.0 OUTLIER -169.2 83.69 0.14 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.632 -179.946 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.421 ' HB3' ' HB ' ' A' ' 31' ' ' VAL . 6.9 p90 -71.27 176.68 4.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.356 0.598 . . . . 0.0 111.333 -179.159 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.431 ' O ' ' CB ' ' A' ' 29' ' ' ALA . 8.7 mt -138.53 70.84 1.38 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.22 179.612 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.402 ' OG1' ' N ' ' A' ' 74' ' ' MET . 65.0 p -29.56 136.2 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.509 0.723 . . . . 0.0 112.61 -178.976 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.437 ' HG2' ' CB ' ' A' ' 29' ' ' ALA . 22.2 mt-10 -52.09 -39.13 59.31 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.314 179.972 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.37 64.59 1.49 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.545 -179.877 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -157.75 -104.75 0.21 Allowed Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.71 -0.956 . . . . 0.0 110.71 179.966 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.402 ' N ' ' OG1' ' A' ' 70' ' ' THR . 0.0 OUTLIER -172.03 -179.03 2.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.826 0.346 . . . . 0.0 110.326 179.969 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.63 -176.86 6.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.412 -179.951 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.421 ' O ' ' CB ' ' A' ' 67' ' ' ARG . 1.0 OUTLIER -178.71 158.89 1.05 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.099 179.979 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 97.2 t -124.52 130.43 73.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.979 0.418 . . . . 0.0 110.509 -179.756 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.473 ' CZ ' HG22 ' A' ' 4' ' ' VAL . 31.8 m-85 -121.71 130.53 53.51 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.158 179.983 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -118.86 155.56 31.01 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.638 -179.653 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 53.5 m-20 58.25 23.71 10.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.792 179.842 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 77.1 t -55.35 -78.36 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 179.61 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 76.7 t -81.71 134.36 50.73 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.125 179.751 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.474 ' HD3' ' CG ' ' A' ' 92' ' ' TYR . 46.6 Cg_endo -71.69 -177.1 2.31 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.437 2.091 . . . . 0.0 111.938 179.79 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -63.04 -64.19 0.98 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.186 179.902 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -102.56 76.86 1.56 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.218 179.798 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . 0.444 ' CD2' HG12 ' A' ' 8' ' ' VAL . 55.7 p90 -54.63 160.95 1.64 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.442 -179.873 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.05 111.86 7.44 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.323 179.917 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 2.7 mp -50.52 100.28 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.456 -179.925 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 133.84 45.95 0.11 Allowed Glycine 0 CA--C 1.523 0.572 0 N-CA-C 110.665 -0.974 . . . . 0.0 110.665 -179.981 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -172.99 153.04 2.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.79 0.329 . . . . 0.0 110.386 179.979 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 40.3 m -102.96 133.49 47.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.504 -179.931 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.474 ' CG ' ' HD3' ' A' ' 83' ' ' PRO . 6.3 m-85 -130.78 110.52 11.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.321 179.88 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.42 ' CB ' ' CD ' ' A' ' 94' ' ' PRO . . . 179.28 177.36 0.32 Allowed Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.306 -179.978 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.42 ' CD ' ' CB ' ' A' ' 93' ' ' ALA . 48.0 Cg_endo . . . . . 0 C--O 1.249 1.059 0 C-N-CA 122.62 2.213 . . . . 0.0 112.078 -179.868 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.413 ' CG ' ' O ' ' A' ' 3' ' ' LYS . 1.8 ptmt . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.86 0.362 . . . . 0.0 110.794 . . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.529 ' CG2' ' CE1' ' A' ' 78' ' ' PHE . 2.9 m -130.11 168.32 23.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.174 179.486 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -146.12 145.68 30.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.325 179.851 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.56 ' CE2' ' CD2' ' A' ' 66' ' ' PHE . 26.3 m-85 -117.66 160.97 20.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.736 -179.688 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -142.43 -164.15 1.76 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.169 179.836 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 47.0 t -141.85 92.74 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.346 -179.918 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.412 ' HG3' HG13 ' A' ' 51' ' ' VAL . 1.4 mm-40 -56.64 158.01 4.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.57 -179.811 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 7.4 ptmm? -58.17 -19.25 31.6 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.896 -179.989 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -49.8 -24.77 6.37 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 111.021 -0.831 . . . . 0.0 111.021 -179.966 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 10.0 p -47.83 113.85 0.8 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.85 0.357 . . . . 0.0 110.78 -179.862 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 42.4 m-20 -116.17 -156.28 0.61 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.147 179.859 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -44.96 -68.44 0.2 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.721 0.296 . . . . 0.0 110.905 -179.868 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.61 40.57 3.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.309 179.869 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 8.5 m80 -118.55 123.29 44.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.365 179.953 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -104.97 97.86 7.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.192 -179.928 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -100.22 104.56 16.06 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.602 -179.788 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 27.7 m -88.3 -175.17 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.129 179.67 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.409 ' HA ' HG13 ' A' ' 51' ' ' VAL . 2.7 tt -139.42 77.55 1.62 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.402 179.724 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 3.3 t -84.01 107.9 15.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.083 179.934 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.57 147.84 4.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.391 -179.969 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 3.9 p90 177.99 128.56 0.05 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.221 -179.909 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -53.4 154.43 3.41 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.512 -179.865 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 107.57 -68.98 0.22 Allowed Glycine 0 CA--C 1.522 0.522 0 N-CA-C 110.59 -1.004 . . . . 0.0 110.59 -179.968 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -94.08 179.28 5.37 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 110.164 -0.31 . . . . 0.0 110.164 179.975 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.417 ' OG1' ' CE ' ' A' ' 72' ' ' LYS . 0.2 OUTLIER -119.19 -163.8 1.0 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.928 0.394 . . . . 0.0 110.525 -179.971 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.43 ' O ' ' CG ' ' A' ' 71' ' ' GLU . 33.7 mtp -129.6 124.11 32.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.297 -179.815 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.42 ' CB ' ' O ' ' A' ' 69' ' ' LEU . . . -129.42 -57.97 1.13 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.937 -179.79 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -141.07 177.19 8.24 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.945 0.402 . . . . 0.0 111.059 -179.673 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.474 HG12 ' CD1' ' A' ' 52' ' ' TRP . 0.3 OUTLIER 171.52 134.2 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.958 -179.986 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -123.55 161.24 25.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.643 -179.549 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.482 ' HG ' ' CE1' ' A' ' 66' ' ' PHE . 2.3 mt -110.0 154.33 23.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.381 179.782 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.485 ' HG3' ' CD2' ' A' ' 41' ' ' TRP . 0.0 OUTLIER -126.99 -163.31 1.23 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.949 179.51 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.425 ' CG ' ' O ' ' A' ' 34' ' ' ARG . 0.2 OUTLIER 176.8 106.71 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.841 0.353 . . . . 0.0 110.171 179.971 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -51.2 95.3 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.206 -179.982 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 126.14 -32.18 3.85 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 110.359 -1.097 . . . . 0.0 110.359 -179.636 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.423 ' HB2' ' CB ' ' A' ' 35' ' ' GLU . 35.0 t -57.09 -25.4 58.69 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.732 0.301 . . . . 0.0 110.398 179.788 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 75.75 97.29 0.07 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.653 179.986 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 72.62 159.59 0.22 Allowed 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.876 179.641 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.501 ' CZ2' ' CD ' ' A' ' 67' ' ' ARG . 51.1 m95 -64.49 167.39 7.11 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.434 -179.899 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 14.9 m -135.1 3.21 1.08 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.852 -179.622 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . 59.92 138.42 0.01 OUTLIER 'General case' 0 C--N 1.334 -0.107 0 CA-C-O 121.129 0.49 . . . . 0.0 111.299 179.391 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.406 ' CE ' ' HB2' ' A' ' 52' ' ' TRP . 0.0 OUTLIER -73.64 -170.35 0.84 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.375 179.862 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.424 ' O ' ' N ' ' A' ' 47' ' ' GLY . 43.4 m -143.31 111.08 5.95 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.144 179.809 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.9 ptpt -62.45 79.12 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.396 -179.908 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.424 ' N ' ' O ' ' A' ' 45' ' ' THR . . . -98.47 -26.77 9.03 Favored Glycine 0 CA--C 1.522 0.525 0 N-CA-C 110.691 -0.963 . . . . 0.0 110.691 -179.966 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.402 ' HG3' HG21 ' A' ' 51' ' ' VAL . 0.5 OUTLIER -87.15 -172.53 4.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.852 0.358 . . . . 0.0 110.432 -179.943 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -110.94 -24.68 5.41 Favored Glycine 0 CA--C 1.522 0.505 0 N-CA-C 110.807 -0.917 . . . . 0.0 110.807 179.95 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -129.28 -1.39 5.69 Favored Glycine 0 CA--C 1.528 0.888 0 N-CA-C 111.957 -0.457 . . . . 0.0 111.957 -179.684 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.412 HG13 ' HG3' ' A' ' 9' ' ' GLU . 17.9 m -146.23 178.26 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 CA-C-N 117.476 0.638 . . . . 0.0 110.761 -179.946 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . 0.474 ' CD1' HG12 ' A' ' 31' ' ' VAL . 10.9 m95 -105.34 141.1 37.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.56 -179.555 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 10.3 p -126.04 162.78 24.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.336 -179.969 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 45.5 t80 -134.54 162.54 31.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.536 -179.881 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -112.86 143.03 44.81 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.224 179.865 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -133.9 178.7 6.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.374 179.934 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -123.94 26.61 7.52 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.345 179.975 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -171.0 155.65 4.53 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.269 179.947 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -71.87 -36.2 6.45 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.707 2.272 . . . . 0.0 112.325 -179.808 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -75.57 148.3 38.98 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.75 -179.55 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -147.74 -174.48 4.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.208 179.978 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -145.06 -148.96 4.93 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 110.734 -0.946 . . . . 0.0 110.734 179.995 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -78.03 158.08 30.59 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.575 2.183 . . . . 0.0 111.796 179.872 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.406 ' HB3' ' CD2' ' A' ' 33' ' ' LEU . 86.5 m-85 -131.6 171.19 13.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.07 0.462 . . . . 0.0 110.79 -179.794 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.424 ' HB2' ' CB ' ' A' ' 34' ' ' ARG . 4.3 m-80 -139.57 137.36 35.33 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.615 179.571 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.56 ' CD2' ' CE2' ' A' ' 6' ' ' PHE . 48.0 m-85 -120.44 159.94 24.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.108 0.48 . . . . 0.0 111.093 -179.217 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.501 ' CD ' ' CZ2' ' A' ' 41' ' ' TRP . 28.6 mtp180 -157.61 81.4 0.88 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.818 179.68 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.452 ' HA ' ' HA ' ' A' ' 31' ' ' VAL . 5.9 p90 -78.7 173.59 12.3 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-O 121.54 0.685 . . . . 0.0 111.37 -179.334 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.42 ' O ' ' CB ' ' A' ' 29' ' ' ALA . 8.8 mt -138.43 74.3 1.47 Allowed 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 114.664 -1.153 . . . . 0.0 109.016 179.496 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.439 ' OG1' ' N ' ' A' ' 74' ' ' MET . 2.7 p -31.18 137.13 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 115.717 -0.674 . . . . 0.0 112.191 -178.976 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.43 ' CG ' ' O ' ' A' ' 28' ' ' MET . 1.1 mm-40 -49.57 -24.88 2.35 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.943 -179.525 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.417 ' CE ' ' OG1' ' A' ' 27' ' ' THR . 0.0 OUTLIER -167.07 36.04 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.596 0.236 . . . . 0.0 111.102 -179.94 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -114.21 -110.76 2.9 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 110.849 -0.9 . . . . 0.0 110.849 179.853 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.439 ' N ' ' OG1' ' A' ' 70' ' ' THR . 3.1 ptt? -166.74 113.29 0.81 Allowed 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 110.164 -0.31 . . . . 0.0 110.164 179.901 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.99 -176.35 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.896 0.379 . . . . 0.0 110.494 -179.782 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 177.43 149.39 0.16 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.468 -179.952 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 72.2 t -90.22 139.18 17.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 121.006 0.431 . . . . 0.0 110.096 179.895 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.529 ' CE1' ' CG2' ' A' ' 4' ' ' VAL . 75.8 m-85 -128.84 142.24 51.03 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.898 -179.313 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -136.1 157.84 45.87 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.953 179.65 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 59.02 35.45 24.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.938 0.399 . . . . 0.0 109.954 -179.66 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.405 ' HA ' ' HA ' ' A' ' 93' ' ' ALA . 42.9 t -76.07 -6.91 9.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.322 -179.757 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 61.4 t -153.87 138.14 11.04 Favored Pre-proline 0 C--N 1.332 -0.17 0 N-CA-C 110.29 -0.263 . . . . 0.0 110.29 179.893 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -75.48 -172.66 1.36 Allowed 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.535 2.157 . . . . 0.0 112.056 179.881 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -67.93 -42.5 80.91 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.244 179.844 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 16.7 mtpt -127.45 77.73 1.77 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.235 179.841 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 45.3 p90 -51.1 158.8 0.69 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.508 -179.851 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 20.8 m -138.33 110.43 7.3 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.075 179.919 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 2.8 mp -50.46 95.06 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.357 -179.942 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 138.04 44.99 0.08 OUTLIER Glycine 0 CA--C 1.523 0.572 0 N-CA-C 110.575 -1.01 . . . . 0.0 110.575 -179.878 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -168.46 141.21 2.95 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.75 0.309 . . . . 0.0 110.243 -179.93 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 85.7 m -91.05 145.85 24.34 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.971 0.415 . . . . 0.0 110.648 -179.939 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.404 ' O ' ' CB ' ' A' ' 93' ' ' ALA . 30.2 m-85 -129.75 -152.24 0.51 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.826 -0.624 . . . . 0.0 109.501 179.674 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.43 ' CB ' ' HD2' ' A' ' 94' ' ' PRO . . . 77.79 174.74 0.08 OUTLIER Pre-proline 0 N--CA 1.465 0.276 0 CA-C-O 120.8 0.333 . . . . 0.0 110.684 179.77 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.43 ' HD2' ' CB ' ' A' ' 93' ' ' ALA . 48.3 Cg_endo . . . . . 0 C--O 1.248 1.02 0 C-N-CA 122.618 2.212 . . . . 0.0 111.989 -179.982 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.457 -0.093 0 CA-C-O 120.815 0.341 . . . . 0.0 110.24 . . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.521 ' CG1' ' CZ ' ' A' ' 78' ' ' PHE . 1.7 p -49.88 163.97 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.253 0.549 . . . . 0.0 110.624 -179.819 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.478 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 15.7 p -141.89 132.63 25.64 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.367 179.907 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.468 ' CD1' HG12 ' A' ' 81' ' ' VAL . 22.7 m-85 -101.09 170.68 8.11 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.301 179.967 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.415 ' O ' ' N ' ' A' ' 20' ' ' LEU . 92.6 m -166.17 132.47 2.52 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.464 -179.947 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 26.4 t -71.1 102.99 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.199 179.82 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.422 ' HG3' ' CG2' ' A' ' 51' ' ' VAL . 6.3 mm-40 -50.33 170.81 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.511 -179.811 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 33.7 mtmm -72.53 -21.38 61.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.721 -179.937 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -90.9 49.1 3.05 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.928 -0.869 . . . . 0.0 110.928 -179.948 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 60.7 p -87.1 134.64 33.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.765 0.317 . . . . 0.0 110.291 179.867 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -134.2 164.63 26.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.306 -179.989 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -67.4 -34.5 77.38 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.333 -179.992 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 1.7 tppp? -93.14 -20.46 20.47 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.225 -179.588 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 39.8 m80 -120.09 133.54 55.49 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.931 0.396 . . . . 0.0 111.024 -179.377 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -104.29 77.94 1.45 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.136 179.567 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -75.41 116.95 16.68 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.414 -179.884 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.406 ' O ' ' CB ' ' A' ' 51' ' ' VAL . 14.8 m -109.17 -168.24 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.17 179.942 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.415 ' N ' ' O ' ' A' ' 7' ' ' THR . 1.0 OUTLIER -142.28 78.74 1.63 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.376 179.855 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 11.7 t -95.41 110.22 23.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.336 -179.933 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -179.05 117.86 0.07 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.453 179.946 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 7.5 p90 -150.48 172.04 16.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.312 179.842 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -92.15 148.33 22.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.368 -179.917 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 114.25 -41.71 2.12 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 110.76 -0.936 . . . . 0.0 110.76 179.998 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -119.38 176.05 5.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.84 0.352 . . . . 0.0 110.418 179.999 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.29 -160.84 0.73 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.401 -179.999 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.418 ' O ' ' CG ' ' A' ' 71' ' ' GLU . 59.1 mtm -137.43 120.42 16.55 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.316 180.0 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.444 ' CB ' ' HG2' ' A' ' 71' ' ' GLU . . . -124.4 -58.39 1.52 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.563 -179.786 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -153.34 161.78 41.98 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.38 -179.864 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 21.5 t -143.46 155.19 16.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.286 -179.999 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.433 ' CB ' ' HA ' ' A' ' 43' ' ' ALA . 1.8 pt-20 -167.24 137.82 3.02 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.53 -179.953 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.485 HD22 ' CG ' ' A' ' 54' ' ' PHE . 3.2 pp -104.24 171.96 7.06 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.322 179.839 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.488 ' HB2' ' CZ3' ' A' ' 41' ' ' TRP . 1.3 ttt180 -97.87 -72.99 0.63 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.616 -179.848 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.484 ' CB ' ' O ' ' A' ' 34' ' ' ARG . 2.6 tm-20 94.34 80.26 0.0 OUTLIER 'General case' 0 CA--C 1.511 -0.523 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 -178.977 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -37.42 134.22 0.65 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.166 -0.925 . . . . 0.0 111.757 -178.362 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 114.07 -28.98 8.0 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 110.397 -1.081 . . . . 0.0 110.397 -179.745 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -82.46 -173.96 4.89 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.778 0.323 . . . . 0.0 110.268 179.864 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.41 ' OD1' ' N ' ' A' ' 40' ' ' GLU . 35.2 p30 -114.31 -21.64 10.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.843 -179.861 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.41 ' N ' ' OD1' ' A' ' 39' ' ' ASP . 9.7 mt-10 -135.0 175.26 9.74 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.84 0.352 . . . . 0.0 110.701 -179.826 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.49 ' CZ3' ' HG2' ' A' ' 67' ' ' ARG . 53.1 m95 -86.18 173.05 10.07 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.466 179.945 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.48 HG22 ' CZ ' ' A' ' 54' ' ' PHE . 9.7 m -135.57 112.8 14.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.329 179.818 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.433 ' HA ' ' CB ' ' A' ' 32' ' ' GLU . . . -51.02 127.13 18.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.299 179.938 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -60.69 -171.39 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.32 -179.887 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 38.3 m -136.72 133.12 35.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.92 0.39 . . . . 0.0 110.496 -179.847 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 2.8 ptmt -100.95 79.87 2.08 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.52 -179.948 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -153.05 26.63 0.8 Allowed Glycine 0 CA--C 1.523 0.574 0 N-CA-C 110.851 -0.9 . . . . 0.0 110.851 -179.976 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.423 ' CG ' HG21 ' A' ' 51' ' ' VAL . 14.0 tp10 -98.05 -24.59 15.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.734 0.302 . . . . 0.0 110.319 179.952 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 128.03 -76.02 0.41 Allowed Glycine 0 CA--C 1.523 0.536 0 N-CA-C 110.566 -1.014 . . . . 0.0 110.566 -179.964 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -113.31 -14.34 9.89 Favored Glycine 0 CA--C 1.527 0.816 0 N-CA-C 111.259 -0.736 . . . . 0.0 111.259 179.878 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.423 HG21 ' CG ' ' A' ' 48' ' ' GLU . 27.2 m -124.95 -175.44 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-O 120.932 0.396 . . . . 0.0 110.74 -179.745 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 8.1 m95 -104.59 146.22 29.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.499 -179.848 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.08 165.89 18.66 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.162 179.8 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.485 ' CG ' HD22 ' A' ' 33' ' ' LEU . 87.3 t80 -144.51 143.18 30.72 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.572 -179.863 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -89.07 102.48 15.14 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.314 179.913 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 69.7 p -86.91 100.82 12.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.465 -179.934 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -101.93 25.3 8.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.41 179.892 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 6.6 pm0 -121.39 140.83 32.08 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.193 179.897 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -73.45 -20.73 20.47 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.574 2.182 . . . . 0.0 112.113 179.992 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 17.3 mt -53.41 150.43 6.55 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.502 -179.95 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 24.1 tt0 -140.75 96.16 2.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.306 179.818 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -149.24 -157.85 7.82 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 110.682 -0.967 . . . . 0.0 110.682 179.992 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -76.35 160.74 35.48 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.565 2.177 . . . . 0.0 112.168 -179.934 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -130.96 100.98 5.43 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.394 179.873 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 48.0 m-80 -66.32 160.33 24.8 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 179.652 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -133.92 176.32 8.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.023 0.439 . . . . 0.0 110.93 -179.894 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.49 ' HG2' ' CZ3' ' A' ' 41' ' ' TRP . 0.0 OUTLIER 176.6 72.3 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.751 179.998 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -67.16 174.96 2.84 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.88 -179.404 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.426 ' O ' ' CB ' ' A' ' 29' ' ' ALA . 8.9 mt -125.26 68.79 1.14 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.311 179.492 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -37.19 140.97 0.16 Allowed 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.728 -179.115 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.444 ' HG2' ' CB ' ' A' ' 29' ' ' ALA . 2.0 mm-40 -55.27 -58.48 7.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.369 -179.821 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -125.73 55.9 1.42 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.316 179.962 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -137.51 -106.7 0.78 Allowed Glycine 0 CA--C 1.524 0.601 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 -179.981 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 1.2 ptt? -178.5 163.4 1.54 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.805 0.336 . . . . 0.0 110.446 -179.924 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.69 134.37 35.46 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.258 -179.867 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -143.32 129.73 20.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.378 179.958 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.425 HG11 ' N ' ' A' ' 78' ' ' PHE . 43.3 t -85.55 142.94 12.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.34 -179.993 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.521 ' CZ ' ' CG1' ' A' ' 4' ' ' VAL . 51.5 m-85 -132.48 120.66 22.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.549 -179.866 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -105.36 163.72 12.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.257 179.83 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 53.79 57.45 6.04 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.271 179.992 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.468 HG12 ' CD1' ' A' ' 6' ' ' PHE . 60.9 t -109.02 7.78 9.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.216 -179.965 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.427 ' CG2' ' O ' ' A' ' 81' ' ' VAL . 70.2 t -158.36 104.35 1.68 Allowed Pre-proline 0 CA--C 1.531 0.212 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 -179.932 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -74.93 178.46 7.22 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.499 2.132 . . . . 0.0 111.935 179.706 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -65.97 121.76 15.83 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.217 179.885 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 3.4 tttt 55.09 65.83 1.39 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.111 -179.823 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 32.6 p90 -49.58 143.23 7.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.755 -179.758 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 9.0 m -110.32 110.03 20.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.13 179.739 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 2.8 mp -49.18 121.1 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.542 -179.844 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 115.57 31.07 2.05 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 110.926 -0.869 . . . . 0.0 110.926 179.976 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.407 ' HB2' ' CE1' ' A' ' 92' ' ' TYR . . . -143.63 176.26 9.35 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.745 0.307 . . . . 0.0 110.253 179.834 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 17.3 m -125.0 124.06 41.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.533 -179.901 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.407 ' CE1' ' HB2' ' A' ' 90' ' ' ALA . 6.0 m-85 -124.2 129.54 50.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.272 179.87 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.456 ' CB ' ' CD ' ' A' ' 94' ' ' PRO . . . 178.01 179.24 0.23 Allowed Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.289 -179.988 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.456 ' CD ' ' CB ' ' A' ' 93' ' ' ALA . 48.7 Cg_endo . . . . . 0 C--O 1.249 1.072 0 C-N-CA 122.519 2.146 . . . . 0.0 111.959 -179.93 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.848 0.356 . . . . 0.0 110.624 . . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.484 ' CG1' ' CE1' ' A' ' 78' ' ' PHE . 1.7 p -153.72 163.7 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 121.176 0.512 . . . . 0.0 110.151 179.705 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.464 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 0.2 OUTLIER -136.15 140.72 43.85 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.438 179.951 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 -105.8 165.91 10.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.965 179.754 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.4 m -160.03 103.49 1.48 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.819 0.343 . . . . 0.0 110.522 -179.823 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 61.1 t -60.04 93.99 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.17 179.771 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -49.8 165.33 0.08 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.609 -179.851 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.24 56.57 2.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.394 179.95 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -135.79 20.65 3.63 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 111.124 -0.79 . . . . 0.0 111.124 -179.909 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.2 p -74.7 108.46 7.47 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.949 0.405 . . . . 0.0 109.994 179.729 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 22.5 m-20 -92.2 -163.53 1.05 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.775 -179.506 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -55.5 -36.34 66.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.819 -179.706 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.434 ' HD3' ' ND1' ' A' ' 16' ' ' HIS . 0.1 OUTLIER -147.6 45.93 1.12 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.784 0.326 . . . . 0.0 110.582 -179.794 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . 0.434 ' ND1' ' HD3' ' A' ' 15' ' ' LYS . 45.0 m80 -133.78 151.57 51.62 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.22 179.783 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 20.9 tp -137.28 92.54 2.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.462 -179.745 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -87.91 123.13 32.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.298 179.885 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 27.2 m -121.02 144.76 28.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.555 -179.811 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.423 ' CD2' ' CG ' ' A' ' 22' ' ' LYS . 0.5 OUTLIER -91.38 83.35 5.44 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.28 179.77 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 24.4 t -89.44 100.3 10.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.543 -179.827 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.423 ' CG ' ' CD2' ' A' ' 20' ' ' LEU . 0.0 OUTLIER 174.9 135.7 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.353 179.859 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.486 ' CE2' ' HB2' ' A' ' 26' ' ' ASP . 0.7 OUTLIER -129.91 -173.29 2.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.1 179.874 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -40.62 -57.42 1.87 Allowed 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 120.795 0.331 . . . . 0.0 111.195 -179.783 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -89.22 -153.77 28.09 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 110.664 -0.974 . . . . 0.0 110.664 179.806 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.486 ' HB2' ' CE2' ' A' ' 23' ' ' TYR . 28.1 t0 68.33 143.52 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.744 0.307 . . . . 0.0 110.408 179.983 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.446 ' CG2' ' O ' ' A' ' 27' ' ' THR . 86.4 m -119.33 13.44 12.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.062 179.863 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.405 ' O ' ' CG ' ' A' ' 71' ' ' GLU . 9.3 mtp 59.51 115.09 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.832 0.349 . . . . 0.0 110.594 179.732 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.421 ' CB ' ' O ' ' A' ' 69' ' ' LEU . . . -126.42 -57.17 1.39 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.13 179.81 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -157.46 166.69 32.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.147 179.789 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.479 HG23 ' CD1' ' A' ' 52' ' ' TRP . 38.5 t -152.41 148.27 14.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.448 -179.899 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.432 ' CB ' ' HA ' ' A' ' 43' ' ' ALA . 14.6 pt-20 -138.81 146.93 41.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.093 179.766 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.521 ' CD2' ' CG ' ' A' ' 54' ' ' PHE . 6.1 tp -128.86 138.3 51.96 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 120.923 0.392 . . . . 0.0 110.19 -179.093 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.468 ' HB2' ' CE3' ' A' ' 41' ' ' TRP . 50.0 ttp85 -124.6 165.67 17.46 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.55 179.184 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -118.92 -83.07 0.65 Allowed 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 -179.975 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER 169.58 158.61 0.06 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.375 179.598 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 50.01 47.01 41.32 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 110.849 -0.901 . . . . 0.0 110.849 179.926 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 32.1 t -136.0 -174.93 3.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.817 0.341 . . . . 0.0 110.329 179.899 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -68.57 -63.57 1.03 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.471 -179.919 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -167.93 -173.87 2.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.343 -179.926 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.468 ' CE3' ' HB2' ' A' ' 34' ' ' ARG . 50.3 m95 -47.68 154.34 0.49 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.591 -179.943 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 24.2 m -129.9 28.86 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.421 179.983 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.432 ' HA ' ' CB ' ' A' ' 32' ' ' GLU . . . 47.24 -175.34 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.131 179.555 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -112.94 -164.74 0.94 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.356 -179.97 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 25.7 m -146.52 104.97 3.81 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.477 -179.933 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.43 71.87 0.95 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.243 179.857 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -99.3 -34.49 5.05 Favored Glycine 0 CA--C 1.523 0.559 0 N-CA-C 110.813 -0.915 . . . . 0.0 110.813 -179.868 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.428 ' HG2' ' CG2' ' A' ' 51' ' ' VAL . 4.1 tp10 -80.5 130.11 34.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.808 0.337 . . . . 0.0 110.35 -179.916 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -78.39 78.38 1.62 Allowed Glycine 0 CA--C 1.522 0.53 0 N-CA-C 110.752 -0.939 . . . . 0.0 110.752 179.895 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 150.67 -32.01 1.0 Allowed Glycine 0 CA--C 1.522 0.502 0 N-CA-C 110.6 -1.0 . . . . 0.0 110.6 -179.959 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.428 ' CG2' ' HG2' ' A' ' 48' ' ' GLU . 17.5 m -145.81 -177.35 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.837 0.351 . . . . 0.0 110.369 -179.997 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . 0.479 ' CD1' HG23 ' A' ' 31' ' ' VAL . 7.5 m95 -102.97 141.15 36.26 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.584 -179.738 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.22 152.22 43.18 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.942 179.7 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.521 ' CG ' ' CD2' ' A' ' 33' ' ' LEU . 80.6 t80 -117.39 161.65 19.21 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.423 -179.925 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -118.15 118.59 32.29 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.32 -179.993 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 40.2 m -111.48 164.24 13.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.449 -179.931 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -161.7 39.9 0.13 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.249 179.932 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -131.91 157.52 77.98 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.338 -179.946 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -71.61 -33.35 10.71 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.615 2.21 . . . . 0.0 112.2 -179.936 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -82.68 174.7 10.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.293 179.909 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 179.81 59.6 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.613 179.935 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -72.88 -139.95 0.37 Allowed Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.477 -1.049 . . . . 0.0 110.477 179.807 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -73.83 174.1 12.88 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.501 2.134 . . . . 0.0 111.699 179.698 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -135.52 177.08 8.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.957 0.408 . . . . 0.0 110.548 -179.937 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 -143.96 131.29 20.87 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.862 179.904 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -116.16 170.13 8.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.044 0.45 . . . . 0.0 110.884 -179.705 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.433 ' HG3' ' CH2' ' A' ' 41' ' ' TRP . 0.1 OUTLIER -172.54 80.75 0.05 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.049 -179.925 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.403 ' HA ' ' HA ' ' A' ' 31' ' ' VAL . 0.5 OUTLIER -81.57 167.02 19.72 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.191 0.52 . . . . 0.0 110.966 -179.594 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.436 HD21 ' CD ' ' A' ' 75' ' ' LYS . 6.8 mt -123.49 74.23 1.24 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.494 179.715 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.412 ' OG1' ' N ' ' A' ' 74' ' ' MET . 13.5 p -36.81 137.77 0.29 Allowed 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.696 -179.334 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.419 ' HG2' ' CB ' ' A' ' 29' ' ' ALA . 8.7 mm-40 -48.88 -46.48 42.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.822 -179.591 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.66 45.9 1.7 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.447 179.86 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -121.06 -110.17 2.17 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 110.863 -0.895 . . . . 0.0 110.863 -179.983 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.412 ' N ' ' OG1' ' A' ' 70' ' ' THR . 2.1 ptt? -171.67 152.69 3.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.831 0.348 . . . . 0.0 110.361 -179.905 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.436 ' CD ' HD21 ' A' ' 69' ' ' LEU . 0.0 OUTLIER -76.58 150.83 36.46 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.463 -179.942 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 55.0 m-20 -156.31 136.73 13.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.542 179.946 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 94.2 t -89.33 138.92 18.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.353 179.927 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.484 ' CE1' ' CG1' ' A' ' 4' ' ' VAL . 40.4 m-85 -126.81 134.87 50.46 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.793 -179.448 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -123.93 150.72 44.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.273 179.85 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 54.39 30.66 13.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.374 -179.904 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.408 ' HA ' ' HA ' ' A' ' 93' ' ' ALA . 54.8 t -53.71 -24.82 10.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.48 -179.925 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.422 ' CG1' ' HB3' ' A' ' 86' ' ' TYR . 59.3 t -134.34 132.3 20.95 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.579 -0.282 . . . . 0.0 110.535 179.897 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.447 ' CD ' ' CD1' ' A' ' 92' ' ' TYR . 49.5 Cg_endo -71.24 -171.48 0.61 Allowed 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.586 2.191 . . . . 0.0 111.996 179.744 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 21.3 pt-20 -85.23 129.92 34.71 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 179.29 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 59.33 50.66 7.51 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 -179.282 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . 0.422 ' HB3' ' CG1' ' A' ' 82' ' ' VAL . 36.6 p90 -43.46 160.43 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.413 -179.407 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -130.92 104.26 7.04 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.925 179.751 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 3.0 mp -45.3 118.65 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.623 -179.798 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 118.42 36.7 0.9 Allowed Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.602 -0.999 . . . . 0.0 110.602 -179.821 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -149.32 153.34 37.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.768 0.318 . . . . 0.0 110.149 -179.96 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 92.4 m -103.63 93.62 5.02 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.727 -179.81 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.447 ' CD1' ' CD ' ' A' ' 83' ' ' PRO . 40.1 m-85 -81.81 -153.76 0.11 Allowed 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 179.31 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.45 ' CB ' ' HD2' ' A' ' 94' ' ' PRO . . . 76.2 175.85 0.07 OUTLIER Pre-proline 0 N--CA 1.464 0.263 0 CA-C-O 120.689 0.281 . . . . 0.0 110.748 179.726 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.45 ' HD2' ' CB ' ' A' ' 93' ' ' ALA . 46.5 Cg_endo . . . . . 0 C--O 1.249 1.027 0 C-N-CA 122.523 2.148 . . . . 0.0 112.053 -179.988 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 7.9 mtmm . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.808 0.337 . . . . 0.0 110.402 . . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.513 ' CG2' ' CE1' ' A' ' 78' ' ' PHE . 18.0 m -72.95 170.86 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.435 -179.979 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 16.0 p -154.66 132.07 11.2 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.516 -179.97 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.405 ' CD1' ' N ' ' A' ' 6' ' ' PHE . 13.6 m-85 -101.3 160.29 14.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.066 179.821 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.6 m -156.49 126.26 6.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.924 0.392 . . . . 0.0 110.683 -179.86 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 98.9 t -60.28 114.73 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.284 179.85 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.426 ' HG3' ' CG2' ' A' ' 51' ' ' VAL . 15.0 mm-40 -94.1 160.92 14.49 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.433 -179.91 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.9 ttmm -55.16 159.25 2.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.339 179.979 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 86.91 25.77 33.66 Favored Glycine 0 CA--C 1.523 0.539 0 N-CA-C 110.772 -0.931 . . . . 0.0 110.772 -179.968 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 58.3 m -94.84 120.3 34.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.813 0.34 . . . . 0.0 110.491 -179.891 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -119.38 -163.94 1.02 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.39 179.927 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -46.99 -61.89 1.66 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.245 -179.693 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.404 ' HG2' ' N ' ' A' ' 16' ' ' HIS . 0.8 OUTLIER -98.95 -28.28 13.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.058 -179.271 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . 0.404 ' N ' ' HG2' ' A' ' 15' ' ' LYS . 1.7 m80 -65.02 123.66 20.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.833 0.349 . . . . 0.0 110.411 -179.818 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -129.51 99.82 5.32 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.419 -179.953 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -95.88 130.93 42.69 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.128 179.83 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.449 ' N ' ' CG1' ' A' ' 51' ' ' VAL . 17.7 m -139.59 134.63 39.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.905 0.383 . . . . 0.0 110.796 -179.969 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -84.77 100.38 11.49 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.481 179.955 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 82.1 t -102.53 92.22 2.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.341 179.866 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.7 139.36 17.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.445 -179.925 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 2.1 p90 -155.0 168.02 28.41 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.257 179.929 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -74.17 125.06 27.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.417 -179.869 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 141.77 -91.35 0.18 Allowed Glycine 0 CA--C 1.523 0.555 0 N-CA-C 110.566 -1.014 . . . . 0.0 110.566 -179.934 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -72.93 -160.58 0.08 Allowed 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 179.805 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.422 ' CG2' ' O ' ' A' ' 27' ' ' THR . 33.5 m -144.14 31.67 1.24 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.637 179.975 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.416 ' O ' ' CG ' ' A' ' 71' ' ' GLU . 16.5 mtm 61.37 123.75 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.618 179.642 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.435 ' CB ' ' HG2' ' A' ' 71' ' ' GLU . . . -124.86 -58.58 1.47 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.527 179.838 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -152.52 152.18 31.6 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.52 -179.958 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 27.9 t -141.76 155.8 20.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.191 179.746 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.421 ' CG ' ' HG3' ' A' ' 67' ' ' ARG . 0.9 OUTLIER -156.45 148.28 22.89 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.384 -179.784 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.7 tp -111.4 148.94 31.97 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 -179.821 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.479 ' HB2' ' CZ3' ' A' ' 41' ' ' TRP . 0.0 OUTLIER -97.77 -68.26 0.81 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.53 -179.818 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.439 ' CB ' ' O ' ' A' ' 34' ' ' ARG . 25.2 mt-10 88.8 74.94 0.01 OUTLIER 'General case' 0 CA--C 1.51 -0.58 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 -178.771 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -37.37 103.31 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.039 -0.982 . . . . 0.0 111.713 -178.097 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 107.13 37.07 2.38 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 110.413 -1.075 . . . . 0.0 110.413 -179.738 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 7.2 t -119.0 -157.5 0.69 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.676 0.274 . . . . 0.0 110.513 -179.641 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -111.25 66.41 0.63 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.855 0.359 . . . . 0.0 110.403 -179.837 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 76.39 160.06 0.22 Allowed 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.394 179.93 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.479 ' CZ3' ' HB2' ' A' ' 34' ' ' ARG . 82.4 m95 -51.18 156.79 1.03 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.566 -179.94 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.481 HG22 ' CZ ' ' A' ' 54' ' ' PHE . 3.2 m -139.15 115.78 10.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.915 179.635 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -48.54 143.04 5.3 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.674 -179.651 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -73.26 -174.16 1.53 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.301 -179.959 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 59.1 m -145.53 120.81 10.22 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.096 179.887 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.42 ' O ' ' CG ' ' A' ' 46' ' ' LYS . 0.8 OUTLIER -68.67 64.4 0.11 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.412 -179.838 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -72.6 -47.54 26.8 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 110.797 -0.921 . . . . 0.0 110.797 -179.981 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.453 ' CB ' ' HB ' ' A' ' 51' ' ' VAL . 0.5 OUTLIER -73.99 -174.34 1.84 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.866 0.365 . . . . 0.0 110.659 -179.814 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -82.79 -35.29 19.57 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 110.599 -1.0 . . . . 0.0 110.599 179.912 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -146.35 27.07 1.69 Allowed Glycine 0 CA--C 1.522 0.47 0 N-CA-C 110.117 -1.193 . . . . 0.0 110.117 179.69 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.453 ' HB ' ' CB ' ' A' ' 48' ' ' GLU . 88.5 t -138.6 145.7 27.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.841 0.353 . . . . 0.0 110.084 -179.689 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . 0.419 ' N ' HG11 ' A' ' 51' ' ' VAL . 4.2 m95 -94.55 114.37 26.34 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.513 -179.619 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 11.1 p -107.24 143.43 35.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.311 -179.937 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.481 ' CZ ' HG22 ' A' ' 42' ' ' VAL . 56.2 t80 -126.44 150.86 48.41 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.446 179.925 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -108.39 95.47 5.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.355 -179.975 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -61.78 167.23 3.78 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.398 -179.967 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -105.79 -32.46 8.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.491 -179.955 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -111.45 153.52 44.13 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.432 -179.876 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -67.94 -32.37 28.88 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.899 2.399 . . . . 0.0 112.393 -179.934 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -77.53 128.07 33.56 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.673 -179.59 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 19.5 pt20 179.87 132.31 0.1 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.134 -179.943 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -138.79 -72.45 0.05 OUTLIER Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 -179.798 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -72.48 122.01 7.93 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.548 2.165 . . . . 0.0 112.006 179.837 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 45.1 m-85 -113.61 102.36 10.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.685 -179.689 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 52.2 m-20 -81.01 137.26 36.07 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 179.391 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -125.69 170.44 11.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.107 0.48 . . . . 0.0 111.077 -179.351 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.459 ' HG2' ' CZ3' ' A' ' 41' ' ' TRP . 0.0 OUTLIER -168.91 53.69 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.791 179.949 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.473 ' CZ ' ' CE2' ' A' ' 78' ' ' PHE . 0.2 OUTLIER -49.77 169.82 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.028 -179.56 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.428 ' O ' ' CB ' ' A' ' 29' ' ' ALA . 6.9 mt -124.77 70.1 1.13 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.22 179.386 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 31.9 p -33.43 141.82 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.157 0.583 . . . . 0.0 112.241 -178.99 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.435 ' HG2' ' CB ' ' A' ' 29' ' ' ALA . 4.7 mm-40 -53.66 -60.11 3.73 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.745 -0.662 . . . . 0.0 110.455 -179.952 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 4.8 tmtt? -124.76 77.75 1.63 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.458 -179.973 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -170.55 -99.94 0.13 Allowed Glycine 0 CA--C 1.523 0.536 0 N-CA-C 110.764 -0.935 . . . . 0.0 110.764 179.901 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 179.29 173.56 0.81 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.864 0.364 . . . . 0.0 110.282 -179.938 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.19 -176.29 3.04 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.347 179.938 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.423 ' O ' ' CB ' ' A' ' 67' ' ' ARG . 2.7 t-20 -178.99 -173.7 0.31 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.016 179.942 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 93.0 t -128.31 127.32 67.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.887 0.375 . . . . 0.0 110.454 -179.884 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.513 ' CE1' ' CG2' ' A' ' 4' ' ' VAL . 58.3 m-85 -112.64 123.24 49.86 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.887 179.741 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -113.89 151.85 31.6 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.781 -179.519 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 35.5 t0 60.26 24.0 13.4 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.762 179.834 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 25.4 t -55.73 -79.39 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.665 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.428 ' CG1' ' HB3' ' A' ' 86' ' ' TYR . 47.2 t -87.11 139.1 32.36 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.453 179.837 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.462 ' HD3' ' CG ' ' A' ' 92' ' ' TYR . 49.2 Cg_endo -71.76 -173.55 1.06 Allowed 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.624 2.216 . . . . 0.0 112.001 179.812 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 32.9 mp0 -64.12 -73.67 0.11 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.057 179.762 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -94.75 73.0 3.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.045 179.642 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . 0.428 ' HB3' ' CG1' ' A' ' 82' ' ' VAL . 30.2 p90 -52.04 159.37 0.9 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.897 -179.574 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.74 109.99 12.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.094 179.747 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 3.3 mp -48.11 111.76 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.748 -179.769 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 110.56 55.0 0.53 Allowed Glycine 0 CA--C 1.523 0.538 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 179.995 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -175.75 131.78 0.26 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.82 0.343 . . . . 0.0 110.465 179.968 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.424 HG21 ' N ' ' A' ' 92' ' ' TYR . 35.5 m -83.16 144.58 29.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.159 179.917 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.462 ' CG ' ' HD3' ' A' ' 83' ' ' PRO . 71.9 m-85 -129.03 -83.79 0.57 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.691 -179.964 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.471 ' CB ' ' CD ' ' A' ' 94' ' ' PRO . . . 49.64 -179.01 0.01 OUTLIER Pre-proline 0 C--O 1.232 0.133 0 CA-C-O 120.624 0.249 . . . . 0.0 110.595 179.94 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.471 ' CD ' ' CB ' ' A' ' 93' ' ' ALA . 48.1 Cg_endo . . . . . 0 C--O 1.249 1.053 0 C-N-CA 122.481 2.121 . . . . 0.0 112.088 -179.902 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt . . . . . 0 CA--C 1.523 -0.09 0 CA-C-O 120.865 0.365 . . . . 0.0 110.38 . . . . . . . . . 0 0 . 1 . 031 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.474 HG23 ' CZ ' ' A' ' 78' ' ' PHE . 34.2 m -66.21 -178.38 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.359 -179.937 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.0 p -161.77 138.34 8.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.296 -179.996 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -102.06 173.1 6.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.459 -179.757 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.416 ' CG2' ' O ' ' A' ' 90' ' ' ALA . 0.3 OUTLIER -165.96 102.92 0.66 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.287 -179.991 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.423 ' CG1' HG13 ' A' ' 88' ' ' ILE . 40.5 t -51.68 96.35 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.341 179.956 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.43 ' CG ' HG22 ' A' ' 51' ' ' VAL . 1.8 mm-40 -62.09 177.1 0.5 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.654 -179.737 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.8 tttt -80.63 60.34 3.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.409 -179.944 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -146.3 21.23 1.72 Allowed Glycine 0 CA--C 1.525 0.668 0 N-CA-C 111.022 -0.831 . . . . 0.0 111.022 179.974 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 25.6 m -110.32 114.58 28.15 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 110.121 -0.325 . . . . 0.0 110.121 179.921 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.419 ' OD1' ' N ' ' A' ' 14' ' ' GLU . 6.1 p30 -113.46 -49.13 2.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.612 -179.793 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.419 ' N ' ' OD1' ' A' ' 13' ' ' ASN . 9.6 mm-40 -154.15 -69.65 0.14 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.776 -179.792 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.435 ' N ' ' HD2' ' A' ' 15' ' ' LYS . 17.9 mmmt -91.25 -28.73 17.61 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.478 -179.478 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 9.5 m80 -76.36 128.59 35.14 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.764 -179.632 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.413 ' CD1' HG11 ' A' ' 19' ' ' VAL . 1.2 tm? -122.32 86.22 2.54 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.943 179.793 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -80.11 129.35 34.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.636 -179.596 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.42 ' N ' ' CG1' ' A' ' 51' ' ' VAL . 24.1 m -134.03 134.35 55.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.401 179.697 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.414 ' HB2' ' CG ' ' A' ' 9' ' ' GLU . 0.7 OUTLIER -89.36 87.47 7.12 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.377 -179.947 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.406 HG13 ' CD2' ' A' ' 68' ' ' PHE . 12.0 t -86.39 108.87 18.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.27 179.923 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.1 mtpt -179.67 176.39 0.79 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.226 179.95 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 20.1 p90 176.85 40.93 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.315 -179.963 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 55.63 174.77 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.353 179.974 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 70.74 -101.19 0.9 Allowed Glycine 0 CA--C 1.523 0.559 0 N-CA-C 110.635 -0.986 . . . . 0.0 110.635 -179.993 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -54.8 166.39 0.49 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.779 0.323 . . . . 0.0 110.359 179.934 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -115.0 -169.31 1.53 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.474 179.949 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.413 ' O ' ' CG ' ' A' ' 71' ' ' GLU . 13.4 mmt -115.21 127.45 55.52 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.637 -179.756 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.439 ' CB ' ' HG2' ' A' ' 71' ' ' GLU . . . -118.03 -59.37 1.91 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.586 -179.904 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -150.44 153.06 35.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.215 -179.943 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.405 ' HA ' ' HA ' ' A' ' 68' ' ' PHE . 4.4 t -147.61 146.68 18.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.017 0.437 . . . . 0.0 110.773 -179.742 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.438 ' CB ' ' HA ' ' A' ' 43' ' ' ALA . 5.9 pt-20 -137.26 146.28 44.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.513 179.203 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.465 HD22 ' CD2' ' A' ' 54' ' ' PHE . 9.8 tp -123.1 153.2 40.25 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-O 120.938 0.399 . . . . 0.0 110.033 -178.907 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.485 ' HB2' ' CE3' ' A' ' 41' ' ' TRP . 0.0 OUTLIER -145.66 162.73 36.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.678 179.574 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.406 ' O ' ' HB2' ' A' ' 36' ' ' HIS . 1.1 mt-10 -120.45 -86.11 0.65 Allowed 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 179.924 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . 0.406 ' HB2' ' O ' ' A' ' 35' ' ' GLU . 0.8 OUTLIER -179.98 -40.62 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.803 0.335 . . . . 0.0 110.373 179.472 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -63.22 -56.83 17.97 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 110.781 -0.928 . . . . 0.0 110.781 -179.951 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.417 ' O ' ' CB ' ' A' ' 39' ' ' ASP . 1.5 t -55.03 -36.2 65.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.777 0.322 . . . . 0.0 110.356 -179.928 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.417 ' CB ' ' O ' ' A' ' 38' ' ' SER . 4.1 t70 81.6 -53.66 0.27 Allowed 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.489 -179.812 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -77.88 145.53 36.17 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.155 179.948 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.485 ' CE3' ' HB2' ' A' ' 34' ' ' ARG . 75.3 m95 -71.0 153.68 42.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.472 -179.864 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.452 HG23 ' CZ ' ' A' ' 54' ' ' PHE . 3.0 m -135.72 111.95 12.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.921 179.671 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.438 ' HA ' ' CB ' ' A' ' 32' ' ' GLU . . . -47.95 155.05 0.47 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.857 -179.479 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -76.42 -173.17 2.39 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.355 179.986 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 53.7 m -152.49 103.57 2.83 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.526 -179.943 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 7.9 ptpt -59.5 88.89 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.229 -0.442 . . . . 0.0 109.934 179.767 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -110.25 -28.46 4.08 Favored Glycine 0 CA--C 1.522 0.52 0 N-CA-C 111.239 -0.745 . . . . 0.0 111.239 -179.56 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.447 ' CB ' ' HB ' ' A' ' 51' ' ' VAL . 1.1 tp10 -72.09 -36.13 69.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.753 0.311 . . . . 0.0 110.698 -179.646 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 115.12 -37.46 3.49 Favored Glycine 0 CA--C 1.52 0.405 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 -179.115 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -138.02 21.32 3.17 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 178.631 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.447 ' HB ' ' CB ' ' A' ' 48' ' ' GLU . 52.6 t -155.44 144.61 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 -179.677 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 3.0 m95 -91.51 110.42 21.74 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.968 0.413 . . . . 0.0 110.327 -179.749 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.1 p -101.81 142.17 33.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.468 -179.7 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.465 ' CD2' HD22 ' A' ' 33' ' ' LEU . 66.3 t80 -130.47 147.26 52.15 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.344 179.902 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 51.8 m-20 -89.04 101.17 13.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.431 -179.938 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.0 t -77.65 170.74 16.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.257 179.889 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -177.4 68.95 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.474 -179.912 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 179.49 118.61 0.21 Allowed Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.375 179.967 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -73.63 -2.43 12.17 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.475 2.117 . . . . 0.0 112.683 179.998 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 10.6 mp -67.05 74.91 0.12 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.727 0.298 . . . . 0.0 110.459 -179.943 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 57.7 mt-30 51.55 -170.06 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.177 179.998 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.47 ' N ' ' HD3' ' A' ' 63' ' ' PRO . . . -128.46 47.95 0.99 Allowed Glycine 0 CA--C 1.527 0.8 0 N-CA-C 111.589 -0.604 . . . . 0.0 111.589 -179.846 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.47 ' HD3' ' N ' ' A' ' 62' ' ' GLY . 51.8 Cg_endo -76.69 90.09 1.24 Allowed 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.389 2.06 . . . . 0.0 111.396 179.327 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.425 ' HB3' ' CD1' ' A' ' 33' ' ' LEU . 24.9 m-85 -92.28 160.51 15.1 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.272 0.558 . . . . 0.0 111.253 -179.238 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 5.0 m-80 -142.35 140.73 32.19 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.371 179.713 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -129.92 156.06 45.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.139 0.495 . . . . 0.0 111.545 -179.058 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.474 ' HG3' ' CZ3' ' A' ' 41' ' ' TRP . 1.8 mtp180 -156.38 61.96 0.55 Allowed 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.212 179.769 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.406 ' CD2' HG13 ' A' ' 21' ' ' VAL . 0.7 OUTLIER -68.18 172.41 5.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.247 0.546 . . . . 0.0 110.856 -179.602 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.433 ' O ' ' CB ' ' A' ' 29' ' ' ALA . 0.5 OUTLIER -131.09 76.05 1.7 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.47 -0.787 . . . . 0.0 109.293 179.728 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 2.7 p -35.4 136.9 0.19 Allowed 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 122.771 0.428 . . . . 0.0 111.813 -179.193 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.439 ' HG2' ' CB ' ' A' ' 29' ' ' ALA . 14.2 mt-10 -50.84 -28.95 10.54 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.582 -179.569 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.3 83.01 1.43 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.541 -179.847 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -177.05 -98.54 0.11 Allowed Glycine 0 CA--C 1.523 0.569 0 N-CA-C 110.846 -0.902 . . . . 0.0 110.846 179.864 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 179.3 -178.96 0.37 Allowed 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 110.201 -0.296 . . . . 0.0 110.201 -179.832 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -93.4 179.9 5.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.873 0.368 . . . . 0.0 110.378 179.926 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 172.11 136.02 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.284 -179.988 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.436 HG23 ' CZ ' ' A' ' 67' ' ' ARG . 99.1 t -92.86 158.76 2.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.483 -179.986 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.474 ' CZ ' HG23 ' A' ' 4' ' ' VAL . 64.8 m-85 -143.25 108.22 4.94 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.12 179.94 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -91.17 147.91 22.73 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.663 -179.654 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 41.3 t0 51.51 52.2 15.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.797 179.742 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 74.9 t -68.72 -62.83 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 179.576 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.436 ' CG1' ' HD2' ' A' ' 83' ' ' PRO . 91.5 t -98.52 140.12 21.6 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.101 179.542 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.436 ' HD2' ' CG1' ' A' ' 82' ' ' VAL . 46.1 Cg_endo -69.74 -170.52 0.4 Allowed 'Trans proline' 0 N--CA 1.474 0.377 0 C-N-CA 122.638 2.225 . . . . 0.0 112.15 179.877 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 33.6 mp0 -77.35 -37.05 53.11 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.288 179.948 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -124.9 77.15 1.59 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.242 179.873 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . 0.414 ' HB3' ' CG1' ' A' ' 82' ' ' VAL . 38.6 p90 -73.25 179.82 3.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.462 -179.871 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -157.69 120.56 3.91 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.305 -179.99 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.423 HG13 ' CG1' ' A' ' 8' ' ' VAL . 4.0 mp -51.54 100.45 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.397 179.941 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 131.41 56.43 0.09 OUTLIER Glycine 0 CA--C 1.523 0.556 0 N-CA-C 110.703 -0.959 . . . . 0.0 110.703 -179.889 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.481 ' HB2' ' CZ ' ' A' ' 92' ' ' TYR . . . -177.99 178.03 0.99 Allowed 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 110.253 -0.277 . . . . 0.0 110.253 179.981 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -111.8 146.24 37.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.889 0.376 . . . . 0.0 110.653 -179.839 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.481 ' CZ ' ' HB2' ' A' ' 90' ' ' ALA . 8.6 m-85 -150.17 104.16 3.24 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.263 179.712 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.429 ' CB ' ' CD ' ' A' ' 94' ' ' PRO . . . 173.66 177.74 0.16 Allowed Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.461 179.968 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.429 ' CD ' ' CB ' ' A' ' 93' ' ' ALA . 50.4 Cg_endo . . . . . 0 C--O 1.249 1.026 0 C-N-CA 122.657 2.238 . . . . 0.0 112.211 -179.924 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 10.0 mttt . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.8 0.333 . . . . 0.0 110.526 . . . . . . . . . 0 0 . 1 . 032 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.536 ' CG1' ' CE1' ' A' ' 78' ' ' PHE . 1.6 p -56.03 164.03 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.189 0.519 . . . . 0.0 110.204 179.894 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.476 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 9.1 p -142.17 128.65 20.15 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.411 179.966 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.55 ' CE2' ' CD2' ' A' ' 66' ' ' PHE . 8.0 m-85 -97.98 173.16 7.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.227 179.996 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 12.9 m -165.37 117.79 1.16 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.469 -179.862 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 20.6 t -59.11 94.57 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.269 179.946 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.406 ' OE1' ' CG2' ' A' ' 51' ' ' VAL . 0.1 OUTLIER -51.21 171.84 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.594 -179.893 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.2 ttmt -85.5 56.54 4.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.413 -179.99 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -147.63 25.36 1.5 Allowed Glycine 0 CA--C 1.524 0.622 0 N-CA-C 110.742 -0.943 . . . . 0.0 110.742 179.949 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -100.05 113.6 26.33 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.813 0.339 . . . . 0.0 110.216 179.939 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.406 ' OD1' ' N ' ' A' ' 14' ' ' GLU . 4.7 p30 -112.94 -51.4 2.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.533 -179.852 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.406 ' N ' ' OD1' ' A' ' 13' ' ' ASN . 0.5 OUTLIER -166.99 -64.98 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.755 -179.874 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.421 ' N ' ' HD2' ' A' ' 15' ' ' LYS . 10.9 mmmt -86.59 -27.11 24.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.54 -179.402 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 19.3 m80 -91.62 126.16 36.61 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.934 0.397 . . . . 0.0 110.849 -179.518 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -116.81 89.63 3.15 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.627 179.425 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.425 ' HB3' ' CG2' ' A' ' 53' ' ' THR . . . -83.51 126.05 32.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.762 -179.368 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.401 HG13 ' CZ ' ' A' ' 66' ' ' PHE . 19.8 m -113.55 -173.41 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.629 179.368 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.6 tt -141.04 59.21 1.53 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.256 179.679 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 28.0 t -55.86 116.54 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.428 -179.937 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.1 mttp -168.09 162.42 13.09 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.154 179.97 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -140.42 -63.67 0.48 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.225 -0.443 . . . . 0.0 109.979 -179.968 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -149.53 -47.25 0.14 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.318 179.981 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 170.22 74.84 0.04 OUTLIER Glycine 0 CA--C 1.524 0.601 0 N-CA-C 110.899 -0.88 . . . . 0.0 110.899 179.982 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -112.9 -168.31 1.3 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.767 0.318 . . . . 0.0 110.206 179.797 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.419 ' HB ' ' HB2' ' A' ' 71' ' ' GLU . 0.9 OUTLIER -113.45 137.78 51.04 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.094 179.984 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 7.8 mtt -101.62 129.57 47.77 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.872 -179.537 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.438 ' CB ' ' O ' ' A' ' 69' ' ' LEU . . . -112.68 -57.6 2.26 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.246 179.824 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.412 ' O ' ' CB ' ' A' ' 68' ' ' PHE . 0.7 OUTLIER -153.11 165.2 36.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.175 179.832 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.488 HG23 ' CD1' ' A' ' 52' ' ' TRP . 4.1 t -152.69 140.27 13.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.264 -0.426 . . . . 0.0 109.939 -179.969 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.448 ' CB ' ' HA ' ' A' ' 43' ' ' ALA . 1.5 pt-20 -137.34 137.34 38.8 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.968 0.413 . . . . 0.0 110.584 -179.701 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.424 HD11 ' CD2' ' A' ' 54' ' ' PHE . 1.6 mt -92.97 -178.52 4.83 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.587 -179.686 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.465 ' HB2' ' CZ3' ' A' ' 41' ' ' TRP . 0.7 OUTLIER -157.5 147.75 20.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.943 179.633 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -113.99 -14.36 12.43 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.957 -179.834 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 70.22 120.83 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.843 0.354 . . . . 0.0 110.31 -179.996 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 118.06 -45.27 1.29 Allowed Glycine 0 CA--C 1.522 0.481 0 N-CA-C 110.472 -1.051 . . . . 0.0 110.472 -179.753 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 20.7 t -63.24 -25.41 68.31 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.774 0.321 . . . . 0.0 110.314 179.778 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.1 t0 70.38 29.32 3.57 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.415 179.908 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -154.37 145.05 22.38 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.513 179.957 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.465 ' CZ3' ' HB2' ' A' ' 34' ' ' ARG . 83.8 m95 -88.14 145.66 25.81 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.036 179.8 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.49 ' CG2' ' CZ ' ' A' ' 54' ' ' PHE . 20.3 m -117.11 107.15 21.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.095 0.474 . . . . 0.0 110.33 -179.862 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.448 ' HA ' ' CB ' ' A' ' 32' ' ' GLU . . . -53.82 139.22 33.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.152 -179.782 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.42 ' CE ' HD13 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -64.86 -171.48 0.07 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.855 -179.644 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.422 ' O ' ' N ' ' A' ' 47' ' ' GLY . 86.7 m -143.55 97.65 3.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.217 179.858 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 13.5 ptmt -61.25 80.7 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.361 -179.883 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' A' ' 45' ' ' THR . . . -120.93 15.37 9.55 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 111.236 -0.745 . . . . 0.0 111.236 179.993 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -106.62 -33.24 7.71 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.847 0.356 . . . . 0.0 110.325 179.96 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 94.89 -36.79 3.63 Favored Glycine 0 CA--C 1.522 0.515 0 N-CA-C 110.667 -0.973 . . . . 0.0 110.667 179.973 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -110.92 -25.55 5.07 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 110.818 -0.913 . . . . 0.0 110.818 -179.877 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.406 ' CG2' ' OE1' ' A' ' 9' ' ' GLU . 15.5 m -140.66 -176.33 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.937 0.399 . . . . 0.0 110.591 -179.904 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . 0.488 ' CD1' HG23 ' A' ' 31' ' ' VAL . 9.5 m95 -108.58 142.28 39.26 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.726 -179.507 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.425 ' CG2' ' HB3' ' A' ' 18' ' ' ALA . 0.7 OUTLIER -130.02 150.76 51.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.967 179.672 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.49 ' CZ ' ' CG2' ' A' ' 42' ' ' VAL . 65.8 t80 -136.18 153.57 51.21 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.884 0.373 . . . . 0.0 110.808 -179.825 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -95.56 96.46 9.07 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.212 179.831 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 31.3 p -50.71 121.62 6.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.562 -179.859 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -80.83 -26.83 36.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.099 179.721 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 23.8 pt-20 -118.32 144.88 35.95 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.18 179.883 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -67.07 -18.52 51.57 Favored 'Trans proline' 0 C--N 1.343 0.246 0 C-N-CA 122.765 2.31 . . . . 0.0 112.19 179.999 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -71.94 118.21 14.51 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.426 179.975 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -101.19 54.14 0.84 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.242 179.86 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -73.15 -143.2 0.58 Allowed Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.715 -0.954 . . . . 0.0 110.715 -179.949 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -77.27 106.16 2.18 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.614 2.209 . . . . 0.0 112.145 -179.856 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.411 ' HB3' ' CD2' ' A' ' 33' ' ' LEU . 16.4 m-85 -77.96 98.32 5.64 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.66 179.961 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.43 ' OD1' ' N ' ' A' ' 65' ' ' ASN . 0.4 OUTLIER -71.32 123.45 22.31 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 179.469 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.55 ' CD2' ' CE2' ' A' ' 6' ' ' PHE . 2.7 m-85 -101.05 176.66 5.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.598 -179.55 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.462 ' HG3' ' CH2' ' A' ' 41' ' ' TRP . 1.7 mtp180 176.51 102.1 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.456 179.916 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.412 ' CB ' ' O ' ' A' ' 30' ' ' GLU . 0.8 OUTLIER -111.29 172.85 6.64 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.427 179.815 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.438 ' O ' ' CB ' ' A' ' 29' ' ' ALA . 2.4 mt -128.88 65.98 1.43 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.376 179.684 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 29.0 p -31.5 143.87 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.246 0.619 . . . . 0.0 112.108 -179.302 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.419 ' HB2' ' HB ' ' A' ' 27' ' ' THR . 0.4 OUTLIER -68.29 -31.23 70.53 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.254 -179.716 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.5 tmtm? -141.03 56.24 1.56 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.47 179.994 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -145.48 -105.66 0.47 Allowed Glycine 0 CA--C 1.523 0.559 0 N-CA-C 110.622 -0.991 . . . . 0.0 110.622 179.9 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 10.6 ptm -178.47 -179.45 0.68 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.787 0.327 . . . . 0.0 110.205 -179.986 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 14.1 mmtm -90.82 158.19 16.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.14 179.871 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -175.25 135.71 0.35 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.801 -179.944 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 94.6 t -94.2 150.25 4.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.233 -0.44 . . . . 0.0 109.963 179.476 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.536 ' CE1' ' CG1' ' A' ' 4' ' ' VAL . 71.2 m-85 -131.5 145.73 51.9 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.97 -179.203 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -139.62 162.19 35.7 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.006 179.76 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 51.97 33.04 10.98 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.113 0.483 . . . . 0.0 109.839 -179.722 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.426 ' O ' ' CG2' ' A' ' 82' ' ' VAL . 87.6 t -78.41 -3.01 5.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.586 -179.406 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.426 ' CG2' ' O ' ' A' ' 81' ' ' VAL . 72.4 t -158.15 119.45 1.95 Allowed Pre-proline 0 CA--C 1.53 0.21 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 179.855 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -75.66 169.64 21.88 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.458 2.105 . . . . 0.0 111.786 179.729 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -66.26 120.02 12.53 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 179.633 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 2.5 mtpt 67.24 58.85 0.54 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.224 -0.443 . . . . 0.0 109.997 -179.609 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 21.4 p90 -52.96 -175.16 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.741 -179.729 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 1.5 m -152.26 108.12 3.36 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.967 179.836 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 3.3 mp -46.45 121.82 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.68 -179.86 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 113.73 29.59 2.83 Favored Glycine 0 CA--C 1.523 0.582 0 N-CA-C 110.736 -0.945 . . . . 0.0 110.736 -179.875 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.426 ' HB2' ' CZ ' ' A' ' 92' ' ' TYR . . . -142.32 167.29 22.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.736 0.303 . . . . 0.0 110.443 -179.944 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 32.8 m -113.44 120.8 42.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.522 -179.968 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.426 ' CZ ' ' HB2' ' A' ' 90' ' ' ALA . 40.8 m-85 -125.62 123.55 39.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.394 179.954 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.442 ' CB ' ' CD ' ' A' ' 94' ' ' PRO . . . 174.56 178.45 0.17 Allowed Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.457 -179.981 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.442 ' CD ' ' CB ' ' A' ' 93' ' ' ALA . 49.8 Cg_endo . . . . . 0 C--O 1.25 1.083 0 C-N-CA 122.547 2.165 . . . . 0.0 112.112 -179.884 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 33.4 mmtm . . . . . 0 N--CA 1.457 -0.117 0 CA-C-O 120.725 0.298 . . . . 0.0 111.07 . . . . . . . . . 0 0 . 1 . 033 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.524 ' CG1' ' CE1' ' A' ' 78' ' ' PHE . 2.1 p -106.26 163.42 4.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.336 0.588 . . . . 0.0 110.365 -179.968 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.461 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 65.9 p -144.2 129.51 18.81 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.294 179.718 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.411 ' O ' ' CG2' ' A' ' 91' ' ' THR . 35.0 m-85 -89.29 -176.75 5.19 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.307 179.904 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -166.15 118.57 1.06 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.152 179.934 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.1 t -68.18 93.43 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.356 -179.899 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -54.11 -178.45 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.303 -179.961 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.26 48.74 1.6 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.455 -179.839 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -112.3 -25.78 4.56 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 110.842 -0.903 . . . . 0.0 110.842 -179.992 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.1 m -50.82 120.97 5.28 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.826 0.346 . . . . 0.0 110.418 -179.982 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -114.13 -81.17 0.6 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.424 -179.912 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -106.78 -82.67 0.54 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.735 0.302 . . . . 0.0 110.41 -179.904 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.36 28.39 8.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.326 -179.995 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 8.9 m80 -104.08 167.39 9.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.325 -179.959 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 17.2 tp -154.13 88.79 1.25 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.452 -179.853 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.422 ' CB ' HG22 ' A' ' 53' ' ' THR . . . -81.37 109.62 16.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.454 -179.902 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.5 m -103.54 141.23 19.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.449 179.941 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -90.41 83.23 5.89 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.611 -179.99 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 16.2 t -79.32 90.61 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.348 179.866 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 176.08 157.29 0.24 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.982 -0.553 . . . . 0.0 109.95 -179.974 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.521 ' CE2' ' HB2' ' A' ' 26' ' ' ASP . 0.0 OUTLIER -113.89 -66.52 1.08 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.541 -179.751 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -153.45 -65.21 0.15 Allowed 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 111.808 0.299 . . . . 0.0 111.808 -179.395 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -106.36 -28.14 5.29 Favored Glycine 0 CA--C 1.525 0.702 0 C-N-CA 121.364 -0.446 . . . . 0.0 112.563 -178.372 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.521 ' HB2' ' CE2' ' A' ' 23' ' ' TYR . 16.8 t0 -42.29 152.02 0.1 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 117.277 0.539 . . . . 0.0 111.417 -179.363 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.63 -174.67 2.7 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.731 -179.462 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.423 ' O ' ' CG ' ' A' ' 71' ' ' GLU . 34.7 mtm -123.17 126.07 46.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.336 -179.883 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.442 ' CB ' ' HG2' ' A' ' 71' ' ' GLU . . . -118.97 -60.35 1.76 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.513 -179.706 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.415 ' HB3' ' CD1' ' A' ' 69' ' ' LEU . 0.6 OUTLIER -154.39 156.26 36.52 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.106 -179.937 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.482 HG12 ' CD1' ' A' ' 52' ' ' TRP . 0.7 OUTLIER -173.95 141.33 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.377 0.608 . . . . 0.0 110.271 -179.87 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.417 ' N ' ' OE1' ' A' ' 32' ' ' GLU . 1.7 pm0 -141.18 169.48 17.53 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.059 -179.444 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.516 ' CD2' ' CE1' ' A' ' 66' ' ' PHE . 1.0 OUTLIER -117.3 174.34 6.19 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.157 0.503 . . . . 0.0 111.096 -179.479 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.416 ' NE ' ' HA ' ' A' ' 34' ' ' ARG . 0.5 OUTLIER -161.75 -176.69 5.41 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.486 179.562 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -129.92 -70.76 0.63 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.797 0.332 . . . . 0.0 110.424 179.928 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 58.2 t-80 -178.53 -50.02 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.344 179.972 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -121.02 25.69 7.02 Favored Glycine 0 CA--C 1.523 0.545 0 N-CA-C 110.733 -0.947 . . . . 0.0 110.733 179.87 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 2.7 m -70.97 -22.43 62.2 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.652 0.263 . . . . 0.0 110.593 179.931 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.4 t0 71.96 97.21 0.07 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.799 0.333 . . . . 0.0 110.326 -179.802 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 76.82 146.44 0.09 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.398 -179.961 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.495 ' CE3' ' HG2' ' A' ' 67' ' ' ARG . 35.5 m95 -79.83 160.95 25.91 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.54 -179.826 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.411 HG12 ' NH1' ' A' ' 34' ' ' ARG . 32.1 m -132.16 122.18 47.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.179 179.832 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -46.51 130.44 11.1 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.8 -179.911 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.432 ' CE ' ' CD1' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -58.79 -167.51 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.22 -179.901 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 53.2 m -137.01 126.34 24.86 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.434 -179.946 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.66 67.16 6.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.231 -0.44 . . . . 0.0 109.987 179.726 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -96.86 -35.98 5.17 Favored Glycine 0 CA--C 1.522 0.503 0 N-CA-C 110.738 -0.945 . . . . 0.0 110.738 -179.772 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.43 ' HG2' ' CG2' ' A' ' 51' ' ' VAL . 31.8 tp10 -80.18 133.91 36.09 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.804 0.335 . . . . 0.0 110.369 179.915 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -79.36 88.39 1.21 Allowed Glycine 0 CA--C 1.523 0.587 0 N-CA-C 111.021 -0.831 . . . . 0.0 111.021 -179.794 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 129.81 -23.4 4.73 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 111.167 -0.773 . . . . 0.0 111.167 179.721 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.43 ' CG2' ' HG2' ' A' ' 48' ' ' GLU . 16.7 m -146.8 -175.56 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.933 0.397 . . . . 0.0 110.684 -179.756 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . 0.482 ' CD1' HG12 ' A' ' 31' ' ' VAL . 8.4 m95 -103.22 144.61 31.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.462 -179.547 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.422 HG22 ' CB ' ' A' ' 18' ' ' ALA . 0.1 OUTLIER -132.57 145.15 50.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.546 -179.759 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -120.62 136.69 54.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.125 179.725 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 11.4 t0 -113.67 156.34 23.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.939 0.4 . . . . 0.0 110.765 -179.706 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -175.39 172.96 2.59 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.326 179.947 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -154.85 30.79 0.41 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.385 -179.97 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -75.64 157.36 84.25 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.473 -179.96 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -71.3 -34.52 9.73 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.67 2.247 . . . . 0.0 112.035 179.881 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 5.4 mt -81.37 167.3 19.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.356 -179.928 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 28.2 tt0 -172.53 111.39 0.25 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.476 -179.98 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -135.35 -143.26 4.71 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.597 -1.001 . . . . 0.0 110.597 179.975 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -77.32 171.84 17.02 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.546 2.164 . . . . 0.0 111.892 179.882 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -124.18 172.45 9.04 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.92 0.39 . . . . 0.0 110.511 -179.948 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -146.36 144.72 29.95 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.176 -179.982 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.516 ' CE1' ' CD2' ' A' ' 33' ' ' LEU . 39.3 m-85 -127.03 -177.12 3.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.019 0.437 . . . . 0.0 110.483 179.978 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.495 ' HG2' ' CE3' ' A' ' 41' ' ' TRP . 0.0 OUTLIER 176.78 72.66 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.799 179.76 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.451 ' HA ' ' HA ' ' A' ' 31' ' ' VAL . 0.0 OUTLIER -71.01 -178.96 2.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.409 0.624 . . . . 0.0 111.626 -179.259 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.425 ' CD2' ' O ' ' A' ' 68' ' ' PHE . 9.1 mt -144.77 49.07 1.31 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.032 -0.985 . . . . 0.0 109.254 179.874 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.412 ' OG1' ' CA ' ' A' ' 73' ' ' GLY . 40.8 p -22.67 137.64 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.129 0.972 . . . . 0.0 112.891 -179.147 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.442 ' HG2' ' CB ' ' A' ' 29' ' ' ALA . 3.2 mm-40 -54.2 -25.27 21.97 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.533 -179.806 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.51 48.89 0.14 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.862 0.363 . . . . 0.0 110.547 -179.907 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.412 ' CA ' ' OG1' ' A' ' 70' ' ' THR . . . -128.34 -107.2 1.35 Allowed Glycine 0 CA--C 1.523 0.592 0 N-CA-C 110.707 -0.957 . . . . 0.0 110.707 179.915 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.409 ' N ' ' OG1' ' A' ' 70' ' ' THR . 66.0 mmm -139.13 171.28 14.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.832 0.349 . . . . 0.0 110.305 179.965 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.439 ' O ' ' CD ' ' A' ' 75' ' ' LYS . 0.0 OUTLIER -138.12 86.56 2.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.306 179.859 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -141.1 140.23 34.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.251 -179.971 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 17.9 m -66.61 -179.73 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.333 -179.958 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.524 ' CE1' ' CG1' ' A' ' 4' ' ' VAL . 66.1 m-85 -149.38 135.54 19.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.631 -179.831 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -119.21 158.99 24.89 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.395 -179.976 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 52.5 49.65 19.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.405 179.91 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.417 ' O ' ' CG2' ' A' ' 82' ' ' VAL . 80.9 t -90.89 -0.65 9.44 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.039 179.836 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.419 ' CG1' ' HB3' ' A' ' 86' ' ' TYR . 94.8 t -157.49 130.2 4.35 Favored Pre-proline 0 CA--C 1.527 0.093 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 179.667 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.484 ' HD3' ' CD1' ' A' ' 92' ' ' TYR . 49.7 Cg_endo -71.0 -167.09 0.25 Allowed 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.577 2.184 . . . . 0.0 112.06 179.767 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -68.78 -34.25 75.24 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.933 179.472 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -137.96 91.19 2.55 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.952 179.683 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . 0.42 ' CD1' ' C ' ' A' ' 86' ' ' TYR . 14.9 p90 -67.62 165.76 16.39 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.794 -179.65 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -141.34 115.24 9.15 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.064 179.844 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 3.4 mp -46.58 131.08 3.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.762 -179.836 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 89.87 39.29 6.21 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 110.685 -0.966 . . . . 0.0 110.685 -179.905 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -146.81 155.93 42.73 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.865 0.364 . . . . 0.0 110.53 -179.918 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.411 ' CG2' ' O ' ' A' ' 6' ' ' PHE . 0.2 OUTLIER -106.42 142.22 36.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.258 179.954 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.484 ' CD1' ' HD3' ' A' ' 83' ' ' PRO . 73.3 m-85 -134.1 -86.48 0.41 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.762 -179.914 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.468 ' CB ' ' CD ' ' A' ' 94' ' ' PRO . . . 50.12 -179.05 0.01 OUTLIER Pre-proline 0 C--N 1.332 -0.154 0 CA-C-O 120.63 0.252 . . . . 0.0 110.547 179.923 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.468 ' CD ' ' CB ' ' A' ' 93' ' ' ALA . 47.9 Cg_endo . . . . . 0 C--O 1.249 1.054 0 C-N-CA 122.539 2.16 . . . . 0.0 112.064 -179.978 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.522 -0.131 0 CA-C-O 120.899 0.381 . . . . 0.0 110.361 . . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.479 HG23 ' CE1' ' A' ' 78' ' ' PHE . 27.0 m -88.45 -176.03 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.087 179.85 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -167.04 146.92 5.44 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.364 179.971 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -118.78 158.13 26.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.22 179.905 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 53.2 m -150.73 104.71 3.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.35 -179.863 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.428 ' CG1' HD12 ' A' ' 88' ' ' ILE . 14.2 t -54.33 94.83 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.416 -179.905 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.41 ' HG3' ' CG1' ' A' ' 51' ' ' VAL . 4.7 mm-40 -69.33 162.89 26.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.286 -179.99 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.67 171.01 3.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.479 -179.967 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 86.67 19.59 56.06 Favored Glycine 0 CA--C 1.527 0.795 0 N-CA-C 111.103 -0.799 . . . . 0.0 111.103 -179.955 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.402 ' O ' ' HB2' ' A' ' 13' ' ' ASN . 8.7 m -109.6 -159.76 0.69 Allowed 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 -179.936 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.402 ' HB2' ' O ' ' A' ' 12' ' ' SER . 10.2 m-80 66.79 -62.39 0.3 Allowed 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.153 179.556 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -43.44 -69.73 0.13 Allowed 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.76 0.314 . . . . 0.0 111.02 -179.555 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.431 ' HA ' ' CE ' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -156.29 25.9 0.35 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.388 179.965 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 55.2 m80 -149.77 165.46 32.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.081 0.467 . . . . 0.0 110.787 -179.572 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -138.56 85.27 2.07 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.285 179.236 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.406 ' CA ' HG21 ' A' ' 53' ' ' THR . . . -78.2 153.42 31.99 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.985 -179.134 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 29.4 m -150.14 141.94 17.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.868 -0.606 . . . . 0.0 109.697 179.424 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -93.21 101.29 13.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.838 0.352 . . . . 0.0 110.621 -179.837 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 6.7 t -112.35 99.65 9.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.138 179.761 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.474 ' O ' ' CG ' ' A' ' 23' ' ' TYR . 24.7 mtpp -140.55 -72.88 0.35 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.671 -179.876 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.479 ' O ' ' CD2' ' A' ' 23' ' ' TYR . 29.7 p90 45.28 98.2 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.884 -179.667 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -46.82 116.1 1.24 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.835 -179.965 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 162.64 -42.32 0.35 Allowed Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.746 -0.942 . . . . 0.0 110.746 179.955 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -123.53 178.92 4.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.777 0.323 . . . . 0.0 110.378 -179.994 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.421 ' CB ' ' HB2' ' A' ' 71' ' ' GLU . 0.2 OUTLIER -103.85 -171.61 1.96 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.3 179.987 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 6.1 mtt -117.4 118.83 33.28 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.819 -179.751 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.448 ' HB1' ' N ' ' A' ' 71' ' ' GLU . . . -113.62 -62.33 1.61 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.109 179.57 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -165.0 165.1 20.39 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.767 -179.986 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.481 HG23 ' CD1' ' A' ' 52' ' ' TRP . 5.2 t -148.27 166.68 4.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.313 -179.896 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -174.72 151.03 1.38 Allowed 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.416 -179.788 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.475 ' HB3' ' CE1' ' A' ' 66' ' ' PHE . 3.0 pp -115.95 177.39 4.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.446 179.957 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.476 ' HB2' ' CE3' ' A' ' 41' ' ' TRP . 2.7 ttm180 -120.2 -40.56 2.69 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.296 179.862 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.444 ' CB ' ' O ' ' A' ' 34' ' ' ARG . 3.8 tt0 87.43 32.97 0.02 OUTLIER 'General case' 0 CA--C 1.515 -0.384 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 -179.102 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . 0.428 ' CE1' ' OE1' ' A' ' 61' ' ' GLN . 41.8 t-80 63.71 -74.03 0.04 OUTLIER 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 114.882 -1.054 . . . . 0.0 110.596 -180.0 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.418 ' N ' ' O ' ' A' ' 35' ' ' GLU . . . -136.49 103.69 0.45 Allowed Glycine 0 CA--C 1.523 0.534 0 N-CA-C 110.766 -0.934 . . . . 0.0 110.766 -179.987 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -139.87 -54.07 0.54 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.826 0.346 . . . . 0.0 110.252 179.907 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.7 p30 179.91 -45.66 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.321 -179.978 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -178.61 171.54 1.51 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.195 -179.964 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.483 ' CZ3' ' HG2' ' A' ' 67' ' ' ARG . 96.7 m95 -55.01 125.3 19.82 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.338 -179.993 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.424 ' CG2' HD13 ' A' ' 33' ' ' LEU . 4.4 m -106.91 116.93 51.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.128 179.861 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -48.83 126.03 11.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.505 -179.91 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.79 -169.85 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.254 -179.929 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 33.8 m -141.13 95.69 2.88 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.425 -179.952 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.26 81.9 1.84 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.217 179.811 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -117.32 -17.85 5.58 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 111.404 -0.678 . . . . 0.0 111.404 -179.744 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -69.78 -32.65 71.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.774 0.321 . . . . 0.0 110.631 -179.766 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 97.4 -35.38 4.51 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 110.523 -1.031 . . . . 0.0 110.523 -179.839 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -113.86 -34.09 1.74 Allowed Glycine 0 CA--C 1.523 0.571 0 N-CA-C 110.458 -1.057 . . . . 0.0 110.458 179.912 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.41 ' CG1' ' HG3' ' A' ' 9' ' ' GLU . 23.9 m -123.78 172.75 10.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.808 0.337 . . . . 0.0 110.127 179.815 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . 0.481 ' CD1' HG23 ' A' ' 31' ' ' VAL . 8.8 m95 -105.06 133.8 49.24 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.529 -179.718 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.406 HG21 ' CA ' ' A' ' 18' ' ' ALA . 0.0 OUTLIER -119.79 -179.02 3.77 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.311 179.875 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 66.8 t80 -175.37 130.85 0.28 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.347 179.95 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 43.8 m-20 -68.91 117.29 10.39 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.359 -179.98 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 9.1 p -119.2 120.04 35.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.368 -179.994 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -100.93 -26.3 13.79 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.48 -179.921 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.402 ' O ' ' CG ' ' A' ' 58' ' ' GLU . 1.1 pt-20 -115.52 112.61 43.29 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.488 -179.872 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -70.7 -21.11 29.55 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.479 2.119 . . . . 0.0 111.891 179.655 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 44.73 -154.71 0.03 OUTLIER 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.854 179.584 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.428 ' OE1' ' CE1' ' A' ' 36' ' ' HIS . 0.0 OUTLIER -45.15 -31.9 1.61 Allowed 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.708 -0.224 . . . . 0.0 111.23 -179.644 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.49 ' N ' ' CD ' ' A' ' 63' ' ' PRO . . . 124.29 -41.98 1.64 Allowed Glycine 0 CA--C 1.531 1.058 0 C-N-CA 121.116 -0.564 . . . . 0.0 112.395 179.894 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.49 ' CD ' ' N ' ' A' ' 62' ' ' GLY . 45.2 Cg_endo -74.64 152.98 43.35 Favored 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 122.052 1.835 . . . . 0.0 112.811 -179.137 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -126.77 101.61 6.68 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.318 179.832 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 20.7 m-20 -65.53 140.34 58.56 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 179.538 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.475 ' CE1' ' HB3' ' A' ' 33' ' ' LEU . 16.5 m-85 -128.96 176.58 7.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.235 0.54 . . . . 0.0 111.246 -179.34 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.483 ' HG2' ' CZ3' ' A' ' 41' ' ' TRP . 0.0 OUTLIER 176.91 89.17 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.447 179.878 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -72.06 176.28 5.23 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.179 0.514 . . . . 0.0 110.874 -179.144 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.44 ' O ' ' CB ' ' A' ' 29' ' ' ALA . 2.3 mt -130.12 61.12 1.59 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.031 179.715 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.407 ' OG1' ' N ' ' A' ' 74' ' ' MET . 0.6 OUTLIER -23.69 137.62 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.871 0.868 . . . . 0.0 113.011 -178.821 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.448 ' N ' ' HB1' ' A' ' 29' ' ' ALA . 0.0 OUTLIER -48.41 -45.02 35.55 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.094 -179.533 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -145.37 38.32 1.15 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.279 179.973 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -114.57 -109.87 2.82 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.889 -0.884 . . . . 0.0 110.889 -179.952 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.407 ' N ' ' OG1' ' A' ' 70' ' ' THR . 20.8 mmt -154.41 -179.67 8.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.745 0.307 . . . . 0.0 110.183 179.909 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.428 ' HD3' ' N ' ' A' ' 75' ' ' LYS . 0.1 OUTLIER -115.85 100.74 8.21 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.996 0.427 . . . . 0.0 110.443 -179.888 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 49.0 t30 -115.9 152.86 32.61 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.241 179.895 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 77.7 t -100.29 160.79 3.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.324 179.843 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.479 ' CE1' HG23 ' A' ' 4' ' ' VAL . 64.9 m-85 -141.13 109.28 5.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.287 -179.907 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -95.77 159.66 14.87 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.496 -179.869 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 54.72 32.84 18.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.551 179.902 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 66.3 t -66.23 -54.68 24.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.286 179.901 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.453 ' CG1' ' HB3' ' A' ' 86' ' ' TYR . 76.2 t -101.1 142.45 24.64 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.02 179.95 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.486 ' HG3' ' CE1' ' A' ' 92' ' ' TYR . 43.5 Cg_endo -68.11 177.83 4.09 Favored 'Trans proline' 0 N--CA 1.475 0.42 0 C-N-CA 122.622 2.214 . . . . 0.0 112.287 179.915 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -59.31 -33.97 71.74 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.233 179.904 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.02 85.27 2.18 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.175 179.9 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . 0.453 ' HB3' ' CG1' ' A' ' 82' ' ' VAL . 26.5 p90 -50.51 145.04 6.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.682 -179.751 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 4.2 m -136.08 111.45 9.14 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.304 179.841 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.428 HD12 ' CG1' ' A' ' 8' ' ' VAL . 38.1 mm -50.49 110.19 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.49 -179.874 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 122.89 47.24 0.27 Allowed Glycine 0 CA--C 1.523 0.553 0 N-CA-C 110.819 -0.912 . . . . 0.0 110.819 179.918 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.47 ' HB2' ' CZ ' ' A' ' 92' ' ' TYR . . . -160.0 159.02 31.61 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.774 0.321 . . . . 0.0 110.44 179.928 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 90.1 m -118.69 91.81 3.65 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.497 179.949 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.486 ' CE1' ' HG3' ' A' ' 83' ' ' PRO . 32.9 m-85 -86.06 -156.71 0.3 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.154 179.847 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.432 ' CB ' ' HD2' ' A' ' 94' ' ' PRO . . . 76.19 173.6 0.09 OUTLIER Pre-proline 0 N--CA 1.463 0.179 0 CA-C-O 120.7 0.286 . . . . 0.0 110.307 -179.805 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.432 ' HD2' ' CB ' ' A' ' 93' ' ' ALA . 46.1 Cg_endo . . . . . 0 C--O 1.249 1.05 0 C-N-CA 122.582 2.188 . . . . 0.0 112.092 -179.908 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.44 ' O ' ' CG2' ' A' ' 4' ' ' VAL . 81.7 mttt . . . . . 0 CA--C 1.52 -0.2 0 CA-C-O 120.701 0.286 . . . . 0.0 110.346 . . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.44 ' CG2' ' O ' ' A' ' 3' ' ' LYS . 23.0 m 44.59 -172.22 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.042 -179.804 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -174.02 136.8 0.53 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.521 -179.72 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -105.17 172.13 6.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.01 179.857 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 19.7 m -165.69 113.35 0.95 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.84 0.352 . . . . 0.0 110.447 -179.974 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 94.9 t -58.0 87.97 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.396 179.971 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -59.44 167.12 2.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.344 179.982 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.06 165.14 5.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.363 179.954 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 79.99 35.0 28.77 Favored Glycine 0 CA--C 1.523 0.582 0 N-CA-C 110.834 -0.906 . . . . 0.0 110.834 179.99 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 74.4 m -96.1 114.95 26.7 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.78 0.324 . . . . 0.0 110.369 -179.948 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -97.46 -168.85 1.75 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.213 179.998 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 67.8 mm-40 -69.24 -27.15 65.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.315 179.861 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.418 ' HG2' ' N ' ' A' ' 16' ' ' HIS . 0.0 OUTLIER -114.55 -30.65 6.46 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.641 -179.857 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . 0.418 ' N ' ' HG2' ' A' ' 15' ' ' LYS . 2.0 m80 -70.59 151.28 45.17 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.851 0.357 . . . . 0.0 110.378 -179.902 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -151.29 91.58 1.7 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.498 -179.965 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.423 ' HB3' ' CG2' ' A' ' 53' ' ' THR . . . -89.31 136.19 33.16 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.868 179.675 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 27.4 m -137.86 135.02 45.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.999 0.428 . . . . 0.0 110.847 -179.793 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -88.57 81.12 7.18 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.454 179.949 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 42.9 t -77.92 107.91 10.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.408 179.97 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -170.43 150.51 3.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.289 -179.986 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 8.4 p90 -166.78 31.4 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.493 -179.938 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 50.84 -167.78 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.513 179.959 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 63.45 -79.97 0.04 OUTLIER Glycine 0 CA--C 1.523 0.536 0 N-CA-C 110.796 -0.921 . . . . 0.0 110.796 179.88 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -71.63 179.54 3.02 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.678 0.275 . . . . 0.0 110.325 179.956 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -121.2 -174.1 2.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.389 -179.886 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.427 ' O ' ' CG ' ' A' ' 71' ' ' GLU . 22.6 mtm -114.99 122.35 45.97 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.677 -179.651 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.433 ' CB ' ' O ' ' A' ' 69' ' ' LEU . . . -120.02 -60.48 1.7 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.338 179.765 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -161.37 147.59 14.31 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.36 179.995 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.1 t -133.97 159.33 42.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.941 0.401 . . . . 0.0 110.596 179.987 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.424 ' OE2' ' N ' ' A' ' 32' ' ' GLU . 0.5 OUTLIER -150.04 147.79 28.24 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.148 -179.944 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.434 ' O ' ' CG2' ' A' ' 42' ' ' VAL . 12.0 tp -116.65 156.07 27.71 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 -179.603 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.98 178.81 7.0 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.087 179.609 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -122.16 -79.91 0.62 Allowed 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 179.719 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -179.34 -38.42 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.349 179.487 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -130.28 22.87 4.67 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.884 -0.887 . . . . 0.0 110.884 179.937 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 8.2 t -77.34 -166.13 0.69 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.872 0.368 . . . . 0.0 110.304 179.959 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -87.2 52.99 2.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.143 179.868 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 69.71 178.61 0.25 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.251 -179.858 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.468 ' CZ3' ' HG2' ' A' ' 67' ' ' ARG . 97.2 m95 -50.47 139.08 16.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.629 -179.994 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.434 ' CG2' ' O ' ' A' ' 33' ' ' LEU . 4.6 m -125.89 111.33 26.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 109.743 -0.465 . . . . 0.0 109.743 179.531 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -44.45 138.15 3.35 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.116 -179.376 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -67.66 -171.73 0.22 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.89 -179.942 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.402 ' O ' ' N ' ' A' ' 47' ' ' GLY . 51.7 m -150.92 106.31 3.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.228 179.846 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 7.3 ptmt -62.77 80.99 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.495 -179.925 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.402 ' N ' ' O ' ' A' ' 45' ' ' THR . . . -98.74 -24.31 10.97 Favored Glycine 0 CA--C 1.523 0.555 0 N-CA-C 110.647 -0.981 . . . . 0.0 110.647 179.846 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.454 ' CB ' ' HB ' ' A' ' 51' ' ' VAL . 2.2 mm-40 -78.18 1.09 22.5 Favored 'General case' 0 CA--C 1.532 0.269 0 O-C-N 122.85 -0.206 . . . . 0.0 111.502 -179.891 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 67.93 17.29 69.41 Favored Glycine 0 CA--C 1.527 0.794 0 N-CA-C 111.13 -0.788 . . . . 0.0 111.13 -179.963 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 178.24 -38.57 0.08 OUTLIER Glycine 0 C--N 1.33 0.229 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 179.93 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.454 ' HB ' ' CB ' ' A' ' 48' ' ' GLU . 22.2 t -101.24 150.3 5.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 179.227 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . 0.421 ' N ' HG11 ' A' ' 51' ' ' VAL . 3.3 m95 -91.75 111.7 23.32 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.477 -179.543 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.423 ' CG2' ' HB3' ' A' ' 18' ' ' ALA . 15.0 p -107.73 150.13 27.33 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.494 -179.736 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 34.6 t80 -136.7 115.12 11.82 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.451 -179.996 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -66.8 162.27 21.88 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.289 179.974 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 6.3 t 65.09 127.04 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.705 179.849 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.424 ' O ' ' O ' ' A' ' 58' ' ' GLU . 5.7 tt0 -117.95 -15.93 9.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.955 179.885 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.424 ' O ' ' O ' ' A' ' 57' ' ' GLU . 2.2 pt-20 48.97 170.43 0.03 OUTLIER Pre-proline 0 N--CA 1.467 0.381 0 C-N-CA 123.213 0.605 . . . . 0.0 111.548 -179.94 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.404 ' CD ' ' HB2' ' A' ' 58' ' ' GLU . 38.3 Cg_endo -96.97 10.41 1.25 Allowed 'Trans proline' 0 N--CA 1.453 -0.877 0 C-N-CA 124.036 3.157 . . . . 0.0 112.961 -178.998 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.9 100.47 0.07 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.841 0.353 . . . . 0.0 110.512 -179.914 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -53.65 127.5 25.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.222 179.861 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 135.7 163.0 9.83 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.601 -0.999 . . . . 0.0 110.601 -179.806 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.425 ' CG ' ' HA ' ' A' ' 80' ' ' ASP . 49.9 Cg_endo -79.33 -171.95 1.39 Allowed 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.642 2.228 . . . . 0.0 112.091 -179.974 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 -97.16 171.64 8.32 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.85 0.357 . . . . 0.0 110.258 179.846 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -144.05 143.88 31.37 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.716 179.813 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 -131.28 177.75 7.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.201 0.524 . . . . 0.0 111.288 -179.466 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.468 ' HG2' ' CZ3' ' A' ' 41' ' ' TRP . 0.1 OUTLIER 175.7 67.28 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.265 -179.964 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -52.57 173.46 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.264 0.554 . . . . 0.0 111.143 -178.963 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.433 ' O ' ' CB ' ' A' ' 29' ' ' ALA . 6.4 mt -128.68 55.91 1.68 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.126 179.595 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -26.73 137.87 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.736 0.815 . . . . 0.0 112.593 -178.915 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.427 ' CG ' ' O ' ' A' ' 28' ' ' MET . 23.6 mt-10 -51.69 -51.75 53.58 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.25 -179.857 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 5.1 tptt -135.95 57.93 1.77 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.042 179.733 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -136.04 -96.64 0.49 Allowed Glycine 0 CA--C 1.523 0.592 0 N-CA-C 110.776 -0.93 . . . . 0.0 110.776 -179.823 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 1.9 ptt? 174.86 165.87 0.26 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.813 0.339 . . . . 0.0 110.515 -179.949 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.419 ' CD ' ' HA ' ' A' ' 69' ' ' LEU . 5.6 mmtp -94.13 137.9 32.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.005 -179.965 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 10.8 t30 -141.29 176.21 9.03 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.285 179.923 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 95.9 t -121.65 146.79 26.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.253 179.995 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -136.12 108.91 7.54 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.523 -179.904 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.402 ' O ' ' N ' ' A' ' 81' ' ' VAL . 54.4 m-20 -80.27 163.34 24.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.178 179.799 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . 0.441 ' O ' ' HB ' ' A' ' 81' ' ' VAL . 1.1 m-20 58.94 -85.72 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.377 -179.813 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.441 ' HB ' ' O ' ' A' ' 80' ' ' ASP . 55.6 t 68.55 -56.26 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 C-N-CA 123.432 0.693 . . . . 0.0 110.881 179.98 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.437 ' CG1' ' HD2' ' A' ' 83' ' ' PRO . 54.6 t -128.78 139.34 35.35 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.501 -179.894 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.437 ' HD2' ' CG1' ' A' ' 82' ' ' VAL . 46.2 Cg_endo -69.81 -170.32 0.39 Allowed 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.585 2.19 . . . . 0.0 112.066 179.699 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -87.07 -39.72 15.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.18 179.754 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -110.75 56.22 0.64 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.213 179.855 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 21.1 p90 -56.78 170.25 0.43 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.52 -179.838 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 26.6 m -151.35 121.16 7.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.149 179.907 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 3.4 mp -50.58 111.29 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.388 -179.82 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 122.41 57.36 0.2 Allowed Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.655 -0.978 . . . . 0.0 110.655 -179.976 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -174.07 148.86 1.4 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.75 0.309 . . . . 0.0 110.378 -179.991 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 50.9 m -106.97 93.88 4.8 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.6 -179.955 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.42 ' CD1' ' HD3' ' A' ' 83' ' ' PRO . 44.0 m-85 -76.42 -155.67 0.06 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.145 -0.479 . . . . 0.0 109.761 179.549 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.435 ' CB ' ' HD2' ' A' ' 94' ' ' PRO . . . 75.65 172.95 0.09 OUTLIER Pre-proline 0 N--CA 1.464 0.227 0 CA-C-O 120.786 0.327 . . . . 0.0 110.811 179.773 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.435 ' HD2' ' CB ' ' A' ' 93' ' ' ALA . 46.9 Cg_endo . . . . . 0 C--O 1.25 1.08 0 C-N-CA 122.606 2.204 . . . . 0.0 111.965 179.884 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.456 -0.143 0 CA-C-O 120.887 0.375 . . . . 0.0 110.283 . . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.518 ' CG1' ' CE1' ' A' ' 78' ' ' PHE . 1.9 p -63.89 163.24 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.285 0.564 . . . . 0.0 110.469 -179.811 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.469 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 80.9 p -137.48 136.11 37.43 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.067 179.871 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 17.7 m-85 -97.0 -175.42 3.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.418 -179.81 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.5 m -167.15 95.53 0.48 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.237 -179.833 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 39.1 t -51.07 97.19 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.563 -179.879 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -61.92 174.52 0.83 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.443 -179.92 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.8 tttt -67.66 163.37 21.59 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.408 -179.977 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 74.27 25.74 70.03 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 179.883 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.43 ' CB ' HD12 ' A' ' 88' ' ' ILE . 0.5 OUTLIER -99.05 121.81 41.46 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.835 0.35 . . . . 0.0 110.431 -179.993 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -177.45 -175.03 0.52 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.427 179.99 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.41 ' O ' ' CB ' ' A' ' 15' ' ' LYS . 3.9 mt-10 -47.59 119.07 2.53 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.175 0.512 . . . . 0.0 110.834 -179.848 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.418 ' O ' ' CG ' ' A' ' 16' ' ' HIS . 0.8 OUTLIER 79.95 24.54 0.4 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.774 179.726 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . 0.418 ' CG ' ' O ' ' A' ' 15' ' ' LYS . 3.2 m80 -174.04 111.75 0.17 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.829 0.347 . . . . 0.0 110.348 179.745 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.405 ' HG ' ' CE2' ' A' ' 64' ' ' PHE . 0.3 OUTLIER -128.93 101.19 5.97 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.489 -179.856 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -97.93 153.05 18.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.232 179.852 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.436 HG22 ' CG2' ' A' ' 21' ' ' VAL . 23.7 m -150.18 134.72 9.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.062 -179.7 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.426 ' HA ' ' CG1' ' A' ' 51' ' ' VAL . 0.5 OUTLIER -86.77 73.34 10.02 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.212 -0.449 . . . . 0.0 109.869 179.105 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.436 ' CG2' HG22 ' A' ' 19' ' ' VAL . 52.7 t -69.83 94.51 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.86 -179.468 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.407 ' HG2' ' CD2' ' A' ' 20' ' ' LEU . 0.0 OUTLIER 175.18 157.8 0.19 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.106 179.712 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.401 ' CE2' ' HB3' ' A' ' 26' ' ' ASP . 0.1 OUTLIER -127.08 -79.05 0.59 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.46 -179.981 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -99.49 -90.78 0.3 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.822 -179.814 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -139.68 32.83 2.19 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 111.132 -0.787 . . . . 0.0 111.132 -179.778 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.401 ' HB3' ' CE2' ' A' ' 23' ' ' TYR . 4.3 p30 -58.58 -171.11 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 179.727 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.443 ' HB ' ' CG ' ' A' ' 71' ' ' GLU . 0.9 OUTLIER -125.57 145.82 49.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.875 0.369 . . . . 0.0 110.37 179.987 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.411 ' O ' ' CG ' ' A' ' 71' ' ' GLU . 0.0 OUTLIER -98.7 129.39 45.16 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.662 -179.506 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.435 ' CB ' ' HG2' ' A' ' 71' ' ' GLU . . . -120.47 -56.8 1.95 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.351 179.956 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -158.0 145.9 18.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.388 -179.982 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.431 HG23 ' CD1' ' A' ' 52' ' ' TRP . 2.4 t -135.68 140.38 44.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.141 179.995 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.455 ' CB ' ' HA ' ' A' ' 43' ' ' ALA . 4.4 pt-20 -139.14 141.39 38.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.858 0.361 . . . . 0.0 110.491 179.955 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.497 ' HG ' ' CE1' ' A' ' 66' ' ' PHE . 2.2 mt -113.0 174.61 5.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.94 -179.444 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.489 ' HB2' ' CZ3' ' A' ' 41' ' ' TRP . 1.5 ttp85 -149.61 -159.17 1.0 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.852 179.585 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -158.67 26.18 0.23 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.698 0.285 . . . . 0.0 110.759 179.887 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 49.4 25.88 1.45 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.726 179.752 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -129.73 -50.45 0.12 Allowed Glycine 0 CA--C 1.522 0.525 0 N-CA-C 110.706 -0.958 . . . . 0.0 110.706 -179.945 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -76.54 115.26 16.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.784 0.326 . . . . 0.0 110.425 -179.977 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -52.09 -25.83 9.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.361 -179.992 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.26 178.73 4.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.219 179.892 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.499 ' CZ2' ' CD ' ' A' ' 67' ' ' ARG . 86.5 m95 -111.88 169.45 8.83 Favored 'General case' 0 CA--C 1.503 -0.862 0 CA-C-O 121.559 0.695 . . . . 0.0 110.876 -179.978 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.421 ' O ' ' CG1' ' A' ' 42' ' ' VAL . 1.0 OUTLIER -142.05 107.63 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.193 0 CA-C-N 114.63 -1.168 . . . . 0.0 109.769 -177.441 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.455 ' HA ' ' CB ' ' A' ' 32' ' ' GLU . . . -50.49 143.39 9.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.578 -179.445 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.429 ' HE1' ' CD1' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -63.14 -169.57 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.783 -179.765 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 46.0 m -135.35 110.18 8.72 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.03 179.811 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.77 66.45 0.09 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.566 -179.793 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -83.35 -40.84 8.8 Favored Glycine 0 CA--C 1.522 0.522 0 N-CA-C 110.351 -1.1 . . . . 0.0 110.351 179.798 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -90.02 144.97 25.44 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 179.74 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -83.83 8.16 67.23 Favored Glycine 0 CA--C 1.528 0.903 0 N-CA-C 111.597 -0.601 . . . . 0.0 111.597 -179.896 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -127.44 -40.0 0.35 Allowed Glycine 0 CA--C 1.524 0.641 0 N-CA-C 110.978 -0.849 . . . . 0.0 110.978 -179.952 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.426 ' CG1' ' HA ' ' A' ' 20' ' ' LEU . 6.9 m -133.67 -176.5 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 121.088 0.47 . . . . 0.0 110.79 -179.605 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . 0.431 ' CD1' HG23 ' A' ' 31' ' ' VAL . 11.1 m95 -109.61 131.39 55.11 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.75 179.543 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 3.0 p -115.98 171.79 7.56 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.863 0.363 . . . . 0.0 110.318 -179.664 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 60.4 t80 -159.63 118.5 2.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.333 179.971 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -70.94 129.14 38.25 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.303 179.956 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 90.8 p -96.25 126.54 41.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.416 -179.949 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -136.58 36.95 2.67 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.394 179.984 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -138.04 156.61 73.97 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.324 179.854 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -72.45 -26.77 16.62 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.671 2.247 . . . . 0.0 112.216 -179.949 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.4 mt -79.5 126.61 31.08 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.541 -179.761 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -156.58 -178.37 7.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.358 -179.845 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 119.73 -106.25 1.2 Allowed Glycine 0 CA--C 1.526 0.725 0 N-CA-C 110.856 -0.898 . . . . 0.0 110.856 179.891 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -77.46 125.08 7.42 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.455 2.103 . . . . 0.0 111.972 179.991 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.405 ' CE2' ' HG ' ' A' ' 17' ' ' LEU . 42.6 m-85 -101.27 147.05 26.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.587 -179.869 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -120.69 131.19 54.43 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.618 179.511 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.497 ' CE1' ' HG ' ' A' ' 33' ' ' LEU . 19.8 m-85 -114.71 163.1 15.94 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.963 0.411 . . . . 0.0 111.47 -179.236 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.499 ' CD ' ' CZ2' ' A' ' 41' ' ' TRP . 48.3 mtp180 -162.07 62.62 0.23 Allowed 'General case' 0 CA--C 1.52 -0.184 0 CA-C-N 115.353 -0.839 . . . . 0.0 109.807 179.014 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.415 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -67.09 -179.15 0.9 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.143 0.497 . . . . 0.0 110.828 -179.455 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.428 ' O ' ' CB ' ' A' ' 29' ' ' ALA . 5.7 mt -136.68 55.07 1.85 Allowed 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 179.321 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 18.5 p -29.02 137.95 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.543 0.737 . . . . 0.0 112.135 -178.904 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.443 ' CG ' ' HB ' ' A' ' 27' ' ' THR . 8.0 mt-10 -51.22 -68.62 0.15 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.663 -179.24 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -106.29 68.45 0.76 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.781 0.324 . . . . 0.0 110.31 179.902 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -158.28 -104.58 0.21 Allowed Glycine 0 CA--C 1.523 0.587 0 N-CA-C 110.952 -0.859 . . . . 0.0 110.952 -179.972 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 13.3 ptm 174.26 179.38 0.11 Allowed 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 -179.838 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.25 175.68 6.85 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.87 0.367 . . . . 0.0 110.352 179.877 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 173.96 170.16 0.2 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.43 179.907 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.407 ' HA ' ' HG2' ' A' ' 67' ' ' ARG . 72.5 t -117.61 157.78 18.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.504 -179.987 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.518 ' CE1' ' CG1' ' A' ' 4' ' ' VAL . 41.3 m-85 -144.99 129.93 18.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.384 -179.932 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -118.85 147.03 44.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.319 179.942 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 59.13 45.45 14.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.455 179.862 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.41 ' HA ' ' HA ' ' A' ' 93' ' ' ALA . 74.4 t -80.4 -3.91 6.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.073 179.893 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.407 ' CG2' ' O ' ' A' ' 81' ' ' VAL . 89.2 t -156.56 122.12 2.48 Favored Pre-proline 0 CA--C 1.528 0.117 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 179.654 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.414 ' HD3' ' CD1' ' A' ' 92' ' ' TYR . 50.8 Cg_endo -75.25 176.07 10.42 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.552 2.168 . . . . 0.0 112.129 -179.923 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -77.31 131.03 37.92 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 179.475 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 2.2 mmtt 59.92 40.75 18.68 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 -179.529 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 28.2 p90 -47.46 174.28 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.855 -179.681 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 10.9 m -129.36 129.66 45.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.242 179.987 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.43 HD12 ' CB ' ' A' ' 12' ' ' SER . 42.2 mm -66.51 115.3 4.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.337 179.981 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 119.45 37.34 0.79 Allowed Glycine 0 CA--C 1.523 0.573 0 N-CA-C 110.725 -0.95 . . . . 0.0 110.725 -179.917 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -147.67 172.57 13.85 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.808 0.337 . . . . 0.0 110.375 179.998 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.425 ' CG2' ' HB ' ' A' ' 5' ' ' THR . 87.9 m -114.83 126.16 54.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.422 -179.992 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.414 ' CD1' ' HD3' ' A' ' 83' ' ' PRO . 54.6 m-85 -127.45 130.5 49.37 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.571 179.985 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.427 ' CB ' ' CD ' ' A' ' 94' ' ' PRO . . . 174.01 177.13 0.19 Allowed Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.435 179.713 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.427 ' CD ' ' CB ' ' A' ' 93' ' ' ALA . 49.4 Cg_endo . . . . . 0 C--O 1.25 1.094 0 C-N-CA 122.642 2.228 . . . . 0.0 112.071 -179.885 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.796 0.331 . . . . 0.0 110.367 . . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.504 ' CG2' ' CE1' ' A' ' 78' ' ' PHE . 16.9 m -71.91 168.3 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.478 -179.967 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.416 ' HB ' ' CG2' ' A' ' 91' ' ' THR . 78.4 p -153.72 129.96 10.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.33 179.819 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -93.44 165.46 12.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.41 -179.865 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -153.72 108.84 3.16 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.546 -179.883 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.424 ' CG1' HG13 ' A' ' 88' ' ' ILE . 92.0 t -57.79 114.26 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.12 179.759 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.403 ' OE1' ' CG1' ' A' ' 51' ' ' VAL . 1.8 mt-10 -84.36 159.11 20.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.61 -179.771 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.63 -25.81 60.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.48 -179.912 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -49.67 -26.4 7.73 Favored Glycine 0 CA--C 1.523 0.567 0 N-CA-C 110.8 -0.92 . . . . 0.0 110.8 -179.908 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.4 m -59.29 106.4 0.44 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.767 0.318 . . . . 0.0 110.289 179.961 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.434 ' O ' ' N ' ' A' ' 15' ' ' LYS . 10.8 p-10 -124.72 136.74 54.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.491 -179.962 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 53.34 -87.04 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.661 179.891 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.434 ' N ' ' O ' ' A' ' 13' ' ' ASN . 42.2 pttt -114.16 -27.39 7.67 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.659 0.266 . . . . 0.0 110.71 -179.963 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 8.9 m80 -49.36 134.19 19.01 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.533 179.947 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.419 ' HG ' ' CE2' ' A' ' 64' ' ' PHE . 0.2 OUTLIER -118.48 100.12 7.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.409 -179.88 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -98.86 130.5 45.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.266 179.942 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.402 HG22 ' CG2' ' A' ' 21' ' ' VAL . 33.4 m -126.15 146.67 31.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.262 -179.914 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -96.66 70.97 2.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.307 -179.947 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.402 ' CG2' HG22 ' A' ' 19' ' ' VAL . 23.5 t -75.16 97.89 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.449 -179.877 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.02 146.39 9.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.405 179.975 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.431 ' CE2' HG13 ' A' ' 4' ' ' VAL . 17.0 p90 -173.16 140.03 0.84 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.455 -179.996 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -52.04 134.91 31.91 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.358 -179.98 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 126.78 -110.44 1.23 Allowed Glycine 0 CA--C 1.523 0.538 0 N-CA-C 110.684 -0.966 . . . . 0.0 110.684 179.993 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -67.01 145.85 54.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.781 0.324 . . . . 0.0 110.259 179.954 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.438 ' HB ' ' CG ' ' A' ' 71' ' ' GLU . 0.3 OUTLIER -80.87 -171.26 3.08 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.419 -179.884 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -117.92 124.63 48.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.567 -179.723 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.447 ' CB ' ' HG2' ' A' ' 71' ' ' GLU . . . -114.54 -60.59 1.87 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.437 -179.783 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -157.78 150.95 23.25 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.224 179.984 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.528 ' CG2' ' CD1' ' A' ' 52' ' ' TRP . 6.1 t -119.59 166.57 13.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.155 -179.899 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.427 ' HA ' ' HA ' ' A' ' 43' ' ' ALA . 1.2 tp10 -153.08 140.06 19.21 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.017 0.437 . . . . 0.0 109.925 -179.416 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.431 HD13 ' N ' ' A' ' 34' ' ' ARG . 3.9 tp -134.3 142.62 47.34 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.182 -178.963 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.44 ' O ' ' CB ' ' A' ' 35' ' ' GLU . 6.7 tpm_? -127.73 -95.91 0.42 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.154 -0.475 . . . . 0.0 109.903 179.012 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.44 ' CB ' ' O ' ' A' ' 34' ' ' ARG . 0.0 OUTLIER 160.79 -83.51 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 120.763 0.316 . . . . 0.0 110.321 179.392 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 3.3 t60 177.88 -55.41 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.317 -179.868 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -59.36 -72.07 0.67 Allowed Glycine 0 CA--C 1.523 0.584 0 N-CA-C 110.639 -0.985 . . . . 0.0 110.639 179.955 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -58.05 122.03 12.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.819 0.342 . . . . 0.0 110.179 179.848 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 33.0 m-20 -83.26 6.71 18.64 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.312 -179.825 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -107.84 100.33 9.71 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 120.82 0.343 . . . . 0.0 110.54 -179.953 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.488 ' CZ3' ' HG2' ' A' ' 67' ' ' ARG . 68.7 m95 -59.4 155.32 15.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.072 179.733 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.424 ' CG2' ' O ' ' A' ' 33' ' ' LEU . 10.0 m -138.47 110.76 6.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-O 120.715 0.293 . . . . 0.0 110.307 179.98 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.427 ' HA ' ' HA ' ' A' ' 32' ' ' GLU . . . -45.68 149.75 0.57 Allowed 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.52 -179.8 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.13 -170.55 0.62 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.916 0.388 . . . . 0.0 110.54 -179.722 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 68.8 m -138.88 126.04 21.37 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.409 -179.945 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 3.1 ptpt -94.56 91.32 6.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.564 -179.804 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -146.34 26.59 1.7 Allowed Glycine 0 CA--C 1.523 0.572 0 N-CA-C 110.81 -0.916 . . . . 0.0 110.81 179.963 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.404 ' CA ' ' OE1' ' A' ' 48' ' ' GLU . 0.0 OUTLIER -106.45 174.52 5.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.836 0.351 . . . . 0.0 110.482 179.939 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -56.13 -29.44 56.02 Favored Glycine 0 CA--C 1.522 0.53 0 N-CA-C 110.487 -1.045 . . . . 0.0 110.487 179.787 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 177.81 37.46 0.06 OUTLIER Glycine 0 CA--C 1.524 0.619 0 N-CA-C 110.861 -0.896 . . . . 0.0 110.861 179.965 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.403 ' CG1' ' OE1' ' A' ' 9' ' ' GLU . 13.1 m -154.78 177.87 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.828 0.347 . . . . 0.0 110.395 179.866 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . 0.528 ' CD1' ' CG2' ' A' ' 31' ' ' VAL . 5.4 m95 -103.92 144.92 30.87 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.379 -179.487 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -137.15 157.91 45.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.382 -179.971 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 78.2 t80 -148.95 155.39 40.77 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.49 -179.952 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -89.81 124.58 34.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.511 -179.89 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 94.0 p -120.56 103.56 9.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.273 179.937 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -110.3 -28.02 8.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.47 -179.906 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -59.55 125.63 80.19 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.458 -179.923 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -72.0 -11.73 27.6 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.519 2.146 . . . . 0.0 112.514 179.97 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -47.57 107.49 0.12 Allowed 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 120.901 0.381 . . . . 0.0 110.749 -179.732 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -76.05 118.89 19.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.345 179.929 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -179.65 170.85 42.39 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 -179.959 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.404 ' CB ' ' HA ' ' A' ' 80' ' ' ASP . 49.6 Cg_endo -79.02 151.63 24.04 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.597 2.198 . . . . 0.0 112.097 -179.893 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.419 ' CE2' ' HG ' ' A' ' 17' ' ' LEU . 29.4 m-85 -84.86 123.11 30.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.277 179.877 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 7.4 m-20 -95.28 134.46 38.03 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 179.516 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.412 ' CE2' ' HB2' ' A' ' 33' ' ' LEU . 51.8 m-85 -121.42 167.9 12.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.129 0.49 . . . . 0.0 111.045 -179.452 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.488 ' HG2' ' CZ3' ' A' ' 41' ' ' TRP . 0.3 OUTLIER -173.77 61.77 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.711 179.984 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -56.78 174.11 0.17 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.99 -179.472 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.426 ' O ' ' CB ' ' A' ' 29' ' ' ALA . 2.9 mt -121.54 72.14 1.0 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.221 179.515 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.401 ' OG1' ' N ' ' A' ' 74' ' ' MET . 62.3 p -35.84 136.17 0.27 Allowed 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.793 -179.241 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.447 ' HG2' ' CB ' ' A' ' 29' ' ' ALA . 14.8 mt-10 -49.96 -52.16 35.74 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.486 -179.861 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 6.3 tptp -129.21 71.67 1.44 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.529 -179.869 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -162.85 -103.71 0.18 Allowed Glycine 0 CA--C 1.522 0.528 0 N-CA-C 110.799 -0.92 . . . . 0.0 110.799 179.897 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.401 ' N ' ' OG1' ' A' ' 70' ' ' THR . 21.1 ptt? -179.21 -175.64 0.38 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.853 0.359 . . . . 0.0 110.292 179.988 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.437 ' N ' ' CD ' ' A' ' 75' ' ' LYS . 0.0 OUTLIER -97.48 148.28 23.38 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.159 -179.69 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -152.62 123.09 7.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.192 179.854 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 98.4 t -81.65 143.73 11.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.526 -179.825 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.504 ' CE1' ' CG2' ' A' ' 4' ' ' VAL . 53.9 m-85 -127.99 122.35 32.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.254 179.993 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -105.26 148.72 26.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.552 -179.699 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . 0.404 ' HA ' ' CB ' ' A' ' 63' ' ' PRO . 1.0 OUTLIER 58.88 46.06 14.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.462 179.9 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 90.1 t -77.0 -75.25 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.187 179.862 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 39.1 t -89.04 137.89 29.37 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.268 179.797 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -73.17 -175.42 1.96 Allowed 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.5 2.133 . . . . 0.0 111.949 179.821 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -82.9 -31.18 27.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.135 179.738 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 6.0 tttp -117.45 51.56 1.02 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.255 179.846 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 48.8 p90 -52.56 159.61 1.02 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.55 -179.894 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -142.4 114.83 8.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.128 179.88 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.424 HG13 ' CG1' ' A' ' 8' ' ' VAL . 3.0 mp -49.83 100.16 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.466 -179.826 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 134.18 53.72 0.07 OUTLIER Glycine 0 CA--C 1.523 0.542 0 N-CA-C 110.602 -0.999 . . . . 0.0 110.602 -179.971 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.461 ' HB2' ' CZ ' ' A' ' 92' ' ' TYR . . . -175.82 179.61 1.33 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.811 0.338 . . . . 0.0 110.359 179.99 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.416 ' CG2' ' HB ' ' A' ' 5' ' ' THR . 24.8 m -120.69 139.78 52.55 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.439 -179.83 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.461 ' CZ ' ' HB2' ' A' ' 90' ' ' ALA . 7.1 m-85 -141.59 104.58 4.58 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.284 179.932 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.441 ' CB ' ' HD2' ' A' ' 94' ' ' PRO . . . 175.06 177.3 0.21 Allowed Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.301 -179.886 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.441 ' HD2' ' CB ' ' A' ' 93' ' ' ALA . 47.6 Cg_endo . . . . . 0 C--O 1.249 1.074 0 C-N-CA 122.486 2.124 . . . . 0.0 112.03 179.973 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 10.4 mmtp . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.678 0.275 . . . . 0.0 110.535 . . . . . . . . . 0 0 . 1 . 038 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.507 ' CG1' ' CE1' ' A' ' 78' ' ' PHE . 2.0 p -65.25 163.25 2.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.172 0.511 . . . . 0.0 110.068 179.808 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.468 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 3.9 p -147.78 131.07 16.53 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.384 -179.989 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.416 ' O ' ' CG2' ' A' ' 91' ' ' THR . 6.0 m-85 -96.46 174.73 6.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.287 -179.958 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.435 ' HB ' ' CB ' ' A' ' 20' ' ' LEU . 2.8 m -166.16 106.88 0.7 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.27 -179.813 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.431 HG13 ' CG1' ' A' ' 88' ' ' ILE . 91.6 t -59.11 94.12 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.406 -179.85 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.423 ' HG3' ' CG1' ' A' ' 51' ' ' VAL . 15.4 mm-40 -56.02 158.86 3.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.236 179.899 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.9 ptmt -77.14 62.57 2.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.435 -179.948 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -154.95 27.32 0.64 Allowed Glycine 0 CA--C 1.523 0.593 0 N-CA-C 110.728 -0.949 . . . . 0.0 110.728 179.963 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 30.4 m -86.87 131.7 34.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.839 0.352 . . . . 0.0 110.358 -179.967 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -110.54 -159.71 0.69 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.143 -0.481 . . . . 0.0 109.986 179.872 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -47.83 -59.35 3.38 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.622 179.908 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.13 -25.07 9.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.588 -180.0 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 27.0 m80 -51.27 134.46 27.7 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.852 0.358 . . . . 0.0 110.421 -179.999 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -127.05 98.03 5.17 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.371 -179.952 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -94.4 127.85 40.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.213 179.929 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.434 HG22 ' CG2' ' A' ' 21' ' ' VAL . 22.7 m -128.0 148.15 32.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.317 -179.957 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.435 ' CB ' ' HB ' ' A' ' 7' ' ' THR . 0.9 OUTLIER -94.53 63.19 2.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.456 -179.936 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.434 ' CG2' HG22 ' A' ' 19' ' ' VAL . 22.8 t -65.66 100.49 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.292 179.969 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.39 152.26 21.83 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.313 -179.994 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 28.1 p90 179.23 157.49 0.56 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.367 -179.941 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -82.81 163.53 21.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.331 179.934 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 106.63 -49.09 0.9 Allowed Glycine 0 CA--C 1.523 0.57 0 N-CA-C 110.652 -0.979 . . . . 0.0 110.652 -179.963 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -130.44 -177.78 4.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.755 0.312 . . . . 0.0 110.171 179.906 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -126.68 162.87 24.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.514 -179.976 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.451 ' O ' ' CG ' ' A' ' 71' ' ' GLU . 0.0 OUTLIER -57.98 -160.84 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.316 179.92 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.445 ' CB ' ' O ' ' A' ' 28' ' ' MET . . . 155.12 -63.71 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.291 0.637 . . . . 0.0 109.532 179.668 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 17.9 tt0 -148.7 161.53 41.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.061 179.8 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.447 HG23 ' CD1' ' A' ' 52' ' ' TRP . 10.7 t -155.11 150.18 11.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.234 179.911 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.425 ' CB ' ' HA ' ' A' ' 43' ' ' ALA . 1.4 pm0 -151.67 144.46 24.38 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.359 -179.955 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.419 ' O ' ' CG2' ' A' ' 42' ' ' VAL . 8.1 tp -112.96 151.14 30.92 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.486 -179.428 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.477 ' HG3' ' CD2' ' A' ' 41' ' ' TRP . 4.7 ttp180 -117.2 -158.16 0.69 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.229 179.913 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 6.9 tm-20 -175.5 107.32 0.09 Allowed 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 -179.968 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -48.39 97.0 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.704 -179.434 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 161.67 -31.27 0.32 Allowed Glycine 0 CA--C 1.522 0.525 0 N-CA-C 110.468 -1.053 . . . . 0.0 110.468 179.859 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -117.87 145.26 44.73 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 179.937 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -94.95 21.45 7.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.778 -179.836 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 29.7 tp10 -130.38 113.52 14.44 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 -179.901 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.477 ' CD2' ' HG3' ' A' ' 34' ' ' ARG . 63.7 m95 -63.72 172.99 1.89 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.162 179.707 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.419 ' CG2' ' O ' ' A' ' 33' ' ' LEU . 4.4 m -146.65 107.34 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.048 179.624 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.425 ' HA ' ' CB ' ' A' ' 32' ' ' GLU . . . -45.49 146.06 1.11 Allowed 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.679 -179.69 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.56 -170.8 0.23 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.709 -179.712 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 92.8 m -145.34 107.19 4.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.436 -179.979 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -66.22 79.08 0.09 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.168 179.87 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -104.29 -22.93 8.32 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 111.056 -0.818 . . . . 0.0 111.056 -179.794 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.432 ' CG ' HG21 ' A' ' 51' ' ' VAL . 0.1 OUTLIER -75.96 -178.62 4.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.979 0.419 . . . . 0.0 110.422 -179.939 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -111.79 38.95 3.05 Favored Glycine 0 CA--C 1.522 0.514 0 N-CA-C 110.244 -1.143 . . . . 0.0 110.244 179.579 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 165.39 -27.81 0.19 Allowed Glycine 0 CA--C 1.526 0.753 0 N-CA-C 111.311 -0.716 . . . . 0.0 111.311 -179.874 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.432 HG21 ' CG ' ' A' ' 48' ' ' GLU . 3.2 m -123.4 -176.3 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-O 120.884 0.373 . . . . 0.0 110.705 -179.726 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . 0.447 ' CD1' HG23 ' A' ' 31' ' ' VAL . 11.2 m95 -108.21 138.27 44.78 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.722 -179.661 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.9 p -130.64 137.86 49.81 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.768 179.549 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 71.5 t80 -123.37 131.12 53.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.878 0.371 . . . . 0.0 110.753 -179.539 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -77.32 107.13 9.51 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.019 179.696 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.0 m -87.76 148.71 24.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.629 -179.693 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -122.97 -42.27 2.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.256 179.887 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -55.72 165.51 1.26 Allowed Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.404 179.987 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -94.32 5.32 2.64 Favored 'Trans proline' 0 N--CA 1.452 -0.934 0 C-N-CA 123.995 3.13 . . . . 0.0 113.015 -179.863 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -103.94 102.9 12.69 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.827 0.346 . . . . 0.0 110.355 179.918 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -122.82 75.13 1.25 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.453 -179.845 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -133.46 -101.03 0.74 Allowed Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.749 -0.94 . . . . 0.0 110.749 179.996 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -78.51 107.9 2.36 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.568 2.178 . . . . 0.0 112.049 -179.954 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 36.7 m-85 -93.42 166.42 12.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.391 -179.947 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.42 ' HB2' ' CB ' ' A' ' 34' ' ' ARG . 1.5 m-80 -133.86 147.41 51.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.018 179.785 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -140.55 175.07 9.9 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.031 0.443 . . . . 0.0 110.962 -179.718 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.475 ' HD2' ' CZ2' ' A' ' 41' ' ' TRP . 6.5 ptm180 -178.99 61.98 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.569 179.941 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -57.4 173.72 0.24 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.028 -179.223 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.428 ' O ' ' CB ' ' A' ' 29' ' ' ALA . 2.9 mt -136.12 78.69 1.73 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.881 179.969 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 61.2 p -38.81 153.19 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.393 -179.646 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.451 ' CG ' ' O ' ' A' ' 28' ' ' MET . 6.3 mt-10 -49.7 -33.97 17.44 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.388 -179.799 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.61 -36.08 82.69 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.354 -179.97 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 113.12 23.37 5.25 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 110.974 -0.851 . . . . 0.0 110.974 179.972 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -92.89 116.13 28.76 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.708 0.29 . . . . 0.0 110.307 179.902 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 3.1 mptt -113.46 173.72 6.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.35 -179.941 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 171.11 129.78 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.999 179.98 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 83.0 t -76.52 153.81 5.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.327 -179.994 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.507 ' CE1' ' CG1' ' A' ' 4' ' ' VAL . 87.1 m-85 -139.12 119.61 13.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.599 -179.879 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -106.03 152.22 23.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.095 179.812 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 11.0 t0 55.2 61.02 3.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.049 -179.751 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.404 ' O ' ' CG2' ' A' ' 82' ' ' VAL . 84.7 t -95.36 -8.19 9.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.234 -179.695 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.404 ' CG2' ' O ' ' A' ' 81' ' ' VAL . 57.3 t -156.33 132.07 5.68 Favored Pre-proline 0 C--N 1.332 -0.166 0 N-CA-C 110.406 -0.22 . . . . 0.0 110.406 179.872 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.485 ' HD3' ' CD1' ' A' ' 92' ' ' TYR . 50.0 Cg_endo -73.0 -176.09 2.23 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.507 2.138 . . . . 0.0 111.946 179.84 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -82.52 135.68 35.04 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 179.446 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 57.75 48.37 13.99 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 -179.466 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 48.8 p90 -43.28 156.36 0.05 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.414 -179.528 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 7.1 m -127.32 103.71 7.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.808 179.609 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.431 ' CG1' HG13 ' A' ' 8' ' ' VAL . 2.5 mp -44.52 122.57 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.012 -179.632 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 117.43 35.37 1.1 Allowed Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.743 -0.943 . . . . 0.0 110.743 -179.935 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -155.74 142.35 18.73 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 110.222 -0.288 . . . . 0.0 110.222 179.978 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.416 ' CG2' ' O ' ' A' ' 6' ' ' PHE . 6.0 m -96.3 113.8 25.42 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.925 0.393 . . . . 0.0 110.716 -179.836 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.485 ' CD1' ' HD3' ' A' ' 83' ' ' PRO . 33.0 m-85 -97.26 -153.58 0.42 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.788 179.751 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.429 ' CB ' ' HD2' ' A' ' 94' ' ' PRO . . . 78.42 173.78 0.08 OUTLIER Pre-proline 0 N--CA 1.465 0.305 0 CA-C-O 120.838 0.351 . . . . 0.0 110.722 179.808 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.429 ' HD2' ' CB ' ' A' ' 93' ' ' ALA . 48.1 Cg_endo . . . . . 0 C--O 1.249 1.053 0 C-N-CA 122.631 2.22 . . . . 0.0 112.079 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 3.3 m . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 110.151 -0.314 . . . . 0.0 110.151 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -75.51 111.14 3.24 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.556 2.171 . . . . 0.0 112.089 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 9.9 tttt -143.13 75.63 1.49 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.428 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.515 ' CG1' ' CE1' ' A' ' 23' ' ' TYR . 30.0 m -92.74 172.06 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.374 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.412 ' CG2' ' O ' ' A' ' 4' ' ' VAL . 4.6 p -163.49 133.8 4.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.397 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.492 ' CD2' ' HB ' ' A' ' 21' ' ' VAL . 23.4 m-85 -95.61 -169.9 2.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.073 179.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -165.75 104.85 0.7 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.809 0.338 . . . . 0.0 110.505 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 95.8 t -55.21 91.84 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.179 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.445 ' HG3' ' CG1' ' A' ' 51' ' ' VAL . 9.9 mm-40 -66.1 169.57 6.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.568 -179.704 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 11.9 tttt -63.18 -15.33 56.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.193 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -45.95 -27.81 2.58 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 111.213 -0.755 . . . . 0.0 111.213 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -71.13 131.29 43.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.77 0.319 . . . . 0.0 110.348 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -145.47 -86.61 0.11 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.434 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -81.68 -66.81 0.84 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.923 0.392 . . . . 0.0 110.121 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.06 26.08 2.72 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.214 179.708 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 54.5 m80 -94.32 139.61 30.86 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.233 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -124.35 89.24 3.04 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.263 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.416 ' HB1' ' CG2' ' A' ' 53' ' ' THR . . . -90.26 153.38 20.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.51 -179.819 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 6.4 m -145.29 137.5 20.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.044 179.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -98.69 51.56 0.99 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.505 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.492 ' HB ' ' CD2' ' A' ' 6' ' ' PHE . 3.0 p -53.57 107.65 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.924 0.393 . . . . 0.0 110.19 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -174.46 120.75 0.25 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.252 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.515 ' CE1' ' CG1' ' A' ' 4' ' ' VAL . 17.0 p90 -127.31 19.61 6.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.831 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 60.44 147.94 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.901 0.381 . . . . 0.0 110.518 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 109.07 -93.47 0.77 Allowed Glycine 0 CA--C 1.523 0.592 0 N-CA-C 110.652 -0.979 . . . . 0.0 110.652 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -57.54 -173.43 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.793 0.33 . . . . 0.0 110.484 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.34 173.69 6.67 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.515 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.424 ' O ' ' CG ' ' A' ' 71' ' ' GLU . 0.1 OUTLIER -109.07 123.51 49.28 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.483 -179.942 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.44 ' CA ' ' HG2' ' A' ' 71' ' ' GLU . . . -115.1 -62.59 1.58 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.284 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -158.95 164.2 35.83 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.595 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.444 ' CG2' ' CD1' ' A' ' 52' ' ' TRP . 16.2 t -138.68 145.43 27.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.211 0.529 . . . . 0.0 111.335 -179.547 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -124.56 130.6 52.76 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.223 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.46 HD21 ' CG ' ' A' ' 54' ' ' PHE . 12.4 tp -114.2 151.77 32.24 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 121.021 0.438 . . . . 0.0 110.172 -179.058 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.423 ' O ' ' CG ' ' A' ' 35' ' ' GLU . 0.0 OUTLIER -125.98 -156.04 0.71 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.699 179.458 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.423 ' CG ' ' O ' ' A' ' 34' ' ' ARG . 14.3 mt-10 -161.57 -88.54 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.497 0.189 . . . . 0.0 110.72 179.711 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.444 ' CG ' ' N ' ' A' ' 37' ' ' GLY . 11.1 p80 -160.76 -46.72 0.05 OUTLIER 'General case' 0 N--CA 1.454 -0.235 0 CA-C-O 120.797 0.332 . . . . 0.0 110.8 -179.716 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.444 ' N ' ' CG ' ' A' ' 36' ' ' HIS . . . -156.97 38.39 0.56 Allowed Glycine 0 CA--C 1.523 0.577 0 N-CA-C 110.914 -0.874 . . . . 0.0 110.914 -179.605 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 5.5 t -73.6 -76.03 0.14 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.828 0.347 . . . . 0.0 110.219 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 37.3 p30 -173.32 55.95 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.131 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 67.83 176.29 0.26 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.242 -179.784 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.481 ' CZ3' ' HG2' ' A' ' 67' ' ' ARG . 98.3 m95 -52.69 138.64 28.3 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.542 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.7 m -130.98 110.72 18.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.935 179.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -48.66 131.42 17.79 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.82 -179.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.23 -171.33 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.578 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.419 ' O ' ' N ' ' A' ' 47' ' ' GLY . 41.3 m -142.03 102.33 4.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.235 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.405 ' O ' ' CG ' ' A' ' 46' ' ' LYS . 0.1 OUTLIER -64.56 76.17 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.331 -179.966 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 45' ' ' THR . . . -107.14 -21.9 7.82 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.923 -0.871 . . . . 0.0 110.923 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.69 -33.41 66.49 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.838 0.351 . . . . 0.0 110.336 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 98.12 -42.38 2.09 Favored Glycine 0 CA--C 1.522 0.526 0 N-CA-C 110.562 -1.015 . . . . 0.0 110.562 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -107.32 -25.12 6.19 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.679 -0.968 . . . . 0.0 110.679 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.445 ' CG1' ' HG3' ' A' ' 9' ' ' GLU . 24.0 m -136.5 179.0 4.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.826 0.346 . . . . 0.0 110.467 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . 0.444 ' CD1' ' CG2' ' A' ' 31' ' ' VAL . 4.0 m95 -109.42 128.35 55.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.417 -179.423 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.416 ' CG2' ' HB1' ' A' ' 18' ' ' ALA . 0.2 OUTLIER -114.69 167.94 10.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.421 -179.964 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.46 ' CG ' HD21 ' A' ' 33' ' ' LEU . 79.2 t80 -146.72 133.2 19.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.316 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 25.5 p-10 -94.65 114.29 26.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.544 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -84.51 146.55 27.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.261 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -113.11 -40.19 4.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.403 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -67.66 151.55 97.07 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.272 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -71.72 -18.77 28.38 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.681 2.254 . . . . 0.0 112.494 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 3.6 mt -96.29 144.13 26.74 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.903 0.382 . . . . 0.0 110.662 -179.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -143.2 91.12 2.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.269 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -96.35 -140.7 11.33 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.775 -0.93 . . . . 0.0 110.775 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -73.9 166.38 29.83 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.527 2.151 . . . . 0.0 111.893 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -125.2 177.46 6.1 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.148 0.499 . . . . 0.0 111.0 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -147.43 134.62 20.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.494 179.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.486 ' HB2' ' CZ ' ' A' ' 6' ' ' PHE . 52.2 m-85 -124.22 168.52 12.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.253 0.549 . . . . 0.0 111.478 -179.072 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.481 ' HG2' ' CZ3' ' A' ' 41' ' ' TRP . 0.0 OUTLIER -170.86 68.36 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.404 179.741 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.486 ' CZ ' HG13 ' A' ' 4' ' ' VAL . 4.5 p90 -51.8 177.81 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.407 0.622 . . . . 0.0 111.544 -178.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 5.7 mt -137.96 55.75 1.76 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.045 -0.979 . . . . 0.0 109.177 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 40.1 p -27.98 136.83 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.762 0.825 . . . . 0.0 112.709 -179.015 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.44 ' HG2' ' CA ' ' A' ' 29' ' ' ALA . 14.4 mt-10 -50.78 -31.15 16.02 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.42 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -63.23 -31.68 72.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.447 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 103.18 62.33 0.7 Allowed Glycine 0 CA--C 1.523 0.576 0 N-CA-C 110.669 -0.972 . . . . 0.0 110.669 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 74.5 mtp -152.18 115.33 4.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.813 0.34 . . . . 0.0 110.313 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.68 176.75 5.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.384 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.421 ' O ' ' CE2' ' A' ' 78' ' ' PHE . 2.0 m-20 173.25 126.94 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.113 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 97.8 t -76.17 152.77 6.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.752 -179.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.511 ' CE1' ' CG2' ' A' ' 4' ' ' VAL . 38.9 m-85 -136.88 121.08 17.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.152 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -109.53 153.02 24.71 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.471 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.7 t0 59.53 30.53 20.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.675 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.423 ' CG1' ' O ' ' A' ' 92' ' ' TYR . 95.9 t -59.77 -73.82 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.19 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.426 ' CG1' ' HD2' ' A' ' 83' ' ' PRO . 50.9 t -87.52 139.32 31.65 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.416 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.426 ' HD2' ' CG1' ' A' ' 82' ' ' VAL . 47.5 Cg_endo -73.83 -168.1 0.43 Allowed 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.572 2.181 . . . . 0.0 112.063 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -76.12 -64.12 1.17 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.341 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 6.3 tppt? -96.42 57.7 1.69 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.282 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 40.4 p90 -51.77 148.9 5.15 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.483 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 3.1 m -122.85 110.24 15.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.181 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 2.7 mp -50.47 100.97 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.459 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 137.51 44.87 0.08 OUTLIER Glycine 0 CA--C 1.523 0.579 0 N-CA-C 110.534 -1.027 . . . . 0.0 110.534 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -166.45 -176.76 3.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.769 0.319 . . . . 0.0 110.345 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 85.3 m -119.68 138.66 53.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.572 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.423 ' O ' ' CG1' ' A' ' 81' ' ' VAL . 7.4 m-85 -143.95 107.74 4.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.168 179.791 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.436 ' CB ' ' CD ' ' A' ' 94' ' ' PRO . . . 176.25 178.02 0.22 Allowed Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.488 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.436 ' CD ' ' CB ' ' A' ' 93' ' ' ALA . 49.4 Cg_endo . . . . . 0 C--O 1.249 1.027 0 C-N-CA 122.565 2.177 . . . . 0.0 112.059 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 61.7 t . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -76.17 135.88 17.48 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.599 2.199 . . . . 0.0 112.196 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 4.6 pttt -119.01 84.68 2.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.281 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.522 ' CG2' ' CE2' ' A' ' 78' ' ' PHE . 17.8 m -55.06 171.07 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.461 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.434 ' HB ' ' CG2' ' A' ' 91' ' ' THR . 21.6 p -153.47 135.6 14.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.375 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.483 ' CD1' HG12 ' A' ' 81' ' ' VAL . 14.9 m-85 -100.58 169.38 9.09 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.455 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.5 m -157.59 112.72 2.74 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.342 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 44.5 t -58.07 91.38 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.275 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.404 ' HG3' ' CG1' ' A' ' 51' ' ' VAL . 6.7 mm-40 -51.0 176.3 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.463 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 61.9 mmtt -67.48 175.5 2.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.314 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 51.13 49.74 42.28 Favored Glycine 0 CA--C 1.523 0.547 0 N-CA-C 110.718 -0.953 . . . . 0.0 110.718 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -102.64 136.9 41.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.873 0.368 . . . . 0.0 110.452 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 3.7 p30 -172.07 162.81 5.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.295 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -49.11 -28.1 3.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.742 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.81 -28.33 44.5 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.373 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 25.1 m80 -149.65 125.22 10.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.507 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -111.83 94.37 4.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.222 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.427 ' CB ' ' CG2' ' A' ' 53' ' ' THR . . . -96.06 125.69 40.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.488 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.417 HG22 ' CG2' ' A' ' 21' ' ' VAL . 33.2 m -113.67 -171.17 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.003 179.765 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.402 ' HA ' HG13 ' A' ' 51' ' ' VAL . 1.4 tt -138.09 80.66 1.81 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.302 179.656 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.417 ' CG2' HG22 ' A' ' 19' ' ' VAL . 2.4 t -97.31 102.39 13.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.989 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.49 ' O ' ' CG ' ' A' ' 23' ' ' TYR . 0.0 OUTLIER -162.87 -65.27 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.878 -179.721 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.49 ' CG ' ' O ' ' A' ' 22' ' ' LYS . 33.5 p90 45.6 -171.78 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.724 -179.454 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -115.85 142.63 46.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.474 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 131.23 -43.88 1.26 Allowed Glycine 0 CA--C 1.523 0.541 0 N-CA-C 110.759 -0.936 . . . . 0.0 110.759 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -126.91 -170.63 2.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.826 0.346 . . . . 0.0 110.601 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -118.8 -175.32 2.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.514 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.437 ' O ' ' CG ' ' A' ' 71' ' ' GLU . 1.5 mtp -105.99 123.73 48.45 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.343 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.432 ' CB ' ' O ' ' A' ' 69' ' ' LEU . . . -132.16 -58.58 0.95 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.924 -179.776 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.402 ' O ' ' CB ' ' A' ' 31' ' ' VAL . 0.0 OUTLIER -140.63 173.6 11.33 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.83 0.348 . . . . 0.0 110.925 -179.778 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.466 HG12 ' CD1' ' A' ' 52' ' ' TRP . 1.3 p 164.3 131.33 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-O 121.518 0.675 . . . . 0.0 109.76 -179.847 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.477 ' O ' ' CD2' ' A' ' 66' ' ' PHE . 2.6 mm-40 -112.04 -172.49 2.05 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.843 -1.071 . . . . 0.0 110.476 -179.546 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.472 HD22 ' CG ' ' A' ' 54' ' ' PHE . 5.8 tp -144.22 145.16 31.89 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 179.302 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.66 -178.84 6.79 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.086 179.712 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -132.27 -85.22 0.48 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.574 -0.284 . . . . 0.0 110.566 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 171.71 39.76 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.823 0.344 . . . . 0.0 110.595 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 167.29 59.15 0.03 OUTLIER Glycine 0 CA--C 1.524 0.621 0 N-CA-C 110.817 -0.913 . . . . 0.0 110.817 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.6 t -133.57 158.85 42.14 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.78 0.324 . . . . 0.0 110.296 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.421 ' O ' ' CG ' ' A' ' 40' ' ' GLU . 0.4 OUTLIER -51.67 -33.48 34.0 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.31 179.907 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.421 ' CG ' ' O ' ' A' ' 39' ' ' ASP . 2.9 mt-10 169.19 -179.19 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.236 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.493 ' CZ3' ' HG3' ' A' ' 67' ' ' ARG . 71.8 m95 -62.14 145.02 54.56 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.339 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.43 HG22 ' CZ ' ' A' ' 54' ' ' PHE . 27.3 m -122.85 2.04 6.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.159 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.425 ' CB ' ' OE2' ' A' ' 32' ' ' GLU . . . 60.07 137.86 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.344 0 CA-C-O 121.301 0.572 . . . . 0.0 111.3 179.322 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.474 ' H ' ' HA ' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -62.51 -167.13 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.372 179.733 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 49.9 m -150.85 125.32 9.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.358 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 13.6 ptmt -69.25 64.66 0.15 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.239 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -91.23 -34.18 7.7 Favored Glycine 0 CA--C 1.523 0.549 0 N-CA-C 110.814 -0.915 . . . . 0.0 110.814 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.427 ' HG2' ' CG2' ' A' ' 51' ' ' VAL . 4.4 tp10 -88.34 124.14 33.61 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.822 0.344 . . . . 0.0 110.503 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -71.56 76.28 0.66 Allowed Glycine 0 CA--C 1.522 0.507 0 N-CA-C 110.637 -0.985 . . . . 0.0 110.637 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 154.04 -36.75 0.71 Allowed Glycine 0 CA--C 1.522 0.49 0 N-CA-C 110.633 -0.987 . . . . 0.0 110.633 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.427 ' CG2' ' HG2' ' A' ' 48' ' ' GLU . 16.2 m -142.82 -176.7 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.95 0.405 . . . . 0.0 110.537 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . 0.466 ' CD1' HG12 ' A' ' 31' ' ' VAL . 5.4 m95 -96.33 131.67 42.62 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.637 -179.436 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.427 ' CG2' ' CB ' ' A' ' 18' ' ' ALA . 0.8 OUTLIER -130.29 147.07 51.96 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.404 -179.958 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.472 ' CG ' HD22 ' A' ' 33' ' ' LEU . 45.6 t80 -137.43 142.27 41.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.239 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -91.25 141.12 29.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.507 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.1 p -143.11 147.01 34.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.278 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -144.45 31.56 1.21 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.456 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -102.87 157.26 34.07 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.228 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -71.1 -32.52 13.07 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.603 2.202 . . . . 0.0 112.142 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.1 mt -80.6 102.3 9.72 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.336 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -138.87 132.79 31.02 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.477 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -177.63 -98.78 0.11 Allowed Glycine 0 CA--C 1.526 0.758 0 N-CA-C 110.644 -0.982 . . . . 0.0 110.644 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -81.38 164.88 18.96 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.609 2.206 . . . . 0.0 112.083 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -139.36 161.34 37.68 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.465 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.404 ' ND2' ' N ' ' A' ' 65' ' ' ASN . 1.2 m-80 -126.99 149.51 49.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.194 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.477 ' CD2' ' O ' ' A' ' 32' ' ' GLU . 85.1 m-85 -138.83 159.84 41.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.967 0.413 . . . . 0.0 111.071 -179.629 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.493 ' HG3' ' CZ3' ' A' ' 41' ' ' TRP . 10.0 mtp-105 -152.42 73.18 1.02 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.84 179.352 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.446 ' HA ' ' HA ' ' A' ' 31' ' ' VAL . 6.3 p90 -70.49 175.2 4.97 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.384 0.612 . . . . 0.0 111.023 -179.531 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.436 ' CD2' ' CG ' ' A' ' 75' ' ' LYS . 23.9 mt -146.88 57.58 1.16 Allowed 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.972 -1.013 . . . . 0.0 109.396 179.789 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 28.4 p -25.84 135.95 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.872 0.869 . . . . 0.0 112.487 -179.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.437 ' CG ' ' O ' ' A' ' 28' ' ' MET . 3.9 mm-40 -51.96 -23.95 5.78 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.599 -179.498 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 17.9 tptp -147.07 68.58 1.16 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.644 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -160.91 -103.82 0.19 Allowed Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.875 -0.89 . . . . 0.0 110.875 179.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -178.58 -176.69 0.5 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.89 0.376 . . . . 0.0 110.638 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.436 ' CG ' ' CD2' ' A' ' 69' ' ' LEU . 0.0 OUTLIER -93.2 172.96 7.97 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.345 -179.858 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 171.81 137.17 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.603 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 45.6 t -99.36 132.48 44.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 179.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.522 ' CE2' ' CG2' ' A' ' 4' ' ' VAL . 52.3 m-85 -117.28 139.8 50.36 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.5 -179.572 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -126.12 161.9 26.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.421 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 51.22 35.83 14.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.441 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.483 HG12 ' CD1' ' A' ' 6' ' ' PHE . 48.9 t -75.91 -2.55 4.23 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.816 179.757 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 84.0 t -154.12 131.63 6.21 Favored Pre-proline 0 CA--C 1.529 0.161 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.482 ' HG3' ' CE1' ' A' ' 92' ' ' TYR . 48.6 Cg_endo -75.22 178.68 6.99 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.516 2.144 . . . . 0.0 112.181 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -64.54 -57.52 8.92 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.12 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.93 73.72 0.83 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.171 179.717 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . 0.491 ' HB2' ' CE2' ' A' ' 92' ' ' TYR . 23.1 p90 -70.22 177.02 3.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.521 -179.854 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 2.7 m -137.27 119.23 15.31 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.094 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 4.3 mp -48.94 119.3 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.547 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 105.06 59.03 0.66 Allowed Glycine 0 CA--C 1.523 0.533 0 N-CA-C 110.591 -1.004 . . . . 0.0 110.591 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -170.75 146.23 2.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.896 0.379 . . . . 0.0 110.639 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.434 ' CG2' ' HB ' ' A' ' 5' ' ' THR . 8.5 m -93.43 122.99 36.42 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.046 179.696 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.491 ' CE2' ' HB2' ' A' ' 86' ' ' TYR . 69.9 m-85 -108.12 -87.55 0.49 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.791 -179.592 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.464 ' CB ' ' CD ' ' A' ' 94' ' ' PRO . . . 50.42 -179.97 0.01 OUTLIER Pre-proline 0 C--O 1.232 0.133 0 CA-C-O 120.641 0.257 . . . . 0.0 110.432 -179.781 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.464 ' CD ' ' CB ' ' A' ' 93' ' ' ALA . 49.3 Cg_endo . . . . . 0 C--O 1.25 1.075 0 C-N-CA 122.45 2.1 . . . . 0.0 111.937 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . 0.418 ' CG2' ' O ' ' A' ' 1' ' ' VAL . 27.8 m . . . . . 0 N--CA 1.492 1.666 0 N-CA-C 110.299 -0.26 . . . . 0.0 110.299 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.42 ' HG3' ' ND2' ' A' ' 76' ' ' ASN . 48.6 Cg_endo -76.57 168.81 23.03 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.546 2.164 . . . . 0.0 112.044 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 4.5 mttm -139.65 85.39 2.04 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.355 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.528 ' CG2' ' CE1' ' A' ' 78' ' ' PHE . 16.8 m -124.85 -176.39 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.424 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -165.14 148.04 8.18 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.235 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.571 ' CE2' ' CD2' ' A' ' 66' ' ' PHE . 48.2 m-85 -123.34 145.56 48.64 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.326 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.403 ' HB ' ' CB ' ' A' ' 20' ' ' LEU . 0.2 OUTLIER -129.3 -176.99 4.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.301 -179.942 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 39.8 t -128.14 87.42 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.4 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.403 ' HG3' HG13 ' A' ' 51' ' ' VAL . 1.3 mm-40 -52.27 147.92 7.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.275 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.27 63.16 0.35 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.371 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -154.39 23.32 0.66 Allowed Glycine 0 CA--C 1.525 0.682 0 N-CA-C 111.022 -0.831 . . . . 0.0 111.022 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 16.9 m -76.07 105.02 6.88 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.442 ' ND2' ' N ' ' A' ' 13' ' ' ASN . 0.4 OUTLIER -75.92 -178.48 4.35 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.096 -179.721 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -62.07 -36.6 82.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.466 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 4.9 ptmt -124.72 36.45 4.6 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.666 -179.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.421 ' HB2' ' CB ' ' A' ' 13' ' ' ASN . 13.2 m80 -136.09 -176.27 4.26 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.844 0.354 . . . . 0.0 110.563 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 32.1 tp -167.07 85.61 0.26 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.269 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -81.33 107.29 13.99 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.58 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.424 HG22 ' CG2' ' A' ' 21' ' ' VAL . 17.8 m -88.99 -170.66 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.163 179.698 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.403 ' CB ' ' HB ' ' A' ' 7' ' ' THR . 1.9 tt -142.4 57.68 1.45 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.308 179.67 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.477 HG23 ' CE2' ' A' ' 6' ' ' PHE . 4.9 t -72.17 114.72 11.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.463 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.93 164.03 20.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.318 179.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.47 ' CE2' HG13 ' A' ' 4' ' ' VAL . 0.4 OUTLIER 174.05 150.05 0.08 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.372 -179.995 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -79.79 -26.89 40.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.485 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -53.56 -75.84 0.21 Allowed Glycine 0 CA--C 1.524 0.625 0 N-CA-C 110.826 -0.91 . . . . 0.0 110.826 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -93.77 -164.21 1.15 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.794 0.33 . . . . 0.0 110.428 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.07 -158.31 0.82 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.415 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.422 ' O ' ' CG ' ' A' ' 71' ' ' GLU . 47.1 mtm -132.25 126.82 34.37 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.704 -179.76 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.426 ' HB1' ' N ' ' A' ' 71' ' ' GLU . . . -125.9 -44.04 1.8 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.083 179.722 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.404 ' O ' ' HB2' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -164.27 168.93 18.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.89 -0.596 . . . . 0.0 109.526 179.712 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 8.9 t -154.11 136.48 6.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.901 0.381 . . . . 0.0 110.975 -179.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.43 ' CB ' ' HA ' ' A' ' 43' ' ' ALA . 3.3 pt-20 -134.08 138.06 45.03 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 178.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.434 HD21 ' CB ' ' A' ' 54' ' ' PHE . 13.4 tp -118.24 155.6 30.26 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 121.157 0.503 . . . . 0.0 110.854 -178.015 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.473 ' NH1' ' CB ' ' A' ' 38' ' ' SER . 0.0 OUTLIER -136.75 -156.97 0.74 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.325 178.946 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.415 ' O ' ' ND2' ' A' ' 65' ' ' ASN . 1.5 mp0 -153.35 -79.72 0.1 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.696 0.284 . . . . 0.0 110.559 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 177.18 119.32 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.79 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 52.64 63.75 4.68 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 111.165 -0.774 . . . . 0.0 111.165 179.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.473 ' CB ' ' NH1' ' A' ' 34' ' ' ARG . 0.3 OUTLIER -111.31 -70.08 0.83 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.946 0.403 . . . . 0.0 110.289 179.797 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 25.4 t0 179.59 -63.3 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.119 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -157.04 163.0 39.53 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.344 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.481 ' CZ2' ' HG3' ' A' ' 67' ' ' ARG . 94.3 m95 -57.57 146.89 28.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.695 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.42 HG12 ' NH2' ' A' ' 34' ' ' ARG . 2.8 m -129.31 107.92 16.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.43 ' HA ' ' CB ' ' A' ' 32' ' ' GLU . . . -45.96 140.86 3.44 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.777 -179.546 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.414 ' HE1' ' CZ ' ' A' ' 66' ' ' PHE . 0.0 OUTLIER -63.02 -170.89 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.539 -179.72 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 86.6 m -138.8 98.84 3.64 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.326 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 13.0 ptmt -67.01 79.29 0.12 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.509 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -128.29 24.87 4.94 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.76 -0.936 . . . . 0.0 110.76 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.434 ' CB ' HG21 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -107.59 175.8 5.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.801 0.334 . . . . 0.0 110.38 179.978 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -60.25 -43.92 98.0 Favored Glycine 0 CA--C 1.523 0.562 0 N-CA-C 110.572 -1.011 . . . . 0.0 110.572 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -160.52 27.6 0.32 Allowed Glycine 0 CA--C 1.524 0.619 0 N-CA-C 110.828 -0.909 . . . . 0.0 110.828 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.434 HG21 ' CB ' ' A' ' 48' ' ' GLU . 14.7 m -143.13 -175.81 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.8 0.333 . . . . 0.0 110.369 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 6.7 m95 -109.29 141.94 40.88 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.712 -179.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -125.81 159.38 32.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.924 179.533 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.434 ' CB ' HD21 ' A' ' 33' ' ' LEU . 68.1 t80 -144.09 133.68 23.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.845 0.355 . . . . 0.0 110.511 -179.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -84.9 128.61 34.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.364 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -122.54 154.15 38.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.379 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -162.22 50.73 0.2 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.467 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -128.71 156.38 77.63 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.569 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -66.99 -28.28 41.95 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.897 2.398 . . . . 0.0 112.123 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -80.06 163.43 24.18 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.28 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -175.29 44.74 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.49 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -83.01 -132.68 1.9 Allowed Glycine 0 CA--C 1.527 0.808 0 N-CA-C 110.36 -1.096 . . . . 0.0 110.36 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -75.29 141.3 25.67 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.355 2.037 . . . . 0.0 111.8 179.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 44.8 m-85 -97.62 153.0 18.49 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.529 -179.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.415 ' ND2' ' O ' ' A' ' 35' ' ' GLU . 6.2 m-80 -124.79 126.23 45.29 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.026 -0.533 . . . . 0.0 109.913 179.581 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.571 ' CD2' ' CE2' ' A' ' 6' ' ' PHE . 2.7 m-85 -104.74 -178.25 3.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.654 -179.573 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.481 ' HG3' ' CZ2' ' A' ' 41' ' ' TRP . 0.0 OUTLIER 175.27 77.85 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.997 179.975 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.404 ' HB2' ' O ' ' A' ' 30' ' ' GLU . 1.4 p90 -84.75 164.08 18.75 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.222 0.534 . . . . 0.0 110.975 -179.653 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.42 ' O ' ' CB ' ' A' ' 29' ' ' ALA . 9.1 mt -109.75 64.26 0.61 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.283 -0.872 . . . . 0.0 108.861 178.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.406 ' OG1' ' HA3' ' A' ' 73' ' ' GLY . 0.8 OUTLIER -33.77 138.06 0.09 Allowed 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 115.552 -0.749 . . . . 0.0 112.206 -178.833 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.426 ' N ' ' HB1' ' A' ' 29' ' ' ALA . 19.0 mt-10 -49.02 -28.13 3.74 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.958 -179.543 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.01 26.64 0.31 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.678 0.275 . . . . 0.0 111.127 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.422 ' O ' ' CB ' ' A' ' 74' ' ' MET . . . -97.15 -36.46 4.94 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 110.381 -1.088 . . . . 0.0 110.381 179.67 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.422 ' CB ' ' O ' ' A' ' 73' ' ' GLY . 0.0 OUTLIER 82.25 70.8 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 120.85 0.357 . . . . 0.0 111.089 179.443 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 48.98 -179.29 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.198 179.209 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.49 ' HB3' ' CE2' ' A' ' 78' ' ' PHE . 0.3 OUTLIER 167.65 128.45 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.882 179.886 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 77.5 t -95.31 137.54 23.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.013 0.435 . . . . 0.0 110.525 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.528 ' CE1' ' CG2' ' A' ' 4' ' ' VAL . 92.4 m-85 -133.39 144.46 49.58 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.494 -179.781 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -133.58 161.49 34.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.194 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 54.02 30.28 11.57 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.94 0.4 . . . . 0.0 110.138 -179.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 87.4 t -64.48 -15.97 18.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.2 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 44.6 t -146.72 132.5 9.36 Favored Pre-proline 0 C--N 1.332 -0.19 0 CA-C-O 120.506 0.193 . . . . 0.0 110.565 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.461 ' CD ' ' CD1' ' A' ' 92' ' ' TYR . 50.6 Cg_endo -75.44 165.81 29.93 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.561 2.174 . . . . 0.0 111.899 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -66.12 126.54 28.98 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.293 -0.412 . . . . 0.0 109.989 179.651 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 24.7 mtmt 60.17 50.12 6.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.942 0.401 . . . . 0.0 109.924 -179.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 51.3 p90 -47.56 158.96 0.16 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.967 -179.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 29.1 m -124.04 108.85 12.8 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.035 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 2.7 mp -47.98 107.64 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.626 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 132.7 44.76 0.14 Allowed Glycine 0 CA--C 1.523 0.565 0 N-CA-C 110.449 -1.061 . . . . 0.0 110.449 -179.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -163.29 156.41 19.01 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.99 101.68 11.23 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.722 -179.78 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.461 ' CD1' ' CD ' ' A' ' 83' ' ' PRO . 32.7 m-85 -87.98 -160.17 0.6 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.868 179.563 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.441 ' CB ' ' HD2' ' A' ' 94' ' ' PRO . . . 66.82 176.58 0.06 OUTLIER Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 120.721 0.296 . . . . 0.0 110.578 179.653 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.441 ' HD2' ' CB ' ' A' ' 93' ' ' ALA . 47.7 Cg_endo . . . . . 0 C--O 1.249 1.056 0 C-N-CA 122.567 2.178 . . . . 0.0 112.04 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 6.2 m . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 110.232 -0.284 . . . . 0.0 110.232 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -78.15 139.6 17.07 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.608 2.206 . . . . 0.0 112.016 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 8.4 mtmt -128.54 55.54 1.69 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.272 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.525 ' CG1' ' CE1' ' A' ' 78' ' ' PHE . 1.7 p -149.32 164.24 4.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.301 0.572 . . . . 0.0 110.215 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.477 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 0.6 OUTLIER -156.99 133.41 9.89 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.516 179.775 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.48 ' CD2' ' HB ' ' A' ' 21' ' ' VAL . 8.2 m-85 -109.77 179.29 4.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.092 -0.504 . . . . 0.0 109.893 179.535 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.5 m -166.23 128.32 1.89 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.846 0.355 . . . . 0.0 110.335 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 29.2 t -70.0 87.51 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.189 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.446 ' CG ' HG22 ' A' ' 51' ' ' VAL . 1.2 mm-40 -58.28 166.09 1.78 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.436 -179.756 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.6 mppt? -54.53 -21.84 11.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.83 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -45.14 -37.43 5.81 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 111.269 -0.733 . . . . 0.0 111.269 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 13.3 m -68.19 124.97 24.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.778 0.323 . . . . 0.0 110.348 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -133.93 -52.74 0.85 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.516 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -146.72 -76.78 0.19 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.658 -179.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 14.4 mmmt -99.32 25.58 6.79 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.462 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 31.4 m80 -125.38 147.51 49.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.451 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -133.44 91.53 2.87 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.0 0.428 . . . . 0.0 110.366 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.437 ' CB ' HG13 ' A' ' 51' ' ' VAL . . . -92.12 131.99 36.94 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.16 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.424 ' N ' ' CG1' ' A' ' 51' ' ' VAL . 14.5 m -127.5 135.33 63.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.847 0.356 . . . . 0.0 110.596 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.3 tt -91.98 67.2 5.14 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.036 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.527 ' CG1' ' CD1' ' A' ' 52' ' ' TRP . 2.2 p -82.19 110.2 17.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 179.395 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 30.3 tttm -178.06 111.13 0.07 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.33 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 29.3 p90 -136.56 151.21 49.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.441 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -50.78 172.99 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.526 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 76.05 -84.8 0.91 Allowed Glycine 0 CA--C 1.523 0.557 0 N-CA-C 110.753 -0.939 . . . . 0.0 110.753 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -64.62 179.11 0.66 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.734 0.302 . . . . 0.0 110.344 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -133.08 178.65 6.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.488 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.422 ' O ' ' CG ' ' A' ' 71' ' ' GLU . 0.1 OUTLIER -105.55 120.42 41.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.26 179.963 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.439 ' HB1' ' N ' ' A' ' 71' ' ' GLU . . . -130.65 -50.68 1.06 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.823 -179.69 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.409 ' CG ' ' O ' ' A' ' 29' ' ' ALA . 29.1 mt-10 -159.23 150.51 20.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.999 0.428 . . . . 0.0 110.848 -179.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 20.3 t -140.43 142.89 30.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.679 179.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.454 ' CB ' ' HA ' ' A' ' 43' ' ' ALA . 1.9 pt-20 -148.77 137.43 21.3 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.875 0.369 . . . . 0.0 110.475 -179.759 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.485 ' HG ' ' CE1' ' A' ' 66' ' ' PHE . 3.9 mt -89.84 173.18 8.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.139 -179.424 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.446 ' O ' ' CB ' ' A' ' 35' ' ' GLU . 20.2 ttt180 -121.49 -63.3 1.33 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.477 179.261 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.448 ' O ' ' N ' ' A' ' 37' ' ' GLY . 14.0 mt-10 89.62 23.65 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 123.555 0.742 . . . . 0.0 109.961 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 58.49 -76.98 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.332 179.427 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.448 ' N ' ' O ' ' A' ' 35' ' ' GLU . . . -48.38 -65.24 2.66 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 111.119 -0.792 . . . . 0.0 111.119 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -49.34 101.3 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.808 0.337 . . . . 0.0 110.591 -179.844 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -59.79 -28.91 67.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.338 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -94.1 129.4 40.67 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.308 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.438 ' CZ3' ' HB2' ' A' ' 34' ' ' ARG . 80.6 m95 -66.39 141.28 58.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.591 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.425 HG22 ' CE1' ' A' ' 54' ' ' PHE . 35.8 m -111.77 111.66 37.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.969 179.706 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.454 ' HA ' ' CB ' ' A' ' 32' ' ' GLU . . . -49.33 141.54 8.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.845 -179.601 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.427 ' HE3' ' CD1' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -70.53 -167.66 0.2 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.121 179.767 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 85.8 m -156.28 98.24 1.83 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.502 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.51 90.47 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.107 179.749 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -112.39 -17.89 7.92 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 111.384 -0.686 . . . . 0.0 111.384 -179.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.439 ' CB ' ' HB ' ' A' ' 51' ' ' VAL . 17.7 tp10 -77.78 -28.69 50.61 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.852 0.326 . . . . 0.0 110.719 -179.706 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 112.55 -39.74 2.76 Favored Glycine 0 CA--C 1.52 0.401 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 -179.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -137.14 16.16 3.68 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 178.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.446 HG22 ' CG ' ' A' ' 9' ' ' GLU . 50.4 t -149.01 147.12 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . 0.527 ' CD1' ' CG1' ' A' ' 21' ' ' VAL . 2.0 m95 -89.87 111.78 22.93 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.282 -179.506 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 4.9 p -99.76 151.05 21.69 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.501 -179.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.425 ' CE1' HG22 ' A' ' 42' ' ' VAL . 57.0 t80 -139.33 151.24 46.22 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.138 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -106.88 129.88 54.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.714 -179.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 14.3 t -127.98 156.03 43.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.11 179.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -156.86 37.48 0.31 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.437 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -124.79 154.33 70.58 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.441 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -72.89 -41.43 1.43 Allowed 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.644 2.229 . . . . 0.0 111.926 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -71.54 77.14 0.8 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.49 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -116.35 89.39 3.1 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.492 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -98.76 -131.79 7.4 Favored Glycine 0 CA--C 1.527 0.79 0 N-CA-C 110.438 -1.065 . . . . 0.0 110.438 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -75.03 145.69 31.65 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.375 2.05 . . . . 0.0 111.767 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.426 ' HB3' ' CD2' ' A' ' 33' ' ' LEU . 56.1 m-85 -97.11 100.71 12.19 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.933 0.396 . . . . 0.0 110.345 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.429 ' OD1' ' N ' ' A' ' 65' ' ' ASN . 0.3 OUTLIER -78.27 141.33 38.6 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.949 -0.568 . . . . 0.0 109.781 179.952 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.485 ' CE1' ' HG ' ' A' ' 33' ' ' LEU . 92.7 m-85 -128.71 -177.45 4.2 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.046 0.451 . . . . 0.0 110.532 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 178.35 52.22 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.691 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -49.98 169.23 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.727 -179.671 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.405 ' O ' ' CB ' ' A' ' 29' ' ' ALA . 1.1 mt -123.95 72.87 1.18 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.213 179.613 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 71.6 p -35.17 137.59 0.15 Allowed 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.783 -179.201 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.439 ' N ' ' HB1' ' A' ' 29' ' ' ALA . 4.8 mm-40 -45.83 -55.1 7.05 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.951 -179.558 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 41.4 tptt -138.85 77.83 1.64 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.528 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -163.42 -91.13 0.08 OUTLIER Glycine 0 CA--C 1.523 0.583 0 N-CA-C 110.57 -1.012 . . . . 0.0 110.57 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER 176.76 172.69 0.44 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.892 0.377 . . . . 0.0 110.459 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.45 145.09 35.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.216 179.848 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -138.75 140.72 38.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.568 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.427 HG11 ' N ' ' A' ' 78' ' ' PHE . 95.5 t -85.54 152.82 3.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.334 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.525 ' CE1' ' CG1' ' A' ' 4' ' ' VAL . 32.6 m-85 -138.46 120.78 15.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.227 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 30.8 p-10 -117.26 48.37 1.35 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.676 -179.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 167.34 65.96 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.419 ' HA ' ' HA ' ' A' ' 93' ' ' ALA . 70.3 t -111.68 -10.07 11.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.564 -178.727 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.406 ' CG2' ' O ' ' A' ' 81' ' ' VAL . 86.9 t -156.04 131.7 5.58 Favored Pre-proline 0 C--N 1.331 -0.197 0 CA-C-O 120.648 0.261 . . . . 0.0 110.765 179.511 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.487 ' HD3' ' CD1' ' A' ' 92' ' ' TYR . 47.5 Cg_endo -68.74 -165.65 0.14 Allowed 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.807 2.338 . . . . 0.0 111.875 179.461 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -77.22 -38.09 52.0 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.15 -0.477 . . . . 0.0 109.852 179.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 1.1 mttt -123.31 74.92 1.27 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.959 179.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 24.5 p90 -47.38 171.02 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.954 -179.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -149.4 109.75 4.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.147 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 2.9 mp -52.69 122.11 2.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.526 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 102.29 42.67 2.16 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 110.936 -0.866 . . . . 0.0 110.936 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -160.07 129.64 5.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.85 0.357 . . . . 0.0 110.57 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 15.1 m -81.4 128.36 33.77 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.136 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.487 ' CD1' ' HD3' ' A' ' 83' ' ' PRO . 63.3 m-85 -111.97 -93.09 0.46 Allowed 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.876 -179.58 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.419 ' HA ' ' HA ' ' A' ' 81' ' ' VAL . . . 53.26 172.35 0.04 OUTLIER Pre-proline 0 N--CA 1.462 0.157 0 CA-C-O 120.852 0.358 . . . . 0.0 110.419 -179.661 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo . . . . . 0 C--O 1.249 1.055 0 C-N-CA 122.783 2.322 . . . . 0.0 112.127 -179.914 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . 0.405 ' CG2' ' HD2' ' A' ' 2' ' ' PRO . 11.9 p . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.405 ' HD2' ' CG2' ' A' ' 1' ' ' VAL . 49.7 Cg_endo -76.12 163.08 33.42 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.468 2.112 . . . . 0.0 111.901 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.33 94.03 3.37 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.239 -179.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.512 ' CG2' ' CE1' ' A' ' 78' ' ' PHE . 35.9 m -85.43 -175.56 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.547 -179.799 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -166.52 151.25 7.73 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.175 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 51.4 m-85 -119.51 165.59 14.2 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.352 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.2 m -159.35 119.38 3.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.402 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 55.6 t -63.85 104.78 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.349 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.428 ' HG3' ' CG1' ' A' ' 51' ' ' VAL . 3.5 mm-40 -74.52 156.95 36.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.452 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 8.5 mttt -52.06 163.83 0.33 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.313 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 82.99 27.46 40.95 Favored Glycine 0 CA--C 1.523 0.54 0 N-CA-C 110.684 -0.966 . . . . 0.0 110.684 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 86.3 p -81.16 114.3 19.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.776 0.322 . . . . 0.0 110.346 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 47.2 m-80 -107.86 179.97 4.07 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.321 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -67.92 -29.82 68.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.41 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 10.4 mmmm -98.35 -44.65 6.45 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.478 -179.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 18.0 m80 -80.4 162.11 24.63 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.743 -179.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.489 ' HG ' ' CE2' ' A' ' 64' ' ' PHE . 2.3 tm? -155.95 77.32 0.95 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.754 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.402 ' HB3' ' CG2' ' A' ' 53' ' ' THR . . . -69.52 140.31 53.91 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.84 -179.427 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 24.6 m -127.85 -178.2 2.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.793 -0.639 . . . . 0.0 109.682 179.544 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.0 tt -134.95 80.42 1.84 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.833 0.349 . . . . 0.0 110.362 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.9 t -90.13 96.21 6.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.33 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 39.5 mttt -148.86 145.79 27.65 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.397 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 2.2 p90 179.0 159.89 0.64 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.272 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -58.91 -175.92 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.425 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 72.53 -90.31 0.54 Allowed Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.66 -0.976 . . . . 0.0 110.66 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -68.1 168.1 12.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.733 0.302 . . . . 0.0 110.348 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.429 ' O ' ' CG2' ' A' ' 27' ' ' THR . 36.7 m -134.68 35.65 3.14 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.925 0.393 . . . . 0.0 110.647 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.423 ' O ' ' CG ' ' A' ' 71' ' ' GLU . 0.0 OUTLIER 61.4 120.85 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.829 179.639 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.429 ' CB ' ' HG2' ' A' ' 71' ' ' GLU . . . -126.26 -51.73 1.52 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.09 179.531 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -157.59 169.26 25.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.868 -0.606 . . . . 0.0 109.737 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.453 HG22 ' CD1' ' A' ' 52' ' ' TRP . 3.2 t -150.6 139.57 15.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.179 0.514 . . . . 0.0 110.775 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -132.73 144.87 50.57 Favored 'General case' 0 N--CA 1.436 -1.126 0 CA-C-N 115.408 -0.814 . . . . 0.0 109.613 -179.217 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.484 HD23 ' CZ ' ' A' ' 66' ' ' PHE . 2.4 mt -121.59 175.22 6.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.398 0.618 . . . . 0.0 111.429 -179.32 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.451 ' HB2' ' CE3' ' A' ' 41' ' ' TRP . 27.5 ttt180 -167.16 162.77 15.39 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.03 -0.986 . . . . 0.0 109.149 179.581 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.428 ' N ' ' HG2' ' A' ' 34' ' ' ARG . 40.8 mt-10 -120.31 -85.1 0.66 Allowed 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 179.869 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.402 ' HB2' ' O ' ' A' ' 35' ' ' GLU . 3.3 t60 179.8 -56.43 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.307 179.374 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -106.06 56.54 0.51 Allowed Glycine 0 CA--C 1.523 0.566 0 N-CA-C 110.616 -0.994 . . . . 0.0 110.616 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 23.1 t -130.76 -160.71 1.06 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.847 0.356 . . . . 0.0 110.386 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -87.23 52.4 2.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.298 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 66.83 -174.63 0.19 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.246 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.456 ' CE3' ' HG2' ' A' ' 67' ' ' ARG . 88.3 m95 -47.97 142.45 5.01 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.722 -179.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 16.8 m -107.07 -142.3 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 179.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -156.27 130.64 8.78 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.51 -179.77 1.14 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.724 0.297 . . . . 0.0 110.532 -179.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 89.8 m -151.43 123.36 8.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.505 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.476 ' HB3' ' CZ3' ' A' ' 52' ' ' TRP . 0.0 OUTLIER -83.62 97.41 9.05 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.363 179.919 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -148.1 23.8 1.42 Allowed Glycine 0 CA--C 1.524 0.601 0 N-CA-C 111.095 -0.802 . . . . 0.0 111.095 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -100.6 -31.59 11.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.8 0.334 . . . . 0.0 110.225 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 96.18 27.9 9.69 Favored Glycine 0 CA--C 1.522 0.525 0 N-CA-C 110.801 -0.92 . . . . 0.0 110.801 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 166.6 -34.47 0.23 Allowed Glycine 0 CA--C 1.523 0.59 0 N-CA-C 110.811 -0.916 . . . . 0.0 110.811 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.428 ' CG1' ' HG3' ' A' ' 9' ' ' GLU . 4.8 m -126.33 -178.38 2.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.875 0.369 . . . . 0.0 110.508 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . 0.476 ' CZ3' ' HB3' ' A' ' 46' ' ' LYS . 7.5 m95 -110.6 142.68 42.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.346 -179.82 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.402 ' CG2' ' HB3' ' A' ' 18' ' ' ALA . 0.8 OUTLIER -134.15 152.05 51.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.314 179.987 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 87.8 t80 -147.31 147.66 30.59 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.43 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -93.87 120.57 34.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.374 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -142.78 175.58 9.71 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.371 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -131.69 -64.66 0.78 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.011 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 48.58 104.34 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 115.982 -0.553 . . . . 0.0 111.458 179.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -64.0 -16.71 56.47 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.345 2.03 . . . . 0.0 111.34 178.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.418 HD11 ' N ' ' A' ' 60' ' ' LEU . 7.1 mp -75.22 -171.31 1.38 Allowed 'General case' 0 C--O 1.232 0.142 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.99 179.509 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 4.9 mp0 -60.43 -79.02 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 179.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.477 ' N ' ' HD3' ' A' ' 63' ' ' PRO . . . -175.5 58.63 0.11 Allowed Glycine 0 CA--C 1.527 0.798 0 N-CA-C 111.276 -0.73 . . . . 0.0 111.276 179.425 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.477 ' HD3' ' N ' ' A' ' 62' ' ' GLY . 51.7 Cg_endo -88.23 108.05 0.56 Allowed 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.798 2.332 . . . . 0.0 111.984 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.489 ' CE2' ' HG ' ' A' ' 17' ' ' LEU . 53.5 m-85 -109.73 166.63 10.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.133 0.492 . . . . 0.0 110.704 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -150.48 129.18 12.35 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.559 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.484 ' CZ ' HD23 ' A' ' 33' ' ' LEU . 33.3 m-85 -115.41 174.87 5.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.104 0.478 . . . . 0.0 111.097 -179.323 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.456 ' HG2' ' CE3' ' A' ' 41' ' ' TRP . 0.0 OUTLIER -175.24 50.34 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.704 179.849 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -56.44 172.79 0.21 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.108 -179.286 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.427 ' O ' ' CB ' ' A' ' 29' ' ' ALA . 7.0 mt -124.86 73.54 1.29 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.282 179.627 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 22.8 p -38.22 142.97 0.14 Allowed 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.803 -179.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.429 ' HG2' ' CB ' ' A' ' 29' ' ' ALA . 3.5 mm-40 -51.47 -43.84 62.25 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.302 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.32 -39.27 69.75 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.316 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 108.97 46.67 0.93 Allowed Glycine 0 CA--C 1.522 0.508 0 N-CA-C 110.574 -1.01 . . . . 0.0 110.574 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 42.3 mtt -136.5 79.43 1.76 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.823 0.344 . . . . 0.0 110.62 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.36 -178.82 7.2 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.191 179.722 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.449 ' O ' ' CE2' ' A' ' 78' ' ' PHE . 0.5 OUTLIER 174.62 140.0 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.472 179.893 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 88.9 t -81.08 144.52 10.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.322 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.512 ' CE1' ' CG2' ' A' ' 4' ' ' VAL . 38.1 m-85 -127.77 126.02 40.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.177 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -93.87 139.77 30.49 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.644 -179.655 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.445 ' O ' ' HB ' ' A' ' 81' ' ' VAL . 0.1 OUTLIER 69.19 -77.05 0.05 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.593 179.756 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.445 ' HB ' ' O ' ' A' ' 80' ' ' ASP . 53.5 t 70.68 -54.47 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 C-N-CA 123.682 0.793 . . . . 0.0 110.653 -179.575 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.437 ' CG1' ' HD2' ' A' ' 83' ' ' PRO . 93.8 t -105.69 140.78 21.53 Favored Pre-proline 0 C--N 1.325 -0.484 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 179.639 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.458 ' HG3' ' CE1' ' A' ' 92' ' ' TYR . 45.1 Cg_endo -71.27 -169.68 0.43 Allowed 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.579 2.186 . . . . 0.0 112.107 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -72.07 -64.42 0.94 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.237 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 14.4 mmtp -108.03 82.98 1.72 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.099 179.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . 0.478 ' HB2' ' CE2' ' A' ' 92' ' ' TYR . 26.5 p90 -71.87 171.28 12.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.58 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 4.5 m -151.52 128.66 11.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.089 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 36.3 mm -50.86 96.41 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.449 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 132.23 48.98 0.1 Allowed Glycine 0 CA--C 1.524 0.598 0 N-CA-C 110.844 -0.902 . . . . 0.0 110.844 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.416 ' HB1' ' CZ ' ' A' ' 92' ' ' TYR . . . -155.72 135.62 12.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.813 0.34 . . . . 0.0 110.362 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 28.7 m -93.42 91.24 7.07 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.418 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.478 ' CE2' ' HB2' ' A' ' 86' ' ' TYR . 30.4 m-85 -82.77 -161.27 0.47 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.202 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.449 ' CB ' ' CD ' ' A' ' 94' ' ' PRO . . . 74.63 177.84 0.06 OUTLIER Pre-proline 0 C--N 1.331 -0.208 0 CA-C-O 120.798 0.333 . . . . 0.0 110.635 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.449 ' CD ' ' CB ' ' A' ' 93' ' ' ALA . 48.5 Cg_endo . . . . . 0 C--O 1.248 0.996 0 C-N-CA 122.648 2.232 . . . . 0.0 112.037 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 7.5 p . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 110.177 -0.305 . . . . 0.0 110.177 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -82.45 155.78 16.43 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.708 2.272 . . . . 0.0 112.12 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 19.2 mttt -102.15 31.27 4.03 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.251 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.528 ' CG1' ' CE1' ' A' ' 78' ' ' PHE . 1.7 p 177.94 164.06 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.174 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.471 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 1.1 p -157.79 128.36 6.38 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.457 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.432 ' CE2' HG22 ' A' ' 21' ' ' VAL . 10.3 m-85 -102.72 177.84 4.74 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.122 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.419 ' O ' ' N ' ' A' ' 9' ' ' GLU . 0.3 OUTLIER -166.13 112.43 0.87 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.361 -179.851 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 14.0 t -57.61 85.52 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.397 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.433 ' CG ' ' HB2' ' A' ' 20' ' ' LEU . 3.6 mm-40 -60.55 161.19 7.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.348 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -56.28 177.59 0.06 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.494 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 77.5 13.24 83.74 Favored Glycine 0 CA--C 1.527 0.805 0 N-CA-C 111.455 -0.658 . . . . 0.0 111.455 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 19.1 m -86.91 109.35 19.27 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.909 0.354 . . . . 0.0 110.051 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.427 ' O ' ' N ' ' A' ' 15' ' ' LYS . 4.6 p-10 -153.28 158.95 42.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.916 0.388 . . . . 0.0 110.806 -179.622 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 54.25 -85.96 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.835 179.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.427 ' N ' ' O ' ' A' ' 13' ' ' ASN . 0.0 OUTLIER -142.49 22.91 1.99 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.622 0.249 . . . . 0.0 110.745 -179.882 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -98.06 120.09 37.85 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 179.743 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.421 ' HG ' ' CE2' ' A' ' 64' ' ' PHE . 0.2 OUTLIER -113.3 98.42 7.1 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.054 0.455 . . . . 0.0 110.772 -179.499 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.453 ' CB ' HG13 ' A' ' 51' ' ' VAL . . . -86.76 138.83 31.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.027 179.572 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.444 ' N ' HG12 ' A' ' 51' ' ' VAL . 26.9 m -141.93 139.8 30.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.869 0.366 . . . . 0.0 110.816 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.433 ' HB2' ' CG ' ' A' ' 9' ' ' GLU . 0.5 OUTLIER -99.41 34.85 2.08 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.517 179.937 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.53 ' CG1' ' CD1' ' A' ' 52' ' ' TRP . 7.2 p -57.02 109.74 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 120.854 0.359 . . . . 0.0 110.521 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -179.59 77.68 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.243 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.485 ' CE2' ' HB ' ' A' ' 4' ' ' VAL . 25.7 p90 -84.63 -179.89 7.23 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.562 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -47.68 -68.28 0.2 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.874 -179.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -56.3 -20.26 28.44 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 111.207 -0.757 . . . . 0.0 111.207 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.479 ' HB2' ' CZ ' ' A' ' 23' ' ' TYR . 5.4 t70 -90.07 137.92 31.94 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.763 0.316 . . . . 0.0 110.594 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.434 ' O ' ' CG2' ' A' ' 27' ' ' THR . 88.5 m -124.63 11.08 8.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.104 179.694 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.413 ' O ' ' CG ' ' A' ' 71' ' ' GLU . 28.6 mtm 58.03 112.63 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.815 0.341 . . . . 0.0 110.625 179.654 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.429 ' CB ' ' O ' ' A' ' 69' ' ' LEU . . . -131.92 -49.06 0.95 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.584 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -176.02 83.56 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.81 0.338 . . . . 0.0 110.907 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.474 HG23 ' CD1' ' A' ' 52' ' ' TRP . 18.5 t -68.45 155.0 7.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.15 179.589 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.46 ' CB ' ' HA ' ' A' ' 43' ' ' ALA . 4.5 pt-20 -147.14 142.09 26.96 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.839 0.352 . . . . 0.0 110.639 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.423 ' HG ' ' CE1' ' A' ' 66' ' ' PHE . 4.2 mt -103.49 -178.41 3.65 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.445 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.477 ' HB2' ' CZ3' ' A' ' 41' ' ' TRP . 6.4 ttt180 -132.85 -64.95 0.73 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.591 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.446 ' CB ' ' O ' ' A' ' 34' ' ' ARG . 23.3 mt-10 92.5 33.65 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.669 0.788 . . . . 0.0 109.187 -179.195 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 3.0 t-80 67.54 -68.81 0.15 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.487 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -157.34 57.87 0.36 Allowed Glycine 0 CA--C 1.523 0.578 0 N-CA-C 110.595 -1.002 . . . . 0.0 110.595 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.415 ' CB ' ' HB2' ' A' ' 35' ' ' GLU . 34.1 t -92.47 -46.17 7.78 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.77 0.319 . . . . 0.0 110.335 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 47.6 p-10 -177.51 52.65 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.537 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 62.51 -177.32 0.14 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.47 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.503 ' CH2' ' HG3' ' A' ' 67' ' ' ARG . 93.7 m95 -60.27 129.88 43.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.533 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.414 HG22 ' CE1' ' A' ' 54' ' ' PHE . 25.1 m -122.76 116.44 48.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.125 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.46 ' HA ' ' CB ' ' A' ' 32' ' ' GLU . . . -56.08 140.28 44.29 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.47 -179.779 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.56 -167.65 0.2 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.173 -0.467 . . . . 0.0 109.953 179.787 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 91.4 m -153.62 127.15 8.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.864 0.364 . . . . 0.0 110.654 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 11.8 ptpt -73.18 77.2 1.28 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.03 179.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -93.22 -25.79 18.08 Favored Glycine 0 CA--C 1.522 0.516 0 N-CA-C 111.169 -0.772 . . . . 0.0 111.169 -179.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.461 ' CB ' ' HB ' ' A' ' 51' ' ' VAL . 2.9 mm-40 -86.95 -18.93 29.58 Favored 'General case' 0 C--N 1.33 -0.249 0 O-C-N 122.759 -0.259 . . . . 0.0 111.284 -179.483 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 96.48 -42.34 2.24 Favored Glycine 0 CA--C 1.523 0.539 0 N-CA-C 110.333 -1.107 . . . . 0.0 110.333 -179.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.42 ' O ' ' CG2' ' A' ' 51' ' ' VAL . . . -132.73 23.36 3.98 Favored Glycine 0 CA--C 1.522 0.51 0 N-CA-C 109.806 -1.318 . . . . 0.0 109.806 179.161 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.461 ' HB ' ' CB ' ' A' ' 48' ' ' GLU . 42.0 t -159.0 145.57 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 -179.621 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . 0.53 ' CD1' ' CG1' ' A' ' 21' ' ' VAL . 1.7 m95 -94.02 117.47 30.15 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.966 0.412 . . . . 0.0 110.607 -179.027 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 3.2 p -110.36 139.55 45.44 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.029 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.414 ' CE1' HG22 ' A' ' 42' ' ' VAL . 58.1 t80 -117.69 142.24 47.47 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.867 0.365 . . . . 0.0 110.611 -179.762 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -103.68 104.86 14.95 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.183 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -84.57 143.94 28.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.532 -179.813 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -112.35 1.83 16.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.122 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -121.96 156.71 59.24 Favored Pre-proline 0 C--O 1.231 0.099 0 CA-C-O 120.668 0.271 . . . . 0.0 110.361 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -70.85 -29.85 18.09 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.691 2.261 . . . . 0.0 112.18 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -81.73 134.1 35.41 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.42 -179.838 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -174.05 40.39 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.325 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -58.19 -93.07 0.01 OUTLIER Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.849 -0.9 . . . . 0.0 110.849 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -79.74 136.63 12.2 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.584 2.189 . . . . 0.0 112.053 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.421 ' CE2' ' HG ' ' A' ' 17' ' ' LEU . 49.8 m-85 -107.73 149.46 28.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.638 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -125.81 116.32 21.39 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 179.013 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.423 ' CE1' ' HG ' ' A' ' 33' ' ' LEU . 29.6 m-85 -100.65 171.11 7.91 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.29 0.566 . . . . 0.0 111.608 -178.706 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.503 ' HG3' ' CH2' ' A' ' 41' ' ' TRP . 0.0 OUTLIER -162.65 83.27 0.53 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.978 179.24 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.43 ' CE2' ' CE2' ' A' ' 78' ' ' PHE . 5.2 p90 -70.87 167.59 18.64 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.432 0.634 . . . . 0.0 111.045 -179.5 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.429 ' O ' ' CB ' ' A' ' 29' ' ' ALA . 4.2 mt -138.82 55.69 1.72 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.966 -1.015 . . . . 0.0 108.756 179.378 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 17.0 p -23.59 134.96 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.907 0.883 . . . . 0.0 112.732 -178.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.413 ' CG ' ' O ' ' A' ' 28' ' ' MET . 3.0 mt-10 -48.76 -26.24 2.25 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.691 -179.656 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -158.22 63.46 0.45 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.31 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -151.59 -103.95 0.26 Allowed Glycine 0 CA--C 1.523 0.576 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -169.31 -174.94 2.09 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.982 0.42 . . . . 0.0 110.561 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.409 ' HB3' HD21 ' A' ' 69' ' ' LEU . 0.5 OUTLIER -123.9 172.36 8.97 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.219 179.959 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 175.73 140.35 0.06 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.931 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.46 ' HA ' ' HG2' ' A' ' 67' ' ' ARG . 2.5 p -79.49 145.56 9.17 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.209 0 CA-C-O 121.26 0.552 . . . . 0.0 110.037 179.561 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.528 ' CE1' ' CG1' ' A' ' 4' ' ' VAL . 98.3 m-85 -126.14 143.86 50.97 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.033 -179.409 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 30.1 t0 -121.69 155.85 34.31 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.901 0.381 . . . . 0.0 110.803 -179.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 4.3 t0 48.77 51.24 16.13 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.654 179.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.426 ' O ' ' CB ' ' A' ' 92' ' ' TYR . 72.5 t -87.88 -16.49 8.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.627 179.782 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.431 ' CG1' ' HB3' ' A' ' 86' ' ' TYR . 59.4 t -148.57 133.35 9.06 Favored Pre-proline 0 C--N 1.332 -0.157 0 N-CA-C 110.433 -0.21 . . . . 0.0 110.433 179.667 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.41 ' HD2' HG11 ' A' ' 82' ' ' VAL . 46.8 Cg_endo -68.53 -165.73 0.13 Allowed 'Trans proline' 0 N--CA 1.475 0.383 0 C-N-CA 122.695 2.263 . . . . 0.0 111.986 179.483 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -80.32 -37.84 31.79 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.282 -0.417 . . . . 0.0 109.957 179.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.98 67.02 1.11 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.218 179.797 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . 0.431 ' HB3' ' CG1' ' A' ' 82' ' ' VAL . 33.6 p90 -55.58 163.88 1.2 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.644 -179.772 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 7.1 m -133.38 113.0 12.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.241 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 2.7 mp -50.67 116.16 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.501 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 115.32 44.26 0.67 Allowed Glycine 0 CA--C 1.524 0.595 0 N-CA-C 110.677 -0.969 . . . . 0.0 110.677 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -163.24 141.18 7.87 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.816 0.341 . . . . 0.0 110.527 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 17.2 m -90.5 112.13 23.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.19 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.426 ' CB ' ' O ' ' A' ' 81' ' ' VAL . 74.2 m-85 -94.39 -99.03 0.15 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.53 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.45 ' CB ' ' CD ' ' A' ' 94' ' ' PRO . . . 50.48 179.13 0.02 OUTLIER Pre-proline 0 C--O 1.231 0.096 0 CA-C-O 120.704 0.288 . . . . 0.0 110.558 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.45 ' CD ' ' CB ' ' A' ' 93' ' ' ALA . 48.0 Cg_endo . . . . . 0 C--O 1.25 1.075 0 C-N-CA 122.464 2.109 . . . . 0.0 112.044 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 19.9 t . . . . . 0 N--CA 1.49 1.535 0 N-CA-C 110.183 -0.303 . . . . 0.0 110.183 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -76.94 169.78 21.02 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.598 2.198 . . . . 0.0 112.062 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 3.8 mttt -174.7 109.55 0.12 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.362 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.483 HG12 ' CE1' ' A' ' 78' ' ' PHE . 1.8 p -135.58 163.57 34.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.361 0.601 . . . . 0.0 110.359 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.48 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 0.1 OUTLIER -142.74 139.91 31.26 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.253 179.579 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.451 ' CD2' HG21 ' A' ' 21' ' ' VAL . 20.9 m-85 -112.96 -175.01 2.57 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.325 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -165.09 -167.0 1.1 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.145 -0.48 . . . . 0.0 109.945 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.3 t -139.37 82.42 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.147 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.434 ' HG3' ' CG1' ' A' ' 51' ' ' VAL . 65.7 mm-40 -50.9 155.1 1.26 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.457 -179.771 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 6.8 mtpt -53.49 175.33 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.379 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 64.18 46.81 90.0 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 110.585 -1.006 . . . . 0.0 110.585 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 61.6 m -102.69 108.66 19.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.796 0.331 . . . . 0.0 110.383 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 55.9 m-80 -101.66 174.46 5.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.255 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -55.56 -34.93 65.19 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.599 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.0 -52.71 4.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.319 -179.645 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 27.1 m80 -73.46 136.92 44.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.002 -179.434 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.401 HD23 ' HA ' ' A' ' 17' ' ' LEU . 0.8 OUTLIER -137.36 84.16 2.04 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.521 179.309 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.431 ' CB ' ' CG2' ' A' ' 53' ' ' THR . . . -74.95 116.91 16.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.896 -179.229 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.4 m -109.8 137.36 42.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.011 179.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.1 tt -84.78 70.53 10.84 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.521 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.451 HG21 ' CD2' ' A' ' 6' ' ' PHE . 3.2 t -85.6 98.61 6.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.131 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.9 ttpm? -167.14 147.56 5.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.484 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -161.78 157.62 24.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.299 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.91 -21.58 66.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.716 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -46.17 -91.0 0.01 OUTLIER Glycine 0 CA--C 1.526 0.722 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -90.83 -160.74 0.74 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.729 0.3 . . . . 0.0 110.428 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.425 ' CG2' ' O ' ' A' ' 27' ' ' THR . 32.5 m -123.67 24.35 8.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.038 -179.737 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.426 ' O ' ' CG ' ' A' ' 71' ' ' GLU . 8.4 mtm 60.61 125.28 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.013 179.402 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.441 ' CB ' ' O ' ' A' ' 69' ' ' LEU . . . -122.06 -61.79 1.45 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.259 179.736 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -147.31 171.44 15.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.1 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.422 ' HA ' ' HA ' ' A' ' 68' ' ' PHE . 1.1 p 175.84 151.01 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.28 0.562 . . . . 0.0 110.519 -179.822 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.423 ' HG3' ' HB3' ' A' ' 41' ' ' TRP . 1.1 pm0 -140.23 171.36 14.27 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.97 -179.564 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 12.0 tp -126.41 154.85 43.05 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-O 120.987 0.423 . . . . 0.0 110.088 -179.036 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.47 ' HB2' ' CE3' ' A' ' 41' ' ' TRP . 0.6 OUTLIER -145.47 173.24 12.19 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.892 -0.594 . . . . 0.0 109.534 179.371 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 17.3 mp0 -133.22 -89.62 0.4 Allowed 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 110.346 -0.242 . . . . 0.0 110.346 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 20.3 p80 -177.35 146.21 0.47 Allowed 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 120.77 0.319 . . . . 0.0 110.514 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 60.92 38.76 95.95 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.844 -0.902 . . . . 0.0 110.844 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.1 t -118.38 173.98 6.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.862 0.363 . . . . 0.0 110.423 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -63.79 -70.58 0.21 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.511 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -153.68 173.73 15.42 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.031 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.47 ' CE3' ' HB2' ' A' ' 34' ' ' ARG . 75.2 m95 -52.71 151.21 4.55 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.189 179.769 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 9.7 m -122.83 118.77 56.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.397 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -50.53 134.85 23.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.624 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.0 -168.62 0.14 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.217 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 30.0 m -147.4 105.87 3.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.356 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.88 87.84 0.37 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.209 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -133.88 21.82 3.91 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.985 -0.846 . . . . 0.0 110.985 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.426 ' CB ' HG22 ' A' ' 51' ' ' VAL . 0.1 OUTLIER -108.59 177.6 4.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.754 0.312 . . . . 0.0 110.292 179.953 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -62.44 -44.66 97.29 Favored Glycine 0 CA--C 1.523 0.545 0 N-CA-C 110.7 -0.96 . . . . 0.0 110.7 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -160.94 31.41 0.35 Allowed Glycine 0 CA--C 1.523 0.567 0 N-CA-C 110.717 -0.953 . . . . 0.0 110.717 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.434 ' CG1' ' HG3' ' A' ' 9' ' ' GLU . 5.2 m -145.77 -179.44 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.854 0.359 . . . . 0.0 110.468 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . 0.415 ' CD1' HG12 ' A' ' 31' ' ' VAL . 9.4 m95 -106.12 140.41 39.14 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.514 -179.769 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.431 ' CG2' ' CB ' ' A' ' 18' ' ' ALA . 0.5 OUTLIER -138.27 153.26 49.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.233 179.886 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 36.0 t80 -159.28 141.52 13.7 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.631 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 20.9 p-10 -93.52 127.94 39.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.27 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 9.5 p -94.96 143.82 26.17 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.36 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 14.0 mp0 -104.27 25.85 9.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.402 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -133.38 156.97 79.21 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.282 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -95.2 32.92 0.17 Allowed 'Trans proline' 0 N--CA 1.451 -1.004 0 C-N-CA 123.924 3.082 . . . . 0.0 112.355 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.491 ' CD1' ' N ' ' A' ' 60' ' ' LEU . 0.0 OUTLIER -49.97 162.82 0.17 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.725 -179.903 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -153.76 27.35 0.49 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.347 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -120.9 -155.19 9.48 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.773 -0.931 . . . . 0.0 110.773 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.438 ' CB ' ' HA ' ' A' ' 80' ' ' ASP . 48.7 Cg_endo -79.89 163.84 23.1 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.622 2.215 . . . . 0.0 112.182 -179.829 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 50.2 m-85 -105.76 -175.21 2.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.236 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -150.67 141.18 22.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.97 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -137.93 178.85 6.81 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.038 0.446 . . . . 0.0 110.885 -179.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.42 ' HG2' ' CZ3' ' A' ' 41' ' ' TRP . 0.1 OUTLIER 176.23 84.15 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.51 -179.982 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.422 ' HA ' ' HA ' ' A' ' 31' ' ' VAL . 5.0 p90 -72.56 -177.38 2.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.275 0.559 . . . . 0.0 110.995 -179.213 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.441 ' O ' ' CB ' ' A' ' 29' ' ' ALA . 9.0 mt -140.18 72.39 1.39 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.125 179.678 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.435 ' OG1' ' N ' ' A' ' 74' ' ' MET . 76.6 p -30.88 140.3 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.403 0.681 . . . . 0.0 112.447 -178.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.436 ' HG2' ' CB ' ' A' ' 29' ' ' ALA . 3.3 mm-40 -55.88 -38.86 70.73 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.809 -179.634 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.56 53.72 1.42 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.745 -179.739 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.423 ' O ' ' CG ' ' A' ' 74' ' ' MET . . . -142.46 -109.39 0.73 Allowed Glycine 0 CA--C 1.523 0.551 0 N-CA-C 110.853 -0.899 . . . . 0.0 110.853 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.435 ' N ' ' OG1' ' A' ' 70' ' ' THR . 32.6 mtp -162.98 -178.68 6.23 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 110.206 -0.294 . . . . 0.0 110.206 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -94.01 -177.61 4.38 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.074 179.693 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 9.6 t30 176.88 155.74 0.26 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.392 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 71.2 t -111.21 147.15 15.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.948 179.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.483 ' CE1' HG12 ' A' ' 4' ' ' VAL . 38.0 m-85 -135.87 127.81 29.49 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.453 -179.77 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 39.8 p-10 -118.86 158.01 26.5 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.126 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.438 ' HA ' ' CB ' ' A' ' 63' ' ' PRO . 1.2 m-20 53.37 33.72 16.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.321 -179.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.402 ' HA ' ' HA ' ' A' ' 93' ' ' ALA . 69.9 t -61.56 -17.21 16.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.759 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.444 ' CG1' ' HD2' ' A' ' 83' ' ' PRO . 70.9 t -147.42 140.06 14.49 Favored Pre-proline 0 C--N 1.331 -0.204 0 CA-C-O 120.652 0.263 . . . . 0.0 110.356 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.444 ' HD2' ' CG1' ' A' ' 82' ' ' VAL . 44.6 Cg_endo -69.39 -165.95 0.16 Allowed 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.665 2.244 . . . . 0.0 112.003 179.798 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -74.31 -65.87 0.8 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.031 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.39 71.48 1.36 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.212 179.735 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . 0.406 ' CD1' ' C ' ' A' ' 86' ' ' TYR . 15.4 p90 -56.95 162.96 2.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.506 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 43.7 m -141.32 122.85 15.06 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.404 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 40.7 mm -51.54 116.95 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.342 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 113.11 30.21 2.79 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.664 -0.975 . . . . 0.0 110.664 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -137.15 134.36 36.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.794 0.33 . . . . 0.0 110.18 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 21.6 m -91.34 105.68 17.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.9 -179.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 39.2 m-85 -97.35 -155.77 0.51 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.0 -0.546 . . . . 0.0 109.642 179.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.435 ' CB ' ' HD2' ' A' ' 94' ' ' PRO . . . 73.91 175.76 0.07 OUTLIER Pre-proline 0 N--CA 1.464 0.232 0 CA-C-O 120.673 0.273 . . . . 0.0 110.779 179.762 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.435 ' HD2' ' CB ' ' A' ' 93' ' ' ALA . 46.9 Cg_endo . . . . . 0 C--O 1.249 1.033 0 C-N-CA 122.536 2.157 . . . . 0.0 112.02 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 28.2 t . . . . . 0 N--CA 1.49 1.57 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -78.78 162.71 26.76 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.618 2.212 . . . . 0.0 112.188 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 10.0 mtpt -151.85 104.41 3.01 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.187 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.528 ' CG1' ' CE1' ' A' ' 78' ' ' PHE . 2.1 p -96.65 162.95 2.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.27 0.557 . . . . 0.0 110.371 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.468 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 1.2 p -145.16 132.91 21.06 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.463 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -99.37 172.5 7.29 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.279 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 16.7 m -166.14 96.56 0.6 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.182 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.8 t -50.77 111.64 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.581 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -70.24 171.54 9.65 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.51 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.69 -8.83 51.17 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.191 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -48.38 -26.55 5.07 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 111.086 -0.806 . . . . 0.0 111.086 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 28.5 p -52.87 126.66 20.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.725 0.298 . . . . 0.0 110.279 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -122.58 -57.61 1.73 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.496 -179.805 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -134.51 -78.21 0.46 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.354 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.22 -20.64 14.59 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.702 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -54.32 177.28 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.804 0.335 . . . . 0.0 110.285 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 25.4 tp -162.2 84.03 0.57 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.312 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -72.83 162.46 29.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.232 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.437 HG13 ' CZ ' ' A' ' 66' ' ' PHE . 30.9 m -156.65 133.32 2.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.815 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -94.62 64.41 3.01 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.169 179.539 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 28.9 t -56.48 111.78 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.593 -179.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.74 168.82 22.58 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.12 179.769 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.481 ' CD1' ' HB2' ' A' ' 26' ' ' ASP . 0.0 OUTLIER -150.55 -68.88 0.19 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.094 -179.95 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 52.0 tt0 -168.88 -61.42 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.515 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -152.18 58.9 0.42 Allowed Glycine 0 CA--C 1.524 0.654 0 N-CA-C 111.094 -0.802 . . . . 0.0 111.094 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.481 ' HB2' ' CD1' ' A' ' 23' ' ' TYR . 77.0 m-20 -108.71 178.81 4.37 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 179.531 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.401 ' HB ' ' HB2' ' A' ' 71' ' ' GLU . 0.2 OUTLIER -110.0 172.2 7.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.893 0.378 . . . . 0.0 110.492 -179.892 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 1.2 mtt -126.18 117.62 23.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.158 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.426 ' CB ' ' HG2' ' A' ' 71' ' ' GLU . . . -116.88 -58.34 2.08 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.642 -179.765 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.42 ' O ' ' CB ' ' A' ' 68' ' ' PHE . 20.8 mm-40 -153.24 162.7 41.01 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.476 -179.843 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.489 HG23 ' CD1' ' A' ' 52' ' ' TRP . 2.5 t -151.96 142.78 15.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.276 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.43 ' CB ' ' HA ' ' A' ' 43' ' ' ALA . 11.9 pm0 -153.2 139.82 18.84 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.755 -179.603 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.414 HD11 ' N ' ' A' ' 34' ' ' ARG . 0.5 OUTLIER -108.99 172.52 6.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.182 179.893 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.44 ' O ' ' CB ' ' A' ' 35' ' ' GLU . 0.1 OUTLIER -94.31 -67.58 0.85 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.634 -0.257 . . . . 0.0 110.698 -179.685 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.44 ' CB ' ' O ' ' A' ' 34' ' ' ARG . 2.0 tt0 88.91 74.5 0.01 OUTLIER 'General case' 0 CA--C 1.51 -0.571 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 -178.622 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -36.97 120.82 0.75 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 114.995 -1.002 . . . . 0.0 111.832 -178.216 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 128.17 -48.87 0.95 Allowed Glycine 0 CA--C 1.523 0.55 0 N-CA-C 110.446 -1.062 . . . . 0.0 110.446 -179.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.414 ' O ' ' CB ' ' A' ' 39' ' ' ASP . 40.6 t -75.03 -32.79 61.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.745 0.307 . . . . 0.0 110.494 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.414 ' CB ' ' O ' ' A' ' 38' ' ' SER . 8.2 t0 81.56 -53.17 0.27 Allowed 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.729 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -72.63 124.04 24.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.573 -179.751 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.484 ' CZ3' ' HB2' ' A' ' 67' ' ' ARG . 77.7 m95 -54.73 155.19 4.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.036 179.743 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.6 m -136.54 124.69 34.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.8 0.333 . . . . 0.0 110.422 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.43 ' HA ' ' CB ' ' A' ' 32' ' ' GLU . . . -57.19 138.56 54.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.243 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.77 -170.14 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.232 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 62.1 m -135.79 95.18 3.18 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.444 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.413 ' O ' ' CG ' ' A' ' 46' ' ' LYS . 14.6 ptmt -74.16 90.98 2.08 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.97 0.414 . . . . 0.0 110.402 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -156.83 25.34 0.5 Allowed Glycine 0 CA--C 1.523 0.581 0 N-CA-C 110.729 -0.948 . . . . 0.0 110.729 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.438 ' CG ' HG21 ' A' ' 51' ' ' VAL . 7.7 tp10 -106.75 165.91 10.97 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.765 0.317 . . . . 0.0 110.265 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -39.85 -49.7 3.34 Favored Glycine 0 CA--C 1.527 0.794 0 N-CA-C 111.784 -0.526 . . . . 0.0 111.784 -179.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -164.49 33.28 0.26 Allowed Glycine 0 CA--C 1.523 0.549 0 N-CA-C 111.001 -0.84 . . . . 0.0 111.001 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.438 HG21 ' CG ' ' A' ' 48' ' ' GLU . 4.3 m -148.79 -178.57 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.916 0.389 . . . . 0.0 110.498 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . 0.489 ' CD1' HG23 ' A' ' 31' ' ' VAL . 6.5 m95 -108.42 119.1 38.52 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.215 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -106.46 -179.46 3.95 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.613 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 16.4 t80 -177.46 124.37 0.13 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.929 0.395 . . . . 0.0 110.626 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -86.06 154.17 21.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.143 179.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 52.5 p -128.51 126.02 39.56 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.463 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -86.76 -37.43 17.88 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.216 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -63.48 139.04 97.53 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.259 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.403 ' O ' ' NE2' ' A' ' 61' ' ' GLN . 49.0 Cg_endo -72.92 -15.46 26.33 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.574 2.183 . . . . 0.0 112.366 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -50.79 128.11 20.04 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.856 0.36 . . . . 0.0 110.522 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.403 ' NE2' ' O ' ' A' ' 59' ' ' PRO . 1.0 OUTLIER -113.78 61.46 0.66 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.263 179.949 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -107.47 -165.22 21.85 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.688 -0.965 . . . . 0.0 110.688 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.409 ' C ' ' CD1' ' A' ' 64' ' ' PHE . 45.7 Cg_endo -74.28 -172.06 1.07 Allowed 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.46 2.107 . . . . 0.0 112.036 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.409 ' CD1' ' C ' ' A' ' 63' ' ' PRO . 57.6 m-85 -152.88 106.35 3.04 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.641 -179.796 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 29.3 m-80 -74.83 119.77 19.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.269 -0.423 . . . . 0.0 109.919 179.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.437 ' CZ ' HG13 ' A' ' 19' ' ' VAL . 8.6 m-85 -87.79 167.87 13.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.816 -179.555 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.484 ' HB2' ' CZ3' ' A' ' 41' ' ' TRP . 3.3 mtp180 -172.68 116.71 0.32 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.581 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.522 ' CZ ' ' CZ ' ' A' ' 78' ' ' PHE . 0.1 OUTLIER -123.39 170.24 10.54 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.017 0.437 . . . . 0.0 110.538 179.785 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.42 ' O ' ' CB ' ' A' ' 29' ' ' ALA . 7.2 mt -125.88 68.21 1.18 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.341 179.534 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 71.4 p -33.69 138.47 0.08 Allowed 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.875 -179.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.426 ' HG2' ' CB ' ' A' ' 29' ' ' ALA . 1.1 mt-10 -54.1 -26.18 25.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.356 -179.697 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.5 tmtt? -67.12 -52.34 42.91 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.283 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 120.24 58.75 0.24 Allowed Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.792 -0.923 . . . . 0.0 110.792 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 1.2 mmt -131.92 70.79 1.46 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.776 0.322 . . . . 0.0 110.38 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.75 155.15 19.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.383 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 177.8 152.25 0.26 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.563 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 92.6 t -104.86 151.8 7.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.158 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.528 ' CE1' ' CG1' ' A' ' 4' ' ' VAL . 55.2 m-85 -127.38 147.57 50.27 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.759 -179.343 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 14.4 t0 -134.61 161.76 34.21 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.248 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 54.65 44.77 28.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.238 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.437 ' O ' ' CG2' ' A' ' 82' ' ' VAL . 60.0 t -93.34 3.09 8.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.238 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.437 ' CG2' ' O ' ' A' ' 81' ' ' VAL . 66.1 t -159.24 110.66 1.54 Allowed Pre-proline 0 CA--C 1.532 0.257 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 179.603 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.43 ' O ' ' N ' ' A' ' 85' ' ' LYS . 47.9 Cg_endo -75.58 62.09 6.25 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.524 2.149 . . . . 0.0 112.41 -179.741 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 53.86 -87.52 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.551 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.43 ' N ' ' O ' ' A' ' 83' ' ' PRO . 0.0 OUTLIER -87.91 56.61 3.95 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 120.934 0.397 . . . . 0.0 109.946 179.74 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . 0.426 ' HB2' ' CE2' ' A' ' 92' ' ' TYR . 48.6 p90 -48.23 175.95 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.854 -179.744 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -144.24 134.15 23.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.113 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 36.5 mm -65.21 118.44 7.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.468 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 114.03 35.22 1.53 Allowed Glycine 0 CA--C 1.523 0.577 0 N-CA-C 110.602 -0.999 . . . . 0.0 110.602 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -138.64 175.53 9.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.768 0.318 . . . . 0.0 110.383 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 18.5 m -126.52 101.23 6.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.3 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.426 ' CE2' ' HB2' ' A' ' 86' ' ' TYR . 19.5 m-85 -107.22 132.35 53.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.294 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.437 ' CB ' ' HD2' ' A' ' 94' ' ' PRO . . . 173.83 178.25 0.16 Allowed Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.397 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.437 ' HD2' ' CB ' ' A' ' 93' ' ' ALA . 49.0 Cg_endo . . . . . 0 C--O 1.248 1.019 0 C-N-CA 122.489 2.126 . . . . 0.0 112.095 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 51.0 t . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -74.58 137.18 22.38 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.622 2.215 . . . . 0.0 112.042 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 27.5 mtpt -151.23 97.41 2.42 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.578 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.483 HG23 ' CZ ' ' A' ' 78' ' ' PHE . 29.5 m -122.22 -176.73 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.21 179.695 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -161.08 137.38 8.38 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.399 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.419 ' CE2' ' CD1' ' A' ' 66' ' ' PHE . 19.6 m-85 -107.05 169.36 8.6 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.943 179.821 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 47.3 m -162.04 103.56 1.14 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.925 0.393 . . . . 0.0 110.497 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 31.0 t -53.22 92.57 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.341 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.408 ' OE1' ' CG2' ' A' ' 51' ' ' VAL . 0.1 OUTLIER -59.61 164.53 3.51 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.593 -179.859 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.438 ' HA ' ' CG2' ' A' ' 88' ' ' ILE . 1.5 pttt -86.03 61.14 6.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.286 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -133.1 22.61 3.99 Favored Glycine 0 CA--C 1.525 0.656 0 N-CA-C 111.001 -0.84 . . . . 0.0 111.001 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.4 t -81.82 146.54 29.83 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -152.45 -88.5 0.06 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.739 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -96.61 -66.32 0.91 Allowed 'General case' 0 N--CA 1.454 -0.235 0 CA-C-O 120.694 0.283 . . . . 0.0 110.3 -179.725 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.434 ' HD3' ' ND1' ' A' ' 16' ' ' HIS . 0.0 OUTLIER -140.81 49.1 1.69 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.627 -179.996 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.434 ' ND1' ' HD3' ' A' ' 15' ' ' LYS . 45.6 m80 -129.93 112.56 13.64 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.075 179.555 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -98.53 81.39 2.71 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.225 -179.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.95 131.54 50.02 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.572 -179.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 29.9 m -135.1 136.38 51.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.238 179.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -89.95 75.53 7.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.686 -179.743 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 14.5 t -75.11 95.32 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.093 179.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 23.6 tttt -171.4 132.41 0.78 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.46 -179.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 10.4 p90 -141.42 25.8 2.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.463 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 49.16 87.75 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.575 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -174.08 -105.38 0.18 Allowed Glycine 0 CA--C 1.523 0.532 0 N-CA-C 110.755 -0.938 . . . . 0.0 110.755 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -64.99 -175.17 0.18 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.75 0.309 . . . . 0.0 110.364 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.407 ' HB ' ' HG3' ' A' ' 71' ' ' GLU . 0.8 OUTLIER -103.78 -173.95 2.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.473 -179.866 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.41 ' O ' ' CG ' ' A' ' 71' ' ' GLU . 3.6 mtm -116.69 130.18 56.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.636 -179.621 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.446 ' CB ' ' HG2' ' A' ' 71' ' ' GLU . . . -122.44 -56.85 1.78 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.641 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -158.42 166.49 32.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.287 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 26.4 t -151.67 152.09 11.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.927 0.394 . . . . 0.0 110.675 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.437 ' CB ' ' HA ' ' A' ' 43' ' ' ALA . 0.5 OUTLIER -155.21 138.84 16.03 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.364 179.963 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.489 ' HG ' ' CE2' ' A' ' 66' ' ' PHE . 1.4 mt -94.27 177.56 5.91 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.676 -179.53 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.419 ' CB ' ' HB2' ' A' ' 65' ' ' ASN . 0.1 OUTLIER -130.26 -156.91 0.79 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.664 179.649 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.402 ' OE2' ' CB ' ' A' ' 56' ' ' SER . 0.0 OUTLIER 178.48 105.25 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.826 0.346 . . . . 0.0 110.134 179.921 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.445 ' CD2' HD23 ' A' ' 60' ' ' LEU . 8.8 p-80 -50.11 119.37 3.57 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.462 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 117.68 -32.06 5.5 Favored Glycine 0 CA--C 1.522 0.53 0 N-CA-C 110.565 -1.014 . . . . 0.0 110.565 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -78.75 174.14 11.75 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.765 0.317 . . . . 0.0 110.16 179.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -129.07 26.44 5.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.5 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -159.92 145.26 15.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.457 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.483 ' CZ3' ' HG2' ' A' ' 67' ' ' ARG . 71.3 m95 -80.69 154.11 27.5 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.194 179.83 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.43 ' CG2' ' O ' ' A' ' 42' ' ' VAL . 29.7 m -115.47 105.42 18.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.957 0.408 . . . . 0.0 110.327 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.437 ' HA ' ' CB ' ' A' ' 32' ' ' GLU . . . -52.35 136.66 30.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.394 -179.819 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -71.69 -171.16 0.63 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.804 -179.801 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 47.5 m -144.55 111.4 5.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.557 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.483 ' HG2' ' CZ3' ' A' ' 52' ' ' TRP . 31.8 mtpt -77.06 95.27 4.16 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.042 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -128.86 -38.96 0.33 Allowed Glycine 0 CA--C 1.525 0.696 0 N-CA-C 111.437 -0.665 . . . . 0.0 111.437 -179.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.404 ' HB2' ' O ' ' A' ' 51' ' ' VAL . 0.0 OUTLIER -52.68 -175.32 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.99 0.424 . . . . 0.0 110.425 -179.741 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -104.01 41.69 2.08 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 145.59 -10.8 1.71 Allowed Glycine 0 CA--C 1.529 0.921 0 C-N-CA 121.015 -0.612 . . . . 0.0 112.428 179.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.408 ' CG2' ' OE1' ' A' ' 9' ' ' GLU . 33.5 m -133.21 175.02 12.34 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.137 0 CA-C-N 117.709 0.754 . . . . 0.0 110.844 -179.627 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . 0.483 ' CZ3' ' HG2' ' A' ' 46' ' ' LYS . 6.9 m95 -106.93 139.94 40.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.572 -179.576 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.6 p -122.4 135.52 54.71 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.359 179.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 1.3 t80 175.05 96.94 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.501 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.423 ' HB2' ' N ' ' A' ' 16' ' ' HIS . 6.0 t0 -99.62 31.03 3.34 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-O 121.43 0.634 . . . . 0.0 110.138 179.396 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.41 ' OG ' ' N ' ' A' ' 57' ' ' GLU . 44.9 t 45.91 -172.93 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 114.928 -1.033 . . . . 0.0 110.98 179.574 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.41 ' N ' ' OG ' ' A' ' 56' ' ' SER . 1.5 mt-10 -100.75 -46.86 5.02 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.225 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -64.03 116.42 27.11 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.451 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -68.33 59.6 1.03 Allowed 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.724 2.282 . . . . 0.0 112.333 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.445 HD23 ' CD2' ' A' ' 36' ' ' HIS . 1.6 mt -94.0 92.51 7.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.845 0.355 . . . . 0.0 110.322 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -77.0 78.38 3.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.469 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -145.93 -162.04 9.52 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.816 -0.913 . . . . 0.0 110.816 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -76.17 128.91 10.9 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.59 2.194 . . . . 0.0 112.075 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.437 ' HB3' ' CD2' ' A' ' 33' ' ' LEU . 27.4 m-85 -88.29 -178.27 5.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.976 0.417 . . . . 0.0 110.554 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.419 ' HB2' ' CB ' ' A' ' 34' ' ' ARG . 2.9 m-80 -153.55 137.65 16.44 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.631 179.75 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.489 ' CE2' ' HG ' ' A' ' 33' ' ' LEU . 80.8 m-85 -121.79 -178.36 3.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.045 0.45 . . . . 0.0 110.97 -179.642 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.483 ' HG2' ' CZ3' ' A' ' 41' ' ' TRP . 0.0 OUTLIER 175.65 47.79 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.656 179.997 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -48.63 172.57 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.108 -179.245 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.403 ' O ' ' CB ' ' A' ' 29' ' ' ALA . 4.9 mt -122.28 72.51 1.06 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.446 179.753 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.414 ' OG1' ' N ' ' A' ' 74' ' ' MET . 0.2 OUTLIER -37.98 142.14 0.18 Allowed 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.685 -179.254 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.446 ' HG2' ' CB ' ' A' ' 29' ' ' ALA . 3.1 mm-40 -51.57 -67.31 0.26 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.725 -179.742 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.79 31.38 5.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.733 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -106.34 -100.52 2.66 Favored Glycine 0 CA--C 1.523 0.547 0 N-CA-C 110.655 -0.978 . . . . 0.0 110.655 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.414 ' N ' ' OG1' ' A' ' 70' ' ' THR . 0.0 OUTLIER 177.52 141.51 0.08 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.853 0.358 . . . . 0.0 110.361 179.958 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.401 ' HG3' ' HA ' ' A' ' 69' ' ' LEU . 0.0 OUTLIER -70.31 178.66 2.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.254 -179.982 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.466 ' O ' ' CE2' ' A' ' 78' ' ' PHE . 0.5 OUTLIER 170.04 131.79 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.582 179.92 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 79.7 t -85.18 150.61 3.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.111 -0.495 . . . . 0.0 109.928 179.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.483 ' CZ ' HG23 ' A' ' 4' ' ' VAL . 61.3 m-85 -137.74 128.33 26.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.882 0.372 . . . . 0.0 110.645 -179.835 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -107.67 156.54 18.96 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.214 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 28.0 t70 51.97 52.81 13.68 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.34 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 85.7 t -85.76 -24.6 6.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.577 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.407 ' CG1' ' HD2' ' A' ' 83' ' ' PRO . 46.3 t -138.87 138.56 21.65 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.579 -179.832 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.48 ' HG3' ' CE1' ' A' ' 92' ' ' TYR . 49.3 Cg_endo -72.09 -166.88 0.28 Allowed 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.619 2.212 . . . . 0.0 111.979 179.621 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.66 -78.47 0.07 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.044 179.67 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.411 ' CG ' ' O ' ' A' ' 85' ' ' LYS . 0.0 OUTLIER -91.9 71.36 5.61 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.001 179.589 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 19.0 p90 -47.93 150.48 1.12 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.776 -179.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 1.2 m -117.63 115.56 25.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.291 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.438 ' CG2' ' HA ' ' A' ' 10' ' ' LYS . 42.3 mm -51.94 110.22 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.27 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 114.32 32.33 2.0 Favored Glycine 0 CA--C 1.523 0.552 0 N-CA-C 110.771 -0.932 . . . . 0.0 110.771 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.404 ' HB2' ' CZ ' ' A' ' 92' ' ' TYR . . . -124.35 164.37 19.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.757 0.313 . . . . 0.0 110.398 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 6.9 m -119.68 89.93 3.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.66 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.48 ' CE1' ' HG3' ' A' ' 83' ' ' PRO . 34.5 m-85 -89.03 -161.5 0.77 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.912 179.669 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.446 ' CB ' ' HD2' ' A' ' 94' ' ' PRO . . . 72.26 176.96 0.06 OUTLIER Pre-proline 0 C--N 1.332 -0.173 0 CA-C-O 120.614 0.245 . . . . 0.0 110.461 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.446 ' HD2' ' CB ' ' A' ' 93' ' ' ALA . 48.7 Cg_endo . . . . . 0 C--O 1.249 1.042 0 C-N-CA 122.506 2.137 . . . . 0.0 112.071 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 27.2 t . . . . . 0 N--CA 1.489 1.519 0 N-CA-C 110.175 -0.305 . . . . 0.0 110.175 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -77.22 105.5 2.07 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.576 2.184 . . . . 0.0 112.113 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 3.9 tttt -133.12 94.37 3.34 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.242 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.438 HG23 ' CE1' ' A' ' 78' ' ' PHE . 27.0 m -80.38 -178.26 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.509 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -170.96 139.71 1.46 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.242 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.574 ' CE2' ' CD2' ' A' ' 66' ' ' PHE . 29.5 m-85 -113.65 168.91 9.37 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.492 -179.81 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 19.1 m -165.57 118.59 1.16 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.381 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.417 ' CG1' HG13 ' A' ' 88' ' ' ILE . 62.6 t -61.65 102.57 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.335 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.432 ' HG3' ' CG2' ' A' ' 51' ' ' VAL . 1.8 mm-40 -70.11 174.67 5.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.502 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.4 mttt -83.17 64.48 7.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.556 -179.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -156.44 33.25 0.59 Allowed Glycine 0 CA--C 1.522 0.506 0 N-CA-C 110.457 -1.057 . . . . 0.0 110.457 179.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.3 p -89.82 114.97 26.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.873 0.368 . . . . 0.0 110.593 -179.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 13.8 m-20 -104.23 -156.05 0.56 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.081 -0.508 . . . . 0.0 109.933 179.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -46.35 -63.98 0.87 Allowed 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 120.846 0.355 . . . . 0.0 110.777 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.87 -22.68 9.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.906 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 28.8 m80 -48.84 136.51 13.81 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.96 0.41 . . . . 0.0 110.884 -179.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -129.05 95.79 4.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.651 179.629 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -90.58 128.31 36.54 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.683 -179.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.408 ' N ' ' CG1' ' A' ' 51' ' ' VAL . 15.3 m -134.26 133.96 55.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.202 179.627 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -83.83 71.93 10.42 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.384 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.424 HG21 ' CD2' ' A' ' 6' ' ' PHE . 61.4 t -70.93 95.14 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.286 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 5.4 tttp -135.62 141.59 45.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.41 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -163.36 149.65 11.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.39 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -76.42 -22.23 54.95 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.743 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -46.91 -50.17 15.8 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 111.081 -0.807 . . . . 0.0 111.081 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -138.04 -174.69 3.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.776 0.322 . . . . 0.0 110.304 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 27.2 m -121.65 54.68 1.13 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.796 -179.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.447 ' O ' ' CB ' ' A' ' 29' ' ' ALA . 33.7 mtm 58.35 -164.11 0.2 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.786 179.55 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.447 ' CB ' ' O ' ' A' ' 28' ' ' MET . . . 154.24 -62.59 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.367 0.667 . . . . 0.0 109.682 179.722 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -160.75 141.17 11.4 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.817 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.411 ' HA ' ' HA ' ' A' ' 68' ' ' PHE . 4.2 t -134.72 156.39 39.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.973 0.416 . . . . 0.0 110.754 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.439 ' CB ' ' HA ' ' A' ' 43' ' ' ALA . 3.1 pt-20 -154.15 157.73 39.31 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.979 179.775 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.6 mt -125.16 -176.54 3.6 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.457 -179.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.483 ' HD2' ' CG ' ' A' ' 41' ' ' TRP . 5.6 ttt180 -145.71 174.24 11.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.075 179.686 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -154.27 93.76 1.65 Allowed 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -40.25 116.07 0.62 Allowed 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.389 -178.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 123.75 -25.41 6.19 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 110.466 -1.054 . . . . 0.0 110.466 -179.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 4.3 m -75.95 -161.34 0.17 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.81 0.338 . . . . 0.0 110.39 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -83.11 -65.81 0.96 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.528 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -153.18 -176.93 6.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.619 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.485 ' CH2' ' HG3' ' A' ' 67' ' ' ARG . 87.0 m95 -50.72 150.66 2.73 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.602 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.431 HG22 ' CE1' ' A' ' 54' ' ' PHE . 10.5 m -131.62 131.91 62.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.139 179.718 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.439 ' HA ' ' CB ' ' A' ' 32' ' ' GLU . . . -57.22 147.23 25.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.569 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.403 ' N ' ' HA ' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -72.61 -166.04 0.25 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.993 179.855 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 90.0 m -154.05 112.61 3.62 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.837 0.351 . . . . 0.0 110.686 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 9.2 ptpt -68.92 69.55 0.18 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.193 -0.458 . . . . 0.0 109.97 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -90.47 -26.41 23.17 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 111.296 -0.722 . . . . 0.0 111.296 -179.491 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.424 ' CG ' ' HB ' ' A' ' 51' ' ' VAL . 5.4 tm-20 -78.45 -14.84 59.18 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.761 0.28 . . . . 0.0 111.222 -179.728 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 99.74 -41.39 2.19 Favored Glycine 0 CA--C 1.522 0.518 0 N-CA-C 109.976 -1.25 . . . . 0.0 109.976 -179.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.438 ' O ' ' CZ3' ' A' ' 52' ' ' TRP . . . -126.61 -45.25 0.23 Allowed Glycine 0 CA--C 1.519 0.287 0 N-CA-C 109.075 -1.61 . . . . 0.0 109.075 179.107 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.432 ' CG2' ' HG3' ' A' ' 9' ' ' GLU . 19.6 t -82.57 151.36 4.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 178.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . 0.438 ' CZ3' ' O ' ' A' ' 50' ' ' GLY . 4.1 m95 -93.05 114.77 27.4 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.996 0.427 . . . . 0.0 110.187 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.8 p -108.07 137.58 45.82 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.286 -179.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.431 ' CE1' HG22 ' A' ' 42' ' ' VAL . 51.2 t80 -120.34 142.79 48.81 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.686 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -99.94 109.38 21.74 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.061 179.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 27.6 p -89.83 158.95 17.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.558 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -134.3 -44.52 0.77 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.42 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -51.88 156.57 2.44 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.395 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -67.88 -34.55 23.49 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.795 2.33 . . . . 0.0 112.433 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 2.2 mt -69.85 151.45 45.69 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.835 -179.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -174.1 72.9 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.22 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -128.44 -96.76 0.87 Allowed Glycine 0 CA--C 1.525 0.687 0 N-CA-C 110.814 -0.914 . . . . 0.0 110.814 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -77.18 97.77 1.17 Allowed 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.587 2.191 . . . . 0.0 112.205 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -73.51 166.47 23.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.588 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.401 ' HB2' ' HB3' ' A' ' 34' ' ' ARG . 0.2 OUTLIER -135.81 122.99 21.64 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 179.227 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.574 ' CD2' ' CE2' ' A' ' 6' ' ' PHE . 2.8 m-85 -105.84 177.88 4.72 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.303 0.573 . . . . 0.0 112.081 -178.569 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.485 ' HG3' ' CH2' ' A' ' 41' ' ' TRP . 7.2 mtp180 -177.56 96.84 0.04 OUTLIER 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 114.877 -1.056 . . . . 0.0 110.287 179.45 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.44 ' CE2' ' CE2' ' A' ' 78' ' ' PHE . 6.0 p90 -91.73 168.13 11.68 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-O 121.151 0.5 . . . . 0.0 110.455 179.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.428 ' O ' ' CB ' ' A' ' 29' ' ' ALA . 5.7 mt -136.28 65.23 1.53 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.641 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 26.8 p -33.5 150.09 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 115.899 -0.591 . . . . 0.0 112.048 -179.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.438 ' CG ' ' O ' ' A' ' 28' ' ' MET . 7.8 mt-10 -49.21 -30.43 7.0 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.333 -179.729 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -69.19 -46.56 67.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.377 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 118.72 43.29 0.54 Allowed Glycine 0 CA--C 1.523 0.557 0 N-CA-C 110.69 -0.964 . . . . 0.0 110.69 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 12.1 mtp -105.61 108.1 19.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.833 0.349 . . . . 0.0 110.448 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.8 149.55 21.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.349 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -177.69 125.13 0.13 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.594 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.447 HG13 ' CZ2' ' A' ' 41' ' ' TRP . 4.5 m -81.99 176.56 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.591 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.44 ' CE2' ' CE2' ' A' ' 68' ' ' PHE . 97.3 m-85 -156.79 112.82 2.97 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.3 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -98.18 158.17 15.72 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.463 -179.759 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 47.1 m-20 59.16 28.53 17.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.557 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 74.3 t -61.17 -75.97 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.434 ' CG1' ' HD2' ' A' ' 83' ' ' PRO . 59.8 t -87.18 139.57 32.33 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.427 -0.352 . . . . 0.0 110.289 179.613 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.434 ' HD2' ' CG1' ' A' ' 82' ' ' VAL . 45.8 Cg_endo -70.5 -167.77 0.27 Allowed 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.595 2.197 . . . . 0.0 112.022 179.765 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.41 ' HG3' ' N ' ' A' ' 85' ' ' LYS . 4.3 pt-20 -83.84 -28.19 28.2 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.23 179.828 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.41 ' N ' ' HG3' ' A' ' 84' ' ' GLU . 0.0 OUTLIER -132.07 63.48 1.62 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.136 179.755 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 51.9 p90 -48.66 148.68 1.99 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.789 -179.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 37.0 m -128.18 113.27 15.49 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.271 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.417 HG13 ' CG1' ' A' ' 8' ' ' VAL . 3.0 mp -51.37 104.46 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.248 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 125.4 47.44 0.22 Allowed Glycine 0 CA--C 1.524 0.598 0 N-CA-C 110.707 -0.957 . . . . 0.0 110.707 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -167.48 175.07 7.4 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.754 0.311 . . . . 0.0 110.365 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 5.1 m -113.32 141.56 46.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.484 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 -141.51 109.18 5.65 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.33 179.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.44 ' CB ' ' HD2' ' A' ' 94' ' ' PRO . . . 170.59 177.49 0.1 OUTLIER Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.406 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.44 ' HD2' ' CB ' ' A' ' 93' ' ' ALA . 48.2 Cg_endo . . . . . 0 C--O 1.249 1.031 0 C-N-CA 122.533 2.156 . . . . 0.0 112.097 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 9.9 p . . . . . 0 N--CA 1.494 1.744 0 N-CA-C 110.24 -0.282 . . . . 0.0 110.24 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -73.37 98.49 1.03 Allowed 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.331 2.021 . . . . 0.0 112.059 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 2.3 tttp -171.35 106.58 0.24 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.35 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.536 ' CG1' ' CE1' ' A' ' 78' ' ' PHE . 1.7 p -116.87 163.67 13.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.232 0.539 . . . . 0.0 110.397 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.466 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 0.6 OUTLIER -132.92 139.5 47.39 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.205 179.838 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.545 ' CE2' ' CD1' ' A' ' 66' ' ' PHE . 32.3 m-85 -98.26 -176.43 3.41 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.298 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.9 m -167.5 112.96 0.72 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.369 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 45.2 t -66.26 101.84 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.309 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.401 ' HG3' HG13 ' A' ' 51' ' ' VAL . 0.7 OUTLIER -54.39 -178.16 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.6 -179.79 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -94.24 46.96 1.17 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.269 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -133.56 23.82 3.76 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 110.895 -0.882 . . . . 0.0 110.895 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 7.9 m -86.65 106.04 17.33 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.782 0.325 . . . . 0.0 110.285 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 20.7 m-20 -100.61 -158.38 0.67 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.371 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -45.76 -62.26 1.38 Allowed 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.076 -179.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.98 19.12 11.7 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.005 -179.824 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 6.7 m80 -100.5 130.77 46.62 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.826 0.346 . . . . 0.0 110.088 179.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.44 ' HG ' ' CE2' ' A' ' 64' ' ' PHE . 0.5 OUTLIER -122.57 90.69 3.35 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.452 -179.628 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -88.67 130.75 35.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.162 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.449 HG22 ' CZ ' ' A' ' 66' ' ' PHE . 25.8 m -129.87 152.3 37.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.555 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.428 ' CD2' ' HG2' ' A' ' 22' ' ' LYS . 0.4 OUTLIER -104.06 98.58 8.38 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.081 179.803 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 25.1 t -98.83 99.09 7.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.808 -179.55 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.428 ' HG2' ' CD2' ' A' ' 20' ' ' LEU . 0.0 OUTLIER 175.84 160.18 0.28 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.259 179.698 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -159.8 47.93 0.28 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.338 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 52.43 178.89 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.506 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 66.29 -82.06 0.1 Allowed Glycine 0 CA--C 1.523 0.547 0 N-CA-C 110.832 -0.907 . . . . 0.0 110.832 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 36.3 m-20 -64.71 167.91 6.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.821 0.343 . . . . 0.0 110.397 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -111.7 -160.05 0.7 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.275 -179.836 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.421 ' O ' ' CG ' ' A' ' 71' ' ' GLU . 6.2 mtt -121.05 125.5 47.46 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.925 0.393 . . . . 0.0 110.631 -179.878 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.424 ' CB ' ' O ' ' A' ' 69' ' ' LEU . . . -115.37 -57.62 2.23 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.4 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -165.86 177.67 7.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.143 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.489 HG12 ' CD1' ' A' ' 52' ' ' TRP . 0.5 OUTLIER 172.17 137.88 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 121.111 0.481 . . . . 0.0 110.251 -179.899 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -128.43 163.24 25.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.083 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.495 ' HG ' ' CE2' ' A' ' 66' ' ' PHE . 1.6 mt -109.49 163.57 13.31 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.055 0.455 . . . . 0.0 111.002 -179.543 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.454 ' HG3' ' CD2' ' A' ' 41' ' ' TRP . 0.7 OUTLIER -139.81 -163.39 1.49 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.688 179.375 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -153.42 -87.41 0.06 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.323 179.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.413 ' CG ' ' N ' ' A' ' 37' ' ' GLY . 48.0 p-80 -179.22 -47.19 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 120.83 0.348 . . . . 0.0 110.617 -179.858 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.413 ' N ' ' CG ' ' A' ' 36' ' ' HIS . . . -110.58 23.67 19.45 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 110.735 -0.946 . . . . 0.0 110.735 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.428 ' O ' ' CB ' ' A' ' 39' ' ' ASP . 1.9 t -86.11 -7.42 58.6 Favored 'General case' 0 C--N 1.33 -0.244 0 O-C-N 122.9 -0.176 . . . . 0.0 111.285 -179.797 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.428 ' CB ' ' O ' ' A' ' 38' ' ' SER . 0.8 OUTLIER 82.43 -51.76 0.2 Allowed 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 122.447 0.299 . . . . 0.0 110.9 179.942 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -142.42 177.88 7.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.915 0.388 . . . . 0.0 110.882 -179.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.47 ' CE2' ' HD2' ' A' ' 67' ' ' ARG . 60.3 m95 -78.55 166.53 22.46 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.443 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 20.6 m -141.51 119.13 8.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.234 179.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -50.66 133.73 25.34 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.576 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.424 ' HE3' ' CD1' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -63.04 -171.0 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.547 179.942 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 66.3 m -145.75 99.46 3.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.574 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 2.8 ptmt -61.17 94.37 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.35 179.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -132.3 14.79 5.07 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 111.19 -0.764 . . . . 0.0 111.19 179.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.408 ' CB ' HG21 ' A' ' 51' ' ' VAL . 0.1 OUTLIER -102.83 -14.17 16.7 Favored 'General case' 0 C--N 1.333 -0.152 0 O-C-N 122.719 -0.283 . . . . 0.0 110.986 179.96 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 66.1 26.16 72.36 Favored Glycine 0 CA--C 1.523 0.539 0 N-CA-C 110.42 -1.072 . . . . 0.0 110.42 -179.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -174.64 -39.42 0.05 OUTLIER Glycine 0 CA--C 1.523 0.591 0 N-CA-C 110.53 -1.028 . . . . 0.0 110.53 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.408 HG21 ' CB ' ' A' ' 48' ' ' GLU . 3.1 m -133.1 -177.16 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.922 0.391 . . . . 0.0 110.363 179.87 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . 0.489 ' CD1' HG12 ' A' ' 31' ' ' VAL . 7.6 m95 -101.38 141.46 34.22 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.605 -179.558 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -133.87 147.47 51.16 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.471 -179.757 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 75.7 t80 -130.98 112.49 12.99 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.407 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -71.58 161.91 30.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.411 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -146.56 170.81 16.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.114 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -146.31 -50.14 0.21 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.51 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -55.35 153.09 14.52 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.443 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -71.94 -50.15 0.28 Allowed 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 122.659 2.239 . . . . 0.0 112.136 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -57.91 130.99 49.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.687 -179.862 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 174.92 159.31 0.19 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.277 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -177.27 -99.77 0.13 Allowed Glycine 0 CA--C 1.526 0.76 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -75.32 157.47 41.43 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.569 2.18 . . . . 0.0 112.135 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.44 ' CE2' ' HG ' ' A' ' 17' ' ' LEU . 72.8 m-85 -124.27 -177.73 3.88 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.093 0.473 . . . . 0.0 110.845 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -153.33 130.42 11.1 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.636 179.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.545 ' CD1' ' CE2' ' A' ' 6' ' ' PHE . 80.8 m-85 -114.07 178.98 4.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.14 0.495 . . . . 0.0 110.838 -179.561 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.47 ' HD2' ' CE2' ' A' ' 41' ' ' TRP . 17.1 ptm180 -176.83 59.15 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.656 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.433 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -54.89 178.54 0.03 OUTLIER 'General case' 0 CA--C 1.518 -0.28 0 CA-C-O 121.388 0.613 . . . . 0.0 111.492 -179.21 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.424 ' O ' ' CB ' ' A' ' 29' ' ' ALA . 7.1 mt -144.64 48.39 1.34 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.107 -0.951 . . . . 0.0 109.182 179.78 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.1 p -25.46 137.12 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.88 0.872 . . . . 0.0 112.741 -179.007 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.421 ' CG ' ' O ' ' A' ' 28' ' ' MET . 6.3 mt-10 -49.62 -59.03 4.15 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.507 -179.69 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 3.6 tmtt? -123.66 58.91 1.13 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.314 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -141.4 -101.63 0.45 Allowed Glycine 0 CA--C 1.522 0.516 0 N-CA-C 110.77 -0.932 . . . . 0.0 110.77 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.6 ptm -173.46 -178.43 1.67 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.709 0.29 . . . . 0.0 110.297 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.86 158.12 45.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.52 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 174.05 128.43 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.266 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.466 HG13 ' CZ2' ' A' ' 41' ' ' TRP . 17.6 m -68.71 140.72 18.49 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.473 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.536 ' CE1' ' CG1' ' A' ' 4' ' ' VAL . 79.6 m-85 -116.81 121.53 41.81 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.311 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 26.1 m-20 -101.64 141.09 35.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.569 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 17.1 t0 60.13 60.84 1.98 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.604 179.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.456 HG12 ' CD1' ' A' ' 6' ' ' PHE . 75.7 t -89.44 -65.57 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 179.695 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.437 ' CG1' ' HD2' ' A' ' 83' ' ' PRO . 60.8 t -87.83 139.83 31.17 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.388 179.78 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.469 ' HD3' ' CG ' ' A' ' 92' ' ' TYR . 47.8 Cg_endo -71.88 173.47 12.71 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.61 2.207 . . . . 0.0 112.071 179.83 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -55.54 -51.21 67.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.098 179.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 5.3 mttt -114.78 87.08 2.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.115 179.655 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . 0.42 ' HB3' ' CG1' ' A' ' 82' ' ' VAL . 28.1 p90 -65.94 164.47 15.01 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.579 -179.799 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 7.4 m -145.43 112.76 6.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.261 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 2.5 mp -50.81 98.64 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.457 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 132.03 54.63 0.08 OUTLIER Glycine 0 CA--C 1.523 0.587 0 N-CA-C 110.781 -0.927 . . . . 0.0 110.781 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.461 ' HB2' ' CZ ' ' A' ' 92' ' ' TYR . . . -172.6 -177.75 1.79 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.816 0.341 . . . . 0.0 110.398 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.434 ' CG2' ' HB ' ' A' ' 5' ' ' THR . 4.1 m -124.97 142.55 51.41 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.375 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.469 ' CG ' ' HD3' ' A' ' 83' ' ' PRO . 4.7 m-85 -146.76 123.59 11.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.359 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.452 ' CB ' ' CD ' ' A' ' 94' ' ' PRO . . . 174.93 178.88 0.18 Allowed Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.41 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.452 ' CD ' ' CB ' ' A' ' 93' ' ' ALA . 47.7 Cg_endo . . . . . 0 C--O 1.249 1.031 0 C-N-CA 122.488 2.125 . . . . 0.0 112.099 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 1.6 m . . . . . 0 N--CA 1.49 1.525 0 N-CA-C 110.121 -0.326 . . . . 0.0 110.121 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -76.39 80.38 2.75 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.584 2.189 . . . . 0.0 112.096 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 7.6 ttpt -126.98 59.94 1.39 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.165 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.484 HG13 ' CZ ' ' A' ' 78' ' ' PHE . 2.4 p -74.75 162.99 4.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.368 0.604 . . . . 0.0 110.552 -179.85 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.459 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 1.8 p -139.6 148.79 42.98 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.133 -0.94 . . . . 0.0 110.124 179.672 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 48.2 m-85 -123.5 145.05 49.15 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.111 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.411 ' O ' ' N ' ' A' ' 20' ' ' LEU . 3.8 m -148.36 129.78 14.81 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.152 -179.88 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 96.1 t -73.21 101.16 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.401 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.412 ' N ' ' O ' ' A' ' 18' ' ' ALA . 6.5 mt-10 -59.1 165.15 2.65 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.485 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.77 65.4 3.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.286 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -154.91 33.44 0.67 Allowed Glycine 0 CA--C 1.524 0.615 0 N-CA-C 110.812 -0.915 . . . . 0.0 110.812 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 21.2 p -82.03 130.08 34.98 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 110.211 -0.292 . . . . 0.0 110.211 179.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 6.2 m-80 -112.44 -161.97 0.78 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.518 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -49.76 -71.06 0.07 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.145 -179.461 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 41.5 pttt -117.99 40.95 3.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.841 -179.328 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 9.0 m80 -113.83 178.95 4.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.4 179.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 43.7 tp -165.15 94.25 0.64 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.419 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.412 ' O ' ' N ' ' A' ' 9' ' ' GLU . . . -91.58 107.47 19.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.372 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.432 HG22 ' CG2' ' A' ' 21' ' ' VAL . 17.1 m -90.72 -173.55 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.286 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.411 ' N ' ' O ' ' A' ' 7' ' ' THR . 2.1 tt -135.11 78.15 1.72 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.502 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.432 ' CG2' HG22 ' A' ' 19' ' ' VAL . 16.0 t -86.23 100.63 9.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.295 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 17.1 tptt -176.11 124.73 0.19 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.548 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 42.6 p90 -156.98 174.29 15.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.251 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -64.21 119.65 10.64 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.495 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 122.07 -65.73 0.49 Allowed Glycine 0 CA--C 1.523 0.557 0 N-CA-C 110.921 -0.872 . . . . 0.0 110.921 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.411 ' OD1' ' CG2' ' A' ' 70' ' ' THR . 32.4 t0 -66.83 137.47 56.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.824 0.345 . . . . 0.0 110.577 -179.79 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.45 ' CG2' ' O ' ' A' ' 27' ' ' THR . 60.2 m -111.38 18.22 19.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.815 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.418 ' O ' ' CG ' ' A' ' 71' ' ' GLU . 19.7 mtp 59.55 114.79 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.797 0.332 . . . . 0.0 110.604 179.777 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.431 ' CB ' ' O ' ' A' ' 69' ' ' LEU . . . -134.53 -58.86 0.82 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.309 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -155.93 153.35 29.47 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.92 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.486 HG12 ' CD1' ' A' ' 52' ' ' TRP . 0.6 OUTLIER -172.43 148.0 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.386 0.612 . . . . 0.0 110.627 -179.713 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.413 ' N ' HG21 ' A' ' 31' ' ' VAL . 2.2 pt-20 -142.22 178.86 7.27 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.065 -0.97 . . . . 0.0 109.688 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.506 ' HG ' ' CE2' ' A' ' 66' ' ' PHE . 4.4 mt -122.87 176.74 5.82 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.133 0.492 . . . . 0.0 111.031 -179.559 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 4.8 ttp180 -145.27 -175.46 4.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.673 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.416 ' CG ' ' HG2' ' A' ' 58' ' ' GLU . 4.9 mm-40 -151.58 29.93 0.6 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.722 0.296 . . . . 0.0 110.81 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER 56.58 164.53 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.555 179.615 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 51.99 25.08 16.09 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 110.887 -0.885 . . . . 0.0 110.887 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -135.91 109.84 8.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.857 0.36 . . . . 0.0 110.356 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -61.54 -22.54 65.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.654 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -100.2 176.52 5.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.914 0.388 . . . . 0.0 110.558 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.483 ' CE3' ' HG2' ' A' ' 67' ' ' ARG . 62.3 m95 -123.26 157.46 33.08 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.072 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.415 ' CG2' ' O ' ' A' ' 33' ' ' LEU . 4.5 m -107.25 105.89 19.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.946 0.403 . . . . 0.0 110.504 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -54.08 121.75 8.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.771 -179.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.88 -169.87 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.267 179.729 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 47.5 m -147.61 105.19 3.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.703 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 14.9 ptmt -62.67 82.92 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 179.509 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -109.72 -25.45 5.43 Favored Glycine 0 CA--C 1.522 0.484 0 N-CA-C 111.067 -0.813 . . . . 0.0 111.067 -179.425 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.434 ' HG2' ' CG2' ' A' ' 51' ' ' VAL . 1.1 tp10 -77.57 -41.04 40.29 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.774 0.321 . . . . 0.0 110.458 -179.776 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 99.42 -44.19 1.71 Allowed Glycine 0 CA--C 1.522 0.482 0 N-CA-C 110.168 -1.173 . . . . 0.0 110.168 -179.487 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -92.49 -29.7 10.72 Favored Glycine 0 CA--C 1.522 0.494 0 N-CA-C 110.208 -1.157 . . . . 0.0 110.208 179.516 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.434 ' CG2' ' HG2' ' A' ' 48' ' ' GLU . 3.5 m -140.41 -176.81 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.895 0.379 . . . . 0.0 110.283 179.65 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . 0.486 ' CD1' HG12 ' A' ' 31' ' ' VAL . 9.5 m95 -106.43 134.42 49.6 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.837 -179.206 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 4.9 p -117.09 145.81 43.52 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.225 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.476 ' CE2' ' HB2' ' A' ' 56' ' ' SER . 85.2 t80 -131.5 138.9 49.16 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.329 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -122.73 134.08 54.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.524 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.476 ' HB2' ' CE2' ' A' ' 54' ' ' PHE . 0.3 OUTLIER -175.31 177.89 1.78 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.396 -179.972 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -155.79 26.88 0.38 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.404 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.416 ' HG2' ' CG ' ' A' ' 35' ' ' GLU . 0.0 OUTLIER -49.22 169.41 0.17 Allowed Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.636 -179.935 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.407 ' CD ' ' HB2' ' A' ' 58' ' ' GLU . 37.8 Cg_endo -93.92 20.09 0.71 Allowed 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 123.851 3.034 . . . . 0.0 112.243 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.6 mt -110.06 51.42 0.76 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.391 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 6.4 mm100 -60.13 121.19 11.3 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.292 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 169.32 -142.76 7.53 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 110.762 -0.935 . . . . 0.0 110.762 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -75.95 169.96 21.09 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.57 2.18 . . . . 0.0 111.975 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -118.26 169.65 9.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.377 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -141.74 134.33 28.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.005 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.506 ' CE2' ' HG ' ' A' ' 33' ' ' LEU . 72.9 m-85 -119.1 179.61 4.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.044 0.449 . . . . 0.0 110.697 -179.808 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.483 ' HG2' ' CE3' ' A' ' 41' ' ' TRP . 0.0 OUTLIER -176.19 60.75 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.683 -0.689 . . . . 0.0 109.71 179.629 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.407 ' HA ' ' HA ' ' A' ' 31' ' ' VAL . 4.6 p90 -56.04 179.44 0.04 OUTLIER 'General case' 0 CA--C 1.519 -0.23 0 CA-C-O 121.263 0.554 . . . . 0.0 111.16 -179.3 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.431 ' O ' ' CB ' ' A' ' 29' ' ' ALA . 6.0 mt -141.7 67.08 1.34 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.245 -0.889 . . . . 0.0 109.179 179.737 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.411 ' CG2' ' OD1' ' A' ' 26' ' ' ASP . 69.9 p -33.03 140.73 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 115.908 -0.587 . . . . 0.0 112.293 -178.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.418 ' CG ' ' O ' ' A' ' 28' ' ' MET . 7.1 mm-40 -53.07 -57.9 8.83 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.567 -179.825 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.09 81.74 2.04 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.506 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -175.7 -95.4 0.1 OUTLIER Glycine 0 CA--C 1.523 0.562 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 16.6 ptm 179.84 -177.53 0.37 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.869 0.366 . . . . 0.0 110.275 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.63 179.82 3.84 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.262 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 177.9 139.87 0.08 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.625 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 87.3 t -89.5 157.38 3.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.131 179.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.484 ' CZ ' HG13 ' A' ' 4' ' ' VAL . 78.8 m-85 -146.34 137.91 24.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.873 0.368 . . . . 0.0 110.539 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 29.5 p-10 -116.1 159.52 21.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.255 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 56.99 45.75 20.62 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.316 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.428 ' O ' ' CG1' ' A' ' 81' ' ' VAL . 60.3 t -94.17 8.08 5.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.104 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.427 ' CG2' ' O ' ' A' ' 81' ' ' VAL . 72.9 t -158.47 129.93 3.91 Favored Pre-proline 0 CA--C 1.53 0.18 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 179.693 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.437 ' HD3' ' CD1' ' A' ' 92' ' ' TYR . 47.6 Cg_endo -74.88 -169.47 0.63 Allowed 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.352 2.035 . . . . 0.0 112.08 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -77.41 -30.81 53.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.252 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 36.3 mttt -132.74 72.92 1.5 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.333 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 50.3 p90 -53.24 149.49 7.13 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.528 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 4.9 t -128.08 115.24 18.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.289 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 3.4 mp -48.93 110.51 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.616 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 110.04 58.03 0.51 Allowed Glycine 0 CA--C 1.523 0.568 0 N-CA-C 110.712 -0.955 . . . . 0.0 110.712 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -176.28 139.78 0.36 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.805 0.336 . . . . 0.0 110.395 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 57.5 m -89.4 123.05 33.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.284 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.437 ' CD1' ' HD3' ' A' ' 83' ' ' PRO . 5.7 m-85 -101.95 -34.68 9.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.636 -179.633 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.448 ' CB ' ' CD ' ' A' ' 94' ' ' PRO . . . -50.02 178.94 0.04 OUTLIER Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.654 -179.782 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.448 ' CD ' ' CB ' ' A' ' 93' ' ' ALA . 48.5 Cg_endo . . . . . 0 C--O 1.249 1.036 0 C-N-CA 122.661 2.241 . . . . 0.0 112.19 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 27.4 m . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 120.705 0.288 . . . . 0.0 110.242 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -76.41 123.2 6.94 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.66 2.24 . . . . 0.0 112.116 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 46.49 93.38 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.977 179.534 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.48 HG23 ' CE1' ' A' ' 78' ' ' PHE . 29.8 m -53.52 171.66 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.205 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 15.0 p -153.15 127.45 9.19 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.385 179.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.426 ' O ' ' CG2' ' A' ' 91' ' ' THR . 45.4 m-85 -84.74 -173.08 4.53 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.938 179.821 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -165.03 117.36 1.19 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.976 0.417 . . . . 0.0 111.028 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.434 ' CG2' ' HA ' ' A' ' 88' ' ' ILE . 14.3 p -49.85 129.31 7.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.423 179.546 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.421 ' HG3' ' CG1' ' A' ' 51' ' ' VAL . 8.9 mm-40 -116.95 163.33 16.37 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.355 179.785 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -50.37 -24.5 3.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.9 -179.538 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.416 ' O ' ' ND2' ' A' ' 13' ' ' ASN . . . -45.95 -27.52 2.45 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 111.12 -0.792 . . . . 0.0 111.12 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.4 m -72.68 115.55 12.1 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 179.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.416 ' ND2' ' O ' ' A' ' 11' ' ' GLY . 5.4 m-80 -115.59 -68.43 0.92 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.41 -179.753 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -125.82 -66.91 0.91 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.126 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.26 27.05 9.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.139 179.759 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 58.1 m80 -109.75 145.66 36.25 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.391 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.464 HD12 ' CD2' ' A' ' 64' ' ' PHE . 8.7 mt -125.93 89.47 3.03 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.957 0.408 . . . . 0.0 110.272 179.766 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.403 ' HB2' ' HB2' ' A' ' 9' ' ' GLU . . . -82.96 143.9 30.36 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.841 179.723 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 17.0 m -139.42 145.39 27.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.772 0.32 . . . . 0.0 110.947 -179.606 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -100.83 56.27 0.87 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.486 179.659 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.457 ' CG1' ' CD1' ' A' ' 52' ' ' TRP . 2.3 p -67.47 102.94 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.175 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -165.45 135.46 3.59 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.328 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 9.5 p90 -156.76 35.26 0.3 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.415 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 51.35 -162.26 0.07 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.454 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 61.42 -103.55 0.57 Allowed Glycine 0 CA--C 1.522 0.529 0 N-CA-C 110.637 -0.985 . . . . 0.0 110.637 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 64.9 m-20 -67.87 132.63 47.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.791 0.329 . . . . 0.0 110.151 179.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.435 ' HB ' ' CG ' ' A' ' 71' ' ' GLU . 0.2 OUTLIER -76.45 175.02 9.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.563 -179.742 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.412 ' O ' ' CG ' ' A' ' 71' ' ' GLU . 0.1 OUTLIER -98.51 130.11 45.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.452 -179.804 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.437 ' CB ' ' HG2' ' A' ' 71' ' ' GLU . . . -118.32 -53.07 2.36 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.691 -179.884 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -161.73 159.16 26.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.905 0.383 . . . . 0.0 110.62 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 18.0 t -143.05 165.12 15.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.936 179.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.431 ' CB ' ' HA ' ' A' ' 43' ' ' ALA . 9.6 pt-20 -174.74 147.86 1.07 Allowed 'General case' 0 N--CA 1.451 -0.411 0 CA-C-O 120.805 0.336 . . . . 0.0 110.687 -179.603 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.484 ' HB3' ' CE1' ' A' ' 66' ' ' PHE . 2.9 pp -109.48 171.19 7.59 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.325 179.619 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.478 ' HB2' ' CZ3' ' A' ' 41' ' ' TRP . 3.8 ttp85 -101.14 -54.65 2.74 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.764 -179.514 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.453 ' CB ' ' O ' ' A' ' 34' ' ' ARG . 3.6 tt0 88.36 30.62 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 109.182 -0.674 . . . . 0.0 109.182 -178.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 29.8 t60 46.81 -87.7 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.068 -0.969 . . . . 0.0 111.469 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.433 ' N ' ' O ' ' A' ' 35' ' ' GLU . . . -42.32 -51.42 5.36 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 111.602 -0.599 . . . . 0.0 111.602 -179.516 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -49.87 100.91 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.767 0.317 . . . . 0.0 110.585 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -51.43 -29.89 17.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.245 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -108.39 164.15 12.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.193 179.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.481 ' CZ3' ' HG2' ' A' ' 67' ' ' ARG . 67.1 m95 -87.77 150.14 23.76 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.314 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.435 ' CG2' HD13 ' A' ' 33' ' ' LEU . 11.0 m -115.66 113.95 44.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.141 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.431 ' HA ' ' CB ' ' A' ' 32' ' ' GLU . . . -48.97 130.83 18.71 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.618 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.86 -169.9 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.145 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 53.9 m -141.28 107.51 5.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.325 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 17.1 ptmt -75.9 63.65 1.74 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.269 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -77.57 -26.4 61.16 Favored Glycine 0 CA--C 1.522 0.496 0 N-CA-C 110.627 -0.989 . . . . 0.0 110.627 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.409 ' HG2' ' CG2' ' A' ' 51' ' ' VAL . 0.7 OUTLIER -84.47 -169.53 2.66 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.824 0.345 . . . . 0.0 110.322 179.95 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -107.13 -27.37 5.37 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 110.825 -0.91 . . . . 0.0 110.825 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -131.13 -3.58 4.34 Favored Glycine 0 CA--C 1.529 0.948 0 C-N-CA 121.363 -0.446 . . . . 0.0 112.34 -179.496 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.421 ' CG1' ' HG3' ' A' ' 9' ' ' GLU . 33.1 m -134.27 167.22 26.62 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.132 0 CA-C-N 117.573 0.687 . . . . 0.0 110.629 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . 0.457 ' CD1' ' CG1' ' A' ' 21' ' ' VAL . 4.7 m95 -115.04 134.97 54.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.532 -179.689 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -122.18 168.63 11.77 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.721 179.414 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.473 ' CG ' HD22 ' A' ' 33' ' ' LEU . 78.8 t80 -154.04 120.13 5.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.755 0.312 . . . . 0.0 110.936 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -78.25 134.17 37.6 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.019 179.552 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -113.52 -177.77 3.21 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.905 0.383 . . . . 0.0 110.752 -179.662 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -152.24 -45.09 0.1 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.415 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.97 156.69 4.93 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.548 -179.797 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -80.31 -19.75 8.9 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.664 2.243 . . . . 0.0 111.857 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.4 tp -48.94 135.01 16.25 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.606 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -139.45 81.71 1.85 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.338 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -137.24 -148.11 5.38 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.744 -0.942 . . . . 0.0 110.744 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -78.93 139.61 15.48 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.572 2.181 . . . . 0.0 112.127 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.464 ' CD2' HD12 ' A' ' 17' ' ' LEU . 60.9 m-85 -115.45 99.1 7.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.229 179.72 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 21.6 m-20 -62.62 164.93 6.95 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.277 -0.419 . . . . 0.0 109.96 179.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.484 ' CE1' ' HB3' ' A' ' 33' ' ' LEU . 21.7 m-85 -142.48 -179.05 6.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.889 0.376 . . . . 0.0 110.777 -179.778 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.481 ' HG2' ' CZ3' ' A' ' 41' ' ' TRP . 7.8 ptm180 174.5 85.31 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.284 -179.755 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -76.95 171.95 13.95 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.134 0.492 . . . . 0.0 110.816 -179.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.431 ' O ' ' CB ' ' A' ' 29' ' ' ALA . 5.4 mt -124.69 61.68 1.15 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.406 179.783 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.2 p -30.63 137.13 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.356 0.662 . . . . 0.0 112.293 -179.066 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.437 ' HG2' ' CB ' ' A' ' 29' ' ' ALA . 13.1 mt-10 -53.56 -67.54 0.25 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.338 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -111.95 61.49 0.62 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.43 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -151.21 -104.69 0.28 Allowed Glycine 0 CA--C 1.523 0.564 0 N-CA-C 110.801 -0.92 . . . . 0.0 110.801 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 179.94 172.31 1.04 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.837 0.351 . . . . 0.0 110.274 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -86.59 -178.36 6.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.413 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 172.75 153.27 0.08 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.195 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 77.2 t -102.16 159.75 4.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.358 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.48 ' CE1' HG23 ' A' ' 4' ' ' VAL . 29.8 m-85 -148.4 122.96 9.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.403 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -109.04 154.2 22.55 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.295 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 56.61 52.86 9.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.386 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.438 ' O ' ' CG2' ' A' ' 82' ' ' VAL . 72.9 t -95.77 5.79 8.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.169 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.438 ' CG2' ' O ' ' A' ' 81' ' ' VAL . 88.3 t -158.69 127.73 3.1 Favored Pre-proline 0 CA--C 1.53 0.18 0 N-CA-C 110.09 -0.337 . . . . 0.0 110.09 179.486 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -81.31 160.49 20.08 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.61 2.207 . . . . 0.0 111.893 179.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -55.88 121.18 8.68 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 179.364 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 61.62 59.69 1.78 Allowed 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 -179.309 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 36.3 p90 -44.48 156.94 0.07 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.25 -179.347 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 88.2 m -135.27 107.78 7.37 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.731 179.641 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.434 ' HA ' ' CG2' ' A' ' 8' ' ' VAL . 2.8 mp -49.42 94.45 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.852 0.358 . . . . 0.0 110.596 -179.559 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 160.47 47.66 0.02 OUTLIER Glycine 0 CA--C 1.523 0.552 0 N-CA-C 111.11 -0.796 . . . . 0.0 111.11 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 174.66 162.82 0.22 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.873 0.368 . . . . 0.0 110.79 179.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.426 ' CG2' ' O ' ' A' ' 6' ' ' PHE . 87.7 m -96.28 141.17 29.93 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.02 179.783 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.419 ' N ' HG21 ' A' ' 91' ' ' THR . 8.4 m-85 -136.43 129.68 31.53 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.454 -179.837 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.449 ' CB ' ' CD ' ' A' ' 94' ' ' PRO . . . 174.98 179.28 0.17 Allowed Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.358 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.449 ' CD ' ' CB ' ' A' ' 93' ' ' ALA . 48.5 Cg_endo . . . . . 0 C--O 1.248 1.017 0 C-N-CA 122.549 2.166 . . . . 0.0 112.1 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 60.5 t . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 110.154 -0.314 . . . . 0.0 110.154 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -74.45 -170.42 0.74 Allowed 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 122.53 2.154 . . . . 0.0 111.948 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 6.0 mtpt -125.4 75.57 1.48 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.497 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.499 ' CG1' ' CE2' ' A' ' 6' ' ' PHE . 0.4 OUTLIER 41.15 -164.28 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 CA-C-O 121.135 0.493 . . . . 0.0 111.127 179.868 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.439 ' HA ' ' CB ' ' A' ' 93' ' ' ALA . 0.6 OUTLIER -174.56 -35.79 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.626 -0.716 . . . . 0.0 111.359 -179.749 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.499 ' CE2' ' CG1' ' A' ' 4' ' ' VAL . 86.2 m-85 66.44 156.17 0.1 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.204 -179.407 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.407 ' O ' ' N ' ' A' ' 20' ' ' LEU . 0.3 OUTLIER -163.58 117.85 1.58 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.568 -179.945 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 95.2 t -64.1 101.33 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.103 179.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.4 ' HG3' HG12 ' A' ' 51' ' ' VAL . 4.4 mm-40 -64.75 162.91 15.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.71 -179.73 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 26.9 tttt -79.21 102.57 8.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.144 179.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 178.42 -35.86 0.08 OUTLIER Glycine 0 CA--C 1.523 0.553 0 N-CA-C 110.858 -0.897 . . . . 0.0 110.858 -179.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -48.18 130.8 16.15 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.815 0.34 . . . . 0.0 110.646 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 20.0 m-80 -123.89 -67.2 0.94 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.356 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -121.39 -78.2 0.59 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.416 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.43 ' HG2' ' N ' ' A' ' 16' ' ' HIS . 0.0 OUTLIER -97.04 -24.77 15.62 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.698 -179.87 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.47 ' CE1' ' OD1' ' A' ' 55' ' ' ASP . 5.9 m80 -63.07 119.26 9.17 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.147 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.4 ' CD2' ' OH ' ' A' ' 86' ' ' TYR . 0.2 OUTLIER -114.03 97.06 6.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.46 -179.844 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -94.19 131.17 40.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.37 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.407 ' O ' ' CB ' ' A' ' 51' ' ' VAL . 18.6 m -125.26 -175.04 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.271 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.441 ' HA ' ' CG1' ' A' ' 51' ' ' VAL . 1.1 tt -134.88 70.39 1.44 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.219 179.88 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 6.3 t -86.25 103.63 12.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.453 -179.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 176.29 131.7 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.412 179.822 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 6.4 p90 -151.0 158.77 44.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.265 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -74.23 115.53 13.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.404 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 155.49 -82.25 0.16 Allowed Glycine 0 CA--C 1.523 0.592 0 N-CA-C 110.743 -0.943 . . . . 0.0 110.743 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -81.91 -166.08 1.14 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.812 0.339 . . . . 0.0 110.378 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -121.42 176.01 5.88 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.465 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.405 ' O ' ' CG ' ' A' ' 71' ' ' GLU . 12.6 mtt -108.49 118.06 35.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.383 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.43 ' CB ' ' O ' ' A' ' 69' ' ' LEU . . . -119.38 -61.38 1.63 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.573 -179.831 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 15.2 tt0 -155.84 163.53 39.69 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.139 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.433 ' CG2' ' CD1' ' A' ' 52' ' ' TRP . 38.7 t -139.57 140.6 36.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.089 0.471 . . . . 0.0 110.721 -179.796 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -134.78 123.33 23.42 Favored 'General case' 0 N--CA 1.441 -0.925 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.271 -179.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.49 ' HB3' ' CE1' ' A' ' 66' ' ' PHE . 2.7 pp -111.92 177.08 4.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.213 0.53 . . . . 0.0 111.223 -179.395 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.428 ' N ' ' CD1' ' A' ' 33' ' ' LEU . 6.8 ttt180 -145.35 175.32 10.39 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.342 179.576 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.417 ' O ' ' HB2' ' A' ' 36' ' ' HIS . 17.9 mt-10 -116.12 -82.76 0.63 Allowed 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 179.728 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.417 ' HB2' ' O ' ' A' ' 35' ' ' GLU . 20.6 t-160 178.08 -37.38 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.062 179.095 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -111.1 -18.66 8.09 Favored Glycine 0 CA--C 1.527 0.813 0 N-CA-C 111.007 -0.837 . . . . 0.0 111.007 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.5 p -47.4 152.1 0.68 Allowed 'General case' 0 N--CA 1.462 0.136 0 CA-C-O 120.847 0.356 . . . . 0.0 110.772 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 36.1 m-20 -53.65 -44.06 69.29 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.516 -179.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -162.76 -177.04 5.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.414 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.473 ' CZ3' ' HG2' ' A' ' 67' ' ' ARG . 55.2 m95 -58.76 156.28 11.39 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.205 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.433 ' CG2' HD13 ' A' ' 33' ' ' LEU . 18.6 m -130.17 113.86 27.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.315 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -55.52 123.2 13.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.214 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -51.7 -176.57 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.804 -179.797 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.418 ' O ' ' N ' ' A' ' 47' ' ' GLY . 33.1 m -149.73 126.03 10.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.393 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 15.1 ptmt -65.19 75.33 0.05 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.2 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.418 ' N ' ' O ' ' A' ' 45' ' ' THR . . . -93.89 -32.11 7.76 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 110.945 -0.862 . . . . 0.0 110.945 -179.825 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -78.42 174.14 11.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.871 0.367 . . . . 0.0 110.29 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -104.64 34.46 5.77 Favored Glycine 0 CA--C 1.522 0.524 0 N-CA-C 110.228 -1.149 . . . . 0.0 110.228 179.724 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 178.78 -35.01 0.08 OUTLIER Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.979 -0.849 . . . . 0.0 110.979 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.441 ' CG1' ' HA ' ' A' ' 20' ' ' LEU . 3.3 m -123.03 -176.31 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 120.87 0.367 . . . . 0.0 110.557 -179.814 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . 0.433 ' CD1' ' CG2' ' A' ' 31' ' ' VAL . 7.1 m95 -98.36 139.49 34.04 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.725 -179.587 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -131.13 152.22 50.64 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.177 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 70.3 t80 -130.21 141.38 50.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.546 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.47 ' OD1' ' CE1' ' A' ' 16' ' ' HIS . 6.0 m-20 -97.86 114.81 26.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.339 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -105.97 179.18 4.34 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.467 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -172.02 39.05 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.607 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -123.34 156.77 63.17 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.339 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -71.75 -43.54 1.27 Allowed 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.614 2.209 . . . . 0.0 112.012 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 3.5 mt -69.53 122.45 19.06 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.474 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.13 88.29 2.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.278 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -104.25 -148.37 18.59 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.854 -0.898 . . . . 0.0 110.854 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -78.24 167.16 23.58 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.573 2.182 . . . . 0.0 112.141 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -123.64 113.84 19.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.378 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 70.9 m-20 -86.86 131.98 33.95 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 179.437 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.49 ' CE1' ' HB3' ' A' ' 33' ' ' LEU . 44.7 m-85 -113.38 178.07 4.41 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.101 0.477 . . . . 0.0 111.105 -179.444 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.473 ' HG2' ' CZ3' ' A' ' 41' ' ' TRP . 0.0 OUTLIER 175.29 55.04 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.494 -0.776 . . . . 0.0 109.696 179.975 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 4.2 p90 -50.23 174.21 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.844 -0.617 . . . . 0.0 111.24 -179.307 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.43 ' O ' ' CB ' ' A' ' 29' ' ' ALA . 2.6 mt -130.09 75.93 1.69 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.194 179.485 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.426 ' OG1' ' N ' ' A' ' 74' ' ' MET . 16.8 p -37.49 149.46 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.6 -179.17 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.422 ' HG2' ' CB ' ' A' ' 29' ' ' ALA . 5.1 mm-40 -60.97 -54.18 48.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.02 -179.338 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -129.81 58.14 1.66 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.89 0.376 . . . . 0.0 110.795 -179.568 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -149.07 -107.95 0.46 Allowed Glycine 0 CA--C 1.523 0.582 0 N-CA-C 110.895 -0.882 . . . . 0.0 110.895 179.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.426 ' N ' ' OG1' ' A' ' 70' ' ' THR . 0.0 OUTLIER -166.33 179.07 5.81 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 110.223 -0.288 . . . . 0.0 110.223 179.936 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.4 138.38 50.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.447 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.423 ' O ' ' CE2' ' A' ' 78' ' ' PHE . 24.8 m-20 -135.46 127.93 30.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.298 179.854 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 58.4 t -77.46 147.59 7.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.617 -179.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.423 ' CE2' ' O ' ' A' ' 76' ' ' ASN . 72.6 m-85 -132.27 121.65 23.93 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.157 179.805 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -110.27 140.88 43.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.698 -179.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 70.0 32.44 3.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.791 179.656 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.478 HG12 ' CD2' ' A' ' 6' ' ' PHE . 18.4 t -65.13 -68.26 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 179.564 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 93.3 t -86.53 131.48 45.63 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.168 179.697 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.438 ' HD3' ' CB ' ' A' ' 92' ' ' TYR . 50.6 Cg_endo -82.79 161.16 16.3 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.557 2.171 . . . . 0.0 112.047 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -62.33 125.24 23.22 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.188 179.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 58.86 47.93 11.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.145 -179.829 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . 0.4 ' OH ' ' CD2' ' A' ' 17' ' ' LEU . 22.7 p90 -50.12 175.67 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.775 -179.814 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -137.23 104.56 5.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.998 179.736 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 2.7 mp -46.14 102.83 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.767 -179.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 145.52 48.49 0.03 OUTLIER Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.741 -0.944 . . . . 0.0 110.741 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 179.1 -176.3 0.25 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.931 0.396 . . . . 0.0 110.423 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.437 HG21 ' N ' ' A' ' 92' ' ' TYR . 89.5 m -118.12 141.38 48.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.259 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.438 ' CB ' ' HD3' ' A' ' 83' ' ' PRO . 6.2 m-85 -140.45 124.13 17.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.533 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.463 ' CB ' ' CD ' ' A' ' 94' ' ' PRO . . . -156.49 179.55 1.33 Allowed Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.121 -0.49 . . . . 0.0 109.93 179.533 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.463 ' CD ' ' CB ' ' A' ' 93' ' ' ALA . 48.5 Cg_endo . . . . . 0 C--O 1.249 1.029 0 C-N-CA 122.525 2.15 . . . . 0.0 112.059 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 9.6 t . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 110.237 -0.283 . . . . 0.0 110.237 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -75.31 95.7 1.0 Allowed 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.56 2.173 . . . . 0.0 111.921 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.1 mmtt -153.46 90.71 1.43 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.63 -179.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.531 ' CG1' ' CE1' ' A' ' 78' ' ' PHE . 2.4 p -115.53 162.72 13.38 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.342 0 CA-C-O 121.223 0.535 . . . . 0.0 109.996 179.503 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.468 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 0.2 OUTLIER -134.32 151.99 51.56 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.566 179.984 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 17.8 m-85 -128.73 -176.09 3.74 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.881 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -167.03 174.63 8.19 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.05 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.43 ' CG1' HG13 ' A' ' 88' ' ' ILE . 93.5 t -123.37 83.29 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.1 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -47.59 161.53 0.09 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.857 -179.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 12.1 mttm -60.72 -18.63 55.52 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.001 -179.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -74.05 -2.3 61.71 Favored Glycine 0 CA--C 1.53 1.004 0 N-CA-C 111.824 -0.51 . . . . 0.0 111.824 -179.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.5 m -76.54 128.59 35.04 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 117.216 0.508 . . . . 0.0 110.538 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 22.9 m-80 -134.28 -164.32 1.49 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.143 179.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.431 ' HG3' ' CD ' ' A' ' 15' ' ' LYS . 22.1 pt-20 -75.87 -41.51 52.0 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.466 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.431 ' CD ' ' HG3' ' A' ' 14' ' ' GLU . 1.5 mmmt -85.12 -39.8 17.5 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.489 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 30.3 m80 -97.61 161.67 13.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.596 -179.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -141.84 85.88 1.96 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.565 179.559 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -79.43 143.01 35.41 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.238 -179.609 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.429 HG22 ' CG2' ' A' ' 21' ' ' VAL . 30.1 m -138.71 137.27 43.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.288 -179.863 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -91.51 65.0 5.13 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.2 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.429 ' CG2' HG22 ' A' ' 19' ' ' VAL . 10.0 t -61.78 115.18 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.415 -179.811 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 2.2 tttp -172.69 178.55 2.63 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.189 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.481 ' N ' ' CD1' ' A' ' 23' ' ' TYR . 0.0 OUTLIER -146.18 -71.31 0.25 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.044 -179.923 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -143.4 -57.88 0.41 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.219 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -168.34 63.36 0.19 Allowed Glycine 0 CA--C 1.523 0.587 0 N-CA-C 110.759 -0.937 . . . . 0.0 110.759 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -97.33 -167.35 1.52 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.776 0.322 . . . . 0.0 110.41 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 29.3 p -119.67 132.01 55.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.447 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.427 ' O ' ' CG ' ' A' ' 71' ' ' GLU . 0.0 OUTLIER -85.99 123.86 31.79 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.7 -179.851 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.435 ' CB ' ' HG2' ' A' ' 71' ' ' GLU . . . -117.81 -61.54 1.67 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.407 -179.852 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -155.83 151.51 27.26 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.025 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.416 ' HA ' ' HA ' ' A' ' 68' ' ' PHE . 12.1 t -141.27 142.95 28.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.661 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.453 ' CB ' ' HA ' ' A' ' 43' ' ' ALA . 3.9 pt-20 -137.3 142.87 41.9 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.022 -0.535 . . . . 0.0 109.905 179.798 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.429 ' O ' ' CG2' ' A' ' 42' ' ' VAL . 5.6 tp -118.92 147.43 44.02 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 -179.47 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.498 ' HD3' ' CD2' ' A' ' 41' ' ' TRP . 4.7 ttp180 -144.08 164.02 31.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.008 179.583 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.452 ' OE1' ' CD1' ' A' ' 64' ' ' PHE . 2.4 mm-40 -118.56 -72.82 0.67 Allowed 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 179.747 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 6.0 t-80 -179.17 -39.33 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.348 179.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -136.32 57.39 0.68 Allowed Glycine 0 CA--C 1.523 0.552 0 N-CA-C 110.545 -1.022 . . . . 0.0 110.545 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.1 t -132.88 68.88 1.49 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.91 0.386 . . . . 0.0 110.486 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 23.6 t0 49.1 38.19 12.39 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.78 179.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 64.73 -173.37 0.18 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.653 179.732 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.498 ' CD2' ' HD3' ' A' ' 34' ' ' ARG . 94.1 m95 -46.84 143.26 2.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.885 -179.841 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.429 ' CG2' ' O ' ' A' ' 33' ' ' LEU . 2.4 m -137.58 111.46 8.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.85 179.531 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.453 ' HA ' ' CB ' ' A' ' 32' ' ' GLU . . . -44.71 152.13 0.24 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.105 -179.452 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -72.16 -169.51 0.5 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.349 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 37.7 m -143.63 101.26 3.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.181 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 10.8 ptmt -64.76 80.71 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.534 -179.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -117.4 -37.14 0.94 Allowed Glycine 0 CA--C 1.523 0.588 0 N-CA-C 110.65 -0.98 . . . . 0.0 110.65 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 8.4 tm-20 -60.86 -33.39 73.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.756 0.312 . . . . 0.0 110.351 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 97.82 -69.76 0.71 Allowed Glycine 0 CA--C 1.523 0.545 0 N-CA-C 110.774 -0.93 . . . . 0.0 110.774 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -74.83 -29.13 61.54 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 110.589 -1.004 . . . . 0.0 110.589 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 14.1 m -136.38 -177.49 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.791 0.329 . . . . 0.0 110.278 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 7.0 m95 -110.25 132.64 54.0 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.558 -179.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -115.3 160.72 19.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.145 179.826 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.422 ' CD2' HD22 ' A' ' 33' ' ' LEU . 40.5 t80 -148.61 112.63 5.17 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.555 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -70.86 135.98 48.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.147 179.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -142.49 125.99 16.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.612 -179.816 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -93.17 -30.45 15.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.01 179.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.441 ' HB2' ' CD ' ' A' ' 59' ' ' PRO . 0.4 OUTLIER -51.84 170.15 0.23 Allowed Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.253 179.754 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.441 ' CD ' ' HB2' ' A' ' 58' ' ' GLU . 37.4 Cg_endo -91.66 56.92 0.9 Allowed 'Trans proline' 0 N--CA 1.45 -1.037 0 C-N-CA 123.569 2.846 . . . . 0.0 111.761 179.339 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -47.44 93.07 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.78 -179.756 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -119.23 47.33 1.71 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.341 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -165.96 -165.19 22.9 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.502 -1.039 . . . . 0.0 110.502 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -79.94 155.7 23.34 Favored 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 122.55 2.166 . . . . 0.0 112.065 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.452 ' CD1' ' OE1' ' A' ' 35' ' ' GLU . 46.8 m-85 -101.8 -173.97 2.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.21 -0.45 . . . . 0.0 109.88 179.743 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -149.27 119.18 7.11 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.095 -179.87 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.408 ' O ' ' HG3' ' A' ' 67' ' ' ARG . 13.4 m-85 -108.21 163.47 13.14 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.423 -179.828 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.484 ' HG3' ' CH2' ' A' ' 41' ' ' TRP . 21.7 mtp180 -163.44 84.69 0.49 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.141 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.416 ' HA ' ' HA ' ' A' ' 31' ' ' VAL . 6.5 p90 -75.82 169.9 17.26 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.2 0.524 . . . . 0.0 110.691 -179.783 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.432 ' O ' ' CB ' ' A' ' 29' ' ' ALA . 3.9 mt -133.9 50.49 2.2 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.184 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 8.3 p -22.74 137.94 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.167 0.987 . . . . 0.0 113.037 -179.035 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.435 ' HG2' ' CB ' ' A' ' 29' ' ' ALA . 2.6 mm-40 -55.94 -31.18 62.71 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.166 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 14.9 tptt -151.14 70.28 0.98 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.165 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -151.1 -97.49 0.16 Allowed Glycine 0 CA--C 1.522 0.488 0 N-CA-C 110.816 -0.914 . . . . 0.0 110.816 -179.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 13.2 ptp 172.63 166.82 0.12 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.748 0.309 . . . . 0.0 110.288 -179.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 18.4 mmtm -83.71 147.84 27.42 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 179.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -154.98 132.56 11.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.804 0.335 . . . . 0.0 110.472 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.43 HG21 ' NE ' ' A' ' 67' ' ' ARG . 93.8 t -97.27 146.67 7.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.148 0.499 . . . . 0.0 110.618 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.531 ' CE1' ' CG1' ' A' ' 4' ' ' VAL . 41.1 m-85 -131.05 133.65 45.91 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.304 -179.486 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -127.14 31.87 5.17 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.368 -179.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -168.39 52.03 0.05 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.483 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.414 ' O ' ' CG2' ' A' ' 82' ' ' VAL . 57.1 t -93.64 -12.2 8.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.549 -179.077 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.428 ' CG1' ' HD2' ' A' ' 83' ' ' PRO . 70.3 t -156.76 141.33 12.02 Favored Pre-proline 0 C--N 1.332 -0.166 0 CA-C-O 120.696 0.284 . . . . 0.0 110.694 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.479 ' HD3' ' CG ' ' A' ' 92' ' ' TYR . 51.9 Cg_endo -81.26 -166.71 0.43 Allowed 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.72 2.28 . . . . 0.0 111.904 179.763 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.411 ' HG3' ' N ' ' A' ' 85' ' ' LYS . 5.1 pt-20 -78.15 -27.11 48.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.173 179.557 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.411 ' N ' ' HG3' ' A' ' 84' ' ' GLU . 0.0 OUTLIER -140.33 73.53 1.43 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.014 179.771 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 45.1 p90 -57.12 173.91 0.2 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.79 -179.624 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -152.43 113.66 4.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.035 179.696 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.43 HG13 ' CG1' ' A' ' 8' ' ' VAL . 3.3 mp -48.5 109.11 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.828 -179.645 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 121.42 52.26 0.24 Allowed Glycine 0 CA--C 1.523 0.589 0 N-CA-C 111.015 -0.834 . . . . 0.0 111.015 179.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -179.31 148.85 0.38 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.846 0.355 . . . . 0.0 110.794 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 19.4 m -92.77 135.51 34.05 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.895 179.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.479 ' CG ' ' HD3' ' A' ' 83' ' ' PRO . 66.8 m-85 -118.7 -26.47 6.11 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.635 -178.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -49.18 171.29 0.11 Allowed Pre-proline 0 C--N 1.331 -0.235 0 CA-C-O 120.648 0.261 . . . . 0.0 110.746 -179.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo . . . . . 0 C--O 1.249 1.066 0 C-N-CA 122.547 2.165 . . . . 0.0 111.991 -179.928 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . 0.407 ' O ' ' CG1' ' A' ' 1' ' ' VAL . 7.1 p . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -74.48 166.15 30.09 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.571 2.181 . . . . 0.0 112.018 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -125.54 80.67 1.91 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.376 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.523 ' CG2' ' CE1' ' A' ' 78' ' ' PHE . 20.3 m -73.94 162.97 4.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.511 -179.889 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 43.5 p -148.34 128.84 14.01 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.176 179.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.476 ' CD1' HG12 ' A' ' 81' ' ' VAL . 42.5 m-85 -87.13 171.91 10.33 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.356 -179.828 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.7 m -163.13 112.29 1.31 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.552 -179.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 57.8 t -61.57 96.16 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.251 179.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.446 ' HG3' ' CG2' ' A' ' 51' ' ' VAL . 8.5 mm-40 -52.14 166.29 0.17 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.351 -179.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 17.1 mttp -60.32 -28.56 68.23 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.685 -179.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.418 ' O ' ' CB ' ' A' ' 18' ' ' ALA . . . -83.22 69.18 3.42 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 110.98 -0.848 . . . . 0.0 110.98 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -130.37 128.65 41.85 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.702 0.287 . . . . 0.0 110.283 179.85 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 17.3 p30 -166.79 -174.96 2.92 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.618 -179.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -54.72 127.0 26.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.339 0.59 . . . . 0.0 110.494 -179.904 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.413 ' O ' ' ND1' ' A' ' 16' ' ' HIS . 0.0 OUTLIER 67.74 20.88 9.38 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.155 -0.929 . . . . 0.0 110.958 179.572 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.413 ' ND1' ' O ' ' A' ' 15' ' ' LYS . 78.2 m80 -157.68 89.01 1.0 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.826 0.346 . . . . 0.0 110.549 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.404 ' CD1' HG12 ' A' ' 19' ' ' VAL . 3.0 tm? -100.97 85.25 2.82 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.937 179.851 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.436 ' HB1' ' CG2' ' A' ' 53' ' ' THR . . . -77.82 145.21 36.48 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.75 -179.632 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.406 ' O ' HG11 ' A' ' 51' ' ' VAL . 31.5 m -147.71 131.0 8.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.033 179.322 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -83.5 85.02 7.32 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.773 -179.568 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 24.3 t -87.4 88.85 2.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.194 179.669 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.437 ' HG2' ' N ' ' A' ' 23' ' ' TYR . 38.5 tttm -145.96 160.25 42.11 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.475 -179.848 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.437 ' N ' ' HG2' ' A' ' 22' ' ' LYS . 18.5 p90 177.01 174.9 0.4 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.345 179.784 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -101.28 128.33 47.47 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.453 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 146.43 -49.03 0.65 Allowed Glycine 0 CA--C 1.523 0.575 0 N-CA-C 110.669 -0.973 . . . . 0.0 110.669 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -135.94 -177.47 4.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.745 0.307 . . . . 0.0 110.336 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -116.13 172.69 7.01 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.496 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.434 ' O ' ' CB ' ' A' ' 71' ' ' GLU . 0.1 OUTLIER -75.74 -173.78 2.34 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.436 -179.934 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.441 ' CB ' ' O ' ' A' ' 69' ' ' LEU . . . 168.52 -64.82 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.29 179.801 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.404 ' O ' ' HB2' ' A' ' 68' ' ' PHE . 0.2 OUTLIER -148.0 162.78 38.65 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.778 -179.862 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.456 ' HB ' ' HB3' ' A' ' 68' ' ' PHE . 1.9 p 174.48 138.94 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.093 0.473 . . . . 0.0 110.384 -179.869 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -137.09 178.29 7.2 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.351 -179.634 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.506 ' HG ' ' CE2' ' A' ' 66' ' ' PHE . 2.3 mt -114.59 176.42 5.06 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.006 0.431 . . . . 0.0 110.767 -179.65 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.48 ' HB2' ' CZ3' ' A' ' 41' ' ' TRP . 0.0 OUTLIER -161.25 170.79 19.57 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.007 179.632 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -139.44 14.65 2.57 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.283 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER 52.99 25.62 4.16 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.613 0.244 . . . . 0.0 110.793 179.58 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -161.58 29.54 0.3 Allowed Glycine 0 CA--C 1.524 0.62 0 N-CA-C 110.964 -0.854 . . . . 0.0 110.964 -179.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -112.09 -16.39 13.06 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.528 0.204 . . . . 0.0 110.97 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 71.21 8.84 6.51 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.78 -0.191 . . . . 0.0 111.067 -179.81 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 26.3 pt-20 179.42 151.47 0.36 Allowed 'General case' 0 C--O 1.231 0.105 0 CA-C-O 120.743 0.306 . . . . 0.0 110.244 179.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.492 ' CE3' ' HG2' ' A' ' 67' ' ' ARG . 86.2 m95 -76.89 160.65 29.04 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.377 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 29.7 m -134.49 106.37 7.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.319 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -44.06 131.5 5.83 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.122 -179.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.416 ' CE ' HD13 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -68.55 -170.13 0.19 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.367 -179.983 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 42.8 m -147.49 118.68 7.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.342 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.1 ptpt -71.77 68.75 0.64 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.576 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -90.01 -12.71 61.61 Favored Glycine 0 CA--C 1.528 0.85 0 N-CA-C 111.227 -0.749 . . . . 0.0 111.227 179.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.418 ' HB3' ' HB ' ' A' ' 51' ' ' VAL . 0.1 OUTLIER -85.41 3.83 38.27 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 116.875 0.338 . . . . 0.0 111.391 -179.831 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 64.19 21.53 66.21 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 111.041 -0.824 . . . . 0.0 111.041 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 171.96 -35.21 0.15 Allowed Glycine 0 CA--C 1.52 0.384 0 N-CA-C 109.959 -1.256 . . . . 0.0 109.959 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.446 ' CG2' ' HG3' ' A' ' 9' ' ' GLU . 3.0 t -106.78 157.81 6.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 179.555 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 3.6 m95 -92.18 123.68 35.7 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.015 0.436 . . . . 0.0 110.945 -179.132 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.436 ' CG2' ' HB1' ' A' ' 18' ' ' ALA . 1.3 p -112.69 140.64 47.29 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.313 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 60.7 t80 -121.16 145.33 47.93 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.368 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -88.56 90.1 8.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.34 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -61.19 110.8 1.49 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.541 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -95.15 -36.75 11.36 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.303 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.407 ' O ' ' CG ' ' A' ' 58' ' ' GLU . 5.6 pt-20 -102.74 116.01 63.34 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.345 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -92.4 42.22 0.31 Allowed 'Trans proline' 0 N--CA 1.451 -0.986 0 C-N-CA 123.356 2.704 . . . . 0.0 112.439 179.669 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 2.1 mp -77.34 -175.0 3.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.229 179.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 19.8 pt20 -105.89 32.63 4.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.385 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -90.79 154.03 22.88 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.638 -0.985 . . . . 0.0 110.638 179.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -79.79 170.02 17.38 Favored 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 122.577 2.184 . . . . 0.0 112.047 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 16.6 m-30 -108.6 149.63 28.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.626 -179.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 6.8 m-80 -133.72 145.94 50.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.817 179.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.506 ' CE2' ' HG ' ' A' ' 33' ' ' LEU . 67.1 m-85 -125.36 -177.83 4.02 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.143 0.497 . . . . 0.0 110.694 -179.818 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.492 ' HG2' ' CE3' ' A' ' 41' ' ' TRP . 0.0 OUTLIER 179.92 70.37 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.411 179.692 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.456 ' HB3' ' HB ' ' A' ' 31' ' ' VAL . 6.5 p90 -72.27 179.68 3.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.375 0.607 . . . . 0.0 111.413 -178.92 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.441 ' O ' ' CB ' ' A' ' 29' ' ' ALA . 9.5 mt -141.5 77.02 1.57 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.428 179.797 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.413 ' OG1' ' CG ' ' A' ' 74' ' ' MET . 21.4 p -36.21 136.54 0.3 Allowed 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 116.06 -0.518 . . . . 0.0 112.006 -179.114 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.434 ' CB ' ' O ' ' A' ' 28' ' ' MET . 0.1 OUTLIER -42.03 -34.23 0.68 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.192 179.782 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 3.1 tmtm? -56.87 -48.79 77.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.476 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 123.85 76.94 0.33 Allowed Glycine 0 CA--C 1.523 0.589 0 N-CA-C 110.794 -0.922 . . . . 0.0 110.794 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.413 ' CG ' ' OG1' ' A' ' 70' ' ' THR . 9.8 ptp -169.72 144.49 2.88 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.788 0.327 . . . . 0.0 110.172 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -111.71 178.62 4.26 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.654 -179.631 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 176.92 127.87 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.045 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 63.4 t -88.85 158.28 3.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.705 -179.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.523 ' CE1' ' CG2' ' A' ' 4' ' ' VAL . 51.1 m-85 -140.38 117.33 11.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.966 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -103.94 150.58 24.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.789 -179.472 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 50.85 57.03 7.09 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.618 179.78 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.476 HG12 ' CD1' ' A' ' 6' ' ' PHE . 57.3 t -84.54 -80.8 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 179.755 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.441 ' CG1' ' HD2' ' A' ' 83' ' ' PRO . 60.5 t -81.91 139.5 46.47 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.438 -0.347 . . . . 0.0 110.53 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.441 ' HD2' ' CG1' ' A' ' 82' ' ' VAL . 46.7 Cg_endo -69.82 -167.06 0.21 Allowed 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.701 2.267 . . . . 0.0 112.031 179.546 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -78.99 -27.82 43.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.156 179.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -138.94 77.38 1.62 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.254 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 18.8 p90 -51.23 160.27 0.55 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.532 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 6.0 m -136.44 111.78 9.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.224 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 2.7 mp -50.41 115.13 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.509 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 114.4 38.45 1.1 Allowed Glycine 0 CA--C 1.522 0.512 0 N-CA-C 110.631 -0.988 . . . . 0.0 110.631 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -156.27 -177.79 6.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.851 0.358 . . . . 0.0 110.492 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 93.3 m -127.27 143.31 51.26 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.399 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -144.45 128.4 17.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.127 179.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.443 ' CB ' ' CD ' ' A' ' 94' ' ' PRO . . . 176.15 179.08 0.2 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.411 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.443 ' CD ' ' CB ' ' A' ' 93' ' ' ALA . 48.5 Cg_endo . . . . . 0 C--O 1.249 1.03 0 C-N-CA 122.61 2.207 . . . . 0.0 112.174 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 6.7 m . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 120.757 0.313 . . . . 0.0 110.222 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -79.65 126.24 6.57 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.627 2.218 . . . . 0.0 111.939 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 37.2 mttm -151.02 65.16 0.91 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.634 -179.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.534 ' CG1' ' CZ ' ' A' ' 78' ' ' PHE . 2.5 p -179.6 163.41 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.341 0.591 . . . . 0.0 110.627 179.843 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.473 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 0.0 OUTLIER -142.02 145.24 34.18 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.108 179.594 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 16.1 m-85 -117.25 165.8 13.01 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.14 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.415 ' O ' ' N ' ' A' ' 20' ' ' LEU . 0.2 OUTLIER -165.97 109.02 0.78 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.226 179.986 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 84.6 t -61.45 90.58 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.451 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.406 ' HG3' ' CG1' ' A' ' 51' ' ' VAL . 21.1 mm-40 -55.1 176.39 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.477 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 12.9 mttt -74.0 -13.1 60.82 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.036 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -46.54 -28.37 3.45 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 111.021 -0.832 . . . . 0.0 111.021 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.5 m -53.08 121.71 7.97 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 179.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -110.61 -71.66 0.75 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.423 -179.894 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -138.62 -58.29 0.62 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.783 0.325 . . . . 0.0 110.54 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 10.2 pttt -104.91 -29.08 10.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.548 -179.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -64.53 166.0 9.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.5 -179.734 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 44.5 tp -146.43 85.3 1.65 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.363 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -76.34 134.8 39.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.44 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 34.8 m -130.26 152.2 37.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.182 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.415 ' N ' ' O ' ' A' ' 7' ' ' THR . 0.9 OUTLIER -99.58 91.46 4.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.294 179.891 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 17.8 t -99.72 97.0 5.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.608 -179.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 176.29 133.21 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.44 179.777 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.423 ' CZ ' ' OD2' ' A' ' 26' ' ' ASP . 0.1 OUTLIER -115.87 -73.87 0.63 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.338 -179.974 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -174.6 -56.93 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.586 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -46.59 -66.73 1.64 Allowed Glycine 0 CA--C 1.525 0.666 0 N-CA-C 111.217 -0.753 . . . . 0.0 111.217 -179.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.424 ' CB ' HG23 ' A' ' 70' ' ' THR . 44.4 p-10 -71.09 165.41 23.6 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.846 0.355 . . . . 0.0 110.482 -179.832 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.407 ' O ' ' CG2' ' A' ' 27' ' ' THR . 50.9 m -127.29 45.32 2.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.229 179.837 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.405 ' O ' ' CG ' ' A' ' 71' ' ' GLU . 14.7 mtt 60.15 175.93 0.09 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.502 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.428 ' CB ' ' O ' ' A' ' 69' ' ' LEU . . . 172.8 -61.7 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.306 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.417 ' O ' ' CG2' ' A' ' 31' ' ' VAL . 19.9 tt0 -160.62 161.61 32.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.345 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.473 HG23 ' CD1' ' A' ' 52' ' ' TRP . 44.4 t -157.27 148.7 10.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.957 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.46 ' CB ' ' HA ' ' A' ' 43' ' ' ALA . 0.3 OUTLIER -148.6 136.15 20.51 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.978 0.418 . . . . 0.0 110.507 -179.81 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.448 HD21 ' CG ' ' A' ' 54' ' ' PHE . 6.0 tp -104.1 141.69 35.78 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.958 -0.564 . . . . 0.0 109.61 -179.599 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.479 ' HB2' ' CE3' ' A' ' 41' ' ' TRP . 1.1 ttm180 -85.25 -63.7 1.28 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.618 -179.858 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.459 ' CB ' ' O ' ' A' ' 34' ' ' ARG . 2.4 tt0 91.16 48.19 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 109.003 -0.739 . . . . 0.0 109.003 -179.154 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.441 ' CG ' ' C ' ' A' ' 35' ' ' GLU . 1.2 p80 44.41 -89.44 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 114.845 -1.071 . . . . 0.0 111.207 -179.639 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.431 ' N ' ' O ' ' A' ' 35' ' ' GLU . . . -106.21 93.53 0.88 Allowed Glycine 0 CA--C 1.523 0.566 0 N-CA-C 110.883 -0.887 . . . . 0.0 110.883 -179.831 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.412 ' O ' ' HB2' ' A' ' 39' ' ' ASP . 8.1 t -139.86 25.27 2.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.586 0.231 . . . . 0.0 110.625 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.412 ' HB2' ' O ' ' A' ' 38' ' ' SER . 23.9 m-20 77.43 -54.87 0.54 Allowed 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 122.993 0.517 . . . . 0.0 110.899 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -157.75 170.75 21.66 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.33 -179.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.48 ' CZ2' ' HD2' ' A' ' 67' ' ' ARG . 81.1 m95 -63.67 164.14 10.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.394 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.411 ' CG2' ' O ' ' A' ' 33' ' ' LEU . 3.5 m -146.82 119.06 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.309 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.46 ' HA ' ' CB ' ' A' ' 32' ' ' GLU . . . -52.87 136.43 34.25 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.38 -179.87 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.74 -169.93 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.397 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 85.0 m -128.91 104.17 7.45 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.199 179.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -74.12 121.0 20.47 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.46 -179.858 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 152.41 46.32 0.02 OUTLIER Glycine 0 CA--C 1.523 0.534 0 N-CA-C 110.608 -0.997 . . . . 0.0 110.608 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.421 ' O ' ' N ' ' A' ' 50' ' ' GLY . 15.8 tp10 -134.04 73.48 1.5 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.698 0.285 . . . . 0.0 110.403 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 58.92 -83.71 0.01 OUTLIER Glycine 0 CA--C 1.523 0.533 0 N-CA-C 110.705 -0.958 . . . . 0.0 110.705 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.421 ' N ' ' O ' ' A' ' 48' ' ' GLU . . . -142.92 27.4 2.18 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 110.675 -0.97 . . . . 0.0 110.675 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.406 ' CG1' ' HG3' ' A' ' 9' ' ' GLU . 5.7 m -145.6 -178.43 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.798 0.333 . . . . 0.0 110.361 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . 0.473 ' CD1' HG23 ' A' ' 31' ' ' VAL . 8.8 m95 -106.13 155.28 19.59 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.513 -179.727 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -141.22 148.3 39.69 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.245 179.904 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.448 ' CG ' HD21 ' A' ' 33' ' ' LEU . 70.3 t80 -125.52 146.65 49.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.254 179.724 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 18.1 p-10 -89.61 93.72 9.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.665 -179.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.3 m -85.62 95.5 9.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.138 179.695 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.77 -34.63 13.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.729 -179.62 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.62 156.09 2.45 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 120.882 0.372 . . . . 0.0 110.644 -179.706 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -77.14 -22.62 11.1 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.546 2.164 . . . . 0.0 111.563 179.551 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.416 ' O ' ' CG ' ' A' ' 61' ' ' GLN . 91.4 mt -60.74 172.74 0.87 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.587 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.416 ' CG ' ' O ' ' A' ' 60' ' ' LEU . 0.0 OUTLIER 174.7 116.86 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.253 -179.975 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 178.84 -125.04 0.95 Allowed Glycine 0 CA--C 1.527 0.788 0 N-CA-C 110.692 -0.963 . . . . 0.0 110.692 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -73.52 146.62 39.57 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.427 2.085 . . . . 0.0 112.144 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.401 ' CD1' HD12 ' A' ' 33' ' ' LEU . 81.6 m-85 -128.91 -177.01 4.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.384 -179.907 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.434 ' HB2' ' CH2' ' A' ' 41' ' ' TRP . 0.7 OUTLIER -144.95 149.48 35.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.307 179.97 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 -141.5 159.89 41.27 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.964 0.411 . . . . 0.0 110.867 -179.736 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.48 ' HD2' ' CZ2' ' A' ' 41' ' ' TRP . 15.8 mtp180 -154.11 61.25 0.71 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.965 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 10.5 p90 -49.23 176.66 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.19 0.519 . . . . 0.0 110.991 -179.46 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.428 ' O ' ' CB ' ' A' ' 29' ' ' ALA . 14.5 mt -141.53 65.51 1.38 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.389 179.451 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.424 HG23 ' CB ' ' A' ' 26' ' ' ASP . 75.9 p -31.05 134.56 0.06 Allowed 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 115.606 -0.725 . . . . 0.0 112.655 -178.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.41 ' HA ' ' HB3' ' A' ' 29' ' ' ALA . 0.1 OUTLIER -40.5 -36.96 0.63 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.452 -0.794 . . . . 0.0 111.553 179.927 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 7.9 tmtt? -61.97 -51.51 67.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.365 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 131.02 52.99 0.1 OUTLIER Glycine 0 CA--C 1.523 0.569 0 N-CA-C 110.807 -0.917 . . . . 0.0 110.807 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 13.2 mtp -133.35 128.63 36.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.847 0.356 . . . . 0.0 110.433 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.471 ' N ' ' CD ' ' A' ' 75' ' ' LYS . 0.4 OUTLIER -117.26 171.66 7.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.043 179.8 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 172.39 139.12 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.458 179.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 86.6 t -88.25 155.35 3.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.296 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.534 ' CZ ' ' CG1' ' A' ' 4' ' ' VAL . 97.5 m-85 -143.85 109.3 5.12 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.077 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -71.71 164.0 26.76 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.004 -179.295 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.423 ' O ' ' HB ' ' A' ' 81' ' ' VAL . 20.3 t70 50.19 -95.9 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.713 179.88 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.449 ' O ' ' CG1' ' A' ' 81' ' ' VAL . 75.6 t 65.73 4.21 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 179.846 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.446 ' CG2' ' O ' ' A' ' 81' ' ' VAL . 88.4 t -159.54 130.5 3.77 Favored Pre-proline 0 CA--C 1.529 0.168 0 O-C-N 122.196 -0.315 . . . . 0.0 110.429 179.319 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.497 ' HD3' ' CG ' ' A' ' 92' ' ' TYR . 49.6 Cg_endo -70.22 -165.44 0.16 Allowed 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.705 2.27 . . . . 0.0 111.768 179.421 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -74.46 -53.71 9.0 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 179.372 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 10.0 mmtp -110.38 79.12 1.17 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.004 -0.543 . . . . 0.0 109.982 179.589 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 48.9 p90 -48.12 136.41 11.82 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.888 -179.648 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 75.3 m -123.3 115.71 22.14 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.15 179.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 2.7 mp -55.55 119.18 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.557 -179.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 107.79 51.13 0.76 Allowed Glycine 0 CA--C 1.523 0.564 0 N-CA-C 111.132 -0.787 . . . . 0.0 111.132 179.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -174.81 135.43 0.38 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.799 0.333 . . . . 0.0 110.784 179.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 11.5 m -79.32 129.74 34.76 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.181 -0.463 . . . . 0.0 109.881 179.565 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.497 ' CG ' ' HD3' ' A' ' 83' ' ' PRO . 35.1 m-85 -114.94 -22.19 9.71 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.186 -179.138 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.44 ' CB ' ' CD ' ' A' ' 94' ' ' PRO . . . -50.32 178.35 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 120.713 0.292 . . . . 0.0 110.527 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.44 ' CD ' ' CB ' ' A' ' 93' ' ' ALA . 47.6 Cg_endo . . . . . 0 C--O 1.249 1.066 0 C-N-CA 122.633 2.222 . . . . 0.0 112.023 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 7.3 p . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -75.76 142.43 25.64 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.593 2.195 . . . . 0.0 112.077 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.433 ' O ' ' CG2' ' A' ' 4' ' ' VAL . 12.7 mtpt -122.69 42.94 3.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.288 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.441 HG23 ' CE1' ' A' ' 78' ' ' PHE . 15.6 m 45.5 -173.89 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.079 -179.852 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.418 ' CG2' ' O ' ' A' ' 4' ' ' VAL . 0.8 OUTLIER -169.78 130.5 1.03 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.518 -179.705 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.462 ' CG ' HG12 ' A' ' 81' ' ' VAL . 8.4 m-85 -104.75 156.39 18.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.085 179.757 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 57.5 m -157.48 121.93 4.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.877 0.37 . . . . 0.0 110.596 -179.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.478 ' CG1' ' CD1' ' A' ' 88' ' ' ILE . 11.9 t -60.07 93.63 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.088 179.737 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -47.62 137.5 9.12 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.757 -179.764 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 4.5 tttt -53.8 140.81 28.9 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.405 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 94.17 34.99 6.18 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.63 -0.988 . . . . 0.0 110.63 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.2 t -74.64 148.24 40.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.814 0.34 . . . . 0.0 110.389 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 -134.33 152.56 51.88 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.459 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -55.21 -32.58 62.36 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.347 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.13 -12.49 28.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.292 -179.83 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 54.9 m80 -132.12 119.5 21.02 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.832 0.349 . . . . 0.0 110.795 -179.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -105.87 88.35 2.8 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.948 179.681 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -84.06 119.15 24.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.981 -179.485 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.427 HG22 ' CG2' ' A' ' 21' ' ' VAL . 17.9 m -108.51 -166.8 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.52 179.23 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.1 tt -140.95 79.18 1.68 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.724 179.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.427 ' CG2' HG22 ' A' ' 19' ' ' VAL . 3.1 t -92.58 88.45 2.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 179.673 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 7.0 mttt -142.37 161.53 37.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.58 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER 170.71 153.19 0.05 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.208 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.414 ' HG3' ' N ' ' A' ' 25' ' ' GLY . 1.5 pt-20 -88.63 -25.62 22.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.515 -179.835 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.414 ' N ' ' HG3' ' A' ' 24' ' ' GLU . . . -55.29 -38.53 68.71 Favored Glycine 0 CA--C 1.523 0.555 0 N-CA-C 110.724 -0.95 . . . . 0.0 110.724 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -131.65 176.17 8.55 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.82 0.343 . . . . 0.0 110.324 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.83 -167.49 1.35 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.378 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.427 ' O ' ' CG ' ' A' ' 71' ' ' GLU . 1.7 mtp -123.36 117.68 25.76 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.368 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.429 ' CB ' ' O ' ' A' ' 69' ' ' LEU . . . -127.52 -60.33 1.18 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.74 -179.783 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -142.85 171.39 14.11 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.325 -179.889 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.493 HG12 ' CD1' ' A' ' 52' ' ' TRP . 0.5 OUTLIER 171.51 139.58 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 121.099 0.476 . . . . 0.0 109.898 -179.786 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.432 ' CB ' ' HA ' ' A' ' 43' ' ' ALA . 1.8 pt-20 -134.79 178.51 6.96 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.178 -179.777 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.494 ' HG ' ' CE2' ' A' ' 66' ' ' PHE . 4.2 mt -118.31 172.66 7.3 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.988 0.423 . . . . 0.0 110.894 -179.608 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.47 -173.06 4.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.732 179.588 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -139.27 25.54 2.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.778 0.323 . . . . 0.0 110.709 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 48.18 31.83 2.76 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.757 179.767 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 164.12 47.43 0.02 OUTLIER Glycine 0 CA--C 1.523 0.551 0 N-CA-C 110.924 -0.87 . . . . 0.0 110.924 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 7.0 t -113.85 148.98 35.73 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 179.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -50.8 -29.73 12.39 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.333 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -171.34 150.11 2.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.31 179.844 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.483 ' CZ3' ' HG2' ' A' ' 67' ' ' ARG . 64.4 m95 -51.68 153.55 2.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.333 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 27.7 m -122.3 119.26 57.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.469 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.432 ' HA ' ' CB ' ' A' ' 32' ' ' GLU . . . -52.98 156.69 1.97 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.502 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -94.16 -176.57 4.02 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.478 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 88.3 m -128.79 106.53 8.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.558 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 31.9 mtmt -77.98 93.14 4.4 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.283 -0.417 . . . . 0.0 109.959 179.773 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -129.49 -41.45 0.25 Allowed Glycine 0 CA--C 1.523 0.584 0 N-CA-C 111.284 -0.726 . . . . 0.0 111.284 -179.549 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -49.28 -40.84 36.01 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.872 0.368 . . . . 0.0 110.628 -179.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 96.7 -33.23 5.84 Favored Glycine 0 CA--C 1.522 0.515 0 N-CA-C 110.196 -1.162 . . . . 0.0 110.196 -179.693 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -107.39 -24.55 6.43 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 110.574 -1.01 . . . . 0.0 110.574 179.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 17.4 m -149.24 178.03 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 120.813 0.339 . . . . 0.0 110.352 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . 0.493 ' CD1' HG12 ' A' ' 31' ' ' VAL . 8.4 m95 -104.79 135.92 45.27 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.103 -179.304 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.2 p -115.74 148.57 39.65 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.072 179.725 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -120.51 158.97 26.14 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.849 0.356 . . . . 0.0 110.671 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -114.45 119.6 37.43 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.297 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 8.2 p -91.76 157.2 17.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.514 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -117.76 -48.83 2.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.511 -179.911 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.402 ' HB2' ' HD2' ' A' ' 59' ' ' PRO . 5.7 pt-20 -102.76 159.09 30.37 Favored Pre-proline 0 C--N 1.331 -0.221 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.394 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.402 ' HD2' ' HB2' ' A' ' 58' ' ' GLU . 43.2 Cg_endo -67.29 -158.36 0.04 OUTLIER 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.211 1.941 . . . . 0.0 110.021 178.337 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.1 mt 58.74 109.63 0.01 OUTLIER 'General case' 0 N--CA 1.441 -0.923 0 CA-C-O 120.872 0.368 . . . . 0.0 110.926 178.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 24.6 mp0 -106.34 104.3 13.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.475 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -95.61 -165.23 34.59 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.92 -0.872 . . . . 0.0 110.92 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -74.84 132.23 15.41 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.613 2.209 . . . . 0.0 111.957 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 30.7 m-85 -94.11 151.32 19.58 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.501 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -131.04 140.96 50.16 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.0 -0.546 . . . . 0.0 109.773 179.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.494 ' CE2' ' HG ' ' A' ' 33' ' ' LEU . 76.5 m-85 -123.56 -178.94 4.16 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.074 0.464 . . . . 0.0 110.748 -179.516 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.483 ' HG2' ' CZ3' ' A' ' 41' ' ' TRP . 5.4 ptm180 -177.33 75.22 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.497 179.771 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.431 ' CE2' ' CE2' ' A' ' 78' ' ' PHE . 9.9 p90 -68.55 179.5 1.67 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.416 0.627 . . . . 0.0 111.315 -179.088 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.429 ' O ' ' CB ' ' A' ' 29' ' ' ALA . 15.2 mt -142.87 72.3 1.37 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.212 179.485 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 72.3 p -31.39 134.1 0.08 Allowed 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 115.642 -0.708 . . . . 0.0 112.447 -178.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.427 ' CG ' ' O ' ' A' ' 28' ' ' MET . 2.3 mm-40 -50.02 -27.15 5.08 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.421 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -63.77 -41.46 97.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.137 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 123.37 65.25 0.21 Allowed Glycine 0 CA--C 1.524 0.61 0 N-CA-C 110.848 -0.901 . . . . 0.0 110.848 179.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 4.2 mtt -155.39 145.48 21.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.793 0.33 . . . . 0.0 110.452 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.461 ' N ' ' CD ' ' A' ' 75' ' ' LYS . 0.0 OUTLIER -121.44 -177.24 3.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.095 179.985 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 173.14 176.03 0.11 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.498 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 97.8 t -131.41 162.21 39.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.15 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.441 ' CE1' HG23 ' A' ' 4' ' ' VAL . 54.9 m-85 -150.92 130.6 13.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.943 0.401 . . . . 0.0 110.656 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -120.98 164.48 16.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.234 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 7.5 t0 52.73 43.19 31.65 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.249 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.462 HG12 ' CG ' ' A' ' 6' ' ' PHE . 98.3 t -88.1 -5.2 10.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.081 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.419 ' CG2' ' O ' ' A' ' 81' ' ' VAL . 86.6 t -156.57 105.71 1.99 Allowed Pre-proline 0 CA--C 1.529 0.138 0 N-CA-C 110.224 -0.287 . . . . 0.0 110.224 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -73.67 -177.35 3.05 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.48 2.12 . . . . 0.0 112.224 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -77.39 130.53 37.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.342 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 63.56 44.36 5.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.258 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 47.9 p90 -50.49 140.94 13.05 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.583 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 2.9 m -106.69 118.83 37.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.196 179.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.478 ' CD1' ' CG1' ' A' ' 8' ' ' VAL . 48.5 mm -53.02 134.88 15.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.353 -179.91 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 102.24 28.42 6.46 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 110.668 -0.973 . . . . 0.0 110.668 -179.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -142.9 136.35 28.55 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.847 0.356 . . . . 0.0 110.51 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 91.8 m -88.12 113.57 23.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.308 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 45.3 m-85 -106.4 152.11 24.03 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.524 -179.745 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.431 ' CB ' ' CD ' ' A' ' 94' ' ' PRO . . . 170.07 177.74 0.09 OUTLIER Pre-proline 0 C--N 1.331 -0.197 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.387 179.769 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.431 ' CD ' ' CB ' ' A' ' 93' ' ' ALA . 48.7 Cg_endo . . . . . 0 C--O 1.249 1.057 0 C-N-CA 122.564 2.176 . . . . 0.0 112.0 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 16.0 m . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 110.187 -0.301 . . . . 0.0 110.187 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -78.48 129.32 9.3 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.571 2.181 . . . . 0.0 111.99 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 49.4 mttp -106.46 34.96 3.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.36 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.517 ' CG2' ' CE2' ' A' ' 78' ' ' PHE . 18.4 m -80.09 163.26 3.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.338 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -162.95 132.07 4.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.444 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.497 ' CD2' ' HB ' ' A' ' 21' ' ' VAL . 9.7 m-85 -103.49 177.69 4.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.185 -0.462 . . . . 0.0 109.926 179.674 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.9 m -167.17 127.7 1.51 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.763 0.316 . . . . 0.0 110.785 -179.628 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.41 HG12 ' HB2' ' A' ' 17' ' ' LEU . 87.7 t -70.77 81.54 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.264 179.529 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.437 ' N ' ' O ' ' A' ' 18' ' ' ALA . 1.7 mm-40 -49.25 178.74 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.816 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 5.8 mttp -67.98 -16.52 64.09 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.857 179.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -45.11 -34.69 4.41 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 111.006 -0.838 . . . . 0.0 111.006 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.431 ' HB3' ' HA ' ' A' ' 17' ' ' LEU . 1.4 p -56.95 127.22 30.76 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 179.564 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.6 p30 -109.56 -56.69 2.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.685 0.279 . . . . 0.0 110.766 -179.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 34.7 mm-40 -130.51 -58.96 1.03 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.906 0.384 . . . . 0.0 110.142 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.417 ' CG ' ' OD1' ' A' ' 55' ' ' ASP . 0.0 OUTLIER -108.35 -25.55 10.95 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.218 179.807 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.474 ' CE1' ' OD1' ' A' ' 55' ' ' ASP . 21.0 m80 -58.0 176.86 0.14 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.359 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.552 ' CD1' ' N ' ' A' ' 17' ' ' LEU . 0.0 OUTLIER -172.98 31.64 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.587 -179.238 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.437 ' O ' ' N ' ' A' ' 9' ' ' GLU . . . -18.93 119.95 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.333 1.053 . . . . 0.0 113.0 -179.854 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.468 HG13 ' CZ ' ' A' ' 66' ' ' PHE . 21.9 m -87.13 138.3 19.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.665 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.426 ' HA ' ' CG1' ' A' ' 51' ' ' VAL . 1.0 OUTLIER -97.94 42.99 1.08 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.387 179.795 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.497 ' HB ' ' CD2' ' A' ' 6' ' ' PHE . 2.7 p -50.63 100.53 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.301 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.22 165.08 32.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.265 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER 176.21 175.07 0.32 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.496 -179.83 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -104.54 154.82 19.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.341 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 94.64 -58.55 1.87 Allowed Glycine 0 CA--C 1.522 0.51 0 N-CA-C 110.71 -0.956 . . . . 0.0 110.71 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -91.92 173.86 7.63 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.778 0.323 . . . . 0.0 110.217 179.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -121.0 -173.14 2.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.528 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.43 ' O ' ' CG ' ' A' ' 71' ' ' GLU . 0.0 OUTLIER -118.39 125.74 50.62 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.504 -179.8 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.428 ' CB ' ' O ' ' A' ' 69' ' ' LEU . . . -121.54 -55.64 1.92 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.621 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -159.92 172.93 16.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.422 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.489 HG12 ' CD1' ' A' ' 52' ' ' TRP . 0.2 OUTLIER -174.4 136.83 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.373 0.606 . . . . 0.0 109.798 179.827 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -121.97 151.77 40.42 Favored 'General case' 0 N--CA 1.441 -0.918 0 CA-C-N 115.055 -0.975 . . . . 0.0 110.103 -178.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.467 ' HG ' ' CE2' ' A' ' 66' ' ' PHE . 3.1 mt -101.56 161.29 13.75 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.197 179.784 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.464 ' NH2' ' NE1' ' A' ' 41' ' ' TRP . 0.0 OUTLIER -124.65 -168.15 1.77 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.413 -179.92 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.425 ' CG ' ' O ' ' A' ' 34' ' ' ARG . 11.6 mt-10 -164.81 95.55 0.71 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.83 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -47.67 103.94 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.746 -179.589 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 136.01 -39.39 1.66 Allowed Glycine 0 CA--C 1.523 0.584 0 N-CA-C 110.785 -0.926 . . . . 0.0 110.785 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -69.27 176.35 3.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.856 0.36 . . . . 0.0 110.414 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -118.84 33.91 5.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.394 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -176.43 163.5 2.48 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.531 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.472 ' CZ3' ' HG2' ' A' ' 67' ' ' ARG . 57.8 m95 -88.56 175.9 7.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.322 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.9 m -137.24 97.68 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.175 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -50.76 127.61 18.73 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.6 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.426 ' CE ' ' HB2' ' A' ' 52' ' ' TRP . 0.0 OUTLIER -61.32 -170.12 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.115 179.914 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 92.9 m -150.78 117.48 5.8 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.156 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 2.4 ptmt -69.12 63.5 0.13 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.387 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -86.83 -27.81 28.04 Favored Glycine 0 CA--C 1.521 0.46 0 N-CA-C 110.383 -1.087 . . . . 0.0 110.383 179.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.436 ' HG2' ' CG2' ' A' ' 51' ' ' VAL . 11.6 tp10 -91.99 125.28 36.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.895 0.379 . . . . 0.0 110.246 179.847 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -71.89 66.82 1.12 Allowed Glycine 0 CA--C 1.522 0.476 0 N-CA-C 110.713 -0.955 . . . . 0.0 110.713 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 160.18 -27.55 0.33 Allowed Glycine 0 CA--C 1.524 0.595 0 N-CA-C 111.175 -0.77 . . . . 0.0 111.175 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.436 ' CG2' ' HG2' ' A' ' 48' ' ' GLU . 3.6 m -148.4 -176.81 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.062 0.458 . . . . 0.0 111.064 -179.692 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . 0.489 ' CD1' HG12 ' A' ' 31' ' ' VAL . 4.3 m95 -104.76 136.45 44.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.939 -179.832 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.435 HG21 ' CB ' ' A' ' 18' ' ' ALA . 3.9 p -120.83 144.62 48.25 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.907 0.384 . . . . 0.0 110.662 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.435 ' CB ' HD13 ' A' ' 33' ' ' LEU . 89.5 t80 -140.75 86.14 2.03 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.016 179.638 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.474 ' OD1' ' CE1' ' A' ' 16' ' ' HIS . 10.7 t0 -48.71 151.1 1.24 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.548 -179.794 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 4.9 t -121.94 121.96 38.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.329 179.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -115.47 50.49 1.0 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.55 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -142.89 154.17 61.8 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.331 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -71.15 -40.44 3.25 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.715 2.277 . . . . 0.0 112.068 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 4.5 mt -73.04 153.97 40.65 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.444 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.73 100.56 2.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.319 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -114.74 -152.42 10.37 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 110.723 -0.951 . . . . 0.0 110.723 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -80.99 149.93 17.84 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.66 2.24 . . . . 0.0 112.009 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.425 ' HB3' ' CD2' ' A' ' 33' ' ' LEU . 45.6 m-85 -102.57 164.3 11.73 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.549 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.42 ' HB2' ' CB ' ' A' ' 34' ' ' ARG . 2.7 m-80 -136.6 139.56 42.21 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.801 179.631 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.468 ' CZ ' HG13 ' A' ' 19' ' ' VAL . 58.5 m-85 -127.31 165.13 20.28 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.135 0.493 . . . . 0.0 111.204 -179.46 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.472 ' HG2' ' CZ3' ' A' ' 41' ' ' TRP . 0.0 OUTLIER -156.99 61.08 0.51 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.48 179.578 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.435 ' HA ' ' HA ' ' A' ' 31' ' ' VAL . 3.1 p90 -52.55 170.72 0.07 Allowed 'General case' 0 CA--C 1.516 -0.338 0 CA-C-O 121.483 0.659 . . . . 0.0 111.398 -179.094 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.433 ' CD2' ' HB3' ' A' ' 75' ' ' LYS . 5.6 mt -135.42 70.91 1.43 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 114.833 -1.076 . . . . 0.0 108.874 179.544 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -30.73 140.61 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.28 0.632 . . . . 0.0 112.317 -178.726 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.43 ' CG ' ' O ' ' A' ' 28' ' ' MET . 13.8 mt-10 -49.79 -47.28 51.3 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.935 -179.455 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.23 47.16 1.9 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.815 0.34 . . . . 0.0 110.844 -179.846 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -133.51 -108.94 1.09 Allowed Glycine 0 CA--C 1.522 0.526 0 N-CA-C 110.609 -0.996 . . . . 0.0 110.609 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 10.2 ptt? -165.9 163.2 18.6 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.757 0.313 . . . . 0.0 110.16 179.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.433 ' HB3' ' CD2' ' A' ' 69' ' ' LEU . 0.0 OUTLIER -98.44 -177.7 3.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.362 -179.922 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.423 ' O ' ' CB ' ' A' ' 67' ' ' ARG . 0.7 OUTLIER -179.4 -167.57 0.1 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.533 179.952 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 96.9 t -134.35 145.7 32.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.128 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.517 ' CE2' ' CG2' ' A' ' 4' ' ' VAL . 52.7 m-85 -134.73 134.64 41.23 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.522 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -113.71 155.72 25.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.444 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 51.08 59.21 4.78 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.445 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.413 ' HA ' ' HA ' ' A' ' 93' ' ' ALA . 95.1 t -94.55 -17.38 7.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.964 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.434 ' CG1' ' HD2' ' A' ' 83' ' ' PRO . 82.5 t -139.71 140.1 23.89 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-O 120.629 0.252 . . . . 0.0 110.389 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.434 ' HD2' ' CG1' ' A' ' 82' ' ' VAL . 48.1 Cg_endo -72.49 176.96 8.01 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.652 2.235 . . . . 0.0 112.092 179.877 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -58.65 -32.24 68.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.254 -0.43 . . . . 0.0 109.976 179.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.62 85.66 2.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.131 179.777 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . 0.403 ' HB3' ' CG1' ' A' ' 82' ' ' VAL . 16.9 p90 -52.09 144.74 11.61 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.684 -179.72 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -123.02 102.41 7.98 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.854 179.572 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.406 ' CD1' ' OG ' ' A' ' 12' ' ' SER . 3.3 mt -44.33 118.26 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.823 -179.712 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 114.41 20.61 5.8 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 110.979 -0.848 . . . . 0.0 110.979 -179.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -136.25 133.11 36.66 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 179.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 56.5 m -91.96 93.56 8.85 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.899 0.381 . . . . 0.0 111.01 -179.657 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 47.4 m-85 -79.55 -153.31 0.08 Allowed 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 178.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.463 ' CB ' ' CD ' ' A' ' 94' ' ' PRO . . . 71.58 179.48 0.05 OUTLIER Pre-proline 0 C--N 1.331 -0.222 0 CA-C-O 120.696 0.284 . . . . 0.0 110.683 179.525 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.463 ' CD ' ' CB ' ' A' ' 93' ' ' ALA . 49.1 Cg_endo . . . . . 0 C--O 1.249 1.042 0 C-N-CA 122.633 2.222 . . . . 0.0 111.99 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 17.6 m . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -77.7 171.61 17.12 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.581 2.187 . . . . 0.0 112.01 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 35.9 mttp -149.93 64.28 0.98 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.242 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.437 HG11 ' N ' ' A' ' 5' ' ' THR . 1.2 p 46.3 -170.98 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.544 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.437 ' N ' HG11 ' A' ' 4' ' ' VAL . 0.6 OUTLIER -177.27 173.12 1.8 Allowed 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.458 -179.996 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 60.6 m-85 -141.64 172.23 12.97 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.048 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.5 m -166.72 112.57 0.8 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.4 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 13.1 t -59.57 113.27 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.14 179.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.92 173.29 12.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.648 -179.661 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -75.48 153.96 37.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.402 -179.931 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 95.26 23.51 19.34 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 51.0 m -80.01 127.43 32.28 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.761 0.315 . . . . 0.0 110.288 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -116.31 -161.74 0.81 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.189 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -51.65 -56.65 12.44 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.485 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.405 ' HG2' ' N ' ' A' ' 16' ' ' HIS . 0.0 OUTLIER -106.15 -28.08 10.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.636 -179.763 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.405 ' N ' ' HG2' ' A' ' 15' ' ' LYS . 14.9 m80 -57.4 112.31 1.37 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.492 -179.897 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -120.85 99.77 6.71 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.181 -0.463 . . . . 0.0 109.897 179.786 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -95.36 128.25 42.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.53 -179.673 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 28.5 m -125.24 141.89 43.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.213 179.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -91.92 64.99 4.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.403 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 14.2 t -68.15 93.28 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.367 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -157.97 144.73 17.8 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.446 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.509 ' N ' ' CD1' ' A' ' 23' ' ' TYR . 0.0 OUTLIER -153.05 -175.16 5.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.229 179.841 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -115.52 96.31 5.58 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.354 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 155.82 -59.71 0.37 Allowed Glycine 0 CA--C 1.524 0.613 0 N-CA-C 110.807 -0.917 . . . . 0.0 110.807 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.4 ' HB2' ' CZ ' ' A' ' 23' ' ' TYR . 0.4 OUTLIER -83.52 -174.79 5.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.733 0.301 . . . . 0.0 110.356 -179.995 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -129.81 -179.3 5.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.637 -179.786 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.433 ' O ' ' CG ' ' A' ' 71' ' ' GLU . 0.0 OUTLIER -105.39 122.91 46.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.429 -179.967 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.435 ' CB ' ' O ' ' A' ' 69' ' ' LEU . . . -128.72 -53.67 1.24 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.787 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -163.31 153.38 15.64 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.794 0.33 . . . . 0.0 110.653 -179.866 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.483 HG23 ' CD1' ' A' ' 52' ' ' TRP . 4.0 t -135.78 137.62 48.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.108 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -136.33 134.55 38.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.758 0.313 . . . . 0.0 110.463 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.8 mt -105.14 179.06 4.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.986 0.422 . . . . 0.0 110.63 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.481 ' HB2' ' CE3' ' A' ' 41' ' ' TRP . 8.6 ttt85 -170.15 158.49 6.95 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.946 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.428 ' N ' ' HG2' ' A' ' 34' ' ' ARG . 5.4 mp0 -117.29 -81.94 0.63 Allowed 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 179.81 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 168.87 118.14 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.459 179.31 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 52.17 38.2 48.08 Favored Glycine 0 CA--C 1.523 0.532 0 N-CA-C 110.816 -0.914 . . . . 0.0 110.816 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 12.0 t -103.56 -76.71 0.58 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.742 0.306 . . . . 0.0 110.459 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -157.36 52.61 0.48 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.423 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 54.69 178.43 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.073 -179.835 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.481 ' CE3' ' HB2' ' A' ' 34' ' ' ARG . 93.9 m95 -59.04 136.74 58.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.847 0.356 . . . . 0.0 110.161 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.476 HG23 ' CZ ' ' A' ' 54' ' ' PHE . 34.6 m -119.73 111.93 34.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.176 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -52.08 137.81 26.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.253 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.23 -171.29 0.05 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.563 -179.749 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 55.5 m -138.1 109.74 7.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.063 179.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.476 ' HG2' ' CZ3' ' A' ' 52' ' ' TRP . 36.4 mtpt -72.69 77.01 1.11 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.514 -179.754 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -102.66 -55.33 0.84 Allowed Glycine 0 CA--C 1.522 0.528 0 N-CA-C 110.473 -1.051 . . . . 0.0 110.473 179.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.41 ' O ' ' N ' ' A' ' 50' ' ' GLY . 11.8 tt0 -65.3 113.58 4.14 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.838 0.351 . . . . 0.0 110.065 179.806 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -61.98 79.22 0.02 OUTLIER Glycine 0 CA--C 1.523 0.57 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 -179.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.41 ' N ' ' O ' ' A' ' 48' ' ' GLU . . . 152.02 -42.54 0.69 Allowed Glycine 0 CA--C 1.523 0.561 0 N-CA-C 111.242 -0.743 . . . . 0.0 111.242 179.801 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 30.0 m -135.46 168.98 21.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.889 0.376 . . . . 0.0 110.806 -179.577 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . 0.483 ' CD1' HG23 ' A' ' 31' ' ' VAL . 7.5 m95 -99.84 140.74 33.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.571 -179.899 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 14.1 p -128.5 146.21 50.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.148 179.767 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.476 ' CZ ' HG23 ' A' ' 42' ' ' VAL . 33.2 t80 -125.04 140.88 52.51 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.535 -179.791 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -97.26 87.52 4.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.255 179.877 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.4 m -69.84 175.8 4.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.359 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 11.3 tt0 -161.67 38.49 0.13 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.296 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -131.29 165.52 34.68 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.427 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -93.59 7.26 2.67 Favored 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 123.849 3.032 . . . . 0.0 112.578 179.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 2.2 tp -59.86 153.29 21.19 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.782 0.325 . . . . 0.0 110.351 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.2 46.12 0.98 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.215 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -122.77 -146.44 7.18 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.67 -0.972 . . . . 0.0 110.67 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -82.73 153.36 15.18 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.719 2.279 . . . . 0.0 112.195 -179.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -101.16 162.19 13.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.139 179.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.44 ' OD1' ' N ' ' A' ' 65' ' ' ASN . 0.0 OUTLIER -127.14 113.11 15.96 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 179.511 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.426 ' O ' ' HG3' ' A' ' 67' ' ' ARG . 5.5 m-85 -97.36 -174.08 2.83 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.871 -179.298 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.433 ' CD ' ' CZ2' ' A' ' 41' ' ' TRP . 2.3 mtp180 170.21 78.04 0.0 OUTLIER 'General case' 0 CA--C 1.521 -0.137 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.88 178.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -79.88 -179.73 7.12 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.147 179.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.435 ' O ' ' CB ' ' A' ' 29' ' ' ALA . 1.0 OUTLIER -136.31 68.67 1.43 Allowed 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 179.642 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 7.1 p -35.11 139.82 0.09 Allowed 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.929 -179.079 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.433 ' CG ' ' O ' ' A' ' 28' ' ' MET . 7.7 mm-40 -50.93 -54.06 27.49 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.605 -179.672 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.4 tptm -116.96 71.46 0.8 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.498 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -167.87 -102.93 0.16 Allowed Glycine 0 CA--C 1.521 0.459 0 N-CA-C 110.552 -1.019 . . . . 0.0 110.552 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 7.6 ptt? 169.13 -177.09 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.774 0.321 . . . . 0.0 110.163 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 4.2 mptt -75.44 -178.08 3.89 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.263 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 175.17 136.36 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.338 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.423 ' HA ' ' HG3' ' A' ' 67' ' ' ARG . 95.9 t -84.35 159.24 3.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.267 179.903 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.431 ' CE1' HG12 ' A' ' 4' ' ' VAL . 86.8 m-85 -150.16 120.03 7.11 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.32 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -115.99 151.81 34.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.458 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 61.95 34.79 16.57 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.357 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.424 ' O ' ' CG1' ' A' ' 81' ' ' VAL . 49.5 t -78.08 -0.5 3.39 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.935 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.437 ' CG1' ' HD2' ' A' ' 83' ' ' PRO . 84.1 t -154.88 139.91 12.06 Favored Pre-proline 0 C--N 1.333 -0.115 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 179.271 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.437 ' HD2' ' CG1' ' A' ' 82' ' ' VAL . 50.3 Cg_endo -71.72 -170.16 0.5 Allowed 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.647 2.231 . . . . 0.0 111.982 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -75.56 -28.57 59.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.188 -0.46 . . . . 0.0 109.96 179.51 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 13.7 mttt -139.25 74.95 1.49 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.982 179.783 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 25.9 p90 -48.3 151.78 0.99 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.876 -179.63 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 2.4 m -136.9 110.07 7.79 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.828 -0.623 . . . . 0.0 109.991 179.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 2.8 mp -46.12 105.96 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.845 -179.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 128.25 44.55 0.21 Allowed Glycine 0 CA--C 1.523 0.541 0 N-CA-C 110.619 -0.992 . . . . 0.0 110.619 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -157.63 160.8 38.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.796 0.332 . . . . 0.0 110.339 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 39.9 m -113.51 102.04 9.92 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.555 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 29.9 m-85 -103.95 144.61 31.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.615 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.419 ' HA ' ' HA ' ' A' ' 81' ' ' VAL . . . 172.46 171.42 0.22 Allowed Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.41 179.701 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo . . . . . 0 C--O 1.249 1.063 0 C-N-CA 122.61 2.207 . . . . 0.0 112.082 -179.956 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 11.3 p . . . . . 0 N--CA 1.493 1.69 0 CA-C-O 120.648 0.261 . . . . 0.0 110.359 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -81.69 98.13 0.97 Allowed 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.678 2.252 . . . . 0.0 112.085 -179.915 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 7.8 mtmt -151.22 82.33 1.31 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.452 179.98 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.476 HG23 ' CE2' ' A' ' 78' ' ' PHE . 3.7 m -53.99 -178.99 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.121 179.866 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.2 p -152.54 131.17 12.3 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.42 179.949 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 16.6 m-85 -98.47 171.57 8.08 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.248 179.878 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -164.44 105.86 0.86 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.298 179.996 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 60.5 t -60.34 101.63 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.297 179.974 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -64.05 -175.72 0.16 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.315 -179.952 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 5.7 pttm -86.25 10.79 13.66 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.168 179.972 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -69.27 -29.71 71.86 Favored Glycine 0 CA--C 1.522 0.487 0 N-CA-C 110.571 -1.012 . . . . 0.0 110.571 179.79 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 53.2 p -53.0 106.11 0.15 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.817 0.341 . . . . 0.0 110.264 179.894 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 10.1 m-80 -89.34 -68.14 0.79 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.337 -179.97 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -135.8 -54.6 0.77 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.393 179.963 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.62 -27.39 8.57 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.392 179.926 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -52.24 179.44 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.358 179.987 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 24.3 tp -159.18 83.42 0.78 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.249 179.967 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.415 ' O ' ' CG1' ' A' ' 19' ' ' VAL . . . -73.79 158.37 34.71 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.511 -179.906 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.415 ' CG1' ' O ' ' A' ' 18' ' ' ALA . 35.4 m -157.55 139.17 5.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.347 179.845 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -97.52 57.87 1.42 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.431 179.987 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 18.3 t -58.8 94.47 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.359 179.975 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.5 ttpm? -152.27 149.01 28.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.448 -179.929 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 12.9 p90 -169.19 137.89 2.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.309 179.916 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -55.37 152.77 8.11 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.27 -179.979 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 113.91 -77.09 0.25 Allowed Glycine 0 CA--C 1.523 0.569 0 N-CA-C 110.736 -0.946 . . . . 0.0 110.736 -179.931 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -103.81 179.94 4.13 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.801 0.334 . . . . 0.0 110.347 179.933 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.52 -160.87 0.74 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.513 -179.813 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.42 ' O ' ' CG ' ' A' ' 71' ' ' GLU . 19.9 mmt -122.72 127.85 49.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.542 -179.77 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.431 ' HB1' ' N ' ' A' ' 71' ' ' GLU . . . -117.23 -55.69 2.3 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.58 -179.933 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -158.55 165.23 35.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.324 -179.937 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 67.2 t -143.64 149.4 18.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.956 0.407 . . . . 0.0 110.451 179.939 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.417 ' OE2' ' N ' ' A' ' 43' ' ' ALA . 9.7 tp10 -134.78 136.99 42.99 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-N 115.96 -0.563 . . . . 0.0 109.79 -179.431 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.484 HD22 ' CD2' ' A' ' 54' ' ' PHE . 13.0 tp -115.89 152.26 33.73 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 -179.918 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.474 ' HB2' ' CE3' ' A' ' 41' ' ' TRP . 0.0 OUTLIER -128.39 176.19 7.91 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.826 0.346 . . . . 0.0 110.543 -179.818 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.419 ' O ' ' N ' ' A' ' 37' ' ' GLY . 1.5 tm-20 -138.85 12.41 2.68 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.16 -179.907 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER 67.48 -68.77 0.15 Allowed 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 120.822 0.344 . . . . 0.0 110.519 -179.973 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 35' ' ' GLU . . . -68.75 -26.33 74.59 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 110.846 -0.901 . . . . 0.0 110.846 -179.951 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 8.6 t -50.87 140.41 15.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.76 0.314 . . . . 0.0 110.357 -179.895 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 16.5 t0 -49.38 -30.9 8.45 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.472 -179.999 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -170.77 172.56 5.65 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.431 179.892 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.474 ' CE3' ' HB2' ' A' ' 34' ' ' ARG . 69.3 m95 -54.87 147.34 15.38 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.262 179.922 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 6.1 m -124.77 109.91 23.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.298 179.929 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.417 ' N ' ' OE2' ' A' ' 32' ' ' GLU . . . -50.54 135.12 23.27 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.482 -179.881 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -53.69 -171.64 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.624 -179.925 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 58.0 m -128.85 93.17 3.55 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.498 -179.896 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 7.0 ptmt -71.05 84.57 0.71 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.403 179.942 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -144.21 30.21 1.89 Allowed Glycine 0 CA--C 1.523 0.533 0 N-CA-C 110.473 -1.051 . . . . 0.0 110.473 179.934 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.436 ' CB ' HG21 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -108.77 174.05 6.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.843 0.354 . . . . 0.0 110.503 -179.879 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -59.82 -31.63 72.36 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 110.718 -0.953 . . . . 0.0 110.718 179.968 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -176.6 35.41 0.09 OUTLIER Glycine 0 CA--C 1.524 0.595 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 -179.978 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.436 HG21 ' CB ' ' A' ' 48' ' ' GLU . 6.6 m -152.16 -179.93 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.776 0.322 . . . . 0.0 110.425 179.803 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 7.0 m95 -108.44 140.0 42.37 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.438 -179.644 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.413 HG21 ' N ' ' A' ' 18' ' ' ALA . 0.0 OUTLIER -127.69 177.0 7.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.126 179.809 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.484 ' CD2' HD22 ' A' ' 33' ' ' LEU . 77.4 t80 -161.77 119.36 2.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.403 179.926 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.443 ' O ' ' CD2' ' A' ' 54' ' ' PHE . 28.3 p-10 -66.87 -177.34 0.6 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.402 -179.988 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 59.24 178.93 0.08 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.443 179.897 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 174.39 50.17 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.218 179.941 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -50.47 121.41 14.12 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.444 -179.847 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -71.56 59.73 2.66 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.444 2.096 . . . . 0.0 112.056 179.87 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -114.88 1.29 14.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.256 179.956 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -177.89 124.44 0.12 Allowed 'General case' 0 C--N 1.334 -0.092 0 CA-C-O 120.778 0.323 . . . . 0.0 110.367 179.939 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.406 ' N ' ' HD2' ' A' ' 63' ' ' PRO . . . -74.23 -54.94 5.94 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 110.814 -0.914 . . . . 0.0 110.814 -179.881 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.406 ' HD2' ' N ' ' A' ' 62' ' ' GLY . 48.0 Cg_endo -74.85 122.02 7.01 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.531 2.154 . . . . 0.0 112.214 -179.932 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -99.46 137.06 38.49 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.082 179.818 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 12.8 m-80 -98.59 134.24 41.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.803 0.335 . . . . 0.0 110.343 -179.923 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -119.92 174.31 6.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.455 179.993 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 12.6 ptm180 -173.52 76.36 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.0 -0.546 . . . . 0.0 109.92 179.923 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -61.42 175.19 0.61 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.192 0.52 . . . . 0.0 110.809 -179.56 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.417 ' O ' ' CB ' ' A' ' 29' ' ' ALA . 8.0 mt -132.02 65.41 1.57 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.129 179.569 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 14.0 p -26.99 135.0 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.644 0.778 . . . . 0.0 112.633 -178.987 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.431 ' N ' ' HB1' ' A' ' 29' ' ' ALA . 16.5 mt-10 -49.74 -26.0 3.46 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.54 -179.713 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.5 tmtm? -64.81 -40.31 95.0 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.317 179.898 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 118.86 53.46 0.28 Allowed Glycine 0 CA--C 1.524 0.604 0 N-CA-C 110.798 -0.921 . . . . 0.0 110.798 179.938 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -144.71 145.61 31.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.797 0.332 . . . . 0.0 110.47 179.964 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.417 ' CG ' HD21 ' A' ' 69' ' ' LEU . 0.8 OUTLIER -127.35 -178.87 4.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.312 179.976 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 174.31 162.92 0.2 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.526 179.964 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 86.9 t -107.18 160.77 6.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.248 179.854 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.476 ' CE2' HG23 ' A' ' 4' ' ' VAL . 71.8 m-85 -151.19 130.39 12.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.525 -179.92 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -115.0 160.56 19.44 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.313 -179.924 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 52.32 55.12 9.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.355 179.932 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.417 ' O ' ' CG1' ' A' ' 81' ' ' VAL . 75.6 t -102.05 2.15 10.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.034 179.957 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 89.3 t -156.26 131.45 5.37 Favored Pre-proline 0 C--N 1.332 -0.154 0 N-CA-C 110.229 -0.286 . . . . 0.0 110.229 179.556 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -70.98 -171.16 0.54 Allowed 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.516 2.144 . . . . 0.0 111.863 179.761 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -74.0 -27.85 61.17 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.883 179.386 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 4.0 tptt -138.46 77.66 1.64 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.093 179.779 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 51.0 p90 -55.05 137.28 46.74 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.589 -179.795 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 5.3 m -116.32 107.29 14.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.12 179.717 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 2.7 mp -47.76 108.39 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.582 -179.872 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 126.05 43.36 0.28 Allowed Glycine 0 CA--C 1.523 0.569 0 N-CA-C 110.587 -1.005 . . . . 0.0 110.587 -179.864 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.485 ' HB2' ' CZ ' ' A' ' 92' ' ' TYR . . . -153.8 -176.32 5.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.796 0.331 . . . . 0.0 110.389 -179.948 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 89.9 m -129.74 104.44 7.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.669 -179.84 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.485 ' CZ ' ' HB2' ' A' ' 90' ' ' ALA . 18.5 m-85 -106.97 140.27 40.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.463 179.901 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.407 ' CB ' ' HD2' ' A' ' 94' ' ' PRO . . . 171.75 171.7 0.2 Allowed Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.389 179.593 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.407 ' HD2' ' CB ' ' A' ' 93' ' ' ALA . 47.6 Cg_endo . . . . . 0 C--O 1.249 1.032 0 C-N-CA 122.606 2.204 . . . . 0.0 111.984 179.804 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 4.7 t . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -76.55 160.61 34.9 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.584 2.189 . . . . 0.0 112.064 -179.952 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.436 ' O ' ' CG2' ' A' ' 4' ' ' VAL . 18.4 mtmt -141.07 65.65 1.39 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.403 179.921 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.472 HG23 ' CE1' ' A' ' 78' ' ' PHE . 19.5 m 44.22 -172.38 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.338 179.807 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.426 ' CG2' ' O ' ' A' ' 4' ' ' VAL . 0.5 OUTLIER -179.55 137.64 0.13 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.301 -179.761 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.428 ' N ' ' CD1' ' A' ' 6' ' ' PHE . 8.2 m-85 -116.13 178.4 4.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.061 179.855 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 48.2 m -164.43 124.06 1.96 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.873 0.368 . . . . 0.0 110.514 -179.94 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 90.1 t -58.64 90.33 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.449 179.99 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.429 ' HG3' ' CG1' ' A' ' 51' ' ' VAL . 1.9 mm-40 -59.1 176.04 0.25 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.432 -179.968 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 5.1 mtmt -69.72 155.37 40.62 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.27 179.878 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 103.37 -33.44 6.58 Favored Glycine 0 CA--C 1.523 0.533 0 N-CA-C 110.851 -0.899 . . . . 0.0 110.851 179.968 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 70.9 m -50.67 112.36 0.69 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.684 0.278 . . . . 0.0 110.316 179.969 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -112.69 -67.06 1.03 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.937 -179.685 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -141.46 -48.66 0.39 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.643 0.258 . . . . 0.0 110.93 -179.702 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 8.9 ptpt -103.93 -39.38 6.62 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.766 0.317 . . . . 0.0 110.498 -179.944 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 13.2 m80 -65.94 110.26 2.83 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 179.794 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -107.21 94.87 5.33 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.41 -179.772 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.431 ' HB3' ' CG2' ' A' ' 53' ' ' THR . . . -95.34 120.44 35.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.381 179.987 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.405 HG22 HG13 ' A' ' 21' ' ' VAL . 21.1 m -114.42 144.24 22.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.218 179.899 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.4 ' HA ' HG13 ' A' ' 51' ' ' VAL . 1.5 tt -97.54 62.53 1.7 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.758 -179.718 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.523 ' CG1' ' CD1' ' A' ' 52' ' ' TRP . 3.4 p -81.75 126.02 39.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.971 0.415 . . . . 0.0 110.103 179.74 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.494 ' O ' ' CG ' ' A' ' 23' ' ' TYR . 5.8 tttp -166.33 -66.98 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.312 -179.863 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.494 ' CG ' ' O ' ' A' ' 22' ' ' LYS . 30.0 p90 44.97 -172.96 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.906 179.824 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -122.06 177.66 5.23 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.353 -179.724 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 96.95 -40.7 2.49 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 110.772 -0.931 . . . . 0.0 110.772 179.949 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -128.99 -175.11 3.45 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.812 0.339 . . . . 0.0 110.266 179.968 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -113.25 -178.98 3.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.548 -179.98 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.429 ' O ' ' CG ' ' A' ' 71' ' ' GLU . 0.4 OUTLIER -128.56 126.66 40.78 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.462 -179.882 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.449 ' HB1' ' N ' ' A' ' 71' ' ' GLU . . . -120.12 -59.85 1.75 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.393 179.957 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -142.8 159.0 43.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.291 179.986 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.449 HG23 ' CD1' ' A' ' 52' ' ' TRP . 47.2 t -138.54 145.98 27.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.038 0.447 . . . . 0.0 110.435 179.96 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.455 ' HB2' ' HA ' ' A' ' 43' ' ' ALA . 11.6 tt0 -139.79 129.53 24.58 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.891 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.454 ' HB2' ' CE2' ' A' ' 66' ' ' PHE . 5.6 tp -110.35 150.19 29.13 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.962 0.411 . . . . 0.0 110.049 -179.027 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.421 ' HG3' ' CD2' ' A' ' 41' ' ' TRP . 0.5 OUTLIER -106.22 -156.31 0.57 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.548 179.462 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -149.73 -87.69 0.08 Allowed 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 121.235 -0.186 . . . . 0.0 110.631 179.883 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 17.3 t-160 175.48 -56.97 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 -179.976 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -91.36 -25.82 22.65 Favored Glycine 0 CA--C 1.522 0.513 0 N-CA-C 110.467 -1.053 . . . . 0.0 110.467 179.607 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.41 ' O ' ' CB ' ' A' ' 39' ' ' ASP . 0.1 OUTLIER -50.66 -31.66 16.87 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.871 0.367 . . . . 0.0 110.327 179.87 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.41 ' CB ' ' O ' ' A' ' 38' ' ' SER . 11.2 t0 81.75 -52.33 0.25 Allowed 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.882 179.856 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -98.24 177.38 5.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.969 0.414 . . . . 0.0 110.753 -179.619 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.421 ' CD2' ' HG3' ' A' ' 34' ' ' ARG . 59.8 m95 -95.96 171.97 8.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.383 -179.946 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.434 ' CG2' ' O ' ' A' ' 33' ' ' LEU . 5.1 m -146.86 105.64 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.201 179.621 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.455 ' HA ' ' HB2' ' A' ' 32' ' ' GLU . . . -49.94 136.49 18.39 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.697 -179.693 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -63.33 -173.09 0.06 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.896 -179.791 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 30.2 m -137.66 99.97 4.08 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.372 -179.999 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 6.5 ptpt -64.51 80.38 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.47 -179.905 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -113.11 -24.78 4.69 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.88 -0.888 . . . . 0.0 110.88 -179.969 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -72.73 -37.28 67.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.894 0.378 . . . . 0.0 110.473 179.987 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 95.65 -38.68 3.04 Favored Glycine 0 CA--C 1.523 0.541 0 N-CA-C 110.274 -1.13 . . . . 0.0 110.274 -179.654 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -102.17 -29.9 5.89 Favored Glycine 0 CA--C 1.523 0.539 0 N-CA-C 110.42 -1.072 . . . . 0.0 110.42 179.734 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.429 ' CG1' ' HG3' ' A' ' 9' ' ' GLU . 8.0 m -138.49 -178.47 2.0 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.768 0.318 . . . . 0.0 110.273 179.773 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . 0.523 ' CD1' ' CG1' ' A' ' 21' ' ' VAL . 5.5 m95 -114.97 136.98 52.53 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.893 0.378 . . . . 0.0 110.772 -179.414 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.431 ' CG2' ' HB3' ' A' ' 18' ' ' ALA . 10.2 p -126.39 151.08 48.14 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.732 179.452 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.407 ' CZ ' ' HB ' ' A' ' 42' ' ' VAL . 63.9 t80 -141.24 152.79 44.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.941 0.401 . . . . 0.0 110.921 -179.634 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -94.02 102.06 14.12 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.106 179.714 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.1 m -83.73 139.11 32.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.712 -179.702 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -100.06 -49.93 4.15 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.243 179.823 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.415 ' HA ' ' HD3' ' A' ' 59' ' ' PRO . 12.3 pt-20 -74.3 126.46 88.97 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.313 179.963 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 58' ' ' GLU . 38.0 Cg_endo -91.97 71.28 0.78 Allowed 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 123.159 2.572 . . . . 0.0 112.066 179.627 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -106.84 -30.34 8.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.058 0.456 . . . . 0.0 110.375 -179.936 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 44.33 36.48 1.61 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.942 179.933 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -94.04 -144.71 16.28 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 110.895 -0.882 . . . . 0.0 110.895 -179.83 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -78.63 120.79 4.88 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.608 2.205 . . . . 0.0 112.291 -179.821 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.403 ' HB3' ' CD1' ' A' ' 33' ' ' LEU . 30.7 m-85 -90.76 178.4 6.07 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.1 179.81 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -152.78 139.77 19.17 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.936 179.81 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.454 ' CE2' ' HB2' ' A' ' 33' ' ' LEU . 11.0 m-85 -127.68 177.25 6.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.05 0.452 . . . . 0.0 111.136 -179.775 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.412 ' CB ' ' O ' ' A' ' 76' ' ' ASN . 0.0 OUTLIER -177.16 66.89 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.592 179.976 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -58.47 173.65 0.37 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.252 -179.277 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 10.2 mt -123.94 83.33 2.13 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.307 -0.86 . . . . 0.0 108.896 178.884 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.418 ' OG1' ' N ' ' A' ' 74' ' ' MET . 1.6 p -35.55 137.08 0.2 Allowed 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.799 -178.954 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.449 ' N ' ' HB1' ' A' ' 29' ' ' ALA . 21.0 mt-10 -46.71 -34.51 5.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.171 -179.16 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.99 60.03 0.59 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.776 0.322 . . . . 0.0 111.017 179.867 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -148.79 -107.18 0.43 Allowed Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.803 -0.919 . . . . 0.0 110.803 179.646 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.418 ' N ' ' OG1' ' A' ' 70' ' ' THR . 21.0 ptm -159.9 -176.42 5.69 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.846 0.355 . . . . 0.0 110.182 179.864 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.01 159.7 20.48 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.638 -179.762 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.412 ' O ' ' CB ' ' A' ' 67' ' ' ARG . 10.7 m-20 -152.43 175.06 13.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.098 -179.953 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 49.5 t -110.24 160.98 8.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.434 -179.907 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.472 ' CE1' HG23 ' A' ' 4' ' ' VAL . 75.9 m-85 -149.85 129.2 12.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.396 -179.922 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 15.2 p-10 -116.47 164.97 13.77 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.35 -179.999 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 32.3 m-20 52.35 27.29 4.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.524 179.959 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 88.3 t -61.79 -16.36 15.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.677 179.838 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.422 ' CG1' ' HD2' ' A' ' 83' ' ' PRO . 54.3 t -150.06 138.92 12.73 Favored Pre-proline 0 C--N 1.331 -0.228 0 N-CA-C 110.292 -0.262 . . . . 0.0 110.292 179.945 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.422 ' HD2' ' CG1' ' A' ' 82' ' ' VAL . 47.8 Cg_endo -72.28 -175.62 1.84 Allowed 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.592 2.195 . . . . 0.0 111.978 179.86 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 26.4 mm-40 -69.45 -54.87 12.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.21 179.849 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 10.5 tttt -113.9 67.4 0.67 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.237 179.98 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 30.8 p90 -57.64 174.42 0.23 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.676 -179.819 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 27.1 m -150.8 120.21 6.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.07 179.827 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 3.9 mp -48.96 104.31 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.742 -179.752 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 133.43 53.4 0.08 OUTLIER Glycine 0 CA--C 1.523 0.561 0 N-CA-C 110.814 -0.914 . . . . 0.0 110.814 179.992 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -173.71 140.79 0.79 Allowed 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 110.228 -0.286 . . . . 0.0 110.228 179.92 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 25.1 m -97.43 89.25 4.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.909 0.385 . . . . 0.0 110.626 -179.89 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.406 ' O ' ' CB ' ' A' ' 93' ' ' ALA . 43.6 m-85 -70.2 -156.94 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.042 -0.526 . . . . 0.0 109.874 179.56 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.437 ' CB ' ' HD2' ' A' ' 94' ' ' PRO . . . 76.65 173.71 0.09 OUTLIER Pre-proline 0 N--CA 1.464 0.24 0 CA-C-O 120.809 0.338 . . . . 0.0 110.69 179.853 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.437 ' HD2' ' CB ' ' A' ' 93' ' ' ALA . 47.5 Cg_endo . . . . . 0 C--O 1.249 1.063 0 C-N-CA 122.583 2.189 . . . . 0.0 112.096 179.891 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 2.5 m . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 110.18 -0.304 . . . . 0.0 110.18 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -75.47 72.62 4.87 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.523 2.148 . . . . 0.0 112.016 179.992 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -167.32 110.1 0.67 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.205 179.98 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.533 ' CG1' ' CE1' ' A' ' 78' ' ' PHE . 1.7 p -115.09 163.38 12.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.368 0.604 . . . . 0.0 110.569 -179.806 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.476 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 0.6 OUTLIER -134.31 148.76 50.82 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.048 179.729 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -118.52 171.79 7.92 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.389 -179.944 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.9 m -167.81 131.8 1.73 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.007 -179.952 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 34.8 t -82.21 94.68 2.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.537 -179.728 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -54.4 178.26 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.513 -179.921 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 4.1 mmmt -85.89 52.35 2.45 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.514 179.936 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -139.69 23.68 2.78 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 110.86 -0.896 . . . . 0.0 110.86 179.974 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 19.0 m -109.89 127.26 54.61 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 110.168 -0.308 . . . . 0.0 110.168 179.944 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -121.85 -87.61 0.64 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.471 -179.863 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 39.0 tp10 -117.61 -61.92 1.63 Allowed 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 120.826 0.346 . . . . 0.0 110.12 -179.79 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.421 ' CE ' ' HG3' ' A' ' 57' ' ' GLU . 5.5 ptpt -98.69 -21.56 16.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.746 -179.847 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 5.4 m80 -73.73 135.48 43.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.835 0.35 . . . . 0.0 110.282 179.926 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -133.44 100.14 4.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.243 -179.968 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -97.12 145.1 26.32 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.377 -179.95 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.436 HG22 ' CG2' ' A' ' 21' ' ' VAL . 14.5 m -139.83 134.19 37.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.579 -179.871 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.43 ' HA ' ' CG1' ' A' ' 51' ' ' VAL . 1.3 tt -83.22 64.0 7.5 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.435 179.876 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.436 ' CG2' HG22 ' A' ' 19' ' ' VAL . 17.2 t -74.04 87.12 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.272 -179.978 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 7.3 tttp -176.61 120.52 0.14 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.401 -179.966 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 27.3 p90 -130.81 29.06 4.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.291 179.99 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 53.91 -177.15 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.327 -179.889 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 77.21 -66.02 2.95 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 110.714 -0.954 . . . . 0.0 110.714 -179.952 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -84.65 179.27 7.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.775 0.322 . . . . 0.0 110.315 179.922 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.4 ' HB ' ' CG ' ' A' ' 71' ' ' GLU . 0.0 OUTLIER -115.47 170.78 8.15 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.275 179.906 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 11.9 mmt -113.65 126.2 55.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.739 -179.712 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.435 ' CB ' ' HG2' ' A' ' 71' ' ' GLU . . . -115.82 -60.87 1.81 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.223 -179.804 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -158.19 161.47 37.84 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.551 179.776 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.448 HG23 ' CD1' ' A' ' 52' ' ' TRP . 12.0 t -136.78 142.79 36.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.316 0.579 . . . . 0.0 111.407 -179.723 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.435 ' CG ' ' HB3' ' A' ' 41' ' ' TRP . 2.5 tp10 -137.5 122.68 19.25 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-N 115.105 -0.952 . . . . 0.0 108.911 -179.827 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.477 ' HB3' ' CE1' ' A' ' 66' ' ' PHE . 2.9 pp -110.66 179.5 4.05 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.254 0.549 . . . . 0.0 111.492 -179.036 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.481 ' HB2' ' CE3' ' A' ' 41' ' ' TRP . 9.4 ttt180 -148.94 170.79 17.53 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.141 179.417 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -119.97 -82.83 0.65 Allowed 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 179.906 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER 178.33 -56.98 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.311 179.383 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -66.02 -28.03 73.33 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 110.697 -0.961 . . . . 0.0 110.697 179.959 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -61.3 166.76 3.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.756 0.312 . . . . 0.0 110.366 179.941 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -121.47 25.66 9.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.487 -179.978 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -179.5 149.13 0.37 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.277 179.968 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.492 ' CE3' ' HG2' ' A' ' 67' ' ' ARG . 58.2 m95 -64.68 160.57 19.59 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.506 -179.983 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 31.5 m -130.33 109.61 17.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.174 179.796 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.42 ' N ' ' OE2' ' A' ' 32' ' ' GLU . . . -49.11 124.73 9.37 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.725 -179.658 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.04 -171.3 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.116 179.77 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 30.5 m -152.11 119.05 5.8 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.58 -179.923 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 14.2 ptpt -74.78 67.52 1.62 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.07 179.708 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -98.16 -19.95 22.14 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 111.21 -0.756 . . . . 0.0 111.21 -179.749 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.437 ' HG2' ' CG2' ' A' ' 51' ' ' VAL . 30.9 tp10 -77.76 -45.06 25.71 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.767 0.317 . . . . 0.0 110.388 -179.884 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 117.58 -63.28 0.4 Allowed Glycine 0 CA--C 1.523 0.561 0 N-CA-C 110.708 -0.957 . . . . 0.0 110.708 179.977 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -84.47 -30.01 28.52 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 110.718 -0.953 . . . . 0.0 110.718 179.97 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.437 ' CG2' ' HG2' ' A' ' 48' ' ' GLU . 6.3 m -132.53 -179.44 3.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.881 0.372 . . . . 0.0 110.437 179.953 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . 0.448 ' CD1' HG23 ' A' ' 31' ' ' VAL . 5.4 m95 -103.72 125.93 50.52 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.183 -179.823 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -118.05 160.66 21.11 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.406 -179.945 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 26.7 t80 -138.21 128.12 25.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.42 -179.966 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 19.7 p-10 -102.18 115.98 31.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.441 179.988 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 4.0 m -170.54 161.5 7.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.203 179.928 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.421 ' HG3' ' CE ' ' A' ' 15' ' ' LYS . 5.3 mt-10 -132.03 26.2 4.59 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.542 -179.903 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.95 156.51 25.47 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.311 179.882 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -72.49 69.42 3.44 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.641 2.227 . . . . 0.0 112.173 -179.942 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.7 pp -81.54 127.49 32.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.366 179.909 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -132.38 32.4 3.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.475 -179.999 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -156.13 -170.29 21.23 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 110.863 -0.895 . . . . 0.0 110.863 -179.996 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -78.32 165.75 25.18 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.721 2.281 . . . . 0.0 112.039 -179.916 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -98.16 105.3 17.43 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.464 179.962 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 17.8 m-80 -77.51 140.65 39.8 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 179.191 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.477 ' CE1' ' HB3' ' A' ' 33' ' ' LEU . 37.1 m-85 -121.57 -178.56 3.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.157 0.503 . . . . 0.0 111.245 -179.245 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.492 ' HG2' ' CE3' ' A' ' 41' ' ' TRP . 0.0 OUTLIER 173.95 59.09 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.728 179.973 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.437 ' HA ' ' HA ' ' A' ' 31' ' ' VAL . 1.2 p90 -50.86 165.24 0.11 Allowed 'General case' 0 CA--C 1.517 -0.321 0 CA-C-O 121.219 0.533 . . . . 0.0 111.054 -179.323 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.2 mt -115.9 63.33 0.7 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.118 179.671 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 12.0 p -29.95 138.22 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 115.594 -0.73 . . . . 0.0 112.476 -179.019 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.435 ' HG2' ' CB ' ' A' ' 29' ' ' ALA . 16.4 mt-10 -52.36 -36.11 52.88 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.364 -179.952 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.09 65.74 1.15 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.505 -179.835 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -151.23 -106.92 0.35 Allowed Glycine 0 CA--C 1.522 0.484 0 N-CA-C 110.58 -1.008 . . . . 0.0 110.58 179.965 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 16.1 ptt? -175.32 176.17 2.07 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.805 0.336 . . . . 0.0 110.194 179.919 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.476 ' N ' ' CD ' ' A' ' 75' ' ' LYS . 0.0 OUTLIER -94.62 120.78 35.39 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.141 179.924 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.423 ' O ' ' CB ' ' A' ' 67' ' ' ARG . 65.5 m-80 -112.05 168.69 9.4 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.727 -179.596 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 94.1 t -120.48 153.23 23.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.046 179.68 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.533 ' CE1' ' CG1' ' A' ' 4' ' ' VAL . 45.6 m-85 -152.9 130.71 11.66 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.576 -179.817 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 36.9 m-20 -118.71 149.55 41.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.178 179.867 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 27.9 t0 64.12 42.88 5.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.435 179.98 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 76.2 t -86.28 -6.35 10.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.054 179.827 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 96.8 t -155.69 115.07 2.24 Favored Pre-proline 0 CA--C 1.528 0.1 0 N-CA-C 110.217 -0.29 . . . . 0.0 110.217 179.795 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -73.55 -170.9 0.73 Allowed 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.417 2.078 . . . . 0.0 112.014 179.862 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -90.67 125.63 35.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.167 179.808 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 64.74 42.46 4.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.094 -179.784 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . 0.426 ' HB2' ' CE2' ' A' ' 92' ' ' TYR . 27.1 p90 -50.76 177.53 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.771 -179.776 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 70.9 m -132.23 110.01 10.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.939 179.692 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 3.2 mp -46.16 124.38 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.729 -179.728 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 106.68 55.68 0.65 Allowed Glycine 0 CA--C 1.524 0.596 0 N-CA-C 110.833 -0.907 . . . . 0.0 110.833 179.958 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -179.6 141.11 0.15 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.808 0.337 . . . . 0.0 110.578 179.986 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 8.2 m -83.89 131.3 34.88 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.042 179.726 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.426 ' CE2' ' HB2' ' A' ' 86' ' ' TYR . 59.5 m-85 -113.54 -23.02 10.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.937 -179.36 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.466 ' CB ' ' CD ' ' A' ' 94' ' ' PRO . . . -51.02 -179.82 0.04 OUTLIER Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.332 179.844 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.466 ' CD ' ' CB ' ' A' ' 93' ' ' ALA . 50.1 Cg_endo . . . . . 0 C--O 1.249 1.027 0 C-N-CA 122.579 2.186 . . . . 0.0 112.071 -179.862 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 7.3 p . . . . . 0 N--CA 1.489 1.502 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -75.12 143.37 28.61 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.408 2.072 . . . . 0.0 111.962 179.966 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 15.0 mtpp -112.36 83.06 1.74 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.377 179.942 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.479 HG21 ' CE2' ' A' ' 78' ' ' PHE . 19.4 m -51.59 -178.65 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.32 179.902 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 20.0 p -155.56 134.23 11.88 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.481 179.965 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.541 ' CE2' ' CD2' ' A' ' 66' ' ' PHE . 37.4 m-85 -97.89 175.72 6.04 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.15 179.87 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.404 ' HB ' ' CB ' ' A' ' 20' ' ' LEU . 0.5 OUTLIER -164.4 107.05 0.9 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.857 0.361 . . . . 0.0 110.537 -179.981 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 40.7 t -60.81 85.27 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.255 179.948 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -50.42 143.97 8.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.673 -179.773 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.434 ' HA ' ' CG2' ' A' ' 88' ' ' ILE . 0.1 OUTLIER -67.4 142.1 56.82 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.276 179.899 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 117.95 14.08 6.84 Favored Glycine 0 CA--C 1.527 0.795 0 N-CA-C 111.41 -0.676 . . . . 0.0 111.41 179.839 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 39.4 m -55.65 104.6 0.14 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.961 0.381 . . . . 0.0 109.987 179.731 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 8.1 m-20 -57.85 -164.91 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.602 -179.589 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -56.68 -48.09 78.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.091 -179.345 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 8.8 pttt -136.13 33.78 2.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.944 -179.391 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 5.2 m80 -111.93 156.56 21.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.804 0.335 . . . . 0.0 110.279 179.703 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 28.9 tp -137.01 103.63 5.2 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.684 -179.77 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.437 ' HB3' ' CG2' ' A' ' 53' ' ' THR . . . -90.7 124.3 34.98 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.068 -0.515 . . . . 0.0 109.894 179.574 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 32.6 m -117.45 138.82 46.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.827 0.346 . . . . 0.0 110.653 -179.698 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.404 ' CB ' ' HB ' ' A' ' 7' ' ' THR . 0.7 OUTLIER -94.64 69.59 3.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.452 179.96 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 18.8 t -80.11 90.01 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.394 -0.367 . . . . 0.0 110.246 179.991 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -151.97 129.16 11.18 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.504 -179.958 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.418 ' CZ ' HG13 ' A' ' 4' ' ' VAL . 15.0 p90 -154.53 176.75 11.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.262 179.843 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -105.43 96.64 6.65 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.358 179.992 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -179.99 -51.5 0.08 OUTLIER Glycine 0 CA--C 1.523 0.54 0 N-CA-C 110.594 -1.002 . . . . 0.0 110.594 -179.912 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -126.58 155.22 42.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.738 0.304 . . . . 0.0 110.296 179.939 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.16 -176.98 6.44 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.406 -179.984 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.426 ' O ' ' CG ' ' A' ' 71' ' ' GLU . 41.0 mtm -117.23 122.24 43.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.623 -179.743 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.428 ' HB1' ' N ' ' A' ' 71' ' ' GLU . . . -122.23 -53.31 1.93 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.276 179.922 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -158.04 164.2 36.96 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.146 179.948 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.456 HG23 ' CD1' ' A' ' 52' ' ' TRP . 12.2 t -147.26 149.83 15.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.633 179.968 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.443 ' CB ' ' HA ' ' A' ' 43' ' ' ALA . 0.3 OUTLIER -158.81 130.56 6.53 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.07 179.966 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.484 ' HB3' ' CE1' ' A' ' 66' ' ' PHE . 3.5 pp -110.99 -177.88 3.33 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.039 0.447 . . . . 0.0 110.998 -179.44 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.482 ' HB2' ' CE3' ' A' ' 41' ' ' TRP . 1.3 ttp180 -143.06 162.09 36.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.007 179.724 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -129.51 25.59 5.4 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.198 179.643 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 49.32 94.15 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.817 179.838 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.414 ' O ' ' N ' ' A' ' 39' ' ' ASP . . . 98.23 -30.13 10.07 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 111.207 -0.757 . . . . 0.0 111.207 179.639 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 14.7 m -65.2 74.14 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.794 0.33 . . . . 0.0 110.703 -179.7 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.414 ' N ' ' O ' ' A' ' 37' ' ' GLY . 8.7 m-20 46.62 43.3 12.43 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.937 179.655 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 52.06 -173.55 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.926 0.393 . . . . 0.0 110.387 179.887 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.499 ' CZ3' ' HG2' ' A' ' 67' ' ' ARG . 80.7 m95 -44.86 144.2 1.24 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.945 -179.936 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.46 HG23 ' CE1' ' A' ' 54' ' ' PHE . 31.1 m -131.07 116.37 33.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.124 179.757 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.443 ' HA ' ' CB ' ' A' ' 32' ' ' GLU . . . -49.51 128.81 18.15 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.25 179.991 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -62.97 -172.13 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.287 -179.808 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 31.6 m -132.5 109.35 9.73 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.446 -179.9 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.442 ' HB3' ' CZ3' ' A' ' 52' ' ' TRP . 39.4 mtpt -85.49 106.58 16.93 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.327 -179.999 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 170.99 43.84 0.03 OUTLIER Glycine 0 CA--C 1.524 0.596 0 N-CA-C 110.749 -0.94 . . . . 0.0 110.749 -179.902 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 24.3 tp10 -130.38 65.34 1.52 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.776 0.322 . . . . 0.0 110.457 179.939 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 67.42 -80.7 0.15 Allowed Glycine 0 CA--C 1.523 0.551 0 N-CA-C 110.75 -0.94 . . . . 0.0 110.75 179.987 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -146.49 21.09 1.69 Allowed Glycine 0 CA--C 1.526 0.737 0 N-CA-C 111.256 -0.737 . . . . 0.0 111.256 -179.954 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 29.6 m -138.85 170.45 16.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 110.159 -0.312 . . . . 0.0 110.159 179.764 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . 0.456 ' CD1' HG23 ' A' ' 31' ' ' VAL . 7.4 m95 -100.24 137.36 38.78 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.026 0.441 . . . . 0.0 111.032 -179.461 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.437 ' CG2' ' HB3' ' A' ' 18' ' ' ALA . 0.2 OUTLIER -120.77 142.45 49.55 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.546 179.31 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.46 ' CE1' HG23 ' A' ' 42' ' ' VAL . 27.7 t80 -108.01 116.14 31.41 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.963 0.411 . . . . 0.0 110.691 -179.547 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 57.9 t0 -107.49 130.2 54.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.112 179.847 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -158.26 -177.65 6.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.908 0.385 . . . . 0.0 110.517 -179.884 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -99.52 -26.23 14.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.448 -179.945 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -50.39 159.09 0.9 Allowed Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.483 -179.945 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -70.56 -20.6 30.87 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.554 2.17 . . . . 0.0 111.856 179.673 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.4 tp 57.12 101.87 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.519 179.739 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -173.97 71.04 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.35 180.0 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.434 ' O ' ' CE2' ' A' ' 64' ' ' PHE . . . 175.46 -158.07 25.07 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 110.762 -0.935 . . . . 0.0 110.762 -179.974 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -78.86 169.71 19.09 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.604 2.203 . . . . 0.0 112.086 -179.949 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.434 ' CE2' ' O ' ' A' ' 62' ' ' GLY . 72.4 m-85 -151.27 111.87 4.21 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.515 -179.968 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 12.0 m-80 -81.13 153.21 27.4 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 179.445 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.541 ' CD2' ' CE2' ' A' ' 6' ' ' PHE . 21.0 m-85 -128.75 178.17 6.54 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.14 0.495 . . . . 0.0 111.257 -179.769 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.499 ' HG2' ' CZ3' ' A' ' 41' ' ' TRP . 0.1 OUTLIER 171.85 78.71 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.552 179.864 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -78.11 169.0 19.0 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.186 0.517 . . . . 0.0 110.932 -179.295 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.403 HD21 ' HG3' ' A' ' 75' ' ' LYS . 2.4 mt -118.16 71.91 0.85 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.234 179.528 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.414 ' OG1' ' N ' ' A' ' 74' ' ' MET . 28.4 p -36.75 140.55 0.15 Allowed 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.742 -179.108 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.428 ' N ' ' HB1' ' A' ' 29' ' ' ALA . 17.7 mt-10 -48.9 -57.34 6.6 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.635 -179.7 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.43 52.28 2.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.441 179.958 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -129.8 -108.7 1.32 Allowed Glycine 0 CA--C 1.523 0.567 0 N-CA-C 110.636 -0.985 . . . . 0.0 110.636 179.917 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.414 ' N ' ' OG1' ' A' ' 70' ' ' THR . 2.4 ptm -173.12 168.13 4.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.838 0.351 . . . . 0.0 110.35 -179.993 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.403 ' HG3' HD21 ' A' ' 69' ' ' LEU . 0.6 OUTLIER -77.95 166.71 22.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.231 179.857 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -171.03 164.69 7.52 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.311 179.917 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 98.1 t -130.37 142.26 44.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.163 179.943 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.479 ' CE2' HG21 ' A' ' 4' ' ' VAL . 86.3 m-85 -134.04 132.69 40.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.602 -179.818 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -119.54 162.22 19.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.276 179.844 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 55.03 39.88 31.77 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.312 -179.871 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 47.0 t -86.62 -10.23 11.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.818 -179.978 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.403 HG11 ' HD2' ' A' ' 83' ' ' PRO . 98.7 t -148.49 130.7 7.64 Favored Pre-proline 0 CA--C 1.529 0.137 0 N-CA-C 110.301 -0.259 . . . . 0.0 110.301 179.782 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.47 ' HD3' ' CD1' ' A' ' 92' ' ' TYR . 47.5 Cg_endo -70.73 -174.35 1.07 Allowed 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.534 2.156 . . . . 0.0 111.819 179.575 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -58.3 -63.94 1.09 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.004 179.668 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -108.76 86.57 2.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.114 179.622 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 31.8 p90 -52.83 150.65 5.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.753 -179.641 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 27.9 m -122.21 101.67 7.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.982 179.748 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.434 ' CG2' ' HA ' ' A' ' 10' ' ' LYS . 2.7 mp -44.36 116.48 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.005 -179.673 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 106.72 56.06 0.64 Allowed Glycine 0 CA--C 1.523 0.593 0 N-CA-C 110.812 -0.915 . . . . 0.0 110.812 179.854 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -174.03 142.72 0.87 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.898 0.38 . . . . 0.0 110.731 179.984 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 10.0 m -87.69 133.65 33.8 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.044 -0.525 . . . . 0.0 109.881 179.561 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.47 ' CD1' ' HD3' ' A' ' 83' ' ' PRO . 65.5 m-85 -117.09 -86.07 0.63 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.022 -179.266 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.476 ' CB ' ' CD ' ' A' ' 94' ' ' PRO . . . 50.59 179.86 0.02 OUTLIER Pre-proline 0 C--N 1.332 -0.192 0 CA-C-O 120.723 0.297 . . . . 0.0 110.438 -179.714 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.476 ' CD ' ' CB ' ' A' ' 93' ' ' ALA . 48.8 Cg_endo . . . . . 0 C--O 1.249 1.066 0 C-N-CA 122.586 2.191 . . . . 0.0 112.097 -179.846 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 6.4 m . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 110.223 -0.288 . . . . 0.0 110.223 . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -76.22 137.37 19.03 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.631 2.22 . . . . 0.0 112.046 -179.932 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 9.0 mtmt -127.67 74.84 1.56 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.44 -179.923 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.523 ' CG1' ' CE1' ' A' ' 78' ' ' PHE . 1.7 p -58.55 163.66 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.268 0.556 . . . . 0.0 110.337 -179.919 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.479 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 5.7 p -148.09 130.6 15.8 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.466 179.907 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -98.87 175.25 6.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.258 -179.994 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.0 m -166.47 107.74 0.69 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.297 -179.966 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 47.8 t -55.34 99.82 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.402 179.997 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -72.29 174.49 7.2 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.596 -179.836 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.04 178.8 0.78 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.385 -179.966 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 67.24 26.81 73.42 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 110.784 -0.926 . . . . 0.0 110.784 179.939 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 85.3 p -87.49 109.25 19.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.767 0.317 . . . . 0.0 110.445 -179.969 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 30.8 m-20 -112.73 -162.52 0.8 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.236 179.815 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -65.54 -60.07 3.32 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.416 179.997 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -94.6 20.26 8.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.905 -179.727 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 19.5 m80 -128.11 112.32 14.45 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.863 0.363 . . . . 0.0 110.462 -179.914 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -119.03 99.27 6.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.281 179.966 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.427 ' HB3' ' CG2' ' A' ' 53' ' ' THR . . . -95.29 132.58 40.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.182 179.877 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 25.7 m -132.43 137.35 54.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.428 -179.999 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -87.88 90.18 8.28 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.393 179.833 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 27.2 t -90.24 101.24 12.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.369 -179.966 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -174.41 144.28 0.9 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.343 -179.926 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.436 ' CE1' ' HB2' ' A' ' 26' ' ' ASP . 5.9 p90 -158.48 62.79 0.43 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.502 -179.894 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 65.12 -71.33 0.08 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.779 179.719 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.427 ' N ' ' O ' ' A' ' 23' ' ' TYR . . . -75.26 -160.66 8.56 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 110.796 -0.922 . . . . 0.0 110.796 -179.879 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.436 ' HB2' ' CE1' ' A' ' 23' ' ' TYR . 47.7 t0 64.55 127.99 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.793 0.33 . . . . 0.0 110.368 179.998 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.411 ' CG2' ' O ' ' A' ' 27' ' ' THR . 31.6 m -109.97 34.26 3.96 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.559 -179.933 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.415 ' O ' ' CG ' ' A' ' 71' ' ' GLU . 0.0 OUTLIER 49.25 -177.6 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.011 179.595 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.411 ' CB ' ' O ' ' A' ' 69' ' ' LEU . . . 168.62 -66.01 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.168 179.832 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -154.5 154.81 33.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.722 179.898 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.441 HG23 ' CD1' ' A' ' 52' ' ' TRP . 12.3 t -148.96 153.64 10.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.084 0.468 . . . . 0.0 111.092 -179.597 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.433 ' CG ' ' HD2' ' A' ' 67' ' ' ARG . 0.0 OUTLIER -163.37 147.72 10.89 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.896 -179.917 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.44 HD22 ' CG ' ' A' ' 54' ' ' PHE . 3.4 pp -121.95 179.94 4.34 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.905 0.383 . . . . 0.0 110.942 -179.512 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.414 ' N ' ' CD1' ' A' ' 33' ' ' LEU . 4.7 ttt180 -133.96 167.13 21.16 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.078 179.847 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -128.21 9.11 6.15 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.281 -179.927 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 3.8 t60 67.98 -67.48 0.19 Allowed 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.766 0.317 . . . . 0.0 110.595 179.791 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -52.22 -53.02 33.05 Favored Glycine 0 CA--C 1.523 0.592 0 N-CA-C 110.972 -0.851 . . . . 0.0 110.972 -179.843 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 58.9 m -51.02 -28.71 10.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.771 0.32 . . . . 0.0 110.487 -179.839 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 24.9 t0 63.26 19.25 11.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.822 179.981 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -155.86 129.05 8.14 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.871 0.367 . . . . 0.0 110.479 179.898 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.477 ' CZ3' ' HG2' ' A' ' 67' ' ' ARG . 84.3 m95 -54.22 139.53 35.59 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.417 179.94 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.476 ' CG2' ' CZ ' ' A' ' 54' ' ' PHE . 28.4 m -115.35 111.87 37.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.28 -0.418 . . . . 0.0 109.908 179.575 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -46.49 136.1 7.82 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.669 -179.617 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.432 ' CE ' HD21 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -65.2 -170.03 0.05 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.234 -179.856 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 23.4 m -144.29 103.9 4.03 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.595 -179.881 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 9.0 ptpt -67.64 72.43 0.15 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.143 179.683 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -103.55 -39.08 2.64 Favored Glycine 0 CA--C 1.521 0.447 0 N-CA-C 110.671 -0.972 . . . . 0.0 110.671 -179.852 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -75.86 134.18 40.39 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.811 0.339 . . . . 0.0 110.367 -179.967 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -78.36 74.65 2.04 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 110.74 -0.944 . . . . 0.0 110.74 -179.989 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 150.71 -52.89 0.5 Allowed Glycine 0 CA--C 1.522 0.52 0 N-CA-C 110.656 -0.978 . . . . 0.0 110.656 179.984 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 18.0 m -114.84 -177.95 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.795 0.331 . . . . 0.0 110.306 179.919 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . 0.441 ' CD1' HG23 ' A' ' 31' ' ' VAL . 13.6 m95 -109.57 141.44 42.07 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.709 -179.842 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.427 ' CG2' ' HB3' ' A' ' 18' ' ' ALA . 1.7 p -126.89 159.71 33.14 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.867 179.705 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.476 ' CZ ' ' CG2' ' A' ' 42' ' ' VAL . 57.1 t80 -130.86 125.33 33.31 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.861 0.363 . . . . 0.0 110.717 -179.664 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -85.09 63.11 7.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.177 179.78 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 52.3 p -57.04 147.06 25.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.436 -179.875 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.6 25.05 4.4 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.518 179.932 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -117.93 138.54 25.5 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.208 179.756 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -75.5 69.35 5.95 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.518 2.146 . . . . 0.0 112.164 -179.694 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 10.7 tp -151.22 106.68 3.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.394 179.898 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -102.02 62.99 0.9 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.037 0.446 . . . . 0.0 110.416 -179.92 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -109.02 -153.15 15.36 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 110.702 -0.959 . . . . 0.0 110.702 179.98 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -75.4 158.7 40.5 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.546 2.164 . . . . 0.0 111.953 179.96 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -131.21 105.28 7.56 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.668 -179.855 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 41.3 m-20 -68.82 168.65 12.99 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 179.432 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -144.74 174.69 10.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.141 0.495 . . . . 0.0 111.047 -179.815 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.477 ' HG2' ' CZ3' ' A' ' 41' ' ' TRP . 0.0 OUTLIER 175.57 54.98 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.559 -179.941 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -55.73 176.24 0.07 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.076 -179.377 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.411 ' O ' ' CB ' ' A' ' 29' ' ' ALA . 11.6 mt -124.99 69.82 1.14 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.59 179.598 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.411 ' O ' ' N ' ' A' ' 73' ' ' GLY . 16.5 p -37.86 140.78 0.23 Allowed 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.928 -179.18 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.415 ' CG ' ' O ' ' A' ' 28' ' ' MET . 0.0 OUTLIER -42.64 -44.91 4.45 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.355 179.988 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -54.74 -32.92 60.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.341 -179.994 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.411 ' N ' ' O ' ' A' ' 70' ' ' THR . . . 105.67 53.59 0.76 Allowed Glycine 0 CA--C 1.522 0.531 0 N-CA-C 110.757 -0.937 . . . . 0.0 110.757 179.986 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 5.0 mmm -129.18 130.13 45.95 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.771 0.32 . . . . 0.0 110.537 179.991 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.01 123.01 45.84 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.197 -0.456 . . . . 0.0 109.872 179.885 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.467 ' O ' ' CE2' ' A' ' 78' ' ' PHE . 6.4 m120 -134.21 126.16 29.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.377 -179.964 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 73.9 t -84.45 142.69 13.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.342 179.988 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.523 ' CE1' ' CG1' ' A' ' 4' ' ' VAL . 23.2 m-85 -129.38 137.02 50.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.52 -179.883 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -114.17 147.57 38.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.219 179.9 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 58.04 49.35 11.76 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.191 -179.867 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.426 ' O ' ' CG2' ' A' ' 82' ' ' VAL . 99.4 t -86.09 -4.75 9.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.23 -179.843 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.426 ' CG2' ' O ' ' A' ' 81' ' ' VAL . 89.4 t -157.09 130.8 4.75 Favored Pre-proline 0 C--N 1.333 -0.149 0 N-CA-C 110.228 -0.286 . . . . 0.0 110.228 179.77 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.478 ' HD3' ' CG ' ' A' ' 92' ' ' TYR . 45.6 Cg_endo -70.18 -170.85 0.45 Allowed 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.589 2.193 . . . . 0.0 111.923 179.676 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 -76.24 -62.61 1.55 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.192 179.788 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.08 66.46 0.91 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.9 179.655 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . 0.42 ' C ' ' CD1' ' A' ' 86' ' ' TYR . 14.3 p90 -49.45 154.13 0.97 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.886 -179.606 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 39.4 m -133.07 109.51 9.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.024 179.751 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 3.7 mp -46.25 100.44 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.908 -179.727 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 138.53 45.61 0.07 OUTLIER Glycine 0 CA--C 1.523 0.555 0 N-CA-C 110.86 -0.896 . . . . 0.0 110.86 179.868 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -162.98 174.61 12.1 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.825 0.345 . . . . 0.0 110.446 179.93 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 94.6 m -119.57 126.98 52.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.237 179.88 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.478 ' CG ' ' HD3' ' A' ' 83' ' ' PRO . 42.0 m-85 -126.21 109.39 12.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.391 -179.906 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.437 ' CB ' ' HD2' ' A' ' 94' ' ' PRO . . . 172.14 176.47 0.15 Allowed Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.257 179.96 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.437 ' HD2' ' CB ' ' A' ' 93' ' ' ALA . 48.1 Cg_endo . . . . . 0 C--O 1.249 1.052 0 C-N-CA 122.558 2.172 . . . . 0.0 112.096 -179.948 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 44.8 t . . . . . 0 N--CA 1.489 1.496 0 N-CA-C 110.24 -0.281 . . . . 0.0 110.24 . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -78.99 143.32 17.98 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.604 2.203 . . . . 0.0 112.079 -179.986 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 9.8 mtpm? -108.62 48.16 0.87 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.502 -179.876 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.473 HG22 ' CZ ' ' A' ' 78' ' ' PHE . 31.2 m -67.52 -175.78 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.496 179.993 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -171.65 153.87 3.53 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.31 179.849 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.486 ' CD2' ' HB ' ' A' ' 21' ' ' VAL . 51.2 m-85 -132.1 145.17 51.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.282 179.894 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 68.3 m -133.45 130.71 39.0 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.348 -179.923 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.444 HG12 ' CD2' ' A' ' 86' ' ' TYR . 84.0 t -67.71 90.99 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.276 -179.992 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.417 ' HG3' ' CG1' ' A' ' 51' ' ' VAL . 6.3 mm-40 -56.21 167.91 0.59 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.401 -179.918 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.09 -18.36 65.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.918 -179.979 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -46.52 -29.33 3.91 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 111.102 -0.799 . . . . 0.0 111.102 -179.846 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 27.8 m -64.71 139.04 58.72 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.727 0.299 . . . . 0.0 110.386 179.928 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.1 p30 -139.05 -50.49 0.53 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.59 179.965 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -147.96 -78.04 0.16 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.405 -179.908 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.18 9.67 41.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.219 -179.951 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 5.9 m80 -105.28 125.68 51.26 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.848 0.356 . . . . 0.0 110.358 -179.964 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -110.14 104.11 12.92 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.296 179.981 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.426 ' CB ' HG23 ' A' ' 53' ' ' THR . . . -110.64 110.49 21.19 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.29 -179.993 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 5.6 m -91.13 -168.61 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.04 0.448 . . . . 0.0 110.461 179.998 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.404 ' HA ' HG13 ' A' ' 51' ' ' VAL . 2.8 tt -141.46 83.39 1.86 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.506 179.905 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.527 ' CG1' ' CD1' ' A' ' 52' ' ' TRP . 2.1 p -102.53 97.68 5.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.007 179.892 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.483 ' O ' ' CG ' ' A' ' 23' ' ' TYR . 11.9 ttmt -145.45 -71.05 0.26 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.255 179.98 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.483 ' CG ' ' O ' ' A' ' 22' ' ' LYS . 30.6 p90 44.36 -170.23 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.067 179.807 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -123.32 146.49 47.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.272 179.972 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 133.76 -58.69 0.69 Allowed Glycine 0 CA--C 1.523 0.58 0 N-CA-C 110.85 -0.9 . . . . 0.0 110.85 179.962 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -112.76 -162.54 0.8 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.801 0.334 . . . . 0.0 110.379 -179.958 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -119.76 -174.72 2.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.478 179.968 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.423 ' O ' ' CG ' ' A' ' 71' ' ' GLU . 12.6 mtm -120.43 119.27 32.55 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.196 -179.976 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.437 ' CB ' ' HG2' ' A' ' 71' ' ' GLU . . . -120.72 -60.6 1.65 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.632 -179.7 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -151.83 168.59 24.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.589 -179.811 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.488 HG12 ' CD1' ' A' ' 52' ' ' TRP . 0.2 OUTLIER -179.01 144.2 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.986 179.967 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.418 ' CB ' ' HA ' ' A' ' 43' ' ' ALA . 3.6 pt-20 -142.12 168.27 20.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.472 -0.786 . . . . 0.0 109.915 -179.771 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.451 ' HB3' ' CE1' ' A' ' 66' ' ' PHE . 3.1 pp -121.73 174.69 6.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.869 0.366 . . . . 0.0 110.767 -179.791 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.425 ' O ' ' CB ' ' A' ' 35' ' ' GLU . 6.8 ttm180 -126.88 -94.61 0.45 Allowed 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.215 179.821 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.436 ' O ' ' CB ' ' A' ' 36' ' ' HIS . 0.0 OUTLIER 163.34 -35.78 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 120.703 0.287 . . . . 0.0 110.239 179.875 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.436 ' CB ' ' O ' ' A' ' 35' ' ' GLU . 5.2 t-160 86.44 -16.5 0.42 Allowed 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.172 -179.626 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -104.14 -27.67 6.13 Favored Glycine 0 CA--C 1.522 0.516 0 N-CA-C 110.412 -1.075 . . . . 0.0 110.412 179.693 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -83.84 -159.1 0.35 Allowed 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 179.796 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 22.4 p30 -141.04 24.27 2.17 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.615 179.985 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -156.4 148.51 23.18 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.916 0.389 . . . . 0.0 110.472 179.909 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.485 ' CZ3' ' HG2' ' A' ' 67' ' ' ARG . 55.2 m95 -85.7 154.83 21.38 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.2 179.867 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.447 HG22 ' CE1' ' A' ' 54' ' ' PHE . 34.3 m -124.16 106.26 16.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.914 0.387 . . . . 0.0 110.146 179.704 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.418 ' HA ' ' CB ' ' A' ' 32' ' ' GLU . . . -49.0 116.97 1.87 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.712 -179.757 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -53.84 -172.06 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.387 179.909 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 31.6 m -151.05 122.74 8.01 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.423 -179.942 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 5.1 ptpt -68.41 67.79 0.13 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.083 179.698 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -90.96 -26.58 21.6 Favored Glycine 0 CA--C 1.522 0.483 0 N-CA-C 110.626 -0.99 . . . . 0.0 110.626 -179.929 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.438 ' HG2' ' CG2' ' A' ' 51' ' ' VAL . 9.8 tp10 -93.3 129.8 39.26 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.816 0.341 . . . . 0.0 110.231 179.946 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -74.03 66.25 1.84 Allowed Glycine 0 CA--C 1.523 0.565 0 N-CA-C 110.912 -0.875 . . . . 0.0 110.912 -179.84 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 158.65 -35.81 0.51 Allowed Glycine 0 CA--C 1.524 0.638 0 N-CA-C 111.085 -0.806 . . . . 0.0 111.085 179.809 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.438 ' CG2' ' HG2' ' A' ' 48' ' ' GLU . 30.4 m -135.81 -176.43 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.94 0.4 . . . . 0.0 110.859 -179.722 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . 0.527 ' CD1' ' CG1' ' A' ' 21' ' ' VAL . 6.1 m95 -101.85 134.29 45.27 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.494 -179.42 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.426 HG23 ' CB ' ' A' ' 18' ' ' ALA . 6.7 p -127.01 156.3 41.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.448 -179.847 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.447 ' CE1' HG22 ' A' ' 42' ' ' VAL . 50.6 t80 -137.99 124.32 20.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.409 179.904 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 20.6 p-10 -86.78 148.89 25.21 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.314 179.972 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -172.88 -179.36 2.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.482 -179.856 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -161.18 61.59 0.28 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.2 179.918 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -133.38 157.42 78.17 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.31 179.996 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -70.87 -35.57 9.18 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.529 2.153 . . . . 0.0 111.989 179.898 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -77.23 98.56 5.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.376 -179.974 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -148.21 48.21 1.05 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.399 -179.98 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -78.12 -101.74 0.2 Allowed Glycine 0 CA--C 1.526 0.747 0 N-CA-C 110.698 -0.961 . . . . 0.0 110.698 -179.973 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -80.69 177.36 8.13 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.63 2.22 . . . . 0.0 112.102 -179.995 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 49.8 m-85 -153.61 103.18 2.61 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.72 -179.969 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 6.2 m-20 -73.44 129.43 37.98 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 179.358 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.451 ' CE1' ' HB3' ' A' ' 33' ' ' LEU . 40.6 m-85 -115.42 170.87 8.08 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.13 0.491 . . . . 0.0 111.096 -179.333 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.485 ' HG2' ' CZ3' ' A' ' 41' ' ' TRP . 0.0 OUTLIER -169.2 83.69 0.14 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.632 -179.946 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.421 ' HB3' ' HB ' ' A' ' 31' ' ' VAL . 6.9 p90 -71.27 176.68 4.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.356 0.598 . . . . 0.0 111.333 -179.159 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.431 ' O ' ' CB ' ' A' ' 29' ' ' ALA . 8.7 mt -138.53 70.84 1.38 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.22 179.612 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.402 ' OG1' ' N ' ' A' ' 74' ' ' MET . 65.0 p -29.56 136.2 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.509 0.723 . . . . 0.0 112.61 -178.976 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.437 ' HG2' ' CB ' ' A' ' 29' ' ' ALA . 22.2 mt-10 -52.09 -39.13 59.31 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.314 179.972 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.37 64.59 1.49 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.545 -179.877 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -157.75 -104.75 0.21 Allowed Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.71 -0.956 . . . . 0.0 110.71 179.966 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.402 ' N ' ' OG1' ' A' ' 70' ' ' THR . 0.0 OUTLIER -172.03 -179.03 2.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.826 0.346 . . . . 0.0 110.326 179.969 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.63 -176.86 6.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.412 -179.951 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.421 ' O ' ' CB ' ' A' ' 67' ' ' ARG . 1.0 OUTLIER -178.71 158.89 1.05 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.099 179.979 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 97.2 t -124.52 130.43 73.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.979 0.418 . . . . 0.0 110.509 -179.756 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.473 ' CZ ' HG22 ' A' ' 4' ' ' VAL . 31.8 m-85 -121.71 130.53 53.51 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.158 179.983 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -118.86 155.56 31.01 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.638 -179.653 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 53.5 m-20 58.25 23.71 10.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.792 179.842 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 77.1 t -55.35 -78.36 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 179.61 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 76.7 t -81.71 134.36 50.73 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.125 179.751 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.474 ' HD3' ' CG ' ' A' ' 92' ' ' TYR . 46.6 Cg_endo -71.69 -177.1 2.31 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.437 2.091 . . . . 0.0 111.938 179.79 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -63.04 -64.19 0.98 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.186 179.902 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -102.56 76.86 1.56 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.218 179.798 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . 0.444 ' CD2' HG12 ' A' ' 8' ' ' VAL . 55.7 p90 -54.63 160.95 1.64 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.442 -179.873 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.05 111.86 7.44 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.323 179.917 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 2.7 mp -50.52 100.28 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.456 -179.925 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 133.84 45.95 0.11 Allowed Glycine 0 CA--C 1.523 0.572 0 N-CA-C 110.665 -0.974 . . . . 0.0 110.665 -179.981 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -172.99 153.04 2.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.79 0.329 . . . . 0.0 110.386 179.979 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 40.3 m -102.96 133.49 47.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.504 -179.931 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.474 ' CG ' ' HD3' ' A' ' 83' ' ' PRO . 6.3 m-85 -130.78 110.52 11.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.321 179.88 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.42 ' CB ' ' CD ' ' A' ' 94' ' ' PRO . . . 179.28 177.36 0.32 Allowed Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.306 -179.978 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.42 ' CD ' ' CB ' ' A' ' 93' ' ' ALA . 48.0 Cg_endo . . . . . 0 C--O 1.249 1.059 0 C-N-CA 122.62 2.213 . . . . 0.0 112.078 -179.868 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 2.2 m . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 110.21 -0.293 . . . . 0.0 110.21 . . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -79.01 145.48 19.59 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.589 2.193 . . . . 0.0 112.09 179.976 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.413 ' CG ' ' O ' ' A' ' 3' ' ' LYS . 1.8 ptmt -152.34 106.16 3.11 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.794 -179.684 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.529 ' CG2' ' CE1' ' A' ' 78' ' ' PHE . 2.9 m -130.11 168.32 23.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.174 179.486 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -146.12 145.68 30.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.325 179.851 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.56 ' CE2' ' CD2' ' A' ' 66' ' ' PHE . 26.3 m-85 -117.66 160.97 20.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.736 -179.688 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -142.43 -164.15 1.76 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.169 179.836 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 47.0 t -141.85 92.74 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.346 -179.918 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.412 ' HG3' HG13 ' A' ' 51' ' ' VAL . 1.4 mm-40 -56.64 158.01 4.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.57 -179.811 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 7.4 ptmm? -58.17 -19.25 31.6 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.896 -179.989 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -49.8 -24.77 6.37 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 111.021 -0.831 . . . . 0.0 111.021 -179.966 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 10.0 p -47.83 113.85 0.8 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.85 0.357 . . . . 0.0 110.78 -179.862 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 42.4 m-20 -116.17 -156.28 0.61 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.147 179.859 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -44.96 -68.44 0.2 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.721 0.296 . . . . 0.0 110.905 -179.868 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.61 40.57 3.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.309 179.869 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 8.5 m80 -118.55 123.29 44.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.365 179.953 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -104.97 97.86 7.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.192 -179.928 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -100.22 104.56 16.06 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.602 -179.788 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 27.7 m -88.3 -175.17 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.129 179.67 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.409 ' HA ' HG13 ' A' ' 51' ' ' VAL . 2.7 tt -139.42 77.55 1.62 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.402 179.724 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 3.3 t -84.01 107.9 15.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.083 179.934 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.57 147.84 4.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.391 -179.969 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 3.9 p90 177.99 128.56 0.05 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.221 -179.909 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -53.4 154.43 3.41 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.512 -179.865 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 107.57 -68.98 0.22 Allowed Glycine 0 CA--C 1.522 0.522 0 N-CA-C 110.59 -1.004 . . . . 0.0 110.59 -179.968 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -94.08 179.28 5.37 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 110.164 -0.31 . . . . 0.0 110.164 179.975 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.417 ' OG1' ' CE ' ' A' ' 72' ' ' LYS . 0.2 OUTLIER -119.19 -163.8 1.0 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.928 0.394 . . . . 0.0 110.525 -179.971 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.43 ' O ' ' CG ' ' A' ' 71' ' ' GLU . 33.7 mtp -129.6 124.11 32.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.297 -179.815 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.42 ' CB ' ' O ' ' A' ' 69' ' ' LEU . . . -129.42 -57.97 1.13 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.937 -179.79 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -141.07 177.19 8.24 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.945 0.402 . . . . 0.0 111.059 -179.673 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.474 HG12 ' CD1' ' A' ' 52' ' ' TRP . 0.3 OUTLIER 171.52 134.2 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.958 -179.986 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -123.55 161.24 25.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.643 -179.549 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.482 ' HG ' ' CE1' ' A' ' 66' ' ' PHE . 2.3 mt -110.0 154.33 23.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.381 179.782 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.485 ' HG3' ' CD2' ' A' ' 41' ' ' TRP . 0.0 OUTLIER -126.99 -163.31 1.23 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.949 179.51 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.425 ' CG ' ' O ' ' A' ' 34' ' ' ARG . 0.2 OUTLIER 176.8 106.71 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.841 0.353 . . . . 0.0 110.171 179.971 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -51.2 95.3 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.206 -179.982 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 126.14 -32.18 3.85 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 110.359 -1.097 . . . . 0.0 110.359 -179.636 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.423 ' HB2' ' CB ' ' A' ' 35' ' ' GLU . 35.0 t -57.09 -25.4 58.69 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.732 0.301 . . . . 0.0 110.398 179.788 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 75.75 97.29 0.07 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.653 179.986 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 72.62 159.59 0.22 Allowed 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.876 179.641 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.501 ' CZ2' ' CD ' ' A' ' 67' ' ' ARG . 51.1 m95 -64.49 167.39 7.11 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.434 -179.899 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 14.9 m -135.1 3.21 1.08 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.852 -179.622 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . 59.92 138.42 0.01 OUTLIER 'General case' 0 C--N 1.334 -0.107 0 CA-C-O 121.129 0.49 . . . . 0.0 111.299 179.391 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.406 ' CE ' ' HB2' ' A' ' 52' ' ' TRP . 0.0 OUTLIER -73.64 -170.35 0.84 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.375 179.862 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.424 ' O ' ' N ' ' A' ' 47' ' ' GLY . 43.4 m -143.31 111.08 5.95 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.144 179.809 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.9 ptpt -62.45 79.12 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.396 -179.908 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.424 ' N ' ' O ' ' A' ' 45' ' ' THR . . . -98.47 -26.77 9.03 Favored Glycine 0 CA--C 1.522 0.525 0 N-CA-C 110.691 -0.963 . . . . 0.0 110.691 -179.966 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.402 ' HG3' HG21 ' A' ' 51' ' ' VAL . 0.5 OUTLIER -87.15 -172.53 4.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.852 0.358 . . . . 0.0 110.432 -179.943 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -110.94 -24.68 5.41 Favored Glycine 0 CA--C 1.522 0.505 0 N-CA-C 110.807 -0.917 . . . . 0.0 110.807 179.95 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -129.28 -1.39 5.69 Favored Glycine 0 CA--C 1.528 0.888 0 N-CA-C 111.957 -0.457 . . . . 0.0 111.957 -179.684 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.412 HG13 ' HG3' ' A' ' 9' ' ' GLU . 17.9 m -146.23 178.26 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 CA-C-N 117.476 0.638 . . . . 0.0 110.761 -179.946 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . 0.474 ' CD1' HG12 ' A' ' 31' ' ' VAL . 10.9 m95 -105.34 141.1 37.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.56 -179.555 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 10.3 p -126.04 162.78 24.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.336 -179.969 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 45.5 t80 -134.54 162.54 31.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.536 -179.881 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -112.86 143.03 44.81 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.224 179.865 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -133.9 178.7 6.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.374 179.934 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -123.94 26.61 7.52 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.345 179.975 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -171.0 155.65 4.53 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.269 179.947 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -71.87 -36.2 6.45 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.707 2.272 . . . . 0.0 112.325 -179.808 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -75.57 148.3 38.98 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.75 -179.55 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -147.74 -174.48 4.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.208 179.978 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -145.06 -148.96 4.93 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 110.734 -0.946 . . . . 0.0 110.734 179.995 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -78.03 158.08 30.59 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.575 2.183 . . . . 0.0 111.796 179.872 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.406 ' HB3' ' CD2' ' A' ' 33' ' ' LEU . 86.5 m-85 -131.6 171.19 13.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.07 0.462 . . . . 0.0 110.79 -179.794 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.424 ' HB2' ' CB ' ' A' ' 34' ' ' ARG . 4.3 m-80 -139.57 137.36 35.33 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.615 179.571 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.56 ' CD2' ' CE2' ' A' ' 6' ' ' PHE . 48.0 m-85 -120.44 159.94 24.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.108 0.48 . . . . 0.0 111.093 -179.217 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.501 ' CD ' ' CZ2' ' A' ' 41' ' ' TRP . 28.6 mtp180 -157.61 81.4 0.88 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.818 179.68 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.452 ' HA ' ' HA ' ' A' ' 31' ' ' VAL . 5.9 p90 -78.7 173.59 12.3 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-O 121.54 0.685 . . . . 0.0 111.37 -179.334 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.42 ' O ' ' CB ' ' A' ' 29' ' ' ALA . 8.8 mt -138.43 74.3 1.47 Allowed 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 114.664 -1.153 . . . . 0.0 109.016 179.496 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.439 ' OG1' ' N ' ' A' ' 74' ' ' MET . 2.7 p -31.18 137.13 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 115.717 -0.674 . . . . 0.0 112.191 -178.976 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.43 ' CG ' ' O ' ' A' ' 28' ' ' MET . 1.1 mm-40 -49.57 -24.88 2.35 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.943 -179.525 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.417 ' CE ' ' OG1' ' A' ' 27' ' ' THR . 0.0 OUTLIER -167.07 36.04 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.596 0.236 . . . . 0.0 111.102 -179.94 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -114.21 -110.76 2.9 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 110.849 -0.9 . . . . 0.0 110.849 179.853 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.439 ' N ' ' OG1' ' A' ' 70' ' ' THR . 3.1 ptt? -166.74 113.29 0.81 Allowed 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 110.164 -0.31 . . . . 0.0 110.164 179.901 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.99 -176.35 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.896 0.379 . . . . 0.0 110.494 -179.782 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 177.43 149.39 0.16 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.468 -179.952 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 72.2 t -90.22 139.18 17.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 121.006 0.431 . . . . 0.0 110.096 179.895 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.529 ' CE1' ' CG2' ' A' ' 4' ' ' VAL . 75.8 m-85 -128.84 142.24 51.03 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.898 -179.313 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -136.1 157.84 45.87 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.953 179.65 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 59.02 35.45 24.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.938 0.399 . . . . 0.0 109.954 -179.66 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.405 ' HA ' ' HA ' ' A' ' 93' ' ' ALA . 42.9 t -76.07 -6.91 9.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.322 -179.757 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 61.4 t -153.87 138.14 11.04 Favored Pre-proline 0 C--N 1.332 -0.17 0 N-CA-C 110.29 -0.263 . . . . 0.0 110.29 179.893 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -75.48 -172.66 1.36 Allowed 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.535 2.157 . . . . 0.0 112.056 179.881 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -67.93 -42.5 80.91 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.244 179.844 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 16.7 mtpt -127.45 77.73 1.77 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.235 179.841 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 45.3 p90 -51.1 158.8 0.69 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.508 -179.851 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 20.8 m -138.33 110.43 7.3 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.075 179.919 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 2.8 mp -50.46 95.06 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.357 -179.942 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 138.04 44.99 0.08 OUTLIER Glycine 0 CA--C 1.523 0.572 0 N-CA-C 110.575 -1.01 . . . . 0.0 110.575 -179.878 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -168.46 141.21 2.95 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.75 0.309 . . . . 0.0 110.243 -179.93 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 85.7 m -91.05 145.85 24.34 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.971 0.415 . . . . 0.0 110.648 -179.939 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.404 ' O ' ' CB ' ' A' ' 93' ' ' ALA . 30.2 m-85 -129.75 -152.24 0.51 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.826 -0.624 . . . . 0.0 109.501 179.674 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.43 ' CB ' ' HD2' ' A' ' 94' ' ' PRO . . . 77.79 174.74 0.08 OUTLIER Pre-proline 0 N--CA 1.465 0.276 0 CA-C-O 120.8 0.333 . . . . 0.0 110.684 179.77 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.43 ' HD2' ' CB ' ' A' ' 93' ' ' ALA . 48.3 Cg_endo . . . . . 0 C--O 1.248 1.02 0 C-N-CA 122.618 2.212 . . . . 0.0 111.989 -179.982 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 32.2 t . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 110.09 -0.337 . . . . 0.0 110.09 . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -77.54 154.14 31.02 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.48 2.12 . . . . 0.0 112.231 -179.883 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.74 78.45 1.68 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.24 179.986 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.521 ' CG1' ' CZ ' ' A' ' 78' ' ' PHE . 1.7 p -49.88 163.97 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.253 0.549 . . . . 0.0 110.624 -179.819 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.478 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 15.7 p -141.89 132.63 25.64 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.367 179.907 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.468 ' CD1' HG12 ' A' ' 81' ' ' VAL . 22.7 m-85 -101.09 170.68 8.11 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.301 179.967 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.415 ' O ' ' N ' ' A' ' 20' ' ' LEU . 92.6 m -166.17 132.47 2.52 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.464 -179.947 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 26.4 t -71.1 102.99 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.199 179.82 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.422 ' HG3' ' CG2' ' A' ' 51' ' ' VAL . 6.3 mm-40 -50.33 170.81 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.511 -179.811 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 33.7 mtmm -72.53 -21.38 61.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.721 -179.937 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -90.9 49.1 3.05 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.928 -0.869 . . . . 0.0 110.928 -179.948 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 60.7 p -87.1 134.64 33.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.765 0.317 . . . . 0.0 110.291 179.867 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -134.2 164.63 26.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.306 -179.989 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -67.4 -34.5 77.38 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.333 -179.992 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 1.7 tppp? -93.14 -20.46 20.47 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.225 -179.588 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 39.8 m80 -120.09 133.54 55.49 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.931 0.396 . . . . 0.0 111.024 -179.377 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -104.29 77.94 1.45 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.136 179.567 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -75.41 116.95 16.68 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.414 -179.884 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.406 ' O ' ' CB ' ' A' ' 51' ' ' VAL . 14.8 m -109.17 -168.24 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.17 179.942 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.415 ' N ' ' O ' ' A' ' 7' ' ' THR . 1.0 OUTLIER -142.28 78.74 1.63 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.376 179.855 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 11.7 t -95.41 110.22 23.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.336 -179.933 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -179.05 117.86 0.07 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.453 179.946 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 7.5 p90 -150.48 172.04 16.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.312 179.842 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -92.15 148.33 22.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.368 -179.917 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 114.25 -41.71 2.12 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 110.76 -0.936 . . . . 0.0 110.76 179.998 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -119.38 176.05 5.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.84 0.352 . . . . 0.0 110.418 179.999 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.29 -160.84 0.73 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.401 -179.999 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.418 ' O ' ' CG ' ' A' ' 71' ' ' GLU . 59.1 mtm -137.43 120.42 16.55 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.316 180.0 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.444 ' CB ' ' HG2' ' A' ' 71' ' ' GLU . . . -124.4 -58.39 1.52 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.563 -179.786 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -153.34 161.78 41.98 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.38 -179.864 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 21.5 t -143.46 155.19 16.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.286 -179.999 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.433 ' CB ' ' HA ' ' A' ' 43' ' ' ALA . 1.8 pt-20 -167.24 137.82 3.02 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.53 -179.953 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.485 HD22 ' CG ' ' A' ' 54' ' ' PHE . 3.2 pp -104.24 171.96 7.06 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.322 179.839 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.488 ' HB2' ' CZ3' ' A' ' 41' ' ' TRP . 1.3 ttt180 -97.87 -72.99 0.63 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.616 -179.848 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.484 ' CB ' ' O ' ' A' ' 34' ' ' ARG . 2.6 tm-20 94.34 80.26 0.0 OUTLIER 'General case' 0 CA--C 1.511 -0.523 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 -178.977 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -37.42 134.22 0.65 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.166 -0.925 . . . . 0.0 111.757 -178.362 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 114.07 -28.98 8.0 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 110.397 -1.081 . . . . 0.0 110.397 -179.745 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -82.46 -173.96 4.89 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.778 0.323 . . . . 0.0 110.268 179.864 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.41 ' OD1' ' N ' ' A' ' 40' ' ' GLU . 35.2 p30 -114.31 -21.64 10.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.843 -179.861 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.41 ' N ' ' OD1' ' A' ' 39' ' ' ASP . 9.7 mt-10 -135.0 175.26 9.74 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.84 0.352 . . . . 0.0 110.701 -179.826 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.49 ' CZ3' ' HG2' ' A' ' 67' ' ' ARG . 53.1 m95 -86.18 173.05 10.07 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.466 179.945 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.48 HG22 ' CZ ' ' A' ' 54' ' ' PHE . 9.7 m -135.57 112.8 14.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.329 179.818 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.433 ' HA ' ' CB ' ' A' ' 32' ' ' GLU . . . -51.02 127.13 18.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.299 179.938 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -60.69 -171.39 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.32 -179.887 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 38.3 m -136.72 133.12 35.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.92 0.39 . . . . 0.0 110.496 -179.847 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 2.8 ptmt -100.95 79.87 2.08 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.52 -179.948 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -153.05 26.63 0.8 Allowed Glycine 0 CA--C 1.523 0.574 0 N-CA-C 110.851 -0.9 . . . . 0.0 110.851 -179.976 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.423 ' CG ' HG21 ' A' ' 51' ' ' VAL . 14.0 tp10 -98.05 -24.59 15.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.734 0.302 . . . . 0.0 110.319 179.952 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 128.03 -76.02 0.41 Allowed Glycine 0 CA--C 1.523 0.536 0 N-CA-C 110.566 -1.014 . . . . 0.0 110.566 -179.964 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -113.31 -14.34 9.89 Favored Glycine 0 CA--C 1.527 0.816 0 N-CA-C 111.259 -0.736 . . . . 0.0 111.259 179.878 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.423 HG21 ' CG ' ' A' ' 48' ' ' GLU . 27.2 m -124.95 -175.44 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-O 120.932 0.396 . . . . 0.0 110.74 -179.745 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 8.1 m95 -104.59 146.22 29.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.499 -179.848 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.08 165.89 18.66 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.162 179.8 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.485 ' CG ' HD22 ' A' ' 33' ' ' LEU . 87.3 t80 -144.51 143.18 30.72 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.572 -179.863 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -89.07 102.48 15.14 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.314 179.913 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 69.7 p -86.91 100.82 12.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.465 -179.934 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -101.93 25.3 8.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.41 179.892 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 6.6 pm0 -121.39 140.83 32.08 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.193 179.897 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -73.45 -20.73 20.47 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.574 2.182 . . . . 0.0 112.113 179.992 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 17.3 mt -53.41 150.43 6.55 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.502 -179.95 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 24.1 tt0 -140.75 96.16 2.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.306 179.818 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -149.24 -157.85 7.82 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 110.682 -0.967 . . . . 0.0 110.682 179.992 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -76.35 160.74 35.48 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.565 2.177 . . . . 0.0 112.168 -179.934 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -130.96 100.98 5.43 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.394 179.873 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 48.0 m-80 -66.32 160.33 24.8 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 179.652 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -133.92 176.32 8.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.023 0.439 . . . . 0.0 110.93 -179.894 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.49 ' HG2' ' CZ3' ' A' ' 41' ' ' TRP . 0.0 OUTLIER 176.6 72.3 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.751 179.998 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -67.16 174.96 2.84 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.88 -179.404 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.426 ' O ' ' CB ' ' A' ' 29' ' ' ALA . 8.9 mt -125.26 68.79 1.14 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.311 179.492 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -37.19 140.97 0.16 Allowed 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.728 -179.115 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.444 ' HG2' ' CB ' ' A' ' 29' ' ' ALA . 2.0 mm-40 -55.27 -58.48 7.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.369 -179.821 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -125.73 55.9 1.42 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.316 179.962 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -137.51 -106.7 0.78 Allowed Glycine 0 CA--C 1.524 0.601 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 -179.981 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 1.2 ptt? -178.5 163.4 1.54 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.805 0.336 . . . . 0.0 110.446 -179.924 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.69 134.37 35.46 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.258 -179.867 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -143.32 129.73 20.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.378 179.958 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.425 HG11 ' N ' ' A' ' 78' ' ' PHE . 43.3 t -85.55 142.94 12.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.34 -179.993 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.521 ' CZ ' ' CG1' ' A' ' 4' ' ' VAL . 51.5 m-85 -132.48 120.66 22.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.549 -179.866 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -105.36 163.72 12.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.257 179.83 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 53.79 57.45 6.04 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.271 179.992 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.468 HG12 ' CD1' ' A' ' 6' ' ' PHE . 60.9 t -109.02 7.78 9.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.216 -179.965 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.427 ' CG2' ' O ' ' A' ' 81' ' ' VAL . 70.2 t -158.36 104.35 1.68 Allowed Pre-proline 0 CA--C 1.531 0.212 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 -179.932 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -74.93 178.46 7.22 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.499 2.132 . . . . 0.0 111.935 179.706 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -65.97 121.76 15.83 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.217 179.885 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 3.4 tttt 55.09 65.83 1.39 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.111 -179.823 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 32.6 p90 -49.58 143.23 7.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.755 -179.758 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 9.0 m -110.32 110.03 20.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.13 179.739 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 2.8 mp -49.18 121.1 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.542 -179.844 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 115.57 31.07 2.05 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 110.926 -0.869 . . . . 0.0 110.926 179.976 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.407 ' HB2' ' CE1' ' A' ' 92' ' ' TYR . . . -143.63 176.26 9.35 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.745 0.307 . . . . 0.0 110.253 179.834 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 17.3 m -125.0 124.06 41.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.533 -179.901 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.407 ' CE1' ' HB2' ' A' ' 90' ' ' ALA . 6.0 m-85 -124.2 129.54 50.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.272 179.87 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.456 ' CB ' ' CD ' ' A' ' 94' ' ' PRO . . . 178.01 179.24 0.23 Allowed Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.289 -179.988 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.456 ' CD ' ' CB ' ' A' ' 93' ' ' ALA . 48.7 Cg_endo . . . . . 0 C--O 1.249 1.072 0 C-N-CA 122.519 2.146 . . . . 0.0 111.959 -179.93 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . 0.417 ' O ' ' CG1' ' A' ' 1' ' ' VAL . 7.6 p . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 . . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -74.1 150.28 42.61 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.508 2.138 . . . . 0.0 111.971 179.928 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -137.55 81.14 1.85 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.624 -179.756 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.484 ' CG1' ' CE1' ' A' ' 78' ' ' PHE . 1.7 p -153.72 163.7 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 121.176 0.512 . . . . 0.0 110.151 179.705 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.464 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 0.2 OUTLIER -136.15 140.72 43.85 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.438 179.951 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 -105.8 165.91 10.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.965 179.754 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.4 m -160.03 103.49 1.48 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.819 0.343 . . . . 0.0 110.522 -179.823 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 61.1 t -60.04 93.99 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.17 179.771 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -49.8 165.33 0.08 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.609 -179.851 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.24 56.57 2.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.394 179.95 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -135.79 20.65 3.63 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 111.124 -0.79 . . . . 0.0 111.124 -179.909 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.2 p -74.7 108.46 7.47 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.949 0.405 . . . . 0.0 109.994 179.729 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 22.5 m-20 -92.2 -163.53 1.05 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.775 -179.506 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -55.5 -36.34 66.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.819 -179.706 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.434 ' HD3' ' ND1' ' A' ' 16' ' ' HIS . 0.1 OUTLIER -147.6 45.93 1.12 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.784 0.326 . . . . 0.0 110.582 -179.794 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.434 ' ND1' ' HD3' ' A' ' 15' ' ' LYS . 45.0 m80 -133.78 151.57 51.62 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.22 179.783 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 20.9 tp -137.28 92.54 2.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.462 -179.745 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -87.91 123.13 32.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.298 179.885 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 27.2 m -121.02 144.76 28.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.555 -179.811 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.423 ' CD2' ' CG ' ' A' ' 22' ' ' LYS . 0.5 OUTLIER -91.38 83.35 5.44 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.28 179.77 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 24.4 t -89.44 100.3 10.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.543 -179.827 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.423 ' CG ' ' CD2' ' A' ' 20' ' ' LEU . 0.0 OUTLIER 174.9 135.7 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.353 179.859 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.486 ' CE2' ' HB2' ' A' ' 26' ' ' ASP . 0.7 OUTLIER -129.91 -173.29 2.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.1 179.874 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -40.62 -57.42 1.87 Allowed 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 120.795 0.331 . . . . 0.0 111.195 -179.783 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -89.22 -153.77 28.09 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 110.664 -0.974 . . . . 0.0 110.664 179.806 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.486 ' HB2' ' CE2' ' A' ' 23' ' ' TYR . 28.1 t0 68.33 143.52 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.744 0.307 . . . . 0.0 110.408 179.983 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.446 ' CG2' ' O ' ' A' ' 27' ' ' THR . 86.4 m -119.33 13.44 12.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.062 179.863 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.405 ' O ' ' CG ' ' A' ' 71' ' ' GLU . 9.3 mtp 59.51 115.09 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.832 0.349 . . . . 0.0 110.594 179.732 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.421 ' CB ' ' O ' ' A' ' 69' ' ' LEU . . . -126.42 -57.17 1.39 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.13 179.81 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -157.46 166.69 32.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.147 179.789 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.479 HG23 ' CD1' ' A' ' 52' ' ' TRP . 38.5 t -152.41 148.27 14.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.448 -179.899 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.432 ' CB ' ' HA ' ' A' ' 43' ' ' ALA . 14.6 pt-20 -138.81 146.93 41.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.093 179.766 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.521 ' CD2' ' CG ' ' A' ' 54' ' ' PHE . 6.1 tp -128.86 138.3 51.96 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 120.923 0.392 . . . . 0.0 110.19 -179.093 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.468 ' HB2' ' CE3' ' A' ' 41' ' ' TRP . 50.0 ttp85 -124.6 165.67 17.46 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.55 179.184 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -118.92 -83.07 0.65 Allowed 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 -179.975 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER 169.58 158.61 0.06 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.375 179.598 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 50.01 47.01 41.32 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 110.849 -0.901 . . . . 0.0 110.849 179.926 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 32.1 t -136.0 -174.93 3.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.817 0.341 . . . . 0.0 110.329 179.899 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -68.57 -63.57 1.03 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.471 -179.919 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -167.93 -173.87 2.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.343 -179.926 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.468 ' CE3' ' HB2' ' A' ' 34' ' ' ARG . 50.3 m95 -47.68 154.34 0.49 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.591 -179.943 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 24.2 m -129.9 28.86 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.421 179.983 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.432 ' HA ' ' CB ' ' A' ' 32' ' ' GLU . . . 47.24 -175.34 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.131 179.555 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -112.94 -164.74 0.94 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.356 -179.97 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 25.7 m -146.52 104.97 3.81 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.477 -179.933 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.43 71.87 0.95 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.243 179.857 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -99.3 -34.49 5.05 Favored Glycine 0 CA--C 1.523 0.559 0 N-CA-C 110.813 -0.915 . . . . 0.0 110.813 -179.868 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.428 ' HG2' ' CG2' ' A' ' 51' ' ' VAL . 4.1 tp10 -80.5 130.11 34.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.808 0.337 . . . . 0.0 110.35 -179.916 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -78.39 78.38 1.62 Allowed Glycine 0 CA--C 1.522 0.53 0 N-CA-C 110.752 -0.939 . . . . 0.0 110.752 179.895 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 150.67 -32.01 1.0 Allowed Glycine 0 CA--C 1.522 0.502 0 N-CA-C 110.6 -1.0 . . . . 0.0 110.6 -179.959 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.428 ' CG2' ' HG2' ' A' ' 48' ' ' GLU . 17.5 m -145.81 -177.35 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.837 0.351 . . . . 0.0 110.369 -179.997 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . 0.479 ' CD1' HG23 ' A' ' 31' ' ' VAL . 7.5 m95 -102.97 141.15 36.26 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.584 -179.738 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.22 152.22 43.18 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.942 179.7 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.521 ' CG ' ' CD2' ' A' ' 33' ' ' LEU . 80.6 t80 -117.39 161.65 19.21 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.423 -179.925 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -118.15 118.59 32.29 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.32 -179.993 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 40.2 m -111.48 164.24 13.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.449 -179.931 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -161.7 39.9 0.13 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.249 179.932 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -131.91 157.52 77.98 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.338 -179.946 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -71.61 -33.35 10.71 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.615 2.21 . . . . 0.0 112.2 -179.936 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -82.68 174.7 10.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.293 179.909 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 179.81 59.6 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.613 179.935 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -72.88 -139.95 0.37 Allowed Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.477 -1.049 . . . . 0.0 110.477 179.807 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -73.83 174.1 12.88 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.501 2.134 . . . . 0.0 111.699 179.698 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -135.52 177.08 8.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.957 0.408 . . . . 0.0 110.548 -179.937 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 -143.96 131.29 20.87 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.862 179.904 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -116.16 170.13 8.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.044 0.45 . . . . 0.0 110.884 -179.705 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.433 ' HG3' ' CH2' ' A' ' 41' ' ' TRP . 0.1 OUTLIER -172.54 80.75 0.05 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.049 -179.925 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.403 ' HA ' ' HA ' ' A' ' 31' ' ' VAL . 0.5 OUTLIER -81.57 167.02 19.72 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.191 0.52 . . . . 0.0 110.966 -179.594 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.436 HD21 ' CD ' ' A' ' 75' ' ' LYS . 6.8 mt -123.49 74.23 1.24 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.494 179.715 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.412 ' OG1' ' N ' ' A' ' 74' ' ' MET . 13.5 p -36.81 137.77 0.29 Allowed 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.696 -179.334 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.419 ' HG2' ' CB ' ' A' ' 29' ' ' ALA . 8.7 mm-40 -48.88 -46.48 42.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.822 -179.591 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.66 45.9 1.7 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.447 179.86 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -121.06 -110.17 2.17 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 110.863 -0.895 . . . . 0.0 110.863 -179.983 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.412 ' N ' ' OG1' ' A' ' 70' ' ' THR . 2.1 ptt? -171.67 152.69 3.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.831 0.348 . . . . 0.0 110.361 -179.905 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.436 ' CD ' HD21 ' A' ' 69' ' ' LEU . 0.0 OUTLIER -76.58 150.83 36.46 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.463 -179.942 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 55.0 m-20 -156.31 136.73 13.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.542 179.946 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 94.2 t -89.33 138.92 18.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.353 179.927 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.484 ' CE1' ' CG1' ' A' ' 4' ' ' VAL . 40.4 m-85 -126.81 134.87 50.46 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.793 -179.448 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -123.93 150.72 44.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.273 179.85 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 54.39 30.66 13.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.374 -179.904 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.408 ' HA ' ' HA ' ' A' ' 93' ' ' ALA . 54.8 t -53.71 -24.82 10.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.48 -179.925 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.422 ' CG1' ' HB3' ' A' ' 86' ' ' TYR . 59.3 t -134.34 132.3 20.95 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.579 -0.282 . . . . 0.0 110.535 179.897 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.447 ' CD ' ' CD1' ' A' ' 92' ' ' TYR . 49.5 Cg_endo -71.24 -171.48 0.61 Allowed 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.586 2.191 . . . . 0.0 111.996 179.744 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 21.3 pt-20 -85.23 129.92 34.71 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 179.29 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 59.33 50.66 7.51 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 -179.282 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . 0.422 ' HB3' ' CG1' ' A' ' 82' ' ' VAL . 36.6 p90 -43.46 160.43 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.413 -179.407 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -130.92 104.26 7.04 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.925 179.751 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 3.0 mp -45.3 118.65 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.623 -179.798 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 118.42 36.7 0.9 Allowed Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.602 -0.999 . . . . 0.0 110.602 -179.821 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -149.32 153.34 37.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.768 0.318 . . . . 0.0 110.149 -179.96 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 92.4 m -103.63 93.62 5.02 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.727 -179.81 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.447 ' CD1' ' CD ' ' A' ' 83' ' ' PRO . 40.1 m-85 -81.81 -153.76 0.11 Allowed 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 179.31 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.45 ' CB ' ' HD2' ' A' ' 94' ' ' PRO . . . 76.2 175.85 0.07 OUTLIER Pre-proline 0 N--CA 1.464 0.263 0 CA-C-O 120.689 0.281 . . . . 0.0 110.748 179.726 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.45 ' HD2' ' CB ' ' A' ' 93' ' ' ALA . 46.5 Cg_endo . . . . . 0 C--O 1.249 1.027 0 C-N-CA 122.523 2.148 . . . . 0.0 112.053 -179.988 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 2.6 m . . . . . 0 N--CA 1.489 1.524 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 . . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -76.41 147.88 29.36 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.566 2.178 . . . . 0.0 112.089 179.965 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 7.9 mtmm -127.04 81.15 2.0 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.402 179.988 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.513 ' CG2' ' CE1' ' A' ' 78' ' ' PHE . 18.0 m -72.95 170.86 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.435 -179.979 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 16.0 p -154.66 132.07 11.2 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.516 -179.97 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.405 ' CD1' ' N ' ' A' ' 6' ' ' PHE . 13.6 m-85 -101.3 160.29 14.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.066 179.821 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.6 m -156.49 126.26 6.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.924 0.392 . . . . 0.0 110.683 -179.86 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 98.9 t -60.28 114.73 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.284 179.85 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.426 ' HG3' ' CG2' ' A' ' 51' ' ' VAL . 15.0 mm-40 -94.1 160.92 14.49 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.433 -179.91 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.9 ttmm -55.16 159.25 2.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.339 179.979 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 86.91 25.77 33.66 Favored Glycine 0 CA--C 1.523 0.539 0 N-CA-C 110.772 -0.931 . . . . 0.0 110.772 -179.968 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 58.3 m -94.84 120.3 34.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.813 0.34 . . . . 0.0 110.491 -179.891 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -119.38 -163.94 1.02 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.39 179.927 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -46.99 -61.89 1.66 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.245 -179.693 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.404 ' HG2' ' N ' ' A' ' 16' ' ' HIS . 0.8 OUTLIER -98.95 -28.28 13.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.058 -179.271 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.404 ' N ' ' HG2' ' A' ' 15' ' ' LYS . 1.7 m80 -65.02 123.66 20.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.833 0.349 . . . . 0.0 110.411 -179.818 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -129.51 99.82 5.32 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.419 -179.953 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -95.88 130.93 42.69 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.128 179.83 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.449 ' N ' ' CG1' ' A' ' 51' ' ' VAL . 17.7 m -139.59 134.63 39.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.905 0.383 . . . . 0.0 110.796 -179.969 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -84.77 100.38 11.49 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.481 179.955 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 82.1 t -102.53 92.22 2.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.341 179.866 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.7 139.36 17.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.445 -179.925 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 2.1 p90 -155.0 168.02 28.41 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.257 179.929 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -74.17 125.06 27.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.417 -179.869 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 141.77 -91.35 0.18 Allowed Glycine 0 CA--C 1.523 0.555 0 N-CA-C 110.566 -1.014 . . . . 0.0 110.566 -179.934 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -72.93 -160.58 0.08 Allowed 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 179.805 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.422 ' CG2' ' O ' ' A' ' 27' ' ' THR . 33.5 m -144.14 31.67 1.24 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.637 179.975 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.416 ' O ' ' CG ' ' A' ' 71' ' ' GLU . 16.5 mtm 61.37 123.75 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.618 179.642 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.435 ' CB ' ' HG2' ' A' ' 71' ' ' GLU . . . -124.86 -58.58 1.47 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.527 179.838 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -152.52 152.18 31.6 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.52 -179.958 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 27.9 t -141.76 155.8 20.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.191 179.746 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.421 ' CG ' ' HG3' ' A' ' 67' ' ' ARG . 0.9 OUTLIER -156.45 148.28 22.89 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.384 -179.784 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.7 tp -111.4 148.94 31.97 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 -179.821 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.479 ' HB2' ' CZ3' ' A' ' 41' ' ' TRP . 0.0 OUTLIER -97.77 -68.26 0.81 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.53 -179.818 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.439 ' CB ' ' O ' ' A' ' 34' ' ' ARG . 25.2 mt-10 88.8 74.94 0.01 OUTLIER 'General case' 0 CA--C 1.51 -0.58 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 -178.771 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -37.37 103.31 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.039 -0.982 . . . . 0.0 111.713 -178.097 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 107.13 37.07 2.38 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 110.413 -1.075 . . . . 0.0 110.413 -179.738 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 7.2 t -119.0 -157.5 0.69 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.676 0.274 . . . . 0.0 110.513 -179.641 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -111.25 66.41 0.63 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.855 0.359 . . . . 0.0 110.403 -179.837 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 76.39 160.06 0.22 Allowed 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.394 179.93 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.479 ' CZ3' ' HB2' ' A' ' 34' ' ' ARG . 82.4 m95 -51.18 156.79 1.03 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.566 -179.94 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.481 HG22 ' CZ ' ' A' ' 54' ' ' PHE . 3.2 m -139.15 115.78 10.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.915 179.635 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -48.54 143.04 5.3 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.674 -179.651 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -73.26 -174.16 1.53 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.301 -179.959 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 59.1 m -145.53 120.81 10.22 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.096 179.887 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.42 ' O ' ' CG ' ' A' ' 46' ' ' LYS . 0.8 OUTLIER -68.67 64.4 0.11 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.412 -179.838 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -72.6 -47.54 26.8 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 110.797 -0.921 . . . . 0.0 110.797 -179.981 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.453 ' CB ' ' HB ' ' A' ' 51' ' ' VAL . 0.5 OUTLIER -73.99 -174.34 1.84 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.866 0.365 . . . . 0.0 110.659 -179.814 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -82.79 -35.29 19.57 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 110.599 -1.0 . . . . 0.0 110.599 179.912 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -146.35 27.07 1.69 Allowed Glycine 0 CA--C 1.522 0.47 0 N-CA-C 110.117 -1.193 . . . . 0.0 110.117 179.69 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.453 ' HB ' ' CB ' ' A' ' 48' ' ' GLU . 88.5 t -138.6 145.7 27.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.841 0.353 . . . . 0.0 110.084 -179.689 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . 0.419 ' N ' HG11 ' A' ' 51' ' ' VAL . 4.2 m95 -94.55 114.37 26.34 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.513 -179.619 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 11.1 p -107.24 143.43 35.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.311 -179.937 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.481 ' CZ ' HG22 ' A' ' 42' ' ' VAL . 56.2 t80 -126.44 150.86 48.41 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.446 179.925 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -108.39 95.47 5.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.355 -179.975 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -61.78 167.23 3.78 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.398 -179.967 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -105.79 -32.46 8.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.491 -179.955 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -111.45 153.52 44.13 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.432 -179.876 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -67.94 -32.37 28.88 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.899 2.399 . . . . 0.0 112.393 -179.934 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -77.53 128.07 33.56 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.673 -179.59 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 19.5 pt20 179.87 132.31 0.1 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.134 -179.943 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -138.79 -72.45 0.05 OUTLIER Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 -179.798 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -72.48 122.01 7.93 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.548 2.165 . . . . 0.0 112.006 179.837 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 45.1 m-85 -113.61 102.36 10.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.685 -179.689 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 52.2 m-20 -81.01 137.26 36.07 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 179.391 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -125.69 170.44 11.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.107 0.48 . . . . 0.0 111.077 -179.351 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.459 ' HG2' ' CZ3' ' A' ' 41' ' ' TRP . 0.0 OUTLIER -168.91 53.69 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.791 179.949 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.473 ' CZ ' ' CE2' ' A' ' 78' ' ' PHE . 0.2 OUTLIER -49.77 169.82 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.028 -179.56 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.428 ' O ' ' CB ' ' A' ' 29' ' ' ALA . 6.9 mt -124.77 70.1 1.13 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.22 179.386 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 31.9 p -33.43 141.82 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.157 0.583 . . . . 0.0 112.241 -178.99 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.435 ' HG2' ' CB ' ' A' ' 29' ' ' ALA . 4.7 mm-40 -53.66 -60.11 3.73 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.745 -0.662 . . . . 0.0 110.455 -179.952 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 4.8 tmtt? -124.76 77.75 1.63 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.458 -179.973 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -170.55 -99.94 0.13 Allowed Glycine 0 CA--C 1.523 0.536 0 N-CA-C 110.764 -0.935 . . . . 0.0 110.764 179.901 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 179.29 173.56 0.81 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.864 0.364 . . . . 0.0 110.282 -179.938 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.19 -176.29 3.04 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.347 179.938 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.423 ' O ' ' CB ' ' A' ' 67' ' ' ARG . 2.7 t-20 -178.99 -173.7 0.31 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.016 179.942 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 93.0 t -128.31 127.32 67.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.887 0.375 . . . . 0.0 110.454 -179.884 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.513 ' CE1' ' CG2' ' A' ' 4' ' ' VAL . 58.3 m-85 -112.64 123.24 49.86 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.887 179.741 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -113.89 151.85 31.6 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.781 -179.519 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 35.5 t0 60.26 24.0 13.4 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.762 179.834 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 25.4 t -55.73 -79.39 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.665 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.428 ' CG1' ' HB3' ' A' ' 86' ' ' TYR . 47.2 t -87.11 139.1 32.36 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.453 179.837 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.462 ' HD3' ' CG ' ' A' ' 92' ' ' TYR . 49.2 Cg_endo -71.76 -173.55 1.06 Allowed 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.624 2.216 . . . . 0.0 112.001 179.812 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 32.9 mp0 -64.12 -73.67 0.11 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.057 179.762 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -94.75 73.0 3.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.045 179.642 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . 0.428 ' HB3' ' CG1' ' A' ' 82' ' ' VAL . 30.2 p90 -52.04 159.37 0.9 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.897 -179.574 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.74 109.99 12.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.094 179.747 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 3.3 mp -48.11 111.76 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.748 -179.769 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 110.56 55.0 0.53 Allowed Glycine 0 CA--C 1.523 0.538 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 179.995 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -175.75 131.78 0.26 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.82 0.343 . . . . 0.0 110.465 179.968 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.424 HG21 ' N ' ' A' ' 92' ' ' TYR . 35.5 m -83.16 144.58 29.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.159 179.917 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.462 ' CG ' ' HD3' ' A' ' 83' ' ' PRO . 71.9 m-85 -129.03 -83.79 0.57 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.691 -179.964 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.471 ' CB ' ' CD ' ' A' ' 94' ' ' PRO . . . 49.64 -179.01 0.01 OUTLIER Pre-proline 0 C--O 1.232 0.133 0 CA-C-O 120.624 0.249 . . . . 0.0 110.595 179.94 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.471 ' CD ' ' CB ' ' A' ' 93' ' ' ALA . 48.1 Cg_endo . . . . . 0 C--O 1.249 1.053 0 C-N-CA 122.481 2.121 . . . . 0.0 112.088 -179.902 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 4.0 m . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 110.128 -0.323 . . . . 0.0 110.128 . . . . . . . . . 0 0 . 1 . 031 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -77.06 159.22 33.95 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.588 2.192 . . . . 0.0 112.033 -179.904 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -139.62 97.47 3.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.38 179.984 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.474 HG23 ' CZ ' ' A' ' 78' ' ' PHE . 34.2 m -66.21 -178.38 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.359 -179.937 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.0 p -161.77 138.34 8.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.296 -179.996 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -102.06 173.1 6.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.459 -179.757 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.416 ' CG2' ' O ' ' A' ' 90' ' ' ALA . 0.3 OUTLIER -165.96 102.92 0.66 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.287 -179.991 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.423 ' CG1' HG13 ' A' ' 88' ' ' ILE . 40.5 t -51.68 96.35 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.341 179.956 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.43 ' CG ' HG22 ' A' ' 51' ' ' VAL . 1.8 mm-40 -62.09 177.1 0.5 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.654 -179.737 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.8 tttt -80.63 60.34 3.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.409 -179.944 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -146.3 21.23 1.72 Allowed Glycine 0 CA--C 1.525 0.668 0 N-CA-C 111.022 -0.831 . . . . 0.0 111.022 179.974 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 25.6 m -110.32 114.58 28.15 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 110.121 -0.325 . . . . 0.0 110.121 179.921 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.419 ' OD1' ' N ' ' A' ' 14' ' ' GLU . 6.1 p30 -113.46 -49.13 2.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.612 -179.793 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.419 ' N ' ' OD1' ' A' ' 13' ' ' ASN . 9.6 mm-40 -154.15 -69.65 0.14 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.776 -179.792 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.435 ' N ' ' HD2' ' A' ' 15' ' ' LYS . 17.9 mmmt -91.25 -28.73 17.61 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.478 -179.478 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 9.5 m80 -76.36 128.59 35.14 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.764 -179.632 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.413 ' CD1' HG11 ' A' ' 19' ' ' VAL . 1.2 tm? -122.32 86.22 2.54 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.943 179.793 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -80.11 129.35 34.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.636 -179.596 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.42 ' N ' ' CG1' ' A' ' 51' ' ' VAL . 24.1 m -134.03 134.35 55.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.401 179.697 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.414 ' HB2' ' CG ' ' A' ' 9' ' ' GLU . 0.7 OUTLIER -89.36 87.47 7.12 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.377 -179.947 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.406 HG13 ' CD2' ' A' ' 68' ' ' PHE . 12.0 t -86.39 108.87 18.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.27 179.923 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.1 mtpt -179.67 176.39 0.79 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.226 179.95 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 20.1 p90 176.85 40.93 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.315 -179.963 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 55.63 174.77 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.353 179.974 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 70.74 -101.19 0.9 Allowed Glycine 0 CA--C 1.523 0.559 0 N-CA-C 110.635 -0.986 . . . . 0.0 110.635 -179.993 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -54.8 166.39 0.49 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.779 0.323 . . . . 0.0 110.359 179.934 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -115.0 -169.31 1.53 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.474 179.949 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.413 ' O ' ' CG ' ' A' ' 71' ' ' GLU . 13.4 mmt -115.21 127.45 55.52 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.637 -179.756 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.439 ' CB ' ' HG2' ' A' ' 71' ' ' GLU . . . -118.03 -59.37 1.91 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.586 -179.904 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -150.44 153.06 35.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.215 -179.943 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.405 ' HA ' ' HA ' ' A' ' 68' ' ' PHE . 4.4 t -147.61 146.68 18.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.017 0.437 . . . . 0.0 110.773 -179.742 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.438 ' CB ' ' HA ' ' A' ' 43' ' ' ALA . 5.9 pt-20 -137.26 146.28 44.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.513 179.203 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.465 HD22 ' CD2' ' A' ' 54' ' ' PHE . 9.8 tp -123.1 153.2 40.25 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-O 120.938 0.399 . . . . 0.0 110.033 -178.907 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.485 ' HB2' ' CE3' ' A' ' 41' ' ' TRP . 0.0 OUTLIER -145.66 162.73 36.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.678 179.574 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.406 ' O ' ' HB2' ' A' ' 36' ' ' HIS . 1.1 mt-10 -120.45 -86.11 0.65 Allowed 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 179.924 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.406 ' HB2' ' O ' ' A' ' 35' ' ' GLU . 0.8 OUTLIER -179.98 -40.62 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.803 0.335 . . . . 0.0 110.373 179.472 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -63.22 -56.83 17.97 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 110.781 -0.928 . . . . 0.0 110.781 -179.951 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.417 ' O ' ' CB ' ' A' ' 39' ' ' ASP . 1.5 t -55.03 -36.2 65.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.777 0.322 . . . . 0.0 110.356 -179.928 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.417 ' CB ' ' O ' ' A' ' 38' ' ' SER . 4.1 t70 81.6 -53.66 0.27 Allowed 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.489 -179.812 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -77.88 145.53 36.17 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.155 179.948 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.485 ' CE3' ' HB2' ' A' ' 34' ' ' ARG . 75.3 m95 -71.0 153.68 42.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.472 -179.864 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.452 HG23 ' CZ ' ' A' ' 54' ' ' PHE . 3.0 m -135.72 111.95 12.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.921 179.671 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.438 ' HA ' ' CB ' ' A' ' 32' ' ' GLU . . . -47.95 155.05 0.47 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.857 -179.479 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -76.42 -173.17 2.39 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.355 179.986 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 53.7 m -152.49 103.57 2.83 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.526 -179.943 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 7.9 ptpt -59.5 88.89 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.229 -0.442 . . . . 0.0 109.934 179.767 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -110.25 -28.46 4.08 Favored Glycine 0 CA--C 1.522 0.52 0 N-CA-C 111.239 -0.745 . . . . 0.0 111.239 -179.56 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.447 ' CB ' ' HB ' ' A' ' 51' ' ' VAL . 1.1 tp10 -72.09 -36.13 69.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.753 0.311 . . . . 0.0 110.698 -179.646 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 115.12 -37.46 3.49 Favored Glycine 0 CA--C 1.52 0.405 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 -179.115 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -138.02 21.32 3.17 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 178.631 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.447 ' HB ' ' CB ' ' A' ' 48' ' ' GLU . 52.6 t -155.44 144.61 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 -179.677 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 3.0 m95 -91.51 110.42 21.74 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.968 0.413 . . . . 0.0 110.327 -179.749 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.1 p -101.81 142.17 33.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.468 -179.7 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.465 ' CD2' HD22 ' A' ' 33' ' ' LEU . 66.3 t80 -130.47 147.26 52.15 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.344 179.902 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 51.8 m-20 -89.04 101.17 13.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.431 -179.938 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.0 t -77.65 170.74 16.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.257 179.889 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -177.4 68.95 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.474 -179.912 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 179.49 118.61 0.21 Allowed Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.375 179.967 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -73.63 -2.43 12.17 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.475 2.117 . . . . 0.0 112.683 179.998 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 10.6 mp -67.05 74.91 0.12 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.727 0.298 . . . . 0.0 110.459 -179.943 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 57.7 mt-30 51.55 -170.06 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.177 179.998 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.47 ' N ' ' HD3' ' A' ' 63' ' ' PRO . . . -128.46 47.95 0.99 Allowed Glycine 0 CA--C 1.527 0.8 0 N-CA-C 111.589 -0.604 . . . . 0.0 111.589 -179.846 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.47 ' HD3' ' N ' ' A' ' 62' ' ' GLY . 51.8 Cg_endo -76.69 90.09 1.24 Allowed 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.389 2.06 . . . . 0.0 111.396 179.327 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.425 ' HB3' ' CD1' ' A' ' 33' ' ' LEU . 24.9 m-85 -92.28 160.51 15.1 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.272 0.558 . . . . 0.0 111.253 -179.238 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 5.0 m-80 -142.35 140.73 32.19 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.371 179.713 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -129.92 156.06 45.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.139 0.495 . . . . 0.0 111.545 -179.058 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.474 ' HG3' ' CZ3' ' A' ' 41' ' ' TRP . 1.8 mtp180 -156.38 61.96 0.55 Allowed 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.212 179.769 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.406 ' CD2' HG13 ' A' ' 21' ' ' VAL . 0.7 OUTLIER -68.18 172.41 5.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.247 0.546 . . . . 0.0 110.856 -179.602 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.433 ' O ' ' CB ' ' A' ' 29' ' ' ALA . 0.5 OUTLIER -131.09 76.05 1.7 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.47 -0.787 . . . . 0.0 109.293 179.728 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 2.7 p -35.4 136.9 0.19 Allowed 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 122.771 0.428 . . . . 0.0 111.813 -179.193 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.439 ' HG2' ' CB ' ' A' ' 29' ' ' ALA . 14.2 mt-10 -50.84 -28.95 10.54 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.582 -179.569 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.3 83.01 1.43 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.541 -179.847 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -177.05 -98.54 0.11 Allowed Glycine 0 CA--C 1.523 0.569 0 N-CA-C 110.846 -0.902 . . . . 0.0 110.846 179.864 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 179.3 -178.96 0.37 Allowed 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 110.201 -0.296 . . . . 0.0 110.201 -179.832 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -93.4 179.9 5.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.873 0.368 . . . . 0.0 110.378 179.926 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 172.11 136.02 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.284 -179.988 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.436 HG23 ' CZ ' ' A' ' 67' ' ' ARG . 99.1 t -92.86 158.76 2.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.483 -179.986 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.474 ' CZ ' HG23 ' A' ' 4' ' ' VAL . 64.8 m-85 -143.25 108.22 4.94 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.12 179.94 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -91.17 147.91 22.73 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.663 -179.654 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 41.3 t0 51.51 52.2 15.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.797 179.742 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 74.9 t -68.72 -62.83 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 179.576 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.436 ' CG1' ' HD2' ' A' ' 83' ' ' PRO . 91.5 t -98.52 140.12 21.6 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.101 179.542 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.436 ' HD2' ' CG1' ' A' ' 82' ' ' VAL . 46.1 Cg_endo -69.74 -170.52 0.4 Allowed 'Trans proline' 0 N--CA 1.474 0.377 0 C-N-CA 122.638 2.225 . . . . 0.0 112.15 179.877 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 33.6 mp0 -77.35 -37.05 53.11 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.288 179.948 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -124.9 77.15 1.59 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.242 179.873 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . 0.414 ' HB3' ' CG1' ' A' ' 82' ' ' VAL . 38.6 p90 -73.25 179.82 3.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.462 -179.871 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -157.69 120.56 3.91 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.305 -179.99 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.423 HG13 ' CG1' ' A' ' 8' ' ' VAL . 4.0 mp -51.54 100.45 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.397 179.941 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 131.41 56.43 0.09 OUTLIER Glycine 0 CA--C 1.523 0.556 0 N-CA-C 110.703 -0.959 . . . . 0.0 110.703 -179.889 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.481 ' HB2' ' CZ ' ' A' ' 92' ' ' TYR . . . -177.99 178.03 0.99 Allowed 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 110.253 -0.277 . . . . 0.0 110.253 179.981 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -111.8 146.24 37.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.889 0.376 . . . . 0.0 110.653 -179.839 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.481 ' CZ ' ' HB2' ' A' ' 90' ' ' ALA . 8.6 m-85 -150.17 104.16 3.24 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.263 179.712 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.429 ' CB ' ' CD ' ' A' ' 94' ' ' PRO . . . 173.66 177.74 0.16 Allowed Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.461 179.968 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.429 ' CD ' ' CB ' ' A' ' 93' ' ' ALA . 50.4 Cg_endo . . . . . 0 C--O 1.249 1.026 0 C-N-CA 122.657 2.238 . . . . 0.0 112.211 -179.924 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 7.7 p . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 . . . . . . . . . 0 0 . 1 . 032 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -75.38 145.09 29.78 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.667 2.245 . . . . 0.0 112.04 179.954 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 10.0 mttt -123.14 83.16 2.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.526 -179.853 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.536 ' CG1' ' CE1' ' A' ' 78' ' ' PHE . 1.6 p -56.03 164.03 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.189 0.519 . . . . 0.0 110.204 179.894 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.476 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 9.1 p -142.17 128.65 20.15 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.411 179.966 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.55 ' CE2' ' CD2' ' A' ' 66' ' ' PHE . 8.0 m-85 -97.98 173.16 7.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.227 179.996 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 12.9 m -165.37 117.79 1.16 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.469 -179.862 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 20.6 t -59.11 94.57 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.269 179.946 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.406 ' OE1' ' CG2' ' A' ' 51' ' ' VAL . 0.1 OUTLIER -51.21 171.84 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.594 -179.893 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.2 ttmt -85.5 56.54 4.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.413 -179.99 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -147.63 25.36 1.5 Allowed Glycine 0 CA--C 1.524 0.622 0 N-CA-C 110.742 -0.943 . . . . 0.0 110.742 179.949 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -100.05 113.6 26.33 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.813 0.339 . . . . 0.0 110.216 179.939 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.406 ' OD1' ' N ' ' A' ' 14' ' ' GLU . 4.7 p30 -112.94 -51.4 2.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.533 -179.852 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.406 ' N ' ' OD1' ' A' ' 13' ' ' ASN . 0.5 OUTLIER -166.99 -64.98 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.755 -179.874 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.421 ' N ' ' HD2' ' A' ' 15' ' ' LYS . 10.9 mmmt -86.59 -27.11 24.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.54 -179.402 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 19.3 m80 -91.62 126.16 36.61 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.934 0.397 . . . . 0.0 110.849 -179.518 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -116.81 89.63 3.15 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.627 179.425 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.425 ' HB3' ' CG2' ' A' ' 53' ' ' THR . . . -83.51 126.05 32.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.762 -179.368 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.401 HG13 ' CZ ' ' A' ' 66' ' ' PHE . 19.8 m -113.55 -173.41 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.629 179.368 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.6 tt -141.04 59.21 1.53 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.256 179.679 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 28.0 t -55.86 116.54 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.428 -179.937 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.1 mttp -168.09 162.42 13.09 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.154 179.97 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -140.42 -63.67 0.48 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.225 -0.443 . . . . 0.0 109.979 -179.968 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -149.53 -47.25 0.14 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.318 179.981 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 170.22 74.84 0.04 OUTLIER Glycine 0 CA--C 1.524 0.601 0 N-CA-C 110.899 -0.88 . . . . 0.0 110.899 179.982 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -112.9 -168.31 1.3 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.767 0.318 . . . . 0.0 110.206 179.797 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.419 ' HB ' ' HB2' ' A' ' 71' ' ' GLU . 0.9 OUTLIER -113.45 137.78 51.04 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.094 179.984 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 7.8 mtt -101.62 129.57 47.77 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.872 -179.537 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.438 ' CB ' ' O ' ' A' ' 69' ' ' LEU . . . -112.68 -57.6 2.26 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.246 179.824 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.412 ' O ' ' CB ' ' A' ' 68' ' ' PHE . 0.7 OUTLIER -153.11 165.2 36.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.175 179.832 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.488 HG23 ' CD1' ' A' ' 52' ' ' TRP . 4.1 t -152.69 140.27 13.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.264 -0.426 . . . . 0.0 109.939 -179.969 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.448 ' CB ' ' HA ' ' A' ' 43' ' ' ALA . 1.5 pt-20 -137.34 137.34 38.8 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.968 0.413 . . . . 0.0 110.584 -179.701 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.424 HD11 ' CD2' ' A' ' 54' ' ' PHE . 1.6 mt -92.97 -178.52 4.83 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.587 -179.686 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.465 ' HB2' ' CZ3' ' A' ' 41' ' ' TRP . 0.7 OUTLIER -157.5 147.75 20.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.943 179.633 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -113.99 -14.36 12.43 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.957 -179.834 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 70.22 120.83 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.843 0.354 . . . . 0.0 110.31 -179.996 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 118.06 -45.27 1.29 Allowed Glycine 0 CA--C 1.522 0.481 0 N-CA-C 110.472 -1.051 . . . . 0.0 110.472 -179.753 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 20.7 t -63.24 -25.41 68.31 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.774 0.321 . . . . 0.0 110.314 179.778 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.1 t0 70.38 29.32 3.57 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.415 179.908 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -154.37 145.05 22.38 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.513 179.957 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.465 ' CZ3' ' HB2' ' A' ' 34' ' ' ARG . 83.8 m95 -88.14 145.66 25.81 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.036 179.8 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.49 ' CG2' ' CZ ' ' A' ' 54' ' ' PHE . 20.3 m -117.11 107.15 21.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.095 0.474 . . . . 0.0 110.33 -179.862 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.448 ' HA ' ' CB ' ' A' ' 32' ' ' GLU . . . -53.82 139.22 33.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.152 -179.782 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.42 ' CE ' HD13 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -64.86 -171.48 0.07 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.855 -179.644 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.422 ' O ' ' N ' ' A' ' 47' ' ' GLY . 86.7 m -143.55 97.65 3.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.217 179.858 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 13.5 ptmt -61.25 80.7 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.361 -179.883 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' A' ' 45' ' ' THR . . . -120.93 15.37 9.55 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 111.236 -0.745 . . . . 0.0 111.236 179.993 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -106.62 -33.24 7.71 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.847 0.356 . . . . 0.0 110.325 179.96 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 94.89 -36.79 3.63 Favored Glycine 0 CA--C 1.522 0.515 0 N-CA-C 110.667 -0.973 . . . . 0.0 110.667 179.973 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -110.92 -25.55 5.07 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 110.818 -0.913 . . . . 0.0 110.818 -179.877 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.406 ' CG2' ' OE1' ' A' ' 9' ' ' GLU . 15.5 m -140.66 -176.33 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.937 0.399 . . . . 0.0 110.591 -179.904 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . 0.488 ' CD1' HG23 ' A' ' 31' ' ' VAL . 9.5 m95 -108.58 142.28 39.26 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.726 -179.507 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.425 ' CG2' ' HB3' ' A' ' 18' ' ' ALA . 0.7 OUTLIER -130.02 150.76 51.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.967 179.672 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.49 ' CZ ' ' CG2' ' A' ' 42' ' ' VAL . 65.8 t80 -136.18 153.57 51.21 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.884 0.373 . . . . 0.0 110.808 -179.825 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -95.56 96.46 9.07 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.212 179.831 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 31.3 p -50.71 121.62 6.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.562 -179.859 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -80.83 -26.83 36.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.099 179.721 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 23.8 pt-20 -118.32 144.88 35.95 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.18 179.883 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -67.07 -18.52 51.57 Favored 'Trans proline' 0 C--N 1.343 0.246 0 C-N-CA 122.765 2.31 . . . . 0.0 112.19 179.999 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -71.94 118.21 14.51 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.426 179.975 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -101.19 54.14 0.84 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.242 179.86 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -73.15 -143.2 0.58 Allowed Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.715 -0.954 . . . . 0.0 110.715 -179.949 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -77.27 106.16 2.18 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.614 2.209 . . . . 0.0 112.145 -179.856 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.411 ' HB3' ' CD2' ' A' ' 33' ' ' LEU . 16.4 m-85 -77.96 98.32 5.64 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.66 179.961 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.43 ' OD1' ' N ' ' A' ' 65' ' ' ASN . 0.4 OUTLIER -71.32 123.45 22.31 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 179.469 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.55 ' CD2' ' CE2' ' A' ' 6' ' ' PHE . 2.7 m-85 -101.05 176.66 5.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.598 -179.55 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.462 ' HG3' ' CH2' ' A' ' 41' ' ' TRP . 1.7 mtp180 176.51 102.1 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.456 179.916 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.412 ' CB ' ' O ' ' A' ' 30' ' ' GLU . 0.8 OUTLIER -111.29 172.85 6.64 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.427 179.815 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.438 ' O ' ' CB ' ' A' ' 29' ' ' ALA . 2.4 mt -128.88 65.98 1.43 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.376 179.684 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 29.0 p -31.5 143.87 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.246 0.619 . . . . 0.0 112.108 -179.302 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.419 ' HB2' ' HB ' ' A' ' 27' ' ' THR . 0.4 OUTLIER -68.29 -31.23 70.53 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.254 -179.716 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.5 tmtm? -141.03 56.24 1.56 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.47 179.994 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -145.48 -105.66 0.47 Allowed Glycine 0 CA--C 1.523 0.559 0 N-CA-C 110.622 -0.991 . . . . 0.0 110.622 179.9 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 10.6 ptm -178.47 -179.45 0.68 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.787 0.327 . . . . 0.0 110.205 -179.986 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 14.1 mmtm -90.82 158.19 16.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.14 179.871 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -175.25 135.71 0.35 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.801 -179.944 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 94.6 t -94.2 150.25 4.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.233 -0.44 . . . . 0.0 109.963 179.476 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.536 ' CE1' ' CG1' ' A' ' 4' ' ' VAL . 71.2 m-85 -131.5 145.73 51.9 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.97 -179.203 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -139.62 162.19 35.7 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.006 179.76 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 51.97 33.04 10.98 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.113 0.483 . . . . 0.0 109.839 -179.722 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.426 ' O ' ' CG2' ' A' ' 82' ' ' VAL . 87.6 t -78.41 -3.01 5.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.586 -179.406 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.426 ' CG2' ' O ' ' A' ' 81' ' ' VAL . 72.4 t -158.15 119.45 1.95 Allowed Pre-proline 0 CA--C 1.53 0.21 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 179.855 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -75.66 169.64 21.88 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.458 2.105 . . . . 0.0 111.786 179.729 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -66.26 120.02 12.53 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 179.633 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 2.5 mtpt 67.24 58.85 0.54 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.224 -0.443 . . . . 0.0 109.997 -179.609 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 21.4 p90 -52.96 -175.16 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.741 -179.729 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 1.5 m -152.26 108.12 3.36 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.967 179.836 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 3.3 mp -46.45 121.82 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.68 -179.86 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 113.73 29.59 2.83 Favored Glycine 0 CA--C 1.523 0.582 0 N-CA-C 110.736 -0.945 . . . . 0.0 110.736 -179.875 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.426 ' HB2' ' CZ ' ' A' ' 92' ' ' TYR . . . -142.32 167.29 22.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.736 0.303 . . . . 0.0 110.443 -179.944 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 32.8 m -113.44 120.8 42.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.522 -179.968 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.426 ' CZ ' ' HB2' ' A' ' 90' ' ' ALA . 40.8 m-85 -125.62 123.55 39.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.394 179.954 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.442 ' CB ' ' CD ' ' A' ' 94' ' ' PRO . . . 174.56 178.45 0.17 Allowed Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.457 -179.981 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.442 ' CD ' ' CB ' ' A' ' 93' ' ' ALA . 49.8 Cg_endo . . . . . 0 C--O 1.25 1.083 0 C-N-CA 122.547 2.165 . . . . 0.0 112.112 -179.884 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 7.4 t . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 . . . . . . . . . 0 0 . 1 . 033 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -77.77 174.4 12.65 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.451 2.101 . . . . 0.0 112.063 -179.994 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 33.4 mmtm 44.97 86.84 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.07 179.497 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.524 ' CG1' ' CE1' ' A' ' 78' ' ' PHE . 2.1 p -106.26 163.42 4.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.336 0.588 . . . . 0.0 110.365 -179.968 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.461 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 65.9 p -144.2 129.51 18.81 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.294 179.718 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.411 ' O ' ' CG2' ' A' ' 91' ' ' THR . 35.0 m-85 -89.29 -176.75 5.19 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.307 179.904 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -166.15 118.57 1.06 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.152 179.934 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.1 t -68.18 93.43 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.356 -179.899 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -54.11 -178.45 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.303 -179.961 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.26 48.74 1.6 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.455 -179.839 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -112.3 -25.78 4.56 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 110.842 -0.903 . . . . 0.0 110.842 -179.992 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.1 m -50.82 120.97 5.28 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.826 0.346 . . . . 0.0 110.418 -179.982 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -114.13 -81.17 0.6 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.424 -179.912 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -106.78 -82.67 0.54 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.735 0.302 . . . . 0.0 110.41 -179.904 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.36 28.39 8.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.326 -179.995 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 8.9 m80 -104.08 167.39 9.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.325 -179.959 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 17.2 tp -154.13 88.79 1.25 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.452 -179.853 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.422 ' CB ' HG22 ' A' ' 53' ' ' THR . . . -81.37 109.62 16.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.454 -179.902 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.5 m -103.54 141.23 19.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.449 179.941 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -90.41 83.23 5.89 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.611 -179.99 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 16.2 t -79.32 90.61 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.348 179.866 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 176.08 157.29 0.24 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.982 -0.553 . . . . 0.0 109.95 -179.974 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.521 ' CE2' ' HB2' ' A' ' 26' ' ' ASP . 0.0 OUTLIER -113.89 -66.52 1.08 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.541 -179.751 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -153.45 -65.21 0.15 Allowed 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 111.808 0.299 . . . . 0.0 111.808 -179.395 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -106.36 -28.14 5.29 Favored Glycine 0 CA--C 1.525 0.702 0 C-N-CA 121.364 -0.446 . . . . 0.0 112.563 -178.372 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.521 ' HB2' ' CE2' ' A' ' 23' ' ' TYR . 16.8 t0 -42.29 152.02 0.1 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 117.277 0.539 . . . . 0.0 111.417 -179.363 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.63 -174.67 2.7 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.731 -179.462 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.423 ' O ' ' CG ' ' A' ' 71' ' ' GLU . 34.7 mtm -123.17 126.07 46.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.336 -179.883 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.442 ' CB ' ' HG2' ' A' ' 71' ' ' GLU . . . -118.97 -60.35 1.76 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.513 -179.706 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.415 ' HB3' ' CD1' ' A' ' 69' ' ' LEU . 0.6 OUTLIER -154.39 156.26 36.52 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.106 -179.937 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.482 HG12 ' CD1' ' A' ' 52' ' ' TRP . 0.7 OUTLIER -173.95 141.33 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.377 0.608 . . . . 0.0 110.271 -179.87 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.417 ' N ' ' OE1' ' A' ' 32' ' ' GLU . 1.7 pm0 -141.18 169.48 17.53 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.059 -179.444 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.516 ' CD2' ' CE1' ' A' ' 66' ' ' PHE . 1.0 OUTLIER -117.3 174.34 6.19 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.157 0.503 . . . . 0.0 111.096 -179.479 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.416 ' NE ' ' HA ' ' A' ' 34' ' ' ARG . 0.5 OUTLIER -161.75 -176.69 5.41 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.486 179.562 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -129.92 -70.76 0.63 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.797 0.332 . . . . 0.0 110.424 179.928 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 58.2 t-80 -178.53 -50.02 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.344 179.972 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -121.02 25.69 7.02 Favored Glycine 0 CA--C 1.523 0.545 0 N-CA-C 110.733 -0.947 . . . . 0.0 110.733 179.87 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 2.7 m -70.97 -22.43 62.2 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.652 0.263 . . . . 0.0 110.593 179.931 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.4 t0 71.96 97.21 0.07 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.799 0.333 . . . . 0.0 110.326 -179.802 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 76.82 146.44 0.09 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.398 -179.961 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.495 ' CE3' ' HG2' ' A' ' 67' ' ' ARG . 35.5 m95 -79.83 160.95 25.91 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.54 -179.826 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.411 HG12 ' NH1' ' A' ' 34' ' ' ARG . 32.1 m -132.16 122.18 47.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.179 179.832 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -46.51 130.44 11.1 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.8 -179.911 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.432 ' CE ' ' CD1' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -58.79 -167.51 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.22 -179.901 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 53.2 m -137.01 126.34 24.86 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.434 -179.946 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.66 67.16 6.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.231 -0.44 . . . . 0.0 109.987 179.726 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -96.86 -35.98 5.17 Favored Glycine 0 CA--C 1.522 0.503 0 N-CA-C 110.738 -0.945 . . . . 0.0 110.738 -179.772 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.43 ' HG2' ' CG2' ' A' ' 51' ' ' VAL . 31.8 tp10 -80.18 133.91 36.09 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.804 0.335 . . . . 0.0 110.369 179.915 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -79.36 88.39 1.21 Allowed Glycine 0 CA--C 1.523 0.587 0 N-CA-C 111.021 -0.831 . . . . 0.0 111.021 -179.794 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 129.81 -23.4 4.73 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 111.167 -0.773 . . . . 0.0 111.167 179.721 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.43 ' CG2' ' HG2' ' A' ' 48' ' ' GLU . 16.7 m -146.8 -175.56 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.933 0.397 . . . . 0.0 110.684 -179.756 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . 0.482 ' CD1' HG12 ' A' ' 31' ' ' VAL . 8.4 m95 -103.22 144.61 31.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.462 -179.547 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.422 HG22 ' CB ' ' A' ' 18' ' ' ALA . 0.1 OUTLIER -132.57 145.15 50.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.546 -179.759 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -120.62 136.69 54.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.125 179.725 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 11.4 t0 -113.67 156.34 23.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.939 0.4 . . . . 0.0 110.765 -179.706 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -175.39 172.96 2.59 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.326 179.947 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -154.85 30.79 0.41 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.385 -179.97 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -75.64 157.36 84.25 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.473 -179.96 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -71.3 -34.52 9.73 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.67 2.247 . . . . 0.0 112.035 179.881 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 5.4 mt -81.37 167.3 19.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.356 -179.928 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 28.2 tt0 -172.53 111.39 0.25 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.476 -179.98 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -135.35 -143.26 4.71 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.597 -1.001 . . . . 0.0 110.597 179.975 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -77.32 171.84 17.02 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.546 2.164 . . . . 0.0 111.892 179.882 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -124.18 172.45 9.04 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.92 0.39 . . . . 0.0 110.511 -179.948 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -146.36 144.72 29.95 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.176 -179.982 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.516 ' CE1' ' CD2' ' A' ' 33' ' ' LEU . 39.3 m-85 -127.03 -177.12 3.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.019 0.437 . . . . 0.0 110.483 179.978 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.495 ' HG2' ' CE3' ' A' ' 41' ' ' TRP . 0.0 OUTLIER 176.78 72.66 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.799 179.76 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.451 ' HA ' ' HA ' ' A' ' 31' ' ' VAL . 0.0 OUTLIER -71.01 -178.96 2.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.409 0.624 . . . . 0.0 111.626 -179.259 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.425 ' CD2' ' O ' ' A' ' 68' ' ' PHE . 9.1 mt -144.77 49.07 1.31 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.032 -0.985 . . . . 0.0 109.254 179.874 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.412 ' OG1' ' CA ' ' A' ' 73' ' ' GLY . 40.8 p -22.67 137.64 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.129 0.972 . . . . 0.0 112.891 -179.147 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.442 ' HG2' ' CB ' ' A' ' 29' ' ' ALA . 3.2 mm-40 -54.2 -25.27 21.97 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.533 -179.806 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.51 48.89 0.14 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.862 0.363 . . . . 0.0 110.547 -179.907 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.412 ' CA ' ' OG1' ' A' ' 70' ' ' THR . . . -128.34 -107.2 1.35 Allowed Glycine 0 CA--C 1.523 0.592 0 N-CA-C 110.707 -0.957 . . . . 0.0 110.707 179.915 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.409 ' N ' ' OG1' ' A' ' 70' ' ' THR . 66.0 mmm -139.13 171.28 14.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.832 0.349 . . . . 0.0 110.305 179.965 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.439 ' O ' ' CD ' ' A' ' 75' ' ' LYS . 0.0 OUTLIER -138.12 86.56 2.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.306 179.859 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -141.1 140.23 34.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.251 -179.971 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 17.9 m -66.61 -179.73 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.333 -179.958 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.524 ' CE1' ' CG1' ' A' ' 4' ' ' VAL . 66.1 m-85 -149.38 135.54 19.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.631 -179.831 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -119.21 158.99 24.89 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.395 -179.976 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 52.5 49.65 19.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.405 179.91 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.417 ' O ' ' CG2' ' A' ' 82' ' ' VAL . 80.9 t -90.89 -0.65 9.44 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.039 179.836 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.419 ' CG1' ' HB3' ' A' ' 86' ' ' TYR . 94.8 t -157.49 130.2 4.35 Favored Pre-proline 0 CA--C 1.527 0.093 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 179.667 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.484 ' HD3' ' CD1' ' A' ' 92' ' ' TYR . 49.7 Cg_endo -71.0 -167.09 0.25 Allowed 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.577 2.184 . . . . 0.0 112.06 179.767 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -68.78 -34.25 75.24 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.933 179.472 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -137.96 91.19 2.55 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.952 179.683 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . 0.42 ' CD1' ' C ' ' A' ' 86' ' ' TYR . 14.9 p90 -67.62 165.76 16.39 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.794 -179.65 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -141.34 115.24 9.15 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.064 179.844 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 3.4 mp -46.58 131.08 3.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.762 -179.836 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 89.87 39.29 6.21 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 110.685 -0.966 . . . . 0.0 110.685 -179.905 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -146.81 155.93 42.73 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.865 0.364 . . . . 0.0 110.53 -179.918 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.411 ' CG2' ' O ' ' A' ' 6' ' ' PHE . 0.2 OUTLIER -106.42 142.22 36.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.258 179.954 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.484 ' CD1' ' HD3' ' A' ' 83' ' ' PRO . 73.3 m-85 -134.1 -86.48 0.41 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.762 -179.914 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.468 ' CB ' ' CD ' ' A' ' 94' ' ' PRO . . . 50.12 -179.05 0.01 OUTLIER Pre-proline 0 C--N 1.332 -0.154 0 CA-C-O 120.63 0.252 . . . . 0.0 110.547 179.923 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.468 ' CD ' ' CB ' ' A' ' 93' ' ' ALA . 47.9 Cg_endo . . . . . 0 C--O 1.249 1.054 0 C-N-CA 122.539 2.16 . . . . 0.0 112.064 -179.978 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 9.2 m . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 110.212 -0.292 . . . . 0.0 110.212 . . . . . . . . . 0 0 . 1 . 034 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -73.98 58.75 4.22 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.488 2.125 . . . . 0.0 112.045 179.943 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.28 30.59 7.14 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.361 179.913 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.479 HG23 ' CE1' ' A' ' 78' ' ' PHE . 27.0 m -88.45 -176.03 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.087 179.85 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -167.04 146.92 5.44 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.364 179.971 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -118.78 158.13 26.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.22 179.905 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 53.2 m -150.73 104.71 3.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.35 -179.863 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.428 ' CG1' HD12 ' A' ' 88' ' ' ILE . 14.2 t -54.33 94.83 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.416 -179.905 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.41 ' HG3' ' CG1' ' A' ' 51' ' ' VAL . 4.7 mm-40 -69.33 162.89 26.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.286 -179.99 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.67 171.01 3.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.479 -179.967 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 86.67 19.59 56.06 Favored Glycine 0 CA--C 1.527 0.795 0 N-CA-C 111.103 -0.799 . . . . 0.0 111.103 -179.955 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.402 ' O ' ' HB2' ' A' ' 13' ' ' ASN . 8.7 m -109.6 -159.76 0.69 Allowed 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 -179.936 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.402 ' HB2' ' O ' ' A' ' 12' ' ' SER . 10.2 m-80 66.79 -62.39 0.3 Allowed 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.153 179.556 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -43.44 -69.73 0.13 Allowed 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.76 0.314 . . . . 0.0 111.02 -179.555 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.431 ' HA ' ' CE ' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -156.29 25.9 0.35 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.388 179.965 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 55.2 m80 -149.77 165.46 32.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.081 0.467 . . . . 0.0 110.787 -179.572 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -138.56 85.27 2.07 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.285 179.236 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.406 ' CA ' HG21 ' A' ' 53' ' ' THR . . . -78.2 153.42 31.99 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.985 -179.134 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 29.4 m -150.14 141.94 17.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.868 -0.606 . . . . 0.0 109.697 179.424 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -93.21 101.29 13.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.838 0.352 . . . . 0.0 110.621 -179.837 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 6.7 t -112.35 99.65 9.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.138 179.761 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.474 ' O ' ' CG ' ' A' ' 23' ' ' TYR . 24.7 mtpp -140.55 -72.88 0.35 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.671 -179.876 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.479 ' O ' ' CD2' ' A' ' 23' ' ' TYR . 29.7 p90 45.28 98.2 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.884 -179.667 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -46.82 116.1 1.24 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.835 -179.965 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 162.64 -42.32 0.35 Allowed Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.746 -0.942 . . . . 0.0 110.746 179.955 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -123.53 178.92 4.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.777 0.323 . . . . 0.0 110.378 -179.994 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.421 ' CB ' ' HB2' ' A' ' 71' ' ' GLU . 0.2 OUTLIER -103.85 -171.61 1.96 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.3 179.987 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 6.1 mtt -117.4 118.83 33.28 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.819 -179.751 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.448 ' HB1' ' N ' ' A' ' 71' ' ' GLU . . . -113.62 -62.33 1.61 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.109 179.57 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -165.0 165.1 20.39 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.767 -179.986 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.481 HG23 ' CD1' ' A' ' 52' ' ' TRP . 5.2 t -148.27 166.68 4.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.313 -179.896 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -174.72 151.03 1.38 Allowed 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.416 -179.788 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.475 ' HB3' ' CE1' ' A' ' 66' ' ' PHE . 3.0 pp -115.95 177.39 4.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.446 179.957 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.476 ' HB2' ' CE3' ' A' ' 41' ' ' TRP . 2.7 ttm180 -120.2 -40.56 2.69 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.296 179.862 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.444 ' CB ' ' O ' ' A' ' 34' ' ' ARG . 3.8 tt0 87.43 32.97 0.02 OUTLIER 'General case' 0 CA--C 1.515 -0.384 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 -179.102 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.428 ' CE1' ' OE1' ' A' ' 61' ' ' GLN . 41.8 t-80 63.71 -74.03 0.04 OUTLIER 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 114.882 -1.054 . . . . 0.0 110.596 -180.0 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.418 ' N ' ' O ' ' A' ' 35' ' ' GLU . . . -136.49 103.69 0.45 Allowed Glycine 0 CA--C 1.523 0.534 0 N-CA-C 110.766 -0.934 . . . . 0.0 110.766 -179.987 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -139.87 -54.07 0.54 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.826 0.346 . . . . 0.0 110.252 179.907 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.7 p30 179.91 -45.66 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.321 -179.978 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -178.61 171.54 1.51 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.195 -179.964 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.483 ' CZ3' ' HG2' ' A' ' 67' ' ' ARG . 96.7 m95 -55.01 125.3 19.82 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.338 -179.993 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.424 ' CG2' HD13 ' A' ' 33' ' ' LEU . 4.4 m -106.91 116.93 51.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.128 179.861 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -48.83 126.03 11.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.505 -179.91 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.79 -169.85 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.254 -179.929 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 33.8 m -141.13 95.69 2.88 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.425 -179.952 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.26 81.9 1.84 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.217 179.811 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -117.32 -17.85 5.58 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 111.404 -0.678 . . . . 0.0 111.404 -179.744 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -69.78 -32.65 71.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.774 0.321 . . . . 0.0 110.631 -179.766 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 97.4 -35.38 4.51 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 110.523 -1.031 . . . . 0.0 110.523 -179.839 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -113.86 -34.09 1.74 Allowed Glycine 0 CA--C 1.523 0.571 0 N-CA-C 110.458 -1.057 . . . . 0.0 110.458 179.912 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.41 ' CG1' ' HG3' ' A' ' 9' ' ' GLU . 23.9 m -123.78 172.75 10.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.808 0.337 . . . . 0.0 110.127 179.815 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . 0.481 ' CD1' HG23 ' A' ' 31' ' ' VAL . 8.8 m95 -105.06 133.8 49.24 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.529 -179.718 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.406 HG21 ' CA ' ' A' ' 18' ' ' ALA . 0.0 OUTLIER -119.79 -179.02 3.77 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.311 179.875 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 66.8 t80 -175.37 130.85 0.28 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.347 179.95 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 43.8 m-20 -68.91 117.29 10.39 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.359 -179.98 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 9.1 p -119.2 120.04 35.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.368 -179.994 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -100.93 -26.3 13.79 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.48 -179.921 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.402 ' O ' ' CG ' ' A' ' 58' ' ' GLU . 1.1 pt-20 -115.52 112.61 43.29 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.488 -179.872 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -70.7 -21.11 29.55 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.479 2.119 . . . . 0.0 111.891 179.655 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 44.73 -154.71 0.03 OUTLIER 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.854 179.584 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.428 ' OE1' ' CE1' ' A' ' 36' ' ' HIS . 0.0 OUTLIER -45.15 -31.9 1.61 Allowed 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.708 -0.224 . . . . 0.0 111.23 -179.644 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.49 ' N ' ' CD ' ' A' ' 63' ' ' PRO . . . 124.29 -41.98 1.64 Allowed Glycine 0 CA--C 1.531 1.058 0 C-N-CA 121.116 -0.564 . . . . 0.0 112.395 179.894 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.49 ' CD ' ' N ' ' A' ' 62' ' ' GLY . 45.2 Cg_endo -74.64 152.98 43.35 Favored 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 122.052 1.835 . . . . 0.0 112.811 -179.137 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -126.77 101.61 6.68 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.318 179.832 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 20.7 m-20 -65.53 140.34 58.56 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 179.538 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.475 ' CE1' ' HB3' ' A' ' 33' ' ' LEU . 16.5 m-85 -128.96 176.58 7.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.235 0.54 . . . . 0.0 111.246 -179.34 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.483 ' HG2' ' CZ3' ' A' ' 41' ' ' TRP . 0.0 OUTLIER 176.91 89.17 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.447 179.878 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -72.06 176.28 5.23 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.179 0.514 . . . . 0.0 110.874 -179.144 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.44 ' O ' ' CB ' ' A' ' 29' ' ' ALA . 2.3 mt -130.12 61.12 1.59 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.031 179.715 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.407 ' OG1' ' N ' ' A' ' 74' ' ' MET . 0.6 OUTLIER -23.69 137.62 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.871 0.868 . . . . 0.0 113.011 -178.821 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.448 ' N ' ' HB1' ' A' ' 29' ' ' ALA . 0.0 OUTLIER -48.41 -45.02 35.55 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.094 -179.533 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -145.37 38.32 1.15 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.279 179.973 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -114.57 -109.87 2.82 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.889 -0.884 . . . . 0.0 110.889 -179.952 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.407 ' N ' ' OG1' ' A' ' 70' ' ' THR . 20.8 mmt -154.41 -179.67 8.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.745 0.307 . . . . 0.0 110.183 179.909 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.428 ' HD3' ' N ' ' A' ' 75' ' ' LYS . 0.1 OUTLIER -115.85 100.74 8.21 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.996 0.427 . . . . 0.0 110.443 -179.888 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 49.0 t30 -115.9 152.86 32.61 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.241 179.895 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 77.7 t -100.29 160.79 3.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.324 179.843 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.479 ' CE1' HG23 ' A' ' 4' ' ' VAL . 64.9 m-85 -141.13 109.28 5.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.287 -179.907 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -95.77 159.66 14.87 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.496 -179.869 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 54.72 32.84 18.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.551 179.902 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 66.3 t -66.23 -54.68 24.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.286 179.901 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.453 ' CG1' ' HB3' ' A' ' 86' ' ' TYR . 76.2 t -101.1 142.45 24.64 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.02 179.95 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.486 ' HG3' ' CE1' ' A' ' 92' ' ' TYR . 43.5 Cg_endo -68.11 177.83 4.09 Favored 'Trans proline' 0 N--CA 1.475 0.42 0 C-N-CA 122.622 2.214 . . . . 0.0 112.287 179.915 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -59.31 -33.97 71.74 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.233 179.904 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.02 85.27 2.18 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.175 179.9 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . 0.453 ' HB3' ' CG1' ' A' ' 82' ' ' VAL . 26.5 p90 -50.51 145.04 6.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.682 -179.751 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 4.2 m -136.08 111.45 9.14 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.304 179.841 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.428 HD12 ' CG1' ' A' ' 8' ' ' VAL . 38.1 mm -50.49 110.19 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.49 -179.874 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 122.89 47.24 0.27 Allowed Glycine 0 CA--C 1.523 0.553 0 N-CA-C 110.819 -0.912 . . . . 0.0 110.819 179.918 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.47 ' HB2' ' CZ ' ' A' ' 92' ' ' TYR . . . -160.0 159.02 31.61 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.774 0.321 . . . . 0.0 110.44 179.928 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 90.1 m -118.69 91.81 3.65 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.497 179.949 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.486 ' CE1' ' HG3' ' A' ' 83' ' ' PRO . 32.9 m-85 -86.06 -156.71 0.3 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.154 179.847 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.432 ' CB ' ' HD2' ' A' ' 94' ' ' PRO . . . 76.19 173.6 0.09 OUTLIER Pre-proline 0 N--CA 1.463 0.179 0 CA-C-O 120.7 0.286 . . . . 0.0 110.307 -179.805 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.432 ' HD2' ' CB ' ' A' ' 93' ' ' ALA . 46.1 Cg_endo . . . . . 0 C--O 1.249 1.05 0 C-N-CA 122.582 2.188 . . . . 0.0 112.092 -179.908 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 8.3 p . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 110.137 -0.32 . . . . 0.0 110.137 . . . . . . . . . 0 0 . 1 . 035 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -75.54 116.96 4.63 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.634 2.223 . . . . 0.0 112.165 -179.94 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.44 ' O ' ' CG2' ' A' ' 4' ' ' VAL . 81.7 mttt -146.45 29.38 1.04 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.346 179.971 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.44 ' CG2' ' O ' ' A' ' 3' ' ' LYS . 23.0 m 44.59 -172.22 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.042 -179.804 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -174.02 136.8 0.53 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.521 -179.72 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -105.17 172.13 6.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.01 179.857 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 19.7 m -165.69 113.35 0.95 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.84 0.352 . . . . 0.0 110.447 -179.974 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 94.9 t -58.0 87.97 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.396 179.971 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -59.44 167.12 2.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.344 179.982 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.06 165.14 5.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.363 179.954 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 79.99 35.0 28.77 Favored Glycine 0 CA--C 1.523 0.582 0 N-CA-C 110.834 -0.906 . . . . 0.0 110.834 179.99 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 74.4 m -96.1 114.95 26.7 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.78 0.324 . . . . 0.0 110.369 -179.948 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -97.46 -168.85 1.75 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.213 179.998 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 67.8 mm-40 -69.24 -27.15 65.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.315 179.861 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.418 ' HG2' ' N ' ' A' ' 16' ' ' HIS . 0.0 OUTLIER -114.55 -30.65 6.46 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.641 -179.857 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.418 ' N ' ' HG2' ' A' ' 15' ' ' LYS . 2.0 m80 -70.59 151.28 45.17 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.851 0.357 . . . . 0.0 110.378 -179.902 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -151.29 91.58 1.7 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.498 -179.965 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.423 ' HB3' ' CG2' ' A' ' 53' ' ' THR . . . -89.31 136.19 33.16 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.868 179.675 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 27.4 m -137.86 135.02 45.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.999 0.428 . . . . 0.0 110.847 -179.793 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -88.57 81.12 7.18 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.454 179.949 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 42.9 t -77.92 107.91 10.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.408 179.97 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -170.43 150.51 3.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.289 -179.986 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 8.4 p90 -166.78 31.4 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.493 -179.938 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 50.84 -167.78 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.513 179.959 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 63.45 -79.97 0.04 OUTLIER Glycine 0 CA--C 1.523 0.536 0 N-CA-C 110.796 -0.921 . . . . 0.0 110.796 179.88 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -71.63 179.54 3.02 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.678 0.275 . . . . 0.0 110.325 179.956 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -121.2 -174.1 2.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.389 -179.886 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.427 ' O ' ' CG ' ' A' ' 71' ' ' GLU . 22.6 mtm -114.99 122.35 45.97 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.677 -179.651 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.433 ' CB ' ' O ' ' A' ' 69' ' ' LEU . . . -120.02 -60.48 1.7 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.338 179.765 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -161.37 147.59 14.31 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.36 179.995 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.1 t -133.97 159.33 42.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.941 0.401 . . . . 0.0 110.596 179.987 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.424 ' OE2' ' N ' ' A' ' 32' ' ' GLU . 0.5 OUTLIER -150.04 147.79 28.24 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.148 -179.944 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.434 ' O ' ' CG2' ' A' ' 42' ' ' VAL . 12.0 tp -116.65 156.07 27.71 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 -179.603 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.98 178.81 7.0 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.087 179.609 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -122.16 -79.91 0.62 Allowed 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 179.719 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -179.34 -38.42 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.349 179.487 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -130.28 22.87 4.67 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.884 -0.887 . . . . 0.0 110.884 179.937 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 8.2 t -77.34 -166.13 0.69 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.872 0.368 . . . . 0.0 110.304 179.959 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -87.2 52.99 2.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.143 179.868 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 69.71 178.61 0.25 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.251 -179.858 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.468 ' CZ3' ' HG2' ' A' ' 67' ' ' ARG . 97.2 m95 -50.47 139.08 16.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.629 -179.994 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.434 ' CG2' ' O ' ' A' ' 33' ' ' LEU . 4.6 m -125.89 111.33 26.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 109.743 -0.465 . . . . 0.0 109.743 179.531 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -44.45 138.15 3.35 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.116 -179.376 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -67.66 -171.73 0.22 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.89 -179.942 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.402 ' O ' ' N ' ' A' ' 47' ' ' GLY . 51.7 m -150.92 106.31 3.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.228 179.846 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 7.3 ptmt -62.77 80.99 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.495 -179.925 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.402 ' N ' ' O ' ' A' ' 45' ' ' THR . . . -98.74 -24.31 10.97 Favored Glycine 0 CA--C 1.523 0.555 0 N-CA-C 110.647 -0.981 . . . . 0.0 110.647 179.846 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.454 ' CB ' ' HB ' ' A' ' 51' ' ' VAL . 2.2 mm-40 -78.18 1.09 22.5 Favored 'General case' 0 CA--C 1.532 0.269 0 O-C-N 122.85 -0.206 . . . . 0.0 111.502 -179.891 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 67.93 17.29 69.41 Favored Glycine 0 CA--C 1.527 0.794 0 N-CA-C 111.13 -0.788 . . . . 0.0 111.13 -179.963 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 178.24 -38.57 0.08 OUTLIER Glycine 0 C--N 1.33 0.229 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 179.93 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.454 ' HB ' ' CB ' ' A' ' 48' ' ' GLU . 22.2 t -101.24 150.3 5.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 179.227 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . 0.421 ' N ' HG11 ' A' ' 51' ' ' VAL . 3.3 m95 -91.75 111.7 23.32 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.477 -179.543 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.423 ' CG2' ' HB3' ' A' ' 18' ' ' ALA . 15.0 p -107.73 150.13 27.33 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.494 -179.736 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 34.6 t80 -136.7 115.12 11.82 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.451 -179.996 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -66.8 162.27 21.88 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.289 179.974 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 6.3 t 65.09 127.04 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.705 179.849 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.424 ' O ' ' O ' ' A' ' 58' ' ' GLU . 5.7 tt0 -117.95 -15.93 9.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.955 179.885 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.424 ' O ' ' O ' ' A' ' 57' ' ' GLU . 2.2 pt-20 48.97 170.43 0.03 OUTLIER Pre-proline 0 N--CA 1.467 0.381 0 C-N-CA 123.213 0.605 . . . . 0.0 111.548 -179.94 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.404 ' CD ' ' HB2' ' A' ' 58' ' ' GLU . 38.3 Cg_endo -96.97 10.41 1.25 Allowed 'Trans proline' 0 N--CA 1.453 -0.877 0 C-N-CA 124.036 3.157 . . . . 0.0 112.961 -178.998 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.9 100.47 0.07 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.841 0.353 . . . . 0.0 110.512 -179.914 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -53.65 127.5 25.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.222 179.861 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 135.7 163.0 9.83 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.601 -0.999 . . . . 0.0 110.601 -179.806 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.425 ' CG ' ' HA ' ' A' ' 80' ' ' ASP . 49.9 Cg_endo -79.33 -171.95 1.39 Allowed 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.642 2.228 . . . . 0.0 112.091 -179.974 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 -97.16 171.64 8.32 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.85 0.357 . . . . 0.0 110.258 179.846 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -144.05 143.88 31.37 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.716 179.813 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 -131.28 177.75 7.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.201 0.524 . . . . 0.0 111.288 -179.466 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.468 ' HG2' ' CZ3' ' A' ' 41' ' ' TRP . 0.1 OUTLIER 175.7 67.28 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.265 -179.964 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -52.57 173.46 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.264 0.554 . . . . 0.0 111.143 -178.963 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.433 ' O ' ' CB ' ' A' ' 29' ' ' ALA . 6.4 mt -128.68 55.91 1.68 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.126 179.595 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -26.73 137.87 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.736 0.815 . . . . 0.0 112.593 -178.915 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.427 ' CG ' ' O ' ' A' ' 28' ' ' MET . 23.6 mt-10 -51.69 -51.75 53.58 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.25 -179.857 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 5.1 tptt -135.95 57.93 1.77 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.042 179.733 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -136.04 -96.64 0.49 Allowed Glycine 0 CA--C 1.523 0.592 0 N-CA-C 110.776 -0.93 . . . . 0.0 110.776 -179.823 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 1.9 ptt? 174.86 165.87 0.26 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.813 0.339 . . . . 0.0 110.515 -179.949 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.419 ' CD ' ' HA ' ' A' ' 69' ' ' LEU . 5.6 mmtp -94.13 137.9 32.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.005 -179.965 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 10.8 t30 -141.29 176.21 9.03 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.285 179.923 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 95.9 t -121.65 146.79 26.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.253 179.995 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -136.12 108.91 7.54 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.523 -179.904 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.402 ' O ' ' N ' ' A' ' 81' ' ' VAL . 54.4 m-20 -80.27 163.34 24.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.178 179.799 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.441 ' O ' ' HB ' ' A' ' 81' ' ' VAL . 1.1 m-20 58.94 -85.72 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.377 -179.813 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.441 ' HB ' ' O ' ' A' ' 80' ' ' ASP . 55.6 t 68.55 -56.26 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 C-N-CA 123.432 0.693 . . . . 0.0 110.881 179.98 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.437 ' CG1' ' HD2' ' A' ' 83' ' ' PRO . 54.6 t -128.78 139.34 35.35 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.501 -179.894 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.437 ' HD2' ' CG1' ' A' ' 82' ' ' VAL . 46.2 Cg_endo -69.81 -170.32 0.39 Allowed 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.585 2.19 . . . . 0.0 112.066 179.699 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -87.07 -39.72 15.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.18 179.754 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -110.75 56.22 0.64 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.213 179.855 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 21.1 p90 -56.78 170.25 0.43 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.52 -179.838 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 26.6 m -151.35 121.16 7.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.149 179.907 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 3.4 mp -50.58 111.29 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.388 -179.82 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 122.41 57.36 0.2 Allowed Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.655 -0.978 . . . . 0.0 110.655 -179.976 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -174.07 148.86 1.4 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.75 0.309 . . . . 0.0 110.378 -179.991 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 50.9 m -106.97 93.88 4.8 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.6 -179.955 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.42 ' CD1' ' HD3' ' A' ' 83' ' ' PRO . 44.0 m-85 -76.42 -155.67 0.06 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.145 -0.479 . . . . 0.0 109.761 179.549 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.435 ' CB ' ' HD2' ' A' ' 94' ' ' PRO . . . 75.65 172.95 0.09 OUTLIER Pre-proline 0 N--CA 1.464 0.227 0 CA-C-O 120.786 0.327 . . . . 0.0 110.811 179.773 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.435 ' HD2' ' CB ' ' A' ' 93' ' ' ALA . 46.9 Cg_endo . . . . . 0 C--O 1.25 1.08 0 C-N-CA 122.606 2.204 . . . . 0.0 111.965 179.884 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . 0.415 ' O ' ' CG1' ' A' ' 1' ' ' VAL . 8.5 p . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 . . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -75.07 134.09 17.27 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.412 2.075 . . . . 0.0 112.188 -179.919 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.65 94.03 2.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.283 -179.904 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.518 ' CG1' ' CE1' ' A' ' 78' ' ' PHE . 1.9 p -63.89 163.24 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.285 0.564 . . . . 0.0 110.469 -179.811 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.469 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 80.9 p -137.48 136.11 37.43 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.067 179.871 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 17.7 m-85 -97.0 -175.42 3.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.418 -179.81 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.5 m -167.15 95.53 0.48 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.237 -179.833 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 39.1 t -51.07 97.19 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.563 -179.879 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -61.92 174.52 0.83 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.443 -179.92 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.8 tttt -67.66 163.37 21.59 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.408 -179.977 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 74.27 25.74 70.03 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 179.883 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.43 ' CB ' HD12 ' A' ' 88' ' ' ILE . 0.5 OUTLIER -99.05 121.81 41.46 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.835 0.35 . . . . 0.0 110.431 -179.993 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -177.45 -175.03 0.52 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.427 179.99 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.41 ' O ' ' CB ' ' A' ' 15' ' ' LYS . 3.9 mt-10 -47.59 119.07 2.53 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.175 0.512 . . . . 0.0 110.834 -179.848 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.418 ' O ' ' CG ' ' A' ' 16' ' ' HIS . 0.8 OUTLIER 79.95 24.54 0.4 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.774 179.726 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.418 ' CG ' ' O ' ' A' ' 15' ' ' LYS . 3.2 m80 -174.04 111.75 0.17 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.829 0.347 . . . . 0.0 110.348 179.745 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.405 ' HG ' ' CE2' ' A' ' 64' ' ' PHE . 0.3 OUTLIER -128.93 101.19 5.97 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.489 -179.856 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -97.93 153.05 18.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.232 179.852 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.436 HG22 ' CG2' ' A' ' 21' ' ' VAL . 23.7 m -150.18 134.72 9.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.062 -179.7 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.426 ' HA ' ' CG1' ' A' ' 51' ' ' VAL . 0.5 OUTLIER -86.77 73.34 10.02 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.212 -0.449 . . . . 0.0 109.869 179.105 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.436 ' CG2' HG22 ' A' ' 19' ' ' VAL . 52.7 t -69.83 94.51 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.86 -179.468 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.407 ' HG2' ' CD2' ' A' ' 20' ' ' LEU . 0.0 OUTLIER 175.18 157.8 0.19 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.106 179.712 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.401 ' CE2' ' HB3' ' A' ' 26' ' ' ASP . 0.1 OUTLIER -127.08 -79.05 0.59 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.46 -179.981 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -99.49 -90.78 0.3 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.822 -179.814 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -139.68 32.83 2.19 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 111.132 -0.787 . . . . 0.0 111.132 -179.778 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.401 ' HB3' ' CE2' ' A' ' 23' ' ' TYR . 4.3 p30 -58.58 -171.11 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 179.727 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.443 ' HB ' ' CG ' ' A' ' 71' ' ' GLU . 0.9 OUTLIER -125.57 145.82 49.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.875 0.369 . . . . 0.0 110.37 179.987 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.411 ' O ' ' CG ' ' A' ' 71' ' ' GLU . 0.0 OUTLIER -98.7 129.39 45.16 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.662 -179.506 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.435 ' CB ' ' HG2' ' A' ' 71' ' ' GLU . . . -120.47 -56.8 1.95 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.351 179.956 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -158.0 145.9 18.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.388 -179.982 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.431 HG23 ' CD1' ' A' ' 52' ' ' TRP . 2.4 t -135.68 140.38 44.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.141 179.995 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.455 ' CB ' ' HA ' ' A' ' 43' ' ' ALA . 4.4 pt-20 -139.14 141.39 38.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.858 0.361 . . . . 0.0 110.491 179.955 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.497 ' HG ' ' CE1' ' A' ' 66' ' ' PHE . 2.2 mt -113.0 174.61 5.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.94 -179.444 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.489 ' HB2' ' CZ3' ' A' ' 41' ' ' TRP . 1.5 ttp85 -149.61 -159.17 1.0 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.852 179.585 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -158.67 26.18 0.23 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.698 0.285 . . . . 0.0 110.759 179.887 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 49.4 25.88 1.45 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.726 179.752 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -129.73 -50.45 0.12 Allowed Glycine 0 CA--C 1.522 0.525 0 N-CA-C 110.706 -0.958 . . . . 0.0 110.706 -179.945 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -76.54 115.26 16.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.784 0.326 . . . . 0.0 110.425 -179.977 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -52.09 -25.83 9.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.361 -179.992 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.26 178.73 4.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.219 179.892 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.499 ' CZ2' ' CD ' ' A' ' 67' ' ' ARG . 86.5 m95 -111.88 169.45 8.83 Favored 'General case' 0 CA--C 1.503 -0.862 0 CA-C-O 121.559 0.695 . . . . 0.0 110.876 -179.978 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.421 ' O ' ' CG1' ' A' ' 42' ' ' VAL . 1.0 OUTLIER -142.05 107.63 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.193 0 CA-C-N 114.63 -1.168 . . . . 0.0 109.769 -177.441 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.455 ' HA ' ' CB ' ' A' ' 32' ' ' GLU . . . -50.49 143.39 9.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.578 -179.445 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.429 ' HE1' ' CD1' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -63.14 -169.57 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.783 -179.765 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 46.0 m -135.35 110.18 8.72 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.03 179.811 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.77 66.45 0.09 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.566 -179.793 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -83.35 -40.84 8.8 Favored Glycine 0 CA--C 1.522 0.522 0 N-CA-C 110.351 -1.1 . . . . 0.0 110.351 179.798 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -90.02 144.97 25.44 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 179.74 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -83.83 8.16 67.23 Favored Glycine 0 CA--C 1.528 0.903 0 N-CA-C 111.597 -0.601 . . . . 0.0 111.597 -179.896 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -127.44 -40.0 0.35 Allowed Glycine 0 CA--C 1.524 0.641 0 N-CA-C 110.978 -0.849 . . . . 0.0 110.978 -179.952 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.426 ' CG1' ' HA ' ' A' ' 20' ' ' LEU . 6.9 m -133.67 -176.5 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 121.088 0.47 . . . . 0.0 110.79 -179.605 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . 0.431 ' CD1' HG23 ' A' ' 31' ' ' VAL . 11.1 m95 -109.61 131.39 55.11 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.75 179.543 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 3.0 p -115.98 171.79 7.56 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.863 0.363 . . . . 0.0 110.318 -179.664 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 60.4 t80 -159.63 118.5 2.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.333 179.971 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -70.94 129.14 38.25 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.303 179.956 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 90.8 p -96.25 126.54 41.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.416 -179.949 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -136.58 36.95 2.67 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.394 179.984 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -138.04 156.61 73.97 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.324 179.854 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -72.45 -26.77 16.62 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.671 2.247 . . . . 0.0 112.216 -179.949 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.4 mt -79.5 126.61 31.08 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.541 -179.761 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -156.58 -178.37 7.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.358 -179.845 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 119.73 -106.25 1.2 Allowed Glycine 0 CA--C 1.526 0.725 0 N-CA-C 110.856 -0.898 . . . . 0.0 110.856 179.891 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -77.46 125.08 7.42 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.455 2.103 . . . . 0.0 111.972 179.991 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.405 ' CE2' ' HG ' ' A' ' 17' ' ' LEU . 42.6 m-85 -101.27 147.05 26.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.587 -179.869 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -120.69 131.19 54.43 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.618 179.511 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.497 ' CE1' ' HG ' ' A' ' 33' ' ' LEU . 19.8 m-85 -114.71 163.1 15.94 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.963 0.411 . . . . 0.0 111.47 -179.236 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.499 ' CD ' ' CZ2' ' A' ' 41' ' ' TRP . 48.3 mtp180 -162.07 62.62 0.23 Allowed 'General case' 0 CA--C 1.52 -0.184 0 CA-C-N 115.353 -0.839 . . . . 0.0 109.807 179.014 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.415 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -67.09 -179.15 0.9 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.143 0.497 . . . . 0.0 110.828 -179.455 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.428 ' O ' ' CB ' ' A' ' 29' ' ' ALA . 5.7 mt -136.68 55.07 1.85 Allowed 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 179.321 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 18.5 p -29.02 137.95 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.543 0.737 . . . . 0.0 112.135 -178.904 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.443 ' CG ' ' HB ' ' A' ' 27' ' ' THR . 8.0 mt-10 -51.22 -68.62 0.15 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.663 -179.24 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -106.29 68.45 0.76 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.781 0.324 . . . . 0.0 110.31 179.902 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -158.28 -104.58 0.21 Allowed Glycine 0 CA--C 1.523 0.587 0 N-CA-C 110.952 -0.859 . . . . 0.0 110.952 -179.972 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 13.3 ptm 174.26 179.38 0.11 Allowed 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 -179.838 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.25 175.68 6.85 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.87 0.367 . . . . 0.0 110.352 179.877 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 173.96 170.16 0.2 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.43 179.907 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.407 ' HA ' ' HG2' ' A' ' 67' ' ' ARG . 72.5 t -117.61 157.78 18.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.504 -179.987 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.518 ' CE1' ' CG1' ' A' ' 4' ' ' VAL . 41.3 m-85 -144.99 129.93 18.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.384 -179.932 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -118.85 147.03 44.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.319 179.942 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 59.13 45.45 14.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.455 179.862 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.41 ' HA ' ' HA ' ' A' ' 93' ' ' ALA . 74.4 t -80.4 -3.91 6.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.073 179.893 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.407 ' CG2' ' O ' ' A' ' 81' ' ' VAL . 89.2 t -156.56 122.12 2.48 Favored Pre-proline 0 CA--C 1.528 0.117 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 179.654 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.414 ' HD3' ' CD1' ' A' ' 92' ' ' TYR . 50.8 Cg_endo -75.25 176.07 10.42 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.552 2.168 . . . . 0.0 112.129 -179.923 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -77.31 131.03 37.92 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 179.475 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 2.2 mmtt 59.92 40.75 18.68 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 -179.529 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 28.2 p90 -47.46 174.28 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.855 -179.681 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 10.9 m -129.36 129.66 45.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.242 179.987 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.43 HD12 ' CB ' ' A' ' 12' ' ' SER . 42.2 mm -66.51 115.3 4.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.337 179.981 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 119.45 37.34 0.79 Allowed Glycine 0 CA--C 1.523 0.573 0 N-CA-C 110.725 -0.95 . . . . 0.0 110.725 -179.917 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -147.67 172.57 13.85 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.808 0.337 . . . . 0.0 110.375 179.998 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.425 ' CG2' ' HB ' ' A' ' 5' ' ' THR . 87.9 m -114.83 126.16 54.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.422 -179.992 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.414 ' CD1' ' HD3' ' A' ' 83' ' ' PRO . 54.6 m-85 -127.45 130.5 49.37 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.571 179.985 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.427 ' CB ' ' CD ' ' A' ' 94' ' ' PRO . . . 174.01 177.13 0.19 Allowed Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.435 179.713 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.427 ' CD ' ' CB ' ' A' ' 93' ' ' ALA . 49.4 Cg_endo . . . . . 0 C--O 1.25 1.094 0 C-N-CA 122.642 2.228 . . . . 0.0 112.071 -179.885 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 12.0 t . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 120.728 0.299 . . . . 0.0 110.232 . . . . . . . . . 0 0 . 1 . 037 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -77.05 167.57 24.82 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.587 2.191 . . . . 0.0 112.077 -179.972 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.86 59.35 0.99 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.367 -179.936 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.504 ' CG2' ' CE1' ' A' ' 78' ' ' PHE . 16.9 m -71.91 168.3 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.478 -179.967 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.416 ' HB ' ' CG2' ' A' ' 91' ' ' THR . 78.4 p -153.72 129.96 10.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.33 179.819 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -93.44 165.46 12.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.41 -179.865 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -153.72 108.84 3.16 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.546 -179.883 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.424 ' CG1' HG13 ' A' ' 88' ' ' ILE . 92.0 t -57.79 114.26 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.12 179.759 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.403 ' OE1' ' CG1' ' A' ' 51' ' ' VAL . 1.8 mt-10 -84.36 159.11 20.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.61 -179.771 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.63 -25.81 60.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.48 -179.912 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -49.67 -26.4 7.73 Favored Glycine 0 CA--C 1.523 0.567 0 N-CA-C 110.8 -0.92 . . . . 0.0 110.8 -179.908 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.4 m -59.29 106.4 0.44 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.767 0.318 . . . . 0.0 110.289 179.961 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.434 ' O ' ' N ' ' A' ' 15' ' ' LYS . 10.8 p-10 -124.72 136.74 54.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.491 -179.962 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 53.34 -87.04 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.661 179.891 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.434 ' N ' ' O ' ' A' ' 13' ' ' ASN . 42.2 pttt -114.16 -27.39 7.67 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.659 0.266 . . . . 0.0 110.71 -179.963 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 8.9 m80 -49.36 134.19 19.01 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.533 179.947 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.419 ' HG ' ' CE2' ' A' ' 64' ' ' PHE . 0.2 OUTLIER -118.48 100.12 7.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.409 -179.88 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -98.86 130.5 45.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.266 179.942 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.402 HG22 ' CG2' ' A' ' 21' ' ' VAL . 33.4 m -126.15 146.67 31.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.262 -179.914 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -96.66 70.97 2.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.307 -179.947 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.402 ' CG2' HG22 ' A' ' 19' ' ' VAL . 23.5 t -75.16 97.89 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.449 -179.877 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.02 146.39 9.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.405 179.975 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.431 ' CE2' HG13 ' A' ' 4' ' ' VAL . 17.0 p90 -173.16 140.03 0.84 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.455 -179.996 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -52.04 134.91 31.91 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.358 -179.98 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 126.78 -110.44 1.23 Allowed Glycine 0 CA--C 1.523 0.538 0 N-CA-C 110.684 -0.966 . . . . 0.0 110.684 179.993 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -67.01 145.85 54.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.781 0.324 . . . . 0.0 110.259 179.954 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.438 ' HB ' ' CG ' ' A' ' 71' ' ' GLU . 0.3 OUTLIER -80.87 -171.26 3.08 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.419 -179.884 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -117.92 124.63 48.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.567 -179.723 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.447 ' CB ' ' HG2' ' A' ' 71' ' ' GLU . . . -114.54 -60.59 1.87 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.437 -179.783 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -157.78 150.95 23.25 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.224 179.984 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.528 ' CG2' ' CD1' ' A' ' 52' ' ' TRP . 6.1 t -119.59 166.57 13.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.155 -179.899 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.427 ' HA ' ' HA ' ' A' ' 43' ' ' ALA . 1.2 tp10 -153.08 140.06 19.21 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.017 0.437 . . . . 0.0 109.925 -179.416 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.431 HD13 ' N ' ' A' ' 34' ' ' ARG . 3.9 tp -134.3 142.62 47.34 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.182 -178.963 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.44 ' O ' ' CB ' ' A' ' 35' ' ' GLU . 6.7 tpm_? -127.73 -95.91 0.42 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.154 -0.475 . . . . 0.0 109.903 179.012 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.44 ' CB ' ' O ' ' A' ' 34' ' ' ARG . 0.0 OUTLIER 160.79 -83.51 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 120.763 0.316 . . . . 0.0 110.321 179.392 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 3.3 t60 177.88 -55.41 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.317 -179.868 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -59.36 -72.07 0.67 Allowed Glycine 0 CA--C 1.523 0.584 0 N-CA-C 110.639 -0.985 . . . . 0.0 110.639 179.955 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -58.05 122.03 12.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.819 0.342 . . . . 0.0 110.179 179.848 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 33.0 m-20 -83.26 6.71 18.64 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.312 -179.825 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -107.84 100.33 9.71 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 120.82 0.343 . . . . 0.0 110.54 -179.953 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.488 ' CZ3' ' HG2' ' A' ' 67' ' ' ARG . 68.7 m95 -59.4 155.32 15.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.072 179.733 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.424 ' CG2' ' O ' ' A' ' 33' ' ' LEU . 10.0 m -138.47 110.76 6.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-O 120.715 0.293 . . . . 0.0 110.307 179.98 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.427 ' HA ' ' HA ' ' A' ' 32' ' ' GLU . . . -45.68 149.75 0.57 Allowed 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.52 -179.8 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.13 -170.55 0.62 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.916 0.388 . . . . 0.0 110.54 -179.722 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 68.8 m -138.88 126.04 21.37 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.409 -179.945 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 3.1 ptpt -94.56 91.32 6.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.564 -179.804 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -146.34 26.59 1.7 Allowed Glycine 0 CA--C 1.523 0.572 0 N-CA-C 110.81 -0.916 . . . . 0.0 110.81 179.963 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.404 ' CA ' ' OE1' ' A' ' 48' ' ' GLU . 0.0 OUTLIER -106.45 174.52 5.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.836 0.351 . . . . 0.0 110.482 179.939 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -56.13 -29.44 56.02 Favored Glycine 0 CA--C 1.522 0.53 0 N-CA-C 110.487 -1.045 . . . . 0.0 110.487 179.787 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 177.81 37.46 0.06 OUTLIER Glycine 0 CA--C 1.524 0.619 0 N-CA-C 110.861 -0.896 . . . . 0.0 110.861 179.965 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.403 ' CG1' ' OE1' ' A' ' 9' ' ' GLU . 13.1 m -154.78 177.87 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.828 0.347 . . . . 0.0 110.395 179.866 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . 0.528 ' CD1' ' CG2' ' A' ' 31' ' ' VAL . 5.4 m95 -103.92 144.92 30.87 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.379 -179.487 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -137.15 157.91 45.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.382 -179.971 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 78.2 t80 -148.95 155.39 40.77 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.49 -179.952 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -89.81 124.58 34.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.511 -179.89 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 94.0 p -120.56 103.56 9.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.273 179.937 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -110.3 -28.02 8.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.47 -179.906 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -59.55 125.63 80.19 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.458 -179.923 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -72.0 -11.73 27.6 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.519 2.146 . . . . 0.0 112.514 179.97 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -47.57 107.49 0.12 Allowed 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 120.901 0.381 . . . . 0.0 110.749 -179.732 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -76.05 118.89 19.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.345 179.929 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -179.65 170.85 42.39 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 -179.959 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.404 ' CB ' ' HA ' ' A' ' 80' ' ' ASP . 49.6 Cg_endo -79.02 151.63 24.04 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.597 2.198 . . . . 0.0 112.097 -179.893 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.419 ' CE2' ' HG ' ' A' ' 17' ' ' LEU . 29.4 m-85 -84.86 123.11 30.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.277 179.877 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 7.4 m-20 -95.28 134.46 38.03 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 179.516 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.412 ' CE2' ' HB2' ' A' ' 33' ' ' LEU . 51.8 m-85 -121.42 167.9 12.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.129 0.49 . . . . 0.0 111.045 -179.452 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.488 ' HG2' ' CZ3' ' A' ' 41' ' ' TRP . 0.3 OUTLIER -173.77 61.77 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.711 179.984 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -56.78 174.11 0.17 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.99 -179.472 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.426 ' O ' ' CB ' ' A' ' 29' ' ' ALA . 2.9 mt -121.54 72.14 1.0 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.221 179.515 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.401 ' OG1' ' N ' ' A' ' 74' ' ' MET . 62.3 p -35.84 136.17 0.27 Allowed 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.793 -179.241 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.447 ' HG2' ' CB ' ' A' ' 29' ' ' ALA . 14.8 mt-10 -49.96 -52.16 35.74 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.486 -179.861 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 6.3 tptp -129.21 71.67 1.44 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.529 -179.869 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -162.85 -103.71 0.18 Allowed Glycine 0 CA--C 1.522 0.528 0 N-CA-C 110.799 -0.92 . . . . 0.0 110.799 179.897 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.401 ' N ' ' OG1' ' A' ' 70' ' ' THR . 21.1 ptt? -179.21 -175.64 0.38 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.853 0.359 . . . . 0.0 110.292 179.988 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.437 ' N ' ' CD ' ' A' ' 75' ' ' LYS . 0.0 OUTLIER -97.48 148.28 23.38 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.159 -179.69 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -152.62 123.09 7.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.192 179.854 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 98.4 t -81.65 143.73 11.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.526 -179.825 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.504 ' CE1' ' CG2' ' A' ' 4' ' ' VAL . 53.9 m-85 -127.99 122.35 32.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.254 179.993 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -105.26 148.72 26.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.552 -179.699 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.404 ' HA ' ' CB ' ' A' ' 63' ' ' PRO . 1.0 OUTLIER 58.88 46.06 14.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.462 179.9 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 90.1 t -77.0 -75.25 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.187 179.862 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 39.1 t -89.04 137.89 29.37 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.268 179.797 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -73.17 -175.42 1.96 Allowed 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.5 2.133 . . . . 0.0 111.949 179.821 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -82.9 -31.18 27.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.135 179.738 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 6.0 tttp -117.45 51.56 1.02 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.255 179.846 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 48.8 p90 -52.56 159.61 1.02 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.55 -179.894 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -142.4 114.83 8.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.128 179.88 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.424 HG13 ' CG1' ' A' ' 8' ' ' VAL . 3.0 mp -49.83 100.16 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.466 -179.826 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 134.18 53.72 0.07 OUTLIER Glycine 0 CA--C 1.523 0.542 0 N-CA-C 110.602 -0.999 . . . . 0.0 110.602 -179.971 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.461 ' HB2' ' CZ ' ' A' ' 92' ' ' TYR . . . -175.82 179.61 1.33 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.811 0.338 . . . . 0.0 110.359 179.99 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.416 ' CG2' ' HB ' ' A' ' 5' ' ' THR . 24.8 m -120.69 139.78 52.55 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.439 -179.83 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.461 ' CZ ' ' HB2' ' A' ' 90' ' ' ALA . 7.1 m-85 -141.59 104.58 4.58 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.284 179.932 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.441 ' CB ' ' HD2' ' A' ' 94' ' ' PRO . . . 175.06 177.3 0.21 Allowed Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.301 -179.886 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.441 ' HD2' ' CB ' ' A' ' 93' ' ' ALA . 47.6 Cg_endo . . . . . 0 C--O 1.249 1.074 0 C-N-CA 122.486 2.124 . . . . 0.0 112.03 179.973 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 59.2 t . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 110.105 -0.332 . . . . 0.0 110.105 . . . . . . . . . 0 0 . 1 . 038 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -72.98 157.42 51.2 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.413 2.075 . . . . 0.0 111.952 179.8 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 10.4 mmtp -131.57 75.32 1.64 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.535 -179.737 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.507 ' CG1' ' CE1' ' A' ' 78' ' ' PHE . 2.0 p -65.25 163.25 2.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.172 0.511 . . . . 0.0 110.068 179.808 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.468 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 3.9 p -147.78 131.07 16.53 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.384 -179.989 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.416 ' O ' ' CG2' ' A' ' 91' ' ' THR . 6.0 m-85 -96.46 174.73 6.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.287 -179.958 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.435 ' HB ' ' CB ' ' A' ' 20' ' ' LEU . 2.8 m -166.16 106.88 0.7 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.27 -179.813 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.431 HG13 ' CG1' ' A' ' 88' ' ' ILE . 91.6 t -59.11 94.12 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.406 -179.85 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.423 ' HG3' ' CG1' ' A' ' 51' ' ' VAL . 15.4 mm-40 -56.02 158.86 3.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.236 179.899 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.9 ptmt -77.14 62.57 2.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.435 -179.948 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -154.95 27.32 0.64 Allowed Glycine 0 CA--C 1.523 0.593 0 N-CA-C 110.728 -0.949 . . . . 0.0 110.728 179.963 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 30.4 m -86.87 131.7 34.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.839 0.352 . . . . 0.0 110.358 -179.967 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -110.54 -159.71 0.69 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.143 -0.481 . . . . 0.0 109.986 179.872 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -47.83 -59.35 3.38 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.622 179.908 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.13 -25.07 9.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.588 -180.0 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 27.0 m80 -51.27 134.46 27.7 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.852 0.358 . . . . 0.0 110.421 -179.999 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -127.05 98.03 5.17 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.371 -179.952 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -94.4 127.85 40.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.213 179.929 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.434 HG22 ' CG2' ' A' ' 21' ' ' VAL . 22.7 m -128.0 148.15 32.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.317 -179.957 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.435 ' CB ' ' HB ' ' A' ' 7' ' ' THR . 0.9 OUTLIER -94.53 63.19 2.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.456 -179.936 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.434 ' CG2' HG22 ' A' ' 19' ' ' VAL . 22.8 t -65.66 100.49 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.292 179.969 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.39 152.26 21.83 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.313 -179.994 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 28.1 p90 179.23 157.49 0.56 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.367 -179.941 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -82.81 163.53 21.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.331 179.934 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 106.63 -49.09 0.9 Allowed Glycine 0 CA--C 1.523 0.57 0 N-CA-C 110.652 -0.979 . . . . 0.0 110.652 -179.963 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -130.44 -177.78 4.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.755 0.312 . . . . 0.0 110.171 179.906 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -126.68 162.87 24.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.514 -179.976 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.451 ' O ' ' CG ' ' A' ' 71' ' ' GLU . 0.0 OUTLIER -57.98 -160.84 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.316 179.92 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.445 ' CB ' ' O ' ' A' ' 28' ' ' MET . . . 155.12 -63.71 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.291 0.637 . . . . 0.0 109.532 179.668 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 17.9 tt0 -148.7 161.53 41.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.061 179.8 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.447 HG23 ' CD1' ' A' ' 52' ' ' TRP . 10.7 t -155.11 150.18 11.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.234 179.911 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.425 ' CB ' ' HA ' ' A' ' 43' ' ' ALA . 1.4 pm0 -151.67 144.46 24.38 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.359 -179.955 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.419 ' O ' ' CG2' ' A' ' 42' ' ' VAL . 8.1 tp -112.96 151.14 30.92 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.486 -179.428 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.477 ' HG3' ' CD2' ' A' ' 41' ' ' TRP . 4.7 ttp180 -117.2 -158.16 0.69 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.229 179.913 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 6.9 tm-20 -175.5 107.32 0.09 Allowed 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 -179.968 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -48.39 97.0 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.704 -179.434 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 161.67 -31.27 0.32 Allowed Glycine 0 CA--C 1.522 0.525 0 N-CA-C 110.468 -1.053 . . . . 0.0 110.468 179.859 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -117.87 145.26 44.73 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 179.937 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -94.95 21.45 7.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.778 -179.836 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 29.7 tp10 -130.38 113.52 14.44 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 -179.901 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.477 ' CD2' ' HG3' ' A' ' 34' ' ' ARG . 63.7 m95 -63.72 172.99 1.89 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.162 179.707 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.419 ' CG2' ' O ' ' A' ' 33' ' ' LEU . 4.4 m -146.65 107.34 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.048 179.624 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.425 ' HA ' ' CB ' ' A' ' 32' ' ' GLU . . . -45.49 146.06 1.11 Allowed 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.679 -179.69 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.56 -170.8 0.23 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.709 -179.712 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 92.8 m -145.34 107.19 4.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.436 -179.979 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -66.22 79.08 0.09 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.168 179.87 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -104.29 -22.93 8.32 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 111.056 -0.818 . . . . 0.0 111.056 -179.794 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.432 ' CG ' HG21 ' A' ' 51' ' ' VAL . 0.1 OUTLIER -75.96 -178.62 4.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.979 0.419 . . . . 0.0 110.422 -179.939 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -111.79 38.95 3.05 Favored Glycine 0 CA--C 1.522 0.514 0 N-CA-C 110.244 -1.143 . . . . 0.0 110.244 179.579 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 165.39 -27.81 0.19 Allowed Glycine 0 CA--C 1.526 0.753 0 N-CA-C 111.311 -0.716 . . . . 0.0 111.311 -179.874 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.432 HG21 ' CG ' ' A' ' 48' ' ' GLU . 3.2 m -123.4 -176.3 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-O 120.884 0.373 . . . . 0.0 110.705 -179.726 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . 0.447 ' CD1' HG23 ' A' ' 31' ' ' VAL . 11.2 m95 -108.21 138.27 44.78 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.722 -179.661 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.9 p -130.64 137.86 49.81 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.768 179.549 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 71.5 t80 -123.37 131.12 53.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.878 0.371 . . . . 0.0 110.753 -179.539 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -77.32 107.13 9.51 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.019 179.696 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.0 m -87.76 148.71 24.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.629 -179.693 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -122.97 -42.27 2.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.256 179.887 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -55.72 165.51 1.26 Allowed Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.404 179.987 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -94.32 5.32 2.64 Favored 'Trans proline' 0 N--CA 1.452 -0.934 0 C-N-CA 123.995 3.13 . . . . 0.0 113.015 -179.863 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -103.94 102.9 12.69 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.827 0.346 . . . . 0.0 110.355 179.918 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -122.82 75.13 1.25 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.453 -179.845 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -133.46 -101.03 0.74 Allowed Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.749 -0.94 . . . . 0.0 110.749 179.996 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -78.51 107.9 2.36 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.568 2.178 . . . . 0.0 112.049 -179.954 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 36.7 m-85 -93.42 166.42 12.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.391 -179.947 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.42 ' HB2' ' CB ' ' A' ' 34' ' ' ARG . 1.5 m-80 -133.86 147.41 51.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.018 179.785 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -140.55 175.07 9.9 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.031 0.443 . . . . 0.0 110.962 -179.718 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.475 ' HD2' ' CZ2' ' A' ' 41' ' ' TRP . 6.5 ptm180 -178.99 61.98 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.569 179.941 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -57.4 173.72 0.24 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.028 -179.223 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.428 ' O ' ' CB ' ' A' ' 29' ' ' ALA . 2.9 mt -136.12 78.69 1.73 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.881 179.969 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 61.2 p -38.81 153.19 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.393 -179.646 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.451 ' CG ' ' O ' ' A' ' 28' ' ' MET . 6.3 mt-10 -49.7 -33.97 17.44 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.388 -179.799 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.61 -36.08 82.69 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.354 -179.97 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 113.12 23.37 5.25 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 110.974 -0.851 . . . . 0.0 110.974 179.972 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -92.89 116.13 28.76 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.708 0.29 . . . . 0.0 110.307 179.902 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 3.1 mptt -113.46 173.72 6.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.35 -179.941 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 171.11 129.78 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.999 179.98 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 83.0 t -76.52 153.81 5.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.327 -179.994 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.507 ' CE1' ' CG1' ' A' ' 4' ' ' VAL . 87.1 m-85 -139.12 119.61 13.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.599 -179.879 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -106.03 152.22 23.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.095 179.812 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 11.0 t0 55.2 61.02 3.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.049 -179.751 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.404 ' O ' ' CG2' ' A' ' 82' ' ' VAL . 84.7 t -95.36 -8.19 9.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.234 -179.695 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.404 ' CG2' ' O ' ' A' ' 81' ' ' VAL . 57.3 t -156.33 132.07 5.68 Favored Pre-proline 0 C--N 1.332 -0.166 0 N-CA-C 110.406 -0.22 . . . . 0.0 110.406 179.872 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.485 ' HD3' ' CD1' ' A' ' 92' ' ' TYR . 50.0 Cg_endo -73.0 -176.09 2.23 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.507 2.138 . . . . 0.0 111.946 179.84 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -82.52 135.68 35.04 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 179.446 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 57.75 48.37 13.99 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 -179.466 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 48.8 p90 -43.28 156.36 0.05 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.414 -179.528 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 7.1 m -127.32 103.71 7.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.808 179.609 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.431 ' CG1' HG13 ' A' ' 8' ' ' VAL . 2.5 mp -44.52 122.57 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.012 -179.632 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 117.43 35.37 1.1 Allowed Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.743 -0.943 . . . . 0.0 110.743 -179.935 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -155.74 142.35 18.73 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 110.222 -0.288 . . . . 0.0 110.222 179.978 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.416 ' CG2' ' O ' ' A' ' 6' ' ' PHE . 6.0 m -96.3 113.8 25.42 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.925 0.393 . . . . 0.0 110.716 -179.836 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.485 ' CD1' ' HD3' ' A' ' 83' ' ' PRO . 33.0 m-85 -97.26 -153.58 0.42 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.788 179.751 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.429 ' CB ' ' HD2' ' A' ' 94' ' ' PRO . . . 78.42 173.78 0.08 OUTLIER Pre-proline 0 N--CA 1.465 0.305 0 CA-C-O 120.838 0.351 . . . . 0.0 110.722 179.808 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.429 ' HD2' ' CB ' ' A' ' 93' ' ' ALA . 48.1 Cg_endo . . . . . 0 C--O 1.249 1.053 0 C-N-CA 122.631 2.22 . . . . 0.0 112.079 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 9.9 tttt . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.731 0.301 . . . . 0.0 110.428 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.946 HG12 ' CE1' ' A' ' 23' ' ' TYR . 30.0 m -92.74 172.06 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.374 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.701 HG23 ' O ' ' A' ' 4' ' ' VAL . 4.6 p -163.49 133.8 4.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.397 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.579 ' O ' HG23 ' A' ' 91' ' ' THR . 23.4 m-85 -95.61 -169.9 2.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.073 179.849 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -165.75 104.85 0.7 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.809 0.338 . . . . 0.0 110.505 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 95.8 t -55.21 91.84 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.179 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 1.021 ' HG3' HG11 ' A' ' 51' ' ' VAL . 9.9 mm-40 -66.1 169.57 6.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.568 -179.704 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.501 ' HA ' HG21 ' A' ' 88' ' ' ILE . 11.9 tttt -63.18 -15.33 56.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.193 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -45.95 -27.81 2.58 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 111.213 -0.755 . . . . 0.0 111.213 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -71.13 131.29 43.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.77 0.319 . . . . 0.0 110.348 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -145.47 -86.61 0.11 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.434 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -81.68 -66.81 0.84 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.923 0.392 . . . . 0.0 110.121 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.06 26.08 2.72 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.214 179.708 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 54.5 m80 -94.32 139.61 30.86 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.233 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.44 ' HA ' HD22 ' A' ' 17' ' ' LEU . 0.4 OUTLIER -124.35 89.24 3.04 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.263 179.907 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.581 ' HB2' ' CG2' ' A' ' 53' ' ' THR . . . -90.26 153.38 20.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.51 -179.819 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 6.4 m -145.29 137.5 20.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.044 179.77 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.563 HD12 ' OE2' ' A' ' 9' ' ' GLU . 0.9 OUTLIER -98.69 51.56 0.99 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.505 -179.943 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.511 ' HB ' ' CD2' ' A' ' 6' ' ' PHE . 3.0 p -53.57 107.65 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.924 0.393 . . . . 0.0 110.19 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -174.46 120.75 0.25 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.252 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.946 ' CE1' HG12 ' A' ' 4' ' ' VAL . 17.0 p90 -127.31 19.61 6.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.831 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 60.44 147.94 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.901 0.381 . . . . 0.0 110.518 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 109.07 -93.47 0.77 Allowed Glycine 0 CA--C 1.523 0.592 0 N-CA-C 110.652 -0.979 . . . . 0.0 110.652 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -57.54 -173.43 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.793 0.33 . . . . 0.0 110.484 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.34 173.69 6.67 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.515 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.424 ' O ' ' CG ' ' A' ' 71' ' ' GLU . 0.1 OUTLIER -109.07 123.51 49.28 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.483 -179.942 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.698 ' HB3' ' O ' ' A' ' 69' ' ' LEU . . . -115.1 -62.59 1.58 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.284 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -158.95 164.2 35.83 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.595 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.86 HG21 ' CD1' ' A' ' 52' ' ' TRP . 16.2 t -138.68 145.43 27.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.211 0.529 . . . . 0.0 111.335 -179.547 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.405 ' HA ' ' HA ' ' A' ' 43' ' ' ALA . 6.0 tp10 -124.56 130.6 52.76 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.223 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.672 HD12 ' H ' ' A' ' 34' ' ' ARG . 12.4 tp -114.2 151.77 32.24 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 121.021 0.438 . . . . 0.0 110.172 -179.058 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.672 ' H ' HD12 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -125.98 -156.04 0.71 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.699 179.458 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.423 ' CG ' ' O ' ' A' ' 34' ' ' ARG . 14.3 mt-10 -161.57 -88.54 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.497 0.189 . . . . 0.0 110.72 179.711 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' HIS . . . . . 0.444 ' CG ' ' N ' ' A' ' 37' ' ' GLY . 11.1 p80 -160.76 -46.72 0.05 OUTLIER 'General case' 0 N--CA 1.454 -0.235 0 CA-C-O 120.797 0.332 . . . . 0.0 110.8 -179.716 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.444 ' N ' ' CG ' ' A' ' 36' ' ' HIS . . . -156.97 38.39 0.56 Allowed Glycine 0 CA--C 1.523 0.577 0 N-CA-C 110.914 -0.874 . . . . 0.0 110.914 -179.605 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 5.5 t -73.6 -76.03 0.14 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.828 0.347 . . . . 0.0 110.219 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 37.3 p30 -173.32 55.95 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.131 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 67.83 176.29 0.26 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.242 -179.784 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.507 ' CZ3' ' HG2' ' A' ' 67' ' ' ARG . 98.3 m95 -52.69 138.64 28.3 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.542 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.7 m -130.98 110.72 18.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.935 179.726 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.405 ' HA ' ' HA ' ' A' ' 32' ' ' GLU . . . -48.66 131.42 17.79 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.82 -179.474 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.23 -171.33 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.578 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.419 ' O ' ' N ' ' A' ' 47' ' ' GLY . 41.3 m -142.03 102.33 4.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.235 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.405 ' O ' ' CG ' ' A' ' 46' ' ' LYS . 0.1 OUTLIER -64.56 76.17 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.331 -179.966 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 45' ' ' THR . . . -107.14 -21.9 7.82 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.923 -0.871 . . . . 0.0 110.923 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.69 -33.41 66.49 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.838 0.351 . . . . 0.0 110.336 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 98.12 -42.38 2.09 Favored Glycine 0 CA--C 1.522 0.526 0 N-CA-C 110.562 -1.015 . . . . 0.0 110.562 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -107.32 -25.12 6.19 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.679 -0.968 . . . . 0.0 110.679 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 1.021 HG11 ' HG3' ' A' ' 9' ' ' GLU . 24.0 m -136.5 179.0 4.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.826 0.346 . . . . 0.0 110.467 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' TRP . . . . . 0.86 ' CD1' HG21 ' A' ' 31' ' ' VAL . 4.0 m95 -109.42 128.35 55.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.417 -179.423 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.581 ' CG2' ' HB2' ' A' ' 18' ' ' ALA . 0.2 OUTLIER -114.69 167.94 10.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.421 -179.964 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.666 ' CG ' HD23 ' A' ' 33' ' ' LEU . 79.2 t80 -146.72 133.2 19.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.316 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 25.5 p-10 -94.65 114.29 26.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.544 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -84.51 146.55 27.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.261 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -113.11 -40.19 4.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.403 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.4 ' HG3' ' O ' ' A' ' 60' ' ' LEU . 1.7 pt-20 -67.66 151.55 97.07 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.272 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -71.72 -18.77 28.38 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.681 2.254 . . . . 0.0 112.494 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.4 ' O ' ' HG3' ' A' ' 58' ' ' GLU . 3.6 mt -96.29 144.13 26.74 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.903 0.382 . . . . 0.0 110.662 -179.645 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -143.2 91.12 2.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.269 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -96.35 -140.7 11.33 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.775 -0.93 . . . . 0.0 110.775 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -73.9 166.38 29.83 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.527 2.151 . . . . 0.0 111.893 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -125.2 177.46 6.1 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.148 0.499 . . . . 0.0 111.0 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -147.43 134.62 20.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.494 179.61 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.565 ' CZ ' HD13 ' A' ' 33' ' ' LEU . 52.2 m-85 -124.22 168.52 12.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.253 0.549 . . . . 0.0 111.478 -179.072 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.507 ' HG2' ' CZ3' ' A' ' 41' ' ' TRP . 0.0 OUTLIER -170.86 68.36 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.404 179.741 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.796 ' O ' HD23 ' A' ' 69' ' ' LEU . 4.5 p90 -51.8 177.81 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.407 0.622 . . . . 0.0 111.544 -178.894 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.796 HD23 ' O ' ' A' ' 68' ' ' PHE . 5.7 mt -137.96 55.75 1.76 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.045 -0.979 . . . . 0.0 109.177 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.429 HG23 ' CD1' ' A' ' 68' ' ' PHE . 40.1 p -27.98 136.83 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.762 0.825 . . . . 0.0 112.709 -179.015 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.592 ' N ' ' HB2' ' A' ' 29' ' ' ALA . 14.4 mt-10 -50.78 -31.15 16.02 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.42 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -63.23 -31.68 72.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.447 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 103.18 62.33 0.7 Allowed Glycine 0 CA--C 1.523 0.576 0 N-CA-C 110.669 -0.972 . . . . 0.0 110.669 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 74.5 mtp -152.18 115.33 4.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.813 0.34 . . . . 0.0 110.313 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.68 176.75 5.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.384 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.421 ' O ' ' CE2' ' A' ' 78' ' ' PHE . 2.0 m-20 173.25 126.94 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.113 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 97.8 t -76.17 152.77 6.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.752 -179.612 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.757 ' CZ ' HG21 ' A' ' 4' ' ' VAL . 38.9 m-85 -136.88 121.08 17.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.152 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -109.53 153.02 24.71 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.471 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.7 t0 59.53 30.53 20.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.675 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.446 HG13 ' O ' ' A' ' 92' ' ' TYR . 95.9 t -59.77 -73.82 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.19 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.497 HG13 ' HD2' ' A' ' 83' ' ' PRO . 50.9 t -87.52 139.32 31.65 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.416 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.497 ' HD2' HG13 ' A' ' 82' ' ' VAL . 47.5 Cg_endo -73.83 -168.1 0.43 Allowed 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.572 2.181 . . . . 0.0 112.063 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -76.12 -64.12 1.17 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.341 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 6.3 tppt? -96.42 57.7 1.69 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.282 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 40.4 p90 -51.77 148.9 5.15 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.483 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 3.1 m -122.85 110.24 15.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.181 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.501 HG21 ' HA ' ' A' ' 10' ' ' LYS . 2.7 mp -50.47 100.97 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.459 -179.748 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 137.51 44.87 0.08 OUTLIER Glycine 0 CA--C 1.523 0.579 0 N-CA-C 110.534 -1.027 . . . . 0.0 110.534 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.71 ' HB3' ' OH ' ' A' ' 92' ' ' TYR . . . -166.45 -176.76 3.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.769 0.319 . . . . 0.0 110.345 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.579 HG23 ' O ' ' A' ' 6' ' ' PHE . 85.3 m -119.68 138.66 53.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.572 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.71 ' OH ' ' HB3' ' A' ' 90' ' ' ALA . 7.4 m-85 -143.95 107.74 4.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.168 179.791 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.898 ' HB1' ' HD2' ' A' ' 94' ' ' PRO . . . 176.25 178.02 0.22 Allowed Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.488 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.898 ' HD2' ' HB1' ' A' ' 93' ' ' ALA . 49.4 Cg_endo . . . . . 0 C--O 1.249 1.027 0 C-N-CA 122.565 2.177 . . . . 0.0 112.059 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 4.6 pttt . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.804 0.335 . . . . 0.0 110.281 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.673 HG11 ' CZ ' ' A' ' 68' ' ' PHE . 17.8 m -55.06 171.07 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.461 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.445 ' HB ' ' CG2' ' A' ' 91' ' ' THR . 21.6 p -153.47 135.6 14.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.375 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.532 ' HD1' ' HB2' ' A' ' 93' ' ' ALA . 14.9 m-85 -100.58 169.38 9.09 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.455 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.5 m -157.59 112.72 2.74 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.342 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 44.5 t -58.07 91.38 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.275 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.775 ' HG3' HG11 ' A' ' 51' ' ' VAL . 6.7 mm-40 -51.0 176.3 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.463 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 61.9 mmtt -67.48 175.5 2.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.314 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 51.13 49.74 42.28 Favored Glycine 0 CA--C 1.523 0.547 0 N-CA-C 110.718 -0.953 . . . . 0.0 110.718 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -102.64 136.9 41.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.873 0.368 . . . . 0.0 110.452 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 3.7 p30 -172.07 162.81 5.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.295 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -49.11 -28.1 3.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.742 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.81 -28.33 44.5 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.373 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 25.1 m80 -149.65 125.22 10.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.507 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.516 ' HA ' HD22 ' A' ' 17' ' ' LEU . 0.3 OUTLIER -111.83 94.37 4.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.222 179.883 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.667 ' HB2' ' CG2' ' A' ' 53' ' ' THR . . . -96.06 125.69 40.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.488 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.455 HG23 HG23 ' A' ' 21' ' ' VAL . 33.2 m -113.67 -171.17 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.003 179.765 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.4 tt -138.09 80.66 1.81 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.302 179.656 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.455 HG23 HG23 ' A' ' 19' ' ' VAL . 2.4 t -97.31 102.39 13.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.989 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.49 ' O ' ' CG ' ' A' ' 23' ' ' TYR . 0.0 OUTLIER -162.87 -65.27 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.878 -179.721 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.635 ' CE2' HG12 ' A' ' 4' ' ' VAL . 33.5 p90 45.6 -171.78 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.724 -179.454 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -115.85 142.63 46.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.474 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 131.23 -43.88 1.26 Allowed Glycine 0 CA--C 1.523 0.541 0 N-CA-C 110.759 -0.936 . . . . 0.0 110.759 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -126.91 -170.63 2.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.826 0.346 . . . . 0.0 110.601 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -118.8 -175.32 2.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.514 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.437 ' O ' ' CG ' ' A' ' 71' ' ' GLU . 1.5 mtp -105.99 123.73 48.45 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.343 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.756 ' HB2' ' HG2' ' A' ' 71' ' ' GLU . . . -132.16 -58.58 0.95 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.924 -179.776 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.581 ' C ' HG12 ' A' ' 31' ' ' VAL . 0.0 OUTLIER -140.63 173.6 11.33 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.83 0.348 . . . . 0.0 110.925 -179.778 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.581 HG12 ' C ' ' A' ' 30' ' ' GLU . 1.3 p 164.3 131.33 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-O 121.518 0.675 . . . . 0.0 109.76 -179.847 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.692 ' OE2' ' HB2' ' A' ' 43' ' ' ALA . 2.6 mm-40 -112.04 -172.49 2.05 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.843 -1.071 . . . . 0.0 110.476 -179.546 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.74 HD12 ' H ' ' A' ' 34' ' ' ARG . 5.8 tp -144.22 145.16 31.89 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 179.302 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.74 ' H ' HD12 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -150.66 -178.84 6.79 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.086 179.712 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -132.27 -85.22 0.48 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.574 -0.284 . . . . 0.0 110.566 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 171.71 39.76 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.823 0.344 . . . . 0.0 110.595 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 167.29 59.15 0.03 OUTLIER Glycine 0 CA--C 1.524 0.621 0 N-CA-C 110.817 -0.913 . . . . 0.0 110.817 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.6 t -133.57 158.85 42.14 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.78 0.324 . . . . 0.0 110.296 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.421 ' O ' ' CG ' ' A' ' 40' ' ' GLU . 0.4 OUTLIER -51.67 -33.48 34.0 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.31 179.907 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.421 ' CG ' ' O ' ' A' ' 39' ' ' ASP . 2.9 mt-10 169.19 -179.19 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.236 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.51 ' CH2' ' HG3' ' A' ' 67' ' ' ARG . 71.8 m95 -62.14 145.02 54.56 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.339 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 27.3 m -122.85 2.04 6.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.159 -179.833 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.692 ' HB2' ' OE2' ' A' ' 32' ' ' GLU . . . 60.07 137.86 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.344 0 CA-C-O 121.301 0.572 . . . . 0.0 111.3 179.322 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.5 ' H ' ' HA ' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -62.51 -167.13 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.372 179.733 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.4 ' O ' ' N ' ' A' ' 47' ' ' GLY . 49.9 m -150.85 125.32 9.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.358 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 13.6 ptmt -69.25 64.66 0.15 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.239 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' A' ' 45' ' ' THR . . . -91.23 -34.18 7.7 Favored Glycine 0 CA--C 1.523 0.549 0 N-CA-C 110.814 -0.915 . . . . 0.0 110.814 -179.832 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.441 ' HG2' ' CG2' ' A' ' 51' ' ' VAL . 4.4 tp10 -88.34 124.14 33.61 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.822 0.344 . . . . 0.0 110.503 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -71.56 76.28 0.66 Allowed Glycine 0 CA--C 1.522 0.507 0 N-CA-C 110.637 -0.985 . . . . 0.0 110.637 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 154.04 -36.75 0.71 Allowed Glycine 0 CA--C 1.522 0.49 0 N-CA-C 110.633 -0.987 . . . . 0.0 110.633 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.775 HG11 ' HG3' ' A' ' 9' ' ' GLU . 16.2 m -142.82 -176.7 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.95 0.405 . . . . 0.0 110.537 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 5.4 m95 -96.33 131.67 42.62 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.637 -179.436 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.667 ' CG2' ' HB2' ' A' ' 18' ' ' ALA . 0.8 OUTLIER -130.29 147.07 51.96 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.404 -179.958 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.544 ' CG ' HD23 ' A' ' 33' ' ' LEU . 45.6 t80 -137.43 142.27 41.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.239 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -91.25 141.12 29.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.507 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.1 p -143.11 147.01 34.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.278 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -144.45 31.56 1.21 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.456 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.4 ' HB2' ' HD2' ' A' ' 59' ' ' PRO . 6.5 pt-20 -102.87 157.26 34.07 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.228 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.4 ' HD2' ' HB2' ' A' ' 58' ' ' GLU . 47.9 Cg_endo -71.1 -32.52 13.07 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.603 2.202 . . . . 0.0 112.142 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.1 mt -80.6 102.3 9.72 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.336 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -138.87 132.79 31.02 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.477 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -177.63 -98.78 0.11 Allowed Glycine 0 CA--C 1.526 0.758 0 N-CA-C 110.644 -0.982 . . . . 0.0 110.644 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -81.38 164.88 18.96 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.609 2.206 . . . . 0.0 112.083 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -139.36 161.34 37.68 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.465 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -126.99 149.51 49.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.194 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.477 ' CD2' ' O ' ' A' ' 32' ' ' GLU . 85.1 m-85 -138.83 159.84 41.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.967 0.413 . . . . 0.0 111.071 -179.629 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.51 ' HG3' ' CH2' ' A' ' 41' ' ' TRP . 10.0 mtp-105 -152.42 73.18 1.02 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.84 179.352 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.691 ' O ' HD23 ' A' ' 69' ' ' LEU . 6.3 p90 -70.49 175.2 4.97 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.384 0.612 . . . . 0.0 111.023 -179.531 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.756 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 23.9 mt -146.88 57.58 1.16 Allowed 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.972 -1.013 . . . . 0.0 109.396 179.789 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 28.4 p -25.84 135.95 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.872 0.869 . . . . 0.0 112.487 -179.137 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.756 ' HG2' ' HB2' ' A' ' 29' ' ' ALA . 3.9 mm-40 -51.96 -23.95 5.78 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.599 -179.498 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 17.9 tptp -147.07 68.58 1.16 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.644 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -160.91 -103.82 0.19 Allowed Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.875 -0.89 . . . . 0.0 110.875 179.731 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -178.58 -176.69 0.5 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.89 0.376 . . . . 0.0 110.638 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.553 ' CG ' HD22 ' A' ' 69' ' ' LEU . 0.0 OUTLIER -93.2 172.96 7.97 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.345 -179.858 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 171.81 137.17 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.603 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.463 HG22 ' CD ' ' A' ' 67' ' ' ARG . 45.6 t -99.36 132.48 44.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 179.527 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.522 ' CE2' ' CG2' ' A' ' 4' ' ' VAL . 52.3 m-85 -117.28 139.8 50.36 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.5 -179.572 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -126.12 161.9 26.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.421 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 51.22 35.83 14.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.441 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.666 HG22 ' HD3' ' A' ' 94' ' ' PRO . 48.9 t -75.91 -2.55 4.23 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.816 179.757 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 84.0 t -154.12 131.63 6.21 Favored Pre-proline 0 CA--C 1.529 0.161 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.499 ' HG3' ' CE1' ' A' ' 92' ' ' TYR . 48.6 Cg_endo -75.22 178.68 6.99 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.516 2.144 . . . . 0.0 112.181 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -64.54 -57.52 8.92 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.12 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.93 73.72 0.83 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.171 179.717 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 0.511 ' HB2' ' CE2' ' A' ' 92' ' ' TYR . 23.1 p90 -70.22 177.02 3.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.521 -179.854 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 2.7 m -137.27 119.23 15.31 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.094 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.617 ' H ' HD12 ' A' ' 88' ' ' ILE . 4.3 mp -48.94 119.3 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.547 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 105.06 59.03 0.66 Allowed Glycine 0 CA--C 1.523 0.533 0 N-CA-C 110.591 -1.004 . . . . 0.0 110.591 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -170.75 146.23 2.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.896 0.379 . . . . 0.0 110.639 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.445 ' CG2' ' HB ' ' A' ' 5' ' ' THR . 8.5 m -93.43 122.99 36.42 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.046 179.696 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.511 ' CE2' ' HB2' ' A' ' 86' ' ' TYR . 69.9 m-85 -108.12 -87.55 0.49 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.791 -179.592 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.91 ' HB1' ' HD2' ' A' ' 94' ' ' PRO . . . 50.42 -179.97 0.01 OUTLIER Pre-proline 0 C--O 1.232 0.133 0 CA-C-O 120.641 0.257 . . . . 0.0 110.432 -179.781 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.91 ' HD2' ' HB1' ' A' ' 93' ' ' ALA . 49.3 Cg_endo . . . . . 0 C--O 1.25 1.075 0 C-N-CA 122.45 2.1 . . . . 0.0 111.937 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 4.5 mttm . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.809 0.338 . . . . 0.0 110.355 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.649 HG21 ' CZ ' ' A' ' 78' ' ' PHE . 16.8 m -124.85 -176.39 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.424 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.429 HG23 ' O ' ' A' ' 4' ' ' VAL . 0.1 OUTLIER -165.14 148.04 8.18 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.235 179.878 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.602 ' H ' ' HB3' ' A' ' 93' ' ' ALA . 48.2 m-85 -123.34 145.56 48.64 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.326 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.503 HG22 ' H ' ' A' ' 8' ' ' VAL . 0.2 OUTLIER -129.3 -176.99 4.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.301 -179.942 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.503 ' H ' HG22 ' A' ' 7' ' ' THR . 39.8 t -128.14 87.42 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.4 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.83 ' HG3' HG11 ' A' ' 51' ' ' VAL . 1.3 mm-40 -52.27 147.92 7.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.275 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.27 63.16 0.35 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.371 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -154.39 23.32 0.66 Allowed Glycine 0 CA--C 1.525 0.682 0 N-CA-C 111.022 -0.831 . . . . 0.0 111.022 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 16.9 m -76.07 105.02 6.88 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.442 ' N ' ' ND2' ' A' ' 13' ' ' ASN . 0.4 OUTLIER -75.92 -178.48 4.35 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.096 -179.721 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -62.07 -36.6 82.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.466 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 4.9 ptmt -124.72 36.45 4.6 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.666 -179.632 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' HIS . . . . . 0.428 ' HB2' ' CB ' ' A' ' 13' ' ' ASN . 13.2 m80 -136.09 -176.27 4.26 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.844 0.354 . . . . 0.0 110.563 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 32.1 tp -167.07 85.61 0.26 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.269 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.436 ' HB2' ' CG2' ' A' ' 53' ' ' THR . . . -81.33 107.29 13.99 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.58 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.52 HG23 HG23 ' A' ' 21' ' ' VAL . 17.8 m -88.99 -170.66 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.163 179.698 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.44 HD12 ' HG2' ' A' ' 9' ' ' GLU . 1.9 tt -142.4 57.68 1.45 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.308 179.67 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.52 HG23 HG23 ' A' ' 19' ' ' VAL . 4.9 t -72.17 114.72 11.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.463 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.93 164.03 20.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.318 179.756 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER 174.05 150.05 0.08 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.372 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -79.79 -26.89 40.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.485 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -53.56 -75.84 0.21 Allowed Glycine 0 CA--C 1.524 0.625 0 N-CA-C 110.826 -0.91 . . . . 0.0 110.826 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -93.77 -164.21 1.15 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.794 0.33 . . . . 0.0 110.428 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.07 -158.31 0.82 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.415 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.422 ' O ' ' CG ' ' A' ' 71' ' ' GLU . 47.1 mtm -132.25 126.82 34.37 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.704 -179.76 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.855 ' HB3' ' O ' ' A' ' 69' ' ' LEU . . . -125.9 -44.04 1.8 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.083 179.722 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.43 ' O ' ' HB2' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -164.27 168.93 18.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.89 -0.596 . . . . 0.0 109.526 179.712 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 8.9 t -154.11 136.48 6.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.901 0.381 . . . . 0.0 110.975 -179.806 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.439 ' CB ' ' HA ' ' A' ' 43' ' ' ALA . 3.3 pt-20 -134.08 138.06 45.03 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 178.96 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.628 HD23 ' CG ' ' A' ' 54' ' ' PHE . 13.4 tp -118.24 155.6 30.26 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 121.157 0.503 . . . . 0.0 110.854 -178.015 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.602 ' H ' HD12 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -136.75 -156.97 0.74 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.325 178.946 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -153.35 -79.72 0.1 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.696 0.284 . . . . 0.0 110.559 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 177.18 119.32 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.79 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 52.64 63.75 4.68 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 111.165 -0.774 . . . . 0.0 111.165 179.61 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.473 ' CB ' ' NH1' ' A' ' 34' ' ' ARG . 0.3 OUTLIER -111.31 -70.08 0.83 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.946 0.403 . . . . 0.0 110.289 179.797 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 25.4 t0 179.59 -63.3 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.119 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -157.04 163.0 39.53 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.344 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.495 ' CZ2' ' HG3' ' A' ' 67' ' ' ARG . 94.3 m95 -57.57 146.89 28.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.695 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.444 HG23 ' O ' ' A' ' 33' ' ' LEU . 2.8 m -129.31 107.92 16.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.439 ' HA ' ' CB ' ' A' ' 32' ' ' GLU . . . -45.96 140.86 3.44 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.777 -179.546 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.02 -170.89 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.539 -179.72 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 86.6 m -138.8 98.84 3.64 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.326 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 13.0 ptmt -67.01 79.29 0.12 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.509 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -128.29 24.87 4.94 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.76 -0.936 . . . . 0.0 110.76 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.421 ' CB ' HG23 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -107.59 175.8 5.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.801 0.334 . . . . 0.0 110.38 179.978 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -60.25 -43.92 98.0 Favored Glycine 0 CA--C 1.523 0.562 0 N-CA-C 110.572 -1.011 . . . . 0.0 110.572 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -160.52 27.6 0.32 Allowed Glycine 0 CA--C 1.524 0.619 0 N-CA-C 110.828 -0.909 . . . . 0.0 110.828 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.83 HG11 ' HG3' ' A' ' 9' ' ' GLU . 14.7 m -143.13 -175.81 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.8 0.333 . . . . 0.0 110.369 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 6.7 m95 -109.29 141.94 40.88 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.712 -179.588 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.436 ' CG2' ' HB2' ' A' ' 18' ' ' ALA . 0.0 OUTLIER -125.81 159.38 32.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.924 179.533 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.628 ' CG ' HD23 ' A' ' 33' ' ' LEU . 68.1 t80 -144.09 133.68 23.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.845 0.355 . . . . 0.0 110.511 -179.843 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -84.9 128.61 34.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.364 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -122.54 154.15 38.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.379 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -162.22 50.73 0.2 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.467 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -128.71 156.38 77.63 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.569 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -66.99 -28.28 41.95 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.897 2.398 . . . . 0.0 112.123 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -80.06 163.43 24.18 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.28 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -175.29 44.74 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.49 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -83.01 -132.68 1.9 Allowed Glycine 0 CA--C 1.527 0.808 0 N-CA-C 110.36 -1.096 . . . . 0.0 110.36 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -75.29 141.3 25.67 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.355 2.037 . . . . 0.0 111.8 179.663 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 44.8 m-85 -97.62 153.0 18.49 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.529 -179.713 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -124.79 126.23 45.29 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.026 -0.533 . . . . 0.0 109.913 179.581 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.571 ' CD2' ' CE2' ' A' ' 6' ' ' PHE . 2.7 m-85 -104.74 -178.25 3.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.654 -179.573 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.495 ' HG3' ' CZ2' ' A' ' 41' ' ' TRP . 0.0 OUTLIER 175.27 77.85 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.997 179.975 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.506 ' HZ ' HG11 ' A' ' 4' ' ' VAL . 1.4 p90 -84.75 164.08 18.75 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.222 0.534 . . . . 0.0 110.975 -179.653 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.855 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 9.1 mt -109.75 64.26 0.61 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.283 -0.872 . . . . 0.0 108.861 178.988 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.428 HG23 ' CD1' ' A' ' 68' ' ' PHE . 0.8 OUTLIER -33.77 138.06 0.09 Allowed 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 115.552 -0.749 . . . . 0.0 112.206 -178.833 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.677 ' HG2' ' HB2' ' A' ' 29' ' ' ALA . 19.0 mt-10 -49.02 -28.13 3.74 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.958 -179.543 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.01 26.64 0.31 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.678 0.275 . . . . 0.0 111.127 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.422 ' O ' ' CB ' ' A' ' 74' ' ' MET . . . -97.15 -36.46 4.94 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 110.381 -1.088 . . . . 0.0 110.381 179.67 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.422 ' CB ' ' O ' ' A' ' 73' ' ' GLY . 0.0 OUTLIER 82.25 70.8 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 120.85 0.357 . . . . 0.0 111.089 179.443 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 48.98 -179.29 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.198 179.209 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.51 ' HB3' ' CE2' ' A' ' 78' ' ' PHE . 0.3 OUTLIER 167.65 128.45 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.882 179.886 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 77.5 t -95.31 137.54 23.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.013 0.435 . . . . 0.0 110.525 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.649 ' CZ ' HG21 ' A' ' 4' ' ' VAL . 92.4 m-85 -133.39 144.46 49.58 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.494 -179.781 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -133.58 161.49 34.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.194 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 54.02 30.28 11.57 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.94 0.4 . . . . 0.0 110.138 -179.865 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.58 HG13 ' HB2' ' A' ' 93' ' ' ALA . 87.4 t -64.48 -15.97 18.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.2 -179.739 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 44.6 t -146.72 132.5 9.36 Favored Pre-proline 0 C--N 1.332 -0.19 0 CA-C-O 120.506 0.193 . . . . 0.0 110.565 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.469 ' HD3' ' CD1' ' A' ' 92' ' ' TYR . 50.6 Cg_endo -75.44 165.81 29.93 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.561 2.174 . . . . 0.0 111.899 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -66.12 126.54 28.98 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.293 -0.412 . . . . 0.0 109.989 179.651 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 24.7 mtmt 60.17 50.12 6.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.942 0.401 . . . . 0.0 109.924 -179.488 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 51.3 p90 -47.56 158.96 0.16 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.967 -179.581 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 29.1 m -124.04 108.85 12.8 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.035 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 2.7 mp -47.98 107.64 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.626 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 132.7 44.76 0.14 Allowed Glycine 0 CA--C 1.523 0.565 0 N-CA-C 110.449 -1.061 . . . . 0.0 110.449 -179.709 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -163.29 156.41 19.01 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.99 101.68 11.23 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.722 -179.78 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.469 ' CD1' ' HD3' ' A' ' 83' ' ' PRO . 32.7 m-85 -87.98 -160.17 0.6 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.868 179.563 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.916 ' HB1' ' HD2' ' A' ' 94' ' ' PRO . . . 66.82 176.58 0.06 OUTLIER Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 120.721 0.296 . . . . 0.0 110.578 179.653 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.916 ' HD2' ' HB1' ' A' ' 93' ' ' ALA . 47.7 Cg_endo . . . . . 0 C--O 1.249 1.056 0 C-N-CA 122.567 2.178 . . . . 0.0 112.04 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 8.4 mtmt . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.864 0.364 . . . . 0.0 110.272 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.751 HG11 ' CE1' ' A' ' 78' ' ' PHE . 1.7 p -149.32 164.24 4.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.301 0.572 . . . . 0.0 110.215 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.481 ' N ' HG22 ' A' ' 4' ' ' VAL . 0.6 OUTLIER -156.99 133.41 9.89 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.516 179.775 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.516 ' HD1' ' HB2' ' A' ' 93' ' ' ALA . 8.2 m-85 -109.77 179.29 4.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.092 -0.504 . . . . 0.0 109.893 179.535 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.5 m -166.23 128.32 1.89 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.846 0.355 . . . . 0.0 110.335 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.687 ' O ' HG23 ' A' ' 88' ' ' ILE . 29.2 t -70.0 87.51 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.189 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.552 ' CG ' HG21 ' A' ' 51' ' ' VAL . 1.2 mm-40 -58.28 166.09 1.78 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.436 -179.756 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.575 ' HA ' HG21 ' A' ' 88' ' ' ILE . 1.6 mppt? -54.53 -21.84 11.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.83 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -45.14 -37.43 5.81 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 111.269 -0.733 . . . . 0.0 111.269 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 13.3 m -68.19 124.97 24.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.778 0.323 . . . . 0.0 110.348 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -133.93 -52.74 0.85 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.516 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -146.72 -76.78 0.19 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.658 -179.859 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 14.4 mmmt -99.32 25.58 6.79 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.462 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 31.4 m80 -125.38 147.51 49.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.451 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.465 HD22 ' HA ' ' A' ' 17' ' ' LEU . 0.2 OUTLIER -133.44 91.53 2.87 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.0 0.428 . . . . 0.0 110.366 179.881 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.714 ' HB1' HG11 ' A' ' 51' ' ' VAL . . . -92.12 131.99 36.94 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.16 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.84 ' O ' HG13 ' A' ' 51' ' ' VAL . 14.5 m -127.5 135.33 63.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.847 0.356 . . . . 0.0 110.596 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.538 HD12 ' OE2' ' A' ' 9' ' ' GLU . 1.3 tt -91.98 67.2 5.14 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.036 -179.789 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.527 ' CG1' ' CD1' ' A' ' 52' ' ' TRP . 2.2 p -82.19 110.2 17.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 179.395 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 30.3 tttm -178.06 111.13 0.07 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.33 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 29.3 p90 -136.56 151.21 49.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.441 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -50.78 172.99 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.526 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 76.05 -84.8 0.91 Allowed Glycine 0 CA--C 1.523 0.557 0 N-CA-C 110.753 -0.939 . . . . 0.0 110.753 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.517 ' HB3' HG21 ' A' ' 70' ' ' THR . 0.8 OUTLIER -64.62 179.11 0.66 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.734 0.302 . . . . 0.0 110.344 -179.994 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -133.08 178.65 6.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.488 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.422 ' O ' ' CG ' ' A' ' 71' ' ' GLU . 0.1 OUTLIER -105.55 120.42 41.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.26 179.963 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.831 ' HB3' ' O ' ' A' ' 69' ' ' LEU . . . -130.65 -50.68 1.06 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.823 -179.69 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.409 ' CG ' ' O ' ' A' ' 29' ' ' ALA . 29.1 mt-10 -159.23 150.51 20.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.999 0.428 . . . . 0.0 110.848 -179.812 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.702 HG21 ' CD1' ' A' ' 52' ' ' TRP . 20.3 t -140.43 142.89 30.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.679 179.53 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.466 ' CB ' ' HA ' ' A' ' 43' ' ' ALA . 1.9 pt-20 -148.77 137.43 21.3 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.875 0.369 . . . . 0.0 110.475 -179.759 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.706 HD21 ' HB3' ' A' ' 64' ' ' PHE . 3.9 mt -89.84 173.18 8.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.139 -179.424 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.449 ' HB2' ' CZ3' ' A' ' 41' ' ' TRP . 20.2 ttt180 -121.49 -63.3 1.33 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.477 179.261 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.448 ' O ' ' N ' ' A' ' 37' ' ' GLY . 14.0 mt-10 89.62 23.65 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 123.555 0.742 . . . . 0.0 109.961 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 58.49 -76.98 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.332 179.427 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.448 ' N ' ' O ' ' A' ' 35' ' ' GLU . . . -48.38 -65.24 2.66 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 111.119 -0.792 . . . . 0.0 111.119 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -49.34 101.3 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.808 0.337 . . . . 0.0 110.591 -179.844 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -59.79 -28.91 67.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.338 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -94.1 129.4 40.67 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.308 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.449 ' CZ3' ' HB2' ' A' ' 34' ' ' ARG . 80.6 m95 -66.39 141.28 58.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.591 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.587 HG23 ' O ' ' A' ' 42' ' ' VAL . 35.8 m -111.77 111.66 37.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.969 179.706 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.466 ' HA ' ' CB ' ' A' ' 32' ' ' GLU . . . -49.33 141.54 8.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.845 -179.601 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.53 -167.66 0.2 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.121 179.767 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 85.8 m -156.28 98.24 1.83 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.502 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.51 90.47 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.107 179.749 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -112.39 -17.89 7.92 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 111.384 -0.686 . . . . 0.0 111.384 -179.656 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.458 ' CB ' ' HB ' ' A' ' 51' ' ' VAL . 17.7 tp10 -77.78 -28.69 50.61 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.852 0.326 . . . . 0.0 110.719 -179.706 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 112.55 -39.74 2.76 Favored Glycine 0 CA--C 1.52 0.401 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 -179.395 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -137.14 16.16 3.68 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 178.693 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.84 HG13 ' O ' ' A' ' 19' ' ' VAL . 50.4 t -149.01 147.12 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' TRP . . . . . 0.702 ' CD1' HG21 ' A' ' 31' ' ' VAL . 2.0 m95 -89.87 111.78 22.93 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.282 -179.506 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.495 HG22 ' HB2' ' A' ' 18' ' ' ALA . 4.9 p -99.76 151.05 21.69 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.501 -179.67 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 57.0 t80 -139.33 151.24 46.22 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.138 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -106.88 129.88 54.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.714 -179.708 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 14.3 t -127.98 156.03 43.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.11 179.759 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -156.86 37.48 0.31 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.437 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -124.79 154.33 70.58 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.441 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -72.89 -41.43 1.43 Allowed 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.644 2.229 . . . . 0.0 111.926 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -71.54 77.14 0.8 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.49 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -116.35 89.39 3.1 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.492 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -98.76 -131.79 7.4 Favored Glycine 0 CA--C 1.527 0.79 0 N-CA-C 110.438 -1.065 . . . . 0.0 110.438 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -75.03 145.69 31.65 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.375 2.05 . . . . 0.0 111.767 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.706 ' HB3' HD21 ' A' ' 33' ' ' LEU . 56.1 m-85 -97.11 100.71 12.19 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.933 0.396 . . . . 0.0 110.345 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.429 ' OD1' ' N ' ' A' ' 65' ' ' ASN . 0.3 OUTLIER -78.27 141.33 38.6 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.949 -0.568 . . . . 0.0 109.781 179.952 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.496 ' CE1' ' HG ' ' A' ' 33' ' ' LEU . 92.7 m-85 -128.71 -177.45 4.2 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.046 0.451 . . . . 0.0 110.532 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.411 ' HG2' ' CE3' ' A' ' 41' ' ' TRP . 0.0 OUTLIER 178.35 52.22 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.691 179.845 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.509 ' HB3' HG22 ' A' ' 31' ' ' VAL . 0.9 OUTLIER -49.98 169.23 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.727 -179.671 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.831 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 1.1 mt -123.95 72.87 1.18 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.213 179.613 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.517 HG21 ' HB3' ' A' ' 26' ' ' ASP . 71.6 p -35.17 137.59 0.15 Allowed 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.783 -179.201 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.746 ' HG2' ' HB2' ' A' ' 29' ' ' ALA . 4.8 mm-40 -45.83 -55.1 7.05 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.951 -179.558 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 41.4 tptt -138.85 77.83 1.64 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.528 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -163.42 -91.13 0.08 OUTLIER Glycine 0 CA--C 1.523 0.583 0 N-CA-C 110.57 -1.012 . . . . 0.0 110.57 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER 176.76 172.69 0.44 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.892 0.377 . . . . 0.0 110.459 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.45 145.09 35.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.216 179.848 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -138.75 140.72 38.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.568 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 95.5 t -85.54 152.82 3.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.334 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.751 ' CE1' HG11 ' A' ' 4' ' ' VAL . 32.6 m-85 -138.46 120.78 15.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.227 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 30.8 p-10 -117.26 48.37 1.35 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.676 -179.443 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 167.34 65.96 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.617 HG22 ' HD3' ' A' ' 94' ' ' PRO . 70.3 t -111.68 -10.07 11.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.564 -178.727 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.433 HG23 ' C ' ' A' ' 81' ' ' VAL . 86.9 t -156.04 131.7 5.58 Favored Pre-proline 0 C--N 1.331 -0.197 0 CA-C-O 120.648 0.261 . . . . 0.0 110.765 179.511 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.51 ' HD3' ' CD1' ' A' ' 92' ' ' TYR . 47.5 Cg_endo -68.74 -165.65 0.14 Allowed 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.807 2.338 . . . . 0.0 111.875 179.461 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -77.22 -38.09 52.0 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.15 -0.477 . . . . 0.0 109.852 179.469 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 1.1 mttt -123.31 74.92 1.27 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.959 179.647 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 0.413 ' HB2' HG21 ' A' ' 8' ' ' VAL . 24.5 p90 -47.38 171.02 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.954 -179.588 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -149.4 109.75 4.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.147 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.687 HG23 ' O ' ' A' ' 8' ' ' VAL . 2.9 mp -52.69 122.11 2.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.526 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 102.29 42.67 2.16 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 110.936 -0.866 . . . . 0.0 110.936 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -160.07 129.64 5.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.85 0.357 . . . . 0.0 110.57 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.467 HG23 ' O ' ' A' ' 6' ' ' PHE . 15.1 m -81.4 128.36 33.77 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.136 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.51 ' CD1' ' HD3' ' A' ' 83' ' ' PRO . 63.3 m-85 -111.97 -93.09 0.46 Allowed 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.876 -179.58 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.627 ' HB1' ' HD2' ' A' ' 94' ' ' PRO . . . 53.26 172.35 0.04 OUTLIER Pre-proline 0 N--CA 1.462 0.157 0 CA-C-O 120.852 0.358 . . . . 0.0 110.419 -179.661 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.627 ' HD2' ' HB1' ' A' ' 93' ' ' ALA . 47.8 Cg_endo . . . . . 0 C--O 1.249 1.055 0 C-N-CA 122.783 2.322 . . . . 0.0 112.127 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.888 0.375 . . . . 0.0 110.239 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.641 ' O ' HG23 ' A' ' 5' ' ' THR . 35.9 m -85.43 -175.56 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.547 -179.799 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.641 HG23 ' O ' ' A' ' 4' ' ' VAL . 0.7 OUTLIER -166.52 151.25 7.73 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.175 179.749 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.571 ' H ' ' HB3' ' A' ' 93' ' ' ALA . 51.4 m-85 -119.51 165.59 14.2 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.352 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.404 HG23 ' HA ' ' A' ' 91' ' ' THR . 1.2 m -159.35 119.38 3.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.402 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.464 HG12 HD13 ' A' ' 88' ' ' ILE . 55.6 t -63.85 104.78 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.349 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.88 ' HG3' HG11 ' A' ' 51' ' ' VAL . 3.5 mm-40 -74.52 156.95 36.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.452 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 8.5 mttt -52.06 163.83 0.33 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.313 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 82.99 27.46 40.95 Favored Glycine 0 CA--C 1.523 0.54 0 N-CA-C 110.684 -0.966 . . . . 0.0 110.684 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.834 ' CB ' HD11 ' A' ' 88' ' ' ILE . 86.3 p -81.16 114.3 19.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.776 0.322 . . . . 0.0 110.346 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 47.2 m-80 -107.86 179.97 4.07 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.321 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -67.92 -29.82 68.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.41 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 10.4 mmmm -98.35 -44.65 6.45 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.478 -179.792 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 18.0 m80 -80.4 162.11 24.63 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.743 -179.667 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.496 ' HG ' ' CE2' ' A' ' 64' ' ' PHE . 2.3 tm? -155.95 77.32 0.95 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.754 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.428 ' HB2' ' CG2' ' A' ' 53' ' ' THR . . . -69.52 140.31 53.91 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.84 -179.427 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.4 ' O ' ' HB ' ' A' ' 51' ' ' VAL . 24.6 m -127.85 -178.2 2.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.793 -0.639 . . . . 0.0 109.682 179.544 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.0 tt -134.95 80.42 1.84 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.833 0.349 . . . . 0.0 110.362 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.9 t -90.13 96.21 6.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.33 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 39.5 mttt -148.86 145.79 27.65 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.397 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 2.2 p90 179.0 159.89 0.64 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.272 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -58.91 -175.92 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.425 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 72.53 -90.31 0.54 Allowed Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.66 -0.976 . . . . 0.0 110.66 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.737 ' OD2' HG21 ' A' ' 70' ' ' THR . 12.0 m-20 -68.1 168.1 12.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.733 0.302 . . . . 0.0 110.348 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.663 HG22 ' O ' ' A' ' 27' ' ' THR . 36.7 m -134.68 35.65 3.14 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.925 0.393 . . . . 0.0 110.647 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.423 ' O ' ' CG ' ' A' ' 71' ' ' GLU . 0.0 OUTLIER 61.4 120.85 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.829 179.639 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.82 ' HB3' ' O ' ' A' ' 69' ' ' LEU . . . -126.26 -51.73 1.52 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.09 179.531 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -157.59 169.26 25.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.868 -0.606 . . . . 0.0 109.737 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.466 HG21 ' CD1' ' A' ' 52' ' ' TRP . 3.2 t -150.6 139.57 15.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.179 0.514 . . . . 0.0 110.775 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.412 ' HG3' ' O ' ' A' ' 42' ' ' VAL . 2.5 tt0 -132.73 144.87 50.57 Favored 'General case' 0 N--CA 1.436 -1.126 0 CA-C-N 115.408 -0.814 . . . . 0.0 109.613 -179.217 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.648 HD21 ' CZ ' ' A' ' 66' ' ' PHE . 2.4 mt -121.59 175.22 6.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.398 0.618 . . . . 0.0 111.429 -179.32 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.475 ' HB2' ' CE3' ' A' ' 41' ' ' TRP . 27.5 ttt180 -167.16 162.77 15.39 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.03 -0.986 . . . . 0.0 109.149 179.581 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.443 ' N ' ' HG2' ' A' ' 34' ' ' ARG . 40.8 mt-10 -120.31 -85.1 0.66 Allowed 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 179.869 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' HIS . . . . . 0.403 ' HB2' ' O ' ' A' ' 35' ' ' GLU . 3.3 t60 179.8 -56.43 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.307 179.374 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -106.06 56.54 0.51 Allowed Glycine 0 CA--C 1.523 0.566 0 N-CA-C 110.616 -0.994 . . . . 0.0 110.616 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 23.1 t -130.76 -160.71 1.06 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.847 0.356 . . . . 0.0 110.386 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -87.23 52.4 2.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.298 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 66.83 -174.63 0.19 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.246 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.476 ' CE3' ' HG2' ' A' ' 67' ' ' ARG . 88.3 m95 -47.97 142.45 5.01 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.722 -179.873 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.598 HG22 ' O ' ' A' ' 33' ' ' LEU . 16.8 m -107.07 -142.3 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 179.491 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.576 ' N ' HG23 ' A' ' 42' ' ' VAL . . . -156.27 130.64 8.78 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.51 -179.77 1.14 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.724 0.297 . . . . 0.0 110.532 -179.818 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 89.8 m -151.43 123.36 8.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.505 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.499 ' HB3' ' CZ3' ' A' ' 52' ' ' TRP . 0.0 OUTLIER -83.62 97.41 9.05 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.363 179.919 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -148.1 23.8 1.42 Allowed Glycine 0 CA--C 1.524 0.601 0 N-CA-C 111.095 -0.802 . . . . 0.0 111.095 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -100.6 -31.59 11.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.8 0.334 . . . . 0.0 110.225 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 96.18 27.9 9.69 Favored Glycine 0 CA--C 1.522 0.525 0 N-CA-C 110.801 -0.92 . . . . 0.0 110.801 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 166.6 -34.47 0.23 Allowed Glycine 0 CA--C 1.523 0.59 0 N-CA-C 110.811 -0.916 . . . . 0.0 110.811 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.88 HG11 ' HG3' ' A' ' 9' ' ' GLU . 4.8 m -126.33 -178.38 2.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.875 0.369 . . . . 0.0 110.508 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' TRP . . . . . 0.499 ' CZ3' ' HB3' ' A' ' 46' ' ' LYS . 7.5 m95 -110.6 142.68 42.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.346 -179.82 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.428 ' CG2' ' HB2' ' A' ' 18' ' ' ALA . 0.8 OUTLIER -134.15 152.05 51.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.314 179.987 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.435 ' CZ ' HG21 ' A' ' 42' ' ' VAL . 87.8 t80 -147.31 147.66 30.59 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.43 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -93.87 120.57 34.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.374 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -142.78 175.58 9.71 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.371 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -131.69 -64.66 0.78 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.011 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 48.58 104.34 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 115.982 -0.553 . . . . 0.0 111.458 179.306 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -64.0 -16.71 56.47 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.345 2.03 . . . . 0.0 111.34 178.38 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 7.1 mp -75.22 -171.31 1.38 Allowed 'General case' 0 C--O 1.232 0.142 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.99 179.509 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 4.9 mp0 -60.43 -79.02 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 179.679 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.493 ' N ' ' HD3' ' A' ' 63' ' ' PRO . . . -175.5 58.63 0.11 Allowed Glycine 0 CA--C 1.527 0.798 0 N-CA-C 111.276 -0.73 . . . . 0.0 111.276 179.425 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.493 ' HD3' ' N ' ' A' ' 62' ' ' GLY . 51.7 Cg_endo -88.23 108.05 0.56 Allowed 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.798 2.332 . . . . 0.0 111.984 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.496 ' CE2' ' HG ' ' A' ' 17' ' ' LEU . 53.5 m-85 -109.73 166.63 10.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.133 0.492 . . . . 0.0 110.704 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -150.48 129.18 12.35 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.559 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.648 ' CZ ' HD21 ' A' ' 33' ' ' LEU . 33.3 m-85 -115.41 174.87 5.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.104 0.478 . . . . 0.0 111.097 -179.323 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.476 ' HG2' ' CE3' ' A' ' 41' ' ' TRP . 0.0 OUTLIER -175.24 50.34 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.704 179.849 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.57 ' O ' HD23 ' A' ' 69' ' ' LEU . 0.2 OUTLIER -56.44 172.79 0.21 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.108 -179.286 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.82 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 7.0 mt -124.86 73.54 1.29 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.282 179.627 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.737 HG21 ' OD2' ' A' ' 26' ' ' ASP . 22.8 p -38.22 142.97 0.14 Allowed 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.803 -179.156 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.72 ' HG2' ' HB2' ' A' ' 29' ' ' ALA . 3.5 mm-40 -51.47 -43.84 62.25 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.302 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.32 -39.27 69.75 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.316 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 108.97 46.67 0.93 Allowed Glycine 0 CA--C 1.522 0.508 0 N-CA-C 110.574 -1.01 . . . . 0.0 110.574 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 42.3 mtt -136.5 79.43 1.76 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.823 0.344 . . . . 0.0 110.62 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.36 -178.82 7.2 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.191 179.722 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.449 ' O ' ' CE2' ' A' ' 78' ' ' PHE . 0.4 OUTLIER 174.62 140.0 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.472 179.893 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.448 HG13 ' CH2' ' A' ' 41' ' ' TRP . 88.9 t -81.08 144.52 10.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.322 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.601 ' CZ ' HG21 ' A' ' 4' ' ' VAL . 38.1 m-85 -127.77 126.02 40.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.177 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -93.87 139.77 30.49 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.644 -179.655 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.457 ' O ' ' HB ' ' A' ' 81' ' ' VAL . 0.1 OUTLIER 69.19 -77.05 0.05 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.593 179.756 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.457 ' HB ' ' O ' ' A' ' 80' ' ' ASP . 53.5 t 70.68 -54.47 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 C-N-CA 123.682 0.793 . . . . 0.0 110.653 -179.575 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.605 HG13 ' HD2' ' A' ' 83' ' ' PRO . 93.8 t -105.69 140.78 21.53 Favored Pre-proline 0 C--N 1.325 -0.484 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 179.639 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.605 ' HD2' HG13 ' A' ' 82' ' ' VAL . 45.1 Cg_endo -71.27 -169.68 0.43 Allowed 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.579 2.186 . . . . 0.0 112.107 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -72.07 -64.42 0.94 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.237 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 14.4 mmtp -108.03 82.98 1.72 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.099 179.769 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 0.493 ' HB2' ' CE2' ' A' ' 92' ' ' TYR . 26.5 p90 -71.87 171.28 12.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.58 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 4.5 m -151.52 128.66 11.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.089 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.834 HD11 ' CB ' ' A' ' 12' ' ' SER . 36.3 mm -50.86 96.41 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.449 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 132.23 48.98 0.1 Allowed Glycine 0 CA--C 1.524 0.598 0 N-CA-C 110.844 -0.902 . . . . 0.0 110.844 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.675 ' HB3' ' CZ ' ' A' ' 92' ' ' TYR . . . -155.72 135.62 12.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.813 0.34 . . . . 0.0 110.362 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.404 ' HA ' HG23 ' A' ' 7' ' ' THR . 28.7 m -93.42 91.24 7.07 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.418 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.675 ' CZ ' ' HB3' ' A' ' 90' ' ' ALA . 30.4 m-85 -82.77 -161.27 0.47 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.202 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.93 ' HB1' ' HD2' ' A' ' 94' ' ' PRO . . . 74.63 177.84 0.06 OUTLIER Pre-proline 0 C--N 1.331 -0.208 0 CA-C-O 120.798 0.333 . . . . 0.0 110.635 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.93 ' HD2' ' HB1' ' A' ' 93' ' ' ALA . 48.5 Cg_endo . . . . . 0 C--O 1.248 0.996 0 C-N-CA 122.648 2.232 . . . . 0.0 112.037 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 19.2 mttt . . . . . 0 CA--C 1.522 -0.109 0 CA-C-O 120.868 0.365 . . . . 0.0 110.251 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.74 HG11 ' CE1' ' A' ' 78' ' ' PHE . 1.7 p 177.94 164.06 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.174 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.48 ' N ' HG22 ' A' ' 4' ' ' VAL . 1.1 p -157.79 128.36 6.38 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.457 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.656 ' HD1' ' HB2' ' A' ' 93' ' ' ALA . 10.3 m-85 -102.72 177.84 4.74 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.122 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.419 ' O ' ' N ' ' A' ' 9' ' ' GLU . 0.3 OUTLIER -166.13 112.43 0.87 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.361 -179.851 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.672 ' O ' HG23 ' A' ' 88' ' ' ILE . 14.0 t -57.61 85.52 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.397 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.51 ' HB2' HG11 ' A' ' 51' ' ' VAL . 3.6 mm-40 -60.55 161.19 7.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.348 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -56.28 177.59 0.06 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.494 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 77.5 13.24 83.74 Favored Glycine 0 CA--C 1.527 0.805 0 N-CA-C 111.455 -0.658 . . . . 0.0 111.455 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 19.1 m -86.91 109.35 19.27 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.909 0.354 . . . . 0.0 110.051 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.427 ' O ' ' N ' ' A' ' 15' ' ' LYS . 4.6 p-10 -153.28 158.95 42.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.916 0.388 . . . . 0.0 110.806 -179.622 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 54.25 -85.96 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.835 179.707 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.427 ' N ' ' O ' ' A' ' 13' ' ' ASN . 0.0 OUTLIER -142.49 22.91 1.99 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.622 0.249 . . . . 0.0 110.745 -179.882 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -98.06 120.09 37.85 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 179.743 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.429 ' HG ' ' CE2' ' A' ' 64' ' ' PHE . 0.2 OUTLIER -113.3 98.42 7.1 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.054 0.455 . . . . 0.0 110.772 -179.499 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.885 ' HB1' HG11 ' A' ' 51' ' ' VAL . . . -86.76 138.83 31.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.027 179.572 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.473 ' N ' HG13 ' A' ' 51' ' ' VAL . 26.9 m -141.93 139.8 30.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.869 0.366 . . . . 0.0 110.816 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.426 ' HB2' ' CG ' ' A' ' 9' ' ' GLU . 0.5 OUTLIER -99.41 34.85 2.08 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.517 179.937 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.558 HG13 ' HE1' ' A' ' 52' ' ' TRP . 7.2 p -57.02 109.74 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 120.854 0.359 . . . . 0.0 110.521 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -179.59 77.68 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.243 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.501 ' CE2' ' HB ' ' A' ' 4' ' ' VAL . 25.7 p90 -84.63 -179.89 7.23 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.562 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -47.68 -68.28 0.2 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.874 -179.726 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -56.3 -20.26 28.44 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 111.207 -0.757 . . . . 0.0 111.207 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.48 ' HB2' ' CZ ' ' A' ' 23' ' ' TYR . 5.4 t70 -90.07 137.92 31.94 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.763 0.316 . . . . 0.0 110.594 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.674 HG22 ' O ' ' A' ' 27' ' ' THR . 88.5 m -124.63 11.08 8.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.104 179.694 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.413 ' O ' ' CG ' ' A' ' 71' ' ' GLU . 28.6 mtm 58.03 112.63 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.815 0.341 . . . . 0.0 110.625 179.654 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.681 ' HB3' ' O ' ' A' ' 69' ' ' LEU . . . -131.92 -49.06 0.95 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.584 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.871 ' HB3' HD12 ' A' ' 69' ' ' LEU . 27.5 tt0 -176.02 83.56 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.81 0.338 . . . . 0.0 110.907 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.742 HG21 ' CD1' ' A' ' 52' ' ' TRP . 18.5 t -68.45 155.0 7.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.15 179.589 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.725 ' OE2' HD21 ' A' ' 69' ' ' LEU . 4.5 pt-20 -147.14 142.09 26.96 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.839 0.352 . . . . 0.0 110.639 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.43 ' HG ' ' CE1' ' A' ' 66' ' ' PHE . 4.2 mt -103.49 -178.41 3.65 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.445 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.492 ' HB2' ' CZ3' ' A' ' 41' ' ' TRP . 6.4 ttt180 -132.85 -64.95 0.73 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.591 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.446 ' CB ' ' O ' ' A' ' 34' ' ' ARG . 23.3 mt-10 92.5 33.65 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.669 0.788 . . . . 0.0 109.187 -179.195 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 3.0 t-80 67.54 -68.81 0.15 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.487 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -157.34 57.87 0.36 Allowed Glycine 0 CA--C 1.523 0.578 0 N-CA-C 110.595 -1.002 . . . . 0.0 110.595 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.43 ' CB ' ' HB2' ' A' ' 35' ' ' GLU . 34.1 t -92.47 -46.17 7.78 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.77 0.319 . . . . 0.0 110.335 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 47.6 p-10 -177.51 52.65 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.537 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 62.51 -177.32 0.14 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.47 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.762 ' HH2' HG23 ' A' ' 77' ' ' VAL . 93.7 m95 -60.27 129.88 43.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.533 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.605 HG21 ' CZ ' ' A' ' 54' ' ' PHE . 25.1 m -122.76 116.44 48.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.125 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.471 ' HA ' ' CB ' ' A' ' 32' ' ' GLU . . . -56.08 140.28 44.29 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.47 -179.779 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.56 -167.65 0.2 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.173 -0.467 . . . . 0.0 109.953 179.787 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 91.4 m -153.62 127.15 8.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.864 0.364 . . . . 0.0 110.654 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 11.8 ptpt -73.18 77.2 1.28 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.03 179.665 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -93.22 -25.79 18.08 Favored Glycine 0 CA--C 1.522 0.516 0 N-CA-C 111.169 -0.772 . . . . 0.0 111.169 -179.583 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.484 ' CB ' ' HB ' ' A' ' 51' ' ' VAL . 2.9 mm-40 -86.95 -18.93 29.58 Favored 'General case' 0 C--N 1.33 -0.249 0 O-C-N 122.759 -0.259 . . . . 0.0 111.284 -179.483 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 96.48 -42.34 2.24 Favored Glycine 0 CA--C 1.523 0.539 0 N-CA-C 110.333 -1.107 . . . . 0.0 110.333 -179.72 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.55 ' O ' HG23 ' A' ' 51' ' ' VAL . . . -132.73 23.36 3.98 Favored Glycine 0 CA--C 1.522 0.51 0 N-CA-C 109.806 -1.318 . . . . 0.0 109.806 179.161 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.885 HG11 ' HB1' ' A' ' 18' ' ' ALA . 42.0 t -159.0 145.57 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 -179.621 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' TRP . . . . . 0.742 ' CD1' HG21 ' A' ' 31' ' ' VAL . 1.7 m95 -94.02 117.47 30.15 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.966 0.412 . . . . 0.0 110.607 -179.027 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.4 ' HA ' ' O ' ' A' ' 17' ' ' LEU . 3.2 p -110.36 139.55 45.44 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.029 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.605 ' CZ ' HG21 ' A' ' 42' ' ' VAL . 58.1 t80 -117.69 142.24 47.47 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.867 0.365 . . . . 0.0 110.611 -179.762 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -103.68 104.86 14.95 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.183 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -84.57 143.94 28.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.532 -179.813 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -112.35 1.83 16.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.122 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -121.96 156.71 59.24 Favored Pre-proline 0 C--O 1.231 0.099 0 CA-C-O 120.668 0.271 . . . . 0.0 110.361 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -70.85 -29.85 18.09 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.691 2.261 . . . . 0.0 112.18 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -81.73 134.1 35.41 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.42 -179.838 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -174.05 40.39 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.325 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -58.19 -93.07 0.01 OUTLIER Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.849 -0.9 . . . . 0.0 110.849 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -79.74 136.63 12.2 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.584 2.189 . . . . 0.0 112.053 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.429 ' CE2' ' HG ' ' A' ' 17' ' ' LEU . 49.8 m-85 -107.73 149.46 28.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.638 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -125.81 116.32 21.39 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 179.013 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.43 ' CE1' ' HG ' ' A' ' 33' ' ' LEU . 29.6 m-85 -100.65 171.11 7.91 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.29 0.566 . . . . 0.0 111.608 -178.706 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.522 ' HG3' ' CH2' ' A' ' 41' ' ' TRP . 0.0 OUTLIER -162.65 83.27 0.53 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.978 179.24 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.724 ' O ' HD23 ' A' ' 69' ' ' LEU . 5.2 p90 -70.87 167.59 18.64 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.432 0.634 . . . . 0.0 111.045 -179.5 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.871 HD12 ' HB3' ' A' ' 30' ' ' GLU . 4.2 mt -138.82 55.69 1.72 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.966 -1.015 . . . . 0.0 108.756 179.378 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.405 HG22 ' HA ' ' A' ' 26' ' ' ASP . 17.0 p -23.59 134.96 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.907 0.883 . . . . 0.0 112.732 -178.823 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.655 ' HG2' ' HB2' ' A' ' 29' ' ' ALA . 3.0 mt-10 -48.76 -26.24 2.25 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.691 -179.656 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -158.22 63.46 0.45 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.31 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -151.59 -103.95 0.26 Allowed Glycine 0 CA--C 1.523 0.576 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -169.31 -174.94 2.09 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.982 0.42 . . . . 0.0 110.561 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -123.9 172.36 8.97 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.219 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 175.73 140.35 0.06 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.931 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.762 HG23 ' HH2' ' A' ' 41' ' ' TRP . 2.5 p -79.49 145.56 9.17 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.209 0 CA-C-O 121.26 0.552 . . . . 0.0 110.037 179.561 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.74 ' CE1' HG11 ' A' ' 4' ' ' VAL . 98.3 m-85 -126.14 143.86 50.97 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.033 -179.409 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 30.1 t0 -121.69 155.85 34.31 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.901 0.381 . . . . 0.0 110.803 -179.623 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 4.3 t0 48.77 51.24 16.13 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.654 179.783 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.504 HG13 ' HA ' ' A' ' 93' ' ' ALA . 72.5 t -87.88 -16.49 8.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.627 179.782 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.53 HG13 ' HB3' ' A' ' 86' ' ' TYR . 59.4 t -148.57 133.35 9.06 Favored Pre-proline 0 C--N 1.332 -0.157 0 N-CA-C 110.433 -0.21 . . . . 0.0 110.433 179.667 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -68.53 -165.73 0.13 Allowed 'Trans proline' 0 N--CA 1.475 0.383 0 C-N-CA 122.695 2.263 . . . . 0.0 111.986 179.483 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -80.32 -37.84 31.79 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.282 -0.417 . . . . 0.0 109.957 179.5 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.98 67.02 1.11 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.218 179.797 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 0.53 ' HB3' HG13 ' A' ' 82' ' ' VAL . 33.6 p90 -55.58 163.88 1.2 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.644 -179.772 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 7.1 m -133.38 113.0 12.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.241 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.672 HG23 ' O ' ' A' ' 8' ' ' VAL . 2.7 mp -50.67 116.16 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.501 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 115.32 44.26 0.67 Allowed Glycine 0 CA--C 1.524 0.595 0 N-CA-C 110.677 -0.969 . . . . 0.0 110.677 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -163.24 141.18 7.87 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.816 0.341 . . . . 0.0 110.527 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.505 HG23 ' O ' ' A' ' 6' ' ' PHE . 17.2 m -90.5 112.13 23.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.19 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.426 ' CB ' ' O ' ' A' ' 81' ' ' VAL . 74.2 m-85 -94.39 -99.03 0.15 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.53 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.932 ' HB1' ' HD2' ' A' ' 94' ' ' PRO . . . 50.48 179.13 0.02 OUTLIER Pre-proline 0 C--O 1.231 0.096 0 CA-C-O 120.704 0.288 . . . . 0.0 110.558 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.932 ' HD2' ' HB1' ' A' ' 93' ' ' ALA . 48.0 Cg_endo . . . . . 0 C--O 1.25 1.075 0 C-N-CA 122.464 2.109 . . . . 0.0 112.044 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 3.8 mttt . . . . . 0 CA--C 1.522 -0.113 0 CA-C-O 120.792 0.33 . . . . 0.0 110.362 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.604 HG11 ' CE1' ' A' ' 78' ' ' PHE . 1.8 p -135.58 163.57 34.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.361 0.601 . . . . 0.0 110.359 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.48 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 0.1 OUTLIER -142.74 139.91 31.26 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.253 179.579 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.501 ' CD2' HG22 ' A' ' 21' ' ' VAL . 20.9 m-85 -112.96 -175.01 2.57 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.325 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.477 HG22 ' H ' ' A' ' 8' ' ' VAL . 0.2 OUTLIER -165.09 -167.0 1.1 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.145 -0.48 . . . . 0.0 109.945 179.803 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.479 HG12 ' CD1' ' A' ' 88' ' ' ILE . 9.3 t -139.37 82.42 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.147 179.772 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.841 ' HG3' HG11 ' A' ' 51' ' ' VAL . 65.7 mm-40 -50.9 155.1 1.26 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.457 -179.771 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 6.8 mtpt -53.49 175.33 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.379 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 64.18 46.81 90.0 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 110.585 -1.006 . . . . 0.0 110.585 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 61.6 m -102.69 108.66 19.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.796 0.331 . . . . 0.0 110.383 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 55.9 m-80 -101.66 174.46 5.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.255 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -55.56 -34.93 65.19 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.599 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.0 -52.71 4.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.319 -179.645 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 27.1 m80 -73.46 136.92 44.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.002 -179.434 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.484 HD22 ' HA ' ' A' ' 17' ' ' LEU . 0.8 OUTLIER -137.36 84.16 2.04 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.521 179.309 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.703 ' HB2' ' CG2' ' A' ' 53' ' ' THR . . . -74.95 116.91 16.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.896 -179.229 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.4 m -109.8 137.36 42.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.011 179.471 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.488 HD12 ' OE2' ' A' ' 9' ' ' GLU . 1.1 tt -84.78 70.53 10.84 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.521 -179.833 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.501 HG22 ' CD2' ' A' ' 6' ' ' PHE . 3.2 t -85.6 98.61 6.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.131 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.9 ttpm? -167.14 147.56 5.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.484 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -161.78 157.62 24.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.299 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.91 -21.58 66.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.716 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -46.17 -91.0 0.01 OUTLIER Glycine 0 CA--C 1.526 0.722 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -90.83 -160.74 0.74 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.729 0.3 . . . . 0.0 110.428 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.675 HG22 ' O ' ' A' ' 27' ' ' THR . 32.5 m -123.67 24.35 8.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.038 -179.737 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.426 ' O ' ' CG ' ' A' ' 71' ' ' GLU . 8.4 mtm 60.61 125.28 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.013 179.402 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.874 ' HB3' ' O ' ' A' ' 69' ' ' LEU . . . -122.06 -61.79 1.45 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.259 179.736 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.414 ' C ' HG12 ' A' ' 31' ' ' VAL . 0.5 OUTLIER -147.31 171.44 15.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.1 179.943 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.441 ' HA ' ' HA ' ' A' ' 68' ' ' PHE . 1.1 p 175.84 151.01 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.28 0.562 . . . . 0.0 110.519 -179.822 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.457 ' HG3' ' HB3' ' A' ' 41' ' ' TRP . 1.1 pm0 -140.23 171.36 14.27 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.97 -179.564 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.699 HD13 ' CZ ' ' A' ' 66' ' ' PHE . 12.0 tp -126.41 154.85 43.05 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-O 120.987 0.423 . . . . 0.0 110.088 -179.036 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.631 ' H ' HD12 ' A' ' 33' ' ' LEU . 0.6 OUTLIER -145.47 173.24 12.19 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.892 -0.594 . . . . 0.0 109.534 179.371 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 17.3 mp0 -133.22 -89.62 0.4 Allowed 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 110.346 -0.242 . . . . 0.0 110.346 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 20.3 p80 -177.35 146.21 0.47 Allowed 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 120.77 0.319 . . . . 0.0 110.514 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 60.92 38.76 95.95 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.844 -0.902 . . . . 0.0 110.844 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.1 t -118.38 173.98 6.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.862 0.363 . . . . 0.0 110.423 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -63.79 -70.58 0.21 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.511 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -153.68 173.73 15.42 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.031 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.488 ' CE3' ' HB2' ' A' ' 34' ' ' ARG . 75.2 m95 -52.71 151.21 4.55 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.189 179.769 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.429 HG22 ' O ' ' A' ' 33' ' ' LEU . 9.7 m -122.83 118.77 56.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.397 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.42 ' HA ' ' HB3' ' A' ' 32' ' ' GLU . . . -50.53 134.85 23.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.624 -179.792 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.0 -168.62 0.14 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.217 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 30.0 m -147.4 105.87 3.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.356 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.88 87.84 0.37 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.209 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -133.88 21.82 3.91 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.985 -0.846 . . . . 0.0 110.985 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.468 ' CB ' HG23 ' A' ' 51' ' ' VAL . 0.1 OUTLIER -108.59 177.6 4.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.754 0.312 . . . . 0.0 110.292 179.953 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -62.44 -44.66 97.29 Favored Glycine 0 CA--C 1.523 0.545 0 N-CA-C 110.7 -0.96 . . . . 0.0 110.7 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -160.94 31.41 0.35 Allowed Glycine 0 CA--C 1.523 0.567 0 N-CA-C 110.717 -0.953 . . . . 0.0 110.717 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.841 HG11 ' HG3' ' A' ' 9' ' ' GLU . 5.2 m -145.77 -179.44 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.854 0.359 . . . . 0.0 110.468 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 9.4 m95 -106.12 140.41 39.14 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.514 -179.769 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.703 ' CG2' ' HB2' ' A' ' 18' ' ' ALA . 0.5 OUTLIER -138.27 153.26 49.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.233 179.886 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 36.0 t80 -159.28 141.52 13.7 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.631 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 20.9 p-10 -93.52 127.94 39.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.27 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 9.5 p -94.96 143.82 26.17 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.36 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 14.0 mp0 -104.27 25.85 9.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.402 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -133.38 156.97 79.21 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.282 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -95.2 32.92 0.17 Allowed 'Trans proline' 0 N--CA 1.451 -1.004 0 C-N-CA 123.924 3.082 . . . . 0.0 112.355 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.655 HD22 ' C ' ' A' ' 60' ' ' LEU . 0.0 OUTLIER -49.97 162.82 0.17 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.725 -179.903 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -153.76 27.35 0.49 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.347 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -120.9 -155.19 9.48 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.773 -0.931 . . . . 0.0 110.773 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.448 ' CB ' ' HA ' ' A' ' 80' ' ' ASP . 48.7 Cg_endo -79.89 163.84 23.1 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.622 2.215 . . . . 0.0 112.182 -179.829 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 50.2 m-85 -105.76 -175.21 2.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.236 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -150.67 141.18 22.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.97 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.699 ' CZ ' HD13 ' A' ' 33' ' ' LEU . 44.4 m-85 -137.93 178.85 6.81 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.038 0.446 . . . . 0.0 110.885 -179.629 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.44 ' HG2' ' CZ3' ' A' ' 41' ' ' TRP . 0.1 OUTLIER 176.23 84.15 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.51 -179.982 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.872 ' O ' HD23 ' A' ' 69' ' ' LEU . 5.0 p90 -72.56 -177.38 2.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.275 0.559 . . . . 0.0 110.995 -179.213 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.874 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 9.0 mt -140.18 72.39 1.39 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.125 179.678 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.484 HG23 ' CE1' ' A' ' 68' ' ' PHE . 76.6 p -30.88 140.3 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.403 0.681 . . . . 0.0 112.447 -178.898 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.676 ' HG2' ' HB2' ' A' ' 29' ' ' ALA . 3.3 mm-40 -55.88 -38.86 70.73 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.809 -179.634 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.56 53.72 1.42 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.745 -179.739 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.423 ' O ' ' CG ' ' A' ' 74' ' ' MET . . . -142.46 -109.39 0.73 Allowed Glycine 0 CA--C 1.523 0.551 0 N-CA-C 110.853 -0.899 . . . . 0.0 110.853 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.435 ' N ' ' OG1' ' A' ' 70' ' ' THR . 32.6 mtp -162.98 -178.68 6.23 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 110.206 -0.294 . . . . 0.0 110.206 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -94.01 -177.61 4.38 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.074 179.693 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 9.6 t30 176.88 155.74 0.26 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.392 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 71.2 t -111.21 147.15 15.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.948 179.758 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.604 ' CE1' HG11 ' A' ' 4' ' ' VAL . 38.0 m-85 -135.87 127.81 29.49 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.453 -179.77 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 39.8 p-10 -118.86 158.01 26.5 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.126 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.448 ' HA ' ' CB ' ' A' ' 63' ' ' PRO . 1.2 m-20 53.37 33.72 16.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.321 -179.791 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.428 ' HA ' ' HA ' ' A' ' 93' ' ' ALA . 69.9 t -61.56 -17.21 16.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.759 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.562 HG13 ' HD2' ' A' ' 83' ' ' PRO . 70.9 t -147.42 140.06 14.49 Favored Pre-proline 0 C--N 1.331 -0.204 0 CA-C-O 120.652 0.263 . . . . 0.0 110.356 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.562 ' HD2' HG13 ' A' ' 82' ' ' VAL . 44.6 Cg_endo -69.39 -165.95 0.16 Allowed 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.665 2.244 . . . . 0.0 112.003 179.798 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -74.31 -65.87 0.8 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.031 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.39 71.48 1.36 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.212 179.735 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 0.416 ' HB3' ' CG1' ' A' ' 82' ' ' VAL . 15.4 p90 -56.95 162.96 2.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.506 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 43.7 m -141.32 122.85 15.06 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.404 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.479 ' CD1' HG12 ' A' ' 8' ' ' VAL . 40.7 mm -51.54 116.95 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.342 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 113.11 30.21 2.79 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.664 -0.975 . . . . 0.0 110.664 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.54 ' HB3' ' CZ ' ' A' ' 92' ' ' TYR . . . -137.15 134.36 36.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.794 0.33 . . . . 0.0 110.18 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 21.6 m -91.34 105.68 17.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.9 -179.636 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.548 ' O ' ' HB3' ' A' ' 93' ' ' ALA . 39.2 m-85 -97.35 -155.77 0.51 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.0 -0.546 . . . . 0.0 109.642 179.525 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.899 ' HB1' ' HD2' ' A' ' 94' ' ' PRO . . . 73.91 175.76 0.07 OUTLIER Pre-proline 0 N--CA 1.464 0.232 0 CA-C-O 120.673 0.273 . . . . 0.0 110.779 179.762 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.899 ' HD2' ' HB1' ' A' ' 93' ' ' ALA . 46.9 Cg_endo . . . . . 0 C--O 1.249 1.033 0 C-N-CA 122.536 2.157 . . . . 0.0 112.02 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 10.0 mtpt . . . . . 0 CA--C 1.522 -0.114 0 CA-C-O 120.789 0.328 . . . . 0.0 110.187 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.626 HG11 ' CE1' ' A' ' 78' ' ' PHE . 2.1 p -96.65 162.95 2.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.27 0.557 . . . . 0.0 110.371 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.481 ' N ' HG22 ' A' ' 4' ' ' VAL . 1.2 p -145.16 132.91 21.06 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.463 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.541 ' O ' HG23 ' A' ' 91' ' ' THR . 6.5 m-85 -99.37 172.5 7.29 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.279 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.836 HG23 ' O ' ' A' ' 90' ' ' ALA . 16.7 m -166.14 96.56 0.6 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.182 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.49 HG12 ' CD1' ' A' ' 88' ' ' ILE . 21.8 t -50.77 111.64 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.581 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.463 ' O ' HD12 ' A' ' 88' ' ' ILE . 3.5 mt-10 -70.24 171.54 9.65 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.51 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.619 ' HA ' HG21 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -69.69 -8.83 51.17 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.191 -179.917 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -48.38 -26.55 5.07 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 111.086 -0.806 . . . . 0.0 111.086 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 28.5 p -52.87 126.66 20.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.725 0.298 . . . . 0.0 110.279 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -122.58 -57.61 1.73 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.496 -179.805 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -134.51 -78.21 0.46 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.354 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.22 -20.64 14.59 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.702 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -54.32 177.28 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.804 0.335 . . . . 0.0 110.285 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 25.4 tp -162.2 84.03 0.57 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.312 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.48 ' HB2' HG23 ' A' ' 53' ' ' THR . . . -72.83 162.46 29.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.232 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.668 HG11 ' CZ ' ' A' ' 66' ' ' PHE . 30.9 m -156.65 133.32 2.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.815 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.433 ' HA ' HG12 ' A' ' 51' ' ' VAL . 0.5 OUTLIER -94.62 64.41 3.01 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.169 179.539 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 28.9 t -56.48 111.78 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.593 -179.738 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.74 168.82 22.58 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.12 179.769 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.494 ' CE1' ' HB2' ' A' ' 26' ' ' ASP . 0.0 OUTLIER -150.55 -68.88 0.19 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.094 -179.95 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 52.0 tt0 -168.88 -61.42 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.515 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -152.18 58.9 0.42 Allowed Glycine 0 CA--C 1.524 0.654 0 N-CA-C 111.094 -0.802 . . . . 0.0 111.094 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.494 ' HB2' ' CE1' ' A' ' 23' ' ' TYR . 77.0 m-20 -108.71 178.81 4.37 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 179.531 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.401 ' HB ' ' HG3' ' A' ' 71' ' ' GLU . 0.2 OUTLIER -110.0 172.2 7.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.893 0.378 . . . . 0.0 110.492 -179.892 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 1.2 mtt -126.18 117.62 23.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.158 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.81 ' HB3' ' O ' ' A' ' 69' ' ' LEU . . . -116.88 -58.34 2.08 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.642 -179.765 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.42 ' O ' ' CB ' ' A' ' 68' ' ' PHE . 20.8 mm-40 -153.24 162.7 41.01 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.476 -179.843 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.532 HG21 ' CD1' ' A' ' 52' ' ' TRP . 2.5 t -151.96 142.78 15.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.276 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.439 ' CB ' ' HA ' ' A' ' 43' ' ' ALA . 11.9 pm0 -153.2 139.82 18.84 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.755 -179.603 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.734 HD21 ' CD2' ' A' ' 54' ' ' PHE . 0.5 OUTLIER -108.99 172.52 6.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.182 179.893 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.508 ' N ' HD12 ' A' ' 33' ' ' LEU . 0.1 OUTLIER -94.31 -67.58 0.85 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.634 -0.257 . . . . 0.0 110.698 -179.685 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.52 ' N ' HD12 ' A' ' 33' ' ' LEU . 2.0 tt0 88.91 74.5 0.01 OUTLIER 'General case' 0 CA--C 1.51 -0.571 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 -178.622 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -36.97 120.82 0.75 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 114.995 -1.002 . . . . 0.0 111.832 -178.216 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 128.17 -48.87 0.95 Allowed Glycine 0 CA--C 1.523 0.55 0 N-CA-C 110.446 -1.062 . . . . 0.0 110.446 -179.769 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.414 ' O ' ' CB ' ' A' ' 39' ' ' ASP . 40.6 t -75.03 -32.79 61.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.745 0.307 . . . . 0.0 110.494 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.414 ' CB ' ' O ' ' A' ' 38' ' ' SER . 8.2 t0 81.56 -53.17 0.27 Allowed 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.729 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -72.63 124.04 24.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.573 -179.751 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.49 ' CZ3' ' HB2' ' A' ' 67' ' ' ARG . 77.7 m95 -54.73 155.19 4.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.036 179.743 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.409 HG23 ' HG ' ' A' ' 33' ' ' LEU . 3.6 m -136.54 124.69 34.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.8 0.333 . . . . 0.0 110.422 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.439 ' HA ' ' CB ' ' A' ' 32' ' ' GLU . . . -57.19 138.56 54.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.243 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.77 -170.14 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.232 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 62.1 m -135.79 95.18 3.18 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.444 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.413 ' CG ' ' O ' ' A' ' 46' ' ' LYS . 14.6 ptmt -74.16 90.98 2.08 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.97 0.414 . . . . 0.0 110.402 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -156.83 25.34 0.5 Allowed Glycine 0 CA--C 1.523 0.581 0 N-CA-C 110.729 -0.948 . . . . 0.0 110.729 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.435 ' HG2' HG23 ' A' ' 51' ' ' VAL . 7.7 tp10 -106.75 165.91 10.97 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.765 0.317 . . . . 0.0 110.265 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -39.85 -49.7 3.34 Favored Glycine 0 CA--C 1.527 0.794 0 N-CA-C 111.784 -0.526 . . . . 0.0 111.784 -179.674 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -164.49 33.28 0.26 Allowed Glycine 0 CA--C 1.523 0.549 0 N-CA-C 111.001 -0.84 . . . . 0.0 111.001 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.437 HG11 ' HG3' ' A' ' 9' ' ' GLU . 4.3 m -148.79 -178.57 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.916 0.389 . . . . 0.0 110.498 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' TRP . . . . . 0.532 ' CD1' HG21 ' A' ' 31' ' ' VAL . 6.5 m95 -108.42 119.1 38.52 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.215 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.48 HG23 ' HB2' ' A' ' 18' ' ' ALA . 0.0 OUTLIER -106.46 -179.46 3.95 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.613 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.734 ' CD2' HD21 ' A' ' 33' ' ' LEU . 16.4 t80 -177.46 124.37 0.13 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.929 0.395 . . . . 0.0 110.626 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -86.06 154.17 21.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.143 179.746 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 52.5 p -128.51 126.02 39.56 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.463 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -86.76 -37.43 17.88 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.216 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -63.48 139.04 97.53 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.259 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -72.92 -15.46 26.33 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.574 2.183 . . . . 0.0 112.366 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -50.79 128.11 20.04 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.856 0.36 . . . . 0.0 110.522 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -113.78 61.46 0.66 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.263 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -107.47 -165.22 21.85 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.688 -0.965 . . . . 0.0 110.688 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.409 ' C ' ' CD1' ' A' ' 64' ' ' PHE . 45.7 Cg_endo -74.28 -172.06 1.07 Allowed 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.46 2.107 . . . . 0.0 112.036 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.469 ' HB3' HD13 ' A' ' 33' ' ' LEU . 57.6 m-85 -152.88 106.35 3.04 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.641 -179.796 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 29.3 m-80 -74.83 119.77 19.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.269 -0.423 . . . . 0.0 109.919 179.571 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.668 ' CZ ' HG11 ' A' ' 19' ' ' VAL . 8.6 m-85 -87.79 167.87 13.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.816 -179.555 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.706 ' HD2' HG22 ' A' ' 77' ' ' VAL . 3.3 mtp180 -172.68 116.71 0.32 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.581 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.626 ' O ' HD23 ' A' ' 69' ' ' LEU . 0.1 OUTLIER -123.39 170.24 10.54 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.017 0.437 . . . . 0.0 110.538 179.785 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.81 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 7.2 mt -125.88 68.21 1.18 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.341 179.534 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 71.4 p -33.69 138.47 0.08 Allowed 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.875 -179.181 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.691 ' HG2' ' HB2' ' A' ' 29' ' ' ALA . 1.1 mt-10 -54.1 -26.18 25.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.356 -179.697 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.5 tmtt? -67.12 -52.34 42.91 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.283 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 120.24 58.75 0.24 Allowed Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.792 -0.923 . . . . 0.0 110.792 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 1.2 mmt -131.92 70.79 1.46 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.776 0.322 . . . . 0.0 110.38 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.503 ' HD2' HD22 ' A' ' 69' ' ' LEU . 0.0 OUTLIER -60.75 155.15 19.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.383 179.99 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 177.8 152.25 0.26 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.563 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.706 HG22 ' HD2' ' A' ' 67' ' ' ARG . 92.6 t -104.86 151.8 7.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.158 179.824 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.626 ' CE1' HG11 ' A' ' 4' ' ' VAL . 55.2 m-85 -127.38 147.57 50.27 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.759 -179.343 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 14.4 t0 -134.61 161.76 34.21 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.248 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 54.65 44.77 28.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.238 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.59 ' O ' HG12 ' A' ' 81' ' ' VAL . 60.0 t -93.34 3.09 8.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.238 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.519 HG23 ' O ' ' A' ' 81' ' ' VAL . 66.1 t -159.24 110.66 1.54 Allowed Pre-proline 0 CA--C 1.532 0.257 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 179.603 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.43 ' O ' ' N ' ' A' ' 85' ' ' LYS . 47.9 Cg_endo -75.58 62.09 6.25 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.524 2.149 . . . . 0.0 112.41 -179.741 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 53.86 -87.52 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.551 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.43 ' N ' ' O ' ' A' ' 83' ' ' PRO . 0.0 OUTLIER -87.91 56.61 3.95 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 120.934 0.397 . . . . 0.0 109.946 179.74 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 0.484 ' HB3' HG13 ' A' ' 82' ' ' VAL . 48.6 p90 -48.23 175.95 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.854 -179.744 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -144.24 134.15 23.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.113 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.619 HG21 ' HA ' ' A' ' 10' ' ' LYS . 36.5 mm -65.21 118.44 7.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.468 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 114.03 35.22 1.53 Allowed Glycine 0 CA--C 1.523 0.577 0 N-CA-C 110.602 -0.999 . . . . 0.0 110.602 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.836 ' O ' HG23 ' A' ' 7' ' ' THR . . . -138.64 175.53 9.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.768 0.318 . . . . 0.0 110.383 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.541 HG23 ' O ' ' A' ' 6' ' ' PHE . 18.5 m -126.52 101.23 6.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.3 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.551 ' CZ ' ' HB3' ' A' ' 90' ' ' ALA . 19.5 m-85 -107.22 132.35 53.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.294 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.895 ' HB1' ' HD2' ' A' ' 94' ' ' PRO . . . 173.83 178.25 0.16 Allowed Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.397 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.895 ' HD2' ' HB1' ' A' ' 93' ' ' ALA . 49.0 Cg_endo . . . . . 0 C--O 1.248 1.019 0 C-N-CA 122.489 2.126 . . . . 0.0 112.095 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 27.5 mtpt . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.852 0.358 . . . . 0.0 110.578 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.798 HG12 ' CE1' ' A' ' 23' ' ' TYR . 29.5 m -122.22 -176.73 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.21 179.695 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.431 HG23 ' O ' ' A' ' 4' ' ' VAL . 0.3 OUTLIER -161.08 137.38 8.38 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.399 179.838 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.56 ' H ' ' HB3' ' A' ' 93' ' ' ALA . 19.6 m-85 -107.05 169.36 8.6 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.943 179.821 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.559 HG23 ' O ' ' A' ' 90' ' ' ALA . 47.3 m -162.04 103.56 1.14 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.925 0.393 . . . . 0.0 110.497 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.403 ' HA ' ' O ' ' A' ' 18' ' ' ALA . 31.0 t -53.22 92.57 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.341 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.6 ' OE1' HG21 ' A' ' 51' ' ' VAL . 0.1 OUTLIER -59.61 164.53 3.51 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.593 -179.859 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.46 ' HA ' HG23 ' A' ' 88' ' ' ILE . 1.5 pttt -86.03 61.14 6.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.286 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -133.1 22.61 3.99 Favored Glycine 0 CA--C 1.525 0.656 0 N-CA-C 111.001 -0.84 . . . . 0.0 111.001 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.4 t -81.82 146.54 29.83 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -152.45 -88.5 0.06 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.739 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -96.61 -66.32 0.91 Allowed 'General case' 0 N--CA 1.454 -0.235 0 CA-C-O 120.694 0.283 . . . . 0.0 110.3 -179.725 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.458 ' HD3' ' ND1' ' A' ' 16' ' ' HIS . 0.0 OUTLIER -140.81 49.1 1.69 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.627 -179.996 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 16' ' ' HIS . . . . . 0.458 ' ND1' ' HD3' ' A' ' 15' ' ' LYS . 45.6 m80 -129.93 112.56 13.64 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.075 179.555 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.452 HD22 ' HA ' ' A' ' 17' ' ' LEU . 1.5 tm? -98.53 81.39 2.71 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.225 -179.686 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.449 ' HB2' HG22 ' A' ' 53' ' ' THR . . . -61.95 131.54 50.02 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.572 -179.705 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.496 HG23 HG23 ' A' ' 21' ' ' VAL . 29.9 m -135.1 136.38 51.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.238 179.682 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.418 ' HB3' ' HB ' ' A' ' 7' ' ' THR . 0.8 OUTLIER -89.95 75.53 7.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.686 -179.743 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.496 HG23 HG23 ' A' ' 19' ' ' VAL . 14.5 t -75.11 95.32 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.093 179.668 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 23.6 tttt -171.4 132.41 0.78 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.46 -179.784 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.798 ' CE1' HG12 ' A' ' 4' ' ' VAL . 10.4 p90 -141.42 25.8 2.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.463 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 49.16 87.75 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.575 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -174.08 -105.38 0.18 Allowed Glycine 0 CA--C 1.523 0.532 0 N-CA-C 110.755 -0.938 . . . . 0.0 110.755 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -64.99 -175.17 0.18 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.75 0.309 . . . . 0.0 110.364 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.416 ' HB ' ' HG3' ' A' ' 71' ' ' GLU . 0.8 OUTLIER -103.78 -173.95 2.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.473 -179.866 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.41 ' O ' ' CG ' ' A' ' 71' ' ' GLU . 3.6 mtm -116.69 130.18 56.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.636 -179.621 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.771 ' HB3' ' O ' ' A' ' 69' ' ' LEU . . . -122.44 -56.85 1.78 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.641 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.405 ' O ' ' HB2' ' A' ' 68' ' ' PHE . 29.2 tt0 -158.42 166.49 32.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.287 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.469 HG21 ' CD1' ' A' ' 52' ' ' TRP . 26.4 t -151.67 152.09 11.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.927 0.394 . . . . 0.0 110.675 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.446 ' CB ' ' HA ' ' A' ' 43' ' ' ALA . 0.5 OUTLIER -155.21 138.84 16.03 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.364 179.963 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.498 ' HG ' ' CE2' ' A' ' 66' ' ' PHE . 1.4 mt -94.27 177.56 5.91 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.676 -179.53 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.421 ' CB ' ' HB2' ' A' ' 65' ' ' ASN . 0.1 OUTLIER -130.26 -156.91 0.79 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.664 179.649 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.402 ' OE2' ' CB ' ' A' ' 56' ' ' SER . 0.0 OUTLIER 178.48 105.25 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.826 0.346 . . . . 0.0 110.134 179.921 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 36' ' ' HIS . . . . . 0.621 ' NE2' HD22 ' A' ' 60' ' ' LEU . 8.8 p-80 -50.11 119.37 3.57 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.462 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 117.68 -32.06 5.5 Favored Glycine 0 CA--C 1.522 0.53 0 N-CA-C 110.565 -1.014 . . . . 0.0 110.565 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -78.75 174.14 11.75 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.765 0.317 . . . . 0.0 110.16 179.831 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -129.07 26.44 5.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.5 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -159.92 145.26 15.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.457 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.503 ' CZ3' ' HG2' ' A' ' 67' ' ' ARG . 71.3 m95 -80.69 154.11 27.5 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.194 179.83 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.656 HG23 ' O ' ' A' ' 42' ' ' VAL . 29.7 m -115.47 105.42 18.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.957 0.408 . . . . 0.0 110.327 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.446 ' HA ' ' CB ' ' A' ' 32' ' ' GLU . . . -52.35 136.66 30.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.394 -179.819 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -71.69 -171.16 0.63 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.804 -179.801 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 47.5 m -144.55 111.4 5.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.557 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.478 ' HG2' ' CZ3' ' A' ' 52' ' ' TRP . 31.8 mtpt -77.06 95.27 4.16 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.042 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -128.86 -38.96 0.33 Allowed Glycine 0 CA--C 1.525 0.696 0 N-CA-C 111.437 -0.665 . . . . 0.0 111.437 -179.513 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.427 ' HB2' ' O ' ' A' ' 51' ' ' VAL . 0.0 OUTLIER -52.68 -175.32 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.99 0.424 . . . . 0.0 110.425 -179.741 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -104.01 41.69 2.08 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 145.59 -10.8 1.71 Allowed Glycine 0 CA--C 1.529 0.921 0 C-N-CA 121.015 -0.612 . . . . 0.0 112.428 179.467 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.6 HG21 ' OE1' ' A' ' 9' ' ' GLU . 33.5 m -133.21 175.02 12.34 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.137 0 CA-C-N 117.709 0.754 . . . . 0.0 110.844 -179.627 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' TRP . . . . . 0.478 ' CZ3' ' HG2' ' A' ' 46' ' ' LYS . 6.9 m95 -106.93 139.94 40.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.572 -179.576 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.449 HG22 ' HB2' ' A' ' 18' ' ' ALA . 2.6 p -122.4 135.52 54.71 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.359 179.739 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 1.3 t80 175.05 96.94 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.501 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.448 ' HB2' ' N ' ' A' ' 16' ' ' HIS . 6.0 t0 -99.62 31.03 3.34 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-O 121.43 0.634 . . . . 0.0 110.138 179.396 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.41 ' OG ' ' N ' ' A' ' 57' ' ' GLU . 44.9 t 45.91 -172.93 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 114.928 -1.033 . . . . 0.0 110.98 179.574 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.41 ' N ' ' OG ' ' A' ' 56' ' ' SER . 1.5 mt-10 -100.75 -46.86 5.02 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.225 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -64.03 116.42 27.11 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.451 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -68.33 59.6 1.03 Allowed 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.724 2.282 . . . . 0.0 112.333 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.621 HD22 ' NE2' ' A' ' 36' ' ' HIS . 1.6 mt -94.0 92.51 7.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.845 0.355 . . . . 0.0 110.322 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -77.0 78.38 3.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.469 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -145.93 -162.04 9.52 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.816 -0.913 . . . . 0.0 110.816 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -76.17 128.91 10.9 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.59 2.194 . . . . 0.0 112.075 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.443 ' HB3' ' CD2' ' A' ' 33' ' ' LEU . 27.4 m-85 -88.29 -178.27 5.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.976 0.417 . . . . 0.0 110.554 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.421 ' HB2' ' CB ' ' A' ' 34' ' ' ARG . 4.9 m120 -153.55 137.65 16.44 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.631 179.75 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.498 ' CE2' ' HG ' ' A' ' 33' ' ' LEU . 80.8 m-85 -121.79 -178.36 3.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.045 0.45 . . . . 0.0 110.97 -179.642 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.503 ' HG2' ' CZ3' ' A' ' 41' ' ' TRP . 0.0 OUTLIER 175.65 47.79 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.656 179.997 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.623 ' HZ ' HG11 ' A' ' 4' ' ' VAL . 0.6 OUTLIER -48.63 172.57 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.108 -179.245 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.771 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 4.9 mt -122.28 72.51 1.06 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.446 179.753 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -37.98 142.14 0.18 Allowed 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.685 -179.254 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.708 ' HG2' ' HB2' ' A' ' 29' ' ' ALA . 3.1 mm-40 -51.57 -67.31 0.26 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.725 -179.742 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.79 31.38 5.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.733 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -106.34 -100.52 2.66 Favored Glycine 0 CA--C 1.523 0.547 0 N-CA-C 110.655 -0.978 . . . . 0.0 110.655 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 177.52 141.51 0.08 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.853 0.358 . . . . 0.0 110.361 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.436 ' HG3' ' HA ' ' A' ' 69' ' ' LEU . 0.0 OUTLIER -70.31 178.66 2.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.254 -179.982 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.466 ' O ' ' CE2' ' A' ' 78' ' ' PHE . 2.4 m-80 170.04 131.79 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.582 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 79.7 t -85.18 150.61 3.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.111 -0.495 . . . . 0.0 109.928 179.545 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.523 ' CE1' HG22 ' A' ' 4' ' ' VAL . 61.3 m-85 -137.74 128.33 26.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.882 0.372 . . . . 0.0 110.645 -179.835 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -107.67 156.54 18.96 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.214 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 28.0 t70 51.97 52.81 13.68 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.34 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.683 HG13 ' HB2' ' A' ' 93' ' ' ALA . 85.7 t -85.76 -24.6 6.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.577 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.471 HG13 ' HD2' ' A' ' 83' ' ' PRO . 46.3 t -138.87 138.56 21.65 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.579 -179.832 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.493 ' HG3' ' CE1' ' A' ' 92' ' ' TYR . 49.3 Cg_endo -72.09 -166.88 0.28 Allowed 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.619 2.212 . . . . 0.0 111.979 179.621 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.66 -78.47 0.07 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.044 179.67 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.411 ' CG ' ' O ' ' A' ' 85' ' ' LYS . 0.0 OUTLIER -91.9 71.36 5.61 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.001 179.589 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 19.0 p90 -47.93 150.48 1.12 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.776 -179.785 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 1.2 m -117.63 115.56 25.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.291 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.46 HG23 ' HA ' ' A' ' 10' ' ' LYS . 42.3 mm -51.94 110.22 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.27 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 114.32 32.33 2.0 Favored Glycine 0 CA--C 1.523 0.552 0 N-CA-C 110.771 -0.932 . . . . 0.0 110.771 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.559 ' O ' HG23 ' A' ' 7' ' ' THR . . . -124.35 164.37 19.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.757 0.313 . . . . 0.0 110.398 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 6.9 m -119.68 89.93 3.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.66 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.532 ' O ' ' HB3' ' A' ' 93' ' ' ALA . 34.5 m-85 -89.03 -161.5 0.77 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.912 179.669 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.915 ' HB1' ' HD2' ' A' ' 94' ' ' PRO . . . 72.26 176.96 0.06 OUTLIER Pre-proline 0 C--N 1.332 -0.173 0 CA-C-O 120.614 0.245 . . . . 0.0 110.461 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.915 ' HD2' ' HB1' ' A' ' 93' ' ' ALA . 48.7 Cg_endo . . . . . 0 C--O 1.249 1.042 0 C-N-CA 122.506 2.137 . . . . 0.0 112.071 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 3.9 tttt . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.78 0.324 . . . . 0.0 110.242 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.874 HG11 ' CE2' ' A' ' 68' ' ' PHE . 27.0 m -80.38 -178.26 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.509 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.694 HG23 ' O ' ' A' ' 4' ' ' VAL . 0.6 OUTLIER -170.96 139.71 1.46 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.242 179.874 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.718 ' O ' HG23 ' A' ' 91' ' ' THR . 29.5 m-85 -113.65 168.91 9.37 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.492 -179.81 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.823 HG23 ' O ' ' A' ' 90' ' ' ALA . 19.1 m -165.57 118.59 1.16 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.381 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.526 HG11 HG13 ' A' ' 88' ' ' ILE . 62.6 t -61.65 102.57 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.335 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.736 ' OE2' HD12 ' A' ' 20' ' ' LEU . 1.8 mm-40 -70.11 174.67 5.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.502 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.4 mttt -83.17 64.48 7.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.556 -179.791 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -156.44 33.25 0.59 Allowed Glycine 0 CA--C 1.522 0.506 0 N-CA-C 110.457 -1.057 . . . . 0.0 110.457 179.821 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.3 p -89.82 114.97 26.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.873 0.368 . . . . 0.0 110.593 -179.745 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 13.8 m-20 -104.23 -156.05 0.56 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.081 -0.508 . . . . 0.0 109.933 179.653 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -46.35 -63.98 0.87 Allowed 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 120.846 0.355 . . . . 0.0 110.777 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.87 -22.68 9.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.906 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 28.8 m80 -48.84 136.51 13.81 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.96 0.41 . . . . 0.0 110.884 -179.682 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.42 ' HA ' HD22 ' A' ' 17' ' ' LEU . 0.2 OUTLIER -129.05 95.79 4.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.651 179.629 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.674 ' HB1' HG11 ' A' ' 51' ' ' VAL . . . -90.58 128.31 36.54 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.683 -179.489 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.687 ' O ' HG13 ' A' ' 51' ' ' VAL . 15.3 m -134.26 133.96 55.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.202 179.627 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.736 HD12 ' OE2' ' A' ' 9' ' ' GLU . 0.5 OUTLIER -83.83 71.93 10.42 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.384 -179.951 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.525 HG23 HG23 ' A' ' 19' ' ' VAL . 61.4 t -70.93 95.14 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.286 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 5.4 tttp -135.62 141.59 45.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.41 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -163.36 149.65 11.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.39 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -76.42 -22.23 54.95 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.743 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -46.91 -50.17 15.8 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 111.081 -0.807 . . . . 0.0 111.081 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -138.04 -174.69 3.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.776 0.322 . . . . 0.0 110.304 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.487 HG22 ' O ' ' A' ' 27' ' ' THR . 27.2 m -121.65 54.68 1.13 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.796 -179.677 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.588 ' O ' ' HB2' ' A' ' 29' ' ' ALA . 33.7 mtm 58.35 -164.11 0.2 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.786 179.55 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.704 ' HB2' ' N ' ' A' ' 71' ' ' GLU . . . 154.24 -62.59 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.367 0.667 . . . . 0.0 109.682 179.722 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.569 ' HB3' HD12 ' A' ' 69' ' ' LEU . 1.2 tt0 -160.75 141.17 11.4 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.817 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.535 HG21 ' CD1' ' A' ' 52' ' ' TRP . 4.2 t -134.72 156.39 39.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.973 0.416 . . . . 0.0 110.754 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.452 ' CB ' ' HA ' ' A' ' 43' ' ' ALA . 3.1 pt-20 -154.15 157.73 39.31 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.979 179.775 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.81 HD23 ' O ' ' A' ' 65' ' ' ASN . 4.6 mt -125.16 -176.54 3.6 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.457 -179.712 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.508 ' HD2' ' CD2' ' A' ' 41' ' ' TRP . 5.6 ttt180 -145.71 174.24 11.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.075 179.686 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.401 ' HG2' ' O ' ' A' ' 34' ' ' ARG . 21.4 mt-10 -154.27 93.76 1.65 Allowed 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 179.811 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -40.25 116.07 0.62 Allowed 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.389 -178.975 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 123.75 -25.41 6.19 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 110.466 -1.054 . . . . 0.0 110.466 -179.568 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 4.3 m -75.95 -161.34 0.17 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.81 0.338 . . . . 0.0 110.39 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -83.11 -65.81 0.96 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.528 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -153.18 -176.93 6.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.619 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.508 ' CD2' ' HD2' ' A' ' 34' ' ' ARG . 87.0 m95 -50.72 150.66 2.73 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.602 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.595 HG21 ' CZ ' ' A' ' 54' ' ' PHE . 10.5 m -131.62 131.91 62.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.139 179.718 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.452 ' HA ' ' CB ' ' A' ' 32' ' ' GLU . . . -57.22 147.23 25.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.569 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.414 ' N ' ' HA ' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -72.61 -166.04 0.25 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.993 179.855 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 90.0 m -154.05 112.61 3.62 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.837 0.351 . . . . 0.0 110.686 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 9.2 ptpt -68.92 69.55 0.18 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.193 -0.458 . . . . 0.0 109.97 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -90.47 -26.41 23.17 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 111.296 -0.722 . . . . 0.0 111.296 -179.491 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.441 ' CG ' ' HB ' ' A' ' 51' ' ' VAL . 5.4 tm-20 -78.45 -14.84 59.18 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.761 0.28 . . . . 0.0 111.222 -179.728 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 99.74 -41.39 2.19 Favored Glycine 0 CA--C 1.522 0.518 0 N-CA-C 109.976 -1.25 . . . . 0.0 109.976 -179.549 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.438 ' O ' ' CZ3' ' A' ' 52' ' ' TRP . . . -126.61 -45.25 0.23 Allowed Glycine 0 CA--C 1.519 0.287 0 N-CA-C 109.075 -1.61 . . . . 0.0 109.075 179.107 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.687 HG13 ' O ' ' A' ' 19' ' ' VAL . 19.6 t -82.57 151.36 4.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 178.908 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' TRP . . . . . 0.535 ' CD1' HG21 ' A' ' 31' ' ' VAL . 4.1 m95 -93.05 114.77 27.4 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.996 0.427 . . . . 0.0 110.187 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.527 ' CG2' ' HB2' ' A' ' 18' ' ' ALA . 1.8 p -108.07 137.58 45.82 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.286 -179.773 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.595 ' CZ ' HG21 ' A' ' 42' ' ' VAL . 51.2 t80 -120.34 142.79 48.81 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.686 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -99.94 109.38 21.74 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.061 179.767 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.4 ' HB2' ' OE2' ' A' ' 35' ' ' GLU . 27.6 p -89.83 158.95 17.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.558 -179.81 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -134.3 -44.52 0.77 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.42 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -51.88 156.57 2.44 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.395 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -67.88 -34.55 23.49 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.795 2.33 . . . . 0.0 112.433 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 2.2 mt -69.85 151.45 45.69 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.835 -179.545 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.3 tp60 -174.1 72.9 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.22 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -128.44 -96.76 0.87 Allowed Glycine 0 CA--C 1.525 0.687 0 N-CA-C 110.814 -0.914 . . . . 0.0 110.814 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -77.18 97.77 1.17 Allowed 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.587 2.191 . . . . 0.0 112.205 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -73.51 166.47 23.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.588 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.81 ' O ' HD23 ' A' ' 33' ' ' LEU . 1.0 OUTLIER -135.81 122.99 21.64 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 179.227 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.574 ' CD2' ' CE2' ' A' ' 6' ' ' PHE . 2.8 m-85 -105.84 177.88 4.72 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.303 0.573 . . . . 0.0 112.081 -178.569 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.797 ' HD2' HG12 ' A' ' 77' ' ' VAL . 7.2 mtp180 -177.56 96.84 0.04 OUTLIER 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 114.877 -1.056 . . . . 0.0 110.287 179.45 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.88 ' O ' HD23 ' A' ' 69' ' ' LEU . 6.0 p90 -91.73 168.13 11.68 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-O 121.151 0.5 . . . . 0.0 110.455 179.789 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.88 HD23 ' O ' ' A' ' 68' ' ' PHE . 5.7 mt -136.28 65.23 1.53 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.641 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 26.8 p -33.5 150.09 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 115.899 -0.591 . . . . 0.0 112.048 -179.264 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.704 ' N ' ' HB2' ' A' ' 29' ' ' ALA . 7.8 mt-10 -49.21 -30.43 7.0 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.333 -179.729 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -69.19 -46.56 67.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.377 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 118.72 43.29 0.54 Allowed Glycine 0 CA--C 1.523 0.557 0 N-CA-C 110.69 -0.964 . . . . 0.0 110.69 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 12.1 mtp -105.61 108.1 19.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.833 0.349 . . . . 0.0 110.448 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.8 149.55 21.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.349 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -177.69 125.13 0.13 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.594 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.797 HG12 ' HD2' ' A' ' 67' ' ' ARG . 4.5 m -81.99 176.56 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.591 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.44 ' CE2' ' CE2' ' A' ' 68' ' ' PHE . 97.3 m-85 -156.79 112.82 2.97 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.3 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -98.18 158.17 15.72 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.463 -179.759 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 47.1 m-20 59.16 28.53 17.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.557 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.41 HG23 ' O ' ' A' ' 78' ' ' PHE . 74.3 t -61.17 -75.97 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 179.735 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.543 HG13 ' HD2' ' A' ' 83' ' ' PRO . 59.8 t -87.18 139.57 32.33 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.427 -0.352 . . . . 0.0 110.289 179.613 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.543 ' HD2' HG13 ' A' ' 82' ' ' VAL . 45.8 Cg_endo -70.5 -167.77 0.27 Allowed 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.595 2.197 . . . . 0.0 112.022 179.765 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.413 ' HG3' ' N ' ' A' ' 85' ' ' LYS . 4.3 pt-20 -83.84 -28.19 28.2 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.23 179.828 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.413 ' N ' ' HG3' ' A' ' 84' ' ' GLU . 0.0 OUTLIER -132.07 63.48 1.62 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.136 179.755 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 51.9 p90 -48.66 148.68 1.99 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.789 -179.75 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 37.0 m -128.18 113.27 15.49 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.271 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.526 HG13 HG11 ' A' ' 8' ' ' VAL . 3.0 mp -51.37 104.46 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.248 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 125.4 47.44 0.22 Allowed Glycine 0 CA--C 1.524 0.598 0 N-CA-C 110.707 -0.957 . . . . 0.0 110.707 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.823 ' O ' HG23 ' A' ' 7' ' ' THR . . . -167.48 175.07 7.4 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.754 0.311 . . . . 0.0 110.365 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.718 HG23 ' O ' ' A' ' 6' ' ' PHE . 5.1 m -113.32 141.56 46.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.484 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.597 ' OH ' ' HB3' ' A' ' 90' ' ' ALA . 11.6 m-85 -141.51 109.18 5.65 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.33 179.753 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.924 ' HB1' ' HD2' ' A' ' 94' ' ' PRO . . . 170.59 177.49 0.1 OUTLIER Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.406 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.924 ' HD2' ' HB1' ' A' ' 93' ' ' ALA . 48.2 Cg_endo . . . . . 0 C--O 1.249 1.031 0 C-N-CA 122.533 2.156 . . . . 0.0 112.097 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 2.3 tttp . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.711 0.291 . . . . 0.0 110.35 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.536 ' CG1' ' CE1' ' A' ' 78' ' ' PHE . 1.7 p -116.87 163.67 13.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.232 0.539 . . . . 0.0 110.397 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.466 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 0.6 OUTLIER -132.92 139.5 47.39 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.205 179.838 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.752 ' O ' HG23 ' A' ' 91' ' ' THR . 32.3 m-85 -98.26 -176.43 3.41 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.298 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.9 m -167.5 112.96 0.72 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.369 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 45.2 t -66.26 101.84 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.309 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.786 ' HG3' HG11 ' A' ' 51' ' ' VAL . 0.7 OUTLIER -54.39 -178.16 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.6 -179.79 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -94.24 46.96 1.17 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.269 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -133.56 23.82 3.76 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 110.895 -0.882 . . . . 0.0 110.895 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 7.9 m -86.65 106.04 17.33 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.782 0.325 . . . . 0.0 110.285 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 20.7 m-20 -100.61 -158.38 0.67 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.371 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -45.76 -62.26 1.38 Allowed 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.076 -179.742 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.98 19.12 11.7 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.005 -179.824 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' HIS . . . . . 0.485 ' CE1' ' OD1' ' A' ' 55' ' ' ASP . 2.1 m-70 -100.5 130.77 46.62 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.826 0.346 . . . . 0.0 110.088 179.716 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.517 ' HA ' HD22 ' A' ' 17' ' ' LEU . 0.5 OUTLIER -122.57 90.69 3.35 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.452 -179.628 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.486 ' HB2' ' CG2' ' A' ' 53' ' ' THR . . . -88.67 130.75 35.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.162 179.866 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.552 HG21 ' CZ ' ' A' ' 66' ' ' PHE . 25.8 m -129.87 152.3 37.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.555 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.498 HD22 ' CG ' ' A' ' 22' ' ' LYS . 0.4 OUTLIER -104.06 98.58 8.38 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.081 179.803 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 25.1 t -98.83 99.09 7.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.808 -179.55 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.498 ' CG ' HD22 ' A' ' 20' ' ' LEU . 0.0 OUTLIER 175.84 160.18 0.28 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.259 179.698 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -159.8 47.93 0.28 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.338 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 52.43 178.89 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.506 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 66.29 -82.06 0.1 Allowed Glycine 0 CA--C 1.523 0.547 0 N-CA-C 110.832 -0.907 . . . . 0.0 110.832 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 36.3 m-20 -64.71 167.91 6.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.821 0.343 . . . . 0.0 110.397 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -111.7 -160.05 0.7 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.275 -179.836 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.421 ' O ' ' CG ' ' A' ' 71' ' ' GLU . 6.2 mtt -121.05 125.5 47.46 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.925 0.393 . . . . 0.0 110.631 -179.878 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.689 ' HB2' ' N ' ' A' ' 71' ' ' GLU . . . -115.37 -57.62 2.23 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.4 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.554 ' C ' HG12 ' A' ' 31' ' ' VAL . 0.2 OUTLIER -165.86 177.67 7.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.143 -179.98 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.554 HG12 ' C ' ' A' ' 30' ' ' GLU . 0.5 OUTLIER 172.17 137.88 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 121.111 0.481 . . . . 0.0 110.251 -179.899 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.407 ' CB ' ' HA ' ' A' ' 43' ' ' ALA . 1.2 pt-20 -128.43 163.24 25.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.083 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.506 ' HG ' ' CE2' ' A' ' 66' ' ' PHE . 1.6 mt -109.49 163.57 13.31 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.055 0.455 . . . . 0.0 111.002 -179.543 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.443 ' HG3' ' CD2' ' A' ' 41' ' ' TRP . 0.7 OUTLIER -139.81 -163.39 1.49 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.688 179.375 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -153.42 -87.41 0.06 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.323 179.766 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' HIS . . . . . 0.413 ' CG ' ' N ' ' A' ' 37' ' ' GLY . 48.0 p-80 -179.22 -47.19 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 120.83 0.348 . . . . 0.0 110.617 -179.858 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.413 ' N ' ' CG ' ' A' ' 36' ' ' HIS . . . -110.58 23.67 19.45 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 110.735 -0.946 . . . . 0.0 110.735 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.428 ' O ' ' CB ' ' A' ' 39' ' ' ASP . 1.9 t -86.11 -7.42 58.6 Favored 'General case' 0 C--N 1.33 -0.244 0 O-C-N 122.9 -0.176 . . . . 0.0 111.285 -179.797 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.428 ' CB ' ' O ' ' A' ' 38' ' ' SER . 0.8 OUTLIER 82.43 -51.76 0.2 Allowed 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 122.447 0.299 . . . . 0.0 110.9 179.942 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -142.42 177.88 7.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.915 0.388 . . . . 0.0 110.882 -179.783 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.494 ' CE2' ' HD2' ' A' ' 67' ' ' ARG . 60.3 m95 -78.55 166.53 22.46 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.443 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.456 HG23 ' O ' ' A' ' 42' ' ' VAL . 20.6 m -141.51 119.13 8.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.234 179.737 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.407 ' HA ' ' CB ' ' A' ' 32' ' ' GLU . . . -50.66 133.73 25.34 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.576 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.462 ' HE3' ' HB2' ' A' ' 52' ' ' TRP . 0.0 OUTLIER -63.04 -171.0 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.547 179.942 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 66.3 m -145.75 99.46 3.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.574 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.408 ' HG3' ' O ' ' A' ' 46' ' ' LYS . 2.8 ptmt -61.17 94.37 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.35 179.868 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -132.3 14.79 5.07 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 111.19 -0.764 . . . . 0.0 111.19 179.842 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -102.83 -14.17 16.7 Favored 'General case' 0 C--N 1.333 -0.152 0 O-C-N 122.719 -0.283 . . . . 0.0 110.986 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 66.1 26.16 72.36 Favored Glycine 0 CA--C 1.523 0.539 0 N-CA-C 110.42 -1.072 . . . . 0.0 110.42 -179.627 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -174.64 -39.42 0.05 OUTLIER Glycine 0 CA--C 1.523 0.591 0 N-CA-C 110.53 -1.028 . . . . 0.0 110.53 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.786 HG11 ' HG3' ' A' ' 9' ' ' GLU . 3.1 m -133.1 -177.16 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.922 0.391 . . . . 0.0 110.363 179.87 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' TRP . . . . . 0.462 ' HB2' ' HE3' ' A' ' 44' ' ' MET . 7.6 m95 -101.38 141.46 34.22 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.605 -179.558 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.486 ' CG2' ' HB2' ' A' ' 18' ' ' ALA . 0.6 OUTLIER -133.87 147.47 51.16 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.471 -179.757 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 75.7 t80 -130.98 112.49 12.99 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.407 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.485 ' OD1' ' CE1' ' A' ' 16' ' ' HIS . 3.3 m-20 -71.58 161.91 30.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.411 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -146.56 170.81 16.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.114 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -146.31 -50.14 0.21 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.51 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -55.35 153.09 14.52 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.443 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -71.94 -50.15 0.28 Allowed 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 122.659 2.239 . . . . 0.0 112.136 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -57.91 130.99 49.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.687 -179.862 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 174.92 159.31 0.19 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.277 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -177.27 -99.77 0.13 Allowed Glycine 0 CA--C 1.526 0.76 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -75.32 157.47 41.43 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.569 2.18 . . . . 0.0 112.135 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.449 ' CE2' ' HG ' ' A' ' 17' ' ' LEU . 72.8 m-85 -124.27 -177.73 3.88 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.093 0.473 . . . . 0.0 110.845 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.404 ' HB2' ' HB3' ' A' ' 34' ' ' ARG . 1.8 m-80 -153.33 130.42 11.1 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.636 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.552 ' CZ ' HG21 ' A' ' 19' ' ' VAL . 80.8 m-85 -114.07 178.98 4.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.14 0.495 . . . . 0.0 110.838 -179.561 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.494 ' HD2' ' CE2' ' A' ' 41' ' ' TRP . 17.1 ptm180 -176.83 59.15 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.656 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.743 ' O ' HD23 ' A' ' 69' ' ' LEU . 0.0 OUTLIER -54.89 178.54 0.03 OUTLIER 'General case' 0 CA--C 1.518 -0.28 0 CA-C-O 121.388 0.613 . . . . 0.0 111.492 -179.21 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.743 HD23 ' O ' ' A' ' 68' ' ' PHE . 7.1 mt -144.64 48.39 1.34 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.107 -0.951 . . . . 0.0 109.182 179.78 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.1 p -25.46 137.12 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.88 0.872 . . . . 0.0 112.741 -179.007 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.689 ' N ' ' HB2' ' A' ' 29' ' ' ALA . 6.3 mt-10 -49.62 -59.03 4.15 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.507 -179.69 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 3.6 tmtt? -123.66 58.91 1.13 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.314 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -141.4 -101.63 0.45 Allowed Glycine 0 CA--C 1.522 0.516 0 N-CA-C 110.77 -0.932 . . . . 0.0 110.77 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.6 ptm -173.46 -178.43 1.67 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.709 0.29 . . . . 0.0 110.297 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.86 158.12 45.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.52 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 174.05 128.43 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.266 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 17.6 m -68.71 140.72 18.49 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.473 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.536 ' CE1' ' CG1' ' A' ' 4' ' ' VAL . 79.6 m-85 -116.81 121.53 41.81 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.311 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 26.1 m-20 -101.64 141.09 35.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.569 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 17.1 t0 60.13 60.84 1.98 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.604 179.699 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.416 ' HA ' ' HA ' ' A' ' 93' ' ' ALA . 75.7 t -89.44 -65.57 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 179.695 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.556 HG13 ' HD2' ' A' ' 83' ' ' PRO . 60.8 t -87.83 139.83 31.17 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.388 179.78 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.556 ' HD2' HG13 ' A' ' 82' ' ' VAL . 47.8 Cg_endo -71.88 173.47 12.71 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.61 2.207 . . . . 0.0 112.071 179.83 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -55.54 -51.21 67.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.098 179.676 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 5.3 mttt -114.78 87.08 2.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.115 179.655 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 0.438 ' HB3' ' CG1' ' A' ' 82' ' ' VAL . 28.1 p90 -65.94 164.47 15.01 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.579 -179.799 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 7.4 m -145.43 112.76 6.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.261 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.549 HG23 ' O ' ' A' ' 9' ' ' GLU . 2.5 mp -50.81 98.64 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.457 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 132.03 54.63 0.08 OUTLIER Glycine 0 CA--C 1.523 0.587 0 N-CA-C 110.781 -0.927 . . . . 0.0 110.781 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.793 ' HB3' ' OH ' ' A' ' 92' ' ' TYR . . . -172.6 -177.75 1.79 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.816 0.341 . . . . 0.0 110.398 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.752 HG23 ' O ' ' A' ' 6' ' ' PHE . 4.1 m -124.97 142.55 51.41 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.375 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.793 ' OH ' ' HB3' ' A' ' 90' ' ' ALA . 4.7 m-85 -146.76 123.59 11.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.359 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.922 ' HB1' ' HD2' ' A' ' 94' ' ' PRO . . . 174.93 178.88 0.18 Allowed Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.41 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.922 ' HD2' ' HB1' ' A' ' 93' ' ' ALA . 47.7 Cg_endo . . . . . 0 C--O 1.249 1.031 0 C-N-CA 122.488 2.125 . . . . 0.0 112.099 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 7.6 ttpt . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.866 0.365 . . . . 0.0 110.165 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.581 HG11 ' CE2' ' A' ' 78' ' ' PHE . 2.4 p -74.75 162.99 4.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.368 0.604 . . . . 0.0 110.552 -179.85 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.495 ' N ' HG22 ' A' ' 4' ' ' VAL . 1.8 p -139.6 148.79 42.98 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.133 -0.94 . . . . 0.0 110.124 179.672 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.433 ' CE2' HG22 ' A' ' 21' ' ' VAL . 48.2 m-85 -123.5 145.05 49.15 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.111 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.411 ' O ' ' N ' ' A' ' 20' ' ' LEU . 3.8 m -148.36 129.78 14.81 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.152 -179.88 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.723 HG23 ' HE2' ' A' ' 92' ' ' TYR . 96.1 t -73.21 101.16 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.401 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.412 ' N ' ' O ' ' A' ' 18' ' ' ALA . 6.5 mt-10 -59.1 165.15 2.65 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.485 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.77 65.4 3.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.286 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -154.91 33.44 0.67 Allowed Glycine 0 CA--C 1.524 0.615 0 N-CA-C 110.812 -0.915 . . . . 0.0 110.812 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 21.2 p -82.03 130.08 34.98 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 110.211 -0.292 . . . . 0.0 110.211 179.837 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -112.44 -161.97 0.78 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.518 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -49.76 -71.06 0.07 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.145 -179.461 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 41.5 pttt -117.99 40.95 3.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.841 -179.328 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 9.0 m80 -113.83 178.95 4.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.4 179.81 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 43.7 tp -165.15 94.25 0.64 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.419 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.484 ' HB2' HG22 ' A' ' 53' ' ' THR . . . -91.58 107.47 19.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.372 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.469 HG23 HG23 ' A' ' 21' ' ' VAL . 17.1 m -90.72 -173.55 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.286 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.411 ' N ' ' O ' ' A' ' 7' ' ' THR . 2.1 tt -135.11 78.15 1.72 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.502 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.469 HG23 HG23 ' A' ' 19' ' ' VAL . 16.0 t -86.23 100.63 9.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.295 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 17.1 tptt -176.11 124.73 0.19 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.548 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.443 ' CE1' HG23 ' A' ' 4' ' ' VAL . 42.6 p90 -156.98 174.29 15.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.251 179.862 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -64.21 119.65 10.64 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.495 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 122.07 -65.73 0.49 Allowed Glycine 0 CA--C 1.523 0.557 0 N-CA-C 110.921 -0.872 . . . . 0.0 110.921 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.817 ' OD1' HG22 ' A' ' 70' ' ' THR . 32.4 t0 -66.83 137.47 56.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.824 0.345 . . . . 0.0 110.577 -179.79 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.704 HG22 ' O ' ' A' ' 27' ' ' THR . 60.2 m -111.38 18.22 19.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.815 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.418 ' O ' ' CG ' ' A' ' 71' ' ' GLU . 19.7 mtp 59.55 114.79 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.797 0.332 . . . . 0.0 110.604 179.777 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.809 ' HB3' ' O ' ' A' ' 69' ' ' LEU . . . -134.53 -58.86 0.82 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.309 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.523 ' HB2' HD12 ' A' ' 69' ' ' LEU . 29.2 mt-10 -155.93 153.35 29.47 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.92 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.429 ' HA ' ' HA ' ' A' ' 68' ' ' PHE . 0.6 OUTLIER -172.43 148.0 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.386 0.612 . . . . 0.0 110.627 -179.713 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.407 ' HG3' ' HB3' ' A' ' 41' ' ' TRP . 2.2 pt-20 -142.22 178.86 7.27 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.065 -0.97 . . . . 0.0 109.688 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.708 HD21 ' CE1' ' A' ' 66' ' ' PHE . 4.4 mt -122.87 176.74 5.82 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.133 0.492 . . . . 0.0 111.031 -179.559 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 4.8 ttp180 -145.27 -175.46 4.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.673 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.44 ' CG ' ' HG2' ' A' ' 58' ' ' GLU . 4.9 mm-40 -151.58 29.93 0.6 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.722 0.296 . . . . 0.0 110.81 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER 56.58 164.53 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.555 179.615 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 51.99 25.08 16.09 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 110.887 -0.885 . . . . 0.0 110.887 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -135.91 109.84 8.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.857 0.36 . . . . 0.0 110.356 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -61.54 -22.54 65.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.654 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -100.2 176.52 5.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.914 0.388 . . . . 0.0 110.558 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.501 ' CE3' ' HG2' ' A' ' 67' ' ' ARG . 62.3 m95 -123.26 157.46 33.08 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.072 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.515 HG22 ' O ' ' A' ' 33' ' ' LEU . 4.5 m -107.25 105.89 19.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.946 0.403 . . . . 0.0 110.504 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -54.08 121.75 8.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.771 -179.724 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.88 -169.87 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.267 179.729 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 47.5 m -147.61 105.19 3.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.703 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 14.9 ptmt -62.67 82.92 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 179.509 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -109.72 -25.45 5.43 Favored Glycine 0 CA--C 1.522 0.484 0 N-CA-C 111.067 -0.813 . . . . 0.0 111.067 -179.425 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.641 ' HG2' HG22 ' A' ' 51' ' ' VAL . 1.1 tp10 -77.57 -41.04 40.29 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.774 0.321 . . . . 0.0 110.458 -179.776 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 99.42 -44.19 1.71 Allowed Glycine 0 CA--C 1.522 0.482 0 N-CA-C 110.168 -1.173 . . . . 0.0 110.168 -179.487 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -92.49 -29.7 10.72 Favored Glycine 0 CA--C 1.522 0.494 0 N-CA-C 110.208 -1.157 . . . . 0.0 110.208 179.516 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.641 HG22 ' HG2' ' A' ' 48' ' ' GLU . 3.5 m -140.41 -176.81 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.895 0.379 . . . . 0.0 110.283 179.65 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 9.5 m95 -106.43 134.42 49.6 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.837 -179.206 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.484 HG22 ' HB2' ' A' ' 18' ' ' ALA . 4.9 p -117.09 145.81 43.52 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.225 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.497 ' CE2' ' HB2' ' A' ' 56' ' ' SER . 85.2 t80 -131.5 138.9 49.16 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.329 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -122.73 134.08 54.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.524 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.497 ' HB2' ' CE2' ' A' ' 54' ' ' PHE . 0.3 OUTLIER -175.31 177.89 1.78 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.396 -179.972 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -155.79 26.88 0.38 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.404 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.44 ' HG2' ' CG ' ' A' ' 35' ' ' GLU . 0.0 OUTLIER -49.22 169.41 0.17 Allowed Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.636 -179.935 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.41 ' CD ' ' HB2' ' A' ' 58' ' ' GLU . 37.8 Cg_endo -93.92 20.09 0.71 Allowed 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 123.851 3.034 . . . . 0.0 112.243 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.6 mt -110.06 51.42 0.76 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.391 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 6.4 mm100 -60.13 121.19 11.3 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.292 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 169.32 -142.76 7.53 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 110.762 -0.935 . . . . 0.0 110.762 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -75.95 169.96 21.09 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.57 2.18 . . . . 0.0 111.975 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.429 ' HD2' HG21 ' A' ' 82' ' ' VAL . 54.6 m-85 -118.26 169.65 9.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.377 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -141.74 134.33 28.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.005 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.708 ' CE1' HD21 ' A' ' 33' ' ' LEU . 72.9 m-85 -119.1 179.61 4.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.044 0.449 . . . . 0.0 110.697 -179.808 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.501 ' HG2' ' CE3' ' A' ' 41' ' ' TRP . 0.0 OUTLIER -176.19 60.75 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.683 -0.689 . . . . 0.0 109.71 179.629 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.833 ' O ' HD23 ' A' ' 69' ' ' LEU . 4.6 p90 -56.04 179.44 0.04 OUTLIER 'General case' 0 CA--C 1.519 -0.23 0 CA-C-O 121.263 0.554 . . . . 0.0 111.16 -179.3 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.833 HD23 ' O ' ' A' ' 68' ' ' PHE . 6.0 mt -141.7 67.08 1.34 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.245 -0.889 . . . . 0.0 109.179 179.737 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.817 HG22 ' OD1' ' A' ' 26' ' ' ASP . 69.9 p -33.03 140.73 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 115.908 -0.587 . . . . 0.0 112.293 -178.958 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.709 ' HG2' ' HB2' ' A' ' 29' ' ' ALA . 7.1 mm-40 -53.07 -57.9 8.83 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.567 -179.825 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.09 81.74 2.04 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.506 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -175.7 -95.4 0.1 OUTLIER Glycine 0 CA--C 1.523 0.562 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 16.6 ptm 179.84 -177.53 0.37 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.869 0.366 . . . . 0.0 110.275 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.63 179.82 3.84 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.262 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 177.9 139.87 0.08 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.625 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.436 HG12 ' N ' ' A' ' 78' ' ' PHE . 87.3 t -89.5 157.38 3.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.131 179.696 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.581 ' CE2' HG11 ' A' ' 4' ' ' VAL . 78.8 m-85 -146.34 137.91 24.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.873 0.368 . . . . 0.0 110.539 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 29.5 p-10 -116.1 159.52 21.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.255 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 56.99 45.75 20.62 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.316 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.653 ' O ' HG12 ' A' ' 81' ' ' VAL . 60.3 t -94.17 8.08 5.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.104 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.491 HG23 ' O ' ' A' ' 81' ' ' VAL . 72.9 t -158.47 129.93 3.91 Favored Pre-proline 0 CA--C 1.53 0.18 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 179.693 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.457 ' HD3' ' CD1' ' A' ' 92' ' ' TYR . 47.6 Cg_endo -74.88 -169.47 0.63 Allowed 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.352 2.035 . . . . 0.0 112.08 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -77.41 -30.81 53.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.252 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 36.3 mttt -132.74 72.92 1.5 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.333 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 50.3 p90 -53.24 149.49 7.13 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.528 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.467 ' O ' HG23 ' A' ' 87' ' ' THR . 4.9 t -128.08 115.24 18.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.289 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.413 ' H ' HD12 ' A' ' 88' ' ' ILE . 3.4 mp -48.93 110.51 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.616 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 110.04 58.03 0.51 Allowed Glycine 0 CA--C 1.523 0.568 0 N-CA-C 110.712 -0.955 . . . . 0.0 110.712 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -176.28 139.78 0.36 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.805 0.336 . . . . 0.0 110.395 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 57.5 m -89.4 123.05 33.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.284 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.723 ' HE2' HG23 ' A' ' 8' ' ' VAL . 5.7 m-85 -101.95 -34.68 9.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.636 -179.633 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.854 ' HB1' ' HD2' ' A' ' 94' ' ' PRO . . . -50.02 178.94 0.04 OUTLIER Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.654 -179.782 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.854 ' HD2' ' HB1' ' A' ' 93' ' ' ALA . 48.5 Cg_endo . . . . . 0 C--O 1.249 1.036 0 C-N-CA 122.661 2.241 . . . . 0.0 112.19 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.457 -0.096 0 CA-C-O 120.798 0.332 . . . . 0.0 110.977 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.45 ' CG2' ' CE1' ' A' ' 78' ' ' PHE . 29.8 m -53.52 171.66 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.205 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 15.0 p -153.15 127.45 9.19 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.385 179.801 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.976 ' O ' HG23 ' A' ' 91' ' ' THR . 45.4 m-85 -84.74 -173.08 4.53 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.938 179.821 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.466 HG23 ' OG1' ' A' ' 91' ' ' THR . 0.2 OUTLIER -165.03 117.36 1.19 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.976 0.417 . . . . 0.0 111.028 -179.988 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.679 HG21 ' HA ' ' A' ' 88' ' ' ILE . 14.3 p -49.85 129.31 7.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.423 179.546 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.735 ' HG3' HG11 ' A' ' 51' ' ' VAL . 8.9 mm-40 -116.95 163.33 16.37 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.355 179.785 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -50.37 -24.5 3.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.9 -179.538 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.637 ' HA3' ' HB2' ' A' ' 18' ' ' ALA . . . -45.95 -27.52 2.45 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 111.12 -0.792 . . . . 0.0 111.12 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.4 m -72.68 115.55 12.1 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 179.686 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -115.59 -68.43 0.92 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.41 -179.753 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -125.82 -66.91 0.91 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.126 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.26 27.05 9.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.139 179.759 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 39.8 m-70 -109.75 145.66 36.25 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.391 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.619 HD11 ' CE2' ' A' ' 64' ' ' PHE . 8.7 mt -125.93 89.47 3.03 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.957 0.408 . . . . 0.0 110.272 179.766 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.656 ' HB2' ' CG2' ' A' ' 53' ' ' THR . . . -82.96 143.9 30.36 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.841 179.723 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.412 ' HB ' ' HB3' ' A' ' 6' ' ' PHE . 17.0 m -139.42 145.39 27.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.772 0.32 . . . . 0.0 110.947 -179.606 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -100.83 56.27 0.87 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.486 179.659 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.457 ' CG1' ' CD1' ' A' ' 52' ' ' TRP . 2.3 p -67.47 102.94 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.175 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -165.45 135.46 3.59 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.328 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 9.5 p90 -156.76 35.26 0.3 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.415 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 51.35 -162.26 0.07 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.454 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 61.42 -103.55 0.57 Allowed Glycine 0 CA--C 1.522 0.529 0 N-CA-C 110.637 -0.985 . . . . 0.0 110.637 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 64.9 m-20 -67.87 132.63 47.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.791 0.329 . . . . 0.0 110.151 179.827 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.519 HG22 ' H ' ' A' ' 28' ' ' MET . 0.2 OUTLIER -76.45 175.02 9.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.563 -179.742 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.519 ' H ' HG22 ' A' ' 27' ' ' THR . 0.1 OUTLIER -98.51 130.11 45.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.452 -179.804 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.817 ' HB3' ' O ' ' A' ' 69' ' ' LEU . . . -118.32 -53.07 2.36 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.691 -179.884 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -161.73 159.16 26.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.905 0.383 . . . . 0.0 110.62 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.828 HG21 ' CD1' ' A' ' 52' ' ' TRP . 18.0 t -143.05 165.12 15.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.936 179.796 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.503 ' N ' HG12 ' A' ' 31' ' ' VAL . 9.6 pt-20 -174.74 147.86 1.07 Allowed 'General case' 0 N--CA 1.451 -0.411 0 CA-C-O 120.805 0.336 . . . . 0.0 110.687 -179.603 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.625 HD12 ' N ' ' A' ' 34' ' ' ARG . 2.9 pp -109.48 171.19 7.59 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.325 179.619 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.625 ' N ' HD12 ' A' ' 33' ' ' LEU . 3.8 ttp85 -101.14 -54.65 2.74 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.764 -179.514 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.453 ' CB ' ' O ' ' A' ' 34' ' ' ARG . 3.6 tt0 88.36 30.62 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 109.182 -0.674 . . . . 0.0 109.182 -178.951 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 29.8 t60 46.81 -87.7 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.068 -0.969 . . . . 0.0 111.469 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.433 ' N ' ' O ' ' A' ' 35' ' ' GLU . . . -42.32 -51.42 5.36 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 111.602 -0.599 . . . . 0.0 111.602 -179.516 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.406 ' HB2' ' HB3' ' A' ' 35' ' ' GLU . 0.6 OUTLIER -49.87 100.91 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.767 0.317 . . . . 0.0 110.585 -179.962 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -51.43 -29.89 17.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.245 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -108.39 164.15 12.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.193 179.834 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.483 ' CZ3' ' HG2' ' A' ' 67' ' ' ARG . 67.1 m95 -87.77 150.14 23.76 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.314 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.605 HG23 ' HG ' ' A' ' 33' ' ' LEU . 11.0 m -115.66 113.95 44.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.141 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.444 ' HA ' ' CB ' ' A' ' 32' ' ' GLU . . . -48.97 130.83 18.71 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.618 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.86 -169.9 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.145 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 53.9 m -141.28 107.51 5.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.325 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 17.1 ptmt -75.9 63.65 1.74 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.269 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -77.57 -26.4 61.16 Favored Glycine 0 CA--C 1.522 0.496 0 N-CA-C 110.627 -0.989 . . . . 0.0 110.627 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -84.47 -169.53 2.66 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.824 0.345 . . . . 0.0 110.322 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -107.13 -27.37 5.37 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 110.825 -0.91 . . . . 0.0 110.825 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -131.13 -3.58 4.34 Favored Glycine 0 CA--C 1.529 0.948 0 C-N-CA 121.363 -0.446 . . . . 0.0 112.34 -179.496 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.735 HG11 ' HG3' ' A' ' 9' ' ' GLU . 33.1 m -134.27 167.22 26.62 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.132 0 CA-C-N 117.573 0.687 . . . . 0.0 110.629 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' TRP . . . . . 0.828 ' CD1' HG21 ' A' ' 31' ' ' VAL . 4.7 m95 -115.04 134.97 54.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.532 -179.689 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.656 ' CG2' ' HB2' ' A' ' 18' ' ' ALA . 0.1 OUTLIER -122.18 168.63 11.77 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.721 179.414 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.601 ' CD2' HD21 ' A' ' 33' ' ' LEU . 78.8 t80 -154.04 120.13 5.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.755 0.312 . . . . 0.0 110.936 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -78.25 134.17 37.6 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.019 179.552 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -113.52 -177.77 3.21 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.905 0.383 . . . . 0.0 110.752 -179.662 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -152.24 -45.09 0.1 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.415 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.97 156.69 4.93 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.548 -179.797 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -80.31 -19.75 8.9 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.664 2.243 . . . . 0.0 111.857 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.4 tp -48.94 135.01 16.25 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.606 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -139.45 81.71 1.85 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.338 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -137.24 -148.11 5.38 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.744 -0.942 . . . . 0.0 110.744 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -78.93 139.61 15.48 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.572 2.181 . . . . 0.0 112.127 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.619 ' CE2' HD11 ' A' ' 17' ' ' LEU . 60.9 m-85 -115.45 99.1 7.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.229 179.72 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.403 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 21.6 m-20 -62.62 164.93 6.95 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.277 -0.419 . . . . 0.0 109.96 179.78 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.498 ' CE1' ' HB3' ' A' ' 33' ' ' LEU . 21.7 m-85 -142.48 -179.05 6.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.889 0.376 . . . . 0.0 110.777 -179.778 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.483 ' HG2' ' CZ3' ' A' ' 41' ' ' TRP . 7.8 ptm180 174.5 85.31 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.284 -179.755 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.49 ' HB3' HG22 ' A' ' 31' ' ' VAL . 1.6 p90 -76.95 171.95 13.95 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.134 0.492 . . . . 0.0 110.816 -179.773 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.817 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 5.4 mt -124.69 61.68 1.15 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.406 179.783 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.2 p -30.63 137.13 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.356 0.662 . . . . 0.0 112.293 -179.066 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.649 ' HG2' ' HB2' ' A' ' 29' ' ' ALA . 13.1 mt-10 -53.56 -67.54 0.25 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.338 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -111.95 61.49 0.62 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.43 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -151.21 -104.69 0.28 Allowed Glycine 0 CA--C 1.523 0.564 0 N-CA-C 110.801 -0.92 . . . . 0.0 110.801 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 179.94 172.31 1.04 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.837 0.351 . . . . 0.0 110.274 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -86.59 -178.36 6.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.413 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 172.75 153.27 0.08 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.195 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.495 HG12 ' N ' ' A' ' 78' ' ' PHE . 77.2 t -102.16 159.75 4.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.358 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.495 ' N ' HG12 ' A' ' 77' ' ' VAL . 29.8 m-85 -148.4 122.96 9.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.403 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -109.04 154.2 22.55 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.295 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 56.61 52.86 9.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.386 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.626 ' O ' HG12 ' A' ' 81' ' ' VAL . 72.9 t -95.77 5.79 8.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.169 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.441 HG23 ' O ' ' A' ' 81' ' ' VAL . 88.3 t -158.69 127.73 3.1 Favored Pre-proline 0 CA--C 1.53 0.18 0 N-CA-C 110.09 -0.337 . . . . 0.0 110.09 179.486 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -81.31 160.49 20.08 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.61 2.207 . . . . 0.0 111.893 179.73 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -55.88 121.18 8.68 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 179.364 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 61.62 59.69 1.78 Allowed 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 -179.309 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 36.3 p90 -44.48 156.94 0.07 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.25 -179.347 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 88.2 m -135.27 107.78 7.37 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.731 179.641 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.679 ' HA ' HG21 ' A' ' 8' ' ' VAL . 2.8 mp -49.42 94.45 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.852 0.358 . . . . 0.0 110.596 -179.559 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.652 ' H ' HG11 ' A' ' 8' ' ' VAL . . . 160.47 47.66 0.02 OUTLIER Glycine 0 CA--C 1.523 0.552 0 N-CA-C 111.11 -0.796 . . . . 0.0 111.11 179.84 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.48 ' HB2' ' O ' ' A' ' 89' ' ' GLY . . . 174.66 162.82 0.22 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.873 0.368 . . . . 0.0 110.79 179.811 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.976 HG23 ' O ' ' A' ' 6' ' ' PHE . 87.7 m -96.28 141.17 29.93 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.02 179.783 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.454 ' O ' ' HB2' ' A' ' 93' ' ' ALA . 8.4 m-85 -136.43 129.68 31.53 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.454 -179.837 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.899 ' HB1' ' HD2' ' A' ' 94' ' ' PRO . . . 174.98 179.28 0.17 Allowed Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.358 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.899 ' HD2' ' HB1' ' A' ' 93' ' ' ALA . 48.5 Cg_endo . . . . . 0 C--O 1.248 1.017 0 C-N-CA 122.549 2.166 . . . . 0.0 112.1 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 6.0 mtpt . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.668 0.271 . . . . 0.0 110.497 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.799 ' O ' HG23 ' A' ' 5' ' ' THR . 0.4 OUTLIER 41.15 -164.28 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 CA-C-O 121.135 0.493 . . . . 0.0 111.127 179.868 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.799 HG23 ' O ' ' A' ' 4' ' ' VAL . 0.6 OUTLIER -174.56 -35.79 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.626 -0.716 . . . . 0.0 111.359 -179.749 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.778 ' O ' HG23 ' A' ' 91' ' ' THR . 86.2 m-85 66.44 156.17 0.1 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.204 -179.407 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.407 ' O ' ' N ' ' A' ' 20' ' ' LEU . 0.3 OUTLIER -163.58 117.85 1.58 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.568 -179.945 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 95.2 t -64.1 101.33 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.103 179.828 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.427 ' HG3' HG21 ' A' ' 51' ' ' VAL . 4.4 mm-40 -64.75 162.91 15.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.71 -179.73 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 26.9 tttt -79.21 102.57 8.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.144 179.752 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 178.42 -35.86 0.08 OUTLIER Glycine 0 CA--C 1.523 0.553 0 N-CA-C 110.858 -0.897 . . . . 0.0 110.858 -179.807 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -48.18 130.8 16.15 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.815 0.34 . . . . 0.0 110.646 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 20.0 m-80 -123.89 -67.2 0.94 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.356 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -121.39 -78.2 0.59 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.416 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.432 ' HG2' ' N ' ' A' ' 16' ' ' HIS . 0.0 OUTLIER -97.04 -24.77 15.62 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.698 -179.87 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 16' ' ' HIS . . . . . 0.432 ' N ' ' HG2' ' A' ' 15' ' ' LYS . 3.2 m-70 -63.07 119.26 9.17 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.147 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.422 HD22 ' HA ' ' A' ' 17' ' ' LEU . 0.2 OUTLIER -114.03 97.06 6.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.46 -179.844 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -94.19 131.17 40.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.37 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.611 HG23 HG23 ' A' ' 21' ' ' VAL . 18.6 m -125.26 -175.04 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.271 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.535 HD23 ' HG2' ' A' ' 22' ' ' LYS . 1.1 tt -134.88 70.39 1.44 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.219 179.88 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.611 HG23 HG23 ' A' ' 19' ' ' VAL . 6.3 t -86.25 103.63 12.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.453 -179.783 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.535 ' HG2' HD23 ' A' ' 20' ' ' LEU . 0.1 OUTLIER 176.29 131.7 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.412 179.822 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.58 ' CE2' HG23 ' A' ' 4' ' ' VAL . 6.4 p90 -151.0 158.77 44.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.265 179.864 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -74.23 115.53 13.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.404 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 155.49 -82.25 0.16 Allowed Glycine 0 CA--C 1.523 0.592 0 N-CA-C 110.743 -0.943 . . . . 0.0 110.743 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -81.91 -166.08 1.14 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.812 0.339 . . . . 0.0 110.378 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -121.42 176.01 5.88 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.465 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.405 ' O ' ' CG ' ' A' ' 71' ' ' GLU . 12.6 mtt -108.49 118.06 35.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.383 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.834 ' HB3' ' O ' ' A' ' 69' ' ' LEU . . . -119.38 -61.38 1.63 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.573 -179.831 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 15.2 tt0 -155.84 163.53 39.69 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.139 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.86 HG21 ' CD1' ' A' ' 52' ' ' TRP . 38.7 t -139.57 140.6 36.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.089 0.471 . . . . 0.0 110.721 -179.796 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.413 ' OE1' ' HB2' ' A' ' 43' ' ' ALA . 5.5 tp10 -134.78 123.33 23.42 Favored 'General case' 0 N--CA 1.441 -0.925 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.271 -179.755 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.787 HD12 ' N ' ' A' ' 34' ' ' ARG . 2.7 pp -111.92 177.08 4.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.213 0.53 . . . . 0.0 111.223 -179.395 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.787 ' N ' HD12 ' A' ' 33' ' ' LEU . 6.8 ttt180 -145.35 175.32 10.39 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.342 179.576 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.423 ' O ' ' HB2' ' A' ' 36' ' ' HIS . 17.9 mt-10 -116.12 -82.76 0.63 Allowed 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 179.728 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' HIS . . . . . 0.423 ' HB2' ' O ' ' A' ' 35' ' ' GLU . 20.6 t-160 178.08 -37.38 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.062 179.095 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -111.1 -18.66 8.09 Favored Glycine 0 CA--C 1.527 0.813 0 N-CA-C 111.007 -0.837 . . . . 0.0 111.007 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.5 p -47.4 152.1 0.68 Allowed 'General case' 0 N--CA 1.462 0.136 0 CA-C-O 120.847 0.356 . . . . 0.0 110.772 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 36.1 m-20 -53.65 -44.06 69.29 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.516 -179.829 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -162.76 -177.04 5.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.414 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.488 ' CZ3' ' HG2' ' A' ' 67' ' ' ARG . 55.2 m95 -58.76 156.28 11.39 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.205 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.509 HG23 ' O ' ' A' ' 42' ' ' VAL . 18.6 m -130.17 113.86 27.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.315 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.413 ' HB2' ' OE1' ' A' ' 32' ' ' GLU . . . -55.52 123.2 13.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.214 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.55 ' HG2' HD23 ' A' ' 33' ' ' LEU . 0.1 OUTLIER -51.7 -176.57 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.804 -179.797 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.418 ' O ' ' N ' ' A' ' 47' ' ' GLY . 33.1 m -149.73 126.03 10.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.393 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 15.1 ptmt -65.19 75.33 0.05 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.2 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.418 ' N ' ' O ' ' A' ' 45' ' ' THR . . . -93.89 -32.11 7.76 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 110.945 -0.862 . . . . 0.0 110.945 -179.825 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.41 ' HB2' ' O ' ' A' ' 51' ' ' VAL . 0.1 OUTLIER -78.42 174.14 11.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.871 0.367 . . . . 0.0 110.29 -179.983 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -104.64 34.46 5.77 Favored Glycine 0 CA--C 1.522 0.524 0 N-CA-C 110.228 -1.149 . . . . 0.0 110.228 179.724 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 178.78 -35.01 0.08 OUTLIER Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.979 -0.849 . . . . 0.0 110.979 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.527 HG11 ' HA ' ' A' ' 20' ' ' LEU . 3.3 m -123.03 -176.31 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 120.87 0.367 . . . . 0.0 110.557 -179.814 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' TRP . . . . . 0.86 ' CD1' HG21 ' A' ' 31' ' ' VAL . 7.1 m95 -98.36 139.49 34.04 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.725 -179.587 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -131.13 152.22 50.64 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.177 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 70.3 t80 -130.21 141.38 50.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.546 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -97.86 114.81 26.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.339 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -105.97 179.18 4.34 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.467 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -172.02 39.05 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.607 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -123.34 156.77 63.17 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.339 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -71.75 -43.54 1.27 Allowed 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.614 2.209 . . . . 0.0 112.012 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 3.5 mt -69.53 122.45 19.06 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.474 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.13 88.29 2.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.278 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -104.25 -148.37 18.59 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.854 -0.898 . . . . 0.0 110.854 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -78.24 167.16 23.58 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.573 2.182 . . . . 0.0 112.141 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -123.64 113.84 19.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.378 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 70.9 m-20 -86.86 131.98 33.95 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 179.437 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.51 ' CE1' ' HB3' ' A' ' 33' ' ' LEU . 44.7 m-85 -113.38 178.07 4.41 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.101 0.477 . . . . 0.0 111.105 -179.444 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.488 ' HG2' ' CZ3' ' A' ' 41' ' ' TRP . 0.0 OUTLIER 175.29 55.04 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.494 -0.776 . . . . 0.0 109.696 179.975 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.668 ' O ' HD23 ' A' ' 69' ' ' LEU . 4.2 p90 -50.23 174.21 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.844 -0.617 . . . . 0.0 111.24 -179.307 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.834 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 2.6 mt -130.09 75.93 1.69 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.194 179.485 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.426 ' OG1' ' N ' ' A' ' 74' ' ' MET . 16.8 p -37.49 149.46 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.6 -179.17 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.672 ' HG2' ' HB2' ' A' ' 29' ' ' ALA . 5.1 mm-40 -60.97 -54.18 48.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.02 -179.338 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -129.81 58.14 1.66 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.89 0.376 . . . . 0.0 110.795 -179.568 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -149.07 -107.95 0.46 Allowed Glycine 0 CA--C 1.523 0.582 0 N-CA-C 110.895 -0.882 . . . . 0.0 110.895 179.784 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.426 ' N ' ' OG1' ' A' ' 70' ' ' THR . 0.0 OUTLIER -166.33 179.07 5.81 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 110.223 -0.288 . . . . 0.0 110.223 179.936 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.4 138.38 50.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.447 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.423 ' O ' ' CE2' ' A' ' 78' ' ' PHE . 24.8 m-20 -135.46 127.93 30.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.298 179.854 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 58.4 t -77.46 147.59 7.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.617 -179.8 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.423 ' CE2' ' O ' ' A' ' 76' ' ' ASN . 72.6 m-85 -132.27 121.65 23.93 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.157 179.805 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -110.27 140.88 43.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.698 -179.733 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 70.0 32.44 3.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.791 179.656 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.601 HG22 ' HD3' ' A' ' 94' ' ' PRO . 18.4 t -65.13 -68.26 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 179.564 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 93.3 t -86.53 131.48 45.63 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.168 179.697 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.453 ' HD3' ' CB ' ' A' ' 92' ' ' TYR . 50.6 Cg_endo -82.79 161.16 16.3 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.557 2.171 . . . . 0.0 112.047 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -62.33 125.24 23.22 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.188 179.817 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 58.86 47.93 11.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.145 -179.829 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 0.4 ' OH ' ' CD2' ' A' ' 17' ' ' LEU . 22.7 p90 -50.12 175.67 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.775 -179.814 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -137.23 104.56 5.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.998 179.736 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 2.7 mp -46.14 102.83 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.767 -179.773 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 145.52 48.49 0.03 OUTLIER Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.741 -0.944 . . . . 0.0 110.741 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 179.1 -176.3 0.25 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.931 0.396 . . . . 0.0 110.423 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.778 HG23 ' O ' ' A' ' 6' ' ' PHE . 89.5 m -118.12 141.38 48.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.259 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.453 ' CB ' ' HD3' ' A' ' 83' ' ' PRO . 6.2 m-85 -140.45 124.13 17.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.533 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.881 ' HB1' ' HD2' ' A' ' 94' ' ' PRO . . . -156.49 179.55 1.33 Allowed Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.121 -0.49 . . . . 0.0 109.93 179.533 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.881 ' HD2' ' HB1' ' A' ' 93' ' ' ALA . 48.5 Cg_endo . . . . . 0 C--O 1.249 1.029 0 C-N-CA 122.525 2.15 . . . . 0.0 112.059 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.1 mmtt . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.685 0.279 . . . . 0.0 110.63 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.708 HG11 ' CZ ' ' A' ' 78' ' ' PHE . 2.4 p -115.53 162.72 13.38 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.342 0 CA-C-O 121.223 0.535 . . . . 0.0 109.996 179.503 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.847 HG22 HG21 ' A' ' 91' ' ' THR . 0.2 OUTLIER -134.32 151.99 51.56 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.566 179.984 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.651 ' CE2' HG22 ' A' ' 21' ' ' VAL . 17.8 m-85 -128.73 -176.09 3.74 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.881 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -167.03 174.63 8.19 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.05 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.812 ' O ' HG23 ' A' ' 88' ' ' ILE . 93.5 t -123.37 83.29 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.1 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.673 ' HG3' HG11 ' A' ' 51' ' ' VAL . 3.4 mt-10 -47.59 161.53 0.09 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.857 -179.589 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 12.1 mttm -60.72 -18.63 55.52 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.001 -179.795 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -74.05 -2.3 61.71 Favored Glycine 0 CA--C 1.53 1.004 0 N-CA-C 111.824 -0.51 . . . . 0.0 111.824 -179.841 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.435 ' OG ' HG13 ' A' ' 8' ' ' VAL . 4.5 m -76.54 128.59 35.04 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 117.216 0.508 . . . . 0.0 110.538 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -134.28 -164.32 1.49 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.143 179.719 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.442 ' HG3' ' CD ' ' A' ' 15' ' ' LYS . 22.1 pt-20 -75.87 -41.51 52.0 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.466 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.442 ' CD ' ' HG3' ' A' ' 14' ' ' GLU . 1.5 mmmt -85.12 -39.8 17.5 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.489 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 30.3 m80 -97.61 161.67 13.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.596 -179.773 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.523 ' HA ' HD22 ' A' ' 17' ' ' LEU . 0.4 OUTLIER -141.84 85.88 1.96 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.565 179.559 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -79.43 143.01 35.41 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.238 -179.609 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.639 HG21 ' CZ ' ' A' ' 66' ' ' PHE . 30.1 m -138.71 137.27 43.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.288 -179.863 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -91.51 65.0 5.13 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.2 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.651 HG22 ' CE2' ' A' ' 6' ' ' PHE . 10.0 t -61.78 115.18 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.415 -179.811 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 2.2 tttp -172.69 178.55 2.63 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.189 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.481 ' CD1' ' N ' ' A' ' 23' ' ' TYR . 0.0 OUTLIER -146.18 -71.31 0.25 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.044 -179.923 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -143.4 -57.88 0.41 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.219 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -168.34 63.36 0.19 Allowed Glycine 0 CA--C 1.523 0.587 0 N-CA-C 110.759 -0.937 . . . . 0.0 110.759 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -97.33 -167.35 1.52 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.776 0.322 . . . . 0.0 110.41 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 29.3 p -119.67 132.01 55.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.447 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.427 ' O ' ' CG ' ' A' ' 71' ' ' GLU . 0.0 OUTLIER -85.99 123.86 31.79 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.7 -179.851 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.703 ' HB3' ' O ' ' A' ' 69' ' ' LEU . . . -117.81 -61.54 1.67 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.407 -179.852 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.677 ' CB ' HD12 ' A' ' 69' ' ' LEU . 4.2 mt-10 -155.83 151.51 27.26 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.025 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.445 ' HA ' ' HA ' ' A' ' 68' ' ' PHE . 12.1 t -141.27 142.95 28.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.661 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.464 ' CB ' ' HA ' ' A' ' 43' ' ' ALA . 3.9 pt-20 -137.3 142.87 41.9 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.022 -0.535 . . . . 0.0 109.905 179.798 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.772 HD12 ' H ' ' A' ' 34' ' ' ARG . 5.6 tp -118.92 147.43 44.02 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 -179.47 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.772 ' H ' HD12 ' A' ' 33' ' ' LEU . 4.7 ttp180 -144.08 164.02 31.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.008 179.583 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.452 ' OE1' ' CD1' ' A' ' 64' ' ' PHE . 2.4 mm-40 -118.56 -72.82 0.67 Allowed 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 179.747 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 6.0 t-80 -179.17 -39.33 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.348 179.656 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -136.32 57.39 0.68 Allowed Glycine 0 CA--C 1.523 0.552 0 N-CA-C 110.545 -1.022 . . . . 0.0 110.545 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.1 t -132.88 68.88 1.49 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.91 0.386 . . . . 0.0 110.486 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 23.6 t0 49.1 38.19 12.39 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.78 179.796 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 64.73 -173.37 0.18 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.653 179.732 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.511 ' CD2' ' HD3' ' A' ' 34' ' ' ARG . 94.1 m95 -46.84 143.26 2.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.885 -179.841 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.548 HG23 ' O ' ' A' ' 33' ' ' LEU . 2.4 m -137.58 111.46 8.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.85 179.531 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.464 ' HA ' ' CB ' ' A' ' 32' ' ' GLU . . . -44.71 152.13 0.24 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.105 -179.452 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -72.16 -169.51 0.5 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.349 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 37.7 m -143.63 101.26 3.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.181 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 10.8 ptmt -64.76 80.71 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.534 -179.833 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -117.4 -37.14 0.94 Allowed Glycine 0 CA--C 1.523 0.588 0 N-CA-C 110.65 -0.98 . . . . 0.0 110.65 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.407 ' HB3' ' O ' ' A' ' 51' ' ' VAL . 8.4 tm-20 -60.86 -33.39 73.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.756 0.312 . . . . 0.0 110.351 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 97.82 -69.76 0.71 Allowed Glycine 0 CA--C 1.523 0.545 0 N-CA-C 110.774 -0.93 . . . . 0.0 110.774 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -74.83 -29.13 61.54 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 110.589 -1.004 . . . . 0.0 110.589 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.673 HG11 ' HG3' ' A' ' 9' ' ' GLU . 14.1 m -136.38 -177.49 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.791 0.329 . . . . 0.0 110.278 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' TRP . . . . . 0.421 ' CD1' HG21 ' A' ' 31' ' ' VAL . 7.0 m95 -110.25 132.64 54.0 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.558 -179.719 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -115.3 160.72 19.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.145 179.826 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.527 ' CB ' HD23 ' A' ' 33' ' ' LEU . 40.5 t80 -148.61 112.63 5.17 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.555 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -70.86 135.98 48.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.147 179.763 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -142.49 125.99 16.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.612 -179.816 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -93.17 -30.45 15.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.01 179.74 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.439 ' HB2' ' CD ' ' A' ' 59' ' ' PRO . 0.4 OUTLIER -51.84 170.15 0.23 Allowed Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.253 179.754 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.439 ' CD ' ' HB2' ' A' ' 58' ' ' GLU . 37.4 Cg_endo -91.66 56.92 0.9 Allowed 'Trans proline' 0 N--CA 1.45 -1.037 0 C-N-CA 123.569 2.846 . . . . 0.0 111.761 179.339 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.73 HD13 ' HZ ' ' A' ' 64' ' ' PHE . 0.6 OUTLIER -47.44 93.07 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.78 -179.756 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -119.23 47.33 1.71 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.341 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -165.96 -165.19 22.9 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.502 -1.039 . . . . 0.0 110.502 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -79.94 155.7 23.34 Favored 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 122.55 2.166 . . . . 0.0 112.065 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.73 ' HZ ' HD13 ' A' ' 60' ' ' LEU . 46.8 m-85 -101.8 -173.97 2.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.21 -0.45 . . . . 0.0 109.88 179.743 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -149.27 119.18 7.11 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.095 -179.87 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.639 ' CZ ' HG21 ' A' ' 19' ' ' VAL . 13.4 m-85 -108.21 163.47 13.14 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.423 -179.828 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.944 ' HD2' HG22 ' A' ' 77' ' ' VAL . 21.7 mtp180 -163.44 84.69 0.49 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.141 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.587 ' O ' HD23 ' A' ' 69' ' ' LEU . 6.5 p90 -75.82 169.9 17.26 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.2 0.524 . . . . 0.0 110.691 -179.783 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.703 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 3.9 mt -133.9 50.49 2.2 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.184 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 8.3 p -22.74 137.94 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.167 0.987 . . . . 0.0 113.037 -179.035 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.653 ' N ' ' HB2' ' A' ' 29' ' ' ALA . 2.6 mm-40 -55.94 -31.18 62.71 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.166 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 14.9 tptt -151.14 70.28 0.98 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.165 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -151.1 -97.49 0.16 Allowed Glycine 0 CA--C 1.522 0.488 0 N-CA-C 110.816 -0.914 . . . . 0.0 110.816 -179.854 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 13.2 ptp 172.63 166.82 0.12 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.748 0.309 . . . . 0.0 110.288 -179.792 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 18.4 mmtm -83.71 147.84 27.42 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 179.718 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -154.98 132.56 11.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.804 0.335 . . . . 0.0 110.472 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.944 HG22 ' HD2' ' A' ' 67' ' ' ARG . 93.8 t -97.27 146.67 7.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.148 0.499 . . . . 0.0 110.618 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.708 ' CZ ' HG11 ' A' ' 4' ' ' VAL . 41.1 m-85 -131.05 133.65 45.91 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.304 -179.486 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -127.14 31.87 5.17 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.368 -179.76 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -168.39 52.03 0.05 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.483 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.451 ' C ' HG23 ' A' ' 82' ' ' VAL . 57.1 t -93.64 -12.2 8.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.549 -179.077 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.534 HG13 ' HD2' ' A' ' 83' ' ' PRO . 70.3 t -156.76 141.33 12.02 Favored Pre-proline 0 C--N 1.332 -0.166 0 CA-C-O 120.696 0.284 . . . . 0.0 110.694 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.534 ' HD2' HG13 ' A' ' 82' ' ' VAL . 51.9 Cg_endo -81.26 -166.71 0.43 Allowed 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.72 2.28 . . . . 0.0 111.904 179.763 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.417 ' HG3' ' N ' ' A' ' 85' ' ' LYS . 5.1 pt-20 -78.15 -27.11 48.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.173 179.557 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.417 ' N ' ' HG3' ' A' ' 84' ' ' GLU . 0.0 OUTLIER -140.33 73.53 1.43 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.014 179.771 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 0.48 ' HB3' HG13 ' A' ' 82' ' ' VAL . 45.1 p90 -57.12 173.91 0.2 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.79 -179.624 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -152.43 113.66 4.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.035 179.696 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.812 HG23 ' O ' ' A' ' 8' ' ' VAL . 3.3 mp -48.5 109.11 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.828 -179.645 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 121.42 52.26 0.24 Allowed Glycine 0 CA--C 1.523 0.589 0 N-CA-C 111.015 -0.834 . . . . 0.0 111.015 179.801 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -179.31 148.85 0.38 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.846 0.355 . . . . 0.0 110.794 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.847 HG21 HG22 ' A' ' 5' ' ' THR . 19.4 m -92.77 135.51 34.05 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.895 179.589 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.498 ' CG ' ' HD3' ' A' ' 83' ' ' PRO . 66.8 m-85 -118.7 -26.47 6.11 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.635 -178.948 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.781 ' HB1' ' HD2' ' A' ' 94' ' ' PRO . . . -49.18 171.29 0.11 Allowed Pre-proline 0 C--N 1.331 -0.235 0 CA-C-O 120.648 0.261 . . . . 0.0 110.746 -179.803 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.781 ' HD2' ' HB1' ' A' ' 93' ' ' ALA . 47.7 Cg_endo . . . . . 0 C--O 1.249 1.066 0 C-N-CA 122.547 2.165 . . . . 0.0 111.991 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.789 0.328 . . . . 0.0 110.376 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.581 HG21 ' CZ ' ' A' ' 78' ' ' PHE . 20.3 m -73.94 162.97 4.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.511 -179.889 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 43.5 p -148.34 128.84 14.01 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.176 179.845 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.624 ' O ' HG23 ' A' ' 91' ' ' THR . 42.5 m-85 -87.13 171.91 10.33 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.356 -179.828 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.755 HG23 ' O ' ' A' ' 90' ' ' ALA . 2.7 m -163.13 112.29 1.31 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.552 -179.859 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.4 HG13 ' OG ' ' A' ' 12' ' ' SER . 57.8 t -61.57 96.16 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.251 179.866 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.971 ' HG3' HG21 ' A' ' 51' ' ' VAL . 8.5 mm-40 -52.14 166.29 0.17 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.351 -179.906 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 17.1 mttp -60.32 -28.56 68.23 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.685 -179.804 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.418 ' O ' ' CB ' ' A' ' 18' ' ' ALA . . . -83.22 69.18 3.42 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 110.98 -0.848 . . . . 0.0 110.98 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.4 ' OG ' HG13 ' A' ' 8' ' ' VAL . 0.4 OUTLIER -130.37 128.65 41.85 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.702 0.287 . . . . 0.0 110.283 179.85 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 17.3 p30 -166.79 -174.96 2.92 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.618 -179.815 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -54.72 127.0 26.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.339 0.59 . . . . 0.0 110.494 -179.904 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.413 ' O ' ' ND1' ' A' ' 16' ' ' HIS . 0.0 OUTLIER 67.74 20.88 9.38 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.155 -0.929 . . . . 0.0 110.958 179.572 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 16' ' ' HIS . . . . . 0.413 ' ND1' ' O ' ' A' ' 15' ' ' LYS . 78.2 m80 -157.68 89.01 1.0 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.826 0.346 . . . . 0.0 110.549 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.573 HD13 ' C ' ' A' ' 17' ' ' LEU . 3.0 tm? -100.97 85.25 2.82 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.937 179.851 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.483 ' HB2' ' CG2' ' A' ' 53' ' ' THR . . . -77.82 145.21 36.48 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.75 -179.632 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.615 ' O ' HG13 ' A' ' 51' ' ' VAL . 31.5 m -147.71 131.0 8.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.033 179.322 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.648 HD12 ' OE1' ' A' ' 9' ' ' GLU . 0.6 OUTLIER -83.5 85.02 7.32 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.773 -179.568 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.507 HG23 HG23 ' A' ' 19' ' ' VAL . 24.3 t -87.4 88.85 2.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.194 179.669 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.452 ' HG2' ' N ' ' A' ' 23' ' ' TYR . 38.5 tttm -145.96 160.25 42.11 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.475 -179.848 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.512 ' CE2' HG12 ' A' ' 4' ' ' VAL . 18.5 p90 177.01 174.9 0.4 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.345 179.784 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -101.28 128.33 47.47 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.453 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 146.43 -49.03 0.65 Allowed Glycine 0 CA--C 1.523 0.575 0 N-CA-C 110.669 -0.973 . . . . 0.0 110.669 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -135.94 -177.47 4.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.745 0.307 . . . . 0.0 110.336 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -116.13 172.69 7.01 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.496 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.549 ' O ' ' HB2' ' A' ' 29' ' ' ALA . 0.1 OUTLIER -75.74 -173.78 2.34 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.436 -179.934 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.768 ' HB3' ' O ' ' A' ' 69' ' ' LEU . . . 168.52 -64.82 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.29 179.801 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.412 ' O ' ' HB2' ' A' ' 68' ' ' PHE . 0.2 OUTLIER -148.0 162.78 38.65 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.778 -179.862 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.532 HG11 ' CD1' ' A' ' 52' ' ' TRP . 1.9 p 174.48 138.94 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.093 0.473 . . . . 0.0 110.384 -179.869 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.43 ' HB3' ' HA ' ' A' ' 43' ' ' ALA . 0.3 OUTLIER -137.09 178.29 7.2 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.351 -179.634 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.548 HD21 ' CZ ' ' A' ' 66' ' ' PHE . 2.3 mt -114.59 176.42 5.06 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.006 0.431 . . . . 0.0 110.767 -179.65 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.493 ' HB2' ' CZ3' ' A' ' 41' ' ' TRP . 0.0 OUTLIER -161.25 170.79 19.57 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.007 179.632 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -139.44 14.65 2.57 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.283 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER 52.99 25.62 4.16 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.613 0.244 . . . . 0.0 110.793 179.58 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -161.58 29.54 0.3 Allowed Glycine 0 CA--C 1.524 0.62 0 N-CA-C 110.964 -0.854 . . . . 0.0 110.964 -179.761 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -112.09 -16.39 13.06 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.528 0.204 . . . . 0.0 110.97 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 71.21 8.84 6.51 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.78 -0.191 . . . . 0.0 111.067 -179.81 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 26.3 pt-20 179.42 151.47 0.36 Allowed 'General case' 0 C--O 1.231 0.105 0 CA-C-O 120.743 0.306 . . . . 0.0 110.244 179.722 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.512 ' CE3' ' HG2' ' A' ' 67' ' ' ARG . 86.2 m95 -76.89 160.65 29.04 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.377 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.584 HG23 ' O ' ' A' ' 42' ' ' VAL . 29.7 m -134.49 106.37 7.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.319 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.43 ' HA ' ' HB3' ' A' ' 32' ' ' GLU . . . -44.06 131.5 5.83 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.122 -179.75 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.55 -170.13 0.19 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.367 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 42.8 m -147.49 118.68 7.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.342 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.408 ' HB3' ' CZ3' ' A' ' 52' ' ' TRP . 1.1 ptpt -71.77 68.75 0.64 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.576 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -90.01 -12.71 61.61 Favored Glycine 0 CA--C 1.528 0.85 0 N-CA-C 111.227 -0.749 . . . . 0.0 111.227 179.753 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.469 ' HB3' ' HB ' ' A' ' 51' ' ' VAL . 0.1 OUTLIER -85.41 3.83 38.27 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 116.875 0.338 . . . . 0.0 111.391 -179.831 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 64.19 21.53 66.21 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 111.041 -0.824 . . . . 0.0 111.041 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 171.96 -35.21 0.15 Allowed Glycine 0 CA--C 1.52 0.384 0 N-CA-C 109.959 -1.256 . . . . 0.0 109.959 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.971 HG21 ' HG3' ' A' ' 9' ' ' GLU . 3.0 t -106.78 157.81 6.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 179.555 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' TRP . . . . . 0.532 ' CD1' HG11 ' A' ' 31' ' ' VAL . 3.6 m95 -92.18 123.68 35.7 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.015 0.436 . . . . 0.0 110.945 -179.132 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.483 ' CG2' ' HB2' ' A' ' 18' ' ' ALA . 1.3 p -112.69 140.64 47.29 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.313 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 60.7 t80 -121.16 145.33 47.93 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.368 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -88.56 90.1 8.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.34 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -61.19 110.8 1.49 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.541 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -95.15 -36.75 11.36 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.303 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.407 ' O ' ' CG ' ' A' ' 58' ' ' GLU . 5.6 pt-20 -102.74 116.01 63.34 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.345 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -92.4 42.22 0.31 Allowed 'Trans proline' 0 N--CA 1.451 -0.986 0 C-N-CA 123.356 2.704 . . . . 0.0 112.439 179.669 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 2.1 mp -77.34 -175.0 3.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.229 179.76 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 19.8 pt20 -105.89 32.63 4.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.385 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -90.79 154.03 22.88 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.638 -0.985 . . . . 0.0 110.638 179.838 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -79.79 170.02 17.38 Favored 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 122.577 2.184 . . . . 0.0 112.047 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 16.6 m-30 -108.6 149.63 28.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.626 -179.844 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.4 ' HB2' ' HB3' ' A' ' 34' ' ' ARG . 6.8 m-80 -133.72 145.94 50.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.817 179.602 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.548 ' CZ ' HD21 ' A' ' 33' ' ' LEU . 67.1 m-85 -125.36 -177.83 4.02 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.143 0.497 . . . . 0.0 110.694 -179.818 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.512 ' HG2' ' CE3' ' A' ' 41' ' ' TRP . 0.0 OUTLIER 179.92 70.37 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.411 179.692 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.593 ' O ' HD23 ' A' ' 69' ' ' LEU . 6.5 p90 -72.27 179.68 3.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.375 0.607 . . . . 0.0 111.413 -178.92 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.768 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 9.5 mt -141.5 77.02 1.57 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.428 179.797 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.426 ' H ' HG23 ' A' ' 70' ' ' THR . 21.4 p -36.21 136.54 0.3 Allowed 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 116.06 -0.518 . . . . 0.0 112.006 -179.114 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.493 ' CA ' ' HB2' ' A' ' 29' ' ' ALA . 0.1 OUTLIER -42.03 -34.23 0.68 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.192 179.782 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 3.1 tmtm? -56.87 -48.79 77.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.476 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 123.85 76.94 0.33 Allowed Glycine 0 CA--C 1.523 0.589 0 N-CA-C 110.794 -0.922 . . . . 0.0 110.794 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.413 ' CG ' ' OG1' ' A' ' 70' ' ' THR . 9.8 ptp -169.72 144.49 2.88 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.788 0.327 . . . . 0.0 110.172 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -111.71 178.62 4.26 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.654 -179.631 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 176.92 127.87 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.045 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.477 HG12 ' N ' ' A' ' 78' ' ' PHE . 63.4 t -88.85 158.28 3.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.705 -179.75 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.581 ' CZ ' HG21 ' A' ' 4' ' ' VAL . 51.1 m-85 -140.38 117.33 11.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.966 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -103.94 150.58 24.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.789 -179.472 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 50.85 57.03 7.09 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.618 179.78 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.537 HG22 ' HD3' ' A' ' 94' ' ' PRO . 57.3 t -84.54 -80.8 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 179.755 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.554 HG13 ' HD2' ' A' ' 83' ' ' PRO . 60.5 t -81.91 139.5 46.47 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.438 -0.347 . . . . 0.0 110.53 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.554 ' HD2' HG13 ' A' ' 82' ' ' VAL . 46.7 Cg_endo -69.82 -167.06 0.21 Allowed 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.701 2.267 . . . . 0.0 112.031 179.546 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -78.99 -27.82 43.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.156 179.715 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -138.94 77.38 1.62 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.254 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 18.8 p90 -51.23 160.27 0.55 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.532 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 6.0 m -136.44 111.78 9.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.224 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 2.7 mp -50.41 115.13 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.509 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 114.4 38.45 1.1 Allowed Glycine 0 CA--C 1.522 0.512 0 N-CA-C 110.631 -0.988 . . . . 0.0 110.631 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.755 ' O ' HG23 ' A' ' 7' ' ' THR . . . -156.27 -177.79 6.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.851 0.358 . . . . 0.0 110.492 -179.904 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.624 HG23 ' O ' ' A' ' 6' ' ' PHE . 93.3 m -127.27 143.31 51.26 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.399 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.564 ' OH ' ' HB3' ' A' ' 90' ' ' ALA . 3.9 m-85 -144.45 128.4 17.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.127 179.796 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.927 ' HB1' ' HD2' ' A' ' 94' ' ' PRO . . . 176.15 179.08 0.2 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.411 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.927 ' HD2' ' HB1' ' A' ' 93' ' ' ALA . 48.5 Cg_endo . . . . . 0 C--O 1.249 1.03 0 C-N-CA 122.61 2.207 . . . . 0.0 112.174 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 37.2 mttm . . . . . 0 C--O 1.232 0.152 0 CA-C-O 120.655 0.264 . . . . 0.0 110.634 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.655 HG11 ' CZ ' ' A' ' 78' ' ' PHE . 2.5 p -179.6 163.41 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.341 0.591 . . . . 0.0 110.627 179.843 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.863 HG22 HG21 ' A' ' 91' ' ' THR . 0.0 OUTLIER -142.02 145.24 34.18 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.108 179.594 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.587 ' CD1' ' HB2' ' A' ' 93' ' ' ALA . 16.1 m-85 -117.25 165.8 13.01 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.14 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.415 ' O ' ' N ' ' A' ' 20' ' ' LEU . 0.2 OUTLIER -165.97 109.02 0.78 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.226 179.986 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.716 ' O ' HG23 ' A' ' 88' ' ' ILE . 84.6 t -61.45 90.58 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.451 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.913 ' HG3' HG11 ' A' ' 51' ' ' VAL . 21.1 mm-40 -55.1 176.39 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.477 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 12.9 mttt -74.0 -13.1 60.82 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.036 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -46.54 -28.37 3.45 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 111.021 -0.832 . . . . 0.0 111.021 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.5 m -53.08 121.71 7.97 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 179.776 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -110.61 -71.66 0.75 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.423 -179.894 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -138.62 -58.29 0.62 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.783 0.325 . . . . 0.0 110.54 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 10.2 pttt -104.91 -29.08 10.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.548 -179.798 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -64.53 166.0 9.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.5 -179.734 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 44.5 tp -146.43 85.3 1.65 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.363 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.501 ' HB2' ' CG2' ' A' ' 53' ' ' THR . . . -76.34 134.8 39.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.44 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.566 HG23 HG23 ' A' ' 21' ' ' VAL . 34.8 m -130.26 152.2 37.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.182 179.851 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.548 HD12 ' OE2' ' A' ' 9' ' ' GLU . 0.9 OUTLIER -99.58 91.46 4.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.294 179.891 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.566 HG23 HG23 ' A' ' 19' ' ' VAL . 17.8 t -99.72 97.0 5.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.608 -179.729 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 176.29 133.21 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.44 179.777 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.423 ' CZ ' ' OD2' ' A' ' 26' ' ' ASP . 0.1 OUTLIER -115.87 -73.87 0.63 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.338 -179.974 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -174.6 -56.93 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.586 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -46.59 -66.73 1.64 Allowed Glycine 0 CA--C 1.525 0.666 0 N-CA-C 111.217 -0.753 . . . . 0.0 111.217 -179.754 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.423 ' OD2' ' CZ ' ' A' ' 23' ' ' TYR . 44.4 p-10 -71.09 165.41 23.6 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.846 0.355 . . . . 0.0 110.482 -179.832 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.65 HG22 ' O ' ' A' ' 27' ' ' THR . 50.9 m -127.29 45.32 2.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.229 179.837 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.492 ' O ' ' HB2' ' A' ' 29' ' ' ALA . 14.7 mtt 60.15 175.93 0.09 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.502 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.634 ' HB3' ' O ' ' A' ' 69' ' ' LEU . . . 172.8 -61.7 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.306 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.447 ' HB3' HD12 ' A' ' 69' ' ' LEU . 19.9 tt0 -160.62 161.61 32.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.345 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.569 HG21 ' CD1' ' A' ' 52' ' ' TRP . 44.4 t -157.27 148.7 10.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.957 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.469 ' CB ' ' HA ' ' A' ' 43' ' ' ALA . 0.3 OUTLIER -148.6 136.15 20.51 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.978 0.418 . . . . 0.0 110.507 -179.81 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.612 HD12 ' N ' ' A' ' 34' ' ' ARG . 6.0 tp -104.1 141.69 35.78 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.958 -0.564 . . . . 0.0 109.61 -179.599 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.612 ' N ' HD12 ' A' ' 33' ' ' LEU . 1.1 ttm180 -85.25 -63.7 1.28 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.618 -179.858 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.459 ' CB ' ' O ' ' A' ' 34' ' ' ARG . 2.4 tt0 91.16 48.19 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 109.003 -0.739 . . . . 0.0 109.003 -179.154 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' HIS . . . . . 0.441 ' CG ' ' C ' ' A' ' 35' ' ' GLU . 1.2 p80 44.41 -89.44 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 114.845 -1.071 . . . . 0.0 111.207 -179.639 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.431 ' N ' ' O ' ' A' ' 35' ' ' GLU . . . -106.21 93.53 0.88 Allowed Glycine 0 CA--C 1.523 0.566 0 N-CA-C 110.883 -0.887 . . . . 0.0 110.883 -179.831 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.433 ' HB2' ' HB3' ' A' ' 35' ' ' GLU . 8.1 t -139.86 25.27 2.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.586 0.231 . . . . 0.0 110.625 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 77.43 -54.87 0.54 Allowed 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 122.993 0.517 . . . . 0.0 110.899 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -157.75 170.75 21.66 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.33 -179.807 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.501 ' CZ2' ' HD2' ' A' ' 67' ' ' ARG . 81.1 m95 -63.67 164.14 10.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.394 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.411 ' CG2' ' O ' ' A' ' 33' ' ' LEU . 3.5 m -146.82 119.06 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.309 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.469 ' HA ' ' CB ' ' A' ' 32' ' ' GLU . . . -52.87 136.43 34.25 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.38 -179.87 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.74 -169.93 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.397 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 85.0 m -128.91 104.17 7.45 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.199 179.804 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -74.12 121.0 20.47 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.46 -179.858 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 152.41 46.32 0.02 OUTLIER Glycine 0 CA--C 1.523 0.534 0 N-CA-C 110.608 -0.997 . . . . 0.0 110.608 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.421 ' O ' ' N ' ' A' ' 50' ' ' GLY . 15.8 tp10 -134.04 73.48 1.5 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.698 0.285 . . . . 0.0 110.403 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 58.92 -83.71 0.01 OUTLIER Glycine 0 CA--C 1.523 0.533 0 N-CA-C 110.705 -0.958 . . . . 0.0 110.705 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.421 ' N ' ' O ' ' A' ' 48' ' ' GLU . . . -142.92 27.4 2.18 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 110.675 -0.97 . . . . 0.0 110.675 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.913 HG11 ' HG3' ' A' ' 9' ' ' GLU . 5.7 m -145.6 -178.43 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.798 0.333 . . . . 0.0 110.361 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' TRP . . . . . 0.569 ' CD1' HG21 ' A' ' 31' ' ' VAL . 8.8 m95 -106.13 155.28 19.59 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.513 -179.727 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.501 ' CG2' ' HB2' ' A' ' 18' ' ' ALA . 0.2 OUTLIER -141.22 148.3 39.69 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.245 179.904 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.476 ' CG ' HD23 ' A' ' 33' ' ' LEU . 70.3 t80 -125.52 146.65 49.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.254 179.724 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 18.1 p-10 -89.61 93.72 9.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.665 -179.801 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.3 m -85.62 95.5 9.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.138 179.695 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.77 -34.63 13.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.729 -179.62 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.62 156.09 2.45 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 120.882 0.372 . . . . 0.0 110.644 -179.706 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -77.14 -22.62 11.1 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.546 2.164 . . . . 0.0 111.563 179.551 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.416 ' O ' ' CG ' ' A' ' 61' ' ' GLN . 91.4 mt -60.74 172.74 0.87 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.587 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.416 ' CG ' ' O ' ' A' ' 60' ' ' LEU . 0.0 OUTLIER 174.7 116.86 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.253 -179.975 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 178.84 -125.04 0.95 Allowed Glycine 0 CA--C 1.527 0.788 0 N-CA-C 110.692 -0.963 . . . . 0.0 110.692 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -73.52 146.62 39.57 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.427 2.085 . . . . 0.0 112.144 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -128.91 -177.01 4.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.384 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.457 ' HB2' ' CH2' ' A' ' 41' ' ' TRP . 2.8 m120 -144.95 149.48 35.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.307 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 -141.5 159.89 41.27 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.964 0.411 . . . . 0.0 110.867 -179.736 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.501 ' HD2' ' CZ2' ' A' ' 41' ' ' TRP . 15.8 mtp180 -154.11 61.25 0.71 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.965 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.767 ' O ' HD23 ' A' ' 69' ' ' LEU . 10.5 p90 -49.23 176.66 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.19 0.519 . . . . 0.0 110.991 -179.46 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.767 HD23 ' O ' ' A' ' 68' ' ' PHE . 14.5 mt -141.53 65.51 1.38 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.389 179.451 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 75.9 p -31.05 134.56 0.06 Allowed 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 115.606 -0.725 . . . . 0.0 112.655 -178.928 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.473 ' N ' ' HB2' ' A' ' 29' ' ' ALA . 0.1 OUTLIER -40.5 -36.96 0.63 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.452 -0.794 . . . . 0.0 111.553 179.927 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 7.9 tmtt? -61.97 -51.51 67.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.365 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 131.02 52.99 0.1 OUTLIER Glycine 0 CA--C 1.523 0.569 0 N-CA-C 110.807 -0.917 . . . . 0.0 110.807 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 13.2 mtp -133.35 128.63 36.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.847 0.356 . . . . 0.0 110.433 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.471 ' CD ' ' N ' ' A' ' 75' ' ' LYS . 0.4 OUTLIER -117.26 171.66 7.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.043 179.8 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 172.39 139.12 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.458 179.925 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.452 HG22 ' CD ' ' A' ' 67' ' ' ARG . 86.6 t -88.25 155.35 3.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.296 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.655 ' CZ ' HG11 ' A' ' 4' ' ' VAL . 97.5 m-85 -143.85 109.3 5.12 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.077 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.687 ' O ' HG23 ' A' ' 81' ' ' VAL . 18.5 t0 -71.71 164.0 26.76 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.004 -179.295 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.433 ' O ' ' HB ' ' A' ' 81' ' ' VAL . 20.3 t70 50.19 -95.9 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.713 179.88 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.687 HG23 ' O ' ' A' ' 79' ' ' ASP . 75.6 t 65.73 4.21 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 179.846 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.451 HG23 ' C ' ' A' ' 81' ' ' VAL . 88.4 t -159.54 130.5 3.77 Favored Pre-proline 0 CA--C 1.529 0.168 0 O-C-N 122.196 -0.315 . . . . 0.0 110.429 179.319 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.531 ' HD3' ' CG ' ' A' ' 92' ' ' TYR . 49.6 Cg_endo -70.22 -165.44 0.16 Allowed 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.705 2.27 . . . . 0.0 111.768 179.421 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -74.46 -53.71 9.0 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 179.372 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 10.0 mmtp -110.38 79.12 1.17 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.004 -0.543 . . . . 0.0 109.982 179.589 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 48.9 p90 -48.12 136.41 11.82 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.888 -179.648 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 75.3 m -123.3 115.71 22.14 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.15 179.81 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.716 HG23 ' O ' ' A' ' 8' ' ' VAL . 2.7 mp -55.55 119.18 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.557 -179.821 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 107.79 51.13 0.76 Allowed Glycine 0 CA--C 1.523 0.564 0 N-CA-C 111.132 -0.787 . . . . 0.0 111.132 179.75 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -174.81 135.43 0.38 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.799 0.333 . . . . 0.0 110.784 179.847 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.863 HG21 HG22 ' A' ' 5' ' ' THR . 11.5 m -79.32 129.74 34.76 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.181 -0.463 . . . . 0.0 109.881 179.565 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.531 ' CG ' ' HD3' ' A' ' 83' ' ' PRO . 35.1 m-85 -114.94 -22.19 9.71 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.186 -179.138 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.865 ' HB1' ' HD2' ' A' ' 94' ' ' PRO . . . -50.32 178.35 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 120.713 0.292 . . . . 0.0 110.527 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.865 ' HD2' ' HB1' ' A' ' 93' ' ' ALA . 47.6 Cg_endo . . . . . 0 C--O 1.249 1.066 0 C-N-CA 122.633 2.222 . . . . 0.0 112.023 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.579 ' O ' HG22 ' A' ' 4' ' ' VAL . 12.7 mtpt . . . . . 0 CA--C 1.522 -0.121 0 CA-C-O 120.76 0.314 . . . . 0.0 110.288 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.799 ' O ' HG23 ' A' ' 5' ' ' THR . 15.6 m 45.5 -173.89 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.079 -179.852 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.799 HG23 ' O ' ' A' ' 4' ' ' VAL . 0.8 OUTLIER -169.78 130.5 1.03 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.518 -179.705 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.475 ' O ' HG23 ' A' ' 91' ' ' THR . 8.4 m-85 -104.75 156.39 18.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.085 179.757 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 57.5 m -157.48 121.93 4.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.877 0.37 . . . . 0.0 110.596 -179.832 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.478 ' CG1' ' CD1' ' A' ' 88' ' ' ILE . 11.9 t -60.07 93.63 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.088 179.737 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.658 ' HG3' HG11 ' A' ' 51' ' ' VAL . 14.8 mm-40 -47.62 137.5 9.12 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.757 -179.764 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 4.5 tttt -53.8 140.81 28.9 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.405 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 94.17 34.99 6.18 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.63 -0.988 . . . . 0.0 110.63 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.2 t -74.64 148.24 40.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.814 0.34 . . . . 0.0 110.389 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -134.33 152.56 51.88 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.459 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -55.21 -32.58 62.36 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.347 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.13 -12.49 28.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.292 -179.83 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 54.9 m80 -132.12 119.5 21.02 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.832 0.349 . . . . 0.0 110.795 -179.802 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.497 ' HA ' HD22 ' A' ' 17' ' ' LEU . 0.8 OUTLIER -105.87 88.35 2.8 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.948 179.681 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -84.06 119.15 24.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.981 -179.485 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.426 HG23 HG23 ' A' ' 21' ' ' VAL . 17.9 m -108.51 -166.8 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.52 179.23 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.1 tt -140.95 79.18 1.68 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.724 179.756 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.426 HG23 HG23 ' A' ' 19' ' ' VAL . 3.1 t -92.58 88.45 2.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 179.673 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.568 ' HG2' ' HE3' ' A' ' 28' ' ' MET . 7.0 mttt -142.37 161.53 37.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.58 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.401 ' CE1' ' HB2' ' A' ' 26' ' ' ASP . 0.4 OUTLIER 170.71 153.19 0.05 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.208 -179.991 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.43 ' HG3' ' N ' ' A' ' 25' ' ' GLY . 1.5 pt-20 -88.63 -25.62 22.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.515 -179.835 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.43 ' N ' ' HG3' ' A' ' 24' ' ' GLU . . . -55.29 -38.53 68.71 Favored Glycine 0 CA--C 1.523 0.555 0 N-CA-C 110.724 -0.95 . . . . 0.0 110.724 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.401 ' HB2' ' CE1' ' A' ' 23' ' ' TYR . 55.3 m-20 -131.65 176.17 8.55 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.82 0.343 . . . . 0.0 110.324 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.83 -167.49 1.35 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.378 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.568 ' HE3' ' HG2' ' A' ' 22' ' ' LYS . 1.7 mtp -123.36 117.68 25.76 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.368 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.845 ' HB3' ' O ' ' A' ' 69' ' ' LEU . . . -127.52 -60.33 1.18 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.74 -179.783 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.556 ' C ' HG12 ' A' ' 31' ' ' VAL . 0.0 OUTLIER -142.85 171.39 14.11 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.325 -179.889 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.556 HG12 ' C ' ' A' ' 30' ' ' GLU . 0.5 OUTLIER 171.51 139.58 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 121.099 0.476 . . . . 0.0 109.898 -179.786 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.446 ' CB ' ' HA ' ' A' ' 43' ' ' ALA . 1.8 pt-20 -134.79 178.51 6.96 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.178 -179.777 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.738 HD21 ' CZ ' ' A' ' 66' ' ' PHE . 4.2 mt -118.31 172.66 7.3 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.988 0.423 . . . . 0.0 110.894 -179.608 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.416 ' HB3' ' HB2' ' A' ' 65' ' ' ASN . 0.0 OUTLIER -151.47 -173.06 4.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.732 179.588 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -139.27 25.54 2.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.778 0.323 . . . . 0.0 110.709 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 48.18 31.83 2.76 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.757 179.767 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 164.12 47.43 0.02 OUTLIER Glycine 0 CA--C 1.523 0.551 0 N-CA-C 110.924 -0.87 . . . . 0.0 110.924 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 7.0 t -113.85 148.98 35.73 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 179.832 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -50.8 -29.73 12.39 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.333 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -171.34 150.11 2.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.31 179.844 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.49 ' CZ3' ' HG2' ' A' ' 67' ' ' ARG . 64.4 m95 -51.68 153.55 2.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.333 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.461 HG23 ' O ' ' A' ' 42' ' ' VAL . 27.7 m -122.3 119.26 57.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.469 -179.847 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.446 ' HA ' ' CB ' ' A' ' 32' ' ' GLU . . . -52.98 156.69 1.97 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.502 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -94.16 -176.57 4.02 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.478 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 88.3 m -128.79 106.53 8.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.558 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 31.9 mtmt -77.98 93.14 4.4 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.283 -0.417 . . . . 0.0 109.959 179.773 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -129.49 -41.45 0.25 Allowed Glycine 0 CA--C 1.523 0.584 0 N-CA-C 111.284 -0.726 . . . . 0.0 111.284 -179.549 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -49.28 -40.84 36.01 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.872 0.368 . . . . 0.0 110.628 -179.775 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 96.7 -33.23 5.84 Favored Glycine 0 CA--C 1.522 0.515 0 N-CA-C 110.196 -1.162 . . . . 0.0 110.196 -179.693 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -107.39 -24.55 6.43 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 110.574 -1.01 . . . . 0.0 110.574 179.723 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.658 HG11 ' HG3' ' A' ' 9' ' ' GLU . 17.4 m -149.24 178.03 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 120.813 0.339 . . . . 0.0 110.352 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 8.4 m95 -104.79 135.92 45.27 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.103 -179.304 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.2 p -115.74 148.57 39.65 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.072 179.725 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.679 ' HB2' HD12 ' A' ' 33' ' ' LEU . 64.9 t80 -120.51 158.97 26.14 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.849 0.356 . . . . 0.0 110.671 -179.833 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -114.45 119.6 37.43 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.297 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 8.2 p -91.76 157.2 17.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.514 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -117.76 -48.83 2.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.511 -179.911 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.41 ' HB2' ' HD2' ' A' ' 59' ' ' PRO . 5.7 pt-20 -102.76 159.09 30.37 Favored Pre-proline 0 C--N 1.331 -0.221 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.394 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.41 ' HD2' ' HB2' ' A' ' 58' ' ' GLU . 43.2 Cg_endo -67.29 -158.36 0.04 OUTLIER 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.211 1.941 . . . . 0.0 110.021 178.337 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.1 mt 58.74 109.63 0.01 OUTLIER 'General case' 0 N--CA 1.441 -0.923 0 CA-C-O 120.872 0.368 . . . . 0.0 110.926 178.985 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 24.6 mp0 -106.34 104.3 13.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.475 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -95.61 -165.23 34.59 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.92 -0.872 . . . . 0.0 110.92 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -74.84 132.23 15.41 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.613 2.209 . . . . 0.0 111.957 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.401 ' HD2' HG21 ' A' ' 82' ' ' VAL . 30.7 m-85 -94.11 151.32 19.58 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.501 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.416 ' HB2' ' HB3' ' A' ' 34' ' ' ARG . 1.9 m-80 -131.04 140.96 50.16 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.0 -0.546 . . . . 0.0 109.773 179.58 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.738 ' CZ ' HD21 ' A' ' 33' ' ' LEU . 76.5 m-85 -123.56 -178.94 4.16 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.074 0.464 . . . . 0.0 110.748 -179.516 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.49 ' HG2' ' CZ3' ' A' ' 41' ' ' TRP . 5.4 ptm180 -177.33 75.22 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.497 179.771 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.735 ' O ' HD23 ' A' ' 69' ' ' LEU . 9.9 p90 -68.55 179.5 1.67 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.416 0.627 . . . . 0.0 111.315 -179.088 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.845 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 15.2 mt -142.87 72.3 1.37 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.212 179.485 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 72.3 p -31.39 134.1 0.08 Allowed 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 115.642 -0.708 . . . . 0.0 112.447 -178.953 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.712 ' HG2' ' HB2' ' A' ' 29' ' ' ALA . 2.3 mm-40 -50.02 -27.15 5.08 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.421 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -63.77 -41.46 97.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.137 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 123.37 65.25 0.21 Allowed Glycine 0 CA--C 1.524 0.61 0 N-CA-C 110.848 -0.901 . . . . 0.0 110.848 179.836 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 4.2 mtt -155.39 145.48 21.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.793 0.33 . . . . 0.0 110.452 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.461 ' CD ' ' N ' ' A' ' 75' ' ' LYS . 0.0 OUTLIER -121.44 -177.24 3.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.095 179.985 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 173.14 176.03 0.11 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.498 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.531 HG12 ' N ' ' A' ' 78' ' ' PHE . 97.8 t -131.41 162.21 39.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.15 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.531 ' N ' HG12 ' A' ' 77' ' ' VAL . 54.9 m-85 -150.92 130.6 13.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.943 0.401 . . . . 0.0 110.656 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -120.98 164.48 16.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.234 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 7.5 t0 52.73 43.19 31.65 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.249 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.524 ' O ' HG12 ' A' ' 81' ' ' VAL . 98.3 t -88.1 -5.2 10.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.081 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.444 HG23 ' C ' ' A' ' 81' ' ' VAL . 86.6 t -156.57 105.71 1.99 Allowed Pre-proline 0 CA--C 1.529 0.138 0 N-CA-C 110.224 -0.287 . . . . 0.0 110.224 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -73.67 -177.35 3.05 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.48 2.12 . . . . 0.0 112.224 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -77.39 130.53 37.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.342 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 63.56 44.36 5.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.258 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 47.9 p90 -50.49 140.94 13.05 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.583 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 2.9 m -106.69 118.83 37.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.196 179.842 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.478 ' CD1' ' CG1' ' A' ' 8' ' ' VAL . 48.5 mm -53.02 134.88 15.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.353 -179.91 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 102.24 28.42 6.46 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 110.668 -0.973 . . . . 0.0 110.668 -179.88 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -142.9 136.35 28.55 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.847 0.356 . . . . 0.0 110.51 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.475 HG23 ' O ' ' A' ' 6' ' ' PHE . 91.8 m -88.12 113.57 23.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.308 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.52 ' O ' ' HB2' ' A' ' 93' ' ' ALA . 45.3 m-85 -106.4 152.11 24.03 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.524 -179.745 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.901 ' HB1' ' HD2' ' A' ' 94' ' ' PRO . . . 170.07 177.74 0.09 OUTLIER Pre-proline 0 C--N 1.331 -0.197 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.387 179.769 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.901 ' HD2' ' HB1' ' A' ' 93' ' ' ALA . 48.7 Cg_endo . . . . . 0 C--O 1.249 1.057 0 C-N-CA 122.564 2.176 . . . . 0.0 112.0 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 49.4 mttp . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.812 0.339 . . . . 0.0 110.36 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.638 HG11 ' CZ ' ' A' ' 68' ' ' PHE . 18.4 m -80.09 163.26 3.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.338 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.619 HG23 ' O ' ' A' ' 4' ' ' VAL . 1.0 OUTLIER -162.95 132.07 4.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.444 179.957 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.514 ' CD2' ' HB ' ' A' ' 21' ' ' VAL . 9.7 m-85 -103.49 177.69 4.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.185 -0.462 . . . . 0.0 109.926 179.674 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.552 HG23 ' O ' ' A' ' 90' ' ' ALA . 2.9 m -167.17 127.7 1.51 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.763 0.316 . . . . 0.0 110.785 -179.628 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.737 HG13 ' CA ' ' A' ' 17' ' ' LEU . 87.7 t -70.77 81.54 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.264 179.529 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.522 ' CD ' HD12 ' A' ' 20' ' ' LEU . 1.7 mm-40 -49.25 178.74 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.816 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 5.8 mttp -67.98 -16.52 64.09 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.857 179.864 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -45.11 -34.69 4.41 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 111.006 -0.838 . . . . 0.0 111.006 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.47 ' OG ' HD11 ' A' ' 88' ' ' ILE . 1.4 p -56.95 127.22 30.76 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 179.564 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.6 p30 -109.56 -56.69 2.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.685 0.279 . . . . 0.0 110.766 -179.748 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 34.7 mm-40 -130.51 -58.96 1.03 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.906 0.384 . . . . 0.0 110.142 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.417 ' CG ' ' OD1' ' A' ' 55' ' ' ASP . 0.0 OUTLIER -108.35 -25.55 10.95 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.218 179.807 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 16' ' ' HIS . . . . . 0.474 ' CE1' ' OD1' ' A' ' 55' ' ' ASP . 21.0 m80 -58.0 176.86 0.14 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.359 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.768 ' N ' HD13 ' A' ' 17' ' ' LEU . 0.0 OUTLIER -172.98 31.64 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.587 -179.238 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.803 ' HB2' HG22 ' A' ' 53' ' ' THR . . . -18.93 119.95 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.333 1.053 . . . . 0.0 113.0 -179.854 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.695 HG11 ' CZ ' ' A' ' 66' ' ' PHE . 21.9 m -87.13 138.3 19.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.665 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.522 HD12 ' CD ' ' A' ' 9' ' ' GLU . 1.0 OUTLIER -97.94 42.99 1.08 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.387 179.795 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.514 ' HB ' ' CD2' ' A' ' 6' ' ' PHE . 2.7 p -50.63 100.53 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.301 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.22 165.08 32.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.265 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER 176.21 175.07 0.32 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.496 -179.83 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -104.54 154.82 19.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.341 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 94.64 -58.55 1.87 Allowed Glycine 0 CA--C 1.522 0.51 0 N-CA-C 110.71 -0.956 . . . . 0.0 110.71 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -91.92 173.86 7.63 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.778 0.323 . . . . 0.0 110.217 179.881 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -121.0 -173.14 2.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.528 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.43 ' O ' ' CG ' ' A' ' 71' ' ' GLU . 0.0 OUTLIER -118.39 125.74 50.62 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.504 -179.8 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.8 ' HB3' ' O ' ' A' ' 69' ' ' LEU . . . -121.54 -55.64 1.92 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.621 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.54 ' C ' HG12 ' A' ' 31' ' ' VAL . 0.7 OUTLIER -159.92 172.93 16.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.422 -179.916 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.54 HG12 ' C ' ' A' ' 30' ' ' GLU . 0.2 OUTLIER -174.4 136.83 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.373 0.606 . . . . 0.0 109.798 179.827 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.415 ' HG2' ' HB3' ' A' ' 41' ' ' TRP . 10.5 tt0 -121.97 151.77 40.42 Favored 'General case' 0 N--CA 1.441 -0.918 0 CA-C-N 115.055 -0.975 . . . . 0.0 110.103 -178.733 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.732 HD21 ' CZ ' ' A' ' 66' ' ' PHE . 3.1 mt -101.56 161.29 13.75 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.197 179.784 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.464 ' NH2' ' NE1' ' A' ' 41' ' ' TRP . 0.0 OUTLIER -124.65 -168.15 1.77 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.413 -179.92 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.425 ' CG ' ' O ' ' A' ' 34' ' ' ARG . 11.6 mt-10 -164.81 95.55 0.71 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.83 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -47.67 103.94 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.746 -179.589 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 136.01 -39.39 1.66 Allowed Glycine 0 CA--C 1.523 0.584 0 N-CA-C 110.785 -0.926 . . . . 0.0 110.785 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -69.27 176.35 3.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.856 0.36 . . . . 0.0 110.414 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -118.84 33.91 5.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.394 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -176.43 163.5 2.48 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.531 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.491 ' CZ3' ' HG2' ' A' ' 67' ' ' ARG . 57.8 m95 -88.56 175.9 7.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.322 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.9 m -137.24 97.68 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.175 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -50.76 127.61 18.73 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.6 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.444 ' CE ' ' HB2' ' A' ' 52' ' ' TRP . 0.0 OUTLIER -61.32 -170.12 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.115 179.914 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.415 ' O ' ' N ' ' A' ' 47' ' ' GLY . 92.9 m -150.78 117.48 5.8 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.156 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 2.4 ptmt -69.12 63.5 0.13 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.387 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.415 ' N ' ' O ' ' A' ' 45' ' ' THR . . . -86.83 -27.81 28.04 Favored Glycine 0 CA--C 1.521 0.46 0 N-CA-C 110.383 -1.087 . . . . 0.0 110.383 179.785 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.452 ' HG2' ' CG2' ' A' ' 51' ' ' VAL . 11.6 tp10 -91.99 125.28 36.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.895 0.379 . . . . 0.0 110.246 179.847 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -71.89 66.82 1.12 Allowed Glycine 0 CA--C 1.522 0.476 0 N-CA-C 110.713 -0.955 . . . . 0.0 110.713 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 160.18 -27.55 0.33 Allowed Glycine 0 CA--C 1.524 0.595 0 N-CA-C 111.175 -0.77 . . . . 0.0 111.175 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.452 ' CG2' ' HG2' ' A' ' 48' ' ' GLU . 3.6 m -148.4 -176.81 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.062 0.458 . . . . 0.0 111.064 -179.692 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' TRP . . . . . 0.444 ' HB2' ' CE ' ' A' ' 44' ' ' MET . 4.3 m95 -104.76 136.45 44.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.939 -179.832 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.803 HG22 ' HB2' ' A' ' 18' ' ' ALA . 3.9 p -120.83 144.62 48.25 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.907 0.384 . . . . 0.0 110.662 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.47 ' CB ' HD12 ' A' ' 33' ' ' LEU . 89.5 t80 -140.75 86.14 2.03 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.016 179.638 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.474 ' OD1' ' CE1' ' A' ' 16' ' ' HIS . 10.7 t0 -48.71 151.1 1.24 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.548 -179.794 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 4.9 t -121.94 121.96 38.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.329 179.84 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -115.47 50.49 1.0 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.55 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -142.89 154.17 61.8 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.331 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -71.15 -40.44 3.25 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.715 2.277 . . . . 0.0 112.068 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 4.5 mt -73.04 153.97 40.65 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.444 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.73 100.56 2.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.319 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -114.74 -152.42 10.37 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 110.723 -0.951 . . . . 0.0 110.723 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -80.99 149.93 17.84 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.66 2.24 . . . . 0.0 112.009 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.476 ' HD2' HG21 ' A' ' 82' ' ' VAL . 45.6 m-85 -102.57 164.3 11.73 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.549 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.422 ' HB2' ' CB ' ' A' ' 34' ' ' ARG . 2.7 m-80 -136.6 139.56 42.21 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.801 179.631 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.732 ' CZ ' HD21 ' A' ' 33' ' ' LEU . 58.5 m-85 -127.31 165.13 20.28 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.135 0.493 . . . . 0.0 111.204 -179.46 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.491 ' HG2' ' CZ3' ' A' ' 41' ' ' TRP . 0.0 OUTLIER -156.99 61.08 0.51 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.48 179.578 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.638 ' CZ ' HG11 ' A' ' 4' ' ' VAL . 3.1 p90 -52.55 170.72 0.07 Allowed 'General case' 0 CA--C 1.516 -0.338 0 CA-C-O 121.483 0.659 . . . . 0.0 111.398 -179.094 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.8 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 5.6 mt -135.42 70.91 1.43 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 114.833 -1.076 . . . . 0.0 108.874 179.544 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -30.73 140.61 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.28 0.632 . . . . 0.0 112.317 -178.726 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.546 ' CA ' ' HB2' ' A' ' 29' ' ' ALA . 13.8 mt-10 -49.79 -47.28 51.3 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.935 -179.455 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.403 ' HD3' ' O ' ' A' ' 72' ' ' LYS . 0.0 OUTLIER -139.23 47.16 1.9 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.815 0.34 . . . . 0.0 110.844 -179.846 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -133.51 -108.94 1.09 Allowed Glycine 0 CA--C 1.522 0.526 0 N-CA-C 110.609 -0.996 . . . . 0.0 110.609 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 10.2 ptt? -165.9 163.2 18.6 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.757 0.313 . . . . 0.0 110.16 179.809 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.755 ' HB3' HD23 ' A' ' 69' ' ' LEU . 0.0 OUTLIER -98.44 -177.7 3.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.362 -179.922 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.445 ' ND2' ' O ' ' A' ' 75' ' ' LYS . 0.4 OUTLIER -179.4 -167.57 0.1 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.533 179.952 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 96.9 t -134.35 145.7 32.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.128 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.605 ' CZ ' HG21 ' A' ' 4' ' ' VAL . 52.7 m-85 -134.73 134.64 41.23 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.522 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -113.71 155.72 25.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.444 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 51.08 59.21 4.78 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.445 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.814 HG13 ' HB2' ' A' ' 93' ' ' ALA . 95.1 t -94.55 -17.38 7.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.964 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.571 HG13 ' HD2' ' A' ' 83' ' ' PRO . 82.5 t -139.71 140.1 23.89 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-O 120.629 0.252 . . . . 0.0 110.389 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.571 ' HD2' HG13 ' A' ' 82' ' ' VAL . 48.1 Cg_endo -72.49 176.96 8.01 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.652 2.235 . . . . 0.0 112.092 179.877 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -58.65 -32.24 68.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.254 -0.43 . . . . 0.0 109.976 179.696 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.62 85.66 2.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.131 179.777 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 0.504 ' CD1' HG11 ' A' ' 8' ' ' VAL . 16.9 p90 -52.09 144.74 11.61 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.684 -179.72 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -123.02 102.41 7.98 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.854 179.572 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.47 HD11 ' OG ' ' A' ' 12' ' ' SER . 3.3 mt -44.33 118.26 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.823 -179.712 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 114.41 20.61 5.8 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 110.979 -0.848 . . . . 0.0 110.979 -179.854 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.552 ' O ' HG23 ' A' ' 7' ' ' THR . . . -136.25 133.11 36.66 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 179.841 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 56.5 m -91.96 93.56 8.85 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.899 0.381 . . . . 0.0 111.01 -179.657 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.551 ' O ' ' HB3' ' A' ' 93' ' ' ALA . 47.4 m-85 -79.55 -153.31 0.08 Allowed 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 178.923 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.918 ' HB1' ' HD2' ' A' ' 94' ' ' PRO . . . 71.58 179.48 0.05 OUTLIER Pre-proline 0 C--N 1.331 -0.222 0 CA-C-O 120.696 0.284 . . . . 0.0 110.683 179.525 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.918 ' HD2' ' HB1' ' A' ' 93' ' ' ALA . 49.1 Cg_endo . . . . . 0 C--O 1.249 1.042 0 C-N-CA 122.633 2.222 . . . . 0.0 111.99 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.51 ' O ' HG12 ' A' ' 4' ' ' VAL . 35.9 mttp . . . . . 0 CA--C 1.522 -0.117 0 CA-C-O 120.839 0.352 . . . . 0.0 110.242 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.79 ' O ' HG23 ' A' ' 5' ' ' THR . 1.2 p 46.3 -170.98 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.544 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.79 HG23 ' O ' ' A' ' 4' ' ' VAL . 0.6 OUTLIER -177.27 173.12 1.8 Allowed 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.458 -179.996 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.636 ' O ' HG23 ' A' ' 91' ' ' THR . 60.6 m-85 -141.64 172.23 12.97 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.048 179.836 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.519 HG23 ' O ' ' A' ' 90' ' ' ALA . 2.5 m -166.72 112.57 0.8 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.4 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 13.1 t -59.57 113.27 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.14 179.792 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.832 ' HG3' HG11 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -80.92 173.29 12.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.648 -179.661 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -75.48 153.96 37.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.402 -179.931 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 95.26 23.51 19.34 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 51.0 m -80.01 127.43 32.28 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.761 0.315 . . . . 0.0 110.288 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -116.31 -161.74 0.81 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.189 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -51.65 -56.65 12.44 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.485 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.408 ' HG2' ' N ' ' A' ' 16' ' ' HIS . 0.0 OUTLIER -106.15 -28.08 10.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.636 -179.763 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 16' ' ' HIS . . . . . 0.408 ' N ' ' HG2' ' A' ' 15' ' ' LYS . 14.9 m80 -57.4 112.31 1.37 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.492 -179.897 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.416 ' HA ' HD22 ' A' ' 17' ' ' LEU . 0.2 OUTLIER -120.85 99.77 6.71 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.181 -0.463 . . . . 0.0 109.897 179.786 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -95.36 128.25 42.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.53 -179.673 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.932 HG23 HG23 ' A' ' 21' ' ' VAL . 28.5 m -125.24 141.89 43.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.213 179.846 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -91.92 64.99 4.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.403 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.932 HG23 HG23 ' A' ' 19' ' ' VAL . 14.2 t -68.15 93.28 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.367 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -157.97 144.73 17.8 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.446 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.706 ' CE2' HG23 ' A' ' 4' ' ' VAL . 0.0 OUTLIER -153.05 -175.16 5.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.229 179.841 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -115.52 96.31 5.58 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.354 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 155.82 -59.71 0.37 Allowed Glycine 0 CA--C 1.524 0.613 0 N-CA-C 110.807 -0.917 . . . . 0.0 110.807 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.426 ' HB2' ' CZ ' ' A' ' 23' ' ' TYR . 0.4 OUTLIER -83.52 -174.79 5.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.733 0.301 . . . . 0.0 110.356 -179.995 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -129.81 -179.3 5.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.637 -179.786 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.433 ' O ' ' CG ' ' A' ' 71' ' ' GLU . 0.0 OUTLIER -105.39 122.91 46.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.429 -179.967 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.776 ' HB3' ' O ' ' A' ' 69' ' ' LEU . . . -128.72 -53.67 1.24 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.787 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.402 ' O ' ' HB2' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -163.31 153.38 15.64 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.794 0.33 . . . . 0.0 110.653 -179.866 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.938 HG21 ' CD1' ' A' ' 52' ' ' TRP . 4.0 t -135.78 137.62 48.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.108 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -136.33 134.55 38.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.758 0.313 . . . . 0.0 110.463 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.8 mt -105.14 179.06 4.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.986 0.422 . . . . 0.0 110.63 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.504 ' HB2' ' CE3' ' A' ' 41' ' ' TRP . 8.6 ttt85 -170.15 158.49 6.95 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.946 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.443 ' N ' ' HG2' ' A' ' 34' ' ' ARG . 5.4 mp0 -117.29 -81.94 0.63 Allowed 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 179.81 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 168.87 118.14 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.459 179.31 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 52.17 38.2 48.08 Favored Glycine 0 CA--C 1.523 0.532 0 N-CA-C 110.816 -0.914 . . . . 0.0 110.816 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 12.0 t -103.56 -76.71 0.58 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.742 0.306 . . . . 0.0 110.459 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -157.36 52.61 0.48 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.423 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 54.69 178.43 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.073 -179.835 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.504 ' CE3' ' HB2' ' A' ' 34' ' ' ARG . 93.9 m95 -59.04 136.74 58.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.847 0.356 . . . . 0.0 110.161 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.654 HG21 ' CZ ' ' A' ' 54' ' ' PHE . 34.6 m -119.73 111.93 34.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.176 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -52.08 137.81 26.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.253 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.23 -171.29 0.05 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.563 -179.749 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 55.5 m -138.1 109.74 7.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.063 179.814 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.467 ' HG2' ' CZ3' ' A' ' 52' ' ' TRP . 36.4 mtpt -72.69 77.01 1.11 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.514 -179.754 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -102.66 -55.33 0.84 Allowed Glycine 0 CA--C 1.522 0.528 0 N-CA-C 110.473 -1.051 . . . . 0.0 110.473 179.853 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.611 ' HG2' HG22 ' A' ' 51' ' ' VAL . 11.8 tt0 -65.3 113.58 4.14 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.838 0.351 . . . . 0.0 110.065 179.806 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -61.98 79.22 0.02 OUTLIER Glycine 0 CA--C 1.523 0.57 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 -179.847 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.41 ' N ' ' O ' ' A' ' 48' ' ' GLU . . . 152.02 -42.54 0.69 Allowed Glycine 0 CA--C 1.523 0.561 0 N-CA-C 111.242 -0.743 . . . . 0.0 111.242 179.801 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.832 HG11 ' HG3' ' A' ' 9' ' ' GLU . 30.0 m -135.46 168.98 21.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.889 0.376 . . . . 0.0 110.806 -179.577 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' TRP . . . . . 0.938 ' CD1' HG21 ' A' ' 31' ' ' VAL . 7.5 m95 -99.84 140.74 33.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.571 -179.899 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 14.1 p -128.5 146.21 50.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.148 179.767 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.654 ' CZ ' HG21 ' A' ' 42' ' ' VAL . 33.2 t80 -125.04 140.88 52.51 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.535 -179.791 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -97.26 87.52 4.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.255 179.877 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.4 m -69.84 175.8 4.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.359 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 11.3 tt0 -161.67 38.49 0.13 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.296 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -131.29 165.52 34.68 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.427 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -93.59 7.26 2.67 Favored 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 123.849 3.032 . . . . 0.0 112.578 179.678 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 2.2 tp -59.86 153.29 21.19 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.782 0.325 . . . . 0.0 110.351 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.2 46.12 0.98 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.215 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -122.77 -146.44 7.18 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.67 -0.972 . . . . 0.0 110.67 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -82.73 153.36 15.18 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.719 2.279 . . . . 0.0 112.195 -179.851 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.412 ' HD2' HG21 ' A' ' 82' ' ' VAL . 25.7 m-85 -101.16 162.19 13.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.139 179.777 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.44 ' OD1' ' N ' ' A' ' 65' ' ' ASN . 0.0 OUTLIER -127.14 113.11 15.96 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 179.511 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.412 ' O ' ' HG3' ' A' ' 67' ' ' ARG . 5.5 m-85 -97.36 -174.08 2.83 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.871 -179.298 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.453 ' HG3' ' HA ' ' A' ' 77' ' ' VAL . 2.3 mtp180 170.21 78.04 0.0 OUTLIER 'General case' 0 CA--C 1.521 -0.137 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.88 178.966 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.813 ' O ' HD23 ' A' ' 69' ' ' LEU . 3.2 p90 -79.88 -179.73 7.12 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.147 179.581 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.813 HD23 ' O ' ' A' ' 68' ' ' PHE . 1.0 OUTLIER -136.31 68.67 1.43 Allowed 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 179.642 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 7.1 p -35.11 139.82 0.09 Allowed 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.929 -179.079 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.665 ' HG2' ' HB2' ' A' ' 29' ' ' ALA . 7.7 mm-40 -50.93 -54.06 27.49 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.605 -179.672 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.4 tptm -116.96 71.46 0.8 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.498 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -167.87 -102.93 0.16 Allowed Glycine 0 CA--C 1.521 0.459 0 N-CA-C 110.552 -1.019 . . . . 0.0 110.552 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 7.6 ptt? 169.13 -177.09 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.774 0.321 . . . . 0.0 110.163 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.545 ' CG ' HD22 ' A' ' 69' ' ' LEU . 4.2 mptt -75.44 -178.08 3.89 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.263 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 175.17 136.36 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.338 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.475 HG12 ' N ' ' A' ' 78' ' ' PHE . 95.9 t -84.35 159.24 3.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.267 179.903 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.549 ' CE1' HG11 ' A' ' 4' ' ' VAL . 86.8 m-85 -150.16 120.03 7.11 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.32 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -115.99 151.81 34.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.458 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 61.95 34.79 16.57 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.357 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.551 HG13 ' CD1' ' A' ' 6' ' ' PHE . 49.5 t -78.08 -0.5 3.39 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.935 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.599 HG13 ' HD2' ' A' ' 83' ' ' PRO . 84.1 t -154.88 139.91 12.06 Favored Pre-proline 0 C--N 1.333 -0.115 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 179.271 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.599 ' HD2' HG13 ' A' ' 82' ' ' VAL . 50.3 Cg_endo -71.72 -170.16 0.5 Allowed 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.647 2.231 . . . . 0.0 111.982 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -75.56 -28.57 59.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.188 -0.46 . . . . 0.0 109.96 179.51 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 13.7 mttt -139.25 74.95 1.49 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.982 179.783 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 0.432 ' HA ' ' HG2' ' A' ' 83' ' ' PRO . 25.9 p90 -48.3 151.78 0.99 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.876 -179.63 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 2.4 m -136.9 110.07 7.79 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.828 -0.623 . . . . 0.0 109.991 179.784 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 2.8 mp -46.12 105.96 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.845 -179.721 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 128.25 44.55 0.21 Allowed Glycine 0 CA--C 1.523 0.541 0 N-CA-C 110.619 -0.992 . . . . 0.0 110.619 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.597 ' HB3' ' CZ ' ' A' ' 92' ' ' TYR . . . -157.63 160.8 38.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.796 0.332 . . . . 0.0 110.339 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.636 HG23 ' O ' ' A' ' 6' ' ' PHE . 39.9 m -113.51 102.04 9.92 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.555 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.597 ' CZ ' ' HB3' ' A' ' 90' ' ' ALA . 29.9 m-85 -103.95 144.61 31.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.615 -179.914 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.781 ' HB1' ' HD2' ' A' ' 94' ' ' PRO . . . 172.46 171.42 0.22 Allowed Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.41 179.701 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.781 ' HD2' ' HB1' ' A' ' 93' ' ' ALA . 49.3 Cg_endo . . . . . 0 C--O 1.249 1.063 0 C-N-CA 122.61 2.207 . . . . 0.0 112.082 -179.956 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 7.8 mtmt . . . . . 0 C--O 1.232 0.158 0 CA-C-O 120.767 0.318 . . . . 0.0 110.452 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 3.7 m -53.99 -178.99 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.121 179.866 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.2 p -152.54 131.17 12.3 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.42 179.949 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.667 ' HD1' ' HB2' ' A' ' 93' ' ' ALA . 16.6 m-85 -98.47 171.57 8.08 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.248 179.878 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.781 HG23 ' O ' ' A' ' 90' ' ' ALA . 0.6 OUTLIER -164.44 105.86 0.86 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.298 179.996 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 60.5 t -60.34 101.63 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.297 179.974 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.619 ' CD ' HG11 ' A' ' 51' ' ' VAL . 2.7 mt-10 -64.05 -175.72 0.16 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.315 -179.952 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 5.7 pttm -86.25 10.79 13.66 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.168 179.972 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.422 ' HA3' ' HB2' ' A' ' 18' ' ' ALA . . . -69.27 -29.71 71.86 Favored Glycine 0 CA--C 1.522 0.487 0 N-CA-C 110.571 -1.012 . . . . 0.0 110.571 179.79 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 53.2 p -53.0 106.11 0.15 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.817 0.341 . . . . 0.0 110.264 179.894 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -89.34 -68.14 0.79 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.337 -179.97 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -135.8 -54.6 0.77 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.393 179.963 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.62 -27.39 8.57 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.392 179.926 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -52.24 179.44 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.358 179.987 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.411 HD12 ' HA ' ' A' ' 17' ' ' LEU . 24.3 tp -159.18 83.42 0.78 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.249 179.967 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.442 ' C ' HG13 ' A' ' 19' ' ' VAL . . . -73.79 158.37 34.71 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.511 -179.906 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.582 HG23 HG23 ' A' ' 21' ' ' VAL . 35.4 m -157.55 139.17 5.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.347 179.845 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -97.52 57.87 1.42 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.431 179.987 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.582 HG23 HG23 ' A' ' 19' ' ' VAL . 18.3 t -58.8 94.47 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.359 179.975 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.5 ttpm? -152.27 149.01 28.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.448 -179.929 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 12.9 p90 -169.19 137.89 2.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.309 179.916 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -55.37 152.77 8.11 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.27 -179.979 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 113.91 -77.09 0.25 Allowed Glycine 0 CA--C 1.523 0.569 0 N-CA-C 110.736 -0.946 . . . . 0.0 110.736 -179.931 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -103.81 179.94 4.13 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.801 0.334 . . . . 0.0 110.347 179.933 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.422 HG22 ' H ' ' A' ' 28' ' ' MET . 0.2 OUTLIER -108.52 -160.87 0.74 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.513 -179.813 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.422 ' H ' HG22 ' A' ' 27' ' ' THR . 19.9 mmt -122.72 127.85 49.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.542 -179.77 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.812 ' HB3' ' O ' ' A' ' 69' ' ' LEU . . . -117.23 -55.69 2.3 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.58 -179.933 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.438 ' HB3' HD12 ' A' ' 69' ' ' LEU . 23.0 tt0 -158.55 165.23 35.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.324 -179.937 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.609 HG21 ' CD1' ' A' ' 52' ' ' TRP . 67.2 t -143.64 149.4 18.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.956 0.407 . . . . 0.0 110.451 179.939 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.417 ' OE2' ' N ' ' A' ' 43' ' ' ALA . 9.7 tp10 -134.78 136.99 42.99 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-N 115.96 -0.563 . . . . 0.0 109.79 -179.431 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.647 HD12 ' H ' ' A' ' 34' ' ' ARG . 13.0 tp -115.89 152.26 33.73 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 -179.918 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.647 ' H ' HD12 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -128.39 176.19 7.91 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.826 0.346 . . . . 0.0 110.543 -179.818 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.419 ' O ' ' N ' ' A' ' 37' ' ' GLY . 1.5 tm-20 -138.85 12.41 2.68 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.16 -179.907 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER 67.48 -68.77 0.15 Allowed 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 120.822 0.344 . . . . 0.0 110.519 -179.973 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 35' ' ' GLU . . . -68.75 -26.33 74.59 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 110.846 -0.901 . . . . 0.0 110.846 -179.951 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 8.6 t -50.87 140.41 15.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.76 0.314 . . . . 0.0 110.357 -179.895 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 16.5 t0 -49.38 -30.9 8.45 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.472 -179.999 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -170.77 172.56 5.65 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.431 179.892 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.477 ' CE3' ' HB2' ' A' ' 34' ' ' ARG . 69.3 m95 -54.87 147.34 15.38 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.262 179.922 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.4 ' O ' HG23 ' A' ' 42' ' ' VAL . 6.1 m -124.77 109.91 23.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.298 179.929 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.417 ' N ' ' OE2' ' A' ' 32' ' ' GLU . . . -50.54 135.12 23.27 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.482 -179.881 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -53.69 -171.64 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.624 -179.925 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 58.0 m -128.85 93.17 3.55 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.498 -179.896 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 7.0 ptmt -71.05 84.57 0.71 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.403 179.942 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -144.21 30.21 1.89 Allowed Glycine 0 CA--C 1.523 0.533 0 N-CA-C 110.473 -1.051 . . . . 0.0 110.473 179.934 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.404 ' HB2' ' O ' ' A' ' 51' ' ' VAL . 0.0 OUTLIER -108.77 174.05 6.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.843 0.354 . . . . 0.0 110.503 -179.879 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -59.82 -31.63 72.36 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 110.718 -0.953 . . . . 0.0 110.718 179.968 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -176.6 35.41 0.09 OUTLIER Glycine 0 CA--C 1.524 0.595 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 -179.978 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.619 HG11 ' CD ' ' A' ' 9' ' ' GLU . 6.6 m -152.16 -179.93 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.776 0.322 . . . . 0.0 110.425 179.803 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 52' ' ' TRP . . . . . 0.609 ' CD1' HG21 ' A' ' 31' ' ' VAL . 7.0 m95 -108.44 140.0 42.37 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.438 -179.644 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -127.69 177.0 7.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.126 179.809 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.636 ' CG ' HD23 ' A' ' 33' ' ' LEU . 77.4 t80 -161.77 119.36 2.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.403 179.926 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.443 ' O ' ' CD2' ' A' ' 54' ' ' PHE . 28.3 p-10 -66.87 -177.34 0.6 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.402 -179.988 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 59.24 178.93 0.08 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.443 179.897 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 174.39 50.17 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.218 179.941 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -50.47 121.41 14.12 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.444 -179.847 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -71.56 59.73 2.66 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.444 2.096 . . . . 0.0 112.056 179.87 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -114.88 1.29 14.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.256 179.956 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -177.89 124.44 0.12 Allowed 'General case' 0 C--N 1.334 -0.092 0 CA-C-O 120.778 0.323 . . . . 0.0 110.367 179.939 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.424 ' N ' ' HD2' ' A' ' 63' ' ' PRO . . . -74.23 -54.94 5.94 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 110.814 -0.914 . . . . 0.0 110.814 -179.881 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.424 ' HD2' ' N ' ' A' ' 62' ' ' GLY . 48.0 Cg_endo -74.85 122.02 7.01 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.531 2.154 . . . . 0.0 112.214 -179.932 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -99.46 137.06 38.49 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.082 179.818 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 12.8 m-80 -98.59 134.24 41.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.803 0.335 . . . . 0.0 110.343 -179.923 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -119.92 174.31 6.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.455 179.993 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 12.6 ptm180 -173.52 76.36 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.0 -0.546 . . . . 0.0 109.92 179.923 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.592 ' O ' HD23 ' A' ' 69' ' ' LEU . 3.5 p90 -61.42 175.19 0.61 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.192 0.52 . . . . 0.0 110.809 -179.56 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.812 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 8.0 mt -132.02 65.41 1.57 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.129 179.569 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 14.0 p -26.99 135.0 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.644 0.778 . . . . 0.0 112.633 -178.987 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.609 ' HG2' ' HB2' ' A' ' 29' ' ' ALA . 16.5 mt-10 -49.74 -26.0 3.46 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.54 -179.713 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.5 tmtm? -64.81 -40.31 95.0 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.317 179.898 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 118.86 53.46 0.28 Allowed Glycine 0 CA--C 1.524 0.604 0 N-CA-C 110.798 -0.921 . . . . 0.0 110.798 179.938 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -144.71 145.61 31.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.797 0.332 . . . . 0.0 110.47 179.964 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.585 ' HG2' HD22 ' A' ' 69' ' ' LEU . 0.8 OUTLIER -127.35 -178.87 4.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.312 179.976 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 174.31 162.92 0.2 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.526 179.964 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.507 HG12 ' N ' ' A' ' 78' ' ' PHE . 86.9 t -107.18 160.77 6.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.248 179.854 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.507 ' N ' HG12 ' A' ' 77' ' ' VAL . 71.8 m-85 -151.19 130.39 12.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.525 -179.92 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -115.0 160.56 19.44 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.313 -179.924 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 52.32 55.12 9.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.355 179.932 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.725 HG22 ' HD3' ' A' ' 94' ' ' PRO . 75.6 t -102.05 2.15 10.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.034 179.957 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.437 HG23 ' C ' ' A' ' 81' ' ' VAL . 89.3 t -156.26 131.45 5.37 Favored Pre-proline 0 C--N 1.332 -0.154 0 N-CA-C 110.229 -0.286 . . . . 0.0 110.229 179.556 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -70.98 -171.16 0.54 Allowed 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.516 2.144 . . . . 0.0 111.863 179.761 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -74.0 -27.85 61.17 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.883 179.386 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 4.0 tptt -138.46 77.66 1.64 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.093 179.779 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 0.437 ' HB3' HG13 ' A' ' 82' ' ' VAL . 51.0 p90 -55.05 137.28 46.74 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.589 -179.795 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 5.3 m -116.32 107.29 14.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.12 179.717 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 2.7 mp -47.76 108.39 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.582 -179.872 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 126.05 43.36 0.28 Allowed Glycine 0 CA--C 1.523 0.569 0 N-CA-C 110.587 -1.005 . . . . 0.0 110.587 -179.864 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.781 ' O ' HG23 ' A' ' 7' ' ' THR . . . -153.8 -176.32 5.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.796 0.331 . . . . 0.0 110.389 -179.948 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 89.9 m -129.74 104.44 7.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.669 -179.84 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.473 ' O ' ' HB2' ' A' ' 93' ' ' ALA . 18.5 m-85 -106.97 140.27 40.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.463 179.901 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.826 ' HB1' ' HD2' ' A' ' 94' ' ' PRO . . . 171.75 171.7 0.2 Allowed Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.389 179.593 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.826 ' HD2' ' HB1' ' A' ' 93' ' ' ALA . 47.6 Cg_endo . . . . . 0 C--O 1.249 1.032 0 C-N-CA 122.606 2.204 . . . . 0.0 111.984 179.804 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.545 ' O ' HG22 ' A' ' 4' ' ' VAL . 18.4 mtmt . . . . . 0 CA--C 1.521 -0.158 0 CA-C-O 120.706 0.288 . . . . 0.0 110.403 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.79 ' O ' HG23 ' A' ' 5' ' ' THR . 19.5 m 44.22 -172.38 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.338 179.807 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.79 HG23 ' O ' ' A' ' 4' ' ' VAL . 0.5 OUTLIER -179.55 137.64 0.13 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.301 -179.761 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.626 ' O ' HG23 ' A' ' 91' ' ' THR . 8.2 m-85 -116.13 178.4 4.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.061 179.855 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.641 HG23 ' O ' ' A' ' 90' ' ' ALA . 48.2 m -164.43 124.06 1.96 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.873 0.368 . . . . 0.0 110.514 -179.94 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 90.1 t -58.64 90.33 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.449 179.99 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.859 ' HG3' HG11 ' A' ' 51' ' ' VAL . 1.9 mm-40 -59.1 176.04 0.25 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.432 -179.968 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 5.1 mtmt -69.72 155.37 40.62 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.27 179.878 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 103.37 -33.44 6.58 Favored Glycine 0 CA--C 1.523 0.533 0 N-CA-C 110.851 -0.899 . . . . 0.0 110.851 179.968 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 70.9 m -50.67 112.36 0.69 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.684 0.278 . . . . 0.0 110.316 179.969 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -112.69 -67.06 1.03 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.937 -179.685 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.404 ' HG3' ' HG2' ' A' ' 15' ' ' LYS . 6.6 pt-20 -141.46 -48.66 0.39 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.643 0.258 . . . . 0.0 110.93 -179.702 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.404 ' HG2' ' HG3' ' A' ' 14' ' ' GLU . 8.9 ptpt -103.93 -39.38 6.62 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.766 0.317 . . . . 0.0 110.498 -179.944 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 13.2 m80 -65.94 110.26 2.83 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 179.794 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.508 HD22 ' HA ' ' A' ' 17' ' ' LEU . 0.3 OUTLIER -107.21 94.87 5.33 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.41 -179.772 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.621 ' HB2' HG22 ' A' ' 53' ' ' THR . . . -95.34 120.44 35.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.381 179.987 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.431 HG11 ' CZ ' ' A' ' 66' ' ' PHE . 21.1 m -114.42 144.24 22.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.218 179.899 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.519 ' HA ' HG12 ' A' ' 51' ' ' VAL . 1.5 tt -97.54 62.53 1.7 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.758 -179.718 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.523 ' CG1' ' CD1' ' A' ' 52' ' ' TRP . 3.4 p -81.75 126.02 39.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.971 0.415 . . . . 0.0 110.103 179.74 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.494 ' O ' ' CG ' ' A' ' 23' ' ' TYR . 5.8 tttp -166.33 -66.98 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.312 -179.863 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.494 ' CG ' ' O ' ' A' ' 22' ' ' LYS . 30.0 p90 44.97 -172.96 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.906 179.824 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -122.06 177.66 5.23 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.353 -179.724 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 96.95 -40.7 2.49 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 110.772 -0.931 . . . . 0.0 110.772 179.949 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -128.99 -175.11 3.45 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.812 0.339 . . . . 0.0 110.266 179.968 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.403 ' OG1' ' HE2' ' A' ' 72' ' ' LYS . 0.8 OUTLIER -113.25 -178.98 3.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.548 -179.98 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.504 ' CE ' HG22 ' A' ' 21' ' ' VAL . 0.4 OUTLIER -128.56 126.66 40.78 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.462 -179.882 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.898 ' HB3' ' O ' ' A' ' 69' ' ' LEU . . . -120.12 -59.85 1.75 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.393 179.957 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -142.8 159.0 43.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.291 179.986 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.818 HG21 ' NE1' ' A' ' 52' ' ' TRP . 47.2 t -138.54 145.98 27.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.038 0.447 . . . . 0.0 110.435 179.96 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.453 ' HB2' ' HA ' ' A' ' 43' ' ' ALA . 11.6 tt0 -139.79 129.53 24.58 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.891 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.713 HD12 ' H ' ' A' ' 34' ' ' ARG . 5.6 tp -110.35 150.19 29.13 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.962 0.411 . . . . 0.0 110.049 -179.027 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.713 ' H ' HD12 ' A' ' 33' ' ' LEU . 0.5 OUTLIER -106.22 -156.31 0.57 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.548 179.462 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.406 ' O ' ' HB2' ' A' ' 36' ' ' HIS . 1.0 OUTLIER -149.73 -87.69 0.08 Allowed 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 121.235 -0.186 . . . . 0.0 110.631 179.883 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 36' ' ' HIS . . . . . 0.406 ' HB2' ' O ' ' A' ' 35' ' ' GLU . 17.3 t-160 175.48 -56.97 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 -179.976 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -91.36 -25.82 22.65 Favored Glycine 0 CA--C 1.522 0.513 0 N-CA-C 110.467 -1.053 . . . . 0.0 110.467 179.607 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.41 ' O ' ' CB ' ' A' ' 39' ' ' ASP . 0.1 OUTLIER -50.66 -31.66 16.87 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.871 0.367 . . . . 0.0 110.327 179.87 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.41 ' CB ' ' O ' ' A' ' 38' ' ' SER . 11.2 t0 81.75 -52.33 0.25 Allowed 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.882 179.856 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -98.24 177.38 5.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.969 0.414 . . . . 0.0 110.753 -179.619 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.425 ' CD2' ' HG3' ' A' ' 34' ' ' ARG . 59.8 m95 -95.96 171.97 8.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.383 -179.946 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.434 ' CG2' ' O ' ' A' ' 33' ' ' LEU . 5.1 m -146.86 105.64 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.201 179.621 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.453 ' HA ' ' HB2' ' A' ' 32' ' ' GLU . . . -49.94 136.49 18.39 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.697 -179.693 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -63.33 -173.09 0.06 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.896 -179.791 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 30.2 m -137.66 99.97 4.08 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.372 -179.999 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 6.5 ptpt -64.51 80.38 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.47 -179.905 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -113.11 -24.78 4.69 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.88 -0.888 . . . . 0.0 110.88 -179.969 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -72.73 -37.28 67.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.894 0.378 . . . . 0.0 110.473 179.987 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 95.65 -38.68 3.04 Favored Glycine 0 CA--C 1.523 0.541 0 N-CA-C 110.274 -1.13 . . . . 0.0 110.274 -179.654 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -102.17 -29.9 5.89 Favored Glycine 0 CA--C 1.523 0.539 0 N-CA-C 110.42 -1.072 . . . . 0.0 110.42 179.734 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.859 HG11 ' HG3' ' A' ' 9' ' ' GLU . 8.0 m -138.49 -178.47 2.0 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.768 0.318 . . . . 0.0 110.273 179.773 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 52' ' ' TRP . . . . . 0.818 ' NE1' HG21 ' A' ' 31' ' ' VAL . 5.5 m95 -114.97 136.98 52.53 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.893 0.378 . . . . 0.0 110.772 -179.414 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.621 HG22 ' HB2' ' A' ' 18' ' ' ALA . 10.2 p -126.39 151.08 48.14 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.732 179.452 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.412 ' CZ ' ' HB ' ' A' ' 42' ' ' VAL . 63.9 t80 -141.24 152.79 44.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.941 0.401 . . . . 0.0 110.921 -179.634 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -94.02 102.06 14.12 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.106 179.714 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.1 m -83.73 139.11 32.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.712 -179.702 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -100.06 -49.93 4.15 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.243 179.823 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.454 ' HA ' ' HD3' ' A' ' 59' ' ' PRO . 12.3 pt-20 -74.3 126.46 88.97 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.313 179.963 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 58' ' ' GLU . 38.0 Cg_endo -91.97 71.28 0.78 Allowed 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 123.159 2.572 . . . . 0.0 112.066 179.627 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -106.84 -30.34 8.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.058 0.456 . . . . 0.0 110.375 -179.936 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 44.33 36.48 1.61 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.942 179.933 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -94.04 -144.71 16.28 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 110.895 -0.882 . . . . 0.0 110.895 -179.83 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -78.63 120.79 4.88 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.608 2.205 . . . . 0.0 112.291 -179.821 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.401 ' HB3' ' CD1' ' A' ' 33' ' ' LEU . 30.7 m-85 -90.76 178.4 6.07 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.1 179.81 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -152.78 139.77 19.17 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.936 179.81 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.478 ' CE1' HD13 ' A' ' 33' ' ' LEU . 11.0 m-85 -127.68 177.25 6.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.05 0.452 . . . . 0.0 111.136 -179.775 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.412 ' CB ' ' O ' ' A' ' 76' ' ' ASN . 0.0 OUTLIER -177.16 66.89 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.592 179.976 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.676 ' HZ ' HG11 ' A' ' 4' ' ' VAL . 0.4 OUTLIER -58.47 173.65 0.37 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.252 -179.277 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.898 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 10.2 mt -123.94 83.33 2.13 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.307 -0.86 . . . . 0.0 108.896 178.884 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.418 ' OG1' ' N ' ' A' ' 74' ' ' MET . 1.6 p -35.55 137.08 0.2 Allowed 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.799 -178.954 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.746 ' HA ' ' HB2' ' A' ' 29' ' ' ALA . 21.0 mt-10 -46.71 -34.51 5.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.171 -179.16 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.406 ' O ' ' HD3' ' A' ' 72' ' ' LYS . 0.0 OUTLIER -155.99 60.03 0.59 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.776 0.322 . . . . 0.0 111.017 179.867 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -148.79 -107.18 0.43 Allowed Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.803 -0.919 . . . . 0.0 110.803 179.646 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.418 ' N ' ' OG1' ' A' ' 70' ' ' THR . 21.0 ptm -159.9 -176.42 5.69 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.846 0.355 . . . . 0.0 110.182 179.864 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.01 159.7 20.48 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.638 -179.762 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.412 ' O ' ' CB ' ' A' ' 67' ' ' ARG . 10.7 m-20 -152.43 175.06 13.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.098 -179.953 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.501 HG12 ' N ' ' A' ' 78' ' ' PHE . 49.5 t -110.24 160.98 8.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.434 -179.907 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.501 ' N ' HG12 ' A' ' 77' ' ' VAL . 75.9 m-85 -149.85 129.2 12.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.396 -179.922 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 15.2 p-10 -116.47 164.97 13.77 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.35 -179.999 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 32.3 m-20 52.35 27.29 4.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.524 179.959 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.47 HG13 ' CD1' ' A' ' 6' ' ' PHE . 88.3 t -61.79 -16.36 15.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.677 179.838 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.498 HG13 ' HD2' ' A' ' 83' ' ' PRO . 54.3 t -150.06 138.92 12.73 Favored Pre-proline 0 C--N 1.331 -0.228 0 N-CA-C 110.292 -0.262 . . . . 0.0 110.292 179.945 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.498 ' HD2' HG13 ' A' ' 82' ' ' VAL . 47.8 Cg_endo -72.28 -175.62 1.84 Allowed 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.592 2.195 . . . . 0.0 111.978 179.86 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 26.4 mm-40 -69.45 -54.87 12.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.21 179.849 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 10.5 tttt -113.9 67.4 0.67 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.237 179.98 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 30.8 p90 -57.64 174.42 0.23 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.676 -179.819 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 27.1 m -150.8 120.21 6.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.07 179.827 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.558 ' H ' HD12 ' A' ' 88' ' ' ILE . 3.9 mp -48.96 104.31 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.742 -179.752 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 133.43 53.4 0.08 OUTLIER Glycine 0 CA--C 1.523 0.561 0 N-CA-C 110.814 -0.914 . . . . 0.0 110.814 179.992 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.641 ' O ' HG23 ' A' ' 7' ' ' THR . . . -173.71 140.79 0.79 Allowed 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 110.228 -0.286 . . . . 0.0 110.228 179.92 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.626 HG23 ' O ' ' A' ' 6' ' ' PHE . 25.1 m -97.43 89.25 4.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.909 0.385 . . . . 0.0 110.626 -179.89 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.578 ' O ' ' HB3' ' A' ' 93' ' ' ALA . 43.6 m-85 -70.2 -156.94 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.042 -0.526 . . . . 0.0 109.874 179.56 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.883 ' HB1' ' HD2' ' A' ' 94' ' ' PRO . . . 76.65 173.71 0.09 OUTLIER Pre-proline 0 N--CA 1.464 0.24 0 CA-C-O 120.809 0.338 . . . . 0.0 110.69 179.853 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.883 ' HD2' ' HB1' ' A' ' 93' ' ' ALA . 47.5 Cg_endo . . . . . 0 C--O 1.249 1.063 0 C-N-CA 122.583 2.189 . . . . 0.0 112.096 179.891 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.523 -0.092 0 CA-C-O 120.792 0.329 . . . . 0.0 110.205 . . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.533 ' CG1' ' CE1' ' A' ' 78' ' ' PHE . 1.7 p -115.09 163.38 12.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.368 0.604 . . . . 0.0 110.569 -179.806 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.484 HG22 HG21 ' A' ' 91' ' ' THR . 0.6 OUTLIER -134.31 148.76 50.82 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.048 179.729 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.692 ' O ' HG23 ' A' ' 91' ' ' THR . 24.8 m-85 -118.52 171.79 7.92 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.389 -179.944 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.9 m -167.81 131.8 1.73 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.007 -179.952 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.853 ' O ' HG23 ' A' ' 88' ' ' ILE . 34.8 t -82.21 94.68 2.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.537 -179.728 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.438 ' HG3' HG11 ' A' ' 51' ' ' VAL . 11.6 mt-10 -54.4 178.26 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.513 -179.921 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 4.1 mmmt -85.89 52.35 2.45 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.514 179.936 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -139.69 23.68 2.78 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 110.86 -0.896 . . . . 0.0 110.86 179.974 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 19.0 m -109.89 127.26 54.61 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 110.168 -0.308 . . . . 0.0 110.168 179.944 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -121.85 -87.61 0.64 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.471 -179.863 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 39.0 tp10 -117.61 -61.92 1.63 Allowed 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 120.826 0.346 . . . . 0.0 110.12 -179.79 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.423 ' CE ' ' HG3' ' A' ' 57' ' ' GLU . 5.5 ptpt -98.69 -21.56 16.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.746 -179.847 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 5.4 m80 -73.73 135.48 43.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.835 0.35 . . . . 0.0 110.282 179.926 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.486 ' HA ' HD22 ' A' ' 17' ' ' LEU . 0.2 OUTLIER -133.44 100.14 4.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.243 -179.968 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -97.12 145.1 26.32 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.377 -179.95 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.682 HG23 HG23 ' A' ' 21' ' ' VAL . 14.5 m -139.83 134.19 37.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.579 -179.871 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.439 ' HA ' ' CG1' ' A' ' 51' ' ' VAL . 1.3 tt -83.22 64.0 7.5 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.435 179.876 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.682 HG23 HG23 ' A' ' 19' ' ' VAL . 17.2 t -74.04 87.12 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.272 -179.978 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 7.3 tttp -176.61 120.52 0.14 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.401 -179.966 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 27.3 p90 -130.81 29.06 4.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.291 179.99 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 53.91 -177.15 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.327 -179.889 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 77.21 -66.02 2.95 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 110.714 -0.954 . . . . 0.0 110.714 -179.952 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -84.65 179.27 7.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.775 0.322 . . . . 0.0 110.315 179.922 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.409 ' HB ' ' CG ' ' A' ' 71' ' ' GLU . 0.0 OUTLIER -115.47 170.78 8.15 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.275 179.906 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 11.9 mmt -113.65 126.2 55.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.739 -179.712 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.767 ' HB3' ' O ' ' A' ' 69' ' ' LEU . . . -115.82 -60.87 1.81 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.223 -179.804 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -158.19 161.47 37.84 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.551 179.776 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.945 HG21 ' CD1' ' A' ' 52' ' ' TRP . 12.0 t -136.78 142.79 36.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.316 0.579 . . . . 0.0 111.407 -179.723 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.457 ' CG ' ' HB3' ' A' ' 41' ' ' TRP . 2.5 tp10 -137.5 122.68 19.25 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-N 115.105 -0.952 . . . . 0.0 108.911 -179.827 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.813 HD12 ' N ' ' A' ' 34' ' ' ARG . 2.9 pp -110.66 179.5 4.05 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.254 0.549 . . . . 0.0 111.492 -179.036 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.813 ' N ' HD12 ' A' ' 33' ' ' LEU . 9.4 ttt180 -148.94 170.79 17.53 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.141 179.417 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.407 ' O ' ' HB2' ' A' ' 36' ' ' HIS . 5.2 mt-10 -119.97 -82.83 0.65 Allowed 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 179.906 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 36' ' ' HIS . . . . . 0.407 ' HB2' ' O ' ' A' ' 35' ' ' GLU . 1.0 OUTLIER 178.33 -56.98 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.311 179.383 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -66.02 -28.03 73.33 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 110.697 -0.961 . . . . 0.0 110.697 179.959 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -61.3 166.76 3.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.756 0.312 . . . . 0.0 110.366 179.941 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -121.47 25.66 9.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.487 -179.978 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -179.5 149.13 0.37 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.277 179.968 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.512 ' CE3' ' HG2' ' A' ' 67' ' ' ARG . 58.2 m95 -64.68 160.57 19.59 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.506 -179.983 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.552 HG23 ' O ' ' A' ' 42' ' ' VAL . 31.5 m -130.33 109.61 17.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.174 179.796 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.42 ' N ' ' OE2' ' A' ' 32' ' ' GLU . . . -49.11 124.73 9.37 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.725 -179.658 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.491 ' HG2' HD23 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -57.04 -171.3 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.116 179.77 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 30.5 m -152.11 119.05 5.8 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.58 -179.923 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 14.2 ptpt -74.78 67.52 1.62 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.07 179.708 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -98.16 -19.95 22.14 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 111.21 -0.756 . . . . 0.0 111.21 -179.749 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.453 ' HG2' ' CG2' ' A' ' 51' ' ' VAL . 30.9 tp10 -77.76 -45.06 25.71 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.767 0.317 . . . . 0.0 110.388 -179.884 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 117.58 -63.28 0.4 Allowed Glycine 0 CA--C 1.523 0.561 0 N-CA-C 110.708 -0.957 . . . . 0.0 110.708 179.977 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -84.47 -30.01 28.52 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 110.718 -0.953 . . . . 0.0 110.718 179.97 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.453 ' CG2' ' HG2' ' A' ' 48' ' ' GLU . 6.3 m -132.53 -179.44 3.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.881 0.372 . . . . 0.0 110.437 179.953 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 52' ' ' TRP . . . . . 0.945 ' CD1' HG21 ' A' ' 31' ' ' VAL . 5.4 m95 -103.72 125.93 50.52 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.183 -179.823 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -118.05 160.66 21.11 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.406 -179.945 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 26.7 t80 -138.21 128.12 25.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.42 -179.966 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 19.7 p-10 -102.18 115.98 31.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.441 179.988 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 4.0 m -170.54 161.5 7.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.203 179.928 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.423 ' HG3' ' CE ' ' A' ' 15' ' ' LYS . 5.3 mt-10 -132.03 26.2 4.59 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.542 -179.903 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.95 156.51 25.47 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.311 179.882 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -72.49 69.42 3.44 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.641 2.227 . . . . 0.0 112.173 -179.942 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.7 pp -81.54 127.49 32.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.366 179.909 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -132.38 32.4 3.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.475 -179.999 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -156.13 -170.29 21.23 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 110.863 -0.895 . . . . 0.0 110.863 -179.996 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.406 ' HG3' ' HA ' ' A' ' 80' ' ' ASP . 49.0 Cg_endo -78.32 165.75 25.18 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.721 2.281 . . . . 0.0 112.039 -179.916 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -98.16 105.3 17.43 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.464 179.962 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 17.8 m-80 -77.51 140.65 39.8 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 179.191 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.5 ' CE1' ' HB3' ' A' ' 33' ' ' LEU . 37.1 m-85 -121.57 -178.56 3.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.157 0.503 . . . . 0.0 111.245 -179.245 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.512 ' HG2' ' CE3' ' A' ' 41' ' ' TRP . 0.0 OUTLIER 173.95 59.09 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.728 179.973 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.461 ' HA ' ' HA ' ' A' ' 31' ' ' VAL . 1.2 p90 -50.86 165.24 0.11 Allowed 'General case' 0 CA--C 1.517 -0.321 0 CA-C-O 121.219 0.533 . . . . 0.0 111.054 -179.323 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.767 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 2.2 mt -115.9 63.33 0.7 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.118 179.671 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 12.0 p -29.95 138.22 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 115.594 -0.73 . . . . 0.0 112.476 -179.019 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.62 ' HG2' ' HB2' ' A' ' 29' ' ' ALA . 16.4 mt-10 -52.36 -36.11 52.88 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.364 -179.952 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.09 65.74 1.15 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.505 -179.835 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -151.23 -106.92 0.35 Allowed Glycine 0 CA--C 1.522 0.484 0 N-CA-C 110.58 -1.008 . . . . 0.0 110.58 179.965 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 16.1 ptt? -175.32 176.17 2.07 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.805 0.336 . . . . 0.0 110.194 179.919 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.476 ' CD ' ' N ' ' A' ' 75' ' ' LYS . 0.0 OUTLIER -94.62 120.78 35.39 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.141 179.924 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.423 ' O ' ' CB ' ' A' ' 67' ' ' ARG . 65.5 m-80 -112.05 168.69 9.4 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.727 -179.596 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 94.1 t -120.48 153.23 23.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.046 179.68 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.533 ' CE1' ' CG1' ' A' ' 4' ' ' VAL . 45.6 m-85 -152.9 130.71 11.66 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.576 -179.817 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 36.9 m-20 -118.71 149.55 41.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.178 179.867 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.406 ' HA ' ' HG3' ' A' ' 63' ' ' PRO . 27.9 t0 64.12 42.88 5.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.435 179.98 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.506 ' O ' HG12 ' A' ' 81' ' ' VAL . 76.2 t -86.28 -6.35 10.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.054 179.827 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.421 HG23 ' C ' ' A' ' 81' ' ' VAL . 96.8 t -155.69 115.07 2.24 Favored Pre-proline 0 CA--C 1.528 0.1 0 N-CA-C 110.217 -0.29 . . . . 0.0 110.217 179.795 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -73.55 -170.9 0.73 Allowed 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.417 2.078 . . . . 0.0 112.014 179.862 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -90.67 125.63 35.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.167 179.808 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 64.74 42.46 4.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.094 -179.784 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 0.445 ' HB2' ' CE2' ' A' ' 92' ' ' TYR . 27.1 p90 -50.76 177.53 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.771 -179.776 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 70.9 m -132.23 110.01 10.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.939 179.692 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.853 HG23 ' O ' ' A' ' 8' ' ' VAL . 3.2 mp -46.16 124.38 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.729 -179.728 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 106.68 55.68 0.65 Allowed Glycine 0 CA--C 1.524 0.596 0 N-CA-C 110.833 -0.907 . . . . 0.0 110.833 179.958 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -179.6 141.11 0.15 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.808 0.337 . . . . 0.0 110.578 179.986 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.692 HG23 ' O ' ' A' ' 6' ' ' PHE . 8.2 m -83.89 131.3 34.88 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.042 179.726 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.445 ' CE2' ' HB2' ' A' ' 86' ' ' TYR . 59.5 m-85 -113.54 -23.02 10.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.937 -179.36 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.896 ' HB1' ' HD2' ' A' ' 94' ' ' PRO . . . -51.02 -179.82 0.04 OUTLIER Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.332 179.844 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.896 ' HD2' ' HB1' ' A' ' 93' ' ' ALA . 50.1 Cg_endo . . . . . 0 C--O 1.249 1.027 0 C-N-CA 122.579 2.186 . . . . 0.0 112.071 -179.862 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 15.0 mtpp . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.794 0.331 . . . . 0.0 110.377 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.587 HG22 ' CE2' ' A' ' 78' ' ' PHE . 19.4 m -51.59 -178.65 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.32 179.902 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.444 HG23 ' O ' ' A' ' 4' ' ' VAL . 20.0 p -155.56 134.23 11.88 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.481 179.965 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.721 ' O ' HG23 ' A' ' 91' ' ' THR . 37.4 m-85 -97.89 175.72 6.04 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.15 179.87 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.41 ' HB ' ' CB ' ' A' ' 20' ' ' LEU . 0.5 OUTLIER -164.4 107.05 0.9 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.857 0.361 . . . . 0.0 110.537 -179.981 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 40.7 t -60.81 85.27 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.255 179.948 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.85 ' CD ' HG11 ' A' ' 51' ' ' VAL . 0.8 OUTLIER -50.42 143.97 8.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.673 -179.773 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.445 ' HA ' ' CG2' ' A' ' 88' ' ' ILE . 0.1 OUTLIER -67.4 142.1 56.82 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.276 179.899 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 117.95 14.08 6.84 Favored Glycine 0 CA--C 1.527 0.795 0 N-CA-C 111.41 -0.676 . . . . 0.0 111.41 179.839 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 39.4 m -55.65 104.6 0.14 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.961 0.381 . . . . 0.0 109.987 179.731 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -57.85 -164.91 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.602 -179.589 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -56.68 -48.09 78.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.091 -179.345 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 8.8 pttt -136.13 33.78 2.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.944 -179.391 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 5.2 m80 -111.93 156.56 21.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.804 0.335 . . . . 0.0 110.279 179.703 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 28.9 tp -137.01 103.63 5.2 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.684 -179.77 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -90.7 124.3 34.98 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.068 -0.515 . . . . 0.0 109.894 179.574 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.643 HG23 HG23 ' A' ' 21' ' ' VAL . 32.6 m -117.45 138.82 46.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.827 0.346 . . . . 0.0 110.653 -179.698 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.41 ' CB ' ' HB ' ' A' ' 7' ' ' THR . 0.7 OUTLIER -94.64 69.59 3.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.452 179.96 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.643 HG23 HG23 ' A' ' 19' ' ' VAL . 18.8 t -80.11 90.01 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.394 -0.367 . . . . 0.0 110.246 179.991 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -151.97 129.16 11.18 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.504 -179.958 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 15.0 p90 -154.53 176.75 11.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.262 179.843 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -105.43 96.64 6.65 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.358 179.992 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -179.99 -51.5 0.08 OUTLIER Glycine 0 CA--C 1.523 0.54 0 N-CA-C 110.594 -1.002 . . . . 0.0 110.594 -179.912 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -126.58 155.22 42.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.738 0.304 . . . . 0.0 110.296 179.939 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.16 -176.98 6.44 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.406 -179.984 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.426 ' O ' ' CG ' ' A' ' 71' ' ' GLU . 41.0 mtm -117.23 122.24 43.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.623 -179.743 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.809 ' HB3' ' O ' ' A' ' 69' ' ' LEU . . . -122.23 -53.31 1.93 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.276 179.922 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -158.04 164.2 36.96 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.146 179.948 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.478 HG21 ' CD1' ' A' ' 52' ' ' TRP . 12.2 t -147.26 149.83 15.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.633 179.968 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.453 ' CB ' ' HA ' ' A' ' 43' ' ' ALA . 0.3 OUTLIER -158.81 130.56 6.53 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.07 179.966 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.799 HD12 ' N ' ' A' ' 34' ' ' ARG . 3.5 pp -110.99 -177.88 3.33 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.039 0.447 . . . . 0.0 110.998 -179.44 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.799 ' N ' HD12 ' A' ' 33' ' ' LEU . 1.3 ttp180 -143.06 162.09 36.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.007 179.724 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.419 ' HB2' ' HB2' ' A' ' 38' ' ' SER . 0.1 OUTLIER -129.51 25.59 5.4 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.198 179.643 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 49.32 94.15 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.817 179.838 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.414 ' O ' ' N ' ' A' ' 39' ' ' ASP . . . 98.23 -30.13 10.07 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 111.207 -0.757 . . . . 0.0 111.207 179.639 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.419 ' HB2' ' HB2' ' A' ' 35' ' ' GLU . 14.7 m -65.2 74.14 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.794 0.33 . . . . 0.0 110.703 -179.7 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.414 ' N ' ' O ' ' A' ' 37' ' ' GLY . 8.7 m-20 46.62 43.3 12.43 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.937 179.655 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 52.06 -173.55 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.926 0.393 . . . . 0.0 110.387 179.887 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.52 ' CZ3' ' HG2' ' A' ' 67' ' ' ARG . 80.7 m95 -44.86 144.2 1.24 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.945 -179.936 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.639 HG21 ' CE1' ' A' ' 54' ' ' PHE . 31.1 m -131.07 116.37 33.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.124 179.757 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.453 ' HA ' ' CB ' ' A' ' 32' ' ' GLU . . . -49.51 128.81 18.15 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.25 179.991 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -62.97 -172.13 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.287 -179.808 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 31.6 m -132.5 109.35 9.73 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.446 -179.9 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.43 ' HB3' ' CZ3' ' A' ' 52' ' ' TRP . 39.4 mtpt -85.49 106.58 16.93 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.327 -179.999 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 170.99 43.84 0.03 OUTLIER Glycine 0 CA--C 1.524 0.596 0 N-CA-C 110.749 -0.94 . . . . 0.0 110.749 -179.902 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.415 ' HB3' ' O ' ' A' ' 51' ' ' VAL . 24.3 tp10 -130.38 65.34 1.52 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.776 0.322 . . . . 0.0 110.457 179.939 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 67.42 -80.7 0.15 Allowed Glycine 0 CA--C 1.523 0.551 0 N-CA-C 110.75 -0.94 . . . . 0.0 110.75 179.987 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -146.49 21.09 1.69 Allowed Glycine 0 CA--C 1.526 0.737 0 N-CA-C 111.256 -0.737 . . . . 0.0 111.256 -179.954 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.85 HG11 ' CD ' ' A' ' 9' ' ' GLU . 29.6 m -138.85 170.45 16.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 110.159 -0.312 . . . . 0.0 110.159 179.764 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 52' ' ' TRP . . . . . 0.478 ' CD1' HG21 ' A' ' 31' ' ' VAL . 7.4 m95 -100.24 137.36 38.78 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.026 0.441 . . . . 0.0 111.032 -179.461 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.77 142.45 49.55 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.546 179.31 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.754 ' CG ' HD21 ' A' ' 33' ' ' LEU . 27.7 t80 -108.01 116.14 31.41 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.963 0.411 . . . . 0.0 110.691 -179.547 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 57.9 t0 -107.49 130.2 54.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.112 179.847 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -158.26 -177.65 6.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.908 0.385 . . . . 0.0 110.517 -179.884 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -99.52 -26.23 14.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.448 -179.945 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -50.39 159.09 0.9 Allowed Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.483 -179.945 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -70.56 -20.6 30.87 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.554 2.17 . . . . 0.0 111.856 179.673 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.4 tp 57.12 101.87 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.519 179.739 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -173.97 71.04 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.35 180.0 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.434 ' O ' ' CE2' ' A' ' 64' ' ' PHE . . . 175.46 -158.07 25.07 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 110.762 -0.935 . . . . 0.0 110.762 -179.974 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -78.86 169.71 19.09 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.604 2.203 . . . . 0.0 112.086 -179.949 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.434 ' CE2' ' O ' ' A' ' 62' ' ' GLY . 72.4 m-85 -151.27 111.87 4.21 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.515 -179.968 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 12.0 m-80 -81.13 153.21 27.4 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 179.445 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.541 ' CD2' ' CE2' ' A' ' 6' ' ' PHE . 21.0 m-85 -128.75 178.17 6.54 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.14 0.495 . . . . 0.0 111.257 -179.769 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.52 ' HG2' ' CZ3' ' A' ' 41' ' ' TRP . 0.1 OUTLIER 171.85 78.71 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.552 179.864 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.669 ' C ' HD23 ' A' ' 69' ' ' LEU . 1.3 p90 -78.11 169.0 19.0 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.186 0.517 . . . . 0.0 110.932 -179.295 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.809 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 2.4 mt -118.16 71.91 0.85 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.234 179.528 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.414 ' OG1' ' N ' ' A' ' 74' ' ' MET . 28.4 p -36.75 140.55 0.15 Allowed 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.742 -179.108 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.613 ' HG2' ' HB2' ' A' ' 29' ' ' ALA . 17.7 mt-10 -48.9 -57.34 6.6 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.635 -179.7 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.43 52.28 2.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.441 179.958 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -129.8 -108.7 1.32 Allowed Glycine 0 CA--C 1.523 0.567 0 N-CA-C 110.636 -0.985 . . . . 0.0 110.636 179.917 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.414 ' N ' ' OG1' ' A' ' 70' ' ' THR . 2.4 ptm -173.12 168.13 4.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.838 0.351 . . . . 0.0 110.35 -179.993 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.542 ' HD2' HD22 ' A' ' 69' ' ' LEU . 0.6 OUTLIER -77.95 166.71 22.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.231 179.857 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -171.03 164.69 7.52 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.311 179.917 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 98.1 t -130.37 142.26 44.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.163 179.943 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.587 ' CE2' HG22 ' A' ' 4' ' ' VAL . 86.3 m-85 -134.04 132.69 40.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.602 -179.818 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -119.54 162.22 19.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.276 179.844 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 55.03 39.88 31.77 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.312 -179.871 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.669 HG22 ' HD3' ' A' ' 94' ' ' PRO . 47.0 t -86.62 -10.23 11.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.818 -179.978 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 98.7 t -148.49 130.7 7.64 Favored Pre-proline 0 CA--C 1.529 0.137 0 N-CA-C 110.301 -0.259 . . . . 0.0 110.301 179.782 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.489 ' HD3' ' CD1' ' A' ' 92' ' ' TYR . 47.5 Cg_endo -70.73 -174.35 1.07 Allowed 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.534 2.156 . . . . 0.0 111.819 179.575 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -58.3 -63.94 1.09 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.004 179.668 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -108.76 86.57 2.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.114 179.622 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 31.8 p90 -52.83 150.65 5.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.753 -179.641 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 27.9 m -122.21 101.67 7.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.982 179.748 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.445 ' CG2' ' HA ' ' A' ' 10' ' ' LYS . 2.7 mp -44.36 116.48 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.005 -179.673 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 106.72 56.06 0.64 Allowed Glycine 0 CA--C 1.523 0.593 0 N-CA-C 110.812 -0.915 . . . . 0.0 110.812 179.854 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -174.03 142.72 0.87 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.898 0.38 . . . . 0.0 110.731 179.984 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.721 HG23 ' O ' ' A' ' 6' ' ' PHE . 10.0 m -87.69 133.65 33.8 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.044 -0.525 . . . . 0.0 109.881 179.561 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.489 ' CD1' ' HD3' ' A' ' 83' ' ' PRO . 65.5 m-85 -117.09 -86.07 0.63 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.022 -179.266 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.894 ' HB1' ' HD2' ' A' ' 94' ' ' PRO . . . 50.59 179.86 0.02 OUTLIER Pre-proline 0 C--N 1.332 -0.192 0 CA-C-O 120.723 0.297 . . . . 0.0 110.438 -179.714 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.894 ' HD2' ' HB1' ' A' ' 93' ' ' ALA . 48.8 Cg_endo . . . . . 0 C--O 1.249 1.066 0 C-N-CA 122.586 2.191 . . . . 0.0 112.097 -179.846 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 9.0 mtmt . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.767 0.318 . . . . 0.0 110.44 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.633 HG11 ' CZ ' ' A' ' 78' ' ' PHE . 1.7 p -58.55 163.66 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.268 0.556 . . . . 0.0 110.337 -179.919 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.479 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 5.7 p -148.09 130.6 15.8 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.466 179.907 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.485 ' O ' HG23 ' A' ' 91' ' ' THR . 11.7 m-85 -98.87 175.25 6.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.258 -179.994 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.657 HG23 ' O ' ' A' ' 90' ' ' ALA . 2.0 m -166.47 107.74 0.69 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.297 -179.966 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.47 HG11 ' CD1' ' A' ' 86' ' ' TYR . 47.8 t -55.34 99.82 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.402 179.997 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.487 ' HG3' HG11 ' A' ' 51' ' ' VAL . 2.5 mt-10 -72.29 174.49 7.2 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.596 -179.836 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.04 178.8 0.78 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.385 -179.966 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 67.24 26.81 73.42 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 110.784 -0.926 . . . . 0.0 110.784 179.939 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.62 ' OG ' HD11 ' A' ' 88' ' ' ILE . 85.3 p -87.49 109.25 19.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.767 0.317 . . . . 0.0 110.445 -179.969 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 30.8 m-20 -112.73 -162.52 0.8 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.236 179.815 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -65.54 -60.07 3.32 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.416 179.997 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -94.6 20.26 8.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.905 -179.727 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 19.5 m80 -128.11 112.32 14.45 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.863 0.363 . . . . 0.0 110.462 -179.914 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.408 ' HA ' HD22 ' A' ' 17' ' ' LEU . 0.2 OUTLIER -119.03 99.27 6.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.281 179.966 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -95.29 132.58 40.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.182 179.877 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.584 HG23 HG23 ' A' ' 21' ' ' VAL . 25.7 m -132.43 137.35 54.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.428 -179.999 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.441 ' HA ' HG12 ' A' ' 51' ' ' VAL . 0.5 OUTLIER -87.88 90.18 8.28 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.393 179.833 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.584 HG23 HG23 ' A' ' 19' ' ' VAL . 27.2 t -90.24 101.24 12.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.369 -179.966 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -174.41 144.28 0.9 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.343 -179.926 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.458 ' CE1' ' HB2' ' A' ' 26' ' ' ASP . 5.9 p90 -158.48 62.79 0.43 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.502 -179.894 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 65.12 -71.33 0.08 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.779 179.719 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.427 ' N ' ' O ' ' A' ' 23' ' ' TYR . . . -75.26 -160.66 8.56 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 110.796 -0.922 . . . . 0.0 110.796 -179.879 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.512 ' OD1' HG22 ' A' ' 70' ' ' THR . 47.7 t0 64.55 127.99 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.793 0.33 . . . . 0.0 110.368 179.998 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.65 HG22 ' O ' ' A' ' 27' ' ' THR . 31.6 m -109.97 34.26 3.96 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.559 -179.933 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.522 ' O ' ' HB2' ' A' ' 29' ' ' ALA . 0.0 OUTLIER 49.25 -177.6 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.011 179.595 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.66 ' HB3' ' O ' ' A' ' 69' ' ' LEU . . . 168.62 -66.01 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.168 179.832 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.405 ' O ' ' HB2' ' A' ' 68' ' ' PHE . 0.5 OUTLIER -154.5 154.81 33.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.722 179.898 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.484 HG21 ' CD1' ' A' ' 52' ' ' TRP . 12.3 t -148.96 153.64 10.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.084 0.468 . . . . 0.0 111.092 -179.597 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.441 ' CG ' ' HD2' ' A' ' 67' ' ' ARG . 0.0 OUTLIER -163.37 147.72 10.89 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.896 -179.917 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.769 HD12 ' N ' ' A' ' 34' ' ' ARG . 3.4 pp -121.95 179.94 4.34 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.905 0.383 . . . . 0.0 110.942 -179.512 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.769 ' N ' HD12 ' A' ' 33' ' ' LEU . 4.7 ttt180 -133.96 167.13 21.16 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.078 179.847 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -128.21 9.11 6.15 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.281 -179.927 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 3.8 t60 67.98 -67.48 0.19 Allowed 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.766 0.317 . . . . 0.0 110.595 179.791 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -52.22 -53.02 33.05 Favored Glycine 0 CA--C 1.523 0.592 0 N-CA-C 110.972 -0.851 . . . . 0.0 110.972 -179.843 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 58.9 m -51.02 -28.71 10.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.771 0.32 . . . . 0.0 110.487 -179.839 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 24.9 t0 63.26 19.25 11.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.822 179.981 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -155.86 129.05 8.14 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.871 0.367 . . . . 0.0 110.479 179.898 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.501 ' CZ3' ' HG2' ' A' ' 67' ' ' ARG . 84.3 m95 -54.22 139.53 35.59 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.417 179.94 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.525 HG21 ' CZ ' ' A' ' 54' ' ' PHE . 28.4 m -115.35 111.87 37.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.28 -0.418 . . . . 0.0 109.908 179.575 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -46.49 136.1 7.82 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.669 -179.617 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.523 ' CE ' HD23 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -65.2 -170.03 0.05 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.234 -179.856 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 23.4 m -144.29 103.9 4.03 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.595 -179.881 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 9.0 ptpt -67.64 72.43 0.15 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.143 179.683 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -103.55 -39.08 2.64 Favored Glycine 0 CA--C 1.521 0.447 0 N-CA-C 110.671 -0.972 . . . . 0.0 110.671 -179.852 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.612 ' HG2' HG22 ' A' ' 51' ' ' VAL . 4.0 tt0 -75.86 134.18 40.39 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.811 0.339 . . . . 0.0 110.367 -179.967 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -78.36 74.65 2.04 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 110.74 -0.944 . . . . 0.0 110.74 -179.989 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 150.71 -52.89 0.5 Allowed Glycine 0 CA--C 1.522 0.52 0 N-CA-C 110.656 -0.978 . . . . 0.0 110.656 179.984 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.612 HG22 ' HG2' ' A' ' 48' ' ' GLU . 18.0 m -114.84 -177.95 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.795 0.331 . . . . 0.0 110.306 179.919 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 52' ' ' TRP . . . . . 0.484 ' CD1' HG21 ' A' ' 31' ' ' VAL . 13.6 m95 -109.57 141.44 42.07 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.709 -179.842 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.7 p -126.89 159.71 33.14 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.867 179.705 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.525 ' CZ ' HG21 ' A' ' 42' ' ' VAL . 57.1 t80 -130.86 125.33 33.31 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.861 0.363 . . . . 0.0 110.717 -179.664 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -85.09 63.11 7.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.177 179.78 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 52.3 p -57.04 147.06 25.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.436 -179.875 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.6 25.05 4.4 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.518 179.932 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -117.93 138.54 25.5 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.208 179.756 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -75.5 69.35 5.95 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.518 2.146 . . . . 0.0 112.164 -179.694 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 10.7 tp -151.22 106.68 3.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.394 179.898 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -102.02 62.99 0.9 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.037 0.446 . . . . 0.0 110.416 -179.92 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -109.02 -153.15 15.36 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 110.702 -0.959 . . . . 0.0 110.702 179.98 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -75.4 158.7 40.5 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.546 2.164 . . . . 0.0 111.953 179.96 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -131.21 105.28 7.56 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.668 -179.855 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 41.3 m-20 -68.82 168.65 12.99 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 179.432 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -144.74 174.69 10.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.141 0.495 . . . . 0.0 111.047 -179.815 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.501 ' HG2' ' CZ3' ' A' ' 41' ' ' TRP . 0.0 OUTLIER 175.57 54.98 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.559 -179.941 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.449 ' O ' HD23 ' A' ' 69' ' ' LEU . 1.0 OUTLIER -55.73 176.24 0.07 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.076 -179.377 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.721 HD22 ' HD2' ' A' ' 75' ' ' LYS . 11.6 mt -124.99 69.82 1.14 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.59 179.598 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.512 HG22 ' OD1' ' A' ' 26' ' ' ASP . 16.5 p -37.86 140.78 0.23 Allowed 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.928 -179.18 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.511 ' N ' ' HB2' ' A' ' 29' ' ' ALA . 0.0 OUTLIER -42.64 -44.91 4.45 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.355 179.988 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -54.74 -32.92 60.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.341 -179.994 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 105.67 53.59 0.76 Allowed Glycine 0 CA--C 1.522 0.531 0 N-CA-C 110.757 -0.937 . . . . 0.0 110.757 179.986 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 5.0 mmm -129.18 130.13 45.95 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.771 0.32 . . . . 0.0 110.537 179.991 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.721 ' HD2' HD22 ' A' ' 69' ' ' LEU . 0.0 OUTLIER -117.01 123.01 45.84 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.197 -0.456 . . . . 0.0 109.872 179.885 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.467 ' O ' ' CE2' ' A' ' 78' ' ' PHE . 6.4 m120 -134.21 126.16 29.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.377 -179.964 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 73.9 t -84.45 142.69 13.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.342 179.988 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.633 ' CZ ' HG11 ' A' ' 4' ' ' VAL . 23.2 m-85 -129.38 137.02 50.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.52 -179.883 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -114.17 147.57 38.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.219 179.9 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 58.04 49.35 11.76 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.191 -179.867 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.526 ' O ' HG12 ' A' ' 81' ' ' VAL . 99.4 t -86.09 -4.75 9.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.23 -179.843 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.444 HG23 ' C ' ' A' ' 81' ' ' VAL . 89.4 t -157.09 130.8 4.75 Favored Pre-proline 0 C--N 1.333 -0.149 0 N-CA-C 110.228 -0.286 . . . . 0.0 110.228 179.77 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.507 ' HD3' ' CG ' ' A' ' 92' ' ' TYR . 45.6 Cg_endo -70.18 -170.85 0.45 Allowed 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.589 2.193 . . . . 0.0 111.923 179.676 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 -76.24 -62.61 1.55 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.192 179.788 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.08 66.46 0.91 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.9 179.655 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 0.47 ' CD1' HG11 ' A' ' 8' ' ' VAL . 14.3 p90 -49.45 154.13 0.97 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.886 -179.606 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 39.4 m -133.07 109.51 9.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.024 179.751 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.62 HD11 ' OG ' ' A' ' 12' ' ' SER . 3.7 mp -46.25 100.44 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.908 -179.727 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 138.53 45.61 0.07 OUTLIER Glycine 0 CA--C 1.523 0.555 0 N-CA-C 110.86 -0.896 . . . . 0.0 110.86 179.868 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.657 ' O ' HG23 ' A' ' 7' ' ' THR . . . -162.98 174.61 12.1 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.825 0.345 . . . . 0.0 110.446 179.93 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.485 HG23 ' O ' ' A' ' 6' ' ' PHE . 94.6 m -119.57 126.98 52.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.237 179.88 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.507 ' CG ' ' HD3' ' A' ' 83' ' ' PRO . 42.0 m-85 -126.21 109.39 12.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.391 -179.906 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.91 ' HB1' ' HD2' ' A' ' 94' ' ' PRO . . . 172.14 176.47 0.15 Allowed Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.257 179.96 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.91 ' HD2' ' HB1' ' A' ' 93' ' ' ALA . 48.1 Cg_endo . . . . . 0 C--O 1.249 1.052 0 C-N-CA 122.558 2.172 . . . . 0.0 112.096 -179.948 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 9.8 mtpm? . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.819 0.342 . . . . 0.0 110.502 . . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.775 ' O ' HG23 ' A' ' 5' ' ' THR . 31.2 m -67.52 -175.78 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.496 179.993 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.775 HG23 ' O ' ' A' ' 4' ' ' VAL . 0.7 OUTLIER -171.65 153.87 3.53 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.31 179.849 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.502 ' CD2' ' HB ' ' A' ' 21' ' ' VAL . 51.2 m-85 -132.1 145.17 51.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.282 179.894 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.525 HG23 ' O ' ' A' ' 90' ' ' ALA . 68.3 m -133.45 130.71 39.0 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.348 -179.923 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.452 HG21 ' HB2' ' A' ' 86' ' ' TYR . 84.0 t -67.71 90.99 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.276 -179.992 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.94 ' HG3' HG11 ' A' ' 51' ' ' VAL . 6.3 mm-40 -56.21 167.91 0.59 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.401 -179.918 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.09 -18.36 65.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.918 -179.979 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -46.52 -29.33 3.91 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 111.102 -0.799 . . . . 0.0 111.102 -179.846 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 27.8 m -64.71 139.04 58.72 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.727 0.299 . . . . 0.0 110.386 179.928 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.1 p30 -139.05 -50.49 0.53 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.59 179.965 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -147.96 -78.04 0.16 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.405 -179.908 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.4 ' HD2' ' HG3' ' A' ' 57' ' ' GLU . 0.0 OUTLIER -101.18 9.67 41.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.219 -179.951 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 5.9 m80 -105.28 125.68 51.26 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.848 0.356 . . . . 0.0 110.358 -179.964 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.472 ' HA ' HD22 ' A' ' 17' ' ' LEU . 0.2 OUTLIER -110.14 104.11 12.92 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.296 179.981 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.847 ' HB2' HG22 ' A' ' 53' ' ' THR . . . -110.64 110.49 21.19 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.29 -179.993 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.407 ' O ' ' HG3' ' A' ' 9' ' ' GLU . 5.6 m -91.13 -168.61 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.04 0.448 . . . . 0.0 110.461 179.998 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.8 tt -141.46 83.39 1.86 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.506 179.905 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.527 ' CG1' ' CD1' ' A' ' 52' ' ' TRP . 2.1 p -102.53 97.68 5.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.007 179.892 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.483 ' O ' ' CG ' ' A' ' 23' ' ' TYR . 11.9 ttmt -145.45 -71.05 0.26 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.255 179.98 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.483 ' CG ' ' O ' ' A' ' 22' ' ' LYS . 30.6 p90 44.36 -170.23 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.067 179.807 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -123.32 146.49 47.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.272 179.972 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 133.76 -58.69 0.69 Allowed Glycine 0 CA--C 1.523 0.58 0 N-CA-C 110.85 -0.9 . . . . 0.0 110.85 179.962 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -112.76 -162.54 0.8 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.801 0.334 . . . . 0.0 110.379 -179.958 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -119.76 -174.72 2.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.478 179.968 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.423 ' O ' ' CG ' ' A' ' 71' ' ' GLU . 12.6 mtm -120.43 119.27 32.55 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.196 -179.976 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.827 ' HB3' ' O ' ' A' ' 69' ' ' LEU . . . -120.72 -60.6 1.65 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.632 -179.7 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.427 ' C ' HG12 ' A' ' 31' ' ' VAL . 0.1 OUTLIER -151.83 168.59 24.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.589 -179.811 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.452 ' HB ' ' HB3' ' A' ' 68' ' ' PHE . 0.2 OUTLIER -179.01 144.2 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.986 179.967 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.434 ' CB ' ' HA ' ' A' ' 43' ' ' ALA . 3.6 pt-20 -142.12 168.27 20.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.472 -0.786 . . . . 0.0 109.915 -179.771 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.715 HD12 ' N ' ' A' ' 34' ' ' ARG . 3.1 pp -121.73 174.69 6.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.869 0.366 . . . . 0.0 110.767 -179.791 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.715 ' N ' HD12 ' A' ' 33' ' ' LEU . 6.8 ttm180 -126.88 -94.61 0.45 Allowed 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.215 179.821 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.436 ' O ' ' CB ' ' A' ' 36' ' ' HIS . 0.0 OUTLIER 163.34 -35.78 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 120.703 0.287 . . . . 0.0 110.239 179.875 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 36' ' ' HIS . . . . . 0.436 ' CB ' ' O ' ' A' ' 35' ' ' GLU . 5.2 t-160 86.44 -16.5 0.42 Allowed 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.172 -179.626 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -104.14 -27.67 6.13 Favored Glycine 0 CA--C 1.522 0.516 0 N-CA-C 110.412 -1.075 . . . . 0.0 110.412 179.693 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -83.84 -159.1 0.35 Allowed 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 179.796 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 22.4 p30 -141.04 24.27 2.17 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.615 179.985 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -156.4 148.51 23.18 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.916 0.389 . . . . 0.0 110.472 179.909 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.504 ' CZ3' ' HG2' ' A' ' 67' ' ' ARG . 55.2 m95 -85.7 154.83 21.38 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.2 179.867 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.655 HG23 ' O ' ' A' ' 42' ' ' VAL . 34.3 m -124.16 106.26 16.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.914 0.387 . . . . 0.0 110.146 179.704 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.434 ' HA ' ' CB ' ' A' ' 32' ' ' GLU . . . -49.0 116.97 1.87 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.712 -179.757 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.644 ' HE2' HD23 ' A' ' 33' ' ' LEU . 0.6 OUTLIER -53.84 -172.06 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.387 179.909 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 31.6 m -151.05 122.74 8.01 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.423 -179.942 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 5.1 ptpt -68.41 67.79 0.13 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.083 179.698 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -90.96 -26.58 21.6 Favored Glycine 0 CA--C 1.522 0.483 0 N-CA-C 110.626 -0.99 . . . . 0.0 110.626 -179.929 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.467 ' HG2' HG22 ' A' ' 51' ' ' VAL . 9.8 tp10 -93.3 129.8 39.26 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.816 0.341 . . . . 0.0 110.231 179.946 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -74.03 66.25 1.84 Allowed Glycine 0 CA--C 1.523 0.565 0 N-CA-C 110.912 -0.875 . . . . 0.0 110.912 -179.84 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 158.65 -35.81 0.51 Allowed Glycine 0 CA--C 1.524 0.638 0 N-CA-C 111.085 -0.806 . . . . 0.0 111.085 179.809 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.94 HG11 ' HG3' ' A' ' 9' ' ' GLU . 30.4 m -135.81 -176.43 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.94 0.4 . . . . 0.0 110.859 -179.722 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 52' ' ' TRP . . . . . 0.527 ' CD1' ' CG1' ' A' ' 21' ' ' VAL . 6.1 m95 -101.85 134.29 45.27 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.494 -179.42 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.847 HG22 ' HB2' ' A' ' 18' ' ' ALA . 6.7 p -127.01 156.3 41.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.448 -179.847 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 50.6 t80 -137.99 124.32 20.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.409 179.904 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 20.6 p-10 -86.78 148.89 25.21 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.314 179.972 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -172.88 -179.36 2.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.482 -179.856 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.4 ' HG3' ' HD2' ' A' ' 15' ' ' LYS . 2.2 mt-10 -161.18 61.59 0.28 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.2 179.918 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.404 ' HB2' ' HD2' ' A' ' 59' ' ' PRO . 7.3 pt-20 -133.38 157.42 78.17 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.31 179.996 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.404 ' HD2' ' HB2' ' A' ' 58' ' ' GLU . 47.4 Cg_endo -70.87 -35.57 9.18 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.529 2.153 . . . . 0.0 111.989 179.898 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -77.23 98.56 5.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.376 -179.974 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -148.21 48.21 1.05 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.399 -179.98 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -78.12 -101.74 0.2 Allowed Glycine 0 CA--C 1.526 0.747 0 N-CA-C 110.698 -0.961 . . . . 0.0 110.698 -179.973 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -80.69 177.36 8.13 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.63 2.22 . . . . 0.0 112.102 -179.995 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 49.8 m-85 -153.61 103.18 2.61 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.72 -179.969 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 6.2 m-20 -73.44 129.43 37.98 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 179.358 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.466 ' CE1' ' HB3' ' A' ' 33' ' ' LEU . 40.6 m-85 -115.42 170.87 8.08 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.13 0.491 . . . . 0.0 111.096 -179.333 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.504 ' HG2' ' CZ3' ' A' ' 41' ' ' TRP . 0.0 OUTLIER -169.2 83.69 0.14 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.632 -179.946 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.894 ' O ' HD23 ' A' ' 69' ' ' LEU . 6.9 p90 -71.27 176.68 4.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.356 0.598 . . . . 0.0 111.333 -179.159 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.894 HD23 ' O ' ' A' ' 68' ' ' PHE . 8.7 mt -138.53 70.84 1.38 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.22 179.612 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.402 ' OG1' ' N ' ' A' ' 74' ' ' MET . 65.0 p -29.56 136.2 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.509 0.723 . . . . 0.0 112.61 -178.976 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.632 ' HG2' ' HB2' ' A' ' 29' ' ' ALA . 22.2 mt-10 -52.09 -39.13 59.31 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.314 179.972 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.37 64.59 1.49 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.545 -179.877 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -157.75 -104.75 0.21 Allowed Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.71 -0.956 . . . . 0.0 110.71 179.966 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.402 ' N ' ' OG1' ' A' ' 70' ' ' THR . 0.0 OUTLIER -172.03 -179.03 2.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.826 0.346 . . . . 0.0 110.326 179.969 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.617 ' CG ' HD22 ' A' ' 69' ' ' LEU . 0.0 OUTLIER -84.63 -176.86 6.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.412 -179.951 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.421 ' O ' ' CB ' ' A' ' 67' ' ' ARG . 1.0 OUTLIER -178.71 158.89 1.05 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.099 179.979 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 97.2 t -124.52 130.43 73.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.979 0.418 . . . . 0.0 110.509 -179.756 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.6 ' CZ ' HG21 ' A' ' 4' ' ' VAL . 31.8 m-85 -121.71 130.53 53.51 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.158 179.983 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -118.86 155.56 31.01 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.638 -179.653 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 53.5 m-20 58.25 23.71 10.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.792 179.842 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.509 HG13 ' O ' ' A' ' 92' ' ' TYR . 77.1 t -55.35 -78.36 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 179.61 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 76.7 t -81.71 134.36 50.73 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.125 179.751 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.501 ' HD3' ' CG ' ' A' ' 92' ' ' TYR . 46.6 Cg_endo -71.69 -177.1 2.31 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.437 2.091 . . . . 0.0 111.938 179.79 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -63.04 -64.19 0.98 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.186 179.902 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -102.56 76.86 1.56 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.218 179.798 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 0.452 ' HB2' HG21 ' A' ' 8' ' ' VAL . 55.7 p90 -54.63 160.95 1.64 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.442 -179.873 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.05 111.86 7.44 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.323 179.917 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 2.7 mp -50.52 100.28 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.456 -179.925 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 133.84 45.95 0.11 Allowed Glycine 0 CA--C 1.523 0.572 0 N-CA-C 110.665 -0.974 . . . . 0.0 110.665 -179.981 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.731 ' HB3' ' OH ' ' A' ' 92' ' ' TYR . . . -172.99 153.04 2.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.79 0.329 . . . . 0.0 110.386 179.979 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 40.3 m -102.96 133.49 47.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.504 -179.931 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.731 ' OH ' ' HB3' ' A' ' 90' ' ' ALA . 6.3 m-85 -130.78 110.52 11.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.321 179.88 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.863 ' HB1' ' HD2' ' A' ' 94' ' ' PRO . . . 179.28 177.36 0.32 Allowed Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.306 -179.978 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.863 ' HD2' ' HB1' ' A' ' 93' ' ' ALA . 48.0 Cg_endo . . . . . 0 C--O 1.249 1.059 0 C-N-CA 122.62 2.213 . . . . 0.0 112.078 -179.868 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.413 ' CG ' ' O ' ' A' ' 3' ' ' LYS . 1.8 ptmt . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.86 0.362 . . . . 0.0 110.794 . . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.58 HG21 ' CZ ' ' A' ' 78' ' ' PHE . 2.9 m -130.11 168.32 23.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.174 179.486 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.406 ' HB ' ' CG2' ' A' ' 91' ' ' THR . 0.6 OUTLIER -146.12 145.68 30.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.325 179.851 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.56 ' CE2' ' CD2' ' A' ' 66' ' ' PHE . 26.3 m-85 -117.66 160.97 20.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.736 -179.688 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.443 HG22 ' H ' ' A' ' 8' ' ' VAL . 0.2 OUTLIER -142.43 -164.15 1.76 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.169 179.836 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.658 ' O ' HG23 ' A' ' 88' ' ' ILE . 47.0 t -141.85 92.74 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.346 -179.918 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.719 ' HG3' HG11 ' A' ' 51' ' ' VAL . 1.4 mm-40 -56.64 158.01 4.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.57 -179.811 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 7.4 ptmm? -58.17 -19.25 31.6 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.896 -179.989 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -49.8 -24.77 6.37 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 111.021 -0.831 . . . . 0.0 111.021 -179.966 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 10.0 p -47.83 113.85 0.8 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.85 0.357 . . . . 0.0 110.78 -179.862 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 42.4 m-20 -116.17 -156.28 0.61 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.147 179.859 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -44.96 -68.44 0.2 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.721 0.296 . . . . 0.0 110.905 -179.868 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.61 40.57 3.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.309 179.869 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 8.5 m80 -118.55 123.29 44.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.365 179.953 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.463 ' HA ' HD22 ' A' ' 17' ' ' LEU . 0.2 OUTLIER -104.97 97.86 7.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.192 -179.928 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.448 ' HB2' HG22 ' A' ' 53' ' ' THR . . . -100.22 104.56 16.06 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.602 -179.788 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.406 ' O ' ' HG3' ' A' ' 9' ' ' GLU . 27.7 m -88.3 -175.17 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.129 179.67 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.7 tt -139.42 77.55 1.62 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.402 179.724 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 3.3 t -84.01 107.9 15.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.083 179.934 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.57 147.84 4.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.391 -179.969 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.523 ' CZ ' HG12 ' A' ' 4' ' ' VAL . 3.9 p90 177.99 128.56 0.05 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.221 -179.909 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -53.4 154.43 3.41 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.512 -179.865 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 107.57 -68.98 0.22 Allowed Glycine 0 CA--C 1.522 0.522 0 N-CA-C 110.59 -1.004 . . . . 0.0 110.59 -179.968 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -94.08 179.28 5.37 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 110.164 -0.31 . . . . 0.0 110.164 179.975 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.417 ' OG1' ' CE ' ' A' ' 72' ' ' LYS . 0.2 OUTLIER -119.19 -163.8 1.0 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.928 0.394 . . . . 0.0 110.525 -179.971 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.43 ' O ' ' CG ' ' A' ' 71' ' ' GLU . 33.7 mtp -129.6 124.11 32.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.297 -179.815 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.866 ' HB3' ' O ' ' A' ' 69' ' ' LEU . . . -129.42 -57.97 1.13 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.937 -179.79 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.597 ' C ' HG12 ' A' ' 31' ' ' VAL . 2.8 tt0 -141.07 177.19 8.24 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.945 0.402 . . . . 0.0 111.059 -179.673 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.597 HG12 ' C ' ' A' ' 30' ' ' GLU . 0.3 OUTLIER 171.52 134.2 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.958 -179.986 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.411 ' HG3' ' CE3' ' A' ' 41' ' ' TRP . 1.1 pt-20 -123.55 161.24 25.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.643 -179.549 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.491 ' HG ' ' CE1' ' A' ' 66' ' ' PHE . 2.3 mt -110.0 154.33 23.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.381 179.782 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.487 ' HG3' ' CD2' ' A' ' 41' ' ' TRP . 0.0 OUTLIER -126.99 -163.31 1.23 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.949 179.51 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.449 ' CB ' ' HB2' ' A' ' 38' ' ' SER . 0.2 OUTLIER 176.8 106.71 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.841 0.353 . . . . 0.0 110.171 179.971 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -51.2 95.3 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.206 -179.982 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 126.14 -32.18 3.85 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 110.359 -1.097 . . . . 0.0 110.359 -179.636 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.449 ' HB2' ' CB ' ' A' ' 35' ' ' GLU . 35.0 t -57.09 -25.4 58.69 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.732 0.301 . . . . 0.0 110.398 179.788 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 75.75 97.29 0.07 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.653 179.986 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 72.62 159.59 0.22 Allowed 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.876 179.641 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.501 ' CZ2' ' CD ' ' A' ' 67' ' ' ARG . 51.1 m95 -64.49 167.39 7.11 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.434 -179.899 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 14.9 m -135.1 3.21 1.08 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.852 -179.622 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . 59.92 138.42 0.01 OUTLIER 'General case' 0 C--N 1.334 -0.107 0 CA-C-O 121.129 0.49 . . . . 0.0 111.299 179.391 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.436 ' HE3' ' HB2' ' A' ' 52' ' ' TRP . 0.0 OUTLIER -73.64 -170.35 0.84 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.375 179.862 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.424 ' O ' ' N ' ' A' ' 47' ' ' GLY . 43.4 m -143.31 111.08 5.95 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.144 179.809 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.9 ptpt -62.45 79.12 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.396 -179.908 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.424 ' N ' ' O ' ' A' ' 45' ' ' THR . . . -98.47 -26.77 9.03 Favored Glycine 0 CA--C 1.522 0.525 0 N-CA-C 110.691 -0.963 . . . . 0.0 110.691 -179.966 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.405 ' HB2' ' O ' ' A' ' 51' ' ' VAL . 0.5 OUTLIER -87.15 -172.53 4.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.852 0.358 . . . . 0.0 110.432 -179.943 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -110.94 -24.68 5.41 Favored Glycine 0 CA--C 1.522 0.505 0 N-CA-C 110.807 -0.917 . . . . 0.0 110.807 179.95 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -129.28 -1.39 5.69 Favored Glycine 0 CA--C 1.528 0.888 0 N-CA-C 111.957 -0.457 . . . . 0.0 111.957 -179.684 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.719 HG11 ' HG3' ' A' ' 9' ' ' GLU . 17.9 m -146.23 178.26 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 CA-C-N 117.476 0.638 . . . . 0.0 110.761 -179.946 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 52' ' ' TRP . . . . . 0.436 ' HB2' ' HE3' ' A' ' 44' ' ' MET . 10.9 m95 -105.34 141.1 37.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.56 -179.555 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.448 HG22 ' HB2' ' A' ' 18' ' ' ALA . 10.3 p -126.04 162.78 24.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.336 -179.969 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 45.5 t80 -134.54 162.54 31.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.536 -179.881 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -112.86 143.03 44.81 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.224 179.865 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -133.9 178.7 6.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.374 179.934 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -123.94 26.61 7.52 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.345 179.975 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -171.0 155.65 4.53 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.269 179.947 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -71.87 -36.2 6.45 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.707 2.272 . . . . 0.0 112.325 -179.808 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -75.57 148.3 38.98 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.75 -179.55 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -147.74 -174.48 4.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.208 179.978 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -145.06 -148.96 4.93 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 110.734 -0.946 . . . . 0.0 110.734 179.995 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -78.03 158.08 30.59 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.575 2.183 . . . . 0.0 111.796 179.872 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.41 ' HB3' ' CD2' ' A' ' 33' ' ' LEU . 86.5 m-85 -131.6 171.19 13.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.07 0.462 . . . . 0.0 110.79 -179.794 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.428 ' HB2' ' CB ' ' A' ' 34' ' ' ARG . 4.3 m-80 -139.57 137.36 35.33 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.615 179.571 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.56 ' CD2' ' CE2' ' A' ' 6' ' ' PHE . 48.0 m-85 -120.44 159.94 24.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.108 0.48 . . . . 0.0 111.093 -179.217 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.588 ' CD ' HG22 ' A' ' 77' ' ' VAL . 28.6 mtp180 -157.61 81.4 0.88 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.818 179.68 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.469 ' HA ' ' HA ' ' A' ' 31' ' ' VAL . 5.9 p90 -78.7 173.59 12.3 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-O 121.54 0.685 . . . . 0.0 111.37 -179.334 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.866 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 8.8 mt -138.43 74.3 1.47 Allowed 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 114.664 -1.153 . . . . 0.0 109.016 179.496 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.439 ' OG1' ' N ' ' A' ' 74' ' ' MET . 2.7 p -31.18 137.13 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 115.717 -0.674 . . . . 0.0 112.191 -178.976 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.619 ' HG2' ' HB2' ' A' ' 29' ' ' ALA . 1.1 mm-40 -49.57 -24.88 2.35 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.943 -179.525 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.417 ' CE ' ' OG1' ' A' ' 27' ' ' THR . 0.0 OUTLIER -167.07 36.04 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.596 0.236 . . . . 0.0 111.102 -179.94 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -114.21 -110.76 2.9 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 110.849 -0.9 . . . . 0.0 110.849 179.853 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.439 ' N ' ' OG1' ' A' ' 70' ' ' THR . 3.1 ptt? -166.74 113.29 0.81 Allowed 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 110.164 -0.31 . . . . 0.0 110.164 179.901 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.817 ' HB3' HD23 ' A' ' 69' ' ' LEU . 0.0 OUTLIER -51.99 -176.35 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.896 0.379 . . . . 0.0 110.494 -179.782 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 177.43 149.39 0.16 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.468 -179.952 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.588 HG22 ' CD ' ' A' ' 67' ' ' ARG . 72.2 t -90.22 139.18 17.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 121.006 0.431 . . . . 0.0 110.096 179.895 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.58 ' CZ ' HG21 ' A' ' 4' ' ' VAL . 75.8 m-85 -128.84 142.24 51.03 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.898 -179.313 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -136.1 157.84 45.87 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.953 179.65 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 59.02 35.45 24.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.938 0.399 . . . . 0.0 109.954 -179.66 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.464 ' O ' HG12 ' A' ' 81' ' ' VAL . 42.9 t -76.07 -6.91 9.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.322 -179.757 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.449 HG13 ' HD2' ' A' ' 83' ' ' PRO . 61.4 t -153.87 138.14 11.04 Favored Pre-proline 0 C--N 1.332 -0.17 0 N-CA-C 110.29 -0.263 . . . . 0.0 110.29 179.893 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.449 ' HD2' HG13 ' A' ' 82' ' ' VAL . 47.6 Cg_endo -75.48 -172.66 1.36 Allowed 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.535 2.157 . . . . 0.0 112.056 179.881 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -67.93 -42.5 80.91 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.244 179.844 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 16.7 mtpt -127.45 77.73 1.77 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.235 179.841 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 45.3 p90 -51.1 158.8 0.69 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.508 -179.851 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 20.8 m -138.33 110.43 7.3 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.075 179.919 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.658 HG23 ' O ' ' A' ' 8' ' ' VAL . 2.8 mp -50.46 95.06 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.357 -179.942 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 138.04 44.99 0.08 OUTLIER Glycine 0 CA--C 1.523 0.572 0 N-CA-C 110.575 -1.01 . . . . 0.0 110.575 -179.878 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -168.46 141.21 2.95 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.75 0.309 . . . . 0.0 110.243 -179.93 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.406 ' CG2' ' HB ' ' A' ' 5' ' ' THR . 85.7 m -91.05 145.85 24.34 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.971 0.415 . . . . 0.0 110.648 -179.939 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.592 ' O ' ' HB3' ' A' ' 93' ' ' ALA . 30.2 m-85 -129.75 -152.24 0.51 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.826 -0.624 . . . . 0.0 109.501 179.674 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.885 ' HB1' ' HD2' ' A' ' 94' ' ' PRO . . . 77.79 174.74 0.08 OUTLIER Pre-proline 0 N--CA 1.465 0.276 0 CA-C-O 120.8 0.333 . . . . 0.0 110.684 179.77 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.885 ' HD2' ' HB1' ' A' ' 93' ' ' ALA . 48.3 Cg_endo . . . . . 0 C--O 1.248 1.02 0 C-N-CA 122.618 2.212 . . . . 0.0 111.989 -179.982 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.457 -0.093 0 CA-C-O 120.815 0.341 . . . . 0.0 110.24 . . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.553 HG11 ' CZ ' ' A' ' 78' ' ' PHE . 1.7 p -49.88 163.97 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.253 0.549 . . . . 0.0 110.624 -179.819 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.478 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 15.7 p -141.89 132.63 25.64 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.367 179.907 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.528 ' O ' HG23 ' A' ' 91' ' ' THR . 22.7 m-85 -101.09 170.68 8.11 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.301 179.967 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.811 HG23 ' O ' ' A' ' 90' ' ' ALA . 92.6 m -166.17 132.47 2.52 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.464 -179.947 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 26.4 t -71.1 102.99 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.199 179.82 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.598 ' HG3' HG21 ' A' ' 51' ' ' VAL . 6.3 mm-40 -50.33 170.81 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.511 -179.811 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 33.7 mtmm -72.53 -21.38 61.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.721 -179.937 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -90.9 49.1 3.05 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.928 -0.869 . . . . 0.0 110.928 -179.948 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 60.7 p -87.1 134.64 33.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.765 0.317 . . . . 0.0 110.291 179.867 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -134.2 164.63 26.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.306 -179.989 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -67.4 -34.5 77.38 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.333 -179.992 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 1.7 tppp? -93.14 -20.46 20.47 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.225 -179.588 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 16' ' ' HIS . . . . . 0.402 ' HA ' ' O ' ' A' ' 54' ' ' PHE . 39.8 m80 -120.09 133.54 55.49 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.931 0.396 . . . . 0.0 111.024 -179.377 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -104.29 77.94 1.45 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.136 179.567 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -75.41 116.95 16.68 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.414 -179.884 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.467 HG23 HG23 ' A' ' 21' ' ' VAL . 14.8 m -109.17 -168.24 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.17 179.942 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.426 ' HB3' ' HB ' ' A' ' 7' ' ' THR . 1.0 OUTLIER -142.28 78.74 1.63 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.376 179.855 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.467 HG23 HG23 ' A' ' 19' ' ' VAL . 11.7 t -95.41 110.22 23.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.336 -179.933 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.409 ' HG2' ' CD2' ' A' ' 20' ' ' LEU . 0.0 OUTLIER -179.05 117.86 0.07 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.453 179.946 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.405 ' CE1' HG23 ' A' ' 4' ' ' VAL . 7.5 p90 -150.48 172.04 16.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.312 179.842 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -92.15 148.33 22.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.368 -179.917 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 114.25 -41.71 2.12 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 110.76 -0.936 . . . . 0.0 110.76 179.998 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -119.38 176.05 5.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.84 0.352 . . . . 0.0 110.418 179.999 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.29 -160.84 0.73 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.401 -179.999 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.418 ' O ' ' CG ' ' A' ' 71' ' ' GLU . 59.1 mtm -137.43 120.42 16.55 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.316 180.0 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.822 ' HB3' ' O ' ' A' ' 69' ' ' LEU . . . -124.4 -58.39 1.52 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.563 -179.786 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -153.34 161.78 41.98 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.38 -179.864 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.747 HG21 ' CD1' ' A' ' 52' ' ' TRP . 21.5 t -143.46 155.19 16.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.286 -179.999 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.444 ' CB ' ' HA ' ' A' ' 43' ' ' ALA . 1.8 pt-20 -167.24 137.82 3.02 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.53 -179.953 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.644 HD12 ' N ' ' A' ' 34' ' ' ARG . 3.2 pp -104.24 171.96 7.06 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.322 179.839 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.644 ' N ' HD12 ' A' ' 33' ' ' LEU . 1.3 ttt180 -97.87 -72.99 0.63 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.616 -179.848 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.484 ' CB ' ' O ' ' A' ' 34' ' ' ARG . 2.6 tm-20 94.34 80.26 0.0 OUTLIER 'General case' 0 CA--C 1.511 -0.523 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 -178.977 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -37.42 134.22 0.65 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.166 -0.925 . . . . 0.0 111.757 -178.362 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 114.07 -28.98 8.0 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 110.397 -1.081 . . . . 0.0 110.397 -179.745 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -82.46 -173.96 4.89 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.778 0.323 . . . . 0.0 110.268 179.864 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.41 ' OD1' ' N ' ' A' ' 40' ' ' GLU . 35.2 p30 -114.31 -21.64 10.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.843 -179.861 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.41 ' N ' ' OD1' ' A' ' 39' ' ' ASP . 9.7 mt-10 -135.0 175.26 9.74 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.84 0.352 . . . . 0.0 110.701 -179.826 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.512 ' CZ3' ' HG2' ' A' ' 67' ' ' ARG . 53.1 m95 -86.18 173.05 10.07 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.466 179.945 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.52 HG23 ' HG ' ' A' ' 33' ' ' LEU . 9.7 m -135.57 112.8 14.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.329 179.818 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.444 ' HA ' ' CB ' ' A' ' 32' ' ' GLU . . . -51.02 127.13 18.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.299 179.938 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -60.69 -171.39 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.32 -179.887 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 38.3 m -136.72 133.12 35.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.92 0.39 . . . . 0.0 110.496 -179.847 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 2.8 ptmt -100.95 79.87 2.08 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.52 -179.948 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -153.05 26.63 0.8 Allowed Glycine 0 CA--C 1.523 0.574 0 N-CA-C 110.851 -0.9 . . . . 0.0 110.851 -179.976 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.42 ' HG2' HG23 ' A' ' 51' ' ' VAL . 14.0 tp10 -98.05 -24.59 15.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.734 0.302 . . . . 0.0 110.319 179.952 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 128.03 -76.02 0.41 Allowed Glycine 0 CA--C 1.523 0.536 0 N-CA-C 110.566 -1.014 . . . . 0.0 110.566 -179.964 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -113.31 -14.34 9.89 Favored Glycine 0 CA--C 1.527 0.816 0 N-CA-C 111.259 -0.736 . . . . 0.0 111.259 179.878 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.598 HG21 ' HG3' ' A' ' 9' ' ' GLU . 27.2 m -124.95 -175.44 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-O 120.932 0.396 . . . . 0.0 110.74 -179.745 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 52' ' ' TRP . . . . . 0.747 ' CD1' HG21 ' A' ' 31' ' ' VAL . 8.1 m95 -104.59 146.22 29.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.499 -179.848 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.08 165.89 18.66 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.162 179.8 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.486 ' CD2' HD21 ' A' ' 33' ' ' LEU . 87.3 t80 -144.51 143.18 30.72 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.572 -179.863 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -89.07 102.48 15.14 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.314 179.913 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 69.7 p -86.91 100.82 12.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.465 -179.934 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -101.93 25.3 8.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.41 179.892 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 6.6 pm0 -121.39 140.83 32.08 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.193 179.897 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -73.45 -20.73 20.47 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.574 2.182 . . . . 0.0 112.113 179.992 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 17.3 mt -53.41 150.43 6.55 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.502 -179.95 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 24.1 tt0 -140.75 96.16 2.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.306 179.818 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -149.24 -157.85 7.82 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 110.682 -0.967 . . . . 0.0 110.682 179.992 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.443 ' HA ' ' HB ' ' A' ' 82' ' ' VAL . 49.1 Cg_endo -76.35 160.74 35.48 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.565 2.177 . . . . 0.0 112.168 -179.934 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.434 ' CD1' HG11 ' A' ' 82' ' ' VAL . 80.2 m-85 -130.96 100.98 5.43 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.394 179.873 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.403 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 48.0 m-80 -66.32 160.33 24.8 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 179.652 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -133.92 176.32 8.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.023 0.439 . . . . 0.0 110.93 -179.894 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.512 ' HG2' ' CZ3' ' A' ' 41' ' ' TRP . 0.0 OUTLIER 176.6 72.3 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.751 179.998 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.556 ' O ' HD23 ' A' ' 69' ' ' LEU . 2.0 p90 -67.16 174.96 2.84 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.88 -179.404 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.822 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 8.9 mt -125.26 68.79 1.14 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.311 179.492 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -37.19 140.97 0.16 Allowed 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.728 -179.115 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.737 ' HG2' ' HB2' ' A' ' 29' ' ' ALA . 2.0 mm-40 -55.27 -58.48 7.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.369 -179.821 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -125.73 55.9 1.42 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.316 179.962 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -137.51 -106.7 0.78 Allowed Glycine 0 CA--C 1.524 0.601 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 -179.981 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 1.2 ptt? -178.5 163.4 1.54 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.805 0.336 . . . . 0.0 110.446 -179.924 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.628 ' HD2' HD22 ' A' ' 69' ' ' LEU . 0.0 OUTLIER -81.69 134.37 35.46 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.258 -179.867 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.415 ' HB3' ' CZ ' ' A' ' 78' ' ' PHE . 0.3 OUTLIER -143.32 129.73 20.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.378 179.958 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 43.3 t -85.55 142.94 12.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.34 -179.993 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.553 ' CZ ' HG11 ' A' ' 4' ' ' VAL . 51.5 m-85 -132.48 120.66 22.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.549 -179.866 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -105.36 163.72 12.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.257 179.83 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 53.79 57.45 6.04 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.271 179.992 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.63 ' O ' HG12 ' A' ' 81' ' ' VAL . 60.9 t -109.02 7.78 9.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.216 -179.965 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.487 HG23 ' O ' ' A' ' 81' ' ' VAL . 70.2 t -158.36 104.35 1.68 Allowed Pre-proline 0 CA--C 1.531 0.212 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 -179.932 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -74.93 178.46 7.22 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.499 2.132 . . . . 0.0 111.935 179.706 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -65.97 121.76 15.83 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.217 179.885 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 3.4 tttt 55.09 65.83 1.39 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.111 -179.823 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 32.6 p90 -49.58 143.23 7.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.755 -179.758 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 9.0 m -110.32 110.03 20.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.13 179.739 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 2.8 mp -49.18 121.1 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.542 -179.844 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 115.57 31.07 2.05 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 110.926 -0.869 . . . . 0.0 110.926 179.976 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.811 ' O ' HG23 ' A' ' 7' ' ' THR . . . -143.63 176.26 9.35 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.745 0.307 . . . . 0.0 110.253 179.834 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.528 HG23 ' O ' ' A' ' 6' ' ' PHE . 17.3 m -125.0 124.06 41.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.533 -179.901 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.525 ' CZ ' ' HB3' ' A' ' 90' ' ' ALA . 6.0 m-85 -124.2 129.54 50.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.272 179.87 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.917 ' HB1' ' HD2' ' A' ' 94' ' ' PRO . . . 178.01 179.24 0.23 Allowed Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.289 -179.988 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.917 ' HD2' ' HB1' ' A' ' 93' ' ' ALA . 48.7 Cg_endo . . . . . 0 C--O 1.249 1.072 0 C-N-CA 122.519 2.146 . . . . 0.0 111.959 -179.93 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.848 0.356 . . . . 0.0 110.624 . . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.484 ' CG1' ' CE1' ' A' ' 78' ' ' PHE . 1.7 p -153.72 163.7 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 121.176 0.512 . . . . 0.0 110.151 179.705 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.468 ' N ' HG22 ' A' ' 4' ' ' VAL . 0.2 OUTLIER -136.15 140.72 43.85 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.438 179.951 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 -105.8 165.91 10.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.965 179.754 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.4 m -160.03 103.49 1.48 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.819 0.343 . . . . 0.0 110.522 -179.823 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 61.1 t -60.04 93.99 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.17 179.771 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.689 ' HG3' HG11 ' A' ' 51' ' ' VAL . 2.4 mm-40 -49.8 165.33 0.08 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.609 -179.851 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.24 56.57 2.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.394 179.95 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -135.79 20.65 3.63 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 111.124 -0.79 . . . . 0.0 111.124 -179.909 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.2 p -74.7 108.46 7.47 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.949 0.405 . . . . 0.0 109.994 179.729 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -92.2 -163.53 1.05 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.775 -179.506 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -55.5 -36.34 66.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.819 -179.706 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.455 ' HD3' ' ND1' ' A' ' 16' ' ' HIS . 0.1 OUTLIER -147.6 45.93 1.12 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.784 0.326 . . . . 0.0 110.582 -179.794 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 16' ' ' HIS . . . . . 0.455 ' ND1' ' HD3' ' A' ' 15' ' ' LYS . 45.0 m80 -133.78 151.57 51.62 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.22 179.783 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.446 HD12 ' HA ' ' A' ' 17' ' ' LEU . 20.9 tp -137.28 92.54 2.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.462 -179.745 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.622 ' HB2' ' CG2' ' A' ' 53' ' ' THR . . . -87.91 123.13 32.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.298 179.885 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.658 HG23 HG23 ' A' ' 21' ' ' VAL . 27.2 m -121.02 144.76 28.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.555 -179.811 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.423 ' CD2' ' CG ' ' A' ' 22' ' ' LYS . 0.5 OUTLIER -91.38 83.35 5.44 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.28 179.77 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.658 HG23 HG23 ' A' ' 19' ' ' VAL . 24.4 t -89.44 100.3 10.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.543 -179.827 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.423 ' CG ' ' CD2' ' A' ' 20' ' ' LEU . 0.0 OUTLIER 174.9 135.7 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.353 179.859 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.504 ' CE2' ' HB2' ' A' ' 26' ' ' ASP . 0.7 OUTLIER -129.91 -173.29 2.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.1 179.874 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -40.62 -57.42 1.87 Allowed 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 120.795 0.331 . . . . 0.0 111.195 -179.783 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -89.22 -153.77 28.09 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 110.664 -0.974 . . . . 0.0 110.664 179.806 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.821 ' OD2' HG22 ' A' ' 70' ' ' THR . 28.1 t0 68.33 143.52 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.744 0.307 . . . . 0.0 110.408 179.983 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.685 HG22 ' O ' ' A' ' 27' ' ' THR . 86.4 m -119.33 13.44 12.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.062 179.863 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.405 ' O ' ' CG ' ' A' ' 71' ' ' GLU . 9.3 mtp 59.51 115.09 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.832 0.349 . . . . 0.0 110.594 179.732 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.785 ' HB3' ' O ' ' A' ' 69' ' ' LEU . . . -126.42 -57.17 1.39 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.13 179.81 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -157.46 166.69 32.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.147 179.789 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.621 HG21 ' CD1' ' A' ' 52' ' ' TRP . 38.5 t -152.41 148.27 14.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.448 -179.899 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.444 ' CB ' ' HA ' ' A' ' 43' ' ' ALA . 14.6 pt-20 -138.81 146.93 41.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.093 179.766 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.811 HD23 ' CG ' ' A' ' 54' ' ' PHE . 6.1 tp -128.86 138.3 51.96 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 120.923 0.392 . . . . 0.0 110.19 -179.093 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.541 ' N ' HD12 ' A' ' 33' ' ' LEU . 50.0 ttp85 -124.6 165.67 17.46 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.55 179.184 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -118.92 -83.07 0.65 Allowed 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 -179.975 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER 169.58 158.61 0.06 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.375 179.598 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 50.01 47.01 41.32 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 110.849 -0.901 . . . . 0.0 110.849 179.926 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 32.1 t -136.0 -174.93 3.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.817 0.341 . . . . 0.0 110.329 179.899 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -68.57 -63.57 1.03 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.471 -179.919 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -167.93 -173.87 2.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.343 -179.926 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.488 ' CE3' ' HB2' ' A' ' 34' ' ' ARG . 50.3 m95 -47.68 154.34 0.49 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.591 -179.943 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.436 HG22 ' O ' ' A' ' 33' ' ' LEU . 24.2 m -129.9 28.86 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.421 179.983 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.444 ' HA ' ' CB ' ' A' ' 32' ' ' GLU . . . 47.24 -175.34 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.131 179.555 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.401 ' HB2' ' O ' ' A' ' 31' ' ' VAL . 0.0 OUTLIER -112.94 -164.74 0.94 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.356 -179.97 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 25.7 m -146.52 104.97 3.81 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.477 -179.933 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.43 71.87 0.95 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.243 179.857 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -99.3 -34.49 5.05 Favored Glycine 0 CA--C 1.523 0.559 0 N-CA-C 110.813 -0.915 . . . . 0.0 110.813 -179.868 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.441 ' HG2' ' CG2' ' A' ' 51' ' ' VAL . 4.1 tp10 -80.5 130.11 34.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.808 0.337 . . . . 0.0 110.35 -179.916 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -78.39 78.38 1.62 Allowed Glycine 0 CA--C 1.522 0.53 0 N-CA-C 110.752 -0.939 . . . . 0.0 110.752 179.895 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 150.67 -32.01 1.0 Allowed Glycine 0 CA--C 1.522 0.502 0 N-CA-C 110.6 -1.0 . . . . 0.0 110.6 -179.959 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.689 HG11 ' HG3' ' A' ' 9' ' ' GLU . 17.5 m -145.81 -177.35 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.837 0.351 . . . . 0.0 110.369 -179.997 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 52' ' ' TRP . . . . . 0.621 ' CD1' HG21 ' A' ' 31' ' ' VAL . 7.5 m95 -102.97 141.15 36.26 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.584 -179.738 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.622 ' CG2' ' HB2' ' A' ' 18' ' ' ALA . 0.2 OUTLIER -124.22 152.22 43.18 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.942 179.7 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.811 ' CG ' HD23 ' A' ' 33' ' ' LEU . 80.6 t80 -117.39 161.65 19.21 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.423 -179.925 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -118.15 118.59 32.29 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.32 -179.993 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 40.2 m -111.48 164.24 13.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.449 -179.931 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -161.7 39.9 0.13 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.249 179.932 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -131.91 157.52 77.98 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.338 -179.946 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -71.61 -33.35 10.71 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.615 2.21 . . . . 0.0 112.2 -179.936 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -82.68 174.7 10.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.293 179.909 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 179.81 59.6 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.613 179.935 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -72.88 -139.95 0.37 Allowed Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.477 -1.049 . . . . 0.0 110.477 179.807 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -73.83 174.1 12.88 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.501 2.134 . . . . 0.0 111.699 179.698 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -135.52 177.08 8.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.957 0.408 . . . . 0.0 110.548 -179.937 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 -143.96 131.29 20.87 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.862 179.904 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -116.16 170.13 8.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.044 0.45 . . . . 0.0 110.884 -179.705 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.446 ' HG3' ' CH2' ' A' ' 41' ' ' TRP . 0.1 OUTLIER -172.54 80.75 0.05 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.049 -179.925 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.426 ' HA ' ' HA ' ' A' ' 31' ' ' VAL . 0.5 OUTLIER -81.57 167.02 19.72 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.191 0.52 . . . . 0.0 110.966 -179.594 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.785 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 6.8 mt -123.49 74.23 1.24 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.494 179.715 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.821 HG22 ' OD2' ' A' ' 26' ' ' ASP . 13.5 p -36.81 137.77 0.29 Allowed 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.696 -179.334 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.707 ' HG2' ' HB2' ' A' ' 29' ' ' ALA . 8.7 mm-40 -48.88 -46.48 42.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.822 -179.591 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.66 45.9 1.7 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.447 179.86 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -121.06 -110.17 2.17 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 110.863 -0.895 . . . . 0.0 110.863 -179.983 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.412 ' N ' ' OG1' ' A' ' 70' ' ' THR . 2.1 ptt? -171.67 152.69 3.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.831 0.348 . . . . 0.0 110.361 -179.905 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.522 ' HG3' HD23 ' A' ' 69' ' ' LEU . 0.0 OUTLIER -76.58 150.83 36.46 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.463 -179.942 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 55.0 m-20 -156.31 136.73 13.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.542 179.946 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.404 ' HA ' ' HG2' ' A' ' 67' ' ' ARG . 94.2 t -89.33 138.92 18.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.353 179.927 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.484 ' CE1' ' CG1' ' A' ' 4' ' ' VAL . 40.4 m-85 -126.81 134.87 50.46 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.793 -179.448 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -123.93 150.72 44.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.273 179.85 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 54.39 30.66 13.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.374 -179.904 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.437 ' HA ' ' HA ' ' A' ' 93' ' ' ALA . 54.8 t -53.71 -24.82 10.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.48 -179.925 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.439 ' CG1' ' HB3' ' A' ' 86' ' ' TYR . 59.3 t -134.34 132.3 20.95 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.579 -0.282 . . . . 0.0 110.535 179.897 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.447 ' CD ' ' CD1' ' A' ' 92' ' ' TYR . 49.5 Cg_endo -71.24 -171.48 0.61 Allowed 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.586 2.191 . . . . 0.0 111.996 179.744 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 21.3 pt-20 -85.23 129.92 34.71 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 179.29 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 59.33 50.66 7.51 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 -179.282 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 0.439 ' HB3' ' CG1' ' A' ' 82' ' ' VAL . 36.6 p90 -43.46 160.43 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.413 -179.407 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -130.92 104.26 7.04 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.925 179.751 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 3.0 mp -45.3 118.65 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.623 -179.798 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 118.42 36.7 0.9 Allowed Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.602 -0.999 . . . . 0.0 110.602 -179.821 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -149.32 153.34 37.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.768 0.318 . . . . 0.0 110.149 -179.96 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 92.4 m -103.63 93.62 5.02 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.727 -179.81 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.589 ' O ' ' HB3' ' A' ' 93' ' ' ALA . 40.1 m-85 -81.81 -153.76 0.11 Allowed 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 179.31 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.913 ' HB1' ' HD2' ' A' ' 94' ' ' PRO . . . 76.2 175.85 0.07 OUTLIER Pre-proline 0 N--CA 1.464 0.263 0 CA-C-O 120.689 0.281 . . . . 0.0 110.748 179.726 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.913 ' HD2' ' HB1' ' A' ' 93' ' ' ALA . 46.5 Cg_endo . . . . . 0 C--O 1.249 1.027 0 C-N-CA 122.523 2.148 . . . . 0.0 112.053 -179.988 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 7.9 mtmm . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.808 0.337 . . . . 0.0 110.402 . . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.586 HG21 ' CZ ' ' A' ' 78' ' ' PHE . 18.0 m -72.95 170.86 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.435 -179.979 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.413 HG23 ' O ' ' A' ' 4' ' ' VAL . 16.0 p -154.66 132.07 11.2 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.516 -179.97 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.528 ' O ' HG23 ' A' ' 91' ' ' THR . 13.6 m-85 -101.3 160.29 14.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.066 179.821 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.6 m -156.49 126.26 6.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.924 0.392 . . . . 0.0 110.683 -179.86 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.595 HG11 HG13 ' A' ' 88' ' ' ILE . 98.9 t -60.28 114.73 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.284 179.85 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.441 ' HB2' HG11 ' A' ' 51' ' ' VAL . 15.0 mm-40 -94.1 160.92 14.49 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.433 -179.91 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.9 ttmm -55.16 159.25 2.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.339 179.979 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 86.91 25.77 33.66 Favored Glycine 0 CA--C 1.523 0.539 0 N-CA-C 110.772 -0.931 . . . . 0.0 110.772 -179.968 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 58.3 m -94.84 120.3 34.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.813 0.34 . . . . 0.0 110.491 -179.891 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -119.38 -163.94 1.02 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.39 179.927 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -46.99 -61.89 1.66 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.245 -179.693 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.416 ' HG2' ' N ' ' A' ' 16' ' ' HIS . 0.8 OUTLIER -98.95 -28.28 13.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.058 -179.271 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 16' ' ' HIS . . . . . 0.416 ' N ' ' HG2' ' A' ' 15' ' ' LYS . 1.7 m80 -65.02 123.66 20.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.833 0.349 . . . . 0.0 110.411 -179.818 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.482 ' HA ' HD22 ' A' ' 17' ' ' LEU . 0.3 OUTLIER -129.51 99.82 5.32 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.419 -179.953 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.588 ' HB1' HG11 ' A' ' 51' ' ' VAL . . . -95.88 130.93 42.69 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.128 179.83 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.68 ' O ' HG13 ' A' ' 51' ' ' VAL . 17.7 m -139.59 134.63 39.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.905 0.383 . . . . 0.0 110.796 -179.969 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -84.77 100.38 11.49 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.481 179.955 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.478 HG23 HG23 ' A' ' 19' ' ' VAL . 82.1 t -102.53 92.22 2.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.341 179.866 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.7 139.36 17.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.445 -179.925 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.425 ' CE1' HG12 ' A' ' 4' ' ' VAL . 2.1 p90 -155.0 168.02 28.41 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.257 179.929 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -74.17 125.06 27.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.417 -179.869 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 141.77 -91.35 0.18 Allowed Glycine 0 CA--C 1.523 0.555 0 N-CA-C 110.566 -1.014 . . . . 0.0 110.566 -179.934 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -72.93 -160.58 0.08 Allowed 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 179.805 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.683 HG22 ' O ' ' A' ' 27' ' ' THR . 33.5 m -144.14 31.67 1.24 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.637 179.975 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.416 ' O ' ' CG ' ' A' ' 71' ' ' GLU . 16.5 mtm 61.37 123.75 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.618 179.642 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.822 ' HB3' ' O ' ' A' ' 69' ' ' LEU . . . -124.86 -58.58 1.47 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.527 179.838 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -152.52 152.18 31.6 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.52 -179.958 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.765 HG21 ' CD1' ' A' ' 52' ' ' TRP . 27.9 t -141.76 155.8 20.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.191 179.746 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.429 ' CG ' ' HG3' ' A' ' 67' ' ' ARG . 0.9 OUTLIER -156.45 148.28 22.89 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.384 -179.784 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.765 HD12 ' H ' ' A' ' 34' ' ' ARG . 4.7 tp -111.4 148.94 31.97 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 -179.821 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.765 ' H ' HD12 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -97.77 -68.26 0.81 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.53 -179.818 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.439 ' CB ' ' O ' ' A' ' 34' ' ' ARG . 25.2 mt-10 88.8 74.94 0.01 OUTLIER 'General case' 0 CA--C 1.51 -0.58 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 -178.771 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -37.37 103.31 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.039 -0.982 . . . . 0.0 111.713 -178.097 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 107.13 37.07 2.38 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 110.413 -1.075 . . . . 0.0 110.413 -179.738 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.429 ' HB2' ' HB2' ' A' ' 35' ' ' GLU . 7.2 t -119.0 -157.5 0.69 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.676 0.274 . . . . 0.0 110.513 -179.641 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -111.25 66.41 0.63 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.855 0.359 . . . . 0.0 110.403 -179.837 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 76.39 160.06 0.22 Allowed 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.394 179.93 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.482 ' CZ3' ' HG2' ' A' ' 67' ' ' ARG . 82.4 m95 -51.18 156.79 1.03 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.566 -179.94 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.2 m -139.15 115.78 10.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.915 179.635 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -48.54 143.04 5.3 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.674 -179.651 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -73.26 -174.16 1.53 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.301 -179.959 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.412 ' O ' ' N ' ' A' ' 47' ' ' GLY . 59.1 m -145.53 120.81 10.22 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.096 179.887 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.42 ' CG ' ' O ' ' A' ' 46' ' ' LYS . 0.8 OUTLIER -68.67 64.4 0.11 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.412 -179.838 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.412 ' N ' ' O ' ' A' ' 45' ' ' THR . . . -72.6 -47.54 26.8 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 110.797 -0.921 . . . . 0.0 110.797 -179.981 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.469 ' CB ' ' HB ' ' A' ' 51' ' ' VAL . 0.5 OUTLIER -73.99 -174.34 1.84 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.866 0.365 . . . . 0.0 110.659 -179.814 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -82.79 -35.29 19.57 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 110.599 -1.0 . . . . 0.0 110.599 179.912 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -146.35 27.07 1.69 Allowed Glycine 0 CA--C 1.522 0.47 0 N-CA-C 110.117 -1.193 . . . . 0.0 110.117 179.69 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.68 HG13 ' O ' ' A' ' 19' ' ' VAL . 88.5 t -138.6 145.7 27.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.841 0.353 . . . . 0.0 110.084 -179.689 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 52' ' ' TRP . . . . . 0.765 ' CD1' HG21 ' A' ' 31' ' ' VAL . 4.2 m95 -94.55 114.37 26.34 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.513 -179.619 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.579 HG22 ' HB2' ' A' ' 18' ' ' ALA . 11.1 p -107.24 143.43 35.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.311 -179.937 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -126.44 150.86 48.41 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.446 179.925 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -108.39 95.47 5.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.355 -179.975 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -61.78 167.23 3.78 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.398 -179.967 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -105.79 -32.46 8.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.491 -179.955 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -111.45 153.52 44.13 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.432 -179.876 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -67.94 -32.37 28.88 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.899 2.399 . . . . 0.0 112.393 -179.934 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -77.53 128.07 33.56 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.673 -179.59 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 19.5 pt20 179.87 132.31 0.1 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.134 -179.943 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -138.79 -72.45 0.05 OUTLIER Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 -179.798 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -72.48 122.01 7.93 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.548 2.165 . . . . 0.0 112.006 179.837 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.596 ' HB3' HD13 ' A' ' 33' ' ' LEU . 45.1 m-85 -113.61 102.36 10.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.685 -179.689 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 52.2 m-20 -81.01 137.26 36.07 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 179.391 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -125.69 170.44 11.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.107 0.48 . . . . 0.0 111.077 -179.351 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.482 ' HG2' ' CZ3' ' A' ' 41' ' ' TRP . 0.0 OUTLIER -168.91 53.69 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.791 179.949 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.506 ' CZ ' HG11 ' A' ' 4' ' ' VAL . 0.2 OUTLIER -49.77 169.82 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.028 -179.56 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.822 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 6.9 mt -124.77 70.1 1.13 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.22 179.386 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 31.9 p -33.43 141.82 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.157 0.583 . . . . 0.0 112.241 -178.99 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.682 ' HG2' ' HB2' ' A' ' 29' ' ' ALA . 4.7 mm-40 -53.66 -60.11 3.73 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.745 -0.662 . . . . 0.0 110.455 -179.952 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 4.8 tmtt? -124.76 77.75 1.63 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.458 -179.973 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -170.55 -99.94 0.13 Allowed Glycine 0 CA--C 1.523 0.536 0 N-CA-C 110.764 -0.935 . . . . 0.0 110.764 179.901 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 179.29 173.56 0.81 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.864 0.364 . . . . 0.0 110.282 -179.938 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.19 -176.29 3.04 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.347 179.938 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.423 ' O ' ' CB ' ' A' ' 67' ' ' ARG . 2.7 t-20 -178.99 -173.7 0.31 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.016 179.942 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 93.0 t -128.31 127.32 67.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.887 0.375 . . . . 0.0 110.454 -179.884 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.586 ' CZ ' HG21 ' A' ' 4' ' ' VAL . 58.3 m-85 -112.64 123.24 49.86 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.887 179.741 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -113.89 151.85 31.6 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.781 -179.519 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 35.5 t0 60.26 24.0 13.4 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.762 179.834 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.654 HG22 ' HD3' ' A' ' 94' ' ' PRO . 25.4 t -55.73 -79.39 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.665 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.612 HG23 HG12 ' A' ' 81' ' ' VAL . 47.2 t -87.11 139.1 32.36 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.453 179.837 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.487 ' HD3' ' CG ' ' A' ' 92' ' ' TYR . 49.2 Cg_endo -71.76 -173.55 1.06 Allowed 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.624 2.216 . . . . 0.0 112.001 179.812 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 32.9 mp0 -64.12 -73.67 0.11 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.057 179.762 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -94.75 73.0 3.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.045 179.642 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 0.449 ' HB3' ' CG1' ' A' ' 82' ' ' VAL . 30.2 p90 -52.04 159.37 0.9 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.897 -179.574 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.74 109.99 12.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.094 179.747 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.595 HG13 HG11 ' A' ' 8' ' ' VAL . 3.3 mp -48.11 111.76 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.748 -179.769 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 110.56 55.0 0.53 Allowed Glycine 0 CA--C 1.523 0.538 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 179.995 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -175.75 131.78 0.26 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.82 0.343 . . . . 0.0 110.465 179.968 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.528 HG23 ' O ' ' A' ' 6' ' ' PHE . 35.5 m -83.16 144.58 29.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.159 179.917 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.487 ' CG ' ' HD3' ' A' ' 83' ' ' PRO . 71.9 m-85 -129.03 -83.79 0.57 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.691 -179.964 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.94 ' HB1' ' HD2' ' A' ' 94' ' ' PRO . . . 49.64 -179.01 0.01 OUTLIER Pre-proline 0 C--O 1.232 0.133 0 CA-C-O 120.624 0.249 . . . . 0.0 110.595 179.94 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.94 ' HD2' ' HB1' ' A' ' 93' ' ' ALA . 48.1 Cg_endo . . . . . 0 C--O 1.249 1.053 0 C-N-CA 122.481 2.121 . . . . 0.0 112.088 -179.902 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt . . . . . 0 CA--C 1.523 -0.09 0 CA-C-O 120.865 0.365 . . . . 0.0 110.38 . . . . . . . . . 0 0 . 1 . 031 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.651 ' O ' HG23 ' A' ' 5' ' ' THR . 34.2 m -66.21 -178.38 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.359 -179.937 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.651 HG23 ' O ' ' A' ' 4' ' ' VAL . 3.0 p -161.77 138.34 8.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.296 -179.996 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.614 ' O ' HG23 ' A' ' 91' ' ' THR . 23.4 m-85 -102.06 173.1 6.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.459 -179.757 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.451 HG23 ' O ' ' A' ' 90' ' ' ALA . 0.3 OUTLIER -165.96 102.92 0.66 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.287 -179.991 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.44 ' CG1' HG13 ' A' ' 88' ' ' ILE . 40.5 t -51.68 96.35 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.341 179.956 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.557 ' CD ' HD12 ' A' ' 20' ' ' LEU . 1.8 mm-40 -62.09 177.1 0.5 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.654 -179.737 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.8 tttt -80.63 60.34 3.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.409 -179.944 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -146.3 21.23 1.72 Allowed Glycine 0 CA--C 1.525 0.668 0 N-CA-C 111.022 -0.831 . . . . 0.0 111.022 179.974 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 25.6 m -110.32 114.58 28.15 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 110.121 -0.325 . . . . 0.0 110.121 179.921 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.419 ' OD1' ' N ' ' A' ' 14' ' ' GLU . 6.1 p30 -113.46 -49.13 2.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.612 -179.793 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.419 ' N ' ' OD1' ' A' ' 13' ' ' ASN . 9.6 mm-40 -154.15 -69.65 0.14 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.776 -179.792 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.433 ' HD2' ' N ' ' A' ' 15' ' ' LYS . 17.9 mmmt -91.25 -28.73 17.61 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.478 -179.478 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 9.5 m80 -76.36 128.59 35.14 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.764 -179.632 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.449 ' HA ' HD22 ' A' ' 17' ' ' LEU . 1.2 tm? -122.32 86.22 2.54 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.943 179.793 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.775 ' HB1' HG11 ' A' ' 51' ' ' VAL . . . -80.11 129.35 34.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.636 -179.596 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.658 ' O ' HG13 ' A' ' 51' ' ' VAL . 24.1 m -134.03 134.35 55.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.401 179.697 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.557 HD12 ' CD ' ' A' ' 9' ' ' GLU . 0.7 OUTLIER -89.36 87.47 7.12 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.377 -179.947 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.47 HG23 HG23 ' A' ' 19' ' ' VAL . 12.0 t -86.39 108.87 18.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.27 179.923 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.1 mtpt -179.67 176.39 0.79 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.226 179.95 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.442 ' CE2' HG12 ' A' ' 4' ' ' VAL . 20.1 p90 176.85 40.93 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.315 -179.963 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 55.63 174.77 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.353 179.974 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 70.74 -101.19 0.9 Allowed Glycine 0 CA--C 1.523 0.559 0 N-CA-C 110.635 -0.986 . . . . 0.0 110.635 -179.993 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -54.8 166.39 0.49 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.779 0.323 . . . . 0.0 110.359 179.934 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -115.0 -169.31 1.53 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.474 179.949 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.413 ' O ' ' CG ' ' A' ' 71' ' ' GLU . 13.4 mmt -115.21 127.45 55.52 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.637 -179.756 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.87 ' HB3' ' O ' ' A' ' 69' ' ' LEU . . . -118.03 -59.37 1.91 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.586 -179.904 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -150.44 153.06 35.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.215 -179.943 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.55 HG22 ' HB3' ' A' ' 68' ' ' PHE . 4.4 t -147.61 146.68 18.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.017 0.437 . . . . 0.0 110.773 -179.742 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.45 ' CB ' ' HA ' ' A' ' 43' ' ' ALA . 5.9 pt-20 -137.26 146.28 44.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.513 179.203 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.668 HD12 ' H ' ' A' ' 34' ' ' ARG . 9.8 tp -123.1 153.2 40.25 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-O 120.938 0.399 . . . . 0.0 110.033 -178.907 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.668 ' H ' HD12 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -145.66 162.73 36.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.678 179.574 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.405 ' O ' ' HB2' ' A' ' 36' ' ' HIS . 1.1 mt-10 -120.45 -86.11 0.65 Allowed 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 179.924 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 36' ' ' HIS . . . . . 0.405 ' HB2' ' O ' ' A' ' 35' ' ' GLU . 0.8 OUTLIER -179.98 -40.62 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.803 0.335 . . . . 0.0 110.373 179.472 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -63.22 -56.83 17.97 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 110.781 -0.928 . . . . 0.0 110.781 -179.951 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.417 ' O ' ' CB ' ' A' ' 39' ' ' ASP . 1.5 t -55.03 -36.2 65.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.777 0.322 . . . . 0.0 110.356 -179.928 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.417 ' CB ' ' O ' ' A' ' 38' ' ' SER . 4.1 t70 81.6 -53.66 0.27 Allowed 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.489 -179.812 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -77.88 145.53 36.17 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.155 179.948 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.508 ' CE3' ' HB2' ' A' ' 34' ' ' ARG . 75.3 m95 -71.0 153.68 42.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.472 -179.864 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.6 HG21 ' CZ ' ' A' ' 54' ' ' PHE . 3.0 m -135.72 111.95 12.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.921 179.671 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.45 ' HA ' ' CB ' ' A' ' 32' ' ' GLU . . . -47.95 155.05 0.47 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.857 -179.479 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -76.42 -173.17 2.39 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.355 179.986 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 53.7 m -152.49 103.57 2.83 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.526 -179.943 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 7.9 ptpt -59.5 88.89 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.229 -0.442 . . . . 0.0 109.934 179.767 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -110.25 -28.46 4.08 Favored Glycine 0 CA--C 1.522 0.52 0 N-CA-C 111.239 -0.745 . . . . 0.0 111.239 -179.56 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.467 ' CB ' ' HB ' ' A' ' 51' ' ' VAL . 1.1 tp10 -72.09 -36.13 69.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.753 0.311 . . . . 0.0 110.698 -179.646 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 115.12 -37.46 3.49 Favored Glycine 0 CA--C 1.52 0.405 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 -179.115 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -138.02 21.32 3.17 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 178.631 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.775 HG11 ' HB1' ' A' ' 18' ' ' ALA . 52.6 t -155.44 144.61 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 -179.677 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 52' ' ' TRP . . . . . 0.495 ' NE1' HG21 ' A' ' 31' ' ' VAL . 3.0 m95 -91.51 110.42 21.74 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.968 0.413 . . . . 0.0 110.327 -179.749 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.461 ' CG2' ' HB2' ' A' ' 18' ' ' ALA . 1.1 p -101.81 142.17 33.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.468 -179.7 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.61 ' CG ' HD23 ' A' ' 33' ' ' LEU . 66.3 t80 -130.47 147.26 52.15 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.344 179.902 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 51.8 m-20 -89.04 101.17 13.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.431 -179.938 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.0 t -77.65 170.74 16.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.257 179.889 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -177.4 68.95 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.474 -179.912 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 179.49 118.61 0.21 Allowed Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.375 179.967 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -73.63 -2.43 12.17 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.475 2.117 . . . . 0.0 112.683 179.998 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 10.6 mp -67.05 74.91 0.12 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.727 0.298 . . . . 0.0 110.459 -179.943 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.423 ' HB2' ' HD3' ' A' ' 63' ' ' PRO . 57.7 mt-30 51.55 -170.06 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.177 179.998 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.492 ' N ' ' HD3' ' A' ' 63' ' ' PRO . . . -128.46 47.95 0.99 Allowed Glycine 0 CA--C 1.527 0.8 0 N-CA-C 111.589 -0.604 . . . . 0.0 111.589 -179.846 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.492 ' HD3' ' N ' ' A' ' 62' ' ' GLY . 51.8 Cg_endo -76.69 90.09 1.24 Allowed 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.389 2.06 . . . . 0.0 111.396 179.327 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.421 ' HB3' ' CD1' ' A' ' 33' ' ' LEU . 24.9 m-85 -92.28 160.51 15.1 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.272 0.558 . . . . 0.0 111.253 -179.238 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 5.0 m-80 -142.35 140.73 32.19 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.371 179.713 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.421 ' CZ ' HD13 ' A' ' 33' ' ' LEU . 79.0 m-85 -129.92 156.06 45.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.139 0.495 . . . . 0.0 111.545 -179.058 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.496 ' HD2' ' CZ2' ' A' ' 41' ' ' TRP . 1.8 mtp180 -156.38 61.96 0.55 Allowed 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.212 179.769 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.556 ' O ' HD23 ' A' ' 69' ' ' LEU . 0.7 OUTLIER -68.18 172.41 5.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.247 0.546 . . . . 0.0 110.856 -179.602 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.87 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 0.5 OUTLIER -131.09 76.05 1.7 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.47 -0.787 . . . . 0.0 109.293 179.728 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 2.7 p -35.4 136.9 0.19 Allowed 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 122.771 0.428 . . . . 0.0 111.813 -179.193 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.638 ' HG2' ' HB2' ' A' ' 29' ' ' ALA . 14.2 mt-10 -50.84 -28.95 10.54 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.582 -179.569 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.3 83.01 1.43 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.541 -179.847 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -177.05 -98.54 0.11 Allowed Glycine 0 CA--C 1.523 0.569 0 N-CA-C 110.846 -0.902 . . . . 0.0 110.846 179.864 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 179.3 -178.96 0.37 Allowed 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 110.201 -0.296 . . . . 0.0 110.201 -179.832 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.43 ' HG2' HD22 ' A' ' 69' ' ' LEU . 0.4 OUTLIER -93.4 179.9 5.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.873 0.368 . . . . 0.0 110.378 179.926 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 172.11 136.02 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.284 -179.988 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.457 HG12 ' N ' ' A' ' 78' ' ' PHE . 99.1 t -92.86 158.76 2.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.483 -179.986 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.457 ' CZ ' HG21 ' A' ' 4' ' ' VAL . 64.8 m-85 -143.25 108.22 4.94 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.12 179.94 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -91.17 147.91 22.73 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.663 -179.654 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 41.3 t0 51.51 52.2 15.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.797 179.742 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 74.9 t -68.72 -62.83 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 179.576 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.573 HG13 ' HD2' ' A' ' 83' ' ' PRO . 91.5 t -98.52 140.12 21.6 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.101 179.542 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.573 ' HD2' HG13 ' A' ' 82' ' ' VAL . 46.1 Cg_endo -69.74 -170.52 0.4 Allowed 'Trans proline' 0 N--CA 1.474 0.377 0 C-N-CA 122.638 2.225 . . . . 0.0 112.15 179.877 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 33.6 mp0 -77.35 -37.05 53.11 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.288 179.948 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -124.9 77.15 1.59 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.242 179.873 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 0.428 ' HB3' ' CG1' ' A' ' 82' ' ' VAL . 38.6 p90 -73.25 179.82 3.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.462 -179.871 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -157.69 120.56 3.91 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.305 -179.99 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.586 ' H ' HD12 ' A' ' 88' ' ' ILE . 4.0 mp -51.54 100.45 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.397 179.941 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 131.41 56.43 0.09 OUTLIER Glycine 0 CA--C 1.523 0.556 0 N-CA-C 110.703 -0.959 . . . . 0.0 110.703 -179.889 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.746 ' HB3' ' OH ' ' A' ' 92' ' ' TYR . . . -177.99 178.03 0.99 Allowed 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 110.253 -0.277 . . . . 0.0 110.253 179.981 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.614 HG23 ' O ' ' A' ' 6' ' ' PHE . 0.7 OUTLIER -111.8 146.24 37.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.889 0.376 . . . . 0.0 110.653 -179.839 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.746 ' OH ' ' HB3' ' A' ' 90' ' ' ALA . 8.6 m-85 -150.17 104.16 3.24 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.263 179.712 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.9 ' HB1' ' HD2' ' A' ' 94' ' ' PRO . . . 173.66 177.74 0.16 Allowed Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.461 179.968 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.9 ' HD2' ' HB1' ' A' ' 93' ' ' ALA . 50.4 Cg_endo . . . . . 0 C--O 1.249 1.026 0 C-N-CA 122.657 2.238 . . . . 0.0 112.211 -179.924 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 10.0 mttt . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.8 0.333 . . . . 0.0 110.526 . . . . . . . . . 0 0 . 1 . 032 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.575 HG11 ' CZ ' ' A' ' 78' ' ' PHE . 1.6 p -56.03 164.03 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.189 0.519 . . . . 0.0 110.204 179.894 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.476 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 9.1 p -142.17 128.65 20.15 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.411 179.966 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.55 ' CE2' ' CD2' ' A' ' 66' ' ' PHE . 8.0 m-85 -97.98 173.16 7.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.227 179.996 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.618 HG23 ' O ' ' A' ' 90' ' ' ALA . 12.9 m -165.37 117.79 1.16 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.469 -179.862 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.504 ' O ' HG23 ' A' ' 88' ' ' ILE . 20.6 t -59.11 94.57 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.269 179.946 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.737 ' HG3' HG11 ' A' ' 51' ' ' VAL . 0.1 OUTLIER -51.21 171.84 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.594 -179.893 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.2 ttmt -85.5 56.54 4.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.413 -179.99 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -147.63 25.36 1.5 Allowed Glycine 0 CA--C 1.524 0.622 0 N-CA-C 110.742 -0.943 . . . . 0.0 110.742 179.949 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -100.05 113.6 26.33 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.813 0.339 . . . . 0.0 110.216 179.939 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.407 ' OD1' ' N ' ' A' ' 14' ' ' GLU . 4.7 p30 -112.94 -51.4 2.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.533 -179.852 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.407 ' N ' ' OD1' ' A' ' 13' ' ' ASN . 0.5 OUTLIER -166.99 -64.98 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.755 -179.874 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.415 ' HD2' ' N ' ' A' ' 15' ' ' LYS . 10.9 mmmt -86.59 -27.11 24.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.54 -179.402 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 19.3 m80 -91.62 126.16 36.61 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.934 0.397 . . . . 0.0 110.849 -179.518 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.457 ' HA ' HD22 ' A' ' 17' ' ' LEU . 0.3 OUTLIER -116.81 89.63 3.15 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.627 179.425 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -83.51 126.05 32.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.762 -179.368 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.592 HG11 ' CZ ' ' A' ' 66' ' ' PHE . 19.8 m -113.55 -173.41 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.629 179.368 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.6 tt -141.04 59.21 1.53 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.256 179.679 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 28.0 t -55.86 116.54 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.428 -179.937 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.1 mttp -168.09 162.42 13.09 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.154 179.97 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -140.42 -63.67 0.48 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.225 -0.443 . . . . 0.0 109.979 -179.968 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -149.53 -47.25 0.14 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.318 179.981 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 170.22 74.84 0.04 OUTLIER Glycine 0 CA--C 1.524 0.601 0 N-CA-C 110.899 -0.88 . . . . 0.0 110.899 179.982 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -112.9 -168.31 1.3 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.767 0.318 . . . . 0.0 110.206 179.797 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.719 HG22 ' HG3' ' A' ' 71' ' ' GLU . 0.9 OUTLIER -113.45 137.78 51.04 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.094 179.984 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 7.8 mtt -101.62 129.57 47.77 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.872 -179.537 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.816 ' HB3' ' O ' ' A' ' 69' ' ' LEU . . . -112.68 -57.6 2.26 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.246 179.824 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.412 ' O ' ' CB ' ' A' ' 68' ' ' PHE . 0.7 OUTLIER -153.11 165.2 36.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.175 179.832 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.53 HG21 ' CD1' ' A' ' 52' ' ' TRP . 4.1 t -152.69 140.27 13.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.264 -0.426 . . . . 0.0 109.939 -179.969 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.454 ' CB ' ' HA ' ' A' ' 43' ' ' ALA . 1.5 pt-20 -137.34 137.34 38.8 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.968 0.413 . . . . 0.0 110.584 -179.701 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.563 HD12 ' CB ' ' A' ' 54' ' ' PHE . 1.6 mt -92.97 -178.52 4.83 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.587 -179.686 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.466 ' HB2' ' CZ3' ' A' ' 41' ' ' TRP . 0.7 OUTLIER -157.5 147.75 20.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.943 179.633 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -113.99 -14.36 12.43 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.957 -179.834 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 70.22 120.83 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.843 0.354 . . . . 0.0 110.31 -179.996 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 118.06 -45.27 1.29 Allowed Glycine 0 CA--C 1.522 0.481 0 N-CA-C 110.472 -1.051 . . . . 0.0 110.472 -179.753 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 20.7 t -63.24 -25.41 68.31 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.774 0.321 . . . . 0.0 110.314 179.778 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.1 t0 70.38 29.32 3.57 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.415 179.908 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -154.37 145.05 22.38 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.513 179.957 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.466 ' CZ3' ' HB2' ' A' ' 34' ' ' ARG . 83.8 m95 -88.14 145.66 25.81 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.036 179.8 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.768 HG21 ' CZ ' ' A' ' 54' ' ' PHE . 20.3 m -117.11 107.15 21.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.095 0.474 . . . . 0.0 110.33 -179.862 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.454 ' HA ' ' CB ' ' A' ' 32' ' ' GLU . . . -53.82 139.22 33.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.152 -179.782 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.86 -171.48 0.07 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.855 -179.644 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.422 ' O ' ' N ' ' A' ' 47' ' ' GLY . 86.7 m -143.55 97.65 3.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.217 179.858 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 13.5 ptmt -61.25 80.7 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.361 -179.883 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' A' ' 45' ' ' THR . . . -120.93 15.37 9.55 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 111.236 -0.745 . . . . 0.0 111.236 179.993 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.412 ' HG3' HG23 ' A' ' 51' ' ' VAL . 1.8 mm-40 -106.62 -33.24 7.71 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.847 0.356 . . . . 0.0 110.325 179.96 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 94.89 -36.79 3.63 Favored Glycine 0 CA--C 1.522 0.515 0 N-CA-C 110.667 -0.973 . . . . 0.0 110.667 179.973 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -110.92 -25.55 5.07 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 110.818 -0.913 . . . . 0.0 110.818 -179.877 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.737 HG11 ' HG3' ' A' ' 9' ' ' GLU . 15.5 m -140.66 -176.33 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.937 0.399 . . . . 0.0 110.591 -179.904 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 52' ' ' TRP . . . . . 0.53 ' CD1' HG21 ' A' ' 31' ' ' VAL . 9.5 m95 -108.58 142.28 39.26 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.726 -179.507 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -130.02 150.76 51.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.967 179.672 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.768 ' CZ ' HG21 ' A' ' 42' ' ' VAL . 65.8 t80 -136.18 153.57 51.21 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.884 0.373 . . . . 0.0 110.808 -179.825 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -95.56 96.46 9.07 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.212 179.831 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 31.3 p -50.71 121.62 6.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.562 -179.859 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -80.83 -26.83 36.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.099 179.721 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 23.8 pt-20 -118.32 144.88 35.95 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.18 179.883 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -67.07 -18.52 51.57 Favored 'Trans proline' 0 C--N 1.343 0.246 0 C-N-CA 122.765 2.31 . . . . 0.0 112.19 179.999 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.423 ' HA ' HD13 ' A' ' 60' ' ' LEU . 0.9 OUTLIER -71.94 118.21 14.51 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.426 179.975 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -101.19 54.14 0.84 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.242 179.86 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -73.15 -143.2 0.58 Allowed Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.715 -0.954 . . . . 0.0 110.715 -179.949 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.411 ' HB3' ' HA ' ' A' ' 80' ' ' ASP . 49.1 Cg_endo -77.27 106.16 2.18 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.614 2.209 . . . . 0.0 112.145 -179.856 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.501 ' HB3' HD21 ' A' ' 33' ' ' LEU . 16.4 m-85 -77.96 98.32 5.64 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.66 179.961 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.43 ' OD1' ' N ' ' A' ' 65' ' ' ASN . 0.4 OUTLIER -71.32 123.45 22.31 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 179.469 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.592 ' CZ ' HG11 ' A' ' 19' ' ' VAL . 2.7 m-85 -101.05 176.66 5.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.598 -179.55 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.858 ' HD2' HG22 ' A' ' 77' ' ' VAL . 1.7 mtp180 176.51 102.1 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.456 179.916 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.773 ' O ' HD23 ' A' ' 69' ' ' LEU . 0.8 OUTLIER -111.29 172.85 6.64 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.427 179.815 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.816 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 2.4 mt -128.88 65.98 1.43 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.376 179.684 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 29.0 p -31.5 143.87 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.246 0.619 . . . . 0.0 112.108 -179.302 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.719 ' HG3' HG22 ' A' ' 27' ' ' THR . 0.4 OUTLIER -68.29 -31.23 70.53 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.254 -179.716 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.5 tmtm? -141.03 56.24 1.56 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.47 179.994 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -145.48 -105.66 0.47 Allowed Glycine 0 CA--C 1.523 0.559 0 N-CA-C 110.622 -0.991 . . . . 0.0 110.622 179.9 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 10.6 ptm -178.47 -179.45 0.68 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.787 0.327 . . . . 0.0 110.205 -179.986 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.745 ' HD2' HD22 ' A' ' 69' ' ' LEU . 14.1 mmtm -90.82 158.19 16.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.14 179.871 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -175.25 135.71 0.35 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.801 -179.944 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.858 HG22 ' HD2' ' A' ' 67' ' ' ARG . 94.6 t -94.2 150.25 4.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.233 -0.44 . . . . 0.0 109.963 179.476 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.575 ' CZ ' HG11 ' A' ' 4' ' ' VAL . 71.2 m-85 -131.5 145.73 51.9 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.97 -179.203 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -139.62 162.19 35.7 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.006 179.76 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.411 ' HA ' ' HB3' ' A' ' 63' ' ' PRO . 0.1 OUTLIER 51.97 33.04 10.98 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.113 0.483 . . . . 0.0 109.839 -179.722 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.542 ' O ' HG12 ' A' ' 81' ' ' VAL . 87.6 t -78.41 -3.01 5.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.586 -179.406 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.445 HG23 ' O ' ' A' ' 81' ' ' VAL . 72.4 t -158.15 119.45 1.95 Allowed Pre-proline 0 CA--C 1.53 0.21 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 179.855 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.416 ' HD3' ' CG ' ' A' ' 92' ' ' TYR . 50.9 Cg_endo -75.66 169.64 21.88 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.458 2.105 . . . . 0.0 111.786 179.729 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -66.26 120.02 12.53 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 179.633 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 2.5 mtpt 67.24 58.85 0.54 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.224 -0.443 . . . . 0.0 109.997 -179.609 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 21.4 p90 -52.96 -175.16 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.741 -179.729 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 1.5 m -152.26 108.12 3.36 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.967 179.836 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.504 HG23 ' O ' ' A' ' 8' ' ' VAL . 3.3 mp -46.45 121.82 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.68 -179.86 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 113.73 29.59 2.83 Favored Glycine 0 CA--C 1.523 0.582 0 N-CA-C 110.736 -0.945 . . . . 0.0 110.736 -179.875 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.618 ' O ' HG23 ' A' ' 7' ' ' THR . . . -142.32 167.29 22.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.736 0.303 . . . . 0.0 110.443 -179.944 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 32.8 m -113.44 120.8 42.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.522 -179.968 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.471 ' O ' ' HB2' ' A' ' 93' ' ' ALA . 40.8 m-85 -125.62 123.55 39.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.394 179.954 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.919 ' HB1' ' HD2' ' A' ' 94' ' ' PRO . . . 174.56 178.45 0.17 Allowed Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.457 -179.981 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.919 ' HD2' ' HB1' ' A' ' 93' ' ' ALA . 49.8 Cg_endo . . . . . 0 C--O 1.25 1.083 0 C-N-CA 122.547 2.165 . . . . 0.0 112.112 -179.884 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 33.4 mmtm . . . . . 0 N--CA 1.457 -0.117 0 CA-C-O 120.725 0.298 . . . . 0.0 111.07 . . . . . . . . . 0 0 . 1 . 033 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.524 ' CG1' ' CE1' ' A' ' 78' ' ' PHE . 2.1 p -106.26 163.42 4.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.336 0.588 . . . . 0.0 110.365 -179.968 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.486 ' N ' HG22 ' A' ' 4' ' ' VAL . 65.9 p -144.2 129.51 18.81 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.294 179.718 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.775 ' O ' HG23 ' A' ' 91' ' ' THR . 35.0 m-85 -89.29 -176.75 5.19 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.307 179.904 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -166.15 118.57 1.06 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.152 179.934 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.1 t -68.18 93.43 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.356 -179.899 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.605 ' O ' HG23 ' A' ' 88' ' ' ILE . 1.8 mm-40 -54.11 -178.45 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.303 -179.961 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.26 48.74 1.6 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.455 -179.839 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -112.3 -25.78 4.56 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 110.842 -0.903 . . . . 0.0 110.842 -179.992 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.1 m -50.82 120.97 5.28 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.826 0.346 . . . . 0.0 110.418 -179.982 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -114.13 -81.17 0.6 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.424 -179.912 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -106.78 -82.67 0.54 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.735 0.302 . . . . 0.0 110.41 -179.904 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.36 28.39 8.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.326 -179.995 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 14.4 m-70 -104.08 167.39 9.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.325 -179.959 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.451 HD12 ' HA ' ' A' ' 17' ' ' LEU . 17.2 tp -154.13 88.79 1.25 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.452 -179.853 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.572 ' HB2' ' CG2' ' A' ' 53' ' ' THR . . . -81.37 109.62 16.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.454 -179.902 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.571 HG23 HG23 ' A' ' 21' ' ' VAL . 21.5 m -103.54 141.23 19.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.449 179.941 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -90.41 83.23 5.89 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.611 -179.99 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.571 HG23 HG23 ' A' ' 19' ' ' VAL . 16.2 t -79.32 90.61 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.348 179.866 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 176.08 157.29 0.24 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.982 -0.553 . . . . 0.0 109.95 -179.974 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.543 ' CE2' ' HB2' ' A' ' 26' ' ' ASP . 0.0 OUTLIER -113.89 -66.52 1.08 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.541 -179.751 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -153.45 -65.21 0.15 Allowed 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 111.808 0.299 . . . . 0.0 111.808 -179.395 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -106.36 -28.14 5.29 Favored Glycine 0 CA--C 1.525 0.702 0 C-N-CA 121.364 -0.446 . . . . 0.0 112.563 -178.372 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.543 ' HB2' ' CE2' ' A' ' 23' ' ' TYR . 16.8 t0 -42.29 152.02 0.1 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 117.277 0.539 . . . . 0.0 111.417 -179.363 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.402 HG22 ' H ' ' A' ' 28' ' ' MET . 0.2 OUTLIER -100.63 -174.67 2.7 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.731 -179.462 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.423 ' O ' ' CG ' ' A' ' 71' ' ' GLU . 34.7 mtm -123.17 126.07 46.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.336 -179.883 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.673 ' HB3' ' O ' ' A' ' 69' ' ' LEU . . . -118.97 -60.35 1.76 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.513 -179.706 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.7 ' HB3' HD12 ' A' ' 69' ' ' LEU . 0.6 OUTLIER -154.39 156.26 36.52 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.106 -179.937 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.474 ' HA ' ' HA ' ' A' ' 68' ' ' PHE . 0.7 OUTLIER -173.95 141.33 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.377 0.608 . . . . 0.0 110.271 -179.87 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.442 ' HG3' ' HB3' ' A' ' 41' ' ' TRP . 1.7 pm0 -141.18 169.48 17.53 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.059 -179.444 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.87 HD21 ' CE1' ' A' ' 66' ' ' PHE . 1.0 OUTLIER -117.3 174.34 6.19 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.157 0.503 . . . . 0.0 111.096 -179.479 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.43 ' NE ' ' HA ' ' A' ' 34' ' ' ARG . 0.5 OUTLIER -161.75 -176.69 5.41 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.486 179.562 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -129.92 -70.76 0.63 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.797 0.332 . . . . 0.0 110.424 179.928 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 58.2 t-80 -178.53 -50.02 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.344 179.972 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -121.02 25.69 7.02 Favored Glycine 0 CA--C 1.523 0.545 0 N-CA-C 110.733 -0.947 . . . . 0.0 110.733 179.87 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 2.7 m -70.97 -22.43 62.2 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.652 0.263 . . . . 0.0 110.593 179.931 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.4 t0 71.96 97.21 0.07 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.799 0.333 . . . . 0.0 110.326 -179.802 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 76.82 146.44 0.09 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.398 -179.961 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.513 ' CE3' ' HG2' ' A' ' 67' ' ' ARG . 35.5 m95 -79.83 160.95 25.91 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.54 -179.826 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.481 HG23 ' O ' ' A' ' 42' ' ' VAL . 32.1 m -132.16 122.18 47.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.179 179.832 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.428 ' HA ' ' HB3' ' A' ' 32' ' ' GLU . . . -46.51 130.44 11.1 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.8 -179.911 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.693 ' CE ' HD12 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -58.79 -167.51 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.22 -179.901 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 53.2 m -137.01 126.34 24.86 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.434 -179.946 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.66 67.16 6.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.231 -0.44 . . . . 0.0 109.987 179.726 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -96.86 -35.98 5.17 Favored Glycine 0 CA--C 1.522 0.503 0 N-CA-C 110.738 -0.945 . . . . 0.0 110.738 -179.772 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.449 ' HG2' ' CG2' ' A' ' 51' ' ' VAL . 31.8 tp10 -80.18 133.91 36.09 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.804 0.335 . . . . 0.0 110.369 179.915 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -79.36 88.39 1.21 Allowed Glycine 0 CA--C 1.523 0.587 0 N-CA-C 111.021 -0.831 . . . . 0.0 111.021 -179.794 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 129.81 -23.4 4.73 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 111.167 -0.773 . . . . 0.0 111.167 179.721 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.511 HG11 ' HG3' ' A' ' 9' ' ' GLU . 16.7 m -146.8 -175.56 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.933 0.397 . . . . 0.0 110.684 -179.756 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 8.4 m95 -103.22 144.61 31.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.462 -179.547 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.572 ' CG2' ' HB2' ' A' ' 18' ' ' ALA . 0.1 OUTLIER -132.57 145.15 50.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.546 -179.759 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -120.62 136.69 54.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.125 179.725 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 11.4 t0 -113.67 156.34 23.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.939 0.4 . . . . 0.0 110.765 -179.706 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -175.39 172.96 2.59 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.326 179.947 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -154.85 30.79 0.41 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.385 -179.97 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -75.64 157.36 84.25 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.473 -179.96 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -71.3 -34.52 9.73 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.67 2.247 . . . . 0.0 112.035 179.881 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 5.4 mt -81.37 167.3 19.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.356 -179.928 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 28.2 tt0 -172.53 111.39 0.25 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.476 -179.98 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -135.35 -143.26 4.71 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.597 -1.001 . . . . 0.0 110.597 179.975 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -77.32 171.84 17.02 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.546 2.164 . . . . 0.0 111.892 179.882 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -124.18 172.45 9.04 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.92 0.39 . . . . 0.0 110.511 -179.948 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.505 ' O ' HD23 ' A' ' 33' ' ' LEU . 5.3 m-80 -146.36 144.72 29.95 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.176 -179.982 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.87 ' CE1' HD21 ' A' ' 33' ' ' LEU . 39.3 m-85 -127.03 -177.12 3.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.019 0.437 . . . . 0.0 110.483 179.978 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.575 ' HB3' HG12 ' A' ' 77' ' ' VAL . 0.0 OUTLIER 176.78 72.66 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.799 179.76 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.831 ' O ' HD23 ' A' ' 69' ' ' LEU . 0.0 OUTLIER -71.01 -178.96 2.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.409 0.624 . . . . 0.0 111.626 -179.259 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.831 HD23 ' O ' ' A' ' 68' ' ' PHE . 9.1 mt -144.77 49.07 1.31 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.032 -0.985 . . . . 0.0 109.254 179.874 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.456 HG21 ' OD2' ' A' ' 26' ' ' ASP . 40.8 p -22.67 137.64 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.129 0.972 . . . . 0.0 112.891 -179.147 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.653 ' HG2' ' HB2' ' A' ' 29' ' ' ALA . 3.2 mm-40 -54.2 -25.27 21.97 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.533 -179.806 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.51 48.89 0.14 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.862 0.363 . . . . 0.0 110.547 -179.907 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.412 ' CA ' ' OG1' ' A' ' 70' ' ' THR . . . -128.34 -107.2 1.35 Allowed Glycine 0 CA--C 1.523 0.592 0 N-CA-C 110.707 -0.957 . . . . 0.0 110.707 179.915 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.409 ' N ' ' OG1' ' A' ' 70' ' ' THR . 66.0 mmm -139.13 171.28 14.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.832 0.349 . . . . 0.0 110.305 179.965 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.439 ' CD ' ' O ' ' A' ' 75' ' ' LYS . 0.0 OUTLIER -138.12 86.56 2.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.306 179.859 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -141.1 140.23 34.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.251 -179.971 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.575 HG12 ' HB3' ' A' ' 67' ' ' ARG . 17.9 m -66.61 -179.73 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.333 -179.958 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.524 ' CE1' ' CG1' ' A' ' 4' ' ' VAL . 66.1 m-85 -149.38 135.54 19.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.631 -179.831 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -119.21 158.99 24.89 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.395 -179.976 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 52.5 49.65 19.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.405 179.91 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.571 ' O ' HG12 ' A' ' 81' ' ' VAL . 80.9 t -90.89 -0.65 9.44 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.039 179.836 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.626 HG13 ' HB3' ' A' ' 86' ' ' TYR . 94.8 t -157.49 130.2 4.35 Favored Pre-proline 0 CA--C 1.527 0.093 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 179.667 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.501 ' HD3' ' CD1' ' A' ' 92' ' ' TYR . 49.7 Cg_endo -71.0 -167.09 0.25 Allowed 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.577 2.184 . . . . 0.0 112.06 179.767 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -68.78 -34.25 75.24 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.933 179.472 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -137.96 91.19 2.55 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.952 179.683 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 0.626 ' HB3' HG13 ' A' ' 82' ' ' VAL . 14.9 p90 -67.62 165.76 16.39 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.794 -179.65 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -141.34 115.24 9.15 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.064 179.844 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.605 HG23 ' O ' ' A' ' 9' ' ' GLU . 3.4 mp -46.58 131.08 3.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.762 -179.836 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 89.87 39.29 6.21 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 110.685 -0.966 . . . . 0.0 110.685 -179.905 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -146.81 155.93 42.73 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.865 0.364 . . . . 0.0 110.53 -179.918 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.775 HG23 ' O ' ' A' ' 6' ' ' PHE . 0.2 OUTLIER -106.42 142.22 36.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.258 179.954 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.501 ' CD1' ' HD3' ' A' ' 83' ' ' PRO . 73.3 m-85 -134.1 -86.48 0.41 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.762 -179.914 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.902 ' HB1' ' HD2' ' A' ' 94' ' ' PRO . . . 50.12 -179.05 0.01 OUTLIER Pre-proline 0 C--N 1.332 -0.154 0 CA-C-O 120.63 0.252 . . . . 0.0 110.547 179.923 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.902 ' HD2' ' HB1' ' A' ' 93' ' ' ALA . 47.9 Cg_endo . . . . . 0 C--O 1.249 1.054 0 C-N-CA 122.539 2.16 . . . . 0.0 112.064 -179.978 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.522 -0.131 0 CA-C-O 120.899 0.381 . . . . 0.0 110.361 . . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.779 HG21 ' CZ ' ' A' ' 78' ' ' PHE . 27.0 m -88.45 -176.03 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.087 179.85 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.587 HG23 ' O ' ' A' ' 4' ' ' VAL . 0.5 OUTLIER -167.04 146.92 5.44 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.364 179.971 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.491 ' H ' ' HB3' ' A' ' 93' ' ' ALA . 37.9 m-85 -118.78 158.13 26.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.22 179.905 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 53.2 m -150.73 104.71 3.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.35 -179.863 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.756 HG12 HD13 ' A' ' 88' ' ' ILE . 14.2 t -54.33 94.83 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.416 -179.905 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.83 ' HG3' HG11 ' A' ' 51' ' ' VAL . 4.7 mm-40 -69.33 162.89 26.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.286 -179.99 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.67 171.01 3.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.479 -179.967 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 86.67 19.59 56.06 Favored Glycine 0 CA--C 1.527 0.795 0 N-CA-C 111.103 -0.799 . . . . 0.0 111.103 -179.955 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.803 ' HB2' HD11 ' A' ' 88' ' ' ILE . 8.7 m -109.6 -159.76 0.69 Allowed 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 -179.936 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.409 ' HB2' ' O ' ' A' ' 12' ' ' SER . 5.2 m120 66.79 -62.39 0.3 Allowed 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.153 179.556 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.402 ' N ' ' O ' ' A' ' 12' ' ' SER . 2.3 tt0 -43.44 -69.73 0.13 Allowed 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.76 0.314 . . . . 0.0 111.02 -179.555 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.432 ' HA ' ' CE ' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -156.29 25.9 0.35 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.388 179.965 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 55.2 m80 -149.77 165.46 32.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.081 0.467 . . . . 0.0 110.787 -179.572 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.479 ' HA ' HD22 ' A' ' 17' ' ' LEU . 0.4 OUTLIER -138.56 85.27 2.07 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.285 179.236 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.624 ' HB2' HG23 ' A' ' 53' ' ' THR . . . -78.2 153.42 31.99 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.985 -179.134 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.43 HG23 HG23 ' A' ' 21' ' ' VAL . 29.4 m -150.14 141.94 17.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.868 -0.606 . . . . 0.0 109.697 179.424 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -93.21 101.29 13.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.838 0.352 . . . . 0.0 110.621 -179.837 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.43 HG23 HG23 ' A' ' 19' ' ' VAL . 6.7 t -112.35 99.65 9.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.138 179.761 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.474 ' O ' ' CG ' ' A' ' 23' ' ' TYR . 24.7 mtpp -140.55 -72.88 0.35 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.671 -179.876 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.479 ' O ' ' CD2' ' A' ' 23' ' ' TYR . 29.7 p90 45.28 98.2 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.884 -179.667 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -46.82 116.1 1.24 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.835 -179.965 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 162.64 -42.32 0.35 Allowed Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.746 -0.942 . . . . 0.0 110.746 179.955 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -123.53 178.92 4.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.777 0.323 . . . . 0.0 110.378 -179.994 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.465 ' CB ' ' HB2' ' A' ' 71' ' ' GLU . 0.2 OUTLIER -103.85 -171.61 1.96 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.3 179.987 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.408 ' O ' ' HG3' ' A' ' 71' ' ' GLU . 6.1 mtt -117.4 118.83 33.28 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.819 -179.751 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.753 ' HB2' ' HA ' ' A' ' 71' ' ' GLU . . . -113.62 -62.33 1.61 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.109 179.57 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -165.0 165.1 20.39 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.767 -179.986 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.666 HG21 ' CD1' ' A' ' 52' ' ' TRP . 5.2 t -148.27 166.68 4.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.313 -179.896 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.482 ' N ' HG12 ' A' ' 31' ' ' VAL . 2.7 pt-20 -174.72 151.03 1.38 Allowed 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.416 -179.788 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.775 HD12 ' N ' ' A' ' 34' ' ' ARG . 3.0 pp -115.95 177.39 4.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.446 179.957 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.775 ' N ' HD12 ' A' ' 33' ' ' LEU . 2.7 ttm180 -120.2 -40.56 2.69 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.296 179.862 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.444 ' CB ' ' O ' ' A' ' 34' ' ' ARG . 3.8 tt0 87.43 32.97 0.02 OUTLIER 'General case' 0 CA--C 1.515 -0.384 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 -179.102 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 36' ' ' HIS . . . . . 0.428 ' CE1' ' OE1' ' A' ' 61' ' ' GLN . 41.8 t-80 63.71 -74.03 0.04 OUTLIER 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 114.882 -1.054 . . . . 0.0 110.596 -180.0 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.421 ' N ' ' O ' ' A' ' 35' ' ' GLU . . . -136.49 103.69 0.45 Allowed Glycine 0 CA--C 1.523 0.534 0 N-CA-C 110.766 -0.934 . . . . 0.0 110.766 -179.987 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -139.87 -54.07 0.54 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.826 0.346 . . . . 0.0 110.252 179.907 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.7 p30 179.91 -45.66 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.321 -179.978 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -178.61 171.54 1.51 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.195 -179.964 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.508 ' CZ3' ' HG2' ' A' ' 67' ' ' ARG . 96.7 m95 -55.01 125.3 19.82 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.338 -179.993 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.466 HG23 ' HG ' ' A' ' 33' ' ' LEU . 4.4 m -106.91 116.93 51.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.128 179.861 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -48.83 126.03 11.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.505 -179.91 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.424 ' HE2' ' CE1' ' A' ' 66' ' ' PHE . 0.0 OUTLIER -55.79 -169.85 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.254 -179.929 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 33.8 m -141.13 95.69 2.88 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.425 -179.952 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.26 81.9 1.84 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.217 179.811 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -117.32 -17.85 5.58 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 111.404 -0.678 . . . . 0.0 111.404 -179.744 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.404 ' HB2' ' O ' ' A' ' 51' ' ' VAL . 0.1 OUTLIER -69.78 -32.65 71.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.774 0.321 . . . . 0.0 110.631 -179.766 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 97.4 -35.38 4.51 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 110.523 -1.031 . . . . 0.0 110.523 -179.839 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -113.86 -34.09 1.74 Allowed Glycine 0 CA--C 1.523 0.571 0 N-CA-C 110.458 -1.057 . . . . 0.0 110.458 179.912 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.83 HG11 ' HG3' ' A' ' 9' ' ' GLU . 23.9 m -123.78 172.75 10.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.808 0.337 . . . . 0.0 110.127 179.815 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 52' ' ' TRP . . . . . 0.666 ' CD1' HG21 ' A' ' 31' ' ' VAL . 8.8 m95 -105.06 133.8 49.24 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.529 -179.718 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.624 HG23 ' HB2' ' A' ' 18' ' ' ALA . 0.0 OUTLIER -119.79 -179.02 3.77 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.311 179.875 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.423 ' CD2' HD21 ' A' ' 33' ' ' LEU . 66.8 t80 -175.37 130.85 0.28 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.347 179.95 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 43.8 m-20 -68.91 117.29 10.39 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.359 -179.98 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 9.1 p -119.2 120.04 35.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.368 -179.994 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -100.93 -26.3 13.79 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.48 -179.921 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.402 ' O ' ' CG ' ' A' ' 58' ' ' GLU . 1.1 pt-20 -115.52 112.61 43.29 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.488 -179.872 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -70.7 -21.11 29.55 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.479 2.119 . . . . 0.0 111.891 179.655 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 44.73 -154.71 0.03 OUTLIER 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.854 179.584 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.428 ' OE1' ' CE1' ' A' ' 36' ' ' HIS . 0.0 OUTLIER -45.15 -31.9 1.61 Allowed 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.708 -0.224 . . . . 0.0 111.23 -179.644 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.499 ' N ' ' HD2' ' A' ' 63' ' ' PRO . . . 124.29 -41.98 1.64 Allowed Glycine 0 CA--C 1.531 1.058 0 C-N-CA 121.116 -0.564 . . . . 0.0 112.395 179.894 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.499 ' HD2' ' N ' ' A' ' 62' ' ' GLY . 45.2 Cg_endo -74.64 152.98 43.35 Favored 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 122.052 1.835 . . . . 0.0 112.811 -179.137 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.438 ' HD2' HG21 ' A' ' 82' ' ' VAL . 78.0 m-85 -126.77 101.61 6.68 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.318 179.832 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 20.7 m-20 -65.53 140.34 58.56 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 179.538 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.489 ' CE1' ' HB3' ' A' ' 33' ' ' LEU . 16.5 m-85 -128.96 176.58 7.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.235 0.54 . . . . 0.0 111.246 -179.34 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.508 ' HG2' ' CZ3' ' A' ' 41' ' ' TRP . 0.0 OUTLIER 176.91 89.17 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.447 179.878 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.676 ' CZ ' HG11 ' A' ' 4' ' ' VAL . 1.4 p90 -72.06 176.28 5.23 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.179 0.514 . . . . 0.0 110.874 -179.144 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.68 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 2.3 mt -130.12 61.12 1.59 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.031 179.715 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.407 ' OG1' ' N ' ' A' ' 74' ' ' MET . 0.6 OUTLIER -23.69 137.62 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.871 0.868 . . . . 0.0 113.011 -178.821 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.753 ' HA ' ' HB2' ' A' ' 29' ' ' ALA . 0.0 OUTLIER -48.41 -45.02 35.55 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.094 -179.533 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -145.37 38.32 1.15 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.279 179.973 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -114.57 -109.87 2.82 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.889 -0.884 . . . . 0.0 110.889 -179.952 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.407 ' N ' ' OG1' ' A' ' 70' ' ' THR . 20.8 mmt -154.41 -179.67 8.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.745 0.307 . . . . 0.0 110.183 179.909 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.439 ' N ' ' HD3' ' A' ' 75' ' ' LYS . 0.1 OUTLIER -115.85 100.74 8.21 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.996 0.427 . . . . 0.0 110.443 -179.888 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 49.0 t30 -115.9 152.86 32.61 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.241 179.895 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.517 HG12 ' N ' ' A' ' 78' ' ' PHE . 77.7 t -100.29 160.79 3.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.324 179.843 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.779 ' CZ ' HG21 ' A' ' 4' ' ' VAL . 64.9 m-85 -141.13 109.28 5.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.287 -179.907 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -95.77 159.66 14.87 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.496 -179.869 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 54.72 32.84 18.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.551 179.902 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.623 HG13 ' HB2' ' A' ' 93' ' ' ALA . 66.3 t -66.23 -54.68 24.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.286 179.901 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.626 HG13 ' HD2' ' A' ' 83' ' ' PRO . 76.2 t -101.1 142.45 24.64 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.02 179.95 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.626 ' HD2' HG13 ' A' ' 82' ' ' VAL . 43.5 Cg_endo -68.11 177.83 4.09 Favored 'Trans proline' 0 N--CA 1.475 0.42 0 C-N-CA 122.622 2.214 . . . . 0.0 112.287 179.915 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -59.31 -33.97 71.74 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.233 179.904 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.02 85.27 2.18 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.175 179.9 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 0.476 ' HB3' ' CG1' ' A' ' 82' ' ' VAL . 26.5 p90 -50.51 145.04 6.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.682 -179.751 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 4.2 m -136.08 111.45 9.14 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.304 179.841 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.803 HD11 ' HB2' ' A' ' 12' ' ' SER . 38.1 mm -50.49 110.19 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.49 -179.874 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 122.89 47.24 0.27 Allowed Glycine 0 CA--C 1.523 0.553 0 N-CA-C 110.819 -0.912 . . . . 0.0 110.819 179.918 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -160.0 159.02 31.61 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.774 0.321 . . . . 0.0 110.44 179.928 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 90.1 m -118.69 91.81 3.65 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.497 179.949 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.553 ' O ' ' HB3' ' A' ' 93' ' ' ALA . 32.9 m-85 -86.06 -156.71 0.3 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.154 179.847 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.877 ' HB1' ' HD2' ' A' ' 94' ' ' PRO . . . 76.19 173.6 0.09 OUTLIER Pre-proline 0 N--CA 1.463 0.179 0 CA-C-O 120.7 0.286 . . . . 0.0 110.307 -179.805 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.877 ' HD2' ' HB1' ' A' ' 93' ' ' ALA . 46.1 Cg_endo . . . . . 0 C--O 1.249 1.05 0 C-N-CA 122.582 2.188 . . . . 0.0 112.092 -179.908 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.535 ' O ' HG22 ' A' ' 4' ' ' VAL . 81.7 mttt . . . . . 0 CA--C 1.52 -0.2 0 CA-C-O 120.701 0.286 . . . . 0.0 110.346 . . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.731 ' O ' HG23 ' A' ' 5' ' ' THR . 23.0 m 44.59 -172.22 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.042 -179.804 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.731 HG23 ' O ' ' A' ' 4' ' ' VAL . 0.5 OUTLIER -174.02 136.8 0.53 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.521 -179.72 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.75 ' O ' HG23 ' A' ' 91' ' ' THR . 14.2 m-85 -105.17 172.13 6.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.01 179.857 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.406 ' HG1' HG23 ' A' ' 91' ' ' THR . 19.7 m -165.69 113.35 0.95 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.84 0.352 . . . . 0.0 110.447 -179.974 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 94.9 t -58.0 87.97 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.396 179.971 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.542 ' HG3' HG21 ' A' ' 51' ' ' VAL . 2.5 mm-40 -59.44 167.12 2.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.344 179.982 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.06 165.14 5.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.363 179.954 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 79.99 35.0 28.77 Favored Glycine 0 CA--C 1.523 0.582 0 N-CA-C 110.834 -0.906 . . . . 0.0 110.834 179.99 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 74.4 m -96.1 114.95 26.7 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.78 0.324 . . . . 0.0 110.369 -179.948 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -97.46 -168.85 1.75 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.213 179.998 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 67.8 mm-40 -69.24 -27.15 65.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.315 179.861 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.42 ' HG2' ' N ' ' A' ' 16' ' ' HIS . 0.0 OUTLIER -114.55 -30.65 6.46 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.641 -179.857 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 16' ' ' HIS . . . . . 0.42 ' N ' ' HG2' ' A' ' 15' ' ' LYS . 2.0 m80 -70.59 151.28 45.17 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.851 0.357 . . . . 0.0 110.378 -179.902 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.507 ' HA ' HD22 ' A' ' 17' ' ' LEU . 0.3 OUTLIER -151.29 91.58 1.7 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.498 -179.965 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.626 ' HB1' HG11 ' A' ' 51' ' ' VAL . . . -89.31 136.19 33.16 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.868 179.675 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.746 ' O ' HG13 ' A' ' 51' ' ' VAL . 27.4 m -137.86 135.02 45.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.999 0.428 . . . . 0.0 110.847 -179.793 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -88.57 81.12 7.18 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.454 179.949 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.433 HG23 HG23 ' A' ' 19' ' ' VAL . 42.9 t -77.92 107.91 10.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.408 179.97 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -170.43 150.51 3.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.289 -179.986 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.485 ' CE1' HG12 ' A' ' 4' ' ' VAL . 8.4 p90 -166.78 31.4 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.493 -179.938 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 50.84 -167.78 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.513 179.959 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 63.45 -79.97 0.04 OUTLIER Glycine 0 CA--C 1.523 0.536 0 N-CA-C 110.796 -0.921 . . . . 0.0 110.796 179.88 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -71.63 179.54 3.02 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.678 0.275 . . . . 0.0 110.325 179.956 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -121.2 -174.1 2.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.389 -179.886 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.427 ' O ' ' CG ' ' A' ' 71' ' ' GLU . 22.6 mtm -114.99 122.35 45.97 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.677 -179.651 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.746 ' HB3' ' O ' ' A' ' 69' ' ' LEU . . . -120.02 -60.48 1.7 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.338 179.765 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.42 ' HB3' HD12 ' A' ' 69' ' ' LEU . 2.7 mt-10 -161.37 147.59 14.31 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.36 179.995 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.648 HG21 ' CD1' ' A' ' 52' ' ' TRP . 3.1 t -133.97 159.33 42.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.941 0.401 . . . . 0.0 110.596 179.987 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.424 ' N ' ' OE2' ' A' ' 32' ' ' GLU . 0.5 OUTLIER -150.04 147.79 28.24 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.148 -179.944 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.627 HD12 ' H ' ' A' ' 34' ' ' ARG . 12.0 tp -116.65 156.07 27.71 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 -179.603 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.627 ' H ' HD12 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -139.98 178.81 7.0 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.087 179.609 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -122.16 -79.91 0.62 Allowed 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 179.719 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -179.34 -38.42 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.349 179.487 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -130.28 22.87 4.67 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.884 -0.887 . . . . 0.0 110.884 179.937 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 8.2 t -77.34 -166.13 0.69 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.872 0.368 . . . . 0.0 110.304 179.959 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -87.2 52.99 2.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.143 179.868 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 69.71 178.61 0.25 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.251 -179.858 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.49 ' CZ3' ' HG2' ' A' ' 67' ' ' ARG . 97.2 m95 -50.47 139.08 16.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.629 -179.994 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.434 ' CG2' ' O ' ' A' ' 33' ' ' LEU . 4.6 m -125.89 111.33 26.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 109.743 -0.465 . . . . 0.0 109.743 179.531 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.41 ' HA ' ' HB3' ' A' ' 32' ' ' GLU . . . -44.45 138.15 3.35 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.116 -179.376 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -67.66 -171.73 0.22 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.89 -179.942 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.402 ' O ' ' N ' ' A' ' 47' ' ' GLY . 51.7 m -150.92 106.31 3.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.228 179.846 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 7.3 ptmt -62.77 80.99 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.495 -179.925 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.402 ' N ' ' O ' ' A' ' 45' ' ' THR . . . -98.74 -24.31 10.97 Favored Glycine 0 CA--C 1.523 0.555 0 N-CA-C 110.647 -0.981 . . . . 0.0 110.647 179.846 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.476 ' CB ' ' HB ' ' A' ' 51' ' ' VAL . 2.2 mm-40 -78.18 1.09 22.5 Favored 'General case' 0 CA--C 1.532 0.269 0 O-C-N 122.85 -0.206 . . . . 0.0 111.502 -179.891 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 67.93 17.29 69.41 Favored Glycine 0 CA--C 1.527 0.794 0 N-CA-C 111.13 -0.788 . . . . 0.0 111.13 -179.963 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 178.24 -38.57 0.08 OUTLIER Glycine 0 C--N 1.33 0.229 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 179.93 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.746 HG13 ' O ' ' A' ' 19' ' ' VAL . 22.2 t -101.24 150.3 5.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 179.227 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 52' ' ' TRP . . . . . 0.648 ' CD1' HG21 ' A' ' 31' ' ' VAL . 3.3 m95 -91.75 111.7 23.32 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.477 -179.543 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.552 HG22 ' HB2' ' A' ' 18' ' ' ALA . 15.0 p -107.73 150.13 27.33 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.494 -179.736 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 34.6 t80 -136.7 115.12 11.82 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.451 -179.996 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -66.8 162.27 21.88 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.289 179.974 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 6.3 t 65.09 127.04 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.705 179.849 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.424 ' O ' ' O ' ' A' ' 58' ' ' GLU . 5.7 tt0 -117.95 -15.93 9.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.955 179.885 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.424 ' O ' ' O ' ' A' ' 57' ' ' GLU . 2.2 pt-20 48.97 170.43 0.03 OUTLIER Pre-proline 0 N--CA 1.467 0.381 0 C-N-CA 123.213 0.605 . . . . 0.0 111.548 -179.94 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.41 ' CD ' ' HB2' ' A' ' 58' ' ' GLU . 38.3 Cg_endo -96.97 10.41 1.25 Allowed 'Trans proline' 0 N--CA 1.453 -0.877 0 C-N-CA 124.036 3.157 . . . . 0.0 112.961 -178.998 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.9 100.47 0.07 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.841 0.353 . . . . 0.0 110.512 -179.914 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -53.65 127.5 25.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.222 179.861 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 135.7 163.0 9.83 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.601 -0.999 . . . . 0.0 110.601 -179.806 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.439 ' CG ' ' HA ' ' A' ' 80' ' ' ASP . 49.9 Cg_endo -79.33 -171.95 1.39 Allowed 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.642 2.228 . . . . 0.0 112.091 -179.974 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 -97.16 171.64 8.32 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.85 0.357 . . . . 0.0 110.258 179.846 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -144.05 143.88 31.37 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.716 179.813 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 -131.28 177.75 7.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.201 0.524 . . . . 0.0 111.288 -179.466 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.49 ' HG2' ' CZ3' ' A' ' 41' ' ' TRP . 0.1 OUTLIER 175.7 67.28 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.265 -179.964 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -52.57 173.46 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.264 0.554 . . . . 0.0 111.143 -178.963 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.746 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 6.4 mt -128.68 55.91 1.68 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.126 179.595 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -26.73 137.87 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.736 0.815 . . . . 0.0 112.593 -178.915 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.578 ' N ' ' HB2' ' A' ' 29' ' ' ALA . 23.6 mt-10 -51.69 -51.75 53.58 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.25 -179.857 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 5.1 tptt -135.95 57.93 1.77 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.042 179.733 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -136.04 -96.64 0.49 Allowed Glycine 0 CA--C 1.523 0.592 0 N-CA-C 110.776 -0.93 . . . . 0.0 110.776 -179.823 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 1.9 ptt? 174.86 165.87 0.26 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.813 0.339 . . . . 0.0 110.515 -179.949 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.432 ' CD ' ' HA ' ' A' ' 69' ' ' LEU . 5.6 mmtp -94.13 137.9 32.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.005 -179.965 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 10.8 t30 -141.29 176.21 9.03 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.285 179.923 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 95.9 t -121.65 146.79 26.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.253 179.995 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -136.12 108.91 7.54 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.523 -179.904 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.402 ' O ' ' N ' ' A' ' 81' ' ' VAL . 54.4 m-20 -80.27 163.34 24.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.178 179.799 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.45 ' O ' ' HB ' ' A' ' 81' ' ' VAL . 1.1 m-20 58.94 -85.72 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.377 -179.813 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.887 HG12 HG23 ' A' ' 82' ' ' VAL . 55.6 t 68.55 -56.26 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 C-N-CA 123.432 0.693 . . . . 0.0 110.881 179.98 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.887 HG23 HG12 ' A' ' 81' ' ' VAL . 54.6 t -128.78 139.34 35.35 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.501 -179.894 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.516 ' HD2' HG13 ' A' ' 82' ' ' VAL . 46.2 Cg_endo -69.81 -170.32 0.39 Allowed 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.585 2.19 . . . . 0.0 112.066 179.699 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -87.07 -39.72 15.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.18 179.754 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -110.75 56.22 0.64 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.213 179.855 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 21.1 p90 -56.78 170.25 0.43 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.52 -179.838 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 26.6 m -151.35 121.16 7.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.149 179.907 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.429 ' H ' HD12 ' A' ' 88' ' ' ILE . 3.4 mp -50.58 111.29 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.388 -179.82 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 122.41 57.36 0.2 Allowed Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.655 -0.978 . . . . 0.0 110.655 -179.976 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.401 ' O ' HG23 ' A' ' 7' ' ' THR . . . -174.07 148.86 1.4 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.75 0.309 . . . . 0.0 110.378 -179.991 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.75 HG23 ' O ' ' A' ' 6' ' ' PHE . 50.9 m -106.97 93.88 4.8 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.6 -179.955 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.569 ' O ' ' HB3' ' A' ' 93' ' ' ALA . 44.0 m-85 -76.42 -155.67 0.06 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.145 -0.479 . . . . 0.0 109.761 179.549 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.89 ' HB1' ' HD2' ' A' ' 94' ' ' PRO . . . 75.65 172.95 0.09 OUTLIER Pre-proline 0 N--CA 1.464 0.227 0 CA-C-O 120.786 0.327 . . . . 0.0 110.811 179.773 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.89 ' HD2' ' HB1' ' A' ' 93' ' ' ALA . 46.9 Cg_endo . . . . . 0 C--O 1.25 1.08 0 C-N-CA 122.606 2.204 . . . . 0.0 111.965 179.884 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.456 -0.143 0 CA-C-O 120.887 0.375 . . . . 0.0 110.283 . . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.518 ' CG1' ' CE1' ' A' ' 78' ' ' PHE . 1.9 p -63.89 163.24 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.285 0.564 . . . . 0.0 110.469 -179.811 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.478 ' N ' HG22 ' A' ' 4' ' ' VAL . 80.9 p -137.48 136.11 37.43 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.067 179.871 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.62 ' O ' HG23 ' A' ' 91' ' ' THR . 17.7 m-85 -97.0 -175.42 3.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.418 -179.81 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.407 ' HB ' ' HB2' ' A' ' 20' ' ' LEU . 2.5 m -167.15 95.53 0.48 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.237 -179.833 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.462 HG12 ' CD1' ' A' ' 88' ' ' ILE . 39.1 t -51.07 97.19 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.563 -179.879 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.492 ' HG3' HG11 ' A' ' 51' ' ' VAL . 4.4 mt-10 -61.92 174.52 0.83 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.443 -179.92 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.8 tttt -67.66 163.37 21.59 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.408 -179.977 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 74.27 25.74 70.03 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 179.883 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.475 ' CB ' HD11 ' A' ' 88' ' ' ILE . 0.5 OUTLIER -99.05 121.81 41.46 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.835 0.35 . . . . 0.0 110.431 -179.993 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -177.45 -175.03 0.52 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.427 179.99 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.41 ' O ' ' CB ' ' A' ' 15' ' ' LYS . 3.9 mt-10 -47.59 119.07 2.53 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.175 0.512 . . . . 0.0 110.834 -179.848 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.418 ' O ' ' CG ' ' A' ' 16' ' ' HIS . 0.8 OUTLIER 79.95 24.54 0.4 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.774 179.726 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 16' ' ' HIS . . . . . 0.418 ' CG ' ' O ' ' A' ' 15' ' ' LYS . 3.2 m80 -174.04 111.75 0.17 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.829 0.347 . . . . 0.0 110.348 179.745 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.444 ' HA ' HD22 ' A' ' 17' ' ' LEU . 0.3 OUTLIER -128.93 101.19 5.97 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.489 -179.856 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -97.93 153.05 18.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.232 179.852 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.594 HG23 HG23 ' A' ' 21' ' ' VAL . 23.7 m -150.18 134.72 9.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.062 -179.7 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.581 HD22 ' CG ' ' A' ' 22' ' ' LYS . 0.5 OUTLIER -86.77 73.34 10.02 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.212 -0.449 . . . . 0.0 109.869 179.105 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.594 HG23 HG23 ' A' ' 19' ' ' VAL . 52.7 t -69.83 94.51 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.86 -179.468 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.581 ' CG ' HD22 ' A' ' 20' ' ' LEU . 0.0 OUTLIER 175.18 157.8 0.19 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.106 179.712 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.41 ' CE2' ' HB3' ' A' ' 26' ' ' ASP . 0.1 OUTLIER -127.08 -79.05 0.59 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.46 -179.981 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -99.49 -90.78 0.3 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.822 -179.814 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -139.68 32.83 2.19 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 111.132 -0.787 . . . . 0.0 111.132 -179.778 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.41 ' HB3' ' CE2' ' A' ' 23' ' ' TYR . 4.3 p30 -58.58 -171.11 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 179.727 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.454 ' HB ' ' CG ' ' A' ' 71' ' ' GLU . 0.9 OUTLIER -125.57 145.82 49.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.875 0.369 . . . . 0.0 110.37 179.987 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.411 ' O ' ' CG ' ' A' ' 71' ' ' GLU . 0.0 OUTLIER -98.7 129.39 45.16 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.662 -179.506 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.757 ' HB3' ' O ' ' A' ' 69' ' ' LEU . . . -120.47 -56.8 1.95 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.351 179.956 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -158.0 145.9 18.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.388 -179.982 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.888 HG21 ' CD1' ' A' ' 52' ' ' TRP . 2.4 t -135.68 140.38 44.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.141 179.995 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.463 ' CB ' ' HA ' ' A' ' 43' ' ' ALA . 4.4 pt-20 -139.14 141.39 38.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.858 0.361 . . . . 0.0 110.491 179.955 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.509 ' HG ' ' CE1' ' A' ' 66' ' ' PHE . 2.2 mt -113.0 174.61 5.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.94 -179.444 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.5 ' HD3' ' CD2' ' A' ' 41' ' ' TRP . 1.5 ttp85 -149.61 -159.17 1.0 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.852 179.585 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -158.67 26.18 0.23 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.698 0.285 . . . . 0.0 110.759 179.887 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 49.4 25.88 1.45 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.726 179.752 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -129.73 -50.45 0.12 Allowed Glycine 0 CA--C 1.522 0.525 0 N-CA-C 110.706 -0.958 . . . . 0.0 110.706 -179.945 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -76.54 115.26 16.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.784 0.326 . . . . 0.0 110.425 -179.977 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -52.09 -25.83 9.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.361 -179.992 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.26 178.73 4.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.219 179.892 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.506 ' CH2' ' HG3' ' A' ' 67' ' ' ARG . 86.5 m95 -111.88 169.45 8.83 Favored 'General case' 0 CA--C 1.503 -0.862 0 CA-C-O 121.559 0.695 . . . . 0.0 110.876 -179.978 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.499 ' O ' HG12 ' A' ' 42' ' ' VAL . 1.0 OUTLIER -142.05 107.63 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.193 0 CA-C-N 114.63 -1.168 . . . . 0.0 109.769 -177.441 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.463 ' HA ' ' CB ' ' A' ' 32' ' ' GLU . . . -50.49 143.39 9.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.578 -179.445 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.463 ' HE2' ' CZ ' ' A' ' 66' ' ' PHE . 0.0 OUTLIER -63.14 -169.57 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.783 -179.765 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.405 ' O ' ' N ' ' A' ' 47' ' ' GLY . 46.0 m -135.35 110.18 8.72 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.03 179.811 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.77 66.45 0.09 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.566 -179.793 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.405 ' N ' ' O ' ' A' ' 45' ' ' THR . . . -83.35 -40.84 8.8 Favored Glycine 0 CA--C 1.522 0.522 0 N-CA-C 110.351 -1.1 . . . . 0.0 110.351 179.798 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -90.02 144.97 25.44 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 179.74 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -83.83 8.16 67.23 Favored Glycine 0 CA--C 1.528 0.903 0 N-CA-C 111.597 -0.601 . . . . 0.0 111.597 -179.896 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -127.44 -40.0 0.35 Allowed Glycine 0 CA--C 1.524 0.641 0 N-CA-C 110.978 -0.849 . . . . 0.0 110.978 -179.952 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.538 HG12 ' HA ' ' A' ' 20' ' ' LEU . 6.9 m -133.67 -176.5 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 121.088 0.47 . . . . 0.0 110.79 -179.605 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 52' ' ' TRP . . . . . 0.888 ' CD1' HG21 ' A' ' 31' ' ' VAL . 11.1 m95 -109.61 131.39 55.11 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.75 179.543 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 3.0 p -115.98 171.79 7.56 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.863 0.363 . . . . 0.0 110.318 -179.664 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 60.4 t80 -159.63 118.5 2.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.333 179.971 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -70.94 129.14 38.25 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.303 179.956 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 90.8 p -96.25 126.54 41.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.416 -179.949 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -136.58 36.95 2.67 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.394 179.984 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -138.04 156.61 73.97 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.324 179.854 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -72.45 -26.77 16.62 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.671 2.247 . . . . 0.0 112.216 -179.949 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.4 mt -79.5 126.61 31.08 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.541 -179.761 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -156.58 -178.37 7.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.358 -179.845 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 119.73 -106.25 1.2 Allowed Glycine 0 CA--C 1.526 0.725 0 N-CA-C 110.856 -0.898 . . . . 0.0 110.856 179.891 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -77.46 125.08 7.42 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.455 2.103 . . . . 0.0 111.972 179.991 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.414 ' CE2' ' HG ' ' A' ' 17' ' ' LEU . 42.6 m-85 -101.27 147.05 26.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.587 -179.869 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.448 ' O ' HD23 ' A' ' 33' ' ' LEU . 1.9 m-80 -120.69 131.19 54.43 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.618 179.511 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.509 ' CE1' ' HG ' ' A' ' 33' ' ' LEU . 19.8 m-85 -114.71 163.1 15.94 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.963 0.411 . . . . 0.0 111.47 -179.236 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.658 ' HD2' HG22 ' A' ' 77' ' ' VAL . 48.3 mtp180 -162.07 62.62 0.23 Allowed 'General case' 0 CA--C 1.52 -0.184 0 CA-C-N 115.353 -0.839 . . . . 0.0 109.807 179.014 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.967 ' O ' HD23 ' A' ' 69' ' ' LEU . 0.0 OUTLIER -67.09 -179.15 0.9 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.143 0.497 . . . . 0.0 110.828 -179.455 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.967 HD23 ' O ' ' A' ' 68' ' ' PHE . 5.7 mt -136.68 55.07 1.85 Allowed 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 179.321 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 18.5 p -29.02 137.95 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.543 0.737 . . . . 0.0 112.135 -178.904 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.678 ' HG2' ' HB2' ' A' ' 29' ' ' ALA . 8.0 mt-10 -51.22 -68.62 0.15 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.663 -179.24 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -106.29 68.45 0.76 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.781 0.324 . . . . 0.0 110.31 179.902 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -158.28 -104.58 0.21 Allowed Glycine 0 CA--C 1.523 0.587 0 N-CA-C 110.952 -0.859 . . . . 0.0 110.952 -179.972 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 13.3 ptm 174.26 179.38 0.11 Allowed 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 -179.838 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.25 175.68 6.85 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.87 0.367 . . . . 0.0 110.352 179.877 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 173.96 170.16 0.2 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.43 179.907 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.658 HG22 ' HD2' ' A' ' 67' ' ' ARG . 72.5 t -117.61 157.78 18.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.504 -179.987 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.518 ' CE1' ' CG1' ' A' ' 4' ' ' VAL . 41.3 m-85 -144.99 129.93 18.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.384 -179.932 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -118.85 147.03 44.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.319 179.942 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 59.13 45.45 14.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.455 179.862 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.503 ' O ' HG12 ' A' ' 81' ' ' VAL . 74.4 t -80.4 -3.91 6.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.073 179.893 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.437 HG23 ' C ' ' A' ' 81' ' ' VAL . 89.2 t -156.56 122.12 2.48 Favored Pre-proline 0 CA--C 1.528 0.117 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 179.654 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.431 ' HD3' ' CD1' ' A' ' 92' ' ' TYR . 50.8 Cg_endo -75.25 176.07 10.42 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.552 2.168 . . . . 0.0 112.129 -179.923 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -77.31 131.03 37.92 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 179.475 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 2.2 mmtt 59.92 40.75 18.68 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 -179.529 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 28.2 p90 -47.46 174.28 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.855 -179.681 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 10.9 m -129.36 129.66 45.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.242 179.987 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.475 HD11 ' CB ' ' A' ' 12' ' ' SER . 42.2 mm -66.51 115.3 4.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.337 179.981 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 119.45 37.34 0.79 Allowed Glycine 0 CA--C 1.523 0.573 0 N-CA-C 110.725 -0.95 . . . . 0.0 110.725 -179.917 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -147.67 172.57 13.85 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.808 0.337 . . . . 0.0 110.375 179.998 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.62 HG23 ' O ' ' A' ' 6' ' ' PHE . 87.9 m -114.83 126.16 54.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.422 -179.992 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.463 ' O ' ' HB2' ' A' ' 93' ' ' ALA . 54.6 m-85 -127.45 130.5 49.37 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.571 179.985 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.897 ' HB1' ' HD2' ' A' ' 94' ' ' PRO . . . 174.01 177.13 0.19 Allowed Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.435 179.713 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.897 ' HD2' ' HB1' ' A' ' 93' ' ' ALA . 49.4 Cg_endo . . . . . 0 C--O 1.25 1.094 0 C-N-CA 122.642 2.228 . . . . 0.0 112.071 -179.885 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.796 0.331 . . . . 0.0 110.367 . . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.801 HG12 ' CE2' ' A' ' 23' ' ' TYR . 16.9 m -71.91 168.3 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.478 -179.967 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.427 ' HB ' ' CG2' ' A' ' 91' ' ' THR . 78.4 p -153.72 129.96 10.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.33 179.819 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.559 ' O ' HG23 ' A' ' 91' ' ' THR . 25.2 m-85 -93.44 165.46 12.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.41 -179.865 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -153.72 108.84 3.16 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.546 -179.883 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.442 ' CG1' HG13 ' A' ' 88' ' ' ILE . 92.0 t -57.79 114.26 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.12 179.759 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.65 ' CD ' HG11 ' A' ' 51' ' ' VAL . 1.8 mt-10 -84.36 159.11 20.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.61 -179.771 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.637 ' HA ' HG21 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -57.63 -25.81 60.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.48 -179.912 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -49.67 -26.4 7.73 Favored Glycine 0 CA--C 1.523 0.567 0 N-CA-C 110.8 -0.92 . . . . 0.0 110.8 -179.908 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.4 m -59.29 106.4 0.44 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.767 0.318 . . . . 0.0 110.289 179.961 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.434 ' O ' ' N ' ' A' ' 15' ' ' LYS . 10.8 p-10 -124.72 136.74 54.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.491 -179.962 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 53.34 -87.04 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.661 179.891 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.434 ' N ' ' O ' ' A' ' 13' ' ' ASN . 42.2 pttt -114.16 -27.39 7.67 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.659 0.266 . . . . 0.0 110.71 -179.963 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 8.9 m80 -49.36 134.19 19.01 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.533 179.947 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.477 HD22 ' HA ' ' A' ' 17' ' ' LEU . 0.2 OUTLIER -118.48 100.12 7.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.409 -179.88 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.583 ' HB2' ' CG2' ' A' ' 53' ' ' THR . . . -98.86 130.5 45.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.266 179.942 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.77 HG23 HG23 ' A' ' 21' ' ' VAL . 33.4 m -126.15 146.67 31.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.262 -179.914 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -96.66 70.97 2.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.307 -179.947 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.77 HG23 HG23 ' A' ' 19' ' ' VAL . 23.5 t -75.16 97.89 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.449 -179.877 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.02 146.39 9.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.405 179.975 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.801 ' CE2' HG12 ' A' ' 4' ' ' VAL . 17.0 p90 -173.16 140.03 0.84 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.455 -179.996 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -52.04 134.91 31.91 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.358 -179.98 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 126.78 -110.44 1.23 Allowed Glycine 0 CA--C 1.523 0.538 0 N-CA-C 110.684 -0.966 . . . . 0.0 110.684 179.993 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -67.01 145.85 54.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.781 0.324 . . . . 0.0 110.259 179.954 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.449 ' HB ' ' CG ' ' A' ' 71' ' ' GLU . 0.3 OUTLIER -80.87 -171.26 3.08 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.419 -179.884 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -117.92 124.63 48.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.567 -179.723 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.845 ' HB3' ' O ' ' A' ' 69' ' ' LEU . . . -114.54 -60.59 1.87 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.437 -179.783 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.559 ' OE2' ' HB1' ' A' ' 43' ' ' ALA . 0.5 OUTLIER -157.78 150.95 23.25 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.224 179.984 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 1.034 HG21 ' CD1' ' A' ' 52' ' ' TRP . 6.1 t -119.59 166.57 13.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.155 -179.899 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.468 ' N ' HG12 ' A' ' 31' ' ' VAL . 1.2 tp10 -153.08 140.06 19.21 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.017 0.437 . . . . 0.0 109.925 -179.416 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.708 HD12 ' N ' ' A' ' 34' ' ' ARG . 3.9 tp -134.3 142.62 47.34 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.182 -178.963 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.708 ' N ' HD12 ' A' ' 33' ' ' LEU . 6.7 tpm_? -127.73 -95.91 0.42 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.154 -0.475 . . . . 0.0 109.903 179.012 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.44 ' CB ' ' O ' ' A' ' 34' ' ' ARG . 0.0 OUTLIER 160.79 -83.51 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 120.763 0.316 . . . . 0.0 110.321 179.392 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 3.3 t60 177.88 -55.41 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.317 -179.868 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -59.36 -72.07 0.67 Allowed Glycine 0 CA--C 1.523 0.584 0 N-CA-C 110.639 -0.985 . . . . 0.0 110.639 179.955 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -58.05 122.03 12.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.819 0.342 . . . . 0.0 110.179 179.848 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 33.0 m-20 -83.26 6.71 18.64 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.312 -179.825 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -107.84 100.33 9.71 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 120.82 0.343 . . . . 0.0 110.54 -179.953 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.507 ' CZ3' ' HG2' ' A' ' 67' ' ' ARG . 68.7 m95 -59.4 155.32 15.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.072 179.733 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.506 HG21 ' CZ ' ' A' ' 54' ' ' PHE . 10.0 m -138.47 110.76 6.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-O 120.715 0.293 . . . . 0.0 110.307 179.98 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.559 ' HB1' ' OE2' ' A' ' 30' ' ' GLU . . . -45.68 149.75 0.57 Allowed 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.52 -179.8 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.403 ' HB2' ' HB ' ' A' ' 31' ' ' VAL . 0.0 OUTLIER -72.13 -170.55 0.62 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.916 0.388 . . . . 0.0 110.54 -179.722 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 68.8 m -138.88 126.04 21.37 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.409 -179.945 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 3.1 ptpt -94.56 91.32 6.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.564 -179.804 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -146.34 26.59 1.7 Allowed Glycine 0 CA--C 1.523 0.572 0 N-CA-C 110.81 -0.916 . . . . 0.0 110.81 179.963 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.493 ' OE2' HG21 ' A' ' 53' ' ' THR . 0.0 OUTLIER -106.45 174.52 5.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.836 0.351 . . . . 0.0 110.482 179.939 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -56.13 -29.44 56.02 Favored Glycine 0 CA--C 1.522 0.53 0 N-CA-C 110.487 -1.045 . . . . 0.0 110.487 179.787 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.437 ' O ' HG13 ' A' ' 51' ' ' VAL . . . 177.81 37.46 0.06 OUTLIER Glycine 0 CA--C 1.524 0.619 0 N-CA-C 110.861 -0.896 . . . . 0.0 110.861 179.965 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.65 HG11 ' CD ' ' A' ' 9' ' ' GLU . 13.1 m -154.78 177.87 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.828 0.347 . . . . 0.0 110.395 179.866 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 52' ' ' TRP . . . . . 1.034 ' CD1' HG21 ' A' ' 31' ' ' VAL . 5.4 m95 -103.92 144.92 30.87 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.379 -179.487 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.583 ' CG2' ' HB2' ' A' ' 18' ' ' ALA . 0.7 OUTLIER -137.15 157.91 45.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.382 -179.971 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.506 ' CZ ' HG21 ' A' ' 42' ' ' VAL . 78.2 t80 -148.95 155.39 40.77 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.49 -179.952 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -89.81 124.58 34.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.511 -179.89 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 94.0 p -120.56 103.56 9.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.273 179.937 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -110.3 -28.02 8.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.47 -179.906 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -59.55 125.63 80.19 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.458 -179.923 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -72.0 -11.73 27.6 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.519 2.146 . . . . 0.0 112.514 179.97 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -47.57 107.49 0.12 Allowed 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 120.901 0.381 . . . . 0.0 110.749 -179.732 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -76.05 118.89 19.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.345 179.929 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -179.65 170.85 42.39 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 -179.959 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.417 ' CB ' ' HA ' ' A' ' 80' ' ' ASP . 49.6 Cg_endo -79.02 151.63 24.04 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.597 2.198 . . . . 0.0 112.097 -179.893 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.571 ' HB3' HD13 ' A' ' 33' ' ' LEU . 29.4 m-85 -84.86 123.11 30.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.277 179.877 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 7.4 m-20 -95.28 134.46 38.03 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 179.516 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.424 ' CE2' ' HB2' ' A' ' 33' ' ' LEU . 51.8 m-85 -121.42 167.9 12.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.129 0.49 . . . . 0.0 111.045 -179.452 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.507 ' HG2' ' CZ3' ' A' ' 41' ' ' TRP . 0.3 OUTLIER -173.77 61.77 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.711 179.984 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.625 ' HZ ' HG11 ' A' ' 4' ' ' VAL . 1.7 p90 -56.78 174.11 0.17 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.99 -179.472 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.845 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 2.9 mt -121.54 72.14 1.0 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.221 179.515 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.401 ' OG1' ' N ' ' A' ' 74' ' ' MET . 62.3 p -35.84 136.17 0.27 Allowed 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.793 -179.241 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.681 ' HG2' ' HB2' ' A' ' 29' ' ' ALA . 14.8 mt-10 -49.96 -52.16 35.74 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.486 -179.861 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 6.3 tptp -129.21 71.67 1.44 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.529 -179.869 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -162.85 -103.71 0.18 Allowed Glycine 0 CA--C 1.522 0.528 0 N-CA-C 110.799 -0.92 . . . . 0.0 110.799 179.897 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.401 ' N ' ' OG1' ' A' ' 70' ' ' THR . 21.1 ptt? -179.21 -175.64 0.38 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.853 0.359 . . . . 0.0 110.292 179.988 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.553 ' HE3' HD22 ' A' ' 69' ' ' LEU . 0.0 OUTLIER -97.48 148.28 23.38 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.159 -179.69 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -152.62 123.09 7.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.192 179.854 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 98.4 t -81.65 143.73 11.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.526 -179.825 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.631 ' CZ ' HG21 ' A' ' 4' ' ' VAL . 53.9 m-85 -127.99 122.35 32.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.254 179.993 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -105.26 148.72 26.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.552 -179.699 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.417 ' HA ' ' CB ' ' A' ' 63' ' ' PRO . 1.0 OUTLIER 58.88 46.06 14.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.462 179.9 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.413 ' O ' ' HB3' ' A' ' 92' ' ' TYR . 90.1 t -77.0 -75.25 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.187 179.862 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.426 HG13 ' HD2' ' A' ' 83' ' ' PRO . 39.1 t -89.04 137.89 29.37 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.268 179.797 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.426 ' HD2' HG13 ' A' ' 82' ' ' VAL . 49.1 Cg_endo -73.17 -175.42 1.96 Allowed 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.5 2.133 . . . . 0.0 111.949 179.821 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -82.9 -31.18 27.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.135 179.738 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 6.0 tttp -117.45 51.56 1.02 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.255 179.846 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 0.403 ' HA ' ' HG2' ' A' ' 83' ' ' PRO . 48.8 p90 -52.56 159.61 1.02 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.55 -179.894 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -142.4 114.83 8.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.128 179.88 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.637 HG21 ' HA ' ' A' ' 10' ' ' LYS . 3.0 mp -49.83 100.16 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.466 -179.826 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 134.18 53.72 0.07 OUTLIER Glycine 0 CA--C 1.523 0.542 0 N-CA-C 110.602 -0.999 . . . . 0.0 110.602 -179.971 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.663 ' HB3' ' OH ' ' A' ' 92' ' ' TYR . . . -175.82 179.61 1.33 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.811 0.338 . . . . 0.0 110.359 179.99 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.559 HG23 ' O ' ' A' ' 6' ' ' PHE . 24.8 m -120.69 139.78 52.55 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.439 -179.83 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.663 ' OH ' ' HB3' ' A' ' 90' ' ' ALA . 7.1 m-85 -141.59 104.58 4.58 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.284 179.932 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.887 ' HB1' ' HD2' ' A' ' 94' ' ' PRO . . . 175.06 177.3 0.21 Allowed Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.301 -179.886 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.887 ' HD2' ' HB1' ' A' ' 93' ' ' ALA . 47.6 Cg_endo . . . . . 0 C--O 1.249 1.074 0 C-N-CA 122.486 2.124 . . . . 0.0 112.03 179.973 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 10.4 mmtp . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.678 0.275 . . . . 0.0 110.535 . . . . . . . . . 0 0 . 1 . 038 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.507 ' CG1' ' CE1' ' A' ' 78' ' ' PHE . 2.0 p -65.25 163.25 2.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.172 0.511 . . . . 0.0 110.068 179.808 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.491 ' N ' HG22 ' A' ' 4' ' ' VAL . 3.9 p -147.78 131.07 16.53 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.384 -179.989 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.815 ' O ' HG23 ' A' ' 91' ' ' THR . 6.0 m-85 -96.46 174.73 6.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.287 -179.958 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.442 ' HB ' ' CB ' ' A' ' 20' ' ' LEU . 2.8 m -166.16 106.88 0.7 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.27 -179.813 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.71 ' O ' HG23 ' A' ' 88' ' ' ILE . 91.6 t -59.11 94.12 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.406 -179.85 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.799 ' HG3' HG11 ' A' ' 51' ' ' VAL . 15.4 mm-40 -56.02 158.86 3.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.236 179.899 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.494 ' HA ' HG21 ' A' ' 88' ' ' ILE . 1.9 ptmt -77.14 62.57 2.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.435 -179.948 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -154.95 27.32 0.64 Allowed Glycine 0 CA--C 1.523 0.593 0 N-CA-C 110.728 -0.949 . . . . 0.0 110.728 179.963 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 30.4 m -86.87 131.7 34.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.839 0.352 . . . . 0.0 110.358 -179.967 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -110.54 -159.71 0.69 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.143 -0.481 . . . . 0.0 109.986 179.872 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -47.83 -59.35 3.38 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.622 179.908 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.13 -25.07 9.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.588 -180.0 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 27.0 m80 -51.27 134.46 27.7 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.852 0.358 . . . . 0.0 110.421 -179.999 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.485 HD22 ' HA ' ' A' ' 17' ' ' LEU . 0.2 OUTLIER -127.05 98.03 5.17 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.371 -179.952 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.552 ' HB2' ' CG2' ' A' ' 53' ' ' THR . . . -94.4 127.85 40.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.213 179.929 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.761 HG23 HG23 ' A' ' 21' ' ' VAL . 22.7 m -128.0 148.15 32.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.317 -179.957 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.442 ' CB ' ' HB ' ' A' ' 7' ' ' THR . 0.9 OUTLIER -94.53 63.19 2.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.456 -179.936 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.761 HG23 HG23 ' A' ' 19' ' ' VAL . 22.8 t -65.66 100.49 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.292 179.969 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.39 152.26 21.83 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.313 -179.994 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 28.1 p90 179.23 157.49 0.56 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.367 -179.941 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -82.81 163.53 21.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.331 179.934 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 106.63 -49.09 0.9 Allowed Glycine 0 CA--C 1.523 0.57 0 N-CA-C 110.652 -0.979 . . . . 0.0 110.652 -179.963 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -130.44 -177.78 4.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.755 0.312 . . . . 0.0 110.171 179.906 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -126.68 162.87 24.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.514 -179.976 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.589 ' O ' ' HB2' ' A' ' 29' ' ' ALA . 0.0 OUTLIER -57.98 -160.84 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.316 179.92 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.755 ' HB2' ' N ' ' A' ' 71' ' ' GLU . . . 155.12 -63.71 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.291 0.637 . . . . 0.0 109.532 179.668 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 17.9 tt0 -148.7 161.53 41.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.061 179.8 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.465 HG21 ' CD1' ' A' ' 52' ' ' TRP . 10.7 t -155.11 150.18 11.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.234 179.911 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.436 ' CB ' ' HA ' ' A' ' 43' ' ' ALA . 1.4 pm0 -151.67 144.46 24.38 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.359 -179.955 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.726 HD12 ' H ' ' A' ' 34' ' ' ARG . 8.1 tp -112.96 151.14 30.92 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.486 -179.428 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.726 ' H ' HD12 ' A' ' 33' ' ' LEU . 4.7 ttp180 -117.2 -158.16 0.69 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.229 179.913 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 6.9 tm-20 -175.5 107.32 0.09 Allowed 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 -179.968 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -48.39 97.0 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.704 -179.434 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 161.67 -31.27 0.32 Allowed Glycine 0 CA--C 1.522 0.525 0 N-CA-C 110.468 -1.053 . . . . 0.0 110.468 179.859 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -117.87 145.26 44.73 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 179.937 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -94.95 21.45 7.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.778 -179.836 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 29.7 tp10 -130.38 113.52 14.44 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 -179.901 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.499 ' CZ2' ' HD2' ' A' ' 67' ' ' ARG . 63.7 m95 -63.72 172.99 1.89 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.162 179.707 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.419 ' CG2' ' O ' ' A' ' 33' ' ' LEU . 4.4 m -146.65 107.34 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.048 179.624 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.436 ' HA ' ' CB ' ' A' ' 32' ' ' GLU . . . -45.49 146.06 1.11 Allowed 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.679 -179.69 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.411 ' CE ' ' HB2' ' A' ' 54' ' ' PHE . 0.0 OUTLIER -68.56 -170.8 0.23 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.709 -179.712 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.403 ' HB ' ' O ' ' A' ' 53' ' ' THR . 92.8 m -145.34 107.19 4.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.436 -179.979 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -66.22 79.08 0.09 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.168 179.87 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -104.29 -22.93 8.32 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 111.056 -0.818 . . . . 0.0 111.056 -179.794 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.465 ' HG3' HG23 ' A' ' 53' ' ' THR . 0.1 OUTLIER -75.96 -178.62 4.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.979 0.419 . . . . 0.0 110.422 -179.939 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -111.79 38.95 3.05 Favored Glycine 0 CA--C 1.522 0.514 0 N-CA-C 110.244 -1.143 . . . . 0.0 110.244 179.579 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 165.39 -27.81 0.19 Allowed Glycine 0 CA--C 1.526 0.753 0 N-CA-C 111.311 -0.716 . . . . 0.0 111.311 -179.874 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.799 HG11 ' HG3' ' A' ' 9' ' ' GLU . 3.2 m -123.4 -176.3 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-O 120.884 0.373 . . . . 0.0 110.705 -179.726 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 52' ' ' TRP . . . . . 0.465 ' CD1' HG21 ' A' ' 31' ' ' VAL . 11.2 m95 -108.21 138.27 44.78 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.722 -179.661 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.552 ' CG2' ' HB2' ' A' ' 18' ' ' ALA . 2.9 p -130.64 137.86 49.81 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.768 179.549 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.411 ' HB2' ' CE ' ' A' ' 44' ' ' MET . 71.5 t80 -123.37 131.12 53.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.878 0.371 . . . . 0.0 110.753 -179.539 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -77.32 107.13 9.51 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.019 179.696 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.0 m -87.76 148.71 24.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.629 -179.693 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -122.97 -42.27 2.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.256 179.887 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -55.72 165.51 1.26 Allowed Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.404 179.987 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -94.32 5.32 2.64 Favored 'Trans proline' 0 N--CA 1.452 -0.934 0 C-N-CA 123.995 3.13 . . . . 0.0 113.015 -179.863 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -103.94 102.9 12.69 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.827 0.346 . . . . 0.0 110.355 179.918 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -122.82 75.13 1.25 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.453 -179.845 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -133.46 -101.03 0.74 Allowed Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.749 -0.94 . . . . 0.0 110.749 179.996 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -78.51 107.9 2.36 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.568 2.178 . . . . 0.0 112.049 -179.954 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 36.7 m-85 -93.42 166.42 12.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.391 -179.947 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.424 ' HB2' ' CB ' ' A' ' 34' ' ' ARG . 4.9 m120 -133.86 147.41 51.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.018 179.785 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -140.55 175.07 9.9 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.031 0.443 . . . . 0.0 110.962 -179.718 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.499 ' HD2' ' CZ2' ' A' ' 41' ' ' TRP . 6.5 ptm180 -178.99 61.98 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.569 179.941 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.652 ' O ' HD23 ' A' ' 69' ' ' LEU . 0.3 OUTLIER -57.4 173.72 0.24 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.028 -179.223 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.723 HD22 ' HG2' ' A' ' 75' ' ' LYS . 2.9 mt -136.12 78.69 1.73 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.881 179.969 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 61.2 p -38.81 153.19 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.393 -179.646 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.755 ' N ' ' HB2' ' A' ' 29' ' ' ALA . 6.3 mt-10 -49.7 -33.97 17.44 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.388 -179.799 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.61 -36.08 82.69 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.354 -179.97 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 113.12 23.37 5.25 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 110.974 -0.851 . . . . 0.0 110.974 179.972 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -92.89 116.13 28.76 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.708 0.29 . . . . 0.0 110.307 179.902 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.723 ' HG2' HD22 ' A' ' 69' ' ' LEU . 3.1 mptt -113.46 173.72 6.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.35 -179.941 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 171.11 129.78 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.999 179.98 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 83.0 t -76.52 153.81 5.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.327 -179.994 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.507 ' CE1' ' CG1' ' A' ' 4' ' ' VAL . 87.1 m-85 -139.12 119.61 13.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.599 -179.879 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -106.03 152.22 23.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.095 179.812 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 11.0 t0 55.2 61.02 3.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.049 -179.751 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.482 ' O ' HG12 ' A' ' 81' ' ' VAL . 84.7 t -95.36 -8.19 9.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.234 -179.695 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.446 HG23 ' C ' ' A' ' 81' ' ' VAL . 57.3 t -156.33 132.07 5.68 Favored Pre-proline 0 C--N 1.332 -0.166 0 N-CA-C 110.406 -0.22 . . . . 0.0 110.406 179.872 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.509 ' HD3' ' CD1' ' A' ' 92' ' ' TYR . 50.0 Cg_endo -73.0 -176.09 2.23 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.507 2.138 . . . . 0.0 111.946 179.84 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -82.52 135.68 35.04 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 179.446 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 57.75 48.37 13.99 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 -179.466 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 48.8 p90 -43.28 156.36 0.05 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.414 -179.528 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 7.1 m -127.32 103.71 7.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.808 179.609 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.71 HG23 ' O ' ' A' ' 8' ' ' VAL . 2.5 mp -44.52 122.57 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.012 -179.632 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 117.43 35.37 1.1 Allowed Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.743 -0.943 . . . . 0.0 110.743 -179.935 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -155.74 142.35 18.73 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 110.222 -0.288 . . . . 0.0 110.222 179.978 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.815 HG23 ' O ' ' A' ' 6' ' ' PHE . 6.0 m -96.3 113.8 25.42 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.925 0.393 . . . . 0.0 110.716 -179.836 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.578 ' O ' ' HB3' ' A' ' 93' ' ' ALA . 33.0 m-85 -97.26 -153.58 0.42 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.788 179.751 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.869 ' HB1' ' HD2' ' A' ' 94' ' ' PRO . . . 78.42 173.78 0.08 OUTLIER Pre-proline 0 N--CA 1.465 0.305 0 CA-C-O 120.838 0.351 . . . . 0.0 110.722 179.808 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.869 ' HD2' ' HB1' ' A' ' 93' ' ' ALA . 48.1 Cg_endo . . . . . 0 C--O 1.249 1.053 0 C-N-CA 122.631 2.22 . . . . 0.0 112.079 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 3.3 m . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 110.151 -0.314 . . . . 0.0 110.151 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -75.51 111.14 3.24 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.556 2.171 . . . . 0.0 112.089 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 9.9 tttt -143.13 75.63 1.49 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.428 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.946 HG12 ' CE1' ' A' ' 23' ' ' TYR . 30.0 m -92.74 172.06 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.374 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.701 HG23 ' O ' ' A' ' 4' ' ' VAL . 4.6 p -163.49 133.8 4.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.397 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.579 ' O ' HG23 ' A' ' 91' ' ' THR . 23.4 m-85 -95.61 -169.9 2.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.073 179.849 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -165.75 104.85 0.7 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.809 0.338 . . . . 0.0 110.505 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 95.8 t -55.21 91.84 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.179 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 1.021 ' HG3' HG11 ' A' ' 51' ' ' VAL . 9.9 mm-40 -66.1 169.57 6.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.568 -179.704 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.501 ' HA ' HG21 ' A' ' 88' ' ' ILE . 11.9 tttt -63.18 -15.33 56.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.193 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -45.95 -27.81 2.58 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 111.213 -0.755 . . . . 0.0 111.213 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -71.13 131.29 43.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.77 0.319 . . . . 0.0 110.348 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -145.47 -86.61 0.11 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.434 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -81.68 -66.81 0.84 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.923 0.392 . . . . 0.0 110.121 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.06 26.08 2.72 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.214 179.708 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 54.5 m80 -94.32 139.61 30.86 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.233 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.44 ' HA ' HD22 ' A' ' 17' ' ' LEU . 0.4 OUTLIER -124.35 89.24 3.04 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.263 179.907 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.581 ' HB2' ' CG2' ' A' ' 53' ' ' THR . . . -90.26 153.38 20.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.51 -179.819 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 6.4 m -145.29 137.5 20.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.044 179.77 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.563 HD12 ' OE2' ' A' ' 9' ' ' GLU . 0.9 OUTLIER -98.69 51.56 0.99 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.505 -179.943 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.511 ' HB ' ' CD2' ' A' ' 6' ' ' PHE . 3.0 p -53.57 107.65 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.924 0.393 . . . . 0.0 110.19 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -174.46 120.75 0.25 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.252 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.946 ' CE1' HG12 ' A' ' 4' ' ' VAL . 17.0 p90 -127.31 19.61 6.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.831 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 60.44 147.94 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.901 0.381 . . . . 0.0 110.518 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 109.07 -93.47 0.77 Allowed Glycine 0 CA--C 1.523 0.592 0 N-CA-C 110.652 -0.979 . . . . 0.0 110.652 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -57.54 -173.43 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.793 0.33 . . . . 0.0 110.484 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.34 173.69 6.67 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.515 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.424 ' O ' ' CG ' ' A' ' 71' ' ' GLU . 0.1 OUTLIER -109.07 123.51 49.28 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.483 -179.942 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.698 ' HB3' ' O ' ' A' ' 69' ' ' LEU . . . -115.1 -62.59 1.58 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.284 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -158.95 164.2 35.83 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.595 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.86 HG21 ' CD1' ' A' ' 52' ' ' TRP . 16.2 t -138.68 145.43 27.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.211 0.529 . . . . 0.0 111.335 -179.547 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.405 ' HA ' ' HA ' ' A' ' 43' ' ' ALA . 6.0 tp10 -124.56 130.6 52.76 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.223 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.672 HD12 ' H ' ' A' ' 34' ' ' ARG . 12.4 tp -114.2 151.77 32.24 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 121.021 0.438 . . . . 0.0 110.172 -179.058 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.672 ' H ' HD12 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -125.98 -156.04 0.71 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.699 179.458 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.423 ' CG ' ' O ' ' A' ' 34' ' ' ARG . 14.3 mt-10 -161.57 -88.54 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.497 0.189 . . . . 0.0 110.72 179.711 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.444 ' CG ' ' N ' ' A' ' 37' ' ' GLY . 11.1 p80 -160.76 -46.72 0.05 OUTLIER 'General case' 0 N--CA 1.454 -0.235 0 CA-C-O 120.797 0.332 . . . . 0.0 110.8 -179.716 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.444 ' N ' ' CG ' ' A' ' 36' ' ' HIS . . . -156.97 38.39 0.56 Allowed Glycine 0 CA--C 1.523 0.577 0 N-CA-C 110.914 -0.874 . . . . 0.0 110.914 -179.605 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 5.5 t -73.6 -76.03 0.14 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.828 0.347 . . . . 0.0 110.219 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 37.3 p30 -173.32 55.95 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.131 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 67.83 176.29 0.26 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.242 -179.784 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.507 ' CZ3' ' HG2' ' A' ' 67' ' ' ARG . 98.3 m95 -52.69 138.64 28.3 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.542 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.7 m -130.98 110.72 18.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.935 179.726 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.405 ' HA ' ' HA ' ' A' ' 32' ' ' GLU . . . -48.66 131.42 17.79 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.82 -179.474 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.23 -171.33 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.578 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.419 ' O ' ' N ' ' A' ' 47' ' ' GLY . 41.3 m -142.03 102.33 4.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.235 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.405 ' O ' ' CG ' ' A' ' 46' ' ' LYS . 0.1 OUTLIER -64.56 76.17 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.331 -179.966 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 45' ' ' THR . . . -107.14 -21.9 7.82 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.923 -0.871 . . . . 0.0 110.923 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.69 -33.41 66.49 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.838 0.351 . . . . 0.0 110.336 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 98.12 -42.38 2.09 Favored Glycine 0 CA--C 1.522 0.526 0 N-CA-C 110.562 -1.015 . . . . 0.0 110.562 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -107.32 -25.12 6.19 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.679 -0.968 . . . . 0.0 110.679 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 1.021 HG11 ' HG3' ' A' ' 9' ' ' GLU . 24.0 m -136.5 179.0 4.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.826 0.346 . . . . 0.0 110.467 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' TRP . . . . . 0.86 ' CD1' HG21 ' A' ' 31' ' ' VAL . 4.0 m95 -109.42 128.35 55.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.417 -179.423 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.581 ' CG2' ' HB2' ' A' ' 18' ' ' ALA . 0.2 OUTLIER -114.69 167.94 10.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.421 -179.964 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.666 ' CG ' HD23 ' A' ' 33' ' ' LEU . 79.2 t80 -146.72 133.2 19.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.316 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 25.5 p-10 -94.65 114.29 26.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.544 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -84.51 146.55 27.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.261 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -113.11 -40.19 4.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.403 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.4 ' HG3' ' O ' ' A' ' 60' ' ' LEU . 1.7 pt-20 -67.66 151.55 97.07 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.272 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -71.72 -18.77 28.38 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.681 2.254 . . . . 0.0 112.494 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.4 ' O ' ' HG3' ' A' ' 58' ' ' GLU . 3.6 mt -96.29 144.13 26.74 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.903 0.382 . . . . 0.0 110.662 -179.645 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -143.2 91.12 2.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.269 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -96.35 -140.7 11.33 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.775 -0.93 . . . . 0.0 110.775 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -73.9 166.38 29.83 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.527 2.151 . . . . 0.0 111.893 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -125.2 177.46 6.1 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.148 0.499 . . . . 0.0 111.0 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -147.43 134.62 20.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.494 179.61 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.565 ' CZ ' HD13 ' A' ' 33' ' ' LEU . 52.2 m-85 -124.22 168.52 12.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.253 0.549 . . . . 0.0 111.478 -179.072 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.507 ' HG2' ' CZ3' ' A' ' 41' ' ' TRP . 0.0 OUTLIER -170.86 68.36 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.404 179.741 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.796 ' O ' HD23 ' A' ' 69' ' ' LEU . 4.5 p90 -51.8 177.81 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.407 0.622 . . . . 0.0 111.544 -178.894 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.796 HD23 ' O ' ' A' ' 68' ' ' PHE . 5.7 mt -137.96 55.75 1.76 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.045 -0.979 . . . . 0.0 109.177 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.429 HG23 ' CD1' ' A' ' 68' ' ' PHE . 40.1 p -27.98 136.83 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.762 0.825 . . . . 0.0 112.709 -179.015 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.592 ' N ' ' HB2' ' A' ' 29' ' ' ALA . 14.4 mt-10 -50.78 -31.15 16.02 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.42 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -63.23 -31.68 72.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.447 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 103.18 62.33 0.7 Allowed Glycine 0 CA--C 1.523 0.576 0 N-CA-C 110.669 -0.972 . . . . 0.0 110.669 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 74.5 mtp -152.18 115.33 4.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.813 0.34 . . . . 0.0 110.313 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.68 176.75 5.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.384 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.421 ' O ' ' CE2' ' A' ' 78' ' ' PHE . 2.0 m-20 173.25 126.94 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.113 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 97.8 t -76.17 152.77 6.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.752 -179.612 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.757 ' CZ ' HG21 ' A' ' 4' ' ' VAL . 38.9 m-85 -136.88 121.08 17.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.152 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -109.53 153.02 24.71 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.471 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.7 t0 59.53 30.53 20.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.675 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.446 HG13 ' O ' ' A' ' 92' ' ' TYR . 95.9 t -59.77 -73.82 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.19 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.497 HG13 ' HD2' ' A' ' 83' ' ' PRO . 50.9 t -87.52 139.32 31.65 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.416 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.497 ' HD2' HG13 ' A' ' 82' ' ' VAL . 47.5 Cg_endo -73.83 -168.1 0.43 Allowed 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.572 2.181 . . . . 0.0 112.063 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -76.12 -64.12 1.17 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.341 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 6.3 tppt? -96.42 57.7 1.69 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.282 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 40.4 p90 -51.77 148.9 5.15 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.483 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 3.1 m -122.85 110.24 15.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.181 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.501 HG21 ' HA ' ' A' ' 10' ' ' LYS . 2.7 mp -50.47 100.97 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.459 -179.748 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 137.51 44.87 0.08 OUTLIER Glycine 0 CA--C 1.523 0.579 0 N-CA-C 110.534 -1.027 . . . . 0.0 110.534 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.71 ' HB3' ' OH ' ' A' ' 92' ' ' TYR . . . -166.45 -176.76 3.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.769 0.319 . . . . 0.0 110.345 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.579 HG23 ' O ' ' A' ' 6' ' ' PHE . 85.3 m -119.68 138.66 53.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.572 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.71 ' OH ' ' HB3' ' A' ' 90' ' ' ALA . 7.4 m-85 -143.95 107.74 4.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.168 179.791 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.898 ' HB1' ' HD2' ' A' ' 94' ' ' PRO . . . 176.25 178.02 0.22 Allowed Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.488 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.898 ' HD2' ' HB1' ' A' ' 93' ' ' ALA . 49.4 Cg_endo . . . . . 0 C--O 1.249 1.027 0 C-N-CA 122.565 2.177 . . . . 0.0 112.059 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 61.7 t . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -76.17 135.88 17.48 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.599 2.199 . . . . 0.0 112.196 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 4.6 pttt -119.01 84.68 2.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.281 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.673 HG11 ' CZ ' ' A' ' 68' ' ' PHE . 17.8 m -55.06 171.07 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.461 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.445 ' HB ' ' CG2' ' A' ' 91' ' ' THR . 21.6 p -153.47 135.6 14.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.375 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.532 ' HD1' ' HB2' ' A' ' 93' ' ' ALA . 14.9 m-85 -100.58 169.38 9.09 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.455 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.5 m -157.59 112.72 2.74 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.342 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 44.5 t -58.07 91.38 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.275 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.775 ' HG3' HG11 ' A' ' 51' ' ' VAL . 6.7 mm-40 -51.0 176.3 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.463 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 61.9 mmtt -67.48 175.5 2.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.314 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 51.13 49.74 42.28 Favored Glycine 0 CA--C 1.523 0.547 0 N-CA-C 110.718 -0.953 . . . . 0.0 110.718 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -102.64 136.9 41.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.873 0.368 . . . . 0.0 110.452 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 3.7 p30 -172.07 162.81 5.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.295 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -49.11 -28.1 3.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.742 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.81 -28.33 44.5 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.373 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 25.1 m80 -149.65 125.22 10.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.507 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.516 ' HA ' HD22 ' A' ' 17' ' ' LEU . 0.3 OUTLIER -111.83 94.37 4.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.222 179.883 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.667 ' HB2' ' CG2' ' A' ' 53' ' ' THR . . . -96.06 125.69 40.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.488 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.455 HG23 HG23 ' A' ' 21' ' ' VAL . 33.2 m -113.67 -171.17 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.003 179.765 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.4 tt -138.09 80.66 1.81 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.302 179.656 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.455 HG23 HG23 ' A' ' 19' ' ' VAL . 2.4 t -97.31 102.39 13.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.989 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.49 ' O ' ' CG ' ' A' ' 23' ' ' TYR . 0.0 OUTLIER -162.87 -65.27 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.878 -179.721 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.635 ' CE2' HG12 ' A' ' 4' ' ' VAL . 33.5 p90 45.6 -171.78 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.724 -179.454 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -115.85 142.63 46.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.474 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 131.23 -43.88 1.26 Allowed Glycine 0 CA--C 1.523 0.541 0 N-CA-C 110.759 -0.936 . . . . 0.0 110.759 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -126.91 -170.63 2.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.826 0.346 . . . . 0.0 110.601 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -118.8 -175.32 2.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.514 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.437 ' O ' ' CG ' ' A' ' 71' ' ' GLU . 1.5 mtp -105.99 123.73 48.45 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.343 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.756 ' HB2' ' HG2' ' A' ' 71' ' ' GLU . . . -132.16 -58.58 0.95 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.924 -179.776 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.581 ' C ' HG12 ' A' ' 31' ' ' VAL . 0.0 OUTLIER -140.63 173.6 11.33 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.83 0.348 . . . . 0.0 110.925 -179.778 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.581 HG12 ' C ' ' A' ' 30' ' ' GLU . 1.3 p 164.3 131.33 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-O 121.518 0.675 . . . . 0.0 109.76 -179.847 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.692 ' OE2' ' HB2' ' A' ' 43' ' ' ALA . 2.6 mm-40 -112.04 -172.49 2.05 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.843 -1.071 . . . . 0.0 110.476 -179.546 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.74 HD12 ' H ' ' A' ' 34' ' ' ARG . 5.8 tp -144.22 145.16 31.89 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 179.302 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.74 ' H ' HD12 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -150.66 -178.84 6.79 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.086 179.712 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -132.27 -85.22 0.48 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.574 -0.284 . . . . 0.0 110.566 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 171.71 39.76 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.823 0.344 . . . . 0.0 110.595 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 167.29 59.15 0.03 OUTLIER Glycine 0 CA--C 1.524 0.621 0 N-CA-C 110.817 -0.913 . . . . 0.0 110.817 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.6 t -133.57 158.85 42.14 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.78 0.324 . . . . 0.0 110.296 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.421 ' O ' ' CG ' ' A' ' 40' ' ' GLU . 0.4 OUTLIER -51.67 -33.48 34.0 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.31 179.907 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.421 ' CG ' ' O ' ' A' ' 39' ' ' ASP . 2.9 mt-10 169.19 -179.19 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.236 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.51 ' CH2' ' HG3' ' A' ' 67' ' ' ARG . 71.8 m95 -62.14 145.02 54.56 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.339 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 27.3 m -122.85 2.04 6.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.159 -179.833 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.692 ' HB2' ' OE2' ' A' ' 32' ' ' GLU . . . 60.07 137.86 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.344 0 CA-C-O 121.301 0.572 . . . . 0.0 111.3 179.322 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.5 ' H ' ' HA ' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -62.51 -167.13 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.372 179.733 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.4 ' O ' ' N ' ' A' ' 47' ' ' GLY . 49.9 m -150.85 125.32 9.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.358 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 13.6 ptmt -69.25 64.66 0.15 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.239 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' A' ' 45' ' ' THR . . . -91.23 -34.18 7.7 Favored Glycine 0 CA--C 1.523 0.549 0 N-CA-C 110.814 -0.915 . . . . 0.0 110.814 -179.832 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.441 ' HG2' ' CG2' ' A' ' 51' ' ' VAL . 4.4 tp10 -88.34 124.14 33.61 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.822 0.344 . . . . 0.0 110.503 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -71.56 76.28 0.66 Allowed Glycine 0 CA--C 1.522 0.507 0 N-CA-C 110.637 -0.985 . . . . 0.0 110.637 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 154.04 -36.75 0.71 Allowed Glycine 0 CA--C 1.522 0.49 0 N-CA-C 110.633 -0.987 . . . . 0.0 110.633 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.775 HG11 ' HG3' ' A' ' 9' ' ' GLU . 16.2 m -142.82 -176.7 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.95 0.405 . . . . 0.0 110.537 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 5.4 m95 -96.33 131.67 42.62 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.637 -179.436 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.667 ' CG2' ' HB2' ' A' ' 18' ' ' ALA . 0.8 OUTLIER -130.29 147.07 51.96 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.404 -179.958 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.544 ' CG ' HD23 ' A' ' 33' ' ' LEU . 45.6 t80 -137.43 142.27 41.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.239 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -91.25 141.12 29.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.507 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.1 p -143.11 147.01 34.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.278 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -144.45 31.56 1.21 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.456 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.4 ' HB2' ' HD2' ' A' ' 59' ' ' PRO . 6.5 pt-20 -102.87 157.26 34.07 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.228 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.4 ' HD2' ' HB2' ' A' ' 58' ' ' GLU . 47.9 Cg_endo -71.1 -32.52 13.07 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.603 2.202 . . . . 0.0 112.142 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.1 mt -80.6 102.3 9.72 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.336 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -138.87 132.79 31.02 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.477 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -177.63 -98.78 0.11 Allowed Glycine 0 CA--C 1.526 0.758 0 N-CA-C 110.644 -0.982 . . . . 0.0 110.644 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -81.38 164.88 18.96 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.609 2.206 . . . . 0.0 112.083 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -139.36 161.34 37.68 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.465 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -126.99 149.51 49.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.194 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.477 ' CD2' ' O ' ' A' ' 32' ' ' GLU . 85.1 m-85 -138.83 159.84 41.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.967 0.413 . . . . 0.0 111.071 -179.629 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.51 ' HG3' ' CH2' ' A' ' 41' ' ' TRP . 10.0 mtp-105 -152.42 73.18 1.02 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.84 179.352 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.691 ' O ' HD23 ' A' ' 69' ' ' LEU . 6.3 p90 -70.49 175.2 4.97 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.384 0.612 . . . . 0.0 111.023 -179.531 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.756 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 23.9 mt -146.88 57.58 1.16 Allowed 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.972 -1.013 . . . . 0.0 109.396 179.789 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 28.4 p -25.84 135.95 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.872 0.869 . . . . 0.0 112.487 -179.137 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.756 ' HG2' ' HB2' ' A' ' 29' ' ' ALA . 3.9 mm-40 -51.96 -23.95 5.78 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.599 -179.498 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 17.9 tptp -147.07 68.58 1.16 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.644 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -160.91 -103.82 0.19 Allowed Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.875 -0.89 . . . . 0.0 110.875 179.731 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -178.58 -176.69 0.5 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.89 0.376 . . . . 0.0 110.638 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.553 ' CG ' HD22 ' A' ' 69' ' ' LEU . 0.0 OUTLIER -93.2 172.96 7.97 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.345 -179.858 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 171.81 137.17 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.603 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.463 HG22 ' CD ' ' A' ' 67' ' ' ARG . 45.6 t -99.36 132.48 44.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 179.527 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.522 ' CE2' ' CG2' ' A' ' 4' ' ' VAL . 52.3 m-85 -117.28 139.8 50.36 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.5 -179.572 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -126.12 161.9 26.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.421 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 51.22 35.83 14.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.441 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.666 HG22 ' HD3' ' A' ' 94' ' ' PRO . 48.9 t -75.91 -2.55 4.23 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.816 179.757 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 84.0 t -154.12 131.63 6.21 Favored Pre-proline 0 CA--C 1.529 0.161 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.499 ' HG3' ' CE1' ' A' ' 92' ' ' TYR . 48.6 Cg_endo -75.22 178.68 6.99 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.516 2.144 . . . . 0.0 112.181 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -64.54 -57.52 8.92 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.12 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.93 73.72 0.83 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.171 179.717 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.511 ' HB2' ' CE2' ' A' ' 92' ' ' TYR . 23.1 p90 -70.22 177.02 3.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.521 -179.854 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 2.7 m -137.27 119.23 15.31 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.094 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.617 ' H ' HD12 ' A' ' 88' ' ' ILE . 4.3 mp -48.94 119.3 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.547 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 105.06 59.03 0.66 Allowed Glycine 0 CA--C 1.523 0.533 0 N-CA-C 110.591 -1.004 . . . . 0.0 110.591 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -170.75 146.23 2.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.896 0.379 . . . . 0.0 110.639 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.445 ' CG2' ' HB ' ' A' ' 5' ' ' THR . 8.5 m -93.43 122.99 36.42 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.046 179.696 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.511 ' CE2' ' HB2' ' A' ' 86' ' ' TYR . 69.9 m-85 -108.12 -87.55 0.49 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.791 -179.592 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.91 ' HB1' ' HD2' ' A' ' 94' ' ' PRO . . . 50.42 -179.97 0.01 OUTLIER Pre-proline 0 C--O 1.232 0.133 0 CA-C-O 120.641 0.257 . . . . 0.0 110.432 -179.781 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.91 ' HD2' ' HB1' ' A' ' 93' ' ' ALA . 49.3 Cg_endo . . . . . 0 C--O 1.25 1.075 0 C-N-CA 122.45 2.1 . . . . 0.0 111.937 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.673 ' O ' HG23 ' A' ' 1' ' ' VAL . 27.8 m . . . . . 0 N--CA 1.492 1.666 0 N-CA-C 110.299 -0.26 . . . . 0.0 110.299 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -76.57 168.81 23.03 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.546 2.164 . . . . 0.0 112.044 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 4.5 mttm -139.65 85.39 2.04 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.355 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.649 HG21 ' CZ ' ' A' ' 78' ' ' PHE . 16.8 m -124.85 -176.39 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.424 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.429 HG23 ' O ' ' A' ' 4' ' ' VAL . 0.1 OUTLIER -165.14 148.04 8.18 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.235 179.878 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.602 ' H ' ' HB3' ' A' ' 93' ' ' ALA . 48.2 m-85 -123.34 145.56 48.64 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.326 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.503 HG22 ' H ' ' A' ' 8' ' ' VAL . 0.2 OUTLIER -129.3 -176.99 4.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.301 -179.942 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.503 ' H ' HG22 ' A' ' 7' ' ' THR . 39.8 t -128.14 87.42 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.4 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.83 ' HG3' HG11 ' A' ' 51' ' ' VAL . 1.3 mm-40 -52.27 147.92 7.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.275 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.27 63.16 0.35 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.371 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -154.39 23.32 0.66 Allowed Glycine 0 CA--C 1.525 0.682 0 N-CA-C 111.022 -0.831 . . . . 0.0 111.022 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 16.9 m -76.07 105.02 6.88 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.442 ' N ' ' ND2' ' A' ' 13' ' ' ASN . 0.4 OUTLIER -75.92 -178.48 4.35 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.096 -179.721 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -62.07 -36.6 82.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.466 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 4.9 ptmt -124.72 36.45 4.6 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.666 -179.632 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.428 ' HB2' ' CB ' ' A' ' 13' ' ' ASN . 13.2 m80 -136.09 -176.27 4.26 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.844 0.354 . . . . 0.0 110.563 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 32.1 tp -167.07 85.61 0.26 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.269 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.436 ' HB2' ' CG2' ' A' ' 53' ' ' THR . . . -81.33 107.29 13.99 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.58 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.52 HG23 HG23 ' A' ' 21' ' ' VAL . 17.8 m -88.99 -170.66 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.163 179.698 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.44 HD12 ' HG2' ' A' ' 9' ' ' GLU . 1.9 tt -142.4 57.68 1.45 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.308 179.67 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.52 HG23 HG23 ' A' ' 19' ' ' VAL . 4.9 t -72.17 114.72 11.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.463 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.93 164.03 20.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.318 179.756 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER 174.05 150.05 0.08 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.372 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -79.79 -26.89 40.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.485 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -53.56 -75.84 0.21 Allowed Glycine 0 CA--C 1.524 0.625 0 N-CA-C 110.826 -0.91 . . . . 0.0 110.826 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -93.77 -164.21 1.15 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.794 0.33 . . . . 0.0 110.428 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.07 -158.31 0.82 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.415 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.422 ' O ' ' CG ' ' A' ' 71' ' ' GLU . 47.1 mtm -132.25 126.82 34.37 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.704 -179.76 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.855 ' HB3' ' O ' ' A' ' 69' ' ' LEU . . . -125.9 -44.04 1.8 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.083 179.722 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.43 ' O ' ' HB2' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -164.27 168.93 18.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.89 -0.596 . . . . 0.0 109.526 179.712 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 8.9 t -154.11 136.48 6.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.901 0.381 . . . . 0.0 110.975 -179.806 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.439 ' CB ' ' HA ' ' A' ' 43' ' ' ALA . 3.3 pt-20 -134.08 138.06 45.03 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 178.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.628 HD23 ' CG ' ' A' ' 54' ' ' PHE . 13.4 tp -118.24 155.6 30.26 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 121.157 0.503 . . . . 0.0 110.854 -178.015 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.602 ' H ' HD12 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -136.75 -156.97 0.74 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.325 178.946 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -153.35 -79.72 0.1 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.696 0.284 . . . . 0.0 110.559 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 177.18 119.32 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.79 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 52.64 63.75 4.68 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 111.165 -0.774 . . . . 0.0 111.165 179.61 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.473 ' CB ' ' NH1' ' A' ' 34' ' ' ARG . 0.3 OUTLIER -111.31 -70.08 0.83 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.946 0.403 . . . . 0.0 110.289 179.797 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 25.4 t0 179.59 -63.3 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.119 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -157.04 163.0 39.53 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.344 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.495 ' CZ2' ' HG3' ' A' ' 67' ' ' ARG . 94.3 m95 -57.57 146.89 28.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.695 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.444 HG23 ' O ' ' A' ' 33' ' ' LEU . 2.8 m -129.31 107.92 16.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.439 ' HA ' ' CB ' ' A' ' 32' ' ' GLU . . . -45.96 140.86 3.44 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.777 -179.546 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.02 -170.89 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.539 -179.72 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 86.6 m -138.8 98.84 3.64 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.326 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 13.0 ptmt -67.01 79.29 0.12 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.509 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -128.29 24.87 4.94 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.76 -0.936 . . . . 0.0 110.76 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.421 ' CB ' HG23 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -107.59 175.8 5.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.801 0.334 . . . . 0.0 110.38 179.978 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -60.25 -43.92 98.0 Favored Glycine 0 CA--C 1.523 0.562 0 N-CA-C 110.572 -1.011 . . . . 0.0 110.572 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -160.52 27.6 0.32 Allowed Glycine 0 CA--C 1.524 0.619 0 N-CA-C 110.828 -0.909 . . . . 0.0 110.828 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.83 HG11 ' HG3' ' A' ' 9' ' ' GLU . 14.7 m -143.13 -175.81 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.8 0.333 . . . . 0.0 110.369 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 6.7 m95 -109.29 141.94 40.88 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.712 -179.588 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.436 ' CG2' ' HB2' ' A' ' 18' ' ' ALA . 0.0 OUTLIER -125.81 159.38 32.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.924 179.533 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.628 ' CG ' HD23 ' A' ' 33' ' ' LEU . 68.1 t80 -144.09 133.68 23.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.845 0.355 . . . . 0.0 110.511 -179.843 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -84.9 128.61 34.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.364 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -122.54 154.15 38.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.379 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -162.22 50.73 0.2 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.467 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -128.71 156.38 77.63 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.569 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -66.99 -28.28 41.95 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.897 2.398 . . . . 0.0 112.123 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -80.06 163.43 24.18 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.28 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -175.29 44.74 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.49 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -83.01 -132.68 1.9 Allowed Glycine 0 CA--C 1.527 0.808 0 N-CA-C 110.36 -1.096 . . . . 0.0 110.36 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -75.29 141.3 25.67 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.355 2.037 . . . . 0.0 111.8 179.663 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 44.8 m-85 -97.62 153.0 18.49 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.529 -179.713 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -124.79 126.23 45.29 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.026 -0.533 . . . . 0.0 109.913 179.581 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.571 ' CD2' ' CE2' ' A' ' 6' ' ' PHE . 2.7 m-85 -104.74 -178.25 3.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.654 -179.573 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.495 ' HG3' ' CZ2' ' A' ' 41' ' ' TRP . 0.0 OUTLIER 175.27 77.85 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.997 179.975 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.506 ' HZ ' HG11 ' A' ' 4' ' ' VAL . 1.4 p90 -84.75 164.08 18.75 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.222 0.534 . . . . 0.0 110.975 -179.653 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.855 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 9.1 mt -109.75 64.26 0.61 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.283 -0.872 . . . . 0.0 108.861 178.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.428 HG23 ' CD1' ' A' ' 68' ' ' PHE . 0.8 OUTLIER -33.77 138.06 0.09 Allowed 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 115.552 -0.749 . . . . 0.0 112.206 -178.833 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.677 ' HG2' ' HB2' ' A' ' 29' ' ' ALA . 19.0 mt-10 -49.02 -28.13 3.74 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.958 -179.543 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.01 26.64 0.31 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.678 0.275 . . . . 0.0 111.127 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.422 ' O ' ' CB ' ' A' ' 74' ' ' MET . . . -97.15 -36.46 4.94 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 110.381 -1.088 . . . . 0.0 110.381 179.67 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.422 ' CB ' ' O ' ' A' ' 73' ' ' GLY . 0.0 OUTLIER 82.25 70.8 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 120.85 0.357 . . . . 0.0 111.089 179.443 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 48.98 -179.29 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.198 179.209 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.51 ' HB3' ' CE2' ' A' ' 78' ' ' PHE . 1.9 m-80 167.65 128.45 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.882 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 77.5 t -95.31 137.54 23.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.013 0.435 . . . . 0.0 110.525 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.649 ' CZ ' HG21 ' A' ' 4' ' ' VAL . 92.4 m-85 -133.39 144.46 49.58 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.494 -179.781 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -133.58 161.49 34.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.194 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 54.02 30.28 11.57 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.94 0.4 . . . . 0.0 110.138 -179.865 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.58 HG13 ' HB2' ' A' ' 93' ' ' ALA . 87.4 t -64.48 -15.97 18.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.2 -179.739 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 44.6 t -146.72 132.5 9.36 Favored Pre-proline 0 C--N 1.332 -0.19 0 CA-C-O 120.506 0.193 . . . . 0.0 110.565 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.469 ' HD3' ' CD1' ' A' ' 92' ' ' TYR . 50.6 Cg_endo -75.44 165.81 29.93 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.561 2.174 . . . . 0.0 111.899 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -66.12 126.54 28.98 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.293 -0.412 . . . . 0.0 109.989 179.651 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 24.7 mtmt 60.17 50.12 6.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.942 0.401 . . . . 0.0 109.924 -179.488 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 51.3 p90 -47.56 158.96 0.16 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.967 -179.581 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 29.1 m -124.04 108.85 12.8 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.035 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 2.7 mp -47.98 107.64 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.626 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 132.7 44.76 0.14 Allowed Glycine 0 CA--C 1.523 0.565 0 N-CA-C 110.449 -1.061 . . . . 0.0 110.449 -179.709 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -163.29 156.41 19.01 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.99 101.68 11.23 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.722 -179.78 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.469 ' CD1' ' HD3' ' A' ' 83' ' ' PRO . 32.7 m-85 -87.98 -160.17 0.6 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.868 179.563 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.916 ' HB1' ' HD2' ' A' ' 94' ' ' PRO . . . 66.82 176.58 0.06 OUTLIER Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 120.721 0.296 . . . . 0.0 110.578 179.653 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.916 ' HD2' ' HB1' ' A' ' 93' ' ' ALA . 47.7 Cg_endo . . . . . 0 C--O 1.249 1.056 0 C-N-CA 122.567 2.178 . . . . 0.0 112.04 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.463 ' O ' HG23 ' A' ' 1' ' ' VAL . 6.2 m . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 110.232 -0.284 . . . . 0.0 110.232 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -78.15 139.6 17.07 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.608 2.206 . . . . 0.0 112.016 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 8.4 mtmt -128.54 55.54 1.69 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.272 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.751 HG11 ' CE1' ' A' ' 78' ' ' PHE . 1.7 p -149.32 164.24 4.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.301 0.572 . . . . 0.0 110.215 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.481 ' N ' HG22 ' A' ' 4' ' ' VAL . 0.6 OUTLIER -156.99 133.41 9.89 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.516 179.775 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.516 ' HD1' ' HB2' ' A' ' 93' ' ' ALA . 8.2 m-85 -109.77 179.29 4.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.092 -0.504 . . . . 0.0 109.893 179.535 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.5 m -166.23 128.32 1.89 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.846 0.355 . . . . 0.0 110.335 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.687 ' O ' HG23 ' A' ' 88' ' ' ILE . 29.2 t -70.0 87.51 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.189 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.552 ' CG ' HG21 ' A' ' 51' ' ' VAL . 1.2 mm-40 -58.28 166.09 1.78 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.436 -179.756 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.575 ' HA ' HG21 ' A' ' 88' ' ' ILE . 1.6 mppt? -54.53 -21.84 11.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.83 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -45.14 -37.43 5.81 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 111.269 -0.733 . . . . 0.0 111.269 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 13.3 m -68.19 124.97 24.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.778 0.323 . . . . 0.0 110.348 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -133.93 -52.74 0.85 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.516 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -146.72 -76.78 0.19 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.658 -179.859 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 14.4 mmmt -99.32 25.58 6.79 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.462 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 31.4 m80 -125.38 147.51 49.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.451 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.465 HD22 ' HA ' ' A' ' 17' ' ' LEU . 0.2 OUTLIER -133.44 91.53 2.87 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.0 0.428 . . . . 0.0 110.366 179.881 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.714 ' HB1' HG11 ' A' ' 51' ' ' VAL . . . -92.12 131.99 36.94 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.16 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.84 ' O ' HG13 ' A' ' 51' ' ' VAL . 14.5 m -127.5 135.33 63.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.847 0.356 . . . . 0.0 110.596 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.538 HD12 ' OE2' ' A' ' 9' ' ' GLU . 1.3 tt -91.98 67.2 5.14 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.036 -179.789 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.527 ' CG1' ' CD1' ' A' ' 52' ' ' TRP . 2.2 p -82.19 110.2 17.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 179.395 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 30.3 tttm -178.06 111.13 0.07 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.33 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 29.3 p90 -136.56 151.21 49.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.441 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -50.78 172.99 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.526 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 76.05 -84.8 0.91 Allowed Glycine 0 CA--C 1.523 0.557 0 N-CA-C 110.753 -0.939 . . . . 0.0 110.753 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.517 ' HB3' HG21 ' A' ' 70' ' ' THR . 0.8 OUTLIER -64.62 179.11 0.66 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.734 0.302 . . . . 0.0 110.344 -179.994 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -133.08 178.65 6.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.488 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.422 ' O ' ' CG ' ' A' ' 71' ' ' GLU . 0.1 OUTLIER -105.55 120.42 41.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.26 179.963 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.831 ' HB3' ' O ' ' A' ' 69' ' ' LEU . . . -130.65 -50.68 1.06 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.823 -179.69 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.409 ' CG ' ' O ' ' A' ' 29' ' ' ALA . 29.1 mt-10 -159.23 150.51 20.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.999 0.428 . . . . 0.0 110.848 -179.812 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.702 HG21 ' CD1' ' A' ' 52' ' ' TRP . 20.3 t -140.43 142.89 30.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.679 179.53 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.466 ' CB ' ' HA ' ' A' ' 43' ' ' ALA . 1.9 pt-20 -148.77 137.43 21.3 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.875 0.369 . . . . 0.0 110.475 -179.759 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.706 HD21 ' HB3' ' A' ' 64' ' ' PHE . 3.9 mt -89.84 173.18 8.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.139 -179.424 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.449 ' HB2' ' CZ3' ' A' ' 41' ' ' TRP . 20.2 ttt180 -121.49 -63.3 1.33 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.477 179.261 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.448 ' O ' ' N ' ' A' ' 37' ' ' GLY . 14.0 mt-10 89.62 23.65 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 123.555 0.742 . . . . 0.0 109.961 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 58.49 -76.98 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.332 179.427 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.448 ' N ' ' O ' ' A' ' 35' ' ' GLU . . . -48.38 -65.24 2.66 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 111.119 -0.792 . . . . 0.0 111.119 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -49.34 101.3 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.808 0.337 . . . . 0.0 110.591 -179.844 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -59.79 -28.91 67.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.338 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -94.1 129.4 40.67 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.308 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.449 ' CZ3' ' HB2' ' A' ' 34' ' ' ARG . 80.6 m95 -66.39 141.28 58.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.591 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.587 HG23 ' O ' ' A' ' 42' ' ' VAL . 35.8 m -111.77 111.66 37.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.969 179.706 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.466 ' HA ' ' CB ' ' A' ' 32' ' ' GLU . . . -49.33 141.54 8.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.845 -179.601 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.53 -167.66 0.2 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.121 179.767 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 85.8 m -156.28 98.24 1.83 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.502 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.51 90.47 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.107 179.749 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -112.39 -17.89 7.92 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 111.384 -0.686 . . . . 0.0 111.384 -179.656 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.458 ' CB ' ' HB ' ' A' ' 51' ' ' VAL . 17.7 tp10 -77.78 -28.69 50.61 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.852 0.326 . . . . 0.0 110.719 -179.706 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 112.55 -39.74 2.76 Favored Glycine 0 CA--C 1.52 0.401 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 -179.395 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -137.14 16.16 3.68 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 178.693 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.84 HG13 ' O ' ' A' ' 19' ' ' VAL . 50.4 t -149.01 147.12 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' TRP . . . . . 0.702 ' CD1' HG21 ' A' ' 31' ' ' VAL . 2.0 m95 -89.87 111.78 22.93 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.282 -179.506 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.495 HG22 ' HB2' ' A' ' 18' ' ' ALA . 4.9 p -99.76 151.05 21.69 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.501 -179.67 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 57.0 t80 -139.33 151.24 46.22 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.138 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -106.88 129.88 54.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.714 -179.708 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 14.3 t -127.98 156.03 43.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.11 179.759 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -156.86 37.48 0.31 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.437 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -124.79 154.33 70.58 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.441 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -72.89 -41.43 1.43 Allowed 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.644 2.229 . . . . 0.0 111.926 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -71.54 77.14 0.8 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.49 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -116.35 89.39 3.1 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.492 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -98.76 -131.79 7.4 Favored Glycine 0 CA--C 1.527 0.79 0 N-CA-C 110.438 -1.065 . . . . 0.0 110.438 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -75.03 145.69 31.65 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.375 2.05 . . . . 0.0 111.767 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.706 ' HB3' HD21 ' A' ' 33' ' ' LEU . 56.1 m-85 -97.11 100.71 12.19 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.933 0.396 . . . . 0.0 110.345 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.429 ' OD1' ' N ' ' A' ' 65' ' ' ASN . 0.3 OUTLIER -78.27 141.33 38.6 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.949 -0.568 . . . . 0.0 109.781 179.952 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.496 ' CE1' ' HG ' ' A' ' 33' ' ' LEU . 92.7 m-85 -128.71 -177.45 4.2 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.046 0.451 . . . . 0.0 110.532 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.411 ' HG2' ' CE3' ' A' ' 41' ' ' TRP . 0.0 OUTLIER 178.35 52.22 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.691 179.845 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.509 ' HB3' HG22 ' A' ' 31' ' ' VAL . 0.9 OUTLIER -49.98 169.23 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.727 -179.671 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.831 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 1.1 mt -123.95 72.87 1.18 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.213 179.613 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.517 HG21 ' HB3' ' A' ' 26' ' ' ASP . 71.6 p -35.17 137.59 0.15 Allowed 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.783 -179.201 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.746 ' HG2' ' HB2' ' A' ' 29' ' ' ALA . 4.8 mm-40 -45.83 -55.1 7.05 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.951 -179.558 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 41.4 tptt -138.85 77.83 1.64 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.528 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -163.42 -91.13 0.08 OUTLIER Glycine 0 CA--C 1.523 0.583 0 N-CA-C 110.57 -1.012 . . . . 0.0 110.57 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER 176.76 172.69 0.44 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.892 0.377 . . . . 0.0 110.459 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.45 145.09 35.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.216 179.848 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -138.75 140.72 38.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.568 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 95.5 t -85.54 152.82 3.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.334 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.751 ' CE1' HG11 ' A' ' 4' ' ' VAL . 32.6 m-85 -138.46 120.78 15.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.227 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 30.8 p-10 -117.26 48.37 1.35 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.676 -179.443 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 167.34 65.96 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.617 HG22 ' HD3' ' A' ' 94' ' ' PRO . 70.3 t -111.68 -10.07 11.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.564 -178.727 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.433 HG23 ' C ' ' A' ' 81' ' ' VAL . 86.9 t -156.04 131.7 5.58 Favored Pre-proline 0 C--N 1.331 -0.197 0 CA-C-O 120.648 0.261 . . . . 0.0 110.765 179.511 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.51 ' HD3' ' CD1' ' A' ' 92' ' ' TYR . 47.5 Cg_endo -68.74 -165.65 0.14 Allowed 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.807 2.338 . . . . 0.0 111.875 179.461 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -77.22 -38.09 52.0 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.15 -0.477 . . . . 0.0 109.852 179.469 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 1.1 mttt -123.31 74.92 1.27 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.959 179.647 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.413 ' HB2' HG21 ' A' ' 8' ' ' VAL . 24.5 p90 -47.38 171.02 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.954 -179.588 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -149.4 109.75 4.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.147 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.687 HG23 ' O ' ' A' ' 8' ' ' VAL . 2.9 mp -52.69 122.11 2.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.526 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 102.29 42.67 2.16 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 110.936 -0.866 . . . . 0.0 110.936 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -160.07 129.64 5.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.85 0.357 . . . . 0.0 110.57 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.467 HG23 ' O ' ' A' ' 6' ' ' PHE . 15.1 m -81.4 128.36 33.77 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.136 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.51 ' CD1' ' HD3' ' A' ' 83' ' ' PRO . 63.3 m-85 -111.97 -93.09 0.46 Allowed 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.876 -179.58 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.627 ' HB1' ' HD2' ' A' ' 94' ' ' PRO . . . 53.26 172.35 0.04 OUTLIER Pre-proline 0 N--CA 1.462 0.157 0 CA-C-O 120.852 0.358 . . . . 0.0 110.419 -179.661 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.627 ' HD2' ' HB1' ' A' ' 93' ' ' ALA . 47.8 Cg_endo . . . . . 0 C--O 1.249 1.055 0 C-N-CA 122.783 2.322 . . . . 0.0 112.127 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.431 HG23 ' HD2' ' A' ' 2' ' ' PRO . 11.9 p . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.431 ' HD2' HG23 ' A' ' 1' ' ' VAL . 49.7 Cg_endo -76.12 163.08 33.42 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.468 2.112 . . . . 0.0 111.901 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.33 94.03 3.37 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.239 -179.864 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.641 ' O ' HG23 ' A' ' 5' ' ' THR . 35.9 m -85.43 -175.56 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.547 -179.799 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.641 HG23 ' O ' ' A' ' 4' ' ' VAL . 0.7 OUTLIER -166.52 151.25 7.73 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.175 179.749 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.571 ' H ' ' HB3' ' A' ' 93' ' ' ALA . 51.4 m-85 -119.51 165.59 14.2 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.352 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.404 HG23 ' HA ' ' A' ' 91' ' ' THR . 1.2 m -159.35 119.38 3.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.402 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.464 HG12 HD13 ' A' ' 88' ' ' ILE . 55.6 t -63.85 104.78 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.349 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.88 ' HG3' HG11 ' A' ' 51' ' ' VAL . 3.5 mm-40 -74.52 156.95 36.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.452 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 8.5 mttt -52.06 163.83 0.33 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.313 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 82.99 27.46 40.95 Favored Glycine 0 CA--C 1.523 0.54 0 N-CA-C 110.684 -0.966 . . . . 0.0 110.684 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.834 ' CB ' HD11 ' A' ' 88' ' ' ILE . 86.3 p -81.16 114.3 19.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.776 0.322 . . . . 0.0 110.346 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 47.2 m-80 -107.86 179.97 4.07 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.321 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -67.92 -29.82 68.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.41 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 10.4 mmmm -98.35 -44.65 6.45 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.478 -179.792 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 18.0 m80 -80.4 162.11 24.63 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.743 -179.667 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.496 ' HG ' ' CE2' ' A' ' 64' ' ' PHE . 2.3 tm? -155.95 77.32 0.95 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.754 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.428 ' HB2' ' CG2' ' A' ' 53' ' ' THR . . . -69.52 140.31 53.91 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.84 -179.427 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.4 ' O ' ' HB ' ' A' ' 51' ' ' VAL . 24.6 m -127.85 -178.2 2.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.793 -0.639 . . . . 0.0 109.682 179.544 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.0 tt -134.95 80.42 1.84 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.833 0.349 . . . . 0.0 110.362 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.9 t -90.13 96.21 6.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.33 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 39.5 mttt -148.86 145.79 27.65 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.397 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 2.2 p90 179.0 159.89 0.64 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.272 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -58.91 -175.92 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.425 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 72.53 -90.31 0.54 Allowed Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.66 -0.976 . . . . 0.0 110.66 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.737 ' OD2' HG21 ' A' ' 70' ' ' THR . 12.0 m-20 -68.1 168.1 12.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.733 0.302 . . . . 0.0 110.348 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.663 HG22 ' O ' ' A' ' 27' ' ' THR . 36.7 m -134.68 35.65 3.14 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.925 0.393 . . . . 0.0 110.647 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.423 ' O ' ' CG ' ' A' ' 71' ' ' GLU . 0.0 OUTLIER 61.4 120.85 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.829 179.639 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.82 ' HB3' ' O ' ' A' ' 69' ' ' LEU . . . -126.26 -51.73 1.52 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.09 179.531 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -157.59 169.26 25.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.868 -0.606 . . . . 0.0 109.737 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.466 HG21 ' CD1' ' A' ' 52' ' ' TRP . 3.2 t -150.6 139.57 15.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.179 0.514 . . . . 0.0 110.775 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.412 ' HG3' ' O ' ' A' ' 42' ' ' VAL . 2.5 tt0 -132.73 144.87 50.57 Favored 'General case' 0 N--CA 1.436 -1.126 0 CA-C-N 115.408 -0.814 . . . . 0.0 109.613 -179.217 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.648 HD21 ' CZ ' ' A' ' 66' ' ' PHE . 2.4 mt -121.59 175.22 6.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.398 0.618 . . . . 0.0 111.429 -179.32 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.475 ' HB2' ' CE3' ' A' ' 41' ' ' TRP . 27.5 ttt180 -167.16 162.77 15.39 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.03 -0.986 . . . . 0.0 109.149 179.581 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.443 ' N ' ' HG2' ' A' ' 34' ' ' ARG . 40.8 mt-10 -120.31 -85.1 0.66 Allowed 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 179.869 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.403 ' HB2' ' O ' ' A' ' 35' ' ' GLU . 3.3 t60 179.8 -56.43 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.307 179.374 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -106.06 56.54 0.51 Allowed Glycine 0 CA--C 1.523 0.566 0 N-CA-C 110.616 -0.994 . . . . 0.0 110.616 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 23.1 t -130.76 -160.71 1.06 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.847 0.356 . . . . 0.0 110.386 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -87.23 52.4 2.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.298 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 66.83 -174.63 0.19 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.246 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.476 ' CE3' ' HG2' ' A' ' 67' ' ' ARG . 88.3 m95 -47.97 142.45 5.01 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.722 -179.873 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.598 HG22 ' O ' ' A' ' 33' ' ' LEU . 16.8 m -107.07 -142.3 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 179.491 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.576 ' N ' HG23 ' A' ' 42' ' ' VAL . . . -156.27 130.64 8.78 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.51 -179.77 1.14 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.724 0.297 . . . . 0.0 110.532 -179.818 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 89.8 m -151.43 123.36 8.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.505 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.499 ' HB3' ' CZ3' ' A' ' 52' ' ' TRP . 0.0 OUTLIER -83.62 97.41 9.05 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.363 179.919 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -148.1 23.8 1.42 Allowed Glycine 0 CA--C 1.524 0.601 0 N-CA-C 111.095 -0.802 . . . . 0.0 111.095 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -100.6 -31.59 11.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.8 0.334 . . . . 0.0 110.225 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 96.18 27.9 9.69 Favored Glycine 0 CA--C 1.522 0.525 0 N-CA-C 110.801 -0.92 . . . . 0.0 110.801 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 166.6 -34.47 0.23 Allowed Glycine 0 CA--C 1.523 0.59 0 N-CA-C 110.811 -0.916 . . . . 0.0 110.811 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.88 HG11 ' HG3' ' A' ' 9' ' ' GLU . 4.8 m -126.33 -178.38 2.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.875 0.369 . . . . 0.0 110.508 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' TRP . . . . . 0.499 ' CZ3' ' HB3' ' A' ' 46' ' ' LYS . 7.5 m95 -110.6 142.68 42.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.346 -179.82 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.428 ' CG2' ' HB2' ' A' ' 18' ' ' ALA . 0.8 OUTLIER -134.15 152.05 51.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.314 179.987 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.435 ' CZ ' HG21 ' A' ' 42' ' ' VAL . 87.8 t80 -147.31 147.66 30.59 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.43 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -93.87 120.57 34.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.374 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -142.78 175.58 9.71 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.371 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -131.69 -64.66 0.78 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.011 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 48.58 104.34 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 115.982 -0.553 . . . . 0.0 111.458 179.306 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -64.0 -16.71 56.47 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.345 2.03 . . . . 0.0 111.34 178.38 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 7.1 mp -75.22 -171.31 1.38 Allowed 'General case' 0 C--O 1.232 0.142 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.99 179.509 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 4.9 mp0 -60.43 -79.02 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 179.679 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.493 ' N ' ' HD3' ' A' ' 63' ' ' PRO . . . -175.5 58.63 0.11 Allowed Glycine 0 CA--C 1.527 0.798 0 N-CA-C 111.276 -0.73 . . . . 0.0 111.276 179.425 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.493 ' HD3' ' N ' ' A' ' 62' ' ' GLY . 51.7 Cg_endo -88.23 108.05 0.56 Allowed 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.798 2.332 . . . . 0.0 111.984 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.496 ' CE2' ' HG ' ' A' ' 17' ' ' LEU . 53.5 m-85 -109.73 166.63 10.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.133 0.492 . . . . 0.0 110.704 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -150.48 129.18 12.35 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.559 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.648 ' CZ ' HD21 ' A' ' 33' ' ' LEU . 33.3 m-85 -115.41 174.87 5.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.104 0.478 . . . . 0.0 111.097 -179.323 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.476 ' HG2' ' CE3' ' A' ' 41' ' ' TRP . 0.0 OUTLIER -175.24 50.34 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.704 179.849 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.57 ' O ' HD23 ' A' ' 69' ' ' LEU . 0.2 OUTLIER -56.44 172.79 0.21 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.108 -179.286 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.82 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 7.0 mt -124.86 73.54 1.29 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.282 179.627 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.737 HG21 ' OD2' ' A' ' 26' ' ' ASP . 22.8 p -38.22 142.97 0.14 Allowed 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.803 -179.156 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.72 ' HG2' ' HB2' ' A' ' 29' ' ' ALA . 3.5 mm-40 -51.47 -43.84 62.25 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.302 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.32 -39.27 69.75 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.316 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 108.97 46.67 0.93 Allowed Glycine 0 CA--C 1.522 0.508 0 N-CA-C 110.574 -1.01 . . . . 0.0 110.574 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 42.3 mtt -136.5 79.43 1.76 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.823 0.344 . . . . 0.0 110.62 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.36 -178.82 7.2 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.191 179.722 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.449 ' O ' ' CE2' ' A' ' 78' ' ' PHE . 0.4 OUTLIER 174.62 140.0 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.472 179.893 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.448 HG13 ' CH2' ' A' ' 41' ' ' TRP . 88.9 t -81.08 144.52 10.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.322 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.601 ' CZ ' HG21 ' A' ' 4' ' ' VAL . 38.1 m-85 -127.77 126.02 40.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.177 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -93.87 139.77 30.49 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.644 -179.655 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.457 ' O ' ' HB ' ' A' ' 81' ' ' VAL . 0.1 OUTLIER 69.19 -77.05 0.05 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.593 179.756 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.457 ' HB ' ' O ' ' A' ' 80' ' ' ASP . 53.5 t 70.68 -54.47 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 C-N-CA 123.682 0.793 . . . . 0.0 110.653 -179.575 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.605 HG13 ' HD2' ' A' ' 83' ' ' PRO . 93.8 t -105.69 140.78 21.53 Favored Pre-proline 0 C--N 1.325 -0.484 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 179.639 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.605 ' HD2' HG13 ' A' ' 82' ' ' VAL . 45.1 Cg_endo -71.27 -169.68 0.43 Allowed 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.579 2.186 . . . . 0.0 112.107 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -72.07 -64.42 0.94 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.237 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 14.4 mmtp -108.03 82.98 1.72 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.099 179.769 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.493 ' HB2' ' CE2' ' A' ' 92' ' ' TYR . 26.5 p90 -71.87 171.28 12.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.58 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 4.5 m -151.52 128.66 11.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.089 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.834 HD11 ' CB ' ' A' ' 12' ' ' SER . 36.3 mm -50.86 96.41 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.449 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 132.23 48.98 0.1 Allowed Glycine 0 CA--C 1.524 0.598 0 N-CA-C 110.844 -0.902 . . . . 0.0 110.844 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.675 ' HB3' ' CZ ' ' A' ' 92' ' ' TYR . . . -155.72 135.62 12.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.813 0.34 . . . . 0.0 110.362 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.404 ' HA ' HG23 ' A' ' 7' ' ' THR . 28.7 m -93.42 91.24 7.07 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.418 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.675 ' CZ ' ' HB3' ' A' ' 90' ' ' ALA . 30.4 m-85 -82.77 -161.27 0.47 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.202 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.93 ' HB1' ' HD2' ' A' ' 94' ' ' PRO . . . 74.63 177.84 0.06 OUTLIER Pre-proline 0 C--N 1.331 -0.208 0 CA-C-O 120.798 0.333 . . . . 0.0 110.635 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.93 ' HD2' ' HB1' ' A' ' 93' ' ' ALA . 48.5 Cg_endo . . . . . 0 C--O 1.248 0.996 0 C-N-CA 122.648 2.232 . . . . 0.0 112.037 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.629 ' O ' HG13 ' A' ' 1' ' ' VAL . 7.5 p . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 110.177 -0.305 . . . . 0.0 110.177 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -82.45 155.78 16.43 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.708 2.272 . . . . 0.0 112.12 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 19.2 mttt -102.15 31.27 4.03 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.251 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.74 HG11 ' CE1' ' A' ' 78' ' ' PHE . 1.7 p 177.94 164.06 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.174 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.48 ' N ' HG22 ' A' ' 4' ' ' VAL . 1.1 p -157.79 128.36 6.38 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.457 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.656 ' HD1' ' HB2' ' A' ' 93' ' ' ALA . 10.3 m-85 -102.72 177.84 4.74 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.122 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.419 ' O ' ' N ' ' A' ' 9' ' ' GLU . 0.3 OUTLIER -166.13 112.43 0.87 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.361 -179.851 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.672 ' O ' HG23 ' A' ' 88' ' ' ILE . 14.0 t -57.61 85.52 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.397 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.51 ' HB2' HG11 ' A' ' 51' ' ' VAL . 3.6 mm-40 -60.55 161.19 7.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.348 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -56.28 177.59 0.06 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.494 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 77.5 13.24 83.74 Favored Glycine 0 CA--C 1.527 0.805 0 N-CA-C 111.455 -0.658 . . . . 0.0 111.455 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 19.1 m -86.91 109.35 19.27 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.909 0.354 . . . . 0.0 110.051 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.427 ' O ' ' N ' ' A' ' 15' ' ' LYS . 4.6 p-10 -153.28 158.95 42.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.916 0.388 . . . . 0.0 110.806 -179.622 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 54.25 -85.96 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.835 179.707 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.427 ' N ' ' O ' ' A' ' 13' ' ' ASN . 0.0 OUTLIER -142.49 22.91 1.99 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.622 0.249 . . . . 0.0 110.745 -179.882 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -98.06 120.09 37.85 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 179.743 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.429 ' HG ' ' CE2' ' A' ' 64' ' ' PHE . 0.2 OUTLIER -113.3 98.42 7.1 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.054 0.455 . . . . 0.0 110.772 -179.499 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.885 ' HB1' HG11 ' A' ' 51' ' ' VAL . . . -86.76 138.83 31.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.027 179.572 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.473 ' N ' HG13 ' A' ' 51' ' ' VAL . 26.9 m -141.93 139.8 30.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.869 0.366 . . . . 0.0 110.816 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.426 ' HB2' ' CG ' ' A' ' 9' ' ' GLU . 0.5 OUTLIER -99.41 34.85 2.08 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.517 179.937 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.558 HG13 ' HE1' ' A' ' 52' ' ' TRP . 7.2 p -57.02 109.74 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 120.854 0.359 . . . . 0.0 110.521 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -179.59 77.68 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.243 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.501 ' CE2' ' HB ' ' A' ' 4' ' ' VAL . 25.7 p90 -84.63 -179.89 7.23 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.562 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -47.68 -68.28 0.2 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.874 -179.726 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -56.3 -20.26 28.44 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 111.207 -0.757 . . . . 0.0 111.207 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.48 ' HB2' ' CZ ' ' A' ' 23' ' ' TYR . 5.4 t70 -90.07 137.92 31.94 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.763 0.316 . . . . 0.0 110.594 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.674 HG22 ' O ' ' A' ' 27' ' ' THR . 88.5 m -124.63 11.08 8.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.104 179.694 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.413 ' O ' ' CG ' ' A' ' 71' ' ' GLU . 28.6 mtm 58.03 112.63 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.815 0.341 . . . . 0.0 110.625 179.654 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.681 ' HB3' ' O ' ' A' ' 69' ' ' LEU . . . -131.92 -49.06 0.95 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.584 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.871 ' HB3' HD12 ' A' ' 69' ' ' LEU . 27.5 tt0 -176.02 83.56 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.81 0.338 . . . . 0.0 110.907 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.742 HG21 ' CD1' ' A' ' 52' ' ' TRP . 18.5 t -68.45 155.0 7.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.15 179.589 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.725 ' OE2' HD21 ' A' ' 69' ' ' LEU . 4.5 pt-20 -147.14 142.09 26.96 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.839 0.352 . . . . 0.0 110.639 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.43 ' HG ' ' CE1' ' A' ' 66' ' ' PHE . 4.2 mt -103.49 -178.41 3.65 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.445 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.492 ' HB2' ' CZ3' ' A' ' 41' ' ' TRP . 6.4 ttt180 -132.85 -64.95 0.73 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.591 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.446 ' CB ' ' O ' ' A' ' 34' ' ' ARG . 23.3 mt-10 92.5 33.65 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.669 0.788 . . . . 0.0 109.187 -179.195 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 3.0 t-80 67.54 -68.81 0.15 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.487 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -157.34 57.87 0.36 Allowed Glycine 0 CA--C 1.523 0.578 0 N-CA-C 110.595 -1.002 . . . . 0.0 110.595 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.43 ' CB ' ' HB2' ' A' ' 35' ' ' GLU . 34.1 t -92.47 -46.17 7.78 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.77 0.319 . . . . 0.0 110.335 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 47.6 p-10 -177.51 52.65 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.537 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 62.51 -177.32 0.14 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.47 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.762 ' HH2' HG23 ' A' ' 77' ' ' VAL . 93.7 m95 -60.27 129.88 43.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.533 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.605 HG21 ' CZ ' ' A' ' 54' ' ' PHE . 25.1 m -122.76 116.44 48.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.125 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.471 ' HA ' ' CB ' ' A' ' 32' ' ' GLU . . . -56.08 140.28 44.29 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.47 -179.779 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.56 -167.65 0.2 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.173 -0.467 . . . . 0.0 109.953 179.787 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 91.4 m -153.62 127.15 8.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.864 0.364 . . . . 0.0 110.654 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 11.8 ptpt -73.18 77.2 1.28 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.03 179.665 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -93.22 -25.79 18.08 Favored Glycine 0 CA--C 1.522 0.516 0 N-CA-C 111.169 -0.772 . . . . 0.0 111.169 -179.583 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.484 ' CB ' ' HB ' ' A' ' 51' ' ' VAL . 2.9 mm-40 -86.95 -18.93 29.58 Favored 'General case' 0 C--N 1.33 -0.249 0 O-C-N 122.759 -0.259 . . . . 0.0 111.284 -179.483 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 96.48 -42.34 2.24 Favored Glycine 0 CA--C 1.523 0.539 0 N-CA-C 110.333 -1.107 . . . . 0.0 110.333 -179.72 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.55 ' O ' HG23 ' A' ' 51' ' ' VAL . . . -132.73 23.36 3.98 Favored Glycine 0 CA--C 1.522 0.51 0 N-CA-C 109.806 -1.318 . . . . 0.0 109.806 179.161 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.885 HG11 ' HB1' ' A' ' 18' ' ' ALA . 42.0 t -159.0 145.57 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 -179.621 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' TRP . . . . . 0.742 ' CD1' HG21 ' A' ' 31' ' ' VAL . 1.7 m95 -94.02 117.47 30.15 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.966 0.412 . . . . 0.0 110.607 -179.027 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.4 ' HA ' ' O ' ' A' ' 17' ' ' LEU . 3.2 p -110.36 139.55 45.44 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.029 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.605 ' CZ ' HG21 ' A' ' 42' ' ' VAL . 58.1 t80 -117.69 142.24 47.47 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.867 0.365 . . . . 0.0 110.611 -179.762 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -103.68 104.86 14.95 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.183 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -84.57 143.94 28.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.532 -179.813 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -112.35 1.83 16.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.122 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -121.96 156.71 59.24 Favored Pre-proline 0 C--O 1.231 0.099 0 CA-C-O 120.668 0.271 . . . . 0.0 110.361 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -70.85 -29.85 18.09 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.691 2.261 . . . . 0.0 112.18 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -81.73 134.1 35.41 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.42 -179.838 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -174.05 40.39 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.325 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -58.19 -93.07 0.01 OUTLIER Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.849 -0.9 . . . . 0.0 110.849 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -79.74 136.63 12.2 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.584 2.189 . . . . 0.0 112.053 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.429 ' CE2' ' HG ' ' A' ' 17' ' ' LEU . 49.8 m-85 -107.73 149.46 28.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.638 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -125.81 116.32 21.39 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 179.013 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.43 ' CE1' ' HG ' ' A' ' 33' ' ' LEU . 29.6 m-85 -100.65 171.11 7.91 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.29 0.566 . . . . 0.0 111.608 -178.706 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.522 ' HG3' ' CH2' ' A' ' 41' ' ' TRP . 0.0 OUTLIER -162.65 83.27 0.53 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.978 179.24 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.724 ' O ' HD23 ' A' ' 69' ' ' LEU . 5.2 p90 -70.87 167.59 18.64 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.432 0.634 . . . . 0.0 111.045 -179.5 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.871 HD12 ' HB3' ' A' ' 30' ' ' GLU . 4.2 mt -138.82 55.69 1.72 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.966 -1.015 . . . . 0.0 108.756 179.378 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.405 HG22 ' HA ' ' A' ' 26' ' ' ASP . 17.0 p -23.59 134.96 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.907 0.883 . . . . 0.0 112.732 -178.823 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.655 ' HG2' ' HB2' ' A' ' 29' ' ' ALA . 3.0 mt-10 -48.76 -26.24 2.25 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.691 -179.656 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -158.22 63.46 0.45 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.31 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -151.59 -103.95 0.26 Allowed Glycine 0 CA--C 1.523 0.576 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -169.31 -174.94 2.09 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.982 0.42 . . . . 0.0 110.561 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -123.9 172.36 8.97 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.219 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 175.73 140.35 0.06 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.931 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.762 HG23 ' HH2' ' A' ' 41' ' ' TRP . 2.5 p -79.49 145.56 9.17 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.209 0 CA-C-O 121.26 0.552 . . . . 0.0 110.037 179.561 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.74 ' CE1' HG11 ' A' ' 4' ' ' VAL . 98.3 m-85 -126.14 143.86 50.97 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.033 -179.409 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 30.1 t0 -121.69 155.85 34.31 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.901 0.381 . . . . 0.0 110.803 -179.623 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 4.3 t0 48.77 51.24 16.13 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.654 179.783 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.504 HG13 ' HA ' ' A' ' 93' ' ' ALA . 72.5 t -87.88 -16.49 8.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.627 179.782 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.53 HG13 ' HB3' ' A' ' 86' ' ' TYR . 59.4 t -148.57 133.35 9.06 Favored Pre-proline 0 C--N 1.332 -0.157 0 N-CA-C 110.433 -0.21 . . . . 0.0 110.433 179.667 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -68.53 -165.73 0.13 Allowed 'Trans proline' 0 N--CA 1.475 0.383 0 C-N-CA 122.695 2.263 . . . . 0.0 111.986 179.483 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -80.32 -37.84 31.79 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.282 -0.417 . . . . 0.0 109.957 179.5 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.98 67.02 1.11 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.218 179.797 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.53 ' HB3' HG13 ' A' ' 82' ' ' VAL . 33.6 p90 -55.58 163.88 1.2 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.644 -179.772 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 7.1 m -133.38 113.0 12.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.241 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.672 HG23 ' O ' ' A' ' 8' ' ' VAL . 2.7 mp -50.67 116.16 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.501 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 115.32 44.26 0.67 Allowed Glycine 0 CA--C 1.524 0.595 0 N-CA-C 110.677 -0.969 . . . . 0.0 110.677 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -163.24 141.18 7.87 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.816 0.341 . . . . 0.0 110.527 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.505 HG23 ' O ' ' A' ' 6' ' ' PHE . 17.2 m -90.5 112.13 23.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.19 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.426 ' CB ' ' O ' ' A' ' 81' ' ' VAL . 74.2 m-85 -94.39 -99.03 0.15 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.53 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.932 ' HB1' ' HD2' ' A' ' 94' ' ' PRO . . . 50.48 179.13 0.02 OUTLIER Pre-proline 0 C--O 1.231 0.096 0 CA-C-O 120.704 0.288 . . . . 0.0 110.558 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.932 ' HD2' ' HB1' ' A' ' 93' ' ' ALA . 48.0 Cg_endo . . . . . 0 C--O 1.25 1.075 0 C-N-CA 122.464 2.109 . . . . 0.0 112.044 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 19.9 t . . . . . 0 N--CA 1.49 1.535 0 N-CA-C 110.183 -0.303 . . . . 0.0 110.183 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -76.94 169.78 21.02 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.598 2.198 . . . . 0.0 112.062 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 3.8 mttt -174.7 109.55 0.12 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.362 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.604 HG11 ' CE1' ' A' ' 78' ' ' PHE . 1.8 p -135.58 163.57 34.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.361 0.601 . . . . 0.0 110.359 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.48 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 0.1 OUTLIER -142.74 139.91 31.26 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.253 179.579 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.501 ' CD2' HG22 ' A' ' 21' ' ' VAL . 20.9 m-85 -112.96 -175.01 2.57 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.325 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.477 HG22 ' H ' ' A' ' 8' ' ' VAL . 0.2 OUTLIER -165.09 -167.0 1.1 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.145 -0.48 . . . . 0.0 109.945 179.803 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.479 HG12 ' CD1' ' A' ' 88' ' ' ILE . 9.3 t -139.37 82.42 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.147 179.772 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.841 ' HG3' HG11 ' A' ' 51' ' ' VAL . 65.7 mm-40 -50.9 155.1 1.26 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.457 -179.771 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 6.8 mtpt -53.49 175.33 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.379 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 64.18 46.81 90.0 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 110.585 -1.006 . . . . 0.0 110.585 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 61.6 m -102.69 108.66 19.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.796 0.331 . . . . 0.0 110.383 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 55.9 m-80 -101.66 174.46 5.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.255 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -55.56 -34.93 65.19 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.599 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.0 -52.71 4.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.319 -179.645 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 27.1 m80 -73.46 136.92 44.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.002 -179.434 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.484 HD22 ' HA ' ' A' ' 17' ' ' LEU . 0.8 OUTLIER -137.36 84.16 2.04 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.521 179.309 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.703 ' HB2' ' CG2' ' A' ' 53' ' ' THR . . . -74.95 116.91 16.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.896 -179.229 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.4 m -109.8 137.36 42.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.011 179.471 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.488 HD12 ' OE2' ' A' ' 9' ' ' GLU . 1.1 tt -84.78 70.53 10.84 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.521 -179.833 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.501 HG22 ' CD2' ' A' ' 6' ' ' PHE . 3.2 t -85.6 98.61 6.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.131 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.9 ttpm? -167.14 147.56 5.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.484 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -161.78 157.62 24.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.299 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.91 -21.58 66.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.716 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -46.17 -91.0 0.01 OUTLIER Glycine 0 CA--C 1.526 0.722 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -90.83 -160.74 0.74 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.729 0.3 . . . . 0.0 110.428 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.675 HG22 ' O ' ' A' ' 27' ' ' THR . 32.5 m -123.67 24.35 8.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.038 -179.737 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.426 ' O ' ' CG ' ' A' ' 71' ' ' GLU . 8.4 mtm 60.61 125.28 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.013 179.402 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.874 ' HB3' ' O ' ' A' ' 69' ' ' LEU . . . -122.06 -61.79 1.45 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.259 179.736 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.414 ' C ' HG12 ' A' ' 31' ' ' VAL . 0.5 OUTLIER -147.31 171.44 15.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.1 179.943 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.441 ' HA ' ' HA ' ' A' ' 68' ' ' PHE . 1.1 p 175.84 151.01 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.28 0.562 . . . . 0.0 110.519 -179.822 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.457 ' HG3' ' HB3' ' A' ' 41' ' ' TRP . 1.1 pm0 -140.23 171.36 14.27 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.97 -179.564 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.699 HD13 ' CZ ' ' A' ' 66' ' ' PHE . 12.0 tp -126.41 154.85 43.05 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-O 120.987 0.423 . . . . 0.0 110.088 -179.036 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.631 ' H ' HD12 ' A' ' 33' ' ' LEU . 0.6 OUTLIER -145.47 173.24 12.19 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.892 -0.594 . . . . 0.0 109.534 179.371 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 17.3 mp0 -133.22 -89.62 0.4 Allowed 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 110.346 -0.242 . . . . 0.0 110.346 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 20.3 p80 -177.35 146.21 0.47 Allowed 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 120.77 0.319 . . . . 0.0 110.514 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 60.92 38.76 95.95 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.844 -0.902 . . . . 0.0 110.844 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.1 t -118.38 173.98 6.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.862 0.363 . . . . 0.0 110.423 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -63.79 -70.58 0.21 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.511 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -153.68 173.73 15.42 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.031 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.488 ' CE3' ' HB2' ' A' ' 34' ' ' ARG . 75.2 m95 -52.71 151.21 4.55 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.189 179.769 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.429 HG22 ' O ' ' A' ' 33' ' ' LEU . 9.7 m -122.83 118.77 56.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.397 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.42 ' HA ' ' HB3' ' A' ' 32' ' ' GLU . . . -50.53 134.85 23.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.624 -179.792 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.0 -168.62 0.14 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.217 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 30.0 m -147.4 105.87 3.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.356 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.88 87.84 0.37 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.209 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -133.88 21.82 3.91 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.985 -0.846 . . . . 0.0 110.985 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.468 ' CB ' HG23 ' A' ' 51' ' ' VAL . 0.1 OUTLIER -108.59 177.6 4.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.754 0.312 . . . . 0.0 110.292 179.953 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -62.44 -44.66 97.29 Favored Glycine 0 CA--C 1.523 0.545 0 N-CA-C 110.7 -0.96 . . . . 0.0 110.7 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -160.94 31.41 0.35 Allowed Glycine 0 CA--C 1.523 0.567 0 N-CA-C 110.717 -0.953 . . . . 0.0 110.717 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.841 HG11 ' HG3' ' A' ' 9' ' ' GLU . 5.2 m -145.77 -179.44 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.854 0.359 . . . . 0.0 110.468 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 9.4 m95 -106.12 140.41 39.14 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.514 -179.769 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.703 ' CG2' ' HB2' ' A' ' 18' ' ' ALA . 0.5 OUTLIER -138.27 153.26 49.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.233 179.886 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 36.0 t80 -159.28 141.52 13.7 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.631 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 20.9 p-10 -93.52 127.94 39.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.27 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 9.5 p -94.96 143.82 26.17 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.36 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 14.0 mp0 -104.27 25.85 9.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.402 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -133.38 156.97 79.21 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.282 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -95.2 32.92 0.17 Allowed 'Trans proline' 0 N--CA 1.451 -1.004 0 C-N-CA 123.924 3.082 . . . . 0.0 112.355 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.655 HD22 ' C ' ' A' ' 60' ' ' LEU . 0.0 OUTLIER -49.97 162.82 0.17 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.725 -179.903 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -153.76 27.35 0.49 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.347 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -120.9 -155.19 9.48 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.773 -0.931 . . . . 0.0 110.773 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.448 ' CB ' ' HA ' ' A' ' 80' ' ' ASP . 48.7 Cg_endo -79.89 163.84 23.1 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.622 2.215 . . . . 0.0 112.182 -179.829 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 50.2 m-85 -105.76 -175.21 2.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.236 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -150.67 141.18 22.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.97 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.699 ' CZ ' HD13 ' A' ' 33' ' ' LEU . 44.4 m-85 -137.93 178.85 6.81 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.038 0.446 . . . . 0.0 110.885 -179.629 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.44 ' HG2' ' CZ3' ' A' ' 41' ' ' TRP . 0.1 OUTLIER 176.23 84.15 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.51 -179.982 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.872 ' O ' HD23 ' A' ' 69' ' ' LEU . 5.0 p90 -72.56 -177.38 2.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.275 0.559 . . . . 0.0 110.995 -179.213 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.874 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 9.0 mt -140.18 72.39 1.39 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.125 179.678 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.484 HG23 ' CE1' ' A' ' 68' ' ' PHE . 76.6 p -30.88 140.3 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.403 0.681 . . . . 0.0 112.447 -178.898 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.676 ' HG2' ' HB2' ' A' ' 29' ' ' ALA . 3.3 mm-40 -55.88 -38.86 70.73 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.809 -179.634 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.56 53.72 1.42 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.745 -179.739 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.423 ' O ' ' CG ' ' A' ' 74' ' ' MET . . . -142.46 -109.39 0.73 Allowed Glycine 0 CA--C 1.523 0.551 0 N-CA-C 110.853 -0.899 . . . . 0.0 110.853 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.435 ' N ' ' OG1' ' A' ' 70' ' ' THR . 32.6 mtp -162.98 -178.68 6.23 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 110.206 -0.294 . . . . 0.0 110.206 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -94.01 -177.61 4.38 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.074 179.693 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 9.6 t30 176.88 155.74 0.26 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.392 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 71.2 t -111.21 147.15 15.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.948 179.758 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.604 ' CE1' HG11 ' A' ' 4' ' ' VAL . 38.0 m-85 -135.87 127.81 29.49 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.453 -179.77 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 39.8 p-10 -118.86 158.01 26.5 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.126 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.448 ' HA ' ' CB ' ' A' ' 63' ' ' PRO . 1.2 m-20 53.37 33.72 16.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.321 -179.791 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.428 ' HA ' ' HA ' ' A' ' 93' ' ' ALA . 69.9 t -61.56 -17.21 16.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.759 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.562 HG13 ' HD2' ' A' ' 83' ' ' PRO . 70.9 t -147.42 140.06 14.49 Favored Pre-proline 0 C--N 1.331 -0.204 0 CA-C-O 120.652 0.263 . . . . 0.0 110.356 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.562 ' HD2' HG13 ' A' ' 82' ' ' VAL . 44.6 Cg_endo -69.39 -165.95 0.16 Allowed 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.665 2.244 . . . . 0.0 112.003 179.798 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -74.31 -65.87 0.8 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.031 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.39 71.48 1.36 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.212 179.735 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.416 ' HB3' ' CG1' ' A' ' 82' ' ' VAL . 15.4 p90 -56.95 162.96 2.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.506 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 43.7 m -141.32 122.85 15.06 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.404 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.479 ' CD1' HG12 ' A' ' 8' ' ' VAL . 40.7 mm -51.54 116.95 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.342 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 113.11 30.21 2.79 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.664 -0.975 . . . . 0.0 110.664 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.54 ' HB3' ' CZ ' ' A' ' 92' ' ' TYR . . . -137.15 134.36 36.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.794 0.33 . . . . 0.0 110.18 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 21.6 m -91.34 105.68 17.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.9 -179.636 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.548 ' O ' ' HB3' ' A' ' 93' ' ' ALA . 39.2 m-85 -97.35 -155.77 0.51 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.0 -0.546 . . . . 0.0 109.642 179.525 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.899 ' HB1' ' HD2' ' A' ' 94' ' ' PRO . . . 73.91 175.76 0.07 OUTLIER Pre-proline 0 N--CA 1.464 0.232 0 CA-C-O 120.673 0.273 . . . . 0.0 110.779 179.762 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.899 ' HD2' ' HB1' ' A' ' 93' ' ' ALA . 46.9 Cg_endo . . . . . 0 C--O 1.249 1.033 0 C-N-CA 122.536 2.157 . . . . 0.0 112.02 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 28.2 t . . . . . 0 N--CA 1.49 1.57 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -78.78 162.71 26.76 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.618 2.212 . . . . 0.0 112.188 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 10.0 mtpt -151.85 104.41 3.01 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.187 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.626 HG11 ' CE1' ' A' ' 78' ' ' PHE . 2.1 p -96.65 162.95 2.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.27 0.557 . . . . 0.0 110.371 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.481 ' N ' HG22 ' A' ' 4' ' ' VAL . 1.2 p -145.16 132.91 21.06 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.463 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.541 ' O ' HG23 ' A' ' 91' ' ' THR . 6.5 m-85 -99.37 172.5 7.29 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.279 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.836 HG23 ' O ' ' A' ' 90' ' ' ALA . 16.7 m -166.14 96.56 0.6 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.182 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.49 HG12 ' CD1' ' A' ' 88' ' ' ILE . 21.8 t -50.77 111.64 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.581 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.463 ' O ' HD12 ' A' ' 88' ' ' ILE . 3.5 mt-10 -70.24 171.54 9.65 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.51 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.619 ' HA ' HG21 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -69.69 -8.83 51.17 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.191 -179.917 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -48.38 -26.55 5.07 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 111.086 -0.806 . . . . 0.0 111.086 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 28.5 p -52.87 126.66 20.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.725 0.298 . . . . 0.0 110.279 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -122.58 -57.61 1.73 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.496 -179.805 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -134.51 -78.21 0.46 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.354 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.22 -20.64 14.59 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.702 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -54.32 177.28 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.804 0.335 . . . . 0.0 110.285 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 25.4 tp -162.2 84.03 0.57 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.312 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.48 ' HB2' HG23 ' A' ' 53' ' ' THR . . . -72.83 162.46 29.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.232 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.668 HG11 ' CZ ' ' A' ' 66' ' ' PHE . 30.9 m -156.65 133.32 2.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.815 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.433 ' HA ' HG12 ' A' ' 51' ' ' VAL . 0.5 OUTLIER -94.62 64.41 3.01 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.169 179.539 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 28.9 t -56.48 111.78 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.593 -179.738 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.74 168.82 22.58 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.12 179.769 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.494 ' CE1' ' HB2' ' A' ' 26' ' ' ASP . 0.0 OUTLIER -150.55 -68.88 0.19 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.094 -179.95 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 52.0 tt0 -168.88 -61.42 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.515 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -152.18 58.9 0.42 Allowed Glycine 0 CA--C 1.524 0.654 0 N-CA-C 111.094 -0.802 . . . . 0.0 111.094 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.494 ' HB2' ' CE1' ' A' ' 23' ' ' TYR . 77.0 m-20 -108.71 178.81 4.37 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 179.531 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.401 ' HB ' ' HG3' ' A' ' 71' ' ' GLU . 0.2 OUTLIER -110.0 172.2 7.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.893 0.378 . . . . 0.0 110.492 -179.892 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 1.2 mtt -126.18 117.62 23.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.158 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.81 ' HB3' ' O ' ' A' ' 69' ' ' LEU . . . -116.88 -58.34 2.08 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.642 -179.765 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.42 ' O ' ' CB ' ' A' ' 68' ' ' PHE . 20.8 mm-40 -153.24 162.7 41.01 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.476 -179.843 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.532 HG21 ' CD1' ' A' ' 52' ' ' TRP . 2.5 t -151.96 142.78 15.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.276 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.439 ' CB ' ' HA ' ' A' ' 43' ' ' ALA . 11.9 pm0 -153.2 139.82 18.84 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.755 -179.603 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.734 HD21 ' CD2' ' A' ' 54' ' ' PHE . 0.5 OUTLIER -108.99 172.52 6.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.182 179.893 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.508 ' N ' HD12 ' A' ' 33' ' ' LEU . 0.1 OUTLIER -94.31 -67.58 0.85 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.634 -0.257 . . . . 0.0 110.698 -179.685 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.52 ' N ' HD12 ' A' ' 33' ' ' LEU . 2.0 tt0 88.91 74.5 0.01 OUTLIER 'General case' 0 CA--C 1.51 -0.571 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 -178.622 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -36.97 120.82 0.75 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 114.995 -1.002 . . . . 0.0 111.832 -178.216 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 128.17 -48.87 0.95 Allowed Glycine 0 CA--C 1.523 0.55 0 N-CA-C 110.446 -1.062 . . . . 0.0 110.446 -179.769 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.414 ' O ' ' CB ' ' A' ' 39' ' ' ASP . 40.6 t -75.03 -32.79 61.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.745 0.307 . . . . 0.0 110.494 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.414 ' CB ' ' O ' ' A' ' 38' ' ' SER . 8.2 t0 81.56 -53.17 0.27 Allowed 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.729 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -72.63 124.04 24.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.573 -179.751 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.49 ' CZ3' ' HB2' ' A' ' 67' ' ' ARG . 77.7 m95 -54.73 155.19 4.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.036 179.743 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.409 HG23 ' HG ' ' A' ' 33' ' ' LEU . 3.6 m -136.54 124.69 34.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.8 0.333 . . . . 0.0 110.422 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.439 ' HA ' ' CB ' ' A' ' 32' ' ' GLU . . . -57.19 138.56 54.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.243 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.77 -170.14 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.232 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 62.1 m -135.79 95.18 3.18 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.444 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.413 ' CG ' ' O ' ' A' ' 46' ' ' LYS . 14.6 ptmt -74.16 90.98 2.08 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.97 0.414 . . . . 0.0 110.402 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -156.83 25.34 0.5 Allowed Glycine 0 CA--C 1.523 0.581 0 N-CA-C 110.729 -0.948 . . . . 0.0 110.729 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.435 ' HG2' HG23 ' A' ' 51' ' ' VAL . 7.7 tp10 -106.75 165.91 10.97 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.765 0.317 . . . . 0.0 110.265 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -39.85 -49.7 3.34 Favored Glycine 0 CA--C 1.527 0.794 0 N-CA-C 111.784 -0.526 . . . . 0.0 111.784 -179.674 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -164.49 33.28 0.26 Allowed Glycine 0 CA--C 1.523 0.549 0 N-CA-C 111.001 -0.84 . . . . 0.0 111.001 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.437 HG11 ' HG3' ' A' ' 9' ' ' GLU . 4.3 m -148.79 -178.57 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.916 0.389 . . . . 0.0 110.498 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' TRP . . . . . 0.532 ' CD1' HG21 ' A' ' 31' ' ' VAL . 6.5 m95 -108.42 119.1 38.52 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.215 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.48 HG23 ' HB2' ' A' ' 18' ' ' ALA . 0.0 OUTLIER -106.46 -179.46 3.95 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.613 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.734 ' CD2' HD21 ' A' ' 33' ' ' LEU . 16.4 t80 -177.46 124.37 0.13 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.929 0.395 . . . . 0.0 110.626 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -86.06 154.17 21.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.143 179.746 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 52.5 p -128.51 126.02 39.56 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.463 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -86.76 -37.43 17.88 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.216 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -63.48 139.04 97.53 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.259 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -72.92 -15.46 26.33 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.574 2.183 . . . . 0.0 112.366 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -50.79 128.11 20.04 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.856 0.36 . . . . 0.0 110.522 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -113.78 61.46 0.66 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.263 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -107.47 -165.22 21.85 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.688 -0.965 . . . . 0.0 110.688 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.409 ' C ' ' CD1' ' A' ' 64' ' ' PHE . 45.7 Cg_endo -74.28 -172.06 1.07 Allowed 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.46 2.107 . . . . 0.0 112.036 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.469 ' HB3' HD13 ' A' ' 33' ' ' LEU . 57.6 m-85 -152.88 106.35 3.04 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.641 -179.796 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 29.3 m-80 -74.83 119.77 19.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.269 -0.423 . . . . 0.0 109.919 179.571 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.668 ' CZ ' HG11 ' A' ' 19' ' ' VAL . 8.6 m-85 -87.79 167.87 13.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.816 -179.555 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.706 ' HD2' HG22 ' A' ' 77' ' ' VAL . 3.3 mtp180 -172.68 116.71 0.32 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.581 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.626 ' O ' HD23 ' A' ' 69' ' ' LEU . 0.1 OUTLIER -123.39 170.24 10.54 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.017 0.437 . . . . 0.0 110.538 179.785 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.81 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 7.2 mt -125.88 68.21 1.18 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.341 179.534 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 71.4 p -33.69 138.47 0.08 Allowed 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.875 -179.181 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.691 ' HG2' ' HB2' ' A' ' 29' ' ' ALA . 1.1 mt-10 -54.1 -26.18 25.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.356 -179.697 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.5 tmtt? -67.12 -52.34 42.91 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.283 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 120.24 58.75 0.24 Allowed Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.792 -0.923 . . . . 0.0 110.792 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 1.2 mmt -131.92 70.79 1.46 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.776 0.322 . . . . 0.0 110.38 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.503 ' HD2' HD22 ' A' ' 69' ' ' LEU . 0.0 OUTLIER -60.75 155.15 19.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.383 179.99 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 177.8 152.25 0.26 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.563 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.706 HG22 ' HD2' ' A' ' 67' ' ' ARG . 92.6 t -104.86 151.8 7.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.158 179.824 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.626 ' CE1' HG11 ' A' ' 4' ' ' VAL . 55.2 m-85 -127.38 147.57 50.27 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.759 -179.343 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 14.4 t0 -134.61 161.76 34.21 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.248 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 54.65 44.77 28.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.238 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.59 ' O ' HG12 ' A' ' 81' ' ' VAL . 60.0 t -93.34 3.09 8.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.238 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.519 HG23 ' O ' ' A' ' 81' ' ' VAL . 66.1 t -159.24 110.66 1.54 Allowed Pre-proline 0 CA--C 1.532 0.257 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 179.603 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.43 ' O ' ' N ' ' A' ' 85' ' ' LYS . 47.9 Cg_endo -75.58 62.09 6.25 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.524 2.149 . . . . 0.0 112.41 -179.741 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 53.86 -87.52 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.551 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.43 ' N ' ' O ' ' A' ' 83' ' ' PRO . 0.0 OUTLIER -87.91 56.61 3.95 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 120.934 0.397 . . . . 0.0 109.946 179.74 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.484 ' HB3' HG13 ' A' ' 82' ' ' VAL . 48.6 p90 -48.23 175.95 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.854 -179.744 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -144.24 134.15 23.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.113 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.619 HG21 ' HA ' ' A' ' 10' ' ' LYS . 36.5 mm -65.21 118.44 7.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.468 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 114.03 35.22 1.53 Allowed Glycine 0 CA--C 1.523 0.577 0 N-CA-C 110.602 -0.999 . . . . 0.0 110.602 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.836 ' O ' HG23 ' A' ' 7' ' ' THR . . . -138.64 175.53 9.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.768 0.318 . . . . 0.0 110.383 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.541 HG23 ' O ' ' A' ' 6' ' ' PHE . 18.5 m -126.52 101.23 6.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.3 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.551 ' CZ ' ' HB3' ' A' ' 90' ' ' ALA . 19.5 m-85 -107.22 132.35 53.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.294 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.895 ' HB1' ' HD2' ' A' ' 94' ' ' PRO . . . 173.83 178.25 0.16 Allowed Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.397 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.895 ' HD2' ' HB1' ' A' ' 93' ' ' ALA . 49.0 Cg_endo . . . . . 0 C--O 1.248 1.019 0 C-N-CA 122.489 2.126 . . . . 0.0 112.095 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 51.0 t . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -74.58 137.18 22.38 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.622 2.215 . . . . 0.0 112.042 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 27.5 mtpt -151.23 97.41 2.42 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.578 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.798 HG12 ' CE1' ' A' ' 23' ' ' TYR . 29.5 m -122.22 -176.73 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.21 179.695 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.431 HG23 ' O ' ' A' ' 4' ' ' VAL . 0.3 OUTLIER -161.08 137.38 8.38 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.399 179.838 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.56 ' H ' ' HB3' ' A' ' 93' ' ' ALA . 19.6 m-85 -107.05 169.36 8.6 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.943 179.821 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.559 HG23 ' O ' ' A' ' 90' ' ' ALA . 47.3 m -162.04 103.56 1.14 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.925 0.393 . . . . 0.0 110.497 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.403 ' HA ' ' O ' ' A' ' 18' ' ' ALA . 31.0 t -53.22 92.57 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.341 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.6 ' OE1' HG21 ' A' ' 51' ' ' VAL . 0.1 OUTLIER -59.61 164.53 3.51 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.593 -179.859 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.46 ' HA ' HG23 ' A' ' 88' ' ' ILE . 1.5 pttt -86.03 61.14 6.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.286 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -133.1 22.61 3.99 Favored Glycine 0 CA--C 1.525 0.656 0 N-CA-C 111.001 -0.84 . . . . 0.0 111.001 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.4 t -81.82 146.54 29.83 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -152.45 -88.5 0.06 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.739 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -96.61 -66.32 0.91 Allowed 'General case' 0 N--CA 1.454 -0.235 0 CA-C-O 120.694 0.283 . . . . 0.0 110.3 -179.725 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.458 ' HD3' ' ND1' ' A' ' 16' ' ' HIS . 0.0 OUTLIER -140.81 49.1 1.69 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.627 -179.996 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.458 ' ND1' ' HD3' ' A' ' 15' ' ' LYS . 45.6 m80 -129.93 112.56 13.64 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.075 179.555 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.452 HD22 ' HA ' ' A' ' 17' ' ' LEU . 1.5 tm? -98.53 81.39 2.71 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.225 -179.686 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.449 ' HB2' HG22 ' A' ' 53' ' ' THR . . . -61.95 131.54 50.02 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.572 -179.705 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.496 HG23 HG23 ' A' ' 21' ' ' VAL . 29.9 m -135.1 136.38 51.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.238 179.682 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.418 ' HB3' ' HB ' ' A' ' 7' ' ' THR . 0.8 OUTLIER -89.95 75.53 7.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.686 -179.743 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.496 HG23 HG23 ' A' ' 19' ' ' VAL . 14.5 t -75.11 95.32 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.093 179.668 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 23.6 tttt -171.4 132.41 0.78 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.46 -179.784 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.798 ' CE1' HG12 ' A' ' 4' ' ' VAL . 10.4 p90 -141.42 25.8 2.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.463 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 49.16 87.75 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.575 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -174.08 -105.38 0.18 Allowed Glycine 0 CA--C 1.523 0.532 0 N-CA-C 110.755 -0.938 . . . . 0.0 110.755 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -64.99 -175.17 0.18 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.75 0.309 . . . . 0.0 110.364 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.416 ' HB ' ' HG3' ' A' ' 71' ' ' GLU . 0.8 OUTLIER -103.78 -173.95 2.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.473 -179.866 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.41 ' O ' ' CG ' ' A' ' 71' ' ' GLU . 3.6 mtm -116.69 130.18 56.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.636 -179.621 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.771 ' HB3' ' O ' ' A' ' 69' ' ' LEU . . . -122.44 -56.85 1.78 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.641 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.405 ' O ' ' HB2' ' A' ' 68' ' ' PHE . 29.2 tt0 -158.42 166.49 32.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.287 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.469 HG21 ' CD1' ' A' ' 52' ' ' TRP . 26.4 t -151.67 152.09 11.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.927 0.394 . . . . 0.0 110.675 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.446 ' CB ' ' HA ' ' A' ' 43' ' ' ALA . 0.5 OUTLIER -155.21 138.84 16.03 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.364 179.963 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.498 ' HG ' ' CE2' ' A' ' 66' ' ' PHE . 1.4 mt -94.27 177.56 5.91 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.676 -179.53 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.421 ' CB ' ' HB2' ' A' ' 65' ' ' ASN . 0.1 OUTLIER -130.26 -156.91 0.79 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.664 179.649 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.402 ' OE2' ' CB ' ' A' ' 56' ' ' SER . 0.0 OUTLIER 178.48 105.25 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.826 0.346 . . . . 0.0 110.134 179.921 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.621 ' NE2' HD22 ' A' ' 60' ' ' LEU . 8.8 p-80 -50.11 119.37 3.57 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.462 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 117.68 -32.06 5.5 Favored Glycine 0 CA--C 1.522 0.53 0 N-CA-C 110.565 -1.014 . . . . 0.0 110.565 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -78.75 174.14 11.75 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.765 0.317 . . . . 0.0 110.16 179.831 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -129.07 26.44 5.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.5 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -159.92 145.26 15.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.457 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.503 ' CZ3' ' HG2' ' A' ' 67' ' ' ARG . 71.3 m95 -80.69 154.11 27.5 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.194 179.83 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.656 HG23 ' O ' ' A' ' 42' ' ' VAL . 29.7 m -115.47 105.42 18.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.957 0.408 . . . . 0.0 110.327 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.446 ' HA ' ' CB ' ' A' ' 32' ' ' GLU . . . -52.35 136.66 30.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.394 -179.819 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -71.69 -171.16 0.63 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.804 -179.801 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 47.5 m -144.55 111.4 5.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.557 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.478 ' HG2' ' CZ3' ' A' ' 52' ' ' TRP . 31.8 mtpt -77.06 95.27 4.16 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.042 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -128.86 -38.96 0.33 Allowed Glycine 0 CA--C 1.525 0.696 0 N-CA-C 111.437 -0.665 . . . . 0.0 111.437 -179.513 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.427 ' HB2' ' O ' ' A' ' 51' ' ' VAL . 0.0 OUTLIER -52.68 -175.32 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.99 0.424 . . . . 0.0 110.425 -179.741 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -104.01 41.69 2.08 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 145.59 -10.8 1.71 Allowed Glycine 0 CA--C 1.529 0.921 0 C-N-CA 121.015 -0.612 . . . . 0.0 112.428 179.467 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.6 HG21 ' OE1' ' A' ' 9' ' ' GLU . 33.5 m -133.21 175.02 12.34 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.137 0 CA-C-N 117.709 0.754 . . . . 0.0 110.844 -179.627 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' TRP . . . . . 0.478 ' CZ3' ' HG2' ' A' ' 46' ' ' LYS . 6.9 m95 -106.93 139.94 40.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.572 -179.576 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.449 HG22 ' HB2' ' A' ' 18' ' ' ALA . 2.6 p -122.4 135.52 54.71 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.359 179.739 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 1.3 t80 175.05 96.94 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.501 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.448 ' HB2' ' N ' ' A' ' 16' ' ' HIS . 6.0 t0 -99.62 31.03 3.34 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-O 121.43 0.634 . . . . 0.0 110.138 179.396 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.41 ' OG ' ' N ' ' A' ' 57' ' ' GLU . 44.9 t 45.91 -172.93 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 114.928 -1.033 . . . . 0.0 110.98 179.574 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.41 ' N ' ' OG ' ' A' ' 56' ' ' SER . 1.5 mt-10 -100.75 -46.86 5.02 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.225 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -64.03 116.42 27.11 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.451 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -68.33 59.6 1.03 Allowed 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.724 2.282 . . . . 0.0 112.333 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.621 HD22 ' NE2' ' A' ' 36' ' ' HIS . 1.6 mt -94.0 92.51 7.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.845 0.355 . . . . 0.0 110.322 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -77.0 78.38 3.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.469 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -145.93 -162.04 9.52 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.816 -0.913 . . . . 0.0 110.816 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -76.17 128.91 10.9 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.59 2.194 . . . . 0.0 112.075 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.443 ' HB3' ' CD2' ' A' ' 33' ' ' LEU . 27.4 m-85 -88.29 -178.27 5.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.976 0.417 . . . . 0.0 110.554 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.421 ' HB2' ' CB ' ' A' ' 34' ' ' ARG . 4.9 m120 -153.55 137.65 16.44 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.631 179.75 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.498 ' CE2' ' HG ' ' A' ' 33' ' ' LEU . 80.8 m-85 -121.79 -178.36 3.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.045 0.45 . . . . 0.0 110.97 -179.642 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.503 ' HG2' ' CZ3' ' A' ' 41' ' ' TRP . 0.0 OUTLIER 175.65 47.79 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.656 179.997 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.623 ' HZ ' HG11 ' A' ' 4' ' ' VAL . 0.6 OUTLIER -48.63 172.57 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.108 -179.245 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.771 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 4.9 mt -122.28 72.51 1.06 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.446 179.753 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -37.98 142.14 0.18 Allowed 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.685 -179.254 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.708 ' HG2' ' HB2' ' A' ' 29' ' ' ALA . 3.1 mm-40 -51.57 -67.31 0.26 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.725 -179.742 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.79 31.38 5.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.733 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -106.34 -100.52 2.66 Favored Glycine 0 CA--C 1.523 0.547 0 N-CA-C 110.655 -0.978 . . . . 0.0 110.655 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 177.52 141.51 0.08 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.853 0.358 . . . . 0.0 110.361 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.436 ' HG3' ' HA ' ' A' ' 69' ' ' LEU . 0.0 OUTLIER -70.31 178.66 2.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.254 -179.982 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.466 ' O ' ' CE2' ' A' ' 78' ' ' PHE . 0.5 OUTLIER 170.04 131.79 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.582 179.92 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 79.7 t -85.18 150.61 3.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.111 -0.495 . . . . 0.0 109.928 179.545 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.523 ' CE1' HG22 ' A' ' 4' ' ' VAL . 61.3 m-85 -137.74 128.33 26.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.882 0.372 . . . . 0.0 110.645 -179.835 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -107.67 156.54 18.96 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.214 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 28.0 t70 51.97 52.81 13.68 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.34 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.683 HG13 ' HB2' ' A' ' 93' ' ' ALA . 85.7 t -85.76 -24.6 6.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.577 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.471 HG13 ' HD2' ' A' ' 83' ' ' PRO . 46.3 t -138.87 138.56 21.65 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.579 -179.832 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.493 ' HG3' ' CE1' ' A' ' 92' ' ' TYR . 49.3 Cg_endo -72.09 -166.88 0.28 Allowed 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.619 2.212 . . . . 0.0 111.979 179.621 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.66 -78.47 0.07 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.044 179.67 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.411 ' CG ' ' O ' ' A' ' 85' ' ' LYS . 0.0 OUTLIER -91.9 71.36 5.61 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.001 179.589 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 19.0 p90 -47.93 150.48 1.12 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.776 -179.785 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 1.2 m -117.63 115.56 25.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.291 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.46 HG23 ' HA ' ' A' ' 10' ' ' LYS . 42.3 mm -51.94 110.22 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.27 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 114.32 32.33 2.0 Favored Glycine 0 CA--C 1.523 0.552 0 N-CA-C 110.771 -0.932 . . . . 0.0 110.771 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.559 ' O ' HG23 ' A' ' 7' ' ' THR . . . -124.35 164.37 19.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.757 0.313 . . . . 0.0 110.398 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 6.9 m -119.68 89.93 3.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.66 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.532 ' O ' ' HB3' ' A' ' 93' ' ' ALA . 34.5 m-85 -89.03 -161.5 0.77 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.912 179.669 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.915 ' HB1' ' HD2' ' A' ' 94' ' ' PRO . . . 72.26 176.96 0.06 OUTLIER Pre-proline 0 C--N 1.332 -0.173 0 CA-C-O 120.614 0.245 . . . . 0.0 110.461 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.915 ' HD2' ' HB1' ' A' ' 93' ' ' ALA . 48.7 Cg_endo . . . . . 0 C--O 1.249 1.042 0 C-N-CA 122.506 2.137 . . . . 0.0 112.071 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 27.2 t . . . . . 0 N--CA 1.489 1.519 0 N-CA-C 110.175 -0.305 . . . . 0.0 110.175 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -77.22 105.5 2.07 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.576 2.184 . . . . 0.0 112.113 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 3.9 tttt -133.12 94.37 3.34 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.242 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.874 HG11 ' CE2' ' A' ' 68' ' ' PHE . 27.0 m -80.38 -178.26 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.509 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.694 HG23 ' O ' ' A' ' 4' ' ' VAL . 0.6 OUTLIER -170.96 139.71 1.46 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.242 179.874 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.718 ' O ' HG23 ' A' ' 91' ' ' THR . 29.5 m-85 -113.65 168.91 9.37 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.492 -179.81 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.823 HG23 ' O ' ' A' ' 90' ' ' ALA . 19.1 m -165.57 118.59 1.16 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.381 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.526 HG11 HG13 ' A' ' 88' ' ' ILE . 62.6 t -61.65 102.57 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.335 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.736 ' OE2' HD12 ' A' ' 20' ' ' LEU . 1.8 mm-40 -70.11 174.67 5.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.502 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.4 mttt -83.17 64.48 7.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.556 -179.791 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -156.44 33.25 0.59 Allowed Glycine 0 CA--C 1.522 0.506 0 N-CA-C 110.457 -1.057 . . . . 0.0 110.457 179.821 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.3 p -89.82 114.97 26.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.873 0.368 . . . . 0.0 110.593 -179.745 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 13.8 m-20 -104.23 -156.05 0.56 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.081 -0.508 . . . . 0.0 109.933 179.653 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -46.35 -63.98 0.87 Allowed 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 120.846 0.355 . . . . 0.0 110.777 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.87 -22.68 9.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.906 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 28.8 m80 -48.84 136.51 13.81 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.96 0.41 . . . . 0.0 110.884 -179.682 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.42 ' HA ' HD22 ' A' ' 17' ' ' LEU . 0.2 OUTLIER -129.05 95.79 4.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.651 179.629 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.674 ' HB1' HG11 ' A' ' 51' ' ' VAL . . . -90.58 128.31 36.54 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.683 -179.489 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.687 ' O ' HG13 ' A' ' 51' ' ' VAL . 15.3 m -134.26 133.96 55.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.202 179.627 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.736 HD12 ' OE2' ' A' ' 9' ' ' GLU . 0.5 OUTLIER -83.83 71.93 10.42 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.384 -179.951 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.525 HG23 HG23 ' A' ' 19' ' ' VAL . 61.4 t -70.93 95.14 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.286 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 5.4 tttp -135.62 141.59 45.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.41 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -163.36 149.65 11.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.39 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -76.42 -22.23 54.95 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.743 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -46.91 -50.17 15.8 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 111.081 -0.807 . . . . 0.0 111.081 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -138.04 -174.69 3.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.776 0.322 . . . . 0.0 110.304 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.487 HG22 ' O ' ' A' ' 27' ' ' THR . 27.2 m -121.65 54.68 1.13 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.796 -179.677 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.588 ' O ' ' HB2' ' A' ' 29' ' ' ALA . 33.7 mtm 58.35 -164.11 0.2 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.786 179.55 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.704 ' HB2' ' N ' ' A' ' 71' ' ' GLU . . . 154.24 -62.59 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.367 0.667 . . . . 0.0 109.682 179.722 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.569 ' HB3' HD12 ' A' ' 69' ' ' LEU . 1.2 tt0 -160.75 141.17 11.4 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.817 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.535 HG21 ' CD1' ' A' ' 52' ' ' TRP . 4.2 t -134.72 156.39 39.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.973 0.416 . . . . 0.0 110.754 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.452 ' CB ' ' HA ' ' A' ' 43' ' ' ALA . 3.1 pt-20 -154.15 157.73 39.31 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.979 179.775 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.81 HD23 ' O ' ' A' ' 65' ' ' ASN . 4.6 mt -125.16 -176.54 3.6 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.457 -179.712 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.508 ' HD2' ' CD2' ' A' ' 41' ' ' TRP . 5.6 ttt180 -145.71 174.24 11.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.075 179.686 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.401 ' HG2' ' O ' ' A' ' 34' ' ' ARG . 21.4 mt-10 -154.27 93.76 1.65 Allowed 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 179.811 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -40.25 116.07 0.62 Allowed 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.389 -178.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 123.75 -25.41 6.19 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 110.466 -1.054 . . . . 0.0 110.466 -179.568 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 4.3 m -75.95 -161.34 0.17 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.81 0.338 . . . . 0.0 110.39 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -83.11 -65.81 0.96 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.528 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -153.18 -176.93 6.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.619 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.508 ' CD2' ' HD2' ' A' ' 34' ' ' ARG . 87.0 m95 -50.72 150.66 2.73 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.602 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.595 HG21 ' CZ ' ' A' ' 54' ' ' PHE . 10.5 m -131.62 131.91 62.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.139 179.718 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.452 ' HA ' ' CB ' ' A' ' 32' ' ' GLU . . . -57.22 147.23 25.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.569 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.414 ' N ' ' HA ' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -72.61 -166.04 0.25 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.993 179.855 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 90.0 m -154.05 112.61 3.62 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.837 0.351 . . . . 0.0 110.686 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 9.2 ptpt -68.92 69.55 0.18 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.193 -0.458 . . . . 0.0 109.97 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -90.47 -26.41 23.17 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 111.296 -0.722 . . . . 0.0 111.296 -179.491 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.441 ' CG ' ' HB ' ' A' ' 51' ' ' VAL . 5.4 tm-20 -78.45 -14.84 59.18 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.761 0.28 . . . . 0.0 111.222 -179.728 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 99.74 -41.39 2.19 Favored Glycine 0 CA--C 1.522 0.518 0 N-CA-C 109.976 -1.25 . . . . 0.0 109.976 -179.549 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.438 ' O ' ' CZ3' ' A' ' 52' ' ' TRP . . . -126.61 -45.25 0.23 Allowed Glycine 0 CA--C 1.519 0.287 0 N-CA-C 109.075 -1.61 . . . . 0.0 109.075 179.107 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.687 HG13 ' O ' ' A' ' 19' ' ' VAL . 19.6 t -82.57 151.36 4.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 178.908 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' TRP . . . . . 0.535 ' CD1' HG21 ' A' ' 31' ' ' VAL . 4.1 m95 -93.05 114.77 27.4 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.996 0.427 . . . . 0.0 110.187 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.527 ' CG2' ' HB2' ' A' ' 18' ' ' ALA . 1.8 p -108.07 137.58 45.82 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.286 -179.773 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.595 ' CZ ' HG21 ' A' ' 42' ' ' VAL . 51.2 t80 -120.34 142.79 48.81 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.686 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -99.94 109.38 21.74 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.061 179.767 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.4 ' HB2' ' OE2' ' A' ' 35' ' ' GLU . 27.6 p -89.83 158.95 17.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.558 -179.81 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -134.3 -44.52 0.77 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.42 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -51.88 156.57 2.44 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.395 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -67.88 -34.55 23.49 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.795 2.33 . . . . 0.0 112.433 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 2.2 mt -69.85 151.45 45.69 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.835 -179.545 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.3 tp60 -174.1 72.9 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.22 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -128.44 -96.76 0.87 Allowed Glycine 0 CA--C 1.525 0.687 0 N-CA-C 110.814 -0.914 . . . . 0.0 110.814 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -77.18 97.77 1.17 Allowed 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.587 2.191 . . . . 0.0 112.205 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -73.51 166.47 23.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.588 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.81 ' O ' HD23 ' A' ' 33' ' ' LEU . 1.0 OUTLIER -135.81 122.99 21.64 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 179.227 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.574 ' CD2' ' CE2' ' A' ' 6' ' ' PHE . 2.8 m-85 -105.84 177.88 4.72 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.303 0.573 . . . . 0.0 112.081 -178.569 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.797 ' HD2' HG12 ' A' ' 77' ' ' VAL . 7.2 mtp180 -177.56 96.84 0.04 OUTLIER 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 114.877 -1.056 . . . . 0.0 110.287 179.45 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.88 ' O ' HD23 ' A' ' 69' ' ' LEU . 6.0 p90 -91.73 168.13 11.68 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-O 121.151 0.5 . . . . 0.0 110.455 179.789 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.88 HD23 ' O ' ' A' ' 68' ' ' PHE . 5.7 mt -136.28 65.23 1.53 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.641 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 26.8 p -33.5 150.09 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 115.899 -0.591 . . . . 0.0 112.048 -179.264 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.704 ' N ' ' HB2' ' A' ' 29' ' ' ALA . 7.8 mt-10 -49.21 -30.43 7.0 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.333 -179.729 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -69.19 -46.56 67.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.377 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 118.72 43.29 0.54 Allowed Glycine 0 CA--C 1.523 0.557 0 N-CA-C 110.69 -0.964 . . . . 0.0 110.69 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 12.1 mtp -105.61 108.1 19.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.833 0.349 . . . . 0.0 110.448 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.8 149.55 21.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.349 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -177.69 125.13 0.13 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.594 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.797 HG12 ' HD2' ' A' ' 67' ' ' ARG . 4.5 m -81.99 176.56 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.591 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.44 ' CE2' ' CE2' ' A' ' 68' ' ' PHE . 97.3 m-85 -156.79 112.82 2.97 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.3 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -98.18 158.17 15.72 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.463 -179.759 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 47.1 m-20 59.16 28.53 17.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.557 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.41 HG23 ' O ' ' A' ' 78' ' ' PHE . 74.3 t -61.17 -75.97 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 179.735 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.543 HG13 ' HD2' ' A' ' 83' ' ' PRO . 59.8 t -87.18 139.57 32.33 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.427 -0.352 . . . . 0.0 110.289 179.613 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.543 ' HD2' HG13 ' A' ' 82' ' ' VAL . 45.8 Cg_endo -70.5 -167.77 0.27 Allowed 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.595 2.197 . . . . 0.0 112.022 179.765 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.413 ' HG3' ' N ' ' A' ' 85' ' ' LYS . 4.3 pt-20 -83.84 -28.19 28.2 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.23 179.828 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.413 ' N ' ' HG3' ' A' ' 84' ' ' GLU . 0.0 OUTLIER -132.07 63.48 1.62 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.136 179.755 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 51.9 p90 -48.66 148.68 1.99 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.789 -179.75 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 37.0 m -128.18 113.27 15.49 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.271 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.526 HG13 HG11 ' A' ' 8' ' ' VAL . 3.0 mp -51.37 104.46 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.248 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 125.4 47.44 0.22 Allowed Glycine 0 CA--C 1.524 0.598 0 N-CA-C 110.707 -0.957 . . . . 0.0 110.707 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.823 ' O ' HG23 ' A' ' 7' ' ' THR . . . -167.48 175.07 7.4 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.754 0.311 . . . . 0.0 110.365 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.718 HG23 ' O ' ' A' ' 6' ' ' PHE . 5.1 m -113.32 141.56 46.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.484 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.597 ' OH ' ' HB3' ' A' ' 90' ' ' ALA . 11.6 m-85 -141.51 109.18 5.65 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.33 179.753 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.924 ' HB1' ' HD2' ' A' ' 94' ' ' PRO . . . 170.59 177.49 0.1 OUTLIER Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.406 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.924 ' HD2' ' HB1' ' A' ' 93' ' ' ALA . 48.2 Cg_endo . . . . . 0 C--O 1.249 1.031 0 C-N-CA 122.533 2.156 . . . . 0.0 112.097 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.626 ' O ' HG13 ' A' ' 1' ' ' VAL . 9.9 p . . . . . 0 N--CA 1.494 1.744 0 N-CA-C 110.24 -0.282 . . . . 0.0 110.24 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -73.37 98.49 1.03 Allowed 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.331 2.021 . . . . 0.0 112.059 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 2.3 tttp -171.35 106.58 0.24 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.35 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.536 ' CG1' ' CE1' ' A' ' 78' ' ' PHE . 1.7 p -116.87 163.67 13.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.232 0.539 . . . . 0.0 110.397 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.466 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 0.6 OUTLIER -132.92 139.5 47.39 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.205 179.838 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.752 ' O ' HG23 ' A' ' 91' ' ' THR . 32.3 m-85 -98.26 -176.43 3.41 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.298 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.9 m -167.5 112.96 0.72 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.369 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 45.2 t -66.26 101.84 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.309 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.786 ' HG3' HG11 ' A' ' 51' ' ' VAL . 0.7 OUTLIER -54.39 -178.16 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.6 -179.79 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -94.24 46.96 1.17 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.269 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -133.56 23.82 3.76 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 110.895 -0.882 . . . . 0.0 110.895 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 7.9 m -86.65 106.04 17.33 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.782 0.325 . . . . 0.0 110.285 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 20.7 m-20 -100.61 -158.38 0.67 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.371 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -45.76 -62.26 1.38 Allowed 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.076 -179.742 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.98 19.12 11.7 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.005 -179.824 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.485 ' CE1' ' OD1' ' A' ' 55' ' ' ASP . 2.1 m-70 -100.5 130.77 46.62 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.826 0.346 . . . . 0.0 110.088 179.716 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.517 ' HA ' HD22 ' A' ' 17' ' ' LEU . 0.5 OUTLIER -122.57 90.69 3.35 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.452 -179.628 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.486 ' HB2' ' CG2' ' A' ' 53' ' ' THR . . . -88.67 130.75 35.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.162 179.866 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.552 HG21 ' CZ ' ' A' ' 66' ' ' PHE . 25.8 m -129.87 152.3 37.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.555 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.498 HD22 ' CG ' ' A' ' 22' ' ' LYS . 0.4 OUTLIER -104.06 98.58 8.38 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.081 179.803 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 25.1 t -98.83 99.09 7.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.808 -179.55 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.498 ' CG ' HD22 ' A' ' 20' ' ' LEU . 0.0 OUTLIER 175.84 160.18 0.28 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.259 179.698 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -159.8 47.93 0.28 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.338 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 52.43 178.89 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.506 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 66.29 -82.06 0.1 Allowed Glycine 0 CA--C 1.523 0.547 0 N-CA-C 110.832 -0.907 . . . . 0.0 110.832 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 36.3 m-20 -64.71 167.91 6.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.821 0.343 . . . . 0.0 110.397 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -111.7 -160.05 0.7 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.275 -179.836 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.421 ' O ' ' CG ' ' A' ' 71' ' ' GLU . 6.2 mtt -121.05 125.5 47.46 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.925 0.393 . . . . 0.0 110.631 -179.878 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.689 ' HB2' ' N ' ' A' ' 71' ' ' GLU . . . -115.37 -57.62 2.23 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.4 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.554 ' C ' HG12 ' A' ' 31' ' ' VAL . 0.2 OUTLIER -165.86 177.67 7.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.143 -179.98 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.554 HG12 ' C ' ' A' ' 30' ' ' GLU . 0.5 OUTLIER 172.17 137.88 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 121.111 0.481 . . . . 0.0 110.251 -179.899 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.407 ' CB ' ' HA ' ' A' ' 43' ' ' ALA . 1.2 pt-20 -128.43 163.24 25.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.083 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.506 ' HG ' ' CE2' ' A' ' 66' ' ' PHE . 1.6 mt -109.49 163.57 13.31 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.055 0.455 . . . . 0.0 111.002 -179.543 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.443 ' HG3' ' CD2' ' A' ' 41' ' ' TRP . 0.7 OUTLIER -139.81 -163.39 1.49 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.688 179.375 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -153.42 -87.41 0.06 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.323 179.766 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.413 ' CG ' ' N ' ' A' ' 37' ' ' GLY . 48.0 p-80 -179.22 -47.19 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 120.83 0.348 . . . . 0.0 110.617 -179.858 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.413 ' N ' ' CG ' ' A' ' 36' ' ' HIS . . . -110.58 23.67 19.45 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 110.735 -0.946 . . . . 0.0 110.735 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.428 ' O ' ' CB ' ' A' ' 39' ' ' ASP . 1.9 t -86.11 -7.42 58.6 Favored 'General case' 0 C--N 1.33 -0.244 0 O-C-N 122.9 -0.176 . . . . 0.0 111.285 -179.797 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.428 ' CB ' ' O ' ' A' ' 38' ' ' SER . 0.8 OUTLIER 82.43 -51.76 0.2 Allowed 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 122.447 0.299 . . . . 0.0 110.9 179.942 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -142.42 177.88 7.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.915 0.388 . . . . 0.0 110.882 -179.783 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.494 ' CE2' ' HD2' ' A' ' 67' ' ' ARG . 60.3 m95 -78.55 166.53 22.46 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.443 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.456 HG23 ' O ' ' A' ' 42' ' ' VAL . 20.6 m -141.51 119.13 8.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.234 179.737 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.407 ' HA ' ' CB ' ' A' ' 32' ' ' GLU . . . -50.66 133.73 25.34 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.576 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.462 ' HE3' ' HB2' ' A' ' 52' ' ' TRP . 0.0 OUTLIER -63.04 -171.0 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.547 179.942 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 66.3 m -145.75 99.46 3.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.574 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.408 ' HG3' ' O ' ' A' ' 46' ' ' LYS . 2.8 ptmt -61.17 94.37 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.35 179.868 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -132.3 14.79 5.07 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 111.19 -0.764 . . . . 0.0 111.19 179.842 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -102.83 -14.17 16.7 Favored 'General case' 0 C--N 1.333 -0.152 0 O-C-N 122.719 -0.283 . . . . 0.0 110.986 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 66.1 26.16 72.36 Favored Glycine 0 CA--C 1.523 0.539 0 N-CA-C 110.42 -1.072 . . . . 0.0 110.42 -179.627 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -174.64 -39.42 0.05 OUTLIER Glycine 0 CA--C 1.523 0.591 0 N-CA-C 110.53 -1.028 . . . . 0.0 110.53 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.786 HG11 ' HG3' ' A' ' 9' ' ' GLU . 3.1 m -133.1 -177.16 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.922 0.391 . . . . 0.0 110.363 179.87 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' TRP . . . . . 0.462 ' HB2' ' HE3' ' A' ' 44' ' ' MET . 7.6 m95 -101.38 141.46 34.22 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.605 -179.558 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.486 ' CG2' ' HB2' ' A' ' 18' ' ' ALA . 0.6 OUTLIER -133.87 147.47 51.16 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.471 -179.757 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 75.7 t80 -130.98 112.49 12.99 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.407 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.485 ' OD1' ' CE1' ' A' ' 16' ' ' HIS . 3.3 m-20 -71.58 161.91 30.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.411 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -146.56 170.81 16.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.114 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -146.31 -50.14 0.21 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.51 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -55.35 153.09 14.52 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.443 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -71.94 -50.15 0.28 Allowed 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 122.659 2.239 . . . . 0.0 112.136 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -57.91 130.99 49.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.687 -179.862 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 174.92 159.31 0.19 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.277 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -177.27 -99.77 0.13 Allowed Glycine 0 CA--C 1.526 0.76 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -75.32 157.47 41.43 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.569 2.18 . . . . 0.0 112.135 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.449 ' CE2' ' HG ' ' A' ' 17' ' ' LEU . 72.8 m-85 -124.27 -177.73 3.88 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.093 0.473 . . . . 0.0 110.845 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.404 ' HB2' ' HB3' ' A' ' 34' ' ' ARG . 1.8 m-80 -153.33 130.42 11.1 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.636 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.552 ' CZ ' HG21 ' A' ' 19' ' ' VAL . 80.8 m-85 -114.07 178.98 4.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.14 0.495 . . . . 0.0 110.838 -179.561 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.494 ' HD2' ' CE2' ' A' ' 41' ' ' TRP . 17.1 ptm180 -176.83 59.15 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.656 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.743 ' O ' HD23 ' A' ' 69' ' ' LEU . 0.0 OUTLIER -54.89 178.54 0.03 OUTLIER 'General case' 0 CA--C 1.518 -0.28 0 CA-C-O 121.388 0.613 . . . . 0.0 111.492 -179.21 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.743 HD23 ' O ' ' A' ' 68' ' ' PHE . 7.1 mt -144.64 48.39 1.34 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.107 -0.951 . . . . 0.0 109.182 179.78 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.1 p -25.46 137.12 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.88 0.872 . . . . 0.0 112.741 -179.007 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.689 ' N ' ' HB2' ' A' ' 29' ' ' ALA . 6.3 mt-10 -49.62 -59.03 4.15 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.507 -179.69 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 3.6 tmtt? -123.66 58.91 1.13 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.314 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -141.4 -101.63 0.45 Allowed Glycine 0 CA--C 1.522 0.516 0 N-CA-C 110.77 -0.932 . . . . 0.0 110.77 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.6 ptm -173.46 -178.43 1.67 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.709 0.29 . . . . 0.0 110.297 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.86 158.12 45.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.52 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 174.05 128.43 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.266 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 17.6 m -68.71 140.72 18.49 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.473 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.536 ' CE1' ' CG1' ' A' ' 4' ' ' VAL . 79.6 m-85 -116.81 121.53 41.81 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.311 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 26.1 m-20 -101.64 141.09 35.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.569 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 17.1 t0 60.13 60.84 1.98 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.604 179.699 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.416 ' HA ' ' HA ' ' A' ' 93' ' ' ALA . 75.7 t -89.44 -65.57 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 179.695 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.556 HG13 ' HD2' ' A' ' 83' ' ' PRO . 60.8 t -87.83 139.83 31.17 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.388 179.78 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.556 ' HD2' HG13 ' A' ' 82' ' ' VAL . 47.8 Cg_endo -71.88 173.47 12.71 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.61 2.207 . . . . 0.0 112.071 179.83 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -55.54 -51.21 67.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.098 179.676 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 5.3 mttt -114.78 87.08 2.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.115 179.655 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.438 ' HB3' ' CG1' ' A' ' 82' ' ' VAL . 28.1 p90 -65.94 164.47 15.01 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.579 -179.799 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 7.4 m -145.43 112.76 6.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.261 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.549 HG23 ' O ' ' A' ' 9' ' ' GLU . 2.5 mp -50.81 98.64 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.457 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 132.03 54.63 0.08 OUTLIER Glycine 0 CA--C 1.523 0.587 0 N-CA-C 110.781 -0.927 . . . . 0.0 110.781 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.793 ' HB3' ' OH ' ' A' ' 92' ' ' TYR . . . -172.6 -177.75 1.79 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.816 0.341 . . . . 0.0 110.398 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.752 HG23 ' O ' ' A' ' 6' ' ' PHE . 4.1 m -124.97 142.55 51.41 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.375 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.793 ' OH ' ' HB3' ' A' ' 90' ' ' ALA . 4.7 m-85 -146.76 123.59 11.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.359 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.922 ' HB1' ' HD2' ' A' ' 94' ' ' PRO . . . 174.93 178.88 0.18 Allowed Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.41 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.922 ' HD2' ' HB1' ' A' ' 93' ' ' ALA . 47.7 Cg_endo . . . . . 0 C--O 1.249 1.031 0 C-N-CA 122.488 2.125 . . . . 0.0 112.099 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 1.6 m . . . . . 0 N--CA 1.49 1.525 0 N-CA-C 110.121 -0.326 . . . . 0.0 110.121 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -76.39 80.38 2.75 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.584 2.189 . . . . 0.0 112.096 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 7.6 ttpt -126.98 59.94 1.39 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.165 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.581 HG11 ' CE2' ' A' ' 78' ' ' PHE . 2.4 p -74.75 162.99 4.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.368 0.604 . . . . 0.0 110.552 -179.85 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.495 ' N ' HG22 ' A' ' 4' ' ' VAL . 1.8 p -139.6 148.79 42.98 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.133 -0.94 . . . . 0.0 110.124 179.672 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.433 ' CE2' HG22 ' A' ' 21' ' ' VAL . 48.2 m-85 -123.5 145.05 49.15 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.111 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.411 ' O ' ' N ' ' A' ' 20' ' ' LEU . 3.8 m -148.36 129.78 14.81 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.152 -179.88 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.723 HG23 ' HE2' ' A' ' 92' ' ' TYR . 96.1 t -73.21 101.16 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.401 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.412 ' N ' ' O ' ' A' ' 18' ' ' ALA . 6.5 mt-10 -59.1 165.15 2.65 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.485 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.77 65.4 3.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.286 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -154.91 33.44 0.67 Allowed Glycine 0 CA--C 1.524 0.615 0 N-CA-C 110.812 -0.915 . . . . 0.0 110.812 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 21.2 p -82.03 130.08 34.98 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 110.211 -0.292 . . . . 0.0 110.211 179.837 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -112.44 -161.97 0.78 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.518 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -49.76 -71.06 0.07 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.145 -179.461 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 41.5 pttt -117.99 40.95 3.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.841 -179.328 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 9.0 m80 -113.83 178.95 4.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.4 179.81 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 43.7 tp -165.15 94.25 0.64 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.419 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.484 ' HB2' HG22 ' A' ' 53' ' ' THR . . . -91.58 107.47 19.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.372 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.469 HG23 HG23 ' A' ' 21' ' ' VAL . 17.1 m -90.72 -173.55 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.286 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.411 ' N ' ' O ' ' A' ' 7' ' ' THR . 2.1 tt -135.11 78.15 1.72 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.502 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.469 HG23 HG23 ' A' ' 19' ' ' VAL . 16.0 t -86.23 100.63 9.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.295 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 17.1 tptt -176.11 124.73 0.19 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.548 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.443 ' CE1' HG23 ' A' ' 4' ' ' VAL . 42.6 p90 -156.98 174.29 15.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.251 179.862 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -64.21 119.65 10.64 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.495 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 122.07 -65.73 0.49 Allowed Glycine 0 CA--C 1.523 0.557 0 N-CA-C 110.921 -0.872 . . . . 0.0 110.921 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.817 ' OD1' HG22 ' A' ' 70' ' ' THR . 32.4 t0 -66.83 137.47 56.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.824 0.345 . . . . 0.0 110.577 -179.79 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.704 HG22 ' O ' ' A' ' 27' ' ' THR . 60.2 m -111.38 18.22 19.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.815 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.418 ' O ' ' CG ' ' A' ' 71' ' ' GLU . 19.7 mtp 59.55 114.79 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.797 0.332 . . . . 0.0 110.604 179.777 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.809 ' HB3' ' O ' ' A' ' 69' ' ' LEU . . . -134.53 -58.86 0.82 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.309 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.523 ' HB2' HD12 ' A' ' 69' ' ' LEU . 29.2 mt-10 -155.93 153.35 29.47 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.92 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.429 ' HA ' ' HA ' ' A' ' 68' ' ' PHE . 0.6 OUTLIER -172.43 148.0 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.386 0.612 . . . . 0.0 110.627 -179.713 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.407 ' HG3' ' HB3' ' A' ' 41' ' ' TRP . 2.2 pt-20 -142.22 178.86 7.27 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.065 -0.97 . . . . 0.0 109.688 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.708 HD21 ' CE1' ' A' ' 66' ' ' PHE . 4.4 mt -122.87 176.74 5.82 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.133 0.492 . . . . 0.0 111.031 -179.559 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 4.8 ttp180 -145.27 -175.46 4.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.673 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.44 ' CG ' ' HG2' ' A' ' 58' ' ' GLU . 4.9 mm-40 -151.58 29.93 0.6 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.722 0.296 . . . . 0.0 110.81 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER 56.58 164.53 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.555 179.615 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 51.99 25.08 16.09 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 110.887 -0.885 . . . . 0.0 110.887 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -135.91 109.84 8.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.857 0.36 . . . . 0.0 110.356 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -61.54 -22.54 65.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.654 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -100.2 176.52 5.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.914 0.388 . . . . 0.0 110.558 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.501 ' CE3' ' HG2' ' A' ' 67' ' ' ARG . 62.3 m95 -123.26 157.46 33.08 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.072 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.515 HG22 ' O ' ' A' ' 33' ' ' LEU . 4.5 m -107.25 105.89 19.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.946 0.403 . . . . 0.0 110.504 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -54.08 121.75 8.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.771 -179.724 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.88 -169.87 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.267 179.729 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 47.5 m -147.61 105.19 3.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.703 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 14.9 ptmt -62.67 82.92 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 179.509 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -109.72 -25.45 5.43 Favored Glycine 0 CA--C 1.522 0.484 0 N-CA-C 111.067 -0.813 . . . . 0.0 111.067 -179.425 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.641 ' HG2' HG22 ' A' ' 51' ' ' VAL . 1.1 tp10 -77.57 -41.04 40.29 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.774 0.321 . . . . 0.0 110.458 -179.776 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 99.42 -44.19 1.71 Allowed Glycine 0 CA--C 1.522 0.482 0 N-CA-C 110.168 -1.173 . . . . 0.0 110.168 -179.487 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -92.49 -29.7 10.72 Favored Glycine 0 CA--C 1.522 0.494 0 N-CA-C 110.208 -1.157 . . . . 0.0 110.208 179.516 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.641 HG22 ' HG2' ' A' ' 48' ' ' GLU . 3.5 m -140.41 -176.81 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.895 0.379 . . . . 0.0 110.283 179.65 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 9.5 m95 -106.43 134.42 49.6 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.837 -179.206 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.484 HG22 ' HB2' ' A' ' 18' ' ' ALA . 4.9 p -117.09 145.81 43.52 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.225 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.497 ' CE2' ' HB2' ' A' ' 56' ' ' SER . 85.2 t80 -131.5 138.9 49.16 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.329 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -122.73 134.08 54.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.524 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.497 ' HB2' ' CE2' ' A' ' 54' ' ' PHE . 0.3 OUTLIER -175.31 177.89 1.78 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.396 -179.972 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -155.79 26.88 0.38 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.404 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.44 ' HG2' ' CG ' ' A' ' 35' ' ' GLU . 0.0 OUTLIER -49.22 169.41 0.17 Allowed Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.636 -179.935 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.41 ' CD ' ' HB2' ' A' ' 58' ' ' GLU . 37.8 Cg_endo -93.92 20.09 0.71 Allowed 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 123.851 3.034 . . . . 0.0 112.243 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.6 mt -110.06 51.42 0.76 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.391 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 6.4 mm100 -60.13 121.19 11.3 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.292 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 169.32 -142.76 7.53 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 110.762 -0.935 . . . . 0.0 110.762 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -75.95 169.96 21.09 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.57 2.18 . . . . 0.0 111.975 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.429 ' HD2' HG21 ' A' ' 82' ' ' VAL . 54.6 m-85 -118.26 169.65 9.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.377 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -141.74 134.33 28.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.005 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.708 ' CE1' HD21 ' A' ' 33' ' ' LEU . 72.9 m-85 -119.1 179.61 4.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.044 0.449 . . . . 0.0 110.697 -179.808 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.501 ' HG2' ' CE3' ' A' ' 41' ' ' TRP . 0.0 OUTLIER -176.19 60.75 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.683 -0.689 . . . . 0.0 109.71 179.629 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.833 ' O ' HD23 ' A' ' 69' ' ' LEU . 4.6 p90 -56.04 179.44 0.04 OUTLIER 'General case' 0 CA--C 1.519 -0.23 0 CA-C-O 121.263 0.554 . . . . 0.0 111.16 -179.3 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.833 HD23 ' O ' ' A' ' 68' ' ' PHE . 6.0 mt -141.7 67.08 1.34 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.245 -0.889 . . . . 0.0 109.179 179.737 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.817 HG22 ' OD1' ' A' ' 26' ' ' ASP . 69.9 p -33.03 140.73 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 115.908 -0.587 . . . . 0.0 112.293 -178.958 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.709 ' HG2' ' HB2' ' A' ' 29' ' ' ALA . 7.1 mm-40 -53.07 -57.9 8.83 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.567 -179.825 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.09 81.74 2.04 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.506 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -175.7 -95.4 0.1 OUTLIER Glycine 0 CA--C 1.523 0.562 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 16.6 ptm 179.84 -177.53 0.37 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.869 0.366 . . . . 0.0 110.275 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.63 179.82 3.84 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.262 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 177.9 139.87 0.08 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.625 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.436 HG12 ' N ' ' A' ' 78' ' ' PHE . 87.3 t -89.5 157.38 3.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.131 179.696 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.581 ' CE2' HG11 ' A' ' 4' ' ' VAL . 78.8 m-85 -146.34 137.91 24.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.873 0.368 . . . . 0.0 110.539 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 29.5 p-10 -116.1 159.52 21.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.255 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 56.99 45.75 20.62 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.316 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.653 ' O ' HG12 ' A' ' 81' ' ' VAL . 60.3 t -94.17 8.08 5.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.104 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.491 HG23 ' O ' ' A' ' 81' ' ' VAL . 72.9 t -158.47 129.93 3.91 Favored Pre-proline 0 CA--C 1.53 0.18 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 179.693 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.457 ' HD3' ' CD1' ' A' ' 92' ' ' TYR . 47.6 Cg_endo -74.88 -169.47 0.63 Allowed 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.352 2.035 . . . . 0.0 112.08 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -77.41 -30.81 53.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.252 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 36.3 mttt -132.74 72.92 1.5 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.333 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 50.3 p90 -53.24 149.49 7.13 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.528 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.467 ' O ' HG23 ' A' ' 87' ' ' THR . 4.9 t -128.08 115.24 18.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.289 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.413 ' H ' HD12 ' A' ' 88' ' ' ILE . 3.4 mp -48.93 110.51 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.616 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 110.04 58.03 0.51 Allowed Glycine 0 CA--C 1.523 0.568 0 N-CA-C 110.712 -0.955 . . . . 0.0 110.712 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -176.28 139.78 0.36 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.805 0.336 . . . . 0.0 110.395 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 57.5 m -89.4 123.05 33.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.284 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.723 ' HE2' HG23 ' A' ' 8' ' ' VAL . 5.7 m-85 -101.95 -34.68 9.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.636 -179.633 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.854 ' HB1' ' HD2' ' A' ' 94' ' ' PRO . . . -50.02 178.94 0.04 OUTLIER Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.654 -179.782 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.854 ' HD2' ' HB1' ' A' ' 93' ' ' ALA . 48.5 Cg_endo . . . . . 0 C--O 1.249 1.036 0 C-N-CA 122.661 2.241 . . . . 0.0 112.19 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 27.4 m . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 120.705 0.288 . . . . 0.0 110.242 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -76.41 123.2 6.94 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.66 2.24 . . . . 0.0 112.116 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 46.49 93.38 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.977 179.534 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.45 ' CG2' ' CE1' ' A' ' 78' ' ' PHE . 29.8 m -53.52 171.66 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.205 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 15.0 p -153.15 127.45 9.19 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.385 179.801 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.976 ' O ' HG23 ' A' ' 91' ' ' THR . 45.4 m-85 -84.74 -173.08 4.53 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.938 179.821 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.466 HG23 ' OG1' ' A' ' 91' ' ' THR . 0.2 OUTLIER -165.03 117.36 1.19 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.976 0.417 . . . . 0.0 111.028 -179.988 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.679 HG21 ' HA ' ' A' ' 88' ' ' ILE . 14.3 p -49.85 129.31 7.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.423 179.546 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.735 ' HG3' HG11 ' A' ' 51' ' ' VAL . 8.9 mm-40 -116.95 163.33 16.37 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.355 179.785 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -50.37 -24.5 3.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.9 -179.538 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.637 ' HA3' ' HB2' ' A' ' 18' ' ' ALA . . . -45.95 -27.52 2.45 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 111.12 -0.792 . . . . 0.0 111.12 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.4 m -72.68 115.55 12.1 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 179.686 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -115.59 -68.43 0.92 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.41 -179.753 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -125.82 -66.91 0.91 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.126 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.26 27.05 9.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.139 179.759 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 39.8 m-70 -109.75 145.66 36.25 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.391 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.619 HD11 ' CE2' ' A' ' 64' ' ' PHE . 8.7 mt -125.93 89.47 3.03 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.957 0.408 . . . . 0.0 110.272 179.766 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.656 ' HB2' ' CG2' ' A' ' 53' ' ' THR . . . -82.96 143.9 30.36 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.841 179.723 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.412 ' HB ' ' HB3' ' A' ' 6' ' ' PHE . 17.0 m -139.42 145.39 27.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.772 0.32 . . . . 0.0 110.947 -179.606 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -100.83 56.27 0.87 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.486 179.659 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.457 ' CG1' ' CD1' ' A' ' 52' ' ' TRP . 2.3 p -67.47 102.94 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.175 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -165.45 135.46 3.59 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.328 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 9.5 p90 -156.76 35.26 0.3 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.415 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 51.35 -162.26 0.07 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.454 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 61.42 -103.55 0.57 Allowed Glycine 0 CA--C 1.522 0.529 0 N-CA-C 110.637 -0.985 . . . . 0.0 110.637 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 64.9 m-20 -67.87 132.63 47.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.791 0.329 . . . . 0.0 110.151 179.827 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.519 HG22 ' H ' ' A' ' 28' ' ' MET . 0.2 OUTLIER -76.45 175.02 9.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.563 -179.742 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.519 ' H ' HG22 ' A' ' 27' ' ' THR . 0.1 OUTLIER -98.51 130.11 45.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.452 -179.804 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.817 ' HB3' ' O ' ' A' ' 69' ' ' LEU . . . -118.32 -53.07 2.36 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.691 -179.884 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -161.73 159.16 26.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.905 0.383 . . . . 0.0 110.62 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.828 HG21 ' CD1' ' A' ' 52' ' ' TRP . 18.0 t -143.05 165.12 15.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.936 179.796 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.503 ' N ' HG12 ' A' ' 31' ' ' VAL . 9.6 pt-20 -174.74 147.86 1.07 Allowed 'General case' 0 N--CA 1.451 -0.411 0 CA-C-O 120.805 0.336 . . . . 0.0 110.687 -179.603 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.625 HD12 ' N ' ' A' ' 34' ' ' ARG . 2.9 pp -109.48 171.19 7.59 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.325 179.619 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.625 ' N ' HD12 ' A' ' 33' ' ' LEU . 3.8 ttp85 -101.14 -54.65 2.74 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.764 -179.514 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.453 ' CB ' ' O ' ' A' ' 34' ' ' ARG . 3.6 tt0 88.36 30.62 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 109.182 -0.674 . . . . 0.0 109.182 -178.951 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 29.8 t60 46.81 -87.7 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.068 -0.969 . . . . 0.0 111.469 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.433 ' N ' ' O ' ' A' ' 35' ' ' GLU . . . -42.32 -51.42 5.36 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 111.602 -0.599 . . . . 0.0 111.602 -179.516 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.406 ' HB2' ' HB3' ' A' ' 35' ' ' GLU . 0.6 OUTLIER -49.87 100.91 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.767 0.317 . . . . 0.0 110.585 -179.962 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -51.43 -29.89 17.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.245 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -108.39 164.15 12.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.193 179.834 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.483 ' CZ3' ' HG2' ' A' ' 67' ' ' ARG . 67.1 m95 -87.77 150.14 23.76 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.314 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.605 HG23 ' HG ' ' A' ' 33' ' ' LEU . 11.0 m -115.66 113.95 44.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.141 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.444 ' HA ' ' CB ' ' A' ' 32' ' ' GLU . . . -48.97 130.83 18.71 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.618 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.86 -169.9 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.145 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 53.9 m -141.28 107.51 5.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.325 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 17.1 ptmt -75.9 63.65 1.74 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.269 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -77.57 -26.4 61.16 Favored Glycine 0 CA--C 1.522 0.496 0 N-CA-C 110.627 -0.989 . . . . 0.0 110.627 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -84.47 -169.53 2.66 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.824 0.345 . . . . 0.0 110.322 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -107.13 -27.37 5.37 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 110.825 -0.91 . . . . 0.0 110.825 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -131.13 -3.58 4.34 Favored Glycine 0 CA--C 1.529 0.948 0 C-N-CA 121.363 -0.446 . . . . 0.0 112.34 -179.496 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.735 HG11 ' HG3' ' A' ' 9' ' ' GLU . 33.1 m -134.27 167.22 26.62 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.132 0 CA-C-N 117.573 0.687 . . . . 0.0 110.629 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' TRP . . . . . 0.828 ' CD1' HG21 ' A' ' 31' ' ' VAL . 4.7 m95 -115.04 134.97 54.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.532 -179.689 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.656 ' CG2' ' HB2' ' A' ' 18' ' ' ALA . 0.1 OUTLIER -122.18 168.63 11.77 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.721 179.414 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.601 ' CD2' HD21 ' A' ' 33' ' ' LEU . 78.8 t80 -154.04 120.13 5.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.755 0.312 . . . . 0.0 110.936 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -78.25 134.17 37.6 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.019 179.552 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -113.52 -177.77 3.21 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.905 0.383 . . . . 0.0 110.752 -179.662 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -152.24 -45.09 0.1 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.415 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.97 156.69 4.93 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.548 -179.797 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -80.31 -19.75 8.9 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.664 2.243 . . . . 0.0 111.857 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.4 tp -48.94 135.01 16.25 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.606 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -139.45 81.71 1.85 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.338 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -137.24 -148.11 5.38 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.744 -0.942 . . . . 0.0 110.744 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -78.93 139.61 15.48 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.572 2.181 . . . . 0.0 112.127 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.619 ' CE2' HD11 ' A' ' 17' ' ' LEU . 60.9 m-85 -115.45 99.1 7.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.229 179.72 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.403 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 21.6 m-20 -62.62 164.93 6.95 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.277 -0.419 . . . . 0.0 109.96 179.78 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.498 ' CE1' ' HB3' ' A' ' 33' ' ' LEU . 21.7 m-85 -142.48 -179.05 6.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.889 0.376 . . . . 0.0 110.777 -179.778 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.483 ' HG2' ' CZ3' ' A' ' 41' ' ' TRP . 7.8 ptm180 174.5 85.31 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.284 -179.755 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.49 ' HB3' HG22 ' A' ' 31' ' ' VAL . 1.6 p90 -76.95 171.95 13.95 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.134 0.492 . . . . 0.0 110.816 -179.773 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.817 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 5.4 mt -124.69 61.68 1.15 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.406 179.783 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.2 p -30.63 137.13 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.356 0.662 . . . . 0.0 112.293 -179.066 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.649 ' HG2' ' HB2' ' A' ' 29' ' ' ALA . 13.1 mt-10 -53.56 -67.54 0.25 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.338 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -111.95 61.49 0.62 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.43 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -151.21 -104.69 0.28 Allowed Glycine 0 CA--C 1.523 0.564 0 N-CA-C 110.801 -0.92 . . . . 0.0 110.801 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 179.94 172.31 1.04 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.837 0.351 . . . . 0.0 110.274 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -86.59 -178.36 6.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.413 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 172.75 153.27 0.08 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.195 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.495 HG12 ' N ' ' A' ' 78' ' ' PHE . 77.2 t -102.16 159.75 4.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.358 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.495 ' N ' HG12 ' A' ' 77' ' ' VAL . 29.8 m-85 -148.4 122.96 9.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.403 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -109.04 154.2 22.55 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.295 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 56.61 52.86 9.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.386 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.626 ' O ' HG12 ' A' ' 81' ' ' VAL . 72.9 t -95.77 5.79 8.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.169 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.441 HG23 ' O ' ' A' ' 81' ' ' VAL . 88.3 t -158.69 127.73 3.1 Favored Pre-proline 0 CA--C 1.53 0.18 0 N-CA-C 110.09 -0.337 . . . . 0.0 110.09 179.486 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -81.31 160.49 20.08 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.61 2.207 . . . . 0.0 111.893 179.73 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -55.88 121.18 8.68 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 179.364 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 61.62 59.69 1.78 Allowed 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 -179.309 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 36.3 p90 -44.48 156.94 0.07 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.25 -179.347 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 88.2 m -135.27 107.78 7.37 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.731 179.641 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.679 ' HA ' HG21 ' A' ' 8' ' ' VAL . 2.8 mp -49.42 94.45 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.852 0.358 . . . . 0.0 110.596 -179.559 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.652 ' H ' HG11 ' A' ' 8' ' ' VAL . . . 160.47 47.66 0.02 OUTLIER Glycine 0 CA--C 1.523 0.552 0 N-CA-C 111.11 -0.796 . . . . 0.0 111.11 179.84 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.48 ' HB2' ' O ' ' A' ' 89' ' ' GLY . . . 174.66 162.82 0.22 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.873 0.368 . . . . 0.0 110.79 179.811 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.976 HG23 ' O ' ' A' ' 6' ' ' PHE . 87.7 m -96.28 141.17 29.93 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.02 179.783 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.454 ' O ' ' HB2' ' A' ' 93' ' ' ALA . 8.4 m-85 -136.43 129.68 31.53 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.454 -179.837 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.899 ' HB1' ' HD2' ' A' ' 94' ' ' PRO . . . 174.98 179.28 0.17 Allowed Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.358 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.899 ' HD2' ' HB1' ' A' ' 93' ' ' ALA . 48.5 Cg_endo . . . . . 0 C--O 1.248 1.017 0 C-N-CA 122.549 2.166 . . . . 0.0 112.1 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 60.5 t . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 110.154 -0.314 . . . . 0.0 110.154 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -74.45 -170.42 0.74 Allowed 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 122.53 2.154 . . . . 0.0 111.948 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 6.0 mtpt -125.4 75.57 1.48 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.497 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.799 ' O ' HG23 ' A' ' 5' ' ' THR . 0.4 OUTLIER 41.15 -164.28 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 CA-C-O 121.135 0.493 . . . . 0.0 111.127 179.868 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.799 HG23 ' O ' ' A' ' 4' ' ' VAL . 0.6 OUTLIER -174.56 -35.79 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.626 -0.716 . . . . 0.0 111.359 -179.749 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.778 ' O ' HG23 ' A' ' 91' ' ' THR . 86.2 m-85 66.44 156.17 0.1 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.204 -179.407 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.407 ' O ' ' N ' ' A' ' 20' ' ' LEU . 0.3 OUTLIER -163.58 117.85 1.58 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.568 -179.945 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 95.2 t -64.1 101.33 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.103 179.828 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.427 ' HG3' HG21 ' A' ' 51' ' ' VAL . 4.4 mm-40 -64.75 162.91 15.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.71 -179.73 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 26.9 tttt -79.21 102.57 8.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.144 179.752 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 178.42 -35.86 0.08 OUTLIER Glycine 0 CA--C 1.523 0.553 0 N-CA-C 110.858 -0.897 . . . . 0.0 110.858 -179.807 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -48.18 130.8 16.15 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.815 0.34 . . . . 0.0 110.646 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 20.0 m-80 -123.89 -67.2 0.94 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.356 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -121.39 -78.2 0.59 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.416 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.432 ' HG2' ' N ' ' A' ' 16' ' ' HIS . 0.0 OUTLIER -97.04 -24.77 15.62 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.698 -179.87 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.432 ' N ' ' HG2' ' A' ' 15' ' ' LYS . 3.2 m-70 -63.07 119.26 9.17 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.147 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.422 HD22 ' HA ' ' A' ' 17' ' ' LEU . 0.2 OUTLIER -114.03 97.06 6.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.46 -179.844 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -94.19 131.17 40.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.37 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.611 HG23 HG23 ' A' ' 21' ' ' VAL . 18.6 m -125.26 -175.04 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.271 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.535 HD23 ' HG2' ' A' ' 22' ' ' LYS . 1.1 tt -134.88 70.39 1.44 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.219 179.88 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.611 HG23 HG23 ' A' ' 19' ' ' VAL . 6.3 t -86.25 103.63 12.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.453 -179.783 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.535 ' HG2' HD23 ' A' ' 20' ' ' LEU . 0.1 OUTLIER 176.29 131.7 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.412 179.822 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.58 ' CE2' HG23 ' A' ' 4' ' ' VAL . 6.4 p90 -151.0 158.77 44.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.265 179.864 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -74.23 115.53 13.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.404 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 155.49 -82.25 0.16 Allowed Glycine 0 CA--C 1.523 0.592 0 N-CA-C 110.743 -0.943 . . . . 0.0 110.743 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -81.91 -166.08 1.14 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.812 0.339 . . . . 0.0 110.378 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -121.42 176.01 5.88 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.465 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.405 ' O ' ' CG ' ' A' ' 71' ' ' GLU . 12.6 mtt -108.49 118.06 35.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.383 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.834 ' HB3' ' O ' ' A' ' 69' ' ' LEU . . . -119.38 -61.38 1.63 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.573 -179.831 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 15.2 tt0 -155.84 163.53 39.69 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.139 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.86 HG21 ' CD1' ' A' ' 52' ' ' TRP . 38.7 t -139.57 140.6 36.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.089 0.471 . . . . 0.0 110.721 -179.796 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.413 ' OE1' ' HB2' ' A' ' 43' ' ' ALA . 5.5 tp10 -134.78 123.33 23.42 Favored 'General case' 0 N--CA 1.441 -0.925 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.271 -179.755 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.787 HD12 ' N ' ' A' ' 34' ' ' ARG . 2.7 pp -111.92 177.08 4.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.213 0.53 . . . . 0.0 111.223 -179.395 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.787 ' N ' HD12 ' A' ' 33' ' ' LEU . 6.8 ttt180 -145.35 175.32 10.39 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.342 179.576 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.423 ' O ' ' HB2' ' A' ' 36' ' ' HIS . 17.9 mt-10 -116.12 -82.76 0.63 Allowed 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 179.728 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.423 ' HB2' ' O ' ' A' ' 35' ' ' GLU . 20.6 t-160 178.08 -37.38 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.062 179.095 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -111.1 -18.66 8.09 Favored Glycine 0 CA--C 1.527 0.813 0 N-CA-C 111.007 -0.837 . . . . 0.0 111.007 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.5 p -47.4 152.1 0.68 Allowed 'General case' 0 N--CA 1.462 0.136 0 CA-C-O 120.847 0.356 . . . . 0.0 110.772 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 36.1 m-20 -53.65 -44.06 69.29 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.516 -179.829 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -162.76 -177.04 5.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.414 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.488 ' CZ3' ' HG2' ' A' ' 67' ' ' ARG . 55.2 m95 -58.76 156.28 11.39 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.205 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.509 HG23 ' O ' ' A' ' 42' ' ' VAL . 18.6 m -130.17 113.86 27.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.315 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.413 ' HB2' ' OE1' ' A' ' 32' ' ' GLU . . . -55.52 123.2 13.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.214 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.55 ' HG2' HD23 ' A' ' 33' ' ' LEU . 0.1 OUTLIER -51.7 -176.57 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.804 -179.797 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.418 ' O ' ' N ' ' A' ' 47' ' ' GLY . 33.1 m -149.73 126.03 10.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.393 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 15.1 ptmt -65.19 75.33 0.05 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.2 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.418 ' N ' ' O ' ' A' ' 45' ' ' THR . . . -93.89 -32.11 7.76 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 110.945 -0.862 . . . . 0.0 110.945 -179.825 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.41 ' HB2' ' O ' ' A' ' 51' ' ' VAL . 0.1 OUTLIER -78.42 174.14 11.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.871 0.367 . . . . 0.0 110.29 -179.983 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -104.64 34.46 5.77 Favored Glycine 0 CA--C 1.522 0.524 0 N-CA-C 110.228 -1.149 . . . . 0.0 110.228 179.724 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 178.78 -35.01 0.08 OUTLIER Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.979 -0.849 . . . . 0.0 110.979 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.527 HG11 ' HA ' ' A' ' 20' ' ' LEU . 3.3 m -123.03 -176.31 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 120.87 0.367 . . . . 0.0 110.557 -179.814 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' TRP . . . . . 0.86 ' CD1' HG21 ' A' ' 31' ' ' VAL . 7.1 m95 -98.36 139.49 34.04 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.725 -179.587 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -131.13 152.22 50.64 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.177 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 70.3 t80 -130.21 141.38 50.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.546 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -97.86 114.81 26.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.339 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -105.97 179.18 4.34 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.467 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -172.02 39.05 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.607 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -123.34 156.77 63.17 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.339 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -71.75 -43.54 1.27 Allowed 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.614 2.209 . . . . 0.0 112.012 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 3.5 mt -69.53 122.45 19.06 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.474 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.13 88.29 2.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.278 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -104.25 -148.37 18.59 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.854 -0.898 . . . . 0.0 110.854 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -78.24 167.16 23.58 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.573 2.182 . . . . 0.0 112.141 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -123.64 113.84 19.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.378 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 70.9 m-20 -86.86 131.98 33.95 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 179.437 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.51 ' CE1' ' HB3' ' A' ' 33' ' ' LEU . 44.7 m-85 -113.38 178.07 4.41 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.101 0.477 . . . . 0.0 111.105 -179.444 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.488 ' HG2' ' CZ3' ' A' ' 41' ' ' TRP . 0.0 OUTLIER 175.29 55.04 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.494 -0.776 . . . . 0.0 109.696 179.975 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.668 ' O ' HD23 ' A' ' 69' ' ' LEU . 4.2 p90 -50.23 174.21 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.844 -0.617 . . . . 0.0 111.24 -179.307 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.834 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 2.6 mt -130.09 75.93 1.69 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.194 179.485 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.426 ' OG1' ' N ' ' A' ' 74' ' ' MET . 16.8 p -37.49 149.46 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.6 -179.17 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.672 ' HG2' ' HB2' ' A' ' 29' ' ' ALA . 5.1 mm-40 -60.97 -54.18 48.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.02 -179.338 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -129.81 58.14 1.66 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.89 0.376 . . . . 0.0 110.795 -179.568 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -149.07 -107.95 0.46 Allowed Glycine 0 CA--C 1.523 0.582 0 N-CA-C 110.895 -0.882 . . . . 0.0 110.895 179.784 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.426 ' N ' ' OG1' ' A' ' 70' ' ' THR . 0.0 OUTLIER -166.33 179.07 5.81 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 110.223 -0.288 . . . . 0.0 110.223 179.936 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.4 138.38 50.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.447 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.423 ' O ' ' CE2' ' A' ' 78' ' ' PHE . 24.8 m-20 -135.46 127.93 30.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.298 179.854 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 58.4 t -77.46 147.59 7.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.617 -179.8 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.423 ' CE2' ' O ' ' A' ' 76' ' ' ASN . 72.6 m-85 -132.27 121.65 23.93 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.157 179.805 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -110.27 140.88 43.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.698 -179.733 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 70.0 32.44 3.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.791 179.656 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.601 HG22 ' HD3' ' A' ' 94' ' ' PRO . 18.4 t -65.13 -68.26 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 179.564 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 93.3 t -86.53 131.48 45.63 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.168 179.697 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.453 ' HD3' ' CB ' ' A' ' 92' ' ' TYR . 50.6 Cg_endo -82.79 161.16 16.3 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.557 2.171 . . . . 0.0 112.047 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -62.33 125.24 23.22 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.188 179.817 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 58.86 47.93 11.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.145 -179.829 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.4 ' OH ' ' CD2' ' A' ' 17' ' ' LEU . 22.7 p90 -50.12 175.67 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.775 -179.814 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -137.23 104.56 5.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.998 179.736 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 2.7 mp -46.14 102.83 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.767 -179.773 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 145.52 48.49 0.03 OUTLIER Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.741 -0.944 . . . . 0.0 110.741 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 179.1 -176.3 0.25 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.931 0.396 . . . . 0.0 110.423 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.778 HG23 ' O ' ' A' ' 6' ' ' PHE . 89.5 m -118.12 141.38 48.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.259 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.453 ' CB ' ' HD3' ' A' ' 83' ' ' PRO . 6.2 m-85 -140.45 124.13 17.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.533 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.881 ' HB1' ' HD2' ' A' ' 94' ' ' PRO . . . -156.49 179.55 1.33 Allowed Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.121 -0.49 . . . . 0.0 109.93 179.533 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.881 ' HD2' ' HB1' ' A' ' 93' ' ' ALA . 48.5 Cg_endo . . . . . 0 C--O 1.249 1.029 0 C-N-CA 122.525 2.15 . . . . 0.0 112.059 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 9.6 t . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 110.237 -0.283 . . . . 0.0 110.237 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -75.31 95.7 1.0 Allowed 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.56 2.173 . . . . 0.0 111.921 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.1 mmtt -153.46 90.71 1.43 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.63 -179.718 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.708 HG11 ' CZ ' ' A' ' 78' ' ' PHE . 2.4 p -115.53 162.72 13.38 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.342 0 CA-C-O 121.223 0.535 . . . . 0.0 109.996 179.503 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.847 HG22 HG21 ' A' ' 91' ' ' THR . 0.2 OUTLIER -134.32 151.99 51.56 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.566 179.984 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.651 ' CE2' HG22 ' A' ' 21' ' ' VAL . 17.8 m-85 -128.73 -176.09 3.74 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.881 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -167.03 174.63 8.19 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.05 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.812 ' O ' HG23 ' A' ' 88' ' ' ILE . 93.5 t -123.37 83.29 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.1 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.673 ' HG3' HG11 ' A' ' 51' ' ' VAL . 3.4 mt-10 -47.59 161.53 0.09 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.857 -179.589 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 12.1 mttm -60.72 -18.63 55.52 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.001 -179.795 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -74.05 -2.3 61.71 Favored Glycine 0 CA--C 1.53 1.004 0 N-CA-C 111.824 -0.51 . . . . 0.0 111.824 -179.841 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.435 ' OG ' HG13 ' A' ' 8' ' ' VAL . 4.5 m -76.54 128.59 35.04 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 117.216 0.508 . . . . 0.0 110.538 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -134.28 -164.32 1.49 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.143 179.719 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.442 ' HG3' ' CD ' ' A' ' 15' ' ' LYS . 22.1 pt-20 -75.87 -41.51 52.0 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.466 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.442 ' CD ' ' HG3' ' A' ' 14' ' ' GLU . 1.5 mmmt -85.12 -39.8 17.5 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.489 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 30.3 m80 -97.61 161.67 13.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.596 -179.773 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.523 ' HA ' HD22 ' A' ' 17' ' ' LEU . 0.4 OUTLIER -141.84 85.88 1.96 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.565 179.559 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -79.43 143.01 35.41 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.238 -179.609 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.639 HG21 ' CZ ' ' A' ' 66' ' ' PHE . 30.1 m -138.71 137.27 43.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.288 -179.863 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -91.51 65.0 5.13 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.2 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.651 HG22 ' CE2' ' A' ' 6' ' ' PHE . 10.0 t -61.78 115.18 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.415 -179.811 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 2.2 tttp -172.69 178.55 2.63 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.189 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.481 ' CD1' ' N ' ' A' ' 23' ' ' TYR . 0.0 OUTLIER -146.18 -71.31 0.25 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.044 -179.923 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -143.4 -57.88 0.41 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.219 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -168.34 63.36 0.19 Allowed Glycine 0 CA--C 1.523 0.587 0 N-CA-C 110.759 -0.937 . . . . 0.0 110.759 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -97.33 -167.35 1.52 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.776 0.322 . . . . 0.0 110.41 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 29.3 p -119.67 132.01 55.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.447 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.427 ' O ' ' CG ' ' A' ' 71' ' ' GLU . 0.0 OUTLIER -85.99 123.86 31.79 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.7 -179.851 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.703 ' HB3' ' O ' ' A' ' 69' ' ' LEU . . . -117.81 -61.54 1.67 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.407 -179.852 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.677 ' CB ' HD12 ' A' ' 69' ' ' LEU . 4.2 mt-10 -155.83 151.51 27.26 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.025 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.445 ' HA ' ' HA ' ' A' ' 68' ' ' PHE . 12.1 t -141.27 142.95 28.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.661 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.464 ' CB ' ' HA ' ' A' ' 43' ' ' ALA . 3.9 pt-20 -137.3 142.87 41.9 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.022 -0.535 . . . . 0.0 109.905 179.798 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.772 HD12 ' H ' ' A' ' 34' ' ' ARG . 5.6 tp -118.92 147.43 44.02 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 -179.47 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.772 ' H ' HD12 ' A' ' 33' ' ' LEU . 4.7 ttp180 -144.08 164.02 31.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.008 179.583 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.452 ' OE1' ' CD1' ' A' ' 64' ' ' PHE . 2.4 mm-40 -118.56 -72.82 0.67 Allowed 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 179.747 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 6.0 t-80 -179.17 -39.33 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.348 179.656 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -136.32 57.39 0.68 Allowed Glycine 0 CA--C 1.523 0.552 0 N-CA-C 110.545 -1.022 . . . . 0.0 110.545 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.1 t -132.88 68.88 1.49 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.91 0.386 . . . . 0.0 110.486 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 23.6 t0 49.1 38.19 12.39 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.78 179.796 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 64.73 -173.37 0.18 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.653 179.732 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.511 ' CD2' ' HD3' ' A' ' 34' ' ' ARG . 94.1 m95 -46.84 143.26 2.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.885 -179.841 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.548 HG23 ' O ' ' A' ' 33' ' ' LEU . 2.4 m -137.58 111.46 8.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.85 179.531 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.464 ' HA ' ' CB ' ' A' ' 32' ' ' GLU . . . -44.71 152.13 0.24 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.105 -179.452 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -72.16 -169.51 0.5 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.349 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 37.7 m -143.63 101.26 3.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.181 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 10.8 ptmt -64.76 80.71 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.534 -179.833 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -117.4 -37.14 0.94 Allowed Glycine 0 CA--C 1.523 0.588 0 N-CA-C 110.65 -0.98 . . . . 0.0 110.65 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.407 ' HB3' ' O ' ' A' ' 51' ' ' VAL . 8.4 tm-20 -60.86 -33.39 73.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.756 0.312 . . . . 0.0 110.351 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 97.82 -69.76 0.71 Allowed Glycine 0 CA--C 1.523 0.545 0 N-CA-C 110.774 -0.93 . . . . 0.0 110.774 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -74.83 -29.13 61.54 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 110.589 -1.004 . . . . 0.0 110.589 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.673 HG11 ' HG3' ' A' ' 9' ' ' GLU . 14.1 m -136.38 -177.49 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.791 0.329 . . . . 0.0 110.278 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' TRP . . . . . 0.421 ' CD1' HG21 ' A' ' 31' ' ' VAL . 7.0 m95 -110.25 132.64 54.0 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.558 -179.719 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -115.3 160.72 19.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.145 179.826 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.527 ' CB ' HD23 ' A' ' 33' ' ' LEU . 40.5 t80 -148.61 112.63 5.17 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.555 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -70.86 135.98 48.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.147 179.763 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -142.49 125.99 16.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.612 -179.816 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -93.17 -30.45 15.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.01 179.74 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.439 ' HB2' ' CD ' ' A' ' 59' ' ' PRO . 0.4 OUTLIER -51.84 170.15 0.23 Allowed Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.253 179.754 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.439 ' CD ' ' HB2' ' A' ' 58' ' ' GLU . 37.4 Cg_endo -91.66 56.92 0.9 Allowed 'Trans proline' 0 N--CA 1.45 -1.037 0 C-N-CA 123.569 2.846 . . . . 0.0 111.761 179.339 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.73 HD13 ' HZ ' ' A' ' 64' ' ' PHE . 0.6 OUTLIER -47.44 93.07 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.78 -179.756 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -119.23 47.33 1.71 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.341 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -165.96 -165.19 22.9 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.502 -1.039 . . . . 0.0 110.502 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -79.94 155.7 23.34 Favored 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 122.55 2.166 . . . . 0.0 112.065 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.73 ' HZ ' HD13 ' A' ' 60' ' ' LEU . 46.8 m-85 -101.8 -173.97 2.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.21 -0.45 . . . . 0.0 109.88 179.743 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -149.27 119.18 7.11 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.095 -179.87 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.639 ' CZ ' HG21 ' A' ' 19' ' ' VAL . 13.4 m-85 -108.21 163.47 13.14 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.423 -179.828 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.944 ' HD2' HG22 ' A' ' 77' ' ' VAL . 21.7 mtp180 -163.44 84.69 0.49 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.141 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.587 ' O ' HD23 ' A' ' 69' ' ' LEU . 6.5 p90 -75.82 169.9 17.26 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.2 0.524 . . . . 0.0 110.691 -179.783 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.703 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 3.9 mt -133.9 50.49 2.2 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.184 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 8.3 p -22.74 137.94 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.167 0.987 . . . . 0.0 113.037 -179.035 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.653 ' N ' ' HB2' ' A' ' 29' ' ' ALA . 2.6 mm-40 -55.94 -31.18 62.71 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.166 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 14.9 tptt -151.14 70.28 0.98 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.165 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -151.1 -97.49 0.16 Allowed Glycine 0 CA--C 1.522 0.488 0 N-CA-C 110.816 -0.914 . . . . 0.0 110.816 -179.854 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 13.2 ptp 172.63 166.82 0.12 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.748 0.309 . . . . 0.0 110.288 -179.792 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 18.4 mmtm -83.71 147.84 27.42 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 179.718 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -154.98 132.56 11.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.804 0.335 . . . . 0.0 110.472 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.944 HG22 ' HD2' ' A' ' 67' ' ' ARG . 93.8 t -97.27 146.67 7.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.148 0.499 . . . . 0.0 110.618 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.708 ' CZ ' HG11 ' A' ' 4' ' ' VAL . 41.1 m-85 -131.05 133.65 45.91 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.304 -179.486 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -127.14 31.87 5.17 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.368 -179.76 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -168.39 52.03 0.05 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.483 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.451 ' C ' HG23 ' A' ' 82' ' ' VAL . 57.1 t -93.64 -12.2 8.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.549 -179.077 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.534 HG13 ' HD2' ' A' ' 83' ' ' PRO . 70.3 t -156.76 141.33 12.02 Favored Pre-proline 0 C--N 1.332 -0.166 0 CA-C-O 120.696 0.284 . . . . 0.0 110.694 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.534 ' HD2' HG13 ' A' ' 82' ' ' VAL . 51.9 Cg_endo -81.26 -166.71 0.43 Allowed 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.72 2.28 . . . . 0.0 111.904 179.763 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.417 ' HG3' ' N ' ' A' ' 85' ' ' LYS . 5.1 pt-20 -78.15 -27.11 48.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.173 179.557 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.417 ' N ' ' HG3' ' A' ' 84' ' ' GLU . 0.0 OUTLIER -140.33 73.53 1.43 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.014 179.771 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.48 ' HB3' HG13 ' A' ' 82' ' ' VAL . 45.1 p90 -57.12 173.91 0.2 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.79 -179.624 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -152.43 113.66 4.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.035 179.696 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.812 HG23 ' O ' ' A' ' 8' ' ' VAL . 3.3 mp -48.5 109.11 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.828 -179.645 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 121.42 52.26 0.24 Allowed Glycine 0 CA--C 1.523 0.589 0 N-CA-C 111.015 -0.834 . . . . 0.0 111.015 179.801 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -179.31 148.85 0.38 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.846 0.355 . . . . 0.0 110.794 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.847 HG21 HG22 ' A' ' 5' ' ' THR . 19.4 m -92.77 135.51 34.05 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.895 179.589 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.498 ' CG ' ' HD3' ' A' ' 83' ' ' PRO . 66.8 m-85 -118.7 -26.47 6.11 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.635 -178.948 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.781 ' HB1' ' HD2' ' A' ' 94' ' ' PRO . . . -49.18 171.29 0.11 Allowed Pre-proline 0 C--N 1.331 -0.235 0 CA-C-O 120.648 0.261 . . . . 0.0 110.746 -179.803 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.781 ' HD2' ' HB1' ' A' ' 93' ' ' ALA . 47.7 Cg_endo . . . . . 0 C--O 1.249 1.066 0 C-N-CA 122.547 2.165 . . . . 0.0 111.991 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.66 ' O ' HG13 ' A' ' 1' ' ' VAL . 7.1 p . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -74.48 166.15 30.09 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.571 2.181 . . . . 0.0 112.018 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -125.54 80.67 1.91 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.376 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.581 HG21 ' CZ ' ' A' ' 78' ' ' PHE . 20.3 m -73.94 162.97 4.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.511 -179.889 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 43.5 p -148.34 128.84 14.01 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.176 179.845 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.624 ' O ' HG23 ' A' ' 91' ' ' THR . 42.5 m-85 -87.13 171.91 10.33 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.356 -179.828 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.755 HG23 ' O ' ' A' ' 90' ' ' ALA . 2.7 m -163.13 112.29 1.31 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.552 -179.859 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.4 HG13 ' OG ' ' A' ' 12' ' ' SER . 57.8 t -61.57 96.16 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.251 179.866 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.971 ' HG3' HG21 ' A' ' 51' ' ' VAL . 8.5 mm-40 -52.14 166.29 0.17 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.351 -179.906 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 17.1 mttp -60.32 -28.56 68.23 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.685 -179.804 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.418 ' O ' ' CB ' ' A' ' 18' ' ' ALA . . . -83.22 69.18 3.42 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 110.98 -0.848 . . . . 0.0 110.98 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.4 ' OG ' HG13 ' A' ' 8' ' ' VAL . 0.4 OUTLIER -130.37 128.65 41.85 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.702 0.287 . . . . 0.0 110.283 179.85 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 17.3 p30 -166.79 -174.96 2.92 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.618 -179.815 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -54.72 127.0 26.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.339 0.59 . . . . 0.0 110.494 -179.904 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.413 ' O ' ' ND1' ' A' ' 16' ' ' HIS . 0.0 OUTLIER 67.74 20.88 9.38 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.155 -0.929 . . . . 0.0 110.958 179.572 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.413 ' ND1' ' O ' ' A' ' 15' ' ' LYS . 78.2 m80 -157.68 89.01 1.0 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.826 0.346 . . . . 0.0 110.549 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.573 HD13 ' C ' ' A' ' 17' ' ' LEU . 3.0 tm? -100.97 85.25 2.82 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.937 179.851 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.483 ' HB2' ' CG2' ' A' ' 53' ' ' THR . . . -77.82 145.21 36.48 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.75 -179.632 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.615 ' O ' HG13 ' A' ' 51' ' ' VAL . 31.5 m -147.71 131.0 8.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.033 179.322 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.648 HD12 ' OE1' ' A' ' 9' ' ' GLU . 0.6 OUTLIER -83.5 85.02 7.32 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.773 -179.568 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.507 HG23 HG23 ' A' ' 19' ' ' VAL . 24.3 t -87.4 88.85 2.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.194 179.669 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.452 ' HG2' ' N ' ' A' ' 23' ' ' TYR . 38.5 tttm -145.96 160.25 42.11 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.475 -179.848 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.512 ' CE2' HG12 ' A' ' 4' ' ' VAL . 18.5 p90 177.01 174.9 0.4 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.345 179.784 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -101.28 128.33 47.47 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.453 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 146.43 -49.03 0.65 Allowed Glycine 0 CA--C 1.523 0.575 0 N-CA-C 110.669 -0.973 . . . . 0.0 110.669 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -135.94 -177.47 4.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.745 0.307 . . . . 0.0 110.336 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -116.13 172.69 7.01 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.496 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.549 ' O ' ' HB2' ' A' ' 29' ' ' ALA . 0.1 OUTLIER -75.74 -173.78 2.34 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.436 -179.934 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.768 ' HB3' ' O ' ' A' ' 69' ' ' LEU . . . 168.52 -64.82 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.29 179.801 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.412 ' O ' ' HB2' ' A' ' 68' ' ' PHE . 0.2 OUTLIER -148.0 162.78 38.65 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.778 -179.862 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.532 HG11 ' CD1' ' A' ' 52' ' ' TRP . 1.9 p 174.48 138.94 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.093 0.473 . . . . 0.0 110.384 -179.869 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.43 ' HB3' ' HA ' ' A' ' 43' ' ' ALA . 0.3 OUTLIER -137.09 178.29 7.2 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.351 -179.634 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.548 HD21 ' CZ ' ' A' ' 66' ' ' PHE . 2.3 mt -114.59 176.42 5.06 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.006 0.431 . . . . 0.0 110.767 -179.65 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.493 ' HB2' ' CZ3' ' A' ' 41' ' ' TRP . 0.0 OUTLIER -161.25 170.79 19.57 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.007 179.632 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -139.44 14.65 2.57 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.283 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER 52.99 25.62 4.16 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.613 0.244 . . . . 0.0 110.793 179.58 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -161.58 29.54 0.3 Allowed Glycine 0 CA--C 1.524 0.62 0 N-CA-C 110.964 -0.854 . . . . 0.0 110.964 -179.761 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -112.09 -16.39 13.06 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.528 0.204 . . . . 0.0 110.97 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 71.21 8.84 6.51 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.78 -0.191 . . . . 0.0 111.067 -179.81 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 26.3 pt-20 179.42 151.47 0.36 Allowed 'General case' 0 C--O 1.231 0.105 0 CA-C-O 120.743 0.306 . . . . 0.0 110.244 179.722 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.512 ' CE3' ' HG2' ' A' ' 67' ' ' ARG . 86.2 m95 -76.89 160.65 29.04 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.377 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.584 HG23 ' O ' ' A' ' 42' ' ' VAL . 29.7 m -134.49 106.37 7.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.319 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.43 ' HA ' ' HB3' ' A' ' 32' ' ' GLU . . . -44.06 131.5 5.83 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.122 -179.75 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.55 -170.13 0.19 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.367 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 42.8 m -147.49 118.68 7.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.342 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.408 ' HB3' ' CZ3' ' A' ' 52' ' ' TRP . 1.1 ptpt -71.77 68.75 0.64 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.576 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -90.01 -12.71 61.61 Favored Glycine 0 CA--C 1.528 0.85 0 N-CA-C 111.227 -0.749 . . . . 0.0 111.227 179.753 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.469 ' HB3' ' HB ' ' A' ' 51' ' ' VAL . 0.1 OUTLIER -85.41 3.83 38.27 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 116.875 0.338 . . . . 0.0 111.391 -179.831 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 64.19 21.53 66.21 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 111.041 -0.824 . . . . 0.0 111.041 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 171.96 -35.21 0.15 Allowed Glycine 0 CA--C 1.52 0.384 0 N-CA-C 109.959 -1.256 . . . . 0.0 109.959 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.971 HG21 ' HG3' ' A' ' 9' ' ' GLU . 3.0 t -106.78 157.81 6.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 179.555 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' TRP . . . . . 0.532 ' CD1' HG11 ' A' ' 31' ' ' VAL . 3.6 m95 -92.18 123.68 35.7 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.015 0.436 . . . . 0.0 110.945 -179.132 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.483 ' CG2' ' HB2' ' A' ' 18' ' ' ALA . 1.3 p -112.69 140.64 47.29 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.313 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 60.7 t80 -121.16 145.33 47.93 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.368 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -88.56 90.1 8.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.34 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -61.19 110.8 1.49 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.541 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -95.15 -36.75 11.36 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.303 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.407 ' O ' ' CG ' ' A' ' 58' ' ' GLU . 5.6 pt-20 -102.74 116.01 63.34 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.345 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -92.4 42.22 0.31 Allowed 'Trans proline' 0 N--CA 1.451 -0.986 0 C-N-CA 123.356 2.704 . . . . 0.0 112.439 179.669 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 2.1 mp -77.34 -175.0 3.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.229 179.76 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 19.8 pt20 -105.89 32.63 4.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.385 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -90.79 154.03 22.88 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.638 -0.985 . . . . 0.0 110.638 179.838 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -79.79 170.02 17.38 Favored 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 122.577 2.184 . . . . 0.0 112.047 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 16.6 m-30 -108.6 149.63 28.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.626 -179.844 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.4 ' HB2' ' HB3' ' A' ' 34' ' ' ARG . 6.8 m-80 -133.72 145.94 50.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.817 179.602 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.548 ' CZ ' HD21 ' A' ' 33' ' ' LEU . 67.1 m-85 -125.36 -177.83 4.02 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.143 0.497 . . . . 0.0 110.694 -179.818 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.512 ' HG2' ' CE3' ' A' ' 41' ' ' TRP . 0.0 OUTLIER 179.92 70.37 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.411 179.692 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.593 ' O ' HD23 ' A' ' 69' ' ' LEU . 6.5 p90 -72.27 179.68 3.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.375 0.607 . . . . 0.0 111.413 -178.92 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.768 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 9.5 mt -141.5 77.02 1.57 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.428 179.797 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.426 ' H ' HG23 ' A' ' 70' ' ' THR . 21.4 p -36.21 136.54 0.3 Allowed 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 116.06 -0.518 . . . . 0.0 112.006 -179.114 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.493 ' CA ' ' HB2' ' A' ' 29' ' ' ALA . 0.1 OUTLIER -42.03 -34.23 0.68 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.192 179.782 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 3.1 tmtm? -56.87 -48.79 77.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.476 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 123.85 76.94 0.33 Allowed Glycine 0 CA--C 1.523 0.589 0 N-CA-C 110.794 -0.922 . . . . 0.0 110.794 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.413 ' CG ' ' OG1' ' A' ' 70' ' ' THR . 9.8 ptp -169.72 144.49 2.88 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.788 0.327 . . . . 0.0 110.172 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -111.71 178.62 4.26 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.654 -179.631 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 176.92 127.87 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.045 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.477 HG12 ' N ' ' A' ' 78' ' ' PHE . 63.4 t -88.85 158.28 3.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.705 -179.75 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.581 ' CZ ' HG21 ' A' ' 4' ' ' VAL . 51.1 m-85 -140.38 117.33 11.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.966 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -103.94 150.58 24.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.789 -179.472 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 50.85 57.03 7.09 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.618 179.78 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.537 HG22 ' HD3' ' A' ' 94' ' ' PRO . 57.3 t -84.54 -80.8 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 179.755 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.554 HG13 ' HD2' ' A' ' 83' ' ' PRO . 60.5 t -81.91 139.5 46.47 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.438 -0.347 . . . . 0.0 110.53 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.554 ' HD2' HG13 ' A' ' 82' ' ' VAL . 46.7 Cg_endo -69.82 -167.06 0.21 Allowed 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.701 2.267 . . . . 0.0 112.031 179.546 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -78.99 -27.82 43.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.156 179.715 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -138.94 77.38 1.62 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.254 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 18.8 p90 -51.23 160.27 0.55 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.532 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 6.0 m -136.44 111.78 9.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.224 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 2.7 mp -50.41 115.13 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.509 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 114.4 38.45 1.1 Allowed Glycine 0 CA--C 1.522 0.512 0 N-CA-C 110.631 -0.988 . . . . 0.0 110.631 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.755 ' O ' HG23 ' A' ' 7' ' ' THR . . . -156.27 -177.79 6.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.851 0.358 . . . . 0.0 110.492 -179.904 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.624 HG23 ' O ' ' A' ' 6' ' ' PHE . 93.3 m -127.27 143.31 51.26 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.399 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.564 ' OH ' ' HB3' ' A' ' 90' ' ' ALA . 3.9 m-85 -144.45 128.4 17.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.127 179.796 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.927 ' HB1' ' HD2' ' A' ' 94' ' ' PRO . . . 176.15 179.08 0.2 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.411 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.927 ' HD2' ' HB1' ' A' ' 93' ' ' ALA . 48.5 Cg_endo . . . . . 0 C--O 1.249 1.03 0 C-N-CA 122.61 2.207 . . . . 0.0 112.174 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 6.7 m . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 120.757 0.313 . . . . 0.0 110.222 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -79.65 126.24 6.57 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.627 2.218 . . . . 0.0 111.939 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 37.2 mttm -151.02 65.16 0.91 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.634 -179.78 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.655 HG11 ' CZ ' ' A' ' 78' ' ' PHE . 2.5 p -179.6 163.41 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.341 0.591 . . . . 0.0 110.627 179.843 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.863 HG22 HG21 ' A' ' 91' ' ' THR . 0.0 OUTLIER -142.02 145.24 34.18 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.108 179.594 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.587 ' CD1' ' HB2' ' A' ' 93' ' ' ALA . 16.1 m-85 -117.25 165.8 13.01 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.14 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.415 ' O ' ' N ' ' A' ' 20' ' ' LEU . 0.2 OUTLIER -165.97 109.02 0.78 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.226 179.986 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.716 ' O ' HG23 ' A' ' 88' ' ' ILE . 84.6 t -61.45 90.58 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.451 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.913 ' HG3' HG11 ' A' ' 51' ' ' VAL . 21.1 mm-40 -55.1 176.39 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.477 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 12.9 mttt -74.0 -13.1 60.82 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.036 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -46.54 -28.37 3.45 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 111.021 -0.832 . . . . 0.0 111.021 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.5 m -53.08 121.71 7.97 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 179.776 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -110.61 -71.66 0.75 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.423 -179.894 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -138.62 -58.29 0.62 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.783 0.325 . . . . 0.0 110.54 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 10.2 pttt -104.91 -29.08 10.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.548 -179.798 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -64.53 166.0 9.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.5 -179.734 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 44.5 tp -146.43 85.3 1.65 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.363 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.501 ' HB2' ' CG2' ' A' ' 53' ' ' THR . . . -76.34 134.8 39.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.44 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.566 HG23 HG23 ' A' ' 21' ' ' VAL . 34.8 m -130.26 152.2 37.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.182 179.851 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.548 HD12 ' OE2' ' A' ' 9' ' ' GLU . 0.9 OUTLIER -99.58 91.46 4.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.294 179.891 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.566 HG23 HG23 ' A' ' 19' ' ' VAL . 17.8 t -99.72 97.0 5.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.608 -179.729 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 176.29 133.21 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.44 179.777 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.423 ' CZ ' ' OD2' ' A' ' 26' ' ' ASP . 0.1 OUTLIER -115.87 -73.87 0.63 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.338 -179.974 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -174.6 -56.93 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.586 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -46.59 -66.73 1.64 Allowed Glycine 0 CA--C 1.525 0.666 0 N-CA-C 111.217 -0.753 . . . . 0.0 111.217 -179.754 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.423 ' OD2' ' CZ ' ' A' ' 23' ' ' TYR . 44.4 p-10 -71.09 165.41 23.6 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.846 0.355 . . . . 0.0 110.482 -179.832 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.65 HG22 ' O ' ' A' ' 27' ' ' THR . 50.9 m -127.29 45.32 2.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.229 179.837 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.492 ' O ' ' HB2' ' A' ' 29' ' ' ALA . 14.7 mtt 60.15 175.93 0.09 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.502 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.634 ' HB3' ' O ' ' A' ' 69' ' ' LEU . . . 172.8 -61.7 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.306 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.447 ' HB3' HD12 ' A' ' 69' ' ' LEU . 19.9 tt0 -160.62 161.61 32.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.345 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.569 HG21 ' CD1' ' A' ' 52' ' ' TRP . 44.4 t -157.27 148.7 10.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.957 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.469 ' CB ' ' HA ' ' A' ' 43' ' ' ALA . 0.3 OUTLIER -148.6 136.15 20.51 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.978 0.418 . . . . 0.0 110.507 -179.81 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.612 HD12 ' N ' ' A' ' 34' ' ' ARG . 6.0 tp -104.1 141.69 35.78 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.958 -0.564 . . . . 0.0 109.61 -179.599 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.612 ' N ' HD12 ' A' ' 33' ' ' LEU . 1.1 ttm180 -85.25 -63.7 1.28 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.618 -179.858 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.459 ' CB ' ' O ' ' A' ' 34' ' ' ARG . 2.4 tt0 91.16 48.19 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 109.003 -0.739 . . . . 0.0 109.003 -179.154 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.441 ' CG ' ' C ' ' A' ' 35' ' ' GLU . 1.2 p80 44.41 -89.44 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 114.845 -1.071 . . . . 0.0 111.207 -179.639 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.431 ' N ' ' O ' ' A' ' 35' ' ' GLU . . . -106.21 93.53 0.88 Allowed Glycine 0 CA--C 1.523 0.566 0 N-CA-C 110.883 -0.887 . . . . 0.0 110.883 -179.831 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.433 ' HB2' ' HB3' ' A' ' 35' ' ' GLU . 8.1 t -139.86 25.27 2.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.586 0.231 . . . . 0.0 110.625 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 77.43 -54.87 0.54 Allowed 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 122.993 0.517 . . . . 0.0 110.899 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -157.75 170.75 21.66 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.33 -179.807 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.501 ' CZ2' ' HD2' ' A' ' 67' ' ' ARG . 81.1 m95 -63.67 164.14 10.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.394 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.411 ' CG2' ' O ' ' A' ' 33' ' ' LEU . 3.5 m -146.82 119.06 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.309 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.469 ' HA ' ' CB ' ' A' ' 32' ' ' GLU . . . -52.87 136.43 34.25 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.38 -179.87 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.74 -169.93 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.397 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 85.0 m -128.91 104.17 7.45 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.199 179.804 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -74.12 121.0 20.47 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.46 -179.858 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 152.41 46.32 0.02 OUTLIER Glycine 0 CA--C 1.523 0.534 0 N-CA-C 110.608 -0.997 . . . . 0.0 110.608 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.421 ' O ' ' N ' ' A' ' 50' ' ' GLY . 15.8 tp10 -134.04 73.48 1.5 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.698 0.285 . . . . 0.0 110.403 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 58.92 -83.71 0.01 OUTLIER Glycine 0 CA--C 1.523 0.533 0 N-CA-C 110.705 -0.958 . . . . 0.0 110.705 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.421 ' N ' ' O ' ' A' ' 48' ' ' GLU . . . -142.92 27.4 2.18 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 110.675 -0.97 . . . . 0.0 110.675 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.913 HG11 ' HG3' ' A' ' 9' ' ' GLU . 5.7 m -145.6 -178.43 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.798 0.333 . . . . 0.0 110.361 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' TRP . . . . . 0.569 ' CD1' HG21 ' A' ' 31' ' ' VAL . 8.8 m95 -106.13 155.28 19.59 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.513 -179.727 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.501 ' CG2' ' HB2' ' A' ' 18' ' ' ALA . 0.2 OUTLIER -141.22 148.3 39.69 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.245 179.904 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.476 ' CG ' HD23 ' A' ' 33' ' ' LEU . 70.3 t80 -125.52 146.65 49.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.254 179.724 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 18.1 p-10 -89.61 93.72 9.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.665 -179.801 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.3 m -85.62 95.5 9.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.138 179.695 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.77 -34.63 13.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.729 -179.62 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.62 156.09 2.45 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 120.882 0.372 . . . . 0.0 110.644 -179.706 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -77.14 -22.62 11.1 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.546 2.164 . . . . 0.0 111.563 179.551 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.416 ' O ' ' CG ' ' A' ' 61' ' ' GLN . 91.4 mt -60.74 172.74 0.87 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.587 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.416 ' CG ' ' O ' ' A' ' 60' ' ' LEU . 0.0 OUTLIER 174.7 116.86 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.253 -179.975 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 178.84 -125.04 0.95 Allowed Glycine 0 CA--C 1.527 0.788 0 N-CA-C 110.692 -0.963 . . . . 0.0 110.692 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -73.52 146.62 39.57 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.427 2.085 . . . . 0.0 112.144 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -128.91 -177.01 4.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.384 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.457 ' HB2' ' CH2' ' A' ' 41' ' ' TRP . 2.8 m120 -144.95 149.48 35.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.307 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 -141.5 159.89 41.27 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.964 0.411 . . . . 0.0 110.867 -179.736 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.501 ' HD2' ' CZ2' ' A' ' 41' ' ' TRP . 15.8 mtp180 -154.11 61.25 0.71 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.965 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.767 ' O ' HD23 ' A' ' 69' ' ' LEU . 10.5 p90 -49.23 176.66 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.19 0.519 . . . . 0.0 110.991 -179.46 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.767 HD23 ' O ' ' A' ' 68' ' ' PHE . 14.5 mt -141.53 65.51 1.38 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.389 179.451 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 75.9 p -31.05 134.56 0.06 Allowed 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 115.606 -0.725 . . . . 0.0 112.655 -178.928 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.473 ' N ' ' HB2' ' A' ' 29' ' ' ALA . 0.1 OUTLIER -40.5 -36.96 0.63 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.452 -0.794 . . . . 0.0 111.553 179.927 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 7.9 tmtt? -61.97 -51.51 67.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.365 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 131.02 52.99 0.1 OUTLIER Glycine 0 CA--C 1.523 0.569 0 N-CA-C 110.807 -0.917 . . . . 0.0 110.807 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 13.2 mtp -133.35 128.63 36.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.847 0.356 . . . . 0.0 110.433 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.471 ' CD ' ' N ' ' A' ' 75' ' ' LYS . 0.4 OUTLIER -117.26 171.66 7.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.043 179.8 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 172.39 139.12 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.458 179.925 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.452 HG22 ' CD ' ' A' ' 67' ' ' ARG . 86.6 t -88.25 155.35 3.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.296 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.655 ' CZ ' HG11 ' A' ' 4' ' ' VAL . 97.5 m-85 -143.85 109.3 5.12 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.077 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.687 ' O ' HG23 ' A' ' 81' ' ' VAL . 18.5 t0 -71.71 164.0 26.76 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.004 -179.295 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.433 ' O ' ' HB ' ' A' ' 81' ' ' VAL . 20.3 t70 50.19 -95.9 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.713 179.88 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.687 HG23 ' O ' ' A' ' 79' ' ' ASP . 75.6 t 65.73 4.21 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 179.846 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.451 HG23 ' C ' ' A' ' 81' ' ' VAL . 88.4 t -159.54 130.5 3.77 Favored Pre-proline 0 CA--C 1.529 0.168 0 O-C-N 122.196 -0.315 . . . . 0.0 110.429 179.319 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.531 ' HD3' ' CG ' ' A' ' 92' ' ' TYR . 49.6 Cg_endo -70.22 -165.44 0.16 Allowed 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.705 2.27 . . . . 0.0 111.768 179.421 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -74.46 -53.71 9.0 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 179.372 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 10.0 mmtp -110.38 79.12 1.17 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.004 -0.543 . . . . 0.0 109.982 179.589 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 48.9 p90 -48.12 136.41 11.82 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.888 -179.648 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 75.3 m -123.3 115.71 22.14 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.15 179.81 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.716 HG23 ' O ' ' A' ' 8' ' ' VAL . 2.7 mp -55.55 119.18 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.557 -179.821 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 107.79 51.13 0.76 Allowed Glycine 0 CA--C 1.523 0.564 0 N-CA-C 111.132 -0.787 . . . . 0.0 111.132 179.75 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -174.81 135.43 0.38 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.799 0.333 . . . . 0.0 110.784 179.847 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.863 HG21 HG22 ' A' ' 5' ' ' THR . 11.5 m -79.32 129.74 34.76 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.181 -0.463 . . . . 0.0 109.881 179.565 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.531 ' CG ' ' HD3' ' A' ' 83' ' ' PRO . 35.1 m-85 -114.94 -22.19 9.71 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.186 -179.138 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.865 ' HB1' ' HD2' ' A' ' 94' ' ' PRO . . . -50.32 178.35 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 120.713 0.292 . . . . 0.0 110.527 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.865 ' HD2' ' HB1' ' A' ' 93' ' ' ALA . 47.6 Cg_endo . . . . . 0 C--O 1.249 1.066 0 C-N-CA 122.633 2.222 . . . . 0.0 112.023 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.613 ' O ' HG13 ' A' ' 1' ' ' VAL . 7.3 p . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -75.76 142.43 25.64 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.593 2.195 . . . . 0.0 112.077 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.579 ' O ' HG22 ' A' ' 4' ' ' VAL . 12.7 mtpt -122.69 42.94 3.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.288 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.799 ' O ' HG23 ' A' ' 5' ' ' THR . 15.6 m 45.5 -173.89 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.079 -179.852 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.799 HG23 ' O ' ' A' ' 4' ' ' VAL . 0.8 OUTLIER -169.78 130.5 1.03 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.518 -179.705 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.475 ' O ' HG23 ' A' ' 91' ' ' THR . 8.4 m-85 -104.75 156.39 18.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.085 179.757 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 57.5 m -157.48 121.93 4.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.877 0.37 . . . . 0.0 110.596 -179.832 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.478 ' CG1' ' CD1' ' A' ' 88' ' ' ILE . 11.9 t -60.07 93.63 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.088 179.737 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.658 ' HG3' HG11 ' A' ' 51' ' ' VAL . 14.8 mm-40 -47.62 137.5 9.12 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.757 -179.764 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 4.5 tttt -53.8 140.81 28.9 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.405 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 94.17 34.99 6.18 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.63 -0.988 . . . . 0.0 110.63 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.2 t -74.64 148.24 40.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.814 0.34 . . . . 0.0 110.389 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -134.33 152.56 51.88 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.459 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -55.21 -32.58 62.36 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.347 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.13 -12.49 28.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.292 -179.83 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 54.9 m80 -132.12 119.5 21.02 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.832 0.349 . . . . 0.0 110.795 -179.802 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.497 ' HA ' HD22 ' A' ' 17' ' ' LEU . 0.8 OUTLIER -105.87 88.35 2.8 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.948 179.681 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -84.06 119.15 24.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.981 -179.485 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.426 HG23 HG23 ' A' ' 21' ' ' VAL . 17.9 m -108.51 -166.8 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.52 179.23 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.1 tt -140.95 79.18 1.68 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.724 179.756 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.426 HG23 HG23 ' A' ' 19' ' ' VAL . 3.1 t -92.58 88.45 2.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 179.673 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.568 ' HG2' ' HE3' ' A' ' 28' ' ' MET . 7.0 mttt -142.37 161.53 37.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.58 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.401 ' CE1' ' HB2' ' A' ' 26' ' ' ASP . 0.4 OUTLIER 170.71 153.19 0.05 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.208 -179.991 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.43 ' HG3' ' N ' ' A' ' 25' ' ' GLY . 1.5 pt-20 -88.63 -25.62 22.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.515 -179.835 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.43 ' N ' ' HG3' ' A' ' 24' ' ' GLU . . . -55.29 -38.53 68.71 Favored Glycine 0 CA--C 1.523 0.555 0 N-CA-C 110.724 -0.95 . . . . 0.0 110.724 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.401 ' HB2' ' CE1' ' A' ' 23' ' ' TYR . 55.3 m-20 -131.65 176.17 8.55 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.82 0.343 . . . . 0.0 110.324 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.83 -167.49 1.35 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.378 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.568 ' HE3' ' HG2' ' A' ' 22' ' ' LYS . 1.7 mtp -123.36 117.68 25.76 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.368 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.845 ' HB3' ' O ' ' A' ' 69' ' ' LEU . . . -127.52 -60.33 1.18 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.74 -179.783 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.556 ' C ' HG12 ' A' ' 31' ' ' VAL . 0.0 OUTLIER -142.85 171.39 14.11 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.325 -179.889 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.556 HG12 ' C ' ' A' ' 30' ' ' GLU . 0.5 OUTLIER 171.51 139.58 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 121.099 0.476 . . . . 0.0 109.898 -179.786 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.446 ' CB ' ' HA ' ' A' ' 43' ' ' ALA . 1.8 pt-20 -134.79 178.51 6.96 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.178 -179.777 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.738 HD21 ' CZ ' ' A' ' 66' ' ' PHE . 4.2 mt -118.31 172.66 7.3 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.988 0.423 . . . . 0.0 110.894 -179.608 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.416 ' HB3' ' HB2' ' A' ' 65' ' ' ASN . 0.0 OUTLIER -151.47 -173.06 4.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.732 179.588 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -139.27 25.54 2.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.778 0.323 . . . . 0.0 110.709 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 48.18 31.83 2.76 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.757 179.767 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 164.12 47.43 0.02 OUTLIER Glycine 0 CA--C 1.523 0.551 0 N-CA-C 110.924 -0.87 . . . . 0.0 110.924 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 7.0 t -113.85 148.98 35.73 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 179.832 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -50.8 -29.73 12.39 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.333 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -171.34 150.11 2.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.31 179.844 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.49 ' CZ3' ' HG2' ' A' ' 67' ' ' ARG . 64.4 m95 -51.68 153.55 2.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.333 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.461 HG23 ' O ' ' A' ' 42' ' ' VAL . 27.7 m -122.3 119.26 57.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.469 -179.847 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.446 ' HA ' ' CB ' ' A' ' 32' ' ' GLU . . . -52.98 156.69 1.97 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.502 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -94.16 -176.57 4.02 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.478 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 88.3 m -128.79 106.53 8.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.558 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 31.9 mtmt -77.98 93.14 4.4 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.283 -0.417 . . . . 0.0 109.959 179.773 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -129.49 -41.45 0.25 Allowed Glycine 0 CA--C 1.523 0.584 0 N-CA-C 111.284 -0.726 . . . . 0.0 111.284 -179.549 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -49.28 -40.84 36.01 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.872 0.368 . . . . 0.0 110.628 -179.775 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 96.7 -33.23 5.84 Favored Glycine 0 CA--C 1.522 0.515 0 N-CA-C 110.196 -1.162 . . . . 0.0 110.196 -179.693 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -107.39 -24.55 6.43 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 110.574 -1.01 . . . . 0.0 110.574 179.723 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.658 HG11 ' HG3' ' A' ' 9' ' ' GLU . 17.4 m -149.24 178.03 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 120.813 0.339 . . . . 0.0 110.352 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 8.4 m95 -104.79 135.92 45.27 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.103 -179.304 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.2 p -115.74 148.57 39.65 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.072 179.725 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.679 ' HB2' HD12 ' A' ' 33' ' ' LEU . 64.9 t80 -120.51 158.97 26.14 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.849 0.356 . . . . 0.0 110.671 -179.833 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -114.45 119.6 37.43 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.297 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 8.2 p -91.76 157.2 17.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.514 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -117.76 -48.83 2.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.511 -179.911 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.41 ' HB2' ' HD2' ' A' ' 59' ' ' PRO . 5.7 pt-20 -102.76 159.09 30.37 Favored Pre-proline 0 C--N 1.331 -0.221 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.394 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.41 ' HD2' ' HB2' ' A' ' 58' ' ' GLU . 43.2 Cg_endo -67.29 -158.36 0.04 OUTLIER 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.211 1.941 . . . . 0.0 110.021 178.337 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.1 mt 58.74 109.63 0.01 OUTLIER 'General case' 0 N--CA 1.441 -0.923 0 CA-C-O 120.872 0.368 . . . . 0.0 110.926 178.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 24.6 mp0 -106.34 104.3 13.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.475 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -95.61 -165.23 34.59 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.92 -0.872 . . . . 0.0 110.92 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -74.84 132.23 15.41 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.613 2.209 . . . . 0.0 111.957 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.401 ' HD2' HG21 ' A' ' 82' ' ' VAL . 30.7 m-85 -94.11 151.32 19.58 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.501 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.416 ' HB2' ' HB3' ' A' ' 34' ' ' ARG . 1.9 m-80 -131.04 140.96 50.16 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.0 -0.546 . . . . 0.0 109.773 179.58 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.738 ' CZ ' HD21 ' A' ' 33' ' ' LEU . 76.5 m-85 -123.56 -178.94 4.16 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.074 0.464 . . . . 0.0 110.748 -179.516 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.49 ' HG2' ' CZ3' ' A' ' 41' ' ' TRP . 5.4 ptm180 -177.33 75.22 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.497 179.771 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.735 ' O ' HD23 ' A' ' 69' ' ' LEU . 9.9 p90 -68.55 179.5 1.67 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.416 0.627 . . . . 0.0 111.315 -179.088 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.845 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 15.2 mt -142.87 72.3 1.37 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.212 179.485 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 72.3 p -31.39 134.1 0.08 Allowed 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 115.642 -0.708 . . . . 0.0 112.447 -178.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.712 ' HG2' ' HB2' ' A' ' 29' ' ' ALA . 2.3 mm-40 -50.02 -27.15 5.08 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.421 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -63.77 -41.46 97.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.137 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 123.37 65.25 0.21 Allowed Glycine 0 CA--C 1.524 0.61 0 N-CA-C 110.848 -0.901 . . . . 0.0 110.848 179.836 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 4.2 mtt -155.39 145.48 21.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.793 0.33 . . . . 0.0 110.452 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.461 ' CD ' ' N ' ' A' ' 75' ' ' LYS . 0.0 OUTLIER -121.44 -177.24 3.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.095 179.985 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 173.14 176.03 0.11 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.498 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.531 HG12 ' N ' ' A' ' 78' ' ' PHE . 97.8 t -131.41 162.21 39.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.15 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.531 ' N ' HG12 ' A' ' 77' ' ' VAL . 54.9 m-85 -150.92 130.6 13.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.943 0.401 . . . . 0.0 110.656 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -120.98 164.48 16.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.234 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 7.5 t0 52.73 43.19 31.65 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.249 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.524 ' O ' HG12 ' A' ' 81' ' ' VAL . 98.3 t -88.1 -5.2 10.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.081 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.444 HG23 ' C ' ' A' ' 81' ' ' VAL . 86.6 t -156.57 105.71 1.99 Allowed Pre-proline 0 CA--C 1.529 0.138 0 N-CA-C 110.224 -0.287 . . . . 0.0 110.224 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -73.67 -177.35 3.05 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.48 2.12 . . . . 0.0 112.224 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -77.39 130.53 37.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.342 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 63.56 44.36 5.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.258 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 47.9 p90 -50.49 140.94 13.05 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.583 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 2.9 m -106.69 118.83 37.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.196 179.842 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.478 ' CD1' ' CG1' ' A' ' 8' ' ' VAL . 48.5 mm -53.02 134.88 15.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.353 -179.91 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 102.24 28.42 6.46 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 110.668 -0.973 . . . . 0.0 110.668 -179.88 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -142.9 136.35 28.55 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.847 0.356 . . . . 0.0 110.51 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.475 HG23 ' O ' ' A' ' 6' ' ' PHE . 91.8 m -88.12 113.57 23.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.308 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.52 ' O ' ' HB2' ' A' ' 93' ' ' ALA . 45.3 m-85 -106.4 152.11 24.03 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.524 -179.745 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.901 ' HB1' ' HD2' ' A' ' 94' ' ' PRO . . . 170.07 177.74 0.09 OUTLIER Pre-proline 0 C--N 1.331 -0.197 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.387 179.769 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.901 ' HD2' ' HB1' ' A' ' 93' ' ' ALA . 48.7 Cg_endo . . . . . 0 C--O 1.249 1.057 0 C-N-CA 122.564 2.176 . . . . 0.0 112.0 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 16.0 m . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 110.187 -0.301 . . . . 0.0 110.187 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -78.48 129.32 9.3 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.571 2.181 . . . . 0.0 111.99 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 49.4 mttp -106.46 34.96 3.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.36 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.638 HG11 ' CZ ' ' A' ' 68' ' ' PHE . 18.4 m -80.09 163.26 3.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.338 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.619 HG23 ' O ' ' A' ' 4' ' ' VAL . 1.0 OUTLIER -162.95 132.07 4.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.444 179.957 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.514 ' CD2' ' HB ' ' A' ' 21' ' ' VAL . 9.7 m-85 -103.49 177.69 4.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.185 -0.462 . . . . 0.0 109.926 179.674 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.552 HG23 ' O ' ' A' ' 90' ' ' ALA . 2.9 m -167.17 127.7 1.51 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.763 0.316 . . . . 0.0 110.785 -179.628 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.737 HG13 ' CA ' ' A' ' 17' ' ' LEU . 87.7 t -70.77 81.54 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.264 179.529 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.522 ' CD ' HD12 ' A' ' 20' ' ' LEU . 1.7 mm-40 -49.25 178.74 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.816 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 5.8 mttp -67.98 -16.52 64.09 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.857 179.864 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -45.11 -34.69 4.41 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 111.006 -0.838 . . . . 0.0 111.006 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.47 ' OG ' HD11 ' A' ' 88' ' ' ILE . 1.4 p -56.95 127.22 30.76 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 179.564 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.6 p30 -109.56 -56.69 2.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.685 0.279 . . . . 0.0 110.766 -179.748 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 34.7 mm-40 -130.51 -58.96 1.03 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.906 0.384 . . . . 0.0 110.142 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.417 ' CG ' ' OD1' ' A' ' 55' ' ' ASP . 0.0 OUTLIER -108.35 -25.55 10.95 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.218 179.807 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.474 ' CE1' ' OD1' ' A' ' 55' ' ' ASP . 21.0 m80 -58.0 176.86 0.14 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.359 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.768 ' N ' HD13 ' A' ' 17' ' ' LEU . 0.0 OUTLIER -172.98 31.64 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.587 -179.238 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.803 ' HB2' HG22 ' A' ' 53' ' ' THR . . . -18.93 119.95 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.333 1.053 . . . . 0.0 113.0 -179.854 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.695 HG11 ' CZ ' ' A' ' 66' ' ' PHE . 21.9 m -87.13 138.3 19.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.665 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.522 HD12 ' CD ' ' A' ' 9' ' ' GLU . 1.0 OUTLIER -97.94 42.99 1.08 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.387 179.795 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.514 ' HB ' ' CD2' ' A' ' 6' ' ' PHE . 2.7 p -50.63 100.53 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.301 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.22 165.08 32.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.265 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER 176.21 175.07 0.32 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.496 -179.83 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -104.54 154.82 19.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.341 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 94.64 -58.55 1.87 Allowed Glycine 0 CA--C 1.522 0.51 0 N-CA-C 110.71 -0.956 . . . . 0.0 110.71 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -91.92 173.86 7.63 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.778 0.323 . . . . 0.0 110.217 179.881 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -121.0 -173.14 2.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.528 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.43 ' O ' ' CG ' ' A' ' 71' ' ' GLU . 0.0 OUTLIER -118.39 125.74 50.62 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.504 -179.8 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.8 ' HB3' ' O ' ' A' ' 69' ' ' LEU . . . -121.54 -55.64 1.92 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.621 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.54 ' C ' HG12 ' A' ' 31' ' ' VAL . 0.7 OUTLIER -159.92 172.93 16.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.422 -179.916 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.54 HG12 ' C ' ' A' ' 30' ' ' GLU . 0.2 OUTLIER -174.4 136.83 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.373 0.606 . . . . 0.0 109.798 179.827 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.415 ' HG2' ' HB3' ' A' ' 41' ' ' TRP . 10.5 tt0 -121.97 151.77 40.42 Favored 'General case' 0 N--CA 1.441 -0.918 0 CA-C-N 115.055 -0.975 . . . . 0.0 110.103 -178.733 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.732 HD21 ' CZ ' ' A' ' 66' ' ' PHE . 3.1 mt -101.56 161.29 13.75 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.197 179.784 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.464 ' NH2' ' NE1' ' A' ' 41' ' ' TRP . 0.0 OUTLIER -124.65 -168.15 1.77 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.413 -179.92 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.425 ' CG ' ' O ' ' A' ' 34' ' ' ARG . 11.6 mt-10 -164.81 95.55 0.71 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.83 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -47.67 103.94 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.746 -179.589 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 136.01 -39.39 1.66 Allowed Glycine 0 CA--C 1.523 0.584 0 N-CA-C 110.785 -0.926 . . . . 0.0 110.785 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -69.27 176.35 3.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.856 0.36 . . . . 0.0 110.414 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -118.84 33.91 5.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.394 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -176.43 163.5 2.48 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.531 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.491 ' CZ3' ' HG2' ' A' ' 67' ' ' ARG . 57.8 m95 -88.56 175.9 7.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.322 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.9 m -137.24 97.68 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.175 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -50.76 127.61 18.73 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.6 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.444 ' CE ' ' HB2' ' A' ' 52' ' ' TRP . 0.0 OUTLIER -61.32 -170.12 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.115 179.914 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.415 ' O ' ' N ' ' A' ' 47' ' ' GLY . 92.9 m -150.78 117.48 5.8 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.156 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 2.4 ptmt -69.12 63.5 0.13 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.387 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.415 ' N ' ' O ' ' A' ' 45' ' ' THR . . . -86.83 -27.81 28.04 Favored Glycine 0 CA--C 1.521 0.46 0 N-CA-C 110.383 -1.087 . . . . 0.0 110.383 179.785 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.452 ' HG2' ' CG2' ' A' ' 51' ' ' VAL . 11.6 tp10 -91.99 125.28 36.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.895 0.379 . . . . 0.0 110.246 179.847 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -71.89 66.82 1.12 Allowed Glycine 0 CA--C 1.522 0.476 0 N-CA-C 110.713 -0.955 . . . . 0.0 110.713 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 160.18 -27.55 0.33 Allowed Glycine 0 CA--C 1.524 0.595 0 N-CA-C 111.175 -0.77 . . . . 0.0 111.175 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.452 ' CG2' ' HG2' ' A' ' 48' ' ' GLU . 3.6 m -148.4 -176.81 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.062 0.458 . . . . 0.0 111.064 -179.692 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' TRP . . . . . 0.444 ' HB2' ' CE ' ' A' ' 44' ' ' MET . 4.3 m95 -104.76 136.45 44.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.939 -179.832 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.803 HG22 ' HB2' ' A' ' 18' ' ' ALA . 3.9 p -120.83 144.62 48.25 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.907 0.384 . . . . 0.0 110.662 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.47 ' CB ' HD12 ' A' ' 33' ' ' LEU . 89.5 t80 -140.75 86.14 2.03 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.016 179.638 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.474 ' OD1' ' CE1' ' A' ' 16' ' ' HIS . 10.7 t0 -48.71 151.1 1.24 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.548 -179.794 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 4.9 t -121.94 121.96 38.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.329 179.84 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -115.47 50.49 1.0 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.55 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -142.89 154.17 61.8 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.331 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -71.15 -40.44 3.25 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.715 2.277 . . . . 0.0 112.068 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 4.5 mt -73.04 153.97 40.65 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.444 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.73 100.56 2.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.319 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -114.74 -152.42 10.37 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 110.723 -0.951 . . . . 0.0 110.723 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -80.99 149.93 17.84 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.66 2.24 . . . . 0.0 112.009 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.476 ' HD2' HG21 ' A' ' 82' ' ' VAL . 45.6 m-85 -102.57 164.3 11.73 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.549 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.422 ' HB2' ' CB ' ' A' ' 34' ' ' ARG . 2.7 m-80 -136.6 139.56 42.21 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.801 179.631 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.732 ' CZ ' HD21 ' A' ' 33' ' ' LEU . 58.5 m-85 -127.31 165.13 20.28 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.135 0.493 . . . . 0.0 111.204 -179.46 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.491 ' HG2' ' CZ3' ' A' ' 41' ' ' TRP . 0.0 OUTLIER -156.99 61.08 0.51 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.48 179.578 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.638 ' CZ ' HG11 ' A' ' 4' ' ' VAL . 3.1 p90 -52.55 170.72 0.07 Allowed 'General case' 0 CA--C 1.516 -0.338 0 CA-C-O 121.483 0.659 . . . . 0.0 111.398 -179.094 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.8 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 5.6 mt -135.42 70.91 1.43 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 114.833 -1.076 . . . . 0.0 108.874 179.544 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -30.73 140.61 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.28 0.632 . . . . 0.0 112.317 -178.726 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.546 ' CA ' ' HB2' ' A' ' 29' ' ' ALA . 13.8 mt-10 -49.79 -47.28 51.3 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.935 -179.455 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.403 ' HD3' ' O ' ' A' ' 72' ' ' LYS . 0.0 OUTLIER -139.23 47.16 1.9 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.815 0.34 . . . . 0.0 110.844 -179.846 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -133.51 -108.94 1.09 Allowed Glycine 0 CA--C 1.522 0.526 0 N-CA-C 110.609 -0.996 . . . . 0.0 110.609 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 10.2 ptt? -165.9 163.2 18.6 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.757 0.313 . . . . 0.0 110.16 179.809 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.755 ' HB3' HD23 ' A' ' 69' ' ' LEU . 0.0 OUTLIER -98.44 -177.7 3.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.362 -179.922 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.445 ' ND2' ' O ' ' A' ' 75' ' ' LYS . 0.4 OUTLIER -179.4 -167.57 0.1 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.533 179.952 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 96.9 t -134.35 145.7 32.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.128 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.605 ' CZ ' HG21 ' A' ' 4' ' ' VAL . 52.7 m-85 -134.73 134.64 41.23 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.522 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -113.71 155.72 25.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.444 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 51.08 59.21 4.78 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.445 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.814 HG13 ' HB2' ' A' ' 93' ' ' ALA . 95.1 t -94.55 -17.38 7.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.964 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.571 HG13 ' HD2' ' A' ' 83' ' ' PRO . 82.5 t -139.71 140.1 23.89 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-O 120.629 0.252 . . . . 0.0 110.389 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.571 ' HD2' HG13 ' A' ' 82' ' ' VAL . 48.1 Cg_endo -72.49 176.96 8.01 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.652 2.235 . . . . 0.0 112.092 179.877 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -58.65 -32.24 68.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.254 -0.43 . . . . 0.0 109.976 179.696 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.62 85.66 2.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.131 179.777 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.504 ' CD1' HG11 ' A' ' 8' ' ' VAL . 16.9 p90 -52.09 144.74 11.61 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.684 -179.72 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -123.02 102.41 7.98 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.854 179.572 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.47 HD11 ' OG ' ' A' ' 12' ' ' SER . 3.3 mt -44.33 118.26 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.823 -179.712 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 114.41 20.61 5.8 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 110.979 -0.848 . . . . 0.0 110.979 -179.854 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.552 ' O ' HG23 ' A' ' 7' ' ' THR . . . -136.25 133.11 36.66 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 179.841 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 56.5 m -91.96 93.56 8.85 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.899 0.381 . . . . 0.0 111.01 -179.657 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.551 ' O ' ' HB3' ' A' ' 93' ' ' ALA . 47.4 m-85 -79.55 -153.31 0.08 Allowed 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 178.923 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.918 ' HB1' ' HD2' ' A' ' 94' ' ' PRO . . . 71.58 179.48 0.05 OUTLIER Pre-proline 0 C--N 1.331 -0.222 0 CA-C-O 120.696 0.284 . . . . 0.0 110.683 179.525 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.918 ' HD2' ' HB1' ' A' ' 93' ' ' ALA . 49.1 Cg_endo . . . . . 0 C--O 1.249 1.042 0 C-N-CA 122.633 2.222 . . . . 0.0 111.99 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.561 ' O ' HG23 ' A' ' 1' ' ' VAL . 17.6 m . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -77.7 171.61 17.12 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.581 2.187 . . . . 0.0 112.01 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.51 ' O ' HG12 ' A' ' 4' ' ' VAL . 35.9 mttp -149.93 64.28 0.98 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.242 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.79 ' O ' HG23 ' A' ' 5' ' ' THR . 1.2 p 46.3 -170.98 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.544 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.79 HG23 ' O ' ' A' ' 4' ' ' VAL . 0.6 OUTLIER -177.27 173.12 1.8 Allowed 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.458 -179.996 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.636 ' O ' HG23 ' A' ' 91' ' ' THR . 60.6 m-85 -141.64 172.23 12.97 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.048 179.836 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.519 HG23 ' O ' ' A' ' 90' ' ' ALA . 2.5 m -166.72 112.57 0.8 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.4 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 13.1 t -59.57 113.27 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.14 179.792 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.832 ' HG3' HG11 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -80.92 173.29 12.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.648 -179.661 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -75.48 153.96 37.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.402 -179.931 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 95.26 23.51 19.34 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 51.0 m -80.01 127.43 32.28 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.761 0.315 . . . . 0.0 110.288 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -116.31 -161.74 0.81 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.189 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -51.65 -56.65 12.44 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.485 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.408 ' HG2' ' N ' ' A' ' 16' ' ' HIS . 0.0 OUTLIER -106.15 -28.08 10.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.636 -179.763 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.408 ' N ' ' HG2' ' A' ' 15' ' ' LYS . 14.9 m80 -57.4 112.31 1.37 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.492 -179.897 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.416 ' HA ' HD22 ' A' ' 17' ' ' LEU . 0.2 OUTLIER -120.85 99.77 6.71 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.181 -0.463 . . . . 0.0 109.897 179.786 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -95.36 128.25 42.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.53 -179.673 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.932 HG23 HG23 ' A' ' 21' ' ' VAL . 28.5 m -125.24 141.89 43.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.213 179.846 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -91.92 64.99 4.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.403 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.932 HG23 HG23 ' A' ' 19' ' ' VAL . 14.2 t -68.15 93.28 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.367 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -157.97 144.73 17.8 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.446 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.706 ' CE2' HG23 ' A' ' 4' ' ' VAL . 0.0 OUTLIER -153.05 -175.16 5.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.229 179.841 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -115.52 96.31 5.58 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.354 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 155.82 -59.71 0.37 Allowed Glycine 0 CA--C 1.524 0.613 0 N-CA-C 110.807 -0.917 . . . . 0.0 110.807 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.426 ' HB2' ' CZ ' ' A' ' 23' ' ' TYR . 0.4 OUTLIER -83.52 -174.79 5.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.733 0.301 . . . . 0.0 110.356 -179.995 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -129.81 -179.3 5.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.637 -179.786 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.433 ' O ' ' CG ' ' A' ' 71' ' ' GLU . 0.0 OUTLIER -105.39 122.91 46.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.429 -179.967 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.776 ' HB3' ' O ' ' A' ' 69' ' ' LEU . . . -128.72 -53.67 1.24 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.787 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.402 ' O ' ' HB2' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -163.31 153.38 15.64 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.794 0.33 . . . . 0.0 110.653 -179.866 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.938 HG21 ' CD1' ' A' ' 52' ' ' TRP . 4.0 t -135.78 137.62 48.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.108 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -136.33 134.55 38.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.758 0.313 . . . . 0.0 110.463 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.8 mt -105.14 179.06 4.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.986 0.422 . . . . 0.0 110.63 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.504 ' HB2' ' CE3' ' A' ' 41' ' ' TRP . 8.6 ttt85 -170.15 158.49 6.95 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.946 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.443 ' N ' ' HG2' ' A' ' 34' ' ' ARG . 5.4 mp0 -117.29 -81.94 0.63 Allowed 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 179.81 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 168.87 118.14 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.459 179.31 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 52.17 38.2 48.08 Favored Glycine 0 CA--C 1.523 0.532 0 N-CA-C 110.816 -0.914 . . . . 0.0 110.816 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 12.0 t -103.56 -76.71 0.58 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.742 0.306 . . . . 0.0 110.459 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -157.36 52.61 0.48 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.423 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 54.69 178.43 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.073 -179.835 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.504 ' CE3' ' HB2' ' A' ' 34' ' ' ARG . 93.9 m95 -59.04 136.74 58.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.847 0.356 . . . . 0.0 110.161 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.654 HG21 ' CZ ' ' A' ' 54' ' ' PHE . 34.6 m -119.73 111.93 34.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.176 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -52.08 137.81 26.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.253 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.23 -171.29 0.05 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.563 -179.749 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 55.5 m -138.1 109.74 7.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.063 179.814 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.467 ' HG2' ' CZ3' ' A' ' 52' ' ' TRP . 36.4 mtpt -72.69 77.01 1.11 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.514 -179.754 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -102.66 -55.33 0.84 Allowed Glycine 0 CA--C 1.522 0.528 0 N-CA-C 110.473 -1.051 . . . . 0.0 110.473 179.853 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.611 ' HG2' HG22 ' A' ' 51' ' ' VAL . 11.8 tt0 -65.3 113.58 4.14 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.838 0.351 . . . . 0.0 110.065 179.806 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -61.98 79.22 0.02 OUTLIER Glycine 0 CA--C 1.523 0.57 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 -179.847 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.41 ' N ' ' O ' ' A' ' 48' ' ' GLU . . . 152.02 -42.54 0.69 Allowed Glycine 0 CA--C 1.523 0.561 0 N-CA-C 111.242 -0.743 . . . . 0.0 111.242 179.801 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.832 HG11 ' HG3' ' A' ' 9' ' ' GLU . 30.0 m -135.46 168.98 21.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.889 0.376 . . . . 0.0 110.806 -179.577 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' TRP . . . . . 0.938 ' CD1' HG21 ' A' ' 31' ' ' VAL . 7.5 m95 -99.84 140.74 33.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.571 -179.899 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 14.1 p -128.5 146.21 50.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.148 179.767 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.654 ' CZ ' HG21 ' A' ' 42' ' ' VAL . 33.2 t80 -125.04 140.88 52.51 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.535 -179.791 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -97.26 87.52 4.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.255 179.877 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.4 m -69.84 175.8 4.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.359 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 11.3 tt0 -161.67 38.49 0.13 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.296 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -131.29 165.52 34.68 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.427 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -93.59 7.26 2.67 Favored 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 123.849 3.032 . . . . 0.0 112.578 179.678 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 2.2 tp -59.86 153.29 21.19 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.782 0.325 . . . . 0.0 110.351 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.2 46.12 0.98 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.215 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -122.77 -146.44 7.18 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.67 -0.972 . . . . 0.0 110.67 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -82.73 153.36 15.18 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.719 2.279 . . . . 0.0 112.195 -179.851 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.412 ' HD2' HG21 ' A' ' 82' ' ' VAL . 25.7 m-85 -101.16 162.19 13.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.139 179.777 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.44 ' OD1' ' N ' ' A' ' 65' ' ' ASN . 0.0 OUTLIER -127.14 113.11 15.96 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 179.511 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.412 ' O ' ' HG3' ' A' ' 67' ' ' ARG . 5.5 m-85 -97.36 -174.08 2.83 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.871 -179.298 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.453 ' HG3' ' HA ' ' A' ' 77' ' ' VAL . 2.3 mtp180 170.21 78.04 0.0 OUTLIER 'General case' 0 CA--C 1.521 -0.137 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.88 178.966 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.813 ' O ' HD23 ' A' ' 69' ' ' LEU . 3.2 p90 -79.88 -179.73 7.12 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.147 179.581 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.813 HD23 ' O ' ' A' ' 68' ' ' PHE . 1.0 OUTLIER -136.31 68.67 1.43 Allowed 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 179.642 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 7.1 p -35.11 139.82 0.09 Allowed 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.929 -179.079 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.665 ' HG2' ' HB2' ' A' ' 29' ' ' ALA . 7.7 mm-40 -50.93 -54.06 27.49 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.605 -179.672 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.4 tptm -116.96 71.46 0.8 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.498 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -167.87 -102.93 0.16 Allowed Glycine 0 CA--C 1.521 0.459 0 N-CA-C 110.552 -1.019 . . . . 0.0 110.552 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 7.6 ptt? 169.13 -177.09 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.774 0.321 . . . . 0.0 110.163 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.545 ' CG ' HD22 ' A' ' 69' ' ' LEU . 4.2 mptt -75.44 -178.08 3.89 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.263 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 175.17 136.36 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.338 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.475 HG12 ' N ' ' A' ' 78' ' ' PHE . 95.9 t -84.35 159.24 3.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.267 179.903 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.549 ' CE1' HG11 ' A' ' 4' ' ' VAL . 86.8 m-85 -150.16 120.03 7.11 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.32 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -115.99 151.81 34.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.458 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 61.95 34.79 16.57 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.357 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.551 HG13 ' CD1' ' A' ' 6' ' ' PHE . 49.5 t -78.08 -0.5 3.39 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.935 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.599 HG13 ' HD2' ' A' ' 83' ' ' PRO . 84.1 t -154.88 139.91 12.06 Favored Pre-proline 0 C--N 1.333 -0.115 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 179.271 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.599 ' HD2' HG13 ' A' ' 82' ' ' VAL . 50.3 Cg_endo -71.72 -170.16 0.5 Allowed 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.647 2.231 . . . . 0.0 111.982 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -75.56 -28.57 59.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.188 -0.46 . . . . 0.0 109.96 179.51 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 13.7 mttt -139.25 74.95 1.49 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.982 179.783 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.432 ' HA ' ' HG2' ' A' ' 83' ' ' PRO . 25.9 p90 -48.3 151.78 0.99 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.876 -179.63 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 2.4 m -136.9 110.07 7.79 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.828 -0.623 . . . . 0.0 109.991 179.784 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 2.8 mp -46.12 105.96 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.845 -179.721 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 128.25 44.55 0.21 Allowed Glycine 0 CA--C 1.523 0.541 0 N-CA-C 110.619 -0.992 . . . . 0.0 110.619 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.597 ' HB3' ' CZ ' ' A' ' 92' ' ' TYR . . . -157.63 160.8 38.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.796 0.332 . . . . 0.0 110.339 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.636 HG23 ' O ' ' A' ' 6' ' ' PHE . 39.9 m -113.51 102.04 9.92 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.555 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.597 ' CZ ' ' HB3' ' A' ' 90' ' ' ALA . 29.9 m-85 -103.95 144.61 31.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.615 -179.914 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.781 ' HB1' ' HD2' ' A' ' 94' ' ' PRO . . . 172.46 171.42 0.22 Allowed Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.41 179.701 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.781 ' HD2' ' HB1' ' A' ' 93' ' ' ALA . 49.3 Cg_endo . . . . . 0 C--O 1.249 1.063 0 C-N-CA 122.61 2.207 . . . . 0.0 112.082 -179.956 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.623 ' O ' HG13 ' A' ' 1' ' ' VAL . 11.3 p . . . . . 0 N--CA 1.493 1.69 0 CA-C-O 120.648 0.261 . . . . 0.0 110.359 . . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -81.69 98.13 0.97 Allowed 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.678 2.252 . . . . 0.0 112.085 -179.915 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 7.8 mtmt -151.22 82.33 1.31 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.452 179.98 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 3.7 m -53.99 -178.99 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.121 179.866 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.2 p -152.54 131.17 12.3 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.42 179.949 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.667 ' HD1' ' HB2' ' A' ' 93' ' ' ALA . 16.6 m-85 -98.47 171.57 8.08 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.248 179.878 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.781 HG23 ' O ' ' A' ' 90' ' ' ALA . 0.6 OUTLIER -164.44 105.86 0.86 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.298 179.996 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 60.5 t -60.34 101.63 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.297 179.974 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.619 ' CD ' HG11 ' A' ' 51' ' ' VAL . 2.7 mt-10 -64.05 -175.72 0.16 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.315 -179.952 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 5.7 pttm -86.25 10.79 13.66 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.168 179.972 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.422 ' HA3' ' HB2' ' A' ' 18' ' ' ALA . . . -69.27 -29.71 71.86 Favored Glycine 0 CA--C 1.522 0.487 0 N-CA-C 110.571 -1.012 . . . . 0.0 110.571 179.79 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 53.2 p -53.0 106.11 0.15 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.817 0.341 . . . . 0.0 110.264 179.894 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -89.34 -68.14 0.79 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.337 -179.97 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -135.8 -54.6 0.77 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.393 179.963 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.62 -27.39 8.57 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.392 179.926 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -52.24 179.44 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.358 179.987 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.411 HD12 ' HA ' ' A' ' 17' ' ' LEU . 24.3 tp -159.18 83.42 0.78 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.249 179.967 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.442 ' C ' HG13 ' A' ' 19' ' ' VAL . . . -73.79 158.37 34.71 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.511 -179.906 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.582 HG23 HG23 ' A' ' 21' ' ' VAL . 35.4 m -157.55 139.17 5.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.347 179.845 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -97.52 57.87 1.42 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.431 179.987 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.582 HG23 HG23 ' A' ' 19' ' ' VAL . 18.3 t -58.8 94.47 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.359 179.975 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.5 ttpm? -152.27 149.01 28.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.448 -179.929 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 12.9 p90 -169.19 137.89 2.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.309 179.916 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -55.37 152.77 8.11 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.27 -179.979 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 113.91 -77.09 0.25 Allowed Glycine 0 CA--C 1.523 0.569 0 N-CA-C 110.736 -0.946 . . . . 0.0 110.736 -179.931 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -103.81 179.94 4.13 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.801 0.334 . . . . 0.0 110.347 179.933 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.422 HG22 ' H ' ' A' ' 28' ' ' MET . 0.2 OUTLIER -108.52 -160.87 0.74 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.513 -179.813 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.422 ' H ' HG22 ' A' ' 27' ' ' THR . 19.9 mmt -122.72 127.85 49.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.542 -179.77 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.812 ' HB3' ' O ' ' A' ' 69' ' ' LEU . . . -117.23 -55.69 2.3 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.58 -179.933 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.438 ' HB3' HD12 ' A' ' 69' ' ' LEU . 23.0 tt0 -158.55 165.23 35.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.324 -179.937 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.609 HG21 ' CD1' ' A' ' 52' ' ' TRP . 67.2 t -143.64 149.4 18.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.956 0.407 . . . . 0.0 110.451 179.939 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.417 ' OE2' ' N ' ' A' ' 43' ' ' ALA . 9.7 tp10 -134.78 136.99 42.99 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-N 115.96 -0.563 . . . . 0.0 109.79 -179.431 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.647 HD12 ' H ' ' A' ' 34' ' ' ARG . 13.0 tp -115.89 152.26 33.73 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 -179.918 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.647 ' H ' HD12 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -128.39 176.19 7.91 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.826 0.346 . . . . 0.0 110.543 -179.818 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.419 ' O ' ' N ' ' A' ' 37' ' ' GLY . 1.5 tm-20 -138.85 12.41 2.68 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.16 -179.907 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER 67.48 -68.77 0.15 Allowed 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 120.822 0.344 . . . . 0.0 110.519 -179.973 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 35' ' ' GLU . . . -68.75 -26.33 74.59 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 110.846 -0.901 . . . . 0.0 110.846 -179.951 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 8.6 t -50.87 140.41 15.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.76 0.314 . . . . 0.0 110.357 -179.895 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 16.5 t0 -49.38 -30.9 8.45 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.472 -179.999 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -170.77 172.56 5.65 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.431 179.892 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.477 ' CE3' ' HB2' ' A' ' 34' ' ' ARG . 69.3 m95 -54.87 147.34 15.38 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.262 179.922 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.4 ' O ' HG23 ' A' ' 42' ' ' VAL . 6.1 m -124.77 109.91 23.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.298 179.929 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.417 ' N ' ' OE2' ' A' ' 32' ' ' GLU . . . -50.54 135.12 23.27 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.482 -179.881 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -53.69 -171.64 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.624 -179.925 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 58.0 m -128.85 93.17 3.55 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.498 -179.896 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 7.0 ptmt -71.05 84.57 0.71 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.403 179.942 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -144.21 30.21 1.89 Allowed Glycine 0 CA--C 1.523 0.533 0 N-CA-C 110.473 -1.051 . . . . 0.0 110.473 179.934 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.404 ' HB2' ' O ' ' A' ' 51' ' ' VAL . 0.0 OUTLIER -108.77 174.05 6.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.843 0.354 . . . . 0.0 110.503 -179.879 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -59.82 -31.63 72.36 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 110.718 -0.953 . . . . 0.0 110.718 179.968 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -176.6 35.41 0.09 OUTLIER Glycine 0 CA--C 1.524 0.595 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 -179.978 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.619 HG11 ' CD ' ' A' ' 9' ' ' GLU . 6.6 m -152.16 -179.93 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.776 0.322 . . . . 0.0 110.425 179.803 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 52' ' ' TRP . . . . . 0.609 ' CD1' HG21 ' A' ' 31' ' ' VAL . 7.0 m95 -108.44 140.0 42.37 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.438 -179.644 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -127.69 177.0 7.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.126 179.809 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.636 ' CG ' HD23 ' A' ' 33' ' ' LEU . 77.4 t80 -161.77 119.36 2.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.403 179.926 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.443 ' O ' ' CD2' ' A' ' 54' ' ' PHE . 28.3 p-10 -66.87 -177.34 0.6 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.402 -179.988 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 59.24 178.93 0.08 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.443 179.897 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 174.39 50.17 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.218 179.941 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -50.47 121.41 14.12 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.444 -179.847 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -71.56 59.73 2.66 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.444 2.096 . . . . 0.0 112.056 179.87 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -114.88 1.29 14.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.256 179.956 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -177.89 124.44 0.12 Allowed 'General case' 0 C--N 1.334 -0.092 0 CA-C-O 120.778 0.323 . . . . 0.0 110.367 179.939 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.424 ' N ' ' HD2' ' A' ' 63' ' ' PRO . . . -74.23 -54.94 5.94 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 110.814 -0.914 . . . . 0.0 110.814 -179.881 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.424 ' HD2' ' N ' ' A' ' 62' ' ' GLY . 48.0 Cg_endo -74.85 122.02 7.01 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.531 2.154 . . . . 0.0 112.214 -179.932 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -99.46 137.06 38.49 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.082 179.818 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 12.8 m-80 -98.59 134.24 41.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.803 0.335 . . . . 0.0 110.343 -179.923 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -119.92 174.31 6.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.455 179.993 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 12.6 ptm180 -173.52 76.36 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.0 -0.546 . . . . 0.0 109.92 179.923 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.592 ' O ' HD23 ' A' ' 69' ' ' LEU . 3.5 p90 -61.42 175.19 0.61 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.192 0.52 . . . . 0.0 110.809 -179.56 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.812 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 8.0 mt -132.02 65.41 1.57 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.129 179.569 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 14.0 p -26.99 135.0 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.644 0.778 . . . . 0.0 112.633 -178.987 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.609 ' HG2' ' HB2' ' A' ' 29' ' ' ALA . 16.5 mt-10 -49.74 -26.0 3.46 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.54 -179.713 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.5 tmtm? -64.81 -40.31 95.0 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.317 179.898 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 118.86 53.46 0.28 Allowed Glycine 0 CA--C 1.524 0.604 0 N-CA-C 110.798 -0.921 . . . . 0.0 110.798 179.938 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -144.71 145.61 31.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.797 0.332 . . . . 0.0 110.47 179.964 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.585 ' HG2' HD22 ' A' ' 69' ' ' LEU . 0.8 OUTLIER -127.35 -178.87 4.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.312 179.976 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 174.31 162.92 0.2 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.526 179.964 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.507 HG12 ' N ' ' A' ' 78' ' ' PHE . 86.9 t -107.18 160.77 6.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.248 179.854 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.507 ' N ' HG12 ' A' ' 77' ' ' VAL . 71.8 m-85 -151.19 130.39 12.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.525 -179.92 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -115.0 160.56 19.44 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.313 -179.924 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 52.32 55.12 9.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.355 179.932 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.725 HG22 ' HD3' ' A' ' 94' ' ' PRO . 75.6 t -102.05 2.15 10.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.034 179.957 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.437 HG23 ' C ' ' A' ' 81' ' ' VAL . 89.3 t -156.26 131.45 5.37 Favored Pre-proline 0 C--N 1.332 -0.154 0 N-CA-C 110.229 -0.286 . . . . 0.0 110.229 179.556 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -70.98 -171.16 0.54 Allowed 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.516 2.144 . . . . 0.0 111.863 179.761 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -74.0 -27.85 61.17 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.883 179.386 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 4.0 tptt -138.46 77.66 1.64 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.093 179.779 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.437 ' HB3' HG13 ' A' ' 82' ' ' VAL . 51.0 p90 -55.05 137.28 46.74 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.589 -179.795 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 5.3 m -116.32 107.29 14.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.12 179.717 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 2.7 mp -47.76 108.39 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.582 -179.872 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 126.05 43.36 0.28 Allowed Glycine 0 CA--C 1.523 0.569 0 N-CA-C 110.587 -1.005 . . . . 0.0 110.587 -179.864 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.781 ' O ' HG23 ' A' ' 7' ' ' THR . . . -153.8 -176.32 5.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.796 0.331 . . . . 0.0 110.389 -179.948 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 89.9 m -129.74 104.44 7.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.669 -179.84 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.473 ' O ' ' HB2' ' A' ' 93' ' ' ALA . 18.5 m-85 -106.97 140.27 40.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.463 179.901 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.826 ' HB1' ' HD2' ' A' ' 94' ' ' PRO . . . 171.75 171.7 0.2 Allowed Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.389 179.593 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.826 ' HD2' ' HB1' ' A' ' 93' ' ' ALA . 47.6 Cg_endo . . . . . 0 C--O 1.249 1.032 0 C-N-CA 122.606 2.204 . . . . 0.0 111.984 179.804 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 4.7 t . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -76.55 160.61 34.9 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.584 2.189 . . . . 0.0 112.064 -179.952 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.545 ' O ' HG22 ' A' ' 4' ' ' VAL . 18.4 mtmt -141.07 65.65 1.39 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.403 179.921 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.79 ' O ' HG23 ' A' ' 5' ' ' THR . 19.5 m 44.22 -172.38 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.338 179.807 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.79 HG23 ' O ' ' A' ' 4' ' ' VAL . 0.5 OUTLIER -179.55 137.64 0.13 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.301 -179.761 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.626 ' O ' HG23 ' A' ' 91' ' ' THR . 8.2 m-85 -116.13 178.4 4.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.061 179.855 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.641 HG23 ' O ' ' A' ' 90' ' ' ALA . 48.2 m -164.43 124.06 1.96 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.873 0.368 . . . . 0.0 110.514 -179.94 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 90.1 t -58.64 90.33 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.449 179.99 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.859 ' HG3' HG11 ' A' ' 51' ' ' VAL . 1.9 mm-40 -59.1 176.04 0.25 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.432 -179.968 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 5.1 mtmt -69.72 155.37 40.62 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.27 179.878 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 103.37 -33.44 6.58 Favored Glycine 0 CA--C 1.523 0.533 0 N-CA-C 110.851 -0.899 . . . . 0.0 110.851 179.968 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 70.9 m -50.67 112.36 0.69 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.684 0.278 . . . . 0.0 110.316 179.969 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -112.69 -67.06 1.03 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.937 -179.685 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.404 ' HG3' ' HG2' ' A' ' 15' ' ' LYS . 6.6 pt-20 -141.46 -48.66 0.39 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.643 0.258 . . . . 0.0 110.93 -179.702 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.404 ' HG2' ' HG3' ' A' ' 14' ' ' GLU . 8.9 ptpt -103.93 -39.38 6.62 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.766 0.317 . . . . 0.0 110.498 -179.944 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 13.2 m80 -65.94 110.26 2.83 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 179.794 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.508 HD22 ' HA ' ' A' ' 17' ' ' LEU . 0.3 OUTLIER -107.21 94.87 5.33 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.41 -179.772 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.621 ' HB2' HG22 ' A' ' 53' ' ' THR . . . -95.34 120.44 35.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.381 179.987 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.431 HG11 ' CZ ' ' A' ' 66' ' ' PHE . 21.1 m -114.42 144.24 22.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.218 179.899 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.519 ' HA ' HG12 ' A' ' 51' ' ' VAL . 1.5 tt -97.54 62.53 1.7 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.758 -179.718 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.523 ' CG1' ' CD1' ' A' ' 52' ' ' TRP . 3.4 p -81.75 126.02 39.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.971 0.415 . . . . 0.0 110.103 179.74 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.494 ' O ' ' CG ' ' A' ' 23' ' ' TYR . 5.8 tttp -166.33 -66.98 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.312 -179.863 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.494 ' CG ' ' O ' ' A' ' 22' ' ' LYS . 30.0 p90 44.97 -172.96 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.906 179.824 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -122.06 177.66 5.23 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.353 -179.724 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 96.95 -40.7 2.49 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 110.772 -0.931 . . . . 0.0 110.772 179.949 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -128.99 -175.11 3.45 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.812 0.339 . . . . 0.0 110.266 179.968 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.403 ' OG1' ' HE2' ' A' ' 72' ' ' LYS . 0.8 OUTLIER -113.25 -178.98 3.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.548 -179.98 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.504 ' CE ' HG22 ' A' ' 21' ' ' VAL . 0.4 OUTLIER -128.56 126.66 40.78 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.462 -179.882 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.898 ' HB3' ' O ' ' A' ' 69' ' ' LEU . . . -120.12 -59.85 1.75 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.393 179.957 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -142.8 159.0 43.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.291 179.986 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.818 HG21 ' NE1' ' A' ' 52' ' ' TRP . 47.2 t -138.54 145.98 27.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.038 0.447 . . . . 0.0 110.435 179.96 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.453 ' HB2' ' HA ' ' A' ' 43' ' ' ALA . 11.6 tt0 -139.79 129.53 24.58 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.891 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.713 HD12 ' H ' ' A' ' 34' ' ' ARG . 5.6 tp -110.35 150.19 29.13 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.962 0.411 . . . . 0.0 110.049 -179.027 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.713 ' H ' HD12 ' A' ' 33' ' ' LEU . 0.5 OUTLIER -106.22 -156.31 0.57 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.548 179.462 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.406 ' O ' ' HB2' ' A' ' 36' ' ' HIS . 1.0 OUTLIER -149.73 -87.69 0.08 Allowed 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 121.235 -0.186 . . . . 0.0 110.631 179.883 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.406 ' HB2' ' O ' ' A' ' 35' ' ' GLU . 17.3 t-160 175.48 -56.97 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 -179.976 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -91.36 -25.82 22.65 Favored Glycine 0 CA--C 1.522 0.513 0 N-CA-C 110.467 -1.053 . . . . 0.0 110.467 179.607 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.41 ' O ' ' CB ' ' A' ' 39' ' ' ASP . 0.1 OUTLIER -50.66 -31.66 16.87 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.871 0.367 . . . . 0.0 110.327 179.87 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.41 ' CB ' ' O ' ' A' ' 38' ' ' SER . 11.2 t0 81.75 -52.33 0.25 Allowed 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.882 179.856 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -98.24 177.38 5.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.969 0.414 . . . . 0.0 110.753 -179.619 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.425 ' CD2' ' HG3' ' A' ' 34' ' ' ARG . 59.8 m95 -95.96 171.97 8.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.383 -179.946 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.434 ' CG2' ' O ' ' A' ' 33' ' ' LEU . 5.1 m -146.86 105.64 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.201 179.621 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.453 ' HA ' ' HB2' ' A' ' 32' ' ' GLU . . . -49.94 136.49 18.39 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.697 -179.693 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -63.33 -173.09 0.06 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.896 -179.791 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 30.2 m -137.66 99.97 4.08 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.372 -179.999 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 6.5 ptpt -64.51 80.38 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.47 -179.905 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -113.11 -24.78 4.69 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.88 -0.888 . . . . 0.0 110.88 -179.969 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -72.73 -37.28 67.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.894 0.378 . . . . 0.0 110.473 179.987 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 95.65 -38.68 3.04 Favored Glycine 0 CA--C 1.523 0.541 0 N-CA-C 110.274 -1.13 . . . . 0.0 110.274 -179.654 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -102.17 -29.9 5.89 Favored Glycine 0 CA--C 1.523 0.539 0 N-CA-C 110.42 -1.072 . . . . 0.0 110.42 179.734 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.859 HG11 ' HG3' ' A' ' 9' ' ' GLU . 8.0 m -138.49 -178.47 2.0 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.768 0.318 . . . . 0.0 110.273 179.773 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 52' ' ' TRP . . . . . 0.818 ' NE1' HG21 ' A' ' 31' ' ' VAL . 5.5 m95 -114.97 136.98 52.53 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.893 0.378 . . . . 0.0 110.772 -179.414 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.621 HG22 ' HB2' ' A' ' 18' ' ' ALA . 10.2 p -126.39 151.08 48.14 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.732 179.452 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.412 ' CZ ' ' HB ' ' A' ' 42' ' ' VAL . 63.9 t80 -141.24 152.79 44.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.941 0.401 . . . . 0.0 110.921 -179.634 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -94.02 102.06 14.12 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.106 179.714 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.1 m -83.73 139.11 32.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.712 -179.702 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -100.06 -49.93 4.15 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.243 179.823 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.454 ' HA ' ' HD3' ' A' ' 59' ' ' PRO . 12.3 pt-20 -74.3 126.46 88.97 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.313 179.963 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 58' ' ' GLU . 38.0 Cg_endo -91.97 71.28 0.78 Allowed 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 123.159 2.572 . . . . 0.0 112.066 179.627 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -106.84 -30.34 8.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.058 0.456 . . . . 0.0 110.375 -179.936 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 44.33 36.48 1.61 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.942 179.933 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -94.04 -144.71 16.28 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 110.895 -0.882 . . . . 0.0 110.895 -179.83 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -78.63 120.79 4.88 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.608 2.205 . . . . 0.0 112.291 -179.821 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.401 ' HB3' ' CD1' ' A' ' 33' ' ' LEU . 30.7 m-85 -90.76 178.4 6.07 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.1 179.81 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -152.78 139.77 19.17 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.936 179.81 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.478 ' CE1' HD13 ' A' ' 33' ' ' LEU . 11.0 m-85 -127.68 177.25 6.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.05 0.452 . . . . 0.0 111.136 -179.775 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.412 ' CB ' ' O ' ' A' ' 76' ' ' ASN . 0.0 OUTLIER -177.16 66.89 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.592 179.976 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.676 ' HZ ' HG11 ' A' ' 4' ' ' VAL . 0.4 OUTLIER -58.47 173.65 0.37 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.252 -179.277 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.898 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 10.2 mt -123.94 83.33 2.13 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.307 -0.86 . . . . 0.0 108.896 178.884 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.418 ' OG1' ' N ' ' A' ' 74' ' ' MET . 1.6 p -35.55 137.08 0.2 Allowed 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.799 -178.954 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.746 ' HA ' ' HB2' ' A' ' 29' ' ' ALA . 21.0 mt-10 -46.71 -34.51 5.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.171 -179.16 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.406 ' O ' ' HD3' ' A' ' 72' ' ' LYS . 0.0 OUTLIER -155.99 60.03 0.59 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.776 0.322 . . . . 0.0 111.017 179.867 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -148.79 -107.18 0.43 Allowed Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.803 -0.919 . . . . 0.0 110.803 179.646 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.418 ' N ' ' OG1' ' A' ' 70' ' ' THR . 21.0 ptm -159.9 -176.42 5.69 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.846 0.355 . . . . 0.0 110.182 179.864 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.01 159.7 20.48 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.638 -179.762 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.412 ' O ' ' CB ' ' A' ' 67' ' ' ARG . 10.7 m-20 -152.43 175.06 13.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.098 -179.953 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.501 HG12 ' N ' ' A' ' 78' ' ' PHE . 49.5 t -110.24 160.98 8.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.434 -179.907 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.501 ' N ' HG12 ' A' ' 77' ' ' VAL . 75.9 m-85 -149.85 129.2 12.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.396 -179.922 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 15.2 p-10 -116.47 164.97 13.77 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.35 -179.999 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 32.3 m-20 52.35 27.29 4.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.524 179.959 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.47 HG13 ' CD1' ' A' ' 6' ' ' PHE . 88.3 t -61.79 -16.36 15.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.677 179.838 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.498 HG13 ' HD2' ' A' ' 83' ' ' PRO . 54.3 t -150.06 138.92 12.73 Favored Pre-proline 0 C--N 1.331 -0.228 0 N-CA-C 110.292 -0.262 . . . . 0.0 110.292 179.945 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.498 ' HD2' HG13 ' A' ' 82' ' ' VAL . 47.8 Cg_endo -72.28 -175.62 1.84 Allowed 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.592 2.195 . . . . 0.0 111.978 179.86 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 26.4 mm-40 -69.45 -54.87 12.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.21 179.849 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 10.5 tttt -113.9 67.4 0.67 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.237 179.98 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 30.8 p90 -57.64 174.42 0.23 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.676 -179.819 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 27.1 m -150.8 120.21 6.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.07 179.827 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.558 ' H ' HD12 ' A' ' 88' ' ' ILE . 3.9 mp -48.96 104.31 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.742 -179.752 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 133.43 53.4 0.08 OUTLIER Glycine 0 CA--C 1.523 0.561 0 N-CA-C 110.814 -0.914 . . . . 0.0 110.814 179.992 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.641 ' O ' HG23 ' A' ' 7' ' ' THR . . . -173.71 140.79 0.79 Allowed 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 110.228 -0.286 . . . . 0.0 110.228 179.92 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.626 HG23 ' O ' ' A' ' 6' ' ' PHE . 25.1 m -97.43 89.25 4.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.909 0.385 . . . . 0.0 110.626 -179.89 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.578 ' O ' ' HB3' ' A' ' 93' ' ' ALA . 43.6 m-85 -70.2 -156.94 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.042 -0.526 . . . . 0.0 109.874 179.56 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.883 ' HB1' ' HD2' ' A' ' 94' ' ' PRO . . . 76.65 173.71 0.09 OUTLIER Pre-proline 0 N--CA 1.464 0.24 0 CA-C-O 120.809 0.338 . . . . 0.0 110.69 179.853 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.883 ' HD2' ' HB1' ' A' ' 93' ' ' ALA . 47.5 Cg_endo . . . . . 0 C--O 1.249 1.063 0 C-N-CA 122.583 2.189 . . . . 0.0 112.096 179.891 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 2.5 m . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 110.18 -0.304 . . . . 0.0 110.18 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -75.47 72.62 4.87 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.523 2.148 . . . . 0.0 112.016 179.992 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -167.32 110.1 0.67 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.205 179.98 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.533 ' CG1' ' CE1' ' A' ' 78' ' ' PHE . 1.7 p -115.09 163.38 12.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.368 0.604 . . . . 0.0 110.569 -179.806 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.484 HG22 HG21 ' A' ' 91' ' ' THR . 0.6 OUTLIER -134.31 148.76 50.82 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.048 179.729 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.692 ' O ' HG23 ' A' ' 91' ' ' THR . 24.8 m-85 -118.52 171.79 7.92 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.389 -179.944 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.9 m -167.81 131.8 1.73 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.007 -179.952 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.853 ' O ' HG23 ' A' ' 88' ' ' ILE . 34.8 t -82.21 94.68 2.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.537 -179.728 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.438 ' HG3' HG11 ' A' ' 51' ' ' VAL . 11.6 mt-10 -54.4 178.26 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.513 -179.921 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 4.1 mmmt -85.89 52.35 2.45 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.514 179.936 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -139.69 23.68 2.78 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 110.86 -0.896 . . . . 0.0 110.86 179.974 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 19.0 m -109.89 127.26 54.61 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 110.168 -0.308 . . . . 0.0 110.168 179.944 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -121.85 -87.61 0.64 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.471 -179.863 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 39.0 tp10 -117.61 -61.92 1.63 Allowed 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 120.826 0.346 . . . . 0.0 110.12 -179.79 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.423 ' CE ' ' HG3' ' A' ' 57' ' ' GLU . 5.5 ptpt -98.69 -21.56 16.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.746 -179.847 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 5.4 m80 -73.73 135.48 43.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.835 0.35 . . . . 0.0 110.282 179.926 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.486 ' HA ' HD22 ' A' ' 17' ' ' LEU . 0.2 OUTLIER -133.44 100.14 4.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.243 -179.968 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -97.12 145.1 26.32 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.377 -179.95 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.682 HG23 HG23 ' A' ' 21' ' ' VAL . 14.5 m -139.83 134.19 37.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.579 -179.871 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.439 ' HA ' ' CG1' ' A' ' 51' ' ' VAL . 1.3 tt -83.22 64.0 7.5 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.435 179.876 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.682 HG23 HG23 ' A' ' 19' ' ' VAL . 17.2 t -74.04 87.12 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.272 -179.978 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 7.3 tttp -176.61 120.52 0.14 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.401 -179.966 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 27.3 p90 -130.81 29.06 4.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.291 179.99 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 53.91 -177.15 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.327 -179.889 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 77.21 -66.02 2.95 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 110.714 -0.954 . . . . 0.0 110.714 -179.952 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -84.65 179.27 7.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.775 0.322 . . . . 0.0 110.315 179.922 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.409 ' HB ' ' CG ' ' A' ' 71' ' ' GLU . 0.0 OUTLIER -115.47 170.78 8.15 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.275 179.906 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 11.9 mmt -113.65 126.2 55.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.739 -179.712 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.767 ' HB3' ' O ' ' A' ' 69' ' ' LEU . . . -115.82 -60.87 1.81 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.223 -179.804 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -158.19 161.47 37.84 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.551 179.776 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.945 HG21 ' CD1' ' A' ' 52' ' ' TRP . 12.0 t -136.78 142.79 36.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.316 0.579 . . . . 0.0 111.407 -179.723 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.457 ' CG ' ' HB3' ' A' ' 41' ' ' TRP . 2.5 tp10 -137.5 122.68 19.25 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-N 115.105 -0.952 . . . . 0.0 108.911 -179.827 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.813 HD12 ' N ' ' A' ' 34' ' ' ARG . 2.9 pp -110.66 179.5 4.05 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.254 0.549 . . . . 0.0 111.492 -179.036 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.813 ' N ' HD12 ' A' ' 33' ' ' LEU . 9.4 ttt180 -148.94 170.79 17.53 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.141 179.417 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.407 ' O ' ' HB2' ' A' ' 36' ' ' HIS . 5.2 mt-10 -119.97 -82.83 0.65 Allowed 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 179.906 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.407 ' HB2' ' O ' ' A' ' 35' ' ' GLU . 1.0 OUTLIER 178.33 -56.98 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.311 179.383 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -66.02 -28.03 73.33 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 110.697 -0.961 . . . . 0.0 110.697 179.959 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -61.3 166.76 3.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.756 0.312 . . . . 0.0 110.366 179.941 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -121.47 25.66 9.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.487 -179.978 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -179.5 149.13 0.37 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.277 179.968 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.512 ' CE3' ' HG2' ' A' ' 67' ' ' ARG . 58.2 m95 -64.68 160.57 19.59 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.506 -179.983 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.552 HG23 ' O ' ' A' ' 42' ' ' VAL . 31.5 m -130.33 109.61 17.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.174 179.796 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.42 ' N ' ' OE2' ' A' ' 32' ' ' GLU . . . -49.11 124.73 9.37 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.725 -179.658 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.491 ' HG2' HD23 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -57.04 -171.3 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.116 179.77 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 30.5 m -152.11 119.05 5.8 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.58 -179.923 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 14.2 ptpt -74.78 67.52 1.62 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.07 179.708 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -98.16 -19.95 22.14 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 111.21 -0.756 . . . . 0.0 111.21 -179.749 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.453 ' HG2' ' CG2' ' A' ' 51' ' ' VAL . 30.9 tp10 -77.76 -45.06 25.71 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.767 0.317 . . . . 0.0 110.388 -179.884 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 117.58 -63.28 0.4 Allowed Glycine 0 CA--C 1.523 0.561 0 N-CA-C 110.708 -0.957 . . . . 0.0 110.708 179.977 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -84.47 -30.01 28.52 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 110.718 -0.953 . . . . 0.0 110.718 179.97 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.453 ' CG2' ' HG2' ' A' ' 48' ' ' GLU . 6.3 m -132.53 -179.44 3.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.881 0.372 . . . . 0.0 110.437 179.953 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 52' ' ' TRP . . . . . 0.945 ' CD1' HG21 ' A' ' 31' ' ' VAL . 5.4 m95 -103.72 125.93 50.52 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.183 -179.823 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -118.05 160.66 21.11 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.406 -179.945 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 26.7 t80 -138.21 128.12 25.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.42 -179.966 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 19.7 p-10 -102.18 115.98 31.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.441 179.988 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 4.0 m -170.54 161.5 7.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.203 179.928 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.423 ' HG3' ' CE ' ' A' ' 15' ' ' LYS . 5.3 mt-10 -132.03 26.2 4.59 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.542 -179.903 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.95 156.51 25.47 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.311 179.882 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -72.49 69.42 3.44 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.641 2.227 . . . . 0.0 112.173 -179.942 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.7 pp -81.54 127.49 32.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.366 179.909 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -132.38 32.4 3.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.475 -179.999 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -156.13 -170.29 21.23 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 110.863 -0.895 . . . . 0.0 110.863 -179.996 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.406 ' HG3' ' HA ' ' A' ' 80' ' ' ASP . 49.0 Cg_endo -78.32 165.75 25.18 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.721 2.281 . . . . 0.0 112.039 -179.916 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -98.16 105.3 17.43 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.464 179.962 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 17.8 m-80 -77.51 140.65 39.8 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 179.191 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.5 ' CE1' ' HB3' ' A' ' 33' ' ' LEU . 37.1 m-85 -121.57 -178.56 3.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.157 0.503 . . . . 0.0 111.245 -179.245 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.512 ' HG2' ' CE3' ' A' ' 41' ' ' TRP . 0.0 OUTLIER 173.95 59.09 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.728 179.973 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.461 ' HA ' ' HA ' ' A' ' 31' ' ' VAL . 1.2 p90 -50.86 165.24 0.11 Allowed 'General case' 0 CA--C 1.517 -0.321 0 CA-C-O 121.219 0.533 . . . . 0.0 111.054 -179.323 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.767 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 2.2 mt -115.9 63.33 0.7 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.118 179.671 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 12.0 p -29.95 138.22 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 115.594 -0.73 . . . . 0.0 112.476 -179.019 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.62 ' HG2' ' HB2' ' A' ' 29' ' ' ALA . 16.4 mt-10 -52.36 -36.11 52.88 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.364 -179.952 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.09 65.74 1.15 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.505 -179.835 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -151.23 -106.92 0.35 Allowed Glycine 0 CA--C 1.522 0.484 0 N-CA-C 110.58 -1.008 . . . . 0.0 110.58 179.965 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 16.1 ptt? -175.32 176.17 2.07 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.805 0.336 . . . . 0.0 110.194 179.919 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.476 ' CD ' ' N ' ' A' ' 75' ' ' LYS . 0.0 OUTLIER -94.62 120.78 35.39 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.141 179.924 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.423 ' O ' ' CB ' ' A' ' 67' ' ' ARG . 65.5 m-80 -112.05 168.69 9.4 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.727 -179.596 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 94.1 t -120.48 153.23 23.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.046 179.68 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.533 ' CE1' ' CG1' ' A' ' 4' ' ' VAL . 45.6 m-85 -152.9 130.71 11.66 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.576 -179.817 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 36.9 m-20 -118.71 149.55 41.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.178 179.867 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.406 ' HA ' ' HG3' ' A' ' 63' ' ' PRO . 27.9 t0 64.12 42.88 5.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.435 179.98 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.506 ' O ' HG12 ' A' ' 81' ' ' VAL . 76.2 t -86.28 -6.35 10.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.054 179.827 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.421 HG23 ' C ' ' A' ' 81' ' ' VAL . 96.8 t -155.69 115.07 2.24 Favored Pre-proline 0 CA--C 1.528 0.1 0 N-CA-C 110.217 -0.29 . . . . 0.0 110.217 179.795 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -73.55 -170.9 0.73 Allowed 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.417 2.078 . . . . 0.0 112.014 179.862 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -90.67 125.63 35.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.167 179.808 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 64.74 42.46 4.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.094 -179.784 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.445 ' HB2' ' CE2' ' A' ' 92' ' ' TYR . 27.1 p90 -50.76 177.53 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.771 -179.776 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 70.9 m -132.23 110.01 10.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.939 179.692 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.853 HG23 ' O ' ' A' ' 8' ' ' VAL . 3.2 mp -46.16 124.38 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.729 -179.728 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 106.68 55.68 0.65 Allowed Glycine 0 CA--C 1.524 0.596 0 N-CA-C 110.833 -0.907 . . . . 0.0 110.833 179.958 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -179.6 141.11 0.15 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.808 0.337 . . . . 0.0 110.578 179.986 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.692 HG23 ' O ' ' A' ' 6' ' ' PHE . 8.2 m -83.89 131.3 34.88 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.042 179.726 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.445 ' CE2' ' HB2' ' A' ' 86' ' ' TYR . 59.5 m-85 -113.54 -23.02 10.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.937 -179.36 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.896 ' HB1' ' HD2' ' A' ' 94' ' ' PRO . . . -51.02 -179.82 0.04 OUTLIER Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.332 179.844 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.896 ' HD2' ' HB1' ' A' ' 93' ' ' ALA . 50.1 Cg_endo . . . . . 0 C--O 1.249 1.027 0 C-N-CA 122.579 2.186 . . . . 0.0 112.071 -179.862 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.405 HG23 ' HD2' ' A' ' 2' ' ' PRO . 7.3 p . . . . . 0 N--CA 1.489 1.502 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 . . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.405 ' HD2' HG23 ' A' ' 1' ' ' VAL . 47.7 Cg_endo -75.12 143.37 28.61 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.408 2.072 . . . . 0.0 111.962 179.966 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 15.0 mtpp -112.36 83.06 1.74 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.377 179.942 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.587 HG22 ' CE2' ' A' ' 78' ' ' PHE . 19.4 m -51.59 -178.65 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.32 179.902 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.444 HG23 ' O ' ' A' ' 4' ' ' VAL . 20.0 p -155.56 134.23 11.88 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.481 179.965 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.721 ' O ' HG23 ' A' ' 91' ' ' THR . 37.4 m-85 -97.89 175.72 6.04 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.15 179.87 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.41 ' HB ' ' CB ' ' A' ' 20' ' ' LEU . 0.5 OUTLIER -164.4 107.05 0.9 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.857 0.361 . . . . 0.0 110.537 -179.981 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 40.7 t -60.81 85.27 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.255 179.948 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.85 ' CD ' HG11 ' A' ' 51' ' ' VAL . 0.8 OUTLIER -50.42 143.97 8.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.673 -179.773 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.445 ' HA ' ' CG2' ' A' ' 88' ' ' ILE . 0.1 OUTLIER -67.4 142.1 56.82 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.276 179.899 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 117.95 14.08 6.84 Favored Glycine 0 CA--C 1.527 0.795 0 N-CA-C 111.41 -0.676 . . . . 0.0 111.41 179.839 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 39.4 m -55.65 104.6 0.14 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.961 0.381 . . . . 0.0 109.987 179.731 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -57.85 -164.91 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.602 -179.589 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -56.68 -48.09 78.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.091 -179.345 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 8.8 pttt -136.13 33.78 2.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.944 -179.391 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 5.2 m80 -111.93 156.56 21.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.804 0.335 . . . . 0.0 110.279 179.703 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 28.9 tp -137.01 103.63 5.2 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.684 -179.77 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -90.7 124.3 34.98 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.068 -0.515 . . . . 0.0 109.894 179.574 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.643 HG23 HG23 ' A' ' 21' ' ' VAL . 32.6 m -117.45 138.82 46.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.827 0.346 . . . . 0.0 110.653 -179.698 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.41 ' CB ' ' HB ' ' A' ' 7' ' ' THR . 0.7 OUTLIER -94.64 69.59 3.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.452 179.96 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.643 HG23 HG23 ' A' ' 19' ' ' VAL . 18.8 t -80.11 90.01 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.394 -0.367 . . . . 0.0 110.246 179.991 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -151.97 129.16 11.18 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.504 -179.958 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 15.0 p90 -154.53 176.75 11.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.262 179.843 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -105.43 96.64 6.65 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.358 179.992 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -179.99 -51.5 0.08 OUTLIER Glycine 0 CA--C 1.523 0.54 0 N-CA-C 110.594 -1.002 . . . . 0.0 110.594 -179.912 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -126.58 155.22 42.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.738 0.304 . . . . 0.0 110.296 179.939 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.16 -176.98 6.44 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.406 -179.984 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.426 ' O ' ' CG ' ' A' ' 71' ' ' GLU . 41.0 mtm -117.23 122.24 43.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.623 -179.743 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.809 ' HB3' ' O ' ' A' ' 69' ' ' LEU . . . -122.23 -53.31 1.93 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.276 179.922 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -158.04 164.2 36.96 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.146 179.948 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.478 HG21 ' CD1' ' A' ' 52' ' ' TRP . 12.2 t -147.26 149.83 15.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.633 179.968 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.453 ' CB ' ' HA ' ' A' ' 43' ' ' ALA . 0.3 OUTLIER -158.81 130.56 6.53 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.07 179.966 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.799 HD12 ' N ' ' A' ' 34' ' ' ARG . 3.5 pp -110.99 -177.88 3.33 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.039 0.447 . . . . 0.0 110.998 -179.44 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.799 ' N ' HD12 ' A' ' 33' ' ' LEU . 1.3 ttp180 -143.06 162.09 36.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.007 179.724 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.419 ' HB2' ' HB2' ' A' ' 38' ' ' SER . 0.1 OUTLIER -129.51 25.59 5.4 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.198 179.643 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 49.32 94.15 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.817 179.838 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.414 ' O ' ' N ' ' A' ' 39' ' ' ASP . . . 98.23 -30.13 10.07 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 111.207 -0.757 . . . . 0.0 111.207 179.639 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.419 ' HB2' ' HB2' ' A' ' 35' ' ' GLU . 14.7 m -65.2 74.14 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.794 0.33 . . . . 0.0 110.703 -179.7 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.414 ' N ' ' O ' ' A' ' 37' ' ' GLY . 8.7 m-20 46.62 43.3 12.43 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.937 179.655 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 52.06 -173.55 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.926 0.393 . . . . 0.0 110.387 179.887 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.52 ' CZ3' ' HG2' ' A' ' 67' ' ' ARG . 80.7 m95 -44.86 144.2 1.24 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.945 -179.936 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.639 HG21 ' CE1' ' A' ' 54' ' ' PHE . 31.1 m -131.07 116.37 33.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.124 179.757 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.453 ' HA ' ' CB ' ' A' ' 32' ' ' GLU . . . -49.51 128.81 18.15 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.25 179.991 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -62.97 -172.13 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.287 -179.808 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 31.6 m -132.5 109.35 9.73 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.446 -179.9 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.43 ' HB3' ' CZ3' ' A' ' 52' ' ' TRP . 39.4 mtpt -85.49 106.58 16.93 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.327 -179.999 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 170.99 43.84 0.03 OUTLIER Glycine 0 CA--C 1.524 0.596 0 N-CA-C 110.749 -0.94 . . . . 0.0 110.749 -179.902 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.415 ' HB3' ' O ' ' A' ' 51' ' ' VAL . 24.3 tp10 -130.38 65.34 1.52 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.776 0.322 . . . . 0.0 110.457 179.939 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 67.42 -80.7 0.15 Allowed Glycine 0 CA--C 1.523 0.551 0 N-CA-C 110.75 -0.94 . . . . 0.0 110.75 179.987 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -146.49 21.09 1.69 Allowed Glycine 0 CA--C 1.526 0.737 0 N-CA-C 111.256 -0.737 . . . . 0.0 111.256 -179.954 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.85 HG11 ' CD ' ' A' ' 9' ' ' GLU . 29.6 m -138.85 170.45 16.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 110.159 -0.312 . . . . 0.0 110.159 179.764 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 52' ' ' TRP . . . . . 0.478 ' CD1' HG21 ' A' ' 31' ' ' VAL . 7.4 m95 -100.24 137.36 38.78 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.026 0.441 . . . . 0.0 111.032 -179.461 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.77 142.45 49.55 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.546 179.31 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.754 ' CG ' HD21 ' A' ' 33' ' ' LEU . 27.7 t80 -108.01 116.14 31.41 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.963 0.411 . . . . 0.0 110.691 -179.547 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 57.9 t0 -107.49 130.2 54.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.112 179.847 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -158.26 -177.65 6.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.908 0.385 . . . . 0.0 110.517 -179.884 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -99.52 -26.23 14.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.448 -179.945 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -50.39 159.09 0.9 Allowed Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.483 -179.945 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -70.56 -20.6 30.87 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.554 2.17 . . . . 0.0 111.856 179.673 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.4 tp 57.12 101.87 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.519 179.739 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -173.97 71.04 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.35 180.0 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.434 ' O ' ' CE2' ' A' ' 64' ' ' PHE . . . 175.46 -158.07 25.07 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 110.762 -0.935 . . . . 0.0 110.762 -179.974 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -78.86 169.71 19.09 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.604 2.203 . . . . 0.0 112.086 -179.949 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.434 ' CE2' ' O ' ' A' ' 62' ' ' GLY . 72.4 m-85 -151.27 111.87 4.21 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.515 -179.968 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 12.0 m-80 -81.13 153.21 27.4 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 179.445 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.541 ' CD2' ' CE2' ' A' ' 6' ' ' PHE . 21.0 m-85 -128.75 178.17 6.54 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.14 0.495 . . . . 0.0 111.257 -179.769 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.52 ' HG2' ' CZ3' ' A' ' 41' ' ' TRP . 0.1 OUTLIER 171.85 78.71 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.552 179.864 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.669 ' C ' HD23 ' A' ' 69' ' ' LEU . 1.3 p90 -78.11 169.0 19.0 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.186 0.517 . . . . 0.0 110.932 -179.295 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.809 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 2.4 mt -118.16 71.91 0.85 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.234 179.528 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.414 ' OG1' ' N ' ' A' ' 74' ' ' MET . 28.4 p -36.75 140.55 0.15 Allowed 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.742 -179.108 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.613 ' HG2' ' HB2' ' A' ' 29' ' ' ALA . 17.7 mt-10 -48.9 -57.34 6.6 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.635 -179.7 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.43 52.28 2.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.441 179.958 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -129.8 -108.7 1.32 Allowed Glycine 0 CA--C 1.523 0.567 0 N-CA-C 110.636 -0.985 . . . . 0.0 110.636 179.917 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.414 ' N ' ' OG1' ' A' ' 70' ' ' THR . 2.4 ptm -173.12 168.13 4.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.838 0.351 . . . . 0.0 110.35 -179.993 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.542 ' HD2' HD22 ' A' ' 69' ' ' LEU . 0.6 OUTLIER -77.95 166.71 22.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.231 179.857 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -171.03 164.69 7.52 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.311 179.917 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 98.1 t -130.37 142.26 44.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.163 179.943 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.587 ' CE2' HG22 ' A' ' 4' ' ' VAL . 86.3 m-85 -134.04 132.69 40.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.602 -179.818 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -119.54 162.22 19.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.276 179.844 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 55.03 39.88 31.77 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.312 -179.871 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.669 HG22 ' HD3' ' A' ' 94' ' ' PRO . 47.0 t -86.62 -10.23 11.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.818 -179.978 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 98.7 t -148.49 130.7 7.64 Favored Pre-proline 0 CA--C 1.529 0.137 0 N-CA-C 110.301 -0.259 . . . . 0.0 110.301 179.782 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.489 ' HD3' ' CD1' ' A' ' 92' ' ' TYR . 47.5 Cg_endo -70.73 -174.35 1.07 Allowed 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.534 2.156 . . . . 0.0 111.819 179.575 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -58.3 -63.94 1.09 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.004 179.668 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -108.76 86.57 2.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.114 179.622 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 31.8 p90 -52.83 150.65 5.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.753 -179.641 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 27.9 m -122.21 101.67 7.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.982 179.748 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.445 ' CG2' ' HA ' ' A' ' 10' ' ' LYS . 2.7 mp -44.36 116.48 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.005 -179.673 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 106.72 56.06 0.64 Allowed Glycine 0 CA--C 1.523 0.593 0 N-CA-C 110.812 -0.915 . . . . 0.0 110.812 179.854 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -174.03 142.72 0.87 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.898 0.38 . . . . 0.0 110.731 179.984 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.721 HG23 ' O ' ' A' ' 6' ' ' PHE . 10.0 m -87.69 133.65 33.8 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.044 -0.525 . . . . 0.0 109.881 179.561 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.489 ' CD1' ' HD3' ' A' ' 83' ' ' PRO . 65.5 m-85 -117.09 -86.07 0.63 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.022 -179.266 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.894 ' HB1' ' HD2' ' A' ' 94' ' ' PRO . . . 50.59 179.86 0.02 OUTLIER Pre-proline 0 C--N 1.332 -0.192 0 CA-C-O 120.723 0.297 . . . . 0.0 110.438 -179.714 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.894 ' HD2' ' HB1' ' A' ' 93' ' ' ALA . 48.8 Cg_endo . . . . . 0 C--O 1.249 1.066 0 C-N-CA 122.586 2.191 . . . . 0.0 112.097 -179.846 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.419 ' O ' HG23 ' A' ' 1' ' ' VAL . 6.4 m . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 110.223 -0.288 . . . . 0.0 110.223 . . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -76.22 137.37 19.03 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.631 2.22 . . . . 0.0 112.046 -179.932 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 9.0 mtmt -127.67 74.84 1.56 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.44 -179.923 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.633 HG11 ' CZ ' ' A' ' 78' ' ' PHE . 1.7 p -58.55 163.66 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.268 0.556 . . . . 0.0 110.337 -179.919 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.479 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 5.7 p -148.09 130.6 15.8 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.466 179.907 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.485 ' O ' HG23 ' A' ' 91' ' ' THR . 11.7 m-85 -98.87 175.25 6.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.258 -179.994 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.657 HG23 ' O ' ' A' ' 90' ' ' ALA . 2.0 m -166.47 107.74 0.69 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.297 -179.966 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.47 HG11 ' CD1' ' A' ' 86' ' ' TYR . 47.8 t -55.34 99.82 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.402 179.997 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.487 ' HG3' HG11 ' A' ' 51' ' ' VAL . 2.5 mt-10 -72.29 174.49 7.2 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.596 -179.836 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.04 178.8 0.78 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.385 -179.966 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 67.24 26.81 73.42 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 110.784 -0.926 . . . . 0.0 110.784 179.939 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.62 ' OG ' HD11 ' A' ' 88' ' ' ILE . 85.3 p -87.49 109.25 19.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.767 0.317 . . . . 0.0 110.445 -179.969 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 30.8 m-20 -112.73 -162.52 0.8 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.236 179.815 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -65.54 -60.07 3.32 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.416 179.997 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -94.6 20.26 8.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.905 -179.727 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 19.5 m80 -128.11 112.32 14.45 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.863 0.363 . . . . 0.0 110.462 -179.914 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.408 ' HA ' HD22 ' A' ' 17' ' ' LEU . 0.2 OUTLIER -119.03 99.27 6.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.281 179.966 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -95.29 132.58 40.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.182 179.877 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.584 HG23 HG23 ' A' ' 21' ' ' VAL . 25.7 m -132.43 137.35 54.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.428 -179.999 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.441 ' HA ' HG12 ' A' ' 51' ' ' VAL . 0.5 OUTLIER -87.88 90.18 8.28 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.393 179.833 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.584 HG23 HG23 ' A' ' 19' ' ' VAL . 27.2 t -90.24 101.24 12.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.369 -179.966 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -174.41 144.28 0.9 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.343 -179.926 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.458 ' CE1' ' HB2' ' A' ' 26' ' ' ASP . 5.9 p90 -158.48 62.79 0.43 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.502 -179.894 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 65.12 -71.33 0.08 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.779 179.719 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.427 ' N ' ' O ' ' A' ' 23' ' ' TYR . . . -75.26 -160.66 8.56 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 110.796 -0.922 . . . . 0.0 110.796 -179.879 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.512 ' OD1' HG22 ' A' ' 70' ' ' THR . 47.7 t0 64.55 127.99 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.793 0.33 . . . . 0.0 110.368 179.998 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.65 HG22 ' O ' ' A' ' 27' ' ' THR . 31.6 m -109.97 34.26 3.96 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.559 -179.933 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.522 ' O ' ' HB2' ' A' ' 29' ' ' ALA . 0.0 OUTLIER 49.25 -177.6 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.011 179.595 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.66 ' HB3' ' O ' ' A' ' 69' ' ' LEU . . . 168.62 -66.01 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.168 179.832 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.405 ' O ' ' HB2' ' A' ' 68' ' ' PHE . 0.5 OUTLIER -154.5 154.81 33.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.722 179.898 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.484 HG21 ' CD1' ' A' ' 52' ' ' TRP . 12.3 t -148.96 153.64 10.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.084 0.468 . . . . 0.0 111.092 -179.597 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.441 ' CG ' ' HD2' ' A' ' 67' ' ' ARG . 0.0 OUTLIER -163.37 147.72 10.89 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.896 -179.917 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.769 HD12 ' N ' ' A' ' 34' ' ' ARG . 3.4 pp -121.95 179.94 4.34 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.905 0.383 . . . . 0.0 110.942 -179.512 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.769 ' N ' HD12 ' A' ' 33' ' ' LEU . 4.7 ttt180 -133.96 167.13 21.16 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.078 179.847 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -128.21 9.11 6.15 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.281 -179.927 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 3.8 t60 67.98 -67.48 0.19 Allowed 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.766 0.317 . . . . 0.0 110.595 179.791 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -52.22 -53.02 33.05 Favored Glycine 0 CA--C 1.523 0.592 0 N-CA-C 110.972 -0.851 . . . . 0.0 110.972 -179.843 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 58.9 m -51.02 -28.71 10.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.771 0.32 . . . . 0.0 110.487 -179.839 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 24.9 t0 63.26 19.25 11.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.822 179.981 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -155.86 129.05 8.14 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.871 0.367 . . . . 0.0 110.479 179.898 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.501 ' CZ3' ' HG2' ' A' ' 67' ' ' ARG . 84.3 m95 -54.22 139.53 35.59 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.417 179.94 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.525 HG21 ' CZ ' ' A' ' 54' ' ' PHE . 28.4 m -115.35 111.87 37.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.28 -0.418 . . . . 0.0 109.908 179.575 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -46.49 136.1 7.82 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.669 -179.617 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.523 ' CE ' HD23 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -65.2 -170.03 0.05 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.234 -179.856 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 23.4 m -144.29 103.9 4.03 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.595 -179.881 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 9.0 ptpt -67.64 72.43 0.15 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.143 179.683 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -103.55 -39.08 2.64 Favored Glycine 0 CA--C 1.521 0.447 0 N-CA-C 110.671 -0.972 . . . . 0.0 110.671 -179.852 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.612 ' HG2' HG22 ' A' ' 51' ' ' VAL . 4.0 tt0 -75.86 134.18 40.39 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.811 0.339 . . . . 0.0 110.367 -179.967 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -78.36 74.65 2.04 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 110.74 -0.944 . . . . 0.0 110.74 -179.989 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 150.71 -52.89 0.5 Allowed Glycine 0 CA--C 1.522 0.52 0 N-CA-C 110.656 -0.978 . . . . 0.0 110.656 179.984 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.612 HG22 ' HG2' ' A' ' 48' ' ' GLU . 18.0 m -114.84 -177.95 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.795 0.331 . . . . 0.0 110.306 179.919 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 52' ' ' TRP . . . . . 0.484 ' CD1' HG21 ' A' ' 31' ' ' VAL . 13.6 m95 -109.57 141.44 42.07 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.709 -179.842 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.7 p -126.89 159.71 33.14 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.867 179.705 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.525 ' CZ ' HG21 ' A' ' 42' ' ' VAL . 57.1 t80 -130.86 125.33 33.31 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.861 0.363 . . . . 0.0 110.717 -179.664 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -85.09 63.11 7.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.177 179.78 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 52.3 p -57.04 147.06 25.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.436 -179.875 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.6 25.05 4.4 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.518 179.932 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -117.93 138.54 25.5 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.208 179.756 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -75.5 69.35 5.95 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.518 2.146 . . . . 0.0 112.164 -179.694 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 10.7 tp -151.22 106.68 3.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.394 179.898 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -102.02 62.99 0.9 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.037 0.446 . . . . 0.0 110.416 -179.92 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -109.02 -153.15 15.36 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 110.702 -0.959 . . . . 0.0 110.702 179.98 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -75.4 158.7 40.5 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.546 2.164 . . . . 0.0 111.953 179.96 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -131.21 105.28 7.56 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.668 -179.855 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 41.3 m-20 -68.82 168.65 12.99 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 179.432 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -144.74 174.69 10.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.141 0.495 . . . . 0.0 111.047 -179.815 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.501 ' HG2' ' CZ3' ' A' ' 41' ' ' TRP . 0.0 OUTLIER 175.57 54.98 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.559 -179.941 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.449 ' O ' HD23 ' A' ' 69' ' ' LEU . 1.0 OUTLIER -55.73 176.24 0.07 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.076 -179.377 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.721 HD22 ' HD2' ' A' ' 75' ' ' LYS . 11.6 mt -124.99 69.82 1.14 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.59 179.598 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.512 HG22 ' OD1' ' A' ' 26' ' ' ASP . 16.5 p -37.86 140.78 0.23 Allowed 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.928 -179.18 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.511 ' N ' ' HB2' ' A' ' 29' ' ' ALA . 0.0 OUTLIER -42.64 -44.91 4.45 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.355 179.988 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -54.74 -32.92 60.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.341 -179.994 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 105.67 53.59 0.76 Allowed Glycine 0 CA--C 1.522 0.531 0 N-CA-C 110.757 -0.937 . . . . 0.0 110.757 179.986 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 5.0 mmm -129.18 130.13 45.95 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.771 0.32 . . . . 0.0 110.537 179.991 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.721 ' HD2' HD22 ' A' ' 69' ' ' LEU . 0.0 OUTLIER -117.01 123.01 45.84 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.197 -0.456 . . . . 0.0 109.872 179.885 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.467 ' O ' ' CE2' ' A' ' 78' ' ' PHE . 6.4 m120 -134.21 126.16 29.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.377 -179.964 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 73.9 t -84.45 142.69 13.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.342 179.988 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.633 ' CZ ' HG11 ' A' ' 4' ' ' VAL . 23.2 m-85 -129.38 137.02 50.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.52 -179.883 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -114.17 147.57 38.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.219 179.9 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 58.04 49.35 11.76 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.191 -179.867 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.526 ' O ' HG12 ' A' ' 81' ' ' VAL . 99.4 t -86.09 -4.75 9.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.23 -179.843 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.444 HG23 ' C ' ' A' ' 81' ' ' VAL . 89.4 t -157.09 130.8 4.75 Favored Pre-proline 0 C--N 1.333 -0.149 0 N-CA-C 110.228 -0.286 . . . . 0.0 110.228 179.77 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.507 ' HD3' ' CG ' ' A' ' 92' ' ' TYR . 45.6 Cg_endo -70.18 -170.85 0.45 Allowed 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.589 2.193 . . . . 0.0 111.923 179.676 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 -76.24 -62.61 1.55 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.192 179.788 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.08 66.46 0.91 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.9 179.655 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.47 ' CD1' HG11 ' A' ' 8' ' ' VAL . 14.3 p90 -49.45 154.13 0.97 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.886 -179.606 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 39.4 m -133.07 109.51 9.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.024 179.751 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.62 HD11 ' OG ' ' A' ' 12' ' ' SER . 3.7 mp -46.25 100.44 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.908 -179.727 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 138.53 45.61 0.07 OUTLIER Glycine 0 CA--C 1.523 0.555 0 N-CA-C 110.86 -0.896 . . . . 0.0 110.86 179.868 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.657 ' O ' HG23 ' A' ' 7' ' ' THR . . . -162.98 174.61 12.1 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.825 0.345 . . . . 0.0 110.446 179.93 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.485 HG23 ' O ' ' A' ' 6' ' ' PHE . 94.6 m -119.57 126.98 52.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.237 179.88 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.507 ' CG ' ' HD3' ' A' ' 83' ' ' PRO . 42.0 m-85 -126.21 109.39 12.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.391 -179.906 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.91 ' HB1' ' HD2' ' A' ' 94' ' ' PRO . . . 172.14 176.47 0.15 Allowed Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.257 179.96 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.91 ' HD2' ' HB1' ' A' ' 93' ' ' ALA . 48.1 Cg_endo . . . . . 0 C--O 1.249 1.052 0 C-N-CA 122.558 2.172 . . . . 0.0 112.096 -179.948 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 44.8 t . . . . . 0 N--CA 1.489 1.496 0 N-CA-C 110.24 -0.281 . . . . 0.0 110.24 . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -78.99 143.32 17.98 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.604 2.203 . . . . 0.0 112.079 -179.986 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 9.8 mtpm? -108.62 48.16 0.87 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.502 -179.876 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.775 ' O ' HG23 ' A' ' 5' ' ' THR . 31.2 m -67.52 -175.78 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.496 179.993 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.775 HG23 ' O ' ' A' ' 4' ' ' VAL . 0.7 OUTLIER -171.65 153.87 3.53 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.31 179.849 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.502 ' CD2' ' HB ' ' A' ' 21' ' ' VAL . 51.2 m-85 -132.1 145.17 51.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.282 179.894 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.525 HG23 ' O ' ' A' ' 90' ' ' ALA . 68.3 m -133.45 130.71 39.0 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.348 -179.923 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.452 HG21 ' HB2' ' A' ' 86' ' ' TYR . 84.0 t -67.71 90.99 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.276 -179.992 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.94 ' HG3' HG11 ' A' ' 51' ' ' VAL . 6.3 mm-40 -56.21 167.91 0.59 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.401 -179.918 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.09 -18.36 65.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.918 -179.979 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -46.52 -29.33 3.91 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 111.102 -0.799 . . . . 0.0 111.102 -179.846 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 27.8 m -64.71 139.04 58.72 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.727 0.299 . . . . 0.0 110.386 179.928 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.1 p30 -139.05 -50.49 0.53 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.59 179.965 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -147.96 -78.04 0.16 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.405 -179.908 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.4 ' HD2' ' HG3' ' A' ' 57' ' ' GLU . 0.0 OUTLIER -101.18 9.67 41.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.219 -179.951 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 5.9 m80 -105.28 125.68 51.26 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.848 0.356 . . . . 0.0 110.358 -179.964 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.472 ' HA ' HD22 ' A' ' 17' ' ' LEU . 0.2 OUTLIER -110.14 104.11 12.92 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.296 179.981 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.847 ' HB2' HG22 ' A' ' 53' ' ' THR . . . -110.64 110.49 21.19 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.29 -179.993 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.407 ' O ' ' HG3' ' A' ' 9' ' ' GLU . 5.6 m -91.13 -168.61 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.04 0.448 . . . . 0.0 110.461 179.998 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.8 tt -141.46 83.39 1.86 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.506 179.905 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.527 ' CG1' ' CD1' ' A' ' 52' ' ' TRP . 2.1 p -102.53 97.68 5.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.007 179.892 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.483 ' O ' ' CG ' ' A' ' 23' ' ' TYR . 11.9 ttmt -145.45 -71.05 0.26 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.255 179.98 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.483 ' CG ' ' O ' ' A' ' 22' ' ' LYS . 30.6 p90 44.36 -170.23 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.067 179.807 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -123.32 146.49 47.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.272 179.972 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 133.76 -58.69 0.69 Allowed Glycine 0 CA--C 1.523 0.58 0 N-CA-C 110.85 -0.9 . . . . 0.0 110.85 179.962 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -112.76 -162.54 0.8 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.801 0.334 . . . . 0.0 110.379 -179.958 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -119.76 -174.72 2.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.478 179.968 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.423 ' O ' ' CG ' ' A' ' 71' ' ' GLU . 12.6 mtm -120.43 119.27 32.55 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.196 -179.976 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.827 ' HB3' ' O ' ' A' ' 69' ' ' LEU . . . -120.72 -60.6 1.65 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.632 -179.7 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.427 ' C ' HG12 ' A' ' 31' ' ' VAL . 0.1 OUTLIER -151.83 168.59 24.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.589 -179.811 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.452 ' HB ' ' HB3' ' A' ' 68' ' ' PHE . 0.2 OUTLIER -179.01 144.2 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.986 179.967 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.434 ' CB ' ' HA ' ' A' ' 43' ' ' ALA . 3.6 pt-20 -142.12 168.27 20.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.472 -0.786 . . . . 0.0 109.915 -179.771 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.715 HD12 ' N ' ' A' ' 34' ' ' ARG . 3.1 pp -121.73 174.69 6.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.869 0.366 . . . . 0.0 110.767 -179.791 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.715 ' N ' HD12 ' A' ' 33' ' ' LEU . 6.8 ttm180 -126.88 -94.61 0.45 Allowed 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.215 179.821 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.436 ' O ' ' CB ' ' A' ' 36' ' ' HIS . 0.0 OUTLIER 163.34 -35.78 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 120.703 0.287 . . . . 0.0 110.239 179.875 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.436 ' CB ' ' O ' ' A' ' 35' ' ' GLU . 5.2 t-160 86.44 -16.5 0.42 Allowed 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.172 -179.626 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -104.14 -27.67 6.13 Favored Glycine 0 CA--C 1.522 0.516 0 N-CA-C 110.412 -1.075 . . . . 0.0 110.412 179.693 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -83.84 -159.1 0.35 Allowed 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 179.796 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 22.4 p30 -141.04 24.27 2.17 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.615 179.985 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -156.4 148.51 23.18 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.916 0.389 . . . . 0.0 110.472 179.909 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.504 ' CZ3' ' HG2' ' A' ' 67' ' ' ARG . 55.2 m95 -85.7 154.83 21.38 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.2 179.867 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.655 HG23 ' O ' ' A' ' 42' ' ' VAL . 34.3 m -124.16 106.26 16.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.914 0.387 . . . . 0.0 110.146 179.704 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.434 ' HA ' ' CB ' ' A' ' 32' ' ' GLU . . . -49.0 116.97 1.87 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.712 -179.757 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.644 ' HE2' HD23 ' A' ' 33' ' ' LEU . 0.6 OUTLIER -53.84 -172.06 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.387 179.909 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 31.6 m -151.05 122.74 8.01 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.423 -179.942 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 5.1 ptpt -68.41 67.79 0.13 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.083 179.698 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -90.96 -26.58 21.6 Favored Glycine 0 CA--C 1.522 0.483 0 N-CA-C 110.626 -0.99 . . . . 0.0 110.626 -179.929 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.467 ' HG2' HG22 ' A' ' 51' ' ' VAL . 9.8 tp10 -93.3 129.8 39.26 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.816 0.341 . . . . 0.0 110.231 179.946 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -74.03 66.25 1.84 Allowed Glycine 0 CA--C 1.523 0.565 0 N-CA-C 110.912 -0.875 . . . . 0.0 110.912 -179.84 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 158.65 -35.81 0.51 Allowed Glycine 0 CA--C 1.524 0.638 0 N-CA-C 111.085 -0.806 . . . . 0.0 111.085 179.809 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.94 HG11 ' HG3' ' A' ' 9' ' ' GLU . 30.4 m -135.81 -176.43 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.94 0.4 . . . . 0.0 110.859 -179.722 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 52' ' ' TRP . . . . . 0.527 ' CD1' ' CG1' ' A' ' 21' ' ' VAL . 6.1 m95 -101.85 134.29 45.27 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.494 -179.42 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.847 HG22 ' HB2' ' A' ' 18' ' ' ALA . 6.7 p -127.01 156.3 41.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.448 -179.847 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 50.6 t80 -137.99 124.32 20.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.409 179.904 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 20.6 p-10 -86.78 148.89 25.21 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.314 179.972 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -172.88 -179.36 2.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.482 -179.856 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.4 ' HG3' ' HD2' ' A' ' 15' ' ' LYS . 2.2 mt-10 -161.18 61.59 0.28 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.2 179.918 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.404 ' HB2' ' HD2' ' A' ' 59' ' ' PRO . 7.3 pt-20 -133.38 157.42 78.17 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.31 179.996 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.404 ' HD2' ' HB2' ' A' ' 58' ' ' GLU . 47.4 Cg_endo -70.87 -35.57 9.18 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.529 2.153 . . . . 0.0 111.989 179.898 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -77.23 98.56 5.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.376 -179.974 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -148.21 48.21 1.05 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.399 -179.98 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -78.12 -101.74 0.2 Allowed Glycine 0 CA--C 1.526 0.747 0 N-CA-C 110.698 -0.961 . . . . 0.0 110.698 -179.973 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -80.69 177.36 8.13 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.63 2.22 . . . . 0.0 112.102 -179.995 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 49.8 m-85 -153.61 103.18 2.61 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.72 -179.969 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 6.2 m-20 -73.44 129.43 37.98 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 179.358 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.466 ' CE1' ' HB3' ' A' ' 33' ' ' LEU . 40.6 m-85 -115.42 170.87 8.08 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.13 0.491 . . . . 0.0 111.096 -179.333 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.504 ' HG2' ' CZ3' ' A' ' 41' ' ' TRP . 0.0 OUTLIER -169.2 83.69 0.14 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.632 -179.946 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.894 ' O ' HD23 ' A' ' 69' ' ' LEU . 6.9 p90 -71.27 176.68 4.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.356 0.598 . . . . 0.0 111.333 -179.159 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.894 HD23 ' O ' ' A' ' 68' ' ' PHE . 8.7 mt -138.53 70.84 1.38 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.22 179.612 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.402 ' OG1' ' N ' ' A' ' 74' ' ' MET . 65.0 p -29.56 136.2 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.509 0.723 . . . . 0.0 112.61 -178.976 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.632 ' HG2' ' HB2' ' A' ' 29' ' ' ALA . 22.2 mt-10 -52.09 -39.13 59.31 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.314 179.972 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.37 64.59 1.49 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.545 -179.877 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -157.75 -104.75 0.21 Allowed Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.71 -0.956 . . . . 0.0 110.71 179.966 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.402 ' N ' ' OG1' ' A' ' 70' ' ' THR . 0.0 OUTLIER -172.03 -179.03 2.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.826 0.346 . . . . 0.0 110.326 179.969 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.617 ' CG ' HD22 ' A' ' 69' ' ' LEU . 0.0 OUTLIER -84.63 -176.86 6.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.412 -179.951 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.421 ' O ' ' CB ' ' A' ' 67' ' ' ARG . 1.0 OUTLIER -178.71 158.89 1.05 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.099 179.979 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 97.2 t -124.52 130.43 73.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.979 0.418 . . . . 0.0 110.509 -179.756 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.6 ' CZ ' HG21 ' A' ' 4' ' ' VAL . 31.8 m-85 -121.71 130.53 53.51 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.158 179.983 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -118.86 155.56 31.01 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.638 -179.653 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 53.5 m-20 58.25 23.71 10.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.792 179.842 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.509 HG13 ' O ' ' A' ' 92' ' ' TYR . 77.1 t -55.35 -78.36 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 179.61 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 76.7 t -81.71 134.36 50.73 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.125 179.751 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.501 ' HD3' ' CG ' ' A' ' 92' ' ' TYR . 46.6 Cg_endo -71.69 -177.1 2.31 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.437 2.091 . . . . 0.0 111.938 179.79 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -63.04 -64.19 0.98 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.186 179.902 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -102.56 76.86 1.56 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.218 179.798 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.452 ' HB2' HG21 ' A' ' 8' ' ' VAL . 55.7 p90 -54.63 160.95 1.64 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.442 -179.873 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.05 111.86 7.44 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.323 179.917 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 2.7 mp -50.52 100.28 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.456 -179.925 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 133.84 45.95 0.11 Allowed Glycine 0 CA--C 1.523 0.572 0 N-CA-C 110.665 -0.974 . . . . 0.0 110.665 -179.981 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.731 ' HB3' ' OH ' ' A' ' 92' ' ' TYR . . . -172.99 153.04 2.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.79 0.329 . . . . 0.0 110.386 179.979 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 40.3 m -102.96 133.49 47.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.504 -179.931 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.731 ' OH ' ' HB3' ' A' ' 90' ' ' ALA . 6.3 m-85 -130.78 110.52 11.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.321 179.88 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.863 ' HB1' ' HD2' ' A' ' 94' ' ' PRO . . . 179.28 177.36 0.32 Allowed Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.306 -179.978 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.863 ' HD2' ' HB1' ' A' ' 93' ' ' ALA . 48.0 Cg_endo . . . . . 0 C--O 1.249 1.059 0 C-N-CA 122.62 2.213 . . . . 0.0 112.078 -179.868 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 2.2 m . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 110.21 -0.293 . . . . 0.0 110.21 . . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -79.01 145.48 19.59 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.589 2.193 . . . . 0.0 112.09 179.976 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.413 ' CG ' ' O ' ' A' ' 3' ' ' LYS . 1.8 ptmt -152.34 106.16 3.11 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.794 -179.684 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.58 HG21 ' CZ ' ' A' ' 78' ' ' PHE . 2.9 m -130.11 168.32 23.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.174 179.486 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.406 ' HB ' ' CG2' ' A' ' 91' ' ' THR . 0.6 OUTLIER -146.12 145.68 30.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.325 179.851 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.56 ' CE2' ' CD2' ' A' ' 66' ' ' PHE . 26.3 m-85 -117.66 160.97 20.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.736 -179.688 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.443 HG22 ' H ' ' A' ' 8' ' ' VAL . 0.2 OUTLIER -142.43 -164.15 1.76 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.169 179.836 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.658 ' O ' HG23 ' A' ' 88' ' ' ILE . 47.0 t -141.85 92.74 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.346 -179.918 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.719 ' HG3' HG11 ' A' ' 51' ' ' VAL . 1.4 mm-40 -56.64 158.01 4.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.57 -179.811 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 7.4 ptmm? -58.17 -19.25 31.6 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.896 -179.989 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -49.8 -24.77 6.37 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 111.021 -0.831 . . . . 0.0 111.021 -179.966 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 10.0 p -47.83 113.85 0.8 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.85 0.357 . . . . 0.0 110.78 -179.862 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 42.4 m-20 -116.17 -156.28 0.61 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.147 179.859 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -44.96 -68.44 0.2 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.721 0.296 . . . . 0.0 110.905 -179.868 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.61 40.57 3.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.309 179.869 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 8.5 m80 -118.55 123.29 44.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.365 179.953 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.463 ' HA ' HD22 ' A' ' 17' ' ' LEU . 0.2 OUTLIER -104.97 97.86 7.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.192 -179.928 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.448 ' HB2' HG22 ' A' ' 53' ' ' THR . . . -100.22 104.56 16.06 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.602 -179.788 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.406 ' O ' ' HG3' ' A' ' 9' ' ' GLU . 27.7 m -88.3 -175.17 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.129 179.67 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.7 tt -139.42 77.55 1.62 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.402 179.724 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 3.3 t -84.01 107.9 15.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.083 179.934 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.57 147.84 4.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.391 -179.969 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.523 ' CZ ' HG12 ' A' ' 4' ' ' VAL . 3.9 p90 177.99 128.56 0.05 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.221 -179.909 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -53.4 154.43 3.41 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.512 -179.865 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 107.57 -68.98 0.22 Allowed Glycine 0 CA--C 1.522 0.522 0 N-CA-C 110.59 -1.004 . . . . 0.0 110.59 -179.968 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -94.08 179.28 5.37 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 110.164 -0.31 . . . . 0.0 110.164 179.975 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.417 ' OG1' ' CE ' ' A' ' 72' ' ' LYS . 0.2 OUTLIER -119.19 -163.8 1.0 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.928 0.394 . . . . 0.0 110.525 -179.971 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.43 ' O ' ' CG ' ' A' ' 71' ' ' GLU . 33.7 mtp -129.6 124.11 32.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.297 -179.815 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.866 ' HB3' ' O ' ' A' ' 69' ' ' LEU . . . -129.42 -57.97 1.13 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.937 -179.79 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.597 ' C ' HG12 ' A' ' 31' ' ' VAL . 2.8 tt0 -141.07 177.19 8.24 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.945 0.402 . . . . 0.0 111.059 -179.673 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.597 HG12 ' C ' ' A' ' 30' ' ' GLU . 0.3 OUTLIER 171.52 134.2 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.958 -179.986 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.411 ' HG3' ' CE3' ' A' ' 41' ' ' TRP . 1.1 pt-20 -123.55 161.24 25.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.643 -179.549 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.491 ' HG ' ' CE1' ' A' ' 66' ' ' PHE . 2.3 mt -110.0 154.33 23.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.381 179.782 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.487 ' HG3' ' CD2' ' A' ' 41' ' ' TRP . 0.0 OUTLIER -126.99 -163.31 1.23 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.949 179.51 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.449 ' CB ' ' HB2' ' A' ' 38' ' ' SER . 0.2 OUTLIER 176.8 106.71 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.841 0.353 . . . . 0.0 110.171 179.971 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -51.2 95.3 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.206 -179.982 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 126.14 -32.18 3.85 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 110.359 -1.097 . . . . 0.0 110.359 -179.636 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.449 ' HB2' ' CB ' ' A' ' 35' ' ' GLU . 35.0 t -57.09 -25.4 58.69 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.732 0.301 . . . . 0.0 110.398 179.788 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 75.75 97.29 0.07 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.653 179.986 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 72.62 159.59 0.22 Allowed 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.876 179.641 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.501 ' CZ2' ' CD ' ' A' ' 67' ' ' ARG . 51.1 m95 -64.49 167.39 7.11 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.434 -179.899 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 14.9 m -135.1 3.21 1.08 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.852 -179.622 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . 59.92 138.42 0.01 OUTLIER 'General case' 0 C--N 1.334 -0.107 0 CA-C-O 121.129 0.49 . . . . 0.0 111.299 179.391 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.436 ' HE3' ' HB2' ' A' ' 52' ' ' TRP . 0.0 OUTLIER -73.64 -170.35 0.84 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.375 179.862 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.424 ' O ' ' N ' ' A' ' 47' ' ' GLY . 43.4 m -143.31 111.08 5.95 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.144 179.809 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.9 ptpt -62.45 79.12 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.396 -179.908 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.424 ' N ' ' O ' ' A' ' 45' ' ' THR . . . -98.47 -26.77 9.03 Favored Glycine 0 CA--C 1.522 0.525 0 N-CA-C 110.691 -0.963 . . . . 0.0 110.691 -179.966 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.405 ' HB2' ' O ' ' A' ' 51' ' ' VAL . 0.5 OUTLIER -87.15 -172.53 4.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.852 0.358 . . . . 0.0 110.432 -179.943 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -110.94 -24.68 5.41 Favored Glycine 0 CA--C 1.522 0.505 0 N-CA-C 110.807 -0.917 . . . . 0.0 110.807 179.95 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -129.28 -1.39 5.69 Favored Glycine 0 CA--C 1.528 0.888 0 N-CA-C 111.957 -0.457 . . . . 0.0 111.957 -179.684 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.719 HG11 ' HG3' ' A' ' 9' ' ' GLU . 17.9 m -146.23 178.26 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 CA-C-N 117.476 0.638 . . . . 0.0 110.761 -179.946 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 52' ' ' TRP . . . . . 0.436 ' HB2' ' HE3' ' A' ' 44' ' ' MET . 10.9 m95 -105.34 141.1 37.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.56 -179.555 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.448 HG22 ' HB2' ' A' ' 18' ' ' ALA . 10.3 p -126.04 162.78 24.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.336 -179.969 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 45.5 t80 -134.54 162.54 31.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.536 -179.881 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -112.86 143.03 44.81 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.224 179.865 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -133.9 178.7 6.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.374 179.934 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -123.94 26.61 7.52 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.345 179.975 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -171.0 155.65 4.53 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.269 179.947 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -71.87 -36.2 6.45 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.707 2.272 . . . . 0.0 112.325 -179.808 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -75.57 148.3 38.98 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.75 -179.55 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -147.74 -174.48 4.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.208 179.978 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -145.06 -148.96 4.93 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 110.734 -0.946 . . . . 0.0 110.734 179.995 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -78.03 158.08 30.59 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.575 2.183 . . . . 0.0 111.796 179.872 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.41 ' HB3' ' CD2' ' A' ' 33' ' ' LEU . 86.5 m-85 -131.6 171.19 13.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.07 0.462 . . . . 0.0 110.79 -179.794 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.428 ' HB2' ' CB ' ' A' ' 34' ' ' ARG . 4.3 m-80 -139.57 137.36 35.33 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.615 179.571 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.56 ' CD2' ' CE2' ' A' ' 6' ' ' PHE . 48.0 m-85 -120.44 159.94 24.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.108 0.48 . . . . 0.0 111.093 -179.217 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.588 ' CD ' HG22 ' A' ' 77' ' ' VAL . 28.6 mtp180 -157.61 81.4 0.88 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.818 179.68 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.469 ' HA ' ' HA ' ' A' ' 31' ' ' VAL . 5.9 p90 -78.7 173.59 12.3 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-O 121.54 0.685 . . . . 0.0 111.37 -179.334 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.866 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 8.8 mt -138.43 74.3 1.47 Allowed 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 114.664 -1.153 . . . . 0.0 109.016 179.496 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.439 ' OG1' ' N ' ' A' ' 74' ' ' MET . 2.7 p -31.18 137.13 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 115.717 -0.674 . . . . 0.0 112.191 -178.976 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.619 ' HG2' ' HB2' ' A' ' 29' ' ' ALA . 1.1 mm-40 -49.57 -24.88 2.35 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.943 -179.525 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.417 ' CE ' ' OG1' ' A' ' 27' ' ' THR . 0.0 OUTLIER -167.07 36.04 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.596 0.236 . . . . 0.0 111.102 -179.94 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -114.21 -110.76 2.9 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 110.849 -0.9 . . . . 0.0 110.849 179.853 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.439 ' N ' ' OG1' ' A' ' 70' ' ' THR . 3.1 ptt? -166.74 113.29 0.81 Allowed 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 110.164 -0.31 . . . . 0.0 110.164 179.901 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.817 ' HB3' HD23 ' A' ' 69' ' ' LEU . 0.0 OUTLIER -51.99 -176.35 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.896 0.379 . . . . 0.0 110.494 -179.782 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 177.43 149.39 0.16 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.468 -179.952 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.588 HG22 ' CD ' ' A' ' 67' ' ' ARG . 72.2 t -90.22 139.18 17.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 121.006 0.431 . . . . 0.0 110.096 179.895 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.58 ' CZ ' HG21 ' A' ' 4' ' ' VAL . 75.8 m-85 -128.84 142.24 51.03 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.898 -179.313 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -136.1 157.84 45.87 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.953 179.65 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 59.02 35.45 24.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.938 0.399 . . . . 0.0 109.954 -179.66 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.464 ' O ' HG12 ' A' ' 81' ' ' VAL . 42.9 t -76.07 -6.91 9.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.322 -179.757 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.449 HG13 ' HD2' ' A' ' 83' ' ' PRO . 61.4 t -153.87 138.14 11.04 Favored Pre-proline 0 C--N 1.332 -0.17 0 N-CA-C 110.29 -0.263 . . . . 0.0 110.29 179.893 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.449 ' HD2' HG13 ' A' ' 82' ' ' VAL . 47.6 Cg_endo -75.48 -172.66 1.36 Allowed 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.535 2.157 . . . . 0.0 112.056 179.881 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -67.93 -42.5 80.91 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.244 179.844 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 16.7 mtpt -127.45 77.73 1.77 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.235 179.841 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 45.3 p90 -51.1 158.8 0.69 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.508 -179.851 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 20.8 m -138.33 110.43 7.3 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.075 179.919 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.658 HG23 ' O ' ' A' ' 8' ' ' VAL . 2.8 mp -50.46 95.06 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.357 -179.942 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 138.04 44.99 0.08 OUTLIER Glycine 0 CA--C 1.523 0.572 0 N-CA-C 110.575 -1.01 . . . . 0.0 110.575 -179.878 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -168.46 141.21 2.95 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.75 0.309 . . . . 0.0 110.243 -179.93 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.406 ' CG2' ' HB ' ' A' ' 5' ' ' THR . 85.7 m -91.05 145.85 24.34 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.971 0.415 . . . . 0.0 110.648 -179.939 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.592 ' O ' ' HB3' ' A' ' 93' ' ' ALA . 30.2 m-85 -129.75 -152.24 0.51 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.826 -0.624 . . . . 0.0 109.501 179.674 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.885 ' HB1' ' HD2' ' A' ' 94' ' ' PRO . . . 77.79 174.74 0.08 OUTLIER Pre-proline 0 N--CA 1.465 0.276 0 CA-C-O 120.8 0.333 . . . . 0.0 110.684 179.77 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.885 ' HD2' ' HB1' ' A' ' 93' ' ' ALA . 48.3 Cg_endo . . . . . 0 C--O 1.248 1.02 0 C-N-CA 122.618 2.212 . . . . 0.0 111.989 -179.982 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 32.2 t . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 110.09 -0.337 . . . . 0.0 110.09 . . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -77.54 154.14 31.02 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.48 2.12 . . . . 0.0 112.231 -179.883 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.74 78.45 1.68 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.24 179.986 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.553 HG11 ' CZ ' ' A' ' 78' ' ' PHE . 1.7 p -49.88 163.97 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.253 0.549 . . . . 0.0 110.624 -179.819 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.478 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 15.7 p -141.89 132.63 25.64 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.367 179.907 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.528 ' O ' HG23 ' A' ' 91' ' ' THR . 22.7 m-85 -101.09 170.68 8.11 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.301 179.967 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.811 HG23 ' O ' ' A' ' 90' ' ' ALA . 92.6 m -166.17 132.47 2.52 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.464 -179.947 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 26.4 t -71.1 102.99 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.199 179.82 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.598 ' HG3' HG21 ' A' ' 51' ' ' VAL . 6.3 mm-40 -50.33 170.81 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.511 -179.811 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 33.7 mtmm -72.53 -21.38 61.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.721 -179.937 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -90.9 49.1 3.05 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.928 -0.869 . . . . 0.0 110.928 -179.948 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 60.7 p -87.1 134.64 33.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.765 0.317 . . . . 0.0 110.291 179.867 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -134.2 164.63 26.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.306 -179.989 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -67.4 -34.5 77.38 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.333 -179.992 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 1.7 tppp? -93.14 -20.46 20.47 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.225 -179.588 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.402 ' HA ' ' O ' ' A' ' 54' ' ' PHE . 39.8 m80 -120.09 133.54 55.49 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.931 0.396 . . . . 0.0 111.024 -179.377 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -104.29 77.94 1.45 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.136 179.567 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -75.41 116.95 16.68 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.414 -179.884 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.467 HG23 HG23 ' A' ' 21' ' ' VAL . 14.8 m -109.17 -168.24 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.17 179.942 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.426 ' HB3' ' HB ' ' A' ' 7' ' ' THR . 1.0 OUTLIER -142.28 78.74 1.63 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.376 179.855 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.467 HG23 HG23 ' A' ' 19' ' ' VAL . 11.7 t -95.41 110.22 23.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.336 -179.933 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.409 ' HG2' ' CD2' ' A' ' 20' ' ' LEU . 0.0 OUTLIER -179.05 117.86 0.07 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.453 179.946 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.405 ' CE1' HG23 ' A' ' 4' ' ' VAL . 7.5 p90 -150.48 172.04 16.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.312 179.842 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -92.15 148.33 22.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.368 -179.917 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 114.25 -41.71 2.12 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 110.76 -0.936 . . . . 0.0 110.76 179.998 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -119.38 176.05 5.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.84 0.352 . . . . 0.0 110.418 179.999 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.29 -160.84 0.73 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.401 -179.999 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.418 ' O ' ' CG ' ' A' ' 71' ' ' GLU . 59.1 mtm -137.43 120.42 16.55 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.316 180.0 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.822 ' HB3' ' O ' ' A' ' 69' ' ' LEU . . . -124.4 -58.39 1.52 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.563 -179.786 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -153.34 161.78 41.98 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.38 -179.864 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.747 HG21 ' CD1' ' A' ' 52' ' ' TRP . 21.5 t -143.46 155.19 16.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.286 -179.999 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.444 ' CB ' ' HA ' ' A' ' 43' ' ' ALA . 1.8 pt-20 -167.24 137.82 3.02 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.53 -179.953 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.644 HD12 ' N ' ' A' ' 34' ' ' ARG . 3.2 pp -104.24 171.96 7.06 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.322 179.839 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.644 ' N ' HD12 ' A' ' 33' ' ' LEU . 1.3 ttt180 -97.87 -72.99 0.63 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.616 -179.848 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.484 ' CB ' ' O ' ' A' ' 34' ' ' ARG . 2.6 tm-20 94.34 80.26 0.0 OUTLIER 'General case' 0 CA--C 1.511 -0.523 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 -178.977 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -37.42 134.22 0.65 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.166 -0.925 . . . . 0.0 111.757 -178.362 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 114.07 -28.98 8.0 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 110.397 -1.081 . . . . 0.0 110.397 -179.745 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -82.46 -173.96 4.89 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.778 0.323 . . . . 0.0 110.268 179.864 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.41 ' OD1' ' N ' ' A' ' 40' ' ' GLU . 35.2 p30 -114.31 -21.64 10.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.843 -179.861 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.41 ' N ' ' OD1' ' A' ' 39' ' ' ASP . 9.7 mt-10 -135.0 175.26 9.74 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.84 0.352 . . . . 0.0 110.701 -179.826 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.512 ' CZ3' ' HG2' ' A' ' 67' ' ' ARG . 53.1 m95 -86.18 173.05 10.07 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.466 179.945 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.52 HG23 ' HG ' ' A' ' 33' ' ' LEU . 9.7 m -135.57 112.8 14.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.329 179.818 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.444 ' HA ' ' CB ' ' A' ' 32' ' ' GLU . . . -51.02 127.13 18.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.299 179.938 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -60.69 -171.39 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.32 -179.887 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 38.3 m -136.72 133.12 35.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.92 0.39 . . . . 0.0 110.496 -179.847 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 2.8 ptmt -100.95 79.87 2.08 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.52 -179.948 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -153.05 26.63 0.8 Allowed Glycine 0 CA--C 1.523 0.574 0 N-CA-C 110.851 -0.9 . . . . 0.0 110.851 -179.976 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.42 ' HG2' HG23 ' A' ' 51' ' ' VAL . 14.0 tp10 -98.05 -24.59 15.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.734 0.302 . . . . 0.0 110.319 179.952 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 128.03 -76.02 0.41 Allowed Glycine 0 CA--C 1.523 0.536 0 N-CA-C 110.566 -1.014 . . . . 0.0 110.566 -179.964 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -113.31 -14.34 9.89 Favored Glycine 0 CA--C 1.527 0.816 0 N-CA-C 111.259 -0.736 . . . . 0.0 111.259 179.878 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.598 HG21 ' HG3' ' A' ' 9' ' ' GLU . 27.2 m -124.95 -175.44 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-O 120.932 0.396 . . . . 0.0 110.74 -179.745 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 52' ' ' TRP . . . . . 0.747 ' CD1' HG21 ' A' ' 31' ' ' VAL . 8.1 m95 -104.59 146.22 29.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.499 -179.848 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.08 165.89 18.66 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.162 179.8 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.486 ' CD2' HD21 ' A' ' 33' ' ' LEU . 87.3 t80 -144.51 143.18 30.72 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.572 -179.863 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -89.07 102.48 15.14 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.314 179.913 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 69.7 p -86.91 100.82 12.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.465 -179.934 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -101.93 25.3 8.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.41 179.892 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 6.6 pm0 -121.39 140.83 32.08 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.193 179.897 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -73.45 -20.73 20.47 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.574 2.182 . . . . 0.0 112.113 179.992 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 17.3 mt -53.41 150.43 6.55 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.502 -179.95 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 24.1 tt0 -140.75 96.16 2.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.306 179.818 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -149.24 -157.85 7.82 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 110.682 -0.967 . . . . 0.0 110.682 179.992 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.443 ' HA ' ' HB ' ' A' ' 82' ' ' VAL . 49.1 Cg_endo -76.35 160.74 35.48 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.565 2.177 . . . . 0.0 112.168 -179.934 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.434 ' CD1' HG11 ' A' ' 82' ' ' VAL . 80.2 m-85 -130.96 100.98 5.43 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.394 179.873 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.403 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 48.0 m-80 -66.32 160.33 24.8 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 179.652 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -133.92 176.32 8.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.023 0.439 . . . . 0.0 110.93 -179.894 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.512 ' HG2' ' CZ3' ' A' ' 41' ' ' TRP . 0.0 OUTLIER 176.6 72.3 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.751 179.998 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.556 ' O ' HD23 ' A' ' 69' ' ' LEU . 2.0 p90 -67.16 174.96 2.84 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.88 -179.404 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.822 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 8.9 mt -125.26 68.79 1.14 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.311 179.492 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -37.19 140.97 0.16 Allowed 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.728 -179.115 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.737 ' HG2' ' HB2' ' A' ' 29' ' ' ALA . 2.0 mm-40 -55.27 -58.48 7.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.369 -179.821 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -125.73 55.9 1.42 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.316 179.962 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -137.51 -106.7 0.78 Allowed Glycine 0 CA--C 1.524 0.601 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 -179.981 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 1.2 ptt? -178.5 163.4 1.54 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.805 0.336 . . . . 0.0 110.446 -179.924 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.628 ' HD2' HD22 ' A' ' 69' ' ' LEU . 0.0 OUTLIER -81.69 134.37 35.46 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.258 -179.867 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.415 ' HB3' ' CZ ' ' A' ' 78' ' ' PHE . 0.3 OUTLIER -143.32 129.73 20.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.378 179.958 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 43.3 t -85.55 142.94 12.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.34 -179.993 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.553 ' CZ ' HG11 ' A' ' 4' ' ' VAL . 51.5 m-85 -132.48 120.66 22.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.549 -179.866 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -105.36 163.72 12.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.257 179.83 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 53.79 57.45 6.04 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.271 179.992 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.63 ' O ' HG12 ' A' ' 81' ' ' VAL . 60.9 t -109.02 7.78 9.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.216 -179.965 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.487 HG23 ' O ' ' A' ' 81' ' ' VAL . 70.2 t -158.36 104.35 1.68 Allowed Pre-proline 0 CA--C 1.531 0.212 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 -179.932 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -74.93 178.46 7.22 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.499 2.132 . . . . 0.0 111.935 179.706 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -65.97 121.76 15.83 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.217 179.885 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 3.4 tttt 55.09 65.83 1.39 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.111 -179.823 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 32.6 p90 -49.58 143.23 7.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.755 -179.758 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 9.0 m -110.32 110.03 20.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.13 179.739 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 2.8 mp -49.18 121.1 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.542 -179.844 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 115.57 31.07 2.05 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 110.926 -0.869 . . . . 0.0 110.926 179.976 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.811 ' O ' HG23 ' A' ' 7' ' ' THR . . . -143.63 176.26 9.35 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.745 0.307 . . . . 0.0 110.253 179.834 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.528 HG23 ' O ' ' A' ' 6' ' ' PHE . 17.3 m -125.0 124.06 41.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.533 -179.901 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.525 ' CZ ' ' HB3' ' A' ' 90' ' ' ALA . 6.0 m-85 -124.2 129.54 50.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.272 179.87 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.917 ' HB1' ' HD2' ' A' ' 94' ' ' PRO . . . 178.01 179.24 0.23 Allowed Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.289 -179.988 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.917 ' HD2' ' HB1' ' A' ' 93' ' ' ALA . 48.7 Cg_endo . . . . . 0 C--O 1.249 1.072 0 C-N-CA 122.519 2.146 . . . . 0.0 111.959 -179.93 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.644 ' O ' HG13 ' A' ' 1' ' ' VAL . 7.6 p . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 . . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -74.1 150.28 42.61 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.508 2.138 . . . . 0.0 111.971 179.928 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -137.55 81.14 1.85 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.624 -179.756 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.484 ' CG1' ' CE1' ' A' ' 78' ' ' PHE . 1.7 p -153.72 163.7 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 121.176 0.512 . . . . 0.0 110.151 179.705 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.468 ' N ' HG22 ' A' ' 4' ' ' VAL . 0.2 OUTLIER -136.15 140.72 43.85 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.438 179.951 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 -105.8 165.91 10.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.965 179.754 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.4 m -160.03 103.49 1.48 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.819 0.343 . . . . 0.0 110.522 -179.823 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 61.1 t -60.04 93.99 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.17 179.771 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.689 ' HG3' HG11 ' A' ' 51' ' ' VAL . 2.4 mm-40 -49.8 165.33 0.08 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.609 -179.851 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.24 56.57 2.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.394 179.95 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -135.79 20.65 3.63 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 111.124 -0.79 . . . . 0.0 111.124 -179.909 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.2 p -74.7 108.46 7.47 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.949 0.405 . . . . 0.0 109.994 179.729 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -92.2 -163.53 1.05 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.775 -179.506 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -55.5 -36.34 66.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.819 -179.706 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.455 ' HD3' ' ND1' ' A' ' 16' ' ' HIS . 0.1 OUTLIER -147.6 45.93 1.12 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.784 0.326 . . . . 0.0 110.582 -179.794 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.455 ' ND1' ' HD3' ' A' ' 15' ' ' LYS . 45.0 m80 -133.78 151.57 51.62 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.22 179.783 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.446 HD12 ' HA ' ' A' ' 17' ' ' LEU . 20.9 tp -137.28 92.54 2.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.462 -179.745 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.622 ' HB2' ' CG2' ' A' ' 53' ' ' THR . . . -87.91 123.13 32.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.298 179.885 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.658 HG23 HG23 ' A' ' 21' ' ' VAL . 27.2 m -121.02 144.76 28.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.555 -179.811 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.423 ' CD2' ' CG ' ' A' ' 22' ' ' LYS . 0.5 OUTLIER -91.38 83.35 5.44 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.28 179.77 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.658 HG23 HG23 ' A' ' 19' ' ' VAL . 24.4 t -89.44 100.3 10.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.543 -179.827 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.423 ' CG ' ' CD2' ' A' ' 20' ' ' LEU . 0.0 OUTLIER 174.9 135.7 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.353 179.859 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.504 ' CE2' ' HB2' ' A' ' 26' ' ' ASP . 0.7 OUTLIER -129.91 -173.29 2.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.1 179.874 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -40.62 -57.42 1.87 Allowed 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 120.795 0.331 . . . . 0.0 111.195 -179.783 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -89.22 -153.77 28.09 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 110.664 -0.974 . . . . 0.0 110.664 179.806 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.821 ' OD2' HG22 ' A' ' 70' ' ' THR . 28.1 t0 68.33 143.52 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.744 0.307 . . . . 0.0 110.408 179.983 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.685 HG22 ' O ' ' A' ' 27' ' ' THR . 86.4 m -119.33 13.44 12.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.062 179.863 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.405 ' O ' ' CG ' ' A' ' 71' ' ' GLU . 9.3 mtp 59.51 115.09 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.832 0.349 . . . . 0.0 110.594 179.732 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.785 ' HB3' ' O ' ' A' ' 69' ' ' LEU . . . -126.42 -57.17 1.39 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.13 179.81 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -157.46 166.69 32.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.147 179.789 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.621 HG21 ' CD1' ' A' ' 52' ' ' TRP . 38.5 t -152.41 148.27 14.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.448 -179.899 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.444 ' CB ' ' HA ' ' A' ' 43' ' ' ALA . 14.6 pt-20 -138.81 146.93 41.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.093 179.766 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.811 HD23 ' CG ' ' A' ' 54' ' ' PHE . 6.1 tp -128.86 138.3 51.96 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 120.923 0.392 . . . . 0.0 110.19 -179.093 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.541 ' N ' HD12 ' A' ' 33' ' ' LEU . 50.0 ttp85 -124.6 165.67 17.46 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.55 179.184 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -118.92 -83.07 0.65 Allowed 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 -179.975 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER 169.58 158.61 0.06 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.375 179.598 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 50.01 47.01 41.32 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 110.849 -0.901 . . . . 0.0 110.849 179.926 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 32.1 t -136.0 -174.93 3.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.817 0.341 . . . . 0.0 110.329 179.899 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -68.57 -63.57 1.03 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.471 -179.919 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -167.93 -173.87 2.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.343 -179.926 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.488 ' CE3' ' HB2' ' A' ' 34' ' ' ARG . 50.3 m95 -47.68 154.34 0.49 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.591 -179.943 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.436 HG22 ' O ' ' A' ' 33' ' ' LEU . 24.2 m -129.9 28.86 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.421 179.983 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.444 ' HA ' ' CB ' ' A' ' 32' ' ' GLU . . . 47.24 -175.34 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.131 179.555 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.401 ' HB2' ' O ' ' A' ' 31' ' ' VAL . 0.0 OUTLIER -112.94 -164.74 0.94 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.356 -179.97 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 25.7 m -146.52 104.97 3.81 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.477 -179.933 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.43 71.87 0.95 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.243 179.857 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -99.3 -34.49 5.05 Favored Glycine 0 CA--C 1.523 0.559 0 N-CA-C 110.813 -0.915 . . . . 0.0 110.813 -179.868 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.441 ' HG2' ' CG2' ' A' ' 51' ' ' VAL . 4.1 tp10 -80.5 130.11 34.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.808 0.337 . . . . 0.0 110.35 -179.916 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -78.39 78.38 1.62 Allowed Glycine 0 CA--C 1.522 0.53 0 N-CA-C 110.752 -0.939 . . . . 0.0 110.752 179.895 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 150.67 -32.01 1.0 Allowed Glycine 0 CA--C 1.522 0.502 0 N-CA-C 110.6 -1.0 . . . . 0.0 110.6 -179.959 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.689 HG11 ' HG3' ' A' ' 9' ' ' GLU . 17.5 m -145.81 -177.35 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.837 0.351 . . . . 0.0 110.369 -179.997 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 52' ' ' TRP . . . . . 0.621 ' CD1' HG21 ' A' ' 31' ' ' VAL . 7.5 m95 -102.97 141.15 36.26 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.584 -179.738 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.622 ' CG2' ' HB2' ' A' ' 18' ' ' ALA . 0.2 OUTLIER -124.22 152.22 43.18 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.942 179.7 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.811 ' CG ' HD23 ' A' ' 33' ' ' LEU . 80.6 t80 -117.39 161.65 19.21 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.423 -179.925 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -118.15 118.59 32.29 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.32 -179.993 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 40.2 m -111.48 164.24 13.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.449 -179.931 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -161.7 39.9 0.13 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.249 179.932 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -131.91 157.52 77.98 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.338 -179.946 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -71.61 -33.35 10.71 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.615 2.21 . . . . 0.0 112.2 -179.936 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -82.68 174.7 10.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.293 179.909 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 179.81 59.6 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.613 179.935 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -72.88 -139.95 0.37 Allowed Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.477 -1.049 . . . . 0.0 110.477 179.807 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -73.83 174.1 12.88 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.501 2.134 . . . . 0.0 111.699 179.698 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -135.52 177.08 8.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.957 0.408 . . . . 0.0 110.548 -179.937 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 -143.96 131.29 20.87 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.862 179.904 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -116.16 170.13 8.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.044 0.45 . . . . 0.0 110.884 -179.705 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.446 ' HG3' ' CH2' ' A' ' 41' ' ' TRP . 0.1 OUTLIER -172.54 80.75 0.05 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.049 -179.925 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.426 ' HA ' ' HA ' ' A' ' 31' ' ' VAL . 0.5 OUTLIER -81.57 167.02 19.72 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.191 0.52 . . . . 0.0 110.966 -179.594 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.785 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 6.8 mt -123.49 74.23 1.24 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.494 179.715 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.821 HG22 ' OD2' ' A' ' 26' ' ' ASP . 13.5 p -36.81 137.77 0.29 Allowed 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.696 -179.334 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.707 ' HG2' ' HB2' ' A' ' 29' ' ' ALA . 8.7 mm-40 -48.88 -46.48 42.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.822 -179.591 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.66 45.9 1.7 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.447 179.86 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -121.06 -110.17 2.17 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 110.863 -0.895 . . . . 0.0 110.863 -179.983 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.412 ' N ' ' OG1' ' A' ' 70' ' ' THR . 2.1 ptt? -171.67 152.69 3.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.831 0.348 . . . . 0.0 110.361 -179.905 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.522 ' HG3' HD23 ' A' ' 69' ' ' LEU . 0.0 OUTLIER -76.58 150.83 36.46 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.463 -179.942 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 55.0 m-20 -156.31 136.73 13.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.542 179.946 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.404 ' HA ' ' HG2' ' A' ' 67' ' ' ARG . 94.2 t -89.33 138.92 18.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.353 179.927 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.484 ' CE1' ' CG1' ' A' ' 4' ' ' VAL . 40.4 m-85 -126.81 134.87 50.46 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.793 -179.448 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -123.93 150.72 44.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.273 179.85 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 54.39 30.66 13.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.374 -179.904 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.437 ' HA ' ' HA ' ' A' ' 93' ' ' ALA . 54.8 t -53.71 -24.82 10.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.48 -179.925 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.439 ' CG1' ' HB3' ' A' ' 86' ' ' TYR . 59.3 t -134.34 132.3 20.95 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.579 -0.282 . . . . 0.0 110.535 179.897 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.447 ' CD ' ' CD1' ' A' ' 92' ' ' TYR . 49.5 Cg_endo -71.24 -171.48 0.61 Allowed 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.586 2.191 . . . . 0.0 111.996 179.744 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 21.3 pt-20 -85.23 129.92 34.71 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 179.29 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 59.33 50.66 7.51 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 -179.282 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.439 ' HB3' ' CG1' ' A' ' 82' ' ' VAL . 36.6 p90 -43.46 160.43 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.413 -179.407 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -130.92 104.26 7.04 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.925 179.751 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 3.0 mp -45.3 118.65 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.623 -179.798 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 118.42 36.7 0.9 Allowed Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.602 -0.999 . . . . 0.0 110.602 -179.821 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -149.32 153.34 37.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.768 0.318 . . . . 0.0 110.149 -179.96 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 92.4 m -103.63 93.62 5.02 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.727 -179.81 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.589 ' O ' ' HB3' ' A' ' 93' ' ' ALA . 40.1 m-85 -81.81 -153.76 0.11 Allowed 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 179.31 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.913 ' HB1' ' HD2' ' A' ' 94' ' ' PRO . . . 76.2 175.85 0.07 OUTLIER Pre-proline 0 N--CA 1.464 0.263 0 CA-C-O 120.689 0.281 . . . . 0.0 110.748 179.726 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.913 ' HD2' ' HB1' ' A' ' 93' ' ' ALA . 46.5 Cg_endo . . . . . 0 C--O 1.249 1.027 0 C-N-CA 122.523 2.148 . . . . 0.0 112.053 -179.988 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 2.6 m . . . . . 0 N--CA 1.489 1.524 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 . . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -76.41 147.88 29.36 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.566 2.178 . . . . 0.0 112.089 179.965 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 7.9 mtmm -127.04 81.15 2.0 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.402 179.988 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.586 HG21 ' CZ ' ' A' ' 78' ' ' PHE . 18.0 m -72.95 170.86 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.435 -179.979 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.413 HG23 ' O ' ' A' ' 4' ' ' VAL . 16.0 p -154.66 132.07 11.2 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.516 -179.97 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.528 ' O ' HG23 ' A' ' 91' ' ' THR . 13.6 m-85 -101.3 160.29 14.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.066 179.821 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.6 m -156.49 126.26 6.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.924 0.392 . . . . 0.0 110.683 -179.86 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.595 HG11 HG13 ' A' ' 88' ' ' ILE . 98.9 t -60.28 114.73 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.284 179.85 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.441 ' HB2' HG11 ' A' ' 51' ' ' VAL . 15.0 mm-40 -94.1 160.92 14.49 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.433 -179.91 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.9 ttmm -55.16 159.25 2.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.339 179.979 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 86.91 25.77 33.66 Favored Glycine 0 CA--C 1.523 0.539 0 N-CA-C 110.772 -0.931 . . . . 0.0 110.772 -179.968 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 58.3 m -94.84 120.3 34.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.813 0.34 . . . . 0.0 110.491 -179.891 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -119.38 -163.94 1.02 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.39 179.927 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -46.99 -61.89 1.66 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.245 -179.693 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.416 ' HG2' ' N ' ' A' ' 16' ' ' HIS . 0.8 OUTLIER -98.95 -28.28 13.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.058 -179.271 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.416 ' N ' ' HG2' ' A' ' 15' ' ' LYS . 1.7 m80 -65.02 123.66 20.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.833 0.349 . . . . 0.0 110.411 -179.818 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.482 ' HA ' HD22 ' A' ' 17' ' ' LEU . 0.3 OUTLIER -129.51 99.82 5.32 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.419 -179.953 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.588 ' HB1' HG11 ' A' ' 51' ' ' VAL . . . -95.88 130.93 42.69 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.128 179.83 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.68 ' O ' HG13 ' A' ' 51' ' ' VAL . 17.7 m -139.59 134.63 39.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.905 0.383 . . . . 0.0 110.796 -179.969 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -84.77 100.38 11.49 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.481 179.955 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.478 HG23 HG23 ' A' ' 19' ' ' VAL . 82.1 t -102.53 92.22 2.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.341 179.866 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.7 139.36 17.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.445 -179.925 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.425 ' CE1' HG12 ' A' ' 4' ' ' VAL . 2.1 p90 -155.0 168.02 28.41 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.257 179.929 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -74.17 125.06 27.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.417 -179.869 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 141.77 -91.35 0.18 Allowed Glycine 0 CA--C 1.523 0.555 0 N-CA-C 110.566 -1.014 . . . . 0.0 110.566 -179.934 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -72.93 -160.58 0.08 Allowed 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 179.805 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.683 HG22 ' O ' ' A' ' 27' ' ' THR . 33.5 m -144.14 31.67 1.24 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.637 179.975 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.416 ' O ' ' CG ' ' A' ' 71' ' ' GLU . 16.5 mtm 61.37 123.75 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.618 179.642 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.822 ' HB3' ' O ' ' A' ' 69' ' ' LEU . . . -124.86 -58.58 1.47 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.527 179.838 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -152.52 152.18 31.6 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.52 -179.958 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.765 HG21 ' CD1' ' A' ' 52' ' ' TRP . 27.9 t -141.76 155.8 20.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.191 179.746 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.429 ' CG ' ' HG3' ' A' ' 67' ' ' ARG . 0.9 OUTLIER -156.45 148.28 22.89 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.384 -179.784 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.765 HD12 ' H ' ' A' ' 34' ' ' ARG . 4.7 tp -111.4 148.94 31.97 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 -179.821 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.765 ' H ' HD12 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -97.77 -68.26 0.81 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.53 -179.818 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.439 ' CB ' ' O ' ' A' ' 34' ' ' ARG . 25.2 mt-10 88.8 74.94 0.01 OUTLIER 'General case' 0 CA--C 1.51 -0.58 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 -178.771 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -37.37 103.31 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.039 -0.982 . . . . 0.0 111.713 -178.097 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 107.13 37.07 2.38 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 110.413 -1.075 . . . . 0.0 110.413 -179.738 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.429 ' HB2' ' HB2' ' A' ' 35' ' ' GLU . 7.2 t -119.0 -157.5 0.69 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.676 0.274 . . . . 0.0 110.513 -179.641 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -111.25 66.41 0.63 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.855 0.359 . . . . 0.0 110.403 -179.837 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 76.39 160.06 0.22 Allowed 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.394 179.93 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.482 ' CZ3' ' HG2' ' A' ' 67' ' ' ARG . 82.4 m95 -51.18 156.79 1.03 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.566 -179.94 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.2 m -139.15 115.78 10.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.915 179.635 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -48.54 143.04 5.3 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.674 -179.651 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -73.26 -174.16 1.53 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.301 -179.959 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.412 ' O ' ' N ' ' A' ' 47' ' ' GLY . 59.1 m -145.53 120.81 10.22 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.096 179.887 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.42 ' CG ' ' O ' ' A' ' 46' ' ' LYS . 0.8 OUTLIER -68.67 64.4 0.11 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.412 -179.838 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.412 ' N ' ' O ' ' A' ' 45' ' ' THR . . . -72.6 -47.54 26.8 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 110.797 -0.921 . . . . 0.0 110.797 -179.981 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.469 ' CB ' ' HB ' ' A' ' 51' ' ' VAL . 0.5 OUTLIER -73.99 -174.34 1.84 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.866 0.365 . . . . 0.0 110.659 -179.814 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -82.79 -35.29 19.57 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 110.599 -1.0 . . . . 0.0 110.599 179.912 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -146.35 27.07 1.69 Allowed Glycine 0 CA--C 1.522 0.47 0 N-CA-C 110.117 -1.193 . . . . 0.0 110.117 179.69 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.68 HG13 ' O ' ' A' ' 19' ' ' VAL . 88.5 t -138.6 145.7 27.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.841 0.353 . . . . 0.0 110.084 -179.689 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 52' ' ' TRP . . . . . 0.765 ' CD1' HG21 ' A' ' 31' ' ' VAL . 4.2 m95 -94.55 114.37 26.34 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.513 -179.619 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.579 HG22 ' HB2' ' A' ' 18' ' ' ALA . 11.1 p -107.24 143.43 35.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.311 -179.937 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -126.44 150.86 48.41 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.446 179.925 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -108.39 95.47 5.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.355 -179.975 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -61.78 167.23 3.78 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.398 -179.967 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -105.79 -32.46 8.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.491 -179.955 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -111.45 153.52 44.13 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.432 -179.876 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -67.94 -32.37 28.88 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.899 2.399 . . . . 0.0 112.393 -179.934 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -77.53 128.07 33.56 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.673 -179.59 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 19.5 pt20 179.87 132.31 0.1 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.134 -179.943 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -138.79 -72.45 0.05 OUTLIER Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 -179.798 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -72.48 122.01 7.93 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.548 2.165 . . . . 0.0 112.006 179.837 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.596 ' HB3' HD13 ' A' ' 33' ' ' LEU . 45.1 m-85 -113.61 102.36 10.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.685 -179.689 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 52.2 m-20 -81.01 137.26 36.07 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 179.391 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -125.69 170.44 11.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.107 0.48 . . . . 0.0 111.077 -179.351 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.482 ' HG2' ' CZ3' ' A' ' 41' ' ' TRP . 0.0 OUTLIER -168.91 53.69 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.791 179.949 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.506 ' CZ ' HG11 ' A' ' 4' ' ' VAL . 0.2 OUTLIER -49.77 169.82 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.028 -179.56 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.822 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 6.9 mt -124.77 70.1 1.13 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.22 179.386 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 31.9 p -33.43 141.82 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.157 0.583 . . . . 0.0 112.241 -178.99 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.682 ' HG2' ' HB2' ' A' ' 29' ' ' ALA . 4.7 mm-40 -53.66 -60.11 3.73 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.745 -0.662 . . . . 0.0 110.455 -179.952 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 4.8 tmtt? -124.76 77.75 1.63 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.458 -179.973 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -170.55 -99.94 0.13 Allowed Glycine 0 CA--C 1.523 0.536 0 N-CA-C 110.764 -0.935 . . . . 0.0 110.764 179.901 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 179.29 173.56 0.81 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.864 0.364 . . . . 0.0 110.282 -179.938 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.19 -176.29 3.04 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.347 179.938 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.423 ' O ' ' CB ' ' A' ' 67' ' ' ARG . 2.7 t-20 -178.99 -173.7 0.31 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.016 179.942 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 93.0 t -128.31 127.32 67.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.887 0.375 . . . . 0.0 110.454 -179.884 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.586 ' CZ ' HG21 ' A' ' 4' ' ' VAL . 58.3 m-85 -112.64 123.24 49.86 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.887 179.741 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -113.89 151.85 31.6 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.781 -179.519 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 35.5 t0 60.26 24.0 13.4 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.762 179.834 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.654 HG22 ' HD3' ' A' ' 94' ' ' PRO . 25.4 t -55.73 -79.39 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.665 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.612 HG23 HG12 ' A' ' 81' ' ' VAL . 47.2 t -87.11 139.1 32.36 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.453 179.837 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.487 ' HD3' ' CG ' ' A' ' 92' ' ' TYR . 49.2 Cg_endo -71.76 -173.55 1.06 Allowed 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.624 2.216 . . . . 0.0 112.001 179.812 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 32.9 mp0 -64.12 -73.67 0.11 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.057 179.762 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -94.75 73.0 3.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.045 179.642 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.449 ' HB3' ' CG1' ' A' ' 82' ' ' VAL . 30.2 p90 -52.04 159.37 0.9 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.897 -179.574 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.74 109.99 12.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.094 179.747 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.595 HG13 HG11 ' A' ' 8' ' ' VAL . 3.3 mp -48.11 111.76 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.748 -179.769 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 110.56 55.0 0.53 Allowed Glycine 0 CA--C 1.523 0.538 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 179.995 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -175.75 131.78 0.26 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.82 0.343 . . . . 0.0 110.465 179.968 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.528 HG23 ' O ' ' A' ' 6' ' ' PHE . 35.5 m -83.16 144.58 29.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.159 179.917 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.487 ' CG ' ' HD3' ' A' ' 83' ' ' PRO . 71.9 m-85 -129.03 -83.79 0.57 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.691 -179.964 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.94 ' HB1' ' HD2' ' A' ' 94' ' ' PRO . . . 49.64 -179.01 0.01 OUTLIER Pre-proline 0 C--O 1.232 0.133 0 CA-C-O 120.624 0.249 . . . . 0.0 110.595 179.94 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.94 ' HD2' ' HB1' ' A' ' 93' ' ' ALA . 48.1 Cg_endo . . . . . 0 C--O 1.249 1.053 0 C-N-CA 122.481 2.121 . . . . 0.0 112.088 -179.902 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 4.0 m . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 110.128 -0.323 . . . . 0.0 110.128 . . . . . . . . . 0 0 . 1 . 031 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -77.06 159.22 33.95 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.588 2.192 . . . . 0.0 112.033 -179.904 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -139.62 97.47 3.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.38 179.984 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.651 ' O ' HG23 ' A' ' 5' ' ' THR . 34.2 m -66.21 -178.38 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.359 -179.937 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.651 HG23 ' O ' ' A' ' 4' ' ' VAL . 3.0 p -161.77 138.34 8.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.296 -179.996 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.614 ' O ' HG23 ' A' ' 91' ' ' THR . 23.4 m-85 -102.06 173.1 6.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.459 -179.757 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.451 HG23 ' O ' ' A' ' 90' ' ' ALA . 0.3 OUTLIER -165.96 102.92 0.66 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.287 -179.991 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.44 ' CG1' HG13 ' A' ' 88' ' ' ILE . 40.5 t -51.68 96.35 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.341 179.956 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.557 ' CD ' HD12 ' A' ' 20' ' ' LEU . 1.8 mm-40 -62.09 177.1 0.5 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.654 -179.737 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.8 tttt -80.63 60.34 3.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.409 -179.944 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -146.3 21.23 1.72 Allowed Glycine 0 CA--C 1.525 0.668 0 N-CA-C 111.022 -0.831 . . . . 0.0 111.022 179.974 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 25.6 m -110.32 114.58 28.15 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 110.121 -0.325 . . . . 0.0 110.121 179.921 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.419 ' OD1' ' N ' ' A' ' 14' ' ' GLU . 6.1 p30 -113.46 -49.13 2.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.612 -179.793 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.419 ' N ' ' OD1' ' A' ' 13' ' ' ASN . 9.6 mm-40 -154.15 -69.65 0.14 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.776 -179.792 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.433 ' HD2' ' N ' ' A' ' 15' ' ' LYS . 17.9 mmmt -91.25 -28.73 17.61 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.478 -179.478 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 9.5 m80 -76.36 128.59 35.14 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.764 -179.632 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.449 ' HA ' HD22 ' A' ' 17' ' ' LEU . 1.2 tm? -122.32 86.22 2.54 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.943 179.793 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.775 ' HB1' HG11 ' A' ' 51' ' ' VAL . . . -80.11 129.35 34.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.636 -179.596 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.658 ' O ' HG13 ' A' ' 51' ' ' VAL . 24.1 m -134.03 134.35 55.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.401 179.697 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.557 HD12 ' CD ' ' A' ' 9' ' ' GLU . 0.7 OUTLIER -89.36 87.47 7.12 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.377 -179.947 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.47 HG23 HG23 ' A' ' 19' ' ' VAL . 12.0 t -86.39 108.87 18.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.27 179.923 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.1 mtpt -179.67 176.39 0.79 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.226 179.95 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.442 ' CE2' HG12 ' A' ' 4' ' ' VAL . 20.1 p90 176.85 40.93 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.315 -179.963 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 55.63 174.77 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.353 179.974 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 70.74 -101.19 0.9 Allowed Glycine 0 CA--C 1.523 0.559 0 N-CA-C 110.635 -0.986 . . . . 0.0 110.635 -179.993 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -54.8 166.39 0.49 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.779 0.323 . . . . 0.0 110.359 179.934 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -115.0 -169.31 1.53 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.474 179.949 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.413 ' O ' ' CG ' ' A' ' 71' ' ' GLU . 13.4 mmt -115.21 127.45 55.52 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.637 -179.756 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.87 ' HB3' ' O ' ' A' ' 69' ' ' LEU . . . -118.03 -59.37 1.91 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.586 -179.904 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -150.44 153.06 35.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.215 -179.943 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.55 HG22 ' HB3' ' A' ' 68' ' ' PHE . 4.4 t -147.61 146.68 18.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.017 0.437 . . . . 0.0 110.773 -179.742 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.45 ' CB ' ' HA ' ' A' ' 43' ' ' ALA . 5.9 pt-20 -137.26 146.28 44.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.513 179.203 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.668 HD12 ' H ' ' A' ' 34' ' ' ARG . 9.8 tp -123.1 153.2 40.25 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-O 120.938 0.399 . . . . 0.0 110.033 -178.907 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.668 ' H ' HD12 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -145.66 162.73 36.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.678 179.574 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.405 ' O ' ' HB2' ' A' ' 36' ' ' HIS . 1.1 mt-10 -120.45 -86.11 0.65 Allowed 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 179.924 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.405 ' HB2' ' O ' ' A' ' 35' ' ' GLU . 0.8 OUTLIER -179.98 -40.62 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.803 0.335 . . . . 0.0 110.373 179.472 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -63.22 -56.83 17.97 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 110.781 -0.928 . . . . 0.0 110.781 -179.951 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.417 ' O ' ' CB ' ' A' ' 39' ' ' ASP . 1.5 t -55.03 -36.2 65.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.777 0.322 . . . . 0.0 110.356 -179.928 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.417 ' CB ' ' O ' ' A' ' 38' ' ' SER . 4.1 t70 81.6 -53.66 0.27 Allowed 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.489 -179.812 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -77.88 145.53 36.17 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.155 179.948 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.508 ' CE3' ' HB2' ' A' ' 34' ' ' ARG . 75.3 m95 -71.0 153.68 42.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.472 -179.864 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.6 HG21 ' CZ ' ' A' ' 54' ' ' PHE . 3.0 m -135.72 111.95 12.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.921 179.671 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.45 ' HA ' ' CB ' ' A' ' 32' ' ' GLU . . . -47.95 155.05 0.47 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.857 -179.479 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -76.42 -173.17 2.39 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.355 179.986 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 53.7 m -152.49 103.57 2.83 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.526 -179.943 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 7.9 ptpt -59.5 88.89 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.229 -0.442 . . . . 0.0 109.934 179.767 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -110.25 -28.46 4.08 Favored Glycine 0 CA--C 1.522 0.52 0 N-CA-C 111.239 -0.745 . . . . 0.0 111.239 -179.56 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.467 ' CB ' ' HB ' ' A' ' 51' ' ' VAL . 1.1 tp10 -72.09 -36.13 69.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.753 0.311 . . . . 0.0 110.698 -179.646 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 115.12 -37.46 3.49 Favored Glycine 0 CA--C 1.52 0.405 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 -179.115 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -138.02 21.32 3.17 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 178.631 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.775 HG11 ' HB1' ' A' ' 18' ' ' ALA . 52.6 t -155.44 144.61 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 -179.677 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 52' ' ' TRP . . . . . 0.495 ' NE1' HG21 ' A' ' 31' ' ' VAL . 3.0 m95 -91.51 110.42 21.74 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.968 0.413 . . . . 0.0 110.327 -179.749 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.461 ' CG2' ' HB2' ' A' ' 18' ' ' ALA . 1.1 p -101.81 142.17 33.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.468 -179.7 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.61 ' CG ' HD23 ' A' ' 33' ' ' LEU . 66.3 t80 -130.47 147.26 52.15 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.344 179.902 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 51.8 m-20 -89.04 101.17 13.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.431 -179.938 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.0 t -77.65 170.74 16.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.257 179.889 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -177.4 68.95 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.474 -179.912 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 179.49 118.61 0.21 Allowed Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.375 179.967 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -73.63 -2.43 12.17 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.475 2.117 . . . . 0.0 112.683 179.998 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 10.6 mp -67.05 74.91 0.12 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.727 0.298 . . . . 0.0 110.459 -179.943 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.423 ' HB2' ' HD3' ' A' ' 63' ' ' PRO . 57.7 mt-30 51.55 -170.06 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.177 179.998 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.492 ' N ' ' HD3' ' A' ' 63' ' ' PRO . . . -128.46 47.95 0.99 Allowed Glycine 0 CA--C 1.527 0.8 0 N-CA-C 111.589 -0.604 . . . . 0.0 111.589 -179.846 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.492 ' HD3' ' N ' ' A' ' 62' ' ' GLY . 51.8 Cg_endo -76.69 90.09 1.24 Allowed 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.389 2.06 . . . . 0.0 111.396 179.327 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.421 ' HB3' ' CD1' ' A' ' 33' ' ' LEU . 24.9 m-85 -92.28 160.51 15.1 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.272 0.558 . . . . 0.0 111.253 -179.238 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 5.0 m-80 -142.35 140.73 32.19 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.371 179.713 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.421 ' CZ ' HD13 ' A' ' 33' ' ' LEU . 79.0 m-85 -129.92 156.06 45.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.139 0.495 . . . . 0.0 111.545 -179.058 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.496 ' HD2' ' CZ2' ' A' ' 41' ' ' TRP . 1.8 mtp180 -156.38 61.96 0.55 Allowed 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.212 179.769 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.556 ' O ' HD23 ' A' ' 69' ' ' LEU . 0.7 OUTLIER -68.18 172.41 5.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.247 0.546 . . . . 0.0 110.856 -179.602 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.87 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 0.5 OUTLIER -131.09 76.05 1.7 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.47 -0.787 . . . . 0.0 109.293 179.728 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 2.7 p -35.4 136.9 0.19 Allowed 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 122.771 0.428 . . . . 0.0 111.813 -179.193 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.638 ' HG2' ' HB2' ' A' ' 29' ' ' ALA . 14.2 mt-10 -50.84 -28.95 10.54 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.582 -179.569 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.3 83.01 1.43 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.541 -179.847 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -177.05 -98.54 0.11 Allowed Glycine 0 CA--C 1.523 0.569 0 N-CA-C 110.846 -0.902 . . . . 0.0 110.846 179.864 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 179.3 -178.96 0.37 Allowed 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 110.201 -0.296 . . . . 0.0 110.201 -179.832 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.43 ' HG2' HD22 ' A' ' 69' ' ' LEU . 0.4 OUTLIER -93.4 179.9 5.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.873 0.368 . . . . 0.0 110.378 179.926 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 172.11 136.02 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.284 -179.988 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.457 HG12 ' N ' ' A' ' 78' ' ' PHE . 99.1 t -92.86 158.76 2.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.483 -179.986 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.457 ' CZ ' HG21 ' A' ' 4' ' ' VAL . 64.8 m-85 -143.25 108.22 4.94 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.12 179.94 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -91.17 147.91 22.73 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.663 -179.654 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 41.3 t0 51.51 52.2 15.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.797 179.742 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 74.9 t -68.72 -62.83 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 179.576 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.573 HG13 ' HD2' ' A' ' 83' ' ' PRO . 91.5 t -98.52 140.12 21.6 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.101 179.542 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.573 ' HD2' HG13 ' A' ' 82' ' ' VAL . 46.1 Cg_endo -69.74 -170.52 0.4 Allowed 'Trans proline' 0 N--CA 1.474 0.377 0 C-N-CA 122.638 2.225 . . . . 0.0 112.15 179.877 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 33.6 mp0 -77.35 -37.05 53.11 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.288 179.948 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -124.9 77.15 1.59 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.242 179.873 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.428 ' HB3' ' CG1' ' A' ' 82' ' ' VAL . 38.6 p90 -73.25 179.82 3.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.462 -179.871 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -157.69 120.56 3.91 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.305 -179.99 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.586 ' H ' HD12 ' A' ' 88' ' ' ILE . 4.0 mp -51.54 100.45 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.397 179.941 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 131.41 56.43 0.09 OUTLIER Glycine 0 CA--C 1.523 0.556 0 N-CA-C 110.703 -0.959 . . . . 0.0 110.703 -179.889 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.746 ' HB3' ' OH ' ' A' ' 92' ' ' TYR . . . -177.99 178.03 0.99 Allowed 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 110.253 -0.277 . . . . 0.0 110.253 179.981 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.614 HG23 ' O ' ' A' ' 6' ' ' PHE . 0.7 OUTLIER -111.8 146.24 37.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.889 0.376 . . . . 0.0 110.653 -179.839 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.746 ' OH ' ' HB3' ' A' ' 90' ' ' ALA . 8.6 m-85 -150.17 104.16 3.24 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.263 179.712 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.9 ' HB1' ' HD2' ' A' ' 94' ' ' PRO . . . 173.66 177.74 0.16 Allowed Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.461 179.968 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.9 ' HD2' ' HB1' ' A' ' 93' ' ' ALA . 50.4 Cg_endo . . . . . 0 C--O 1.249 1.026 0 C-N-CA 122.657 2.238 . . . . 0.0 112.211 -179.924 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.632 ' O ' HG13 ' A' ' 1' ' ' VAL . 7.7 p . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 . . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -75.38 145.09 29.78 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.667 2.245 . . . . 0.0 112.04 179.954 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 10.0 mttt -123.14 83.16 2.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.526 -179.853 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.575 HG11 ' CZ ' ' A' ' 78' ' ' PHE . 1.6 p -56.03 164.03 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.189 0.519 . . . . 0.0 110.204 179.894 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.476 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 9.1 p -142.17 128.65 20.15 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.411 179.966 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.55 ' CE2' ' CD2' ' A' ' 66' ' ' PHE . 8.0 m-85 -97.98 173.16 7.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.227 179.996 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.618 HG23 ' O ' ' A' ' 90' ' ' ALA . 12.9 m -165.37 117.79 1.16 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.469 -179.862 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.504 ' O ' HG23 ' A' ' 88' ' ' ILE . 20.6 t -59.11 94.57 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.269 179.946 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.737 ' HG3' HG11 ' A' ' 51' ' ' VAL . 0.1 OUTLIER -51.21 171.84 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.594 -179.893 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.2 ttmt -85.5 56.54 4.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.413 -179.99 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -147.63 25.36 1.5 Allowed Glycine 0 CA--C 1.524 0.622 0 N-CA-C 110.742 -0.943 . . . . 0.0 110.742 179.949 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -100.05 113.6 26.33 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.813 0.339 . . . . 0.0 110.216 179.939 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.407 ' OD1' ' N ' ' A' ' 14' ' ' GLU . 4.7 p30 -112.94 -51.4 2.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.533 -179.852 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.407 ' N ' ' OD1' ' A' ' 13' ' ' ASN . 0.5 OUTLIER -166.99 -64.98 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.755 -179.874 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.415 ' HD2' ' N ' ' A' ' 15' ' ' LYS . 10.9 mmmt -86.59 -27.11 24.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.54 -179.402 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 19.3 m80 -91.62 126.16 36.61 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.934 0.397 . . . . 0.0 110.849 -179.518 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.457 ' HA ' HD22 ' A' ' 17' ' ' LEU . 0.3 OUTLIER -116.81 89.63 3.15 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.627 179.425 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -83.51 126.05 32.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.762 -179.368 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.592 HG11 ' CZ ' ' A' ' 66' ' ' PHE . 19.8 m -113.55 -173.41 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.629 179.368 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.6 tt -141.04 59.21 1.53 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.256 179.679 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 28.0 t -55.86 116.54 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.428 -179.937 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.1 mttp -168.09 162.42 13.09 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.154 179.97 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -140.42 -63.67 0.48 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.225 -0.443 . . . . 0.0 109.979 -179.968 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -149.53 -47.25 0.14 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.318 179.981 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 170.22 74.84 0.04 OUTLIER Glycine 0 CA--C 1.524 0.601 0 N-CA-C 110.899 -0.88 . . . . 0.0 110.899 179.982 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -112.9 -168.31 1.3 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.767 0.318 . . . . 0.0 110.206 179.797 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.719 HG22 ' HG3' ' A' ' 71' ' ' GLU . 0.9 OUTLIER -113.45 137.78 51.04 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.094 179.984 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 7.8 mtt -101.62 129.57 47.77 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.872 -179.537 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.816 ' HB3' ' O ' ' A' ' 69' ' ' LEU . . . -112.68 -57.6 2.26 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.246 179.824 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.412 ' O ' ' CB ' ' A' ' 68' ' ' PHE . 0.7 OUTLIER -153.11 165.2 36.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.175 179.832 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.53 HG21 ' CD1' ' A' ' 52' ' ' TRP . 4.1 t -152.69 140.27 13.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.264 -0.426 . . . . 0.0 109.939 -179.969 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.454 ' CB ' ' HA ' ' A' ' 43' ' ' ALA . 1.5 pt-20 -137.34 137.34 38.8 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.968 0.413 . . . . 0.0 110.584 -179.701 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.563 HD12 ' CB ' ' A' ' 54' ' ' PHE . 1.6 mt -92.97 -178.52 4.83 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.587 -179.686 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.466 ' HB2' ' CZ3' ' A' ' 41' ' ' TRP . 0.7 OUTLIER -157.5 147.75 20.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.943 179.633 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -113.99 -14.36 12.43 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.957 -179.834 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 70.22 120.83 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.843 0.354 . . . . 0.0 110.31 -179.996 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 118.06 -45.27 1.29 Allowed Glycine 0 CA--C 1.522 0.481 0 N-CA-C 110.472 -1.051 . . . . 0.0 110.472 -179.753 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 20.7 t -63.24 -25.41 68.31 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.774 0.321 . . . . 0.0 110.314 179.778 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.1 t0 70.38 29.32 3.57 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.415 179.908 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -154.37 145.05 22.38 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.513 179.957 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.466 ' CZ3' ' HB2' ' A' ' 34' ' ' ARG . 83.8 m95 -88.14 145.66 25.81 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.036 179.8 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.768 HG21 ' CZ ' ' A' ' 54' ' ' PHE . 20.3 m -117.11 107.15 21.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.095 0.474 . . . . 0.0 110.33 -179.862 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.454 ' HA ' ' CB ' ' A' ' 32' ' ' GLU . . . -53.82 139.22 33.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.152 -179.782 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.86 -171.48 0.07 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.855 -179.644 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.422 ' O ' ' N ' ' A' ' 47' ' ' GLY . 86.7 m -143.55 97.65 3.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.217 179.858 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 13.5 ptmt -61.25 80.7 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.361 -179.883 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' A' ' 45' ' ' THR . . . -120.93 15.37 9.55 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 111.236 -0.745 . . . . 0.0 111.236 179.993 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.412 ' HG3' HG23 ' A' ' 51' ' ' VAL . 1.8 mm-40 -106.62 -33.24 7.71 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.847 0.356 . . . . 0.0 110.325 179.96 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 94.89 -36.79 3.63 Favored Glycine 0 CA--C 1.522 0.515 0 N-CA-C 110.667 -0.973 . . . . 0.0 110.667 179.973 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -110.92 -25.55 5.07 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 110.818 -0.913 . . . . 0.0 110.818 -179.877 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.737 HG11 ' HG3' ' A' ' 9' ' ' GLU . 15.5 m -140.66 -176.33 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.937 0.399 . . . . 0.0 110.591 -179.904 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 52' ' ' TRP . . . . . 0.53 ' CD1' HG21 ' A' ' 31' ' ' VAL . 9.5 m95 -108.58 142.28 39.26 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.726 -179.507 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -130.02 150.76 51.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.967 179.672 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.768 ' CZ ' HG21 ' A' ' 42' ' ' VAL . 65.8 t80 -136.18 153.57 51.21 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.884 0.373 . . . . 0.0 110.808 -179.825 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -95.56 96.46 9.07 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.212 179.831 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 31.3 p -50.71 121.62 6.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.562 -179.859 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -80.83 -26.83 36.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.099 179.721 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 23.8 pt-20 -118.32 144.88 35.95 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.18 179.883 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -67.07 -18.52 51.57 Favored 'Trans proline' 0 C--N 1.343 0.246 0 C-N-CA 122.765 2.31 . . . . 0.0 112.19 179.999 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.423 ' HA ' HD13 ' A' ' 60' ' ' LEU . 0.9 OUTLIER -71.94 118.21 14.51 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.426 179.975 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -101.19 54.14 0.84 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.242 179.86 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -73.15 -143.2 0.58 Allowed Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.715 -0.954 . . . . 0.0 110.715 -179.949 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.411 ' HB3' ' HA ' ' A' ' 80' ' ' ASP . 49.1 Cg_endo -77.27 106.16 2.18 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.614 2.209 . . . . 0.0 112.145 -179.856 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.501 ' HB3' HD21 ' A' ' 33' ' ' LEU . 16.4 m-85 -77.96 98.32 5.64 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.66 179.961 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.43 ' OD1' ' N ' ' A' ' 65' ' ' ASN . 0.4 OUTLIER -71.32 123.45 22.31 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 179.469 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.592 ' CZ ' HG11 ' A' ' 19' ' ' VAL . 2.7 m-85 -101.05 176.66 5.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.598 -179.55 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.858 ' HD2' HG22 ' A' ' 77' ' ' VAL . 1.7 mtp180 176.51 102.1 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.456 179.916 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.773 ' O ' HD23 ' A' ' 69' ' ' LEU . 0.8 OUTLIER -111.29 172.85 6.64 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.427 179.815 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.816 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 2.4 mt -128.88 65.98 1.43 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.376 179.684 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 29.0 p -31.5 143.87 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.246 0.619 . . . . 0.0 112.108 -179.302 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.719 ' HG3' HG22 ' A' ' 27' ' ' THR . 0.4 OUTLIER -68.29 -31.23 70.53 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.254 -179.716 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.5 tmtm? -141.03 56.24 1.56 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.47 179.994 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -145.48 -105.66 0.47 Allowed Glycine 0 CA--C 1.523 0.559 0 N-CA-C 110.622 -0.991 . . . . 0.0 110.622 179.9 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 10.6 ptm -178.47 -179.45 0.68 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.787 0.327 . . . . 0.0 110.205 -179.986 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.745 ' HD2' HD22 ' A' ' 69' ' ' LEU . 14.1 mmtm -90.82 158.19 16.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.14 179.871 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -175.25 135.71 0.35 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.801 -179.944 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.858 HG22 ' HD2' ' A' ' 67' ' ' ARG . 94.6 t -94.2 150.25 4.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.233 -0.44 . . . . 0.0 109.963 179.476 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.575 ' CZ ' HG11 ' A' ' 4' ' ' VAL . 71.2 m-85 -131.5 145.73 51.9 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.97 -179.203 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -139.62 162.19 35.7 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.006 179.76 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.411 ' HA ' ' HB3' ' A' ' 63' ' ' PRO . 0.1 OUTLIER 51.97 33.04 10.98 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.113 0.483 . . . . 0.0 109.839 -179.722 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.542 ' O ' HG12 ' A' ' 81' ' ' VAL . 87.6 t -78.41 -3.01 5.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.586 -179.406 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.445 HG23 ' O ' ' A' ' 81' ' ' VAL . 72.4 t -158.15 119.45 1.95 Allowed Pre-proline 0 CA--C 1.53 0.21 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 179.855 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.416 ' HD3' ' CG ' ' A' ' 92' ' ' TYR . 50.9 Cg_endo -75.66 169.64 21.88 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.458 2.105 . . . . 0.0 111.786 179.729 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -66.26 120.02 12.53 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 179.633 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 2.5 mtpt 67.24 58.85 0.54 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.224 -0.443 . . . . 0.0 109.997 -179.609 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 21.4 p90 -52.96 -175.16 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.741 -179.729 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 1.5 m -152.26 108.12 3.36 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.967 179.836 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.504 HG23 ' O ' ' A' ' 8' ' ' VAL . 3.3 mp -46.45 121.82 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.68 -179.86 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 113.73 29.59 2.83 Favored Glycine 0 CA--C 1.523 0.582 0 N-CA-C 110.736 -0.945 . . . . 0.0 110.736 -179.875 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.618 ' O ' HG23 ' A' ' 7' ' ' THR . . . -142.32 167.29 22.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.736 0.303 . . . . 0.0 110.443 -179.944 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 32.8 m -113.44 120.8 42.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.522 -179.968 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.471 ' O ' ' HB2' ' A' ' 93' ' ' ALA . 40.8 m-85 -125.62 123.55 39.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.394 179.954 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.919 ' HB1' ' HD2' ' A' ' 94' ' ' PRO . . . 174.56 178.45 0.17 Allowed Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.457 -179.981 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.919 ' HD2' ' HB1' ' A' ' 93' ' ' ALA . 49.8 Cg_endo . . . . . 0 C--O 1.25 1.083 0 C-N-CA 122.547 2.165 . . . . 0.0 112.112 -179.884 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 7.4 t . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 . . . . . . . . . 0 0 . 1 . 033 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -77.77 174.4 12.65 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.451 2.101 . . . . 0.0 112.063 -179.994 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 33.4 mmtm 44.97 86.84 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.07 179.497 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.524 ' CG1' ' CE1' ' A' ' 78' ' ' PHE . 2.1 p -106.26 163.42 4.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.336 0.588 . . . . 0.0 110.365 -179.968 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.486 ' N ' HG22 ' A' ' 4' ' ' VAL . 65.9 p -144.2 129.51 18.81 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.294 179.718 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.775 ' O ' HG23 ' A' ' 91' ' ' THR . 35.0 m-85 -89.29 -176.75 5.19 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.307 179.904 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -166.15 118.57 1.06 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.152 179.934 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.1 t -68.18 93.43 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.356 -179.899 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.605 ' O ' HG23 ' A' ' 88' ' ' ILE . 1.8 mm-40 -54.11 -178.45 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.303 -179.961 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.26 48.74 1.6 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.455 -179.839 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -112.3 -25.78 4.56 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 110.842 -0.903 . . . . 0.0 110.842 -179.992 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.1 m -50.82 120.97 5.28 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.826 0.346 . . . . 0.0 110.418 -179.982 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -114.13 -81.17 0.6 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.424 -179.912 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -106.78 -82.67 0.54 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.735 0.302 . . . . 0.0 110.41 -179.904 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.36 28.39 8.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.326 -179.995 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 14.4 m-70 -104.08 167.39 9.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.325 -179.959 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.451 HD12 ' HA ' ' A' ' 17' ' ' LEU . 17.2 tp -154.13 88.79 1.25 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.452 -179.853 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.572 ' HB2' ' CG2' ' A' ' 53' ' ' THR . . . -81.37 109.62 16.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.454 -179.902 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.571 HG23 HG23 ' A' ' 21' ' ' VAL . 21.5 m -103.54 141.23 19.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.449 179.941 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -90.41 83.23 5.89 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.611 -179.99 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.571 HG23 HG23 ' A' ' 19' ' ' VAL . 16.2 t -79.32 90.61 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.348 179.866 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 176.08 157.29 0.24 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.982 -0.553 . . . . 0.0 109.95 -179.974 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.543 ' CE2' ' HB2' ' A' ' 26' ' ' ASP . 0.0 OUTLIER -113.89 -66.52 1.08 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.541 -179.751 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -153.45 -65.21 0.15 Allowed 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 111.808 0.299 . . . . 0.0 111.808 -179.395 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -106.36 -28.14 5.29 Favored Glycine 0 CA--C 1.525 0.702 0 C-N-CA 121.364 -0.446 . . . . 0.0 112.563 -178.372 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.543 ' HB2' ' CE2' ' A' ' 23' ' ' TYR . 16.8 t0 -42.29 152.02 0.1 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 117.277 0.539 . . . . 0.0 111.417 -179.363 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.402 HG22 ' H ' ' A' ' 28' ' ' MET . 0.2 OUTLIER -100.63 -174.67 2.7 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.731 -179.462 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.423 ' O ' ' CG ' ' A' ' 71' ' ' GLU . 34.7 mtm -123.17 126.07 46.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.336 -179.883 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.673 ' HB3' ' O ' ' A' ' 69' ' ' LEU . . . -118.97 -60.35 1.76 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.513 -179.706 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.7 ' HB3' HD12 ' A' ' 69' ' ' LEU . 0.6 OUTLIER -154.39 156.26 36.52 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.106 -179.937 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.474 ' HA ' ' HA ' ' A' ' 68' ' ' PHE . 0.7 OUTLIER -173.95 141.33 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.377 0.608 . . . . 0.0 110.271 -179.87 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.442 ' HG3' ' HB3' ' A' ' 41' ' ' TRP . 1.7 pm0 -141.18 169.48 17.53 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.059 -179.444 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.87 HD21 ' CE1' ' A' ' 66' ' ' PHE . 1.0 OUTLIER -117.3 174.34 6.19 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.157 0.503 . . . . 0.0 111.096 -179.479 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.43 ' NE ' ' HA ' ' A' ' 34' ' ' ARG . 0.5 OUTLIER -161.75 -176.69 5.41 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.486 179.562 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -129.92 -70.76 0.63 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.797 0.332 . . . . 0.0 110.424 179.928 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 58.2 t-80 -178.53 -50.02 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.344 179.972 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -121.02 25.69 7.02 Favored Glycine 0 CA--C 1.523 0.545 0 N-CA-C 110.733 -0.947 . . . . 0.0 110.733 179.87 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 2.7 m -70.97 -22.43 62.2 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.652 0.263 . . . . 0.0 110.593 179.931 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.4 t0 71.96 97.21 0.07 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.799 0.333 . . . . 0.0 110.326 -179.802 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 76.82 146.44 0.09 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.398 -179.961 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.513 ' CE3' ' HG2' ' A' ' 67' ' ' ARG . 35.5 m95 -79.83 160.95 25.91 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.54 -179.826 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.481 HG23 ' O ' ' A' ' 42' ' ' VAL . 32.1 m -132.16 122.18 47.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.179 179.832 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.428 ' HA ' ' HB3' ' A' ' 32' ' ' GLU . . . -46.51 130.44 11.1 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.8 -179.911 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.693 ' CE ' HD12 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -58.79 -167.51 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.22 -179.901 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 53.2 m -137.01 126.34 24.86 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.434 -179.946 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.66 67.16 6.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.231 -0.44 . . . . 0.0 109.987 179.726 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -96.86 -35.98 5.17 Favored Glycine 0 CA--C 1.522 0.503 0 N-CA-C 110.738 -0.945 . . . . 0.0 110.738 -179.772 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.449 ' HG2' ' CG2' ' A' ' 51' ' ' VAL . 31.8 tp10 -80.18 133.91 36.09 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.804 0.335 . . . . 0.0 110.369 179.915 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -79.36 88.39 1.21 Allowed Glycine 0 CA--C 1.523 0.587 0 N-CA-C 111.021 -0.831 . . . . 0.0 111.021 -179.794 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 129.81 -23.4 4.73 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 111.167 -0.773 . . . . 0.0 111.167 179.721 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.511 HG11 ' HG3' ' A' ' 9' ' ' GLU . 16.7 m -146.8 -175.56 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.933 0.397 . . . . 0.0 110.684 -179.756 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 8.4 m95 -103.22 144.61 31.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.462 -179.547 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.572 ' CG2' ' HB2' ' A' ' 18' ' ' ALA . 0.1 OUTLIER -132.57 145.15 50.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.546 -179.759 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -120.62 136.69 54.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.125 179.725 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 11.4 t0 -113.67 156.34 23.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.939 0.4 . . . . 0.0 110.765 -179.706 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -175.39 172.96 2.59 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.326 179.947 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -154.85 30.79 0.41 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.385 -179.97 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -75.64 157.36 84.25 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.473 -179.96 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -71.3 -34.52 9.73 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.67 2.247 . . . . 0.0 112.035 179.881 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 5.4 mt -81.37 167.3 19.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.356 -179.928 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 28.2 tt0 -172.53 111.39 0.25 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.476 -179.98 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -135.35 -143.26 4.71 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.597 -1.001 . . . . 0.0 110.597 179.975 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -77.32 171.84 17.02 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.546 2.164 . . . . 0.0 111.892 179.882 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -124.18 172.45 9.04 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.92 0.39 . . . . 0.0 110.511 -179.948 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.505 ' O ' HD23 ' A' ' 33' ' ' LEU . 5.3 m-80 -146.36 144.72 29.95 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.176 -179.982 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.87 ' CE1' HD21 ' A' ' 33' ' ' LEU . 39.3 m-85 -127.03 -177.12 3.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.019 0.437 . . . . 0.0 110.483 179.978 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.575 ' HB3' HG12 ' A' ' 77' ' ' VAL . 0.0 OUTLIER 176.78 72.66 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.799 179.76 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.831 ' O ' HD23 ' A' ' 69' ' ' LEU . 0.0 OUTLIER -71.01 -178.96 2.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.409 0.624 . . . . 0.0 111.626 -179.259 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.831 HD23 ' O ' ' A' ' 68' ' ' PHE . 9.1 mt -144.77 49.07 1.31 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.032 -0.985 . . . . 0.0 109.254 179.874 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.456 HG21 ' OD2' ' A' ' 26' ' ' ASP . 40.8 p -22.67 137.64 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.129 0.972 . . . . 0.0 112.891 -179.147 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.653 ' HG2' ' HB2' ' A' ' 29' ' ' ALA . 3.2 mm-40 -54.2 -25.27 21.97 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.533 -179.806 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.51 48.89 0.14 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.862 0.363 . . . . 0.0 110.547 -179.907 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.412 ' CA ' ' OG1' ' A' ' 70' ' ' THR . . . -128.34 -107.2 1.35 Allowed Glycine 0 CA--C 1.523 0.592 0 N-CA-C 110.707 -0.957 . . . . 0.0 110.707 179.915 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.409 ' N ' ' OG1' ' A' ' 70' ' ' THR . 66.0 mmm -139.13 171.28 14.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.832 0.349 . . . . 0.0 110.305 179.965 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.439 ' CD ' ' O ' ' A' ' 75' ' ' LYS . 0.0 OUTLIER -138.12 86.56 2.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.306 179.859 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -141.1 140.23 34.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.251 -179.971 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.575 HG12 ' HB3' ' A' ' 67' ' ' ARG . 17.9 m -66.61 -179.73 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.333 -179.958 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.524 ' CE1' ' CG1' ' A' ' 4' ' ' VAL . 66.1 m-85 -149.38 135.54 19.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.631 -179.831 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -119.21 158.99 24.89 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.395 -179.976 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 52.5 49.65 19.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.405 179.91 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.571 ' O ' HG12 ' A' ' 81' ' ' VAL . 80.9 t -90.89 -0.65 9.44 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.039 179.836 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.626 HG13 ' HB3' ' A' ' 86' ' ' TYR . 94.8 t -157.49 130.2 4.35 Favored Pre-proline 0 CA--C 1.527 0.093 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 179.667 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.501 ' HD3' ' CD1' ' A' ' 92' ' ' TYR . 49.7 Cg_endo -71.0 -167.09 0.25 Allowed 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.577 2.184 . . . . 0.0 112.06 179.767 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -68.78 -34.25 75.24 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.933 179.472 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -137.96 91.19 2.55 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.952 179.683 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.626 ' HB3' HG13 ' A' ' 82' ' ' VAL . 14.9 p90 -67.62 165.76 16.39 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.794 -179.65 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -141.34 115.24 9.15 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.064 179.844 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.605 HG23 ' O ' ' A' ' 9' ' ' GLU . 3.4 mp -46.58 131.08 3.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.762 -179.836 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 89.87 39.29 6.21 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 110.685 -0.966 . . . . 0.0 110.685 -179.905 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -146.81 155.93 42.73 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.865 0.364 . . . . 0.0 110.53 -179.918 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.775 HG23 ' O ' ' A' ' 6' ' ' PHE . 0.2 OUTLIER -106.42 142.22 36.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.258 179.954 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.501 ' CD1' ' HD3' ' A' ' 83' ' ' PRO . 73.3 m-85 -134.1 -86.48 0.41 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.762 -179.914 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.902 ' HB1' ' HD2' ' A' ' 94' ' ' PRO . . . 50.12 -179.05 0.01 OUTLIER Pre-proline 0 C--N 1.332 -0.154 0 CA-C-O 120.63 0.252 . . . . 0.0 110.547 179.923 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.902 ' HD2' ' HB1' ' A' ' 93' ' ' ALA . 47.9 Cg_endo . . . . . 0 C--O 1.249 1.054 0 C-N-CA 122.539 2.16 . . . . 0.0 112.064 -179.978 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 9.2 m . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 110.212 -0.292 . . . . 0.0 110.212 . . . . . . . . . 0 0 . 1 . 034 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -73.98 58.75 4.22 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.488 2.125 . . . . 0.0 112.045 179.943 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.28 30.59 7.14 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.361 179.913 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.779 HG21 ' CZ ' ' A' ' 78' ' ' PHE . 27.0 m -88.45 -176.03 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.087 179.85 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.587 HG23 ' O ' ' A' ' 4' ' ' VAL . 0.5 OUTLIER -167.04 146.92 5.44 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.364 179.971 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.491 ' H ' ' HB3' ' A' ' 93' ' ' ALA . 37.9 m-85 -118.78 158.13 26.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.22 179.905 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 53.2 m -150.73 104.71 3.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.35 -179.863 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.756 HG12 HD13 ' A' ' 88' ' ' ILE . 14.2 t -54.33 94.83 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.416 -179.905 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.83 ' HG3' HG11 ' A' ' 51' ' ' VAL . 4.7 mm-40 -69.33 162.89 26.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.286 -179.99 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.67 171.01 3.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.479 -179.967 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 86.67 19.59 56.06 Favored Glycine 0 CA--C 1.527 0.795 0 N-CA-C 111.103 -0.799 . . . . 0.0 111.103 -179.955 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.803 ' HB2' HD11 ' A' ' 88' ' ' ILE . 8.7 m -109.6 -159.76 0.69 Allowed 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 -179.936 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.409 ' HB2' ' O ' ' A' ' 12' ' ' SER . 5.2 m120 66.79 -62.39 0.3 Allowed 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.153 179.556 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.402 ' N ' ' O ' ' A' ' 12' ' ' SER . 2.3 tt0 -43.44 -69.73 0.13 Allowed 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.76 0.314 . . . . 0.0 111.02 -179.555 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.432 ' HA ' ' CE ' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -156.29 25.9 0.35 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.388 179.965 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 55.2 m80 -149.77 165.46 32.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.081 0.467 . . . . 0.0 110.787 -179.572 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.479 ' HA ' HD22 ' A' ' 17' ' ' LEU . 0.4 OUTLIER -138.56 85.27 2.07 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.285 179.236 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.624 ' HB2' HG23 ' A' ' 53' ' ' THR . . . -78.2 153.42 31.99 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.985 -179.134 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.43 HG23 HG23 ' A' ' 21' ' ' VAL . 29.4 m -150.14 141.94 17.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.868 -0.606 . . . . 0.0 109.697 179.424 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -93.21 101.29 13.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.838 0.352 . . . . 0.0 110.621 -179.837 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.43 HG23 HG23 ' A' ' 19' ' ' VAL . 6.7 t -112.35 99.65 9.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.138 179.761 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.474 ' O ' ' CG ' ' A' ' 23' ' ' TYR . 24.7 mtpp -140.55 -72.88 0.35 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.671 -179.876 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.479 ' O ' ' CD2' ' A' ' 23' ' ' TYR . 29.7 p90 45.28 98.2 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.884 -179.667 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -46.82 116.1 1.24 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.835 -179.965 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 162.64 -42.32 0.35 Allowed Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.746 -0.942 . . . . 0.0 110.746 179.955 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -123.53 178.92 4.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.777 0.323 . . . . 0.0 110.378 -179.994 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.465 ' CB ' ' HB2' ' A' ' 71' ' ' GLU . 0.2 OUTLIER -103.85 -171.61 1.96 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.3 179.987 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.408 ' O ' ' HG3' ' A' ' 71' ' ' GLU . 6.1 mtt -117.4 118.83 33.28 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.819 -179.751 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.753 ' HB2' ' HA ' ' A' ' 71' ' ' GLU . . . -113.62 -62.33 1.61 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.109 179.57 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -165.0 165.1 20.39 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.767 -179.986 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.666 HG21 ' CD1' ' A' ' 52' ' ' TRP . 5.2 t -148.27 166.68 4.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.313 -179.896 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.482 ' N ' HG12 ' A' ' 31' ' ' VAL . 2.7 pt-20 -174.72 151.03 1.38 Allowed 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.416 -179.788 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.775 HD12 ' N ' ' A' ' 34' ' ' ARG . 3.0 pp -115.95 177.39 4.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.446 179.957 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.775 ' N ' HD12 ' A' ' 33' ' ' LEU . 2.7 ttm180 -120.2 -40.56 2.69 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.296 179.862 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.444 ' CB ' ' O ' ' A' ' 34' ' ' ARG . 3.8 tt0 87.43 32.97 0.02 OUTLIER 'General case' 0 CA--C 1.515 -0.384 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 -179.102 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.428 ' CE1' ' OE1' ' A' ' 61' ' ' GLN . 41.8 t-80 63.71 -74.03 0.04 OUTLIER 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 114.882 -1.054 . . . . 0.0 110.596 -180.0 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.421 ' N ' ' O ' ' A' ' 35' ' ' GLU . . . -136.49 103.69 0.45 Allowed Glycine 0 CA--C 1.523 0.534 0 N-CA-C 110.766 -0.934 . . . . 0.0 110.766 -179.987 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -139.87 -54.07 0.54 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.826 0.346 . . . . 0.0 110.252 179.907 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.7 p30 179.91 -45.66 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.321 -179.978 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -178.61 171.54 1.51 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.195 -179.964 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.508 ' CZ3' ' HG2' ' A' ' 67' ' ' ARG . 96.7 m95 -55.01 125.3 19.82 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.338 -179.993 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.466 HG23 ' HG ' ' A' ' 33' ' ' LEU . 4.4 m -106.91 116.93 51.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.128 179.861 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -48.83 126.03 11.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.505 -179.91 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.424 ' HE2' ' CE1' ' A' ' 66' ' ' PHE . 0.0 OUTLIER -55.79 -169.85 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.254 -179.929 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 33.8 m -141.13 95.69 2.88 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.425 -179.952 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.26 81.9 1.84 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.217 179.811 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -117.32 -17.85 5.58 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 111.404 -0.678 . . . . 0.0 111.404 -179.744 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.404 ' HB2' ' O ' ' A' ' 51' ' ' VAL . 0.1 OUTLIER -69.78 -32.65 71.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.774 0.321 . . . . 0.0 110.631 -179.766 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 97.4 -35.38 4.51 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 110.523 -1.031 . . . . 0.0 110.523 -179.839 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -113.86 -34.09 1.74 Allowed Glycine 0 CA--C 1.523 0.571 0 N-CA-C 110.458 -1.057 . . . . 0.0 110.458 179.912 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.83 HG11 ' HG3' ' A' ' 9' ' ' GLU . 23.9 m -123.78 172.75 10.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.808 0.337 . . . . 0.0 110.127 179.815 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 52' ' ' TRP . . . . . 0.666 ' CD1' HG21 ' A' ' 31' ' ' VAL . 8.8 m95 -105.06 133.8 49.24 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.529 -179.718 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.624 HG23 ' HB2' ' A' ' 18' ' ' ALA . 0.0 OUTLIER -119.79 -179.02 3.77 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.311 179.875 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.423 ' CD2' HD21 ' A' ' 33' ' ' LEU . 66.8 t80 -175.37 130.85 0.28 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.347 179.95 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 43.8 m-20 -68.91 117.29 10.39 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.359 -179.98 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 9.1 p -119.2 120.04 35.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.368 -179.994 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -100.93 -26.3 13.79 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.48 -179.921 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.402 ' O ' ' CG ' ' A' ' 58' ' ' GLU . 1.1 pt-20 -115.52 112.61 43.29 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.488 -179.872 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -70.7 -21.11 29.55 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.479 2.119 . . . . 0.0 111.891 179.655 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 44.73 -154.71 0.03 OUTLIER 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.854 179.584 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.428 ' OE1' ' CE1' ' A' ' 36' ' ' HIS . 0.0 OUTLIER -45.15 -31.9 1.61 Allowed 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.708 -0.224 . . . . 0.0 111.23 -179.644 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.499 ' N ' ' HD2' ' A' ' 63' ' ' PRO . . . 124.29 -41.98 1.64 Allowed Glycine 0 CA--C 1.531 1.058 0 C-N-CA 121.116 -0.564 . . . . 0.0 112.395 179.894 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.499 ' HD2' ' N ' ' A' ' 62' ' ' GLY . 45.2 Cg_endo -74.64 152.98 43.35 Favored 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 122.052 1.835 . . . . 0.0 112.811 -179.137 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.438 ' HD2' HG21 ' A' ' 82' ' ' VAL . 78.0 m-85 -126.77 101.61 6.68 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.318 179.832 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 20.7 m-20 -65.53 140.34 58.56 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 179.538 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.489 ' CE1' ' HB3' ' A' ' 33' ' ' LEU . 16.5 m-85 -128.96 176.58 7.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.235 0.54 . . . . 0.0 111.246 -179.34 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.508 ' HG2' ' CZ3' ' A' ' 41' ' ' TRP . 0.0 OUTLIER 176.91 89.17 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.447 179.878 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.676 ' CZ ' HG11 ' A' ' 4' ' ' VAL . 1.4 p90 -72.06 176.28 5.23 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.179 0.514 . . . . 0.0 110.874 -179.144 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.68 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 2.3 mt -130.12 61.12 1.59 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.031 179.715 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.407 ' OG1' ' N ' ' A' ' 74' ' ' MET . 0.6 OUTLIER -23.69 137.62 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.871 0.868 . . . . 0.0 113.011 -178.821 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.753 ' HA ' ' HB2' ' A' ' 29' ' ' ALA . 0.0 OUTLIER -48.41 -45.02 35.55 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.094 -179.533 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -145.37 38.32 1.15 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.279 179.973 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -114.57 -109.87 2.82 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.889 -0.884 . . . . 0.0 110.889 -179.952 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.407 ' N ' ' OG1' ' A' ' 70' ' ' THR . 20.8 mmt -154.41 -179.67 8.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.745 0.307 . . . . 0.0 110.183 179.909 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.439 ' N ' ' HD3' ' A' ' 75' ' ' LYS . 0.1 OUTLIER -115.85 100.74 8.21 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.996 0.427 . . . . 0.0 110.443 -179.888 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 49.0 t30 -115.9 152.86 32.61 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.241 179.895 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.517 HG12 ' N ' ' A' ' 78' ' ' PHE . 77.7 t -100.29 160.79 3.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.324 179.843 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.779 ' CZ ' HG21 ' A' ' 4' ' ' VAL . 64.9 m-85 -141.13 109.28 5.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.287 -179.907 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -95.77 159.66 14.87 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.496 -179.869 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 54.72 32.84 18.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.551 179.902 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.623 HG13 ' HB2' ' A' ' 93' ' ' ALA . 66.3 t -66.23 -54.68 24.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.286 179.901 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.626 HG13 ' HD2' ' A' ' 83' ' ' PRO . 76.2 t -101.1 142.45 24.64 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.02 179.95 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.626 ' HD2' HG13 ' A' ' 82' ' ' VAL . 43.5 Cg_endo -68.11 177.83 4.09 Favored 'Trans proline' 0 N--CA 1.475 0.42 0 C-N-CA 122.622 2.214 . . . . 0.0 112.287 179.915 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -59.31 -33.97 71.74 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.233 179.904 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.02 85.27 2.18 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.175 179.9 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.476 ' HB3' ' CG1' ' A' ' 82' ' ' VAL . 26.5 p90 -50.51 145.04 6.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.682 -179.751 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 4.2 m -136.08 111.45 9.14 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.304 179.841 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.803 HD11 ' HB2' ' A' ' 12' ' ' SER . 38.1 mm -50.49 110.19 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.49 -179.874 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 122.89 47.24 0.27 Allowed Glycine 0 CA--C 1.523 0.553 0 N-CA-C 110.819 -0.912 . . . . 0.0 110.819 179.918 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -160.0 159.02 31.61 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.774 0.321 . . . . 0.0 110.44 179.928 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 90.1 m -118.69 91.81 3.65 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.497 179.949 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.553 ' O ' ' HB3' ' A' ' 93' ' ' ALA . 32.9 m-85 -86.06 -156.71 0.3 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.154 179.847 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.877 ' HB1' ' HD2' ' A' ' 94' ' ' PRO . . . 76.19 173.6 0.09 OUTLIER Pre-proline 0 N--CA 1.463 0.179 0 CA-C-O 120.7 0.286 . . . . 0.0 110.307 -179.805 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.877 ' HD2' ' HB1' ' A' ' 93' ' ' ALA . 46.1 Cg_endo . . . . . 0 C--O 1.249 1.05 0 C-N-CA 122.582 2.188 . . . . 0.0 112.092 -179.908 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.569 ' O ' HG13 ' A' ' 1' ' ' VAL . 8.3 p . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 110.137 -0.32 . . . . 0.0 110.137 . . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -75.54 116.96 4.63 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.634 2.223 . . . . 0.0 112.165 -179.94 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.535 ' O ' HG22 ' A' ' 4' ' ' VAL . 81.7 mttt -146.45 29.38 1.04 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.346 179.971 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.731 ' O ' HG23 ' A' ' 5' ' ' THR . 23.0 m 44.59 -172.22 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.042 -179.804 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.731 HG23 ' O ' ' A' ' 4' ' ' VAL . 0.5 OUTLIER -174.02 136.8 0.53 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.521 -179.72 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.75 ' O ' HG23 ' A' ' 91' ' ' THR . 14.2 m-85 -105.17 172.13 6.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.01 179.857 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.406 ' HG1' HG23 ' A' ' 91' ' ' THR . 19.7 m -165.69 113.35 0.95 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.84 0.352 . . . . 0.0 110.447 -179.974 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 94.9 t -58.0 87.97 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.396 179.971 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.542 ' HG3' HG21 ' A' ' 51' ' ' VAL . 2.5 mm-40 -59.44 167.12 2.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.344 179.982 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.06 165.14 5.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.363 179.954 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 79.99 35.0 28.77 Favored Glycine 0 CA--C 1.523 0.582 0 N-CA-C 110.834 -0.906 . . . . 0.0 110.834 179.99 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 74.4 m -96.1 114.95 26.7 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.78 0.324 . . . . 0.0 110.369 -179.948 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -97.46 -168.85 1.75 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.213 179.998 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 67.8 mm-40 -69.24 -27.15 65.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.315 179.861 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.42 ' HG2' ' N ' ' A' ' 16' ' ' HIS . 0.0 OUTLIER -114.55 -30.65 6.46 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.641 -179.857 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.42 ' N ' ' HG2' ' A' ' 15' ' ' LYS . 2.0 m80 -70.59 151.28 45.17 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.851 0.357 . . . . 0.0 110.378 -179.902 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.507 ' HA ' HD22 ' A' ' 17' ' ' LEU . 0.3 OUTLIER -151.29 91.58 1.7 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.498 -179.965 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.626 ' HB1' HG11 ' A' ' 51' ' ' VAL . . . -89.31 136.19 33.16 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.868 179.675 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.746 ' O ' HG13 ' A' ' 51' ' ' VAL . 27.4 m -137.86 135.02 45.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.999 0.428 . . . . 0.0 110.847 -179.793 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -88.57 81.12 7.18 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.454 179.949 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.433 HG23 HG23 ' A' ' 19' ' ' VAL . 42.9 t -77.92 107.91 10.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.408 179.97 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -170.43 150.51 3.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.289 -179.986 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.485 ' CE1' HG12 ' A' ' 4' ' ' VAL . 8.4 p90 -166.78 31.4 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.493 -179.938 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 50.84 -167.78 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.513 179.959 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 63.45 -79.97 0.04 OUTLIER Glycine 0 CA--C 1.523 0.536 0 N-CA-C 110.796 -0.921 . . . . 0.0 110.796 179.88 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -71.63 179.54 3.02 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.678 0.275 . . . . 0.0 110.325 179.956 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -121.2 -174.1 2.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.389 -179.886 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.427 ' O ' ' CG ' ' A' ' 71' ' ' GLU . 22.6 mtm -114.99 122.35 45.97 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.677 -179.651 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.746 ' HB3' ' O ' ' A' ' 69' ' ' LEU . . . -120.02 -60.48 1.7 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.338 179.765 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.42 ' HB3' HD12 ' A' ' 69' ' ' LEU . 2.7 mt-10 -161.37 147.59 14.31 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.36 179.995 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.648 HG21 ' CD1' ' A' ' 52' ' ' TRP . 3.1 t -133.97 159.33 42.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.941 0.401 . . . . 0.0 110.596 179.987 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.424 ' N ' ' OE2' ' A' ' 32' ' ' GLU . 0.5 OUTLIER -150.04 147.79 28.24 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.148 -179.944 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.627 HD12 ' H ' ' A' ' 34' ' ' ARG . 12.0 tp -116.65 156.07 27.71 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 -179.603 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.627 ' H ' HD12 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -139.98 178.81 7.0 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.087 179.609 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -122.16 -79.91 0.62 Allowed 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 179.719 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -179.34 -38.42 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.349 179.487 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -130.28 22.87 4.67 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.884 -0.887 . . . . 0.0 110.884 179.937 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 8.2 t -77.34 -166.13 0.69 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.872 0.368 . . . . 0.0 110.304 179.959 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -87.2 52.99 2.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.143 179.868 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 69.71 178.61 0.25 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.251 -179.858 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.49 ' CZ3' ' HG2' ' A' ' 67' ' ' ARG . 97.2 m95 -50.47 139.08 16.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.629 -179.994 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.434 ' CG2' ' O ' ' A' ' 33' ' ' LEU . 4.6 m -125.89 111.33 26.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 109.743 -0.465 . . . . 0.0 109.743 179.531 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.41 ' HA ' ' HB3' ' A' ' 32' ' ' GLU . . . -44.45 138.15 3.35 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.116 -179.376 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -67.66 -171.73 0.22 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.89 -179.942 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.402 ' O ' ' N ' ' A' ' 47' ' ' GLY . 51.7 m -150.92 106.31 3.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.228 179.846 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 7.3 ptmt -62.77 80.99 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.495 -179.925 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.402 ' N ' ' O ' ' A' ' 45' ' ' THR . . . -98.74 -24.31 10.97 Favored Glycine 0 CA--C 1.523 0.555 0 N-CA-C 110.647 -0.981 . . . . 0.0 110.647 179.846 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.476 ' CB ' ' HB ' ' A' ' 51' ' ' VAL . 2.2 mm-40 -78.18 1.09 22.5 Favored 'General case' 0 CA--C 1.532 0.269 0 O-C-N 122.85 -0.206 . . . . 0.0 111.502 -179.891 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 67.93 17.29 69.41 Favored Glycine 0 CA--C 1.527 0.794 0 N-CA-C 111.13 -0.788 . . . . 0.0 111.13 -179.963 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 178.24 -38.57 0.08 OUTLIER Glycine 0 C--N 1.33 0.229 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 179.93 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.746 HG13 ' O ' ' A' ' 19' ' ' VAL . 22.2 t -101.24 150.3 5.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 179.227 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 52' ' ' TRP . . . . . 0.648 ' CD1' HG21 ' A' ' 31' ' ' VAL . 3.3 m95 -91.75 111.7 23.32 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.477 -179.543 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.552 HG22 ' HB2' ' A' ' 18' ' ' ALA . 15.0 p -107.73 150.13 27.33 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.494 -179.736 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 34.6 t80 -136.7 115.12 11.82 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.451 -179.996 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -66.8 162.27 21.88 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.289 179.974 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 6.3 t 65.09 127.04 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.705 179.849 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.424 ' O ' ' O ' ' A' ' 58' ' ' GLU . 5.7 tt0 -117.95 -15.93 9.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.955 179.885 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.424 ' O ' ' O ' ' A' ' 57' ' ' GLU . 2.2 pt-20 48.97 170.43 0.03 OUTLIER Pre-proline 0 N--CA 1.467 0.381 0 C-N-CA 123.213 0.605 . . . . 0.0 111.548 -179.94 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.41 ' CD ' ' HB2' ' A' ' 58' ' ' GLU . 38.3 Cg_endo -96.97 10.41 1.25 Allowed 'Trans proline' 0 N--CA 1.453 -0.877 0 C-N-CA 124.036 3.157 . . . . 0.0 112.961 -178.998 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.9 100.47 0.07 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.841 0.353 . . . . 0.0 110.512 -179.914 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -53.65 127.5 25.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.222 179.861 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 135.7 163.0 9.83 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.601 -0.999 . . . . 0.0 110.601 -179.806 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.439 ' CG ' ' HA ' ' A' ' 80' ' ' ASP . 49.9 Cg_endo -79.33 -171.95 1.39 Allowed 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.642 2.228 . . . . 0.0 112.091 -179.974 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 -97.16 171.64 8.32 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.85 0.357 . . . . 0.0 110.258 179.846 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -144.05 143.88 31.37 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.716 179.813 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 -131.28 177.75 7.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.201 0.524 . . . . 0.0 111.288 -179.466 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.49 ' HG2' ' CZ3' ' A' ' 41' ' ' TRP . 0.1 OUTLIER 175.7 67.28 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.265 -179.964 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -52.57 173.46 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.264 0.554 . . . . 0.0 111.143 -178.963 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.746 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 6.4 mt -128.68 55.91 1.68 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.126 179.595 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -26.73 137.87 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.736 0.815 . . . . 0.0 112.593 -178.915 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.578 ' N ' ' HB2' ' A' ' 29' ' ' ALA . 23.6 mt-10 -51.69 -51.75 53.58 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.25 -179.857 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 5.1 tptt -135.95 57.93 1.77 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.042 179.733 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -136.04 -96.64 0.49 Allowed Glycine 0 CA--C 1.523 0.592 0 N-CA-C 110.776 -0.93 . . . . 0.0 110.776 -179.823 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 1.9 ptt? 174.86 165.87 0.26 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.813 0.339 . . . . 0.0 110.515 -179.949 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.432 ' CD ' ' HA ' ' A' ' 69' ' ' LEU . 5.6 mmtp -94.13 137.9 32.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.005 -179.965 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 10.8 t30 -141.29 176.21 9.03 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.285 179.923 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 95.9 t -121.65 146.79 26.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.253 179.995 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -136.12 108.91 7.54 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.523 -179.904 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.402 ' O ' ' N ' ' A' ' 81' ' ' VAL . 54.4 m-20 -80.27 163.34 24.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.178 179.799 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.45 ' O ' ' HB ' ' A' ' 81' ' ' VAL . 1.1 m-20 58.94 -85.72 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.377 -179.813 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.887 HG12 HG23 ' A' ' 82' ' ' VAL . 55.6 t 68.55 -56.26 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 C-N-CA 123.432 0.693 . . . . 0.0 110.881 179.98 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.887 HG23 HG12 ' A' ' 81' ' ' VAL . 54.6 t -128.78 139.34 35.35 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.501 -179.894 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.516 ' HD2' HG13 ' A' ' 82' ' ' VAL . 46.2 Cg_endo -69.81 -170.32 0.39 Allowed 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.585 2.19 . . . . 0.0 112.066 179.699 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -87.07 -39.72 15.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.18 179.754 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -110.75 56.22 0.64 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.213 179.855 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 21.1 p90 -56.78 170.25 0.43 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.52 -179.838 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 26.6 m -151.35 121.16 7.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.149 179.907 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.429 ' H ' HD12 ' A' ' 88' ' ' ILE . 3.4 mp -50.58 111.29 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.388 -179.82 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 122.41 57.36 0.2 Allowed Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.655 -0.978 . . . . 0.0 110.655 -179.976 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.401 ' O ' HG23 ' A' ' 7' ' ' THR . . . -174.07 148.86 1.4 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.75 0.309 . . . . 0.0 110.378 -179.991 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.75 HG23 ' O ' ' A' ' 6' ' ' PHE . 50.9 m -106.97 93.88 4.8 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.6 -179.955 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.569 ' O ' ' HB3' ' A' ' 93' ' ' ALA . 44.0 m-85 -76.42 -155.67 0.06 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.145 -0.479 . . . . 0.0 109.761 179.549 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.89 ' HB1' ' HD2' ' A' ' 94' ' ' PRO . . . 75.65 172.95 0.09 OUTLIER Pre-proline 0 N--CA 1.464 0.227 0 CA-C-O 120.786 0.327 . . . . 0.0 110.811 179.773 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.89 ' HD2' ' HB1' ' A' ' 93' ' ' ALA . 46.9 Cg_endo . . . . . 0 C--O 1.25 1.08 0 C-N-CA 122.606 2.204 . . . . 0.0 111.965 179.884 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.653 ' O ' HG13 ' A' ' 1' ' ' VAL . 8.5 p . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 . . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -75.07 134.09 17.27 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.412 2.075 . . . . 0.0 112.188 -179.919 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.65 94.03 2.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.283 -179.904 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.518 ' CG1' ' CE1' ' A' ' 78' ' ' PHE . 1.9 p -63.89 163.24 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.285 0.564 . . . . 0.0 110.469 -179.811 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.478 ' N ' HG22 ' A' ' 4' ' ' VAL . 80.9 p -137.48 136.11 37.43 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.067 179.871 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.62 ' O ' HG23 ' A' ' 91' ' ' THR . 17.7 m-85 -97.0 -175.42 3.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.418 -179.81 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.407 ' HB ' ' HB2' ' A' ' 20' ' ' LEU . 2.5 m -167.15 95.53 0.48 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.237 -179.833 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.462 HG12 ' CD1' ' A' ' 88' ' ' ILE . 39.1 t -51.07 97.19 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.563 -179.879 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.492 ' HG3' HG11 ' A' ' 51' ' ' VAL . 4.4 mt-10 -61.92 174.52 0.83 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.443 -179.92 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.8 tttt -67.66 163.37 21.59 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.408 -179.977 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 74.27 25.74 70.03 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 179.883 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.475 ' CB ' HD11 ' A' ' 88' ' ' ILE . 0.5 OUTLIER -99.05 121.81 41.46 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.835 0.35 . . . . 0.0 110.431 -179.993 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -177.45 -175.03 0.52 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.427 179.99 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.41 ' O ' ' CB ' ' A' ' 15' ' ' LYS . 3.9 mt-10 -47.59 119.07 2.53 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.175 0.512 . . . . 0.0 110.834 -179.848 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.418 ' O ' ' CG ' ' A' ' 16' ' ' HIS . 0.8 OUTLIER 79.95 24.54 0.4 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.774 179.726 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.418 ' CG ' ' O ' ' A' ' 15' ' ' LYS . 3.2 m80 -174.04 111.75 0.17 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.829 0.347 . . . . 0.0 110.348 179.745 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.444 ' HA ' HD22 ' A' ' 17' ' ' LEU . 0.3 OUTLIER -128.93 101.19 5.97 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.489 -179.856 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -97.93 153.05 18.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.232 179.852 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.594 HG23 HG23 ' A' ' 21' ' ' VAL . 23.7 m -150.18 134.72 9.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.062 -179.7 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.581 HD22 ' CG ' ' A' ' 22' ' ' LYS . 0.5 OUTLIER -86.77 73.34 10.02 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.212 -0.449 . . . . 0.0 109.869 179.105 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.594 HG23 HG23 ' A' ' 19' ' ' VAL . 52.7 t -69.83 94.51 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.86 -179.468 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.581 ' CG ' HD22 ' A' ' 20' ' ' LEU . 0.0 OUTLIER 175.18 157.8 0.19 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.106 179.712 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.41 ' CE2' ' HB3' ' A' ' 26' ' ' ASP . 0.1 OUTLIER -127.08 -79.05 0.59 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.46 -179.981 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -99.49 -90.78 0.3 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.822 -179.814 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -139.68 32.83 2.19 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 111.132 -0.787 . . . . 0.0 111.132 -179.778 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.41 ' HB3' ' CE2' ' A' ' 23' ' ' TYR . 4.3 p30 -58.58 -171.11 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 179.727 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.454 ' HB ' ' CG ' ' A' ' 71' ' ' GLU . 0.9 OUTLIER -125.57 145.82 49.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.875 0.369 . . . . 0.0 110.37 179.987 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.411 ' O ' ' CG ' ' A' ' 71' ' ' GLU . 0.0 OUTLIER -98.7 129.39 45.16 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.662 -179.506 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.757 ' HB3' ' O ' ' A' ' 69' ' ' LEU . . . -120.47 -56.8 1.95 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.351 179.956 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -158.0 145.9 18.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.388 -179.982 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.888 HG21 ' CD1' ' A' ' 52' ' ' TRP . 2.4 t -135.68 140.38 44.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.141 179.995 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.463 ' CB ' ' HA ' ' A' ' 43' ' ' ALA . 4.4 pt-20 -139.14 141.39 38.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.858 0.361 . . . . 0.0 110.491 179.955 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.509 ' HG ' ' CE1' ' A' ' 66' ' ' PHE . 2.2 mt -113.0 174.61 5.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.94 -179.444 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.5 ' HD3' ' CD2' ' A' ' 41' ' ' TRP . 1.5 ttp85 -149.61 -159.17 1.0 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.852 179.585 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -158.67 26.18 0.23 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.698 0.285 . . . . 0.0 110.759 179.887 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 49.4 25.88 1.45 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.726 179.752 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -129.73 -50.45 0.12 Allowed Glycine 0 CA--C 1.522 0.525 0 N-CA-C 110.706 -0.958 . . . . 0.0 110.706 -179.945 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -76.54 115.26 16.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.784 0.326 . . . . 0.0 110.425 -179.977 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -52.09 -25.83 9.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.361 -179.992 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.26 178.73 4.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.219 179.892 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.506 ' CH2' ' HG3' ' A' ' 67' ' ' ARG . 86.5 m95 -111.88 169.45 8.83 Favored 'General case' 0 CA--C 1.503 -0.862 0 CA-C-O 121.559 0.695 . . . . 0.0 110.876 -179.978 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.499 ' O ' HG12 ' A' ' 42' ' ' VAL . 1.0 OUTLIER -142.05 107.63 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.193 0 CA-C-N 114.63 -1.168 . . . . 0.0 109.769 -177.441 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.463 ' HA ' ' CB ' ' A' ' 32' ' ' GLU . . . -50.49 143.39 9.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.578 -179.445 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.463 ' HE2' ' CZ ' ' A' ' 66' ' ' PHE . 0.0 OUTLIER -63.14 -169.57 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.783 -179.765 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.405 ' O ' ' N ' ' A' ' 47' ' ' GLY . 46.0 m -135.35 110.18 8.72 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.03 179.811 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.77 66.45 0.09 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.566 -179.793 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.405 ' N ' ' O ' ' A' ' 45' ' ' THR . . . -83.35 -40.84 8.8 Favored Glycine 0 CA--C 1.522 0.522 0 N-CA-C 110.351 -1.1 . . . . 0.0 110.351 179.798 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -90.02 144.97 25.44 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 179.74 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -83.83 8.16 67.23 Favored Glycine 0 CA--C 1.528 0.903 0 N-CA-C 111.597 -0.601 . . . . 0.0 111.597 -179.896 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -127.44 -40.0 0.35 Allowed Glycine 0 CA--C 1.524 0.641 0 N-CA-C 110.978 -0.849 . . . . 0.0 110.978 -179.952 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.538 HG12 ' HA ' ' A' ' 20' ' ' LEU . 6.9 m -133.67 -176.5 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 121.088 0.47 . . . . 0.0 110.79 -179.605 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 52' ' ' TRP . . . . . 0.888 ' CD1' HG21 ' A' ' 31' ' ' VAL . 11.1 m95 -109.61 131.39 55.11 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.75 179.543 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 3.0 p -115.98 171.79 7.56 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.863 0.363 . . . . 0.0 110.318 -179.664 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 60.4 t80 -159.63 118.5 2.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.333 179.971 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -70.94 129.14 38.25 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.303 179.956 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 90.8 p -96.25 126.54 41.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.416 -179.949 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -136.58 36.95 2.67 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.394 179.984 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -138.04 156.61 73.97 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.324 179.854 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -72.45 -26.77 16.62 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.671 2.247 . . . . 0.0 112.216 -179.949 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.4 mt -79.5 126.61 31.08 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.541 -179.761 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -156.58 -178.37 7.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.358 -179.845 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 119.73 -106.25 1.2 Allowed Glycine 0 CA--C 1.526 0.725 0 N-CA-C 110.856 -0.898 . . . . 0.0 110.856 179.891 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -77.46 125.08 7.42 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.455 2.103 . . . . 0.0 111.972 179.991 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.414 ' CE2' ' HG ' ' A' ' 17' ' ' LEU . 42.6 m-85 -101.27 147.05 26.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.587 -179.869 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.448 ' O ' HD23 ' A' ' 33' ' ' LEU . 1.9 m-80 -120.69 131.19 54.43 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.618 179.511 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.509 ' CE1' ' HG ' ' A' ' 33' ' ' LEU . 19.8 m-85 -114.71 163.1 15.94 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.963 0.411 . . . . 0.0 111.47 -179.236 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.658 ' HD2' HG22 ' A' ' 77' ' ' VAL . 48.3 mtp180 -162.07 62.62 0.23 Allowed 'General case' 0 CA--C 1.52 -0.184 0 CA-C-N 115.353 -0.839 . . . . 0.0 109.807 179.014 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.967 ' O ' HD23 ' A' ' 69' ' ' LEU . 0.0 OUTLIER -67.09 -179.15 0.9 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.143 0.497 . . . . 0.0 110.828 -179.455 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.967 HD23 ' O ' ' A' ' 68' ' ' PHE . 5.7 mt -136.68 55.07 1.85 Allowed 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 179.321 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 18.5 p -29.02 137.95 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.543 0.737 . . . . 0.0 112.135 -178.904 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.678 ' HG2' ' HB2' ' A' ' 29' ' ' ALA . 8.0 mt-10 -51.22 -68.62 0.15 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.663 -179.24 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -106.29 68.45 0.76 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.781 0.324 . . . . 0.0 110.31 179.902 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -158.28 -104.58 0.21 Allowed Glycine 0 CA--C 1.523 0.587 0 N-CA-C 110.952 -0.859 . . . . 0.0 110.952 -179.972 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 13.3 ptm 174.26 179.38 0.11 Allowed 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 -179.838 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.25 175.68 6.85 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.87 0.367 . . . . 0.0 110.352 179.877 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 173.96 170.16 0.2 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.43 179.907 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.658 HG22 ' HD2' ' A' ' 67' ' ' ARG . 72.5 t -117.61 157.78 18.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.504 -179.987 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.518 ' CE1' ' CG1' ' A' ' 4' ' ' VAL . 41.3 m-85 -144.99 129.93 18.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.384 -179.932 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -118.85 147.03 44.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.319 179.942 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 59.13 45.45 14.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.455 179.862 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.503 ' O ' HG12 ' A' ' 81' ' ' VAL . 74.4 t -80.4 -3.91 6.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.073 179.893 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.437 HG23 ' C ' ' A' ' 81' ' ' VAL . 89.2 t -156.56 122.12 2.48 Favored Pre-proline 0 CA--C 1.528 0.117 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 179.654 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.431 ' HD3' ' CD1' ' A' ' 92' ' ' TYR . 50.8 Cg_endo -75.25 176.07 10.42 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.552 2.168 . . . . 0.0 112.129 -179.923 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -77.31 131.03 37.92 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 179.475 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 2.2 mmtt 59.92 40.75 18.68 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 -179.529 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 28.2 p90 -47.46 174.28 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.855 -179.681 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 10.9 m -129.36 129.66 45.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.242 179.987 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.475 HD11 ' CB ' ' A' ' 12' ' ' SER . 42.2 mm -66.51 115.3 4.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.337 179.981 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 119.45 37.34 0.79 Allowed Glycine 0 CA--C 1.523 0.573 0 N-CA-C 110.725 -0.95 . . . . 0.0 110.725 -179.917 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -147.67 172.57 13.85 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.808 0.337 . . . . 0.0 110.375 179.998 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.62 HG23 ' O ' ' A' ' 6' ' ' PHE . 87.9 m -114.83 126.16 54.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.422 -179.992 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.463 ' O ' ' HB2' ' A' ' 93' ' ' ALA . 54.6 m-85 -127.45 130.5 49.37 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.571 179.985 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.897 ' HB1' ' HD2' ' A' ' 94' ' ' PRO . . . 174.01 177.13 0.19 Allowed Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.435 179.713 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.897 ' HD2' ' HB1' ' A' ' 93' ' ' ALA . 49.4 Cg_endo . . . . . 0 C--O 1.25 1.094 0 C-N-CA 122.642 2.228 . . . . 0.0 112.071 -179.885 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 12.0 t . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 120.728 0.299 . . . . 0.0 110.232 . . . . . . . . . 0 0 . 1 . 037 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -77.05 167.57 24.82 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.587 2.191 . . . . 0.0 112.077 -179.972 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.86 59.35 0.99 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.367 -179.936 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.801 HG12 ' CE2' ' A' ' 23' ' ' TYR . 16.9 m -71.91 168.3 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.478 -179.967 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.427 ' HB ' ' CG2' ' A' ' 91' ' ' THR . 78.4 p -153.72 129.96 10.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.33 179.819 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.559 ' O ' HG23 ' A' ' 91' ' ' THR . 25.2 m-85 -93.44 165.46 12.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.41 -179.865 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -153.72 108.84 3.16 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.546 -179.883 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.442 ' CG1' HG13 ' A' ' 88' ' ' ILE . 92.0 t -57.79 114.26 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.12 179.759 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.65 ' CD ' HG11 ' A' ' 51' ' ' VAL . 1.8 mt-10 -84.36 159.11 20.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.61 -179.771 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.637 ' HA ' HG21 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -57.63 -25.81 60.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.48 -179.912 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -49.67 -26.4 7.73 Favored Glycine 0 CA--C 1.523 0.567 0 N-CA-C 110.8 -0.92 . . . . 0.0 110.8 -179.908 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.4 m -59.29 106.4 0.44 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.767 0.318 . . . . 0.0 110.289 179.961 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.434 ' O ' ' N ' ' A' ' 15' ' ' LYS . 10.8 p-10 -124.72 136.74 54.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.491 -179.962 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 53.34 -87.04 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.661 179.891 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.434 ' N ' ' O ' ' A' ' 13' ' ' ASN . 42.2 pttt -114.16 -27.39 7.67 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.659 0.266 . . . . 0.0 110.71 -179.963 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 8.9 m80 -49.36 134.19 19.01 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.533 179.947 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.477 HD22 ' HA ' ' A' ' 17' ' ' LEU . 0.2 OUTLIER -118.48 100.12 7.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.409 -179.88 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.583 ' HB2' ' CG2' ' A' ' 53' ' ' THR . . . -98.86 130.5 45.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.266 179.942 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.77 HG23 HG23 ' A' ' 21' ' ' VAL . 33.4 m -126.15 146.67 31.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.262 -179.914 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -96.66 70.97 2.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.307 -179.947 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.77 HG23 HG23 ' A' ' 19' ' ' VAL . 23.5 t -75.16 97.89 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.449 -179.877 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.02 146.39 9.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.405 179.975 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.801 ' CE2' HG12 ' A' ' 4' ' ' VAL . 17.0 p90 -173.16 140.03 0.84 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.455 -179.996 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -52.04 134.91 31.91 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.358 -179.98 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 126.78 -110.44 1.23 Allowed Glycine 0 CA--C 1.523 0.538 0 N-CA-C 110.684 -0.966 . . . . 0.0 110.684 179.993 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -67.01 145.85 54.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.781 0.324 . . . . 0.0 110.259 179.954 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.449 ' HB ' ' CG ' ' A' ' 71' ' ' GLU . 0.3 OUTLIER -80.87 -171.26 3.08 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.419 -179.884 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -117.92 124.63 48.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.567 -179.723 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.845 ' HB3' ' O ' ' A' ' 69' ' ' LEU . . . -114.54 -60.59 1.87 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.437 -179.783 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.559 ' OE2' ' HB1' ' A' ' 43' ' ' ALA . 0.5 OUTLIER -157.78 150.95 23.25 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.224 179.984 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 1.034 HG21 ' CD1' ' A' ' 52' ' ' TRP . 6.1 t -119.59 166.57 13.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.155 -179.899 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.468 ' N ' HG12 ' A' ' 31' ' ' VAL . 1.2 tp10 -153.08 140.06 19.21 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.017 0.437 . . . . 0.0 109.925 -179.416 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.708 HD12 ' N ' ' A' ' 34' ' ' ARG . 3.9 tp -134.3 142.62 47.34 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.182 -178.963 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.708 ' N ' HD12 ' A' ' 33' ' ' LEU . 6.7 tpm_? -127.73 -95.91 0.42 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.154 -0.475 . . . . 0.0 109.903 179.012 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.44 ' CB ' ' O ' ' A' ' 34' ' ' ARG . 0.0 OUTLIER 160.79 -83.51 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 120.763 0.316 . . . . 0.0 110.321 179.392 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 3.3 t60 177.88 -55.41 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.317 -179.868 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -59.36 -72.07 0.67 Allowed Glycine 0 CA--C 1.523 0.584 0 N-CA-C 110.639 -0.985 . . . . 0.0 110.639 179.955 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -58.05 122.03 12.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.819 0.342 . . . . 0.0 110.179 179.848 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 33.0 m-20 -83.26 6.71 18.64 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.312 -179.825 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -107.84 100.33 9.71 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 120.82 0.343 . . . . 0.0 110.54 -179.953 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.507 ' CZ3' ' HG2' ' A' ' 67' ' ' ARG . 68.7 m95 -59.4 155.32 15.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.072 179.733 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.506 HG21 ' CZ ' ' A' ' 54' ' ' PHE . 10.0 m -138.47 110.76 6.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-O 120.715 0.293 . . . . 0.0 110.307 179.98 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.559 ' HB1' ' OE2' ' A' ' 30' ' ' GLU . . . -45.68 149.75 0.57 Allowed 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.52 -179.8 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.403 ' HB2' ' HB ' ' A' ' 31' ' ' VAL . 0.0 OUTLIER -72.13 -170.55 0.62 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.916 0.388 . . . . 0.0 110.54 -179.722 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 68.8 m -138.88 126.04 21.37 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.409 -179.945 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 3.1 ptpt -94.56 91.32 6.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.564 -179.804 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -146.34 26.59 1.7 Allowed Glycine 0 CA--C 1.523 0.572 0 N-CA-C 110.81 -0.916 . . . . 0.0 110.81 179.963 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.493 ' OE2' HG21 ' A' ' 53' ' ' THR . 0.0 OUTLIER -106.45 174.52 5.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.836 0.351 . . . . 0.0 110.482 179.939 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -56.13 -29.44 56.02 Favored Glycine 0 CA--C 1.522 0.53 0 N-CA-C 110.487 -1.045 . . . . 0.0 110.487 179.787 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.437 ' O ' HG13 ' A' ' 51' ' ' VAL . . . 177.81 37.46 0.06 OUTLIER Glycine 0 CA--C 1.524 0.619 0 N-CA-C 110.861 -0.896 . . . . 0.0 110.861 179.965 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.65 HG11 ' CD ' ' A' ' 9' ' ' GLU . 13.1 m -154.78 177.87 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.828 0.347 . . . . 0.0 110.395 179.866 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 52' ' ' TRP . . . . . 1.034 ' CD1' HG21 ' A' ' 31' ' ' VAL . 5.4 m95 -103.92 144.92 30.87 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.379 -179.487 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.583 ' CG2' ' HB2' ' A' ' 18' ' ' ALA . 0.7 OUTLIER -137.15 157.91 45.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.382 -179.971 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.506 ' CZ ' HG21 ' A' ' 42' ' ' VAL . 78.2 t80 -148.95 155.39 40.77 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.49 -179.952 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -89.81 124.58 34.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.511 -179.89 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 94.0 p -120.56 103.56 9.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.273 179.937 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -110.3 -28.02 8.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.47 -179.906 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -59.55 125.63 80.19 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.458 -179.923 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -72.0 -11.73 27.6 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.519 2.146 . . . . 0.0 112.514 179.97 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -47.57 107.49 0.12 Allowed 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 120.901 0.381 . . . . 0.0 110.749 -179.732 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -76.05 118.89 19.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.345 179.929 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -179.65 170.85 42.39 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 -179.959 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.417 ' CB ' ' HA ' ' A' ' 80' ' ' ASP . 49.6 Cg_endo -79.02 151.63 24.04 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.597 2.198 . . . . 0.0 112.097 -179.893 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.571 ' HB3' HD13 ' A' ' 33' ' ' LEU . 29.4 m-85 -84.86 123.11 30.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.277 179.877 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 7.4 m-20 -95.28 134.46 38.03 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 179.516 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.424 ' CE2' ' HB2' ' A' ' 33' ' ' LEU . 51.8 m-85 -121.42 167.9 12.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.129 0.49 . . . . 0.0 111.045 -179.452 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.507 ' HG2' ' CZ3' ' A' ' 41' ' ' TRP . 0.3 OUTLIER -173.77 61.77 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.711 179.984 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.625 ' HZ ' HG11 ' A' ' 4' ' ' VAL . 1.7 p90 -56.78 174.11 0.17 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.99 -179.472 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.845 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 2.9 mt -121.54 72.14 1.0 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.221 179.515 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.401 ' OG1' ' N ' ' A' ' 74' ' ' MET . 62.3 p -35.84 136.17 0.27 Allowed 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.793 -179.241 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.681 ' HG2' ' HB2' ' A' ' 29' ' ' ALA . 14.8 mt-10 -49.96 -52.16 35.74 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.486 -179.861 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 6.3 tptp -129.21 71.67 1.44 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.529 -179.869 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -162.85 -103.71 0.18 Allowed Glycine 0 CA--C 1.522 0.528 0 N-CA-C 110.799 -0.92 . . . . 0.0 110.799 179.897 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.401 ' N ' ' OG1' ' A' ' 70' ' ' THR . 21.1 ptt? -179.21 -175.64 0.38 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.853 0.359 . . . . 0.0 110.292 179.988 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.553 ' HE3' HD22 ' A' ' 69' ' ' LEU . 0.0 OUTLIER -97.48 148.28 23.38 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.159 -179.69 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -152.62 123.09 7.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.192 179.854 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 98.4 t -81.65 143.73 11.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.526 -179.825 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.631 ' CZ ' HG21 ' A' ' 4' ' ' VAL . 53.9 m-85 -127.99 122.35 32.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.254 179.993 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -105.26 148.72 26.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.552 -179.699 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.417 ' HA ' ' CB ' ' A' ' 63' ' ' PRO . 1.0 OUTLIER 58.88 46.06 14.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.462 179.9 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.413 ' O ' ' HB3' ' A' ' 92' ' ' TYR . 90.1 t -77.0 -75.25 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.187 179.862 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.426 HG13 ' HD2' ' A' ' 83' ' ' PRO . 39.1 t -89.04 137.89 29.37 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.268 179.797 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.426 ' HD2' HG13 ' A' ' 82' ' ' VAL . 49.1 Cg_endo -73.17 -175.42 1.96 Allowed 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.5 2.133 . . . . 0.0 111.949 179.821 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -82.9 -31.18 27.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.135 179.738 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 6.0 tttp -117.45 51.56 1.02 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.255 179.846 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.403 ' HA ' ' HG2' ' A' ' 83' ' ' PRO . 48.8 p90 -52.56 159.61 1.02 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.55 -179.894 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -142.4 114.83 8.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.128 179.88 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.637 HG21 ' HA ' ' A' ' 10' ' ' LYS . 3.0 mp -49.83 100.16 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.466 -179.826 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 134.18 53.72 0.07 OUTLIER Glycine 0 CA--C 1.523 0.542 0 N-CA-C 110.602 -0.999 . . . . 0.0 110.602 -179.971 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.663 ' HB3' ' OH ' ' A' ' 92' ' ' TYR . . . -175.82 179.61 1.33 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.811 0.338 . . . . 0.0 110.359 179.99 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.559 HG23 ' O ' ' A' ' 6' ' ' PHE . 24.8 m -120.69 139.78 52.55 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.439 -179.83 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.663 ' OH ' ' HB3' ' A' ' 90' ' ' ALA . 7.1 m-85 -141.59 104.58 4.58 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.284 179.932 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.887 ' HB1' ' HD2' ' A' ' 94' ' ' PRO . . . 175.06 177.3 0.21 Allowed Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.301 -179.886 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.887 ' HD2' ' HB1' ' A' ' 93' ' ' ALA . 47.6 Cg_endo . . . . . 0 C--O 1.249 1.074 0 C-N-CA 122.486 2.124 . . . . 0.0 112.03 179.973 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.755 HG12 ' HE3' ' A' ' 3' ' ' LYS . 59.2 t . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 110.105 -0.332 . . . . 0.0 110.105 . . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -72.98 157.42 51.2 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.413 2.075 . . . . 0.0 111.952 179.8 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.755 ' HE3' HG12 ' A' ' 1' ' ' VAL . 10.4 mmtp -131.57 75.32 1.64 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.535 -179.737 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.507 ' CG1' ' CE1' ' A' ' 78' ' ' PHE . 2.0 p -65.25 163.25 2.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.172 0.511 . . . . 0.0 110.068 179.808 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.491 ' N ' HG22 ' A' ' 4' ' ' VAL . 3.9 p -147.78 131.07 16.53 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.384 -179.989 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.815 ' O ' HG23 ' A' ' 91' ' ' THR . 6.0 m-85 -96.46 174.73 6.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.287 -179.958 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.442 ' HB ' ' CB ' ' A' ' 20' ' ' LEU . 2.8 m -166.16 106.88 0.7 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.27 -179.813 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.71 ' O ' HG23 ' A' ' 88' ' ' ILE . 91.6 t -59.11 94.12 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.406 -179.85 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.799 ' HG3' HG11 ' A' ' 51' ' ' VAL . 15.4 mm-40 -56.02 158.86 3.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.236 179.899 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.494 ' HA ' HG21 ' A' ' 88' ' ' ILE . 1.9 ptmt -77.14 62.57 2.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.435 -179.948 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -154.95 27.32 0.64 Allowed Glycine 0 CA--C 1.523 0.593 0 N-CA-C 110.728 -0.949 . . . . 0.0 110.728 179.963 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 30.4 m -86.87 131.7 34.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.839 0.352 . . . . 0.0 110.358 -179.967 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -110.54 -159.71 0.69 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.143 -0.481 . . . . 0.0 109.986 179.872 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -47.83 -59.35 3.38 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.622 179.908 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.13 -25.07 9.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.588 -180.0 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 27.0 m80 -51.27 134.46 27.7 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.852 0.358 . . . . 0.0 110.421 -179.999 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.485 HD22 ' HA ' ' A' ' 17' ' ' LEU . 0.2 OUTLIER -127.05 98.03 5.17 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.371 -179.952 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.552 ' HB2' ' CG2' ' A' ' 53' ' ' THR . . . -94.4 127.85 40.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.213 179.929 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.761 HG23 HG23 ' A' ' 21' ' ' VAL . 22.7 m -128.0 148.15 32.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.317 -179.957 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.442 ' CB ' ' HB ' ' A' ' 7' ' ' THR . 0.9 OUTLIER -94.53 63.19 2.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.456 -179.936 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.761 HG23 HG23 ' A' ' 19' ' ' VAL . 22.8 t -65.66 100.49 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.292 179.969 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.39 152.26 21.83 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.313 -179.994 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 28.1 p90 179.23 157.49 0.56 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.367 -179.941 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -82.81 163.53 21.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.331 179.934 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 106.63 -49.09 0.9 Allowed Glycine 0 CA--C 1.523 0.57 0 N-CA-C 110.652 -0.979 . . . . 0.0 110.652 -179.963 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -130.44 -177.78 4.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.755 0.312 . . . . 0.0 110.171 179.906 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -126.68 162.87 24.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.514 -179.976 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.589 ' O ' ' HB2' ' A' ' 29' ' ' ALA . 0.0 OUTLIER -57.98 -160.84 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.316 179.92 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.755 ' HB2' ' N ' ' A' ' 71' ' ' GLU . . . 155.12 -63.71 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.291 0.637 . . . . 0.0 109.532 179.668 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 17.9 tt0 -148.7 161.53 41.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.061 179.8 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.465 HG21 ' CD1' ' A' ' 52' ' ' TRP . 10.7 t -155.11 150.18 11.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.234 179.911 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.436 ' CB ' ' HA ' ' A' ' 43' ' ' ALA . 1.4 pm0 -151.67 144.46 24.38 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.359 -179.955 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.726 HD12 ' H ' ' A' ' 34' ' ' ARG . 8.1 tp -112.96 151.14 30.92 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.486 -179.428 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.726 ' H ' HD12 ' A' ' 33' ' ' LEU . 4.7 ttp180 -117.2 -158.16 0.69 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.229 179.913 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 6.9 tm-20 -175.5 107.32 0.09 Allowed 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 -179.968 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -48.39 97.0 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.704 -179.434 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 161.67 -31.27 0.32 Allowed Glycine 0 CA--C 1.522 0.525 0 N-CA-C 110.468 -1.053 . . . . 0.0 110.468 179.859 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -117.87 145.26 44.73 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 179.937 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -94.95 21.45 7.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.778 -179.836 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 29.7 tp10 -130.38 113.52 14.44 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 -179.901 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.499 ' CZ2' ' HD2' ' A' ' 67' ' ' ARG . 63.7 m95 -63.72 172.99 1.89 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.162 179.707 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.419 ' CG2' ' O ' ' A' ' 33' ' ' LEU . 4.4 m -146.65 107.34 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.048 179.624 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.436 ' HA ' ' CB ' ' A' ' 32' ' ' GLU . . . -45.49 146.06 1.11 Allowed 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.679 -179.69 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.411 ' CE ' ' HB2' ' A' ' 54' ' ' PHE . 0.0 OUTLIER -68.56 -170.8 0.23 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.709 -179.712 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.403 ' HB ' ' O ' ' A' ' 53' ' ' THR . 92.8 m -145.34 107.19 4.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.436 -179.979 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -66.22 79.08 0.09 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.168 179.87 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -104.29 -22.93 8.32 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 111.056 -0.818 . . . . 0.0 111.056 -179.794 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.465 ' HG3' HG23 ' A' ' 53' ' ' THR . 0.1 OUTLIER -75.96 -178.62 4.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.979 0.419 . . . . 0.0 110.422 -179.939 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -111.79 38.95 3.05 Favored Glycine 0 CA--C 1.522 0.514 0 N-CA-C 110.244 -1.143 . . . . 0.0 110.244 179.579 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 165.39 -27.81 0.19 Allowed Glycine 0 CA--C 1.526 0.753 0 N-CA-C 111.311 -0.716 . . . . 0.0 111.311 -179.874 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.799 HG11 ' HG3' ' A' ' 9' ' ' GLU . 3.2 m -123.4 -176.3 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-O 120.884 0.373 . . . . 0.0 110.705 -179.726 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 52' ' ' TRP . . . . . 0.465 ' CD1' HG21 ' A' ' 31' ' ' VAL . 11.2 m95 -108.21 138.27 44.78 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.722 -179.661 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.552 ' CG2' ' HB2' ' A' ' 18' ' ' ALA . 2.9 p -130.64 137.86 49.81 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.768 179.549 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.411 ' HB2' ' CE ' ' A' ' 44' ' ' MET . 71.5 t80 -123.37 131.12 53.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.878 0.371 . . . . 0.0 110.753 -179.539 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -77.32 107.13 9.51 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.019 179.696 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.0 m -87.76 148.71 24.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.629 -179.693 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -122.97 -42.27 2.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.256 179.887 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -55.72 165.51 1.26 Allowed Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.404 179.987 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -94.32 5.32 2.64 Favored 'Trans proline' 0 N--CA 1.452 -0.934 0 C-N-CA 123.995 3.13 . . . . 0.0 113.015 -179.863 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -103.94 102.9 12.69 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.827 0.346 . . . . 0.0 110.355 179.918 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -122.82 75.13 1.25 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.453 -179.845 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -133.46 -101.03 0.74 Allowed Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.749 -0.94 . . . . 0.0 110.749 179.996 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -78.51 107.9 2.36 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.568 2.178 . . . . 0.0 112.049 -179.954 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 36.7 m-85 -93.42 166.42 12.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.391 -179.947 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.424 ' HB2' ' CB ' ' A' ' 34' ' ' ARG . 4.9 m120 -133.86 147.41 51.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.018 179.785 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -140.55 175.07 9.9 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.031 0.443 . . . . 0.0 110.962 -179.718 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.499 ' HD2' ' CZ2' ' A' ' 41' ' ' TRP . 6.5 ptm180 -178.99 61.98 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.569 179.941 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.652 ' O ' HD23 ' A' ' 69' ' ' LEU . 0.3 OUTLIER -57.4 173.72 0.24 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.028 -179.223 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.723 HD22 ' HG2' ' A' ' 75' ' ' LYS . 2.9 mt -136.12 78.69 1.73 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.881 179.969 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 61.2 p -38.81 153.19 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.393 -179.646 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.755 ' N ' ' HB2' ' A' ' 29' ' ' ALA . 6.3 mt-10 -49.7 -33.97 17.44 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.388 -179.799 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.61 -36.08 82.69 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.354 -179.97 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 113.12 23.37 5.25 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 110.974 -0.851 . . . . 0.0 110.974 179.972 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -92.89 116.13 28.76 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.708 0.29 . . . . 0.0 110.307 179.902 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.723 ' HG2' HD22 ' A' ' 69' ' ' LEU . 3.1 mptt -113.46 173.72 6.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.35 -179.941 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 171.11 129.78 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.999 179.98 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 83.0 t -76.52 153.81 5.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.327 -179.994 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.507 ' CE1' ' CG1' ' A' ' 4' ' ' VAL . 87.1 m-85 -139.12 119.61 13.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.599 -179.879 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -106.03 152.22 23.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.095 179.812 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 11.0 t0 55.2 61.02 3.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.049 -179.751 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.482 ' O ' HG12 ' A' ' 81' ' ' VAL . 84.7 t -95.36 -8.19 9.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.234 -179.695 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.446 HG23 ' C ' ' A' ' 81' ' ' VAL . 57.3 t -156.33 132.07 5.68 Favored Pre-proline 0 C--N 1.332 -0.166 0 N-CA-C 110.406 -0.22 . . . . 0.0 110.406 179.872 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.509 ' HD3' ' CD1' ' A' ' 92' ' ' TYR . 50.0 Cg_endo -73.0 -176.09 2.23 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.507 2.138 . . . . 0.0 111.946 179.84 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -82.52 135.68 35.04 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 179.446 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 57.75 48.37 13.99 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 -179.466 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 48.8 p90 -43.28 156.36 0.05 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.414 -179.528 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 7.1 m -127.32 103.71 7.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.808 179.609 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.71 HG23 ' O ' ' A' ' 8' ' ' VAL . 2.5 mp -44.52 122.57 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.012 -179.632 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 117.43 35.37 1.1 Allowed Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.743 -0.943 . . . . 0.0 110.743 -179.935 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -155.74 142.35 18.73 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 110.222 -0.288 . . . . 0.0 110.222 179.978 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.815 HG23 ' O ' ' A' ' 6' ' ' PHE . 6.0 m -96.3 113.8 25.42 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.925 0.393 . . . . 0.0 110.716 -179.836 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.578 ' O ' ' HB3' ' A' ' 93' ' ' ALA . 33.0 m-85 -97.26 -153.58 0.42 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.788 179.751 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.869 ' HB1' ' HD2' ' A' ' 94' ' ' PRO . . . 78.42 173.78 0.08 OUTLIER Pre-proline 0 N--CA 1.465 0.305 0 CA-C-O 120.838 0.351 . . . . 0.0 110.722 179.808 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.869 ' HD2' ' HB1' ' A' ' 93' ' ' ALA . 48.1 Cg_endo . . . . . 0 C--O 1.249 1.053 0 C-N-CA 122.631 2.22 . . . . 0.0 112.079 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 9.9 tttt . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.731 0.301 . . . . 0.0 110.428 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.946 HG12 ' CE1' ' A' ' 23' ' ' TYR . 30.0 m -92.74 172.06 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.374 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.701 HG23 ' O ' ' A' ' 4' ' ' VAL . 4.6 p -163.49 133.8 4.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.397 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.579 ' O ' HG23 ' A' ' 91' ' ' THR . 23.4 m-85 -95.61 -169.9 2.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.073 179.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -165.75 104.85 0.7 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.809 0.338 . . . . 0.0 110.505 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 95.8 t -55.21 91.84 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.179 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 1.021 ' HG3' HG11 ' A' ' 51' ' ' VAL . 9.9 mm-40 -66.1 169.57 6.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.568 -179.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.501 ' HA ' HG21 ' A' ' 88' ' ' ILE . 11.9 tttt -63.18 -15.33 56.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.193 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -45.95 -27.81 2.58 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 111.213 -0.755 . . . . 0.0 111.213 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -71.13 131.29 43.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.77 0.319 . . . . 0.0 110.348 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -145.47 -86.61 0.11 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.434 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -81.68 -66.81 0.84 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.923 0.392 . . . . 0.0 110.121 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.06 26.08 2.72 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.214 179.708 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 54.5 m80 -94.32 139.61 30.86 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.233 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.44 HD22 ' HA ' ' A' ' 17' ' ' LEU . 0.4 OUTLIER -124.35 89.24 3.04 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.263 179.907 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.581 ' HB2' ' CG2' ' A' ' 53' ' ' THR . . . -90.26 153.38 20.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.51 -179.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 6.4 m -145.29 137.5 20.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.044 179.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.563 HD12 ' OE2' ' A' ' 9' ' ' GLU . 0.9 OUTLIER -98.69 51.56 0.99 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.505 -179.943 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.511 ' HB ' ' CD2' ' A' ' 6' ' ' PHE . 3.0 p -53.57 107.65 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.924 0.393 . . . . 0.0 110.19 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -174.46 120.75 0.25 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.252 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.946 ' CE1' HG12 ' A' ' 4' ' ' VAL . 17.0 p90 -127.31 19.61 6.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.831 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 60.44 147.94 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.901 0.381 . . . . 0.0 110.518 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 109.07 -93.47 0.77 Allowed Glycine 0 CA--C 1.523 0.592 0 N-CA-C 110.652 -0.979 . . . . 0.0 110.652 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -57.54 -173.43 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.793 0.33 . . . . 0.0 110.484 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.34 173.69 6.67 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.515 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.424 ' O ' ' CG ' ' A' ' 71' ' ' GLU . 0.1 OUTLIER -109.07 123.51 49.28 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.483 -179.942 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.698 ' HB3' ' O ' ' A' ' 69' ' ' LEU . . . -115.1 -62.59 1.58 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.284 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -158.95 164.2 35.83 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.595 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.86 HG21 ' CD1' ' A' ' 52' ' ' TRP . 16.2 t -138.68 145.43 27.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.211 0.529 . . . . 0.0 111.335 -179.547 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.405 ' HA ' ' HA ' ' A' ' 43' ' ' ALA . 6.0 tp10 -124.56 130.6 52.76 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.223 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.672 HD12 ' H ' ' A' ' 34' ' ' ARG . 12.4 tp -114.2 151.77 32.24 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 121.021 0.438 . . . . 0.0 110.172 -179.058 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.672 ' H ' HD12 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -125.98 -156.04 0.71 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.699 179.458 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.423 ' CG ' ' O ' ' A' ' 34' ' ' ARG . 14.3 mt-10 -161.57 -88.54 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.497 0.189 . . . . 0.0 110.72 179.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 0.444 ' CG ' ' N ' ' A' ' 37' ' ' GLY . 11.1 p80 -160.76 -46.72 0.05 OUTLIER 'General case' 0 N--CA 1.454 -0.235 0 CA-C-O 120.797 0.332 . . . . 0.0 110.8 -179.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.444 ' N ' ' CG ' ' A' ' 36' ' ' HIS . . . -156.97 38.39 0.56 Allowed Glycine 0 CA--C 1.523 0.577 0 N-CA-C 110.914 -0.874 . . . . 0.0 110.914 -179.605 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 5.5 t -73.6 -76.03 0.14 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.828 0.347 . . . . 0.0 110.219 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 37.3 p30 -173.32 55.95 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.131 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 67.83 176.29 0.26 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.242 -179.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.507 ' CZ3' ' HG2' ' A' ' 67' ' ' ARG . 98.3 m95 -52.69 138.64 28.3 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.542 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.7 m -130.98 110.72 18.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.935 179.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.405 ' HA ' ' HA ' ' A' ' 32' ' ' GLU . . . -48.66 131.42 17.79 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.82 -179.474 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.23 -171.33 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.578 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.419 ' O ' ' N ' ' A' ' 47' ' ' GLY . 41.3 m -142.03 102.33 4.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.235 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.405 ' O ' ' CG ' ' A' ' 46' ' ' LYS . 0.1 OUTLIER -64.56 76.17 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.331 -179.966 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 45' ' ' THR . . . -107.14 -21.9 7.82 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.923 -0.871 . . . . 0.0 110.923 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.69 -33.41 66.49 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.838 0.351 . . . . 0.0 110.336 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 98.12 -42.38 2.09 Favored Glycine 0 CA--C 1.522 0.526 0 N-CA-C 110.562 -1.015 . . . . 0.0 110.562 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -107.32 -25.12 6.19 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.679 -0.968 . . . . 0.0 110.679 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 1.021 HG11 ' HG3' ' A' ' 9' ' ' GLU . 24.0 m -136.5 179.0 4.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.826 0.346 . . . . 0.0 110.467 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . 0.86 ' CD1' HG21 ' A' ' 31' ' ' VAL . 4.0 m95 -109.42 128.35 55.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.417 -179.423 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.581 ' CG2' ' HB2' ' A' ' 18' ' ' ALA . 0.2 OUTLIER -114.69 167.94 10.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.421 -179.964 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.666 ' CG ' HD23 ' A' ' 33' ' ' LEU . 79.2 t80 -146.72 133.2 19.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.316 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 25.5 p-10 -94.65 114.29 26.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.544 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -84.51 146.55 27.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.261 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -113.11 -40.19 4.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.403 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.4 ' HG3' ' O ' ' A' ' 60' ' ' LEU . 1.7 pt-20 -67.66 151.55 97.07 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.272 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -71.72 -18.77 28.38 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.681 2.254 . . . . 0.0 112.494 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.4 ' O ' ' HG3' ' A' ' 58' ' ' GLU . 3.6 mt -96.29 144.13 26.74 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.903 0.382 . . . . 0.0 110.662 -179.645 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -143.2 91.12 2.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.269 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -96.35 -140.7 11.33 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.775 -0.93 . . . . 0.0 110.775 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -73.9 166.38 29.83 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.527 2.151 . . . . 0.0 111.893 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -125.2 177.46 6.1 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.148 0.499 . . . . 0.0 111.0 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -147.43 134.62 20.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.494 179.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.565 ' CZ ' HD13 ' A' ' 33' ' ' LEU . 52.2 m-85 -124.22 168.52 12.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.253 0.549 . . . . 0.0 111.478 -179.072 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.507 ' HG2' ' CZ3' ' A' ' 41' ' ' TRP . 0.0 OUTLIER -170.86 68.36 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.404 179.741 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.796 ' O ' HD23 ' A' ' 69' ' ' LEU . 4.5 p90 -51.8 177.81 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.407 0.622 . . . . 0.0 111.544 -178.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.796 HD23 ' O ' ' A' ' 68' ' ' PHE . 5.7 mt -137.96 55.75 1.76 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.045 -0.979 . . . . 0.0 109.177 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.429 HG23 ' CD1' ' A' ' 68' ' ' PHE . 40.1 p -27.98 136.83 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.762 0.825 . . . . 0.0 112.709 -179.015 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.592 ' N ' ' HB2' ' A' ' 29' ' ' ALA . 14.4 mt-10 -50.78 -31.15 16.02 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.42 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -63.23 -31.68 72.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.447 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 103.18 62.33 0.7 Allowed Glycine 0 CA--C 1.523 0.576 0 N-CA-C 110.669 -0.972 . . . . 0.0 110.669 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 74.5 mtp -152.18 115.33 4.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.813 0.34 . . . . 0.0 110.313 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.68 176.75 5.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.384 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.421 ' O ' ' CE2' ' A' ' 78' ' ' PHE . 2.0 m-20 173.25 126.94 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.113 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 97.8 t -76.17 152.77 6.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.752 -179.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.757 ' CZ ' HG21 ' A' ' 4' ' ' VAL . 38.9 m-85 -136.88 121.08 17.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.152 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -109.53 153.02 24.71 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.471 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.7 t0 59.53 30.53 20.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.675 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.446 HG13 ' O ' ' A' ' 92' ' ' TYR . 95.9 t -59.77 -73.82 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.19 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.497 HG13 ' HD2' ' A' ' 83' ' ' PRO . 50.9 t -87.52 139.32 31.65 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.416 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.497 ' HD2' HG13 ' A' ' 82' ' ' VAL . 47.5 Cg_endo -73.83 -168.1 0.43 Allowed 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.572 2.181 . . . . 0.0 112.063 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -76.12 -64.12 1.17 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.341 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 6.3 tppt? -96.42 57.7 1.69 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.282 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 40.4 p90 -51.77 148.9 5.15 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.483 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 3.1 m -122.85 110.24 15.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.181 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.501 HG21 ' HA ' ' A' ' 10' ' ' LYS . 2.7 mp -50.47 100.97 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.459 -179.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 137.51 44.87 0.08 OUTLIER Glycine 0 CA--C 1.523 0.579 0 N-CA-C 110.534 -1.027 . . . . 0.0 110.534 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.71 ' HB3' ' OH ' ' A' ' 92' ' ' TYR . . . -166.45 -176.76 3.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.769 0.319 . . . . 0.0 110.345 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.579 HG23 ' O ' ' A' ' 6' ' ' PHE . 85.3 m -119.68 138.66 53.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.572 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.71 ' OH ' ' HB3' ' A' ' 90' ' ' ALA . 7.4 m-85 -143.95 107.74 4.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.168 179.791 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.898 ' HB1' ' HD2' ' A' ' 94' ' ' PRO . . . 176.25 178.02 0.22 Allowed Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.488 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.898 ' HD2' ' HB1' ' A' ' 93' ' ' ALA . 49.4 Cg_endo . . . . . 0 C--O 1.249 1.027 0 C-N-CA 122.565 2.177 . . . . 0.0 112.059 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 4.6 pttt . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.804 0.335 . . . . 0.0 110.281 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.673 HG11 ' CZ ' ' A' ' 68' ' ' PHE . 17.8 m -55.06 171.07 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.461 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.445 ' HB ' ' CG2' ' A' ' 91' ' ' THR . 21.6 p -153.47 135.6 14.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.375 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.532 ' HD1' ' HB2' ' A' ' 93' ' ' ALA . 14.9 m-85 -100.58 169.38 9.09 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.455 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.5 m -157.59 112.72 2.74 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.342 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 44.5 t -58.07 91.38 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.275 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.775 ' HG3' HG11 ' A' ' 51' ' ' VAL . 6.7 mm-40 -51.0 176.3 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.463 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 61.9 mmtt -67.48 175.5 2.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.314 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 51.13 49.74 42.28 Favored Glycine 0 CA--C 1.523 0.547 0 N-CA-C 110.718 -0.953 . . . . 0.0 110.718 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -102.64 136.9 41.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.873 0.368 . . . . 0.0 110.452 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 3.7 p30 -172.07 162.81 5.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.295 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -49.11 -28.1 3.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.742 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.81 -28.33 44.5 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.373 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 25.1 m80 -149.65 125.22 10.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.507 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.516 HD22 ' HA ' ' A' ' 17' ' ' LEU . 0.3 OUTLIER -111.83 94.37 4.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.222 179.883 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.667 ' HB2' ' CG2' ' A' ' 53' ' ' THR . . . -96.06 125.69 40.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.488 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.455 HG23 HG23 ' A' ' 21' ' ' VAL . 33.2 m -113.67 -171.17 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.003 179.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.4 tt -138.09 80.66 1.81 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.302 179.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.455 HG23 HG23 ' A' ' 19' ' ' VAL . 2.4 t -97.31 102.39 13.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.989 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.49 ' O ' ' CG ' ' A' ' 23' ' ' TYR . 0.0 OUTLIER -162.87 -65.27 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.878 -179.721 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.635 ' CE2' HG12 ' A' ' 4' ' ' VAL . 33.5 p90 45.6 -171.78 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.724 -179.454 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -115.85 142.63 46.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.474 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 131.23 -43.88 1.26 Allowed Glycine 0 CA--C 1.523 0.541 0 N-CA-C 110.759 -0.936 . . . . 0.0 110.759 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -126.91 -170.63 2.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.826 0.346 . . . . 0.0 110.601 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -118.8 -175.32 2.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.514 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.437 ' O ' ' CG ' ' A' ' 71' ' ' GLU . 1.5 mtp -105.99 123.73 48.45 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.343 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.756 ' HB2' ' HG2' ' A' ' 71' ' ' GLU . . . -132.16 -58.58 0.95 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.924 -179.776 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.581 ' C ' HG12 ' A' ' 31' ' ' VAL . 0.0 OUTLIER -140.63 173.6 11.33 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.83 0.348 . . . . 0.0 110.925 -179.778 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.581 HG12 ' C ' ' A' ' 30' ' ' GLU . 1.3 p 164.3 131.33 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-O 121.518 0.675 . . . . 0.0 109.76 -179.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.692 ' OE2' ' HB2' ' A' ' 43' ' ' ALA . 2.6 mm-40 -112.04 -172.49 2.05 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.843 -1.071 . . . . 0.0 110.476 -179.546 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.74 HD12 ' H ' ' A' ' 34' ' ' ARG . 5.8 tp -144.22 145.16 31.89 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 179.302 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.74 ' H ' HD12 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -150.66 -178.84 6.79 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.086 179.712 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -132.27 -85.22 0.48 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.574 -0.284 . . . . 0.0 110.566 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 171.71 39.76 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.823 0.344 . . . . 0.0 110.595 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 167.29 59.15 0.03 OUTLIER Glycine 0 CA--C 1.524 0.621 0 N-CA-C 110.817 -0.913 . . . . 0.0 110.817 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.6 t -133.57 158.85 42.14 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.78 0.324 . . . . 0.0 110.296 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.421 ' O ' ' CG ' ' A' ' 40' ' ' GLU . 0.4 OUTLIER -51.67 -33.48 34.0 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.31 179.907 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.421 ' CG ' ' O ' ' A' ' 39' ' ' ASP . 2.9 mt-10 169.19 -179.19 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.236 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.51 ' CH2' ' HG3' ' A' ' 67' ' ' ARG . 71.8 m95 -62.14 145.02 54.56 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.339 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 27.3 m -122.85 2.04 6.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.159 -179.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.692 ' HB2' ' OE2' ' A' ' 32' ' ' GLU . . . 60.07 137.86 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.344 0 CA-C-O 121.301 0.572 . . . . 0.0 111.3 179.322 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.5 ' H ' ' HA ' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -62.51 -167.13 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.372 179.733 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.4 ' O ' ' N ' ' A' ' 47' ' ' GLY . 49.9 m -150.85 125.32 9.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.358 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 13.6 ptmt -69.25 64.66 0.15 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.239 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' A' ' 45' ' ' THR . . . -91.23 -34.18 7.7 Favored Glycine 0 CA--C 1.523 0.549 0 N-CA-C 110.814 -0.915 . . . . 0.0 110.814 -179.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.441 ' HG2' ' CG2' ' A' ' 51' ' ' VAL . 4.4 tp10 -88.34 124.14 33.61 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.822 0.344 . . . . 0.0 110.503 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -71.56 76.28 0.66 Allowed Glycine 0 CA--C 1.522 0.507 0 N-CA-C 110.637 -0.985 . . . . 0.0 110.637 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 154.04 -36.75 0.71 Allowed Glycine 0 CA--C 1.522 0.49 0 N-CA-C 110.633 -0.987 . . . . 0.0 110.633 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.775 HG11 ' HG3' ' A' ' 9' ' ' GLU . 16.2 m -142.82 -176.7 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.95 0.405 . . . . 0.0 110.537 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 5.4 m95 -96.33 131.67 42.62 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.637 -179.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.667 ' CG2' ' HB2' ' A' ' 18' ' ' ALA . 0.8 OUTLIER -130.29 147.07 51.96 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.404 -179.958 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.544 ' CG ' HD23 ' A' ' 33' ' ' LEU . 45.6 t80 -137.43 142.27 41.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.239 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -91.25 141.12 29.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.507 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.1 p -143.11 147.01 34.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.278 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -144.45 31.56 1.21 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.456 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.4 ' HB2' ' HD2' ' A' ' 59' ' ' PRO . 6.5 pt-20 -102.87 157.26 34.07 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.228 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.4 ' HD2' ' HB2' ' A' ' 58' ' ' GLU . 47.9 Cg_endo -71.1 -32.52 13.07 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.603 2.202 . . . . 0.0 112.142 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.1 mt -80.6 102.3 9.72 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.336 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -138.87 132.79 31.02 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.477 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -177.63 -98.78 0.11 Allowed Glycine 0 CA--C 1.526 0.758 0 N-CA-C 110.644 -0.982 . . . . 0.0 110.644 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -81.38 164.88 18.96 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.609 2.206 . . . . 0.0 112.083 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -139.36 161.34 37.68 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.465 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.404 ' ND2' ' N ' ' A' ' 65' ' ' ASN . 1.2 m-80 -126.99 149.51 49.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.194 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.477 ' CD2' ' O ' ' A' ' 32' ' ' GLU . 85.1 m-85 -138.83 159.84 41.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.967 0.413 . . . . 0.0 111.071 -179.629 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.51 ' HG3' ' CH2' ' A' ' 41' ' ' TRP . 10.0 mtp-105 -152.42 73.18 1.02 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.84 179.352 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.691 ' O ' HD23 ' A' ' 69' ' ' LEU . 6.3 p90 -70.49 175.2 4.97 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.384 0.612 . . . . 0.0 111.023 -179.531 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.756 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 23.9 mt -146.88 57.58 1.16 Allowed 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.972 -1.013 . . . . 0.0 109.396 179.789 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 28.4 p -25.84 135.95 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.872 0.869 . . . . 0.0 112.487 -179.137 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.756 ' HG2' ' HB2' ' A' ' 29' ' ' ALA . 3.9 mm-40 -51.96 -23.95 5.78 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.599 -179.498 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 17.9 tptp -147.07 68.58 1.16 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.644 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -160.91 -103.82 0.19 Allowed Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.875 -0.89 . . . . 0.0 110.875 179.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -178.58 -176.69 0.5 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.89 0.376 . . . . 0.0 110.638 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.553 ' CG ' HD22 ' A' ' 69' ' ' LEU . 0.0 OUTLIER -93.2 172.96 7.97 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.345 -179.858 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 171.81 137.17 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.603 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.463 HG22 ' CD ' ' A' ' 67' ' ' ARG . 45.6 t -99.36 132.48 44.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 179.527 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.522 ' CE2' ' CG2' ' A' ' 4' ' ' VAL . 52.3 m-85 -117.28 139.8 50.36 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.5 -179.572 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -126.12 161.9 26.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.421 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 51.22 35.83 14.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.441 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.666 HG22 ' HD3' ' A' ' 94' ' ' PRO . 48.9 t -75.91 -2.55 4.23 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.816 179.757 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 84.0 t -154.12 131.63 6.21 Favored Pre-proline 0 CA--C 1.529 0.161 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.499 ' HG3' ' CE1' ' A' ' 92' ' ' TYR . 48.6 Cg_endo -75.22 178.68 6.99 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.516 2.144 . . . . 0.0 112.181 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -64.54 -57.52 8.92 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.12 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.93 73.72 0.83 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.171 179.717 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 0.511 ' HB2' ' CE2' ' A' ' 92' ' ' TYR . 23.1 p90 -70.22 177.02 3.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.521 -179.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 2.7 m -137.27 119.23 15.31 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.094 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.617 ' H ' HD12 ' A' ' 88' ' ' ILE . 4.3 mp -48.94 119.3 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.547 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 105.06 59.03 0.66 Allowed Glycine 0 CA--C 1.523 0.533 0 N-CA-C 110.591 -1.004 . . . . 0.0 110.591 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -170.75 146.23 2.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.896 0.379 . . . . 0.0 110.639 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.445 ' CG2' ' HB ' ' A' ' 5' ' ' THR . 8.5 m -93.43 122.99 36.42 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.046 179.696 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.511 ' CE2' ' HB2' ' A' ' 86' ' ' TYR . 69.9 m-85 -108.12 -87.55 0.49 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.791 -179.592 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.91 ' HB1' ' HD2' ' A' ' 94' ' ' PRO . . . 50.42 -179.97 0.01 OUTLIER Pre-proline 0 C--O 1.232 0.133 0 CA-C-O 120.641 0.257 . . . . 0.0 110.432 -179.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.91 ' HD2' ' HB1' ' A' ' 93' ' ' ALA . 49.3 Cg_endo . . . . . 0 C--O 1.25 1.075 0 C-N-CA 122.45 2.1 . . . . 0.0 111.937 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 4.5 mttm . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.809 0.338 . . . . 0.0 110.355 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.649 HG21 ' CZ ' ' A' ' 78' ' ' PHE . 16.8 m -124.85 -176.39 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.424 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.429 HG23 ' O ' ' A' ' 4' ' ' VAL . 0.1 OUTLIER -165.14 148.04 8.18 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.235 179.878 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.602 ' H ' ' HB3' ' A' ' 93' ' ' ALA . 48.2 m-85 -123.34 145.56 48.64 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.326 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.503 HG22 ' H ' ' A' ' 8' ' ' VAL . 0.2 OUTLIER -129.3 -176.99 4.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.301 -179.942 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.503 ' H ' HG22 ' A' ' 7' ' ' THR . 39.8 t -128.14 87.42 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.4 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.83 ' HG3' HG11 ' A' ' 51' ' ' VAL . 1.3 mm-40 -52.27 147.92 7.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.275 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.27 63.16 0.35 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.371 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -154.39 23.32 0.66 Allowed Glycine 0 CA--C 1.525 0.682 0 N-CA-C 111.022 -0.831 . . . . 0.0 111.022 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 16.9 m -76.07 105.02 6.88 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.442 ' ND2' ' N ' ' A' ' 13' ' ' ASN . 0.4 OUTLIER -75.92 -178.48 4.35 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.096 -179.721 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -62.07 -36.6 82.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.466 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 4.9 ptmt -124.72 36.45 4.6 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.666 -179.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . 0.428 ' HB2' ' CB ' ' A' ' 13' ' ' ASN . 13.2 m80 -136.09 -176.27 4.26 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.844 0.354 . . . . 0.0 110.563 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 32.1 tp -167.07 85.61 0.26 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.269 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.436 ' HB2' ' CG2' ' A' ' 53' ' ' THR . . . -81.33 107.29 13.99 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.58 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.52 HG23 HG23 ' A' ' 21' ' ' VAL . 17.8 m -88.99 -170.66 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.163 179.698 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.44 HD12 ' HG2' ' A' ' 9' ' ' GLU . 1.9 tt -142.4 57.68 1.45 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.308 179.67 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.52 HG23 HG23 ' A' ' 19' ' ' VAL . 4.9 t -72.17 114.72 11.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.463 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.93 164.03 20.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.318 179.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER 174.05 150.05 0.08 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.372 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -79.79 -26.89 40.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.485 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -53.56 -75.84 0.21 Allowed Glycine 0 CA--C 1.524 0.625 0 N-CA-C 110.826 -0.91 . . . . 0.0 110.826 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -93.77 -164.21 1.15 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.794 0.33 . . . . 0.0 110.428 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.07 -158.31 0.82 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.415 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.422 ' O ' ' CG ' ' A' ' 71' ' ' GLU . 47.1 mtm -132.25 126.82 34.37 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.704 -179.76 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.855 ' HB3' ' O ' ' A' ' 69' ' ' LEU . . . -125.9 -44.04 1.8 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.083 179.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.43 ' O ' ' HB2' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -164.27 168.93 18.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.89 -0.596 . . . . 0.0 109.526 179.712 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 8.9 t -154.11 136.48 6.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.901 0.381 . . . . 0.0 110.975 -179.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.439 ' CB ' ' HA ' ' A' ' 43' ' ' ALA . 3.3 pt-20 -134.08 138.06 45.03 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 178.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.628 HD23 ' CG ' ' A' ' 54' ' ' PHE . 13.4 tp -118.24 155.6 30.26 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 121.157 0.503 . . . . 0.0 110.854 -178.015 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.602 ' H ' HD12 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -136.75 -156.97 0.74 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.325 178.946 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.415 ' O ' ' ND2' ' A' ' 65' ' ' ASN . 1.5 mp0 -153.35 -79.72 0.1 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.696 0.284 . . . . 0.0 110.559 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 177.18 119.32 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.79 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 52.64 63.75 4.68 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 111.165 -0.774 . . . . 0.0 111.165 179.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.473 ' CB ' ' NH1' ' A' ' 34' ' ' ARG . 0.3 OUTLIER -111.31 -70.08 0.83 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.946 0.403 . . . . 0.0 110.289 179.797 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 25.4 t0 179.59 -63.3 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.119 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -157.04 163.0 39.53 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.344 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.495 ' CZ2' ' HG3' ' A' ' 67' ' ' ARG . 94.3 m95 -57.57 146.89 28.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.695 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.444 HG23 ' O ' ' A' ' 33' ' ' LEU . 2.8 m -129.31 107.92 16.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.439 ' HA ' ' CB ' ' A' ' 32' ' ' GLU . . . -45.96 140.86 3.44 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.777 -179.546 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.02 -170.89 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.539 -179.72 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 86.6 m -138.8 98.84 3.64 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.326 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 13.0 ptmt -67.01 79.29 0.12 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.509 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -128.29 24.87 4.94 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.76 -0.936 . . . . 0.0 110.76 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.421 ' CB ' HG23 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -107.59 175.8 5.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.801 0.334 . . . . 0.0 110.38 179.978 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -60.25 -43.92 98.0 Favored Glycine 0 CA--C 1.523 0.562 0 N-CA-C 110.572 -1.011 . . . . 0.0 110.572 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -160.52 27.6 0.32 Allowed Glycine 0 CA--C 1.524 0.619 0 N-CA-C 110.828 -0.909 . . . . 0.0 110.828 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.83 HG11 ' HG3' ' A' ' 9' ' ' GLU . 14.7 m -143.13 -175.81 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.8 0.333 . . . . 0.0 110.369 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 6.7 m95 -109.29 141.94 40.88 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.712 -179.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.436 ' CG2' ' HB2' ' A' ' 18' ' ' ALA . 0.0 OUTLIER -125.81 159.38 32.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.924 179.533 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.628 ' CG ' HD23 ' A' ' 33' ' ' LEU . 68.1 t80 -144.09 133.68 23.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.845 0.355 . . . . 0.0 110.511 -179.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -84.9 128.61 34.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.364 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -122.54 154.15 38.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.379 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -162.22 50.73 0.2 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.467 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -128.71 156.38 77.63 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.569 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -66.99 -28.28 41.95 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.897 2.398 . . . . 0.0 112.123 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -80.06 163.43 24.18 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.28 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -175.29 44.74 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.49 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -83.01 -132.68 1.9 Allowed Glycine 0 CA--C 1.527 0.808 0 N-CA-C 110.36 -1.096 . . . . 0.0 110.36 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -75.29 141.3 25.67 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.355 2.037 . . . . 0.0 111.8 179.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 44.8 m-85 -97.62 153.0 18.49 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.529 -179.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.415 ' ND2' ' O ' ' A' ' 35' ' ' GLU . 6.2 m-80 -124.79 126.23 45.29 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.026 -0.533 . . . . 0.0 109.913 179.581 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.571 ' CD2' ' CE2' ' A' ' 6' ' ' PHE . 2.7 m-85 -104.74 -178.25 3.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.654 -179.573 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.495 ' HG3' ' CZ2' ' A' ' 41' ' ' TRP . 0.0 OUTLIER 175.27 77.85 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.997 179.975 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.506 ' HZ ' HG11 ' A' ' 4' ' ' VAL . 1.4 p90 -84.75 164.08 18.75 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.222 0.534 . . . . 0.0 110.975 -179.653 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.855 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 9.1 mt -109.75 64.26 0.61 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.283 -0.872 . . . . 0.0 108.861 178.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.428 HG23 ' CD1' ' A' ' 68' ' ' PHE . 0.8 OUTLIER -33.77 138.06 0.09 Allowed 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 115.552 -0.749 . . . . 0.0 112.206 -178.833 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.677 ' HG2' ' HB2' ' A' ' 29' ' ' ALA . 19.0 mt-10 -49.02 -28.13 3.74 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.958 -179.543 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.01 26.64 0.31 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.678 0.275 . . . . 0.0 111.127 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.422 ' O ' ' CB ' ' A' ' 74' ' ' MET . . . -97.15 -36.46 4.94 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 110.381 -1.088 . . . . 0.0 110.381 179.67 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.422 ' CB ' ' O ' ' A' ' 73' ' ' GLY . 0.0 OUTLIER 82.25 70.8 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 120.85 0.357 . . . . 0.0 111.089 179.443 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 48.98 -179.29 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.198 179.209 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.51 ' HB3' ' CE2' ' A' ' 78' ' ' PHE . 0.3 OUTLIER 167.65 128.45 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.882 179.886 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 77.5 t -95.31 137.54 23.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.013 0.435 . . . . 0.0 110.525 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.649 ' CZ ' HG21 ' A' ' 4' ' ' VAL . 92.4 m-85 -133.39 144.46 49.58 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.494 -179.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -133.58 161.49 34.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.194 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 54.02 30.28 11.57 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.94 0.4 . . . . 0.0 110.138 -179.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.58 HG13 ' HB2' ' A' ' 93' ' ' ALA . 87.4 t -64.48 -15.97 18.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.2 -179.739 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 44.6 t -146.72 132.5 9.36 Favored Pre-proline 0 C--N 1.332 -0.19 0 CA-C-O 120.506 0.193 . . . . 0.0 110.565 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.469 ' HD3' ' CD1' ' A' ' 92' ' ' TYR . 50.6 Cg_endo -75.44 165.81 29.93 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.561 2.174 . . . . 0.0 111.899 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -66.12 126.54 28.98 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.293 -0.412 . . . . 0.0 109.989 179.651 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 24.7 mtmt 60.17 50.12 6.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.942 0.401 . . . . 0.0 109.924 -179.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 51.3 p90 -47.56 158.96 0.16 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.967 -179.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 29.1 m -124.04 108.85 12.8 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.035 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 2.7 mp -47.98 107.64 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.626 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 132.7 44.76 0.14 Allowed Glycine 0 CA--C 1.523 0.565 0 N-CA-C 110.449 -1.061 . . . . 0.0 110.449 -179.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -163.29 156.41 19.01 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.99 101.68 11.23 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.722 -179.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.469 ' CD1' ' HD3' ' A' ' 83' ' ' PRO . 32.7 m-85 -87.98 -160.17 0.6 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.868 179.563 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.916 ' HB1' ' HD2' ' A' ' 94' ' ' PRO . . . 66.82 176.58 0.06 OUTLIER Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 120.721 0.296 . . . . 0.0 110.578 179.653 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.916 ' HD2' ' HB1' ' A' ' 93' ' ' ALA . 47.7 Cg_endo . . . . . 0 C--O 1.249 1.056 0 C-N-CA 122.567 2.178 . . . . 0.0 112.04 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 8.4 mtmt . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.864 0.364 . . . . 0.0 110.272 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.751 HG11 ' CE1' ' A' ' 78' ' ' PHE . 1.7 p -149.32 164.24 4.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.301 0.572 . . . . 0.0 110.215 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.481 ' N ' HG22 ' A' ' 4' ' ' VAL . 0.6 OUTLIER -156.99 133.41 9.89 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.516 179.775 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.516 ' HD1' ' HB2' ' A' ' 93' ' ' ALA . 8.2 m-85 -109.77 179.29 4.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.092 -0.504 . . . . 0.0 109.893 179.535 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.5 m -166.23 128.32 1.89 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.846 0.355 . . . . 0.0 110.335 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.687 ' O ' HG23 ' A' ' 88' ' ' ILE . 29.2 t -70.0 87.51 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.189 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.552 ' CG ' HG21 ' A' ' 51' ' ' VAL . 1.2 mm-40 -58.28 166.09 1.78 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.436 -179.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.575 ' HA ' HG21 ' A' ' 88' ' ' ILE . 1.6 mppt? -54.53 -21.84 11.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.83 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -45.14 -37.43 5.81 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 111.269 -0.733 . . . . 0.0 111.269 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 13.3 m -68.19 124.97 24.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.778 0.323 . . . . 0.0 110.348 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -133.93 -52.74 0.85 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.516 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -146.72 -76.78 0.19 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.658 -179.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 14.4 mmmt -99.32 25.58 6.79 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.462 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 31.4 m80 -125.38 147.51 49.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.451 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.465 HD22 ' HA ' ' A' ' 17' ' ' LEU . 0.2 OUTLIER -133.44 91.53 2.87 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.0 0.428 . . . . 0.0 110.366 179.881 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.714 ' HB1' HG11 ' A' ' 51' ' ' VAL . . . -92.12 131.99 36.94 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.16 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.84 ' O ' HG13 ' A' ' 51' ' ' VAL . 14.5 m -127.5 135.33 63.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.847 0.356 . . . . 0.0 110.596 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.538 HD12 ' OE2' ' A' ' 9' ' ' GLU . 1.3 tt -91.98 67.2 5.14 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.036 -179.789 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.527 ' CG1' ' CD1' ' A' ' 52' ' ' TRP . 2.2 p -82.19 110.2 17.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 179.395 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 30.3 tttm -178.06 111.13 0.07 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.33 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 29.3 p90 -136.56 151.21 49.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.441 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -50.78 172.99 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.526 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 76.05 -84.8 0.91 Allowed Glycine 0 CA--C 1.523 0.557 0 N-CA-C 110.753 -0.939 . . . . 0.0 110.753 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.517 ' HB3' HG21 ' A' ' 70' ' ' THR . 0.8 OUTLIER -64.62 179.11 0.66 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.734 0.302 . . . . 0.0 110.344 -179.994 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -133.08 178.65 6.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.488 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.422 ' O ' ' CG ' ' A' ' 71' ' ' GLU . 0.1 OUTLIER -105.55 120.42 41.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.26 179.963 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.831 ' HB3' ' O ' ' A' ' 69' ' ' LEU . . . -130.65 -50.68 1.06 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.823 -179.69 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.409 ' CG ' ' O ' ' A' ' 29' ' ' ALA . 29.1 mt-10 -159.23 150.51 20.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.999 0.428 . . . . 0.0 110.848 -179.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.702 HG21 ' CD1' ' A' ' 52' ' ' TRP . 20.3 t -140.43 142.89 30.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.679 179.53 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.466 ' CB ' ' HA ' ' A' ' 43' ' ' ALA . 1.9 pt-20 -148.77 137.43 21.3 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.875 0.369 . . . . 0.0 110.475 -179.759 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.706 HD21 ' HB3' ' A' ' 64' ' ' PHE . 3.9 mt -89.84 173.18 8.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.139 -179.424 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.449 ' HB2' ' CZ3' ' A' ' 41' ' ' TRP . 20.2 ttt180 -121.49 -63.3 1.33 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.477 179.261 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.448 ' O ' ' N ' ' A' ' 37' ' ' GLY . 14.0 mt-10 89.62 23.65 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 123.555 0.742 . . . . 0.0 109.961 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 58.49 -76.98 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.332 179.427 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.448 ' N ' ' O ' ' A' ' 35' ' ' GLU . . . -48.38 -65.24 2.66 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 111.119 -0.792 . . . . 0.0 111.119 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -49.34 101.3 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.808 0.337 . . . . 0.0 110.591 -179.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -59.79 -28.91 67.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.338 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -94.1 129.4 40.67 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.308 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.449 ' CZ3' ' HB2' ' A' ' 34' ' ' ARG . 80.6 m95 -66.39 141.28 58.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.591 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.587 HG23 ' O ' ' A' ' 42' ' ' VAL . 35.8 m -111.77 111.66 37.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.969 179.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.466 ' HA ' ' CB ' ' A' ' 32' ' ' GLU . . . -49.33 141.54 8.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.845 -179.601 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.53 -167.66 0.2 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.121 179.767 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 85.8 m -156.28 98.24 1.83 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.502 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.51 90.47 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.107 179.749 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -112.39 -17.89 7.92 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 111.384 -0.686 . . . . 0.0 111.384 -179.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.458 ' CB ' ' HB ' ' A' ' 51' ' ' VAL . 17.7 tp10 -77.78 -28.69 50.61 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.852 0.326 . . . . 0.0 110.719 -179.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 112.55 -39.74 2.76 Favored Glycine 0 CA--C 1.52 0.401 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 -179.395 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -137.14 16.16 3.68 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 178.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.84 HG13 ' O ' ' A' ' 19' ' ' VAL . 50.4 t -149.01 147.12 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . 0.702 ' CD1' HG21 ' A' ' 31' ' ' VAL . 2.0 m95 -89.87 111.78 22.93 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.282 -179.506 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.495 HG22 ' HB2' ' A' ' 18' ' ' ALA . 4.9 p -99.76 151.05 21.69 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.501 -179.67 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 57.0 t80 -139.33 151.24 46.22 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.138 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -106.88 129.88 54.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.714 -179.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 14.3 t -127.98 156.03 43.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.11 179.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -156.86 37.48 0.31 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.437 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -124.79 154.33 70.58 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.441 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -72.89 -41.43 1.43 Allowed 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.644 2.229 . . . . 0.0 111.926 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -71.54 77.14 0.8 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.49 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -116.35 89.39 3.1 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.492 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -98.76 -131.79 7.4 Favored Glycine 0 CA--C 1.527 0.79 0 N-CA-C 110.438 -1.065 . . . . 0.0 110.438 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -75.03 145.69 31.65 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.375 2.05 . . . . 0.0 111.767 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.706 ' HB3' HD21 ' A' ' 33' ' ' LEU . 56.1 m-85 -97.11 100.71 12.19 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.933 0.396 . . . . 0.0 110.345 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.429 ' OD1' ' N ' ' A' ' 65' ' ' ASN . 0.3 OUTLIER -78.27 141.33 38.6 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.949 -0.568 . . . . 0.0 109.781 179.952 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.496 ' CE1' ' HG ' ' A' ' 33' ' ' LEU . 92.7 m-85 -128.71 -177.45 4.2 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.046 0.451 . . . . 0.0 110.532 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.411 ' HG2' ' CE3' ' A' ' 41' ' ' TRP . 0.0 OUTLIER 178.35 52.22 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.691 179.845 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.509 ' HB3' HG22 ' A' ' 31' ' ' VAL . 0.9 OUTLIER -49.98 169.23 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.727 -179.671 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.831 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 1.1 mt -123.95 72.87 1.18 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.213 179.613 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.517 HG21 ' HB3' ' A' ' 26' ' ' ASP . 71.6 p -35.17 137.59 0.15 Allowed 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.783 -179.201 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.746 ' HG2' ' HB2' ' A' ' 29' ' ' ALA . 4.8 mm-40 -45.83 -55.1 7.05 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.951 -179.558 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 41.4 tptt -138.85 77.83 1.64 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.528 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -163.42 -91.13 0.08 OUTLIER Glycine 0 CA--C 1.523 0.583 0 N-CA-C 110.57 -1.012 . . . . 0.0 110.57 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER 176.76 172.69 0.44 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.892 0.377 . . . . 0.0 110.459 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.45 145.09 35.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.216 179.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -138.75 140.72 38.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.568 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 95.5 t -85.54 152.82 3.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.334 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.751 ' CE1' HG11 ' A' ' 4' ' ' VAL . 32.6 m-85 -138.46 120.78 15.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.227 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 30.8 p-10 -117.26 48.37 1.35 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.676 -179.443 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 167.34 65.96 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.617 HG22 ' HD3' ' A' ' 94' ' ' PRO . 70.3 t -111.68 -10.07 11.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.564 -178.727 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.433 HG23 ' C ' ' A' ' 81' ' ' VAL . 86.9 t -156.04 131.7 5.58 Favored Pre-proline 0 C--N 1.331 -0.197 0 CA-C-O 120.648 0.261 . . . . 0.0 110.765 179.511 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.51 ' HD3' ' CD1' ' A' ' 92' ' ' TYR . 47.5 Cg_endo -68.74 -165.65 0.14 Allowed 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.807 2.338 . . . . 0.0 111.875 179.461 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -77.22 -38.09 52.0 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.15 -0.477 . . . . 0.0 109.852 179.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 1.1 mttt -123.31 74.92 1.27 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.959 179.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 0.413 ' HB2' HG21 ' A' ' 8' ' ' VAL . 24.5 p90 -47.38 171.02 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.954 -179.588 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -149.4 109.75 4.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.147 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.687 HG23 ' O ' ' A' ' 8' ' ' VAL . 2.9 mp -52.69 122.11 2.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.526 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 102.29 42.67 2.16 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 110.936 -0.866 . . . . 0.0 110.936 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -160.07 129.64 5.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.85 0.357 . . . . 0.0 110.57 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.467 HG23 ' O ' ' A' ' 6' ' ' PHE . 15.1 m -81.4 128.36 33.77 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.136 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.51 ' CD1' ' HD3' ' A' ' 83' ' ' PRO . 63.3 m-85 -111.97 -93.09 0.46 Allowed 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.876 -179.58 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.627 ' HB1' ' HD2' ' A' ' 94' ' ' PRO . . . 53.26 172.35 0.04 OUTLIER Pre-proline 0 N--CA 1.462 0.157 0 CA-C-O 120.852 0.358 . . . . 0.0 110.419 -179.661 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.627 ' HD2' ' HB1' ' A' ' 93' ' ' ALA . 47.8 Cg_endo . . . . . 0 C--O 1.249 1.055 0 C-N-CA 122.783 2.322 . . . . 0.0 112.127 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.888 0.375 . . . . 0.0 110.239 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.641 ' O ' HG23 ' A' ' 5' ' ' THR . 35.9 m -85.43 -175.56 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.547 -179.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.641 HG23 ' O ' ' A' ' 4' ' ' VAL . 0.7 OUTLIER -166.52 151.25 7.73 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.175 179.749 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.571 ' H ' ' HB3' ' A' ' 93' ' ' ALA . 51.4 m-85 -119.51 165.59 14.2 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.352 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.404 HG23 ' HA ' ' A' ' 91' ' ' THR . 1.2 m -159.35 119.38 3.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.402 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.464 HG12 HD13 ' A' ' 88' ' ' ILE . 55.6 t -63.85 104.78 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.349 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.88 ' HG3' HG11 ' A' ' 51' ' ' VAL . 3.5 mm-40 -74.52 156.95 36.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.452 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 8.5 mttt -52.06 163.83 0.33 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.313 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 82.99 27.46 40.95 Favored Glycine 0 CA--C 1.523 0.54 0 N-CA-C 110.684 -0.966 . . . . 0.0 110.684 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.834 ' CB ' HD11 ' A' ' 88' ' ' ILE . 86.3 p -81.16 114.3 19.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.776 0.322 . . . . 0.0 110.346 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 47.2 m-80 -107.86 179.97 4.07 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.321 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -67.92 -29.82 68.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.41 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 10.4 mmmm -98.35 -44.65 6.45 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.478 -179.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 18.0 m80 -80.4 162.11 24.63 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.743 -179.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.496 ' HG ' ' CE2' ' A' ' 64' ' ' PHE . 2.3 tm? -155.95 77.32 0.95 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.754 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.428 ' HB2' ' CG2' ' A' ' 53' ' ' THR . . . -69.52 140.31 53.91 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.84 -179.427 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.4 ' O ' ' HB ' ' A' ' 51' ' ' VAL . 24.6 m -127.85 -178.2 2.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.793 -0.639 . . . . 0.0 109.682 179.544 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.0 tt -134.95 80.42 1.84 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.833 0.349 . . . . 0.0 110.362 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.9 t -90.13 96.21 6.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.33 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 39.5 mttt -148.86 145.79 27.65 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.397 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 2.2 p90 179.0 159.89 0.64 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.272 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -58.91 -175.92 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.425 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 72.53 -90.31 0.54 Allowed Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.66 -0.976 . . . . 0.0 110.66 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.737 ' OD2' HG21 ' A' ' 70' ' ' THR . 12.0 m-20 -68.1 168.1 12.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.733 0.302 . . . . 0.0 110.348 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.663 ' O ' HG22 ' A' ' 27' ' ' THR . 36.7 m -134.68 35.65 3.14 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.925 0.393 . . . . 0.0 110.647 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.423 ' O ' ' CG ' ' A' ' 71' ' ' GLU . 0.0 OUTLIER 61.4 120.85 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.829 179.639 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.82 ' HB3' ' O ' ' A' ' 69' ' ' LEU . . . -126.26 -51.73 1.52 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.09 179.531 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -157.59 169.26 25.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.868 -0.606 . . . . 0.0 109.737 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.466 HG21 ' CD1' ' A' ' 52' ' ' TRP . 3.2 t -150.6 139.57 15.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.179 0.514 . . . . 0.0 110.775 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.412 ' HG3' ' O ' ' A' ' 42' ' ' VAL . 2.5 tt0 -132.73 144.87 50.57 Favored 'General case' 0 N--CA 1.436 -1.126 0 CA-C-N 115.408 -0.814 . . . . 0.0 109.613 -179.217 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.648 HD21 ' CZ ' ' A' ' 66' ' ' PHE . 2.4 mt -121.59 175.22 6.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.398 0.618 . . . . 0.0 111.429 -179.32 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.475 ' HB2' ' CE3' ' A' ' 41' ' ' TRP . 27.5 ttt180 -167.16 162.77 15.39 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.03 -0.986 . . . . 0.0 109.149 179.581 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.443 ' N ' ' HG2' ' A' ' 34' ' ' ARG . 40.8 mt-10 -120.31 -85.1 0.66 Allowed 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 179.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 0.403 ' HB2' ' O ' ' A' ' 35' ' ' GLU . 3.3 t60 179.8 -56.43 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.307 179.374 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -106.06 56.54 0.51 Allowed Glycine 0 CA--C 1.523 0.566 0 N-CA-C 110.616 -0.994 . . . . 0.0 110.616 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 23.1 t -130.76 -160.71 1.06 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.847 0.356 . . . . 0.0 110.386 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -87.23 52.4 2.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.298 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 66.83 -174.63 0.19 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.246 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.476 ' CE3' ' HG2' ' A' ' 67' ' ' ARG . 88.3 m95 -47.97 142.45 5.01 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.722 -179.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.598 HG22 ' O ' ' A' ' 33' ' ' LEU . 16.8 m -107.07 -142.3 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 179.491 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.576 ' N ' HG23 ' A' ' 42' ' ' VAL . . . -156.27 130.64 8.78 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.51 -179.77 1.14 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.724 0.297 . . . . 0.0 110.532 -179.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 89.8 m -151.43 123.36 8.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.505 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.499 ' HB3' ' CZ3' ' A' ' 52' ' ' TRP . 0.0 OUTLIER -83.62 97.41 9.05 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.363 179.919 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -148.1 23.8 1.42 Allowed Glycine 0 CA--C 1.524 0.601 0 N-CA-C 111.095 -0.802 . . . . 0.0 111.095 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -100.6 -31.59 11.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.8 0.334 . . . . 0.0 110.225 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 96.18 27.9 9.69 Favored Glycine 0 CA--C 1.522 0.525 0 N-CA-C 110.801 -0.92 . . . . 0.0 110.801 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 166.6 -34.47 0.23 Allowed Glycine 0 CA--C 1.523 0.59 0 N-CA-C 110.811 -0.916 . . . . 0.0 110.811 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.88 HG11 ' HG3' ' A' ' 9' ' ' GLU . 4.8 m -126.33 -178.38 2.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.875 0.369 . . . . 0.0 110.508 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . 0.499 ' CZ3' ' HB3' ' A' ' 46' ' ' LYS . 7.5 m95 -110.6 142.68 42.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.346 -179.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.428 ' CG2' ' HB2' ' A' ' 18' ' ' ALA . 0.8 OUTLIER -134.15 152.05 51.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.314 179.987 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.435 ' CZ ' HG21 ' A' ' 42' ' ' VAL . 87.8 t80 -147.31 147.66 30.59 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.43 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -93.87 120.57 34.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.374 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -142.78 175.58 9.71 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.371 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -131.69 -64.66 0.78 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.011 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 48.58 104.34 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 115.982 -0.553 . . . . 0.0 111.458 179.306 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -64.0 -16.71 56.47 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.345 2.03 . . . . 0.0 111.34 178.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 7.1 mp -75.22 -171.31 1.38 Allowed 'General case' 0 C--O 1.232 0.142 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.99 179.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 4.9 mp0 -60.43 -79.02 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 179.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.493 ' N ' ' HD3' ' A' ' 63' ' ' PRO . . . -175.5 58.63 0.11 Allowed Glycine 0 CA--C 1.527 0.798 0 N-CA-C 111.276 -0.73 . . . . 0.0 111.276 179.425 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.493 ' HD3' ' N ' ' A' ' 62' ' ' GLY . 51.7 Cg_endo -88.23 108.05 0.56 Allowed 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.798 2.332 . . . . 0.0 111.984 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.496 ' CE2' ' HG ' ' A' ' 17' ' ' LEU . 53.5 m-85 -109.73 166.63 10.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.133 0.492 . . . . 0.0 110.704 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -150.48 129.18 12.35 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.559 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.648 ' CZ ' HD21 ' A' ' 33' ' ' LEU . 33.3 m-85 -115.41 174.87 5.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.104 0.478 . . . . 0.0 111.097 -179.323 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.476 ' HG2' ' CE3' ' A' ' 41' ' ' TRP . 0.0 OUTLIER -175.24 50.34 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.704 179.849 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.57 ' O ' HD23 ' A' ' 69' ' ' LEU . 0.2 OUTLIER -56.44 172.79 0.21 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.108 -179.286 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.82 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 7.0 mt -124.86 73.54 1.29 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.282 179.627 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.737 HG21 ' OD2' ' A' ' 26' ' ' ASP . 22.8 p -38.22 142.97 0.14 Allowed 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.803 -179.156 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.72 ' HG2' ' HB2' ' A' ' 29' ' ' ALA . 3.5 mm-40 -51.47 -43.84 62.25 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.302 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.32 -39.27 69.75 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.316 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 108.97 46.67 0.93 Allowed Glycine 0 CA--C 1.522 0.508 0 N-CA-C 110.574 -1.01 . . . . 0.0 110.574 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 42.3 mtt -136.5 79.43 1.76 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.823 0.344 . . . . 0.0 110.62 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.36 -178.82 7.2 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.191 179.722 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.449 ' O ' ' CE2' ' A' ' 78' ' ' PHE . 0.5 OUTLIER 174.62 140.0 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.472 179.893 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.448 HG13 ' CH2' ' A' ' 41' ' ' TRP . 88.9 t -81.08 144.52 10.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.322 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.601 ' CZ ' HG21 ' A' ' 4' ' ' VAL . 38.1 m-85 -127.77 126.02 40.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.177 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -93.87 139.77 30.49 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.644 -179.655 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.457 ' O ' ' HB ' ' A' ' 81' ' ' VAL . 0.1 OUTLIER 69.19 -77.05 0.05 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.593 179.756 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.457 ' HB ' ' O ' ' A' ' 80' ' ' ASP . 53.5 t 70.68 -54.47 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 C-N-CA 123.682 0.793 . . . . 0.0 110.653 -179.575 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.605 HG13 ' HD2' ' A' ' 83' ' ' PRO . 93.8 t -105.69 140.78 21.53 Favored Pre-proline 0 C--N 1.325 -0.484 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 179.639 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.605 ' HD2' HG13 ' A' ' 82' ' ' VAL . 45.1 Cg_endo -71.27 -169.68 0.43 Allowed 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.579 2.186 . . . . 0.0 112.107 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -72.07 -64.42 0.94 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.237 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 14.4 mmtp -108.03 82.98 1.72 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.099 179.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 0.493 ' HB2' ' CE2' ' A' ' 92' ' ' TYR . 26.5 p90 -71.87 171.28 12.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.58 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 4.5 m -151.52 128.66 11.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.089 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.834 HD11 ' CB ' ' A' ' 12' ' ' SER . 36.3 mm -50.86 96.41 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.449 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 132.23 48.98 0.1 Allowed Glycine 0 CA--C 1.524 0.598 0 N-CA-C 110.844 -0.902 . . . . 0.0 110.844 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.675 ' HB3' ' CZ ' ' A' ' 92' ' ' TYR . . . -155.72 135.62 12.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.813 0.34 . . . . 0.0 110.362 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.404 ' HA ' HG23 ' A' ' 7' ' ' THR . 28.7 m -93.42 91.24 7.07 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.418 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.675 ' CZ ' ' HB3' ' A' ' 90' ' ' ALA . 30.4 m-85 -82.77 -161.27 0.47 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.202 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.93 ' HB1' ' HD2' ' A' ' 94' ' ' PRO . . . 74.63 177.84 0.06 OUTLIER Pre-proline 0 C--N 1.331 -0.208 0 CA-C-O 120.798 0.333 . . . . 0.0 110.635 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.93 ' HD2' ' HB1' ' A' ' 93' ' ' ALA . 48.5 Cg_endo . . . . . 0 C--O 1.248 0.996 0 C-N-CA 122.648 2.232 . . . . 0.0 112.037 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 19.2 mttt . . . . . 0 CA--C 1.522 -0.109 0 CA-C-O 120.868 0.365 . . . . 0.0 110.251 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.74 HG11 ' CE1' ' A' ' 78' ' ' PHE . 1.7 p 177.94 164.06 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.174 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.48 ' N ' HG22 ' A' ' 4' ' ' VAL . 1.1 p -157.79 128.36 6.38 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.457 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.656 ' HD1' ' HB2' ' A' ' 93' ' ' ALA . 10.3 m-85 -102.72 177.84 4.74 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.122 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.419 ' O ' ' N ' ' A' ' 9' ' ' GLU . 0.3 OUTLIER -166.13 112.43 0.87 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.361 -179.851 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.672 ' O ' HG23 ' A' ' 88' ' ' ILE . 14.0 t -57.61 85.52 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.397 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.51 ' HB2' HG11 ' A' ' 51' ' ' VAL . 3.6 mm-40 -60.55 161.19 7.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.348 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -56.28 177.59 0.06 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.494 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 77.5 13.24 83.74 Favored Glycine 0 CA--C 1.527 0.805 0 N-CA-C 111.455 -0.658 . . . . 0.0 111.455 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 19.1 m -86.91 109.35 19.27 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.909 0.354 . . . . 0.0 110.051 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.427 ' O ' ' N ' ' A' ' 15' ' ' LYS . 4.6 p-10 -153.28 158.95 42.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.916 0.388 . . . . 0.0 110.806 -179.622 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 54.25 -85.96 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.835 179.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.427 ' N ' ' O ' ' A' ' 13' ' ' ASN . 0.0 OUTLIER -142.49 22.91 1.99 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.622 0.249 . . . . 0.0 110.745 -179.882 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -98.06 120.09 37.85 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 179.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.429 ' HG ' ' CE2' ' A' ' 64' ' ' PHE . 0.2 OUTLIER -113.3 98.42 7.1 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.054 0.455 . . . . 0.0 110.772 -179.499 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.885 ' HB1' HG11 ' A' ' 51' ' ' VAL . . . -86.76 138.83 31.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.027 179.572 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.473 ' N ' HG13 ' A' ' 51' ' ' VAL . 26.9 m -141.93 139.8 30.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.869 0.366 . . . . 0.0 110.816 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.426 ' HB2' ' CG ' ' A' ' 9' ' ' GLU . 0.5 OUTLIER -99.41 34.85 2.08 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.517 179.937 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.558 HG13 ' HE1' ' A' ' 52' ' ' TRP . 7.2 p -57.02 109.74 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 120.854 0.359 . . . . 0.0 110.521 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -179.59 77.68 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.243 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.501 ' CE2' ' HB ' ' A' ' 4' ' ' VAL . 25.7 p90 -84.63 -179.89 7.23 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.562 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -47.68 -68.28 0.2 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.874 -179.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -56.3 -20.26 28.44 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 111.207 -0.757 . . . . 0.0 111.207 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.48 ' HB2' ' CZ ' ' A' ' 23' ' ' TYR . 5.4 t70 -90.07 137.92 31.94 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.763 0.316 . . . . 0.0 110.594 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.674 ' O ' HG22 ' A' ' 27' ' ' THR . 88.5 m -124.63 11.08 8.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.104 179.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.413 ' O ' ' CG ' ' A' ' 71' ' ' GLU . 28.6 mtm 58.03 112.63 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.815 0.341 . . . . 0.0 110.625 179.654 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.681 ' HB3' ' O ' ' A' ' 69' ' ' LEU . . . -131.92 -49.06 0.95 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.584 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.871 ' HB3' HD12 ' A' ' 69' ' ' LEU . 27.5 tt0 -176.02 83.56 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.81 0.338 . . . . 0.0 110.907 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.742 HG21 ' CD1' ' A' ' 52' ' ' TRP . 18.5 t -68.45 155.0 7.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.15 179.589 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.725 ' OE2' HD21 ' A' ' 69' ' ' LEU . 4.5 pt-20 -147.14 142.09 26.96 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.839 0.352 . . . . 0.0 110.639 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.43 ' HG ' ' CE1' ' A' ' 66' ' ' PHE . 4.2 mt -103.49 -178.41 3.65 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.445 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.492 ' HB2' ' CZ3' ' A' ' 41' ' ' TRP . 6.4 ttt180 -132.85 -64.95 0.73 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.591 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.446 ' CB ' ' O ' ' A' ' 34' ' ' ARG . 23.3 mt-10 92.5 33.65 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.669 0.788 . . . . 0.0 109.187 -179.195 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 3.0 t-80 67.54 -68.81 0.15 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.487 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -157.34 57.87 0.36 Allowed Glycine 0 CA--C 1.523 0.578 0 N-CA-C 110.595 -1.002 . . . . 0.0 110.595 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.43 ' CB ' ' HB2' ' A' ' 35' ' ' GLU . 34.1 t -92.47 -46.17 7.78 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.77 0.319 . . . . 0.0 110.335 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 47.6 p-10 -177.51 52.65 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.537 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 62.51 -177.32 0.14 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.47 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.762 ' HH2' HG23 ' A' ' 77' ' ' VAL . 93.7 m95 -60.27 129.88 43.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.533 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.605 HG21 ' CZ ' ' A' ' 54' ' ' PHE . 25.1 m -122.76 116.44 48.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.125 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.471 ' HA ' ' CB ' ' A' ' 32' ' ' GLU . . . -56.08 140.28 44.29 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.47 -179.779 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.56 -167.65 0.2 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.173 -0.467 . . . . 0.0 109.953 179.787 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 91.4 m -153.62 127.15 8.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.864 0.364 . . . . 0.0 110.654 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 11.8 ptpt -73.18 77.2 1.28 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.03 179.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -93.22 -25.79 18.08 Favored Glycine 0 CA--C 1.522 0.516 0 N-CA-C 111.169 -0.772 . . . . 0.0 111.169 -179.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.484 ' CB ' ' HB ' ' A' ' 51' ' ' VAL . 2.9 mm-40 -86.95 -18.93 29.58 Favored 'General case' 0 C--N 1.33 -0.249 0 O-C-N 122.759 -0.259 . . . . 0.0 111.284 -179.483 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 96.48 -42.34 2.24 Favored Glycine 0 CA--C 1.523 0.539 0 N-CA-C 110.333 -1.107 . . . . 0.0 110.333 -179.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.55 ' O ' HG23 ' A' ' 51' ' ' VAL . . . -132.73 23.36 3.98 Favored Glycine 0 CA--C 1.522 0.51 0 N-CA-C 109.806 -1.318 . . . . 0.0 109.806 179.161 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.885 HG11 ' HB1' ' A' ' 18' ' ' ALA . 42.0 t -159.0 145.57 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 -179.621 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . 0.742 ' CD1' HG21 ' A' ' 31' ' ' VAL . 1.7 m95 -94.02 117.47 30.15 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.966 0.412 . . . . 0.0 110.607 -179.027 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.4 ' HA ' ' O ' ' A' ' 17' ' ' LEU . 3.2 p -110.36 139.55 45.44 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.029 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.605 ' CZ ' HG21 ' A' ' 42' ' ' VAL . 58.1 t80 -117.69 142.24 47.47 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.867 0.365 . . . . 0.0 110.611 -179.762 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -103.68 104.86 14.95 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.183 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -84.57 143.94 28.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.532 -179.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -112.35 1.83 16.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.122 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -121.96 156.71 59.24 Favored Pre-proline 0 C--O 1.231 0.099 0 CA-C-O 120.668 0.271 . . . . 0.0 110.361 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -70.85 -29.85 18.09 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.691 2.261 . . . . 0.0 112.18 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -81.73 134.1 35.41 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.42 -179.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -174.05 40.39 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.325 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -58.19 -93.07 0.01 OUTLIER Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.849 -0.9 . . . . 0.0 110.849 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -79.74 136.63 12.2 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.584 2.189 . . . . 0.0 112.053 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.429 ' CE2' ' HG ' ' A' ' 17' ' ' LEU . 49.8 m-85 -107.73 149.46 28.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.638 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -125.81 116.32 21.39 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 179.013 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.43 ' CE1' ' HG ' ' A' ' 33' ' ' LEU . 29.6 m-85 -100.65 171.11 7.91 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.29 0.566 . . . . 0.0 111.608 -178.706 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.522 ' HG3' ' CH2' ' A' ' 41' ' ' TRP . 0.0 OUTLIER -162.65 83.27 0.53 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.978 179.24 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.724 ' O ' HD23 ' A' ' 69' ' ' LEU . 5.2 p90 -70.87 167.59 18.64 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.432 0.634 . . . . 0.0 111.045 -179.5 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.871 HD12 ' HB3' ' A' ' 30' ' ' GLU . 4.2 mt -138.82 55.69 1.72 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.966 -1.015 . . . . 0.0 108.756 179.378 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.405 HG22 ' HA ' ' A' ' 26' ' ' ASP . 17.0 p -23.59 134.96 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.907 0.883 . . . . 0.0 112.732 -178.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.655 ' HG2' ' HB2' ' A' ' 29' ' ' ALA . 3.0 mt-10 -48.76 -26.24 2.25 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.691 -179.656 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -158.22 63.46 0.45 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.31 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -151.59 -103.95 0.26 Allowed Glycine 0 CA--C 1.523 0.576 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -169.31 -174.94 2.09 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.982 0.42 . . . . 0.0 110.561 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -123.9 172.36 8.97 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.219 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 175.73 140.35 0.06 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.931 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.762 HG23 ' HH2' ' A' ' 41' ' ' TRP . 2.5 p -79.49 145.56 9.17 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.209 0 CA-C-O 121.26 0.552 . . . . 0.0 110.037 179.561 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.74 ' CE1' HG11 ' A' ' 4' ' ' VAL . 98.3 m-85 -126.14 143.86 50.97 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.033 -179.409 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 30.1 t0 -121.69 155.85 34.31 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.901 0.381 . . . . 0.0 110.803 -179.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 4.3 t0 48.77 51.24 16.13 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.654 179.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.504 HG13 ' HA ' ' A' ' 93' ' ' ALA . 72.5 t -87.88 -16.49 8.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.627 179.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.53 HG13 ' HB3' ' A' ' 86' ' ' TYR . 59.4 t -148.57 133.35 9.06 Favored Pre-proline 0 C--N 1.332 -0.157 0 N-CA-C 110.433 -0.21 . . . . 0.0 110.433 179.667 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -68.53 -165.73 0.13 Allowed 'Trans proline' 0 N--CA 1.475 0.383 0 C-N-CA 122.695 2.263 . . . . 0.0 111.986 179.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -80.32 -37.84 31.79 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.282 -0.417 . . . . 0.0 109.957 179.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.98 67.02 1.11 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.218 179.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 0.53 ' HB3' HG13 ' A' ' 82' ' ' VAL . 33.6 p90 -55.58 163.88 1.2 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.644 -179.772 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 7.1 m -133.38 113.0 12.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.241 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.672 HG23 ' O ' ' A' ' 8' ' ' VAL . 2.7 mp -50.67 116.16 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.501 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 115.32 44.26 0.67 Allowed Glycine 0 CA--C 1.524 0.595 0 N-CA-C 110.677 -0.969 . . . . 0.0 110.677 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -163.24 141.18 7.87 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.816 0.341 . . . . 0.0 110.527 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.505 HG23 ' O ' ' A' ' 6' ' ' PHE . 17.2 m -90.5 112.13 23.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.19 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.426 ' CB ' ' O ' ' A' ' 81' ' ' VAL . 74.2 m-85 -94.39 -99.03 0.15 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.53 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.932 ' HB1' ' HD2' ' A' ' 94' ' ' PRO . . . 50.48 179.13 0.02 OUTLIER Pre-proline 0 C--O 1.231 0.096 0 CA-C-O 120.704 0.288 . . . . 0.0 110.558 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.932 ' HD2' ' HB1' ' A' ' 93' ' ' ALA . 48.0 Cg_endo . . . . . 0 C--O 1.25 1.075 0 C-N-CA 122.464 2.109 . . . . 0.0 112.044 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 3.8 mttt . . . . . 0 CA--C 1.522 -0.113 0 CA-C-O 120.792 0.33 . . . . 0.0 110.362 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.604 HG11 ' CE1' ' A' ' 78' ' ' PHE . 1.8 p -135.58 163.57 34.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.361 0.601 . . . . 0.0 110.359 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.48 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 0.1 OUTLIER -142.74 139.91 31.26 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.253 179.579 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.501 ' CD2' HG22 ' A' ' 21' ' ' VAL . 20.9 m-85 -112.96 -175.01 2.57 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.325 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.477 HG22 ' H ' ' A' ' 8' ' ' VAL . 0.2 OUTLIER -165.09 -167.0 1.1 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.145 -0.48 . . . . 0.0 109.945 179.803 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.479 HG12 ' CD1' ' A' ' 88' ' ' ILE . 9.3 t -139.37 82.42 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.147 179.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.841 ' HG3' HG11 ' A' ' 51' ' ' VAL . 65.7 mm-40 -50.9 155.1 1.26 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.457 -179.771 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 6.8 mtpt -53.49 175.33 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.379 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 64.18 46.81 90.0 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 110.585 -1.006 . . . . 0.0 110.585 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 61.6 m -102.69 108.66 19.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.796 0.331 . . . . 0.0 110.383 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 55.9 m-80 -101.66 174.46 5.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.255 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -55.56 -34.93 65.19 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.599 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.0 -52.71 4.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.319 -179.645 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 27.1 m80 -73.46 136.92 44.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.002 -179.434 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.484 HD22 ' HA ' ' A' ' 17' ' ' LEU . 0.8 OUTLIER -137.36 84.16 2.04 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.521 179.309 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.703 ' HB2' ' CG2' ' A' ' 53' ' ' THR . . . -74.95 116.91 16.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.896 -179.229 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.4 m -109.8 137.36 42.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.011 179.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.488 HD12 ' OE2' ' A' ' 9' ' ' GLU . 1.1 tt -84.78 70.53 10.84 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.521 -179.833 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.501 HG22 ' CD2' ' A' ' 6' ' ' PHE . 3.2 t -85.6 98.61 6.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.131 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.9 ttpm? -167.14 147.56 5.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.484 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -161.78 157.62 24.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.299 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.91 -21.58 66.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.716 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -46.17 -91.0 0.01 OUTLIER Glycine 0 CA--C 1.526 0.722 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -90.83 -160.74 0.74 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.729 0.3 . . . . 0.0 110.428 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.675 ' O ' HG22 ' A' ' 27' ' ' THR . 32.5 m -123.67 24.35 8.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.038 -179.737 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.426 ' O ' ' CG ' ' A' ' 71' ' ' GLU . 8.4 mtm 60.61 125.28 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.013 179.402 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.874 ' HB3' ' O ' ' A' ' 69' ' ' LEU . . . -122.06 -61.79 1.45 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.259 179.736 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.414 ' C ' HG12 ' A' ' 31' ' ' VAL . 0.5 OUTLIER -147.31 171.44 15.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.1 179.943 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.441 ' HA ' ' HA ' ' A' ' 68' ' ' PHE . 1.1 p 175.84 151.01 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.28 0.562 . . . . 0.0 110.519 -179.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.457 ' HG3' ' HB3' ' A' ' 41' ' ' TRP . 1.1 pm0 -140.23 171.36 14.27 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.97 -179.564 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.699 HD13 ' CZ ' ' A' ' 66' ' ' PHE . 12.0 tp -126.41 154.85 43.05 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-O 120.987 0.423 . . . . 0.0 110.088 -179.036 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.631 ' H ' HD12 ' A' ' 33' ' ' LEU . 0.6 OUTLIER -145.47 173.24 12.19 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.892 -0.594 . . . . 0.0 109.534 179.371 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 17.3 mp0 -133.22 -89.62 0.4 Allowed 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 110.346 -0.242 . . . . 0.0 110.346 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 20.3 p80 -177.35 146.21 0.47 Allowed 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 120.77 0.319 . . . . 0.0 110.514 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 60.92 38.76 95.95 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.844 -0.902 . . . . 0.0 110.844 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.1 t -118.38 173.98 6.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.862 0.363 . . . . 0.0 110.423 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -63.79 -70.58 0.21 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.511 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -153.68 173.73 15.42 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.031 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.488 ' CE3' ' HB2' ' A' ' 34' ' ' ARG . 75.2 m95 -52.71 151.21 4.55 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.189 179.769 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.429 HG22 ' O ' ' A' ' 33' ' ' LEU . 9.7 m -122.83 118.77 56.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.397 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.42 ' HA ' ' HB3' ' A' ' 32' ' ' GLU . . . -50.53 134.85 23.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.624 -179.792 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.0 -168.62 0.14 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.217 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 30.0 m -147.4 105.87 3.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.356 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.88 87.84 0.37 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.209 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -133.88 21.82 3.91 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.985 -0.846 . . . . 0.0 110.985 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.468 ' CB ' HG23 ' A' ' 51' ' ' VAL . 0.1 OUTLIER -108.59 177.6 4.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.754 0.312 . . . . 0.0 110.292 179.953 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -62.44 -44.66 97.29 Favored Glycine 0 CA--C 1.523 0.545 0 N-CA-C 110.7 -0.96 . . . . 0.0 110.7 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -160.94 31.41 0.35 Allowed Glycine 0 CA--C 1.523 0.567 0 N-CA-C 110.717 -0.953 . . . . 0.0 110.717 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.841 HG11 ' HG3' ' A' ' 9' ' ' GLU . 5.2 m -145.77 -179.44 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.854 0.359 . . . . 0.0 110.468 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 9.4 m95 -106.12 140.41 39.14 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.514 -179.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.703 ' CG2' ' HB2' ' A' ' 18' ' ' ALA . 0.5 OUTLIER -138.27 153.26 49.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.233 179.886 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 36.0 t80 -159.28 141.52 13.7 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.631 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 20.9 p-10 -93.52 127.94 39.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.27 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 9.5 p -94.96 143.82 26.17 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.36 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 14.0 mp0 -104.27 25.85 9.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.402 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -133.38 156.97 79.21 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.282 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -95.2 32.92 0.17 Allowed 'Trans proline' 0 N--CA 1.451 -1.004 0 C-N-CA 123.924 3.082 . . . . 0.0 112.355 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.655 ' C ' HD22 ' A' ' 60' ' ' LEU . 0.0 OUTLIER -49.97 162.82 0.17 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.725 -179.903 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -153.76 27.35 0.49 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.347 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -120.9 -155.19 9.48 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.773 -0.931 . . . . 0.0 110.773 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.448 ' CB ' ' HA ' ' A' ' 80' ' ' ASP . 48.7 Cg_endo -79.89 163.84 23.1 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.622 2.215 . . . . 0.0 112.182 -179.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 50.2 m-85 -105.76 -175.21 2.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.236 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -150.67 141.18 22.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.97 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.699 ' CZ ' HD13 ' A' ' 33' ' ' LEU . 44.4 m-85 -137.93 178.85 6.81 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.038 0.446 . . . . 0.0 110.885 -179.629 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.44 ' HG2' ' CZ3' ' A' ' 41' ' ' TRP . 0.1 OUTLIER 176.23 84.15 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.51 -179.982 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.872 ' O ' HD23 ' A' ' 69' ' ' LEU . 5.0 p90 -72.56 -177.38 2.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.275 0.559 . . . . 0.0 110.995 -179.213 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.874 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 9.0 mt -140.18 72.39 1.39 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.125 179.678 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.484 HG23 ' CE1' ' A' ' 68' ' ' PHE . 76.6 p -30.88 140.3 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.403 0.681 . . . . 0.0 112.447 -178.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.676 ' HG2' ' HB2' ' A' ' 29' ' ' ALA . 3.3 mm-40 -55.88 -38.86 70.73 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.809 -179.634 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.56 53.72 1.42 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.745 -179.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.423 ' O ' ' CG ' ' A' ' 74' ' ' MET . . . -142.46 -109.39 0.73 Allowed Glycine 0 CA--C 1.523 0.551 0 N-CA-C 110.853 -0.899 . . . . 0.0 110.853 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.435 ' N ' ' OG1' ' A' ' 70' ' ' THR . 32.6 mtp -162.98 -178.68 6.23 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 110.206 -0.294 . . . . 0.0 110.206 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -94.01 -177.61 4.38 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.074 179.693 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 9.6 t30 176.88 155.74 0.26 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.392 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 71.2 t -111.21 147.15 15.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.948 179.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.604 ' CE1' HG11 ' A' ' 4' ' ' VAL . 38.0 m-85 -135.87 127.81 29.49 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.453 -179.77 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 39.8 p-10 -118.86 158.01 26.5 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.126 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.448 ' HA ' ' CB ' ' A' ' 63' ' ' PRO . 1.2 m-20 53.37 33.72 16.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.321 -179.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.428 ' HA ' ' HA ' ' A' ' 93' ' ' ALA . 69.9 t -61.56 -17.21 16.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.759 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.562 HG13 ' HD2' ' A' ' 83' ' ' PRO . 70.9 t -147.42 140.06 14.49 Favored Pre-proline 0 C--N 1.331 -0.204 0 CA-C-O 120.652 0.263 . . . . 0.0 110.356 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.562 ' HD2' HG13 ' A' ' 82' ' ' VAL . 44.6 Cg_endo -69.39 -165.95 0.16 Allowed 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.665 2.244 . . . . 0.0 112.003 179.798 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -74.31 -65.87 0.8 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.031 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.39 71.48 1.36 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.212 179.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 0.416 ' HB3' ' CG1' ' A' ' 82' ' ' VAL . 15.4 p90 -56.95 162.96 2.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.506 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 43.7 m -141.32 122.85 15.06 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.404 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.479 ' CD1' HG12 ' A' ' 8' ' ' VAL . 40.7 mm -51.54 116.95 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.342 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 113.11 30.21 2.79 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.664 -0.975 . . . . 0.0 110.664 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.54 ' HB3' ' CZ ' ' A' ' 92' ' ' TYR . . . -137.15 134.36 36.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.794 0.33 . . . . 0.0 110.18 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 21.6 m -91.34 105.68 17.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.9 -179.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.548 ' O ' ' HB3' ' A' ' 93' ' ' ALA . 39.2 m-85 -97.35 -155.77 0.51 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.0 -0.546 . . . . 0.0 109.642 179.525 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.899 ' HB1' ' HD2' ' A' ' 94' ' ' PRO . . . 73.91 175.76 0.07 OUTLIER Pre-proline 0 N--CA 1.464 0.232 0 CA-C-O 120.673 0.273 . . . . 0.0 110.779 179.762 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.899 ' HD2' ' HB1' ' A' ' 93' ' ' ALA . 46.9 Cg_endo . . . . . 0 C--O 1.249 1.033 0 C-N-CA 122.536 2.157 . . . . 0.0 112.02 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 10.0 mtpt . . . . . 0 CA--C 1.522 -0.114 0 CA-C-O 120.789 0.328 . . . . 0.0 110.187 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.626 HG11 ' CE1' ' A' ' 78' ' ' PHE . 2.1 p -96.65 162.95 2.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.27 0.557 . . . . 0.0 110.371 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.481 ' N ' HG22 ' A' ' 4' ' ' VAL . 1.2 p -145.16 132.91 21.06 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.463 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.541 ' O ' HG23 ' A' ' 91' ' ' THR . 6.5 m-85 -99.37 172.5 7.29 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.279 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.836 HG23 ' O ' ' A' ' 90' ' ' ALA . 16.7 m -166.14 96.56 0.6 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.182 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.49 HG12 ' CD1' ' A' ' 88' ' ' ILE . 21.8 t -50.77 111.64 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.581 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.463 ' O ' HD12 ' A' ' 88' ' ' ILE . 3.5 mt-10 -70.24 171.54 9.65 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.51 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.619 ' HA ' HG21 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -69.69 -8.83 51.17 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.191 -179.917 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -48.38 -26.55 5.07 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 111.086 -0.806 . . . . 0.0 111.086 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 28.5 p -52.87 126.66 20.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.725 0.298 . . . . 0.0 110.279 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -122.58 -57.61 1.73 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.496 -179.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -134.51 -78.21 0.46 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.354 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.22 -20.64 14.59 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.702 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -54.32 177.28 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.804 0.335 . . . . 0.0 110.285 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 25.4 tp -162.2 84.03 0.57 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.312 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.48 ' HB2' HG23 ' A' ' 53' ' ' THR . . . -72.83 162.46 29.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.232 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.668 HG11 ' CZ ' ' A' ' 66' ' ' PHE . 30.9 m -156.65 133.32 2.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.815 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.433 ' HA ' HG12 ' A' ' 51' ' ' VAL . 0.5 OUTLIER -94.62 64.41 3.01 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.169 179.539 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 28.9 t -56.48 111.78 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.593 -179.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.74 168.82 22.58 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.12 179.769 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.494 ' CE1' ' HB2' ' A' ' 26' ' ' ASP . 0.0 OUTLIER -150.55 -68.88 0.19 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.094 -179.95 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 52.0 tt0 -168.88 -61.42 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.515 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -152.18 58.9 0.42 Allowed Glycine 0 CA--C 1.524 0.654 0 N-CA-C 111.094 -0.802 . . . . 0.0 111.094 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.494 ' HB2' ' CE1' ' A' ' 23' ' ' TYR . 77.0 m-20 -108.71 178.81 4.37 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 179.531 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.401 ' HB ' ' HG3' ' A' ' 71' ' ' GLU . 0.2 OUTLIER -110.0 172.2 7.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.893 0.378 . . . . 0.0 110.492 -179.892 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 1.2 mtt -126.18 117.62 23.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.158 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.81 ' HB3' ' O ' ' A' ' 69' ' ' LEU . . . -116.88 -58.34 2.08 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.642 -179.765 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.42 ' O ' ' CB ' ' A' ' 68' ' ' PHE . 20.8 mm-40 -153.24 162.7 41.01 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.476 -179.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.532 HG21 ' CD1' ' A' ' 52' ' ' TRP . 2.5 t -151.96 142.78 15.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.276 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.439 ' CB ' ' HA ' ' A' ' 43' ' ' ALA . 11.9 pm0 -153.2 139.82 18.84 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.755 -179.603 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.734 HD21 ' CD2' ' A' ' 54' ' ' PHE . 0.5 OUTLIER -108.99 172.52 6.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.182 179.893 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.508 ' N ' HD12 ' A' ' 33' ' ' LEU . 0.1 OUTLIER -94.31 -67.58 0.85 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.634 -0.257 . . . . 0.0 110.698 -179.685 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.52 ' N ' HD12 ' A' ' 33' ' ' LEU . 2.0 tt0 88.91 74.5 0.01 OUTLIER 'General case' 0 CA--C 1.51 -0.571 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 -178.622 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -36.97 120.82 0.75 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 114.995 -1.002 . . . . 0.0 111.832 -178.216 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 128.17 -48.87 0.95 Allowed Glycine 0 CA--C 1.523 0.55 0 N-CA-C 110.446 -1.062 . . . . 0.0 110.446 -179.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.414 ' O ' ' CB ' ' A' ' 39' ' ' ASP . 40.6 t -75.03 -32.79 61.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.745 0.307 . . . . 0.0 110.494 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.414 ' CB ' ' O ' ' A' ' 38' ' ' SER . 8.2 t0 81.56 -53.17 0.27 Allowed 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.729 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -72.63 124.04 24.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.573 -179.751 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.49 ' CZ3' ' HB2' ' A' ' 67' ' ' ARG . 77.7 m95 -54.73 155.19 4.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.036 179.743 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.409 HG23 ' HG ' ' A' ' 33' ' ' LEU . 3.6 m -136.54 124.69 34.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.8 0.333 . . . . 0.0 110.422 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.439 ' HA ' ' CB ' ' A' ' 32' ' ' GLU . . . -57.19 138.56 54.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.243 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.77 -170.14 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.232 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 62.1 m -135.79 95.18 3.18 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.444 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.413 ' O ' ' CG ' ' A' ' 46' ' ' LYS . 14.6 ptmt -74.16 90.98 2.08 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.97 0.414 . . . . 0.0 110.402 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -156.83 25.34 0.5 Allowed Glycine 0 CA--C 1.523 0.581 0 N-CA-C 110.729 -0.948 . . . . 0.0 110.729 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.435 ' HG2' HG23 ' A' ' 51' ' ' VAL . 7.7 tp10 -106.75 165.91 10.97 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.765 0.317 . . . . 0.0 110.265 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -39.85 -49.7 3.34 Favored Glycine 0 CA--C 1.527 0.794 0 N-CA-C 111.784 -0.526 . . . . 0.0 111.784 -179.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -164.49 33.28 0.26 Allowed Glycine 0 CA--C 1.523 0.549 0 N-CA-C 111.001 -0.84 . . . . 0.0 111.001 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.437 HG11 ' HG3' ' A' ' 9' ' ' GLU . 4.3 m -148.79 -178.57 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.916 0.389 . . . . 0.0 110.498 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . 0.532 ' CD1' HG21 ' A' ' 31' ' ' VAL . 6.5 m95 -108.42 119.1 38.52 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.215 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.48 HG23 ' HB2' ' A' ' 18' ' ' ALA . 0.0 OUTLIER -106.46 -179.46 3.95 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.613 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.734 ' CD2' HD21 ' A' ' 33' ' ' LEU . 16.4 t80 -177.46 124.37 0.13 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.929 0.395 . . . . 0.0 110.626 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -86.06 154.17 21.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.143 179.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 52.5 p -128.51 126.02 39.56 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.463 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -86.76 -37.43 17.88 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.216 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -63.48 139.04 97.53 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.259 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.403 ' O ' ' NE2' ' A' ' 61' ' ' GLN . 49.0 Cg_endo -72.92 -15.46 26.33 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.574 2.183 . . . . 0.0 112.366 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -50.79 128.11 20.04 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.856 0.36 . . . . 0.0 110.522 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.403 ' NE2' ' O ' ' A' ' 59' ' ' PRO . 1.0 OUTLIER -113.78 61.46 0.66 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.263 179.949 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -107.47 -165.22 21.85 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.688 -0.965 . . . . 0.0 110.688 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.409 ' C ' ' CD1' ' A' ' 64' ' ' PHE . 45.7 Cg_endo -74.28 -172.06 1.07 Allowed 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.46 2.107 . . . . 0.0 112.036 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.469 ' HB3' HD13 ' A' ' 33' ' ' LEU . 57.6 m-85 -152.88 106.35 3.04 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.641 -179.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 29.3 m-80 -74.83 119.77 19.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.269 -0.423 . . . . 0.0 109.919 179.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.668 ' CZ ' HG11 ' A' ' 19' ' ' VAL . 8.6 m-85 -87.79 167.87 13.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.816 -179.555 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.706 ' HD2' HG22 ' A' ' 77' ' ' VAL . 3.3 mtp180 -172.68 116.71 0.32 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.581 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.626 ' O ' HD23 ' A' ' 69' ' ' LEU . 0.1 OUTLIER -123.39 170.24 10.54 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.017 0.437 . . . . 0.0 110.538 179.785 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.81 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 7.2 mt -125.88 68.21 1.18 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.341 179.534 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 71.4 p -33.69 138.47 0.08 Allowed 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.875 -179.181 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.691 ' HG2' ' HB2' ' A' ' 29' ' ' ALA . 1.1 mt-10 -54.1 -26.18 25.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.356 -179.697 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.5 tmtt? -67.12 -52.34 42.91 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.283 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 120.24 58.75 0.24 Allowed Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.792 -0.923 . . . . 0.0 110.792 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 1.2 mmt -131.92 70.79 1.46 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.776 0.322 . . . . 0.0 110.38 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.503 ' HD2' HD22 ' A' ' 69' ' ' LEU . 0.0 OUTLIER -60.75 155.15 19.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.383 179.99 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 177.8 152.25 0.26 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.563 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.706 HG22 ' HD2' ' A' ' 67' ' ' ARG . 92.6 t -104.86 151.8 7.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.158 179.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.626 ' CE1' HG11 ' A' ' 4' ' ' VAL . 55.2 m-85 -127.38 147.57 50.27 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.759 -179.343 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 14.4 t0 -134.61 161.76 34.21 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.248 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 54.65 44.77 28.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.238 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.59 ' O ' HG12 ' A' ' 81' ' ' VAL . 60.0 t -93.34 3.09 8.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.238 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.519 HG23 ' O ' ' A' ' 81' ' ' VAL . 66.1 t -159.24 110.66 1.54 Allowed Pre-proline 0 CA--C 1.532 0.257 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 179.603 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.43 ' O ' ' N ' ' A' ' 85' ' ' LYS . 47.9 Cg_endo -75.58 62.09 6.25 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.524 2.149 . . . . 0.0 112.41 -179.741 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 53.86 -87.52 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.551 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.43 ' N ' ' O ' ' A' ' 83' ' ' PRO . 0.0 OUTLIER -87.91 56.61 3.95 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 120.934 0.397 . . . . 0.0 109.946 179.74 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 0.484 ' HB3' HG13 ' A' ' 82' ' ' VAL . 48.6 p90 -48.23 175.95 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.854 -179.744 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -144.24 134.15 23.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.113 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.619 HG21 ' HA ' ' A' ' 10' ' ' LYS . 36.5 mm -65.21 118.44 7.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.468 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 114.03 35.22 1.53 Allowed Glycine 0 CA--C 1.523 0.577 0 N-CA-C 110.602 -0.999 . . . . 0.0 110.602 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.836 ' O ' HG23 ' A' ' 7' ' ' THR . . . -138.64 175.53 9.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.768 0.318 . . . . 0.0 110.383 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.541 HG23 ' O ' ' A' ' 6' ' ' PHE . 18.5 m -126.52 101.23 6.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.3 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.551 ' CZ ' ' HB3' ' A' ' 90' ' ' ALA . 19.5 m-85 -107.22 132.35 53.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.294 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.895 ' HB1' ' HD2' ' A' ' 94' ' ' PRO . . . 173.83 178.25 0.16 Allowed Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.397 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.895 ' HD2' ' HB1' ' A' ' 93' ' ' ALA . 49.0 Cg_endo . . . . . 0 C--O 1.248 1.019 0 C-N-CA 122.489 2.126 . . . . 0.0 112.095 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 27.5 mtpt . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.852 0.358 . . . . 0.0 110.578 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.798 HG12 ' CE1' ' A' ' 23' ' ' TYR . 29.5 m -122.22 -176.73 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.21 179.695 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.431 HG23 ' O ' ' A' ' 4' ' ' VAL . 0.3 OUTLIER -161.08 137.38 8.38 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.399 179.838 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.56 ' H ' ' HB3' ' A' ' 93' ' ' ALA . 19.6 m-85 -107.05 169.36 8.6 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.943 179.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.559 HG23 ' O ' ' A' ' 90' ' ' ALA . 47.3 m -162.04 103.56 1.14 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.925 0.393 . . . . 0.0 110.497 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.403 ' HA ' ' O ' ' A' ' 18' ' ' ALA . 31.0 t -53.22 92.57 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.341 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.6 ' OE1' HG21 ' A' ' 51' ' ' VAL . 0.1 OUTLIER -59.61 164.53 3.51 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.593 -179.859 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.46 ' HA ' HG23 ' A' ' 88' ' ' ILE . 1.5 pttt -86.03 61.14 6.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.286 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -133.1 22.61 3.99 Favored Glycine 0 CA--C 1.525 0.656 0 N-CA-C 111.001 -0.84 . . . . 0.0 111.001 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.4 t -81.82 146.54 29.83 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -152.45 -88.5 0.06 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.739 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -96.61 -66.32 0.91 Allowed 'General case' 0 N--CA 1.454 -0.235 0 CA-C-O 120.694 0.283 . . . . 0.0 110.3 -179.725 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.458 ' HD3' ' ND1' ' A' ' 16' ' ' HIS . 0.0 OUTLIER -140.81 49.1 1.69 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.627 -179.996 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . 0.458 ' ND1' ' HD3' ' A' ' 15' ' ' LYS . 45.6 m80 -129.93 112.56 13.64 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.075 179.555 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.452 HD22 ' HA ' ' A' ' 17' ' ' LEU . 1.5 tm? -98.53 81.39 2.71 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.225 -179.686 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.449 ' HB2' HG22 ' A' ' 53' ' ' THR . . . -61.95 131.54 50.02 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.572 -179.705 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.496 HG23 HG23 ' A' ' 21' ' ' VAL . 29.9 m -135.1 136.38 51.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.238 179.682 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.418 ' HB3' ' HB ' ' A' ' 7' ' ' THR . 0.8 OUTLIER -89.95 75.53 7.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.686 -179.743 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.496 HG23 HG23 ' A' ' 19' ' ' VAL . 14.5 t -75.11 95.32 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.093 179.668 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 23.6 tttt -171.4 132.41 0.78 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.46 -179.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.798 ' CE1' HG12 ' A' ' 4' ' ' VAL . 10.4 p90 -141.42 25.8 2.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.463 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 49.16 87.75 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.575 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -174.08 -105.38 0.18 Allowed Glycine 0 CA--C 1.523 0.532 0 N-CA-C 110.755 -0.938 . . . . 0.0 110.755 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -64.99 -175.17 0.18 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.75 0.309 . . . . 0.0 110.364 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.416 ' HB ' ' HG3' ' A' ' 71' ' ' GLU . 0.8 OUTLIER -103.78 -173.95 2.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.473 -179.866 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.41 ' O ' ' CG ' ' A' ' 71' ' ' GLU . 3.6 mtm -116.69 130.18 56.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.636 -179.621 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.771 ' HB3' ' O ' ' A' ' 69' ' ' LEU . . . -122.44 -56.85 1.78 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.641 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.405 ' O ' ' HB2' ' A' ' 68' ' ' PHE . 29.2 tt0 -158.42 166.49 32.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.287 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.469 HG21 ' CD1' ' A' ' 52' ' ' TRP . 26.4 t -151.67 152.09 11.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.927 0.394 . . . . 0.0 110.675 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.446 ' CB ' ' HA ' ' A' ' 43' ' ' ALA . 0.5 OUTLIER -155.21 138.84 16.03 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.364 179.963 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.498 ' HG ' ' CE2' ' A' ' 66' ' ' PHE . 1.4 mt -94.27 177.56 5.91 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.676 -179.53 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.421 ' CB ' ' HB2' ' A' ' 65' ' ' ASN . 0.1 OUTLIER -130.26 -156.91 0.79 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.664 179.649 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.402 ' OE2' ' CB ' ' A' ' 56' ' ' SER . 0.0 OUTLIER 178.48 105.25 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.826 0.346 . . . . 0.0 110.134 179.921 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 0.621 ' NE2' HD22 ' A' ' 60' ' ' LEU . 8.8 p-80 -50.11 119.37 3.57 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.462 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 117.68 -32.06 5.5 Favored Glycine 0 CA--C 1.522 0.53 0 N-CA-C 110.565 -1.014 . . . . 0.0 110.565 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -78.75 174.14 11.75 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.765 0.317 . . . . 0.0 110.16 179.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -129.07 26.44 5.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.5 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -159.92 145.26 15.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.457 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.503 ' CZ3' ' HG2' ' A' ' 67' ' ' ARG . 71.3 m95 -80.69 154.11 27.5 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.194 179.83 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.656 HG23 ' O ' ' A' ' 42' ' ' VAL . 29.7 m -115.47 105.42 18.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.957 0.408 . . . . 0.0 110.327 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.446 ' HA ' ' CB ' ' A' ' 32' ' ' GLU . . . -52.35 136.66 30.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.394 -179.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -71.69 -171.16 0.63 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.804 -179.801 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 47.5 m -144.55 111.4 5.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.557 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.478 ' HG2' ' CZ3' ' A' ' 52' ' ' TRP . 31.8 mtpt -77.06 95.27 4.16 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.042 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -128.86 -38.96 0.33 Allowed Glycine 0 CA--C 1.525 0.696 0 N-CA-C 111.437 -0.665 . . . . 0.0 111.437 -179.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.427 ' HB2' ' O ' ' A' ' 51' ' ' VAL . 0.0 OUTLIER -52.68 -175.32 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.99 0.424 . . . . 0.0 110.425 -179.741 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -104.01 41.69 2.08 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 145.59 -10.8 1.71 Allowed Glycine 0 CA--C 1.529 0.921 0 C-N-CA 121.015 -0.612 . . . . 0.0 112.428 179.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.6 HG21 ' OE1' ' A' ' 9' ' ' GLU . 33.5 m -133.21 175.02 12.34 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.137 0 CA-C-N 117.709 0.754 . . . . 0.0 110.844 -179.627 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . 0.478 ' CZ3' ' HG2' ' A' ' 46' ' ' LYS . 6.9 m95 -106.93 139.94 40.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.572 -179.576 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.449 HG22 ' HB2' ' A' ' 18' ' ' ALA . 2.6 p -122.4 135.52 54.71 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.359 179.739 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 1.3 t80 175.05 96.94 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.501 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.448 ' HB2' ' N ' ' A' ' 16' ' ' HIS . 6.0 t0 -99.62 31.03 3.34 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-O 121.43 0.634 . . . . 0.0 110.138 179.396 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.41 ' OG ' ' N ' ' A' ' 57' ' ' GLU . 44.9 t 45.91 -172.93 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 114.928 -1.033 . . . . 0.0 110.98 179.574 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.41 ' N ' ' OG ' ' A' ' 56' ' ' SER . 1.5 mt-10 -100.75 -46.86 5.02 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.225 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -64.03 116.42 27.11 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.451 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -68.33 59.6 1.03 Allowed 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.724 2.282 . . . . 0.0 112.333 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.621 HD22 ' NE2' ' A' ' 36' ' ' HIS . 1.6 mt -94.0 92.51 7.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.845 0.355 . . . . 0.0 110.322 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -77.0 78.38 3.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.469 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -145.93 -162.04 9.52 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.816 -0.913 . . . . 0.0 110.816 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -76.17 128.91 10.9 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.59 2.194 . . . . 0.0 112.075 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.443 ' HB3' ' CD2' ' A' ' 33' ' ' LEU . 27.4 m-85 -88.29 -178.27 5.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.976 0.417 . . . . 0.0 110.554 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.421 ' HB2' ' CB ' ' A' ' 34' ' ' ARG . 2.9 m-80 -153.55 137.65 16.44 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.631 179.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.498 ' CE2' ' HG ' ' A' ' 33' ' ' LEU . 80.8 m-85 -121.79 -178.36 3.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.045 0.45 . . . . 0.0 110.97 -179.642 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.503 ' HG2' ' CZ3' ' A' ' 41' ' ' TRP . 0.0 OUTLIER 175.65 47.79 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.656 179.997 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.623 ' HZ ' HG11 ' A' ' 4' ' ' VAL . 0.6 OUTLIER -48.63 172.57 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.108 -179.245 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.771 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 4.9 mt -122.28 72.51 1.06 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.446 179.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -37.98 142.14 0.18 Allowed 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.685 -179.254 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.708 ' HG2' ' HB2' ' A' ' 29' ' ' ALA . 3.1 mm-40 -51.57 -67.31 0.26 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.725 -179.742 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.79 31.38 5.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.733 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -106.34 -100.52 2.66 Favored Glycine 0 CA--C 1.523 0.547 0 N-CA-C 110.655 -0.978 . . . . 0.0 110.655 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 177.52 141.51 0.08 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.853 0.358 . . . . 0.0 110.361 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.436 ' HG3' ' HA ' ' A' ' 69' ' ' LEU . 0.0 OUTLIER -70.31 178.66 2.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.254 -179.982 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.466 ' O ' ' CE2' ' A' ' 78' ' ' PHE . 0.5 OUTLIER 170.04 131.79 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.582 179.92 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 79.7 t -85.18 150.61 3.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.111 -0.495 . . . . 0.0 109.928 179.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.523 ' CE1' HG22 ' A' ' 4' ' ' VAL . 61.3 m-85 -137.74 128.33 26.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.882 0.372 . . . . 0.0 110.645 -179.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -107.67 156.54 18.96 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.214 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 28.0 t70 51.97 52.81 13.68 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.34 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.683 HG13 ' HB2' ' A' ' 93' ' ' ALA . 85.7 t -85.76 -24.6 6.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.577 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.471 HG13 ' HD2' ' A' ' 83' ' ' PRO . 46.3 t -138.87 138.56 21.65 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.579 -179.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.493 ' HG3' ' CE1' ' A' ' 92' ' ' TYR . 49.3 Cg_endo -72.09 -166.88 0.28 Allowed 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.619 2.212 . . . . 0.0 111.979 179.621 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.66 -78.47 0.07 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.044 179.67 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.411 ' CG ' ' O ' ' A' ' 85' ' ' LYS . 0.0 OUTLIER -91.9 71.36 5.61 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.001 179.589 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 19.0 p90 -47.93 150.48 1.12 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.776 -179.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 1.2 m -117.63 115.56 25.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.291 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.46 HG23 ' HA ' ' A' ' 10' ' ' LYS . 42.3 mm -51.94 110.22 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.27 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 114.32 32.33 2.0 Favored Glycine 0 CA--C 1.523 0.552 0 N-CA-C 110.771 -0.932 . . . . 0.0 110.771 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.559 ' O ' HG23 ' A' ' 7' ' ' THR . . . -124.35 164.37 19.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.757 0.313 . . . . 0.0 110.398 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 6.9 m -119.68 89.93 3.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.66 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.532 ' O ' ' HB3' ' A' ' 93' ' ' ALA . 34.5 m-85 -89.03 -161.5 0.77 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.912 179.669 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.915 ' HB1' ' HD2' ' A' ' 94' ' ' PRO . . . 72.26 176.96 0.06 OUTLIER Pre-proline 0 C--N 1.332 -0.173 0 CA-C-O 120.614 0.245 . . . . 0.0 110.461 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.915 ' HD2' ' HB1' ' A' ' 93' ' ' ALA . 48.7 Cg_endo . . . . . 0 C--O 1.249 1.042 0 C-N-CA 122.506 2.137 . . . . 0.0 112.071 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 3.9 tttt . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.78 0.324 . . . . 0.0 110.242 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.874 HG11 ' CE2' ' A' ' 68' ' ' PHE . 27.0 m -80.38 -178.26 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.509 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.694 HG23 ' O ' ' A' ' 4' ' ' VAL . 0.6 OUTLIER -170.96 139.71 1.46 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.242 179.874 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.718 ' O ' HG23 ' A' ' 91' ' ' THR . 29.5 m-85 -113.65 168.91 9.37 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.492 -179.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.823 HG23 ' O ' ' A' ' 90' ' ' ALA . 19.1 m -165.57 118.59 1.16 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.381 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.526 HG11 HG13 ' A' ' 88' ' ' ILE . 62.6 t -61.65 102.57 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.335 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.736 ' OE2' HD12 ' A' ' 20' ' ' LEU . 1.8 mm-40 -70.11 174.67 5.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.502 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.4 mttt -83.17 64.48 7.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.556 -179.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -156.44 33.25 0.59 Allowed Glycine 0 CA--C 1.522 0.506 0 N-CA-C 110.457 -1.057 . . . . 0.0 110.457 179.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.3 p -89.82 114.97 26.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.873 0.368 . . . . 0.0 110.593 -179.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 13.8 m-20 -104.23 -156.05 0.56 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.081 -0.508 . . . . 0.0 109.933 179.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -46.35 -63.98 0.87 Allowed 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 120.846 0.355 . . . . 0.0 110.777 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.87 -22.68 9.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.906 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 28.8 m80 -48.84 136.51 13.81 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.96 0.41 . . . . 0.0 110.884 -179.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.42 HD22 ' HA ' ' A' ' 17' ' ' LEU . 0.2 OUTLIER -129.05 95.79 4.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.651 179.629 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.674 ' HB1' HG11 ' A' ' 51' ' ' VAL . . . -90.58 128.31 36.54 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.683 -179.489 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.687 ' O ' HG13 ' A' ' 51' ' ' VAL . 15.3 m -134.26 133.96 55.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.202 179.627 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.736 HD12 ' OE2' ' A' ' 9' ' ' GLU . 0.5 OUTLIER -83.83 71.93 10.42 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.384 -179.951 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.525 HG23 HG23 ' A' ' 19' ' ' VAL . 61.4 t -70.93 95.14 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.286 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 5.4 tttp -135.62 141.59 45.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.41 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -163.36 149.65 11.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.39 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -76.42 -22.23 54.95 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.743 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -46.91 -50.17 15.8 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 111.081 -0.807 . . . . 0.0 111.081 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -138.04 -174.69 3.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.776 0.322 . . . . 0.0 110.304 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.487 ' O ' HG22 ' A' ' 27' ' ' THR . 27.2 m -121.65 54.68 1.13 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.796 -179.677 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.588 ' O ' ' HB2' ' A' ' 29' ' ' ALA . 33.7 mtm 58.35 -164.11 0.2 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.786 179.55 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.704 ' HB2' ' N ' ' A' ' 71' ' ' GLU . . . 154.24 -62.59 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.367 0.667 . . . . 0.0 109.682 179.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.569 ' HB3' HD12 ' A' ' 69' ' ' LEU . 1.2 tt0 -160.75 141.17 11.4 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.817 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.535 HG21 ' CD1' ' A' ' 52' ' ' TRP . 4.2 t -134.72 156.39 39.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.973 0.416 . . . . 0.0 110.754 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.452 ' CB ' ' HA ' ' A' ' 43' ' ' ALA . 3.1 pt-20 -154.15 157.73 39.31 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.979 179.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.81 HD23 ' O ' ' A' ' 65' ' ' ASN . 4.6 mt -125.16 -176.54 3.6 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.457 -179.712 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.508 ' HD2' ' CD2' ' A' ' 41' ' ' TRP . 5.6 ttt180 -145.71 174.24 11.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.075 179.686 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.401 ' HG2' ' O ' ' A' ' 34' ' ' ARG . 21.4 mt-10 -154.27 93.76 1.65 Allowed 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 179.811 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -40.25 116.07 0.62 Allowed 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.389 -178.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 123.75 -25.41 6.19 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 110.466 -1.054 . . . . 0.0 110.466 -179.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 4.3 m -75.95 -161.34 0.17 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.81 0.338 . . . . 0.0 110.39 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -83.11 -65.81 0.96 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.528 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -153.18 -176.93 6.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.619 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.508 ' CD2' ' HD2' ' A' ' 34' ' ' ARG . 87.0 m95 -50.72 150.66 2.73 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.602 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.595 HG21 ' CZ ' ' A' ' 54' ' ' PHE . 10.5 m -131.62 131.91 62.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.139 179.718 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.452 ' HA ' ' CB ' ' A' ' 32' ' ' GLU . . . -57.22 147.23 25.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.569 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.414 ' N ' ' HA ' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -72.61 -166.04 0.25 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.993 179.855 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 90.0 m -154.05 112.61 3.62 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.837 0.351 . . . . 0.0 110.686 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 9.2 ptpt -68.92 69.55 0.18 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.193 -0.458 . . . . 0.0 109.97 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -90.47 -26.41 23.17 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 111.296 -0.722 . . . . 0.0 111.296 -179.491 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.441 ' CG ' ' HB ' ' A' ' 51' ' ' VAL . 5.4 tm-20 -78.45 -14.84 59.18 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.761 0.28 . . . . 0.0 111.222 -179.728 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 99.74 -41.39 2.19 Favored Glycine 0 CA--C 1.522 0.518 0 N-CA-C 109.976 -1.25 . . . . 0.0 109.976 -179.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.438 ' O ' ' CZ3' ' A' ' 52' ' ' TRP . . . -126.61 -45.25 0.23 Allowed Glycine 0 CA--C 1.519 0.287 0 N-CA-C 109.075 -1.61 . . . . 0.0 109.075 179.107 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.687 HG13 ' O ' ' A' ' 19' ' ' VAL . 19.6 t -82.57 151.36 4.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 178.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . 0.535 ' CD1' HG21 ' A' ' 31' ' ' VAL . 4.1 m95 -93.05 114.77 27.4 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.996 0.427 . . . . 0.0 110.187 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.527 ' CG2' ' HB2' ' A' ' 18' ' ' ALA . 1.8 p -108.07 137.58 45.82 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.286 -179.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.595 ' CZ ' HG21 ' A' ' 42' ' ' VAL . 51.2 t80 -120.34 142.79 48.81 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.686 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -99.94 109.38 21.74 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.061 179.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.4 ' HB2' ' OE2' ' A' ' 35' ' ' GLU . 27.6 p -89.83 158.95 17.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.558 -179.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -134.3 -44.52 0.77 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.42 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -51.88 156.57 2.44 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.395 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -67.88 -34.55 23.49 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.795 2.33 . . . . 0.0 112.433 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 2.2 mt -69.85 151.45 45.69 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.835 -179.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -174.1 72.9 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.22 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -128.44 -96.76 0.87 Allowed Glycine 0 CA--C 1.525 0.687 0 N-CA-C 110.814 -0.914 . . . . 0.0 110.814 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -77.18 97.77 1.17 Allowed 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.587 2.191 . . . . 0.0 112.205 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -73.51 166.47 23.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.588 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.81 ' O ' HD23 ' A' ' 33' ' ' LEU . 0.2 OUTLIER -135.81 122.99 21.64 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 179.227 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.574 ' CD2' ' CE2' ' A' ' 6' ' ' PHE . 2.8 m-85 -105.84 177.88 4.72 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.303 0.573 . . . . 0.0 112.081 -178.569 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.797 ' HD2' HG12 ' A' ' 77' ' ' VAL . 7.2 mtp180 -177.56 96.84 0.04 OUTLIER 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 114.877 -1.056 . . . . 0.0 110.287 179.45 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.88 ' O ' HD23 ' A' ' 69' ' ' LEU . 6.0 p90 -91.73 168.13 11.68 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-O 121.151 0.5 . . . . 0.0 110.455 179.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.88 HD23 ' O ' ' A' ' 68' ' ' PHE . 5.7 mt -136.28 65.23 1.53 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.641 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 26.8 p -33.5 150.09 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 115.899 -0.591 . . . . 0.0 112.048 -179.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.704 ' N ' ' HB2' ' A' ' 29' ' ' ALA . 7.8 mt-10 -49.21 -30.43 7.0 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.333 -179.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -69.19 -46.56 67.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.377 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 118.72 43.29 0.54 Allowed Glycine 0 CA--C 1.523 0.557 0 N-CA-C 110.69 -0.964 . . . . 0.0 110.69 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 12.1 mtp -105.61 108.1 19.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.833 0.349 . . . . 0.0 110.448 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.8 149.55 21.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.349 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -177.69 125.13 0.13 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.594 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.797 HG12 ' HD2' ' A' ' 67' ' ' ARG . 4.5 m -81.99 176.56 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.591 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.44 ' CE2' ' CE2' ' A' ' 68' ' ' PHE . 97.3 m-85 -156.79 112.82 2.97 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.3 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -98.18 158.17 15.72 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.463 -179.759 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 47.1 m-20 59.16 28.53 17.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.557 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.41 HG23 ' O ' ' A' ' 78' ' ' PHE . 74.3 t -61.17 -75.97 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 179.735 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.543 HG13 ' HD2' ' A' ' 83' ' ' PRO . 59.8 t -87.18 139.57 32.33 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.427 -0.352 . . . . 0.0 110.289 179.613 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.543 ' HD2' HG13 ' A' ' 82' ' ' VAL . 45.8 Cg_endo -70.5 -167.77 0.27 Allowed 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.595 2.197 . . . . 0.0 112.022 179.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.413 ' HG3' ' N ' ' A' ' 85' ' ' LYS . 4.3 pt-20 -83.84 -28.19 28.2 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.23 179.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.413 ' N ' ' HG3' ' A' ' 84' ' ' GLU . 0.0 OUTLIER -132.07 63.48 1.62 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.136 179.755 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 51.9 p90 -48.66 148.68 1.99 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.789 -179.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 37.0 m -128.18 113.27 15.49 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.271 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.526 HG13 HG11 ' A' ' 8' ' ' VAL . 3.0 mp -51.37 104.46 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.248 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 125.4 47.44 0.22 Allowed Glycine 0 CA--C 1.524 0.598 0 N-CA-C 110.707 -0.957 . . . . 0.0 110.707 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.823 ' O ' HG23 ' A' ' 7' ' ' THR . . . -167.48 175.07 7.4 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.754 0.311 . . . . 0.0 110.365 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.718 HG23 ' O ' ' A' ' 6' ' ' PHE . 5.1 m -113.32 141.56 46.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.484 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.597 ' OH ' ' HB3' ' A' ' 90' ' ' ALA . 11.6 m-85 -141.51 109.18 5.65 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.33 179.753 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.924 ' HB1' ' HD2' ' A' ' 94' ' ' PRO . . . 170.59 177.49 0.1 OUTLIER Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.406 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.924 ' HD2' ' HB1' ' A' ' 93' ' ' ALA . 48.2 Cg_endo . . . . . 0 C--O 1.249 1.031 0 C-N-CA 122.533 2.156 . . . . 0.0 112.097 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 2.3 tttp . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.711 0.291 . . . . 0.0 110.35 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.536 ' CG1' ' CE1' ' A' ' 78' ' ' PHE . 1.7 p -116.87 163.67 13.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.232 0.539 . . . . 0.0 110.397 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.466 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 0.6 OUTLIER -132.92 139.5 47.39 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.205 179.838 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.752 ' O ' HG23 ' A' ' 91' ' ' THR . 32.3 m-85 -98.26 -176.43 3.41 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.298 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.9 m -167.5 112.96 0.72 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.369 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 45.2 t -66.26 101.84 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.309 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.786 ' HG3' HG11 ' A' ' 51' ' ' VAL . 0.7 OUTLIER -54.39 -178.16 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.6 -179.79 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -94.24 46.96 1.17 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.269 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -133.56 23.82 3.76 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 110.895 -0.882 . . . . 0.0 110.895 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 7.9 m -86.65 106.04 17.33 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.782 0.325 . . . . 0.0 110.285 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 20.7 m-20 -100.61 -158.38 0.67 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.371 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -45.76 -62.26 1.38 Allowed 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.076 -179.742 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.98 19.12 11.7 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.005 -179.824 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 6.7 m80 -100.5 130.77 46.62 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.826 0.346 . . . . 0.0 110.088 179.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.517 HD22 ' HA ' ' A' ' 17' ' ' LEU . 0.5 OUTLIER -122.57 90.69 3.35 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.452 -179.628 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.486 ' HB2' ' CG2' ' A' ' 53' ' ' THR . . . -88.67 130.75 35.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.162 179.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.552 HG21 ' CZ ' ' A' ' 66' ' ' PHE . 25.8 m -129.87 152.3 37.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.555 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.498 HD22 ' CG ' ' A' ' 22' ' ' LYS . 0.4 OUTLIER -104.06 98.58 8.38 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.081 179.803 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 25.1 t -98.83 99.09 7.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.808 -179.55 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.498 ' CG ' HD22 ' A' ' 20' ' ' LEU . 0.0 OUTLIER 175.84 160.18 0.28 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.259 179.698 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -159.8 47.93 0.28 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.338 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 52.43 178.89 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.506 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 66.29 -82.06 0.1 Allowed Glycine 0 CA--C 1.523 0.547 0 N-CA-C 110.832 -0.907 . . . . 0.0 110.832 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 36.3 m-20 -64.71 167.91 6.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.821 0.343 . . . . 0.0 110.397 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -111.7 -160.05 0.7 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.275 -179.836 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.421 ' O ' ' CG ' ' A' ' 71' ' ' GLU . 6.2 mtt -121.05 125.5 47.46 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.925 0.393 . . . . 0.0 110.631 -179.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.689 ' HB2' ' N ' ' A' ' 71' ' ' GLU . . . -115.37 -57.62 2.23 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.4 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.554 ' C ' HG12 ' A' ' 31' ' ' VAL . 0.2 OUTLIER -165.86 177.67 7.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.143 -179.98 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.554 HG12 ' C ' ' A' ' 30' ' ' GLU . 0.5 OUTLIER 172.17 137.88 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 121.111 0.481 . . . . 0.0 110.251 -179.899 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.407 ' CB ' ' HA ' ' A' ' 43' ' ' ALA . 1.2 pt-20 -128.43 163.24 25.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.083 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.506 ' HG ' ' CE2' ' A' ' 66' ' ' PHE . 1.6 mt -109.49 163.57 13.31 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.055 0.455 . . . . 0.0 111.002 -179.543 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.443 ' HG3' ' CD2' ' A' ' 41' ' ' TRP . 0.7 OUTLIER -139.81 -163.39 1.49 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.688 179.375 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -153.42 -87.41 0.06 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.323 179.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 0.413 ' CG ' ' N ' ' A' ' 37' ' ' GLY . 48.0 p-80 -179.22 -47.19 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 120.83 0.348 . . . . 0.0 110.617 -179.858 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.413 ' N ' ' CG ' ' A' ' 36' ' ' HIS . . . -110.58 23.67 19.45 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 110.735 -0.946 . . . . 0.0 110.735 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.428 ' O ' ' CB ' ' A' ' 39' ' ' ASP . 1.9 t -86.11 -7.42 58.6 Favored 'General case' 0 C--N 1.33 -0.244 0 O-C-N 122.9 -0.176 . . . . 0.0 111.285 -179.797 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.428 ' CB ' ' O ' ' A' ' 38' ' ' SER . 0.8 OUTLIER 82.43 -51.76 0.2 Allowed 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 122.447 0.299 . . . . 0.0 110.9 179.942 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -142.42 177.88 7.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.915 0.388 . . . . 0.0 110.882 -179.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.494 ' CE2' ' HD2' ' A' ' 67' ' ' ARG . 60.3 m95 -78.55 166.53 22.46 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.443 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.456 HG23 ' O ' ' A' ' 42' ' ' VAL . 20.6 m -141.51 119.13 8.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.234 179.737 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.407 ' HA ' ' CB ' ' A' ' 32' ' ' GLU . . . -50.66 133.73 25.34 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.576 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.462 ' HE3' ' HB2' ' A' ' 52' ' ' TRP . 0.0 OUTLIER -63.04 -171.0 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.547 179.942 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 66.3 m -145.75 99.46 3.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.574 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.408 ' O ' ' HG3' ' A' ' 46' ' ' LYS . 2.8 ptmt -61.17 94.37 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.35 179.868 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -132.3 14.79 5.07 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 111.19 -0.764 . . . . 0.0 111.19 179.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -102.83 -14.17 16.7 Favored 'General case' 0 C--N 1.333 -0.152 0 O-C-N 122.719 -0.283 . . . . 0.0 110.986 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 66.1 26.16 72.36 Favored Glycine 0 CA--C 1.523 0.539 0 N-CA-C 110.42 -1.072 . . . . 0.0 110.42 -179.627 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -174.64 -39.42 0.05 OUTLIER Glycine 0 CA--C 1.523 0.591 0 N-CA-C 110.53 -1.028 . . . . 0.0 110.53 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.786 HG11 ' HG3' ' A' ' 9' ' ' GLU . 3.1 m -133.1 -177.16 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.922 0.391 . . . . 0.0 110.363 179.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . 0.462 ' HB2' ' HE3' ' A' ' 44' ' ' MET . 7.6 m95 -101.38 141.46 34.22 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.605 -179.558 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.486 ' CG2' ' HB2' ' A' ' 18' ' ' ALA . 0.6 OUTLIER -133.87 147.47 51.16 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.471 -179.757 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 75.7 t80 -130.98 112.49 12.99 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.407 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -71.58 161.91 30.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.411 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -146.56 170.81 16.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.114 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -146.31 -50.14 0.21 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.51 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -55.35 153.09 14.52 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.443 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -71.94 -50.15 0.28 Allowed 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 122.659 2.239 . . . . 0.0 112.136 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -57.91 130.99 49.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.687 -179.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 174.92 159.31 0.19 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.277 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -177.27 -99.77 0.13 Allowed Glycine 0 CA--C 1.526 0.76 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -75.32 157.47 41.43 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.569 2.18 . . . . 0.0 112.135 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.449 ' CE2' ' HG ' ' A' ' 17' ' ' LEU . 72.8 m-85 -124.27 -177.73 3.88 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.093 0.473 . . . . 0.0 110.845 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.404 ' HB2' ' HB3' ' A' ' 34' ' ' ARG . 1.8 m-80 -153.33 130.42 11.1 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.636 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.552 ' CZ ' HG21 ' A' ' 19' ' ' VAL . 80.8 m-85 -114.07 178.98 4.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.14 0.495 . . . . 0.0 110.838 -179.561 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.494 ' HD2' ' CE2' ' A' ' 41' ' ' TRP . 17.1 ptm180 -176.83 59.15 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.656 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.743 ' O ' HD23 ' A' ' 69' ' ' LEU . 0.0 OUTLIER -54.89 178.54 0.03 OUTLIER 'General case' 0 CA--C 1.518 -0.28 0 CA-C-O 121.388 0.613 . . . . 0.0 111.492 -179.21 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.743 HD23 ' O ' ' A' ' 68' ' ' PHE . 7.1 mt -144.64 48.39 1.34 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.107 -0.951 . . . . 0.0 109.182 179.78 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.1 p -25.46 137.12 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.88 0.872 . . . . 0.0 112.741 -179.007 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.689 ' N ' ' HB2' ' A' ' 29' ' ' ALA . 6.3 mt-10 -49.62 -59.03 4.15 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.507 -179.69 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 3.6 tmtt? -123.66 58.91 1.13 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.314 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -141.4 -101.63 0.45 Allowed Glycine 0 CA--C 1.522 0.516 0 N-CA-C 110.77 -0.932 . . . . 0.0 110.77 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.6 ptm -173.46 -178.43 1.67 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.709 0.29 . . . . 0.0 110.297 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.86 158.12 45.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.52 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 174.05 128.43 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.266 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 17.6 m -68.71 140.72 18.49 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.473 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.536 ' CE1' ' CG1' ' A' ' 4' ' ' VAL . 79.6 m-85 -116.81 121.53 41.81 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.311 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 26.1 m-20 -101.64 141.09 35.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.569 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 17.1 t0 60.13 60.84 1.98 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.604 179.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.416 ' HA ' ' HA ' ' A' ' 93' ' ' ALA . 75.7 t -89.44 -65.57 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 179.695 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.556 HG13 ' HD2' ' A' ' 83' ' ' PRO . 60.8 t -87.83 139.83 31.17 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.388 179.78 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.556 ' HD2' HG13 ' A' ' 82' ' ' VAL . 47.8 Cg_endo -71.88 173.47 12.71 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.61 2.207 . . . . 0.0 112.071 179.83 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -55.54 -51.21 67.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.098 179.676 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 5.3 mttt -114.78 87.08 2.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.115 179.655 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 0.438 ' HB3' ' CG1' ' A' ' 82' ' ' VAL . 28.1 p90 -65.94 164.47 15.01 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.579 -179.799 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 7.4 m -145.43 112.76 6.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.261 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.549 HG23 ' O ' ' A' ' 9' ' ' GLU . 2.5 mp -50.81 98.64 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.457 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 132.03 54.63 0.08 OUTLIER Glycine 0 CA--C 1.523 0.587 0 N-CA-C 110.781 -0.927 . . . . 0.0 110.781 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.793 ' HB3' ' OH ' ' A' ' 92' ' ' TYR . . . -172.6 -177.75 1.79 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.816 0.341 . . . . 0.0 110.398 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.752 HG23 ' O ' ' A' ' 6' ' ' PHE . 4.1 m -124.97 142.55 51.41 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.375 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.793 ' OH ' ' HB3' ' A' ' 90' ' ' ALA . 4.7 m-85 -146.76 123.59 11.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.359 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.922 ' HB1' ' HD2' ' A' ' 94' ' ' PRO . . . 174.93 178.88 0.18 Allowed Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.41 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.922 ' HD2' ' HB1' ' A' ' 93' ' ' ALA . 47.7 Cg_endo . . . . . 0 C--O 1.249 1.031 0 C-N-CA 122.488 2.125 . . . . 0.0 112.099 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 7.6 ttpt . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.866 0.365 . . . . 0.0 110.165 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.581 HG11 ' CE2' ' A' ' 78' ' ' PHE . 2.4 p -74.75 162.99 4.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.368 0.604 . . . . 0.0 110.552 -179.85 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.495 ' N ' HG22 ' A' ' 4' ' ' VAL . 1.8 p -139.6 148.79 42.98 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.133 -0.94 . . . . 0.0 110.124 179.672 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.433 ' CE2' HG22 ' A' ' 21' ' ' VAL . 48.2 m-85 -123.5 145.05 49.15 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.111 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.411 ' O ' ' N ' ' A' ' 20' ' ' LEU . 3.8 m -148.36 129.78 14.81 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.152 -179.88 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.723 HG23 ' HE2' ' A' ' 92' ' ' TYR . 96.1 t -73.21 101.16 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.401 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.412 ' N ' ' O ' ' A' ' 18' ' ' ALA . 6.5 mt-10 -59.1 165.15 2.65 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.485 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.77 65.4 3.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.286 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -154.91 33.44 0.67 Allowed Glycine 0 CA--C 1.524 0.615 0 N-CA-C 110.812 -0.915 . . . . 0.0 110.812 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 21.2 p -82.03 130.08 34.98 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 110.211 -0.292 . . . . 0.0 110.211 179.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 6.2 m-80 -112.44 -161.97 0.78 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.518 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -49.76 -71.06 0.07 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.145 -179.461 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 41.5 pttt -117.99 40.95 3.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.841 -179.328 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 9.0 m80 -113.83 178.95 4.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.4 179.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 43.7 tp -165.15 94.25 0.64 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.419 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.484 ' HB2' HG22 ' A' ' 53' ' ' THR . . . -91.58 107.47 19.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.372 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.469 HG23 HG23 ' A' ' 21' ' ' VAL . 17.1 m -90.72 -173.55 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.286 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.411 ' N ' ' O ' ' A' ' 7' ' ' THR . 2.1 tt -135.11 78.15 1.72 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.502 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.469 HG23 HG23 ' A' ' 19' ' ' VAL . 16.0 t -86.23 100.63 9.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.295 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 17.1 tptt -176.11 124.73 0.19 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.548 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.443 ' CE1' HG23 ' A' ' 4' ' ' VAL . 42.6 p90 -156.98 174.29 15.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.251 179.862 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -64.21 119.65 10.64 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.495 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 122.07 -65.73 0.49 Allowed Glycine 0 CA--C 1.523 0.557 0 N-CA-C 110.921 -0.872 . . . . 0.0 110.921 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.817 ' OD1' HG22 ' A' ' 70' ' ' THR . 32.4 t0 -66.83 137.47 56.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.824 0.345 . . . . 0.0 110.577 -179.79 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.704 ' O ' HG22 ' A' ' 27' ' ' THR . 60.2 m -111.38 18.22 19.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.815 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.418 ' O ' ' CG ' ' A' ' 71' ' ' GLU . 19.7 mtp 59.55 114.79 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.797 0.332 . . . . 0.0 110.604 179.777 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.809 ' HB3' ' O ' ' A' ' 69' ' ' LEU . . . -134.53 -58.86 0.82 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.309 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.523 ' HB2' HD12 ' A' ' 69' ' ' LEU . 29.2 mt-10 -155.93 153.35 29.47 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.92 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.429 ' HA ' ' HA ' ' A' ' 68' ' ' PHE . 0.6 OUTLIER -172.43 148.0 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.386 0.612 . . . . 0.0 110.627 -179.713 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.407 ' HG3' ' HB3' ' A' ' 41' ' ' TRP . 2.2 pt-20 -142.22 178.86 7.27 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.065 -0.97 . . . . 0.0 109.688 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.708 HD21 ' CE1' ' A' ' 66' ' ' PHE . 4.4 mt -122.87 176.74 5.82 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.133 0.492 . . . . 0.0 111.031 -179.559 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 4.8 ttp180 -145.27 -175.46 4.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.673 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.44 ' CG ' ' HG2' ' A' ' 58' ' ' GLU . 4.9 mm-40 -151.58 29.93 0.6 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.722 0.296 . . . . 0.0 110.81 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER 56.58 164.53 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.555 179.615 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 51.99 25.08 16.09 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 110.887 -0.885 . . . . 0.0 110.887 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -135.91 109.84 8.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.857 0.36 . . . . 0.0 110.356 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -61.54 -22.54 65.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.654 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -100.2 176.52 5.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.914 0.388 . . . . 0.0 110.558 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.501 ' CE3' ' HG2' ' A' ' 67' ' ' ARG . 62.3 m95 -123.26 157.46 33.08 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.072 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.515 HG22 ' O ' ' A' ' 33' ' ' LEU . 4.5 m -107.25 105.89 19.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.946 0.403 . . . . 0.0 110.504 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -54.08 121.75 8.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.771 -179.724 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.88 -169.87 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.267 179.729 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 47.5 m -147.61 105.19 3.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.703 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 14.9 ptmt -62.67 82.92 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 179.509 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -109.72 -25.45 5.43 Favored Glycine 0 CA--C 1.522 0.484 0 N-CA-C 111.067 -0.813 . . . . 0.0 111.067 -179.425 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.641 ' HG2' HG22 ' A' ' 51' ' ' VAL . 1.1 tp10 -77.57 -41.04 40.29 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.774 0.321 . . . . 0.0 110.458 -179.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 99.42 -44.19 1.71 Allowed Glycine 0 CA--C 1.522 0.482 0 N-CA-C 110.168 -1.173 . . . . 0.0 110.168 -179.487 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -92.49 -29.7 10.72 Favored Glycine 0 CA--C 1.522 0.494 0 N-CA-C 110.208 -1.157 . . . . 0.0 110.208 179.516 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.641 HG22 ' HG2' ' A' ' 48' ' ' GLU . 3.5 m -140.41 -176.81 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.895 0.379 . . . . 0.0 110.283 179.65 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 9.5 m95 -106.43 134.42 49.6 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.837 -179.206 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.484 HG22 ' HB2' ' A' ' 18' ' ' ALA . 4.9 p -117.09 145.81 43.52 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.225 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.497 ' CE2' ' HB2' ' A' ' 56' ' ' SER . 85.2 t80 -131.5 138.9 49.16 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.329 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -122.73 134.08 54.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.524 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.497 ' HB2' ' CE2' ' A' ' 54' ' ' PHE . 0.3 OUTLIER -175.31 177.89 1.78 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.396 -179.972 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -155.79 26.88 0.38 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.404 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.44 ' HG2' ' CG ' ' A' ' 35' ' ' GLU . 0.0 OUTLIER -49.22 169.41 0.17 Allowed Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.636 -179.935 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.41 ' CD ' ' HB2' ' A' ' 58' ' ' GLU . 37.8 Cg_endo -93.92 20.09 0.71 Allowed 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 123.851 3.034 . . . . 0.0 112.243 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.6 mt -110.06 51.42 0.76 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.391 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 6.4 mm100 -60.13 121.19 11.3 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.292 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 169.32 -142.76 7.53 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 110.762 -0.935 . . . . 0.0 110.762 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -75.95 169.96 21.09 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.57 2.18 . . . . 0.0 111.975 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.429 ' HD2' HG21 ' A' ' 82' ' ' VAL . 54.6 m-85 -118.26 169.65 9.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.377 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -141.74 134.33 28.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.005 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.708 ' CE1' HD21 ' A' ' 33' ' ' LEU . 72.9 m-85 -119.1 179.61 4.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.044 0.449 . . . . 0.0 110.697 -179.808 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.501 ' HG2' ' CE3' ' A' ' 41' ' ' TRP . 0.0 OUTLIER -176.19 60.75 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.683 -0.689 . . . . 0.0 109.71 179.629 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.833 ' O ' HD23 ' A' ' 69' ' ' LEU . 4.6 p90 -56.04 179.44 0.04 OUTLIER 'General case' 0 CA--C 1.519 -0.23 0 CA-C-O 121.263 0.554 . . . . 0.0 111.16 -179.3 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.833 HD23 ' O ' ' A' ' 68' ' ' PHE . 6.0 mt -141.7 67.08 1.34 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.245 -0.889 . . . . 0.0 109.179 179.737 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.817 HG22 ' OD1' ' A' ' 26' ' ' ASP . 69.9 p -33.03 140.73 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 115.908 -0.587 . . . . 0.0 112.293 -178.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.709 ' HG2' ' HB2' ' A' ' 29' ' ' ALA . 7.1 mm-40 -53.07 -57.9 8.83 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.567 -179.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.09 81.74 2.04 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.506 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -175.7 -95.4 0.1 OUTLIER Glycine 0 CA--C 1.523 0.562 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 16.6 ptm 179.84 -177.53 0.37 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.869 0.366 . . . . 0.0 110.275 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.63 179.82 3.84 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.262 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 177.9 139.87 0.08 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.625 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.436 HG12 ' N ' ' A' ' 78' ' ' PHE . 87.3 t -89.5 157.38 3.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.131 179.696 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.581 ' CE2' HG11 ' A' ' 4' ' ' VAL . 78.8 m-85 -146.34 137.91 24.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.873 0.368 . . . . 0.0 110.539 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 29.5 p-10 -116.1 159.52 21.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.255 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 56.99 45.75 20.62 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.316 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.653 ' O ' HG12 ' A' ' 81' ' ' VAL . 60.3 t -94.17 8.08 5.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.104 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.491 HG23 ' O ' ' A' ' 81' ' ' VAL . 72.9 t -158.47 129.93 3.91 Favored Pre-proline 0 CA--C 1.53 0.18 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 179.693 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.457 ' HD3' ' CD1' ' A' ' 92' ' ' TYR . 47.6 Cg_endo -74.88 -169.47 0.63 Allowed 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.352 2.035 . . . . 0.0 112.08 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -77.41 -30.81 53.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.252 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 36.3 mttt -132.74 72.92 1.5 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.333 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 50.3 p90 -53.24 149.49 7.13 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.528 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.467 ' O ' HG23 ' A' ' 87' ' ' THR . 4.9 t -128.08 115.24 18.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.289 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.413 ' H ' HD12 ' A' ' 88' ' ' ILE . 3.4 mp -48.93 110.51 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.616 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 110.04 58.03 0.51 Allowed Glycine 0 CA--C 1.523 0.568 0 N-CA-C 110.712 -0.955 . . . . 0.0 110.712 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -176.28 139.78 0.36 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.805 0.336 . . . . 0.0 110.395 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 57.5 m -89.4 123.05 33.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.284 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.723 ' HE2' HG23 ' A' ' 8' ' ' VAL . 5.7 m-85 -101.95 -34.68 9.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.636 -179.633 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.854 ' HB1' ' HD2' ' A' ' 94' ' ' PRO . . . -50.02 178.94 0.04 OUTLIER Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.654 -179.782 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.854 ' HD2' ' HB1' ' A' ' 93' ' ' ALA . 48.5 Cg_endo . . . . . 0 C--O 1.249 1.036 0 C-N-CA 122.661 2.241 . . . . 0.0 112.19 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.457 -0.096 0 CA-C-O 120.798 0.332 . . . . 0.0 110.977 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.45 ' CG2' ' CE1' ' A' ' 78' ' ' PHE . 29.8 m -53.52 171.66 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.205 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 15.0 p -153.15 127.45 9.19 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.385 179.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.976 ' O ' HG23 ' A' ' 91' ' ' THR . 45.4 m-85 -84.74 -173.08 4.53 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.938 179.821 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.466 HG23 ' OG1' ' A' ' 91' ' ' THR . 0.2 OUTLIER -165.03 117.36 1.19 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.976 0.417 . . . . 0.0 111.028 -179.988 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.679 HG21 ' HA ' ' A' ' 88' ' ' ILE . 14.3 p -49.85 129.31 7.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.423 179.546 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.735 ' HG3' HG11 ' A' ' 51' ' ' VAL . 8.9 mm-40 -116.95 163.33 16.37 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.355 179.785 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -50.37 -24.5 3.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.9 -179.538 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.637 ' HA3' ' HB2' ' A' ' 18' ' ' ALA . . . -45.95 -27.52 2.45 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 111.12 -0.792 . . . . 0.0 111.12 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.4 m -72.68 115.55 12.1 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 179.686 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.416 ' ND2' ' O ' ' A' ' 11' ' ' GLY . 5.4 m-80 -115.59 -68.43 0.92 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.41 -179.753 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -125.82 -66.91 0.91 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.126 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.26 27.05 9.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.139 179.759 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 58.1 m80 -109.75 145.66 36.25 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.391 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.619 HD11 ' CE2' ' A' ' 64' ' ' PHE . 8.7 mt -125.93 89.47 3.03 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.957 0.408 . . . . 0.0 110.272 179.766 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.656 ' HB2' ' CG2' ' A' ' 53' ' ' THR . . . -82.96 143.9 30.36 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.841 179.723 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.412 ' HB ' ' HB3' ' A' ' 6' ' ' PHE . 17.0 m -139.42 145.39 27.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.772 0.32 . . . . 0.0 110.947 -179.606 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -100.83 56.27 0.87 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.486 179.659 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.457 ' CG1' ' CD1' ' A' ' 52' ' ' TRP . 2.3 p -67.47 102.94 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.175 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -165.45 135.46 3.59 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.328 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 9.5 p90 -156.76 35.26 0.3 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.415 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 51.35 -162.26 0.07 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.454 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 61.42 -103.55 0.57 Allowed Glycine 0 CA--C 1.522 0.529 0 N-CA-C 110.637 -0.985 . . . . 0.0 110.637 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 64.9 m-20 -67.87 132.63 47.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.791 0.329 . . . . 0.0 110.151 179.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.519 HG22 ' H ' ' A' ' 28' ' ' MET . 0.2 OUTLIER -76.45 175.02 9.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.563 -179.742 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.519 ' H ' HG22 ' A' ' 27' ' ' THR . 0.1 OUTLIER -98.51 130.11 45.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.452 -179.804 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.817 ' HB3' ' O ' ' A' ' 69' ' ' LEU . . . -118.32 -53.07 2.36 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.691 -179.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -161.73 159.16 26.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.905 0.383 . . . . 0.0 110.62 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.828 HG21 ' CD1' ' A' ' 52' ' ' TRP . 18.0 t -143.05 165.12 15.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.936 179.796 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.503 ' N ' HG12 ' A' ' 31' ' ' VAL . 9.6 pt-20 -174.74 147.86 1.07 Allowed 'General case' 0 N--CA 1.451 -0.411 0 CA-C-O 120.805 0.336 . . . . 0.0 110.687 -179.603 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.625 HD12 ' N ' ' A' ' 34' ' ' ARG . 2.9 pp -109.48 171.19 7.59 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.325 179.619 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.625 ' N ' HD12 ' A' ' 33' ' ' LEU . 3.8 ttp85 -101.14 -54.65 2.74 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.764 -179.514 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.453 ' CB ' ' O ' ' A' ' 34' ' ' ARG . 3.6 tt0 88.36 30.62 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 109.182 -0.674 . . . . 0.0 109.182 -178.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 29.8 t60 46.81 -87.7 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.068 -0.969 . . . . 0.0 111.469 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.433 ' N ' ' O ' ' A' ' 35' ' ' GLU . . . -42.32 -51.42 5.36 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 111.602 -0.599 . . . . 0.0 111.602 -179.516 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.406 ' HB2' ' HB3' ' A' ' 35' ' ' GLU . 0.6 OUTLIER -49.87 100.91 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.767 0.317 . . . . 0.0 110.585 -179.962 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -51.43 -29.89 17.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.245 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -108.39 164.15 12.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.193 179.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.483 ' CZ3' ' HG2' ' A' ' 67' ' ' ARG . 67.1 m95 -87.77 150.14 23.76 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.314 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.605 HG23 ' HG ' ' A' ' 33' ' ' LEU . 11.0 m -115.66 113.95 44.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.141 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.444 ' HA ' ' CB ' ' A' ' 32' ' ' GLU . . . -48.97 130.83 18.71 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.618 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.86 -169.9 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.145 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 53.9 m -141.28 107.51 5.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.325 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 17.1 ptmt -75.9 63.65 1.74 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.269 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -77.57 -26.4 61.16 Favored Glycine 0 CA--C 1.522 0.496 0 N-CA-C 110.627 -0.989 . . . . 0.0 110.627 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -84.47 -169.53 2.66 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.824 0.345 . . . . 0.0 110.322 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -107.13 -27.37 5.37 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 110.825 -0.91 . . . . 0.0 110.825 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -131.13 -3.58 4.34 Favored Glycine 0 CA--C 1.529 0.948 0 C-N-CA 121.363 -0.446 . . . . 0.0 112.34 -179.496 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.735 HG11 ' HG3' ' A' ' 9' ' ' GLU . 33.1 m -134.27 167.22 26.62 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.132 0 CA-C-N 117.573 0.687 . . . . 0.0 110.629 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . 0.828 ' CD1' HG21 ' A' ' 31' ' ' VAL . 4.7 m95 -115.04 134.97 54.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.532 -179.689 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.656 ' CG2' ' HB2' ' A' ' 18' ' ' ALA . 0.1 OUTLIER -122.18 168.63 11.77 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.721 179.414 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.601 ' CD2' HD21 ' A' ' 33' ' ' LEU . 78.8 t80 -154.04 120.13 5.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.755 0.312 . . . . 0.0 110.936 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -78.25 134.17 37.6 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.019 179.552 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -113.52 -177.77 3.21 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.905 0.383 . . . . 0.0 110.752 -179.662 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -152.24 -45.09 0.1 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.415 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.97 156.69 4.93 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.548 -179.797 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -80.31 -19.75 8.9 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.664 2.243 . . . . 0.0 111.857 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.4 tp -48.94 135.01 16.25 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.606 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -139.45 81.71 1.85 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.338 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -137.24 -148.11 5.38 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.744 -0.942 . . . . 0.0 110.744 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -78.93 139.61 15.48 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.572 2.181 . . . . 0.0 112.127 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.619 ' CE2' HD11 ' A' ' 17' ' ' LEU . 60.9 m-85 -115.45 99.1 7.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.229 179.72 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.403 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 21.6 m-20 -62.62 164.93 6.95 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.277 -0.419 . . . . 0.0 109.96 179.78 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.498 ' CE1' ' HB3' ' A' ' 33' ' ' LEU . 21.7 m-85 -142.48 -179.05 6.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.889 0.376 . . . . 0.0 110.777 -179.778 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.483 ' HG2' ' CZ3' ' A' ' 41' ' ' TRP . 7.8 ptm180 174.5 85.31 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.284 -179.755 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.49 ' HB3' HG22 ' A' ' 31' ' ' VAL . 1.6 p90 -76.95 171.95 13.95 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.134 0.492 . . . . 0.0 110.816 -179.773 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.817 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 5.4 mt -124.69 61.68 1.15 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.406 179.783 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.2 p -30.63 137.13 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.356 0.662 . . . . 0.0 112.293 -179.066 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.649 ' HG2' ' HB2' ' A' ' 29' ' ' ALA . 13.1 mt-10 -53.56 -67.54 0.25 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.338 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -111.95 61.49 0.62 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.43 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -151.21 -104.69 0.28 Allowed Glycine 0 CA--C 1.523 0.564 0 N-CA-C 110.801 -0.92 . . . . 0.0 110.801 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 179.94 172.31 1.04 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.837 0.351 . . . . 0.0 110.274 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -86.59 -178.36 6.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.413 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 172.75 153.27 0.08 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.195 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.495 HG12 ' N ' ' A' ' 78' ' ' PHE . 77.2 t -102.16 159.75 4.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.358 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.495 ' N ' HG12 ' A' ' 77' ' ' VAL . 29.8 m-85 -148.4 122.96 9.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.403 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -109.04 154.2 22.55 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.295 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 56.61 52.86 9.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.386 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.626 ' O ' HG12 ' A' ' 81' ' ' VAL . 72.9 t -95.77 5.79 8.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.169 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.441 HG23 ' O ' ' A' ' 81' ' ' VAL . 88.3 t -158.69 127.73 3.1 Favored Pre-proline 0 CA--C 1.53 0.18 0 N-CA-C 110.09 -0.337 . . . . 0.0 110.09 179.486 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -81.31 160.49 20.08 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.61 2.207 . . . . 0.0 111.893 179.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -55.88 121.18 8.68 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 179.364 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 61.62 59.69 1.78 Allowed 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 -179.309 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 36.3 p90 -44.48 156.94 0.07 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.25 -179.347 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 88.2 m -135.27 107.78 7.37 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.731 179.641 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.679 ' HA ' HG21 ' A' ' 8' ' ' VAL . 2.8 mp -49.42 94.45 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.852 0.358 . . . . 0.0 110.596 -179.559 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.652 ' H ' HG11 ' A' ' 8' ' ' VAL . . . 160.47 47.66 0.02 OUTLIER Glycine 0 CA--C 1.523 0.552 0 N-CA-C 111.11 -0.796 . . . . 0.0 111.11 179.84 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.48 ' HB2' ' O ' ' A' ' 89' ' ' GLY . . . 174.66 162.82 0.22 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.873 0.368 . . . . 0.0 110.79 179.811 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.976 HG23 ' O ' ' A' ' 6' ' ' PHE . 87.7 m -96.28 141.17 29.93 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.02 179.783 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.454 ' O ' ' HB2' ' A' ' 93' ' ' ALA . 8.4 m-85 -136.43 129.68 31.53 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.454 -179.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.899 ' HB1' ' HD2' ' A' ' 94' ' ' PRO . . . 174.98 179.28 0.17 Allowed Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.358 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.899 ' HD2' ' HB1' ' A' ' 93' ' ' ALA . 48.5 Cg_endo . . . . . 0 C--O 1.248 1.017 0 C-N-CA 122.549 2.166 . . . . 0.0 112.1 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 6.0 mtpt . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.668 0.271 . . . . 0.0 110.497 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.799 ' O ' HG23 ' A' ' 5' ' ' THR . 0.4 OUTLIER 41.15 -164.28 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 CA-C-O 121.135 0.493 . . . . 0.0 111.127 179.868 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.799 HG23 ' O ' ' A' ' 4' ' ' VAL . 0.6 OUTLIER -174.56 -35.79 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.626 -0.716 . . . . 0.0 111.359 -179.749 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.778 ' O ' HG23 ' A' ' 91' ' ' THR . 86.2 m-85 66.44 156.17 0.1 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.204 -179.407 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.407 ' O ' ' N ' ' A' ' 20' ' ' LEU . 0.3 OUTLIER -163.58 117.85 1.58 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.568 -179.945 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 95.2 t -64.1 101.33 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.103 179.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.427 ' HG3' HG21 ' A' ' 51' ' ' VAL . 4.4 mm-40 -64.75 162.91 15.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.71 -179.73 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 26.9 tttt -79.21 102.57 8.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.144 179.752 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 178.42 -35.86 0.08 OUTLIER Glycine 0 CA--C 1.523 0.553 0 N-CA-C 110.858 -0.897 . . . . 0.0 110.858 -179.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -48.18 130.8 16.15 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.815 0.34 . . . . 0.0 110.646 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 20.0 m-80 -123.89 -67.2 0.94 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.356 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -121.39 -78.2 0.59 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.416 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.432 ' HG2' ' N ' ' A' ' 16' ' ' HIS . 0.0 OUTLIER -97.04 -24.77 15.62 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.698 -179.87 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . 0.47 ' CE1' ' OD1' ' A' ' 55' ' ' ASP . 5.9 m80 -63.07 119.26 9.17 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.147 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.422 HD22 ' HA ' ' A' ' 17' ' ' LEU . 0.2 OUTLIER -114.03 97.06 6.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.46 -179.844 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -94.19 131.17 40.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.37 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.611 HG23 HG23 ' A' ' 21' ' ' VAL . 18.6 m -125.26 -175.04 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.271 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.535 HD23 ' HG2' ' A' ' 22' ' ' LYS . 1.1 tt -134.88 70.39 1.44 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.219 179.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.611 HG23 HG23 ' A' ' 19' ' ' VAL . 6.3 t -86.25 103.63 12.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.453 -179.783 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.535 ' HG2' HD23 ' A' ' 20' ' ' LEU . 0.1 OUTLIER 176.29 131.7 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.412 179.822 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.58 ' CE2' HG23 ' A' ' 4' ' ' VAL . 6.4 p90 -151.0 158.77 44.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.265 179.864 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -74.23 115.53 13.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.404 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 155.49 -82.25 0.16 Allowed Glycine 0 CA--C 1.523 0.592 0 N-CA-C 110.743 -0.943 . . . . 0.0 110.743 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -81.91 -166.08 1.14 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.812 0.339 . . . . 0.0 110.378 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -121.42 176.01 5.88 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.465 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.405 ' O ' ' CG ' ' A' ' 71' ' ' GLU . 12.6 mtt -108.49 118.06 35.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.383 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.834 ' HB3' ' O ' ' A' ' 69' ' ' LEU . . . -119.38 -61.38 1.63 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.573 -179.831 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 15.2 tt0 -155.84 163.53 39.69 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.139 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.86 HG21 ' CD1' ' A' ' 52' ' ' TRP . 38.7 t -139.57 140.6 36.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.089 0.471 . . . . 0.0 110.721 -179.796 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.413 ' OE1' ' HB2' ' A' ' 43' ' ' ALA . 5.5 tp10 -134.78 123.33 23.42 Favored 'General case' 0 N--CA 1.441 -0.925 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.271 -179.755 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.787 HD12 ' N ' ' A' ' 34' ' ' ARG . 2.7 pp -111.92 177.08 4.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.213 0.53 . . . . 0.0 111.223 -179.395 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.787 ' N ' HD12 ' A' ' 33' ' ' LEU . 6.8 ttt180 -145.35 175.32 10.39 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.342 179.576 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.423 ' O ' ' HB2' ' A' ' 36' ' ' HIS . 17.9 mt-10 -116.12 -82.76 0.63 Allowed 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 179.728 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 0.423 ' HB2' ' O ' ' A' ' 35' ' ' GLU . 20.6 t-160 178.08 -37.38 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.062 179.095 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -111.1 -18.66 8.09 Favored Glycine 0 CA--C 1.527 0.813 0 N-CA-C 111.007 -0.837 . . . . 0.0 111.007 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.5 p -47.4 152.1 0.68 Allowed 'General case' 0 N--CA 1.462 0.136 0 CA-C-O 120.847 0.356 . . . . 0.0 110.772 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 36.1 m-20 -53.65 -44.06 69.29 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.516 -179.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -162.76 -177.04 5.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.414 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.488 ' CZ3' ' HG2' ' A' ' 67' ' ' ARG . 55.2 m95 -58.76 156.28 11.39 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.205 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.509 HG23 ' O ' ' A' ' 42' ' ' VAL . 18.6 m -130.17 113.86 27.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.315 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.413 ' HB2' ' OE1' ' A' ' 32' ' ' GLU . . . -55.52 123.2 13.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.214 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.55 ' HG2' HD23 ' A' ' 33' ' ' LEU . 0.1 OUTLIER -51.7 -176.57 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.804 -179.797 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.418 ' O ' ' N ' ' A' ' 47' ' ' GLY . 33.1 m -149.73 126.03 10.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.393 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 15.1 ptmt -65.19 75.33 0.05 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.2 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.418 ' N ' ' O ' ' A' ' 45' ' ' THR . . . -93.89 -32.11 7.76 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 110.945 -0.862 . . . . 0.0 110.945 -179.825 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.41 ' HB2' ' O ' ' A' ' 51' ' ' VAL . 0.1 OUTLIER -78.42 174.14 11.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.871 0.367 . . . . 0.0 110.29 -179.983 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -104.64 34.46 5.77 Favored Glycine 0 CA--C 1.522 0.524 0 N-CA-C 110.228 -1.149 . . . . 0.0 110.228 179.724 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 178.78 -35.01 0.08 OUTLIER Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.979 -0.849 . . . . 0.0 110.979 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.527 HG11 ' HA ' ' A' ' 20' ' ' LEU . 3.3 m -123.03 -176.31 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 120.87 0.367 . . . . 0.0 110.557 -179.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . 0.86 ' CD1' HG21 ' A' ' 31' ' ' VAL . 7.1 m95 -98.36 139.49 34.04 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.725 -179.587 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -131.13 152.22 50.64 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.177 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 70.3 t80 -130.21 141.38 50.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.546 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.47 ' OD1' ' CE1' ' A' ' 16' ' ' HIS . 6.0 m-20 -97.86 114.81 26.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.339 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -105.97 179.18 4.34 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.467 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -172.02 39.05 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.607 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -123.34 156.77 63.17 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.339 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -71.75 -43.54 1.27 Allowed 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.614 2.209 . . . . 0.0 112.012 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 3.5 mt -69.53 122.45 19.06 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.474 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.13 88.29 2.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.278 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -104.25 -148.37 18.59 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.854 -0.898 . . . . 0.0 110.854 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -78.24 167.16 23.58 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.573 2.182 . . . . 0.0 112.141 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -123.64 113.84 19.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.378 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 70.9 m-20 -86.86 131.98 33.95 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 179.437 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.51 ' CE1' ' HB3' ' A' ' 33' ' ' LEU . 44.7 m-85 -113.38 178.07 4.41 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.101 0.477 . . . . 0.0 111.105 -179.444 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.488 ' HG2' ' CZ3' ' A' ' 41' ' ' TRP . 0.0 OUTLIER 175.29 55.04 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.494 -0.776 . . . . 0.0 109.696 179.975 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.668 ' O ' HD23 ' A' ' 69' ' ' LEU . 4.2 p90 -50.23 174.21 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.844 -0.617 . . . . 0.0 111.24 -179.307 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.834 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 2.6 mt -130.09 75.93 1.69 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.194 179.485 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.426 ' OG1' ' N ' ' A' ' 74' ' ' MET . 16.8 p -37.49 149.46 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.6 -179.17 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.672 ' HG2' ' HB2' ' A' ' 29' ' ' ALA . 5.1 mm-40 -60.97 -54.18 48.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.02 -179.338 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -129.81 58.14 1.66 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.89 0.376 . . . . 0.0 110.795 -179.568 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -149.07 -107.95 0.46 Allowed Glycine 0 CA--C 1.523 0.582 0 N-CA-C 110.895 -0.882 . . . . 0.0 110.895 179.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.426 ' N ' ' OG1' ' A' ' 70' ' ' THR . 0.0 OUTLIER -166.33 179.07 5.81 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 110.223 -0.288 . . . . 0.0 110.223 179.936 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.4 138.38 50.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.447 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.423 ' O ' ' CE2' ' A' ' 78' ' ' PHE . 24.8 m-20 -135.46 127.93 30.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.298 179.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 58.4 t -77.46 147.59 7.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.617 -179.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.423 ' CE2' ' O ' ' A' ' 76' ' ' ASN . 72.6 m-85 -132.27 121.65 23.93 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.157 179.805 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -110.27 140.88 43.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.698 -179.733 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 70.0 32.44 3.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.791 179.656 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.601 HG22 ' HD3' ' A' ' 94' ' ' PRO . 18.4 t -65.13 -68.26 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 179.564 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 93.3 t -86.53 131.48 45.63 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.168 179.697 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.453 ' HD3' ' CB ' ' A' ' 92' ' ' TYR . 50.6 Cg_endo -82.79 161.16 16.3 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.557 2.171 . . . . 0.0 112.047 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -62.33 125.24 23.22 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.188 179.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 58.86 47.93 11.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.145 -179.829 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 0.4 ' OH ' ' CD2' ' A' ' 17' ' ' LEU . 22.7 p90 -50.12 175.67 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.775 -179.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -137.23 104.56 5.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.998 179.736 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 2.7 mp -46.14 102.83 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.767 -179.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 145.52 48.49 0.03 OUTLIER Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.741 -0.944 . . . . 0.0 110.741 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 179.1 -176.3 0.25 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.931 0.396 . . . . 0.0 110.423 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.778 HG23 ' O ' ' A' ' 6' ' ' PHE . 89.5 m -118.12 141.38 48.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.259 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.453 ' CB ' ' HD3' ' A' ' 83' ' ' PRO . 6.2 m-85 -140.45 124.13 17.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.533 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.881 ' HB1' ' HD2' ' A' ' 94' ' ' PRO . . . -156.49 179.55 1.33 Allowed Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.121 -0.49 . . . . 0.0 109.93 179.533 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.881 ' HD2' ' HB1' ' A' ' 93' ' ' ALA . 48.5 Cg_endo . . . . . 0 C--O 1.249 1.029 0 C-N-CA 122.525 2.15 . . . . 0.0 112.059 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.1 mmtt . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.685 0.279 . . . . 0.0 110.63 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.708 HG11 ' CZ ' ' A' ' 78' ' ' PHE . 2.4 p -115.53 162.72 13.38 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.342 0 CA-C-O 121.223 0.535 . . . . 0.0 109.996 179.503 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.847 HG22 HG21 ' A' ' 91' ' ' THR . 0.2 OUTLIER -134.32 151.99 51.56 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.566 179.984 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.651 ' CE2' HG22 ' A' ' 21' ' ' VAL . 17.8 m-85 -128.73 -176.09 3.74 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.881 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -167.03 174.63 8.19 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.05 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.812 ' O ' HG23 ' A' ' 88' ' ' ILE . 93.5 t -123.37 83.29 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.1 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.673 ' HG3' HG11 ' A' ' 51' ' ' VAL . 3.4 mt-10 -47.59 161.53 0.09 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.857 -179.589 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 12.1 mttm -60.72 -18.63 55.52 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.001 -179.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -74.05 -2.3 61.71 Favored Glycine 0 CA--C 1.53 1.004 0 N-CA-C 111.824 -0.51 . . . . 0.0 111.824 -179.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.435 ' OG ' HG13 ' A' ' 8' ' ' VAL . 4.5 m -76.54 128.59 35.04 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 117.216 0.508 . . . . 0.0 110.538 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 22.9 m-80 -134.28 -164.32 1.49 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.143 179.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.442 ' HG3' ' CD ' ' A' ' 15' ' ' LYS . 22.1 pt-20 -75.87 -41.51 52.0 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.466 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.442 ' CD ' ' HG3' ' A' ' 14' ' ' GLU . 1.5 mmmt -85.12 -39.8 17.5 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.489 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 30.3 m80 -97.61 161.67 13.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.596 -179.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.523 HD22 ' HA ' ' A' ' 17' ' ' LEU . 0.4 OUTLIER -141.84 85.88 1.96 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.565 179.559 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -79.43 143.01 35.41 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.238 -179.609 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.639 HG21 ' CZ ' ' A' ' 66' ' ' PHE . 30.1 m -138.71 137.27 43.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.288 -179.863 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -91.51 65.0 5.13 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.2 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.651 HG22 ' CE2' ' A' ' 6' ' ' PHE . 10.0 t -61.78 115.18 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.415 -179.811 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 2.2 tttp -172.69 178.55 2.63 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.189 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.481 ' N ' ' CD1' ' A' ' 23' ' ' TYR . 0.0 OUTLIER -146.18 -71.31 0.25 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.044 -179.923 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -143.4 -57.88 0.41 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.219 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -168.34 63.36 0.19 Allowed Glycine 0 CA--C 1.523 0.587 0 N-CA-C 110.759 -0.937 . . . . 0.0 110.759 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -97.33 -167.35 1.52 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.776 0.322 . . . . 0.0 110.41 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 29.3 p -119.67 132.01 55.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.447 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.427 ' O ' ' CG ' ' A' ' 71' ' ' GLU . 0.0 OUTLIER -85.99 123.86 31.79 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.7 -179.851 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.703 ' HB3' ' O ' ' A' ' 69' ' ' LEU . . . -117.81 -61.54 1.67 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.407 -179.852 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.677 ' CB ' HD12 ' A' ' 69' ' ' LEU . 4.2 mt-10 -155.83 151.51 27.26 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.025 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.445 ' HA ' ' HA ' ' A' ' 68' ' ' PHE . 12.1 t -141.27 142.95 28.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.661 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.464 ' CB ' ' HA ' ' A' ' 43' ' ' ALA . 3.9 pt-20 -137.3 142.87 41.9 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.022 -0.535 . . . . 0.0 109.905 179.798 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.772 HD12 ' H ' ' A' ' 34' ' ' ARG . 5.6 tp -118.92 147.43 44.02 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 -179.47 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.772 ' H ' HD12 ' A' ' 33' ' ' LEU . 4.7 ttp180 -144.08 164.02 31.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.008 179.583 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.452 ' OE1' ' CD1' ' A' ' 64' ' ' PHE . 2.4 mm-40 -118.56 -72.82 0.67 Allowed 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 179.747 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 6.0 t-80 -179.17 -39.33 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.348 179.656 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -136.32 57.39 0.68 Allowed Glycine 0 CA--C 1.523 0.552 0 N-CA-C 110.545 -1.022 . . . . 0.0 110.545 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.1 t -132.88 68.88 1.49 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.91 0.386 . . . . 0.0 110.486 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 23.6 t0 49.1 38.19 12.39 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.78 179.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 64.73 -173.37 0.18 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.653 179.732 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.511 ' CD2' ' HD3' ' A' ' 34' ' ' ARG . 94.1 m95 -46.84 143.26 2.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.885 -179.841 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.548 HG23 ' O ' ' A' ' 33' ' ' LEU . 2.4 m -137.58 111.46 8.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.85 179.531 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.464 ' HA ' ' CB ' ' A' ' 32' ' ' GLU . . . -44.71 152.13 0.24 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.105 -179.452 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -72.16 -169.51 0.5 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.349 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 37.7 m -143.63 101.26 3.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.181 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 10.8 ptmt -64.76 80.71 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.534 -179.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -117.4 -37.14 0.94 Allowed Glycine 0 CA--C 1.523 0.588 0 N-CA-C 110.65 -0.98 . . . . 0.0 110.65 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.407 ' HB3' ' O ' ' A' ' 51' ' ' VAL . 8.4 tm-20 -60.86 -33.39 73.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.756 0.312 . . . . 0.0 110.351 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 97.82 -69.76 0.71 Allowed Glycine 0 CA--C 1.523 0.545 0 N-CA-C 110.774 -0.93 . . . . 0.0 110.774 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -74.83 -29.13 61.54 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 110.589 -1.004 . . . . 0.0 110.589 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.673 HG11 ' HG3' ' A' ' 9' ' ' GLU . 14.1 m -136.38 -177.49 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.791 0.329 . . . . 0.0 110.278 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . 0.421 ' CD1' HG21 ' A' ' 31' ' ' VAL . 7.0 m95 -110.25 132.64 54.0 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.558 -179.719 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -115.3 160.72 19.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.145 179.826 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.527 ' CB ' HD23 ' A' ' 33' ' ' LEU . 40.5 t80 -148.61 112.63 5.17 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.555 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -70.86 135.98 48.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.147 179.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -142.49 125.99 16.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.612 -179.816 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -93.17 -30.45 15.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.01 179.74 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.439 ' HB2' ' CD ' ' A' ' 59' ' ' PRO . 0.4 OUTLIER -51.84 170.15 0.23 Allowed Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.253 179.754 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.439 ' CD ' ' HB2' ' A' ' 58' ' ' GLU . 37.4 Cg_endo -91.66 56.92 0.9 Allowed 'Trans proline' 0 N--CA 1.45 -1.037 0 C-N-CA 123.569 2.846 . . . . 0.0 111.761 179.339 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.73 HD13 ' HZ ' ' A' ' 64' ' ' PHE . 0.6 OUTLIER -47.44 93.07 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.78 -179.756 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -119.23 47.33 1.71 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.341 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -165.96 -165.19 22.9 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.502 -1.039 . . . . 0.0 110.502 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -79.94 155.7 23.34 Favored 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 122.55 2.166 . . . . 0.0 112.065 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.73 ' HZ ' HD13 ' A' ' 60' ' ' LEU . 46.8 m-85 -101.8 -173.97 2.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.21 -0.45 . . . . 0.0 109.88 179.743 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -149.27 119.18 7.11 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.095 -179.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.639 ' CZ ' HG21 ' A' ' 19' ' ' VAL . 13.4 m-85 -108.21 163.47 13.14 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.423 -179.828 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.944 ' HD2' HG22 ' A' ' 77' ' ' VAL . 21.7 mtp180 -163.44 84.69 0.49 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.141 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.587 ' O ' HD23 ' A' ' 69' ' ' LEU . 6.5 p90 -75.82 169.9 17.26 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.2 0.524 . . . . 0.0 110.691 -179.783 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.703 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 3.9 mt -133.9 50.49 2.2 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.184 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 8.3 p -22.74 137.94 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.167 0.987 . . . . 0.0 113.037 -179.035 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.653 ' N ' ' HB2' ' A' ' 29' ' ' ALA . 2.6 mm-40 -55.94 -31.18 62.71 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.166 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 14.9 tptt -151.14 70.28 0.98 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.165 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -151.1 -97.49 0.16 Allowed Glycine 0 CA--C 1.522 0.488 0 N-CA-C 110.816 -0.914 . . . . 0.0 110.816 -179.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 13.2 ptp 172.63 166.82 0.12 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.748 0.309 . . . . 0.0 110.288 -179.792 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 18.4 mmtm -83.71 147.84 27.42 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 179.718 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -154.98 132.56 11.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.804 0.335 . . . . 0.0 110.472 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.944 HG22 ' HD2' ' A' ' 67' ' ' ARG . 93.8 t -97.27 146.67 7.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.148 0.499 . . . . 0.0 110.618 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.708 ' CZ ' HG11 ' A' ' 4' ' ' VAL . 41.1 m-85 -131.05 133.65 45.91 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.304 -179.486 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -127.14 31.87 5.17 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.368 -179.76 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -168.39 52.03 0.05 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.483 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.451 ' C ' HG23 ' A' ' 82' ' ' VAL . 57.1 t -93.64 -12.2 8.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.549 -179.077 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.534 HG13 ' HD2' ' A' ' 83' ' ' PRO . 70.3 t -156.76 141.33 12.02 Favored Pre-proline 0 C--N 1.332 -0.166 0 CA-C-O 120.696 0.284 . . . . 0.0 110.694 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.534 ' HD2' HG13 ' A' ' 82' ' ' VAL . 51.9 Cg_endo -81.26 -166.71 0.43 Allowed 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.72 2.28 . . . . 0.0 111.904 179.763 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.417 ' HG3' ' N ' ' A' ' 85' ' ' LYS . 5.1 pt-20 -78.15 -27.11 48.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.173 179.557 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.417 ' N ' ' HG3' ' A' ' 84' ' ' GLU . 0.0 OUTLIER -140.33 73.53 1.43 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.014 179.771 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 0.48 ' HB3' HG13 ' A' ' 82' ' ' VAL . 45.1 p90 -57.12 173.91 0.2 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.79 -179.624 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -152.43 113.66 4.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.035 179.696 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.812 HG23 ' O ' ' A' ' 8' ' ' VAL . 3.3 mp -48.5 109.11 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.828 -179.645 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 121.42 52.26 0.24 Allowed Glycine 0 CA--C 1.523 0.589 0 N-CA-C 111.015 -0.834 . . . . 0.0 111.015 179.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -179.31 148.85 0.38 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.846 0.355 . . . . 0.0 110.794 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.847 HG21 HG22 ' A' ' 5' ' ' THR . 19.4 m -92.77 135.51 34.05 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.895 179.589 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.498 ' CG ' ' HD3' ' A' ' 83' ' ' PRO . 66.8 m-85 -118.7 -26.47 6.11 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.635 -178.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.781 ' HB1' ' HD2' ' A' ' 94' ' ' PRO . . . -49.18 171.29 0.11 Allowed Pre-proline 0 C--N 1.331 -0.235 0 CA-C-O 120.648 0.261 . . . . 0.0 110.746 -179.803 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.781 ' HD2' ' HB1' ' A' ' 93' ' ' ALA . 47.7 Cg_endo . . . . . 0 C--O 1.249 1.066 0 C-N-CA 122.547 2.165 . . . . 0.0 111.991 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.789 0.328 . . . . 0.0 110.376 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.581 HG21 ' CZ ' ' A' ' 78' ' ' PHE . 20.3 m -73.94 162.97 4.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.511 -179.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 43.5 p -148.34 128.84 14.01 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.176 179.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.624 ' O ' HG23 ' A' ' 91' ' ' THR . 42.5 m-85 -87.13 171.91 10.33 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.356 -179.828 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.755 HG23 ' O ' ' A' ' 90' ' ' ALA . 2.7 m -163.13 112.29 1.31 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.552 -179.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.4 HG13 ' OG ' ' A' ' 12' ' ' SER . 57.8 t -61.57 96.16 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.251 179.866 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.971 ' HG3' HG21 ' A' ' 51' ' ' VAL . 8.5 mm-40 -52.14 166.29 0.17 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.351 -179.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 17.1 mttp -60.32 -28.56 68.23 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.685 -179.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.418 ' O ' ' CB ' ' A' ' 18' ' ' ALA . . . -83.22 69.18 3.42 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 110.98 -0.848 . . . . 0.0 110.98 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.4 ' OG ' HG13 ' A' ' 8' ' ' VAL . 0.4 OUTLIER -130.37 128.65 41.85 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.702 0.287 . . . . 0.0 110.283 179.85 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 17.3 p30 -166.79 -174.96 2.92 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.618 -179.815 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -54.72 127.0 26.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.339 0.59 . . . . 0.0 110.494 -179.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.413 ' O ' ' ND1' ' A' ' 16' ' ' HIS . 0.0 OUTLIER 67.74 20.88 9.38 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.155 -0.929 . . . . 0.0 110.958 179.572 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . 0.413 ' ND1' ' O ' ' A' ' 15' ' ' LYS . 78.2 m80 -157.68 89.01 1.0 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.826 0.346 . . . . 0.0 110.549 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.573 ' C ' HD13 ' A' ' 17' ' ' LEU . 3.0 tm? -100.97 85.25 2.82 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.937 179.851 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.483 ' HB2' ' CG2' ' A' ' 53' ' ' THR . . . -77.82 145.21 36.48 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.75 -179.632 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.615 ' O ' HG13 ' A' ' 51' ' ' VAL . 31.5 m -147.71 131.0 8.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.033 179.322 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.648 HD12 ' OE1' ' A' ' 9' ' ' GLU . 0.6 OUTLIER -83.5 85.02 7.32 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.773 -179.568 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.507 HG23 HG23 ' A' ' 19' ' ' VAL . 24.3 t -87.4 88.85 2.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.194 179.669 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.452 ' HG2' ' N ' ' A' ' 23' ' ' TYR . 38.5 tttm -145.96 160.25 42.11 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.475 -179.848 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.512 ' CE2' HG12 ' A' ' 4' ' ' VAL . 18.5 p90 177.01 174.9 0.4 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.345 179.784 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -101.28 128.33 47.47 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.453 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 146.43 -49.03 0.65 Allowed Glycine 0 CA--C 1.523 0.575 0 N-CA-C 110.669 -0.973 . . . . 0.0 110.669 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -135.94 -177.47 4.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.745 0.307 . . . . 0.0 110.336 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -116.13 172.69 7.01 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.496 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.549 ' O ' ' HB2' ' A' ' 29' ' ' ALA . 0.1 OUTLIER -75.74 -173.78 2.34 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.436 -179.934 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.768 ' HB3' ' O ' ' A' ' 69' ' ' LEU . . . 168.52 -64.82 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.29 179.801 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.412 ' O ' ' HB2' ' A' ' 68' ' ' PHE . 0.2 OUTLIER -148.0 162.78 38.65 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.778 -179.862 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.532 HG11 ' CD1' ' A' ' 52' ' ' TRP . 1.9 p 174.48 138.94 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.093 0.473 . . . . 0.0 110.384 -179.869 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.43 ' HB3' ' HA ' ' A' ' 43' ' ' ALA . 0.3 OUTLIER -137.09 178.29 7.2 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.351 -179.634 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.548 HD21 ' CZ ' ' A' ' 66' ' ' PHE . 2.3 mt -114.59 176.42 5.06 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.006 0.431 . . . . 0.0 110.767 -179.65 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.493 ' HB2' ' CZ3' ' A' ' 41' ' ' TRP . 0.0 OUTLIER -161.25 170.79 19.57 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.007 179.632 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -139.44 14.65 2.57 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.283 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER 52.99 25.62 4.16 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.613 0.244 . . . . 0.0 110.793 179.58 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -161.58 29.54 0.3 Allowed Glycine 0 CA--C 1.524 0.62 0 N-CA-C 110.964 -0.854 . . . . 0.0 110.964 -179.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -112.09 -16.39 13.06 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.528 0.204 . . . . 0.0 110.97 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 71.21 8.84 6.51 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.78 -0.191 . . . . 0.0 111.067 -179.81 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 26.3 pt-20 179.42 151.47 0.36 Allowed 'General case' 0 C--O 1.231 0.105 0 CA-C-O 120.743 0.306 . . . . 0.0 110.244 179.722 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.512 ' CE3' ' HG2' ' A' ' 67' ' ' ARG . 86.2 m95 -76.89 160.65 29.04 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.377 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.584 HG23 ' O ' ' A' ' 42' ' ' VAL . 29.7 m -134.49 106.37 7.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.319 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.43 ' HA ' ' HB3' ' A' ' 32' ' ' GLU . . . -44.06 131.5 5.83 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.122 -179.75 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.55 -170.13 0.19 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.367 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 42.8 m -147.49 118.68 7.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.342 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.408 ' HB3' ' CZ3' ' A' ' 52' ' ' TRP . 1.1 ptpt -71.77 68.75 0.64 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.576 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -90.01 -12.71 61.61 Favored Glycine 0 CA--C 1.528 0.85 0 N-CA-C 111.227 -0.749 . . . . 0.0 111.227 179.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.469 ' HB3' ' HB ' ' A' ' 51' ' ' VAL . 0.1 OUTLIER -85.41 3.83 38.27 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 116.875 0.338 . . . . 0.0 111.391 -179.831 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 64.19 21.53 66.21 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 111.041 -0.824 . . . . 0.0 111.041 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 171.96 -35.21 0.15 Allowed Glycine 0 CA--C 1.52 0.384 0 N-CA-C 109.959 -1.256 . . . . 0.0 109.959 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.971 HG21 ' HG3' ' A' ' 9' ' ' GLU . 3.0 t -106.78 157.81 6.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 179.555 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . 0.532 ' CD1' HG11 ' A' ' 31' ' ' VAL . 3.6 m95 -92.18 123.68 35.7 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.015 0.436 . . . . 0.0 110.945 -179.132 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.483 ' CG2' ' HB2' ' A' ' 18' ' ' ALA . 1.3 p -112.69 140.64 47.29 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.313 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 60.7 t80 -121.16 145.33 47.93 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.368 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -88.56 90.1 8.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.34 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -61.19 110.8 1.49 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.541 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -95.15 -36.75 11.36 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.303 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.407 ' O ' ' CG ' ' A' ' 58' ' ' GLU . 5.6 pt-20 -102.74 116.01 63.34 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.345 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -92.4 42.22 0.31 Allowed 'Trans proline' 0 N--CA 1.451 -0.986 0 C-N-CA 123.356 2.704 . . . . 0.0 112.439 179.669 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 2.1 mp -77.34 -175.0 3.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.229 179.76 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 19.8 pt20 -105.89 32.63 4.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.385 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -90.79 154.03 22.88 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.638 -0.985 . . . . 0.0 110.638 179.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -79.79 170.02 17.38 Favored 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 122.577 2.184 . . . . 0.0 112.047 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 16.6 m-30 -108.6 149.63 28.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.626 -179.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.4 ' HB2' ' HB3' ' A' ' 34' ' ' ARG . 6.8 m-80 -133.72 145.94 50.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.817 179.602 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.548 ' CZ ' HD21 ' A' ' 33' ' ' LEU . 67.1 m-85 -125.36 -177.83 4.02 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.143 0.497 . . . . 0.0 110.694 -179.818 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.512 ' HG2' ' CE3' ' A' ' 41' ' ' TRP . 0.0 OUTLIER 179.92 70.37 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.411 179.692 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.593 ' O ' HD23 ' A' ' 69' ' ' LEU . 6.5 p90 -72.27 179.68 3.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.375 0.607 . . . . 0.0 111.413 -178.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.768 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 9.5 mt -141.5 77.02 1.57 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.428 179.797 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.426 HG23 ' H ' ' A' ' 70' ' ' THR . 21.4 p -36.21 136.54 0.3 Allowed 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 116.06 -0.518 . . . . 0.0 112.006 -179.114 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.493 ' CA ' ' HB2' ' A' ' 29' ' ' ALA . 0.1 OUTLIER -42.03 -34.23 0.68 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.192 179.782 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 3.1 tmtm? -56.87 -48.79 77.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.476 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 123.85 76.94 0.33 Allowed Glycine 0 CA--C 1.523 0.589 0 N-CA-C 110.794 -0.922 . . . . 0.0 110.794 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.413 ' CG ' ' OG1' ' A' ' 70' ' ' THR . 9.8 ptp -169.72 144.49 2.88 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.788 0.327 . . . . 0.0 110.172 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -111.71 178.62 4.26 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.654 -179.631 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 176.92 127.87 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.045 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.477 HG12 ' N ' ' A' ' 78' ' ' PHE . 63.4 t -88.85 158.28 3.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.705 -179.75 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.581 ' CZ ' HG21 ' A' ' 4' ' ' VAL . 51.1 m-85 -140.38 117.33 11.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.966 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -103.94 150.58 24.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.789 -179.472 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 50.85 57.03 7.09 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.618 179.78 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.537 HG22 ' HD3' ' A' ' 94' ' ' PRO . 57.3 t -84.54 -80.8 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 179.755 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.554 HG13 ' HD2' ' A' ' 83' ' ' PRO . 60.5 t -81.91 139.5 46.47 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.438 -0.347 . . . . 0.0 110.53 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.554 ' HD2' HG13 ' A' ' 82' ' ' VAL . 46.7 Cg_endo -69.82 -167.06 0.21 Allowed 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.701 2.267 . . . . 0.0 112.031 179.546 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -78.99 -27.82 43.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.156 179.715 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -138.94 77.38 1.62 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.254 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 18.8 p90 -51.23 160.27 0.55 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.532 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 6.0 m -136.44 111.78 9.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.224 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 2.7 mp -50.41 115.13 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.509 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 114.4 38.45 1.1 Allowed Glycine 0 CA--C 1.522 0.512 0 N-CA-C 110.631 -0.988 . . . . 0.0 110.631 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.755 ' O ' HG23 ' A' ' 7' ' ' THR . . . -156.27 -177.79 6.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.851 0.358 . . . . 0.0 110.492 -179.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.624 HG23 ' O ' ' A' ' 6' ' ' PHE . 93.3 m -127.27 143.31 51.26 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.399 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.564 ' OH ' ' HB3' ' A' ' 90' ' ' ALA . 3.9 m-85 -144.45 128.4 17.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.127 179.796 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.927 ' HB1' ' HD2' ' A' ' 94' ' ' PRO . . . 176.15 179.08 0.2 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.411 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.927 ' HD2' ' HB1' ' A' ' 93' ' ' ALA . 48.5 Cg_endo . . . . . 0 C--O 1.249 1.03 0 C-N-CA 122.61 2.207 . . . . 0.0 112.174 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 37.2 mttm . . . . . 0 C--O 1.232 0.152 0 CA-C-O 120.655 0.264 . . . . 0.0 110.634 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.655 HG11 ' CZ ' ' A' ' 78' ' ' PHE . 2.5 p -179.6 163.41 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.341 0.591 . . . . 0.0 110.627 179.843 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.863 HG22 HG21 ' A' ' 91' ' ' THR . 0.0 OUTLIER -142.02 145.24 34.18 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.108 179.594 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.587 ' CD1' ' HB2' ' A' ' 93' ' ' ALA . 16.1 m-85 -117.25 165.8 13.01 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.14 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.415 ' O ' ' N ' ' A' ' 20' ' ' LEU . 0.2 OUTLIER -165.97 109.02 0.78 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.226 179.986 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.716 ' O ' HG23 ' A' ' 88' ' ' ILE . 84.6 t -61.45 90.58 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.451 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.913 ' HG3' HG11 ' A' ' 51' ' ' VAL . 21.1 mm-40 -55.1 176.39 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.477 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 12.9 mttt -74.0 -13.1 60.82 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.036 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -46.54 -28.37 3.45 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 111.021 -0.832 . . . . 0.0 111.021 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.5 m -53.08 121.71 7.97 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 179.776 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -110.61 -71.66 0.75 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.423 -179.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -138.62 -58.29 0.62 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.783 0.325 . . . . 0.0 110.54 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 10.2 pttt -104.91 -29.08 10.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.548 -179.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -64.53 166.0 9.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.5 -179.734 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 44.5 tp -146.43 85.3 1.65 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.363 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.501 ' HB2' ' CG2' ' A' ' 53' ' ' THR . . . -76.34 134.8 39.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.44 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.566 HG23 HG23 ' A' ' 21' ' ' VAL . 34.8 m -130.26 152.2 37.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.182 179.851 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.548 HD12 ' OE2' ' A' ' 9' ' ' GLU . 0.9 OUTLIER -99.58 91.46 4.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.294 179.891 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.566 HG23 HG23 ' A' ' 19' ' ' VAL . 17.8 t -99.72 97.0 5.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.608 -179.729 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 176.29 133.21 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.44 179.777 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.423 ' CZ ' ' OD2' ' A' ' 26' ' ' ASP . 0.1 OUTLIER -115.87 -73.87 0.63 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.338 -179.974 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -174.6 -56.93 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.586 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -46.59 -66.73 1.64 Allowed Glycine 0 CA--C 1.525 0.666 0 N-CA-C 111.217 -0.753 . . . . 0.0 111.217 -179.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.423 ' OD2' ' CZ ' ' A' ' 23' ' ' TYR . 44.4 p-10 -71.09 165.41 23.6 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.846 0.355 . . . . 0.0 110.482 -179.832 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.65 ' O ' HG22 ' A' ' 27' ' ' THR . 50.9 m -127.29 45.32 2.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.229 179.837 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.492 ' O ' ' HB2' ' A' ' 29' ' ' ALA . 14.7 mtt 60.15 175.93 0.09 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.502 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.634 ' HB3' ' O ' ' A' ' 69' ' ' LEU . . . 172.8 -61.7 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.306 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.447 ' HB3' HD12 ' A' ' 69' ' ' LEU . 19.9 tt0 -160.62 161.61 32.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.345 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.569 HG21 ' CD1' ' A' ' 52' ' ' TRP . 44.4 t -157.27 148.7 10.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.957 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.469 ' CB ' ' HA ' ' A' ' 43' ' ' ALA . 0.3 OUTLIER -148.6 136.15 20.51 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.978 0.418 . . . . 0.0 110.507 -179.81 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.612 HD12 ' N ' ' A' ' 34' ' ' ARG . 6.0 tp -104.1 141.69 35.78 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.958 -0.564 . . . . 0.0 109.61 -179.599 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.612 ' N ' HD12 ' A' ' 33' ' ' LEU . 1.1 ttm180 -85.25 -63.7 1.28 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.618 -179.858 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.459 ' CB ' ' O ' ' A' ' 34' ' ' ARG . 2.4 tt0 91.16 48.19 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 109.003 -0.739 . . . . 0.0 109.003 -179.154 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 0.441 ' CG ' ' C ' ' A' ' 35' ' ' GLU . 1.2 p80 44.41 -89.44 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 114.845 -1.071 . . . . 0.0 111.207 -179.639 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.431 ' N ' ' O ' ' A' ' 35' ' ' GLU . . . -106.21 93.53 0.88 Allowed Glycine 0 CA--C 1.523 0.566 0 N-CA-C 110.883 -0.887 . . . . 0.0 110.883 -179.831 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.433 ' HB2' ' HB3' ' A' ' 35' ' ' GLU . 8.1 t -139.86 25.27 2.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.586 0.231 . . . . 0.0 110.625 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 77.43 -54.87 0.54 Allowed 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 122.993 0.517 . . . . 0.0 110.899 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -157.75 170.75 21.66 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.33 -179.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.501 ' CZ2' ' HD2' ' A' ' 67' ' ' ARG . 81.1 m95 -63.67 164.14 10.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.394 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.411 ' CG2' ' O ' ' A' ' 33' ' ' LEU . 3.5 m -146.82 119.06 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.309 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.469 ' HA ' ' CB ' ' A' ' 32' ' ' GLU . . . -52.87 136.43 34.25 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.38 -179.87 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.74 -169.93 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.397 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 85.0 m -128.91 104.17 7.45 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.199 179.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -74.12 121.0 20.47 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.46 -179.858 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 152.41 46.32 0.02 OUTLIER Glycine 0 CA--C 1.523 0.534 0 N-CA-C 110.608 -0.997 . . . . 0.0 110.608 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.421 ' O ' ' N ' ' A' ' 50' ' ' GLY . 15.8 tp10 -134.04 73.48 1.5 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.698 0.285 . . . . 0.0 110.403 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 58.92 -83.71 0.01 OUTLIER Glycine 0 CA--C 1.523 0.533 0 N-CA-C 110.705 -0.958 . . . . 0.0 110.705 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.421 ' N ' ' O ' ' A' ' 48' ' ' GLU . . . -142.92 27.4 2.18 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 110.675 -0.97 . . . . 0.0 110.675 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.913 HG11 ' HG3' ' A' ' 9' ' ' GLU . 5.7 m -145.6 -178.43 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.798 0.333 . . . . 0.0 110.361 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . 0.569 ' CD1' HG21 ' A' ' 31' ' ' VAL . 8.8 m95 -106.13 155.28 19.59 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.513 -179.727 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.501 ' CG2' ' HB2' ' A' ' 18' ' ' ALA . 0.2 OUTLIER -141.22 148.3 39.69 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.245 179.904 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.476 ' CG ' HD23 ' A' ' 33' ' ' LEU . 70.3 t80 -125.52 146.65 49.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.254 179.724 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 18.1 p-10 -89.61 93.72 9.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.665 -179.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.3 m -85.62 95.5 9.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.138 179.695 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.77 -34.63 13.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.729 -179.62 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.62 156.09 2.45 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 120.882 0.372 . . . . 0.0 110.644 -179.706 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -77.14 -22.62 11.1 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.546 2.164 . . . . 0.0 111.563 179.551 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.416 ' O ' ' CG ' ' A' ' 61' ' ' GLN . 91.4 mt -60.74 172.74 0.87 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.587 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.416 ' CG ' ' O ' ' A' ' 60' ' ' LEU . 0.0 OUTLIER 174.7 116.86 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.253 -179.975 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 178.84 -125.04 0.95 Allowed Glycine 0 CA--C 1.527 0.788 0 N-CA-C 110.692 -0.963 . . . . 0.0 110.692 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -73.52 146.62 39.57 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.427 2.085 . . . . 0.0 112.144 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -128.91 -177.01 4.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.384 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.457 ' HB2' ' CH2' ' A' ' 41' ' ' TRP . 0.7 OUTLIER -144.95 149.48 35.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.307 179.97 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 -141.5 159.89 41.27 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.964 0.411 . . . . 0.0 110.867 -179.736 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.501 ' HD2' ' CZ2' ' A' ' 41' ' ' TRP . 15.8 mtp180 -154.11 61.25 0.71 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.965 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.767 ' O ' HD23 ' A' ' 69' ' ' LEU . 10.5 p90 -49.23 176.66 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.19 0.519 . . . . 0.0 110.991 -179.46 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.767 HD23 ' O ' ' A' ' 68' ' ' PHE . 14.5 mt -141.53 65.51 1.38 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.389 179.451 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 75.9 p -31.05 134.56 0.06 Allowed 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 115.606 -0.725 . . . . 0.0 112.655 -178.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.473 ' N ' ' HB2' ' A' ' 29' ' ' ALA . 0.1 OUTLIER -40.5 -36.96 0.63 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.452 -0.794 . . . . 0.0 111.553 179.927 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 7.9 tmtt? -61.97 -51.51 67.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.365 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 131.02 52.99 0.1 OUTLIER Glycine 0 CA--C 1.523 0.569 0 N-CA-C 110.807 -0.917 . . . . 0.0 110.807 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 13.2 mtp -133.35 128.63 36.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.847 0.356 . . . . 0.0 110.433 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.471 ' N ' ' CD ' ' A' ' 75' ' ' LYS . 0.4 OUTLIER -117.26 171.66 7.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.043 179.8 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 172.39 139.12 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.458 179.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.452 HG22 ' CD ' ' A' ' 67' ' ' ARG . 86.6 t -88.25 155.35 3.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.296 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.655 ' CZ ' HG11 ' A' ' 4' ' ' VAL . 97.5 m-85 -143.85 109.3 5.12 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.077 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.687 ' O ' HG23 ' A' ' 81' ' ' VAL . 18.5 t0 -71.71 164.0 26.76 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.004 -179.295 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.433 ' O ' ' HB ' ' A' ' 81' ' ' VAL . 20.3 t70 50.19 -95.9 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.713 179.88 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.687 HG23 ' O ' ' A' ' 79' ' ' ASP . 75.6 t 65.73 4.21 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 179.846 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.451 HG23 ' C ' ' A' ' 81' ' ' VAL . 88.4 t -159.54 130.5 3.77 Favored Pre-proline 0 CA--C 1.529 0.168 0 O-C-N 122.196 -0.315 . . . . 0.0 110.429 179.319 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.531 ' HD3' ' CG ' ' A' ' 92' ' ' TYR . 49.6 Cg_endo -70.22 -165.44 0.16 Allowed 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.705 2.27 . . . . 0.0 111.768 179.421 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -74.46 -53.71 9.0 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 179.372 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 10.0 mmtp -110.38 79.12 1.17 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.004 -0.543 . . . . 0.0 109.982 179.589 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 48.9 p90 -48.12 136.41 11.82 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.888 -179.648 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 75.3 m -123.3 115.71 22.14 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.15 179.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.716 HG23 ' O ' ' A' ' 8' ' ' VAL . 2.7 mp -55.55 119.18 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.557 -179.821 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 107.79 51.13 0.76 Allowed Glycine 0 CA--C 1.523 0.564 0 N-CA-C 111.132 -0.787 . . . . 0.0 111.132 179.75 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -174.81 135.43 0.38 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.799 0.333 . . . . 0.0 110.784 179.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.863 HG21 HG22 ' A' ' 5' ' ' THR . 11.5 m -79.32 129.74 34.76 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.181 -0.463 . . . . 0.0 109.881 179.565 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.531 ' CG ' ' HD3' ' A' ' 83' ' ' PRO . 35.1 m-85 -114.94 -22.19 9.71 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.186 -179.138 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.865 ' HB1' ' HD2' ' A' ' 94' ' ' PRO . . . -50.32 178.35 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 120.713 0.292 . . . . 0.0 110.527 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.865 ' HD2' ' HB1' ' A' ' 93' ' ' ALA . 47.6 Cg_endo . . . . . 0 C--O 1.249 1.066 0 C-N-CA 122.633 2.222 . . . . 0.0 112.023 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.579 ' O ' HG22 ' A' ' 4' ' ' VAL . 12.7 mtpt . . . . . 0 CA--C 1.522 -0.121 0 CA-C-O 120.76 0.314 . . . . 0.0 110.288 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.799 ' O ' HG23 ' A' ' 5' ' ' THR . 15.6 m 45.5 -173.89 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.079 -179.852 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.799 HG23 ' O ' ' A' ' 4' ' ' VAL . 0.8 OUTLIER -169.78 130.5 1.03 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.518 -179.705 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.475 ' O ' HG23 ' A' ' 91' ' ' THR . 8.4 m-85 -104.75 156.39 18.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.085 179.757 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 57.5 m -157.48 121.93 4.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.877 0.37 . . . . 0.0 110.596 -179.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.478 ' CG1' ' CD1' ' A' ' 88' ' ' ILE . 11.9 t -60.07 93.63 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.088 179.737 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.658 ' HG3' HG11 ' A' ' 51' ' ' VAL . 14.8 mm-40 -47.62 137.5 9.12 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.757 -179.764 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 4.5 tttt -53.8 140.81 28.9 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.405 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 94.17 34.99 6.18 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.63 -0.988 . . . . 0.0 110.63 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.2 t -74.64 148.24 40.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.814 0.34 . . . . 0.0 110.389 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 -134.33 152.56 51.88 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.459 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -55.21 -32.58 62.36 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.347 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.13 -12.49 28.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.292 -179.83 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 54.9 m80 -132.12 119.5 21.02 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.832 0.349 . . . . 0.0 110.795 -179.802 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.497 HD22 ' HA ' ' A' ' 17' ' ' LEU . 0.8 OUTLIER -105.87 88.35 2.8 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.948 179.681 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -84.06 119.15 24.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.981 -179.485 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.426 HG23 HG23 ' A' ' 21' ' ' VAL . 17.9 m -108.51 -166.8 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.52 179.23 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.1 tt -140.95 79.18 1.68 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.724 179.756 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.426 HG23 HG23 ' A' ' 19' ' ' VAL . 3.1 t -92.58 88.45 2.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 179.673 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.568 ' HG2' ' HE3' ' A' ' 28' ' ' MET . 7.0 mttt -142.37 161.53 37.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.58 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.401 ' CE1' ' HB2' ' A' ' 26' ' ' ASP . 0.4 OUTLIER 170.71 153.19 0.05 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.208 -179.991 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.43 ' HG3' ' N ' ' A' ' 25' ' ' GLY . 1.5 pt-20 -88.63 -25.62 22.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.515 -179.835 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.43 ' N ' ' HG3' ' A' ' 24' ' ' GLU . . . -55.29 -38.53 68.71 Favored Glycine 0 CA--C 1.523 0.555 0 N-CA-C 110.724 -0.95 . . . . 0.0 110.724 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.401 ' HB2' ' CE1' ' A' ' 23' ' ' TYR . 55.3 m-20 -131.65 176.17 8.55 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.82 0.343 . . . . 0.0 110.324 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.83 -167.49 1.35 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.378 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.568 ' HE3' ' HG2' ' A' ' 22' ' ' LYS . 1.7 mtp -123.36 117.68 25.76 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.368 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.845 ' HB3' ' O ' ' A' ' 69' ' ' LEU . . . -127.52 -60.33 1.18 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.74 -179.783 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.556 ' C ' HG12 ' A' ' 31' ' ' VAL . 0.0 OUTLIER -142.85 171.39 14.11 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.325 -179.889 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.556 HG12 ' C ' ' A' ' 30' ' ' GLU . 0.5 OUTLIER 171.51 139.58 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 121.099 0.476 . . . . 0.0 109.898 -179.786 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.446 ' CB ' ' HA ' ' A' ' 43' ' ' ALA . 1.8 pt-20 -134.79 178.51 6.96 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.178 -179.777 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.738 HD21 ' CZ ' ' A' ' 66' ' ' PHE . 4.2 mt -118.31 172.66 7.3 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.988 0.423 . . . . 0.0 110.894 -179.608 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.416 ' HB3' ' HB2' ' A' ' 65' ' ' ASN . 0.0 OUTLIER -151.47 -173.06 4.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.732 179.588 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -139.27 25.54 2.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.778 0.323 . . . . 0.0 110.709 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 48.18 31.83 2.76 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.757 179.767 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 164.12 47.43 0.02 OUTLIER Glycine 0 CA--C 1.523 0.551 0 N-CA-C 110.924 -0.87 . . . . 0.0 110.924 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 7.0 t -113.85 148.98 35.73 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 179.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -50.8 -29.73 12.39 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.333 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -171.34 150.11 2.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.31 179.844 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.49 ' CZ3' ' HG2' ' A' ' 67' ' ' ARG . 64.4 m95 -51.68 153.55 2.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.333 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.461 HG23 ' O ' ' A' ' 42' ' ' VAL . 27.7 m -122.3 119.26 57.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.469 -179.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.446 ' HA ' ' CB ' ' A' ' 32' ' ' GLU . . . -52.98 156.69 1.97 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.502 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -94.16 -176.57 4.02 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.478 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 88.3 m -128.79 106.53 8.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.558 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 31.9 mtmt -77.98 93.14 4.4 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.283 -0.417 . . . . 0.0 109.959 179.773 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -129.49 -41.45 0.25 Allowed Glycine 0 CA--C 1.523 0.584 0 N-CA-C 111.284 -0.726 . . . . 0.0 111.284 -179.549 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -49.28 -40.84 36.01 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.872 0.368 . . . . 0.0 110.628 -179.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 96.7 -33.23 5.84 Favored Glycine 0 CA--C 1.522 0.515 0 N-CA-C 110.196 -1.162 . . . . 0.0 110.196 -179.693 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -107.39 -24.55 6.43 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 110.574 -1.01 . . . . 0.0 110.574 179.723 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.658 HG11 ' HG3' ' A' ' 9' ' ' GLU . 17.4 m -149.24 178.03 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 120.813 0.339 . . . . 0.0 110.352 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 8.4 m95 -104.79 135.92 45.27 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.103 -179.304 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.2 p -115.74 148.57 39.65 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.072 179.725 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.679 ' HB2' HD12 ' A' ' 33' ' ' LEU . 64.9 t80 -120.51 158.97 26.14 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.849 0.356 . . . . 0.0 110.671 -179.833 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -114.45 119.6 37.43 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.297 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 8.2 p -91.76 157.2 17.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.514 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -117.76 -48.83 2.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.511 -179.911 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.41 ' HB2' ' HD2' ' A' ' 59' ' ' PRO . 5.7 pt-20 -102.76 159.09 30.37 Favored Pre-proline 0 C--N 1.331 -0.221 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.394 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.41 ' HD2' ' HB2' ' A' ' 58' ' ' GLU . 43.2 Cg_endo -67.29 -158.36 0.04 OUTLIER 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.211 1.941 . . . . 0.0 110.021 178.337 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.1 mt 58.74 109.63 0.01 OUTLIER 'General case' 0 N--CA 1.441 -0.923 0 CA-C-O 120.872 0.368 . . . . 0.0 110.926 178.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 24.6 mp0 -106.34 104.3 13.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.475 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -95.61 -165.23 34.59 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.92 -0.872 . . . . 0.0 110.92 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -74.84 132.23 15.41 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.613 2.209 . . . . 0.0 111.957 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.401 ' HD2' HG21 ' A' ' 82' ' ' VAL . 30.7 m-85 -94.11 151.32 19.58 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.501 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.416 ' HB2' ' HB3' ' A' ' 34' ' ' ARG . 1.9 m-80 -131.04 140.96 50.16 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.0 -0.546 . . . . 0.0 109.773 179.58 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.738 ' CZ ' HD21 ' A' ' 33' ' ' LEU . 76.5 m-85 -123.56 -178.94 4.16 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.074 0.464 . . . . 0.0 110.748 -179.516 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.49 ' HG2' ' CZ3' ' A' ' 41' ' ' TRP . 5.4 ptm180 -177.33 75.22 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.497 179.771 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.735 ' O ' HD23 ' A' ' 69' ' ' LEU . 9.9 p90 -68.55 179.5 1.67 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.416 0.627 . . . . 0.0 111.315 -179.088 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.845 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 15.2 mt -142.87 72.3 1.37 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.212 179.485 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 72.3 p -31.39 134.1 0.08 Allowed 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 115.642 -0.708 . . . . 0.0 112.447 -178.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.712 ' HG2' ' HB2' ' A' ' 29' ' ' ALA . 2.3 mm-40 -50.02 -27.15 5.08 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.421 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -63.77 -41.46 97.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.137 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 123.37 65.25 0.21 Allowed Glycine 0 CA--C 1.524 0.61 0 N-CA-C 110.848 -0.901 . . . . 0.0 110.848 179.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 4.2 mtt -155.39 145.48 21.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.793 0.33 . . . . 0.0 110.452 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.461 ' N ' ' CD ' ' A' ' 75' ' ' LYS . 0.0 OUTLIER -121.44 -177.24 3.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.095 179.985 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 173.14 176.03 0.11 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.498 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.531 HG12 ' N ' ' A' ' 78' ' ' PHE . 97.8 t -131.41 162.21 39.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.15 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.531 ' N ' HG12 ' A' ' 77' ' ' VAL . 54.9 m-85 -150.92 130.6 13.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.943 0.401 . . . . 0.0 110.656 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -120.98 164.48 16.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.234 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 7.5 t0 52.73 43.19 31.65 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.249 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.524 ' O ' HG12 ' A' ' 81' ' ' VAL . 98.3 t -88.1 -5.2 10.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.081 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.444 HG23 ' C ' ' A' ' 81' ' ' VAL . 86.6 t -156.57 105.71 1.99 Allowed Pre-proline 0 CA--C 1.529 0.138 0 N-CA-C 110.224 -0.287 . . . . 0.0 110.224 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -73.67 -177.35 3.05 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.48 2.12 . . . . 0.0 112.224 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -77.39 130.53 37.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.342 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 63.56 44.36 5.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.258 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 47.9 p90 -50.49 140.94 13.05 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.583 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 2.9 m -106.69 118.83 37.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.196 179.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.478 ' CD1' ' CG1' ' A' ' 8' ' ' VAL . 48.5 mm -53.02 134.88 15.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.353 -179.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 102.24 28.42 6.46 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 110.668 -0.973 . . . . 0.0 110.668 -179.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -142.9 136.35 28.55 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.847 0.356 . . . . 0.0 110.51 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.475 HG23 ' O ' ' A' ' 6' ' ' PHE . 91.8 m -88.12 113.57 23.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.308 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.52 ' O ' ' HB2' ' A' ' 93' ' ' ALA . 45.3 m-85 -106.4 152.11 24.03 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.524 -179.745 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.901 ' HB1' ' HD2' ' A' ' 94' ' ' PRO . . . 170.07 177.74 0.09 OUTLIER Pre-proline 0 C--N 1.331 -0.197 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.387 179.769 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.901 ' HD2' ' HB1' ' A' ' 93' ' ' ALA . 48.7 Cg_endo . . . . . 0 C--O 1.249 1.057 0 C-N-CA 122.564 2.176 . . . . 0.0 112.0 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 49.4 mttp . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.812 0.339 . . . . 0.0 110.36 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.638 HG11 ' CZ ' ' A' ' 68' ' ' PHE . 18.4 m -80.09 163.26 3.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.338 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.619 HG23 ' O ' ' A' ' 4' ' ' VAL . 1.0 OUTLIER -162.95 132.07 4.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.444 179.957 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.514 ' CD2' ' HB ' ' A' ' 21' ' ' VAL . 9.7 m-85 -103.49 177.69 4.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.185 -0.462 . . . . 0.0 109.926 179.674 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.552 HG23 ' O ' ' A' ' 90' ' ' ALA . 2.9 m -167.17 127.7 1.51 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.763 0.316 . . . . 0.0 110.785 -179.628 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.737 HG13 ' CA ' ' A' ' 17' ' ' LEU . 87.7 t -70.77 81.54 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.264 179.529 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.522 ' CD ' HD12 ' A' ' 20' ' ' LEU . 1.7 mm-40 -49.25 178.74 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.816 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 5.8 mttp -67.98 -16.52 64.09 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.857 179.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -45.11 -34.69 4.41 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 111.006 -0.838 . . . . 0.0 111.006 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.47 ' OG ' HD11 ' A' ' 88' ' ' ILE . 1.4 p -56.95 127.22 30.76 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 179.564 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.6 p30 -109.56 -56.69 2.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.685 0.279 . . . . 0.0 110.766 -179.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 34.7 mm-40 -130.51 -58.96 1.03 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.906 0.384 . . . . 0.0 110.142 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.417 ' CG ' ' OD1' ' A' ' 55' ' ' ASP . 0.0 OUTLIER -108.35 -25.55 10.95 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.218 179.807 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . 0.474 ' CE1' ' OD1' ' A' ' 55' ' ' ASP . 21.0 m80 -58.0 176.86 0.14 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.359 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.768 HD13 ' N ' ' A' ' 17' ' ' LEU . 0.0 OUTLIER -172.98 31.64 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.587 -179.238 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.803 ' HB2' HG22 ' A' ' 53' ' ' THR . . . -18.93 119.95 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.333 1.053 . . . . 0.0 113.0 -179.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.695 HG11 ' CZ ' ' A' ' 66' ' ' PHE . 21.9 m -87.13 138.3 19.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.665 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.522 HD12 ' CD ' ' A' ' 9' ' ' GLU . 1.0 OUTLIER -97.94 42.99 1.08 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.387 179.795 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.514 ' HB ' ' CD2' ' A' ' 6' ' ' PHE . 2.7 p -50.63 100.53 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.301 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.22 165.08 32.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.265 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER 176.21 175.07 0.32 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.496 -179.83 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -104.54 154.82 19.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.341 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 94.64 -58.55 1.87 Allowed Glycine 0 CA--C 1.522 0.51 0 N-CA-C 110.71 -0.956 . . . . 0.0 110.71 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -91.92 173.86 7.63 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.778 0.323 . . . . 0.0 110.217 179.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -121.0 -173.14 2.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.528 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.43 ' O ' ' CG ' ' A' ' 71' ' ' GLU . 0.0 OUTLIER -118.39 125.74 50.62 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.504 -179.8 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.8 ' HB3' ' O ' ' A' ' 69' ' ' LEU . . . -121.54 -55.64 1.92 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.621 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.54 ' C ' HG12 ' A' ' 31' ' ' VAL . 0.7 OUTLIER -159.92 172.93 16.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.422 -179.916 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.54 HG12 ' C ' ' A' ' 30' ' ' GLU . 0.2 OUTLIER -174.4 136.83 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.373 0.606 . . . . 0.0 109.798 179.827 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.415 ' HG2' ' HB3' ' A' ' 41' ' ' TRP . 10.5 tt0 -121.97 151.77 40.42 Favored 'General case' 0 N--CA 1.441 -0.918 0 CA-C-N 115.055 -0.975 . . . . 0.0 110.103 -178.733 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.732 HD21 ' CZ ' ' A' ' 66' ' ' PHE . 3.1 mt -101.56 161.29 13.75 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.197 179.784 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.464 ' NH2' ' NE1' ' A' ' 41' ' ' TRP . 0.0 OUTLIER -124.65 -168.15 1.77 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.413 -179.92 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.425 ' CG ' ' O ' ' A' ' 34' ' ' ARG . 11.6 mt-10 -164.81 95.55 0.71 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.83 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -47.67 103.94 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.746 -179.589 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 136.01 -39.39 1.66 Allowed Glycine 0 CA--C 1.523 0.584 0 N-CA-C 110.785 -0.926 . . . . 0.0 110.785 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -69.27 176.35 3.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.856 0.36 . . . . 0.0 110.414 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -118.84 33.91 5.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.394 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -176.43 163.5 2.48 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.531 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.491 ' CZ3' ' HG2' ' A' ' 67' ' ' ARG . 57.8 m95 -88.56 175.9 7.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.322 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.9 m -137.24 97.68 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.175 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -50.76 127.61 18.73 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.6 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.444 ' CE ' ' HB2' ' A' ' 52' ' ' TRP . 0.0 OUTLIER -61.32 -170.12 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.115 179.914 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.415 ' O ' ' N ' ' A' ' 47' ' ' GLY . 92.9 m -150.78 117.48 5.8 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.156 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 2.4 ptmt -69.12 63.5 0.13 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.387 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.415 ' N ' ' O ' ' A' ' 45' ' ' THR . . . -86.83 -27.81 28.04 Favored Glycine 0 CA--C 1.521 0.46 0 N-CA-C 110.383 -1.087 . . . . 0.0 110.383 179.785 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.452 ' HG2' ' CG2' ' A' ' 51' ' ' VAL . 11.6 tp10 -91.99 125.28 36.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.895 0.379 . . . . 0.0 110.246 179.847 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -71.89 66.82 1.12 Allowed Glycine 0 CA--C 1.522 0.476 0 N-CA-C 110.713 -0.955 . . . . 0.0 110.713 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 160.18 -27.55 0.33 Allowed Glycine 0 CA--C 1.524 0.595 0 N-CA-C 111.175 -0.77 . . . . 0.0 111.175 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.452 ' CG2' ' HG2' ' A' ' 48' ' ' GLU . 3.6 m -148.4 -176.81 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.062 0.458 . . . . 0.0 111.064 -179.692 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . 0.444 ' HB2' ' CE ' ' A' ' 44' ' ' MET . 4.3 m95 -104.76 136.45 44.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.939 -179.832 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.803 HG22 ' HB2' ' A' ' 18' ' ' ALA . 3.9 p -120.83 144.62 48.25 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.907 0.384 . . . . 0.0 110.662 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.47 ' CB ' HD12 ' A' ' 33' ' ' LEU . 89.5 t80 -140.75 86.14 2.03 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.016 179.638 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.474 ' OD1' ' CE1' ' A' ' 16' ' ' HIS . 10.7 t0 -48.71 151.1 1.24 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.548 -179.794 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 4.9 t -121.94 121.96 38.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.329 179.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -115.47 50.49 1.0 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.55 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -142.89 154.17 61.8 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.331 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -71.15 -40.44 3.25 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.715 2.277 . . . . 0.0 112.068 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 4.5 mt -73.04 153.97 40.65 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.444 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.73 100.56 2.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.319 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -114.74 -152.42 10.37 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 110.723 -0.951 . . . . 0.0 110.723 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -80.99 149.93 17.84 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.66 2.24 . . . . 0.0 112.009 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.476 ' HD2' HG21 ' A' ' 82' ' ' VAL . 45.6 m-85 -102.57 164.3 11.73 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.549 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.422 ' HB2' ' CB ' ' A' ' 34' ' ' ARG . 2.7 m-80 -136.6 139.56 42.21 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.801 179.631 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.732 ' CZ ' HD21 ' A' ' 33' ' ' LEU . 58.5 m-85 -127.31 165.13 20.28 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.135 0.493 . . . . 0.0 111.204 -179.46 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.491 ' HG2' ' CZ3' ' A' ' 41' ' ' TRP . 0.0 OUTLIER -156.99 61.08 0.51 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.48 179.578 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.638 ' CZ ' HG11 ' A' ' 4' ' ' VAL . 3.1 p90 -52.55 170.72 0.07 Allowed 'General case' 0 CA--C 1.516 -0.338 0 CA-C-O 121.483 0.659 . . . . 0.0 111.398 -179.094 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.8 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 5.6 mt -135.42 70.91 1.43 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 114.833 -1.076 . . . . 0.0 108.874 179.544 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -30.73 140.61 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.28 0.632 . . . . 0.0 112.317 -178.726 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.546 ' CA ' ' HB2' ' A' ' 29' ' ' ALA . 13.8 mt-10 -49.79 -47.28 51.3 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.935 -179.455 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.403 ' HD3' ' O ' ' A' ' 72' ' ' LYS . 0.0 OUTLIER -139.23 47.16 1.9 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.815 0.34 . . . . 0.0 110.844 -179.846 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -133.51 -108.94 1.09 Allowed Glycine 0 CA--C 1.522 0.526 0 N-CA-C 110.609 -0.996 . . . . 0.0 110.609 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 10.2 ptt? -165.9 163.2 18.6 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.757 0.313 . . . . 0.0 110.16 179.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.755 ' HB3' HD23 ' A' ' 69' ' ' LEU . 0.0 OUTLIER -98.44 -177.7 3.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.362 -179.922 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.423 ' O ' ' CB ' ' A' ' 67' ' ' ARG . 0.7 OUTLIER -179.4 -167.57 0.1 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.533 179.952 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 96.9 t -134.35 145.7 32.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.128 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.605 ' CZ ' HG21 ' A' ' 4' ' ' VAL . 52.7 m-85 -134.73 134.64 41.23 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.522 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -113.71 155.72 25.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.444 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 51.08 59.21 4.78 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.445 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.814 HG13 ' HB2' ' A' ' 93' ' ' ALA . 95.1 t -94.55 -17.38 7.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.964 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.571 HG13 ' HD2' ' A' ' 83' ' ' PRO . 82.5 t -139.71 140.1 23.89 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-O 120.629 0.252 . . . . 0.0 110.389 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.571 ' HD2' HG13 ' A' ' 82' ' ' VAL . 48.1 Cg_endo -72.49 176.96 8.01 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.652 2.235 . . . . 0.0 112.092 179.877 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -58.65 -32.24 68.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.254 -0.43 . . . . 0.0 109.976 179.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.62 85.66 2.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.131 179.777 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 0.504 ' CD1' HG11 ' A' ' 8' ' ' VAL . 16.9 p90 -52.09 144.74 11.61 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.684 -179.72 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -123.02 102.41 7.98 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.854 179.572 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.47 HD11 ' OG ' ' A' ' 12' ' ' SER . 3.3 mt -44.33 118.26 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.823 -179.712 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 114.41 20.61 5.8 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 110.979 -0.848 . . . . 0.0 110.979 -179.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.552 ' O ' HG23 ' A' ' 7' ' ' THR . . . -136.25 133.11 36.66 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 179.841 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 56.5 m -91.96 93.56 8.85 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.899 0.381 . . . . 0.0 111.01 -179.657 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.551 ' O ' ' HB3' ' A' ' 93' ' ' ALA . 47.4 m-85 -79.55 -153.31 0.08 Allowed 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 178.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.918 ' HB1' ' HD2' ' A' ' 94' ' ' PRO . . . 71.58 179.48 0.05 OUTLIER Pre-proline 0 C--N 1.331 -0.222 0 CA-C-O 120.696 0.284 . . . . 0.0 110.683 179.525 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.918 ' HD2' ' HB1' ' A' ' 93' ' ' ALA . 49.1 Cg_endo . . . . . 0 C--O 1.249 1.042 0 C-N-CA 122.633 2.222 . . . . 0.0 111.99 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.51 ' O ' HG12 ' A' ' 4' ' ' VAL . 35.9 mttp . . . . . 0 CA--C 1.522 -0.117 0 CA-C-O 120.839 0.352 . . . . 0.0 110.242 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.79 ' O ' HG23 ' A' ' 5' ' ' THR . 1.2 p 46.3 -170.98 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.544 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.79 HG23 ' O ' ' A' ' 4' ' ' VAL . 0.6 OUTLIER -177.27 173.12 1.8 Allowed 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.458 -179.996 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.636 ' O ' HG23 ' A' ' 91' ' ' THR . 60.6 m-85 -141.64 172.23 12.97 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.048 179.836 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.519 HG23 ' O ' ' A' ' 90' ' ' ALA . 2.5 m -166.72 112.57 0.8 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.4 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 13.1 t -59.57 113.27 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.14 179.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.832 ' HG3' HG11 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -80.92 173.29 12.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.648 -179.661 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -75.48 153.96 37.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.402 -179.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 95.26 23.51 19.34 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 51.0 m -80.01 127.43 32.28 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.761 0.315 . . . . 0.0 110.288 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -116.31 -161.74 0.81 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.189 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -51.65 -56.65 12.44 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.485 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.408 ' HG2' ' N ' ' A' ' 16' ' ' HIS . 0.0 OUTLIER -106.15 -28.08 10.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.636 -179.763 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . 0.408 ' N ' ' HG2' ' A' ' 15' ' ' LYS . 14.9 m80 -57.4 112.31 1.37 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.492 -179.897 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.416 HD22 ' HA ' ' A' ' 17' ' ' LEU . 0.2 OUTLIER -120.85 99.77 6.71 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.181 -0.463 . . . . 0.0 109.897 179.786 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -95.36 128.25 42.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.53 -179.673 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.932 HG23 HG23 ' A' ' 21' ' ' VAL . 28.5 m -125.24 141.89 43.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.213 179.846 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -91.92 64.99 4.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.403 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.932 HG23 HG23 ' A' ' 19' ' ' VAL . 14.2 t -68.15 93.28 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.367 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -157.97 144.73 17.8 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.446 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.706 ' CE2' HG23 ' A' ' 4' ' ' VAL . 0.0 OUTLIER -153.05 -175.16 5.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.229 179.841 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -115.52 96.31 5.58 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.354 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 155.82 -59.71 0.37 Allowed Glycine 0 CA--C 1.524 0.613 0 N-CA-C 110.807 -0.917 . . . . 0.0 110.807 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.426 ' HB2' ' CZ ' ' A' ' 23' ' ' TYR . 0.4 OUTLIER -83.52 -174.79 5.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.733 0.301 . . . . 0.0 110.356 -179.995 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -129.81 -179.3 5.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.637 -179.786 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.433 ' O ' ' CG ' ' A' ' 71' ' ' GLU . 0.0 OUTLIER -105.39 122.91 46.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.429 -179.967 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.776 ' HB3' ' O ' ' A' ' 69' ' ' LEU . . . -128.72 -53.67 1.24 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.787 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.402 ' O ' ' HB2' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -163.31 153.38 15.64 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.794 0.33 . . . . 0.0 110.653 -179.866 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.938 HG21 ' CD1' ' A' ' 52' ' ' TRP . 4.0 t -135.78 137.62 48.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.108 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -136.33 134.55 38.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.758 0.313 . . . . 0.0 110.463 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.8 mt -105.14 179.06 4.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.986 0.422 . . . . 0.0 110.63 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.504 ' HB2' ' CE3' ' A' ' 41' ' ' TRP . 8.6 ttt85 -170.15 158.49 6.95 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.946 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.443 ' N ' ' HG2' ' A' ' 34' ' ' ARG . 5.4 mp0 -117.29 -81.94 0.63 Allowed 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 179.81 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 168.87 118.14 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.459 179.31 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 52.17 38.2 48.08 Favored Glycine 0 CA--C 1.523 0.532 0 N-CA-C 110.816 -0.914 . . . . 0.0 110.816 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 12.0 t -103.56 -76.71 0.58 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.742 0.306 . . . . 0.0 110.459 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -157.36 52.61 0.48 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.423 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 54.69 178.43 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.073 -179.835 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.504 ' CE3' ' HB2' ' A' ' 34' ' ' ARG . 93.9 m95 -59.04 136.74 58.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.847 0.356 . . . . 0.0 110.161 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.654 HG21 ' CZ ' ' A' ' 54' ' ' PHE . 34.6 m -119.73 111.93 34.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.176 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -52.08 137.81 26.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.253 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.23 -171.29 0.05 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.563 -179.749 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 55.5 m -138.1 109.74 7.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.063 179.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.467 ' HG2' ' CZ3' ' A' ' 52' ' ' TRP . 36.4 mtpt -72.69 77.01 1.11 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.514 -179.754 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -102.66 -55.33 0.84 Allowed Glycine 0 CA--C 1.522 0.528 0 N-CA-C 110.473 -1.051 . . . . 0.0 110.473 179.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.611 ' HG2' HG22 ' A' ' 51' ' ' VAL . 11.8 tt0 -65.3 113.58 4.14 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.838 0.351 . . . . 0.0 110.065 179.806 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -61.98 79.22 0.02 OUTLIER Glycine 0 CA--C 1.523 0.57 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 -179.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.41 ' N ' ' O ' ' A' ' 48' ' ' GLU . . . 152.02 -42.54 0.69 Allowed Glycine 0 CA--C 1.523 0.561 0 N-CA-C 111.242 -0.743 . . . . 0.0 111.242 179.801 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.832 HG11 ' HG3' ' A' ' 9' ' ' GLU . 30.0 m -135.46 168.98 21.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.889 0.376 . . . . 0.0 110.806 -179.577 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . 0.938 ' CD1' HG21 ' A' ' 31' ' ' VAL . 7.5 m95 -99.84 140.74 33.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.571 -179.899 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 14.1 p -128.5 146.21 50.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.148 179.767 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.654 ' CZ ' HG21 ' A' ' 42' ' ' VAL . 33.2 t80 -125.04 140.88 52.51 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.535 -179.791 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -97.26 87.52 4.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.255 179.877 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.4 m -69.84 175.8 4.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.359 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 11.3 tt0 -161.67 38.49 0.13 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.296 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -131.29 165.52 34.68 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.427 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -93.59 7.26 2.67 Favored 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 123.849 3.032 . . . . 0.0 112.578 179.678 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 2.2 tp -59.86 153.29 21.19 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.782 0.325 . . . . 0.0 110.351 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.2 46.12 0.98 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.215 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -122.77 -146.44 7.18 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.67 -0.972 . . . . 0.0 110.67 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -82.73 153.36 15.18 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.719 2.279 . . . . 0.0 112.195 -179.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.412 ' HD2' HG21 ' A' ' 82' ' ' VAL . 25.7 m-85 -101.16 162.19 13.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.139 179.777 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.44 ' OD1' ' N ' ' A' ' 65' ' ' ASN . 0.0 OUTLIER -127.14 113.11 15.96 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 179.511 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.412 ' O ' ' HG3' ' A' ' 67' ' ' ARG . 5.5 m-85 -97.36 -174.08 2.83 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.871 -179.298 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.453 ' HG3' ' HA ' ' A' ' 77' ' ' VAL . 2.3 mtp180 170.21 78.04 0.0 OUTLIER 'General case' 0 CA--C 1.521 -0.137 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.88 178.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.813 ' O ' HD23 ' A' ' 69' ' ' LEU . 3.2 p90 -79.88 -179.73 7.12 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.147 179.581 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.813 HD23 ' O ' ' A' ' 68' ' ' PHE . 1.0 OUTLIER -136.31 68.67 1.43 Allowed 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 179.642 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 7.1 p -35.11 139.82 0.09 Allowed 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.929 -179.079 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.665 ' HG2' ' HB2' ' A' ' 29' ' ' ALA . 7.7 mm-40 -50.93 -54.06 27.49 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.605 -179.672 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.4 tptm -116.96 71.46 0.8 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.498 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -167.87 -102.93 0.16 Allowed Glycine 0 CA--C 1.521 0.459 0 N-CA-C 110.552 -1.019 . . . . 0.0 110.552 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 7.6 ptt? 169.13 -177.09 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.774 0.321 . . . . 0.0 110.163 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.545 ' CG ' HD22 ' A' ' 69' ' ' LEU . 4.2 mptt -75.44 -178.08 3.89 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.263 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 175.17 136.36 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.338 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.475 HG12 ' N ' ' A' ' 78' ' ' PHE . 95.9 t -84.35 159.24 3.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.267 179.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.549 ' CE1' HG11 ' A' ' 4' ' ' VAL . 86.8 m-85 -150.16 120.03 7.11 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.32 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -115.99 151.81 34.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.458 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 61.95 34.79 16.57 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.357 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.551 HG13 ' CD1' ' A' ' 6' ' ' PHE . 49.5 t -78.08 -0.5 3.39 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.935 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.599 HG13 ' HD2' ' A' ' 83' ' ' PRO . 84.1 t -154.88 139.91 12.06 Favored Pre-proline 0 C--N 1.333 -0.115 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 179.271 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.599 ' HD2' HG13 ' A' ' 82' ' ' VAL . 50.3 Cg_endo -71.72 -170.16 0.5 Allowed 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.647 2.231 . . . . 0.0 111.982 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -75.56 -28.57 59.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.188 -0.46 . . . . 0.0 109.96 179.51 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 13.7 mttt -139.25 74.95 1.49 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.982 179.783 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 0.432 ' HA ' ' HG2' ' A' ' 83' ' ' PRO . 25.9 p90 -48.3 151.78 0.99 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.876 -179.63 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 2.4 m -136.9 110.07 7.79 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.828 -0.623 . . . . 0.0 109.991 179.784 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 2.8 mp -46.12 105.96 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.845 -179.721 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 128.25 44.55 0.21 Allowed Glycine 0 CA--C 1.523 0.541 0 N-CA-C 110.619 -0.992 . . . . 0.0 110.619 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.597 ' HB3' ' CZ ' ' A' ' 92' ' ' TYR . . . -157.63 160.8 38.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.796 0.332 . . . . 0.0 110.339 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.636 HG23 ' O ' ' A' ' 6' ' ' PHE . 39.9 m -113.51 102.04 9.92 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.555 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.597 ' CZ ' ' HB3' ' A' ' 90' ' ' ALA . 29.9 m-85 -103.95 144.61 31.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.615 -179.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.781 ' HB1' ' HD2' ' A' ' 94' ' ' PRO . . . 172.46 171.42 0.22 Allowed Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.41 179.701 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.781 ' HD2' ' HB1' ' A' ' 93' ' ' ALA . 49.3 Cg_endo . . . . . 0 C--O 1.249 1.063 0 C-N-CA 122.61 2.207 . . . . 0.0 112.082 -179.956 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 7.8 mtmt . . . . . 0 C--O 1.232 0.158 0 CA-C-O 120.767 0.318 . . . . 0.0 110.452 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 3.7 m -53.99 -178.99 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.121 179.866 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.2 p -152.54 131.17 12.3 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.42 179.949 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.667 ' HD1' ' HB2' ' A' ' 93' ' ' ALA . 16.6 m-85 -98.47 171.57 8.08 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.248 179.878 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.781 HG23 ' O ' ' A' ' 90' ' ' ALA . 0.6 OUTLIER -164.44 105.86 0.86 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.298 179.996 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 60.5 t -60.34 101.63 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.297 179.974 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.619 ' CD ' HG11 ' A' ' 51' ' ' VAL . 2.7 mt-10 -64.05 -175.72 0.16 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.315 -179.952 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 5.7 pttm -86.25 10.79 13.66 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.168 179.972 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.422 ' HA3' ' HB2' ' A' ' 18' ' ' ALA . . . -69.27 -29.71 71.86 Favored Glycine 0 CA--C 1.522 0.487 0 N-CA-C 110.571 -1.012 . . . . 0.0 110.571 179.79 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 53.2 p -53.0 106.11 0.15 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.817 0.341 . . . . 0.0 110.264 179.894 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 10.1 m-80 -89.34 -68.14 0.79 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.337 -179.97 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -135.8 -54.6 0.77 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.393 179.963 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.62 -27.39 8.57 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.392 179.926 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -52.24 179.44 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.358 179.987 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.411 HD12 ' HA ' ' A' ' 17' ' ' LEU . 24.3 tp -159.18 83.42 0.78 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.249 179.967 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.442 ' C ' HG13 ' A' ' 19' ' ' VAL . . . -73.79 158.37 34.71 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.511 -179.906 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.582 HG23 HG23 ' A' ' 21' ' ' VAL . 35.4 m -157.55 139.17 5.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.347 179.845 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -97.52 57.87 1.42 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.431 179.987 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.582 HG23 HG23 ' A' ' 19' ' ' VAL . 18.3 t -58.8 94.47 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.359 179.975 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.5 ttpm? -152.27 149.01 28.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.448 -179.929 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 12.9 p90 -169.19 137.89 2.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.309 179.916 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -55.37 152.77 8.11 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.27 -179.979 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 113.91 -77.09 0.25 Allowed Glycine 0 CA--C 1.523 0.569 0 N-CA-C 110.736 -0.946 . . . . 0.0 110.736 -179.931 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -103.81 179.94 4.13 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.801 0.334 . . . . 0.0 110.347 179.933 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.422 HG22 ' H ' ' A' ' 28' ' ' MET . 0.2 OUTLIER -108.52 -160.87 0.74 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.513 -179.813 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.422 ' H ' HG22 ' A' ' 27' ' ' THR . 19.9 mmt -122.72 127.85 49.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.542 -179.77 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.812 ' HB3' ' O ' ' A' ' 69' ' ' LEU . . . -117.23 -55.69 2.3 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.58 -179.933 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.438 ' HB3' HD12 ' A' ' 69' ' ' LEU . 23.0 tt0 -158.55 165.23 35.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.324 -179.937 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.609 HG21 ' CD1' ' A' ' 52' ' ' TRP . 67.2 t -143.64 149.4 18.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.956 0.407 . . . . 0.0 110.451 179.939 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.417 ' OE2' ' N ' ' A' ' 43' ' ' ALA . 9.7 tp10 -134.78 136.99 42.99 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-N 115.96 -0.563 . . . . 0.0 109.79 -179.431 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.647 HD12 ' H ' ' A' ' 34' ' ' ARG . 13.0 tp -115.89 152.26 33.73 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 -179.918 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.647 ' H ' HD12 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -128.39 176.19 7.91 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.826 0.346 . . . . 0.0 110.543 -179.818 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.419 ' O ' ' N ' ' A' ' 37' ' ' GLY . 1.5 tm-20 -138.85 12.41 2.68 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.16 -179.907 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER 67.48 -68.77 0.15 Allowed 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 120.822 0.344 . . . . 0.0 110.519 -179.973 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 35' ' ' GLU . . . -68.75 -26.33 74.59 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 110.846 -0.901 . . . . 0.0 110.846 -179.951 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 8.6 t -50.87 140.41 15.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.76 0.314 . . . . 0.0 110.357 -179.895 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 16.5 t0 -49.38 -30.9 8.45 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.472 -179.999 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -170.77 172.56 5.65 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.431 179.892 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.477 ' CE3' ' HB2' ' A' ' 34' ' ' ARG . 69.3 m95 -54.87 147.34 15.38 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.262 179.922 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.4 ' O ' HG23 ' A' ' 42' ' ' VAL . 6.1 m -124.77 109.91 23.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.298 179.929 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.417 ' N ' ' OE2' ' A' ' 32' ' ' GLU . . . -50.54 135.12 23.27 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.482 -179.881 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -53.69 -171.64 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.624 -179.925 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 58.0 m -128.85 93.17 3.55 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.498 -179.896 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 7.0 ptmt -71.05 84.57 0.71 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.403 179.942 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -144.21 30.21 1.89 Allowed Glycine 0 CA--C 1.523 0.533 0 N-CA-C 110.473 -1.051 . . . . 0.0 110.473 179.934 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.404 ' HB2' ' O ' ' A' ' 51' ' ' VAL . 0.0 OUTLIER -108.77 174.05 6.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.843 0.354 . . . . 0.0 110.503 -179.879 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -59.82 -31.63 72.36 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 110.718 -0.953 . . . . 0.0 110.718 179.968 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -176.6 35.41 0.09 OUTLIER Glycine 0 CA--C 1.524 0.595 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 -179.978 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.619 HG11 ' CD ' ' A' ' 9' ' ' GLU . 6.6 m -152.16 -179.93 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.776 0.322 . . . . 0.0 110.425 179.803 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . 0.609 ' CD1' HG21 ' A' ' 31' ' ' VAL . 7.0 m95 -108.44 140.0 42.37 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.438 -179.644 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -127.69 177.0 7.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.126 179.809 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.636 ' CG ' HD23 ' A' ' 33' ' ' LEU . 77.4 t80 -161.77 119.36 2.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.403 179.926 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.443 ' O ' ' CD2' ' A' ' 54' ' ' PHE . 28.3 p-10 -66.87 -177.34 0.6 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.402 -179.988 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 59.24 178.93 0.08 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.443 179.897 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 174.39 50.17 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.218 179.941 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -50.47 121.41 14.12 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.444 -179.847 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -71.56 59.73 2.66 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.444 2.096 . . . . 0.0 112.056 179.87 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -114.88 1.29 14.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.256 179.956 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -177.89 124.44 0.12 Allowed 'General case' 0 C--N 1.334 -0.092 0 CA-C-O 120.778 0.323 . . . . 0.0 110.367 179.939 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.424 ' N ' ' HD2' ' A' ' 63' ' ' PRO . . . -74.23 -54.94 5.94 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 110.814 -0.914 . . . . 0.0 110.814 -179.881 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.424 ' HD2' ' N ' ' A' ' 62' ' ' GLY . 48.0 Cg_endo -74.85 122.02 7.01 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.531 2.154 . . . . 0.0 112.214 -179.932 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -99.46 137.06 38.49 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.082 179.818 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 12.8 m-80 -98.59 134.24 41.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.803 0.335 . . . . 0.0 110.343 -179.923 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -119.92 174.31 6.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.455 179.993 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 12.6 ptm180 -173.52 76.36 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.0 -0.546 . . . . 0.0 109.92 179.923 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.592 ' O ' HD23 ' A' ' 69' ' ' LEU . 3.5 p90 -61.42 175.19 0.61 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.192 0.52 . . . . 0.0 110.809 -179.56 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.812 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 8.0 mt -132.02 65.41 1.57 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.129 179.569 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 14.0 p -26.99 135.0 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.644 0.778 . . . . 0.0 112.633 -178.987 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.609 ' HG2' ' HB2' ' A' ' 29' ' ' ALA . 16.5 mt-10 -49.74 -26.0 3.46 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.54 -179.713 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.5 tmtm? -64.81 -40.31 95.0 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.317 179.898 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 118.86 53.46 0.28 Allowed Glycine 0 CA--C 1.524 0.604 0 N-CA-C 110.798 -0.921 . . . . 0.0 110.798 179.938 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -144.71 145.61 31.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.797 0.332 . . . . 0.0 110.47 179.964 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.585 ' HG2' HD22 ' A' ' 69' ' ' LEU . 0.8 OUTLIER -127.35 -178.87 4.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.312 179.976 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 174.31 162.92 0.2 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.526 179.964 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.507 HG12 ' N ' ' A' ' 78' ' ' PHE . 86.9 t -107.18 160.77 6.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.248 179.854 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.507 ' N ' HG12 ' A' ' 77' ' ' VAL . 71.8 m-85 -151.19 130.39 12.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.525 -179.92 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -115.0 160.56 19.44 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.313 -179.924 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 52.32 55.12 9.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.355 179.932 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.725 HG22 ' HD3' ' A' ' 94' ' ' PRO . 75.6 t -102.05 2.15 10.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.034 179.957 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.437 HG23 ' C ' ' A' ' 81' ' ' VAL . 89.3 t -156.26 131.45 5.37 Favored Pre-proline 0 C--N 1.332 -0.154 0 N-CA-C 110.229 -0.286 . . . . 0.0 110.229 179.556 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -70.98 -171.16 0.54 Allowed 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.516 2.144 . . . . 0.0 111.863 179.761 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -74.0 -27.85 61.17 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.883 179.386 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 4.0 tptt -138.46 77.66 1.64 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.093 179.779 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 0.437 ' HB3' HG13 ' A' ' 82' ' ' VAL . 51.0 p90 -55.05 137.28 46.74 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.589 -179.795 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 5.3 m -116.32 107.29 14.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.12 179.717 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 2.7 mp -47.76 108.39 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.582 -179.872 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 126.05 43.36 0.28 Allowed Glycine 0 CA--C 1.523 0.569 0 N-CA-C 110.587 -1.005 . . . . 0.0 110.587 -179.864 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.781 ' O ' HG23 ' A' ' 7' ' ' THR . . . -153.8 -176.32 5.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.796 0.331 . . . . 0.0 110.389 -179.948 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 89.9 m -129.74 104.44 7.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.669 -179.84 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.473 ' O ' ' HB2' ' A' ' 93' ' ' ALA . 18.5 m-85 -106.97 140.27 40.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.463 179.901 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.826 ' HB1' ' HD2' ' A' ' 94' ' ' PRO . . . 171.75 171.7 0.2 Allowed Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.389 179.593 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.826 ' HD2' ' HB1' ' A' ' 93' ' ' ALA . 47.6 Cg_endo . . . . . 0 C--O 1.249 1.032 0 C-N-CA 122.606 2.204 . . . . 0.0 111.984 179.804 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.545 ' O ' HG22 ' A' ' 4' ' ' VAL . 18.4 mtmt . . . . . 0 CA--C 1.521 -0.158 0 CA-C-O 120.706 0.288 . . . . 0.0 110.403 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.79 ' O ' HG23 ' A' ' 5' ' ' THR . 19.5 m 44.22 -172.38 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.338 179.807 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.79 HG23 ' O ' ' A' ' 4' ' ' VAL . 0.5 OUTLIER -179.55 137.64 0.13 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.301 -179.761 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.626 ' O ' HG23 ' A' ' 91' ' ' THR . 8.2 m-85 -116.13 178.4 4.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.061 179.855 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.641 HG23 ' O ' ' A' ' 90' ' ' ALA . 48.2 m -164.43 124.06 1.96 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.873 0.368 . . . . 0.0 110.514 -179.94 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 90.1 t -58.64 90.33 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.449 179.99 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.859 ' HG3' HG11 ' A' ' 51' ' ' VAL . 1.9 mm-40 -59.1 176.04 0.25 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.432 -179.968 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 5.1 mtmt -69.72 155.37 40.62 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.27 179.878 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 103.37 -33.44 6.58 Favored Glycine 0 CA--C 1.523 0.533 0 N-CA-C 110.851 -0.899 . . . . 0.0 110.851 179.968 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 70.9 m -50.67 112.36 0.69 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.684 0.278 . . . . 0.0 110.316 179.969 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -112.69 -67.06 1.03 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.937 -179.685 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.404 ' HG3' ' HG2' ' A' ' 15' ' ' LYS . 6.6 pt-20 -141.46 -48.66 0.39 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.643 0.258 . . . . 0.0 110.93 -179.702 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.404 ' HG2' ' HG3' ' A' ' 14' ' ' GLU . 8.9 ptpt -103.93 -39.38 6.62 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.766 0.317 . . . . 0.0 110.498 -179.944 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 13.2 m80 -65.94 110.26 2.83 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 179.794 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.508 HD22 ' HA ' ' A' ' 17' ' ' LEU . 0.3 OUTLIER -107.21 94.87 5.33 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.41 -179.772 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.621 ' HB2' HG22 ' A' ' 53' ' ' THR . . . -95.34 120.44 35.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.381 179.987 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.431 HG11 ' CZ ' ' A' ' 66' ' ' PHE . 21.1 m -114.42 144.24 22.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.218 179.899 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.519 ' HA ' HG12 ' A' ' 51' ' ' VAL . 1.5 tt -97.54 62.53 1.7 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.758 -179.718 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.523 ' CG1' ' CD1' ' A' ' 52' ' ' TRP . 3.4 p -81.75 126.02 39.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.971 0.415 . . . . 0.0 110.103 179.74 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.494 ' O ' ' CG ' ' A' ' 23' ' ' TYR . 5.8 tttp -166.33 -66.98 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.312 -179.863 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.494 ' CG ' ' O ' ' A' ' 22' ' ' LYS . 30.0 p90 44.97 -172.96 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.906 179.824 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -122.06 177.66 5.23 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.353 -179.724 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 96.95 -40.7 2.49 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 110.772 -0.931 . . . . 0.0 110.772 179.949 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -128.99 -175.11 3.45 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.812 0.339 . . . . 0.0 110.266 179.968 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.403 ' OG1' ' HE2' ' A' ' 72' ' ' LYS . 0.8 OUTLIER -113.25 -178.98 3.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.548 -179.98 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.504 ' CE ' HG22 ' A' ' 21' ' ' VAL . 0.4 OUTLIER -128.56 126.66 40.78 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.462 -179.882 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.898 ' HB3' ' O ' ' A' ' 69' ' ' LEU . . . -120.12 -59.85 1.75 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.393 179.957 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -142.8 159.0 43.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.291 179.986 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.818 HG21 ' NE1' ' A' ' 52' ' ' TRP . 47.2 t -138.54 145.98 27.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.038 0.447 . . . . 0.0 110.435 179.96 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.453 ' HB2' ' HA ' ' A' ' 43' ' ' ALA . 11.6 tt0 -139.79 129.53 24.58 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.891 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.713 HD12 ' H ' ' A' ' 34' ' ' ARG . 5.6 tp -110.35 150.19 29.13 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.962 0.411 . . . . 0.0 110.049 -179.027 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.713 ' H ' HD12 ' A' ' 33' ' ' LEU . 0.5 OUTLIER -106.22 -156.31 0.57 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.548 179.462 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.406 ' O ' ' HB2' ' A' ' 36' ' ' HIS . 1.0 OUTLIER -149.73 -87.69 0.08 Allowed 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 121.235 -0.186 . . . . 0.0 110.631 179.883 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 0.406 ' HB2' ' O ' ' A' ' 35' ' ' GLU . 17.3 t-160 175.48 -56.97 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 -179.976 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -91.36 -25.82 22.65 Favored Glycine 0 CA--C 1.522 0.513 0 N-CA-C 110.467 -1.053 . . . . 0.0 110.467 179.607 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.41 ' O ' ' CB ' ' A' ' 39' ' ' ASP . 0.1 OUTLIER -50.66 -31.66 16.87 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.871 0.367 . . . . 0.0 110.327 179.87 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.41 ' CB ' ' O ' ' A' ' 38' ' ' SER . 11.2 t0 81.75 -52.33 0.25 Allowed 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.882 179.856 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -98.24 177.38 5.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.969 0.414 . . . . 0.0 110.753 -179.619 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.425 ' CD2' ' HG3' ' A' ' 34' ' ' ARG . 59.8 m95 -95.96 171.97 8.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.383 -179.946 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.434 ' CG2' ' O ' ' A' ' 33' ' ' LEU . 5.1 m -146.86 105.64 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.201 179.621 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.453 ' HA ' ' HB2' ' A' ' 32' ' ' GLU . . . -49.94 136.49 18.39 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.697 -179.693 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -63.33 -173.09 0.06 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.896 -179.791 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 30.2 m -137.66 99.97 4.08 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.372 -179.999 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 6.5 ptpt -64.51 80.38 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.47 -179.905 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -113.11 -24.78 4.69 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.88 -0.888 . . . . 0.0 110.88 -179.969 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -72.73 -37.28 67.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.894 0.378 . . . . 0.0 110.473 179.987 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 95.65 -38.68 3.04 Favored Glycine 0 CA--C 1.523 0.541 0 N-CA-C 110.274 -1.13 . . . . 0.0 110.274 -179.654 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -102.17 -29.9 5.89 Favored Glycine 0 CA--C 1.523 0.539 0 N-CA-C 110.42 -1.072 . . . . 0.0 110.42 179.734 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.859 HG11 ' HG3' ' A' ' 9' ' ' GLU . 8.0 m -138.49 -178.47 2.0 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.768 0.318 . . . . 0.0 110.273 179.773 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . 0.818 ' NE1' HG21 ' A' ' 31' ' ' VAL . 5.5 m95 -114.97 136.98 52.53 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.893 0.378 . . . . 0.0 110.772 -179.414 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.621 HG22 ' HB2' ' A' ' 18' ' ' ALA . 10.2 p -126.39 151.08 48.14 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.732 179.452 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.412 ' CZ ' ' HB ' ' A' ' 42' ' ' VAL . 63.9 t80 -141.24 152.79 44.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.941 0.401 . . . . 0.0 110.921 -179.634 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -94.02 102.06 14.12 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.106 179.714 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.1 m -83.73 139.11 32.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.712 -179.702 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -100.06 -49.93 4.15 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.243 179.823 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.454 ' HA ' ' HD3' ' A' ' 59' ' ' PRO . 12.3 pt-20 -74.3 126.46 88.97 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.313 179.963 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 58' ' ' GLU . 38.0 Cg_endo -91.97 71.28 0.78 Allowed 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 123.159 2.572 . . . . 0.0 112.066 179.627 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -106.84 -30.34 8.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.058 0.456 . . . . 0.0 110.375 -179.936 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 44.33 36.48 1.61 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.942 179.933 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -94.04 -144.71 16.28 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 110.895 -0.882 . . . . 0.0 110.895 -179.83 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -78.63 120.79 4.88 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.608 2.205 . . . . 0.0 112.291 -179.821 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.401 ' HB3' ' CD1' ' A' ' 33' ' ' LEU . 30.7 m-85 -90.76 178.4 6.07 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.1 179.81 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -152.78 139.77 19.17 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.936 179.81 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.478 ' CE1' HD13 ' A' ' 33' ' ' LEU . 11.0 m-85 -127.68 177.25 6.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.05 0.452 . . . . 0.0 111.136 -179.775 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.412 ' CB ' ' O ' ' A' ' 76' ' ' ASN . 0.0 OUTLIER -177.16 66.89 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.592 179.976 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.676 ' HZ ' HG11 ' A' ' 4' ' ' VAL . 0.4 OUTLIER -58.47 173.65 0.37 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.252 -179.277 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.898 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 10.2 mt -123.94 83.33 2.13 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.307 -0.86 . . . . 0.0 108.896 178.884 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.418 ' OG1' ' N ' ' A' ' 74' ' ' MET . 1.6 p -35.55 137.08 0.2 Allowed 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.799 -178.954 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.746 ' HA ' ' HB2' ' A' ' 29' ' ' ALA . 21.0 mt-10 -46.71 -34.51 5.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.171 -179.16 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.406 ' O ' ' HD3' ' A' ' 72' ' ' LYS . 0.0 OUTLIER -155.99 60.03 0.59 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.776 0.322 . . . . 0.0 111.017 179.867 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -148.79 -107.18 0.43 Allowed Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.803 -0.919 . . . . 0.0 110.803 179.646 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.418 ' N ' ' OG1' ' A' ' 70' ' ' THR . 21.0 ptm -159.9 -176.42 5.69 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.846 0.355 . . . . 0.0 110.182 179.864 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.01 159.7 20.48 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.638 -179.762 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.412 ' O ' ' CB ' ' A' ' 67' ' ' ARG . 10.7 m-20 -152.43 175.06 13.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.098 -179.953 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.501 HG12 ' N ' ' A' ' 78' ' ' PHE . 49.5 t -110.24 160.98 8.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.434 -179.907 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.501 ' N ' HG12 ' A' ' 77' ' ' VAL . 75.9 m-85 -149.85 129.2 12.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.396 -179.922 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 15.2 p-10 -116.47 164.97 13.77 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.35 -179.999 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 32.3 m-20 52.35 27.29 4.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.524 179.959 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.47 HG13 ' CD1' ' A' ' 6' ' ' PHE . 88.3 t -61.79 -16.36 15.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.677 179.838 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.498 HG13 ' HD2' ' A' ' 83' ' ' PRO . 54.3 t -150.06 138.92 12.73 Favored Pre-proline 0 C--N 1.331 -0.228 0 N-CA-C 110.292 -0.262 . . . . 0.0 110.292 179.945 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.498 ' HD2' HG13 ' A' ' 82' ' ' VAL . 47.8 Cg_endo -72.28 -175.62 1.84 Allowed 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.592 2.195 . . . . 0.0 111.978 179.86 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 26.4 mm-40 -69.45 -54.87 12.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.21 179.849 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 10.5 tttt -113.9 67.4 0.67 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.237 179.98 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 30.8 p90 -57.64 174.42 0.23 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.676 -179.819 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 27.1 m -150.8 120.21 6.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.07 179.827 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.558 ' H ' HD12 ' A' ' 88' ' ' ILE . 3.9 mp -48.96 104.31 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.742 -179.752 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 133.43 53.4 0.08 OUTLIER Glycine 0 CA--C 1.523 0.561 0 N-CA-C 110.814 -0.914 . . . . 0.0 110.814 179.992 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.641 ' O ' HG23 ' A' ' 7' ' ' THR . . . -173.71 140.79 0.79 Allowed 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 110.228 -0.286 . . . . 0.0 110.228 179.92 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.626 HG23 ' O ' ' A' ' 6' ' ' PHE . 25.1 m -97.43 89.25 4.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.909 0.385 . . . . 0.0 110.626 -179.89 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.578 ' O ' ' HB3' ' A' ' 93' ' ' ALA . 43.6 m-85 -70.2 -156.94 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.042 -0.526 . . . . 0.0 109.874 179.56 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.883 ' HB1' ' HD2' ' A' ' 94' ' ' PRO . . . 76.65 173.71 0.09 OUTLIER Pre-proline 0 N--CA 1.464 0.24 0 CA-C-O 120.809 0.338 . . . . 0.0 110.69 179.853 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.883 ' HD2' ' HB1' ' A' ' 93' ' ' ALA . 47.5 Cg_endo . . . . . 0 C--O 1.249 1.063 0 C-N-CA 122.583 2.189 . . . . 0.0 112.096 179.891 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.523 -0.092 0 CA-C-O 120.792 0.329 . . . . 0.0 110.205 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.533 ' CG1' ' CE1' ' A' ' 78' ' ' PHE . 1.7 p -115.09 163.38 12.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.368 0.604 . . . . 0.0 110.569 -179.806 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.484 HG22 HG21 ' A' ' 91' ' ' THR . 0.6 OUTLIER -134.31 148.76 50.82 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.048 179.729 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.692 ' O ' HG23 ' A' ' 91' ' ' THR . 24.8 m-85 -118.52 171.79 7.92 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.389 -179.944 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.9 m -167.81 131.8 1.73 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.007 -179.952 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.853 ' O ' HG23 ' A' ' 88' ' ' ILE . 34.8 t -82.21 94.68 2.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.537 -179.728 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.438 ' HG3' HG11 ' A' ' 51' ' ' VAL . 11.6 mt-10 -54.4 178.26 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.513 -179.921 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 4.1 mmmt -85.89 52.35 2.45 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.514 179.936 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -139.69 23.68 2.78 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 110.86 -0.896 . . . . 0.0 110.86 179.974 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 19.0 m -109.89 127.26 54.61 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 110.168 -0.308 . . . . 0.0 110.168 179.944 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -121.85 -87.61 0.64 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.471 -179.863 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 39.0 tp10 -117.61 -61.92 1.63 Allowed 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 120.826 0.346 . . . . 0.0 110.12 -179.79 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.423 ' CE ' ' HG3' ' A' ' 57' ' ' GLU . 5.5 ptpt -98.69 -21.56 16.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.746 -179.847 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 5.4 m80 -73.73 135.48 43.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.835 0.35 . . . . 0.0 110.282 179.926 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.486 HD22 ' HA ' ' A' ' 17' ' ' LEU . 0.2 OUTLIER -133.44 100.14 4.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.243 -179.968 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -97.12 145.1 26.32 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.377 -179.95 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.682 HG23 HG23 ' A' ' 21' ' ' VAL . 14.5 m -139.83 134.19 37.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.579 -179.871 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.439 ' HA ' ' CG1' ' A' ' 51' ' ' VAL . 1.3 tt -83.22 64.0 7.5 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.435 179.876 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.682 HG23 HG23 ' A' ' 19' ' ' VAL . 17.2 t -74.04 87.12 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.272 -179.978 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 7.3 tttp -176.61 120.52 0.14 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.401 -179.966 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 27.3 p90 -130.81 29.06 4.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.291 179.99 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 53.91 -177.15 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.327 -179.889 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 77.21 -66.02 2.95 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 110.714 -0.954 . . . . 0.0 110.714 -179.952 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -84.65 179.27 7.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.775 0.322 . . . . 0.0 110.315 179.922 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.409 ' HB ' ' CG ' ' A' ' 71' ' ' GLU . 0.0 OUTLIER -115.47 170.78 8.15 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.275 179.906 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 11.9 mmt -113.65 126.2 55.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.739 -179.712 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.767 ' HB3' ' O ' ' A' ' 69' ' ' LEU . . . -115.82 -60.87 1.81 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.223 -179.804 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -158.19 161.47 37.84 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.551 179.776 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.945 HG21 ' CD1' ' A' ' 52' ' ' TRP . 12.0 t -136.78 142.79 36.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.316 0.579 . . . . 0.0 111.407 -179.723 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.457 ' CG ' ' HB3' ' A' ' 41' ' ' TRP . 2.5 tp10 -137.5 122.68 19.25 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-N 115.105 -0.952 . . . . 0.0 108.911 -179.827 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.813 HD12 ' N ' ' A' ' 34' ' ' ARG . 2.9 pp -110.66 179.5 4.05 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.254 0.549 . . . . 0.0 111.492 -179.036 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.813 ' N ' HD12 ' A' ' 33' ' ' LEU . 9.4 ttt180 -148.94 170.79 17.53 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.141 179.417 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.407 ' O ' ' HB2' ' A' ' 36' ' ' HIS . 5.2 mt-10 -119.97 -82.83 0.65 Allowed 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 179.906 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 0.407 ' HB2' ' O ' ' A' ' 35' ' ' GLU . 1.0 OUTLIER 178.33 -56.98 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.311 179.383 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -66.02 -28.03 73.33 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 110.697 -0.961 . . . . 0.0 110.697 179.959 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -61.3 166.76 3.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.756 0.312 . . . . 0.0 110.366 179.941 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -121.47 25.66 9.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.487 -179.978 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -179.5 149.13 0.37 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.277 179.968 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.512 ' CE3' ' HG2' ' A' ' 67' ' ' ARG . 58.2 m95 -64.68 160.57 19.59 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.506 -179.983 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.552 HG23 ' O ' ' A' ' 42' ' ' VAL . 31.5 m -130.33 109.61 17.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.174 179.796 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.42 ' N ' ' OE2' ' A' ' 32' ' ' GLU . . . -49.11 124.73 9.37 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.725 -179.658 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.491 ' HG2' HD23 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -57.04 -171.3 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.116 179.77 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 30.5 m -152.11 119.05 5.8 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.58 -179.923 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 14.2 ptpt -74.78 67.52 1.62 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.07 179.708 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -98.16 -19.95 22.14 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 111.21 -0.756 . . . . 0.0 111.21 -179.749 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.453 ' HG2' ' CG2' ' A' ' 51' ' ' VAL . 30.9 tp10 -77.76 -45.06 25.71 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.767 0.317 . . . . 0.0 110.388 -179.884 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 117.58 -63.28 0.4 Allowed Glycine 0 CA--C 1.523 0.561 0 N-CA-C 110.708 -0.957 . . . . 0.0 110.708 179.977 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -84.47 -30.01 28.52 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 110.718 -0.953 . . . . 0.0 110.718 179.97 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.453 ' CG2' ' HG2' ' A' ' 48' ' ' GLU . 6.3 m -132.53 -179.44 3.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.881 0.372 . . . . 0.0 110.437 179.953 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . 0.945 ' CD1' HG21 ' A' ' 31' ' ' VAL . 5.4 m95 -103.72 125.93 50.52 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.183 -179.823 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -118.05 160.66 21.11 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.406 -179.945 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 26.7 t80 -138.21 128.12 25.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.42 -179.966 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 19.7 p-10 -102.18 115.98 31.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.441 179.988 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 4.0 m -170.54 161.5 7.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.203 179.928 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.423 ' HG3' ' CE ' ' A' ' 15' ' ' LYS . 5.3 mt-10 -132.03 26.2 4.59 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.542 -179.903 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.95 156.51 25.47 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.311 179.882 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -72.49 69.42 3.44 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.641 2.227 . . . . 0.0 112.173 -179.942 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.7 pp -81.54 127.49 32.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.366 179.909 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -132.38 32.4 3.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.475 -179.999 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -156.13 -170.29 21.23 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 110.863 -0.895 . . . . 0.0 110.863 -179.996 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.406 ' HG3' ' HA ' ' A' ' 80' ' ' ASP . 49.0 Cg_endo -78.32 165.75 25.18 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.721 2.281 . . . . 0.0 112.039 -179.916 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -98.16 105.3 17.43 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.464 179.962 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 17.8 m-80 -77.51 140.65 39.8 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 179.191 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.5 ' CE1' ' HB3' ' A' ' 33' ' ' LEU . 37.1 m-85 -121.57 -178.56 3.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.157 0.503 . . . . 0.0 111.245 -179.245 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.512 ' HG2' ' CE3' ' A' ' 41' ' ' TRP . 0.0 OUTLIER 173.95 59.09 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.728 179.973 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.461 ' HA ' ' HA ' ' A' ' 31' ' ' VAL . 1.2 p90 -50.86 165.24 0.11 Allowed 'General case' 0 CA--C 1.517 -0.321 0 CA-C-O 121.219 0.533 . . . . 0.0 111.054 -179.323 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.767 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 2.2 mt -115.9 63.33 0.7 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.118 179.671 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 12.0 p -29.95 138.22 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 115.594 -0.73 . . . . 0.0 112.476 -179.019 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.62 ' HG2' ' HB2' ' A' ' 29' ' ' ALA . 16.4 mt-10 -52.36 -36.11 52.88 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.364 -179.952 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.09 65.74 1.15 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.505 -179.835 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -151.23 -106.92 0.35 Allowed Glycine 0 CA--C 1.522 0.484 0 N-CA-C 110.58 -1.008 . . . . 0.0 110.58 179.965 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 16.1 ptt? -175.32 176.17 2.07 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.805 0.336 . . . . 0.0 110.194 179.919 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.476 ' N ' ' CD ' ' A' ' 75' ' ' LYS . 0.0 OUTLIER -94.62 120.78 35.39 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.141 179.924 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.423 ' O ' ' CB ' ' A' ' 67' ' ' ARG . 65.5 m-80 -112.05 168.69 9.4 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.727 -179.596 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 94.1 t -120.48 153.23 23.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.046 179.68 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.533 ' CE1' ' CG1' ' A' ' 4' ' ' VAL . 45.6 m-85 -152.9 130.71 11.66 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.576 -179.817 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 36.9 m-20 -118.71 149.55 41.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.178 179.867 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.406 ' HA ' ' HG3' ' A' ' 63' ' ' PRO . 27.9 t0 64.12 42.88 5.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.435 179.98 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.506 ' O ' HG12 ' A' ' 81' ' ' VAL . 76.2 t -86.28 -6.35 10.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.054 179.827 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.421 HG23 ' C ' ' A' ' 81' ' ' VAL . 96.8 t -155.69 115.07 2.24 Favored Pre-proline 0 CA--C 1.528 0.1 0 N-CA-C 110.217 -0.29 . . . . 0.0 110.217 179.795 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -73.55 -170.9 0.73 Allowed 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.417 2.078 . . . . 0.0 112.014 179.862 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -90.67 125.63 35.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.167 179.808 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 64.74 42.46 4.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.094 -179.784 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 0.445 ' HB2' ' CE2' ' A' ' 92' ' ' TYR . 27.1 p90 -50.76 177.53 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.771 -179.776 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 70.9 m -132.23 110.01 10.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.939 179.692 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.853 HG23 ' O ' ' A' ' 8' ' ' VAL . 3.2 mp -46.16 124.38 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.729 -179.728 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 106.68 55.68 0.65 Allowed Glycine 0 CA--C 1.524 0.596 0 N-CA-C 110.833 -0.907 . . . . 0.0 110.833 179.958 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -179.6 141.11 0.15 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.808 0.337 . . . . 0.0 110.578 179.986 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.692 HG23 ' O ' ' A' ' 6' ' ' PHE . 8.2 m -83.89 131.3 34.88 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.042 179.726 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.445 ' CE2' ' HB2' ' A' ' 86' ' ' TYR . 59.5 m-85 -113.54 -23.02 10.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.937 -179.36 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.896 ' HB1' ' HD2' ' A' ' 94' ' ' PRO . . . -51.02 -179.82 0.04 OUTLIER Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.332 179.844 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.896 ' HD2' ' HB1' ' A' ' 93' ' ' ALA . 50.1 Cg_endo . . . . . 0 C--O 1.249 1.027 0 C-N-CA 122.579 2.186 . . . . 0.0 112.071 -179.862 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 15.0 mtpp . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.794 0.331 . . . . 0.0 110.377 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.587 HG22 ' CE2' ' A' ' 78' ' ' PHE . 19.4 m -51.59 -178.65 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.32 179.902 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.444 HG23 ' O ' ' A' ' 4' ' ' VAL . 20.0 p -155.56 134.23 11.88 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.481 179.965 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.721 ' O ' HG23 ' A' ' 91' ' ' THR . 37.4 m-85 -97.89 175.72 6.04 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.15 179.87 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.41 ' HB ' ' CB ' ' A' ' 20' ' ' LEU . 0.5 OUTLIER -164.4 107.05 0.9 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.857 0.361 . . . . 0.0 110.537 -179.981 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 40.7 t -60.81 85.27 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.255 179.948 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.85 ' CD ' HG11 ' A' ' 51' ' ' VAL . 0.8 OUTLIER -50.42 143.97 8.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.673 -179.773 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.445 ' HA ' ' CG2' ' A' ' 88' ' ' ILE . 0.1 OUTLIER -67.4 142.1 56.82 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.276 179.899 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 117.95 14.08 6.84 Favored Glycine 0 CA--C 1.527 0.795 0 N-CA-C 111.41 -0.676 . . . . 0.0 111.41 179.839 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 39.4 m -55.65 104.6 0.14 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.961 0.381 . . . . 0.0 109.987 179.731 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 8.1 m-20 -57.85 -164.91 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.602 -179.589 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -56.68 -48.09 78.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.091 -179.345 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 8.8 pttt -136.13 33.78 2.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.944 -179.391 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 5.2 m80 -111.93 156.56 21.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.804 0.335 . . . . 0.0 110.279 179.703 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 28.9 tp -137.01 103.63 5.2 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.684 -179.77 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -90.7 124.3 34.98 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.068 -0.515 . . . . 0.0 109.894 179.574 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.643 HG23 HG23 ' A' ' 21' ' ' VAL . 32.6 m -117.45 138.82 46.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.827 0.346 . . . . 0.0 110.653 -179.698 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.41 ' CB ' ' HB ' ' A' ' 7' ' ' THR . 0.7 OUTLIER -94.64 69.59 3.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.452 179.96 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.643 HG23 HG23 ' A' ' 19' ' ' VAL . 18.8 t -80.11 90.01 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.394 -0.367 . . . . 0.0 110.246 179.991 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -151.97 129.16 11.18 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.504 -179.958 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 15.0 p90 -154.53 176.75 11.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.262 179.843 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -105.43 96.64 6.65 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.358 179.992 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -179.99 -51.5 0.08 OUTLIER Glycine 0 CA--C 1.523 0.54 0 N-CA-C 110.594 -1.002 . . . . 0.0 110.594 -179.912 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -126.58 155.22 42.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.738 0.304 . . . . 0.0 110.296 179.939 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.16 -176.98 6.44 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.406 -179.984 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.426 ' O ' ' CG ' ' A' ' 71' ' ' GLU . 41.0 mtm -117.23 122.24 43.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.623 -179.743 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.809 ' HB3' ' O ' ' A' ' 69' ' ' LEU . . . -122.23 -53.31 1.93 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.276 179.922 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -158.04 164.2 36.96 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.146 179.948 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.478 HG21 ' CD1' ' A' ' 52' ' ' TRP . 12.2 t -147.26 149.83 15.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.633 179.968 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.453 ' CB ' ' HA ' ' A' ' 43' ' ' ALA . 0.3 OUTLIER -158.81 130.56 6.53 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.07 179.966 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.799 HD12 ' N ' ' A' ' 34' ' ' ARG . 3.5 pp -110.99 -177.88 3.33 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.039 0.447 . . . . 0.0 110.998 -179.44 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.799 ' N ' HD12 ' A' ' 33' ' ' LEU . 1.3 ttp180 -143.06 162.09 36.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.007 179.724 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.419 ' HB2' ' HB2' ' A' ' 38' ' ' SER . 0.1 OUTLIER -129.51 25.59 5.4 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.198 179.643 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 49.32 94.15 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.817 179.838 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.414 ' O ' ' N ' ' A' ' 39' ' ' ASP . . . 98.23 -30.13 10.07 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 111.207 -0.757 . . . . 0.0 111.207 179.639 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.419 ' HB2' ' HB2' ' A' ' 35' ' ' GLU . 14.7 m -65.2 74.14 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.794 0.33 . . . . 0.0 110.703 -179.7 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.414 ' N ' ' O ' ' A' ' 37' ' ' GLY . 8.7 m-20 46.62 43.3 12.43 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.937 179.655 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 52.06 -173.55 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.926 0.393 . . . . 0.0 110.387 179.887 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.52 ' CZ3' ' HG2' ' A' ' 67' ' ' ARG . 80.7 m95 -44.86 144.2 1.24 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.945 -179.936 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.639 HG21 ' CE1' ' A' ' 54' ' ' PHE . 31.1 m -131.07 116.37 33.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.124 179.757 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.453 ' HA ' ' CB ' ' A' ' 32' ' ' GLU . . . -49.51 128.81 18.15 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.25 179.991 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -62.97 -172.13 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.287 -179.808 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 31.6 m -132.5 109.35 9.73 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.446 -179.9 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.43 ' HB3' ' CZ3' ' A' ' 52' ' ' TRP . 39.4 mtpt -85.49 106.58 16.93 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.327 -179.999 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 170.99 43.84 0.03 OUTLIER Glycine 0 CA--C 1.524 0.596 0 N-CA-C 110.749 -0.94 . . . . 0.0 110.749 -179.902 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.415 ' HB3' ' O ' ' A' ' 51' ' ' VAL . 24.3 tp10 -130.38 65.34 1.52 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.776 0.322 . . . . 0.0 110.457 179.939 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 67.42 -80.7 0.15 Allowed Glycine 0 CA--C 1.523 0.551 0 N-CA-C 110.75 -0.94 . . . . 0.0 110.75 179.987 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -146.49 21.09 1.69 Allowed Glycine 0 CA--C 1.526 0.737 0 N-CA-C 111.256 -0.737 . . . . 0.0 111.256 -179.954 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.85 HG11 ' CD ' ' A' ' 9' ' ' GLU . 29.6 m -138.85 170.45 16.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 110.159 -0.312 . . . . 0.0 110.159 179.764 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . 0.478 ' CD1' HG21 ' A' ' 31' ' ' VAL . 7.4 m95 -100.24 137.36 38.78 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.026 0.441 . . . . 0.0 111.032 -179.461 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.77 142.45 49.55 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.546 179.31 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.754 ' CG ' HD21 ' A' ' 33' ' ' LEU . 27.7 t80 -108.01 116.14 31.41 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.963 0.411 . . . . 0.0 110.691 -179.547 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 57.9 t0 -107.49 130.2 54.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.112 179.847 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -158.26 -177.65 6.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.908 0.385 . . . . 0.0 110.517 -179.884 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -99.52 -26.23 14.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.448 -179.945 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -50.39 159.09 0.9 Allowed Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.483 -179.945 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -70.56 -20.6 30.87 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.554 2.17 . . . . 0.0 111.856 179.673 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.4 tp 57.12 101.87 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.519 179.739 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -173.97 71.04 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.35 180.0 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.434 ' O ' ' CE2' ' A' ' 64' ' ' PHE . . . 175.46 -158.07 25.07 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 110.762 -0.935 . . . . 0.0 110.762 -179.974 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -78.86 169.71 19.09 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.604 2.203 . . . . 0.0 112.086 -179.949 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.434 ' CE2' ' O ' ' A' ' 62' ' ' GLY . 72.4 m-85 -151.27 111.87 4.21 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.515 -179.968 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 12.0 m-80 -81.13 153.21 27.4 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 179.445 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.541 ' CD2' ' CE2' ' A' ' 6' ' ' PHE . 21.0 m-85 -128.75 178.17 6.54 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.14 0.495 . . . . 0.0 111.257 -179.769 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.52 ' HG2' ' CZ3' ' A' ' 41' ' ' TRP . 0.1 OUTLIER 171.85 78.71 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.552 179.864 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.669 ' C ' HD23 ' A' ' 69' ' ' LEU . 1.3 p90 -78.11 169.0 19.0 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.186 0.517 . . . . 0.0 110.932 -179.295 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.809 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 2.4 mt -118.16 71.91 0.85 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.234 179.528 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.414 ' OG1' ' N ' ' A' ' 74' ' ' MET . 28.4 p -36.75 140.55 0.15 Allowed 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.742 -179.108 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.613 ' HG2' ' HB2' ' A' ' 29' ' ' ALA . 17.7 mt-10 -48.9 -57.34 6.6 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.635 -179.7 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.43 52.28 2.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.441 179.958 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -129.8 -108.7 1.32 Allowed Glycine 0 CA--C 1.523 0.567 0 N-CA-C 110.636 -0.985 . . . . 0.0 110.636 179.917 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.414 ' N ' ' OG1' ' A' ' 70' ' ' THR . 2.4 ptm -173.12 168.13 4.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.838 0.351 . . . . 0.0 110.35 -179.993 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.542 ' HD2' HD22 ' A' ' 69' ' ' LEU . 0.6 OUTLIER -77.95 166.71 22.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.231 179.857 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -171.03 164.69 7.52 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.311 179.917 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 98.1 t -130.37 142.26 44.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.163 179.943 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.587 ' CE2' HG22 ' A' ' 4' ' ' VAL . 86.3 m-85 -134.04 132.69 40.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.602 -179.818 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -119.54 162.22 19.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.276 179.844 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 55.03 39.88 31.77 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.312 -179.871 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.669 HG22 ' HD3' ' A' ' 94' ' ' PRO . 47.0 t -86.62 -10.23 11.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.818 -179.978 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 98.7 t -148.49 130.7 7.64 Favored Pre-proline 0 CA--C 1.529 0.137 0 N-CA-C 110.301 -0.259 . . . . 0.0 110.301 179.782 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.489 ' HD3' ' CD1' ' A' ' 92' ' ' TYR . 47.5 Cg_endo -70.73 -174.35 1.07 Allowed 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.534 2.156 . . . . 0.0 111.819 179.575 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -58.3 -63.94 1.09 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.004 179.668 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -108.76 86.57 2.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.114 179.622 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 31.8 p90 -52.83 150.65 5.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.753 -179.641 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 27.9 m -122.21 101.67 7.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.982 179.748 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.445 ' CG2' ' HA ' ' A' ' 10' ' ' LYS . 2.7 mp -44.36 116.48 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.005 -179.673 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 106.72 56.06 0.64 Allowed Glycine 0 CA--C 1.523 0.593 0 N-CA-C 110.812 -0.915 . . . . 0.0 110.812 179.854 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -174.03 142.72 0.87 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.898 0.38 . . . . 0.0 110.731 179.984 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.721 HG23 ' O ' ' A' ' 6' ' ' PHE . 10.0 m -87.69 133.65 33.8 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.044 -0.525 . . . . 0.0 109.881 179.561 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.489 ' CD1' ' HD3' ' A' ' 83' ' ' PRO . 65.5 m-85 -117.09 -86.07 0.63 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.022 -179.266 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.894 ' HB1' ' HD2' ' A' ' 94' ' ' PRO . . . 50.59 179.86 0.02 OUTLIER Pre-proline 0 C--N 1.332 -0.192 0 CA-C-O 120.723 0.297 . . . . 0.0 110.438 -179.714 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.894 ' HD2' ' HB1' ' A' ' 93' ' ' ALA . 48.8 Cg_endo . . . . . 0 C--O 1.249 1.066 0 C-N-CA 122.586 2.191 . . . . 0.0 112.097 -179.846 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 9.0 mtmt . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.767 0.318 . . . . 0.0 110.44 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.633 HG11 ' CZ ' ' A' ' 78' ' ' PHE . 1.7 p -58.55 163.66 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.268 0.556 . . . . 0.0 110.337 -179.919 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.479 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 5.7 p -148.09 130.6 15.8 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.466 179.907 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.485 ' O ' HG23 ' A' ' 91' ' ' THR . 11.7 m-85 -98.87 175.25 6.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.258 -179.994 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.657 HG23 ' O ' ' A' ' 90' ' ' ALA . 2.0 m -166.47 107.74 0.69 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.297 -179.966 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.47 HG11 ' CD1' ' A' ' 86' ' ' TYR . 47.8 t -55.34 99.82 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.402 179.997 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.487 ' HG3' HG11 ' A' ' 51' ' ' VAL . 2.5 mt-10 -72.29 174.49 7.2 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.596 -179.836 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.04 178.8 0.78 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.385 -179.966 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 67.24 26.81 73.42 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 110.784 -0.926 . . . . 0.0 110.784 179.939 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.62 ' OG ' HD11 ' A' ' 88' ' ' ILE . 85.3 p -87.49 109.25 19.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.767 0.317 . . . . 0.0 110.445 -179.969 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 30.8 m-20 -112.73 -162.52 0.8 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.236 179.815 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -65.54 -60.07 3.32 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.416 179.997 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -94.6 20.26 8.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.905 -179.727 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 19.5 m80 -128.11 112.32 14.45 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.863 0.363 . . . . 0.0 110.462 -179.914 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.408 ' HA ' HD22 ' A' ' 17' ' ' LEU . 0.2 OUTLIER -119.03 99.27 6.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.281 179.966 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -95.29 132.58 40.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.182 179.877 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.584 HG23 HG23 ' A' ' 21' ' ' VAL . 25.7 m -132.43 137.35 54.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.428 -179.999 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.441 ' HA ' HG12 ' A' ' 51' ' ' VAL . 0.5 OUTLIER -87.88 90.18 8.28 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.393 179.833 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.584 HG23 HG23 ' A' ' 19' ' ' VAL . 27.2 t -90.24 101.24 12.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.369 -179.966 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -174.41 144.28 0.9 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.343 -179.926 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.458 ' CE1' ' HB2' ' A' ' 26' ' ' ASP . 5.9 p90 -158.48 62.79 0.43 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.502 -179.894 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 65.12 -71.33 0.08 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.779 179.719 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.427 ' N ' ' O ' ' A' ' 23' ' ' TYR . . . -75.26 -160.66 8.56 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 110.796 -0.922 . . . . 0.0 110.796 -179.879 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.512 ' OD1' HG22 ' A' ' 70' ' ' THR . 47.7 t0 64.55 127.99 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.793 0.33 . . . . 0.0 110.368 179.998 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.65 ' O ' HG22 ' A' ' 27' ' ' THR . 31.6 m -109.97 34.26 3.96 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.559 -179.933 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.522 ' O ' ' HB2' ' A' ' 29' ' ' ALA . 0.0 OUTLIER 49.25 -177.6 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.011 179.595 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.66 ' HB3' ' O ' ' A' ' 69' ' ' LEU . . . 168.62 -66.01 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.168 179.832 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.405 ' O ' ' HB2' ' A' ' 68' ' ' PHE . 0.5 OUTLIER -154.5 154.81 33.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.722 179.898 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.484 HG21 ' CD1' ' A' ' 52' ' ' TRP . 12.3 t -148.96 153.64 10.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.084 0.468 . . . . 0.0 111.092 -179.597 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.441 ' CG ' ' HD2' ' A' ' 67' ' ' ARG . 0.0 OUTLIER -163.37 147.72 10.89 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.896 -179.917 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.769 HD12 ' N ' ' A' ' 34' ' ' ARG . 3.4 pp -121.95 179.94 4.34 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.905 0.383 . . . . 0.0 110.942 -179.512 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.769 ' N ' HD12 ' A' ' 33' ' ' LEU . 4.7 ttt180 -133.96 167.13 21.16 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.078 179.847 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -128.21 9.11 6.15 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.281 -179.927 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 3.8 t60 67.98 -67.48 0.19 Allowed 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.766 0.317 . . . . 0.0 110.595 179.791 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -52.22 -53.02 33.05 Favored Glycine 0 CA--C 1.523 0.592 0 N-CA-C 110.972 -0.851 . . . . 0.0 110.972 -179.843 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 58.9 m -51.02 -28.71 10.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.771 0.32 . . . . 0.0 110.487 -179.839 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 24.9 t0 63.26 19.25 11.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.822 179.981 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -155.86 129.05 8.14 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.871 0.367 . . . . 0.0 110.479 179.898 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.501 ' CZ3' ' HG2' ' A' ' 67' ' ' ARG . 84.3 m95 -54.22 139.53 35.59 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.417 179.94 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.525 HG21 ' CZ ' ' A' ' 54' ' ' PHE . 28.4 m -115.35 111.87 37.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.28 -0.418 . . . . 0.0 109.908 179.575 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -46.49 136.1 7.82 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.669 -179.617 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.523 ' CE ' HD23 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -65.2 -170.03 0.05 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.234 -179.856 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 23.4 m -144.29 103.9 4.03 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.595 -179.881 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 9.0 ptpt -67.64 72.43 0.15 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.143 179.683 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -103.55 -39.08 2.64 Favored Glycine 0 CA--C 1.521 0.447 0 N-CA-C 110.671 -0.972 . . . . 0.0 110.671 -179.852 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.612 ' HG2' HG22 ' A' ' 51' ' ' VAL . 4.0 tt0 -75.86 134.18 40.39 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.811 0.339 . . . . 0.0 110.367 -179.967 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -78.36 74.65 2.04 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 110.74 -0.944 . . . . 0.0 110.74 -179.989 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 150.71 -52.89 0.5 Allowed Glycine 0 CA--C 1.522 0.52 0 N-CA-C 110.656 -0.978 . . . . 0.0 110.656 179.984 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.612 HG22 ' HG2' ' A' ' 48' ' ' GLU . 18.0 m -114.84 -177.95 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.795 0.331 . . . . 0.0 110.306 179.919 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . 0.484 ' CD1' HG21 ' A' ' 31' ' ' VAL . 13.6 m95 -109.57 141.44 42.07 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.709 -179.842 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.7 p -126.89 159.71 33.14 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.867 179.705 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.525 ' CZ ' HG21 ' A' ' 42' ' ' VAL . 57.1 t80 -130.86 125.33 33.31 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.861 0.363 . . . . 0.0 110.717 -179.664 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -85.09 63.11 7.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.177 179.78 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 52.3 p -57.04 147.06 25.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.436 -179.875 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.6 25.05 4.4 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.518 179.932 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -117.93 138.54 25.5 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.208 179.756 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -75.5 69.35 5.95 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.518 2.146 . . . . 0.0 112.164 -179.694 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 10.7 tp -151.22 106.68 3.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.394 179.898 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -102.02 62.99 0.9 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.037 0.446 . . . . 0.0 110.416 -179.92 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -109.02 -153.15 15.36 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 110.702 -0.959 . . . . 0.0 110.702 179.98 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -75.4 158.7 40.5 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.546 2.164 . . . . 0.0 111.953 179.96 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -131.21 105.28 7.56 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.668 -179.855 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 41.3 m-20 -68.82 168.65 12.99 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 179.432 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -144.74 174.69 10.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.141 0.495 . . . . 0.0 111.047 -179.815 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.501 ' HG2' ' CZ3' ' A' ' 41' ' ' TRP . 0.0 OUTLIER 175.57 54.98 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.559 -179.941 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.449 ' O ' HD23 ' A' ' 69' ' ' LEU . 1.0 OUTLIER -55.73 176.24 0.07 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.076 -179.377 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.721 HD22 ' HD2' ' A' ' 75' ' ' LYS . 11.6 mt -124.99 69.82 1.14 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.59 179.598 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.512 HG22 ' OD1' ' A' ' 26' ' ' ASP . 16.5 p -37.86 140.78 0.23 Allowed 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.928 -179.18 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.511 ' N ' ' HB2' ' A' ' 29' ' ' ALA . 0.0 OUTLIER -42.64 -44.91 4.45 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.355 179.988 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -54.74 -32.92 60.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.341 -179.994 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 105.67 53.59 0.76 Allowed Glycine 0 CA--C 1.522 0.531 0 N-CA-C 110.757 -0.937 . . . . 0.0 110.757 179.986 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 5.0 mmm -129.18 130.13 45.95 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.771 0.32 . . . . 0.0 110.537 179.991 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.721 ' HD2' HD22 ' A' ' 69' ' ' LEU . 0.0 OUTLIER -117.01 123.01 45.84 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.197 -0.456 . . . . 0.0 109.872 179.885 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.467 ' O ' ' CE2' ' A' ' 78' ' ' PHE . 6.4 m120 -134.21 126.16 29.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.377 -179.964 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 73.9 t -84.45 142.69 13.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.342 179.988 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.633 ' CZ ' HG11 ' A' ' 4' ' ' VAL . 23.2 m-85 -129.38 137.02 50.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.52 -179.883 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -114.17 147.57 38.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.219 179.9 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 58.04 49.35 11.76 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.191 -179.867 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.526 ' O ' HG12 ' A' ' 81' ' ' VAL . 99.4 t -86.09 -4.75 9.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.23 -179.843 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.444 HG23 ' C ' ' A' ' 81' ' ' VAL . 89.4 t -157.09 130.8 4.75 Favored Pre-proline 0 C--N 1.333 -0.149 0 N-CA-C 110.228 -0.286 . . . . 0.0 110.228 179.77 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.507 ' HD3' ' CG ' ' A' ' 92' ' ' TYR . 45.6 Cg_endo -70.18 -170.85 0.45 Allowed 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.589 2.193 . . . . 0.0 111.923 179.676 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 -76.24 -62.61 1.55 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.192 179.788 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.08 66.46 0.91 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.9 179.655 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 0.47 ' CD1' HG11 ' A' ' 8' ' ' VAL . 14.3 p90 -49.45 154.13 0.97 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.886 -179.606 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 39.4 m -133.07 109.51 9.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.024 179.751 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.62 HD11 ' OG ' ' A' ' 12' ' ' SER . 3.7 mp -46.25 100.44 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.908 -179.727 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 138.53 45.61 0.07 OUTLIER Glycine 0 CA--C 1.523 0.555 0 N-CA-C 110.86 -0.896 . . . . 0.0 110.86 179.868 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.657 ' O ' HG23 ' A' ' 7' ' ' THR . . . -162.98 174.61 12.1 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.825 0.345 . . . . 0.0 110.446 179.93 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.485 HG23 ' O ' ' A' ' 6' ' ' PHE . 94.6 m -119.57 126.98 52.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.237 179.88 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.507 ' CG ' ' HD3' ' A' ' 83' ' ' PRO . 42.0 m-85 -126.21 109.39 12.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.391 -179.906 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.91 ' HB1' ' HD2' ' A' ' 94' ' ' PRO . . . 172.14 176.47 0.15 Allowed Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.257 179.96 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.91 ' HD2' ' HB1' ' A' ' 93' ' ' ALA . 48.1 Cg_endo . . . . . 0 C--O 1.249 1.052 0 C-N-CA 122.558 2.172 . . . . 0.0 112.096 -179.948 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 9.8 mtpm? . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.819 0.342 . . . . 0.0 110.502 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.775 ' O ' HG23 ' A' ' 5' ' ' THR . 31.2 m -67.52 -175.78 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.496 179.993 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.775 HG23 ' O ' ' A' ' 4' ' ' VAL . 0.7 OUTLIER -171.65 153.87 3.53 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.31 179.849 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.502 ' CD2' ' HB ' ' A' ' 21' ' ' VAL . 51.2 m-85 -132.1 145.17 51.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.282 179.894 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.525 HG23 ' O ' ' A' ' 90' ' ' ALA . 68.3 m -133.45 130.71 39.0 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.348 -179.923 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.452 HG21 ' HB2' ' A' ' 86' ' ' TYR . 84.0 t -67.71 90.99 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.276 -179.992 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.94 ' HG3' HG11 ' A' ' 51' ' ' VAL . 6.3 mm-40 -56.21 167.91 0.59 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.401 -179.918 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.09 -18.36 65.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.918 -179.979 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -46.52 -29.33 3.91 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 111.102 -0.799 . . . . 0.0 111.102 -179.846 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 27.8 m -64.71 139.04 58.72 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.727 0.299 . . . . 0.0 110.386 179.928 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.1 p30 -139.05 -50.49 0.53 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.59 179.965 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -147.96 -78.04 0.16 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.405 -179.908 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.4 ' HD2' ' HG3' ' A' ' 57' ' ' GLU . 0.0 OUTLIER -101.18 9.67 41.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.219 -179.951 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 5.9 m80 -105.28 125.68 51.26 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.848 0.356 . . . . 0.0 110.358 -179.964 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.472 HD22 ' HA ' ' A' ' 17' ' ' LEU . 0.2 OUTLIER -110.14 104.11 12.92 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.296 179.981 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.847 ' HB2' HG22 ' A' ' 53' ' ' THR . . . -110.64 110.49 21.19 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.29 -179.993 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.407 ' O ' ' HG3' ' A' ' 9' ' ' GLU . 5.6 m -91.13 -168.61 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.04 0.448 . . . . 0.0 110.461 179.998 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.8 tt -141.46 83.39 1.86 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.506 179.905 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.527 ' CG1' ' CD1' ' A' ' 52' ' ' TRP . 2.1 p -102.53 97.68 5.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.007 179.892 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.483 ' O ' ' CG ' ' A' ' 23' ' ' TYR . 11.9 ttmt -145.45 -71.05 0.26 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.255 179.98 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.483 ' CG ' ' O ' ' A' ' 22' ' ' LYS . 30.6 p90 44.36 -170.23 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.067 179.807 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -123.32 146.49 47.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.272 179.972 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 133.76 -58.69 0.69 Allowed Glycine 0 CA--C 1.523 0.58 0 N-CA-C 110.85 -0.9 . . . . 0.0 110.85 179.962 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -112.76 -162.54 0.8 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.801 0.334 . . . . 0.0 110.379 -179.958 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -119.76 -174.72 2.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.478 179.968 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.423 ' O ' ' CG ' ' A' ' 71' ' ' GLU . 12.6 mtm -120.43 119.27 32.55 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.196 -179.976 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.827 ' HB3' ' O ' ' A' ' 69' ' ' LEU . . . -120.72 -60.6 1.65 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.632 -179.7 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.427 ' C ' HG12 ' A' ' 31' ' ' VAL . 0.1 OUTLIER -151.83 168.59 24.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.589 -179.811 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.452 ' HB ' ' HB3' ' A' ' 68' ' ' PHE . 0.2 OUTLIER -179.01 144.2 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.986 179.967 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.434 ' CB ' ' HA ' ' A' ' 43' ' ' ALA . 3.6 pt-20 -142.12 168.27 20.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.472 -0.786 . . . . 0.0 109.915 -179.771 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.715 HD12 ' N ' ' A' ' 34' ' ' ARG . 3.1 pp -121.73 174.69 6.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.869 0.366 . . . . 0.0 110.767 -179.791 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.715 ' N ' HD12 ' A' ' 33' ' ' LEU . 6.8 ttm180 -126.88 -94.61 0.45 Allowed 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.215 179.821 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.436 ' O ' ' CB ' ' A' ' 36' ' ' HIS . 0.0 OUTLIER 163.34 -35.78 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 120.703 0.287 . . . . 0.0 110.239 179.875 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 0.436 ' CB ' ' O ' ' A' ' 35' ' ' GLU . 5.2 t-160 86.44 -16.5 0.42 Allowed 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.172 -179.626 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -104.14 -27.67 6.13 Favored Glycine 0 CA--C 1.522 0.516 0 N-CA-C 110.412 -1.075 . . . . 0.0 110.412 179.693 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -83.84 -159.1 0.35 Allowed 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 179.796 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 22.4 p30 -141.04 24.27 2.17 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.615 179.985 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -156.4 148.51 23.18 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.916 0.389 . . . . 0.0 110.472 179.909 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.504 ' CZ3' ' HG2' ' A' ' 67' ' ' ARG . 55.2 m95 -85.7 154.83 21.38 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.2 179.867 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.655 HG23 ' O ' ' A' ' 42' ' ' VAL . 34.3 m -124.16 106.26 16.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.914 0.387 . . . . 0.0 110.146 179.704 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.434 ' HA ' ' CB ' ' A' ' 32' ' ' GLU . . . -49.0 116.97 1.87 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.712 -179.757 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.644 ' HE2' HD23 ' A' ' 33' ' ' LEU . 0.6 OUTLIER -53.84 -172.06 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.387 179.909 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 31.6 m -151.05 122.74 8.01 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.423 -179.942 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 5.1 ptpt -68.41 67.79 0.13 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.083 179.698 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -90.96 -26.58 21.6 Favored Glycine 0 CA--C 1.522 0.483 0 N-CA-C 110.626 -0.99 . . . . 0.0 110.626 -179.929 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.467 ' HG2' HG22 ' A' ' 51' ' ' VAL . 9.8 tp10 -93.3 129.8 39.26 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.816 0.341 . . . . 0.0 110.231 179.946 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -74.03 66.25 1.84 Allowed Glycine 0 CA--C 1.523 0.565 0 N-CA-C 110.912 -0.875 . . . . 0.0 110.912 -179.84 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 158.65 -35.81 0.51 Allowed Glycine 0 CA--C 1.524 0.638 0 N-CA-C 111.085 -0.806 . . . . 0.0 111.085 179.809 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.94 HG11 ' HG3' ' A' ' 9' ' ' GLU . 30.4 m -135.81 -176.43 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.94 0.4 . . . . 0.0 110.859 -179.722 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . 0.527 ' CD1' ' CG1' ' A' ' 21' ' ' VAL . 6.1 m95 -101.85 134.29 45.27 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.494 -179.42 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.847 HG22 ' HB2' ' A' ' 18' ' ' ALA . 6.7 p -127.01 156.3 41.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.448 -179.847 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 50.6 t80 -137.99 124.32 20.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.409 179.904 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 20.6 p-10 -86.78 148.89 25.21 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.314 179.972 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -172.88 -179.36 2.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.482 -179.856 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.4 ' HG3' ' HD2' ' A' ' 15' ' ' LYS . 2.2 mt-10 -161.18 61.59 0.28 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.2 179.918 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.404 ' HB2' ' HD2' ' A' ' 59' ' ' PRO . 7.3 pt-20 -133.38 157.42 78.17 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.31 179.996 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.404 ' HD2' ' HB2' ' A' ' 58' ' ' GLU . 47.4 Cg_endo -70.87 -35.57 9.18 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.529 2.153 . . . . 0.0 111.989 179.898 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -77.23 98.56 5.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.376 -179.974 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -148.21 48.21 1.05 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.399 -179.98 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -78.12 -101.74 0.2 Allowed Glycine 0 CA--C 1.526 0.747 0 N-CA-C 110.698 -0.961 . . . . 0.0 110.698 -179.973 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -80.69 177.36 8.13 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.63 2.22 . . . . 0.0 112.102 -179.995 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 49.8 m-85 -153.61 103.18 2.61 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.72 -179.969 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 6.2 m-20 -73.44 129.43 37.98 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 179.358 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.466 ' CE1' ' HB3' ' A' ' 33' ' ' LEU . 40.6 m-85 -115.42 170.87 8.08 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.13 0.491 . . . . 0.0 111.096 -179.333 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.504 ' HG2' ' CZ3' ' A' ' 41' ' ' TRP . 0.0 OUTLIER -169.2 83.69 0.14 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.632 -179.946 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.894 ' O ' HD23 ' A' ' 69' ' ' LEU . 6.9 p90 -71.27 176.68 4.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.356 0.598 . . . . 0.0 111.333 -179.159 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.894 HD23 ' O ' ' A' ' 68' ' ' PHE . 8.7 mt -138.53 70.84 1.38 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.22 179.612 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.402 ' OG1' ' N ' ' A' ' 74' ' ' MET . 65.0 p -29.56 136.2 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.509 0.723 . . . . 0.0 112.61 -178.976 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.632 ' HG2' ' HB2' ' A' ' 29' ' ' ALA . 22.2 mt-10 -52.09 -39.13 59.31 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.314 179.972 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.37 64.59 1.49 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.545 -179.877 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -157.75 -104.75 0.21 Allowed Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.71 -0.956 . . . . 0.0 110.71 179.966 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.402 ' N ' ' OG1' ' A' ' 70' ' ' THR . 0.0 OUTLIER -172.03 -179.03 2.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.826 0.346 . . . . 0.0 110.326 179.969 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.617 ' CG ' HD22 ' A' ' 69' ' ' LEU . 0.0 OUTLIER -84.63 -176.86 6.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.412 -179.951 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.421 ' O ' ' CB ' ' A' ' 67' ' ' ARG . 1.0 OUTLIER -178.71 158.89 1.05 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.099 179.979 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 97.2 t -124.52 130.43 73.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.979 0.418 . . . . 0.0 110.509 -179.756 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.6 ' CZ ' HG21 ' A' ' 4' ' ' VAL . 31.8 m-85 -121.71 130.53 53.51 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.158 179.983 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -118.86 155.56 31.01 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.638 -179.653 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 53.5 m-20 58.25 23.71 10.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.792 179.842 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.509 HG13 ' O ' ' A' ' 92' ' ' TYR . 77.1 t -55.35 -78.36 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 179.61 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 76.7 t -81.71 134.36 50.73 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.125 179.751 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.501 ' HD3' ' CG ' ' A' ' 92' ' ' TYR . 46.6 Cg_endo -71.69 -177.1 2.31 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.437 2.091 . . . . 0.0 111.938 179.79 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -63.04 -64.19 0.98 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.186 179.902 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -102.56 76.86 1.56 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.218 179.798 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 0.452 ' HB2' HG21 ' A' ' 8' ' ' VAL . 55.7 p90 -54.63 160.95 1.64 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.442 -179.873 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.05 111.86 7.44 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.323 179.917 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 2.7 mp -50.52 100.28 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.456 -179.925 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 133.84 45.95 0.11 Allowed Glycine 0 CA--C 1.523 0.572 0 N-CA-C 110.665 -0.974 . . . . 0.0 110.665 -179.981 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.731 ' HB3' ' OH ' ' A' ' 92' ' ' TYR . . . -172.99 153.04 2.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.79 0.329 . . . . 0.0 110.386 179.979 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 40.3 m -102.96 133.49 47.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.504 -179.931 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.731 ' OH ' ' HB3' ' A' ' 90' ' ' ALA . 6.3 m-85 -130.78 110.52 11.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.321 179.88 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.863 ' HB1' ' HD2' ' A' ' 94' ' ' PRO . . . 179.28 177.36 0.32 Allowed Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.306 -179.978 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.863 ' HD2' ' HB1' ' A' ' 93' ' ' ALA . 48.0 Cg_endo . . . . . 0 C--O 1.249 1.059 0 C-N-CA 122.62 2.213 . . . . 0.0 112.078 -179.868 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.413 ' CG ' ' O ' ' A' ' 3' ' ' LYS . 1.8 ptmt . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.86 0.362 . . . . 0.0 110.794 . . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.58 HG21 ' CZ ' ' A' ' 78' ' ' PHE . 2.9 m -130.11 168.32 23.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.174 179.486 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.406 ' HB ' ' CG2' ' A' ' 91' ' ' THR . 0.6 OUTLIER -146.12 145.68 30.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.325 179.851 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.56 ' CE2' ' CD2' ' A' ' 66' ' ' PHE . 26.3 m-85 -117.66 160.97 20.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.736 -179.688 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.443 HG22 ' H ' ' A' ' 8' ' ' VAL . 0.2 OUTLIER -142.43 -164.15 1.76 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.169 179.836 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.658 ' O ' HG23 ' A' ' 88' ' ' ILE . 47.0 t -141.85 92.74 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.346 -179.918 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.719 ' HG3' HG11 ' A' ' 51' ' ' VAL . 1.4 mm-40 -56.64 158.01 4.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.57 -179.811 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 7.4 ptmm? -58.17 -19.25 31.6 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.896 -179.989 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -49.8 -24.77 6.37 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 111.021 -0.831 . . . . 0.0 111.021 -179.966 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 10.0 p -47.83 113.85 0.8 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.85 0.357 . . . . 0.0 110.78 -179.862 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 42.4 m-20 -116.17 -156.28 0.61 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.147 179.859 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -44.96 -68.44 0.2 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.721 0.296 . . . . 0.0 110.905 -179.868 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.61 40.57 3.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.309 179.869 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 8.5 m80 -118.55 123.29 44.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.365 179.953 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.463 HD22 ' HA ' ' A' ' 17' ' ' LEU . 0.2 OUTLIER -104.97 97.86 7.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.192 -179.928 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.448 ' HB2' HG22 ' A' ' 53' ' ' THR . . . -100.22 104.56 16.06 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.602 -179.788 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.406 ' O ' ' HG3' ' A' ' 9' ' ' GLU . 27.7 m -88.3 -175.17 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.129 179.67 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.7 tt -139.42 77.55 1.62 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.402 179.724 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 3.3 t -84.01 107.9 15.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.083 179.934 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.57 147.84 4.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.391 -179.969 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.523 ' CZ ' HG12 ' A' ' 4' ' ' VAL . 3.9 p90 177.99 128.56 0.05 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.221 -179.909 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -53.4 154.43 3.41 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.512 -179.865 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 107.57 -68.98 0.22 Allowed Glycine 0 CA--C 1.522 0.522 0 N-CA-C 110.59 -1.004 . . . . 0.0 110.59 -179.968 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -94.08 179.28 5.37 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 110.164 -0.31 . . . . 0.0 110.164 179.975 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.417 ' OG1' ' CE ' ' A' ' 72' ' ' LYS . 0.2 OUTLIER -119.19 -163.8 1.0 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.928 0.394 . . . . 0.0 110.525 -179.971 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.43 ' O ' ' CG ' ' A' ' 71' ' ' GLU . 33.7 mtp -129.6 124.11 32.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.297 -179.815 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.866 ' HB3' ' O ' ' A' ' 69' ' ' LEU . . . -129.42 -57.97 1.13 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.937 -179.79 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.597 ' C ' HG12 ' A' ' 31' ' ' VAL . 2.8 tt0 -141.07 177.19 8.24 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.945 0.402 . . . . 0.0 111.059 -179.673 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.597 HG12 ' C ' ' A' ' 30' ' ' GLU . 0.3 OUTLIER 171.52 134.2 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.958 -179.986 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.411 ' HG3' ' CE3' ' A' ' 41' ' ' TRP . 1.1 pt-20 -123.55 161.24 25.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.643 -179.549 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.491 ' HG ' ' CE1' ' A' ' 66' ' ' PHE . 2.3 mt -110.0 154.33 23.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.381 179.782 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.487 ' HG3' ' CD2' ' A' ' 41' ' ' TRP . 0.0 OUTLIER -126.99 -163.31 1.23 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.949 179.51 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.449 ' CB ' ' HB2' ' A' ' 38' ' ' SER . 0.2 OUTLIER 176.8 106.71 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.841 0.353 . . . . 0.0 110.171 179.971 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -51.2 95.3 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.206 -179.982 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 126.14 -32.18 3.85 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 110.359 -1.097 . . . . 0.0 110.359 -179.636 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.449 ' HB2' ' CB ' ' A' ' 35' ' ' GLU . 35.0 t -57.09 -25.4 58.69 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.732 0.301 . . . . 0.0 110.398 179.788 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 75.75 97.29 0.07 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.653 179.986 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 72.62 159.59 0.22 Allowed 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.876 179.641 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.501 ' CZ2' ' CD ' ' A' ' 67' ' ' ARG . 51.1 m95 -64.49 167.39 7.11 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.434 -179.899 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 14.9 m -135.1 3.21 1.08 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.852 -179.622 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . 59.92 138.42 0.01 OUTLIER 'General case' 0 C--N 1.334 -0.107 0 CA-C-O 121.129 0.49 . . . . 0.0 111.299 179.391 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.436 ' HE3' ' HB2' ' A' ' 52' ' ' TRP . 0.0 OUTLIER -73.64 -170.35 0.84 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.375 179.862 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.424 ' O ' ' N ' ' A' ' 47' ' ' GLY . 43.4 m -143.31 111.08 5.95 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.144 179.809 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.9 ptpt -62.45 79.12 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.396 -179.908 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.424 ' N ' ' O ' ' A' ' 45' ' ' THR . . . -98.47 -26.77 9.03 Favored Glycine 0 CA--C 1.522 0.525 0 N-CA-C 110.691 -0.963 . . . . 0.0 110.691 -179.966 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.405 ' HB2' ' O ' ' A' ' 51' ' ' VAL . 0.5 OUTLIER -87.15 -172.53 4.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.852 0.358 . . . . 0.0 110.432 -179.943 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -110.94 -24.68 5.41 Favored Glycine 0 CA--C 1.522 0.505 0 N-CA-C 110.807 -0.917 . . . . 0.0 110.807 179.95 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -129.28 -1.39 5.69 Favored Glycine 0 CA--C 1.528 0.888 0 N-CA-C 111.957 -0.457 . . . . 0.0 111.957 -179.684 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.719 HG11 ' HG3' ' A' ' 9' ' ' GLU . 17.9 m -146.23 178.26 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 CA-C-N 117.476 0.638 . . . . 0.0 110.761 -179.946 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . 0.436 ' HB2' ' HE3' ' A' ' 44' ' ' MET . 10.9 m95 -105.34 141.1 37.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.56 -179.555 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.448 HG22 ' HB2' ' A' ' 18' ' ' ALA . 10.3 p -126.04 162.78 24.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.336 -179.969 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 45.5 t80 -134.54 162.54 31.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.536 -179.881 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -112.86 143.03 44.81 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.224 179.865 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -133.9 178.7 6.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.374 179.934 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -123.94 26.61 7.52 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.345 179.975 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -171.0 155.65 4.53 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.269 179.947 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -71.87 -36.2 6.45 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.707 2.272 . . . . 0.0 112.325 -179.808 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -75.57 148.3 38.98 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.75 -179.55 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -147.74 -174.48 4.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.208 179.978 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -145.06 -148.96 4.93 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 110.734 -0.946 . . . . 0.0 110.734 179.995 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -78.03 158.08 30.59 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.575 2.183 . . . . 0.0 111.796 179.872 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.41 ' HB3' ' CD2' ' A' ' 33' ' ' LEU . 86.5 m-85 -131.6 171.19 13.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.07 0.462 . . . . 0.0 110.79 -179.794 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.428 ' HB2' ' CB ' ' A' ' 34' ' ' ARG . 4.3 m-80 -139.57 137.36 35.33 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.615 179.571 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.56 ' CD2' ' CE2' ' A' ' 6' ' ' PHE . 48.0 m-85 -120.44 159.94 24.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.108 0.48 . . . . 0.0 111.093 -179.217 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.588 ' CD ' HG22 ' A' ' 77' ' ' VAL . 28.6 mtp180 -157.61 81.4 0.88 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.818 179.68 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.469 ' HA ' ' HA ' ' A' ' 31' ' ' VAL . 5.9 p90 -78.7 173.59 12.3 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-O 121.54 0.685 . . . . 0.0 111.37 -179.334 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.866 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 8.8 mt -138.43 74.3 1.47 Allowed 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 114.664 -1.153 . . . . 0.0 109.016 179.496 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.439 ' OG1' ' N ' ' A' ' 74' ' ' MET . 2.7 p -31.18 137.13 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 115.717 -0.674 . . . . 0.0 112.191 -178.976 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.619 ' HG2' ' HB2' ' A' ' 29' ' ' ALA . 1.1 mm-40 -49.57 -24.88 2.35 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.943 -179.525 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.417 ' CE ' ' OG1' ' A' ' 27' ' ' THR . 0.0 OUTLIER -167.07 36.04 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.596 0.236 . . . . 0.0 111.102 -179.94 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -114.21 -110.76 2.9 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 110.849 -0.9 . . . . 0.0 110.849 179.853 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.439 ' N ' ' OG1' ' A' ' 70' ' ' THR . 3.1 ptt? -166.74 113.29 0.81 Allowed 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 110.164 -0.31 . . . . 0.0 110.164 179.901 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.817 ' HB3' HD23 ' A' ' 69' ' ' LEU . 0.0 OUTLIER -51.99 -176.35 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.896 0.379 . . . . 0.0 110.494 -179.782 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 177.43 149.39 0.16 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.468 -179.952 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.588 HG22 ' CD ' ' A' ' 67' ' ' ARG . 72.2 t -90.22 139.18 17.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 121.006 0.431 . . . . 0.0 110.096 179.895 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.58 ' CZ ' HG21 ' A' ' 4' ' ' VAL . 75.8 m-85 -128.84 142.24 51.03 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.898 -179.313 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -136.1 157.84 45.87 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.953 179.65 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 59.02 35.45 24.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.938 0.399 . . . . 0.0 109.954 -179.66 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.464 ' O ' HG12 ' A' ' 81' ' ' VAL . 42.9 t -76.07 -6.91 9.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.322 -179.757 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.449 HG13 ' HD2' ' A' ' 83' ' ' PRO . 61.4 t -153.87 138.14 11.04 Favored Pre-proline 0 C--N 1.332 -0.17 0 N-CA-C 110.29 -0.263 . . . . 0.0 110.29 179.893 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.449 ' HD2' HG13 ' A' ' 82' ' ' VAL . 47.6 Cg_endo -75.48 -172.66 1.36 Allowed 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.535 2.157 . . . . 0.0 112.056 179.881 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -67.93 -42.5 80.91 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.244 179.844 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 16.7 mtpt -127.45 77.73 1.77 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.235 179.841 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 45.3 p90 -51.1 158.8 0.69 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.508 -179.851 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 20.8 m -138.33 110.43 7.3 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.075 179.919 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.658 HG23 ' O ' ' A' ' 8' ' ' VAL . 2.8 mp -50.46 95.06 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.357 -179.942 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 138.04 44.99 0.08 OUTLIER Glycine 0 CA--C 1.523 0.572 0 N-CA-C 110.575 -1.01 . . . . 0.0 110.575 -179.878 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -168.46 141.21 2.95 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.75 0.309 . . . . 0.0 110.243 -179.93 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.406 ' CG2' ' HB ' ' A' ' 5' ' ' THR . 85.7 m -91.05 145.85 24.34 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.971 0.415 . . . . 0.0 110.648 -179.939 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.592 ' O ' ' HB3' ' A' ' 93' ' ' ALA . 30.2 m-85 -129.75 -152.24 0.51 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.826 -0.624 . . . . 0.0 109.501 179.674 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.885 ' HB1' ' HD2' ' A' ' 94' ' ' PRO . . . 77.79 174.74 0.08 OUTLIER Pre-proline 0 N--CA 1.465 0.276 0 CA-C-O 120.8 0.333 . . . . 0.0 110.684 179.77 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.885 ' HD2' ' HB1' ' A' ' 93' ' ' ALA . 48.3 Cg_endo . . . . . 0 C--O 1.248 1.02 0 C-N-CA 122.618 2.212 . . . . 0.0 111.989 -179.982 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.457 -0.093 0 CA-C-O 120.815 0.341 . . . . 0.0 110.24 . . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.553 HG11 ' CZ ' ' A' ' 78' ' ' PHE . 1.7 p -49.88 163.97 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.253 0.549 . . . . 0.0 110.624 -179.819 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.478 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 15.7 p -141.89 132.63 25.64 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.367 179.907 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.528 ' O ' HG23 ' A' ' 91' ' ' THR . 22.7 m-85 -101.09 170.68 8.11 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.301 179.967 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.811 HG23 ' O ' ' A' ' 90' ' ' ALA . 92.6 m -166.17 132.47 2.52 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.464 -179.947 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 26.4 t -71.1 102.99 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.199 179.82 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.598 ' HG3' HG21 ' A' ' 51' ' ' VAL . 6.3 mm-40 -50.33 170.81 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.511 -179.811 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 33.7 mtmm -72.53 -21.38 61.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.721 -179.937 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -90.9 49.1 3.05 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.928 -0.869 . . . . 0.0 110.928 -179.948 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 60.7 p -87.1 134.64 33.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.765 0.317 . . . . 0.0 110.291 179.867 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -134.2 164.63 26.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.306 -179.989 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -67.4 -34.5 77.38 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.333 -179.992 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 1.7 tppp? -93.14 -20.46 20.47 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.225 -179.588 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . 0.402 ' HA ' ' O ' ' A' ' 54' ' ' PHE . 39.8 m80 -120.09 133.54 55.49 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.931 0.396 . . . . 0.0 111.024 -179.377 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -104.29 77.94 1.45 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.136 179.567 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -75.41 116.95 16.68 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.414 -179.884 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.467 HG23 HG23 ' A' ' 21' ' ' VAL . 14.8 m -109.17 -168.24 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.17 179.942 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.426 ' HB3' ' HB ' ' A' ' 7' ' ' THR . 1.0 OUTLIER -142.28 78.74 1.63 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.376 179.855 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.467 HG23 HG23 ' A' ' 19' ' ' VAL . 11.7 t -95.41 110.22 23.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.336 -179.933 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.409 ' HG2' ' CD2' ' A' ' 20' ' ' LEU . 0.0 OUTLIER -179.05 117.86 0.07 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.453 179.946 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.405 ' CE1' HG23 ' A' ' 4' ' ' VAL . 7.5 p90 -150.48 172.04 16.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.312 179.842 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -92.15 148.33 22.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.368 -179.917 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 114.25 -41.71 2.12 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 110.76 -0.936 . . . . 0.0 110.76 179.998 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -119.38 176.05 5.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.84 0.352 . . . . 0.0 110.418 179.999 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.29 -160.84 0.73 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.401 -179.999 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.418 ' O ' ' CG ' ' A' ' 71' ' ' GLU . 59.1 mtm -137.43 120.42 16.55 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.316 180.0 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.822 ' HB3' ' O ' ' A' ' 69' ' ' LEU . . . -124.4 -58.39 1.52 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.563 -179.786 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -153.34 161.78 41.98 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.38 -179.864 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.747 HG21 ' CD1' ' A' ' 52' ' ' TRP . 21.5 t -143.46 155.19 16.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.286 -179.999 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.444 ' CB ' ' HA ' ' A' ' 43' ' ' ALA . 1.8 pt-20 -167.24 137.82 3.02 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.53 -179.953 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.644 HD12 ' N ' ' A' ' 34' ' ' ARG . 3.2 pp -104.24 171.96 7.06 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.322 179.839 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.644 ' N ' HD12 ' A' ' 33' ' ' LEU . 1.3 ttt180 -97.87 -72.99 0.63 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.616 -179.848 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.484 ' CB ' ' O ' ' A' ' 34' ' ' ARG . 2.6 tm-20 94.34 80.26 0.0 OUTLIER 'General case' 0 CA--C 1.511 -0.523 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 -178.977 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -37.42 134.22 0.65 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.166 -0.925 . . . . 0.0 111.757 -178.362 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 114.07 -28.98 8.0 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 110.397 -1.081 . . . . 0.0 110.397 -179.745 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -82.46 -173.96 4.89 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.778 0.323 . . . . 0.0 110.268 179.864 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.41 ' OD1' ' N ' ' A' ' 40' ' ' GLU . 35.2 p30 -114.31 -21.64 10.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.843 -179.861 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.41 ' N ' ' OD1' ' A' ' 39' ' ' ASP . 9.7 mt-10 -135.0 175.26 9.74 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.84 0.352 . . . . 0.0 110.701 -179.826 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.512 ' CZ3' ' HG2' ' A' ' 67' ' ' ARG . 53.1 m95 -86.18 173.05 10.07 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.466 179.945 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.52 HG23 ' HG ' ' A' ' 33' ' ' LEU . 9.7 m -135.57 112.8 14.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.329 179.818 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.444 ' HA ' ' CB ' ' A' ' 32' ' ' GLU . . . -51.02 127.13 18.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.299 179.938 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -60.69 -171.39 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.32 -179.887 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 38.3 m -136.72 133.12 35.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.92 0.39 . . . . 0.0 110.496 -179.847 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 2.8 ptmt -100.95 79.87 2.08 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.52 -179.948 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -153.05 26.63 0.8 Allowed Glycine 0 CA--C 1.523 0.574 0 N-CA-C 110.851 -0.9 . . . . 0.0 110.851 -179.976 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.42 ' HG2' HG23 ' A' ' 51' ' ' VAL . 14.0 tp10 -98.05 -24.59 15.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.734 0.302 . . . . 0.0 110.319 179.952 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 128.03 -76.02 0.41 Allowed Glycine 0 CA--C 1.523 0.536 0 N-CA-C 110.566 -1.014 . . . . 0.0 110.566 -179.964 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -113.31 -14.34 9.89 Favored Glycine 0 CA--C 1.527 0.816 0 N-CA-C 111.259 -0.736 . . . . 0.0 111.259 179.878 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.598 HG21 ' HG3' ' A' ' 9' ' ' GLU . 27.2 m -124.95 -175.44 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-O 120.932 0.396 . . . . 0.0 110.74 -179.745 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . 0.747 ' CD1' HG21 ' A' ' 31' ' ' VAL . 8.1 m95 -104.59 146.22 29.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.499 -179.848 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.08 165.89 18.66 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.162 179.8 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.486 ' CD2' HD21 ' A' ' 33' ' ' LEU . 87.3 t80 -144.51 143.18 30.72 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.572 -179.863 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -89.07 102.48 15.14 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.314 179.913 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 69.7 p -86.91 100.82 12.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.465 -179.934 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -101.93 25.3 8.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.41 179.892 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 6.6 pm0 -121.39 140.83 32.08 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.193 179.897 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -73.45 -20.73 20.47 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.574 2.182 . . . . 0.0 112.113 179.992 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 17.3 mt -53.41 150.43 6.55 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.502 -179.95 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 24.1 tt0 -140.75 96.16 2.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.306 179.818 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -149.24 -157.85 7.82 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 110.682 -0.967 . . . . 0.0 110.682 179.992 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.443 ' HA ' ' HB ' ' A' ' 82' ' ' VAL . 49.1 Cg_endo -76.35 160.74 35.48 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.565 2.177 . . . . 0.0 112.168 -179.934 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.434 ' CD1' HG11 ' A' ' 82' ' ' VAL . 80.2 m-85 -130.96 100.98 5.43 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.394 179.873 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.403 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 48.0 m-80 -66.32 160.33 24.8 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 179.652 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -133.92 176.32 8.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.023 0.439 . . . . 0.0 110.93 -179.894 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.512 ' HG2' ' CZ3' ' A' ' 41' ' ' TRP . 0.0 OUTLIER 176.6 72.3 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.751 179.998 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.556 ' O ' HD23 ' A' ' 69' ' ' LEU . 2.0 p90 -67.16 174.96 2.84 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.88 -179.404 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.822 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 8.9 mt -125.26 68.79 1.14 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.311 179.492 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -37.19 140.97 0.16 Allowed 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.728 -179.115 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.737 ' HG2' ' HB2' ' A' ' 29' ' ' ALA . 2.0 mm-40 -55.27 -58.48 7.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.369 -179.821 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -125.73 55.9 1.42 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.316 179.962 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -137.51 -106.7 0.78 Allowed Glycine 0 CA--C 1.524 0.601 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 -179.981 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 1.2 ptt? -178.5 163.4 1.54 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.805 0.336 . . . . 0.0 110.446 -179.924 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.628 ' HD2' HD22 ' A' ' 69' ' ' LEU . 0.0 OUTLIER -81.69 134.37 35.46 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.258 -179.867 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.415 ' HB3' ' CZ ' ' A' ' 78' ' ' PHE . 0.3 OUTLIER -143.32 129.73 20.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.378 179.958 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 43.3 t -85.55 142.94 12.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.34 -179.993 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.553 ' CZ ' HG11 ' A' ' 4' ' ' VAL . 51.5 m-85 -132.48 120.66 22.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.549 -179.866 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -105.36 163.72 12.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.257 179.83 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 53.79 57.45 6.04 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.271 179.992 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.63 ' O ' HG12 ' A' ' 81' ' ' VAL . 60.9 t -109.02 7.78 9.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.216 -179.965 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.487 HG23 ' O ' ' A' ' 81' ' ' VAL . 70.2 t -158.36 104.35 1.68 Allowed Pre-proline 0 CA--C 1.531 0.212 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 -179.932 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -74.93 178.46 7.22 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.499 2.132 . . . . 0.0 111.935 179.706 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -65.97 121.76 15.83 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.217 179.885 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 3.4 tttt 55.09 65.83 1.39 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.111 -179.823 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 32.6 p90 -49.58 143.23 7.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.755 -179.758 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 9.0 m -110.32 110.03 20.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.13 179.739 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 2.8 mp -49.18 121.1 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.542 -179.844 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 115.57 31.07 2.05 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 110.926 -0.869 . . . . 0.0 110.926 179.976 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.811 ' O ' HG23 ' A' ' 7' ' ' THR . . . -143.63 176.26 9.35 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.745 0.307 . . . . 0.0 110.253 179.834 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.528 HG23 ' O ' ' A' ' 6' ' ' PHE . 17.3 m -125.0 124.06 41.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.533 -179.901 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.525 ' CZ ' ' HB3' ' A' ' 90' ' ' ALA . 6.0 m-85 -124.2 129.54 50.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.272 179.87 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.917 ' HB1' ' HD2' ' A' ' 94' ' ' PRO . . . 178.01 179.24 0.23 Allowed Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.289 -179.988 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.917 ' HD2' ' HB1' ' A' ' 93' ' ' ALA . 48.7 Cg_endo . . . . . 0 C--O 1.249 1.072 0 C-N-CA 122.519 2.146 . . . . 0.0 111.959 -179.93 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.848 0.356 . . . . 0.0 110.624 . . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.484 ' CG1' ' CE1' ' A' ' 78' ' ' PHE . 1.7 p -153.72 163.7 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 121.176 0.512 . . . . 0.0 110.151 179.705 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.468 ' N ' HG22 ' A' ' 4' ' ' VAL . 0.2 OUTLIER -136.15 140.72 43.85 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.438 179.951 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 -105.8 165.91 10.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.965 179.754 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.4 m -160.03 103.49 1.48 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.819 0.343 . . . . 0.0 110.522 -179.823 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 61.1 t -60.04 93.99 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.17 179.771 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.689 ' HG3' HG11 ' A' ' 51' ' ' VAL . 2.4 mm-40 -49.8 165.33 0.08 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.609 -179.851 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.24 56.57 2.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.394 179.95 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -135.79 20.65 3.63 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 111.124 -0.79 . . . . 0.0 111.124 -179.909 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.2 p -74.7 108.46 7.47 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.949 0.405 . . . . 0.0 109.994 179.729 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 22.5 m-20 -92.2 -163.53 1.05 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.775 -179.506 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -55.5 -36.34 66.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.819 -179.706 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.455 ' HD3' ' ND1' ' A' ' 16' ' ' HIS . 0.1 OUTLIER -147.6 45.93 1.12 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.784 0.326 . . . . 0.0 110.582 -179.794 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . 0.455 ' ND1' ' HD3' ' A' ' 15' ' ' LYS . 45.0 m80 -133.78 151.57 51.62 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.22 179.783 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.446 HD12 ' HA ' ' A' ' 17' ' ' LEU . 20.9 tp -137.28 92.54 2.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.462 -179.745 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.622 ' HB2' ' CG2' ' A' ' 53' ' ' THR . . . -87.91 123.13 32.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.298 179.885 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.658 HG23 HG23 ' A' ' 21' ' ' VAL . 27.2 m -121.02 144.76 28.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.555 -179.811 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.423 ' CD2' ' CG ' ' A' ' 22' ' ' LYS . 0.5 OUTLIER -91.38 83.35 5.44 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.28 179.77 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.658 HG23 HG23 ' A' ' 19' ' ' VAL . 24.4 t -89.44 100.3 10.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.543 -179.827 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.423 ' CG ' ' CD2' ' A' ' 20' ' ' LEU . 0.0 OUTLIER 174.9 135.7 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.353 179.859 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.504 ' CE2' ' HB2' ' A' ' 26' ' ' ASP . 0.7 OUTLIER -129.91 -173.29 2.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.1 179.874 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -40.62 -57.42 1.87 Allowed 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 120.795 0.331 . . . . 0.0 111.195 -179.783 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -89.22 -153.77 28.09 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 110.664 -0.974 . . . . 0.0 110.664 179.806 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.821 ' OD2' HG22 ' A' ' 70' ' ' THR . 28.1 t0 68.33 143.52 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.744 0.307 . . . . 0.0 110.408 179.983 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.685 ' O ' HG22 ' A' ' 27' ' ' THR . 86.4 m -119.33 13.44 12.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.062 179.863 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.405 ' O ' ' CG ' ' A' ' 71' ' ' GLU . 9.3 mtp 59.51 115.09 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.832 0.349 . . . . 0.0 110.594 179.732 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.785 ' HB3' ' O ' ' A' ' 69' ' ' LEU . . . -126.42 -57.17 1.39 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.13 179.81 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -157.46 166.69 32.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.147 179.789 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.621 HG21 ' CD1' ' A' ' 52' ' ' TRP . 38.5 t -152.41 148.27 14.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.448 -179.899 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.444 ' CB ' ' HA ' ' A' ' 43' ' ' ALA . 14.6 pt-20 -138.81 146.93 41.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.093 179.766 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.811 HD23 ' CG ' ' A' ' 54' ' ' PHE . 6.1 tp -128.86 138.3 51.96 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 120.923 0.392 . . . . 0.0 110.19 -179.093 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.541 ' N ' HD12 ' A' ' 33' ' ' LEU . 50.0 ttp85 -124.6 165.67 17.46 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.55 179.184 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -118.92 -83.07 0.65 Allowed 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 -179.975 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER 169.58 158.61 0.06 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.375 179.598 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 50.01 47.01 41.32 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 110.849 -0.901 . . . . 0.0 110.849 179.926 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 32.1 t -136.0 -174.93 3.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.817 0.341 . . . . 0.0 110.329 179.899 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -68.57 -63.57 1.03 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.471 -179.919 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -167.93 -173.87 2.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.343 -179.926 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.488 ' CE3' ' HB2' ' A' ' 34' ' ' ARG . 50.3 m95 -47.68 154.34 0.49 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.591 -179.943 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.436 HG22 ' O ' ' A' ' 33' ' ' LEU . 24.2 m -129.9 28.86 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.421 179.983 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.444 ' HA ' ' CB ' ' A' ' 32' ' ' GLU . . . 47.24 -175.34 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.131 179.555 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.401 ' HB2' ' O ' ' A' ' 31' ' ' VAL . 0.0 OUTLIER -112.94 -164.74 0.94 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.356 -179.97 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 25.7 m -146.52 104.97 3.81 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.477 -179.933 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.43 71.87 0.95 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.243 179.857 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -99.3 -34.49 5.05 Favored Glycine 0 CA--C 1.523 0.559 0 N-CA-C 110.813 -0.915 . . . . 0.0 110.813 -179.868 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.441 ' HG2' ' CG2' ' A' ' 51' ' ' VAL . 4.1 tp10 -80.5 130.11 34.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.808 0.337 . . . . 0.0 110.35 -179.916 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -78.39 78.38 1.62 Allowed Glycine 0 CA--C 1.522 0.53 0 N-CA-C 110.752 -0.939 . . . . 0.0 110.752 179.895 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 150.67 -32.01 1.0 Allowed Glycine 0 CA--C 1.522 0.502 0 N-CA-C 110.6 -1.0 . . . . 0.0 110.6 -179.959 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.689 HG11 ' HG3' ' A' ' 9' ' ' GLU . 17.5 m -145.81 -177.35 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.837 0.351 . . . . 0.0 110.369 -179.997 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . 0.621 ' CD1' HG21 ' A' ' 31' ' ' VAL . 7.5 m95 -102.97 141.15 36.26 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.584 -179.738 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.622 ' CG2' ' HB2' ' A' ' 18' ' ' ALA . 0.2 OUTLIER -124.22 152.22 43.18 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.942 179.7 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.811 ' CG ' HD23 ' A' ' 33' ' ' LEU . 80.6 t80 -117.39 161.65 19.21 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.423 -179.925 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -118.15 118.59 32.29 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.32 -179.993 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 40.2 m -111.48 164.24 13.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.449 -179.931 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -161.7 39.9 0.13 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.249 179.932 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -131.91 157.52 77.98 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.338 -179.946 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -71.61 -33.35 10.71 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.615 2.21 . . . . 0.0 112.2 -179.936 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -82.68 174.7 10.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.293 179.909 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 179.81 59.6 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.613 179.935 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -72.88 -139.95 0.37 Allowed Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.477 -1.049 . . . . 0.0 110.477 179.807 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -73.83 174.1 12.88 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.501 2.134 . . . . 0.0 111.699 179.698 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -135.52 177.08 8.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.957 0.408 . . . . 0.0 110.548 -179.937 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 -143.96 131.29 20.87 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.862 179.904 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -116.16 170.13 8.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.044 0.45 . . . . 0.0 110.884 -179.705 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.446 ' HG3' ' CH2' ' A' ' 41' ' ' TRP . 0.1 OUTLIER -172.54 80.75 0.05 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.049 -179.925 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.426 ' HA ' ' HA ' ' A' ' 31' ' ' VAL . 0.5 OUTLIER -81.57 167.02 19.72 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.191 0.52 . . . . 0.0 110.966 -179.594 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.785 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 6.8 mt -123.49 74.23 1.24 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.494 179.715 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.821 HG22 ' OD2' ' A' ' 26' ' ' ASP . 13.5 p -36.81 137.77 0.29 Allowed 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.696 -179.334 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.707 ' HG2' ' HB2' ' A' ' 29' ' ' ALA . 8.7 mm-40 -48.88 -46.48 42.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.822 -179.591 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.66 45.9 1.7 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.447 179.86 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -121.06 -110.17 2.17 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 110.863 -0.895 . . . . 0.0 110.863 -179.983 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.412 ' N ' ' OG1' ' A' ' 70' ' ' THR . 2.1 ptt? -171.67 152.69 3.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.831 0.348 . . . . 0.0 110.361 -179.905 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.522 ' HG3' HD23 ' A' ' 69' ' ' LEU . 0.0 OUTLIER -76.58 150.83 36.46 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.463 -179.942 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 55.0 m-20 -156.31 136.73 13.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.542 179.946 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.404 ' HA ' ' HG2' ' A' ' 67' ' ' ARG . 94.2 t -89.33 138.92 18.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.353 179.927 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.484 ' CE1' ' CG1' ' A' ' 4' ' ' VAL . 40.4 m-85 -126.81 134.87 50.46 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.793 -179.448 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -123.93 150.72 44.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.273 179.85 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 54.39 30.66 13.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.374 -179.904 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.437 ' HA ' ' HA ' ' A' ' 93' ' ' ALA . 54.8 t -53.71 -24.82 10.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.48 -179.925 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.439 ' CG1' ' HB3' ' A' ' 86' ' ' TYR . 59.3 t -134.34 132.3 20.95 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.579 -0.282 . . . . 0.0 110.535 179.897 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.447 ' CD ' ' CD1' ' A' ' 92' ' ' TYR . 49.5 Cg_endo -71.24 -171.48 0.61 Allowed 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.586 2.191 . . . . 0.0 111.996 179.744 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 21.3 pt-20 -85.23 129.92 34.71 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 179.29 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 59.33 50.66 7.51 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 -179.282 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 0.439 ' HB3' ' CG1' ' A' ' 82' ' ' VAL . 36.6 p90 -43.46 160.43 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.413 -179.407 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -130.92 104.26 7.04 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.925 179.751 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 3.0 mp -45.3 118.65 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.623 -179.798 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 118.42 36.7 0.9 Allowed Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.602 -0.999 . . . . 0.0 110.602 -179.821 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -149.32 153.34 37.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.768 0.318 . . . . 0.0 110.149 -179.96 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 92.4 m -103.63 93.62 5.02 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.727 -179.81 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.589 ' O ' ' HB3' ' A' ' 93' ' ' ALA . 40.1 m-85 -81.81 -153.76 0.11 Allowed 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 179.31 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.913 ' HB1' ' HD2' ' A' ' 94' ' ' PRO . . . 76.2 175.85 0.07 OUTLIER Pre-proline 0 N--CA 1.464 0.263 0 CA-C-O 120.689 0.281 . . . . 0.0 110.748 179.726 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.913 ' HD2' ' HB1' ' A' ' 93' ' ' ALA . 46.5 Cg_endo . . . . . 0 C--O 1.249 1.027 0 C-N-CA 122.523 2.148 . . . . 0.0 112.053 -179.988 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 7.9 mtmm . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.808 0.337 . . . . 0.0 110.402 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.586 HG21 ' CZ ' ' A' ' 78' ' ' PHE . 18.0 m -72.95 170.86 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.435 -179.979 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.413 HG23 ' O ' ' A' ' 4' ' ' VAL . 16.0 p -154.66 132.07 11.2 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.516 -179.97 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.528 ' O ' HG23 ' A' ' 91' ' ' THR . 13.6 m-85 -101.3 160.29 14.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.066 179.821 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.6 m -156.49 126.26 6.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.924 0.392 . . . . 0.0 110.683 -179.86 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.595 HG11 HG13 ' A' ' 88' ' ' ILE . 98.9 t -60.28 114.73 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.284 179.85 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.441 ' HB2' HG11 ' A' ' 51' ' ' VAL . 15.0 mm-40 -94.1 160.92 14.49 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.433 -179.91 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.9 ttmm -55.16 159.25 2.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.339 179.979 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 86.91 25.77 33.66 Favored Glycine 0 CA--C 1.523 0.539 0 N-CA-C 110.772 -0.931 . . . . 0.0 110.772 -179.968 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 58.3 m -94.84 120.3 34.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.813 0.34 . . . . 0.0 110.491 -179.891 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -119.38 -163.94 1.02 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.39 179.927 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -46.99 -61.89 1.66 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.245 -179.693 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.416 ' HG2' ' N ' ' A' ' 16' ' ' HIS . 0.8 OUTLIER -98.95 -28.28 13.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.058 -179.271 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . 0.416 ' N ' ' HG2' ' A' ' 15' ' ' LYS . 1.7 m80 -65.02 123.66 20.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.833 0.349 . . . . 0.0 110.411 -179.818 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.482 HD22 ' HA ' ' A' ' 17' ' ' LEU . 0.3 OUTLIER -129.51 99.82 5.32 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.419 -179.953 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.588 ' HB1' HG11 ' A' ' 51' ' ' VAL . . . -95.88 130.93 42.69 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.128 179.83 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.68 ' O ' HG13 ' A' ' 51' ' ' VAL . 17.7 m -139.59 134.63 39.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.905 0.383 . . . . 0.0 110.796 -179.969 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -84.77 100.38 11.49 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.481 179.955 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.478 HG23 HG23 ' A' ' 19' ' ' VAL . 82.1 t -102.53 92.22 2.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.341 179.866 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.7 139.36 17.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.445 -179.925 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.425 ' CE1' HG12 ' A' ' 4' ' ' VAL . 2.1 p90 -155.0 168.02 28.41 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.257 179.929 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -74.17 125.06 27.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.417 -179.869 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 141.77 -91.35 0.18 Allowed Glycine 0 CA--C 1.523 0.555 0 N-CA-C 110.566 -1.014 . . . . 0.0 110.566 -179.934 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -72.93 -160.58 0.08 Allowed 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 179.805 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.683 ' O ' HG22 ' A' ' 27' ' ' THR . 33.5 m -144.14 31.67 1.24 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.637 179.975 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.416 ' O ' ' CG ' ' A' ' 71' ' ' GLU . 16.5 mtm 61.37 123.75 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.618 179.642 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.822 ' HB3' ' O ' ' A' ' 69' ' ' LEU . . . -124.86 -58.58 1.47 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.527 179.838 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -152.52 152.18 31.6 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.52 -179.958 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.765 HG21 ' CD1' ' A' ' 52' ' ' TRP . 27.9 t -141.76 155.8 20.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.191 179.746 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.429 ' CG ' ' HG3' ' A' ' 67' ' ' ARG . 0.9 OUTLIER -156.45 148.28 22.89 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.384 -179.784 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.765 HD12 ' H ' ' A' ' 34' ' ' ARG . 4.7 tp -111.4 148.94 31.97 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 -179.821 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.765 ' H ' HD12 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -97.77 -68.26 0.81 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.53 -179.818 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.439 ' CB ' ' O ' ' A' ' 34' ' ' ARG . 25.2 mt-10 88.8 74.94 0.01 OUTLIER 'General case' 0 CA--C 1.51 -0.58 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 -178.771 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -37.37 103.31 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.039 -0.982 . . . . 0.0 111.713 -178.097 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 107.13 37.07 2.38 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 110.413 -1.075 . . . . 0.0 110.413 -179.738 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.429 ' HB2' ' HB2' ' A' ' 35' ' ' GLU . 7.2 t -119.0 -157.5 0.69 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.676 0.274 . . . . 0.0 110.513 -179.641 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -111.25 66.41 0.63 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.855 0.359 . . . . 0.0 110.403 -179.837 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 76.39 160.06 0.22 Allowed 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.394 179.93 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.482 ' CZ3' ' HG2' ' A' ' 67' ' ' ARG . 82.4 m95 -51.18 156.79 1.03 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.566 -179.94 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.2 m -139.15 115.78 10.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.915 179.635 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -48.54 143.04 5.3 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.674 -179.651 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -73.26 -174.16 1.53 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.301 -179.959 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.412 ' O ' ' N ' ' A' ' 47' ' ' GLY . 59.1 m -145.53 120.81 10.22 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.096 179.887 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.42 ' O ' ' CG ' ' A' ' 46' ' ' LYS . 0.8 OUTLIER -68.67 64.4 0.11 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.412 -179.838 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.412 ' N ' ' O ' ' A' ' 45' ' ' THR . . . -72.6 -47.54 26.8 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 110.797 -0.921 . . . . 0.0 110.797 -179.981 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.469 ' CB ' ' HB ' ' A' ' 51' ' ' VAL . 0.5 OUTLIER -73.99 -174.34 1.84 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.866 0.365 . . . . 0.0 110.659 -179.814 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -82.79 -35.29 19.57 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 110.599 -1.0 . . . . 0.0 110.599 179.912 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -146.35 27.07 1.69 Allowed Glycine 0 CA--C 1.522 0.47 0 N-CA-C 110.117 -1.193 . . . . 0.0 110.117 179.69 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.68 HG13 ' O ' ' A' ' 19' ' ' VAL . 88.5 t -138.6 145.7 27.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.841 0.353 . . . . 0.0 110.084 -179.689 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . 0.765 ' CD1' HG21 ' A' ' 31' ' ' VAL . 4.2 m95 -94.55 114.37 26.34 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.513 -179.619 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.579 HG22 ' HB2' ' A' ' 18' ' ' ALA . 11.1 p -107.24 143.43 35.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.311 -179.937 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -126.44 150.86 48.41 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.446 179.925 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -108.39 95.47 5.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.355 -179.975 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -61.78 167.23 3.78 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.398 -179.967 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -105.79 -32.46 8.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.491 -179.955 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -111.45 153.52 44.13 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.432 -179.876 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -67.94 -32.37 28.88 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.899 2.399 . . . . 0.0 112.393 -179.934 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -77.53 128.07 33.56 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.673 -179.59 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 19.5 pt20 179.87 132.31 0.1 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.134 -179.943 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -138.79 -72.45 0.05 OUTLIER Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 -179.798 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -72.48 122.01 7.93 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.548 2.165 . . . . 0.0 112.006 179.837 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.596 ' HB3' HD13 ' A' ' 33' ' ' LEU . 45.1 m-85 -113.61 102.36 10.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.685 -179.689 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 52.2 m-20 -81.01 137.26 36.07 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 179.391 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -125.69 170.44 11.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.107 0.48 . . . . 0.0 111.077 -179.351 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.482 ' HG2' ' CZ3' ' A' ' 41' ' ' TRP . 0.0 OUTLIER -168.91 53.69 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.791 179.949 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.506 ' CZ ' HG11 ' A' ' 4' ' ' VAL . 0.2 OUTLIER -49.77 169.82 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.028 -179.56 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.822 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 6.9 mt -124.77 70.1 1.13 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.22 179.386 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 31.9 p -33.43 141.82 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.157 0.583 . . . . 0.0 112.241 -178.99 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.682 ' HG2' ' HB2' ' A' ' 29' ' ' ALA . 4.7 mm-40 -53.66 -60.11 3.73 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.745 -0.662 . . . . 0.0 110.455 -179.952 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 4.8 tmtt? -124.76 77.75 1.63 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.458 -179.973 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -170.55 -99.94 0.13 Allowed Glycine 0 CA--C 1.523 0.536 0 N-CA-C 110.764 -0.935 . . . . 0.0 110.764 179.901 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 179.29 173.56 0.81 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.864 0.364 . . . . 0.0 110.282 -179.938 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.19 -176.29 3.04 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.347 179.938 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.423 ' O ' ' CB ' ' A' ' 67' ' ' ARG . 2.7 t-20 -178.99 -173.7 0.31 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.016 179.942 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 93.0 t -128.31 127.32 67.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.887 0.375 . . . . 0.0 110.454 -179.884 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.586 ' CZ ' HG21 ' A' ' 4' ' ' VAL . 58.3 m-85 -112.64 123.24 49.86 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.887 179.741 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -113.89 151.85 31.6 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.781 -179.519 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 35.5 t0 60.26 24.0 13.4 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.762 179.834 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.654 HG22 ' HD3' ' A' ' 94' ' ' PRO . 25.4 t -55.73 -79.39 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.665 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.612 HG23 HG12 ' A' ' 81' ' ' VAL . 47.2 t -87.11 139.1 32.36 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.453 179.837 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.487 ' HD3' ' CG ' ' A' ' 92' ' ' TYR . 49.2 Cg_endo -71.76 -173.55 1.06 Allowed 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.624 2.216 . . . . 0.0 112.001 179.812 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 32.9 mp0 -64.12 -73.67 0.11 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.057 179.762 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -94.75 73.0 3.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.045 179.642 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 0.449 ' HB3' ' CG1' ' A' ' 82' ' ' VAL . 30.2 p90 -52.04 159.37 0.9 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.897 -179.574 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.74 109.99 12.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.094 179.747 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.595 HG13 HG11 ' A' ' 8' ' ' VAL . 3.3 mp -48.11 111.76 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.748 -179.769 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 110.56 55.0 0.53 Allowed Glycine 0 CA--C 1.523 0.538 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 179.995 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -175.75 131.78 0.26 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.82 0.343 . . . . 0.0 110.465 179.968 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.528 HG23 ' O ' ' A' ' 6' ' ' PHE . 35.5 m -83.16 144.58 29.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.159 179.917 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.487 ' CG ' ' HD3' ' A' ' 83' ' ' PRO . 71.9 m-85 -129.03 -83.79 0.57 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.691 -179.964 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.94 ' HB1' ' HD2' ' A' ' 94' ' ' PRO . . . 49.64 -179.01 0.01 OUTLIER Pre-proline 0 C--O 1.232 0.133 0 CA-C-O 120.624 0.249 . . . . 0.0 110.595 179.94 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.94 ' HD2' ' HB1' ' A' ' 93' ' ' ALA . 48.1 Cg_endo . . . . . 0 C--O 1.249 1.053 0 C-N-CA 122.481 2.121 . . . . 0.0 112.088 -179.902 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt . . . . . 0 CA--C 1.523 -0.09 0 CA-C-O 120.865 0.365 . . . . 0.0 110.38 . . . . . . . . . 0 0 . 1 . 031 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.651 ' O ' HG23 ' A' ' 5' ' ' THR . 34.2 m -66.21 -178.38 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.359 -179.937 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.651 HG23 ' O ' ' A' ' 4' ' ' VAL . 3.0 p -161.77 138.34 8.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.296 -179.996 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.614 ' O ' HG23 ' A' ' 91' ' ' THR . 23.4 m-85 -102.06 173.1 6.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.459 -179.757 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.451 HG23 ' O ' ' A' ' 90' ' ' ALA . 0.3 OUTLIER -165.96 102.92 0.66 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.287 -179.991 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.44 ' CG1' HG13 ' A' ' 88' ' ' ILE . 40.5 t -51.68 96.35 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.341 179.956 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.557 ' CD ' HD12 ' A' ' 20' ' ' LEU . 1.8 mm-40 -62.09 177.1 0.5 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.654 -179.737 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.8 tttt -80.63 60.34 3.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.409 -179.944 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -146.3 21.23 1.72 Allowed Glycine 0 CA--C 1.525 0.668 0 N-CA-C 111.022 -0.831 . . . . 0.0 111.022 179.974 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 25.6 m -110.32 114.58 28.15 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 110.121 -0.325 . . . . 0.0 110.121 179.921 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.419 ' OD1' ' N ' ' A' ' 14' ' ' GLU . 6.1 p30 -113.46 -49.13 2.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.612 -179.793 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.419 ' N ' ' OD1' ' A' ' 13' ' ' ASN . 9.6 mm-40 -154.15 -69.65 0.14 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.776 -179.792 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.433 ' N ' ' HD2' ' A' ' 15' ' ' LYS . 17.9 mmmt -91.25 -28.73 17.61 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.478 -179.478 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 9.5 m80 -76.36 128.59 35.14 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.764 -179.632 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.449 ' HA ' HD22 ' A' ' 17' ' ' LEU . 1.2 tm? -122.32 86.22 2.54 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.943 179.793 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.775 ' HB1' HG11 ' A' ' 51' ' ' VAL . . . -80.11 129.35 34.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.636 -179.596 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.658 ' O ' HG13 ' A' ' 51' ' ' VAL . 24.1 m -134.03 134.35 55.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.401 179.697 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.557 HD12 ' CD ' ' A' ' 9' ' ' GLU . 0.7 OUTLIER -89.36 87.47 7.12 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.377 -179.947 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.47 HG23 HG23 ' A' ' 19' ' ' VAL . 12.0 t -86.39 108.87 18.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.27 179.923 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.1 mtpt -179.67 176.39 0.79 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.226 179.95 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.442 ' CE2' HG12 ' A' ' 4' ' ' VAL . 20.1 p90 176.85 40.93 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.315 -179.963 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 55.63 174.77 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.353 179.974 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 70.74 -101.19 0.9 Allowed Glycine 0 CA--C 1.523 0.559 0 N-CA-C 110.635 -0.986 . . . . 0.0 110.635 -179.993 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -54.8 166.39 0.49 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.779 0.323 . . . . 0.0 110.359 179.934 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -115.0 -169.31 1.53 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.474 179.949 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.413 ' O ' ' CG ' ' A' ' 71' ' ' GLU . 13.4 mmt -115.21 127.45 55.52 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.637 -179.756 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.87 ' HB3' ' O ' ' A' ' 69' ' ' LEU . . . -118.03 -59.37 1.91 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.586 -179.904 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -150.44 153.06 35.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.215 -179.943 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.55 HG22 ' HB3' ' A' ' 68' ' ' PHE . 4.4 t -147.61 146.68 18.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.017 0.437 . . . . 0.0 110.773 -179.742 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.45 ' CB ' ' HA ' ' A' ' 43' ' ' ALA . 5.9 pt-20 -137.26 146.28 44.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.513 179.203 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.668 HD12 ' H ' ' A' ' 34' ' ' ARG . 9.8 tp -123.1 153.2 40.25 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-O 120.938 0.399 . . . . 0.0 110.033 -178.907 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.668 ' H ' HD12 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -145.66 162.73 36.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.678 179.574 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.405 ' O ' ' HB2' ' A' ' 36' ' ' HIS . 1.1 mt-10 -120.45 -86.11 0.65 Allowed 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 179.924 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 0.405 ' HB2' ' O ' ' A' ' 35' ' ' GLU . 0.8 OUTLIER -179.98 -40.62 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.803 0.335 . . . . 0.0 110.373 179.472 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -63.22 -56.83 17.97 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 110.781 -0.928 . . . . 0.0 110.781 -179.951 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.417 ' O ' ' CB ' ' A' ' 39' ' ' ASP . 1.5 t -55.03 -36.2 65.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.777 0.322 . . . . 0.0 110.356 -179.928 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.417 ' CB ' ' O ' ' A' ' 38' ' ' SER . 4.1 t70 81.6 -53.66 0.27 Allowed 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.489 -179.812 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -77.88 145.53 36.17 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.155 179.948 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.508 ' CE3' ' HB2' ' A' ' 34' ' ' ARG . 75.3 m95 -71.0 153.68 42.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.472 -179.864 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.6 HG21 ' CZ ' ' A' ' 54' ' ' PHE . 3.0 m -135.72 111.95 12.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.921 179.671 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.45 ' HA ' ' CB ' ' A' ' 32' ' ' GLU . . . -47.95 155.05 0.47 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.857 -179.479 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -76.42 -173.17 2.39 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.355 179.986 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 53.7 m -152.49 103.57 2.83 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.526 -179.943 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 7.9 ptpt -59.5 88.89 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.229 -0.442 . . . . 0.0 109.934 179.767 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -110.25 -28.46 4.08 Favored Glycine 0 CA--C 1.522 0.52 0 N-CA-C 111.239 -0.745 . . . . 0.0 111.239 -179.56 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.467 ' CB ' ' HB ' ' A' ' 51' ' ' VAL . 1.1 tp10 -72.09 -36.13 69.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.753 0.311 . . . . 0.0 110.698 -179.646 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 115.12 -37.46 3.49 Favored Glycine 0 CA--C 1.52 0.405 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 -179.115 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -138.02 21.32 3.17 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 178.631 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.775 HG11 ' HB1' ' A' ' 18' ' ' ALA . 52.6 t -155.44 144.61 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 -179.677 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . 0.495 ' NE1' HG21 ' A' ' 31' ' ' VAL . 3.0 m95 -91.51 110.42 21.74 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.968 0.413 . . . . 0.0 110.327 -179.749 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.461 ' CG2' ' HB2' ' A' ' 18' ' ' ALA . 1.1 p -101.81 142.17 33.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.468 -179.7 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.61 ' CG ' HD23 ' A' ' 33' ' ' LEU . 66.3 t80 -130.47 147.26 52.15 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.344 179.902 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 51.8 m-20 -89.04 101.17 13.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.431 -179.938 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.0 t -77.65 170.74 16.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.257 179.889 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -177.4 68.95 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.474 -179.912 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 179.49 118.61 0.21 Allowed Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.375 179.967 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -73.63 -2.43 12.17 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.475 2.117 . . . . 0.0 112.683 179.998 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 10.6 mp -67.05 74.91 0.12 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.727 0.298 . . . . 0.0 110.459 -179.943 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.423 ' HB2' ' HD3' ' A' ' 63' ' ' PRO . 57.7 mt-30 51.55 -170.06 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.177 179.998 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.492 ' N ' ' HD3' ' A' ' 63' ' ' PRO . . . -128.46 47.95 0.99 Allowed Glycine 0 CA--C 1.527 0.8 0 N-CA-C 111.589 -0.604 . . . . 0.0 111.589 -179.846 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.492 ' HD3' ' N ' ' A' ' 62' ' ' GLY . 51.8 Cg_endo -76.69 90.09 1.24 Allowed 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.389 2.06 . . . . 0.0 111.396 179.327 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.421 ' HB3' ' CD1' ' A' ' 33' ' ' LEU . 24.9 m-85 -92.28 160.51 15.1 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.272 0.558 . . . . 0.0 111.253 -179.238 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 5.0 m-80 -142.35 140.73 32.19 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.371 179.713 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.421 ' CZ ' HD13 ' A' ' 33' ' ' LEU . 79.0 m-85 -129.92 156.06 45.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.139 0.495 . . . . 0.0 111.545 -179.058 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.496 ' HD2' ' CZ2' ' A' ' 41' ' ' TRP . 1.8 mtp180 -156.38 61.96 0.55 Allowed 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.212 179.769 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.556 ' O ' HD23 ' A' ' 69' ' ' LEU . 0.7 OUTLIER -68.18 172.41 5.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.247 0.546 . . . . 0.0 110.856 -179.602 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.87 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 0.5 OUTLIER -131.09 76.05 1.7 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.47 -0.787 . . . . 0.0 109.293 179.728 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 2.7 p -35.4 136.9 0.19 Allowed 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 122.771 0.428 . . . . 0.0 111.813 -179.193 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.638 ' HG2' ' HB2' ' A' ' 29' ' ' ALA . 14.2 mt-10 -50.84 -28.95 10.54 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.582 -179.569 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.3 83.01 1.43 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.541 -179.847 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -177.05 -98.54 0.11 Allowed Glycine 0 CA--C 1.523 0.569 0 N-CA-C 110.846 -0.902 . . . . 0.0 110.846 179.864 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 179.3 -178.96 0.37 Allowed 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 110.201 -0.296 . . . . 0.0 110.201 -179.832 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.43 ' HG2' HD22 ' A' ' 69' ' ' LEU . 0.4 OUTLIER -93.4 179.9 5.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.873 0.368 . . . . 0.0 110.378 179.926 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 172.11 136.02 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.284 -179.988 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.457 HG12 ' N ' ' A' ' 78' ' ' PHE . 99.1 t -92.86 158.76 2.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.483 -179.986 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.457 ' CZ ' HG21 ' A' ' 4' ' ' VAL . 64.8 m-85 -143.25 108.22 4.94 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.12 179.94 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -91.17 147.91 22.73 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.663 -179.654 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 41.3 t0 51.51 52.2 15.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.797 179.742 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 74.9 t -68.72 -62.83 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 179.576 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.573 HG13 ' HD2' ' A' ' 83' ' ' PRO . 91.5 t -98.52 140.12 21.6 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.101 179.542 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.573 ' HD2' HG13 ' A' ' 82' ' ' VAL . 46.1 Cg_endo -69.74 -170.52 0.4 Allowed 'Trans proline' 0 N--CA 1.474 0.377 0 C-N-CA 122.638 2.225 . . . . 0.0 112.15 179.877 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 33.6 mp0 -77.35 -37.05 53.11 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.288 179.948 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -124.9 77.15 1.59 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.242 179.873 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 0.428 ' HB3' ' CG1' ' A' ' 82' ' ' VAL . 38.6 p90 -73.25 179.82 3.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.462 -179.871 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -157.69 120.56 3.91 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.305 -179.99 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.586 ' H ' HD12 ' A' ' 88' ' ' ILE . 4.0 mp -51.54 100.45 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.397 179.941 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 131.41 56.43 0.09 OUTLIER Glycine 0 CA--C 1.523 0.556 0 N-CA-C 110.703 -0.959 . . . . 0.0 110.703 -179.889 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.746 ' HB3' ' OH ' ' A' ' 92' ' ' TYR . . . -177.99 178.03 0.99 Allowed 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 110.253 -0.277 . . . . 0.0 110.253 179.981 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.614 HG23 ' O ' ' A' ' 6' ' ' PHE . 0.7 OUTLIER -111.8 146.24 37.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.889 0.376 . . . . 0.0 110.653 -179.839 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.746 ' OH ' ' HB3' ' A' ' 90' ' ' ALA . 8.6 m-85 -150.17 104.16 3.24 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.263 179.712 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.9 ' HB1' ' HD2' ' A' ' 94' ' ' PRO . . . 173.66 177.74 0.16 Allowed Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.461 179.968 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.9 ' HD2' ' HB1' ' A' ' 93' ' ' ALA . 50.4 Cg_endo . . . . . 0 C--O 1.249 1.026 0 C-N-CA 122.657 2.238 . . . . 0.0 112.211 -179.924 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 10.0 mttt . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.8 0.333 . . . . 0.0 110.526 . . . . . . . . . 0 0 . 1 . 032 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.575 HG11 ' CZ ' ' A' ' 78' ' ' PHE . 1.6 p -56.03 164.03 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.189 0.519 . . . . 0.0 110.204 179.894 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.476 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 9.1 p -142.17 128.65 20.15 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.411 179.966 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.55 ' CE2' ' CD2' ' A' ' 66' ' ' PHE . 8.0 m-85 -97.98 173.16 7.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.227 179.996 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.618 HG23 ' O ' ' A' ' 90' ' ' ALA . 12.9 m -165.37 117.79 1.16 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.469 -179.862 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.504 ' O ' HG23 ' A' ' 88' ' ' ILE . 20.6 t -59.11 94.57 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.269 179.946 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.737 ' HG3' HG11 ' A' ' 51' ' ' VAL . 0.1 OUTLIER -51.21 171.84 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.594 -179.893 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.2 ttmt -85.5 56.54 4.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.413 -179.99 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -147.63 25.36 1.5 Allowed Glycine 0 CA--C 1.524 0.622 0 N-CA-C 110.742 -0.943 . . . . 0.0 110.742 179.949 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -100.05 113.6 26.33 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.813 0.339 . . . . 0.0 110.216 179.939 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.407 ' OD1' ' N ' ' A' ' 14' ' ' GLU . 4.7 p30 -112.94 -51.4 2.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.533 -179.852 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.407 ' N ' ' OD1' ' A' ' 13' ' ' ASN . 0.5 OUTLIER -166.99 -64.98 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.755 -179.874 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.415 ' N ' ' HD2' ' A' ' 15' ' ' LYS . 10.9 mmmt -86.59 -27.11 24.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.54 -179.402 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 19.3 m80 -91.62 126.16 36.61 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.934 0.397 . . . . 0.0 110.849 -179.518 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.457 HD22 ' HA ' ' A' ' 17' ' ' LEU . 0.3 OUTLIER -116.81 89.63 3.15 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.627 179.425 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -83.51 126.05 32.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.762 -179.368 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.592 HG11 ' CZ ' ' A' ' 66' ' ' PHE . 19.8 m -113.55 -173.41 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.629 179.368 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.6 tt -141.04 59.21 1.53 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.256 179.679 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 28.0 t -55.86 116.54 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.428 -179.937 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.1 mttp -168.09 162.42 13.09 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.154 179.97 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -140.42 -63.67 0.48 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.225 -0.443 . . . . 0.0 109.979 -179.968 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -149.53 -47.25 0.14 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.318 179.981 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 170.22 74.84 0.04 OUTLIER Glycine 0 CA--C 1.524 0.601 0 N-CA-C 110.899 -0.88 . . . . 0.0 110.899 179.982 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -112.9 -168.31 1.3 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.767 0.318 . . . . 0.0 110.206 179.797 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.719 HG22 ' HG3' ' A' ' 71' ' ' GLU . 0.9 OUTLIER -113.45 137.78 51.04 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.094 179.984 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 7.8 mtt -101.62 129.57 47.77 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.872 -179.537 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.816 ' HB3' ' O ' ' A' ' 69' ' ' LEU . . . -112.68 -57.6 2.26 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.246 179.824 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.412 ' O ' ' CB ' ' A' ' 68' ' ' PHE . 0.7 OUTLIER -153.11 165.2 36.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.175 179.832 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.53 HG21 ' CD1' ' A' ' 52' ' ' TRP . 4.1 t -152.69 140.27 13.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.264 -0.426 . . . . 0.0 109.939 -179.969 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.454 ' CB ' ' HA ' ' A' ' 43' ' ' ALA . 1.5 pt-20 -137.34 137.34 38.8 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.968 0.413 . . . . 0.0 110.584 -179.701 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.563 HD12 ' CB ' ' A' ' 54' ' ' PHE . 1.6 mt -92.97 -178.52 4.83 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.587 -179.686 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.466 ' HB2' ' CZ3' ' A' ' 41' ' ' TRP . 0.7 OUTLIER -157.5 147.75 20.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.943 179.633 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -113.99 -14.36 12.43 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.957 -179.834 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 70.22 120.83 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.843 0.354 . . . . 0.0 110.31 -179.996 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 118.06 -45.27 1.29 Allowed Glycine 0 CA--C 1.522 0.481 0 N-CA-C 110.472 -1.051 . . . . 0.0 110.472 -179.753 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 20.7 t -63.24 -25.41 68.31 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.774 0.321 . . . . 0.0 110.314 179.778 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.1 t0 70.38 29.32 3.57 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.415 179.908 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -154.37 145.05 22.38 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.513 179.957 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.466 ' CZ3' ' HB2' ' A' ' 34' ' ' ARG . 83.8 m95 -88.14 145.66 25.81 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.036 179.8 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.768 HG21 ' CZ ' ' A' ' 54' ' ' PHE . 20.3 m -117.11 107.15 21.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.095 0.474 . . . . 0.0 110.33 -179.862 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.454 ' HA ' ' CB ' ' A' ' 32' ' ' GLU . . . -53.82 139.22 33.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.152 -179.782 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.86 -171.48 0.07 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.855 -179.644 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.422 ' O ' ' N ' ' A' ' 47' ' ' GLY . 86.7 m -143.55 97.65 3.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.217 179.858 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 13.5 ptmt -61.25 80.7 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.361 -179.883 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' A' ' 45' ' ' THR . . . -120.93 15.37 9.55 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 111.236 -0.745 . . . . 0.0 111.236 179.993 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.412 ' HG3' HG23 ' A' ' 51' ' ' VAL . 1.8 mm-40 -106.62 -33.24 7.71 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.847 0.356 . . . . 0.0 110.325 179.96 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 94.89 -36.79 3.63 Favored Glycine 0 CA--C 1.522 0.515 0 N-CA-C 110.667 -0.973 . . . . 0.0 110.667 179.973 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -110.92 -25.55 5.07 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 110.818 -0.913 . . . . 0.0 110.818 -179.877 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.737 HG11 ' HG3' ' A' ' 9' ' ' GLU . 15.5 m -140.66 -176.33 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.937 0.399 . . . . 0.0 110.591 -179.904 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . 0.53 ' CD1' HG21 ' A' ' 31' ' ' VAL . 9.5 m95 -108.58 142.28 39.26 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.726 -179.507 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -130.02 150.76 51.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.967 179.672 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.768 ' CZ ' HG21 ' A' ' 42' ' ' VAL . 65.8 t80 -136.18 153.57 51.21 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.884 0.373 . . . . 0.0 110.808 -179.825 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -95.56 96.46 9.07 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.212 179.831 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 31.3 p -50.71 121.62 6.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.562 -179.859 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -80.83 -26.83 36.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.099 179.721 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 23.8 pt-20 -118.32 144.88 35.95 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.18 179.883 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -67.07 -18.52 51.57 Favored 'Trans proline' 0 C--N 1.343 0.246 0 C-N-CA 122.765 2.31 . . . . 0.0 112.19 179.999 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.423 ' HA ' HD13 ' A' ' 60' ' ' LEU . 0.9 OUTLIER -71.94 118.21 14.51 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.426 179.975 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -101.19 54.14 0.84 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.242 179.86 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -73.15 -143.2 0.58 Allowed Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.715 -0.954 . . . . 0.0 110.715 -179.949 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.411 ' HB3' ' HA ' ' A' ' 80' ' ' ASP . 49.1 Cg_endo -77.27 106.16 2.18 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.614 2.209 . . . . 0.0 112.145 -179.856 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.501 ' HB3' HD21 ' A' ' 33' ' ' LEU . 16.4 m-85 -77.96 98.32 5.64 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.66 179.961 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.43 ' OD1' ' N ' ' A' ' 65' ' ' ASN . 0.4 OUTLIER -71.32 123.45 22.31 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 179.469 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.592 ' CZ ' HG11 ' A' ' 19' ' ' VAL . 2.7 m-85 -101.05 176.66 5.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.598 -179.55 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.858 ' HD2' HG22 ' A' ' 77' ' ' VAL . 1.7 mtp180 176.51 102.1 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.456 179.916 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.773 ' O ' HD23 ' A' ' 69' ' ' LEU . 0.8 OUTLIER -111.29 172.85 6.64 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.427 179.815 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.816 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 2.4 mt -128.88 65.98 1.43 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.376 179.684 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 29.0 p -31.5 143.87 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.246 0.619 . . . . 0.0 112.108 -179.302 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.719 ' HG3' HG22 ' A' ' 27' ' ' THR . 0.4 OUTLIER -68.29 -31.23 70.53 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.254 -179.716 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.5 tmtm? -141.03 56.24 1.56 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.47 179.994 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -145.48 -105.66 0.47 Allowed Glycine 0 CA--C 1.523 0.559 0 N-CA-C 110.622 -0.991 . . . . 0.0 110.622 179.9 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 10.6 ptm -178.47 -179.45 0.68 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.787 0.327 . . . . 0.0 110.205 -179.986 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.745 ' HD2' HD22 ' A' ' 69' ' ' LEU . 14.1 mmtm -90.82 158.19 16.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.14 179.871 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -175.25 135.71 0.35 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.801 -179.944 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.858 HG22 ' HD2' ' A' ' 67' ' ' ARG . 94.6 t -94.2 150.25 4.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.233 -0.44 . . . . 0.0 109.963 179.476 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.575 ' CZ ' HG11 ' A' ' 4' ' ' VAL . 71.2 m-85 -131.5 145.73 51.9 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.97 -179.203 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -139.62 162.19 35.7 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.006 179.76 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.411 ' HA ' ' HB3' ' A' ' 63' ' ' PRO . 0.1 OUTLIER 51.97 33.04 10.98 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.113 0.483 . . . . 0.0 109.839 -179.722 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.542 ' O ' HG12 ' A' ' 81' ' ' VAL . 87.6 t -78.41 -3.01 5.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.586 -179.406 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.445 HG23 ' O ' ' A' ' 81' ' ' VAL . 72.4 t -158.15 119.45 1.95 Allowed Pre-proline 0 CA--C 1.53 0.21 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 179.855 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.416 ' HD3' ' CG ' ' A' ' 92' ' ' TYR . 50.9 Cg_endo -75.66 169.64 21.88 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.458 2.105 . . . . 0.0 111.786 179.729 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -66.26 120.02 12.53 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 179.633 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 2.5 mtpt 67.24 58.85 0.54 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.224 -0.443 . . . . 0.0 109.997 -179.609 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 21.4 p90 -52.96 -175.16 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.741 -179.729 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 1.5 m -152.26 108.12 3.36 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.967 179.836 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.504 HG23 ' O ' ' A' ' 8' ' ' VAL . 3.3 mp -46.45 121.82 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.68 -179.86 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 113.73 29.59 2.83 Favored Glycine 0 CA--C 1.523 0.582 0 N-CA-C 110.736 -0.945 . . . . 0.0 110.736 -179.875 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.618 ' O ' HG23 ' A' ' 7' ' ' THR . . . -142.32 167.29 22.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.736 0.303 . . . . 0.0 110.443 -179.944 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 32.8 m -113.44 120.8 42.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.522 -179.968 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.471 ' O ' ' HB2' ' A' ' 93' ' ' ALA . 40.8 m-85 -125.62 123.55 39.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.394 179.954 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.919 ' HB1' ' HD2' ' A' ' 94' ' ' PRO . . . 174.56 178.45 0.17 Allowed Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.457 -179.981 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.919 ' HD2' ' HB1' ' A' ' 93' ' ' ALA . 49.8 Cg_endo . . . . . 0 C--O 1.25 1.083 0 C-N-CA 122.547 2.165 . . . . 0.0 112.112 -179.884 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 33.4 mmtm . . . . . 0 N--CA 1.457 -0.117 0 CA-C-O 120.725 0.298 . . . . 0.0 111.07 . . . . . . . . . 0 0 . 1 . 033 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.524 ' CG1' ' CE1' ' A' ' 78' ' ' PHE . 2.1 p -106.26 163.42 4.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.336 0.588 . . . . 0.0 110.365 -179.968 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.486 ' N ' HG22 ' A' ' 4' ' ' VAL . 65.9 p -144.2 129.51 18.81 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.294 179.718 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.775 ' O ' HG23 ' A' ' 91' ' ' THR . 35.0 m-85 -89.29 -176.75 5.19 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.307 179.904 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -166.15 118.57 1.06 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.152 179.934 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.1 t -68.18 93.43 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.356 -179.899 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.605 ' O ' HG23 ' A' ' 88' ' ' ILE . 1.8 mm-40 -54.11 -178.45 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.303 -179.961 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.26 48.74 1.6 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.455 -179.839 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -112.3 -25.78 4.56 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 110.842 -0.903 . . . . 0.0 110.842 -179.992 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.1 m -50.82 120.97 5.28 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.826 0.346 . . . . 0.0 110.418 -179.982 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -114.13 -81.17 0.6 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.424 -179.912 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -106.78 -82.67 0.54 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.735 0.302 . . . . 0.0 110.41 -179.904 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.36 28.39 8.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.326 -179.995 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 8.9 m80 -104.08 167.39 9.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.325 -179.959 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.451 HD12 ' HA ' ' A' ' 17' ' ' LEU . 17.2 tp -154.13 88.79 1.25 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.452 -179.853 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.572 ' HB2' ' CG2' ' A' ' 53' ' ' THR . . . -81.37 109.62 16.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.454 -179.902 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.571 HG23 HG23 ' A' ' 21' ' ' VAL . 21.5 m -103.54 141.23 19.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.449 179.941 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -90.41 83.23 5.89 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.611 -179.99 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.571 HG23 HG23 ' A' ' 19' ' ' VAL . 16.2 t -79.32 90.61 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.348 179.866 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 176.08 157.29 0.24 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.982 -0.553 . . . . 0.0 109.95 -179.974 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.543 ' CE2' ' HB2' ' A' ' 26' ' ' ASP . 0.0 OUTLIER -113.89 -66.52 1.08 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.541 -179.751 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -153.45 -65.21 0.15 Allowed 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 111.808 0.299 . . . . 0.0 111.808 -179.395 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -106.36 -28.14 5.29 Favored Glycine 0 CA--C 1.525 0.702 0 C-N-CA 121.364 -0.446 . . . . 0.0 112.563 -178.372 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.543 ' HB2' ' CE2' ' A' ' 23' ' ' TYR . 16.8 t0 -42.29 152.02 0.1 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 117.277 0.539 . . . . 0.0 111.417 -179.363 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.402 HG22 ' H ' ' A' ' 28' ' ' MET . 0.2 OUTLIER -100.63 -174.67 2.7 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.731 -179.462 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.423 ' O ' ' CG ' ' A' ' 71' ' ' GLU . 34.7 mtm -123.17 126.07 46.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.336 -179.883 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.673 ' HB3' ' O ' ' A' ' 69' ' ' LEU . . . -118.97 -60.35 1.76 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.513 -179.706 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.7 ' HB3' HD12 ' A' ' 69' ' ' LEU . 0.6 OUTLIER -154.39 156.26 36.52 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.106 -179.937 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.474 ' HA ' ' HA ' ' A' ' 68' ' ' PHE . 0.7 OUTLIER -173.95 141.33 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.377 0.608 . . . . 0.0 110.271 -179.87 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.442 ' HG3' ' HB3' ' A' ' 41' ' ' TRP . 1.7 pm0 -141.18 169.48 17.53 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.059 -179.444 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.87 HD21 ' CE1' ' A' ' 66' ' ' PHE . 1.0 OUTLIER -117.3 174.34 6.19 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.157 0.503 . . . . 0.0 111.096 -179.479 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.43 ' NE ' ' HA ' ' A' ' 34' ' ' ARG . 0.5 OUTLIER -161.75 -176.69 5.41 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.486 179.562 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -129.92 -70.76 0.63 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.797 0.332 . . . . 0.0 110.424 179.928 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 58.2 t-80 -178.53 -50.02 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.344 179.972 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -121.02 25.69 7.02 Favored Glycine 0 CA--C 1.523 0.545 0 N-CA-C 110.733 -0.947 . . . . 0.0 110.733 179.87 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 2.7 m -70.97 -22.43 62.2 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.652 0.263 . . . . 0.0 110.593 179.931 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.4 t0 71.96 97.21 0.07 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.799 0.333 . . . . 0.0 110.326 -179.802 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 76.82 146.44 0.09 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.398 -179.961 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.513 ' CE3' ' HG2' ' A' ' 67' ' ' ARG . 35.5 m95 -79.83 160.95 25.91 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.54 -179.826 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.481 HG23 ' O ' ' A' ' 42' ' ' VAL . 32.1 m -132.16 122.18 47.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.179 179.832 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.428 ' HA ' ' HB3' ' A' ' 32' ' ' GLU . . . -46.51 130.44 11.1 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.8 -179.911 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.693 ' CE ' HD12 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -58.79 -167.51 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.22 -179.901 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 53.2 m -137.01 126.34 24.86 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.434 -179.946 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.66 67.16 6.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.231 -0.44 . . . . 0.0 109.987 179.726 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -96.86 -35.98 5.17 Favored Glycine 0 CA--C 1.522 0.503 0 N-CA-C 110.738 -0.945 . . . . 0.0 110.738 -179.772 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.449 ' HG2' ' CG2' ' A' ' 51' ' ' VAL . 31.8 tp10 -80.18 133.91 36.09 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.804 0.335 . . . . 0.0 110.369 179.915 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -79.36 88.39 1.21 Allowed Glycine 0 CA--C 1.523 0.587 0 N-CA-C 111.021 -0.831 . . . . 0.0 111.021 -179.794 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 129.81 -23.4 4.73 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 111.167 -0.773 . . . . 0.0 111.167 179.721 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.511 HG11 ' HG3' ' A' ' 9' ' ' GLU . 16.7 m -146.8 -175.56 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.933 0.397 . . . . 0.0 110.684 -179.756 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 8.4 m95 -103.22 144.61 31.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.462 -179.547 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.572 ' CG2' ' HB2' ' A' ' 18' ' ' ALA . 0.1 OUTLIER -132.57 145.15 50.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.546 -179.759 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -120.62 136.69 54.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.125 179.725 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 11.4 t0 -113.67 156.34 23.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.939 0.4 . . . . 0.0 110.765 -179.706 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -175.39 172.96 2.59 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.326 179.947 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -154.85 30.79 0.41 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.385 -179.97 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -75.64 157.36 84.25 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.473 -179.96 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -71.3 -34.52 9.73 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.67 2.247 . . . . 0.0 112.035 179.881 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 5.4 mt -81.37 167.3 19.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.356 -179.928 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 28.2 tt0 -172.53 111.39 0.25 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.476 -179.98 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -135.35 -143.26 4.71 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.597 -1.001 . . . . 0.0 110.597 179.975 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -77.32 171.84 17.02 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.546 2.164 . . . . 0.0 111.892 179.882 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -124.18 172.45 9.04 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.92 0.39 . . . . 0.0 110.511 -179.948 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.505 ' O ' HD23 ' A' ' 33' ' ' LEU . 5.3 m-80 -146.36 144.72 29.95 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.176 -179.982 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.87 ' CE1' HD21 ' A' ' 33' ' ' LEU . 39.3 m-85 -127.03 -177.12 3.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.019 0.437 . . . . 0.0 110.483 179.978 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.575 ' HB3' HG12 ' A' ' 77' ' ' VAL . 0.0 OUTLIER 176.78 72.66 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.799 179.76 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.831 ' O ' HD23 ' A' ' 69' ' ' LEU . 0.0 OUTLIER -71.01 -178.96 2.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.409 0.624 . . . . 0.0 111.626 -179.259 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.831 HD23 ' O ' ' A' ' 68' ' ' PHE . 9.1 mt -144.77 49.07 1.31 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.032 -0.985 . . . . 0.0 109.254 179.874 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.456 HG21 ' OD2' ' A' ' 26' ' ' ASP . 40.8 p -22.67 137.64 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.129 0.972 . . . . 0.0 112.891 -179.147 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.653 ' HG2' ' HB2' ' A' ' 29' ' ' ALA . 3.2 mm-40 -54.2 -25.27 21.97 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.533 -179.806 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.51 48.89 0.14 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.862 0.363 . . . . 0.0 110.547 -179.907 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.412 ' CA ' ' OG1' ' A' ' 70' ' ' THR . . . -128.34 -107.2 1.35 Allowed Glycine 0 CA--C 1.523 0.592 0 N-CA-C 110.707 -0.957 . . . . 0.0 110.707 179.915 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.409 ' N ' ' OG1' ' A' ' 70' ' ' THR . 66.0 mmm -139.13 171.28 14.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.832 0.349 . . . . 0.0 110.305 179.965 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.439 ' O ' ' CD ' ' A' ' 75' ' ' LYS . 0.0 OUTLIER -138.12 86.56 2.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.306 179.859 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -141.1 140.23 34.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.251 -179.971 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.575 HG12 ' HB3' ' A' ' 67' ' ' ARG . 17.9 m -66.61 -179.73 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.333 -179.958 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.524 ' CE1' ' CG1' ' A' ' 4' ' ' VAL . 66.1 m-85 -149.38 135.54 19.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.631 -179.831 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -119.21 158.99 24.89 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.395 -179.976 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 52.5 49.65 19.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.405 179.91 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.571 ' O ' HG12 ' A' ' 81' ' ' VAL . 80.9 t -90.89 -0.65 9.44 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.039 179.836 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.626 HG13 ' HB3' ' A' ' 86' ' ' TYR . 94.8 t -157.49 130.2 4.35 Favored Pre-proline 0 CA--C 1.527 0.093 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 179.667 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.501 ' HD3' ' CD1' ' A' ' 92' ' ' TYR . 49.7 Cg_endo -71.0 -167.09 0.25 Allowed 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.577 2.184 . . . . 0.0 112.06 179.767 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -68.78 -34.25 75.24 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.933 179.472 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -137.96 91.19 2.55 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.952 179.683 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 0.626 ' HB3' HG13 ' A' ' 82' ' ' VAL . 14.9 p90 -67.62 165.76 16.39 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.794 -179.65 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -141.34 115.24 9.15 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.064 179.844 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.605 HG23 ' O ' ' A' ' 9' ' ' GLU . 3.4 mp -46.58 131.08 3.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.762 -179.836 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 89.87 39.29 6.21 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 110.685 -0.966 . . . . 0.0 110.685 -179.905 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -146.81 155.93 42.73 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.865 0.364 . . . . 0.0 110.53 -179.918 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.775 HG23 ' O ' ' A' ' 6' ' ' PHE . 0.2 OUTLIER -106.42 142.22 36.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.258 179.954 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.501 ' CD1' ' HD3' ' A' ' 83' ' ' PRO . 73.3 m-85 -134.1 -86.48 0.41 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.762 -179.914 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.902 ' HB1' ' HD2' ' A' ' 94' ' ' PRO . . . 50.12 -179.05 0.01 OUTLIER Pre-proline 0 C--N 1.332 -0.154 0 CA-C-O 120.63 0.252 . . . . 0.0 110.547 179.923 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.902 ' HD2' ' HB1' ' A' ' 93' ' ' ALA . 47.9 Cg_endo . . . . . 0 C--O 1.249 1.054 0 C-N-CA 122.539 2.16 . . . . 0.0 112.064 -179.978 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.522 -0.131 0 CA-C-O 120.899 0.381 . . . . 0.0 110.361 . . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.779 HG21 ' CZ ' ' A' ' 78' ' ' PHE . 27.0 m -88.45 -176.03 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.087 179.85 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.587 HG23 ' O ' ' A' ' 4' ' ' VAL . 0.5 OUTLIER -167.04 146.92 5.44 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.364 179.971 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.491 ' H ' ' HB3' ' A' ' 93' ' ' ALA . 37.9 m-85 -118.78 158.13 26.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.22 179.905 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 53.2 m -150.73 104.71 3.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.35 -179.863 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.756 HG12 HD13 ' A' ' 88' ' ' ILE . 14.2 t -54.33 94.83 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.416 -179.905 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.83 ' HG3' HG11 ' A' ' 51' ' ' VAL . 4.7 mm-40 -69.33 162.89 26.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.286 -179.99 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.67 171.01 3.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.479 -179.967 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 86.67 19.59 56.06 Favored Glycine 0 CA--C 1.527 0.795 0 N-CA-C 111.103 -0.799 . . . . 0.0 111.103 -179.955 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.803 ' HB2' HD11 ' A' ' 88' ' ' ILE . 8.7 m -109.6 -159.76 0.69 Allowed 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 -179.936 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.409 ' HB2' ' O ' ' A' ' 12' ' ' SER . 10.2 m-80 66.79 -62.39 0.3 Allowed 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.153 179.556 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.402 ' N ' ' O ' ' A' ' 12' ' ' SER . 2.3 tt0 -43.44 -69.73 0.13 Allowed 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.76 0.314 . . . . 0.0 111.02 -179.555 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.432 ' HA ' ' CE ' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -156.29 25.9 0.35 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.388 179.965 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 55.2 m80 -149.77 165.46 32.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.081 0.467 . . . . 0.0 110.787 -179.572 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.479 HD22 ' HA ' ' A' ' 17' ' ' LEU . 0.4 OUTLIER -138.56 85.27 2.07 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.285 179.236 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.624 ' HB2' HG23 ' A' ' 53' ' ' THR . . . -78.2 153.42 31.99 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.985 -179.134 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.43 HG23 HG23 ' A' ' 21' ' ' VAL . 29.4 m -150.14 141.94 17.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.868 -0.606 . . . . 0.0 109.697 179.424 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -93.21 101.29 13.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.838 0.352 . . . . 0.0 110.621 -179.837 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.43 HG23 HG23 ' A' ' 19' ' ' VAL . 6.7 t -112.35 99.65 9.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.138 179.761 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.474 ' O ' ' CG ' ' A' ' 23' ' ' TYR . 24.7 mtpp -140.55 -72.88 0.35 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.671 -179.876 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.479 ' O ' ' CD2' ' A' ' 23' ' ' TYR . 29.7 p90 45.28 98.2 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.884 -179.667 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -46.82 116.1 1.24 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.835 -179.965 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 162.64 -42.32 0.35 Allowed Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.746 -0.942 . . . . 0.0 110.746 179.955 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -123.53 178.92 4.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.777 0.323 . . . . 0.0 110.378 -179.994 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.465 ' CB ' ' HB2' ' A' ' 71' ' ' GLU . 0.2 OUTLIER -103.85 -171.61 1.96 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.3 179.987 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.408 ' O ' ' HG3' ' A' ' 71' ' ' GLU . 6.1 mtt -117.4 118.83 33.28 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.819 -179.751 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.753 ' HB2' ' HA ' ' A' ' 71' ' ' GLU . . . -113.62 -62.33 1.61 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.109 179.57 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -165.0 165.1 20.39 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.767 -179.986 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.666 HG21 ' CD1' ' A' ' 52' ' ' TRP . 5.2 t -148.27 166.68 4.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.313 -179.896 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.482 ' N ' HG12 ' A' ' 31' ' ' VAL . 2.7 pt-20 -174.72 151.03 1.38 Allowed 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.416 -179.788 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.775 HD12 ' N ' ' A' ' 34' ' ' ARG . 3.0 pp -115.95 177.39 4.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.446 179.957 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.775 ' N ' HD12 ' A' ' 33' ' ' LEU . 2.7 ttm180 -120.2 -40.56 2.69 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.296 179.862 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.444 ' CB ' ' O ' ' A' ' 34' ' ' ARG . 3.8 tt0 87.43 32.97 0.02 OUTLIER 'General case' 0 CA--C 1.515 -0.384 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 -179.102 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 0.428 ' CE1' ' OE1' ' A' ' 61' ' ' GLN . 41.8 t-80 63.71 -74.03 0.04 OUTLIER 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 114.882 -1.054 . . . . 0.0 110.596 -180.0 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.421 ' N ' ' O ' ' A' ' 35' ' ' GLU . . . -136.49 103.69 0.45 Allowed Glycine 0 CA--C 1.523 0.534 0 N-CA-C 110.766 -0.934 . . . . 0.0 110.766 -179.987 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -139.87 -54.07 0.54 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.826 0.346 . . . . 0.0 110.252 179.907 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.7 p30 179.91 -45.66 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.321 -179.978 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -178.61 171.54 1.51 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.195 -179.964 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.508 ' CZ3' ' HG2' ' A' ' 67' ' ' ARG . 96.7 m95 -55.01 125.3 19.82 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.338 -179.993 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.466 HG23 ' HG ' ' A' ' 33' ' ' LEU . 4.4 m -106.91 116.93 51.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.128 179.861 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -48.83 126.03 11.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.505 -179.91 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.424 ' HE2' ' CE1' ' A' ' 66' ' ' PHE . 0.0 OUTLIER -55.79 -169.85 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.254 -179.929 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 33.8 m -141.13 95.69 2.88 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.425 -179.952 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.26 81.9 1.84 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.217 179.811 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -117.32 -17.85 5.58 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 111.404 -0.678 . . . . 0.0 111.404 -179.744 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.404 ' HB2' ' O ' ' A' ' 51' ' ' VAL . 0.1 OUTLIER -69.78 -32.65 71.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.774 0.321 . . . . 0.0 110.631 -179.766 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 97.4 -35.38 4.51 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 110.523 -1.031 . . . . 0.0 110.523 -179.839 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -113.86 -34.09 1.74 Allowed Glycine 0 CA--C 1.523 0.571 0 N-CA-C 110.458 -1.057 . . . . 0.0 110.458 179.912 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.83 HG11 ' HG3' ' A' ' 9' ' ' GLU . 23.9 m -123.78 172.75 10.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.808 0.337 . . . . 0.0 110.127 179.815 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . 0.666 ' CD1' HG21 ' A' ' 31' ' ' VAL . 8.8 m95 -105.06 133.8 49.24 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.529 -179.718 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.624 HG23 ' HB2' ' A' ' 18' ' ' ALA . 0.0 OUTLIER -119.79 -179.02 3.77 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.311 179.875 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.423 ' CD2' HD21 ' A' ' 33' ' ' LEU . 66.8 t80 -175.37 130.85 0.28 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.347 179.95 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 43.8 m-20 -68.91 117.29 10.39 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.359 -179.98 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 9.1 p -119.2 120.04 35.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.368 -179.994 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -100.93 -26.3 13.79 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.48 -179.921 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.402 ' O ' ' CG ' ' A' ' 58' ' ' GLU . 1.1 pt-20 -115.52 112.61 43.29 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.488 -179.872 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -70.7 -21.11 29.55 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.479 2.119 . . . . 0.0 111.891 179.655 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 44.73 -154.71 0.03 OUTLIER 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.854 179.584 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.428 ' OE1' ' CE1' ' A' ' 36' ' ' HIS . 0.0 OUTLIER -45.15 -31.9 1.61 Allowed 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.708 -0.224 . . . . 0.0 111.23 -179.644 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.499 ' N ' ' HD2' ' A' ' 63' ' ' PRO . . . 124.29 -41.98 1.64 Allowed Glycine 0 CA--C 1.531 1.058 0 C-N-CA 121.116 -0.564 . . . . 0.0 112.395 179.894 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.499 ' HD2' ' N ' ' A' ' 62' ' ' GLY . 45.2 Cg_endo -74.64 152.98 43.35 Favored 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 122.052 1.835 . . . . 0.0 112.811 -179.137 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.438 ' HD2' HG21 ' A' ' 82' ' ' VAL . 78.0 m-85 -126.77 101.61 6.68 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.318 179.832 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 20.7 m-20 -65.53 140.34 58.56 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 179.538 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.489 ' CE1' ' HB3' ' A' ' 33' ' ' LEU . 16.5 m-85 -128.96 176.58 7.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.235 0.54 . . . . 0.0 111.246 -179.34 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.508 ' HG2' ' CZ3' ' A' ' 41' ' ' TRP . 0.0 OUTLIER 176.91 89.17 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.447 179.878 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.676 ' CZ ' HG11 ' A' ' 4' ' ' VAL . 1.4 p90 -72.06 176.28 5.23 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.179 0.514 . . . . 0.0 110.874 -179.144 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.68 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 2.3 mt -130.12 61.12 1.59 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.031 179.715 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.407 ' OG1' ' N ' ' A' ' 74' ' ' MET . 0.6 OUTLIER -23.69 137.62 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.871 0.868 . . . . 0.0 113.011 -178.821 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.753 ' HA ' ' HB2' ' A' ' 29' ' ' ALA . 0.0 OUTLIER -48.41 -45.02 35.55 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.094 -179.533 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -145.37 38.32 1.15 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.279 179.973 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -114.57 -109.87 2.82 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.889 -0.884 . . . . 0.0 110.889 -179.952 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.407 ' N ' ' OG1' ' A' ' 70' ' ' THR . 20.8 mmt -154.41 -179.67 8.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.745 0.307 . . . . 0.0 110.183 179.909 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.439 ' HD3' ' N ' ' A' ' 75' ' ' LYS . 0.1 OUTLIER -115.85 100.74 8.21 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.996 0.427 . . . . 0.0 110.443 -179.888 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 49.0 t30 -115.9 152.86 32.61 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.241 179.895 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.517 HG12 ' N ' ' A' ' 78' ' ' PHE . 77.7 t -100.29 160.79 3.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.324 179.843 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.779 ' CZ ' HG21 ' A' ' 4' ' ' VAL . 64.9 m-85 -141.13 109.28 5.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.287 -179.907 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -95.77 159.66 14.87 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.496 -179.869 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 54.72 32.84 18.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.551 179.902 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.623 HG13 ' HB2' ' A' ' 93' ' ' ALA . 66.3 t -66.23 -54.68 24.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.286 179.901 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.626 HG13 ' HD2' ' A' ' 83' ' ' PRO . 76.2 t -101.1 142.45 24.64 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.02 179.95 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.626 ' HD2' HG13 ' A' ' 82' ' ' VAL . 43.5 Cg_endo -68.11 177.83 4.09 Favored 'Trans proline' 0 N--CA 1.475 0.42 0 C-N-CA 122.622 2.214 . . . . 0.0 112.287 179.915 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -59.31 -33.97 71.74 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.233 179.904 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.02 85.27 2.18 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.175 179.9 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 0.476 ' HB3' ' CG1' ' A' ' 82' ' ' VAL . 26.5 p90 -50.51 145.04 6.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.682 -179.751 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 4.2 m -136.08 111.45 9.14 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.304 179.841 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.803 HD11 ' HB2' ' A' ' 12' ' ' SER . 38.1 mm -50.49 110.19 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.49 -179.874 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 122.89 47.24 0.27 Allowed Glycine 0 CA--C 1.523 0.553 0 N-CA-C 110.819 -0.912 . . . . 0.0 110.819 179.918 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -160.0 159.02 31.61 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.774 0.321 . . . . 0.0 110.44 179.928 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 90.1 m -118.69 91.81 3.65 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.497 179.949 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.553 ' O ' ' HB3' ' A' ' 93' ' ' ALA . 32.9 m-85 -86.06 -156.71 0.3 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.154 179.847 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.877 ' HB1' ' HD2' ' A' ' 94' ' ' PRO . . . 76.19 173.6 0.09 OUTLIER Pre-proline 0 N--CA 1.463 0.179 0 CA-C-O 120.7 0.286 . . . . 0.0 110.307 -179.805 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.877 ' HD2' ' HB1' ' A' ' 93' ' ' ALA . 46.1 Cg_endo . . . . . 0 C--O 1.249 1.05 0 C-N-CA 122.582 2.188 . . . . 0.0 112.092 -179.908 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.535 ' O ' HG22 ' A' ' 4' ' ' VAL . 81.7 mttt . . . . . 0 CA--C 1.52 -0.2 0 CA-C-O 120.701 0.286 . . . . 0.0 110.346 . . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.731 ' O ' HG23 ' A' ' 5' ' ' THR . 23.0 m 44.59 -172.22 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.042 -179.804 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.731 HG23 ' O ' ' A' ' 4' ' ' VAL . 0.5 OUTLIER -174.02 136.8 0.53 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.521 -179.72 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.75 ' O ' HG23 ' A' ' 91' ' ' THR . 14.2 m-85 -105.17 172.13 6.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.01 179.857 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.406 ' HG1' HG23 ' A' ' 91' ' ' THR . 19.7 m -165.69 113.35 0.95 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.84 0.352 . . . . 0.0 110.447 -179.974 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 94.9 t -58.0 87.97 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.396 179.971 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.542 ' HG3' HG21 ' A' ' 51' ' ' VAL . 2.5 mm-40 -59.44 167.12 2.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.344 179.982 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.06 165.14 5.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.363 179.954 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 79.99 35.0 28.77 Favored Glycine 0 CA--C 1.523 0.582 0 N-CA-C 110.834 -0.906 . . . . 0.0 110.834 179.99 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 74.4 m -96.1 114.95 26.7 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.78 0.324 . . . . 0.0 110.369 -179.948 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -97.46 -168.85 1.75 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.213 179.998 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 67.8 mm-40 -69.24 -27.15 65.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.315 179.861 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.42 ' HG2' ' N ' ' A' ' 16' ' ' HIS . 0.0 OUTLIER -114.55 -30.65 6.46 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.641 -179.857 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . 0.42 ' N ' ' HG2' ' A' ' 15' ' ' LYS . 2.0 m80 -70.59 151.28 45.17 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.851 0.357 . . . . 0.0 110.378 -179.902 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.507 HD22 ' HA ' ' A' ' 17' ' ' LEU . 0.3 OUTLIER -151.29 91.58 1.7 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.498 -179.965 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.626 ' HB1' HG11 ' A' ' 51' ' ' VAL . . . -89.31 136.19 33.16 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.868 179.675 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.746 ' O ' HG13 ' A' ' 51' ' ' VAL . 27.4 m -137.86 135.02 45.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.999 0.428 . . . . 0.0 110.847 -179.793 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -88.57 81.12 7.18 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.454 179.949 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.433 HG23 HG23 ' A' ' 19' ' ' VAL . 42.9 t -77.92 107.91 10.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.408 179.97 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -170.43 150.51 3.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.289 -179.986 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.485 ' CE1' HG12 ' A' ' 4' ' ' VAL . 8.4 p90 -166.78 31.4 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.493 -179.938 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 50.84 -167.78 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.513 179.959 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 63.45 -79.97 0.04 OUTLIER Glycine 0 CA--C 1.523 0.536 0 N-CA-C 110.796 -0.921 . . . . 0.0 110.796 179.88 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -71.63 179.54 3.02 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.678 0.275 . . . . 0.0 110.325 179.956 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -121.2 -174.1 2.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.389 -179.886 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.427 ' O ' ' CG ' ' A' ' 71' ' ' GLU . 22.6 mtm -114.99 122.35 45.97 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.677 -179.651 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.746 ' HB3' ' O ' ' A' ' 69' ' ' LEU . . . -120.02 -60.48 1.7 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.338 179.765 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.42 ' HB3' HD12 ' A' ' 69' ' ' LEU . 2.7 mt-10 -161.37 147.59 14.31 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.36 179.995 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.648 HG21 ' CD1' ' A' ' 52' ' ' TRP . 3.1 t -133.97 159.33 42.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.941 0.401 . . . . 0.0 110.596 179.987 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.424 ' OE2' ' N ' ' A' ' 32' ' ' GLU . 0.5 OUTLIER -150.04 147.79 28.24 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.148 -179.944 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.627 HD12 ' H ' ' A' ' 34' ' ' ARG . 12.0 tp -116.65 156.07 27.71 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 -179.603 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.627 ' H ' HD12 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -139.98 178.81 7.0 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.087 179.609 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -122.16 -79.91 0.62 Allowed 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 179.719 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -179.34 -38.42 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.349 179.487 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -130.28 22.87 4.67 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.884 -0.887 . . . . 0.0 110.884 179.937 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 8.2 t -77.34 -166.13 0.69 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.872 0.368 . . . . 0.0 110.304 179.959 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -87.2 52.99 2.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.143 179.868 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 69.71 178.61 0.25 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.251 -179.858 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.49 ' CZ3' ' HG2' ' A' ' 67' ' ' ARG . 97.2 m95 -50.47 139.08 16.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.629 -179.994 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.434 ' CG2' ' O ' ' A' ' 33' ' ' LEU . 4.6 m -125.89 111.33 26.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 109.743 -0.465 . . . . 0.0 109.743 179.531 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.41 ' HA ' ' HB3' ' A' ' 32' ' ' GLU . . . -44.45 138.15 3.35 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.116 -179.376 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -67.66 -171.73 0.22 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.89 -179.942 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.402 ' O ' ' N ' ' A' ' 47' ' ' GLY . 51.7 m -150.92 106.31 3.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.228 179.846 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 7.3 ptmt -62.77 80.99 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.495 -179.925 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.402 ' N ' ' O ' ' A' ' 45' ' ' THR . . . -98.74 -24.31 10.97 Favored Glycine 0 CA--C 1.523 0.555 0 N-CA-C 110.647 -0.981 . . . . 0.0 110.647 179.846 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.476 ' CB ' ' HB ' ' A' ' 51' ' ' VAL . 2.2 mm-40 -78.18 1.09 22.5 Favored 'General case' 0 CA--C 1.532 0.269 0 O-C-N 122.85 -0.206 . . . . 0.0 111.502 -179.891 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 67.93 17.29 69.41 Favored Glycine 0 CA--C 1.527 0.794 0 N-CA-C 111.13 -0.788 . . . . 0.0 111.13 -179.963 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 178.24 -38.57 0.08 OUTLIER Glycine 0 C--N 1.33 0.229 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 179.93 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.746 HG13 ' O ' ' A' ' 19' ' ' VAL . 22.2 t -101.24 150.3 5.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 179.227 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . 0.648 ' CD1' HG21 ' A' ' 31' ' ' VAL . 3.3 m95 -91.75 111.7 23.32 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.477 -179.543 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.552 HG22 ' HB2' ' A' ' 18' ' ' ALA . 15.0 p -107.73 150.13 27.33 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.494 -179.736 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 34.6 t80 -136.7 115.12 11.82 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.451 -179.996 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -66.8 162.27 21.88 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.289 179.974 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 6.3 t 65.09 127.04 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.705 179.849 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.424 ' O ' ' O ' ' A' ' 58' ' ' GLU . 5.7 tt0 -117.95 -15.93 9.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.955 179.885 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.424 ' O ' ' O ' ' A' ' 57' ' ' GLU . 2.2 pt-20 48.97 170.43 0.03 OUTLIER Pre-proline 0 N--CA 1.467 0.381 0 C-N-CA 123.213 0.605 . . . . 0.0 111.548 -179.94 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.41 ' CD ' ' HB2' ' A' ' 58' ' ' GLU . 38.3 Cg_endo -96.97 10.41 1.25 Allowed 'Trans proline' 0 N--CA 1.453 -0.877 0 C-N-CA 124.036 3.157 . . . . 0.0 112.961 -178.998 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.9 100.47 0.07 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.841 0.353 . . . . 0.0 110.512 -179.914 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -53.65 127.5 25.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.222 179.861 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 135.7 163.0 9.83 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.601 -0.999 . . . . 0.0 110.601 -179.806 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.439 ' CG ' ' HA ' ' A' ' 80' ' ' ASP . 49.9 Cg_endo -79.33 -171.95 1.39 Allowed 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.642 2.228 . . . . 0.0 112.091 -179.974 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 -97.16 171.64 8.32 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.85 0.357 . . . . 0.0 110.258 179.846 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -144.05 143.88 31.37 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.716 179.813 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 -131.28 177.75 7.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.201 0.524 . . . . 0.0 111.288 -179.466 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.49 ' HG2' ' CZ3' ' A' ' 41' ' ' TRP . 0.1 OUTLIER 175.7 67.28 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.265 -179.964 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -52.57 173.46 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.264 0.554 . . . . 0.0 111.143 -178.963 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.746 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 6.4 mt -128.68 55.91 1.68 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.126 179.595 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -26.73 137.87 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.736 0.815 . . . . 0.0 112.593 -178.915 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.578 ' N ' ' HB2' ' A' ' 29' ' ' ALA . 23.6 mt-10 -51.69 -51.75 53.58 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.25 -179.857 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 5.1 tptt -135.95 57.93 1.77 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.042 179.733 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -136.04 -96.64 0.49 Allowed Glycine 0 CA--C 1.523 0.592 0 N-CA-C 110.776 -0.93 . . . . 0.0 110.776 -179.823 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 1.9 ptt? 174.86 165.87 0.26 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.813 0.339 . . . . 0.0 110.515 -179.949 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.432 ' CD ' ' HA ' ' A' ' 69' ' ' LEU . 5.6 mmtp -94.13 137.9 32.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.005 -179.965 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 10.8 t30 -141.29 176.21 9.03 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.285 179.923 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 95.9 t -121.65 146.79 26.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.253 179.995 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -136.12 108.91 7.54 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.523 -179.904 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.402 ' O ' ' N ' ' A' ' 81' ' ' VAL . 54.4 m-20 -80.27 163.34 24.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.178 179.799 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.45 ' O ' ' HB ' ' A' ' 81' ' ' VAL . 1.1 m-20 58.94 -85.72 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.377 -179.813 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.887 HG12 HG23 ' A' ' 82' ' ' VAL . 55.6 t 68.55 -56.26 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 C-N-CA 123.432 0.693 . . . . 0.0 110.881 179.98 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.887 HG23 HG12 ' A' ' 81' ' ' VAL . 54.6 t -128.78 139.34 35.35 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.501 -179.894 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.516 ' HD2' HG13 ' A' ' 82' ' ' VAL . 46.2 Cg_endo -69.81 -170.32 0.39 Allowed 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.585 2.19 . . . . 0.0 112.066 179.699 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -87.07 -39.72 15.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.18 179.754 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -110.75 56.22 0.64 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.213 179.855 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 21.1 p90 -56.78 170.25 0.43 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.52 -179.838 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 26.6 m -151.35 121.16 7.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.149 179.907 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.429 ' H ' HD12 ' A' ' 88' ' ' ILE . 3.4 mp -50.58 111.29 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.388 -179.82 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 122.41 57.36 0.2 Allowed Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.655 -0.978 . . . . 0.0 110.655 -179.976 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.401 ' O ' HG23 ' A' ' 7' ' ' THR . . . -174.07 148.86 1.4 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.75 0.309 . . . . 0.0 110.378 -179.991 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.75 HG23 ' O ' ' A' ' 6' ' ' PHE . 50.9 m -106.97 93.88 4.8 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.6 -179.955 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.569 ' O ' ' HB3' ' A' ' 93' ' ' ALA . 44.0 m-85 -76.42 -155.67 0.06 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.145 -0.479 . . . . 0.0 109.761 179.549 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.89 ' HB1' ' HD2' ' A' ' 94' ' ' PRO . . . 75.65 172.95 0.09 OUTLIER Pre-proline 0 N--CA 1.464 0.227 0 CA-C-O 120.786 0.327 . . . . 0.0 110.811 179.773 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.89 ' HD2' ' HB1' ' A' ' 93' ' ' ALA . 46.9 Cg_endo . . . . . 0 C--O 1.25 1.08 0 C-N-CA 122.606 2.204 . . . . 0.0 111.965 179.884 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.456 -0.143 0 CA-C-O 120.887 0.375 . . . . 0.0 110.283 . . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.518 ' CG1' ' CE1' ' A' ' 78' ' ' PHE . 1.9 p -63.89 163.24 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.285 0.564 . . . . 0.0 110.469 -179.811 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.478 ' N ' HG22 ' A' ' 4' ' ' VAL . 80.9 p -137.48 136.11 37.43 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.067 179.871 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.62 ' O ' HG23 ' A' ' 91' ' ' THR . 17.7 m-85 -97.0 -175.42 3.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.418 -179.81 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.407 ' HB ' ' HB2' ' A' ' 20' ' ' LEU . 2.5 m -167.15 95.53 0.48 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.237 -179.833 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.462 HG12 ' CD1' ' A' ' 88' ' ' ILE . 39.1 t -51.07 97.19 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.563 -179.879 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.492 ' HG3' HG11 ' A' ' 51' ' ' VAL . 4.4 mt-10 -61.92 174.52 0.83 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.443 -179.92 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.8 tttt -67.66 163.37 21.59 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.408 -179.977 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 74.27 25.74 70.03 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 179.883 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.475 ' CB ' HD11 ' A' ' 88' ' ' ILE . 0.5 OUTLIER -99.05 121.81 41.46 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.835 0.35 . . . . 0.0 110.431 -179.993 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -177.45 -175.03 0.52 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.427 179.99 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.41 ' O ' ' CB ' ' A' ' 15' ' ' LYS . 3.9 mt-10 -47.59 119.07 2.53 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.175 0.512 . . . . 0.0 110.834 -179.848 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.418 ' O ' ' CG ' ' A' ' 16' ' ' HIS . 0.8 OUTLIER 79.95 24.54 0.4 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.774 179.726 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . 0.418 ' CG ' ' O ' ' A' ' 15' ' ' LYS . 3.2 m80 -174.04 111.75 0.17 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.829 0.347 . . . . 0.0 110.348 179.745 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.444 HD22 ' HA ' ' A' ' 17' ' ' LEU . 0.3 OUTLIER -128.93 101.19 5.97 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.489 -179.856 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -97.93 153.05 18.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.232 179.852 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.594 HG23 HG23 ' A' ' 21' ' ' VAL . 23.7 m -150.18 134.72 9.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.062 -179.7 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.581 HD22 ' CG ' ' A' ' 22' ' ' LYS . 0.5 OUTLIER -86.77 73.34 10.02 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.212 -0.449 . . . . 0.0 109.869 179.105 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.594 HG23 HG23 ' A' ' 19' ' ' VAL . 52.7 t -69.83 94.51 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.86 -179.468 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.581 ' CG ' HD22 ' A' ' 20' ' ' LEU . 0.0 OUTLIER 175.18 157.8 0.19 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.106 179.712 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.41 ' CE2' ' HB3' ' A' ' 26' ' ' ASP . 0.1 OUTLIER -127.08 -79.05 0.59 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.46 -179.981 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -99.49 -90.78 0.3 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.822 -179.814 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -139.68 32.83 2.19 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 111.132 -0.787 . . . . 0.0 111.132 -179.778 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.41 ' HB3' ' CE2' ' A' ' 23' ' ' TYR . 4.3 p30 -58.58 -171.11 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 179.727 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.454 ' HB ' ' CG ' ' A' ' 71' ' ' GLU . 0.9 OUTLIER -125.57 145.82 49.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.875 0.369 . . . . 0.0 110.37 179.987 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.411 ' O ' ' CG ' ' A' ' 71' ' ' GLU . 0.0 OUTLIER -98.7 129.39 45.16 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.662 -179.506 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.757 ' HB3' ' O ' ' A' ' 69' ' ' LEU . . . -120.47 -56.8 1.95 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.351 179.956 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -158.0 145.9 18.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.388 -179.982 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.888 HG21 ' CD1' ' A' ' 52' ' ' TRP . 2.4 t -135.68 140.38 44.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.141 179.995 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.463 ' CB ' ' HA ' ' A' ' 43' ' ' ALA . 4.4 pt-20 -139.14 141.39 38.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.858 0.361 . . . . 0.0 110.491 179.955 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.509 ' HG ' ' CE1' ' A' ' 66' ' ' PHE . 2.2 mt -113.0 174.61 5.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.94 -179.444 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.5 ' HB2' ' CZ3' ' A' ' 41' ' ' TRP . 1.5 ttp85 -149.61 -159.17 1.0 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.852 179.585 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -158.67 26.18 0.23 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.698 0.285 . . . . 0.0 110.759 179.887 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 49.4 25.88 1.45 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.726 179.752 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -129.73 -50.45 0.12 Allowed Glycine 0 CA--C 1.522 0.525 0 N-CA-C 110.706 -0.958 . . . . 0.0 110.706 -179.945 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -76.54 115.26 16.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.784 0.326 . . . . 0.0 110.425 -179.977 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -52.09 -25.83 9.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.361 -179.992 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.26 178.73 4.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.219 179.892 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.506 ' CH2' ' HG3' ' A' ' 67' ' ' ARG . 86.5 m95 -111.88 169.45 8.83 Favored 'General case' 0 CA--C 1.503 -0.862 0 CA-C-O 121.559 0.695 . . . . 0.0 110.876 -179.978 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.499 HG12 ' O ' ' A' ' 42' ' ' VAL . 1.0 OUTLIER -142.05 107.63 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.193 0 CA-C-N 114.63 -1.168 . . . . 0.0 109.769 -177.441 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.463 ' HA ' ' CB ' ' A' ' 32' ' ' GLU . . . -50.49 143.39 9.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.578 -179.445 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.463 ' HE2' ' CZ ' ' A' ' 66' ' ' PHE . 0.0 OUTLIER -63.14 -169.57 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.783 -179.765 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.405 ' O ' ' N ' ' A' ' 47' ' ' GLY . 46.0 m -135.35 110.18 8.72 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.03 179.811 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.77 66.45 0.09 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.566 -179.793 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.405 ' N ' ' O ' ' A' ' 45' ' ' THR . . . -83.35 -40.84 8.8 Favored Glycine 0 CA--C 1.522 0.522 0 N-CA-C 110.351 -1.1 . . . . 0.0 110.351 179.798 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -90.02 144.97 25.44 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 179.74 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -83.83 8.16 67.23 Favored Glycine 0 CA--C 1.528 0.903 0 N-CA-C 111.597 -0.601 . . . . 0.0 111.597 -179.896 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -127.44 -40.0 0.35 Allowed Glycine 0 CA--C 1.524 0.641 0 N-CA-C 110.978 -0.849 . . . . 0.0 110.978 -179.952 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.538 HG12 ' HA ' ' A' ' 20' ' ' LEU . 6.9 m -133.67 -176.5 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 121.088 0.47 . . . . 0.0 110.79 -179.605 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . 0.888 ' CD1' HG21 ' A' ' 31' ' ' VAL . 11.1 m95 -109.61 131.39 55.11 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.75 179.543 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 3.0 p -115.98 171.79 7.56 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.863 0.363 . . . . 0.0 110.318 -179.664 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 60.4 t80 -159.63 118.5 2.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.333 179.971 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -70.94 129.14 38.25 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.303 179.956 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 90.8 p -96.25 126.54 41.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.416 -179.949 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -136.58 36.95 2.67 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.394 179.984 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -138.04 156.61 73.97 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.324 179.854 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -72.45 -26.77 16.62 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.671 2.247 . . . . 0.0 112.216 -179.949 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.4 mt -79.5 126.61 31.08 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.541 -179.761 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -156.58 -178.37 7.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.358 -179.845 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 119.73 -106.25 1.2 Allowed Glycine 0 CA--C 1.526 0.725 0 N-CA-C 110.856 -0.898 . . . . 0.0 110.856 179.891 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -77.46 125.08 7.42 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.455 2.103 . . . . 0.0 111.972 179.991 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.414 ' CE2' ' HG ' ' A' ' 17' ' ' LEU . 42.6 m-85 -101.27 147.05 26.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.587 -179.869 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.448 ' O ' HD23 ' A' ' 33' ' ' LEU . 1.9 m-80 -120.69 131.19 54.43 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.618 179.511 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.509 ' CE1' ' HG ' ' A' ' 33' ' ' LEU . 19.8 m-85 -114.71 163.1 15.94 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.963 0.411 . . . . 0.0 111.47 -179.236 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.658 ' HD2' HG22 ' A' ' 77' ' ' VAL . 48.3 mtp180 -162.07 62.62 0.23 Allowed 'General case' 0 CA--C 1.52 -0.184 0 CA-C-N 115.353 -0.839 . . . . 0.0 109.807 179.014 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.967 ' O ' HD23 ' A' ' 69' ' ' LEU . 0.0 OUTLIER -67.09 -179.15 0.9 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.143 0.497 . . . . 0.0 110.828 -179.455 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.967 HD23 ' O ' ' A' ' 68' ' ' PHE . 5.7 mt -136.68 55.07 1.85 Allowed 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 179.321 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 18.5 p -29.02 137.95 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.543 0.737 . . . . 0.0 112.135 -178.904 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.678 ' HG2' ' HB2' ' A' ' 29' ' ' ALA . 8.0 mt-10 -51.22 -68.62 0.15 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.663 -179.24 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -106.29 68.45 0.76 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.781 0.324 . . . . 0.0 110.31 179.902 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -158.28 -104.58 0.21 Allowed Glycine 0 CA--C 1.523 0.587 0 N-CA-C 110.952 -0.859 . . . . 0.0 110.952 -179.972 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 13.3 ptm 174.26 179.38 0.11 Allowed 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 -179.838 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.25 175.68 6.85 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.87 0.367 . . . . 0.0 110.352 179.877 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 173.96 170.16 0.2 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.43 179.907 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.658 HG22 ' HD2' ' A' ' 67' ' ' ARG . 72.5 t -117.61 157.78 18.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.504 -179.987 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.518 ' CE1' ' CG1' ' A' ' 4' ' ' VAL . 41.3 m-85 -144.99 129.93 18.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.384 -179.932 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -118.85 147.03 44.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.319 179.942 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 59.13 45.45 14.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.455 179.862 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.503 ' O ' HG12 ' A' ' 81' ' ' VAL . 74.4 t -80.4 -3.91 6.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.073 179.893 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.437 HG23 ' C ' ' A' ' 81' ' ' VAL . 89.2 t -156.56 122.12 2.48 Favored Pre-proline 0 CA--C 1.528 0.117 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 179.654 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.431 ' HD3' ' CD1' ' A' ' 92' ' ' TYR . 50.8 Cg_endo -75.25 176.07 10.42 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.552 2.168 . . . . 0.0 112.129 -179.923 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -77.31 131.03 37.92 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 179.475 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 2.2 mmtt 59.92 40.75 18.68 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 -179.529 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 28.2 p90 -47.46 174.28 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.855 -179.681 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 10.9 m -129.36 129.66 45.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.242 179.987 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.475 HD11 ' CB ' ' A' ' 12' ' ' SER . 42.2 mm -66.51 115.3 4.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.337 179.981 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 119.45 37.34 0.79 Allowed Glycine 0 CA--C 1.523 0.573 0 N-CA-C 110.725 -0.95 . . . . 0.0 110.725 -179.917 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -147.67 172.57 13.85 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.808 0.337 . . . . 0.0 110.375 179.998 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.62 HG23 ' O ' ' A' ' 6' ' ' PHE . 87.9 m -114.83 126.16 54.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.422 -179.992 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.463 ' O ' ' HB2' ' A' ' 93' ' ' ALA . 54.6 m-85 -127.45 130.5 49.37 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.571 179.985 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.897 ' HB1' ' HD2' ' A' ' 94' ' ' PRO . . . 174.01 177.13 0.19 Allowed Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.435 179.713 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.897 ' HD2' ' HB1' ' A' ' 93' ' ' ALA . 49.4 Cg_endo . . . . . 0 C--O 1.25 1.094 0 C-N-CA 122.642 2.228 . . . . 0.0 112.071 -179.885 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.796 0.331 . . . . 0.0 110.367 . . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.801 HG12 ' CE2' ' A' ' 23' ' ' TYR . 16.9 m -71.91 168.3 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.478 -179.967 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.427 ' HB ' ' CG2' ' A' ' 91' ' ' THR . 78.4 p -153.72 129.96 10.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.33 179.819 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.559 ' O ' HG23 ' A' ' 91' ' ' THR . 25.2 m-85 -93.44 165.46 12.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.41 -179.865 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -153.72 108.84 3.16 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.546 -179.883 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.442 ' CG1' HG13 ' A' ' 88' ' ' ILE . 92.0 t -57.79 114.26 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.12 179.759 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.65 ' CD ' HG11 ' A' ' 51' ' ' VAL . 1.8 mt-10 -84.36 159.11 20.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.61 -179.771 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.637 ' HA ' HG21 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -57.63 -25.81 60.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.48 -179.912 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -49.67 -26.4 7.73 Favored Glycine 0 CA--C 1.523 0.567 0 N-CA-C 110.8 -0.92 . . . . 0.0 110.8 -179.908 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.4 m -59.29 106.4 0.44 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.767 0.318 . . . . 0.0 110.289 179.961 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.434 ' O ' ' N ' ' A' ' 15' ' ' LYS . 10.8 p-10 -124.72 136.74 54.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.491 -179.962 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 53.34 -87.04 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.661 179.891 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.434 ' N ' ' O ' ' A' ' 13' ' ' ASN . 42.2 pttt -114.16 -27.39 7.67 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.659 0.266 . . . . 0.0 110.71 -179.963 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 8.9 m80 -49.36 134.19 19.01 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.533 179.947 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.477 HD22 ' HA ' ' A' ' 17' ' ' LEU . 0.2 OUTLIER -118.48 100.12 7.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.409 -179.88 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.583 ' HB2' ' CG2' ' A' ' 53' ' ' THR . . . -98.86 130.5 45.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.266 179.942 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.77 HG23 HG23 ' A' ' 21' ' ' VAL . 33.4 m -126.15 146.67 31.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.262 -179.914 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -96.66 70.97 2.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.307 -179.947 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.77 HG23 HG23 ' A' ' 19' ' ' VAL . 23.5 t -75.16 97.89 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.449 -179.877 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.02 146.39 9.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.405 179.975 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.801 ' CE2' HG12 ' A' ' 4' ' ' VAL . 17.0 p90 -173.16 140.03 0.84 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.455 -179.996 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -52.04 134.91 31.91 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.358 -179.98 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 126.78 -110.44 1.23 Allowed Glycine 0 CA--C 1.523 0.538 0 N-CA-C 110.684 -0.966 . . . . 0.0 110.684 179.993 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -67.01 145.85 54.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.781 0.324 . . . . 0.0 110.259 179.954 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.449 ' HB ' ' CG ' ' A' ' 71' ' ' GLU . 0.3 OUTLIER -80.87 -171.26 3.08 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.419 -179.884 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -117.92 124.63 48.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.567 -179.723 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.845 ' HB3' ' O ' ' A' ' 69' ' ' LEU . . . -114.54 -60.59 1.87 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.437 -179.783 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.559 ' OE2' ' HB1' ' A' ' 43' ' ' ALA . 0.5 OUTLIER -157.78 150.95 23.25 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.224 179.984 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 1.034 HG21 ' CD1' ' A' ' 52' ' ' TRP . 6.1 t -119.59 166.57 13.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.155 -179.899 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.468 ' N ' HG12 ' A' ' 31' ' ' VAL . 1.2 tp10 -153.08 140.06 19.21 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.017 0.437 . . . . 0.0 109.925 -179.416 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.708 HD12 ' N ' ' A' ' 34' ' ' ARG . 3.9 tp -134.3 142.62 47.34 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.182 -178.963 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.708 ' N ' HD12 ' A' ' 33' ' ' LEU . 6.7 tpm_? -127.73 -95.91 0.42 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.154 -0.475 . . . . 0.0 109.903 179.012 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.44 ' CB ' ' O ' ' A' ' 34' ' ' ARG . 0.0 OUTLIER 160.79 -83.51 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 120.763 0.316 . . . . 0.0 110.321 179.392 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 3.3 t60 177.88 -55.41 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.317 -179.868 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -59.36 -72.07 0.67 Allowed Glycine 0 CA--C 1.523 0.584 0 N-CA-C 110.639 -0.985 . . . . 0.0 110.639 179.955 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -58.05 122.03 12.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.819 0.342 . . . . 0.0 110.179 179.848 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 33.0 m-20 -83.26 6.71 18.64 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.312 -179.825 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -107.84 100.33 9.71 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 120.82 0.343 . . . . 0.0 110.54 -179.953 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.507 ' CZ3' ' HG2' ' A' ' 67' ' ' ARG . 68.7 m95 -59.4 155.32 15.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.072 179.733 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.506 HG21 ' CZ ' ' A' ' 54' ' ' PHE . 10.0 m -138.47 110.76 6.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-O 120.715 0.293 . . . . 0.0 110.307 179.98 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.559 ' HB1' ' OE2' ' A' ' 30' ' ' GLU . . . -45.68 149.75 0.57 Allowed 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.52 -179.8 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.403 ' HB2' ' HB ' ' A' ' 31' ' ' VAL . 0.0 OUTLIER -72.13 -170.55 0.62 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.916 0.388 . . . . 0.0 110.54 -179.722 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 68.8 m -138.88 126.04 21.37 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.409 -179.945 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 3.1 ptpt -94.56 91.32 6.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.564 -179.804 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -146.34 26.59 1.7 Allowed Glycine 0 CA--C 1.523 0.572 0 N-CA-C 110.81 -0.916 . . . . 0.0 110.81 179.963 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.493 ' OE2' HG21 ' A' ' 53' ' ' THR . 0.0 OUTLIER -106.45 174.52 5.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.836 0.351 . . . . 0.0 110.482 179.939 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -56.13 -29.44 56.02 Favored Glycine 0 CA--C 1.522 0.53 0 N-CA-C 110.487 -1.045 . . . . 0.0 110.487 179.787 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.437 ' O ' HG13 ' A' ' 51' ' ' VAL . . . 177.81 37.46 0.06 OUTLIER Glycine 0 CA--C 1.524 0.619 0 N-CA-C 110.861 -0.896 . . . . 0.0 110.861 179.965 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.65 HG11 ' CD ' ' A' ' 9' ' ' GLU . 13.1 m -154.78 177.87 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.828 0.347 . . . . 0.0 110.395 179.866 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . 1.034 ' CD1' HG21 ' A' ' 31' ' ' VAL . 5.4 m95 -103.92 144.92 30.87 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.379 -179.487 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.583 ' CG2' ' HB2' ' A' ' 18' ' ' ALA . 0.7 OUTLIER -137.15 157.91 45.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.382 -179.971 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.506 ' CZ ' HG21 ' A' ' 42' ' ' VAL . 78.2 t80 -148.95 155.39 40.77 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.49 -179.952 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -89.81 124.58 34.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.511 -179.89 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 94.0 p -120.56 103.56 9.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.273 179.937 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -110.3 -28.02 8.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.47 -179.906 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -59.55 125.63 80.19 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.458 -179.923 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -72.0 -11.73 27.6 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.519 2.146 . . . . 0.0 112.514 179.97 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -47.57 107.49 0.12 Allowed 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 120.901 0.381 . . . . 0.0 110.749 -179.732 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -76.05 118.89 19.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.345 179.929 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -179.65 170.85 42.39 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 -179.959 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.417 ' CB ' ' HA ' ' A' ' 80' ' ' ASP . 49.6 Cg_endo -79.02 151.63 24.04 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.597 2.198 . . . . 0.0 112.097 -179.893 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.571 ' HB3' HD13 ' A' ' 33' ' ' LEU . 29.4 m-85 -84.86 123.11 30.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.277 179.877 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 7.4 m-20 -95.28 134.46 38.03 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 179.516 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.424 ' CE2' ' HB2' ' A' ' 33' ' ' LEU . 51.8 m-85 -121.42 167.9 12.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.129 0.49 . . . . 0.0 111.045 -179.452 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.507 ' HG2' ' CZ3' ' A' ' 41' ' ' TRP . 0.3 OUTLIER -173.77 61.77 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.711 179.984 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.625 ' HZ ' HG11 ' A' ' 4' ' ' VAL . 1.7 p90 -56.78 174.11 0.17 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.99 -179.472 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.845 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 2.9 mt -121.54 72.14 1.0 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.221 179.515 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.401 ' OG1' ' N ' ' A' ' 74' ' ' MET . 62.3 p -35.84 136.17 0.27 Allowed 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.793 -179.241 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.681 ' HG2' ' HB2' ' A' ' 29' ' ' ALA . 14.8 mt-10 -49.96 -52.16 35.74 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.486 -179.861 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 6.3 tptp -129.21 71.67 1.44 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.529 -179.869 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -162.85 -103.71 0.18 Allowed Glycine 0 CA--C 1.522 0.528 0 N-CA-C 110.799 -0.92 . . . . 0.0 110.799 179.897 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.401 ' N ' ' OG1' ' A' ' 70' ' ' THR . 21.1 ptt? -179.21 -175.64 0.38 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.853 0.359 . . . . 0.0 110.292 179.988 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.553 ' HE3' HD22 ' A' ' 69' ' ' LEU . 0.0 OUTLIER -97.48 148.28 23.38 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.159 -179.69 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -152.62 123.09 7.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.192 179.854 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 98.4 t -81.65 143.73 11.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.526 -179.825 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.631 ' CZ ' HG21 ' A' ' 4' ' ' VAL . 53.9 m-85 -127.99 122.35 32.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.254 179.993 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -105.26 148.72 26.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.552 -179.699 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.417 ' HA ' ' CB ' ' A' ' 63' ' ' PRO . 1.0 OUTLIER 58.88 46.06 14.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.462 179.9 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.413 ' O ' ' HB3' ' A' ' 92' ' ' TYR . 90.1 t -77.0 -75.25 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.187 179.862 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.426 HG13 ' HD2' ' A' ' 83' ' ' PRO . 39.1 t -89.04 137.89 29.37 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.268 179.797 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.426 ' HD2' HG13 ' A' ' 82' ' ' VAL . 49.1 Cg_endo -73.17 -175.42 1.96 Allowed 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.5 2.133 . . . . 0.0 111.949 179.821 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -82.9 -31.18 27.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.135 179.738 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 6.0 tttp -117.45 51.56 1.02 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.255 179.846 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 0.403 ' HA ' ' HG2' ' A' ' 83' ' ' PRO . 48.8 p90 -52.56 159.61 1.02 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.55 -179.894 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -142.4 114.83 8.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.128 179.88 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.637 HG21 ' HA ' ' A' ' 10' ' ' LYS . 3.0 mp -49.83 100.16 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.466 -179.826 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 134.18 53.72 0.07 OUTLIER Glycine 0 CA--C 1.523 0.542 0 N-CA-C 110.602 -0.999 . . . . 0.0 110.602 -179.971 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.663 ' HB3' ' OH ' ' A' ' 92' ' ' TYR . . . -175.82 179.61 1.33 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.811 0.338 . . . . 0.0 110.359 179.99 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.559 HG23 ' O ' ' A' ' 6' ' ' PHE . 24.8 m -120.69 139.78 52.55 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.439 -179.83 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.663 ' OH ' ' HB3' ' A' ' 90' ' ' ALA . 7.1 m-85 -141.59 104.58 4.58 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.284 179.932 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.887 ' HB1' ' HD2' ' A' ' 94' ' ' PRO . . . 175.06 177.3 0.21 Allowed Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.301 -179.886 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.887 ' HD2' ' HB1' ' A' ' 93' ' ' ALA . 47.6 Cg_endo . . . . . 0 C--O 1.249 1.074 0 C-N-CA 122.486 2.124 . . . . 0.0 112.03 179.973 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 10.4 mmtp . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.678 0.275 . . . . 0.0 110.535 . . . . . . . . . 0 0 . 1 . 038 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.507 ' CG1' ' CE1' ' A' ' 78' ' ' PHE . 2.0 p -65.25 163.25 2.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.172 0.511 . . . . 0.0 110.068 179.808 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.491 ' N ' HG22 ' A' ' 4' ' ' VAL . 3.9 p -147.78 131.07 16.53 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.384 -179.989 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.815 ' O ' HG23 ' A' ' 91' ' ' THR . 6.0 m-85 -96.46 174.73 6.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.287 -179.958 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.442 ' HB ' ' CB ' ' A' ' 20' ' ' LEU . 2.8 m -166.16 106.88 0.7 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.27 -179.813 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.71 ' O ' HG23 ' A' ' 88' ' ' ILE . 91.6 t -59.11 94.12 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.406 -179.85 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.799 ' HG3' HG11 ' A' ' 51' ' ' VAL . 15.4 mm-40 -56.02 158.86 3.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.236 179.899 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.494 ' HA ' HG21 ' A' ' 88' ' ' ILE . 1.9 ptmt -77.14 62.57 2.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.435 -179.948 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -154.95 27.32 0.64 Allowed Glycine 0 CA--C 1.523 0.593 0 N-CA-C 110.728 -0.949 . . . . 0.0 110.728 179.963 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 30.4 m -86.87 131.7 34.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.839 0.352 . . . . 0.0 110.358 -179.967 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -110.54 -159.71 0.69 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.143 -0.481 . . . . 0.0 109.986 179.872 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -47.83 -59.35 3.38 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.622 179.908 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.13 -25.07 9.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.588 -180.0 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 27.0 m80 -51.27 134.46 27.7 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.852 0.358 . . . . 0.0 110.421 -179.999 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.485 HD22 ' HA ' ' A' ' 17' ' ' LEU . 0.2 OUTLIER -127.05 98.03 5.17 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.371 -179.952 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.552 ' HB2' ' CG2' ' A' ' 53' ' ' THR . . . -94.4 127.85 40.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.213 179.929 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.761 HG23 HG23 ' A' ' 21' ' ' VAL . 22.7 m -128.0 148.15 32.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.317 -179.957 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.442 ' CB ' ' HB ' ' A' ' 7' ' ' THR . 0.9 OUTLIER -94.53 63.19 2.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.456 -179.936 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.761 HG23 HG23 ' A' ' 19' ' ' VAL . 22.8 t -65.66 100.49 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.292 179.969 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.39 152.26 21.83 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.313 -179.994 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 28.1 p90 179.23 157.49 0.56 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.367 -179.941 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -82.81 163.53 21.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.331 179.934 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 106.63 -49.09 0.9 Allowed Glycine 0 CA--C 1.523 0.57 0 N-CA-C 110.652 -0.979 . . . . 0.0 110.652 -179.963 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -130.44 -177.78 4.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.755 0.312 . . . . 0.0 110.171 179.906 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -126.68 162.87 24.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.514 -179.976 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.589 ' O ' ' HB2' ' A' ' 29' ' ' ALA . 0.0 OUTLIER -57.98 -160.84 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.316 179.92 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.755 ' HB2' ' N ' ' A' ' 71' ' ' GLU . . . 155.12 -63.71 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.291 0.637 . . . . 0.0 109.532 179.668 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 17.9 tt0 -148.7 161.53 41.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.061 179.8 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.465 HG21 ' CD1' ' A' ' 52' ' ' TRP . 10.7 t -155.11 150.18 11.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.234 179.911 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.436 ' CB ' ' HA ' ' A' ' 43' ' ' ALA . 1.4 pm0 -151.67 144.46 24.38 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.359 -179.955 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.726 HD12 ' H ' ' A' ' 34' ' ' ARG . 8.1 tp -112.96 151.14 30.92 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.486 -179.428 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.726 ' H ' HD12 ' A' ' 33' ' ' LEU . 4.7 ttp180 -117.2 -158.16 0.69 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.229 179.913 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 6.9 tm-20 -175.5 107.32 0.09 Allowed 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 -179.968 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -48.39 97.0 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.704 -179.434 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 161.67 -31.27 0.32 Allowed Glycine 0 CA--C 1.522 0.525 0 N-CA-C 110.468 -1.053 . . . . 0.0 110.468 179.859 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -117.87 145.26 44.73 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 179.937 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -94.95 21.45 7.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.778 -179.836 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 29.7 tp10 -130.38 113.52 14.44 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 -179.901 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.499 ' CZ2' ' HD2' ' A' ' 67' ' ' ARG . 63.7 m95 -63.72 172.99 1.89 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.162 179.707 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.419 ' CG2' ' O ' ' A' ' 33' ' ' LEU . 4.4 m -146.65 107.34 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.048 179.624 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.436 ' HA ' ' CB ' ' A' ' 32' ' ' GLU . . . -45.49 146.06 1.11 Allowed 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.679 -179.69 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.411 ' CE ' ' HB2' ' A' ' 54' ' ' PHE . 0.0 OUTLIER -68.56 -170.8 0.23 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.709 -179.712 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.403 ' HB ' ' O ' ' A' ' 53' ' ' THR . 92.8 m -145.34 107.19 4.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.436 -179.979 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -66.22 79.08 0.09 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.168 179.87 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -104.29 -22.93 8.32 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 111.056 -0.818 . . . . 0.0 111.056 -179.794 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.465 ' HG3' HG23 ' A' ' 53' ' ' THR . 0.1 OUTLIER -75.96 -178.62 4.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.979 0.419 . . . . 0.0 110.422 -179.939 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -111.79 38.95 3.05 Favored Glycine 0 CA--C 1.522 0.514 0 N-CA-C 110.244 -1.143 . . . . 0.0 110.244 179.579 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 165.39 -27.81 0.19 Allowed Glycine 0 CA--C 1.526 0.753 0 N-CA-C 111.311 -0.716 . . . . 0.0 111.311 -179.874 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.799 HG11 ' HG3' ' A' ' 9' ' ' GLU . 3.2 m -123.4 -176.3 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-O 120.884 0.373 . . . . 0.0 110.705 -179.726 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . 0.465 ' CD1' HG21 ' A' ' 31' ' ' VAL . 11.2 m95 -108.21 138.27 44.78 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.722 -179.661 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.552 ' CG2' ' HB2' ' A' ' 18' ' ' ALA . 2.9 p -130.64 137.86 49.81 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.768 179.549 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.411 ' HB2' ' CE ' ' A' ' 44' ' ' MET . 71.5 t80 -123.37 131.12 53.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.878 0.371 . . . . 0.0 110.753 -179.539 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -77.32 107.13 9.51 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.019 179.696 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.0 m -87.76 148.71 24.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.629 -179.693 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -122.97 -42.27 2.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.256 179.887 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -55.72 165.51 1.26 Allowed Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.404 179.987 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -94.32 5.32 2.64 Favored 'Trans proline' 0 N--CA 1.452 -0.934 0 C-N-CA 123.995 3.13 . . . . 0.0 113.015 -179.863 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -103.94 102.9 12.69 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.827 0.346 . . . . 0.0 110.355 179.918 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -122.82 75.13 1.25 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.453 -179.845 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -133.46 -101.03 0.74 Allowed Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.749 -0.94 . . . . 0.0 110.749 179.996 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -78.51 107.9 2.36 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.568 2.178 . . . . 0.0 112.049 -179.954 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 36.7 m-85 -93.42 166.42 12.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.391 -179.947 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.424 ' HB2' ' CB ' ' A' ' 34' ' ' ARG . 1.5 m-80 -133.86 147.41 51.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.018 179.785 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -140.55 175.07 9.9 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.031 0.443 . . . . 0.0 110.962 -179.718 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.499 ' HD2' ' CZ2' ' A' ' 41' ' ' TRP . 6.5 ptm180 -178.99 61.98 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.569 179.941 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.652 ' O ' HD23 ' A' ' 69' ' ' LEU . 0.3 OUTLIER -57.4 173.72 0.24 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.028 -179.223 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.723 HD22 ' HG2' ' A' ' 75' ' ' LYS . 2.9 mt -136.12 78.69 1.73 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.881 179.969 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 61.2 p -38.81 153.19 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.393 -179.646 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.755 ' N ' ' HB2' ' A' ' 29' ' ' ALA . 6.3 mt-10 -49.7 -33.97 17.44 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.388 -179.799 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.61 -36.08 82.69 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.354 -179.97 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 113.12 23.37 5.25 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 110.974 -0.851 . . . . 0.0 110.974 179.972 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -92.89 116.13 28.76 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.708 0.29 . . . . 0.0 110.307 179.902 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.723 ' HG2' HD22 ' A' ' 69' ' ' LEU . 3.1 mptt -113.46 173.72 6.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.35 -179.941 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 171.11 129.78 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.999 179.98 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 83.0 t -76.52 153.81 5.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.327 -179.994 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.507 ' CE1' ' CG1' ' A' ' 4' ' ' VAL . 87.1 m-85 -139.12 119.61 13.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.599 -179.879 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -106.03 152.22 23.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.095 179.812 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 11.0 t0 55.2 61.02 3.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.049 -179.751 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.482 ' O ' HG12 ' A' ' 81' ' ' VAL . 84.7 t -95.36 -8.19 9.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.234 -179.695 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.446 HG23 ' C ' ' A' ' 81' ' ' VAL . 57.3 t -156.33 132.07 5.68 Favored Pre-proline 0 C--N 1.332 -0.166 0 N-CA-C 110.406 -0.22 . . . . 0.0 110.406 179.872 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.509 ' HD3' ' CD1' ' A' ' 92' ' ' TYR . 50.0 Cg_endo -73.0 -176.09 2.23 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.507 2.138 . . . . 0.0 111.946 179.84 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -82.52 135.68 35.04 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 179.446 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 57.75 48.37 13.99 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 -179.466 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 48.8 p90 -43.28 156.36 0.05 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.414 -179.528 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 7.1 m -127.32 103.71 7.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.808 179.609 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.71 HG23 ' O ' ' A' ' 8' ' ' VAL . 2.5 mp -44.52 122.57 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.012 -179.632 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 117.43 35.37 1.1 Allowed Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.743 -0.943 . . . . 0.0 110.743 -179.935 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -155.74 142.35 18.73 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 110.222 -0.288 . . . . 0.0 110.222 179.978 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.815 HG23 ' O ' ' A' ' 6' ' ' PHE . 6.0 m -96.3 113.8 25.42 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.925 0.393 . . . . 0.0 110.716 -179.836 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.578 ' O ' ' HB3' ' A' ' 93' ' ' ALA . 33.0 m-85 -97.26 -153.58 0.42 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.788 179.751 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.869 ' HB1' ' HD2' ' A' ' 94' ' ' PRO . . . 78.42 173.78 0.08 OUTLIER Pre-proline 0 N--CA 1.465 0.305 0 CA-C-O 120.838 0.351 . . . . 0.0 110.722 179.808 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.869 ' HD2' ' HB1' ' A' ' 93' ' ' ALA . 48.1 Cg_endo . . . . . 0 C--O 1.249 1.053 0 C-N-CA 122.631 2.22 . . . . 0.0 112.079 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 3.3 m . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 110.151 -0.314 . . . . 0.0 110.151 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -75.51 111.14 3.24 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.556 2.171 . . . . 0.0 112.089 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 9.9 tttt -143.13 75.63 1.49 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.428 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.946 HG12 ' CE1' ' A' ' 23' ' ' TYR . 30.0 m -92.74 172.06 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.374 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.701 HG23 ' O ' ' A' ' 4' ' ' VAL . 4.6 p -163.49 133.8 4.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.397 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.579 ' O ' HG23 ' A' ' 91' ' ' THR . 23.4 m-85 -95.61 -169.9 2.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.073 179.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -165.75 104.85 0.7 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.809 0.338 . . . . 0.0 110.505 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 95.8 t -55.21 91.84 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.179 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 1.021 ' HG3' HG11 ' A' ' 51' ' ' VAL . 9.9 mm-40 -66.1 169.57 6.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.568 -179.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.501 ' HA ' HG21 ' A' ' 88' ' ' ILE . 11.9 tttt -63.18 -15.33 56.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.193 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -45.95 -27.81 2.58 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 111.213 -0.755 . . . . 0.0 111.213 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -71.13 131.29 43.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.77 0.319 . . . . 0.0 110.348 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -145.47 -86.61 0.11 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.434 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -81.68 -66.81 0.84 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.923 0.392 . . . . 0.0 110.121 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.06 26.08 2.72 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.214 179.708 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 54.5 m80 -94.32 139.61 30.86 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.233 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.44 HD22 ' HA ' ' A' ' 17' ' ' LEU . 0.4 OUTLIER -124.35 89.24 3.04 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.263 179.907 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.581 ' HB2' ' CG2' ' A' ' 53' ' ' THR . . . -90.26 153.38 20.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.51 -179.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 6.4 m -145.29 137.5 20.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.044 179.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.563 HD12 ' OE2' ' A' ' 9' ' ' GLU . 0.9 OUTLIER -98.69 51.56 0.99 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.505 -179.943 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.511 ' HB ' ' CD2' ' A' ' 6' ' ' PHE . 3.0 p -53.57 107.65 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.924 0.393 . . . . 0.0 110.19 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -174.46 120.75 0.25 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.252 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.946 ' CE1' HG12 ' A' ' 4' ' ' VAL . 17.0 p90 -127.31 19.61 6.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.831 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 60.44 147.94 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.901 0.381 . . . . 0.0 110.518 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 109.07 -93.47 0.77 Allowed Glycine 0 CA--C 1.523 0.592 0 N-CA-C 110.652 -0.979 . . . . 0.0 110.652 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -57.54 -173.43 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.793 0.33 . . . . 0.0 110.484 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.34 173.69 6.67 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.515 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.424 ' O ' ' CG ' ' A' ' 71' ' ' GLU . 0.1 OUTLIER -109.07 123.51 49.28 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.483 -179.942 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.698 ' HB3' ' O ' ' A' ' 69' ' ' LEU . . . -115.1 -62.59 1.58 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.284 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -158.95 164.2 35.83 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.595 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.86 HG21 ' CD1' ' A' ' 52' ' ' TRP . 16.2 t -138.68 145.43 27.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.211 0.529 . . . . 0.0 111.335 -179.547 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.405 ' HA ' ' HA ' ' A' ' 43' ' ' ALA . 6.0 tp10 -124.56 130.6 52.76 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.223 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.672 HD12 ' H ' ' A' ' 34' ' ' ARG . 12.4 tp -114.2 151.77 32.24 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 121.021 0.438 . . . . 0.0 110.172 -179.058 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.672 ' H ' HD12 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -125.98 -156.04 0.71 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.699 179.458 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.423 ' CG ' ' O ' ' A' ' 34' ' ' ARG . 14.3 mt-10 -161.57 -88.54 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.497 0.189 . . . . 0.0 110.72 179.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.444 ' CG ' ' N ' ' A' ' 37' ' ' GLY . 11.1 p80 -160.76 -46.72 0.05 OUTLIER 'General case' 0 N--CA 1.454 -0.235 0 CA-C-O 120.797 0.332 . . . . 0.0 110.8 -179.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.444 ' N ' ' CG ' ' A' ' 36' ' ' HIS . . . -156.97 38.39 0.56 Allowed Glycine 0 CA--C 1.523 0.577 0 N-CA-C 110.914 -0.874 . . . . 0.0 110.914 -179.605 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 5.5 t -73.6 -76.03 0.14 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.828 0.347 . . . . 0.0 110.219 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 37.3 p30 -173.32 55.95 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.131 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 67.83 176.29 0.26 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.242 -179.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.507 ' CZ3' ' HG2' ' A' ' 67' ' ' ARG . 98.3 m95 -52.69 138.64 28.3 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.542 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.7 m -130.98 110.72 18.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.935 179.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.405 ' HA ' ' HA ' ' A' ' 32' ' ' GLU . . . -48.66 131.42 17.79 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.82 -179.474 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.23 -171.33 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.578 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.419 ' O ' ' N ' ' A' ' 47' ' ' GLY . 41.3 m -142.03 102.33 4.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.235 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.405 ' O ' ' CG ' ' A' ' 46' ' ' LYS . 0.1 OUTLIER -64.56 76.17 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.331 -179.966 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 45' ' ' THR . . . -107.14 -21.9 7.82 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.923 -0.871 . . . . 0.0 110.923 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.69 -33.41 66.49 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.838 0.351 . . . . 0.0 110.336 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 98.12 -42.38 2.09 Favored Glycine 0 CA--C 1.522 0.526 0 N-CA-C 110.562 -1.015 . . . . 0.0 110.562 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -107.32 -25.12 6.19 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.679 -0.968 . . . . 0.0 110.679 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 1.021 HG11 ' HG3' ' A' ' 9' ' ' GLU . 24.0 m -136.5 179.0 4.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.826 0.346 . . . . 0.0 110.467 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . 0.86 ' CD1' HG21 ' A' ' 31' ' ' VAL . 4.0 m95 -109.42 128.35 55.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.417 -179.423 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.581 ' CG2' ' HB2' ' A' ' 18' ' ' ALA . 0.2 OUTLIER -114.69 167.94 10.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.421 -179.964 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.666 ' CG ' HD23 ' A' ' 33' ' ' LEU . 79.2 t80 -146.72 133.2 19.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.316 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 25.5 p-10 -94.65 114.29 26.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.544 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -84.51 146.55 27.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.261 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -113.11 -40.19 4.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.403 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.4 ' HG3' ' O ' ' A' ' 60' ' ' LEU . 1.7 pt-20 -67.66 151.55 97.07 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.272 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -71.72 -18.77 28.38 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.681 2.254 . . . . 0.0 112.494 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.4 ' O ' ' HG3' ' A' ' 58' ' ' GLU . 3.6 mt -96.29 144.13 26.74 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.903 0.382 . . . . 0.0 110.662 -179.645 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -143.2 91.12 2.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.269 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -96.35 -140.7 11.33 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.775 -0.93 . . . . 0.0 110.775 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -73.9 166.38 29.83 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.527 2.151 . . . . 0.0 111.893 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -125.2 177.46 6.1 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.148 0.499 . . . . 0.0 111.0 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -147.43 134.62 20.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.494 179.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.565 ' CZ ' HD13 ' A' ' 33' ' ' LEU . 52.2 m-85 -124.22 168.52 12.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.253 0.549 . . . . 0.0 111.478 -179.072 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.507 ' HG2' ' CZ3' ' A' ' 41' ' ' TRP . 0.0 OUTLIER -170.86 68.36 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.404 179.741 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.796 ' O ' HD23 ' A' ' 69' ' ' LEU . 4.5 p90 -51.8 177.81 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.407 0.622 . . . . 0.0 111.544 -178.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.796 HD23 ' O ' ' A' ' 68' ' ' PHE . 5.7 mt -137.96 55.75 1.76 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.045 -0.979 . . . . 0.0 109.177 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.429 HG23 ' CD1' ' A' ' 68' ' ' PHE . 40.1 p -27.98 136.83 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.762 0.825 . . . . 0.0 112.709 -179.015 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.592 ' N ' ' HB2' ' A' ' 29' ' ' ALA . 14.4 mt-10 -50.78 -31.15 16.02 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.42 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -63.23 -31.68 72.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.447 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 103.18 62.33 0.7 Allowed Glycine 0 CA--C 1.523 0.576 0 N-CA-C 110.669 -0.972 . . . . 0.0 110.669 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 74.5 mtp -152.18 115.33 4.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.813 0.34 . . . . 0.0 110.313 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.68 176.75 5.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.384 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.421 ' O ' ' CE2' ' A' ' 78' ' ' PHE . 2.0 m-20 173.25 126.94 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.113 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 97.8 t -76.17 152.77 6.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.752 -179.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.757 ' CZ ' HG21 ' A' ' 4' ' ' VAL . 38.9 m-85 -136.88 121.08 17.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.152 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -109.53 153.02 24.71 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.471 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.7 t0 59.53 30.53 20.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.675 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.446 HG13 ' O ' ' A' ' 92' ' ' TYR . 95.9 t -59.77 -73.82 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.19 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.497 HG13 ' HD2' ' A' ' 83' ' ' PRO . 50.9 t -87.52 139.32 31.65 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.416 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.497 ' HD2' HG13 ' A' ' 82' ' ' VAL . 47.5 Cg_endo -73.83 -168.1 0.43 Allowed 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.572 2.181 . . . . 0.0 112.063 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -76.12 -64.12 1.17 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.341 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 6.3 tppt? -96.42 57.7 1.69 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.282 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 40.4 p90 -51.77 148.9 5.15 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.483 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 3.1 m -122.85 110.24 15.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.181 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.501 HG21 ' HA ' ' A' ' 10' ' ' LYS . 2.7 mp -50.47 100.97 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.459 -179.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 137.51 44.87 0.08 OUTLIER Glycine 0 CA--C 1.523 0.579 0 N-CA-C 110.534 -1.027 . . . . 0.0 110.534 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.71 ' HB3' ' OH ' ' A' ' 92' ' ' TYR . . . -166.45 -176.76 3.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.769 0.319 . . . . 0.0 110.345 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.579 HG23 ' O ' ' A' ' 6' ' ' PHE . 85.3 m -119.68 138.66 53.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.572 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.71 ' OH ' ' HB3' ' A' ' 90' ' ' ALA . 7.4 m-85 -143.95 107.74 4.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.168 179.791 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.898 ' HB1' ' HD2' ' A' ' 94' ' ' PRO . . . 176.25 178.02 0.22 Allowed Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.488 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.898 ' HD2' ' HB1' ' A' ' 93' ' ' ALA . 49.4 Cg_endo . . . . . 0 C--O 1.249 1.027 0 C-N-CA 122.565 2.177 . . . . 0.0 112.059 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 61.7 t . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -76.17 135.88 17.48 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.599 2.199 . . . . 0.0 112.196 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 4.6 pttt -119.01 84.68 2.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.281 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.673 HG11 ' CZ ' ' A' ' 68' ' ' PHE . 17.8 m -55.06 171.07 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.461 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.445 ' HB ' ' CG2' ' A' ' 91' ' ' THR . 21.6 p -153.47 135.6 14.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.375 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.532 ' HD1' ' HB2' ' A' ' 93' ' ' ALA . 14.9 m-85 -100.58 169.38 9.09 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.455 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.5 m -157.59 112.72 2.74 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.342 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 44.5 t -58.07 91.38 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.275 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.775 ' HG3' HG11 ' A' ' 51' ' ' VAL . 6.7 mm-40 -51.0 176.3 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.463 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 61.9 mmtt -67.48 175.5 2.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.314 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 51.13 49.74 42.28 Favored Glycine 0 CA--C 1.523 0.547 0 N-CA-C 110.718 -0.953 . . . . 0.0 110.718 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -102.64 136.9 41.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.873 0.368 . . . . 0.0 110.452 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 3.7 p30 -172.07 162.81 5.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.295 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -49.11 -28.1 3.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.742 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.81 -28.33 44.5 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.373 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 25.1 m80 -149.65 125.22 10.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.507 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.516 HD22 ' HA ' ' A' ' 17' ' ' LEU . 0.3 OUTLIER -111.83 94.37 4.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.222 179.883 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.667 ' HB2' ' CG2' ' A' ' 53' ' ' THR . . . -96.06 125.69 40.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.488 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.455 HG23 HG23 ' A' ' 21' ' ' VAL . 33.2 m -113.67 -171.17 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.003 179.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.4 tt -138.09 80.66 1.81 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.302 179.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.455 HG23 HG23 ' A' ' 19' ' ' VAL . 2.4 t -97.31 102.39 13.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.989 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.49 ' O ' ' CG ' ' A' ' 23' ' ' TYR . 0.0 OUTLIER -162.87 -65.27 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.878 -179.721 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.635 ' CE2' HG12 ' A' ' 4' ' ' VAL . 33.5 p90 45.6 -171.78 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.724 -179.454 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -115.85 142.63 46.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.474 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 131.23 -43.88 1.26 Allowed Glycine 0 CA--C 1.523 0.541 0 N-CA-C 110.759 -0.936 . . . . 0.0 110.759 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -126.91 -170.63 2.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.826 0.346 . . . . 0.0 110.601 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -118.8 -175.32 2.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.514 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.437 ' O ' ' CG ' ' A' ' 71' ' ' GLU . 1.5 mtp -105.99 123.73 48.45 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.343 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.756 ' HB2' ' HG2' ' A' ' 71' ' ' GLU . . . -132.16 -58.58 0.95 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.924 -179.776 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.581 ' C ' HG12 ' A' ' 31' ' ' VAL . 0.0 OUTLIER -140.63 173.6 11.33 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.83 0.348 . . . . 0.0 110.925 -179.778 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.581 HG12 ' C ' ' A' ' 30' ' ' GLU . 1.3 p 164.3 131.33 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-O 121.518 0.675 . . . . 0.0 109.76 -179.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.692 ' OE2' ' HB2' ' A' ' 43' ' ' ALA . 2.6 mm-40 -112.04 -172.49 2.05 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.843 -1.071 . . . . 0.0 110.476 -179.546 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.74 HD12 ' H ' ' A' ' 34' ' ' ARG . 5.8 tp -144.22 145.16 31.89 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 179.302 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.74 ' H ' HD12 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -150.66 -178.84 6.79 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.086 179.712 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -132.27 -85.22 0.48 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.574 -0.284 . . . . 0.0 110.566 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 171.71 39.76 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.823 0.344 . . . . 0.0 110.595 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 167.29 59.15 0.03 OUTLIER Glycine 0 CA--C 1.524 0.621 0 N-CA-C 110.817 -0.913 . . . . 0.0 110.817 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.6 t -133.57 158.85 42.14 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.78 0.324 . . . . 0.0 110.296 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.421 ' O ' ' CG ' ' A' ' 40' ' ' GLU . 0.4 OUTLIER -51.67 -33.48 34.0 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.31 179.907 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.421 ' CG ' ' O ' ' A' ' 39' ' ' ASP . 2.9 mt-10 169.19 -179.19 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.236 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.51 ' CH2' ' HG3' ' A' ' 67' ' ' ARG . 71.8 m95 -62.14 145.02 54.56 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.339 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 27.3 m -122.85 2.04 6.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.159 -179.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.692 ' HB2' ' OE2' ' A' ' 32' ' ' GLU . . . 60.07 137.86 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.344 0 CA-C-O 121.301 0.572 . . . . 0.0 111.3 179.322 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.5 ' H ' ' HA ' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -62.51 -167.13 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.372 179.733 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.4 ' O ' ' N ' ' A' ' 47' ' ' GLY . 49.9 m -150.85 125.32 9.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.358 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 13.6 ptmt -69.25 64.66 0.15 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.239 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' A' ' 45' ' ' THR . . . -91.23 -34.18 7.7 Favored Glycine 0 CA--C 1.523 0.549 0 N-CA-C 110.814 -0.915 . . . . 0.0 110.814 -179.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.441 ' HG2' ' CG2' ' A' ' 51' ' ' VAL . 4.4 tp10 -88.34 124.14 33.61 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.822 0.344 . . . . 0.0 110.503 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -71.56 76.28 0.66 Allowed Glycine 0 CA--C 1.522 0.507 0 N-CA-C 110.637 -0.985 . . . . 0.0 110.637 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 154.04 -36.75 0.71 Allowed Glycine 0 CA--C 1.522 0.49 0 N-CA-C 110.633 -0.987 . . . . 0.0 110.633 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.775 HG11 ' HG3' ' A' ' 9' ' ' GLU . 16.2 m -142.82 -176.7 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.95 0.405 . . . . 0.0 110.537 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 5.4 m95 -96.33 131.67 42.62 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.637 -179.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.667 ' CG2' ' HB2' ' A' ' 18' ' ' ALA . 0.8 OUTLIER -130.29 147.07 51.96 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.404 -179.958 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.544 ' CG ' HD23 ' A' ' 33' ' ' LEU . 45.6 t80 -137.43 142.27 41.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.239 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -91.25 141.12 29.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.507 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.1 p -143.11 147.01 34.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.278 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -144.45 31.56 1.21 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.456 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.4 ' HB2' ' HD2' ' A' ' 59' ' ' PRO . 6.5 pt-20 -102.87 157.26 34.07 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.228 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.4 ' HD2' ' HB2' ' A' ' 58' ' ' GLU . 47.9 Cg_endo -71.1 -32.52 13.07 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.603 2.202 . . . . 0.0 112.142 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.1 mt -80.6 102.3 9.72 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.336 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -138.87 132.79 31.02 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.477 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -177.63 -98.78 0.11 Allowed Glycine 0 CA--C 1.526 0.758 0 N-CA-C 110.644 -0.982 . . . . 0.0 110.644 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -81.38 164.88 18.96 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.609 2.206 . . . . 0.0 112.083 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -139.36 161.34 37.68 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.465 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.404 ' ND2' ' N ' ' A' ' 65' ' ' ASN . 1.2 m-80 -126.99 149.51 49.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.194 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.477 ' CD2' ' O ' ' A' ' 32' ' ' GLU . 85.1 m-85 -138.83 159.84 41.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.967 0.413 . . . . 0.0 111.071 -179.629 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.51 ' HG3' ' CH2' ' A' ' 41' ' ' TRP . 10.0 mtp-105 -152.42 73.18 1.02 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.84 179.352 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.691 ' O ' HD23 ' A' ' 69' ' ' LEU . 6.3 p90 -70.49 175.2 4.97 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.384 0.612 . . . . 0.0 111.023 -179.531 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.756 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 23.9 mt -146.88 57.58 1.16 Allowed 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.972 -1.013 . . . . 0.0 109.396 179.789 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 28.4 p -25.84 135.95 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.872 0.869 . . . . 0.0 112.487 -179.137 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.756 ' HG2' ' HB2' ' A' ' 29' ' ' ALA . 3.9 mm-40 -51.96 -23.95 5.78 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.599 -179.498 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 17.9 tptp -147.07 68.58 1.16 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.644 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -160.91 -103.82 0.19 Allowed Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.875 -0.89 . . . . 0.0 110.875 179.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -178.58 -176.69 0.5 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.89 0.376 . . . . 0.0 110.638 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.553 ' CG ' HD22 ' A' ' 69' ' ' LEU . 0.0 OUTLIER -93.2 172.96 7.97 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.345 -179.858 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 171.81 137.17 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.603 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.463 HG22 ' CD ' ' A' ' 67' ' ' ARG . 45.6 t -99.36 132.48 44.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 179.527 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.522 ' CE2' ' CG2' ' A' ' 4' ' ' VAL . 52.3 m-85 -117.28 139.8 50.36 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.5 -179.572 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -126.12 161.9 26.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.421 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 51.22 35.83 14.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.441 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.666 HG22 ' HD3' ' A' ' 94' ' ' PRO . 48.9 t -75.91 -2.55 4.23 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.816 179.757 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 84.0 t -154.12 131.63 6.21 Favored Pre-proline 0 CA--C 1.529 0.161 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.499 ' HG3' ' CE1' ' A' ' 92' ' ' TYR . 48.6 Cg_endo -75.22 178.68 6.99 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.516 2.144 . . . . 0.0 112.181 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -64.54 -57.52 8.92 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.12 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.93 73.72 0.83 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.171 179.717 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.511 ' HB2' ' CE2' ' A' ' 92' ' ' TYR . 23.1 p90 -70.22 177.02 3.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.521 -179.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 2.7 m -137.27 119.23 15.31 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.094 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.617 ' H ' HD12 ' A' ' 88' ' ' ILE . 4.3 mp -48.94 119.3 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.547 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 105.06 59.03 0.66 Allowed Glycine 0 CA--C 1.523 0.533 0 N-CA-C 110.591 -1.004 . . . . 0.0 110.591 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -170.75 146.23 2.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.896 0.379 . . . . 0.0 110.639 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.445 ' CG2' ' HB ' ' A' ' 5' ' ' THR . 8.5 m -93.43 122.99 36.42 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.046 179.696 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.511 ' CE2' ' HB2' ' A' ' 86' ' ' TYR . 69.9 m-85 -108.12 -87.55 0.49 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.791 -179.592 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.91 ' HB1' ' HD2' ' A' ' 94' ' ' PRO . . . 50.42 -179.97 0.01 OUTLIER Pre-proline 0 C--O 1.232 0.133 0 CA-C-O 120.641 0.257 . . . . 0.0 110.432 -179.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.91 ' HD2' ' HB1' ' A' ' 93' ' ' ALA . 49.3 Cg_endo . . . . . 0 C--O 1.25 1.075 0 C-N-CA 122.45 2.1 . . . . 0.0 111.937 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.673 HG23 ' O ' ' A' ' 1' ' ' VAL . 27.8 m . . . . . 0 N--CA 1.492 1.666 0 N-CA-C 110.299 -0.26 . . . . 0.0 110.299 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.425 ' HG3' ' ND2' ' A' ' 76' ' ' ASN . 48.6 Cg_endo -76.57 168.81 23.03 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.546 2.164 . . . . 0.0 112.044 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 4.5 mttm -139.65 85.39 2.04 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.355 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.649 HG21 ' CZ ' ' A' ' 78' ' ' PHE . 16.8 m -124.85 -176.39 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.424 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.429 HG23 ' O ' ' A' ' 4' ' ' VAL . 0.1 OUTLIER -165.14 148.04 8.18 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.235 179.878 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.602 ' H ' ' HB3' ' A' ' 93' ' ' ALA . 48.2 m-85 -123.34 145.56 48.64 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.326 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.503 HG22 ' H ' ' A' ' 8' ' ' VAL . 0.2 OUTLIER -129.3 -176.99 4.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.301 -179.942 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.503 ' H ' HG22 ' A' ' 7' ' ' THR . 39.8 t -128.14 87.42 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.4 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.83 ' HG3' HG11 ' A' ' 51' ' ' VAL . 1.3 mm-40 -52.27 147.92 7.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.275 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.27 63.16 0.35 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.371 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -154.39 23.32 0.66 Allowed Glycine 0 CA--C 1.525 0.682 0 N-CA-C 111.022 -0.831 . . . . 0.0 111.022 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 16.9 m -76.07 105.02 6.88 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.442 ' ND2' ' N ' ' A' ' 13' ' ' ASN . 0.4 OUTLIER -75.92 -178.48 4.35 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.096 -179.721 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -62.07 -36.6 82.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.466 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 4.9 ptmt -124.72 36.45 4.6 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.666 -179.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.428 ' HB2' ' CB ' ' A' ' 13' ' ' ASN . 13.2 m80 -136.09 -176.27 4.26 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.844 0.354 . . . . 0.0 110.563 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 32.1 tp -167.07 85.61 0.26 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.269 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.436 ' HB2' ' CG2' ' A' ' 53' ' ' THR . . . -81.33 107.29 13.99 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.58 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.52 HG23 HG23 ' A' ' 21' ' ' VAL . 17.8 m -88.99 -170.66 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.163 179.698 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.44 HD12 ' HG2' ' A' ' 9' ' ' GLU . 1.9 tt -142.4 57.68 1.45 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.308 179.67 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.52 HG23 HG23 ' A' ' 19' ' ' VAL . 4.9 t -72.17 114.72 11.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.463 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.93 164.03 20.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.318 179.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER 174.05 150.05 0.08 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.372 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -79.79 -26.89 40.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.485 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -53.56 -75.84 0.21 Allowed Glycine 0 CA--C 1.524 0.625 0 N-CA-C 110.826 -0.91 . . . . 0.0 110.826 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -93.77 -164.21 1.15 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.794 0.33 . . . . 0.0 110.428 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.07 -158.31 0.82 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.415 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.422 ' O ' ' CG ' ' A' ' 71' ' ' GLU . 47.1 mtm -132.25 126.82 34.37 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.704 -179.76 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.855 ' HB3' ' O ' ' A' ' 69' ' ' LEU . . . -125.9 -44.04 1.8 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.083 179.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.43 ' O ' ' HB2' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -164.27 168.93 18.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.89 -0.596 . . . . 0.0 109.526 179.712 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 8.9 t -154.11 136.48 6.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.901 0.381 . . . . 0.0 110.975 -179.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.439 ' CB ' ' HA ' ' A' ' 43' ' ' ALA . 3.3 pt-20 -134.08 138.06 45.03 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 178.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.628 HD23 ' CG ' ' A' ' 54' ' ' PHE . 13.4 tp -118.24 155.6 30.26 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 121.157 0.503 . . . . 0.0 110.854 -178.015 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.602 ' H ' HD12 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -136.75 -156.97 0.74 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.325 178.946 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.415 ' O ' ' ND2' ' A' ' 65' ' ' ASN . 1.5 mp0 -153.35 -79.72 0.1 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.696 0.284 . . . . 0.0 110.559 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 177.18 119.32 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.79 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 52.64 63.75 4.68 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 111.165 -0.774 . . . . 0.0 111.165 179.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.473 ' CB ' ' NH1' ' A' ' 34' ' ' ARG . 0.3 OUTLIER -111.31 -70.08 0.83 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.946 0.403 . . . . 0.0 110.289 179.797 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 25.4 t0 179.59 -63.3 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.119 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -157.04 163.0 39.53 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.344 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.495 ' CZ2' ' HG3' ' A' ' 67' ' ' ARG . 94.3 m95 -57.57 146.89 28.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.695 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.444 HG23 ' O ' ' A' ' 33' ' ' LEU . 2.8 m -129.31 107.92 16.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.439 ' HA ' ' CB ' ' A' ' 32' ' ' GLU . . . -45.96 140.86 3.44 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.777 -179.546 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.02 -170.89 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.539 -179.72 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 86.6 m -138.8 98.84 3.64 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.326 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 13.0 ptmt -67.01 79.29 0.12 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.509 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -128.29 24.87 4.94 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.76 -0.936 . . . . 0.0 110.76 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.421 ' CB ' HG23 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -107.59 175.8 5.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.801 0.334 . . . . 0.0 110.38 179.978 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -60.25 -43.92 98.0 Favored Glycine 0 CA--C 1.523 0.562 0 N-CA-C 110.572 -1.011 . . . . 0.0 110.572 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -160.52 27.6 0.32 Allowed Glycine 0 CA--C 1.524 0.619 0 N-CA-C 110.828 -0.909 . . . . 0.0 110.828 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.83 HG11 ' HG3' ' A' ' 9' ' ' GLU . 14.7 m -143.13 -175.81 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.8 0.333 . . . . 0.0 110.369 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 6.7 m95 -109.29 141.94 40.88 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.712 -179.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.436 ' CG2' ' HB2' ' A' ' 18' ' ' ALA . 0.0 OUTLIER -125.81 159.38 32.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.924 179.533 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.628 ' CG ' HD23 ' A' ' 33' ' ' LEU . 68.1 t80 -144.09 133.68 23.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.845 0.355 . . . . 0.0 110.511 -179.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -84.9 128.61 34.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.364 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -122.54 154.15 38.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.379 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -162.22 50.73 0.2 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.467 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -128.71 156.38 77.63 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.569 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -66.99 -28.28 41.95 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.897 2.398 . . . . 0.0 112.123 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -80.06 163.43 24.18 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.28 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -175.29 44.74 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.49 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -83.01 -132.68 1.9 Allowed Glycine 0 CA--C 1.527 0.808 0 N-CA-C 110.36 -1.096 . . . . 0.0 110.36 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -75.29 141.3 25.67 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.355 2.037 . . . . 0.0 111.8 179.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 44.8 m-85 -97.62 153.0 18.49 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.529 -179.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.415 ' ND2' ' O ' ' A' ' 35' ' ' GLU . 6.2 m-80 -124.79 126.23 45.29 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.026 -0.533 . . . . 0.0 109.913 179.581 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.571 ' CD2' ' CE2' ' A' ' 6' ' ' PHE . 2.7 m-85 -104.74 -178.25 3.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.654 -179.573 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.495 ' HG3' ' CZ2' ' A' ' 41' ' ' TRP . 0.0 OUTLIER 175.27 77.85 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.997 179.975 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.506 ' HZ ' HG11 ' A' ' 4' ' ' VAL . 1.4 p90 -84.75 164.08 18.75 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.222 0.534 . . . . 0.0 110.975 -179.653 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.855 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 9.1 mt -109.75 64.26 0.61 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.283 -0.872 . . . . 0.0 108.861 178.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.428 HG23 ' CD1' ' A' ' 68' ' ' PHE . 0.8 OUTLIER -33.77 138.06 0.09 Allowed 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 115.552 -0.749 . . . . 0.0 112.206 -178.833 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.677 ' HG2' ' HB2' ' A' ' 29' ' ' ALA . 19.0 mt-10 -49.02 -28.13 3.74 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.958 -179.543 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.01 26.64 0.31 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.678 0.275 . . . . 0.0 111.127 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.422 ' O ' ' CB ' ' A' ' 74' ' ' MET . . . -97.15 -36.46 4.94 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 110.381 -1.088 . . . . 0.0 110.381 179.67 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.422 ' CB ' ' O ' ' A' ' 73' ' ' GLY . 0.0 OUTLIER 82.25 70.8 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 120.85 0.357 . . . . 0.0 111.089 179.443 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 48.98 -179.29 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.198 179.209 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.51 ' HB3' ' CE2' ' A' ' 78' ' ' PHE . 0.3 OUTLIER 167.65 128.45 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.882 179.886 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 77.5 t -95.31 137.54 23.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.013 0.435 . . . . 0.0 110.525 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.649 ' CZ ' HG21 ' A' ' 4' ' ' VAL . 92.4 m-85 -133.39 144.46 49.58 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.494 -179.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -133.58 161.49 34.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.194 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 54.02 30.28 11.57 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.94 0.4 . . . . 0.0 110.138 -179.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.58 HG13 ' HB2' ' A' ' 93' ' ' ALA . 87.4 t -64.48 -15.97 18.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.2 -179.739 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 44.6 t -146.72 132.5 9.36 Favored Pre-proline 0 C--N 1.332 -0.19 0 CA-C-O 120.506 0.193 . . . . 0.0 110.565 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.469 ' HD3' ' CD1' ' A' ' 92' ' ' TYR . 50.6 Cg_endo -75.44 165.81 29.93 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.561 2.174 . . . . 0.0 111.899 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -66.12 126.54 28.98 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.293 -0.412 . . . . 0.0 109.989 179.651 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 24.7 mtmt 60.17 50.12 6.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.942 0.401 . . . . 0.0 109.924 -179.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 51.3 p90 -47.56 158.96 0.16 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.967 -179.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 29.1 m -124.04 108.85 12.8 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.035 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 2.7 mp -47.98 107.64 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.626 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 132.7 44.76 0.14 Allowed Glycine 0 CA--C 1.523 0.565 0 N-CA-C 110.449 -1.061 . . . . 0.0 110.449 -179.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -163.29 156.41 19.01 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.99 101.68 11.23 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.722 -179.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.469 ' CD1' ' HD3' ' A' ' 83' ' ' PRO . 32.7 m-85 -87.98 -160.17 0.6 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.868 179.563 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.916 ' HB1' ' HD2' ' A' ' 94' ' ' PRO . . . 66.82 176.58 0.06 OUTLIER Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 120.721 0.296 . . . . 0.0 110.578 179.653 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.916 ' HD2' ' HB1' ' A' ' 93' ' ' ALA . 47.7 Cg_endo . . . . . 0 C--O 1.249 1.056 0 C-N-CA 122.567 2.178 . . . . 0.0 112.04 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.463 HG23 ' O ' ' A' ' 1' ' ' VAL . 6.2 m . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 110.232 -0.284 . . . . 0.0 110.232 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -78.15 139.6 17.07 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.608 2.206 . . . . 0.0 112.016 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 8.4 mtmt -128.54 55.54 1.69 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.272 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.751 HG11 ' CE1' ' A' ' 78' ' ' PHE . 1.7 p -149.32 164.24 4.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.301 0.572 . . . . 0.0 110.215 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.481 ' N ' HG22 ' A' ' 4' ' ' VAL . 0.6 OUTLIER -156.99 133.41 9.89 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.516 179.775 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.516 ' HD1' ' HB2' ' A' ' 93' ' ' ALA . 8.2 m-85 -109.77 179.29 4.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.092 -0.504 . . . . 0.0 109.893 179.535 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.5 m -166.23 128.32 1.89 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.846 0.355 . . . . 0.0 110.335 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.687 ' O ' HG23 ' A' ' 88' ' ' ILE . 29.2 t -70.0 87.51 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.189 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.552 ' CG ' HG21 ' A' ' 51' ' ' VAL . 1.2 mm-40 -58.28 166.09 1.78 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.436 -179.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.575 ' HA ' HG21 ' A' ' 88' ' ' ILE . 1.6 mppt? -54.53 -21.84 11.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.83 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -45.14 -37.43 5.81 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 111.269 -0.733 . . . . 0.0 111.269 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 13.3 m -68.19 124.97 24.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.778 0.323 . . . . 0.0 110.348 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -133.93 -52.74 0.85 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.516 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -146.72 -76.78 0.19 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.658 -179.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 14.4 mmmt -99.32 25.58 6.79 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.462 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 31.4 m80 -125.38 147.51 49.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.451 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.465 HD22 ' HA ' ' A' ' 17' ' ' LEU . 0.2 OUTLIER -133.44 91.53 2.87 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.0 0.428 . . . . 0.0 110.366 179.881 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.714 ' HB1' HG11 ' A' ' 51' ' ' VAL . . . -92.12 131.99 36.94 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.16 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.84 ' O ' HG13 ' A' ' 51' ' ' VAL . 14.5 m -127.5 135.33 63.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.847 0.356 . . . . 0.0 110.596 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.538 HD12 ' OE2' ' A' ' 9' ' ' GLU . 1.3 tt -91.98 67.2 5.14 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.036 -179.789 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.527 ' CG1' ' CD1' ' A' ' 52' ' ' TRP . 2.2 p -82.19 110.2 17.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 179.395 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 30.3 tttm -178.06 111.13 0.07 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.33 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 29.3 p90 -136.56 151.21 49.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.441 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -50.78 172.99 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.526 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 76.05 -84.8 0.91 Allowed Glycine 0 CA--C 1.523 0.557 0 N-CA-C 110.753 -0.939 . . . . 0.0 110.753 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.517 ' HB3' HG21 ' A' ' 70' ' ' THR . 0.8 OUTLIER -64.62 179.11 0.66 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.734 0.302 . . . . 0.0 110.344 -179.994 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -133.08 178.65 6.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.488 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.422 ' O ' ' CG ' ' A' ' 71' ' ' GLU . 0.1 OUTLIER -105.55 120.42 41.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.26 179.963 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.831 ' HB3' ' O ' ' A' ' 69' ' ' LEU . . . -130.65 -50.68 1.06 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.823 -179.69 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.409 ' CG ' ' O ' ' A' ' 29' ' ' ALA . 29.1 mt-10 -159.23 150.51 20.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.999 0.428 . . . . 0.0 110.848 -179.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.702 HG21 ' CD1' ' A' ' 52' ' ' TRP . 20.3 t -140.43 142.89 30.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.679 179.53 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.466 ' CB ' ' HA ' ' A' ' 43' ' ' ALA . 1.9 pt-20 -148.77 137.43 21.3 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.875 0.369 . . . . 0.0 110.475 -179.759 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.706 HD21 ' HB3' ' A' ' 64' ' ' PHE . 3.9 mt -89.84 173.18 8.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.139 -179.424 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.449 ' HB2' ' CZ3' ' A' ' 41' ' ' TRP . 20.2 ttt180 -121.49 -63.3 1.33 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.477 179.261 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.448 ' O ' ' N ' ' A' ' 37' ' ' GLY . 14.0 mt-10 89.62 23.65 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 123.555 0.742 . . . . 0.0 109.961 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 58.49 -76.98 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.332 179.427 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.448 ' N ' ' O ' ' A' ' 35' ' ' GLU . . . -48.38 -65.24 2.66 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 111.119 -0.792 . . . . 0.0 111.119 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -49.34 101.3 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.808 0.337 . . . . 0.0 110.591 -179.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -59.79 -28.91 67.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.338 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -94.1 129.4 40.67 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.308 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.449 ' CZ3' ' HB2' ' A' ' 34' ' ' ARG . 80.6 m95 -66.39 141.28 58.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.591 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.587 HG23 ' O ' ' A' ' 42' ' ' VAL . 35.8 m -111.77 111.66 37.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.969 179.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.466 ' HA ' ' CB ' ' A' ' 32' ' ' GLU . . . -49.33 141.54 8.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.845 -179.601 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.53 -167.66 0.2 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.121 179.767 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 85.8 m -156.28 98.24 1.83 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.502 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.51 90.47 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.107 179.749 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -112.39 -17.89 7.92 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 111.384 -0.686 . . . . 0.0 111.384 -179.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.458 ' CB ' ' HB ' ' A' ' 51' ' ' VAL . 17.7 tp10 -77.78 -28.69 50.61 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.852 0.326 . . . . 0.0 110.719 -179.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 112.55 -39.74 2.76 Favored Glycine 0 CA--C 1.52 0.401 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 -179.395 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -137.14 16.16 3.68 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 178.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.84 HG13 ' O ' ' A' ' 19' ' ' VAL . 50.4 t -149.01 147.12 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . 0.702 ' CD1' HG21 ' A' ' 31' ' ' VAL . 2.0 m95 -89.87 111.78 22.93 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.282 -179.506 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.495 HG22 ' HB2' ' A' ' 18' ' ' ALA . 4.9 p -99.76 151.05 21.69 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.501 -179.67 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 57.0 t80 -139.33 151.24 46.22 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.138 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -106.88 129.88 54.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.714 -179.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 14.3 t -127.98 156.03 43.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.11 179.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -156.86 37.48 0.31 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.437 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -124.79 154.33 70.58 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.441 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -72.89 -41.43 1.43 Allowed 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.644 2.229 . . . . 0.0 111.926 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -71.54 77.14 0.8 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.49 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -116.35 89.39 3.1 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.492 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -98.76 -131.79 7.4 Favored Glycine 0 CA--C 1.527 0.79 0 N-CA-C 110.438 -1.065 . . . . 0.0 110.438 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -75.03 145.69 31.65 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.375 2.05 . . . . 0.0 111.767 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.706 ' HB3' HD21 ' A' ' 33' ' ' LEU . 56.1 m-85 -97.11 100.71 12.19 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.933 0.396 . . . . 0.0 110.345 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.429 ' OD1' ' N ' ' A' ' 65' ' ' ASN . 0.3 OUTLIER -78.27 141.33 38.6 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.949 -0.568 . . . . 0.0 109.781 179.952 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.496 ' CE1' ' HG ' ' A' ' 33' ' ' LEU . 92.7 m-85 -128.71 -177.45 4.2 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.046 0.451 . . . . 0.0 110.532 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.411 ' HG2' ' CE3' ' A' ' 41' ' ' TRP . 0.0 OUTLIER 178.35 52.22 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.691 179.845 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.509 ' HB3' HG22 ' A' ' 31' ' ' VAL . 0.9 OUTLIER -49.98 169.23 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.727 -179.671 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.831 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 1.1 mt -123.95 72.87 1.18 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.213 179.613 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.517 HG21 ' HB3' ' A' ' 26' ' ' ASP . 71.6 p -35.17 137.59 0.15 Allowed 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.783 -179.201 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.746 ' HG2' ' HB2' ' A' ' 29' ' ' ALA . 4.8 mm-40 -45.83 -55.1 7.05 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.951 -179.558 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 41.4 tptt -138.85 77.83 1.64 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.528 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -163.42 -91.13 0.08 OUTLIER Glycine 0 CA--C 1.523 0.583 0 N-CA-C 110.57 -1.012 . . . . 0.0 110.57 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER 176.76 172.69 0.44 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.892 0.377 . . . . 0.0 110.459 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.45 145.09 35.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.216 179.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -138.75 140.72 38.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.568 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 95.5 t -85.54 152.82 3.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.334 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.751 ' CE1' HG11 ' A' ' 4' ' ' VAL . 32.6 m-85 -138.46 120.78 15.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.227 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 30.8 p-10 -117.26 48.37 1.35 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.676 -179.443 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 167.34 65.96 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.617 HG22 ' HD3' ' A' ' 94' ' ' PRO . 70.3 t -111.68 -10.07 11.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.564 -178.727 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.433 HG23 ' C ' ' A' ' 81' ' ' VAL . 86.9 t -156.04 131.7 5.58 Favored Pre-proline 0 C--N 1.331 -0.197 0 CA-C-O 120.648 0.261 . . . . 0.0 110.765 179.511 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.51 ' HD3' ' CD1' ' A' ' 92' ' ' TYR . 47.5 Cg_endo -68.74 -165.65 0.14 Allowed 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.807 2.338 . . . . 0.0 111.875 179.461 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -77.22 -38.09 52.0 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.15 -0.477 . . . . 0.0 109.852 179.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 1.1 mttt -123.31 74.92 1.27 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.959 179.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.413 ' HB2' HG21 ' A' ' 8' ' ' VAL . 24.5 p90 -47.38 171.02 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.954 -179.588 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -149.4 109.75 4.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.147 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.687 HG23 ' O ' ' A' ' 8' ' ' VAL . 2.9 mp -52.69 122.11 2.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.526 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 102.29 42.67 2.16 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 110.936 -0.866 . . . . 0.0 110.936 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -160.07 129.64 5.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.85 0.357 . . . . 0.0 110.57 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.467 HG23 ' O ' ' A' ' 6' ' ' PHE . 15.1 m -81.4 128.36 33.77 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.136 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.51 ' CD1' ' HD3' ' A' ' 83' ' ' PRO . 63.3 m-85 -111.97 -93.09 0.46 Allowed 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.876 -179.58 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.627 ' HB1' ' HD2' ' A' ' 94' ' ' PRO . . . 53.26 172.35 0.04 OUTLIER Pre-proline 0 N--CA 1.462 0.157 0 CA-C-O 120.852 0.358 . . . . 0.0 110.419 -179.661 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.627 ' HD2' ' HB1' ' A' ' 93' ' ' ALA . 47.8 Cg_endo . . . . . 0 C--O 1.249 1.055 0 C-N-CA 122.783 2.322 . . . . 0.0 112.127 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.431 HG23 ' HD2' ' A' ' 2' ' ' PRO . 11.9 p . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.431 ' HD2' HG23 ' A' ' 1' ' ' VAL . 49.7 Cg_endo -76.12 163.08 33.42 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.468 2.112 . . . . 0.0 111.901 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.33 94.03 3.37 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.239 -179.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.641 ' O ' HG23 ' A' ' 5' ' ' THR . 35.9 m -85.43 -175.56 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.547 -179.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.641 HG23 ' O ' ' A' ' 4' ' ' VAL . 0.7 OUTLIER -166.52 151.25 7.73 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.175 179.749 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.571 ' H ' ' HB3' ' A' ' 93' ' ' ALA . 51.4 m-85 -119.51 165.59 14.2 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.352 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.404 HG23 ' HA ' ' A' ' 91' ' ' THR . 1.2 m -159.35 119.38 3.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.402 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.464 HG12 HD13 ' A' ' 88' ' ' ILE . 55.6 t -63.85 104.78 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.349 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.88 ' HG3' HG11 ' A' ' 51' ' ' VAL . 3.5 mm-40 -74.52 156.95 36.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.452 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 8.5 mttt -52.06 163.83 0.33 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.313 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 82.99 27.46 40.95 Favored Glycine 0 CA--C 1.523 0.54 0 N-CA-C 110.684 -0.966 . . . . 0.0 110.684 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.834 ' CB ' HD11 ' A' ' 88' ' ' ILE . 86.3 p -81.16 114.3 19.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.776 0.322 . . . . 0.0 110.346 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 47.2 m-80 -107.86 179.97 4.07 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.321 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -67.92 -29.82 68.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.41 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 10.4 mmmm -98.35 -44.65 6.45 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.478 -179.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 18.0 m80 -80.4 162.11 24.63 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.743 -179.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.496 ' HG ' ' CE2' ' A' ' 64' ' ' PHE . 2.3 tm? -155.95 77.32 0.95 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.754 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.428 ' HB2' ' CG2' ' A' ' 53' ' ' THR . . . -69.52 140.31 53.91 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.84 -179.427 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.4 ' O ' ' HB ' ' A' ' 51' ' ' VAL . 24.6 m -127.85 -178.2 2.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.793 -0.639 . . . . 0.0 109.682 179.544 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.0 tt -134.95 80.42 1.84 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.833 0.349 . . . . 0.0 110.362 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.9 t -90.13 96.21 6.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.33 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 39.5 mttt -148.86 145.79 27.65 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.397 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 2.2 p90 179.0 159.89 0.64 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.272 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -58.91 -175.92 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.425 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 72.53 -90.31 0.54 Allowed Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.66 -0.976 . . . . 0.0 110.66 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.737 ' OD2' HG21 ' A' ' 70' ' ' THR . 12.0 m-20 -68.1 168.1 12.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.733 0.302 . . . . 0.0 110.348 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.663 ' O ' HG22 ' A' ' 27' ' ' THR . 36.7 m -134.68 35.65 3.14 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.925 0.393 . . . . 0.0 110.647 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.423 ' O ' ' CG ' ' A' ' 71' ' ' GLU . 0.0 OUTLIER 61.4 120.85 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.829 179.639 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.82 ' HB3' ' O ' ' A' ' 69' ' ' LEU . . . -126.26 -51.73 1.52 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.09 179.531 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -157.59 169.26 25.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.868 -0.606 . . . . 0.0 109.737 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.466 HG21 ' CD1' ' A' ' 52' ' ' TRP . 3.2 t -150.6 139.57 15.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.179 0.514 . . . . 0.0 110.775 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.412 ' HG3' ' O ' ' A' ' 42' ' ' VAL . 2.5 tt0 -132.73 144.87 50.57 Favored 'General case' 0 N--CA 1.436 -1.126 0 CA-C-N 115.408 -0.814 . . . . 0.0 109.613 -179.217 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.648 HD21 ' CZ ' ' A' ' 66' ' ' PHE . 2.4 mt -121.59 175.22 6.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.398 0.618 . . . . 0.0 111.429 -179.32 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.475 ' HB2' ' CE3' ' A' ' 41' ' ' TRP . 27.5 ttt180 -167.16 162.77 15.39 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.03 -0.986 . . . . 0.0 109.149 179.581 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.443 ' N ' ' HG2' ' A' ' 34' ' ' ARG . 40.8 mt-10 -120.31 -85.1 0.66 Allowed 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 179.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.403 ' HB2' ' O ' ' A' ' 35' ' ' GLU . 3.3 t60 179.8 -56.43 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.307 179.374 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -106.06 56.54 0.51 Allowed Glycine 0 CA--C 1.523 0.566 0 N-CA-C 110.616 -0.994 . . . . 0.0 110.616 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 23.1 t -130.76 -160.71 1.06 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.847 0.356 . . . . 0.0 110.386 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -87.23 52.4 2.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.298 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 66.83 -174.63 0.19 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.246 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.476 ' CE3' ' HG2' ' A' ' 67' ' ' ARG . 88.3 m95 -47.97 142.45 5.01 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.722 -179.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.598 HG22 ' O ' ' A' ' 33' ' ' LEU . 16.8 m -107.07 -142.3 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 179.491 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.576 ' N ' HG23 ' A' ' 42' ' ' VAL . . . -156.27 130.64 8.78 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.51 -179.77 1.14 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.724 0.297 . . . . 0.0 110.532 -179.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 89.8 m -151.43 123.36 8.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.505 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.499 ' HB3' ' CZ3' ' A' ' 52' ' ' TRP . 0.0 OUTLIER -83.62 97.41 9.05 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.363 179.919 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -148.1 23.8 1.42 Allowed Glycine 0 CA--C 1.524 0.601 0 N-CA-C 111.095 -0.802 . . . . 0.0 111.095 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -100.6 -31.59 11.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.8 0.334 . . . . 0.0 110.225 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 96.18 27.9 9.69 Favored Glycine 0 CA--C 1.522 0.525 0 N-CA-C 110.801 -0.92 . . . . 0.0 110.801 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 166.6 -34.47 0.23 Allowed Glycine 0 CA--C 1.523 0.59 0 N-CA-C 110.811 -0.916 . . . . 0.0 110.811 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.88 HG11 ' HG3' ' A' ' 9' ' ' GLU . 4.8 m -126.33 -178.38 2.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.875 0.369 . . . . 0.0 110.508 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . 0.499 ' CZ3' ' HB3' ' A' ' 46' ' ' LYS . 7.5 m95 -110.6 142.68 42.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.346 -179.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.428 ' CG2' ' HB2' ' A' ' 18' ' ' ALA . 0.8 OUTLIER -134.15 152.05 51.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.314 179.987 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.435 ' CZ ' HG21 ' A' ' 42' ' ' VAL . 87.8 t80 -147.31 147.66 30.59 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.43 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -93.87 120.57 34.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.374 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -142.78 175.58 9.71 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.371 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -131.69 -64.66 0.78 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.011 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 48.58 104.34 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 115.982 -0.553 . . . . 0.0 111.458 179.306 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -64.0 -16.71 56.47 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.345 2.03 . . . . 0.0 111.34 178.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 7.1 mp -75.22 -171.31 1.38 Allowed 'General case' 0 C--O 1.232 0.142 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.99 179.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 4.9 mp0 -60.43 -79.02 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 179.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.493 ' N ' ' HD3' ' A' ' 63' ' ' PRO . . . -175.5 58.63 0.11 Allowed Glycine 0 CA--C 1.527 0.798 0 N-CA-C 111.276 -0.73 . . . . 0.0 111.276 179.425 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.493 ' HD3' ' N ' ' A' ' 62' ' ' GLY . 51.7 Cg_endo -88.23 108.05 0.56 Allowed 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.798 2.332 . . . . 0.0 111.984 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.496 ' CE2' ' HG ' ' A' ' 17' ' ' LEU . 53.5 m-85 -109.73 166.63 10.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.133 0.492 . . . . 0.0 110.704 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -150.48 129.18 12.35 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.559 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.648 ' CZ ' HD21 ' A' ' 33' ' ' LEU . 33.3 m-85 -115.41 174.87 5.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.104 0.478 . . . . 0.0 111.097 -179.323 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.476 ' HG2' ' CE3' ' A' ' 41' ' ' TRP . 0.0 OUTLIER -175.24 50.34 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.704 179.849 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.57 ' O ' HD23 ' A' ' 69' ' ' LEU . 0.2 OUTLIER -56.44 172.79 0.21 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.108 -179.286 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.82 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 7.0 mt -124.86 73.54 1.29 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.282 179.627 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.737 HG21 ' OD2' ' A' ' 26' ' ' ASP . 22.8 p -38.22 142.97 0.14 Allowed 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.803 -179.156 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.72 ' HG2' ' HB2' ' A' ' 29' ' ' ALA . 3.5 mm-40 -51.47 -43.84 62.25 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.302 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.32 -39.27 69.75 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.316 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 108.97 46.67 0.93 Allowed Glycine 0 CA--C 1.522 0.508 0 N-CA-C 110.574 -1.01 . . . . 0.0 110.574 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 42.3 mtt -136.5 79.43 1.76 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.823 0.344 . . . . 0.0 110.62 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.36 -178.82 7.2 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.191 179.722 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.449 ' O ' ' CE2' ' A' ' 78' ' ' PHE . 0.5 OUTLIER 174.62 140.0 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.472 179.893 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.448 HG13 ' CH2' ' A' ' 41' ' ' TRP . 88.9 t -81.08 144.52 10.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.322 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.601 ' CZ ' HG21 ' A' ' 4' ' ' VAL . 38.1 m-85 -127.77 126.02 40.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.177 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -93.87 139.77 30.49 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.644 -179.655 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.457 ' O ' ' HB ' ' A' ' 81' ' ' VAL . 0.1 OUTLIER 69.19 -77.05 0.05 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.593 179.756 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.457 ' HB ' ' O ' ' A' ' 80' ' ' ASP . 53.5 t 70.68 -54.47 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 C-N-CA 123.682 0.793 . . . . 0.0 110.653 -179.575 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.605 HG13 ' HD2' ' A' ' 83' ' ' PRO . 93.8 t -105.69 140.78 21.53 Favored Pre-proline 0 C--N 1.325 -0.484 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 179.639 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.605 ' HD2' HG13 ' A' ' 82' ' ' VAL . 45.1 Cg_endo -71.27 -169.68 0.43 Allowed 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.579 2.186 . . . . 0.0 112.107 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -72.07 -64.42 0.94 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.237 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 14.4 mmtp -108.03 82.98 1.72 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.099 179.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.493 ' HB2' ' CE2' ' A' ' 92' ' ' TYR . 26.5 p90 -71.87 171.28 12.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.58 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 4.5 m -151.52 128.66 11.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.089 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.834 HD11 ' CB ' ' A' ' 12' ' ' SER . 36.3 mm -50.86 96.41 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.449 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 132.23 48.98 0.1 Allowed Glycine 0 CA--C 1.524 0.598 0 N-CA-C 110.844 -0.902 . . . . 0.0 110.844 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.675 ' HB3' ' CZ ' ' A' ' 92' ' ' TYR . . . -155.72 135.62 12.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.813 0.34 . . . . 0.0 110.362 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.404 ' HA ' HG23 ' A' ' 7' ' ' THR . 28.7 m -93.42 91.24 7.07 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.418 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.675 ' CZ ' ' HB3' ' A' ' 90' ' ' ALA . 30.4 m-85 -82.77 -161.27 0.47 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.202 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.93 ' HB1' ' HD2' ' A' ' 94' ' ' PRO . . . 74.63 177.84 0.06 OUTLIER Pre-proline 0 C--N 1.331 -0.208 0 CA-C-O 120.798 0.333 . . . . 0.0 110.635 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.93 ' HD2' ' HB1' ' A' ' 93' ' ' ALA . 48.5 Cg_endo . . . . . 0 C--O 1.248 0.996 0 C-N-CA 122.648 2.232 . . . . 0.0 112.037 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.629 HG13 ' O ' ' A' ' 1' ' ' VAL . 7.5 p . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 110.177 -0.305 . . . . 0.0 110.177 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -82.45 155.78 16.43 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.708 2.272 . . . . 0.0 112.12 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 19.2 mttt -102.15 31.27 4.03 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.251 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.74 HG11 ' CE1' ' A' ' 78' ' ' PHE . 1.7 p 177.94 164.06 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.174 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.48 ' N ' HG22 ' A' ' 4' ' ' VAL . 1.1 p -157.79 128.36 6.38 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.457 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.656 ' HD1' ' HB2' ' A' ' 93' ' ' ALA . 10.3 m-85 -102.72 177.84 4.74 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.122 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.419 ' O ' ' N ' ' A' ' 9' ' ' GLU . 0.3 OUTLIER -166.13 112.43 0.87 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.361 -179.851 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.672 ' O ' HG23 ' A' ' 88' ' ' ILE . 14.0 t -57.61 85.52 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.397 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.51 ' HB2' HG11 ' A' ' 51' ' ' VAL . 3.6 mm-40 -60.55 161.19 7.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.348 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -56.28 177.59 0.06 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.494 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 77.5 13.24 83.74 Favored Glycine 0 CA--C 1.527 0.805 0 N-CA-C 111.455 -0.658 . . . . 0.0 111.455 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 19.1 m -86.91 109.35 19.27 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.909 0.354 . . . . 0.0 110.051 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.427 ' O ' ' N ' ' A' ' 15' ' ' LYS . 4.6 p-10 -153.28 158.95 42.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.916 0.388 . . . . 0.0 110.806 -179.622 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 54.25 -85.96 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.835 179.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.427 ' N ' ' O ' ' A' ' 13' ' ' ASN . 0.0 OUTLIER -142.49 22.91 1.99 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.622 0.249 . . . . 0.0 110.745 -179.882 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -98.06 120.09 37.85 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 179.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.429 ' HG ' ' CE2' ' A' ' 64' ' ' PHE . 0.2 OUTLIER -113.3 98.42 7.1 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.054 0.455 . . . . 0.0 110.772 -179.499 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.885 ' HB1' HG11 ' A' ' 51' ' ' VAL . . . -86.76 138.83 31.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.027 179.572 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.473 ' N ' HG13 ' A' ' 51' ' ' VAL . 26.9 m -141.93 139.8 30.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.869 0.366 . . . . 0.0 110.816 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.426 ' HB2' ' CG ' ' A' ' 9' ' ' GLU . 0.5 OUTLIER -99.41 34.85 2.08 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.517 179.937 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.558 HG13 ' HE1' ' A' ' 52' ' ' TRP . 7.2 p -57.02 109.74 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 120.854 0.359 . . . . 0.0 110.521 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -179.59 77.68 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.243 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.501 ' CE2' ' HB ' ' A' ' 4' ' ' VAL . 25.7 p90 -84.63 -179.89 7.23 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.562 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -47.68 -68.28 0.2 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.874 -179.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -56.3 -20.26 28.44 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 111.207 -0.757 . . . . 0.0 111.207 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.48 ' HB2' ' CZ ' ' A' ' 23' ' ' TYR . 5.4 t70 -90.07 137.92 31.94 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.763 0.316 . . . . 0.0 110.594 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.674 ' O ' HG22 ' A' ' 27' ' ' THR . 88.5 m -124.63 11.08 8.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.104 179.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.413 ' O ' ' CG ' ' A' ' 71' ' ' GLU . 28.6 mtm 58.03 112.63 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.815 0.341 . . . . 0.0 110.625 179.654 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.681 ' HB3' ' O ' ' A' ' 69' ' ' LEU . . . -131.92 -49.06 0.95 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.584 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.871 ' HB3' HD12 ' A' ' 69' ' ' LEU . 27.5 tt0 -176.02 83.56 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.81 0.338 . . . . 0.0 110.907 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.742 HG21 ' CD1' ' A' ' 52' ' ' TRP . 18.5 t -68.45 155.0 7.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.15 179.589 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.725 ' OE2' HD21 ' A' ' 69' ' ' LEU . 4.5 pt-20 -147.14 142.09 26.96 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.839 0.352 . . . . 0.0 110.639 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.43 ' HG ' ' CE1' ' A' ' 66' ' ' PHE . 4.2 mt -103.49 -178.41 3.65 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.445 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.492 ' HB2' ' CZ3' ' A' ' 41' ' ' TRP . 6.4 ttt180 -132.85 -64.95 0.73 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.591 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.446 ' CB ' ' O ' ' A' ' 34' ' ' ARG . 23.3 mt-10 92.5 33.65 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.669 0.788 . . . . 0.0 109.187 -179.195 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 3.0 t-80 67.54 -68.81 0.15 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.487 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -157.34 57.87 0.36 Allowed Glycine 0 CA--C 1.523 0.578 0 N-CA-C 110.595 -1.002 . . . . 0.0 110.595 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.43 ' CB ' ' HB2' ' A' ' 35' ' ' GLU . 34.1 t -92.47 -46.17 7.78 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.77 0.319 . . . . 0.0 110.335 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 47.6 p-10 -177.51 52.65 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.537 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 62.51 -177.32 0.14 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.47 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.762 ' HH2' HG23 ' A' ' 77' ' ' VAL . 93.7 m95 -60.27 129.88 43.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.533 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.605 HG21 ' CZ ' ' A' ' 54' ' ' PHE . 25.1 m -122.76 116.44 48.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.125 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.471 ' HA ' ' CB ' ' A' ' 32' ' ' GLU . . . -56.08 140.28 44.29 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.47 -179.779 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.56 -167.65 0.2 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.173 -0.467 . . . . 0.0 109.953 179.787 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 91.4 m -153.62 127.15 8.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.864 0.364 . . . . 0.0 110.654 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 11.8 ptpt -73.18 77.2 1.28 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.03 179.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -93.22 -25.79 18.08 Favored Glycine 0 CA--C 1.522 0.516 0 N-CA-C 111.169 -0.772 . . . . 0.0 111.169 -179.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.484 ' CB ' ' HB ' ' A' ' 51' ' ' VAL . 2.9 mm-40 -86.95 -18.93 29.58 Favored 'General case' 0 C--N 1.33 -0.249 0 O-C-N 122.759 -0.259 . . . . 0.0 111.284 -179.483 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 96.48 -42.34 2.24 Favored Glycine 0 CA--C 1.523 0.539 0 N-CA-C 110.333 -1.107 . . . . 0.0 110.333 -179.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.55 ' O ' HG23 ' A' ' 51' ' ' VAL . . . -132.73 23.36 3.98 Favored Glycine 0 CA--C 1.522 0.51 0 N-CA-C 109.806 -1.318 . . . . 0.0 109.806 179.161 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.885 HG11 ' HB1' ' A' ' 18' ' ' ALA . 42.0 t -159.0 145.57 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 -179.621 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . 0.742 ' CD1' HG21 ' A' ' 31' ' ' VAL . 1.7 m95 -94.02 117.47 30.15 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.966 0.412 . . . . 0.0 110.607 -179.027 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.4 ' HA ' ' O ' ' A' ' 17' ' ' LEU . 3.2 p -110.36 139.55 45.44 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.029 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.605 ' CZ ' HG21 ' A' ' 42' ' ' VAL . 58.1 t80 -117.69 142.24 47.47 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.867 0.365 . . . . 0.0 110.611 -179.762 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -103.68 104.86 14.95 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.183 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -84.57 143.94 28.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.532 -179.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -112.35 1.83 16.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.122 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -121.96 156.71 59.24 Favored Pre-proline 0 C--O 1.231 0.099 0 CA-C-O 120.668 0.271 . . . . 0.0 110.361 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -70.85 -29.85 18.09 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.691 2.261 . . . . 0.0 112.18 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -81.73 134.1 35.41 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.42 -179.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -174.05 40.39 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.325 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -58.19 -93.07 0.01 OUTLIER Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.849 -0.9 . . . . 0.0 110.849 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -79.74 136.63 12.2 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.584 2.189 . . . . 0.0 112.053 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.429 ' CE2' ' HG ' ' A' ' 17' ' ' LEU . 49.8 m-85 -107.73 149.46 28.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.638 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -125.81 116.32 21.39 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 179.013 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.43 ' CE1' ' HG ' ' A' ' 33' ' ' LEU . 29.6 m-85 -100.65 171.11 7.91 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.29 0.566 . . . . 0.0 111.608 -178.706 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.522 ' HG3' ' CH2' ' A' ' 41' ' ' TRP . 0.0 OUTLIER -162.65 83.27 0.53 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.978 179.24 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.724 ' O ' HD23 ' A' ' 69' ' ' LEU . 5.2 p90 -70.87 167.59 18.64 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.432 0.634 . . . . 0.0 111.045 -179.5 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.871 HD12 ' HB3' ' A' ' 30' ' ' GLU . 4.2 mt -138.82 55.69 1.72 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.966 -1.015 . . . . 0.0 108.756 179.378 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.405 HG22 ' HA ' ' A' ' 26' ' ' ASP . 17.0 p -23.59 134.96 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.907 0.883 . . . . 0.0 112.732 -178.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.655 ' HG2' ' HB2' ' A' ' 29' ' ' ALA . 3.0 mt-10 -48.76 -26.24 2.25 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.691 -179.656 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -158.22 63.46 0.45 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.31 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -151.59 -103.95 0.26 Allowed Glycine 0 CA--C 1.523 0.576 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -169.31 -174.94 2.09 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.982 0.42 . . . . 0.0 110.561 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -123.9 172.36 8.97 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.219 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 175.73 140.35 0.06 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.931 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.762 HG23 ' HH2' ' A' ' 41' ' ' TRP . 2.5 p -79.49 145.56 9.17 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.209 0 CA-C-O 121.26 0.552 . . . . 0.0 110.037 179.561 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.74 ' CE1' HG11 ' A' ' 4' ' ' VAL . 98.3 m-85 -126.14 143.86 50.97 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.033 -179.409 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 30.1 t0 -121.69 155.85 34.31 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.901 0.381 . . . . 0.0 110.803 -179.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 4.3 t0 48.77 51.24 16.13 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.654 179.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.504 HG13 ' HA ' ' A' ' 93' ' ' ALA . 72.5 t -87.88 -16.49 8.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.627 179.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.53 HG13 ' HB3' ' A' ' 86' ' ' TYR . 59.4 t -148.57 133.35 9.06 Favored Pre-proline 0 C--N 1.332 -0.157 0 N-CA-C 110.433 -0.21 . . . . 0.0 110.433 179.667 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -68.53 -165.73 0.13 Allowed 'Trans proline' 0 N--CA 1.475 0.383 0 C-N-CA 122.695 2.263 . . . . 0.0 111.986 179.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -80.32 -37.84 31.79 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.282 -0.417 . . . . 0.0 109.957 179.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.98 67.02 1.11 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.218 179.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.53 ' HB3' HG13 ' A' ' 82' ' ' VAL . 33.6 p90 -55.58 163.88 1.2 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.644 -179.772 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 7.1 m -133.38 113.0 12.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.241 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.672 HG23 ' O ' ' A' ' 8' ' ' VAL . 2.7 mp -50.67 116.16 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.501 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 115.32 44.26 0.67 Allowed Glycine 0 CA--C 1.524 0.595 0 N-CA-C 110.677 -0.969 . . . . 0.0 110.677 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -163.24 141.18 7.87 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.816 0.341 . . . . 0.0 110.527 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.505 HG23 ' O ' ' A' ' 6' ' ' PHE . 17.2 m -90.5 112.13 23.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.19 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.426 ' CB ' ' O ' ' A' ' 81' ' ' VAL . 74.2 m-85 -94.39 -99.03 0.15 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.53 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.932 ' HB1' ' HD2' ' A' ' 94' ' ' PRO . . . 50.48 179.13 0.02 OUTLIER Pre-proline 0 C--O 1.231 0.096 0 CA-C-O 120.704 0.288 . . . . 0.0 110.558 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.932 ' HD2' ' HB1' ' A' ' 93' ' ' ALA . 48.0 Cg_endo . . . . . 0 C--O 1.25 1.075 0 C-N-CA 122.464 2.109 . . . . 0.0 112.044 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 19.9 t . . . . . 0 N--CA 1.49 1.535 0 N-CA-C 110.183 -0.303 . . . . 0.0 110.183 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -76.94 169.78 21.02 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.598 2.198 . . . . 0.0 112.062 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 3.8 mttt -174.7 109.55 0.12 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.362 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.604 HG11 ' CE1' ' A' ' 78' ' ' PHE . 1.8 p -135.58 163.57 34.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.361 0.601 . . . . 0.0 110.359 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.48 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 0.1 OUTLIER -142.74 139.91 31.26 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.253 179.579 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.501 ' CD2' HG22 ' A' ' 21' ' ' VAL . 20.9 m-85 -112.96 -175.01 2.57 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.325 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.477 HG22 ' H ' ' A' ' 8' ' ' VAL . 0.2 OUTLIER -165.09 -167.0 1.1 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.145 -0.48 . . . . 0.0 109.945 179.803 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.479 HG12 ' CD1' ' A' ' 88' ' ' ILE . 9.3 t -139.37 82.42 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.147 179.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.841 ' HG3' HG11 ' A' ' 51' ' ' VAL . 65.7 mm-40 -50.9 155.1 1.26 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.457 -179.771 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 6.8 mtpt -53.49 175.33 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.379 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 64.18 46.81 90.0 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 110.585 -1.006 . . . . 0.0 110.585 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 61.6 m -102.69 108.66 19.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.796 0.331 . . . . 0.0 110.383 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 55.9 m-80 -101.66 174.46 5.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.255 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -55.56 -34.93 65.19 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.599 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.0 -52.71 4.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.319 -179.645 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 27.1 m80 -73.46 136.92 44.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.002 -179.434 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.484 HD22 ' HA ' ' A' ' 17' ' ' LEU . 0.8 OUTLIER -137.36 84.16 2.04 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.521 179.309 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.703 ' HB2' ' CG2' ' A' ' 53' ' ' THR . . . -74.95 116.91 16.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.896 -179.229 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.4 m -109.8 137.36 42.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.011 179.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.488 HD12 ' OE2' ' A' ' 9' ' ' GLU . 1.1 tt -84.78 70.53 10.84 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.521 -179.833 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.501 HG22 ' CD2' ' A' ' 6' ' ' PHE . 3.2 t -85.6 98.61 6.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.131 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.9 ttpm? -167.14 147.56 5.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.484 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -161.78 157.62 24.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.299 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.91 -21.58 66.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.716 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -46.17 -91.0 0.01 OUTLIER Glycine 0 CA--C 1.526 0.722 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -90.83 -160.74 0.74 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.729 0.3 . . . . 0.0 110.428 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.675 ' O ' HG22 ' A' ' 27' ' ' THR . 32.5 m -123.67 24.35 8.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.038 -179.737 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.426 ' O ' ' CG ' ' A' ' 71' ' ' GLU . 8.4 mtm 60.61 125.28 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.013 179.402 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.874 ' HB3' ' O ' ' A' ' 69' ' ' LEU . . . -122.06 -61.79 1.45 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.259 179.736 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.414 ' C ' HG12 ' A' ' 31' ' ' VAL . 0.5 OUTLIER -147.31 171.44 15.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.1 179.943 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.441 ' HA ' ' HA ' ' A' ' 68' ' ' PHE . 1.1 p 175.84 151.01 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.28 0.562 . . . . 0.0 110.519 -179.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.457 ' HG3' ' HB3' ' A' ' 41' ' ' TRP . 1.1 pm0 -140.23 171.36 14.27 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.97 -179.564 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.699 HD13 ' CZ ' ' A' ' 66' ' ' PHE . 12.0 tp -126.41 154.85 43.05 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-O 120.987 0.423 . . . . 0.0 110.088 -179.036 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.631 ' H ' HD12 ' A' ' 33' ' ' LEU . 0.6 OUTLIER -145.47 173.24 12.19 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.892 -0.594 . . . . 0.0 109.534 179.371 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 17.3 mp0 -133.22 -89.62 0.4 Allowed 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 110.346 -0.242 . . . . 0.0 110.346 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 20.3 p80 -177.35 146.21 0.47 Allowed 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 120.77 0.319 . . . . 0.0 110.514 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 60.92 38.76 95.95 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.844 -0.902 . . . . 0.0 110.844 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.1 t -118.38 173.98 6.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.862 0.363 . . . . 0.0 110.423 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -63.79 -70.58 0.21 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.511 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -153.68 173.73 15.42 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.031 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.488 ' CE3' ' HB2' ' A' ' 34' ' ' ARG . 75.2 m95 -52.71 151.21 4.55 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.189 179.769 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.429 HG22 ' O ' ' A' ' 33' ' ' LEU . 9.7 m -122.83 118.77 56.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.397 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.42 ' HA ' ' HB3' ' A' ' 32' ' ' GLU . . . -50.53 134.85 23.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.624 -179.792 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.0 -168.62 0.14 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.217 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 30.0 m -147.4 105.87 3.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.356 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.88 87.84 0.37 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.209 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -133.88 21.82 3.91 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.985 -0.846 . . . . 0.0 110.985 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.468 ' CB ' HG23 ' A' ' 51' ' ' VAL . 0.1 OUTLIER -108.59 177.6 4.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.754 0.312 . . . . 0.0 110.292 179.953 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -62.44 -44.66 97.29 Favored Glycine 0 CA--C 1.523 0.545 0 N-CA-C 110.7 -0.96 . . . . 0.0 110.7 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -160.94 31.41 0.35 Allowed Glycine 0 CA--C 1.523 0.567 0 N-CA-C 110.717 -0.953 . . . . 0.0 110.717 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.841 HG11 ' HG3' ' A' ' 9' ' ' GLU . 5.2 m -145.77 -179.44 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.854 0.359 . . . . 0.0 110.468 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 9.4 m95 -106.12 140.41 39.14 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.514 -179.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.703 ' CG2' ' HB2' ' A' ' 18' ' ' ALA . 0.5 OUTLIER -138.27 153.26 49.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.233 179.886 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 36.0 t80 -159.28 141.52 13.7 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.631 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 20.9 p-10 -93.52 127.94 39.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.27 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 9.5 p -94.96 143.82 26.17 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.36 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 14.0 mp0 -104.27 25.85 9.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.402 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -133.38 156.97 79.21 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.282 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -95.2 32.92 0.17 Allowed 'Trans proline' 0 N--CA 1.451 -1.004 0 C-N-CA 123.924 3.082 . . . . 0.0 112.355 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.655 ' C ' HD22 ' A' ' 60' ' ' LEU . 0.0 OUTLIER -49.97 162.82 0.17 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.725 -179.903 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -153.76 27.35 0.49 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.347 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -120.9 -155.19 9.48 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.773 -0.931 . . . . 0.0 110.773 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.448 ' CB ' ' HA ' ' A' ' 80' ' ' ASP . 48.7 Cg_endo -79.89 163.84 23.1 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.622 2.215 . . . . 0.0 112.182 -179.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 50.2 m-85 -105.76 -175.21 2.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.236 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -150.67 141.18 22.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.97 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.699 ' CZ ' HD13 ' A' ' 33' ' ' LEU . 44.4 m-85 -137.93 178.85 6.81 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.038 0.446 . . . . 0.0 110.885 -179.629 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.44 ' HG2' ' CZ3' ' A' ' 41' ' ' TRP . 0.1 OUTLIER 176.23 84.15 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.51 -179.982 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.872 ' O ' HD23 ' A' ' 69' ' ' LEU . 5.0 p90 -72.56 -177.38 2.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.275 0.559 . . . . 0.0 110.995 -179.213 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.874 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 9.0 mt -140.18 72.39 1.39 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.125 179.678 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.484 HG23 ' CE1' ' A' ' 68' ' ' PHE . 76.6 p -30.88 140.3 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.403 0.681 . . . . 0.0 112.447 -178.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.676 ' HG2' ' HB2' ' A' ' 29' ' ' ALA . 3.3 mm-40 -55.88 -38.86 70.73 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.809 -179.634 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.56 53.72 1.42 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.745 -179.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.423 ' O ' ' CG ' ' A' ' 74' ' ' MET . . . -142.46 -109.39 0.73 Allowed Glycine 0 CA--C 1.523 0.551 0 N-CA-C 110.853 -0.899 . . . . 0.0 110.853 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.435 ' N ' ' OG1' ' A' ' 70' ' ' THR . 32.6 mtp -162.98 -178.68 6.23 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 110.206 -0.294 . . . . 0.0 110.206 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -94.01 -177.61 4.38 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.074 179.693 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 9.6 t30 176.88 155.74 0.26 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.392 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 71.2 t -111.21 147.15 15.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.948 179.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.604 ' CE1' HG11 ' A' ' 4' ' ' VAL . 38.0 m-85 -135.87 127.81 29.49 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.453 -179.77 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 39.8 p-10 -118.86 158.01 26.5 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.126 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.448 ' HA ' ' CB ' ' A' ' 63' ' ' PRO . 1.2 m-20 53.37 33.72 16.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.321 -179.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.428 ' HA ' ' HA ' ' A' ' 93' ' ' ALA . 69.9 t -61.56 -17.21 16.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.759 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.562 HG13 ' HD2' ' A' ' 83' ' ' PRO . 70.9 t -147.42 140.06 14.49 Favored Pre-proline 0 C--N 1.331 -0.204 0 CA-C-O 120.652 0.263 . . . . 0.0 110.356 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.562 ' HD2' HG13 ' A' ' 82' ' ' VAL . 44.6 Cg_endo -69.39 -165.95 0.16 Allowed 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.665 2.244 . . . . 0.0 112.003 179.798 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -74.31 -65.87 0.8 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.031 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.39 71.48 1.36 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.212 179.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.416 ' HB3' ' CG1' ' A' ' 82' ' ' VAL . 15.4 p90 -56.95 162.96 2.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.506 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 43.7 m -141.32 122.85 15.06 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.404 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.479 ' CD1' HG12 ' A' ' 8' ' ' VAL . 40.7 mm -51.54 116.95 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.342 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 113.11 30.21 2.79 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.664 -0.975 . . . . 0.0 110.664 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.54 ' HB3' ' CZ ' ' A' ' 92' ' ' TYR . . . -137.15 134.36 36.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.794 0.33 . . . . 0.0 110.18 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 21.6 m -91.34 105.68 17.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.9 -179.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.548 ' O ' ' HB3' ' A' ' 93' ' ' ALA . 39.2 m-85 -97.35 -155.77 0.51 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.0 -0.546 . . . . 0.0 109.642 179.525 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.899 ' HB1' ' HD2' ' A' ' 94' ' ' PRO . . . 73.91 175.76 0.07 OUTLIER Pre-proline 0 N--CA 1.464 0.232 0 CA-C-O 120.673 0.273 . . . . 0.0 110.779 179.762 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.899 ' HD2' ' HB1' ' A' ' 93' ' ' ALA . 46.9 Cg_endo . . . . . 0 C--O 1.249 1.033 0 C-N-CA 122.536 2.157 . . . . 0.0 112.02 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 28.2 t . . . . . 0 N--CA 1.49 1.57 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -78.78 162.71 26.76 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.618 2.212 . . . . 0.0 112.188 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 10.0 mtpt -151.85 104.41 3.01 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.187 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.626 HG11 ' CE1' ' A' ' 78' ' ' PHE . 2.1 p -96.65 162.95 2.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.27 0.557 . . . . 0.0 110.371 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.481 ' N ' HG22 ' A' ' 4' ' ' VAL . 1.2 p -145.16 132.91 21.06 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.463 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.541 ' O ' HG23 ' A' ' 91' ' ' THR . 6.5 m-85 -99.37 172.5 7.29 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.279 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.836 HG23 ' O ' ' A' ' 90' ' ' ALA . 16.7 m -166.14 96.56 0.6 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.182 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.49 HG12 ' CD1' ' A' ' 88' ' ' ILE . 21.8 t -50.77 111.64 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.581 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.463 ' O ' HD12 ' A' ' 88' ' ' ILE . 3.5 mt-10 -70.24 171.54 9.65 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.51 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.619 ' HA ' HG21 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -69.69 -8.83 51.17 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.191 -179.917 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -48.38 -26.55 5.07 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 111.086 -0.806 . . . . 0.0 111.086 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 28.5 p -52.87 126.66 20.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.725 0.298 . . . . 0.0 110.279 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -122.58 -57.61 1.73 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.496 -179.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -134.51 -78.21 0.46 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.354 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.22 -20.64 14.59 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.702 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -54.32 177.28 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.804 0.335 . . . . 0.0 110.285 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 25.4 tp -162.2 84.03 0.57 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.312 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.48 ' HB2' HG23 ' A' ' 53' ' ' THR . . . -72.83 162.46 29.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.232 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.668 HG11 ' CZ ' ' A' ' 66' ' ' PHE . 30.9 m -156.65 133.32 2.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.815 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.433 ' HA ' HG12 ' A' ' 51' ' ' VAL . 0.5 OUTLIER -94.62 64.41 3.01 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.169 179.539 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 28.9 t -56.48 111.78 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.593 -179.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.74 168.82 22.58 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.12 179.769 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.494 ' CE1' ' HB2' ' A' ' 26' ' ' ASP . 0.0 OUTLIER -150.55 -68.88 0.19 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.094 -179.95 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 52.0 tt0 -168.88 -61.42 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.515 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -152.18 58.9 0.42 Allowed Glycine 0 CA--C 1.524 0.654 0 N-CA-C 111.094 -0.802 . . . . 0.0 111.094 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.494 ' HB2' ' CE1' ' A' ' 23' ' ' TYR . 77.0 m-20 -108.71 178.81 4.37 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 179.531 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.401 ' HB ' ' HG3' ' A' ' 71' ' ' GLU . 0.2 OUTLIER -110.0 172.2 7.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.893 0.378 . . . . 0.0 110.492 -179.892 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 1.2 mtt -126.18 117.62 23.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.158 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.81 ' HB3' ' O ' ' A' ' 69' ' ' LEU . . . -116.88 -58.34 2.08 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.642 -179.765 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.42 ' O ' ' CB ' ' A' ' 68' ' ' PHE . 20.8 mm-40 -153.24 162.7 41.01 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.476 -179.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.532 HG21 ' CD1' ' A' ' 52' ' ' TRP . 2.5 t -151.96 142.78 15.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.276 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.439 ' CB ' ' HA ' ' A' ' 43' ' ' ALA . 11.9 pm0 -153.2 139.82 18.84 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.755 -179.603 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.734 HD21 ' CD2' ' A' ' 54' ' ' PHE . 0.5 OUTLIER -108.99 172.52 6.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.182 179.893 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.508 ' N ' HD12 ' A' ' 33' ' ' LEU . 0.1 OUTLIER -94.31 -67.58 0.85 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.634 -0.257 . . . . 0.0 110.698 -179.685 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.52 ' N ' HD12 ' A' ' 33' ' ' LEU . 2.0 tt0 88.91 74.5 0.01 OUTLIER 'General case' 0 CA--C 1.51 -0.571 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 -178.622 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -36.97 120.82 0.75 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 114.995 -1.002 . . . . 0.0 111.832 -178.216 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 128.17 -48.87 0.95 Allowed Glycine 0 CA--C 1.523 0.55 0 N-CA-C 110.446 -1.062 . . . . 0.0 110.446 -179.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.414 ' O ' ' CB ' ' A' ' 39' ' ' ASP . 40.6 t -75.03 -32.79 61.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.745 0.307 . . . . 0.0 110.494 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.414 ' CB ' ' O ' ' A' ' 38' ' ' SER . 8.2 t0 81.56 -53.17 0.27 Allowed 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.729 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -72.63 124.04 24.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.573 -179.751 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.49 ' CZ3' ' HB2' ' A' ' 67' ' ' ARG . 77.7 m95 -54.73 155.19 4.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.036 179.743 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.409 HG23 ' HG ' ' A' ' 33' ' ' LEU . 3.6 m -136.54 124.69 34.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.8 0.333 . . . . 0.0 110.422 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.439 ' HA ' ' CB ' ' A' ' 32' ' ' GLU . . . -57.19 138.56 54.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.243 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.77 -170.14 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.232 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 62.1 m -135.79 95.18 3.18 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.444 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.413 ' O ' ' CG ' ' A' ' 46' ' ' LYS . 14.6 ptmt -74.16 90.98 2.08 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.97 0.414 . . . . 0.0 110.402 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -156.83 25.34 0.5 Allowed Glycine 0 CA--C 1.523 0.581 0 N-CA-C 110.729 -0.948 . . . . 0.0 110.729 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.435 ' HG2' HG23 ' A' ' 51' ' ' VAL . 7.7 tp10 -106.75 165.91 10.97 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.765 0.317 . . . . 0.0 110.265 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -39.85 -49.7 3.34 Favored Glycine 0 CA--C 1.527 0.794 0 N-CA-C 111.784 -0.526 . . . . 0.0 111.784 -179.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -164.49 33.28 0.26 Allowed Glycine 0 CA--C 1.523 0.549 0 N-CA-C 111.001 -0.84 . . . . 0.0 111.001 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.437 HG11 ' HG3' ' A' ' 9' ' ' GLU . 4.3 m -148.79 -178.57 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.916 0.389 . . . . 0.0 110.498 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . 0.532 ' CD1' HG21 ' A' ' 31' ' ' VAL . 6.5 m95 -108.42 119.1 38.52 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.215 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.48 HG23 ' HB2' ' A' ' 18' ' ' ALA . 0.0 OUTLIER -106.46 -179.46 3.95 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.613 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.734 ' CD2' HD21 ' A' ' 33' ' ' LEU . 16.4 t80 -177.46 124.37 0.13 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.929 0.395 . . . . 0.0 110.626 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -86.06 154.17 21.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.143 179.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 52.5 p -128.51 126.02 39.56 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.463 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -86.76 -37.43 17.88 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.216 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -63.48 139.04 97.53 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.259 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.403 ' O ' ' NE2' ' A' ' 61' ' ' GLN . 49.0 Cg_endo -72.92 -15.46 26.33 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.574 2.183 . . . . 0.0 112.366 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -50.79 128.11 20.04 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.856 0.36 . . . . 0.0 110.522 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.403 ' NE2' ' O ' ' A' ' 59' ' ' PRO . 1.0 OUTLIER -113.78 61.46 0.66 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.263 179.949 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -107.47 -165.22 21.85 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.688 -0.965 . . . . 0.0 110.688 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.409 ' C ' ' CD1' ' A' ' 64' ' ' PHE . 45.7 Cg_endo -74.28 -172.06 1.07 Allowed 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.46 2.107 . . . . 0.0 112.036 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.469 ' HB3' HD13 ' A' ' 33' ' ' LEU . 57.6 m-85 -152.88 106.35 3.04 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.641 -179.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 29.3 m-80 -74.83 119.77 19.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.269 -0.423 . . . . 0.0 109.919 179.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.668 ' CZ ' HG11 ' A' ' 19' ' ' VAL . 8.6 m-85 -87.79 167.87 13.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.816 -179.555 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.706 ' HD2' HG22 ' A' ' 77' ' ' VAL . 3.3 mtp180 -172.68 116.71 0.32 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.581 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.626 ' O ' HD23 ' A' ' 69' ' ' LEU . 0.1 OUTLIER -123.39 170.24 10.54 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.017 0.437 . . . . 0.0 110.538 179.785 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.81 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 7.2 mt -125.88 68.21 1.18 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.341 179.534 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 71.4 p -33.69 138.47 0.08 Allowed 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.875 -179.181 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.691 ' HG2' ' HB2' ' A' ' 29' ' ' ALA . 1.1 mt-10 -54.1 -26.18 25.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.356 -179.697 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.5 tmtt? -67.12 -52.34 42.91 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.283 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 120.24 58.75 0.24 Allowed Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.792 -0.923 . . . . 0.0 110.792 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 1.2 mmt -131.92 70.79 1.46 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.776 0.322 . . . . 0.0 110.38 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.503 ' HD2' HD22 ' A' ' 69' ' ' LEU . 0.0 OUTLIER -60.75 155.15 19.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.383 179.99 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 177.8 152.25 0.26 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.563 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.706 HG22 ' HD2' ' A' ' 67' ' ' ARG . 92.6 t -104.86 151.8 7.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.158 179.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.626 ' CE1' HG11 ' A' ' 4' ' ' VAL . 55.2 m-85 -127.38 147.57 50.27 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.759 -179.343 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 14.4 t0 -134.61 161.76 34.21 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.248 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 54.65 44.77 28.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.238 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.59 ' O ' HG12 ' A' ' 81' ' ' VAL . 60.0 t -93.34 3.09 8.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.238 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.519 HG23 ' O ' ' A' ' 81' ' ' VAL . 66.1 t -159.24 110.66 1.54 Allowed Pre-proline 0 CA--C 1.532 0.257 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 179.603 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.43 ' O ' ' N ' ' A' ' 85' ' ' LYS . 47.9 Cg_endo -75.58 62.09 6.25 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.524 2.149 . . . . 0.0 112.41 -179.741 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 53.86 -87.52 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.551 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.43 ' N ' ' O ' ' A' ' 83' ' ' PRO . 0.0 OUTLIER -87.91 56.61 3.95 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 120.934 0.397 . . . . 0.0 109.946 179.74 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.484 ' HB3' HG13 ' A' ' 82' ' ' VAL . 48.6 p90 -48.23 175.95 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.854 -179.744 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -144.24 134.15 23.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.113 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.619 HG21 ' HA ' ' A' ' 10' ' ' LYS . 36.5 mm -65.21 118.44 7.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.468 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 114.03 35.22 1.53 Allowed Glycine 0 CA--C 1.523 0.577 0 N-CA-C 110.602 -0.999 . . . . 0.0 110.602 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.836 ' O ' HG23 ' A' ' 7' ' ' THR . . . -138.64 175.53 9.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.768 0.318 . . . . 0.0 110.383 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.541 HG23 ' O ' ' A' ' 6' ' ' PHE . 18.5 m -126.52 101.23 6.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.3 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.551 ' CZ ' ' HB3' ' A' ' 90' ' ' ALA . 19.5 m-85 -107.22 132.35 53.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.294 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.895 ' HB1' ' HD2' ' A' ' 94' ' ' PRO . . . 173.83 178.25 0.16 Allowed Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.397 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.895 ' HD2' ' HB1' ' A' ' 93' ' ' ALA . 49.0 Cg_endo . . . . . 0 C--O 1.248 1.019 0 C-N-CA 122.489 2.126 . . . . 0.0 112.095 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 51.0 t . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -74.58 137.18 22.38 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.622 2.215 . . . . 0.0 112.042 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 27.5 mtpt -151.23 97.41 2.42 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.578 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.798 HG12 ' CE1' ' A' ' 23' ' ' TYR . 29.5 m -122.22 -176.73 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.21 179.695 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.431 HG23 ' O ' ' A' ' 4' ' ' VAL . 0.3 OUTLIER -161.08 137.38 8.38 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.399 179.838 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.56 ' H ' ' HB3' ' A' ' 93' ' ' ALA . 19.6 m-85 -107.05 169.36 8.6 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.943 179.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.559 HG23 ' O ' ' A' ' 90' ' ' ALA . 47.3 m -162.04 103.56 1.14 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.925 0.393 . . . . 0.0 110.497 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.403 ' HA ' ' O ' ' A' ' 18' ' ' ALA . 31.0 t -53.22 92.57 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.341 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.6 ' OE1' HG21 ' A' ' 51' ' ' VAL . 0.1 OUTLIER -59.61 164.53 3.51 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.593 -179.859 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.46 ' HA ' HG23 ' A' ' 88' ' ' ILE . 1.5 pttt -86.03 61.14 6.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.286 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -133.1 22.61 3.99 Favored Glycine 0 CA--C 1.525 0.656 0 N-CA-C 111.001 -0.84 . . . . 0.0 111.001 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.4 t -81.82 146.54 29.83 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -152.45 -88.5 0.06 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.739 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -96.61 -66.32 0.91 Allowed 'General case' 0 N--CA 1.454 -0.235 0 CA-C-O 120.694 0.283 . . . . 0.0 110.3 -179.725 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.458 ' HD3' ' ND1' ' A' ' 16' ' ' HIS . 0.0 OUTLIER -140.81 49.1 1.69 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.627 -179.996 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.458 ' ND1' ' HD3' ' A' ' 15' ' ' LYS . 45.6 m80 -129.93 112.56 13.64 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.075 179.555 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.452 HD22 ' HA ' ' A' ' 17' ' ' LEU . 1.5 tm? -98.53 81.39 2.71 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.225 -179.686 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.449 ' HB2' HG22 ' A' ' 53' ' ' THR . . . -61.95 131.54 50.02 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.572 -179.705 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.496 HG23 HG23 ' A' ' 21' ' ' VAL . 29.9 m -135.1 136.38 51.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.238 179.682 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.418 ' HB3' ' HB ' ' A' ' 7' ' ' THR . 0.8 OUTLIER -89.95 75.53 7.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.686 -179.743 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.496 HG23 HG23 ' A' ' 19' ' ' VAL . 14.5 t -75.11 95.32 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.093 179.668 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 23.6 tttt -171.4 132.41 0.78 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.46 -179.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.798 ' CE1' HG12 ' A' ' 4' ' ' VAL . 10.4 p90 -141.42 25.8 2.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.463 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 49.16 87.75 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.575 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -174.08 -105.38 0.18 Allowed Glycine 0 CA--C 1.523 0.532 0 N-CA-C 110.755 -0.938 . . . . 0.0 110.755 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -64.99 -175.17 0.18 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.75 0.309 . . . . 0.0 110.364 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.416 ' HB ' ' HG3' ' A' ' 71' ' ' GLU . 0.8 OUTLIER -103.78 -173.95 2.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.473 -179.866 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.41 ' O ' ' CG ' ' A' ' 71' ' ' GLU . 3.6 mtm -116.69 130.18 56.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.636 -179.621 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.771 ' HB3' ' O ' ' A' ' 69' ' ' LEU . . . -122.44 -56.85 1.78 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.641 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.405 ' O ' ' HB2' ' A' ' 68' ' ' PHE . 29.2 tt0 -158.42 166.49 32.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.287 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.469 HG21 ' CD1' ' A' ' 52' ' ' TRP . 26.4 t -151.67 152.09 11.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.927 0.394 . . . . 0.0 110.675 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.446 ' CB ' ' HA ' ' A' ' 43' ' ' ALA . 0.5 OUTLIER -155.21 138.84 16.03 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.364 179.963 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.498 ' HG ' ' CE2' ' A' ' 66' ' ' PHE . 1.4 mt -94.27 177.56 5.91 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.676 -179.53 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.421 ' CB ' ' HB2' ' A' ' 65' ' ' ASN . 0.1 OUTLIER -130.26 -156.91 0.79 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.664 179.649 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.402 ' OE2' ' CB ' ' A' ' 56' ' ' SER . 0.0 OUTLIER 178.48 105.25 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.826 0.346 . . . . 0.0 110.134 179.921 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.621 ' NE2' HD22 ' A' ' 60' ' ' LEU . 8.8 p-80 -50.11 119.37 3.57 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.462 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 117.68 -32.06 5.5 Favored Glycine 0 CA--C 1.522 0.53 0 N-CA-C 110.565 -1.014 . . . . 0.0 110.565 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -78.75 174.14 11.75 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.765 0.317 . . . . 0.0 110.16 179.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -129.07 26.44 5.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.5 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -159.92 145.26 15.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.457 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.503 ' CZ3' ' HG2' ' A' ' 67' ' ' ARG . 71.3 m95 -80.69 154.11 27.5 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.194 179.83 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.656 HG23 ' O ' ' A' ' 42' ' ' VAL . 29.7 m -115.47 105.42 18.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.957 0.408 . . . . 0.0 110.327 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.446 ' HA ' ' CB ' ' A' ' 32' ' ' GLU . . . -52.35 136.66 30.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.394 -179.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -71.69 -171.16 0.63 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.804 -179.801 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 47.5 m -144.55 111.4 5.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.557 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.478 ' HG2' ' CZ3' ' A' ' 52' ' ' TRP . 31.8 mtpt -77.06 95.27 4.16 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.042 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -128.86 -38.96 0.33 Allowed Glycine 0 CA--C 1.525 0.696 0 N-CA-C 111.437 -0.665 . . . . 0.0 111.437 -179.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.427 ' HB2' ' O ' ' A' ' 51' ' ' VAL . 0.0 OUTLIER -52.68 -175.32 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.99 0.424 . . . . 0.0 110.425 -179.741 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -104.01 41.69 2.08 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 145.59 -10.8 1.71 Allowed Glycine 0 CA--C 1.529 0.921 0 C-N-CA 121.015 -0.612 . . . . 0.0 112.428 179.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.6 HG21 ' OE1' ' A' ' 9' ' ' GLU . 33.5 m -133.21 175.02 12.34 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.137 0 CA-C-N 117.709 0.754 . . . . 0.0 110.844 -179.627 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . 0.478 ' CZ3' ' HG2' ' A' ' 46' ' ' LYS . 6.9 m95 -106.93 139.94 40.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.572 -179.576 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.449 HG22 ' HB2' ' A' ' 18' ' ' ALA . 2.6 p -122.4 135.52 54.71 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.359 179.739 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 1.3 t80 175.05 96.94 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.501 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.448 ' HB2' ' N ' ' A' ' 16' ' ' HIS . 6.0 t0 -99.62 31.03 3.34 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-O 121.43 0.634 . . . . 0.0 110.138 179.396 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.41 ' OG ' ' N ' ' A' ' 57' ' ' GLU . 44.9 t 45.91 -172.93 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 114.928 -1.033 . . . . 0.0 110.98 179.574 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.41 ' N ' ' OG ' ' A' ' 56' ' ' SER . 1.5 mt-10 -100.75 -46.86 5.02 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.225 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -64.03 116.42 27.11 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.451 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -68.33 59.6 1.03 Allowed 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.724 2.282 . . . . 0.0 112.333 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.621 HD22 ' NE2' ' A' ' 36' ' ' HIS . 1.6 mt -94.0 92.51 7.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.845 0.355 . . . . 0.0 110.322 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -77.0 78.38 3.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.469 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -145.93 -162.04 9.52 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.816 -0.913 . . . . 0.0 110.816 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -76.17 128.91 10.9 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.59 2.194 . . . . 0.0 112.075 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.443 ' HB3' ' CD2' ' A' ' 33' ' ' LEU . 27.4 m-85 -88.29 -178.27 5.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.976 0.417 . . . . 0.0 110.554 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.421 ' HB2' ' CB ' ' A' ' 34' ' ' ARG . 2.9 m-80 -153.55 137.65 16.44 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.631 179.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.498 ' CE2' ' HG ' ' A' ' 33' ' ' LEU . 80.8 m-85 -121.79 -178.36 3.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.045 0.45 . . . . 0.0 110.97 -179.642 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.503 ' HG2' ' CZ3' ' A' ' 41' ' ' TRP . 0.0 OUTLIER 175.65 47.79 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.656 179.997 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.623 ' HZ ' HG11 ' A' ' 4' ' ' VAL . 0.6 OUTLIER -48.63 172.57 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.108 -179.245 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.771 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 4.9 mt -122.28 72.51 1.06 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.446 179.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -37.98 142.14 0.18 Allowed 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.685 -179.254 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.708 ' HG2' ' HB2' ' A' ' 29' ' ' ALA . 3.1 mm-40 -51.57 -67.31 0.26 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.725 -179.742 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.79 31.38 5.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.733 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -106.34 -100.52 2.66 Favored Glycine 0 CA--C 1.523 0.547 0 N-CA-C 110.655 -0.978 . . . . 0.0 110.655 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 177.52 141.51 0.08 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.853 0.358 . . . . 0.0 110.361 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.436 ' HG3' ' HA ' ' A' ' 69' ' ' LEU . 0.0 OUTLIER -70.31 178.66 2.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.254 -179.982 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.466 ' O ' ' CE2' ' A' ' 78' ' ' PHE . 0.5 OUTLIER 170.04 131.79 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.582 179.92 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 79.7 t -85.18 150.61 3.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.111 -0.495 . . . . 0.0 109.928 179.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.523 ' CE1' HG22 ' A' ' 4' ' ' VAL . 61.3 m-85 -137.74 128.33 26.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.882 0.372 . . . . 0.0 110.645 -179.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -107.67 156.54 18.96 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.214 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 28.0 t70 51.97 52.81 13.68 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.34 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.683 HG13 ' HB2' ' A' ' 93' ' ' ALA . 85.7 t -85.76 -24.6 6.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.577 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.471 HG13 ' HD2' ' A' ' 83' ' ' PRO . 46.3 t -138.87 138.56 21.65 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.579 -179.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.493 ' HG3' ' CE1' ' A' ' 92' ' ' TYR . 49.3 Cg_endo -72.09 -166.88 0.28 Allowed 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.619 2.212 . . . . 0.0 111.979 179.621 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.66 -78.47 0.07 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.044 179.67 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.411 ' CG ' ' O ' ' A' ' 85' ' ' LYS . 0.0 OUTLIER -91.9 71.36 5.61 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.001 179.589 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 19.0 p90 -47.93 150.48 1.12 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.776 -179.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 1.2 m -117.63 115.56 25.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.291 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.46 HG23 ' HA ' ' A' ' 10' ' ' LYS . 42.3 mm -51.94 110.22 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.27 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 114.32 32.33 2.0 Favored Glycine 0 CA--C 1.523 0.552 0 N-CA-C 110.771 -0.932 . . . . 0.0 110.771 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.559 ' O ' HG23 ' A' ' 7' ' ' THR . . . -124.35 164.37 19.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.757 0.313 . . . . 0.0 110.398 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 6.9 m -119.68 89.93 3.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.66 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.532 ' O ' ' HB3' ' A' ' 93' ' ' ALA . 34.5 m-85 -89.03 -161.5 0.77 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.912 179.669 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.915 ' HB1' ' HD2' ' A' ' 94' ' ' PRO . . . 72.26 176.96 0.06 OUTLIER Pre-proline 0 C--N 1.332 -0.173 0 CA-C-O 120.614 0.245 . . . . 0.0 110.461 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.915 ' HD2' ' HB1' ' A' ' 93' ' ' ALA . 48.7 Cg_endo . . . . . 0 C--O 1.249 1.042 0 C-N-CA 122.506 2.137 . . . . 0.0 112.071 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 27.2 t . . . . . 0 N--CA 1.489 1.519 0 N-CA-C 110.175 -0.305 . . . . 0.0 110.175 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -77.22 105.5 2.07 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.576 2.184 . . . . 0.0 112.113 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 3.9 tttt -133.12 94.37 3.34 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.242 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.874 HG11 ' CE2' ' A' ' 68' ' ' PHE . 27.0 m -80.38 -178.26 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.509 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.694 HG23 ' O ' ' A' ' 4' ' ' VAL . 0.6 OUTLIER -170.96 139.71 1.46 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.242 179.874 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.718 ' O ' HG23 ' A' ' 91' ' ' THR . 29.5 m-85 -113.65 168.91 9.37 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.492 -179.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.823 HG23 ' O ' ' A' ' 90' ' ' ALA . 19.1 m -165.57 118.59 1.16 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.381 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.526 HG11 HG13 ' A' ' 88' ' ' ILE . 62.6 t -61.65 102.57 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.335 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.736 ' OE2' HD12 ' A' ' 20' ' ' LEU . 1.8 mm-40 -70.11 174.67 5.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.502 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.4 mttt -83.17 64.48 7.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.556 -179.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -156.44 33.25 0.59 Allowed Glycine 0 CA--C 1.522 0.506 0 N-CA-C 110.457 -1.057 . . . . 0.0 110.457 179.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.3 p -89.82 114.97 26.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.873 0.368 . . . . 0.0 110.593 -179.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 13.8 m-20 -104.23 -156.05 0.56 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.081 -0.508 . . . . 0.0 109.933 179.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -46.35 -63.98 0.87 Allowed 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 120.846 0.355 . . . . 0.0 110.777 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.87 -22.68 9.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.906 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 28.8 m80 -48.84 136.51 13.81 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.96 0.41 . . . . 0.0 110.884 -179.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.42 HD22 ' HA ' ' A' ' 17' ' ' LEU . 0.2 OUTLIER -129.05 95.79 4.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.651 179.629 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.674 ' HB1' HG11 ' A' ' 51' ' ' VAL . . . -90.58 128.31 36.54 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.683 -179.489 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.687 ' O ' HG13 ' A' ' 51' ' ' VAL . 15.3 m -134.26 133.96 55.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.202 179.627 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.736 HD12 ' OE2' ' A' ' 9' ' ' GLU . 0.5 OUTLIER -83.83 71.93 10.42 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.384 -179.951 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.525 HG23 HG23 ' A' ' 19' ' ' VAL . 61.4 t -70.93 95.14 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.286 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 5.4 tttp -135.62 141.59 45.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.41 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -163.36 149.65 11.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.39 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -76.42 -22.23 54.95 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.743 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -46.91 -50.17 15.8 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 111.081 -0.807 . . . . 0.0 111.081 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -138.04 -174.69 3.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.776 0.322 . . . . 0.0 110.304 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.487 ' O ' HG22 ' A' ' 27' ' ' THR . 27.2 m -121.65 54.68 1.13 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.796 -179.677 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.588 ' O ' ' HB2' ' A' ' 29' ' ' ALA . 33.7 mtm 58.35 -164.11 0.2 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.786 179.55 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.704 ' HB2' ' N ' ' A' ' 71' ' ' GLU . . . 154.24 -62.59 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.367 0.667 . . . . 0.0 109.682 179.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.569 ' HB3' HD12 ' A' ' 69' ' ' LEU . 1.2 tt0 -160.75 141.17 11.4 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.817 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.535 HG21 ' CD1' ' A' ' 52' ' ' TRP . 4.2 t -134.72 156.39 39.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.973 0.416 . . . . 0.0 110.754 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.452 ' CB ' ' HA ' ' A' ' 43' ' ' ALA . 3.1 pt-20 -154.15 157.73 39.31 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.979 179.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.81 HD23 ' O ' ' A' ' 65' ' ' ASN . 4.6 mt -125.16 -176.54 3.6 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.457 -179.712 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.508 ' HD2' ' CD2' ' A' ' 41' ' ' TRP . 5.6 ttt180 -145.71 174.24 11.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.075 179.686 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.401 ' HG2' ' O ' ' A' ' 34' ' ' ARG . 21.4 mt-10 -154.27 93.76 1.65 Allowed 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 179.811 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -40.25 116.07 0.62 Allowed 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.389 -178.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 123.75 -25.41 6.19 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 110.466 -1.054 . . . . 0.0 110.466 -179.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 4.3 m -75.95 -161.34 0.17 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.81 0.338 . . . . 0.0 110.39 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -83.11 -65.81 0.96 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.528 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -153.18 -176.93 6.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.619 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.508 ' CD2' ' HD2' ' A' ' 34' ' ' ARG . 87.0 m95 -50.72 150.66 2.73 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.602 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.595 HG21 ' CZ ' ' A' ' 54' ' ' PHE . 10.5 m -131.62 131.91 62.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.139 179.718 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.452 ' HA ' ' CB ' ' A' ' 32' ' ' GLU . . . -57.22 147.23 25.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.569 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.414 ' N ' ' HA ' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -72.61 -166.04 0.25 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.993 179.855 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 90.0 m -154.05 112.61 3.62 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.837 0.351 . . . . 0.0 110.686 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 9.2 ptpt -68.92 69.55 0.18 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.193 -0.458 . . . . 0.0 109.97 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -90.47 -26.41 23.17 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 111.296 -0.722 . . . . 0.0 111.296 -179.491 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.441 ' CG ' ' HB ' ' A' ' 51' ' ' VAL . 5.4 tm-20 -78.45 -14.84 59.18 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.761 0.28 . . . . 0.0 111.222 -179.728 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 99.74 -41.39 2.19 Favored Glycine 0 CA--C 1.522 0.518 0 N-CA-C 109.976 -1.25 . . . . 0.0 109.976 -179.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.438 ' O ' ' CZ3' ' A' ' 52' ' ' TRP . . . -126.61 -45.25 0.23 Allowed Glycine 0 CA--C 1.519 0.287 0 N-CA-C 109.075 -1.61 . . . . 0.0 109.075 179.107 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.687 HG13 ' O ' ' A' ' 19' ' ' VAL . 19.6 t -82.57 151.36 4.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 178.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . 0.535 ' CD1' HG21 ' A' ' 31' ' ' VAL . 4.1 m95 -93.05 114.77 27.4 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.996 0.427 . . . . 0.0 110.187 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.527 ' CG2' ' HB2' ' A' ' 18' ' ' ALA . 1.8 p -108.07 137.58 45.82 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.286 -179.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.595 ' CZ ' HG21 ' A' ' 42' ' ' VAL . 51.2 t80 -120.34 142.79 48.81 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.686 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -99.94 109.38 21.74 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.061 179.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.4 ' HB2' ' OE2' ' A' ' 35' ' ' GLU . 27.6 p -89.83 158.95 17.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.558 -179.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -134.3 -44.52 0.77 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.42 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -51.88 156.57 2.44 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.395 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -67.88 -34.55 23.49 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.795 2.33 . . . . 0.0 112.433 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 2.2 mt -69.85 151.45 45.69 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.835 -179.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -174.1 72.9 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.22 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -128.44 -96.76 0.87 Allowed Glycine 0 CA--C 1.525 0.687 0 N-CA-C 110.814 -0.914 . . . . 0.0 110.814 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -77.18 97.77 1.17 Allowed 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.587 2.191 . . . . 0.0 112.205 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -73.51 166.47 23.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.588 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.81 ' O ' HD23 ' A' ' 33' ' ' LEU . 0.2 OUTLIER -135.81 122.99 21.64 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 179.227 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.574 ' CD2' ' CE2' ' A' ' 6' ' ' PHE . 2.8 m-85 -105.84 177.88 4.72 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.303 0.573 . . . . 0.0 112.081 -178.569 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.797 ' HD2' HG12 ' A' ' 77' ' ' VAL . 7.2 mtp180 -177.56 96.84 0.04 OUTLIER 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 114.877 -1.056 . . . . 0.0 110.287 179.45 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.88 ' O ' HD23 ' A' ' 69' ' ' LEU . 6.0 p90 -91.73 168.13 11.68 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-O 121.151 0.5 . . . . 0.0 110.455 179.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.88 HD23 ' O ' ' A' ' 68' ' ' PHE . 5.7 mt -136.28 65.23 1.53 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.641 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 26.8 p -33.5 150.09 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 115.899 -0.591 . . . . 0.0 112.048 -179.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.704 ' N ' ' HB2' ' A' ' 29' ' ' ALA . 7.8 mt-10 -49.21 -30.43 7.0 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.333 -179.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -69.19 -46.56 67.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.377 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 118.72 43.29 0.54 Allowed Glycine 0 CA--C 1.523 0.557 0 N-CA-C 110.69 -0.964 . . . . 0.0 110.69 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 12.1 mtp -105.61 108.1 19.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.833 0.349 . . . . 0.0 110.448 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.8 149.55 21.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.349 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -177.69 125.13 0.13 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.594 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.797 HG12 ' HD2' ' A' ' 67' ' ' ARG . 4.5 m -81.99 176.56 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.591 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.44 ' CE2' ' CE2' ' A' ' 68' ' ' PHE . 97.3 m-85 -156.79 112.82 2.97 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.3 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -98.18 158.17 15.72 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.463 -179.759 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 47.1 m-20 59.16 28.53 17.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.557 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.41 HG23 ' O ' ' A' ' 78' ' ' PHE . 74.3 t -61.17 -75.97 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 179.735 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.543 HG13 ' HD2' ' A' ' 83' ' ' PRO . 59.8 t -87.18 139.57 32.33 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.427 -0.352 . . . . 0.0 110.289 179.613 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.543 ' HD2' HG13 ' A' ' 82' ' ' VAL . 45.8 Cg_endo -70.5 -167.77 0.27 Allowed 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.595 2.197 . . . . 0.0 112.022 179.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.413 ' HG3' ' N ' ' A' ' 85' ' ' LYS . 4.3 pt-20 -83.84 -28.19 28.2 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.23 179.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.413 ' N ' ' HG3' ' A' ' 84' ' ' GLU . 0.0 OUTLIER -132.07 63.48 1.62 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.136 179.755 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 51.9 p90 -48.66 148.68 1.99 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.789 -179.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 37.0 m -128.18 113.27 15.49 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.271 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.526 HG13 HG11 ' A' ' 8' ' ' VAL . 3.0 mp -51.37 104.46 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.248 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 125.4 47.44 0.22 Allowed Glycine 0 CA--C 1.524 0.598 0 N-CA-C 110.707 -0.957 . . . . 0.0 110.707 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.823 ' O ' HG23 ' A' ' 7' ' ' THR . . . -167.48 175.07 7.4 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.754 0.311 . . . . 0.0 110.365 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.718 HG23 ' O ' ' A' ' 6' ' ' PHE . 5.1 m -113.32 141.56 46.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.484 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.597 ' OH ' ' HB3' ' A' ' 90' ' ' ALA . 11.6 m-85 -141.51 109.18 5.65 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.33 179.753 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.924 ' HB1' ' HD2' ' A' ' 94' ' ' PRO . . . 170.59 177.49 0.1 OUTLIER Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.406 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.924 ' HD2' ' HB1' ' A' ' 93' ' ' ALA . 48.2 Cg_endo . . . . . 0 C--O 1.249 1.031 0 C-N-CA 122.533 2.156 . . . . 0.0 112.097 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.626 HG13 ' O ' ' A' ' 1' ' ' VAL . 9.9 p . . . . . 0 N--CA 1.494 1.744 0 N-CA-C 110.24 -0.282 . . . . 0.0 110.24 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -73.37 98.49 1.03 Allowed 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.331 2.021 . . . . 0.0 112.059 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 2.3 tttp -171.35 106.58 0.24 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.35 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.536 ' CG1' ' CE1' ' A' ' 78' ' ' PHE . 1.7 p -116.87 163.67 13.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.232 0.539 . . . . 0.0 110.397 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.466 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 0.6 OUTLIER -132.92 139.5 47.39 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.205 179.838 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.752 ' O ' HG23 ' A' ' 91' ' ' THR . 32.3 m-85 -98.26 -176.43 3.41 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.298 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.9 m -167.5 112.96 0.72 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.369 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 45.2 t -66.26 101.84 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.309 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.786 ' HG3' HG11 ' A' ' 51' ' ' VAL . 0.7 OUTLIER -54.39 -178.16 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.6 -179.79 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -94.24 46.96 1.17 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.269 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -133.56 23.82 3.76 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 110.895 -0.882 . . . . 0.0 110.895 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 7.9 m -86.65 106.04 17.33 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.782 0.325 . . . . 0.0 110.285 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 20.7 m-20 -100.61 -158.38 0.67 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.371 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -45.76 -62.26 1.38 Allowed 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.076 -179.742 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.98 19.12 11.7 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.005 -179.824 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 6.7 m80 -100.5 130.77 46.62 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.826 0.346 . . . . 0.0 110.088 179.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.517 HD22 ' HA ' ' A' ' 17' ' ' LEU . 0.5 OUTLIER -122.57 90.69 3.35 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.452 -179.628 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.486 ' HB2' ' CG2' ' A' ' 53' ' ' THR . . . -88.67 130.75 35.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.162 179.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.552 HG21 ' CZ ' ' A' ' 66' ' ' PHE . 25.8 m -129.87 152.3 37.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.555 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.498 HD22 ' CG ' ' A' ' 22' ' ' LYS . 0.4 OUTLIER -104.06 98.58 8.38 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.081 179.803 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 25.1 t -98.83 99.09 7.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.808 -179.55 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.498 ' CG ' HD22 ' A' ' 20' ' ' LEU . 0.0 OUTLIER 175.84 160.18 0.28 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.259 179.698 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -159.8 47.93 0.28 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.338 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 52.43 178.89 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.506 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 66.29 -82.06 0.1 Allowed Glycine 0 CA--C 1.523 0.547 0 N-CA-C 110.832 -0.907 . . . . 0.0 110.832 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 36.3 m-20 -64.71 167.91 6.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.821 0.343 . . . . 0.0 110.397 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -111.7 -160.05 0.7 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.275 -179.836 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.421 ' O ' ' CG ' ' A' ' 71' ' ' GLU . 6.2 mtt -121.05 125.5 47.46 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.925 0.393 . . . . 0.0 110.631 -179.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.689 ' HB2' ' N ' ' A' ' 71' ' ' GLU . . . -115.37 -57.62 2.23 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.4 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.554 ' C ' HG12 ' A' ' 31' ' ' VAL . 0.2 OUTLIER -165.86 177.67 7.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.143 -179.98 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.554 HG12 ' C ' ' A' ' 30' ' ' GLU . 0.5 OUTLIER 172.17 137.88 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 121.111 0.481 . . . . 0.0 110.251 -179.899 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.407 ' CB ' ' HA ' ' A' ' 43' ' ' ALA . 1.2 pt-20 -128.43 163.24 25.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.083 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.506 ' HG ' ' CE2' ' A' ' 66' ' ' PHE . 1.6 mt -109.49 163.57 13.31 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.055 0.455 . . . . 0.0 111.002 -179.543 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.443 ' HG3' ' CD2' ' A' ' 41' ' ' TRP . 0.7 OUTLIER -139.81 -163.39 1.49 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.688 179.375 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -153.42 -87.41 0.06 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.323 179.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.413 ' CG ' ' N ' ' A' ' 37' ' ' GLY . 48.0 p-80 -179.22 -47.19 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 120.83 0.348 . . . . 0.0 110.617 -179.858 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.413 ' N ' ' CG ' ' A' ' 36' ' ' HIS . . . -110.58 23.67 19.45 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 110.735 -0.946 . . . . 0.0 110.735 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.428 ' O ' ' CB ' ' A' ' 39' ' ' ASP . 1.9 t -86.11 -7.42 58.6 Favored 'General case' 0 C--N 1.33 -0.244 0 O-C-N 122.9 -0.176 . . . . 0.0 111.285 -179.797 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.428 ' CB ' ' O ' ' A' ' 38' ' ' SER . 0.8 OUTLIER 82.43 -51.76 0.2 Allowed 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 122.447 0.299 . . . . 0.0 110.9 179.942 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -142.42 177.88 7.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.915 0.388 . . . . 0.0 110.882 -179.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.494 ' CE2' ' HD2' ' A' ' 67' ' ' ARG . 60.3 m95 -78.55 166.53 22.46 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.443 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.456 HG23 ' O ' ' A' ' 42' ' ' VAL . 20.6 m -141.51 119.13 8.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.234 179.737 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.407 ' HA ' ' CB ' ' A' ' 32' ' ' GLU . . . -50.66 133.73 25.34 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.576 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.462 ' HE3' ' HB2' ' A' ' 52' ' ' TRP . 0.0 OUTLIER -63.04 -171.0 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.547 179.942 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 66.3 m -145.75 99.46 3.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.574 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.408 ' O ' ' HG3' ' A' ' 46' ' ' LYS . 2.8 ptmt -61.17 94.37 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.35 179.868 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -132.3 14.79 5.07 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 111.19 -0.764 . . . . 0.0 111.19 179.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -102.83 -14.17 16.7 Favored 'General case' 0 C--N 1.333 -0.152 0 O-C-N 122.719 -0.283 . . . . 0.0 110.986 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 66.1 26.16 72.36 Favored Glycine 0 CA--C 1.523 0.539 0 N-CA-C 110.42 -1.072 . . . . 0.0 110.42 -179.627 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -174.64 -39.42 0.05 OUTLIER Glycine 0 CA--C 1.523 0.591 0 N-CA-C 110.53 -1.028 . . . . 0.0 110.53 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.786 HG11 ' HG3' ' A' ' 9' ' ' GLU . 3.1 m -133.1 -177.16 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.922 0.391 . . . . 0.0 110.363 179.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . 0.462 ' HB2' ' HE3' ' A' ' 44' ' ' MET . 7.6 m95 -101.38 141.46 34.22 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.605 -179.558 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.486 ' CG2' ' HB2' ' A' ' 18' ' ' ALA . 0.6 OUTLIER -133.87 147.47 51.16 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.471 -179.757 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 75.7 t80 -130.98 112.49 12.99 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.407 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -71.58 161.91 30.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.411 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -146.56 170.81 16.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.114 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -146.31 -50.14 0.21 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.51 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -55.35 153.09 14.52 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.443 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -71.94 -50.15 0.28 Allowed 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 122.659 2.239 . . . . 0.0 112.136 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -57.91 130.99 49.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.687 -179.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 174.92 159.31 0.19 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.277 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -177.27 -99.77 0.13 Allowed Glycine 0 CA--C 1.526 0.76 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -75.32 157.47 41.43 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.569 2.18 . . . . 0.0 112.135 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.449 ' CE2' ' HG ' ' A' ' 17' ' ' LEU . 72.8 m-85 -124.27 -177.73 3.88 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.093 0.473 . . . . 0.0 110.845 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.404 ' HB2' ' HB3' ' A' ' 34' ' ' ARG . 1.8 m-80 -153.33 130.42 11.1 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.636 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.552 ' CZ ' HG21 ' A' ' 19' ' ' VAL . 80.8 m-85 -114.07 178.98 4.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.14 0.495 . . . . 0.0 110.838 -179.561 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.494 ' HD2' ' CE2' ' A' ' 41' ' ' TRP . 17.1 ptm180 -176.83 59.15 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.656 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.743 ' O ' HD23 ' A' ' 69' ' ' LEU . 0.0 OUTLIER -54.89 178.54 0.03 OUTLIER 'General case' 0 CA--C 1.518 -0.28 0 CA-C-O 121.388 0.613 . . . . 0.0 111.492 -179.21 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.743 HD23 ' O ' ' A' ' 68' ' ' PHE . 7.1 mt -144.64 48.39 1.34 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.107 -0.951 . . . . 0.0 109.182 179.78 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.1 p -25.46 137.12 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.88 0.872 . . . . 0.0 112.741 -179.007 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.689 ' N ' ' HB2' ' A' ' 29' ' ' ALA . 6.3 mt-10 -49.62 -59.03 4.15 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.507 -179.69 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 3.6 tmtt? -123.66 58.91 1.13 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.314 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -141.4 -101.63 0.45 Allowed Glycine 0 CA--C 1.522 0.516 0 N-CA-C 110.77 -0.932 . . . . 0.0 110.77 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.6 ptm -173.46 -178.43 1.67 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.709 0.29 . . . . 0.0 110.297 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.86 158.12 45.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.52 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 174.05 128.43 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.266 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 17.6 m -68.71 140.72 18.49 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.473 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.536 ' CE1' ' CG1' ' A' ' 4' ' ' VAL . 79.6 m-85 -116.81 121.53 41.81 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.311 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 26.1 m-20 -101.64 141.09 35.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.569 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 17.1 t0 60.13 60.84 1.98 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.604 179.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.416 ' HA ' ' HA ' ' A' ' 93' ' ' ALA . 75.7 t -89.44 -65.57 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 179.695 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.556 HG13 ' HD2' ' A' ' 83' ' ' PRO . 60.8 t -87.83 139.83 31.17 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.388 179.78 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.556 ' HD2' HG13 ' A' ' 82' ' ' VAL . 47.8 Cg_endo -71.88 173.47 12.71 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.61 2.207 . . . . 0.0 112.071 179.83 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -55.54 -51.21 67.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.098 179.676 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 5.3 mttt -114.78 87.08 2.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.115 179.655 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.438 ' HB3' ' CG1' ' A' ' 82' ' ' VAL . 28.1 p90 -65.94 164.47 15.01 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.579 -179.799 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 7.4 m -145.43 112.76 6.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.261 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.549 HG23 ' O ' ' A' ' 9' ' ' GLU . 2.5 mp -50.81 98.64 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.457 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 132.03 54.63 0.08 OUTLIER Glycine 0 CA--C 1.523 0.587 0 N-CA-C 110.781 -0.927 . . . . 0.0 110.781 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.793 ' HB3' ' OH ' ' A' ' 92' ' ' TYR . . . -172.6 -177.75 1.79 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.816 0.341 . . . . 0.0 110.398 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.752 HG23 ' O ' ' A' ' 6' ' ' PHE . 4.1 m -124.97 142.55 51.41 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.375 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.793 ' OH ' ' HB3' ' A' ' 90' ' ' ALA . 4.7 m-85 -146.76 123.59 11.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.359 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.922 ' HB1' ' HD2' ' A' ' 94' ' ' PRO . . . 174.93 178.88 0.18 Allowed Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.41 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.922 ' HD2' ' HB1' ' A' ' 93' ' ' ALA . 47.7 Cg_endo . . . . . 0 C--O 1.249 1.031 0 C-N-CA 122.488 2.125 . . . . 0.0 112.099 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 1.6 m . . . . . 0 N--CA 1.49 1.525 0 N-CA-C 110.121 -0.326 . . . . 0.0 110.121 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -76.39 80.38 2.75 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.584 2.189 . . . . 0.0 112.096 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 7.6 ttpt -126.98 59.94 1.39 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.165 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.581 HG11 ' CE2' ' A' ' 78' ' ' PHE . 2.4 p -74.75 162.99 4.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.368 0.604 . . . . 0.0 110.552 -179.85 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.495 ' N ' HG22 ' A' ' 4' ' ' VAL . 1.8 p -139.6 148.79 42.98 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.133 -0.94 . . . . 0.0 110.124 179.672 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.433 ' CE2' HG22 ' A' ' 21' ' ' VAL . 48.2 m-85 -123.5 145.05 49.15 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.111 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.411 ' O ' ' N ' ' A' ' 20' ' ' LEU . 3.8 m -148.36 129.78 14.81 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.152 -179.88 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.723 HG23 ' HE2' ' A' ' 92' ' ' TYR . 96.1 t -73.21 101.16 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.401 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.412 ' N ' ' O ' ' A' ' 18' ' ' ALA . 6.5 mt-10 -59.1 165.15 2.65 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.485 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.77 65.4 3.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.286 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -154.91 33.44 0.67 Allowed Glycine 0 CA--C 1.524 0.615 0 N-CA-C 110.812 -0.915 . . . . 0.0 110.812 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 21.2 p -82.03 130.08 34.98 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 110.211 -0.292 . . . . 0.0 110.211 179.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 6.2 m-80 -112.44 -161.97 0.78 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.518 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -49.76 -71.06 0.07 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.145 -179.461 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 41.5 pttt -117.99 40.95 3.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.841 -179.328 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 9.0 m80 -113.83 178.95 4.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.4 179.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 43.7 tp -165.15 94.25 0.64 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.419 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.484 ' HB2' HG22 ' A' ' 53' ' ' THR . . . -91.58 107.47 19.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.372 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.469 HG23 HG23 ' A' ' 21' ' ' VAL . 17.1 m -90.72 -173.55 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.286 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.411 ' N ' ' O ' ' A' ' 7' ' ' THR . 2.1 tt -135.11 78.15 1.72 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.502 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.469 HG23 HG23 ' A' ' 19' ' ' VAL . 16.0 t -86.23 100.63 9.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.295 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 17.1 tptt -176.11 124.73 0.19 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.548 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.443 ' CE1' HG23 ' A' ' 4' ' ' VAL . 42.6 p90 -156.98 174.29 15.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.251 179.862 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -64.21 119.65 10.64 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.495 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 122.07 -65.73 0.49 Allowed Glycine 0 CA--C 1.523 0.557 0 N-CA-C 110.921 -0.872 . . . . 0.0 110.921 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.817 ' OD1' HG22 ' A' ' 70' ' ' THR . 32.4 t0 -66.83 137.47 56.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.824 0.345 . . . . 0.0 110.577 -179.79 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.704 ' O ' HG22 ' A' ' 27' ' ' THR . 60.2 m -111.38 18.22 19.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.815 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.418 ' O ' ' CG ' ' A' ' 71' ' ' GLU . 19.7 mtp 59.55 114.79 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.797 0.332 . . . . 0.0 110.604 179.777 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.809 ' HB3' ' O ' ' A' ' 69' ' ' LEU . . . -134.53 -58.86 0.82 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.309 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.523 ' HB2' HD12 ' A' ' 69' ' ' LEU . 29.2 mt-10 -155.93 153.35 29.47 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.92 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.429 ' HA ' ' HA ' ' A' ' 68' ' ' PHE . 0.6 OUTLIER -172.43 148.0 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.386 0.612 . . . . 0.0 110.627 -179.713 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.407 ' HG3' ' HB3' ' A' ' 41' ' ' TRP . 2.2 pt-20 -142.22 178.86 7.27 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.065 -0.97 . . . . 0.0 109.688 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.708 HD21 ' CE1' ' A' ' 66' ' ' PHE . 4.4 mt -122.87 176.74 5.82 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.133 0.492 . . . . 0.0 111.031 -179.559 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 4.8 ttp180 -145.27 -175.46 4.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.673 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.44 ' CG ' ' HG2' ' A' ' 58' ' ' GLU . 4.9 mm-40 -151.58 29.93 0.6 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.722 0.296 . . . . 0.0 110.81 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER 56.58 164.53 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.555 179.615 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 51.99 25.08 16.09 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 110.887 -0.885 . . . . 0.0 110.887 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -135.91 109.84 8.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.857 0.36 . . . . 0.0 110.356 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -61.54 -22.54 65.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.654 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -100.2 176.52 5.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.914 0.388 . . . . 0.0 110.558 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.501 ' CE3' ' HG2' ' A' ' 67' ' ' ARG . 62.3 m95 -123.26 157.46 33.08 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.072 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.515 HG22 ' O ' ' A' ' 33' ' ' LEU . 4.5 m -107.25 105.89 19.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.946 0.403 . . . . 0.0 110.504 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -54.08 121.75 8.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.771 -179.724 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.88 -169.87 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.267 179.729 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 47.5 m -147.61 105.19 3.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.703 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 14.9 ptmt -62.67 82.92 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 179.509 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -109.72 -25.45 5.43 Favored Glycine 0 CA--C 1.522 0.484 0 N-CA-C 111.067 -0.813 . . . . 0.0 111.067 -179.425 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.641 ' HG2' HG22 ' A' ' 51' ' ' VAL . 1.1 tp10 -77.57 -41.04 40.29 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.774 0.321 . . . . 0.0 110.458 -179.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 99.42 -44.19 1.71 Allowed Glycine 0 CA--C 1.522 0.482 0 N-CA-C 110.168 -1.173 . . . . 0.0 110.168 -179.487 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -92.49 -29.7 10.72 Favored Glycine 0 CA--C 1.522 0.494 0 N-CA-C 110.208 -1.157 . . . . 0.0 110.208 179.516 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.641 HG22 ' HG2' ' A' ' 48' ' ' GLU . 3.5 m -140.41 -176.81 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.895 0.379 . . . . 0.0 110.283 179.65 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 9.5 m95 -106.43 134.42 49.6 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.837 -179.206 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.484 HG22 ' HB2' ' A' ' 18' ' ' ALA . 4.9 p -117.09 145.81 43.52 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.225 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.497 ' CE2' ' HB2' ' A' ' 56' ' ' SER . 85.2 t80 -131.5 138.9 49.16 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.329 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -122.73 134.08 54.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.524 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.497 ' HB2' ' CE2' ' A' ' 54' ' ' PHE . 0.3 OUTLIER -175.31 177.89 1.78 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.396 -179.972 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -155.79 26.88 0.38 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.404 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.44 ' HG2' ' CG ' ' A' ' 35' ' ' GLU . 0.0 OUTLIER -49.22 169.41 0.17 Allowed Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.636 -179.935 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.41 ' CD ' ' HB2' ' A' ' 58' ' ' GLU . 37.8 Cg_endo -93.92 20.09 0.71 Allowed 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 123.851 3.034 . . . . 0.0 112.243 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.6 mt -110.06 51.42 0.76 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.391 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 6.4 mm100 -60.13 121.19 11.3 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.292 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 169.32 -142.76 7.53 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 110.762 -0.935 . . . . 0.0 110.762 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -75.95 169.96 21.09 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.57 2.18 . . . . 0.0 111.975 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.429 ' HD2' HG21 ' A' ' 82' ' ' VAL . 54.6 m-85 -118.26 169.65 9.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.377 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -141.74 134.33 28.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.005 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.708 ' CE1' HD21 ' A' ' 33' ' ' LEU . 72.9 m-85 -119.1 179.61 4.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.044 0.449 . . . . 0.0 110.697 -179.808 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.501 ' HG2' ' CE3' ' A' ' 41' ' ' TRP . 0.0 OUTLIER -176.19 60.75 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.683 -0.689 . . . . 0.0 109.71 179.629 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.833 ' O ' HD23 ' A' ' 69' ' ' LEU . 4.6 p90 -56.04 179.44 0.04 OUTLIER 'General case' 0 CA--C 1.519 -0.23 0 CA-C-O 121.263 0.554 . . . . 0.0 111.16 -179.3 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.833 HD23 ' O ' ' A' ' 68' ' ' PHE . 6.0 mt -141.7 67.08 1.34 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.245 -0.889 . . . . 0.0 109.179 179.737 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.817 HG22 ' OD1' ' A' ' 26' ' ' ASP . 69.9 p -33.03 140.73 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 115.908 -0.587 . . . . 0.0 112.293 -178.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.709 ' HG2' ' HB2' ' A' ' 29' ' ' ALA . 7.1 mm-40 -53.07 -57.9 8.83 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.567 -179.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.09 81.74 2.04 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.506 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -175.7 -95.4 0.1 OUTLIER Glycine 0 CA--C 1.523 0.562 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 16.6 ptm 179.84 -177.53 0.37 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.869 0.366 . . . . 0.0 110.275 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.63 179.82 3.84 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.262 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 177.9 139.87 0.08 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.625 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.436 HG12 ' N ' ' A' ' 78' ' ' PHE . 87.3 t -89.5 157.38 3.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.131 179.696 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.581 ' CE2' HG11 ' A' ' 4' ' ' VAL . 78.8 m-85 -146.34 137.91 24.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.873 0.368 . . . . 0.0 110.539 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 29.5 p-10 -116.1 159.52 21.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.255 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 56.99 45.75 20.62 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.316 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.653 ' O ' HG12 ' A' ' 81' ' ' VAL . 60.3 t -94.17 8.08 5.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.104 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.491 HG23 ' O ' ' A' ' 81' ' ' VAL . 72.9 t -158.47 129.93 3.91 Favored Pre-proline 0 CA--C 1.53 0.18 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 179.693 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.457 ' HD3' ' CD1' ' A' ' 92' ' ' TYR . 47.6 Cg_endo -74.88 -169.47 0.63 Allowed 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.352 2.035 . . . . 0.0 112.08 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -77.41 -30.81 53.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.252 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 36.3 mttt -132.74 72.92 1.5 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.333 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 50.3 p90 -53.24 149.49 7.13 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.528 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.467 ' O ' HG23 ' A' ' 87' ' ' THR . 4.9 t -128.08 115.24 18.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.289 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.413 ' H ' HD12 ' A' ' 88' ' ' ILE . 3.4 mp -48.93 110.51 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.616 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 110.04 58.03 0.51 Allowed Glycine 0 CA--C 1.523 0.568 0 N-CA-C 110.712 -0.955 . . . . 0.0 110.712 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -176.28 139.78 0.36 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.805 0.336 . . . . 0.0 110.395 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 57.5 m -89.4 123.05 33.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.284 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.723 ' HE2' HG23 ' A' ' 8' ' ' VAL . 5.7 m-85 -101.95 -34.68 9.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.636 -179.633 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.854 ' HB1' ' HD2' ' A' ' 94' ' ' PRO . . . -50.02 178.94 0.04 OUTLIER Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.654 -179.782 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.854 ' HD2' ' HB1' ' A' ' 93' ' ' ALA . 48.5 Cg_endo . . . . . 0 C--O 1.249 1.036 0 C-N-CA 122.661 2.241 . . . . 0.0 112.19 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 27.4 m . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 120.705 0.288 . . . . 0.0 110.242 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -76.41 123.2 6.94 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.66 2.24 . . . . 0.0 112.116 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 46.49 93.38 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.977 179.534 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.45 ' CG2' ' CE1' ' A' ' 78' ' ' PHE . 29.8 m -53.52 171.66 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.205 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 15.0 p -153.15 127.45 9.19 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.385 179.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.976 ' O ' HG23 ' A' ' 91' ' ' THR . 45.4 m-85 -84.74 -173.08 4.53 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.938 179.821 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.466 HG23 ' OG1' ' A' ' 91' ' ' THR . 0.2 OUTLIER -165.03 117.36 1.19 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.976 0.417 . . . . 0.0 111.028 -179.988 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.679 HG21 ' HA ' ' A' ' 88' ' ' ILE . 14.3 p -49.85 129.31 7.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.423 179.546 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.735 ' HG3' HG11 ' A' ' 51' ' ' VAL . 8.9 mm-40 -116.95 163.33 16.37 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.355 179.785 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -50.37 -24.5 3.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.9 -179.538 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.637 ' HA3' ' HB2' ' A' ' 18' ' ' ALA . . . -45.95 -27.52 2.45 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 111.12 -0.792 . . . . 0.0 111.12 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.4 m -72.68 115.55 12.1 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 179.686 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.416 ' ND2' ' O ' ' A' ' 11' ' ' GLY . 5.4 m-80 -115.59 -68.43 0.92 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.41 -179.753 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -125.82 -66.91 0.91 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.126 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.26 27.05 9.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.139 179.759 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 58.1 m80 -109.75 145.66 36.25 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.391 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.619 HD11 ' CE2' ' A' ' 64' ' ' PHE . 8.7 mt -125.93 89.47 3.03 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.957 0.408 . . . . 0.0 110.272 179.766 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.656 ' HB2' ' CG2' ' A' ' 53' ' ' THR . . . -82.96 143.9 30.36 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.841 179.723 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.412 ' HB ' ' HB3' ' A' ' 6' ' ' PHE . 17.0 m -139.42 145.39 27.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.772 0.32 . . . . 0.0 110.947 -179.606 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -100.83 56.27 0.87 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.486 179.659 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.457 ' CG1' ' CD1' ' A' ' 52' ' ' TRP . 2.3 p -67.47 102.94 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.175 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -165.45 135.46 3.59 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.328 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 9.5 p90 -156.76 35.26 0.3 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.415 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 51.35 -162.26 0.07 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.454 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 61.42 -103.55 0.57 Allowed Glycine 0 CA--C 1.522 0.529 0 N-CA-C 110.637 -0.985 . . . . 0.0 110.637 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 64.9 m-20 -67.87 132.63 47.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.791 0.329 . . . . 0.0 110.151 179.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.519 HG22 ' H ' ' A' ' 28' ' ' MET . 0.2 OUTLIER -76.45 175.02 9.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.563 -179.742 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.519 ' H ' HG22 ' A' ' 27' ' ' THR . 0.1 OUTLIER -98.51 130.11 45.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.452 -179.804 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.817 ' HB3' ' O ' ' A' ' 69' ' ' LEU . . . -118.32 -53.07 2.36 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.691 -179.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -161.73 159.16 26.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.905 0.383 . . . . 0.0 110.62 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.828 HG21 ' CD1' ' A' ' 52' ' ' TRP . 18.0 t -143.05 165.12 15.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.936 179.796 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.503 ' N ' HG12 ' A' ' 31' ' ' VAL . 9.6 pt-20 -174.74 147.86 1.07 Allowed 'General case' 0 N--CA 1.451 -0.411 0 CA-C-O 120.805 0.336 . . . . 0.0 110.687 -179.603 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.625 HD12 ' N ' ' A' ' 34' ' ' ARG . 2.9 pp -109.48 171.19 7.59 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.325 179.619 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.625 ' N ' HD12 ' A' ' 33' ' ' LEU . 3.8 ttp85 -101.14 -54.65 2.74 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.764 -179.514 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.453 ' CB ' ' O ' ' A' ' 34' ' ' ARG . 3.6 tt0 88.36 30.62 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 109.182 -0.674 . . . . 0.0 109.182 -178.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 29.8 t60 46.81 -87.7 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.068 -0.969 . . . . 0.0 111.469 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.433 ' N ' ' O ' ' A' ' 35' ' ' GLU . . . -42.32 -51.42 5.36 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 111.602 -0.599 . . . . 0.0 111.602 -179.516 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.406 ' HB2' ' HB3' ' A' ' 35' ' ' GLU . 0.6 OUTLIER -49.87 100.91 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.767 0.317 . . . . 0.0 110.585 -179.962 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -51.43 -29.89 17.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.245 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -108.39 164.15 12.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.193 179.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.483 ' CZ3' ' HG2' ' A' ' 67' ' ' ARG . 67.1 m95 -87.77 150.14 23.76 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.314 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.605 HG23 ' HG ' ' A' ' 33' ' ' LEU . 11.0 m -115.66 113.95 44.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.141 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.444 ' HA ' ' CB ' ' A' ' 32' ' ' GLU . . . -48.97 130.83 18.71 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.618 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.86 -169.9 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.145 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 53.9 m -141.28 107.51 5.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.325 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 17.1 ptmt -75.9 63.65 1.74 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.269 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -77.57 -26.4 61.16 Favored Glycine 0 CA--C 1.522 0.496 0 N-CA-C 110.627 -0.989 . . . . 0.0 110.627 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -84.47 -169.53 2.66 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.824 0.345 . . . . 0.0 110.322 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -107.13 -27.37 5.37 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 110.825 -0.91 . . . . 0.0 110.825 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -131.13 -3.58 4.34 Favored Glycine 0 CA--C 1.529 0.948 0 C-N-CA 121.363 -0.446 . . . . 0.0 112.34 -179.496 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.735 HG11 ' HG3' ' A' ' 9' ' ' GLU . 33.1 m -134.27 167.22 26.62 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.132 0 CA-C-N 117.573 0.687 . . . . 0.0 110.629 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . 0.828 ' CD1' HG21 ' A' ' 31' ' ' VAL . 4.7 m95 -115.04 134.97 54.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.532 -179.689 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.656 ' CG2' ' HB2' ' A' ' 18' ' ' ALA . 0.1 OUTLIER -122.18 168.63 11.77 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.721 179.414 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.601 ' CD2' HD21 ' A' ' 33' ' ' LEU . 78.8 t80 -154.04 120.13 5.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.755 0.312 . . . . 0.0 110.936 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -78.25 134.17 37.6 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.019 179.552 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -113.52 -177.77 3.21 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.905 0.383 . . . . 0.0 110.752 -179.662 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -152.24 -45.09 0.1 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.415 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.97 156.69 4.93 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.548 -179.797 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -80.31 -19.75 8.9 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.664 2.243 . . . . 0.0 111.857 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.4 tp -48.94 135.01 16.25 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.606 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -139.45 81.71 1.85 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.338 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -137.24 -148.11 5.38 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.744 -0.942 . . . . 0.0 110.744 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -78.93 139.61 15.48 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.572 2.181 . . . . 0.0 112.127 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.619 ' CE2' HD11 ' A' ' 17' ' ' LEU . 60.9 m-85 -115.45 99.1 7.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.229 179.72 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.403 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 21.6 m-20 -62.62 164.93 6.95 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.277 -0.419 . . . . 0.0 109.96 179.78 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.498 ' CE1' ' HB3' ' A' ' 33' ' ' LEU . 21.7 m-85 -142.48 -179.05 6.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.889 0.376 . . . . 0.0 110.777 -179.778 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.483 ' HG2' ' CZ3' ' A' ' 41' ' ' TRP . 7.8 ptm180 174.5 85.31 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.284 -179.755 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.49 ' HB3' HG22 ' A' ' 31' ' ' VAL . 1.6 p90 -76.95 171.95 13.95 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.134 0.492 . . . . 0.0 110.816 -179.773 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.817 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 5.4 mt -124.69 61.68 1.15 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.406 179.783 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.2 p -30.63 137.13 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.356 0.662 . . . . 0.0 112.293 -179.066 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.649 ' HG2' ' HB2' ' A' ' 29' ' ' ALA . 13.1 mt-10 -53.56 -67.54 0.25 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.338 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -111.95 61.49 0.62 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.43 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -151.21 -104.69 0.28 Allowed Glycine 0 CA--C 1.523 0.564 0 N-CA-C 110.801 -0.92 . . . . 0.0 110.801 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 179.94 172.31 1.04 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.837 0.351 . . . . 0.0 110.274 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -86.59 -178.36 6.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.413 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 172.75 153.27 0.08 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.195 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.495 HG12 ' N ' ' A' ' 78' ' ' PHE . 77.2 t -102.16 159.75 4.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.358 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.495 ' N ' HG12 ' A' ' 77' ' ' VAL . 29.8 m-85 -148.4 122.96 9.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.403 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -109.04 154.2 22.55 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.295 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 56.61 52.86 9.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.386 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.626 ' O ' HG12 ' A' ' 81' ' ' VAL . 72.9 t -95.77 5.79 8.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.169 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.441 HG23 ' O ' ' A' ' 81' ' ' VAL . 88.3 t -158.69 127.73 3.1 Favored Pre-proline 0 CA--C 1.53 0.18 0 N-CA-C 110.09 -0.337 . . . . 0.0 110.09 179.486 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -81.31 160.49 20.08 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.61 2.207 . . . . 0.0 111.893 179.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -55.88 121.18 8.68 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 179.364 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 61.62 59.69 1.78 Allowed 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 -179.309 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 36.3 p90 -44.48 156.94 0.07 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.25 -179.347 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 88.2 m -135.27 107.78 7.37 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.731 179.641 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.679 ' HA ' HG21 ' A' ' 8' ' ' VAL . 2.8 mp -49.42 94.45 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.852 0.358 . . . . 0.0 110.596 -179.559 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.652 ' H ' HG11 ' A' ' 8' ' ' VAL . . . 160.47 47.66 0.02 OUTLIER Glycine 0 CA--C 1.523 0.552 0 N-CA-C 111.11 -0.796 . . . . 0.0 111.11 179.84 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.48 ' HB2' ' O ' ' A' ' 89' ' ' GLY . . . 174.66 162.82 0.22 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.873 0.368 . . . . 0.0 110.79 179.811 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.976 HG23 ' O ' ' A' ' 6' ' ' PHE . 87.7 m -96.28 141.17 29.93 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.02 179.783 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.454 ' O ' ' HB2' ' A' ' 93' ' ' ALA . 8.4 m-85 -136.43 129.68 31.53 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.454 -179.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.899 ' HB1' ' HD2' ' A' ' 94' ' ' PRO . . . 174.98 179.28 0.17 Allowed Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.358 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.899 ' HD2' ' HB1' ' A' ' 93' ' ' ALA . 48.5 Cg_endo . . . . . 0 C--O 1.248 1.017 0 C-N-CA 122.549 2.166 . . . . 0.0 112.1 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 60.5 t . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 110.154 -0.314 . . . . 0.0 110.154 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -74.45 -170.42 0.74 Allowed 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 122.53 2.154 . . . . 0.0 111.948 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 6.0 mtpt -125.4 75.57 1.48 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.497 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.799 ' O ' HG23 ' A' ' 5' ' ' THR . 0.4 OUTLIER 41.15 -164.28 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 CA-C-O 121.135 0.493 . . . . 0.0 111.127 179.868 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.799 HG23 ' O ' ' A' ' 4' ' ' VAL . 0.6 OUTLIER -174.56 -35.79 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.626 -0.716 . . . . 0.0 111.359 -179.749 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.778 ' O ' HG23 ' A' ' 91' ' ' THR . 86.2 m-85 66.44 156.17 0.1 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.204 -179.407 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.407 ' O ' ' N ' ' A' ' 20' ' ' LEU . 0.3 OUTLIER -163.58 117.85 1.58 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.568 -179.945 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 95.2 t -64.1 101.33 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.103 179.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.427 ' HG3' HG21 ' A' ' 51' ' ' VAL . 4.4 mm-40 -64.75 162.91 15.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.71 -179.73 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 26.9 tttt -79.21 102.57 8.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.144 179.752 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 178.42 -35.86 0.08 OUTLIER Glycine 0 CA--C 1.523 0.553 0 N-CA-C 110.858 -0.897 . . . . 0.0 110.858 -179.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -48.18 130.8 16.15 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.815 0.34 . . . . 0.0 110.646 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 20.0 m-80 -123.89 -67.2 0.94 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.356 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -121.39 -78.2 0.59 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.416 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.432 ' HG2' ' N ' ' A' ' 16' ' ' HIS . 0.0 OUTLIER -97.04 -24.77 15.62 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.698 -179.87 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.47 ' CE1' ' OD1' ' A' ' 55' ' ' ASP . 5.9 m80 -63.07 119.26 9.17 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.147 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.422 HD22 ' HA ' ' A' ' 17' ' ' LEU . 0.2 OUTLIER -114.03 97.06 6.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.46 -179.844 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -94.19 131.17 40.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.37 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.611 HG23 HG23 ' A' ' 21' ' ' VAL . 18.6 m -125.26 -175.04 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.271 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.535 HD23 ' HG2' ' A' ' 22' ' ' LYS . 1.1 tt -134.88 70.39 1.44 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.219 179.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.611 HG23 HG23 ' A' ' 19' ' ' VAL . 6.3 t -86.25 103.63 12.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.453 -179.783 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.535 ' HG2' HD23 ' A' ' 20' ' ' LEU . 0.1 OUTLIER 176.29 131.7 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.412 179.822 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.58 ' CE2' HG23 ' A' ' 4' ' ' VAL . 6.4 p90 -151.0 158.77 44.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.265 179.864 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -74.23 115.53 13.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.404 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 155.49 -82.25 0.16 Allowed Glycine 0 CA--C 1.523 0.592 0 N-CA-C 110.743 -0.943 . . . . 0.0 110.743 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -81.91 -166.08 1.14 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.812 0.339 . . . . 0.0 110.378 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -121.42 176.01 5.88 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.465 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.405 ' O ' ' CG ' ' A' ' 71' ' ' GLU . 12.6 mtt -108.49 118.06 35.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.383 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.834 ' HB3' ' O ' ' A' ' 69' ' ' LEU . . . -119.38 -61.38 1.63 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.573 -179.831 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 15.2 tt0 -155.84 163.53 39.69 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.139 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.86 HG21 ' CD1' ' A' ' 52' ' ' TRP . 38.7 t -139.57 140.6 36.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.089 0.471 . . . . 0.0 110.721 -179.796 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.413 ' OE1' ' HB2' ' A' ' 43' ' ' ALA . 5.5 tp10 -134.78 123.33 23.42 Favored 'General case' 0 N--CA 1.441 -0.925 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.271 -179.755 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.787 HD12 ' N ' ' A' ' 34' ' ' ARG . 2.7 pp -111.92 177.08 4.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.213 0.53 . . . . 0.0 111.223 -179.395 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.787 ' N ' HD12 ' A' ' 33' ' ' LEU . 6.8 ttt180 -145.35 175.32 10.39 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.342 179.576 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.423 ' O ' ' HB2' ' A' ' 36' ' ' HIS . 17.9 mt-10 -116.12 -82.76 0.63 Allowed 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 179.728 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.423 ' HB2' ' O ' ' A' ' 35' ' ' GLU . 20.6 t-160 178.08 -37.38 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.062 179.095 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -111.1 -18.66 8.09 Favored Glycine 0 CA--C 1.527 0.813 0 N-CA-C 111.007 -0.837 . . . . 0.0 111.007 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.5 p -47.4 152.1 0.68 Allowed 'General case' 0 N--CA 1.462 0.136 0 CA-C-O 120.847 0.356 . . . . 0.0 110.772 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 36.1 m-20 -53.65 -44.06 69.29 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.516 -179.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -162.76 -177.04 5.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.414 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.488 ' CZ3' ' HG2' ' A' ' 67' ' ' ARG . 55.2 m95 -58.76 156.28 11.39 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.205 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.509 HG23 ' O ' ' A' ' 42' ' ' VAL . 18.6 m -130.17 113.86 27.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.315 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.413 ' HB2' ' OE1' ' A' ' 32' ' ' GLU . . . -55.52 123.2 13.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.214 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.55 ' HG2' HD23 ' A' ' 33' ' ' LEU . 0.1 OUTLIER -51.7 -176.57 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.804 -179.797 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.418 ' O ' ' N ' ' A' ' 47' ' ' GLY . 33.1 m -149.73 126.03 10.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.393 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 15.1 ptmt -65.19 75.33 0.05 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.2 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.418 ' N ' ' O ' ' A' ' 45' ' ' THR . . . -93.89 -32.11 7.76 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 110.945 -0.862 . . . . 0.0 110.945 -179.825 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.41 ' HB2' ' O ' ' A' ' 51' ' ' VAL . 0.1 OUTLIER -78.42 174.14 11.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.871 0.367 . . . . 0.0 110.29 -179.983 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -104.64 34.46 5.77 Favored Glycine 0 CA--C 1.522 0.524 0 N-CA-C 110.228 -1.149 . . . . 0.0 110.228 179.724 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 178.78 -35.01 0.08 OUTLIER Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.979 -0.849 . . . . 0.0 110.979 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.527 HG11 ' HA ' ' A' ' 20' ' ' LEU . 3.3 m -123.03 -176.31 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 120.87 0.367 . . . . 0.0 110.557 -179.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . 0.86 ' CD1' HG21 ' A' ' 31' ' ' VAL . 7.1 m95 -98.36 139.49 34.04 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.725 -179.587 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -131.13 152.22 50.64 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.177 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 70.3 t80 -130.21 141.38 50.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.546 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.47 ' OD1' ' CE1' ' A' ' 16' ' ' HIS . 6.0 m-20 -97.86 114.81 26.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.339 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -105.97 179.18 4.34 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.467 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -172.02 39.05 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.607 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -123.34 156.77 63.17 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.339 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -71.75 -43.54 1.27 Allowed 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.614 2.209 . . . . 0.0 112.012 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 3.5 mt -69.53 122.45 19.06 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.474 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.13 88.29 2.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.278 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -104.25 -148.37 18.59 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.854 -0.898 . . . . 0.0 110.854 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -78.24 167.16 23.58 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.573 2.182 . . . . 0.0 112.141 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -123.64 113.84 19.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.378 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 70.9 m-20 -86.86 131.98 33.95 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 179.437 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.51 ' CE1' ' HB3' ' A' ' 33' ' ' LEU . 44.7 m-85 -113.38 178.07 4.41 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.101 0.477 . . . . 0.0 111.105 -179.444 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.488 ' HG2' ' CZ3' ' A' ' 41' ' ' TRP . 0.0 OUTLIER 175.29 55.04 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.494 -0.776 . . . . 0.0 109.696 179.975 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.668 ' O ' HD23 ' A' ' 69' ' ' LEU . 4.2 p90 -50.23 174.21 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.844 -0.617 . . . . 0.0 111.24 -179.307 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.834 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 2.6 mt -130.09 75.93 1.69 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.194 179.485 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.426 ' OG1' ' N ' ' A' ' 74' ' ' MET . 16.8 p -37.49 149.46 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.6 -179.17 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.672 ' HG2' ' HB2' ' A' ' 29' ' ' ALA . 5.1 mm-40 -60.97 -54.18 48.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.02 -179.338 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -129.81 58.14 1.66 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.89 0.376 . . . . 0.0 110.795 -179.568 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -149.07 -107.95 0.46 Allowed Glycine 0 CA--C 1.523 0.582 0 N-CA-C 110.895 -0.882 . . . . 0.0 110.895 179.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.426 ' N ' ' OG1' ' A' ' 70' ' ' THR . 0.0 OUTLIER -166.33 179.07 5.81 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 110.223 -0.288 . . . . 0.0 110.223 179.936 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.4 138.38 50.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.447 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.423 ' O ' ' CE2' ' A' ' 78' ' ' PHE . 24.8 m-20 -135.46 127.93 30.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.298 179.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 58.4 t -77.46 147.59 7.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.617 -179.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.423 ' CE2' ' O ' ' A' ' 76' ' ' ASN . 72.6 m-85 -132.27 121.65 23.93 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.157 179.805 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -110.27 140.88 43.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.698 -179.733 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 70.0 32.44 3.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.791 179.656 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.601 HG22 ' HD3' ' A' ' 94' ' ' PRO . 18.4 t -65.13 -68.26 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 179.564 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 93.3 t -86.53 131.48 45.63 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.168 179.697 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.453 ' HD3' ' CB ' ' A' ' 92' ' ' TYR . 50.6 Cg_endo -82.79 161.16 16.3 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.557 2.171 . . . . 0.0 112.047 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -62.33 125.24 23.22 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.188 179.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 58.86 47.93 11.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.145 -179.829 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.4 ' OH ' ' CD2' ' A' ' 17' ' ' LEU . 22.7 p90 -50.12 175.67 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.775 -179.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -137.23 104.56 5.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.998 179.736 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 2.7 mp -46.14 102.83 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.767 -179.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 145.52 48.49 0.03 OUTLIER Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.741 -0.944 . . . . 0.0 110.741 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 179.1 -176.3 0.25 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.931 0.396 . . . . 0.0 110.423 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.778 HG23 ' O ' ' A' ' 6' ' ' PHE . 89.5 m -118.12 141.38 48.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.259 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.453 ' CB ' ' HD3' ' A' ' 83' ' ' PRO . 6.2 m-85 -140.45 124.13 17.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.533 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.881 ' HB1' ' HD2' ' A' ' 94' ' ' PRO . . . -156.49 179.55 1.33 Allowed Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.121 -0.49 . . . . 0.0 109.93 179.533 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.881 ' HD2' ' HB1' ' A' ' 93' ' ' ALA . 48.5 Cg_endo . . . . . 0 C--O 1.249 1.029 0 C-N-CA 122.525 2.15 . . . . 0.0 112.059 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 9.6 t . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 110.237 -0.283 . . . . 0.0 110.237 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -75.31 95.7 1.0 Allowed 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.56 2.173 . . . . 0.0 111.921 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.1 mmtt -153.46 90.71 1.43 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.63 -179.718 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.708 HG11 ' CZ ' ' A' ' 78' ' ' PHE . 2.4 p -115.53 162.72 13.38 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.342 0 CA-C-O 121.223 0.535 . . . . 0.0 109.996 179.503 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.847 HG22 HG21 ' A' ' 91' ' ' THR . 0.2 OUTLIER -134.32 151.99 51.56 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.566 179.984 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.651 ' CE2' HG22 ' A' ' 21' ' ' VAL . 17.8 m-85 -128.73 -176.09 3.74 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.881 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -167.03 174.63 8.19 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.05 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.812 ' O ' HG23 ' A' ' 88' ' ' ILE . 93.5 t -123.37 83.29 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.1 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.673 ' HG3' HG11 ' A' ' 51' ' ' VAL . 3.4 mt-10 -47.59 161.53 0.09 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.857 -179.589 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 12.1 mttm -60.72 -18.63 55.52 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.001 -179.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -74.05 -2.3 61.71 Favored Glycine 0 CA--C 1.53 1.004 0 N-CA-C 111.824 -0.51 . . . . 0.0 111.824 -179.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.435 ' OG ' HG13 ' A' ' 8' ' ' VAL . 4.5 m -76.54 128.59 35.04 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 117.216 0.508 . . . . 0.0 110.538 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 22.9 m-80 -134.28 -164.32 1.49 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.143 179.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.442 ' HG3' ' CD ' ' A' ' 15' ' ' LYS . 22.1 pt-20 -75.87 -41.51 52.0 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.466 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.442 ' CD ' ' HG3' ' A' ' 14' ' ' GLU . 1.5 mmmt -85.12 -39.8 17.5 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.489 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 30.3 m80 -97.61 161.67 13.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.596 -179.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.523 HD22 ' HA ' ' A' ' 17' ' ' LEU . 0.4 OUTLIER -141.84 85.88 1.96 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.565 179.559 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -79.43 143.01 35.41 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.238 -179.609 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.639 HG21 ' CZ ' ' A' ' 66' ' ' PHE . 30.1 m -138.71 137.27 43.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.288 -179.863 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -91.51 65.0 5.13 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.2 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.651 HG22 ' CE2' ' A' ' 6' ' ' PHE . 10.0 t -61.78 115.18 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.415 -179.811 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 2.2 tttp -172.69 178.55 2.63 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.189 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.481 ' N ' ' CD1' ' A' ' 23' ' ' TYR . 0.0 OUTLIER -146.18 -71.31 0.25 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.044 -179.923 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -143.4 -57.88 0.41 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.219 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -168.34 63.36 0.19 Allowed Glycine 0 CA--C 1.523 0.587 0 N-CA-C 110.759 -0.937 . . . . 0.0 110.759 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -97.33 -167.35 1.52 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.776 0.322 . . . . 0.0 110.41 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 29.3 p -119.67 132.01 55.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.447 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.427 ' O ' ' CG ' ' A' ' 71' ' ' GLU . 0.0 OUTLIER -85.99 123.86 31.79 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.7 -179.851 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.703 ' HB3' ' O ' ' A' ' 69' ' ' LEU . . . -117.81 -61.54 1.67 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.407 -179.852 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.677 ' CB ' HD12 ' A' ' 69' ' ' LEU . 4.2 mt-10 -155.83 151.51 27.26 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.025 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.445 ' HA ' ' HA ' ' A' ' 68' ' ' PHE . 12.1 t -141.27 142.95 28.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.661 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.464 ' CB ' ' HA ' ' A' ' 43' ' ' ALA . 3.9 pt-20 -137.3 142.87 41.9 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.022 -0.535 . . . . 0.0 109.905 179.798 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.772 HD12 ' H ' ' A' ' 34' ' ' ARG . 5.6 tp -118.92 147.43 44.02 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 -179.47 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.772 ' H ' HD12 ' A' ' 33' ' ' LEU . 4.7 ttp180 -144.08 164.02 31.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.008 179.583 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.452 ' OE1' ' CD1' ' A' ' 64' ' ' PHE . 2.4 mm-40 -118.56 -72.82 0.67 Allowed 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 179.747 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 6.0 t-80 -179.17 -39.33 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.348 179.656 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -136.32 57.39 0.68 Allowed Glycine 0 CA--C 1.523 0.552 0 N-CA-C 110.545 -1.022 . . . . 0.0 110.545 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.1 t -132.88 68.88 1.49 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.91 0.386 . . . . 0.0 110.486 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 23.6 t0 49.1 38.19 12.39 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.78 179.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 64.73 -173.37 0.18 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.653 179.732 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.511 ' CD2' ' HD3' ' A' ' 34' ' ' ARG . 94.1 m95 -46.84 143.26 2.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.885 -179.841 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.548 HG23 ' O ' ' A' ' 33' ' ' LEU . 2.4 m -137.58 111.46 8.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.85 179.531 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.464 ' HA ' ' CB ' ' A' ' 32' ' ' GLU . . . -44.71 152.13 0.24 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.105 -179.452 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -72.16 -169.51 0.5 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.349 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 37.7 m -143.63 101.26 3.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.181 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 10.8 ptmt -64.76 80.71 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.534 -179.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -117.4 -37.14 0.94 Allowed Glycine 0 CA--C 1.523 0.588 0 N-CA-C 110.65 -0.98 . . . . 0.0 110.65 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.407 ' HB3' ' O ' ' A' ' 51' ' ' VAL . 8.4 tm-20 -60.86 -33.39 73.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.756 0.312 . . . . 0.0 110.351 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 97.82 -69.76 0.71 Allowed Glycine 0 CA--C 1.523 0.545 0 N-CA-C 110.774 -0.93 . . . . 0.0 110.774 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -74.83 -29.13 61.54 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 110.589 -1.004 . . . . 0.0 110.589 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.673 HG11 ' HG3' ' A' ' 9' ' ' GLU . 14.1 m -136.38 -177.49 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.791 0.329 . . . . 0.0 110.278 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . 0.421 ' CD1' HG21 ' A' ' 31' ' ' VAL . 7.0 m95 -110.25 132.64 54.0 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.558 -179.719 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -115.3 160.72 19.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.145 179.826 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.527 ' CB ' HD23 ' A' ' 33' ' ' LEU . 40.5 t80 -148.61 112.63 5.17 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.555 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -70.86 135.98 48.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.147 179.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -142.49 125.99 16.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.612 -179.816 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -93.17 -30.45 15.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.01 179.74 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.439 ' HB2' ' CD ' ' A' ' 59' ' ' PRO . 0.4 OUTLIER -51.84 170.15 0.23 Allowed Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.253 179.754 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.439 ' CD ' ' HB2' ' A' ' 58' ' ' GLU . 37.4 Cg_endo -91.66 56.92 0.9 Allowed 'Trans proline' 0 N--CA 1.45 -1.037 0 C-N-CA 123.569 2.846 . . . . 0.0 111.761 179.339 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.73 HD13 ' HZ ' ' A' ' 64' ' ' PHE . 0.6 OUTLIER -47.44 93.07 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.78 -179.756 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -119.23 47.33 1.71 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.341 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -165.96 -165.19 22.9 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.502 -1.039 . . . . 0.0 110.502 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -79.94 155.7 23.34 Favored 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 122.55 2.166 . . . . 0.0 112.065 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.73 ' HZ ' HD13 ' A' ' 60' ' ' LEU . 46.8 m-85 -101.8 -173.97 2.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.21 -0.45 . . . . 0.0 109.88 179.743 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -149.27 119.18 7.11 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.095 -179.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.639 ' CZ ' HG21 ' A' ' 19' ' ' VAL . 13.4 m-85 -108.21 163.47 13.14 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.423 -179.828 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.944 ' HD2' HG22 ' A' ' 77' ' ' VAL . 21.7 mtp180 -163.44 84.69 0.49 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.141 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.587 ' O ' HD23 ' A' ' 69' ' ' LEU . 6.5 p90 -75.82 169.9 17.26 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.2 0.524 . . . . 0.0 110.691 -179.783 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.703 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 3.9 mt -133.9 50.49 2.2 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.184 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 8.3 p -22.74 137.94 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.167 0.987 . . . . 0.0 113.037 -179.035 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.653 ' N ' ' HB2' ' A' ' 29' ' ' ALA . 2.6 mm-40 -55.94 -31.18 62.71 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.166 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 14.9 tptt -151.14 70.28 0.98 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.165 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -151.1 -97.49 0.16 Allowed Glycine 0 CA--C 1.522 0.488 0 N-CA-C 110.816 -0.914 . . . . 0.0 110.816 -179.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 13.2 ptp 172.63 166.82 0.12 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.748 0.309 . . . . 0.0 110.288 -179.792 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 18.4 mmtm -83.71 147.84 27.42 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 179.718 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -154.98 132.56 11.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.804 0.335 . . . . 0.0 110.472 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.944 HG22 ' HD2' ' A' ' 67' ' ' ARG . 93.8 t -97.27 146.67 7.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.148 0.499 . . . . 0.0 110.618 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.708 ' CZ ' HG11 ' A' ' 4' ' ' VAL . 41.1 m-85 -131.05 133.65 45.91 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.304 -179.486 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -127.14 31.87 5.17 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.368 -179.76 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -168.39 52.03 0.05 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.483 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.451 ' C ' HG23 ' A' ' 82' ' ' VAL . 57.1 t -93.64 -12.2 8.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.549 -179.077 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.534 HG13 ' HD2' ' A' ' 83' ' ' PRO . 70.3 t -156.76 141.33 12.02 Favored Pre-proline 0 C--N 1.332 -0.166 0 CA-C-O 120.696 0.284 . . . . 0.0 110.694 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.534 ' HD2' HG13 ' A' ' 82' ' ' VAL . 51.9 Cg_endo -81.26 -166.71 0.43 Allowed 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.72 2.28 . . . . 0.0 111.904 179.763 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.417 ' HG3' ' N ' ' A' ' 85' ' ' LYS . 5.1 pt-20 -78.15 -27.11 48.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.173 179.557 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.417 ' N ' ' HG3' ' A' ' 84' ' ' GLU . 0.0 OUTLIER -140.33 73.53 1.43 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.014 179.771 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.48 ' HB3' HG13 ' A' ' 82' ' ' VAL . 45.1 p90 -57.12 173.91 0.2 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.79 -179.624 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -152.43 113.66 4.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.035 179.696 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.812 HG23 ' O ' ' A' ' 8' ' ' VAL . 3.3 mp -48.5 109.11 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.828 -179.645 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 121.42 52.26 0.24 Allowed Glycine 0 CA--C 1.523 0.589 0 N-CA-C 111.015 -0.834 . . . . 0.0 111.015 179.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -179.31 148.85 0.38 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.846 0.355 . . . . 0.0 110.794 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.847 HG21 HG22 ' A' ' 5' ' ' THR . 19.4 m -92.77 135.51 34.05 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.895 179.589 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.498 ' CG ' ' HD3' ' A' ' 83' ' ' PRO . 66.8 m-85 -118.7 -26.47 6.11 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.635 -178.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.781 ' HB1' ' HD2' ' A' ' 94' ' ' PRO . . . -49.18 171.29 0.11 Allowed Pre-proline 0 C--N 1.331 -0.235 0 CA-C-O 120.648 0.261 . . . . 0.0 110.746 -179.803 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.781 ' HD2' ' HB1' ' A' ' 93' ' ' ALA . 47.7 Cg_endo . . . . . 0 C--O 1.249 1.066 0 C-N-CA 122.547 2.165 . . . . 0.0 111.991 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.66 HG13 ' O ' ' A' ' 1' ' ' VAL . 7.1 p . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -74.48 166.15 30.09 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.571 2.181 . . . . 0.0 112.018 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -125.54 80.67 1.91 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.376 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.581 HG21 ' CZ ' ' A' ' 78' ' ' PHE . 20.3 m -73.94 162.97 4.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.511 -179.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 43.5 p -148.34 128.84 14.01 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.176 179.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.624 ' O ' HG23 ' A' ' 91' ' ' THR . 42.5 m-85 -87.13 171.91 10.33 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.356 -179.828 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.755 HG23 ' O ' ' A' ' 90' ' ' ALA . 2.7 m -163.13 112.29 1.31 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.552 -179.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.4 HG13 ' OG ' ' A' ' 12' ' ' SER . 57.8 t -61.57 96.16 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.251 179.866 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.971 ' HG3' HG21 ' A' ' 51' ' ' VAL . 8.5 mm-40 -52.14 166.29 0.17 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.351 -179.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 17.1 mttp -60.32 -28.56 68.23 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.685 -179.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.418 ' O ' ' CB ' ' A' ' 18' ' ' ALA . . . -83.22 69.18 3.42 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 110.98 -0.848 . . . . 0.0 110.98 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.4 ' OG ' HG13 ' A' ' 8' ' ' VAL . 0.4 OUTLIER -130.37 128.65 41.85 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.702 0.287 . . . . 0.0 110.283 179.85 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 17.3 p30 -166.79 -174.96 2.92 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.618 -179.815 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -54.72 127.0 26.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.339 0.59 . . . . 0.0 110.494 -179.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.413 ' O ' ' ND1' ' A' ' 16' ' ' HIS . 0.0 OUTLIER 67.74 20.88 9.38 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.155 -0.929 . . . . 0.0 110.958 179.572 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.413 ' ND1' ' O ' ' A' ' 15' ' ' LYS . 78.2 m80 -157.68 89.01 1.0 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.826 0.346 . . . . 0.0 110.549 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.573 ' C ' HD13 ' A' ' 17' ' ' LEU . 3.0 tm? -100.97 85.25 2.82 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.937 179.851 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.483 ' HB2' ' CG2' ' A' ' 53' ' ' THR . . . -77.82 145.21 36.48 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.75 -179.632 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.615 ' O ' HG13 ' A' ' 51' ' ' VAL . 31.5 m -147.71 131.0 8.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.033 179.322 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.648 HD12 ' OE1' ' A' ' 9' ' ' GLU . 0.6 OUTLIER -83.5 85.02 7.32 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.773 -179.568 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.507 HG23 HG23 ' A' ' 19' ' ' VAL . 24.3 t -87.4 88.85 2.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.194 179.669 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.452 ' HG2' ' N ' ' A' ' 23' ' ' TYR . 38.5 tttm -145.96 160.25 42.11 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.475 -179.848 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.512 ' CE2' HG12 ' A' ' 4' ' ' VAL . 18.5 p90 177.01 174.9 0.4 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.345 179.784 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -101.28 128.33 47.47 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.453 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 146.43 -49.03 0.65 Allowed Glycine 0 CA--C 1.523 0.575 0 N-CA-C 110.669 -0.973 . . . . 0.0 110.669 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -135.94 -177.47 4.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.745 0.307 . . . . 0.0 110.336 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -116.13 172.69 7.01 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.496 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.549 ' O ' ' HB2' ' A' ' 29' ' ' ALA . 0.1 OUTLIER -75.74 -173.78 2.34 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.436 -179.934 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.768 ' HB3' ' O ' ' A' ' 69' ' ' LEU . . . 168.52 -64.82 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.29 179.801 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.412 ' O ' ' HB2' ' A' ' 68' ' ' PHE . 0.2 OUTLIER -148.0 162.78 38.65 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.778 -179.862 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.532 HG11 ' CD1' ' A' ' 52' ' ' TRP . 1.9 p 174.48 138.94 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.093 0.473 . . . . 0.0 110.384 -179.869 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.43 ' HB3' ' HA ' ' A' ' 43' ' ' ALA . 0.3 OUTLIER -137.09 178.29 7.2 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.351 -179.634 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.548 HD21 ' CZ ' ' A' ' 66' ' ' PHE . 2.3 mt -114.59 176.42 5.06 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.006 0.431 . . . . 0.0 110.767 -179.65 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.493 ' HB2' ' CZ3' ' A' ' 41' ' ' TRP . 0.0 OUTLIER -161.25 170.79 19.57 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.007 179.632 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -139.44 14.65 2.57 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.283 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER 52.99 25.62 4.16 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.613 0.244 . . . . 0.0 110.793 179.58 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -161.58 29.54 0.3 Allowed Glycine 0 CA--C 1.524 0.62 0 N-CA-C 110.964 -0.854 . . . . 0.0 110.964 -179.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -112.09 -16.39 13.06 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.528 0.204 . . . . 0.0 110.97 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 71.21 8.84 6.51 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.78 -0.191 . . . . 0.0 111.067 -179.81 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 26.3 pt-20 179.42 151.47 0.36 Allowed 'General case' 0 C--O 1.231 0.105 0 CA-C-O 120.743 0.306 . . . . 0.0 110.244 179.722 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.512 ' CE3' ' HG2' ' A' ' 67' ' ' ARG . 86.2 m95 -76.89 160.65 29.04 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.377 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.584 HG23 ' O ' ' A' ' 42' ' ' VAL . 29.7 m -134.49 106.37 7.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.319 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.43 ' HA ' ' HB3' ' A' ' 32' ' ' GLU . . . -44.06 131.5 5.83 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.122 -179.75 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.55 -170.13 0.19 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.367 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 42.8 m -147.49 118.68 7.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.342 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.408 ' HB3' ' CZ3' ' A' ' 52' ' ' TRP . 1.1 ptpt -71.77 68.75 0.64 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.576 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -90.01 -12.71 61.61 Favored Glycine 0 CA--C 1.528 0.85 0 N-CA-C 111.227 -0.749 . . . . 0.0 111.227 179.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.469 ' HB3' ' HB ' ' A' ' 51' ' ' VAL . 0.1 OUTLIER -85.41 3.83 38.27 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 116.875 0.338 . . . . 0.0 111.391 -179.831 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 64.19 21.53 66.21 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 111.041 -0.824 . . . . 0.0 111.041 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 171.96 -35.21 0.15 Allowed Glycine 0 CA--C 1.52 0.384 0 N-CA-C 109.959 -1.256 . . . . 0.0 109.959 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.971 HG21 ' HG3' ' A' ' 9' ' ' GLU . 3.0 t -106.78 157.81 6.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 179.555 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . 0.532 ' CD1' HG11 ' A' ' 31' ' ' VAL . 3.6 m95 -92.18 123.68 35.7 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.015 0.436 . . . . 0.0 110.945 -179.132 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.483 ' CG2' ' HB2' ' A' ' 18' ' ' ALA . 1.3 p -112.69 140.64 47.29 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.313 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 60.7 t80 -121.16 145.33 47.93 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.368 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -88.56 90.1 8.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.34 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -61.19 110.8 1.49 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.541 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -95.15 -36.75 11.36 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.303 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.407 ' O ' ' CG ' ' A' ' 58' ' ' GLU . 5.6 pt-20 -102.74 116.01 63.34 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.345 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -92.4 42.22 0.31 Allowed 'Trans proline' 0 N--CA 1.451 -0.986 0 C-N-CA 123.356 2.704 . . . . 0.0 112.439 179.669 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 2.1 mp -77.34 -175.0 3.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.229 179.76 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 19.8 pt20 -105.89 32.63 4.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.385 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -90.79 154.03 22.88 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.638 -0.985 . . . . 0.0 110.638 179.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -79.79 170.02 17.38 Favored 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 122.577 2.184 . . . . 0.0 112.047 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 16.6 m-30 -108.6 149.63 28.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.626 -179.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.4 ' HB2' ' HB3' ' A' ' 34' ' ' ARG . 6.8 m-80 -133.72 145.94 50.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.817 179.602 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.548 ' CZ ' HD21 ' A' ' 33' ' ' LEU . 67.1 m-85 -125.36 -177.83 4.02 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.143 0.497 . . . . 0.0 110.694 -179.818 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.512 ' HG2' ' CE3' ' A' ' 41' ' ' TRP . 0.0 OUTLIER 179.92 70.37 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.411 179.692 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.593 ' O ' HD23 ' A' ' 69' ' ' LEU . 6.5 p90 -72.27 179.68 3.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.375 0.607 . . . . 0.0 111.413 -178.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.768 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 9.5 mt -141.5 77.02 1.57 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.428 179.797 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.426 HG23 ' H ' ' A' ' 70' ' ' THR . 21.4 p -36.21 136.54 0.3 Allowed 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 116.06 -0.518 . . . . 0.0 112.006 -179.114 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.493 ' CA ' ' HB2' ' A' ' 29' ' ' ALA . 0.1 OUTLIER -42.03 -34.23 0.68 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.192 179.782 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 3.1 tmtm? -56.87 -48.79 77.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.476 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 123.85 76.94 0.33 Allowed Glycine 0 CA--C 1.523 0.589 0 N-CA-C 110.794 -0.922 . . . . 0.0 110.794 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.413 ' CG ' ' OG1' ' A' ' 70' ' ' THR . 9.8 ptp -169.72 144.49 2.88 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.788 0.327 . . . . 0.0 110.172 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -111.71 178.62 4.26 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.654 -179.631 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 176.92 127.87 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.045 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.477 HG12 ' N ' ' A' ' 78' ' ' PHE . 63.4 t -88.85 158.28 3.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.705 -179.75 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.581 ' CZ ' HG21 ' A' ' 4' ' ' VAL . 51.1 m-85 -140.38 117.33 11.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.966 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -103.94 150.58 24.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.789 -179.472 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 50.85 57.03 7.09 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.618 179.78 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.537 HG22 ' HD3' ' A' ' 94' ' ' PRO . 57.3 t -84.54 -80.8 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 179.755 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.554 HG13 ' HD2' ' A' ' 83' ' ' PRO . 60.5 t -81.91 139.5 46.47 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.438 -0.347 . . . . 0.0 110.53 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.554 ' HD2' HG13 ' A' ' 82' ' ' VAL . 46.7 Cg_endo -69.82 -167.06 0.21 Allowed 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.701 2.267 . . . . 0.0 112.031 179.546 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -78.99 -27.82 43.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.156 179.715 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -138.94 77.38 1.62 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.254 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 18.8 p90 -51.23 160.27 0.55 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.532 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 6.0 m -136.44 111.78 9.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.224 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 2.7 mp -50.41 115.13 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.509 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 114.4 38.45 1.1 Allowed Glycine 0 CA--C 1.522 0.512 0 N-CA-C 110.631 -0.988 . . . . 0.0 110.631 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.755 ' O ' HG23 ' A' ' 7' ' ' THR . . . -156.27 -177.79 6.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.851 0.358 . . . . 0.0 110.492 -179.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.624 HG23 ' O ' ' A' ' 6' ' ' PHE . 93.3 m -127.27 143.31 51.26 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.399 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.564 ' OH ' ' HB3' ' A' ' 90' ' ' ALA . 3.9 m-85 -144.45 128.4 17.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.127 179.796 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.927 ' HB1' ' HD2' ' A' ' 94' ' ' PRO . . . 176.15 179.08 0.2 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.411 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.927 ' HD2' ' HB1' ' A' ' 93' ' ' ALA . 48.5 Cg_endo . . . . . 0 C--O 1.249 1.03 0 C-N-CA 122.61 2.207 . . . . 0.0 112.174 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 6.7 m . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 120.757 0.313 . . . . 0.0 110.222 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -79.65 126.24 6.57 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.627 2.218 . . . . 0.0 111.939 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 37.2 mttm -151.02 65.16 0.91 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.634 -179.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.655 HG11 ' CZ ' ' A' ' 78' ' ' PHE . 2.5 p -179.6 163.41 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.341 0.591 . . . . 0.0 110.627 179.843 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.863 HG22 HG21 ' A' ' 91' ' ' THR . 0.0 OUTLIER -142.02 145.24 34.18 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.108 179.594 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.587 ' CD1' ' HB2' ' A' ' 93' ' ' ALA . 16.1 m-85 -117.25 165.8 13.01 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.14 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.415 ' O ' ' N ' ' A' ' 20' ' ' LEU . 0.2 OUTLIER -165.97 109.02 0.78 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.226 179.986 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.716 ' O ' HG23 ' A' ' 88' ' ' ILE . 84.6 t -61.45 90.58 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.451 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.913 ' HG3' HG11 ' A' ' 51' ' ' VAL . 21.1 mm-40 -55.1 176.39 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.477 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 12.9 mttt -74.0 -13.1 60.82 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.036 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -46.54 -28.37 3.45 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 111.021 -0.832 . . . . 0.0 111.021 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.5 m -53.08 121.71 7.97 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 179.776 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -110.61 -71.66 0.75 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.423 -179.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -138.62 -58.29 0.62 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.783 0.325 . . . . 0.0 110.54 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 10.2 pttt -104.91 -29.08 10.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.548 -179.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -64.53 166.0 9.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.5 -179.734 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 44.5 tp -146.43 85.3 1.65 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.363 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.501 ' HB2' ' CG2' ' A' ' 53' ' ' THR . . . -76.34 134.8 39.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.44 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.566 HG23 HG23 ' A' ' 21' ' ' VAL . 34.8 m -130.26 152.2 37.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.182 179.851 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.548 HD12 ' OE2' ' A' ' 9' ' ' GLU . 0.9 OUTLIER -99.58 91.46 4.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.294 179.891 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.566 HG23 HG23 ' A' ' 19' ' ' VAL . 17.8 t -99.72 97.0 5.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.608 -179.729 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 176.29 133.21 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.44 179.777 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.423 ' CZ ' ' OD2' ' A' ' 26' ' ' ASP . 0.1 OUTLIER -115.87 -73.87 0.63 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.338 -179.974 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -174.6 -56.93 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.586 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -46.59 -66.73 1.64 Allowed Glycine 0 CA--C 1.525 0.666 0 N-CA-C 111.217 -0.753 . . . . 0.0 111.217 -179.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.423 ' OD2' ' CZ ' ' A' ' 23' ' ' TYR . 44.4 p-10 -71.09 165.41 23.6 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.846 0.355 . . . . 0.0 110.482 -179.832 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.65 ' O ' HG22 ' A' ' 27' ' ' THR . 50.9 m -127.29 45.32 2.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.229 179.837 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.492 ' O ' ' HB2' ' A' ' 29' ' ' ALA . 14.7 mtt 60.15 175.93 0.09 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.502 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.634 ' HB3' ' O ' ' A' ' 69' ' ' LEU . . . 172.8 -61.7 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.306 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.447 ' HB3' HD12 ' A' ' 69' ' ' LEU . 19.9 tt0 -160.62 161.61 32.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.345 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.569 HG21 ' CD1' ' A' ' 52' ' ' TRP . 44.4 t -157.27 148.7 10.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.957 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.469 ' CB ' ' HA ' ' A' ' 43' ' ' ALA . 0.3 OUTLIER -148.6 136.15 20.51 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.978 0.418 . . . . 0.0 110.507 -179.81 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.612 HD12 ' N ' ' A' ' 34' ' ' ARG . 6.0 tp -104.1 141.69 35.78 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.958 -0.564 . . . . 0.0 109.61 -179.599 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.612 ' N ' HD12 ' A' ' 33' ' ' LEU . 1.1 ttm180 -85.25 -63.7 1.28 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.618 -179.858 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.459 ' CB ' ' O ' ' A' ' 34' ' ' ARG . 2.4 tt0 91.16 48.19 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 109.003 -0.739 . . . . 0.0 109.003 -179.154 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.441 ' CG ' ' C ' ' A' ' 35' ' ' GLU . 1.2 p80 44.41 -89.44 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 114.845 -1.071 . . . . 0.0 111.207 -179.639 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.431 ' N ' ' O ' ' A' ' 35' ' ' GLU . . . -106.21 93.53 0.88 Allowed Glycine 0 CA--C 1.523 0.566 0 N-CA-C 110.883 -0.887 . . . . 0.0 110.883 -179.831 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.433 ' HB2' ' HB3' ' A' ' 35' ' ' GLU . 8.1 t -139.86 25.27 2.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.586 0.231 . . . . 0.0 110.625 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 77.43 -54.87 0.54 Allowed 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 122.993 0.517 . . . . 0.0 110.899 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -157.75 170.75 21.66 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.33 -179.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.501 ' CZ2' ' HD2' ' A' ' 67' ' ' ARG . 81.1 m95 -63.67 164.14 10.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.394 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.411 ' CG2' ' O ' ' A' ' 33' ' ' LEU . 3.5 m -146.82 119.06 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.309 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.469 ' HA ' ' CB ' ' A' ' 32' ' ' GLU . . . -52.87 136.43 34.25 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.38 -179.87 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.74 -169.93 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.397 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 85.0 m -128.91 104.17 7.45 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.199 179.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -74.12 121.0 20.47 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.46 -179.858 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 152.41 46.32 0.02 OUTLIER Glycine 0 CA--C 1.523 0.534 0 N-CA-C 110.608 -0.997 . . . . 0.0 110.608 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.421 ' O ' ' N ' ' A' ' 50' ' ' GLY . 15.8 tp10 -134.04 73.48 1.5 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.698 0.285 . . . . 0.0 110.403 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 58.92 -83.71 0.01 OUTLIER Glycine 0 CA--C 1.523 0.533 0 N-CA-C 110.705 -0.958 . . . . 0.0 110.705 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.421 ' N ' ' O ' ' A' ' 48' ' ' GLU . . . -142.92 27.4 2.18 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 110.675 -0.97 . . . . 0.0 110.675 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.913 HG11 ' HG3' ' A' ' 9' ' ' GLU . 5.7 m -145.6 -178.43 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.798 0.333 . . . . 0.0 110.361 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . 0.569 ' CD1' HG21 ' A' ' 31' ' ' VAL . 8.8 m95 -106.13 155.28 19.59 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.513 -179.727 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.501 ' CG2' ' HB2' ' A' ' 18' ' ' ALA . 0.2 OUTLIER -141.22 148.3 39.69 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.245 179.904 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.476 ' CG ' HD23 ' A' ' 33' ' ' LEU . 70.3 t80 -125.52 146.65 49.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.254 179.724 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 18.1 p-10 -89.61 93.72 9.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.665 -179.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.3 m -85.62 95.5 9.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.138 179.695 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.77 -34.63 13.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.729 -179.62 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.62 156.09 2.45 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 120.882 0.372 . . . . 0.0 110.644 -179.706 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -77.14 -22.62 11.1 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.546 2.164 . . . . 0.0 111.563 179.551 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.416 ' O ' ' CG ' ' A' ' 61' ' ' GLN . 91.4 mt -60.74 172.74 0.87 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.587 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.416 ' CG ' ' O ' ' A' ' 60' ' ' LEU . 0.0 OUTLIER 174.7 116.86 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.253 -179.975 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 178.84 -125.04 0.95 Allowed Glycine 0 CA--C 1.527 0.788 0 N-CA-C 110.692 -0.963 . . . . 0.0 110.692 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -73.52 146.62 39.57 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.427 2.085 . . . . 0.0 112.144 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -128.91 -177.01 4.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.384 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.457 ' HB2' ' CH2' ' A' ' 41' ' ' TRP . 0.7 OUTLIER -144.95 149.48 35.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.307 179.97 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 -141.5 159.89 41.27 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.964 0.411 . . . . 0.0 110.867 -179.736 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.501 ' HD2' ' CZ2' ' A' ' 41' ' ' TRP . 15.8 mtp180 -154.11 61.25 0.71 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.965 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.767 ' O ' HD23 ' A' ' 69' ' ' LEU . 10.5 p90 -49.23 176.66 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.19 0.519 . . . . 0.0 110.991 -179.46 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.767 HD23 ' O ' ' A' ' 68' ' ' PHE . 14.5 mt -141.53 65.51 1.38 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.389 179.451 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 75.9 p -31.05 134.56 0.06 Allowed 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 115.606 -0.725 . . . . 0.0 112.655 -178.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.473 ' N ' ' HB2' ' A' ' 29' ' ' ALA . 0.1 OUTLIER -40.5 -36.96 0.63 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.452 -0.794 . . . . 0.0 111.553 179.927 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 7.9 tmtt? -61.97 -51.51 67.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.365 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 131.02 52.99 0.1 OUTLIER Glycine 0 CA--C 1.523 0.569 0 N-CA-C 110.807 -0.917 . . . . 0.0 110.807 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 13.2 mtp -133.35 128.63 36.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.847 0.356 . . . . 0.0 110.433 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.471 ' N ' ' CD ' ' A' ' 75' ' ' LYS . 0.4 OUTLIER -117.26 171.66 7.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.043 179.8 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 172.39 139.12 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.458 179.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.452 HG22 ' CD ' ' A' ' 67' ' ' ARG . 86.6 t -88.25 155.35 3.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.296 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.655 ' CZ ' HG11 ' A' ' 4' ' ' VAL . 97.5 m-85 -143.85 109.3 5.12 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.077 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.687 ' O ' HG23 ' A' ' 81' ' ' VAL . 18.5 t0 -71.71 164.0 26.76 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.004 -179.295 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.433 ' O ' ' HB ' ' A' ' 81' ' ' VAL . 20.3 t70 50.19 -95.9 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.713 179.88 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.687 HG23 ' O ' ' A' ' 79' ' ' ASP . 75.6 t 65.73 4.21 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 179.846 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.451 HG23 ' C ' ' A' ' 81' ' ' VAL . 88.4 t -159.54 130.5 3.77 Favored Pre-proline 0 CA--C 1.529 0.168 0 O-C-N 122.196 -0.315 . . . . 0.0 110.429 179.319 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.531 ' HD3' ' CG ' ' A' ' 92' ' ' TYR . 49.6 Cg_endo -70.22 -165.44 0.16 Allowed 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.705 2.27 . . . . 0.0 111.768 179.421 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -74.46 -53.71 9.0 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 179.372 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 10.0 mmtp -110.38 79.12 1.17 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.004 -0.543 . . . . 0.0 109.982 179.589 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 48.9 p90 -48.12 136.41 11.82 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.888 -179.648 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 75.3 m -123.3 115.71 22.14 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.15 179.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.716 HG23 ' O ' ' A' ' 8' ' ' VAL . 2.7 mp -55.55 119.18 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.557 -179.821 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 107.79 51.13 0.76 Allowed Glycine 0 CA--C 1.523 0.564 0 N-CA-C 111.132 -0.787 . . . . 0.0 111.132 179.75 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -174.81 135.43 0.38 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.799 0.333 . . . . 0.0 110.784 179.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.863 HG21 HG22 ' A' ' 5' ' ' THR . 11.5 m -79.32 129.74 34.76 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.181 -0.463 . . . . 0.0 109.881 179.565 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.531 ' CG ' ' HD3' ' A' ' 83' ' ' PRO . 35.1 m-85 -114.94 -22.19 9.71 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.186 -179.138 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.865 ' HB1' ' HD2' ' A' ' 94' ' ' PRO . . . -50.32 178.35 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 120.713 0.292 . . . . 0.0 110.527 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.865 ' HD2' ' HB1' ' A' ' 93' ' ' ALA . 47.6 Cg_endo . . . . . 0 C--O 1.249 1.066 0 C-N-CA 122.633 2.222 . . . . 0.0 112.023 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.613 HG13 ' O ' ' A' ' 1' ' ' VAL . 7.3 p . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -75.76 142.43 25.64 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.593 2.195 . . . . 0.0 112.077 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.579 ' O ' HG22 ' A' ' 4' ' ' VAL . 12.7 mtpt -122.69 42.94 3.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.288 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.799 ' O ' HG23 ' A' ' 5' ' ' THR . 15.6 m 45.5 -173.89 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.079 -179.852 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.799 HG23 ' O ' ' A' ' 4' ' ' VAL . 0.8 OUTLIER -169.78 130.5 1.03 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.518 -179.705 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.475 ' O ' HG23 ' A' ' 91' ' ' THR . 8.4 m-85 -104.75 156.39 18.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.085 179.757 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 57.5 m -157.48 121.93 4.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.877 0.37 . . . . 0.0 110.596 -179.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.478 ' CG1' ' CD1' ' A' ' 88' ' ' ILE . 11.9 t -60.07 93.63 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.088 179.737 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.658 ' HG3' HG11 ' A' ' 51' ' ' VAL . 14.8 mm-40 -47.62 137.5 9.12 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.757 -179.764 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 4.5 tttt -53.8 140.81 28.9 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.405 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 94.17 34.99 6.18 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.63 -0.988 . . . . 0.0 110.63 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.2 t -74.64 148.24 40.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.814 0.34 . . . . 0.0 110.389 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 -134.33 152.56 51.88 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.459 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -55.21 -32.58 62.36 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.347 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.13 -12.49 28.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.292 -179.83 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 54.9 m80 -132.12 119.5 21.02 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.832 0.349 . . . . 0.0 110.795 -179.802 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.497 HD22 ' HA ' ' A' ' 17' ' ' LEU . 0.8 OUTLIER -105.87 88.35 2.8 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.948 179.681 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -84.06 119.15 24.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.981 -179.485 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.426 HG23 HG23 ' A' ' 21' ' ' VAL . 17.9 m -108.51 -166.8 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.52 179.23 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.1 tt -140.95 79.18 1.68 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.724 179.756 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.426 HG23 HG23 ' A' ' 19' ' ' VAL . 3.1 t -92.58 88.45 2.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 179.673 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.568 ' HG2' ' HE3' ' A' ' 28' ' ' MET . 7.0 mttt -142.37 161.53 37.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.58 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.401 ' CE1' ' HB2' ' A' ' 26' ' ' ASP . 0.4 OUTLIER 170.71 153.19 0.05 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.208 -179.991 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.43 ' HG3' ' N ' ' A' ' 25' ' ' GLY . 1.5 pt-20 -88.63 -25.62 22.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.515 -179.835 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.43 ' N ' ' HG3' ' A' ' 24' ' ' GLU . . . -55.29 -38.53 68.71 Favored Glycine 0 CA--C 1.523 0.555 0 N-CA-C 110.724 -0.95 . . . . 0.0 110.724 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.401 ' HB2' ' CE1' ' A' ' 23' ' ' TYR . 55.3 m-20 -131.65 176.17 8.55 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.82 0.343 . . . . 0.0 110.324 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.83 -167.49 1.35 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.378 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.568 ' HE3' ' HG2' ' A' ' 22' ' ' LYS . 1.7 mtp -123.36 117.68 25.76 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.368 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.845 ' HB3' ' O ' ' A' ' 69' ' ' LEU . . . -127.52 -60.33 1.18 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.74 -179.783 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.556 ' C ' HG12 ' A' ' 31' ' ' VAL . 0.0 OUTLIER -142.85 171.39 14.11 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.325 -179.889 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.556 HG12 ' C ' ' A' ' 30' ' ' GLU . 0.5 OUTLIER 171.51 139.58 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 121.099 0.476 . . . . 0.0 109.898 -179.786 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.446 ' CB ' ' HA ' ' A' ' 43' ' ' ALA . 1.8 pt-20 -134.79 178.51 6.96 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.178 -179.777 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.738 HD21 ' CZ ' ' A' ' 66' ' ' PHE . 4.2 mt -118.31 172.66 7.3 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.988 0.423 . . . . 0.0 110.894 -179.608 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.416 ' HB3' ' HB2' ' A' ' 65' ' ' ASN . 0.0 OUTLIER -151.47 -173.06 4.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.732 179.588 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -139.27 25.54 2.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.778 0.323 . . . . 0.0 110.709 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 48.18 31.83 2.76 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.757 179.767 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 164.12 47.43 0.02 OUTLIER Glycine 0 CA--C 1.523 0.551 0 N-CA-C 110.924 -0.87 . . . . 0.0 110.924 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 7.0 t -113.85 148.98 35.73 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 179.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -50.8 -29.73 12.39 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.333 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -171.34 150.11 2.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.31 179.844 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.49 ' CZ3' ' HG2' ' A' ' 67' ' ' ARG . 64.4 m95 -51.68 153.55 2.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.333 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.461 HG23 ' O ' ' A' ' 42' ' ' VAL . 27.7 m -122.3 119.26 57.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.469 -179.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.446 ' HA ' ' CB ' ' A' ' 32' ' ' GLU . . . -52.98 156.69 1.97 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.502 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -94.16 -176.57 4.02 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.478 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 88.3 m -128.79 106.53 8.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.558 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 31.9 mtmt -77.98 93.14 4.4 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.283 -0.417 . . . . 0.0 109.959 179.773 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -129.49 -41.45 0.25 Allowed Glycine 0 CA--C 1.523 0.584 0 N-CA-C 111.284 -0.726 . . . . 0.0 111.284 -179.549 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -49.28 -40.84 36.01 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.872 0.368 . . . . 0.0 110.628 -179.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 96.7 -33.23 5.84 Favored Glycine 0 CA--C 1.522 0.515 0 N-CA-C 110.196 -1.162 . . . . 0.0 110.196 -179.693 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -107.39 -24.55 6.43 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 110.574 -1.01 . . . . 0.0 110.574 179.723 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.658 HG11 ' HG3' ' A' ' 9' ' ' GLU . 17.4 m -149.24 178.03 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 120.813 0.339 . . . . 0.0 110.352 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 8.4 m95 -104.79 135.92 45.27 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.103 -179.304 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.2 p -115.74 148.57 39.65 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.072 179.725 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.679 ' HB2' HD12 ' A' ' 33' ' ' LEU . 64.9 t80 -120.51 158.97 26.14 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.849 0.356 . . . . 0.0 110.671 -179.833 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -114.45 119.6 37.43 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.297 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 8.2 p -91.76 157.2 17.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.514 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -117.76 -48.83 2.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.511 -179.911 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.41 ' HB2' ' HD2' ' A' ' 59' ' ' PRO . 5.7 pt-20 -102.76 159.09 30.37 Favored Pre-proline 0 C--N 1.331 -0.221 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.394 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.41 ' HD2' ' HB2' ' A' ' 58' ' ' GLU . 43.2 Cg_endo -67.29 -158.36 0.04 OUTLIER 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.211 1.941 . . . . 0.0 110.021 178.337 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.1 mt 58.74 109.63 0.01 OUTLIER 'General case' 0 N--CA 1.441 -0.923 0 CA-C-O 120.872 0.368 . . . . 0.0 110.926 178.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 24.6 mp0 -106.34 104.3 13.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.475 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -95.61 -165.23 34.59 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.92 -0.872 . . . . 0.0 110.92 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -74.84 132.23 15.41 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.613 2.209 . . . . 0.0 111.957 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.401 ' HD2' HG21 ' A' ' 82' ' ' VAL . 30.7 m-85 -94.11 151.32 19.58 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.501 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.416 ' HB2' ' HB3' ' A' ' 34' ' ' ARG . 1.9 m-80 -131.04 140.96 50.16 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.0 -0.546 . . . . 0.0 109.773 179.58 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.738 ' CZ ' HD21 ' A' ' 33' ' ' LEU . 76.5 m-85 -123.56 -178.94 4.16 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.074 0.464 . . . . 0.0 110.748 -179.516 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.49 ' HG2' ' CZ3' ' A' ' 41' ' ' TRP . 5.4 ptm180 -177.33 75.22 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.497 179.771 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.735 ' O ' HD23 ' A' ' 69' ' ' LEU . 9.9 p90 -68.55 179.5 1.67 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.416 0.627 . . . . 0.0 111.315 -179.088 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.845 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 15.2 mt -142.87 72.3 1.37 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.212 179.485 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 72.3 p -31.39 134.1 0.08 Allowed 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 115.642 -0.708 . . . . 0.0 112.447 -178.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.712 ' HG2' ' HB2' ' A' ' 29' ' ' ALA . 2.3 mm-40 -50.02 -27.15 5.08 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.421 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -63.77 -41.46 97.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.137 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 123.37 65.25 0.21 Allowed Glycine 0 CA--C 1.524 0.61 0 N-CA-C 110.848 -0.901 . . . . 0.0 110.848 179.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 4.2 mtt -155.39 145.48 21.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.793 0.33 . . . . 0.0 110.452 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.461 ' N ' ' CD ' ' A' ' 75' ' ' LYS . 0.0 OUTLIER -121.44 -177.24 3.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.095 179.985 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 173.14 176.03 0.11 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.498 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.531 HG12 ' N ' ' A' ' 78' ' ' PHE . 97.8 t -131.41 162.21 39.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.15 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.531 ' N ' HG12 ' A' ' 77' ' ' VAL . 54.9 m-85 -150.92 130.6 13.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.943 0.401 . . . . 0.0 110.656 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -120.98 164.48 16.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.234 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 7.5 t0 52.73 43.19 31.65 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.249 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.524 ' O ' HG12 ' A' ' 81' ' ' VAL . 98.3 t -88.1 -5.2 10.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.081 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.444 HG23 ' C ' ' A' ' 81' ' ' VAL . 86.6 t -156.57 105.71 1.99 Allowed Pre-proline 0 CA--C 1.529 0.138 0 N-CA-C 110.224 -0.287 . . . . 0.0 110.224 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -73.67 -177.35 3.05 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.48 2.12 . . . . 0.0 112.224 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -77.39 130.53 37.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.342 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 63.56 44.36 5.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.258 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 47.9 p90 -50.49 140.94 13.05 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.583 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 2.9 m -106.69 118.83 37.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.196 179.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.478 ' CD1' ' CG1' ' A' ' 8' ' ' VAL . 48.5 mm -53.02 134.88 15.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.353 -179.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 102.24 28.42 6.46 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 110.668 -0.973 . . . . 0.0 110.668 -179.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -142.9 136.35 28.55 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.847 0.356 . . . . 0.0 110.51 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.475 HG23 ' O ' ' A' ' 6' ' ' PHE . 91.8 m -88.12 113.57 23.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.308 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.52 ' O ' ' HB2' ' A' ' 93' ' ' ALA . 45.3 m-85 -106.4 152.11 24.03 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.524 -179.745 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.901 ' HB1' ' HD2' ' A' ' 94' ' ' PRO . . . 170.07 177.74 0.09 OUTLIER Pre-proline 0 C--N 1.331 -0.197 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.387 179.769 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.901 ' HD2' ' HB1' ' A' ' 93' ' ' ALA . 48.7 Cg_endo . . . . . 0 C--O 1.249 1.057 0 C-N-CA 122.564 2.176 . . . . 0.0 112.0 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 16.0 m . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 110.187 -0.301 . . . . 0.0 110.187 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -78.48 129.32 9.3 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.571 2.181 . . . . 0.0 111.99 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 49.4 mttp -106.46 34.96 3.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.36 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.638 HG11 ' CZ ' ' A' ' 68' ' ' PHE . 18.4 m -80.09 163.26 3.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.338 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.619 HG23 ' O ' ' A' ' 4' ' ' VAL . 1.0 OUTLIER -162.95 132.07 4.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.444 179.957 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.514 ' CD2' ' HB ' ' A' ' 21' ' ' VAL . 9.7 m-85 -103.49 177.69 4.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.185 -0.462 . . . . 0.0 109.926 179.674 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.552 HG23 ' O ' ' A' ' 90' ' ' ALA . 2.9 m -167.17 127.7 1.51 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.763 0.316 . . . . 0.0 110.785 -179.628 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.737 HG13 ' CA ' ' A' ' 17' ' ' LEU . 87.7 t -70.77 81.54 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.264 179.529 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.522 ' CD ' HD12 ' A' ' 20' ' ' LEU . 1.7 mm-40 -49.25 178.74 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.816 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 5.8 mttp -67.98 -16.52 64.09 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.857 179.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -45.11 -34.69 4.41 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 111.006 -0.838 . . . . 0.0 111.006 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.47 ' OG ' HD11 ' A' ' 88' ' ' ILE . 1.4 p -56.95 127.22 30.76 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 179.564 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.6 p30 -109.56 -56.69 2.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.685 0.279 . . . . 0.0 110.766 -179.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 34.7 mm-40 -130.51 -58.96 1.03 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.906 0.384 . . . . 0.0 110.142 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.417 ' CG ' ' OD1' ' A' ' 55' ' ' ASP . 0.0 OUTLIER -108.35 -25.55 10.95 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.218 179.807 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.474 ' CE1' ' OD1' ' A' ' 55' ' ' ASP . 21.0 m80 -58.0 176.86 0.14 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.359 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.768 HD13 ' N ' ' A' ' 17' ' ' LEU . 0.0 OUTLIER -172.98 31.64 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.587 -179.238 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.803 ' HB2' HG22 ' A' ' 53' ' ' THR . . . -18.93 119.95 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.333 1.053 . . . . 0.0 113.0 -179.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.695 HG11 ' CZ ' ' A' ' 66' ' ' PHE . 21.9 m -87.13 138.3 19.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.665 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.522 HD12 ' CD ' ' A' ' 9' ' ' GLU . 1.0 OUTLIER -97.94 42.99 1.08 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.387 179.795 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.514 ' HB ' ' CD2' ' A' ' 6' ' ' PHE . 2.7 p -50.63 100.53 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.301 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.22 165.08 32.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.265 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER 176.21 175.07 0.32 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.496 -179.83 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -104.54 154.82 19.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.341 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 94.64 -58.55 1.87 Allowed Glycine 0 CA--C 1.522 0.51 0 N-CA-C 110.71 -0.956 . . . . 0.0 110.71 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -91.92 173.86 7.63 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.778 0.323 . . . . 0.0 110.217 179.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -121.0 -173.14 2.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.528 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.43 ' O ' ' CG ' ' A' ' 71' ' ' GLU . 0.0 OUTLIER -118.39 125.74 50.62 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.504 -179.8 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.8 ' HB3' ' O ' ' A' ' 69' ' ' LEU . . . -121.54 -55.64 1.92 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.621 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.54 ' C ' HG12 ' A' ' 31' ' ' VAL . 0.7 OUTLIER -159.92 172.93 16.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.422 -179.916 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.54 HG12 ' C ' ' A' ' 30' ' ' GLU . 0.2 OUTLIER -174.4 136.83 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.373 0.606 . . . . 0.0 109.798 179.827 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.415 ' HG2' ' HB3' ' A' ' 41' ' ' TRP . 10.5 tt0 -121.97 151.77 40.42 Favored 'General case' 0 N--CA 1.441 -0.918 0 CA-C-N 115.055 -0.975 . . . . 0.0 110.103 -178.733 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.732 HD21 ' CZ ' ' A' ' 66' ' ' PHE . 3.1 mt -101.56 161.29 13.75 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.197 179.784 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.464 ' NH2' ' NE1' ' A' ' 41' ' ' TRP . 0.0 OUTLIER -124.65 -168.15 1.77 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.413 -179.92 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.425 ' CG ' ' O ' ' A' ' 34' ' ' ARG . 11.6 mt-10 -164.81 95.55 0.71 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.83 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -47.67 103.94 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.746 -179.589 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 136.01 -39.39 1.66 Allowed Glycine 0 CA--C 1.523 0.584 0 N-CA-C 110.785 -0.926 . . . . 0.0 110.785 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -69.27 176.35 3.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.856 0.36 . . . . 0.0 110.414 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -118.84 33.91 5.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.394 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -176.43 163.5 2.48 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.531 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.491 ' CZ3' ' HG2' ' A' ' 67' ' ' ARG . 57.8 m95 -88.56 175.9 7.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.322 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.9 m -137.24 97.68 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.175 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -50.76 127.61 18.73 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.6 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.444 ' CE ' ' HB2' ' A' ' 52' ' ' TRP . 0.0 OUTLIER -61.32 -170.12 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.115 179.914 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.415 ' O ' ' N ' ' A' ' 47' ' ' GLY . 92.9 m -150.78 117.48 5.8 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.156 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 2.4 ptmt -69.12 63.5 0.13 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.387 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.415 ' N ' ' O ' ' A' ' 45' ' ' THR . . . -86.83 -27.81 28.04 Favored Glycine 0 CA--C 1.521 0.46 0 N-CA-C 110.383 -1.087 . . . . 0.0 110.383 179.785 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.452 ' HG2' ' CG2' ' A' ' 51' ' ' VAL . 11.6 tp10 -91.99 125.28 36.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.895 0.379 . . . . 0.0 110.246 179.847 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -71.89 66.82 1.12 Allowed Glycine 0 CA--C 1.522 0.476 0 N-CA-C 110.713 -0.955 . . . . 0.0 110.713 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 160.18 -27.55 0.33 Allowed Glycine 0 CA--C 1.524 0.595 0 N-CA-C 111.175 -0.77 . . . . 0.0 111.175 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.452 ' CG2' ' HG2' ' A' ' 48' ' ' GLU . 3.6 m -148.4 -176.81 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.062 0.458 . . . . 0.0 111.064 -179.692 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . 0.444 ' HB2' ' CE ' ' A' ' 44' ' ' MET . 4.3 m95 -104.76 136.45 44.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.939 -179.832 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.803 HG22 ' HB2' ' A' ' 18' ' ' ALA . 3.9 p -120.83 144.62 48.25 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.907 0.384 . . . . 0.0 110.662 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.47 ' CB ' HD12 ' A' ' 33' ' ' LEU . 89.5 t80 -140.75 86.14 2.03 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.016 179.638 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.474 ' OD1' ' CE1' ' A' ' 16' ' ' HIS . 10.7 t0 -48.71 151.1 1.24 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.548 -179.794 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 4.9 t -121.94 121.96 38.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.329 179.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -115.47 50.49 1.0 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.55 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -142.89 154.17 61.8 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.331 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -71.15 -40.44 3.25 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.715 2.277 . . . . 0.0 112.068 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 4.5 mt -73.04 153.97 40.65 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.444 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.73 100.56 2.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.319 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -114.74 -152.42 10.37 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 110.723 -0.951 . . . . 0.0 110.723 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -80.99 149.93 17.84 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.66 2.24 . . . . 0.0 112.009 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.476 ' HD2' HG21 ' A' ' 82' ' ' VAL . 45.6 m-85 -102.57 164.3 11.73 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.549 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.422 ' HB2' ' CB ' ' A' ' 34' ' ' ARG . 2.7 m-80 -136.6 139.56 42.21 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.801 179.631 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.732 ' CZ ' HD21 ' A' ' 33' ' ' LEU . 58.5 m-85 -127.31 165.13 20.28 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.135 0.493 . . . . 0.0 111.204 -179.46 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.491 ' HG2' ' CZ3' ' A' ' 41' ' ' TRP . 0.0 OUTLIER -156.99 61.08 0.51 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.48 179.578 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.638 ' CZ ' HG11 ' A' ' 4' ' ' VAL . 3.1 p90 -52.55 170.72 0.07 Allowed 'General case' 0 CA--C 1.516 -0.338 0 CA-C-O 121.483 0.659 . . . . 0.0 111.398 -179.094 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.8 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 5.6 mt -135.42 70.91 1.43 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 114.833 -1.076 . . . . 0.0 108.874 179.544 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -30.73 140.61 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.28 0.632 . . . . 0.0 112.317 -178.726 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.546 ' CA ' ' HB2' ' A' ' 29' ' ' ALA . 13.8 mt-10 -49.79 -47.28 51.3 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.935 -179.455 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.403 ' HD3' ' O ' ' A' ' 72' ' ' LYS . 0.0 OUTLIER -139.23 47.16 1.9 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.815 0.34 . . . . 0.0 110.844 -179.846 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -133.51 -108.94 1.09 Allowed Glycine 0 CA--C 1.522 0.526 0 N-CA-C 110.609 -0.996 . . . . 0.0 110.609 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 10.2 ptt? -165.9 163.2 18.6 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.757 0.313 . . . . 0.0 110.16 179.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.755 ' HB3' HD23 ' A' ' 69' ' ' LEU . 0.0 OUTLIER -98.44 -177.7 3.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.362 -179.922 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.423 ' O ' ' CB ' ' A' ' 67' ' ' ARG . 0.7 OUTLIER -179.4 -167.57 0.1 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.533 179.952 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 96.9 t -134.35 145.7 32.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.128 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.605 ' CZ ' HG21 ' A' ' 4' ' ' VAL . 52.7 m-85 -134.73 134.64 41.23 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.522 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -113.71 155.72 25.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.444 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 51.08 59.21 4.78 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.445 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.814 HG13 ' HB2' ' A' ' 93' ' ' ALA . 95.1 t -94.55 -17.38 7.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.964 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.571 HG13 ' HD2' ' A' ' 83' ' ' PRO . 82.5 t -139.71 140.1 23.89 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-O 120.629 0.252 . . . . 0.0 110.389 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.571 ' HD2' HG13 ' A' ' 82' ' ' VAL . 48.1 Cg_endo -72.49 176.96 8.01 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.652 2.235 . . . . 0.0 112.092 179.877 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -58.65 -32.24 68.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.254 -0.43 . . . . 0.0 109.976 179.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.62 85.66 2.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.131 179.777 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.504 ' CD1' HG11 ' A' ' 8' ' ' VAL . 16.9 p90 -52.09 144.74 11.61 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.684 -179.72 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -123.02 102.41 7.98 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.854 179.572 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.47 HD11 ' OG ' ' A' ' 12' ' ' SER . 3.3 mt -44.33 118.26 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.823 -179.712 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 114.41 20.61 5.8 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 110.979 -0.848 . . . . 0.0 110.979 -179.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.552 ' O ' HG23 ' A' ' 7' ' ' THR . . . -136.25 133.11 36.66 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 179.841 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 56.5 m -91.96 93.56 8.85 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.899 0.381 . . . . 0.0 111.01 -179.657 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.551 ' O ' ' HB3' ' A' ' 93' ' ' ALA . 47.4 m-85 -79.55 -153.31 0.08 Allowed 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 178.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.918 ' HB1' ' HD2' ' A' ' 94' ' ' PRO . . . 71.58 179.48 0.05 OUTLIER Pre-proline 0 C--N 1.331 -0.222 0 CA-C-O 120.696 0.284 . . . . 0.0 110.683 179.525 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.918 ' HD2' ' HB1' ' A' ' 93' ' ' ALA . 49.1 Cg_endo . . . . . 0 C--O 1.249 1.042 0 C-N-CA 122.633 2.222 . . . . 0.0 111.99 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.561 HG23 ' O ' ' A' ' 1' ' ' VAL . 17.6 m . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -77.7 171.61 17.12 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.581 2.187 . . . . 0.0 112.01 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.51 ' O ' HG12 ' A' ' 4' ' ' VAL . 35.9 mttp -149.93 64.28 0.98 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.242 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.79 ' O ' HG23 ' A' ' 5' ' ' THR . 1.2 p 46.3 -170.98 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.544 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.79 HG23 ' O ' ' A' ' 4' ' ' VAL . 0.6 OUTLIER -177.27 173.12 1.8 Allowed 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.458 -179.996 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.636 ' O ' HG23 ' A' ' 91' ' ' THR . 60.6 m-85 -141.64 172.23 12.97 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.048 179.836 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.519 HG23 ' O ' ' A' ' 90' ' ' ALA . 2.5 m -166.72 112.57 0.8 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.4 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 13.1 t -59.57 113.27 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.14 179.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.832 ' HG3' HG11 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -80.92 173.29 12.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.648 -179.661 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -75.48 153.96 37.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.402 -179.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 95.26 23.51 19.34 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 51.0 m -80.01 127.43 32.28 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.761 0.315 . . . . 0.0 110.288 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -116.31 -161.74 0.81 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.189 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -51.65 -56.65 12.44 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.485 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.408 ' HG2' ' N ' ' A' ' 16' ' ' HIS . 0.0 OUTLIER -106.15 -28.08 10.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.636 -179.763 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.408 ' N ' ' HG2' ' A' ' 15' ' ' LYS . 14.9 m80 -57.4 112.31 1.37 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.492 -179.897 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.416 HD22 ' HA ' ' A' ' 17' ' ' LEU . 0.2 OUTLIER -120.85 99.77 6.71 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.181 -0.463 . . . . 0.0 109.897 179.786 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -95.36 128.25 42.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.53 -179.673 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.932 HG23 HG23 ' A' ' 21' ' ' VAL . 28.5 m -125.24 141.89 43.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.213 179.846 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -91.92 64.99 4.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.403 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.932 HG23 HG23 ' A' ' 19' ' ' VAL . 14.2 t -68.15 93.28 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.367 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -157.97 144.73 17.8 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.446 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.706 ' CE2' HG23 ' A' ' 4' ' ' VAL . 0.0 OUTLIER -153.05 -175.16 5.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.229 179.841 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -115.52 96.31 5.58 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.354 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 155.82 -59.71 0.37 Allowed Glycine 0 CA--C 1.524 0.613 0 N-CA-C 110.807 -0.917 . . . . 0.0 110.807 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.426 ' HB2' ' CZ ' ' A' ' 23' ' ' TYR . 0.4 OUTLIER -83.52 -174.79 5.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.733 0.301 . . . . 0.0 110.356 -179.995 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -129.81 -179.3 5.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.637 -179.786 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.433 ' O ' ' CG ' ' A' ' 71' ' ' GLU . 0.0 OUTLIER -105.39 122.91 46.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.429 -179.967 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.776 ' HB3' ' O ' ' A' ' 69' ' ' LEU . . . -128.72 -53.67 1.24 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.787 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.402 ' O ' ' HB2' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -163.31 153.38 15.64 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.794 0.33 . . . . 0.0 110.653 -179.866 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.938 HG21 ' CD1' ' A' ' 52' ' ' TRP . 4.0 t -135.78 137.62 48.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.108 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -136.33 134.55 38.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.758 0.313 . . . . 0.0 110.463 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.8 mt -105.14 179.06 4.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.986 0.422 . . . . 0.0 110.63 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.504 ' HB2' ' CE3' ' A' ' 41' ' ' TRP . 8.6 ttt85 -170.15 158.49 6.95 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.946 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.443 ' N ' ' HG2' ' A' ' 34' ' ' ARG . 5.4 mp0 -117.29 -81.94 0.63 Allowed 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 179.81 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 168.87 118.14 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.459 179.31 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 52.17 38.2 48.08 Favored Glycine 0 CA--C 1.523 0.532 0 N-CA-C 110.816 -0.914 . . . . 0.0 110.816 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 12.0 t -103.56 -76.71 0.58 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.742 0.306 . . . . 0.0 110.459 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -157.36 52.61 0.48 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.423 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 54.69 178.43 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.073 -179.835 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.504 ' CE3' ' HB2' ' A' ' 34' ' ' ARG . 93.9 m95 -59.04 136.74 58.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.847 0.356 . . . . 0.0 110.161 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.654 HG21 ' CZ ' ' A' ' 54' ' ' PHE . 34.6 m -119.73 111.93 34.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.176 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -52.08 137.81 26.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.253 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.23 -171.29 0.05 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.563 -179.749 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 55.5 m -138.1 109.74 7.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.063 179.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.467 ' HG2' ' CZ3' ' A' ' 52' ' ' TRP . 36.4 mtpt -72.69 77.01 1.11 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.514 -179.754 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -102.66 -55.33 0.84 Allowed Glycine 0 CA--C 1.522 0.528 0 N-CA-C 110.473 -1.051 . . . . 0.0 110.473 179.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.611 ' HG2' HG22 ' A' ' 51' ' ' VAL . 11.8 tt0 -65.3 113.58 4.14 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.838 0.351 . . . . 0.0 110.065 179.806 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -61.98 79.22 0.02 OUTLIER Glycine 0 CA--C 1.523 0.57 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 -179.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.41 ' N ' ' O ' ' A' ' 48' ' ' GLU . . . 152.02 -42.54 0.69 Allowed Glycine 0 CA--C 1.523 0.561 0 N-CA-C 111.242 -0.743 . . . . 0.0 111.242 179.801 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.832 HG11 ' HG3' ' A' ' 9' ' ' GLU . 30.0 m -135.46 168.98 21.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.889 0.376 . . . . 0.0 110.806 -179.577 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . 0.938 ' CD1' HG21 ' A' ' 31' ' ' VAL . 7.5 m95 -99.84 140.74 33.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.571 -179.899 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 14.1 p -128.5 146.21 50.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.148 179.767 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.654 ' CZ ' HG21 ' A' ' 42' ' ' VAL . 33.2 t80 -125.04 140.88 52.51 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.535 -179.791 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -97.26 87.52 4.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.255 179.877 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.4 m -69.84 175.8 4.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.359 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 11.3 tt0 -161.67 38.49 0.13 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.296 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -131.29 165.52 34.68 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.427 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -93.59 7.26 2.67 Favored 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 123.849 3.032 . . . . 0.0 112.578 179.678 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 2.2 tp -59.86 153.29 21.19 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.782 0.325 . . . . 0.0 110.351 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.2 46.12 0.98 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.215 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -122.77 -146.44 7.18 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.67 -0.972 . . . . 0.0 110.67 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -82.73 153.36 15.18 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.719 2.279 . . . . 0.0 112.195 -179.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.412 ' HD2' HG21 ' A' ' 82' ' ' VAL . 25.7 m-85 -101.16 162.19 13.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.139 179.777 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.44 ' OD1' ' N ' ' A' ' 65' ' ' ASN . 0.0 OUTLIER -127.14 113.11 15.96 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 179.511 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.412 ' O ' ' HG3' ' A' ' 67' ' ' ARG . 5.5 m-85 -97.36 -174.08 2.83 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.871 -179.298 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.453 ' HG3' ' HA ' ' A' ' 77' ' ' VAL . 2.3 mtp180 170.21 78.04 0.0 OUTLIER 'General case' 0 CA--C 1.521 -0.137 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.88 178.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.813 ' O ' HD23 ' A' ' 69' ' ' LEU . 3.2 p90 -79.88 -179.73 7.12 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.147 179.581 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.813 HD23 ' O ' ' A' ' 68' ' ' PHE . 1.0 OUTLIER -136.31 68.67 1.43 Allowed 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 179.642 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 7.1 p -35.11 139.82 0.09 Allowed 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.929 -179.079 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.665 ' HG2' ' HB2' ' A' ' 29' ' ' ALA . 7.7 mm-40 -50.93 -54.06 27.49 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.605 -179.672 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.4 tptm -116.96 71.46 0.8 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.498 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -167.87 -102.93 0.16 Allowed Glycine 0 CA--C 1.521 0.459 0 N-CA-C 110.552 -1.019 . . . . 0.0 110.552 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 7.6 ptt? 169.13 -177.09 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.774 0.321 . . . . 0.0 110.163 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.545 ' CG ' HD22 ' A' ' 69' ' ' LEU . 4.2 mptt -75.44 -178.08 3.89 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.263 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 175.17 136.36 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.338 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.475 HG12 ' N ' ' A' ' 78' ' ' PHE . 95.9 t -84.35 159.24 3.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.267 179.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.549 ' CE1' HG11 ' A' ' 4' ' ' VAL . 86.8 m-85 -150.16 120.03 7.11 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.32 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -115.99 151.81 34.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.458 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 61.95 34.79 16.57 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.357 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.551 HG13 ' CD1' ' A' ' 6' ' ' PHE . 49.5 t -78.08 -0.5 3.39 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.935 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.599 HG13 ' HD2' ' A' ' 83' ' ' PRO . 84.1 t -154.88 139.91 12.06 Favored Pre-proline 0 C--N 1.333 -0.115 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 179.271 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.599 ' HD2' HG13 ' A' ' 82' ' ' VAL . 50.3 Cg_endo -71.72 -170.16 0.5 Allowed 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.647 2.231 . . . . 0.0 111.982 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -75.56 -28.57 59.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.188 -0.46 . . . . 0.0 109.96 179.51 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 13.7 mttt -139.25 74.95 1.49 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.982 179.783 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.432 ' HA ' ' HG2' ' A' ' 83' ' ' PRO . 25.9 p90 -48.3 151.78 0.99 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.876 -179.63 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 2.4 m -136.9 110.07 7.79 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.828 -0.623 . . . . 0.0 109.991 179.784 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 2.8 mp -46.12 105.96 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.845 -179.721 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 128.25 44.55 0.21 Allowed Glycine 0 CA--C 1.523 0.541 0 N-CA-C 110.619 -0.992 . . . . 0.0 110.619 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.597 ' HB3' ' CZ ' ' A' ' 92' ' ' TYR . . . -157.63 160.8 38.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.796 0.332 . . . . 0.0 110.339 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.636 HG23 ' O ' ' A' ' 6' ' ' PHE . 39.9 m -113.51 102.04 9.92 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.555 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.597 ' CZ ' ' HB3' ' A' ' 90' ' ' ALA . 29.9 m-85 -103.95 144.61 31.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.615 -179.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.781 ' HB1' ' HD2' ' A' ' 94' ' ' PRO . . . 172.46 171.42 0.22 Allowed Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.41 179.701 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.781 ' HD2' ' HB1' ' A' ' 93' ' ' ALA . 49.3 Cg_endo . . . . . 0 C--O 1.249 1.063 0 C-N-CA 122.61 2.207 . . . . 0.0 112.082 -179.956 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.623 HG13 ' O ' ' A' ' 1' ' ' VAL . 11.3 p . . . . . 0 N--CA 1.493 1.69 0 CA-C-O 120.648 0.261 . . . . 0.0 110.359 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -81.69 98.13 0.97 Allowed 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.678 2.252 . . . . 0.0 112.085 -179.915 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 7.8 mtmt -151.22 82.33 1.31 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.452 179.98 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 3.7 m -53.99 -178.99 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.121 179.866 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.2 p -152.54 131.17 12.3 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.42 179.949 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.667 ' HD1' ' HB2' ' A' ' 93' ' ' ALA . 16.6 m-85 -98.47 171.57 8.08 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.248 179.878 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.781 HG23 ' O ' ' A' ' 90' ' ' ALA . 0.6 OUTLIER -164.44 105.86 0.86 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.298 179.996 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 60.5 t -60.34 101.63 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.297 179.974 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.619 ' CD ' HG11 ' A' ' 51' ' ' VAL . 2.7 mt-10 -64.05 -175.72 0.16 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.315 -179.952 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 5.7 pttm -86.25 10.79 13.66 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.168 179.972 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.422 ' HA3' ' HB2' ' A' ' 18' ' ' ALA . . . -69.27 -29.71 71.86 Favored Glycine 0 CA--C 1.522 0.487 0 N-CA-C 110.571 -1.012 . . . . 0.0 110.571 179.79 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 53.2 p -53.0 106.11 0.15 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.817 0.341 . . . . 0.0 110.264 179.894 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 10.1 m-80 -89.34 -68.14 0.79 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.337 -179.97 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -135.8 -54.6 0.77 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.393 179.963 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.62 -27.39 8.57 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.392 179.926 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -52.24 179.44 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.358 179.987 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.411 HD12 ' HA ' ' A' ' 17' ' ' LEU . 24.3 tp -159.18 83.42 0.78 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.249 179.967 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.442 ' C ' HG13 ' A' ' 19' ' ' VAL . . . -73.79 158.37 34.71 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.511 -179.906 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.582 HG23 HG23 ' A' ' 21' ' ' VAL . 35.4 m -157.55 139.17 5.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.347 179.845 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -97.52 57.87 1.42 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.431 179.987 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.582 HG23 HG23 ' A' ' 19' ' ' VAL . 18.3 t -58.8 94.47 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.359 179.975 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.5 ttpm? -152.27 149.01 28.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.448 -179.929 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 12.9 p90 -169.19 137.89 2.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.309 179.916 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -55.37 152.77 8.11 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.27 -179.979 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 113.91 -77.09 0.25 Allowed Glycine 0 CA--C 1.523 0.569 0 N-CA-C 110.736 -0.946 . . . . 0.0 110.736 -179.931 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -103.81 179.94 4.13 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.801 0.334 . . . . 0.0 110.347 179.933 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.422 HG22 ' H ' ' A' ' 28' ' ' MET . 0.2 OUTLIER -108.52 -160.87 0.74 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.513 -179.813 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.422 ' H ' HG22 ' A' ' 27' ' ' THR . 19.9 mmt -122.72 127.85 49.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.542 -179.77 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.812 ' HB3' ' O ' ' A' ' 69' ' ' LEU . . . -117.23 -55.69 2.3 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.58 -179.933 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.438 ' HB3' HD12 ' A' ' 69' ' ' LEU . 23.0 tt0 -158.55 165.23 35.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.324 -179.937 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.609 HG21 ' CD1' ' A' ' 52' ' ' TRP . 67.2 t -143.64 149.4 18.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.956 0.407 . . . . 0.0 110.451 179.939 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.417 ' OE2' ' N ' ' A' ' 43' ' ' ALA . 9.7 tp10 -134.78 136.99 42.99 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-N 115.96 -0.563 . . . . 0.0 109.79 -179.431 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.647 HD12 ' H ' ' A' ' 34' ' ' ARG . 13.0 tp -115.89 152.26 33.73 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 -179.918 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.647 ' H ' HD12 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -128.39 176.19 7.91 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.826 0.346 . . . . 0.0 110.543 -179.818 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.419 ' O ' ' N ' ' A' ' 37' ' ' GLY . 1.5 tm-20 -138.85 12.41 2.68 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.16 -179.907 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER 67.48 -68.77 0.15 Allowed 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 120.822 0.344 . . . . 0.0 110.519 -179.973 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 35' ' ' GLU . . . -68.75 -26.33 74.59 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 110.846 -0.901 . . . . 0.0 110.846 -179.951 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 8.6 t -50.87 140.41 15.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.76 0.314 . . . . 0.0 110.357 -179.895 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 16.5 t0 -49.38 -30.9 8.45 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.472 -179.999 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -170.77 172.56 5.65 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.431 179.892 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.477 ' CE3' ' HB2' ' A' ' 34' ' ' ARG . 69.3 m95 -54.87 147.34 15.38 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.262 179.922 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.4 ' O ' HG23 ' A' ' 42' ' ' VAL . 6.1 m -124.77 109.91 23.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.298 179.929 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.417 ' N ' ' OE2' ' A' ' 32' ' ' GLU . . . -50.54 135.12 23.27 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.482 -179.881 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -53.69 -171.64 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.624 -179.925 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 58.0 m -128.85 93.17 3.55 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.498 -179.896 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 7.0 ptmt -71.05 84.57 0.71 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.403 179.942 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -144.21 30.21 1.89 Allowed Glycine 0 CA--C 1.523 0.533 0 N-CA-C 110.473 -1.051 . . . . 0.0 110.473 179.934 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.404 ' HB2' ' O ' ' A' ' 51' ' ' VAL . 0.0 OUTLIER -108.77 174.05 6.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.843 0.354 . . . . 0.0 110.503 -179.879 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -59.82 -31.63 72.36 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 110.718 -0.953 . . . . 0.0 110.718 179.968 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -176.6 35.41 0.09 OUTLIER Glycine 0 CA--C 1.524 0.595 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 -179.978 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.619 HG11 ' CD ' ' A' ' 9' ' ' GLU . 6.6 m -152.16 -179.93 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.776 0.322 . . . . 0.0 110.425 179.803 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . 0.609 ' CD1' HG21 ' A' ' 31' ' ' VAL . 7.0 m95 -108.44 140.0 42.37 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.438 -179.644 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -127.69 177.0 7.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.126 179.809 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.636 ' CG ' HD23 ' A' ' 33' ' ' LEU . 77.4 t80 -161.77 119.36 2.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.403 179.926 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.443 ' O ' ' CD2' ' A' ' 54' ' ' PHE . 28.3 p-10 -66.87 -177.34 0.6 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.402 -179.988 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 59.24 178.93 0.08 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.443 179.897 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 174.39 50.17 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.218 179.941 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -50.47 121.41 14.12 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.444 -179.847 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -71.56 59.73 2.66 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.444 2.096 . . . . 0.0 112.056 179.87 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -114.88 1.29 14.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.256 179.956 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -177.89 124.44 0.12 Allowed 'General case' 0 C--N 1.334 -0.092 0 CA-C-O 120.778 0.323 . . . . 0.0 110.367 179.939 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.424 ' N ' ' HD2' ' A' ' 63' ' ' PRO . . . -74.23 -54.94 5.94 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 110.814 -0.914 . . . . 0.0 110.814 -179.881 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.424 ' HD2' ' N ' ' A' ' 62' ' ' GLY . 48.0 Cg_endo -74.85 122.02 7.01 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.531 2.154 . . . . 0.0 112.214 -179.932 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -99.46 137.06 38.49 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.082 179.818 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 12.8 m-80 -98.59 134.24 41.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.803 0.335 . . . . 0.0 110.343 -179.923 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -119.92 174.31 6.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.455 179.993 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 12.6 ptm180 -173.52 76.36 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.0 -0.546 . . . . 0.0 109.92 179.923 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.592 ' O ' HD23 ' A' ' 69' ' ' LEU . 3.5 p90 -61.42 175.19 0.61 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.192 0.52 . . . . 0.0 110.809 -179.56 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.812 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 8.0 mt -132.02 65.41 1.57 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.129 179.569 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 14.0 p -26.99 135.0 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.644 0.778 . . . . 0.0 112.633 -178.987 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.609 ' HG2' ' HB2' ' A' ' 29' ' ' ALA . 16.5 mt-10 -49.74 -26.0 3.46 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.54 -179.713 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.5 tmtm? -64.81 -40.31 95.0 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.317 179.898 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 118.86 53.46 0.28 Allowed Glycine 0 CA--C 1.524 0.604 0 N-CA-C 110.798 -0.921 . . . . 0.0 110.798 179.938 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -144.71 145.61 31.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.797 0.332 . . . . 0.0 110.47 179.964 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.585 ' HG2' HD22 ' A' ' 69' ' ' LEU . 0.8 OUTLIER -127.35 -178.87 4.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.312 179.976 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 174.31 162.92 0.2 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.526 179.964 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.507 HG12 ' N ' ' A' ' 78' ' ' PHE . 86.9 t -107.18 160.77 6.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.248 179.854 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.507 ' N ' HG12 ' A' ' 77' ' ' VAL . 71.8 m-85 -151.19 130.39 12.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.525 -179.92 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -115.0 160.56 19.44 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.313 -179.924 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 52.32 55.12 9.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.355 179.932 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.725 HG22 ' HD3' ' A' ' 94' ' ' PRO . 75.6 t -102.05 2.15 10.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.034 179.957 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.437 HG23 ' C ' ' A' ' 81' ' ' VAL . 89.3 t -156.26 131.45 5.37 Favored Pre-proline 0 C--N 1.332 -0.154 0 N-CA-C 110.229 -0.286 . . . . 0.0 110.229 179.556 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -70.98 -171.16 0.54 Allowed 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.516 2.144 . . . . 0.0 111.863 179.761 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -74.0 -27.85 61.17 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.883 179.386 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 4.0 tptt -138.46 77.66 1.64 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.093 179.779 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.437 ' HB3' HG13 ' A' ' 82' ' ' VAL . 51.0 p90 -55.05 137.28 46.74 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.589 -179.795 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 5.3 m -116.32 107.29 14.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.12 179.717 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 2.7 mp -47.76 108.39 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.582 -179.872 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 126.05 43.36 0.28 Allowed Glycine 0 CA--C 1.523 0.569 0 N-CA-C 110.587 -1.005 . . . . 0.0 110.587 -179.864 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.781 ' O ' HG23 ' A' ' 7' ' ' THR . . . -153.8 -176.32 5.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.796 0.331 . . . . 0.0 110.389 -179.948 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 89.9 m -129.74 104.44 7.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.669 -179.84 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.473 ' O ' ' HB2' ' A' ' 93' ' ' ALA . 18.5 m-85 -106.97 140.27 40.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.463 179.901 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.826 ' HB1' ' HD2' ' A' ' 94' ' ' PRO . . . 171.75 171.7 0.2 Allowed Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.389 179.593 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.826 ' HD2' ' HB1' ' A' ' 93' ' ' ALA . 47.6 Cg_endo . . . . . 0 C--O 1.249 1.032 0 C-N-CA 122.606 2.204 . . . . 0.0 111.984 179.804 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 4.7 t . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -76.55 160.61 34.9 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.584 2.189 . . . . 0.0 112.064 -179.952 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.545 ' O ' HG22 ' A' ' 4' ' ' VAL . 18.4 mtmt -141.07 65.65 1.39 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.403 179.921 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.79 ' O ' HG23 ' A' ' 5' ' ' THR . 19.5 m 44.22 -172.38 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.338 179.807 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.79 HG23 ' O ' ' A' ' 4' ' ' VAL . 0.5 OUTLIER -179.55 137.64 0.13 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.301 -179.761 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.626 ' O ' HG23 ' A' ' 91' ' ' THR . 8.2 m-85 -116.13 178.4 4.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.061 179.855 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.641 HG23 ' O ' ' A' ' 90' ' ' ALA . 48.2 m -164.43 124.06 1.96 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.873 0.368 . . . . 0.0 110.514 -179.94 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 90.1 t -58.64 90.33 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.449 179.99 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.859 ' HG3' HG11 ' A' ' 51' ' ' VAL . 1.9 mm-40 -59.1 176.04 0.25 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.432 -179.968 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 5.1 mtmt -69.72 155.37 40.62 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.27 179.878 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 103.37 -33.44 6.58 Favored Glycine 0 CA--C 1.523 0.533 0 N-CA-C 110.851 -0.899 . . . . 0.0 110.851 179.968 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 70.9 m -50.67 112.36 0.69 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.684 0.278 . . . . 0.0 110.316 179.969 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -112.69 -67.06 1.03 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.937 -179.685 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.404 ' HG3' ' HG2' ' A' ' 15' ' ' LYS . 6.6 pt-20 -141.46 -48.66 0.39 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.643 0.258 . . . . 0.0 110.93 -179.702 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.404 ' HG2' ' HG3' ' A' ' 14' ' ' GLU . 8.9 ptpt -103.93 -39.38 6.62 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.766 0.317 . . . . 0.0 110.498 -179.944 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 13.2 m80 -65.94 110.26 2.83 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 179.794 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.508 HD22 ' HA ' ' A' ' 17' ' ' LEU . 0.3 OUTLIER -107.21 94.87 5.33 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.41 -179.772 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.621 ' HB2' HG22 ' A' ' 53' ' ' THR . . . -95.34 120.44 35.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.381 179.987 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.431 HG11 ' CZ ' ' A' ' 66' ' ' PHE . 21.1 m -114.42 144.24 22.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.218 179.899 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.519 ' HA ' HG12 ' A' ' 51' ' ' VAL . 1.5 tt -97.54 62.53 1.7 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.758 -179.718 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.523 ' CG1' ' CD1' ' A' ' 52' ' ' TRP . 3.4 p -81.75 126.02 39.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.971 0.415 . . . . 0.0 110.103 179.74 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.494 ' O ' ' CG ' ' A' ' 23' ' ' TYR . 5.8 tttp -166.33 -66.98 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.312 -179.863 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.494 ' CG ' ' O ' ' A' ' 22' ' ' LYS . 30.0 p90 44.97 -172.96 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.906 179.824 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -122.06 177.66 5.23 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.353 -179.724 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 96.95 -40.7 2.49 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 110.772 -0.931 . . . . 0.0 110.772 179.949 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -128.99 -175.11 3.45 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.812 0.339 . . . . 0.0 110.266 179.968 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.403 ' OG1' ' HE2' ' A' ' 72' ' ' LYS . 0.8 OUTLIER -113.25 -178.98 3.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.548 -179.98 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.504 ' CE ' HG22 ' A' ' 21' ' ' VAL . 0.4 OUTLIER -128.56 126.66 40.78 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.462 -179.882 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.898 ' HB3' ' O ' ' A' ' 69' ' ' LEU . . . -120.12 -59.85 1.75 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.393 179.957 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -142.8 159.0 43.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.291 179.986 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.818 HG21 ' NE1' ' A' ' 52' ' ' TRP . 47.2 t -138.54 145.98 27.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.038 0.447 . . . . 0.0 110.435 179.96 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.453 ' HB2' ' HA ' ' A' ' 43' ' ' ALA . 11.6 tt0 -139.79 129.53 24.58 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.891 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.713 HD12 ' H ' ' A' ' 34' ' ' ARG . 5.6 tp -110.35 150.19 29.13 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.962 0.411 . . . . 0.0 110.049 -179.027 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.713 ' H ' HD12 ' A' ' 33' ' ' LEU . 0.5 OUTLIER -106.22 -156.31 0.57 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.548 179.462 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.406 ' O ' ' HB2' ' A' ' 36' ' ' HIS . 1.0 OUTLIER -149.73 -87.69 0.08 Allowed 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 121.235 -0.186 . . . . 0.0 110.631 179.883 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.406 ' HB2' ' O ' ' A' ' 35' ' ' GLU . 17.3 t-160 175.48 -56.97 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 -179.976 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -91.36 -25.82 22.65 Favored Glycine 0 CA--C 1.522 0.513 0 N-CA-C 110.467 -1.053 . . . . 0.0 110.467 179.607 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.41 ' O ' ' CB ' ' A' ' 39' ' ' ASP . 0.1 OUTLIER -50.66 -31.66 16.87 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.871 0.367 . . . . 0.0 110.327 179.87 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.41 ' CB ' ' O ' ' A' ' 38' ' ' SER . 11.2 t0 81.75 -52.33 0.25 Allowed 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.882 179.856 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -98.24 177.38 5.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.969 0.414 . . . . 0.0 110.753 -179.619 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.425 ' CD2' ' HG3' ' A' ' 34' ' ' ARG . 59.8 m95 -95.96 171.97 8.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.383 -179.946 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.434 ' CG2' ' O ' ' A' ' 33' ' ' LEU . 5.1 m -146.86 105.64 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.201 179.621 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.453 ' HA ' ' HB2' ' A' ' 32' ' ' GLU . . . -49.94 136.49 18.39 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.697 -179.693 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -63.33 -173.09 0.06 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.896 -179.791 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 30.2 m -137.66 99.97 4.08 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.372 -179.999 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 6.5 ptpt -64.51 80.38 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.47 -179.905 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -113.11 -24.78 4.69 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.88 -0.888 . . . . 0.0 110.88 -179.969 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -72.73 -37.28 67.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.894 0.378 . . . . 0.0 110.473 179.987 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 95.65 -38.68 3.04 Favored Glycine 0 CA--C 1.523 0.541 0 N-CA-C 110.274 -1.13 . . . . 0.0 110.274 -179.654 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -102.17 -29.9 5.89 Favored Glycine 0 CA--C 1.523 0.539 0 N-CA-C 110.42 -1.072 . . . . 0.0 110.42 179.734 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.859 HG11 ' HG3' ' A' ' 9' ' ' GLU . 8.0 m -138.49 -178.47 2.0 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.768 0.318 . . . . 0.0 110.273 179.773 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . 0.818 ' NE1' HG21 ' A' ' 31' ' ' VAL . 5.5 m95 -114.97 136.98 52.53 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.893 0.378 . . . . 0.0 110.772 -179.414 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.621 HG22 ' HB2' ' A' ' 18' ' ' ALA . 10.2 p -126.39 151.08 48.14 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.732 179.452 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.412 ' CZ ' ' HB ' ' A' ' 42' ' ' VAL . 63.9 t80 -141.24 152.79 44.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.941 0.401 . . . . 0.0 110.921 -179.634 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -94.02 102.06 14.12 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.106 179.714 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.1 m -83.73 139.11 32.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.712 -179.702 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -100.06 -49.93 4.15 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.243 179.823 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.454 ' HA ' ' HD3' ' A' ' 59' ' ' PRO . 12.3 pt-20 -74.3 126.46 88.97 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.313 179.963 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 58' ' ' GLU . 38.0 Cg_endo -91.97 71.28 0.78 Allowed 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 123.159 2.572 . . . . 0.0 112.066 179.627 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -106.84 -30.34 8.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.058 0.456 . . . . 0.0 110.375 -179.936 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 44.33 36.48 1.61 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.942 179.933 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -94.04 -144.71 16.28 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 110.895 -0.882 . . . . 0.0 110.895 -179.83 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -78.63 120.79 4.88 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.608 2.205 . . . . 0.0 112.291 -179.821 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.401 ' HB3' ' CD1' ' A' ' 33' ' ' LEU . 30.7 m-85 -90.76 178.4 6.07 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.1 179.81 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -152.78 139.77 19.17 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.936 179.81 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.478 ' CE1' HD13 ' A' ' 33' ' ' LEU . 11.0 m-85 -127.68 177.25 6.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.05 0.452 . . . . 0.0 111.136 -179.775 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.412 ' CB ' ' O ' ' A' ' 76' ' ' ASN . 0.0 OUTLIER -177.16 66.89 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.592 179.976 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.676 ' HZ ' HG11 ' A' ' 4' ' ' VAL . 0.4 OUTLIER -58.47 173.65 0.37 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.252 -179.277 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.898 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 10.2 mt -123.94 83.33 2.13 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.307 -0.86 . . . . 0.0 108.896 178.884 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.418 ' OG1' ' N ' ' A' ' 74' ' ' MET . 1.6 p -35.55 137.08 0.2 Allowed 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.799 -178.954 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.746 ' HA ' ' HB2' ' A' ' 29' ' ' ALA . 21.0 mt-10 -46.71 -34.51 5.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.171 -179.16 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.406 ' O ' ' HD3' ' A' ' 72' ' ' LYS . 0.0 OUTLIER -155.99 60.03 0.59 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.776 0.322 . . . . 0.0 111.017 179.867 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -148.79 -107.18 0.43 Allowed Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.803 -0.919 . . . . 0.0 110.803 179.646 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.418 ' N ' ' OG1' ' A' ' 70' ' ' THR . 21.0 ptm -159.9 -176.42 5.69 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.846 0.355 . . . . 0.0 110.182 179.864 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.01 159.7 20.48 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.638 -179.762 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.412 ' O ' ' CB ' ' A' ' 67' ' ' ARG . 10.7 m-20 -152.43 175.06 13.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.098 -179.953 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.501 HG12 ' N ' ' A' ' 78' ' ' PHE . 49.5 t -110.24 160.98 8.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.434 -179.907 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.501 ' N ' HG12 ' A' ' 77' ' ' VAL . 75.9 m-85 -149.85 129.2 12.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.396 -179.922 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 15.2 p-10 -116.47 164.97 13.77 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.35 -179.999 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 32.3 m-20 52.35 27.29 4.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.524 179.959 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.47 HG13 ' CD1' ' A' ' 6' ' ' PHE . 88.3 t -61.79 -16.36 15.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.677 179.838 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.498 HG13 ' HD2' ' A' ' 83' ' ' PRO . 54.3 t -150.06 138.92 12.73 Favored Pre-proline 0 C--N 1.331 -0.228 0 N-CA-C 110.292 -0.262 . . . . 0.0 110.292 179.945 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.498 ' HD2' HG13 ' A' ' 82' ' ' VAL . 47.8 Cg_endo -72.28 -175.62 1.84 Allowed 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.592 2.195 . . . . 0.0 111.978 179.86 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 26.4 mm-40 -69.45 -54.87 12.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.21 179.849 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 10.5 tttt -113.9 67.4 0.67 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.237 179.98 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 30.8 p90 -57.64 174.42 0.23 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.676 -179.819 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 27.1 m -150.8 120.21 6.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.07 179.827 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.558 ' H ' HD12 ' A' ' 88' ' ' ILE . 3.9 mp -48.96 104.31 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.742 -179.752 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 133.43 53.4 0.08 OUTLIER Glycine 0 CA--C 1.523 0.561 0 N-CA-C 110.814 -0.914 . . . . 0.0 110.814 179.992 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.641 ' O ' HG23 ' A' ' 7' ' ' THR . . . -173.71 140.79 0.79 Allowed 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 110.228 -0.286 . . . . 0.0 110.228 179.92 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.626 HG23 ' O ' ' A' ' 6' ' ' PHE . 25.1 m -97.43 89.25 4.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.909 0.385 . . . . 0.0 110.626 -179.89 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.578 ' O ' ' HB3' ' A' ' 93' ' ' ALA . 43.6 m-85 -70.2 -156.94 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.042 -0.526 . . . . 0.0 109.874 179.56 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.883 ' HB1' ' HD2' ' A' ' 94' ' ' PRO . . . 76.65 173.71 0.09 OUTLIER Pre-proline 0 N--CA 1.464 0.24 0 CA-C-O 120.809 0.338 . . . . 0.0 110.69 179.853 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.883 ' HD2' ' HB1' ' A' ' 93' ' ' ALA . 47.5 Cg_endo . . . . . 0 C--O 1.249 1.063 0 C-N-CA 122.583 2.189 . . . . 0.0 112.096 179.891 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 2.5 m . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 110.18 -0.304 . . . . 0.0 110.18 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -75.47 72.62 4.87 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.523 2.148 . . . . 0.0 112.016 179.992 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -167.32 110.1 0.67 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.205 179.98 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.533 ' CG1' ' CE1' ' A' ' 78' ' ' PHE . 1.7 p -115.09 163.38 12.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.368 0.604 . . . . 0.0 110.569 -179.806 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.484 HG22 HG21 ' A' ' 91' ' ' THR . 0.6 OUTLIER -134.31 148.76 50.82 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.048 179.729 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.692 ' O ' HG23 ' A' ' 91' ' ' THR . 24.8 m-85 -118.52 171.79 7.92 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.389 -179.944 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.9 m -167.81 131.8 1.73 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.007 -179.952 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.853 ' O ' HG23 ' A' ' 88' ' ' ILE . 34.8 t -82.21 94.68 2.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.537 -179.728 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.438 ' HG3' HG11 ' A' ' 51' ' ' VAL . 11.6 mt-10 -54.4 178.26 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.513 -179.921 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 4.1 mmmt -85.89 52.35 2.45 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.514 179.936 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -139.69 23.68 2.78 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 110.86 -0.896 . . . . 0.0 110.86 179.974 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 19.0 m -109.89 127.26 54.61 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 110.168 -0.308 . . . . 0.0 110.168 179.944 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -121.85 -87.61 0.64 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.471 -179.863 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 39.0 tp10 -117.61 -61.92 1.63 Allowed 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 120.826 0.346 . . . . 0.0 110.12 -179.79 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.423 ' CE ' ' HG3' ' A' ' 57' ' ' GLU . 5.5 ptpt -98.69 -21.56 16.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.746 -179.847 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 5.4 m80 -73.73 135.48 43.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.835 0.35 . . . . 0.0 110.282 179.926 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.486 HD22 ' HA ' ' A' ' 17' ' ' LEU . 0.2 OUTLIER -133.44 100.14 4.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.243 -179.968 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -97.12 145.1 26.32 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.377 -179.95 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.682 HG23 HG23 ' A' ' 21' ' ' VAL . 14.5 m -139.83 134.19 37.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.579 -179.871 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.439 ' HA ' ' CG1' ' A' ' 51' ' ' VAL . 1.3 tt -83.22 64.0 7.5 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.435 179.876 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.682 HG23 HG23 ' A' ' 19' ' ' VAL . 17.2 t -74.04 87.12 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.272 -179.978 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 7.3 tttp -176.61 120.52 0.14 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.401 -179.966 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 27.3 p90 -130.81 29.06 4.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.291 179.99 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 53.91 -177.15 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.327 -179.889 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 77.21 -66.02 2.95 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 110.714 -0.954 . . . . 0.0 110.714 -179.952 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -84.65 179.27 7.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.775 0.322 . . . . 0.0 110.315 179.922 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.409 ' HB ' ' CG ' ' A' ' 71' ' ' GLU . 0.0 OUTLIER -115.47 170.78 8.15 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.275 179.906 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 11.9 mmt -113.65 126.2 55.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.739 -179.712 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.767 ' HB3' ' O ' ' A' ' 69' ' ' LEU . . . -115.82 -60.87 1.81 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.223 -179.804 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -158.19 161.47 37.84 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.551 179.776 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.945 HG21 ' CD1' ' A' ' 52' ' ' TRP . 12.0 t -136.78 142.79 36.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.316 0.579 . . . . 0.0 111.407 -179.723 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.457 ' CG ' ' HB3' ' A' ' 41' ' ' TRP . 2.5 tp10 -137.5 122.68 19.25 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-N 115.105 -0.952 . . . . 0.0 108.911 -179.827 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.813 HD12 ' N ' ' A' ' 34' ' ' ARG . 2.9 pp -110.66 179.5 4.05 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.254 0.549 . . . . 0.0 111.492 -179.036 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.813 ' N ' HD12 ' A' ' 33' ' ' LEU . 9.4 ttt180 -148.94 170.79 17.53 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.141 179.417 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.407 ' O ' ' HB2' ' A' ' 36' ' ' HIS . 5.2 mt-10 -119.97 -82.83 0.65 Allowed 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 179.906 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.407 ' HB2' ' O ' ' A' ' 35' ' ' GLU . 1.0 OUTLIER 178.33 -56.98 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.311 179.383 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -66.02 -28.03 73.33 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 110.697 -0.961 . . . . 0.0 110.697 179.959 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -61.3 166.76 3.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.756 0.312 . . . . 0.0 110.366 179.941 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -121.47 25.66 9.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.487 -179.978 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -179.5 149.13 0.37 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.277 179.968 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.512 ' CE3' ' HG2' ' A' ' 67' ' ' ARG . 58.2 m95 -64.68 160.57 19.59 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.506 -179.983 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.552 HG23 ' O ' ' A' ' 42' ' ' VAL . 31.5 m -130.33 109.61 17.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.174 179.796 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.42 ' N ' ' OE2' ' A' ' 32' ' ' GLU . . . -49.11 124.73 9.37 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.725 -179.658 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.491 ' HG2' HD23 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -57.04 -171.3 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.116 179.77 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 30.5 m -152.11 119.05 5.8 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.58 -179.923 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 14.2 ptpt -74.78 67.52 1.62 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.07 179.708 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -98.16 -19.95 22.14 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 111.21 -0.756 . . . . 0.0 111.21 -179.749 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.453 ' HG2' ' CG2' ' A' ' 51' ' ' VAL . 30.9 tp10 -77.76 -45.06 25.71 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.767 0.317 . . . . 0.0 110.388 -179.884 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 117.58 -63.28 0.4 Allowed Glycine 0 CA--C 1.523 0.561 0 N-CA-C 110.708 -0.957 . . . . 0.0 110.708 179.977 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -84.47 -30.01 28.52 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 110.718 -0.953 . . . . 0.0 110.718 179.97 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.453 ' CG2' ' HG2' ' A' ' 48' ' ' GLU . 6.3 m -132.53 -179.44 3.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.881 0.372 . . . . 0.0 110.437 179.953 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . 0.945 ' CD1' HG21 ' A' ' 31' ' ' VAL . 5.4 m95 -103.72 125.93 50.52 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.183 -179.823 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -118.05 160.66 21.11 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.406 -179.945 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 26.7 t80 -138.21 128.12 25.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.42 -179.966 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 19.7 p-10 -102.18 115.98 31.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.441 179.988 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 4.0 m -170.54 161.5 7.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.203 179.928 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.423 ' HG3' ' CE ' ' A' ' 15' ' ' LYS . 5.3 mt-10 -132.03 26.2 4.59 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.542 -179.903 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.95 156.51 25.47 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.311 179.882 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -72.49 69.42 3.44 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.641 2.227 . . . . 0.0 112.173 -179.942 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.7 pp -81.54 127.49 32.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.366 179.909 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -132.38 32.4 3.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.475 -179.999 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -156.13 -170.29 21.23 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 110.863 -0.895 . . . . 0.0 110.863 -179.996 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.406 ' HG3' ' HA ' ' A' ' 80' ' ' ASP . 49.0 Cg_endo -78.32 165.75 25.18 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.721 2.281 . . . . 0.0 112.039 -179.916 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -98.16 105.3 17.43 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.464 179.962 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 17.8 m-80 -77.51 140.65 39.8 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 179.191 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.5 ' CE1' ' HB3' ' A' ' 33' ' ' LEU . 37.1 m-85 -121.57 -178.56 3.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.157 0.503 . . . . 0.0 111.245 -179.245 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.512 ' HG2' ' CE3' ' A' ' 41' ' ' TRP . 0.0 OUTLIER 173.95 59.09 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.728 179.973 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.461 ' HA ' ' HA ' ' A' ' 31' ' ' VAL . 1.2 p90 -50.86 165.24 0.11 Allowed 'General case' 0 CA--C 1.517 -0.321 0 CA-C-O 121.219 0.533 . . . . 0.0 111.054 -179.323 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.767 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 2.2 mt -115.9 63.33 0.7 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.118 179.671 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 12.0 p -29.95 138.22 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 115.594 -0.73 . . . . 0.0 112.476 -179.019 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.62 ' HG2' ' HB2' ' A' ' 29' ' ' ALA . 16.4 mt-10 -52.36 -36.11 52.88 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.364 -179.952 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.09 65.74 1.15 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.505 -179.835 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -151.23 -106.92 0.35 Allowed Glycine 0 CA--C 1.522 0.484 0 N-CA-C 110.58 -1.008 . . . . 0.0 110.58 179.965 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 16.1 ptt? -175.32 176.17 2.07 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.805 0.336 . . . . 0.0 110.194 179.919 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.476 ' N ' ' CD ' ' A' ' 75' ' ' LYS . 0.0 OUTLIER -94.62 120.78 35.39 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.141 179.924 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.423 ' O ' ' CB ' ' A' ' 67' ' ' ARG . 65.5 m-80 -112.05 168.69 9.4 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.727 -179.596 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 94.1 t -120.48 153.23 23.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.046 179.68 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.533 ' CE1' ' CG1' ' A' ' 4' ' ' VAL . 45.6 m-85 -152.9 130.71 11.66 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.576 -179.817 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 36.9 m-20 -118.71 149.55 41.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.178 179.867 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.406 ' HA ' ' HG3' ' A' ' 63' ' ' PRO . 27.9 t0 64.12 42.88 5.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.435 179.98 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.506 ' O ' HG12 ' A' ' 81' ' ' VAL . 76.2 t -86.28 -6.35 10.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.054 179.827 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.421 HG23 ' C ' ' A' ' 81' ' ' VAL . 96.8 t -155.69 115.07 2.24 Favored Pre-proline 0 CA--C 1.528 0.1 0 N-CA-C 110.217 -0.29 . . . . 0.0 110.217 179.795 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -73.55 -170.9 0.73 Allowed 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.417 2.078 . . . . 0.0 112.014 179.862 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -90.67 125.63 35.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.167 179.808 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 64.74 42.46 4.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.094 -179.784 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.445 ' HB2' ' CE2' ' A' ' 92' ' ' TYR . 27.1 p90 -50.76 177.53 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.771 -179.776 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 70.9 m -132.23 110.01 10.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.939 179.692 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.853 HG23 ' O ' ' A' ' 8' ' ' VAL . 3.2 mp -46.16 124.38 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.729 -179.728 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 106.68 55.68 0.65 Allowed Glycine 0 CA--C 1.524 0.596 0 N-CA-C 110.833 -0.907 . . . . 0.0 110.833 179.958 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -179.6 141.11 0.15 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.808 0.337 . . . . 0.0 110.578 179.986 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.692 HG23 ' O ' ' A' ' 6' ' ' PHE . 8.2 m -83.89 131.3 34.88 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.042 179.726 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.445 ' CE2' ' HB2' ' A' ' 86' ' ' TYR . 59.5 m-85 -113.54 -23.02 10.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.937 -179.36 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.896 ' HB1' ' HD2' ' A' ' 94' ' ' PRO . . . -51.02 -179.82 0.04 OUTLIER Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.332 179.844 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.896 ' HD2' ' HB1' ' A' ' 93' ' ' ALA . 50.1 Cg_endo . . . . . 0 C--O 1.249 1.027 0 C-N-CA 122.579 2.186 . . . . 0.0 112.071 -179.862 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.405 HG23 ' HD2' ' A' ' 2' ' ' PRO . 7.3 p . . . . . 0 N--CA 1.489 1.502 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.405 ' HD2' HG23 ' A' ' 1' ' ' VAL . 47.7 Cg_endo -75.12 143.37 28.61 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.408 2.072 . . . . 0.0 111.962 179.966 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 15.0 mtpp -112.36 83.06 1.74 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.377 179.942 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.587 HG22 ' CE2' ' A' ' 78' ' ' PHE . 19.4 m -51.59 -178.65 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.32 179.902 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.444 HG23 ' O ' ' A' ' 4' ' ' VAL . 20.0 p -155.56 134.23 11.88 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.481 179.965 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.721 ' O ' HG23 ' A' ' 91' ' ' THR . 37.4 m-85 -97.89 175.72 6.04 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.15 179.87 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.41 ' HB ' ' CB ' ' A' ' 20' ' ' LEU . 0.5 OUTLIER -164.4 107.05 0.9 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.857 0.361 . . . . 0.0 110.537 -179.981 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 40.7 t -60.81 85.27 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.255 179.948 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.85 ' CD ' HG11 ' A' ' 51' ' ' VAL . 0.8 OUTLIER -50.42 143.97 8.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.673 -179.773 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.445 ' HA ' ' CG2' ' A' ' 88' ' ' ILE . 0.1 OUTLIER -67.4 142.1 56.82 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.276 179.899 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 117.95 14.08 6.84 Favored Glycine 0 CA--C 1.527 0.795 0 N-CA-C 111.41 -0.676 . . . . 0.0 111.41 179.839 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 39.4 m -55.65 104.6 0.14 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.961 0.381 . . . . 0.0 109.987 179.731 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 8.1 m-20 -57.85 -164.91 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.602 -179.589 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -56.68 -48.09 78.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.091 -179.345 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 8.8 pttt -136.13 33.78 2.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.944 -179.391 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 5.2 m80 -111.93 156.56 21.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.804 0.335 . . . . 0.0 110.279 179.703 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 28.9 tp -137.01 103.63 5.2 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.684 -179.77 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -90.7 124.3 34.98 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.068 -0.515 . . . . 0.0 109.894 179.574 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.643 HG23 HG23 ' A' ' 21' ' ' VAL . 32.6 m -117.45 138.82 46.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.827 0.346 . . . . 0.0 110.653 -179.698 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.41 ' CB ' ' HB ' ' A' ' 7' ' ' THR . 0.7 OUTLIER -94.64 69.59 3.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.452 179.96 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.643 HG23 HG23 ' A' ' 19' ' ' VAL . 18.8 t -80.11 90.01 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.394 -0.367 . . . . 0.0 110.246 179.991 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -151.97 129.16 11.18 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.504 -179.958 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 15.0 p90 -154.53 176.75 11.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.262 179.843 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -105.43 96.64 6.65 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.358 179.992 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -179.99 -51.5 0.08 OUTLIER Glycine 0 CA--C 1.523 0.54 0 N-CA-C 110.594 -1.002 . . . . 0.0 110.594 -179.912 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -126.58 155.22 42.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.738 0.304 . . . . 0.0 110.296 179.939 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.16 -176.98 6.44 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.406 -179.984 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.426 ' O ' ' CG ' ' A' ' 71' ' ' GLU . 41.0 mtm -117.23 122.24 43.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.623 -179.743 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.809 ' HB3' ' O ' ' A' ' 69' ' ' LEU . . . -122.23 -53.31 1.93 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.276 179.922 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -158.04 164.2 36.96 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.146 179.948 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.478 HG21 ' CD1' ' A' ' 52' ' ' TRP . 12.2 t -147.26 149.83 15.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.633 179.968 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.453 ' CB ' ' HA ' ' A' ' 43' ' ' ALA . 0.3 OUTLIER -158.81 130.56 6.53 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.07 179.966 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.799 HD12 ' N ' ' A' ' 34' ' ' ARG . 3.5 pp -110.99 -177.88 3.33 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.039 0.447 . . . . 0.0 110.998 -179.44 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.799 ' N ' HD12 ' A' ' 33' ' ' LEU . 1.3 ttp180 -143.06 162.09 36.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.007 179.724 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.419 ' HB2' ' HB2' ' A' ' 38' ' ' SER . 0.1 OUTLIER -129.51 25.59 5.4 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.198 179.643 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 49.32 94.15 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.817 179.838 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.414 ' O ' ' N ' ' A' ' 39' ' ' ASP . . . 98.23 -30.13 10.07 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 111.207 -0.757 . . . . 0.0 111.207 179.639 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.419 ' HB2' ' HB2' ' A' ' 35' ' ' GLU . 14.7 m -65.2 74.14 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.794 0.33 . . . . 0.0 110.703 -179.7 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.414 ' N ' ' O ' ' A' ' 37' ' ' GLY . 8.7 m-20 46.62 43.3 12.43 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.937 179.655 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 52.06 -173.55 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.926 0.393 . . . . 0.0 110.387 179.887 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.52 ' CZ3' ' HG2' ' A' ' 67' ' ' ARG . 80.7 m95 -44.86 144.2 1.24 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.945 -179.936 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.639 HG21 ' CE1' ' A' ' 54' ' ' PHE . 31.1 m -131.07 116.37 33.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.124 179.757 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.453 ' HA ' ' CB ' ' A' ' 32' ' ' GLU . . . -49.51 128.81 18.15 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.25 179.991 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -62.97 -172.13 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.287 -179.808 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 31.6 m -132.5 109.35 9.73 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.446 -179.9 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.43 ' HB3' ' CZ3' ' A' ' 52' ' ' TRP . 39.4 mtpt -85.49 106.58 16.93 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.327 -179.999 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 170.99 43.84 0.03 OUTLIER Glycine 0 CA--C 1.524 0.596 0 N-CA-C 110.749 -0.94 . . . . 0.0 110.749 -179.902 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.415 ' HB3' ' O ' ' A' ' 51' ' ' VAL . 24.3 tp10 -130.38 65.34 1.52 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.776 0.322 . . . . 0.0 110.457 179.939 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 67.42 -80.7 0.15 Allowed Glycine 0 CA--C 1.523 0.551 0 N-CA-C 110.75 -0.94 . . . . 0.0 110.75 179.987 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -146.49 21.09 1.69 Allowed Glycine 0 CA--C 1.526 0.737 0 N-CA-C 111.256 -0.737 . . . . 0.0 111.256 -179.954 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.85 HG11 ' CD ' ' A' ' 9' ' ' GLU . 29.6 m -138.85 170.45 16.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 110.159 -0.312 . . . . 0.0 110.159 179.764 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . 0.478 ' CD1' HG21 ' A' ' 31' ' ' VAL . 7.4 m95 -100.24 137.36 38.78 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.026 0.441 . . . . 0.0 111.032 -179.461 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.77 142.45 49.55 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.546 179.31 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.754 ' CG ' HD21 ' A' ' 33' ' ' LEU . 27.7 t80 -108.01 116.14 31.41 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.963 0.411 . . . . 0.0 110.691 -179.547 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 57.9 t0 -107.49 130.2 54.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.112 179.847 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -158.26 -177.65 6.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.908 0.385 . . . . 0.0 110.517 -179.884 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -99.52 -26.23 14.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.448 -179.945 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -50.39 159.09 0.9 Allowed Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.483 -179.945 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -70.56 -20.6 30.87 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.554 2.17 . . . . 0.0 111.856 179.673 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.4 tp 57.12 101.87 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.519 179.739 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -173.97 71.04 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.35 180.0 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.434 ' O ' ' CE2' ' A' ' 64' ' ' PHE . . . 175.46 -158.07 25.07 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 110.762 -0.935 . . . . 0.0 110.762 -179.974 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -78.86 169.71 19.09 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.604 2.203 . . . . 0.0 112.086 -179.949 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.434 ' CE2' ' O ' ' A' ' 62' ' ' GLY . 72.4 m-85 -151.27 111.87 4.21 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.515 -179.968 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 12.0 m-80 -81.13 153.21 27.4 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 179.445 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.541 ' CD2' ' CE2' ' A' ' 6' ' ' PHE . 21.0 m-85 -128.75 178.17 6.54 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.14 0.495 . . . . 0.0 111.257 -179.769 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.52 ' HG2' ' CZ3' ' A' ' 41' ' ' TRP . 0.1 OUTLIER 171.85 78.71 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.552 179.864 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.669 ' C ' HD23 ' A' ' 69' ' ' LEU . 1.3 p90 -78.11 169.0 19.0 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.186 0.517 . . . . 0.0 110.932 -179.295 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.809 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 2.4 mt -118.16 71.91 0.85 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.234 179.528 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.414 ' OG1' ' N ' ' A' ' 74' ' ' MET . 28.4 p -36.75 140.55 0.15 Allowed 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.742 -179.108 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.613 ' HG2' ' HB2' ' A' ' 29' ' ' ALA . 17.7 mt-10 -48.9 -57.34 6.6 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.635 -179.7 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.43 52.28 2.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.441 179.958 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -129.8 -108.7 1.32 Allowed Glycine 0 CA--C 1.523 0.567 0 N-CA-C 110.636 -0.985 . . . . 0.0 110.636 179.917 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.414 ' N ' ' OG1' ' A' ' 70' ' ' THR . 2.4 ptm -173.12 168.13 4.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.838 0.351 . . . . 0.0 110.35 -179.993 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.542 ' HD2' HD22 ' A' ' 69' ' ' LEU . 0.6 OUTLIER -77.95 166.71 22.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.231 179.857 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -171.03 164.69 7.52 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.311 179.917 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 98.1 t -130.37 142.26 44.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.163 179.943 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.587 ' CE2' HG22 ' A' ' 4' ' ' VAL . 86.3 m-85 -134.04 132.69 40.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.602 -179.818 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -119.54 162.22 19.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.276 179.844 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 55.03 39.88 31.77 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.312 -179.871 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.669 HG22 ' HD3' ' A' ' 94' ' ' PRO . 47.0 t -86.62 -10.23 11.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.818 -179.978 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 98.7 t -148.49 130.7 7.64 Favored Pre-proline 0 CA--C 1.529 0.137 0 N-CA-C 110.301 -0.259 . . . . 0.0 110.301 179.782 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.489 ' HD3' ' CD1' ' A' ' 92' ' ' TYR . 47.5 Cg_endo -70.73 -174.35 1.07 Allowed 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.534 2.156 . . . . 0.0 111.819 179.575 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -58.3 -63.94 1.09 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.004 179.668 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -108.76 86.57 2.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.114 179.622 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 31.8 p90 -52.83 150.65 5.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.753 -179.641 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 27.9 m -122.21 101.67 7.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.982 179.748 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.445 ' CG2' ' HA ' ' A' ' 10' ' ' LYS . 2.7 mp -44.36 116.48 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.005 -179.673 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 106.72 56.06 0.64 Allowed Glycine 0 CA--C 1.523 0.593 0 N-CA-C 110.812 -0.915 . . . . 0.0 110.812 179.854 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -174.03 142.72 0.87 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.898 0.38 . . . . 0.0 110.731 179.984 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.721 HG23 ' O ' ' A' ' 6' ' ' PHE . 10.0 m -87.69 133.65 33.8 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.044 -0.525 . . . . 0.0 109.881 179.561 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.489 ' CD1' ' HD3' ' A' ' 83' ' ' PRO . 65.5 m-85 -117.09 -86.07 0.63 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.022 -179.266 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.894 ' HB1' ' HD2' ' A' ' 94' ' ' PRO . . . 50.59 179.86 0.02 OUTLIER Pre-proline 0 C--N 1.332 -0.192 0 CA-C-O 120.723 0.297 . . . . 0.0 110.438 -179.714 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.894 ' HD2' ' HB1' ' A' ' 93' ' ' ALA . 48.8 Cg_endo . . . . . 0 C--O 1.249 1.066 0 C-N-CA 122.586 2.191 . . . . 0.0 112.097 -179.846 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.419 HG23 ' O ' ' A' ' 1' ' ' VAL . 6.4 m . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 110.223 -0.288 . . . . 0.0 110.223 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -76.22 137.37 19.03 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.631 2.22 . . . . 0.0 112.046 -179.932 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 9.0 mtmt -127.67 74.84 1.56 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.44 -179.923 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.633 HG11 ' CZ ' ' A' ' 78' ' ' PHE . 1.7 p -58.55 163.66 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.268 0.556 . . . . 0.0 110.337 -179.919 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.479 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 5.7 p -148.09 130.6 15.8 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.466 179.907 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.485 ' O ' HG23 ' A' ' 91' ' ' THR . 11.7 m-85 -98.87 175.25 6.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.258 -179.994 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.657 HG23 ' O ' ' A' ' 90' ' ' ALA . 2.0 m -166.47 107.74 0.69 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.297 -179.966 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.47 HG11 ' CD1' ' A' ' 86' ' ' TYR . 47.8 t -55.34 99.82 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.402 179.997 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.487 ' HG3' HG11 ' A' ' 51' ' ' VAL . 2.5 mt-10 -72.29 174.49 7.2 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.596 -179.836 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.04 178.8 0.78 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.385 -179.966 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 67.24 26.81 73.42 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 110.784 -0.926 . . . . 0.0 110.784 179.939 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.62 ' OG ' HD11 ' A' ' 88' ' ' ILE . 85.3 p -87.49 109.25 19.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.767 0.317 . . . . 0.0 110.445 -179.969 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 30.8 m-20 -112.73 -162.52 0.8 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.236 179.815 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -65.54 -60.07 3.32 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.416 179.997 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -94.6 20.26 8.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.905 -179.727 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 19.5 m80 -128.11 112.32 14.45 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.863 0.363 . . . . 0.0 110.462 -179.914 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.408 ' HA ' HD22 ' A' ' 17' ' ' LEU . 0.2 OUTLIER -119.03 99.27 6.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.281 179.966 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -95.29 132.58 40.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.182 179.877 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.584 HG23 HG23 ' A' ' 21' ' ' VAL . 25.7 m -132.43 137.35 54.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.428 -179.999 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.441 ' HA ' HG12 ' A' ' 51' ' ' VAL . 0.5 OUTLIER -87.88 90.18 8.28 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.393 179.833 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.584 HG23 HG23 ' A' ' 19' ' ' VAL . 27.2 t -90.24 101.24 12.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.369 -179.966 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -174.41 144.28 0.9 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.343 -179.926 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.458 ' CE1' ' HB2' ' A' ' 26' ' ' ASP . 5.9 p90 -158.48 62.79 0.43 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.502 -179.894 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 65.12 -71.33 0.08 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.779 179.719 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.427 ' N ' ' O ' ' A' ' 23' ' ' TYR . . . -75.26 -160.66 8.56 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 110.796 -0.922 . . . . 0.0 110.796 -179.879 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.512 ' OD1' HG22 ' A' ' 70' ' ' THR . 47.7 t0 64.55 127.99 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.793 0.33 . . . . 0.0 110.368 179.998 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.65 ' O ' HG22 ' A' ' 27' ' ' THR . 31.6 m -109.97 34.26 3.96 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.559 -179.933 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.522 ' O ' ' HB2' ' A' ' 29' ' ' ALA . 0.0 OUTLIER 49.25 -177.6 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.011 179.595 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.66 ' HB3' ' O ' ' A' ' 69' ' ' LEU . . . 168.62 -66.01 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.168 179.832 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.405 ' O ' ' HB2' ' A' ' 68' ' ' PHE . 0.5 OUTLIER -154.5 154.81 33.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.722 179.898 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.484 HG21 ' CD1' ' A' ' 52' ' ' TRP . 12.3 t -148.96 153.64 10.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.084 0.468 . . . . 0.0 111.092 -179.597 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.441 ' CG ' ' HD2' ' A' ' 67' ' ' ARG . 0.0 OUTLIER -163.37 147.72 10.89 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.896 -179.917 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.769 HD12 ' N ' ' A' ' 34' ' ' ARG . 3.4 pp -121.95 179.94 4.34 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.905 0.383 . . . . 0.0 110.942 -179.512 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.769 ' N ' HD12 ' A' ' 33' ' ' LEU . 4.7 ttt180 -133.96 167.13 21.16 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.078 179.847 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -128.21 9.11 6.15 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.281 -179.927 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 3.8 t60 67.98 -67.48 0.19 Allowed 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.766 0.317 . . . . 0.0 110.595 179.791 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -52.22 -53.02 33.05 Favored Glycine 0 CA--C 1.523 0.592 0 N-CA-C 110.972 -0.851 . . . . 0.0 110.972 -179.843 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 58.9 m -51.02 -28.71 10.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.771 0.32 . . . . 0.0 110.487 -179.839 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 24.9 t0 63.26 19.25 11.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.822 179.981 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -155.86 129.05 8.14 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.871 0.367 . . . . 0.0 110.479 179.898 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.501 ' CZ3' ' HG2' ' A' ' 67' ' ' ARG . 84.3 m95 -54.22 139.53 35.59 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.417 179.94 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.525 HG21 ' CZ ' ' A' ' 54' ' ' PHE . 28.4 m -115.35 111.87 37.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.28 -0.418 . . . . 0.0 109.908 179.575 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -46.49 136.1 7.82 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.669 -179.617 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.523 ' CE ' HD23 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -65.2 -170.03 0.05 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.234 -179.856 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 23.4 m -144.29 103.9 4.03 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.595 -179.881 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 9.0 ptpt -67.64 72.43 0.15 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.143 179.683 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -103.55 -39.08 2.64 Favored Glycine 0 CA--C 1.521 0.447 0 N-CA-C 110.671 -0.972 . . . . 0.0 110.671 -179.852 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.612 ' HG2' HG22 ' A' ' 51' ' ' VAL . 4.0 tt0 -75.86 134.18 40.39 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.811 0.339 . . . . 0.0 110.367 -179.967 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -78.36 74.65 2.04 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 110.74 -0.944 . . . . 0.0 110.74 -179.989 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 150.71 -52.89 0.5 Allowed Glycine 0 CA--C 1.522 0.52 0 N-CA-C 110.656 -0.978 . . . . 0.0 110.656 179.984 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.612 HG22 ' HG2' ' A' ' 48' ' ' GLU . 18.0 m -114.84 -177.95 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.795 0.331 . . . . 0.0 110.306 179.919 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . 0.484 ' CD1' HG21 ' A' ' 31' ' ' VAL . 13.6 m95 -109.57 141.44 42.07 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.709 -179.842 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.7 p -126.89 159.71 33.14 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.867 179.705 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.525 ' CZ ' HG21 ' A' ' 42' ' ' VAL . 57.1 t80 -130.86 125.33 33.31 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.861 0.363 . . . . 0.0 110.717 -179.664 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -85.09 63.11 7.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.177 179.78 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 52.3 p -57.04 147.06 25.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.436 -179.875 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.6 25.05 4.4 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.518 179.932 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -117.93 138.54 25.5 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.208 179.756 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -75.5 69.35 5.95 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.518 2.146 . . . . 0.0 112.164 -179.694 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 10.7 tp -151.22 106.68 3.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.394 179.898 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -102.02 62.99 0.9 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.037 0.446 . . . . 0.0 110.416 -179.92 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -109.02 -153.15 15.36 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 110.702 -0.959 . . . . 0.0 110.702 179.98 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -75.4 158.7 40.5 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.546 2.164 . . . . 0.0 111.953 179.96 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -131.21 105.28 7.56 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.668 -179.855 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 41.3 m-20 -68.82 168.65 12.99 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 179.432 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -144.74 174.69 10.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.141 0.495 . . . . 0.0 111.047 -179.815 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.501 ' HG2' ' CZ3' ' A' ' 41' ' ' TRP . 0.0 OUTLIER 175.57 54.98 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.559 -179.941 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.449 ' O ' HD23 ' A' ' 69' ' ' LEU . 1.0 OUTLIER -55.73 176.24 0.07 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.076 -179.377 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.721 HD22 ' HD2' ' A' ' 75' ' ' LYS . 11.6 mt -124.99 69.82 1.14 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.59 179.598 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.512 HG22 ' OD1' ' A' ' 26' ' ' ASP . 16.5 p -37.86 140.78 0.23 Allowed 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.928 -179.18 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.511 ' N ' ' HB2' ' A' ' 29' ' ' ALA . 0.0 OUTLIER -42.64 -44.91 4.45 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.355 179.988 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -54.74 -32.92 60.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.341 -179.994 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 105.67 53.59 0.76 Allowed Glycine 0 CA--C 1.522 0.531 0 N-CA-C 110.757 -0.937 . . . . 0.0 110.757 179.986 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 5.0 mmm -129.18 130.13 45.95 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.771 0.32 . . . . 0.0 110.537 179.991 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.721 ' HD2' HD22 ' A' ' 69' ' ' LEU . 0.0 OUTLIER -117.01 123.01 45.84 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.197 -0.456 . . . . 0.0 109.872 179.885 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.467 ' O ' ' CE2' ' A' ' 78' ' ' PHE . 6.4 m120 -134.21 126.16 29.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.377 -179.964 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 73.9 t -84.45 142.69 13.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.342 179.988 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.633 ' CZ ' HG11 ' A' ' 4' ' ' VAL . 23.2 m-85 -129.38 137.02 50.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.52 -179.883 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -114.17 147.57 38.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.219 179.9 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 58.04 49.35 11.76 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.191 -179.867 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.526 ' O ' HG12 ' A' ' 81' ' ' VAL . 99.4 t -86.09 -4.75 9.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.23 -179.843 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.444 HG23 ' C ' ' A' ' 81' ' ' VAL . 89.4 t -157.09 130.8 4.75 Favored Pre-proline 0 C--N 1.333 -0.149 0 N-CA-C 110.228 -0.286 . . . . 0.0 110.228 179.77 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.507 ' HD3' ' CG ' ' A' ' 92' ' ' TYR . 45.6 Cg_endo -70.18 -170.85 0.45 Allowed 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.589 2.193 . . . . 0.0 111.923 179.676 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 -76.24 -62.61 1.55 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.192 179.788 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.08 66.46 0.91 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.9 179.655 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.47 ' CD1' HG11 ' A' ' 8' ' ' VAL . 14.3 p90 -49.45 154.13 0.97 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.886 -179.606 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 39.4 m -133.07 109.51 9.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.024 179.751 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.62 HD11 ' OG ' ' A' ' 12' ' ' SER . 3.7 mp -46.25 100.44 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.908 -179.727 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 138.53 45.61 0.07 OUTLIER Glycine 0 CA--C 1.523 0.555 0 N-CA-C 110.86 -0.896 . . . . 0.0 110.86 179.868 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.657 ' O ' HG23 ' A' ' 7' ' ' THR . . . -162.98 174.61 12.1 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.825 0.345 . . . . 0.0 110.446 179.93 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.485 HG23 ' O ' ' A' ' 6' ' ' PHE . 94.6 m -119.57 126.98 52.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.237 179.88 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.507 ' CG ' ' HD3' ' A' ' 83' ' ' PRO . 42.0 m-85 -126.21 109.39 12.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.391 -179.906 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.91 ' HB1' ' HD2' ' A' ' 94' ' ' PRO . . . 172.14 176.47 0.15 Allowed Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.257 179.96 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.91 ' HD2' ' HB1' ' A' ' 93' ' ' ALA . 48.1 Cg_endo . . . . . 0 C--O 1.249 1.052 0 C-N-CA 122.558 2.172 . . . . 0.0 112.096 -179.948 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 44.8 t . . . . . 0 N--CA 1.489 1.496 0 N-CA-C 110.24 -0.281 . . . . 0.0 110.24 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -78.99 143.32 17.98 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.604 2.203 . . . . 0.0 112.079 -179.986 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 9.8 mtpm? -108.62 48.16 0.87 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.502 -179.876 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.775 ' O ' HG23 ' A' ' 5' ' ' THR . 31.2 m -67.52 -175.78 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.496 179.993 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.775 HG23 ' O ' ' A' ' 4' ' ' VAL . 0.7 OUTLIER -171.65 153.87 3.53 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.31 179.849 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.502 ' CD2' ' HB ' ' A' ' 21' ' ' VAL . 51.2 m-85 -132.1 145.17 51.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.282 179.894 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.525 HG23 ' O ' ' A' ' 90' ' ' ALA . 68.3 m -133.45 130.71 39.0 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.348 -179.923 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.452 HG21 ' HB2' ' A' ' 86' ' ' TYR . 84.0 t -67.71 90.99 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.276 -179.992 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.94 ' HG3' HG11 ' A' ' 51' ' ' VAL . 6.3 mm-40 -56.21 167.91 0.59 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.401 -179.918 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.09 -18.36 65.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.918 -179.979 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -46.52 -29.33 3.91 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 111.102 -0.799 . . . . 0.0 111.102 -179.846 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 27.8 m -64.71 139.04 58.72 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.727 0.299 . . . . 0.0 110.386 179.928 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.1 p30 -139.05 -50.49 0.53 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.59 179.965 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -147.96 -78.04 0.16 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.405 -179.908 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.4 ' HD2' ' HG3' ' A' ' 57' ' ' GLU . 0.0 OUTLIER -101.18 9.67 41.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.219 -179.951 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 5.9 m80 -105.28 125.68 51.26 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.848 0.356 . . . . 0.0 110.358 -179.964 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.472 HD22 ' HA ' ' A' ' 17' ' ' LEU . 0.2 OUTLIER -110.14 104.11 12.92 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.296 179.981 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.847 ' HB2' HG22 ' A' ' 53' ' ' THR . . . -110.64 110.49 21.19 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.29 -179.993 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.407 ' O ' ' HG3' ' A' ' 9' ' ' GLU . 5.6 m -91.13 -168.61 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.04 0.448 . . . . 0.0 110.461 179.998 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.8 tt -141.46 83.39 1.86 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.506 179.905 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.527 ' CG1' ' CD1' ' A' ' 52' ' ' TRP . 2.1 p -102.53 97.68 5.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.007 179.892 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.483 ' O ' ' CG ' ' A' ' 23' ' ' TYR . 11.9 ttmt -145.45 -71.05 0.26 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.255 179.98 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.483 ' CG ' ' O ' ' A' ' 22' ' ' LYS . 30.6 p90 44.36 -170.23 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.067 179.807 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -123.32 146.49 47.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.272 179.972 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 133.76 -58.69 0.69 Allowed Glycine 0 CA--C 1.523 0.58 0 N-CA-C 110.85 -0.9 . . . . 0.0 110.85 179.962 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -112.76 -162.54 0.8 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.801 0.334 . . . . 0.0 110.379 -179.958 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -119.76 -174.72 2.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.478 179.968 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.423 ' O ' ' CG ' ' A' ' 71' ' ' GLU . 12.6 mtm -120.43 119.27 32.55 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.196 -179.976 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.827 ' HB3' ' O ' ' A' ' 69' ' ' LEU . . . -120.72 -60.6 1.65 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.632 -179.7 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.427 ' C ' HG12 ' A' ' 31' ' ' VAL . 0.1 OUTLIER -151.83 168.59 24.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.589 -179.811 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.452 ' HB ' ' HB3' ' A' ' 68' ' ' PHE . 0.2 OUTLIER -179.01 144.2 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.986 179.967 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.434 ' CB ' ' HA ' ' A' ' 43' ' ' ALA . 3.6 pt-20 -142.12 168.27 20.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.472 -0.786 . . . . 0.0 109.915 -179.771 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.715 HD12 ' N ' ' A' ' 34' ' ' ARG . 3.1 pp -121.73 174.69 6.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.869 0.366 . . . . 0.0 110.767 -179.791 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.715 ' N ' HD12 ' A' ' 33' ' ' LEU . 6.8 ttm180 -126.88 -94.61 0.45 Allowed 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.215 179.821 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.436 ' O ' ' CB ' ' A' ' 36' ' ' HIS . 0.0 OUTLIER 163.34 -35.78 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 120.703 0.287 . . . . 0.0 110.239 179.875 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.436 ' CB ' ' O ' ' A' ' 35' ' ' GLU . 5.2 t-160 86.44 -16.5 0.42 Allowed 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.172 -179.626 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -104.14 -27.67 6.13 Favored Glycine 0 CA--C 1.522 0.516 0 N-CA-C 110.412 -1.075 . . . . 0.0 110.412 179.693 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -83.84 -159.1 0.35 Allowed 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 179.796 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 22.4 p30 -141.04 24.27 2.17 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.615 179.985 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -156.4 148.51 23.18 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.916 0.389 . . . . 0.0 110.472 179.909 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.504 ' CZ3' ' HG2' ' A' ' 67' ' ' ARG . 55.2 m95 -85.7 154.83 21.38 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.2 179.867 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.655 HG23 ' O ' ' A' ' 42' ' ' VAL . 34.3 m -124.16 106.26 16.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.914 0.387 . . . . 0.0 110.146 179.704 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.434 ' HA ' ' CB ' ' A' ' 32' ' ' GLU . . . -49.0 116.97 1.87 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.712 -179.757 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.644 ' HE2' HD23 ' A' ' 33' ' ' LEU . 0.6 OUTLIER -53.84 -172.06 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.387 179.909 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 31.6 m -151.05 122.74 8.01 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.423 -179.942 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 5.1 ptpt -68.41 67.79 0.13 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.083 179.698 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -90.96 -26.58 21.6 Favored Glycine 0 CA--C 1.522 0.483 0 N-CA-C 110.626 -0.99 . . . . 0.0 110.626 -179.929 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.467 ' HG2' HG22 ' A' ' 51' ' ' VAL . 9.8 tp10 -93.3 129.8 39.26 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.816 0.341 . . . . 0.0 110.231 179.946 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -74.03 66.25 1.84 Allowed Glycine 0 CA--C 1.523 0.565 0 N-CA-C 110.912 -0.875 . . . . 0.0 110.912 -179.84 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 158.65 -35.81 0.51 Allowed Glycine 0 CA--C 1.524 0.638 0 N-CA-C 111.085 -0.806 . . . . 0.0 111.085 179.809 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.94 HG11 ' HG3' ' A' ' 9' ' ' GLU . 30.4 m -135.81 -176.43 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.94 0.4 . . . . 0.0 110.859 -179.722 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . 0.527 ' CD1' ' CG1' ' A' ' 21' ' ' VAL . 6.1 m95 -101.85 134.29 45.27 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.494 -179.42 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.847 HG22 ' HB2' ' A' ' 18' ' ' ALA . 6.7 p -127.01 156.3 41.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.448 -179.847 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 50.6 t80 -137.99 124.32 20.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.409 179.904 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 20.6 p-10 -86.78 148.89 25.21 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.314 179.972 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -172.88 -179.36 2.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.482 -179.856 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.4 ' HG3' ' HD2' ' A' ' 15' ' ' LYS . 2.2 mt-10 -161.18 61.59 0.28 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.2 179.918 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.404 ' HB2' ' HD2' ' A' ' 59' ' ' PRO . 7.3 pt-20 -133.38 157.42 78.17 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.31 179.996 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.404 ' HD2' ' HB2' ' A' ' 58' ' ' GLU . 47.4 Cg_endo -70.87 -35.57 9.18 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.529 2.153 . . . . 0.0 111.989 179.898 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -77.23 98.56 5.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.376 -179.974 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -148.21 48.21 1.05 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.399 -179.98 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -78.12 -101.74 0.2 Allowed Glycine 0 CA--C 1.526 0.747 0 N-CA-C 110.698 -0.961 . . . . 0.0 110.698 -179.973 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -80.69 177.36 8.13 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.63 2.22 . . . . 0.0 112.102 -179.995 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 49.8 m-85 -153.61 103.18 2.61 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.72 -179.969 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 6.2 m-20 -73.44 129.43 37.98 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 179.358 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.466 ' CE1' ' HB3' ' A' ' 33' ' ' LEU . 40.6 m-85 -115.42 170.87 8.08 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.13 0.491 . . . . 0.0 111.096 -179.333 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.504 ' HG2' ' CZ3' ' A' ' 41' ' ' TRP . 0.0 OUTLIER -169.2 83.69 0.14 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.632 -179.946 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.894 ' O ' HD23 ' A' ' 69' ' ' LEU . 6.9 p90 -71.27 176.68 4.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.356 0.598 . . . . 0.0 111.333 -179.159 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.894 HD23 ' O ' ' A' ' 68' ' ' PHE . 8.7 mt -138.53 70.84 1.38 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.22 179.612 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.402 ' OG1' ' N ' ' A' ' 74' ' ' MET . 65.0 p -29.56 136.2 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.509 0.723 . . . . 0.0 112.61 -178.976 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.632 ' HG2' ' HB2' ' A' ' 29' ' ' ALA . 22.2 mt-10 -52.09 -39.13 59.31 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.314 179.972 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.37 64.59 1.49 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.545 -179.877 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -157.75 -104.75 0.21 Allowed Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.71 -0.956 . . . . 0.0 110.71 179.966 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.402 ' N ' ' OG1' ' A' ' 70' ' ' THR . 0.0 OUTLIER -172.03 -179.03 2.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.826 0.346 . . . . 0.0 110.326 179.969 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.617 ' CG ' HD22 ' A' ' 69' ' ' LEU . 0.0 OUTLIER -84.63 -176.86 6.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.412 -179.951 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.421 ' O ' ' CB ' ' A' ' 67' ' ' ARG . 1.0 OUTLIER -178.71 158.89 1.05 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.099 179.979 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 97.2 t -124.52 130.43 73.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.979 0.418 . . . . 0.0 110.509 -179.756 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.6 ' CZ ' HG21 ' A' ' 4' ' ' VAL . 31.8 m-85 -121.71 130.53 53.51 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.158 179.983 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -118.86 155.56 31.01 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.638 -179.653 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 53.5 m-20 58.25 23.71 10.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.792 179.842 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.509 HG13 ' O ' ' A' ' 92' ' ' TYR . 77.1 t -55.35 -78.36 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 179.61 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 76.7 t -81.71 134.36 50.73 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.125 179.751 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.501 ' HD3' ' CG ' ' A' ' 92' ' ' TYR . 46.6 Cg_endo -71.69 -177.1 2.31 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.437 2.091 . . . . 0.0 111.938 179.79 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -63.04 -64.19 0.98 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.186 179.902 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -102.56 76.86 1.56 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.218 179.798 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.452 ' HB2' HG21 ' A' ' 8' ' ' VAL . 55.7 p90 -54.63 160.95 1.64 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.442 -179.873 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.05 111.86 7.44 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.323 179.917 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 2.7 mp -50.52 100.28 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.456 -179.925 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 133.84 45.95 0.11 Allowed Glycine 0 CA--C 1.523 0.572 0 N-CA-C 110.665 -0.974 . . . . 0.0 110.665 -179.981 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.731 ' HB3' ' OH ' ' A' ' 92' ' ' TYR . . . -172.99 153.04 2.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.79 0.329 . . . . 0.0 110.386 179.979 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 40.3 m -102.96 133.49 47.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.504 -179.931 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.731 ' OH ' ' HB3' ' A' ' 90' ' ' ALA . 6.3 m-85 -130.78 110.52 11.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.321 179.88 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.863 ' HB1' ' HD2' ' A' ' 94' ' ' PRO . . . 179.28 177.36 0.32 Allowed Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.306 -179.978 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.863 ' HD2' ' HB1' ' A' ' 93' ' ' ALA . 48.0 Cg_endo . . . . . 0 C--O 1.249 1.059 0 C-N-CA 122.62 2.213 . . . . 0.0 112.078 -179.868 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 2.2 m . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 110.21 -0.293 . . . . 0.0 110.21 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -79.01 145.48 19.59 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.589 2.193 . . . . 0.0 112.09 179.976 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.413 ' CG ' ' O ' ' A' ' 3' ' ' LYS . 1.8 ptmt -152.34 106.16 3.11 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.794 -179.684 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.58 HG21 ' CZ ' ' A' ' 78' ' ' PHE . 2.9 m -130.11 168.32 23.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.174 179.486 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.406 ' HB ' ' CG2' ' A' ' 91' ' ' THR . 0.6 OUTLIER -146.12 145.68 30.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.325 179.851 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.56 ' CE2' ' CD2' ' A' ' 66' ' ' PHE . 26.3 m-85 -117.66 160.97 20.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.736 -179.688 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.443 HG22 ' H ' ' A' ' 8' ' ' VAL . 0.2 OUTLIER -142.43 -164.15 1.76 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.169 179.836 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.658 ' O ' HG23 ' A' ' 88' ' ' ILE . 47.0 t -141.85 92.74 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.346 -179.918 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.719 ' HG3' HG11 ' A' ' 51' ' ' VAL . 1.4 mm-40 -56.64 158.01 4.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.57 -179.811 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 7.4 ptmm? -58.17 -19.25 31.6 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.896 -179.989 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -49.8 -24.77 6.37 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 111.021 -0.831 . . . . 0.0 111.021 -179.966 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 10.0 p -47.83 113.85 0.8 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.85 0.357 . . . . 0.0 110.78 -179.862 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 42.4 m-20 -116.17 -156.28 0.61 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.147 179.859 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -44.96 -68.44 0.2 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.721 0.296 . . . . 0.0 110.905 -179.868 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.61 40.57 3.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.309 179.869 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 8.5 m80 -118.55 123.29 44.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.365 179.953 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.463 HD22 ' HA ' ' A' ' 17' ' ' LEU . 0.2 OUTLIER -104.97 97.86 7.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.192 -179.928 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.448 ' HB2' HG22 ' A' ' 53' ' ' THR . . . -100.22 104.56 16.06 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.602 -179.788 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.406 ' O ' ' HG3' ' A' ' 9' ' ' GLU . 27.7 m -88.3 -175.17 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.129 179.67 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.7 tt -139.42 77.55 1.62 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.402 179.724 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 3.3 t -84.01 107.9 15.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.083 179.934 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.57 147.84 4.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.391 -179.969 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.523 ' CZ ' HG12 ' A' ' 4' ' ' VAL . 3.9 p90 177.99 128.56 0.05 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.221 -179.909 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -53.4 154.43 3.41 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.512 -179.865 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 107.57 -68.98 0.22 Allowed Glycine 0 CA--C 1.522 0.522 0 N-CA-C 110.59 -1.004 . . . . 0.0 110.59 -179.968 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -94.08 179.28 5.37 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 110.164 -0.31 . . . . 0.0 110.164 179.975 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.417 ' OG1' ' CE ' ' A' ' 72' ' ' LYS . 0.2 OUTLIER -119.19 -163.8 1.0 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.928 0.394 . . . . 0.0 110.525 -179.971 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.43 ' O ' ' CG ' ' A' ' 71' ' ' GLU . 33.7 mtp -129.6 124.11 32.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.297 -179.815 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.866 ' HB3' ' O ' ' A' ' 69' ' ' LEU . . . -129.42 -57.97 1.13 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.937 -179.79 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.597 ' C ' HG12 ' A' ' 31' ' ' VAL . 2.8 tt0 -141.07 177.19 8.24 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.945 0.402 . . . . 0.0 111.059 -179.673 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.597 HG12 ' C ' ' A' ' 30' ' ' GLU . 0.3 OUTLIER 171.52 134.2 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.958 -179.986 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.411 ' HG3' ' CE3' ' A' ' 41' ' ' TRP . 1.1 pt-20 -123.55 161.24 25.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.643 -179.549 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.491 ' HG ' ' CE1' ' A' ' 66' ' ' PHE . 2.3 mt -110.0 154.33 23.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.381 179.782 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.487 ' HG3' ' CD2' ' A' ' 41' ' ' TRP . 0.0 OUTLIER -126.99 -163.31 1.23 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.949 179.51 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.449 ' CB ' ' HB2' ' A' ' 38' ' ' SER . 0.2 OUTLIER 176.8 106.71 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.841 0.353 . . . . 0.0 110.171 179.971 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -51.2 95.3 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.206 -179.982 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 126.14 -32.18 3.85 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 110.359 -1.097 . . . . 0.0 110.359 -179.636 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.449 ' HB2' ' CB ' ' A' ' 35' ' ' GLU . 35.0 t -57.09 -25.4 58.69 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.732 0.301 . . . . 0.0 110.398 179.788 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 75.75 97.29 0.07 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.653 179.986 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 72.62 159.59 0.22 Allowed 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.876 179.641 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.501 ' CZ2' ' CD ' ' A' ' 67' ' ' ARG . 51.1 m95 -64.49 167.39 7.11 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.434 -179.899 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 14.9 m -135.1 3.21 1.08 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.852 -179.622 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . 59.92 138.42 0.01 OUTLIER 'General case' 0 C--N 1.334 -0.107 0 CA-C-O 121.129 0.49 . . . . 0.0 111.299 179.391 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.436 ' HE3' ' HB2' ' A' ' 52' ' ' TRP . 0.0 OUTLIER -73.64 -170.35 0.84 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.375 179.862 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.424 ' O ' ' N ' ' A' ' 47' ' ' GLY . 43.4 m -143.31 111.08 5.95 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.144 179.809 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.9 ptpt -62.45 79.12 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.396 -179.908 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.424 ' N ' ' O ' ' A' ' 45' ' ' THR . . . -98.47 -26.77 9.03 Favored Glycine 0 CA--C 1.522 0.525 0 N-CA-C 110.691 -0.963 . . . . 0.0 110.691 -179.966 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.405 ' HB2' ' O ' ' A' ' 51' ' ' VAL . 0.5 OUTLIER -87.15 -172.53 4.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.852 0.358 . . . . 0.0 110.432 -179.943 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -110.94 -24.68 5.41 Favored Glycine 0 CA--C 1.522 0.505 0 N-CA-C 110.807 -0.917 . . . . 0.0 110.807 179.95 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -129.28 -1.39 5.69 Favored Glycine 0 CA--C 1.528 0.888 0 N-CA-C 111.957 -0.457 . . . . 0.0 111.957 -179.684 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.719 HG11 ' HG3' ' A' ' 9' ' ' GLU . 17.9 m -146.23 178.26 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 CA-C-N 117.476 0.638 . . . . 0.0 110.761 -179.946 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . 0.436 ' HB2' ' HE3' ' A' ' 44' ' ' MET . 10.9 m95 -105.34 141.1 37.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.56 -179.555 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.448 HG22 ' HB2' ' A' ' 18' ' ' ALA . 10.3 p -126.04 162.78 24.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.336 -179.969 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 45.5 t80 -134.54 162.54 31.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.536 -179.881 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -112.86 143.03 44.81 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.224 179.865 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -133.9 178.7 6.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.374 179.934 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -123.94 26.61 7.52 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.345 179.975 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -171.0 155.65 4.53 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.269 179.947 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -71.87 -36.2 6.45 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.707 2.272 . . . . 0.0 112.325 -179.808 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -75.57 148.3 38.98 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.75 -179.55 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -147.74 -174.48 4.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.208 179.978 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -145.06 -148.96 4.93 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 110.734 -0.946 . . . . 0.0 110.734 179.995 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -78.03 158.08 30.59 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.575 2.183 . . . . 0.0 111.796 179.872 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.41 ' HB3' ' CD2' ' A' ' 33' ' ' LEU . 86.5 m-85 -131.6 171.19 13.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.07 0.462 . . . . 0.0 110.79 -179.794 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.428 ' HB2' ' CB ' ' A' ' 34' ' ' ARG . 4.3 m-80 -139.57 137.36 35.33 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.615 179.571 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.56 ' CD2' ' CE2' ' A' ' 6' ' ' PHE . 48.0 m-85 -120.44 159.94 24.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.108 0.48 . . . . 0.0 111.093 -179.217 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.588 ' CD ' HG22 ' A' ' 77' ' ' VAL . 28.6 mtp180 -157.61 81.4 0.88 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.818 179.68 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.469 ' HA ' ' HA ' ' A' ' 31' ' ' VAL . 5.9 p90 -78.7 173.59 12.3 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-O 121.54 0.685 . . . . 0.0 111.37 -179.334 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.866 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 8.8 mt -138.43 74.3 1.47 Allowed 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 114.664 -1.153 . . . . 0.0 109.016 179.496 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.439 ' OG1' ' N ' ' A' ' 74' ' ' MET . 2.7 p -31.18 137.13 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 115.717 -0.674 . . . . 0.0 112.191 -178.976 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.619 ' HG2' ' HB2' ' A' ' 29' ' ' ALA . 1.1 mm-40 -49.57 -24.88 2.35 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.943 -179.525 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.417 ' CE ' ' OG1' ' A' ' 27' ' ' THR . 0.0 OUTLIER -167.07 36.04 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.596 0.236 . . . . 0.0 111.102 -179.94 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -114.21 -110.76 2.9 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 110.849 -0.9 . . . . 0.0 110.849 179.853 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.439 ' N ' ' OG1' ' A' ' 70' ' ' THR . 3.1 ptt? -166.74 113.29 0.81 Allowed 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 110.164 -0.31 . . . . 0.0 110.164 179.901 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.817 ' HB3' HD23 ' A' ' 69' ' ' LEU . 0.0 OUTLIER -51.99 -176.35 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.896 0.379 . . . . 0.0 110.494 -179.782 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 177.43 149.39 0.16 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.468 -179.952 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.588 HG22 ' CD ' ' A' ' 67' ' ' ARG . 72.2 t -90.22 139.18 17.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 121.006 0.431 . . . . 0.0 110.096 179.895 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.58 ' CZ ' HG21 ' A' ' 4' ' ' VAL . 75.8 m-85 -128.84 142.24 51.03 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.898 -179.313 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -136.1 157.84 45.87 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.953 179.65 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 59.02 35.45 24.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.938 0.399 . . . . 0.0 109.954 -179.66 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.464 ' O ' HG12 ' A' ' 81' ' ' VAL . 42.9 t -76.07 -6.91 9.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.322 -179.757 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.449 HG13 ' HD2' ' A' ' 83' ' ' PRO . 61.4 t -153.87 138.14 11.04 Favored Pre-proline 0 C--N 1.332 -0.17 0 N-CA-C 110.29 -0.263 . . . . 0.0 110.29 179.893 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.449 ' HD2' HG13 ' A' ' 82' ' ' VAL . 47.6 Cg_endo -75.48 -172.66 1.36 Allowed 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.535 2.157 . . . . 0.0 112.056 179.881 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -67.93 -42.5 80.91 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.244 179.844 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 16.7 mtpt -127.45 77.73 1.77 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.235 179.841 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 45.3 p90 -51.1 158.8 0.69 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.508 -179.851 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 20.8 m -138.33 110.43 7.3 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.075 179.919 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.658 HG23 ' O ' ' A' ' 8' ' ' VAL . 2.8 mp -50.46 95.06 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.357 -179.942 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 138.04 44.99 0.08 OUTLIER Glycine 0 CA--C 1.523 0.572 0 N-CA-C 110.575 -1.01 . . . . 0.0 110.575 -179.878 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -168.46 141.21 2.95 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.75 0.309 . . . . 0.0 110.243 -179.93 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.406 ' CG2' ' HB ' ' A' ' 5' ' ' THR . 85.7 m -91.05 145.85 24.34 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.971 0.415 . . . . 0.0 110.648 -179.939 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.592 ' O ' ' HB3' ' A' ' 93' ' ' ALA . 30.2 m-85 -129.75 -152.24 0.51 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.826 -0.624 . . . . 0.0 109.501 179.674 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.885 ' HB1' ' HD2' ' A' ' 94' ' ' PRO . . . 77.79 174.74 0.08 OUTLIER Pre-proline 0 N--CA 1.465 0.276 0 CA-C-O 120.8 0.333 . . . . 0.0 110.684 179.77 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.885 ' HD2' ' HB1' ' A' ' 93' ' ' ALA . 48.3 Cg_endo . . . . . 0 C--O 1.248 1.02 0 C-N-CA 122.618 2.212 . . . . 0.0 111.989 -179.982 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 32.2 t . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 110.09 -0.337 . . . . 0.0 110.09 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -77.54 154.14 31.02 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.48 2.12 . . . . 0.0 112.231 -179.883 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.74 78.45 1.68 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.24 179.986 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.553 HG11 ' CZ ' ' A' ' 78' ' ' PHE . 1.7 p -49.88 163.97 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.253 0.549 . . . . 0.0 110.624 -179.819 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.478 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 15.7 p -141.89 132.63 25.64 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.367 179.907 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.528 ' O ' HG23 ' A' ' 91' ' ' THR . 22.7 m-85 -101.09 170.68 8.11 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.301 179.967 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.811 HG23 ' O ' ' A' ' 90' ' ' ALA . 92.6 m -166.17 132.47 2.52 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.464 -179.947 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 26.4 t -71.1 102.99 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.199 179.82 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.598 ' HG3' HG21 ' A' ' 51' ' ' VAL . 6.3 mm-40 -50.33 170.81 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.511 -179.811 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 33.7 mtmm -72.53 -21.38 61.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.721 -179.937 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -90.9 49.1 3.05 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.928 -0.869 . . . . 0.0 110.928 -179.948 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 60.7 p -87.1 134.64 33.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.765 0.317 . . . . 0.0 110.291 179.867 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -134.2 164.63 26.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.306 -179.989 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -67.4 -34.5 77.38 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.333 -179.992 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 1.7 tppp? -93.14 -20.46 20.47 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.225 -179.588 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.402 ' HA ' ' O ' ' A' ' 54' ' ' PHE . 39.8 m80 -120.09 133.54 55.49 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.931 0.396 . . . . 0.0 111.024 -179.377 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -104.29 77.94 1.45 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.136 179.567 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -75.41 116.95 16.68 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.414 -179.884 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.467 HG23 HG23 ' A' ' 21' ' ' VAL . 14.8 m -109.17 -168.24 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.17 179.942 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.426 ' HB3' ' HB ' ' A' ' 7' ' ' THR . 1.0 OUTLIER -142.28 78.74 1.63 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.376 179.855 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.467 HG23 HG23 ' A' ' 19' ' ' VAL . 11.7 t -95.41 110.22 23.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.336 -179.933 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.409 ' HG2' ' CD2' ' A' ' 20' ' ' LEU . 0.0 OUTLIER -179.05 117.86 0.07 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.453 179.946 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.405 ' CE1' HG23 ' A' ' 4' ' ' VAL . 7.5 p90 -150.48 172.04 16.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.312 179.842 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -92.15 148.33 22.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.368 -179.917 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 114.25 -41.71 2.12 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 110.76 -0.936 . . . . 0.0 110.76 179.998 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -119.38 176.05 5.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.84 0.352 . . . . 0.0 110.418 179.999 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.29 -160.84 0.73 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.401 -179.999 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.418 ' O ' ' CG ' ' A' ' 71' ' ' GLU . 59.1 mtm -137.43 120.42 16.55 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.316 180.0 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.822 ' HB3' ' O ' ' A' ' 69' ' ' LEU . . . -124.4 -58.39 1.52 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.563 -179.786 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -153.34 161.78 41.98 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.38 -179.864 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.747 HG21 ' CD1' ' A' ' 52' ' ' TRP . 21.5 t -143.46 155.19 16.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.286 -179.999 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.444 ' CB ' ' HA ' ' A' ' 43' ' ' ALA . 1.8 pt-20 -167.24 137.82 3.02 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.53 -179.953 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.644 HD12 ' N ' ' A' ' 34' ' ' ARG . 3.2 pp -104.24 171.96 7.06 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.322 179.839 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.644 ' N ' HD12 ' A' ' 33' ' ' LEU . 1.3 ttt180 -97.87 -72.99 0.63 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.616 -179.848 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.484 ' CB ' ' O ' ' A' ' 34' ' ' ARG . 2.6 tm-20 94.34 80.26 0.0 OUTLIER 'General case' 0 CA--C 1.511 -0.523 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 -178.977 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -37.42 134.22 0.65 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.166 -0.925 . . . . 0.0 111.757 -178.362 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 114.07 -28.98 8.0 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 110.397 -1.081 . . . . 0.0 110.397 -179.745 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -82.46 -173.96 4.89 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.778 0.323 . . . . 0.0 110.268 179.864 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.41 ' OD1' ' N ' ' A' ' 40' ' ' GLU . 35.2 p30 -114.31 -21.64 10.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.843 -179.861 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.41 ' N ' ' OD1' ' A' ' 39' ' ' ASP . 9.7 mt-10 -135.0 175.26 9.74 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.84 0.352 . . . . 0.0 110.701 -179.826 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.512 ' CZ3' ' HG2' ' A' ' 67' ' ' ARG . 53.1 m95 -86.18 173.05 10.07 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.466 179.945 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.52 HG23 ' HG ' ' A' ' 33' ' ' LEU . 9.7 m -135.57 112.8 14.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.329 179.818 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.444 ' HA ' ' CB ' ' A' ' 32' ' ' GLU . . . -51.02 127.13 18.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.299 179.938 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -60.69 -171.39 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.32 -179.887 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 38.3 m -136.72 133.12 35.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.92 0.39 . . . . 0.0 110.496 -179.847 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 2.8 ptmt -100.95 79.87 2.08 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.52 -179.948 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -153.05 26.63 0.8 Allowed Glycine 0 CA--C 1.523 0.574 0 N-CA-C 110.851 -0.9 . . . . 0.0 110.851 -179.976 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.42 ' HG2' HG23 ' A' ' 51' ' ' VAL . 14.0 tp10 -98.05 -24.59 15.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.734 0.302 . . . . 0.0 110.319 179.952 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 128.03 -76.02 0.41 Allowed Glycine 0 CA--C 1.523 0.536 0 N-CA-C 110.566 -1.014 . . . . 0.0 110.566 -179.964 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -113.31 -14.34 9.89 Favored Glycine 0 CA--C 1.527 0.816 0 N-CA-C 111.259 -0.736 . . . . 0.0 111.259 179.878 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.598 HG21 ' HG3' ' A' ' 9' ' ' GLU . 27.2 m -124.95 -175.44 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-O 120.932 0.396 . . . . 0.0 110.74 -179.745 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . 0.747 ' CD1' HG21 ' A' ' 31' ' ' VAL . 8.1 m95 -104.59 146.22 29.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.499 -179.848 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.08 165.89 18.66 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.162 179.8 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.486 ' CD2' HD21 ' A' ' 33' ' ' LEU . 87.3 t80 -144.51 143.18 30.72 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.572 -179.863 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -89.07 102.48 15.14 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.314 179.913 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 69.7 p -86.91 100.82 12.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.465 -179.934 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -101.93 25.3 8.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.41 179.892 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 6.6 pm0 -121.39 140.83 32.08 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.193 179.897 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -73.45 -20.73 20.47 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.574 2.182 . . . . 0.0 112.113 179.992 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 17.3 mt -53.41 150.43 6.55 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.502 -179.95 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 24.1 tt0 -140.75 96.16 2.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.306 179.818 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -149.24 -157.85 7.82 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 110.682 -0.967 . . . . 0.0 110.682 179.992 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.443 ' HA ' ' HB ' ' A' ' 82' ' ' VAL . 49.1 Cg_endo -76.35 160.74 35.48 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.565 2.177 . . . . 0.0 112.168 -179.934 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.434 ' CD1' HG11 ' A' ' 82' ' ' VAL . 80.2 m-85 -130.96 100.98 5.43 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.394 179.873 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.403 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 48.0 m-80 -66.32 160.33 24.8 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 179.652 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -133.92 176.32 8.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.023 0.439 . . . . 0.0 110.93 -179.894 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.512 ' HG2' ' CZ3' ' A' ' 41' ' ' TRP . 0.0 OUTLIER 176.6 72.3 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.751 179.998 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.556 ' O ' HD23 ' A' ' 69' ' ' LEU . 2.0 p90 -67.16 174.96 2.84 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.88 -179.404 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.822 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 8.9 mt -125.26 68.79 1.14 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.311 179.492 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -37.19 140.97 0.16 Allowed 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.728 -179.115 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.737 ' HG2' ' HB2' ' A' ' 29' ' ' ALA . 2.0 mm-40 -55.27 -58.48 7.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.369 -179.821 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -125.73 55.9 1.42 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.316 179.962 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -137.51 -106.7 0.78 Allowed Glycine 0 CA--C 1.524 0.601 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 -179.981 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 1.2 ptt? -178.5 163.4 1.54 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.805 0.336 . . . . 0.0 110.446 -179.924 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.628 ' HD2' HD22 ' A' ' 69' ' ' LEU . 0.0 OUTLIER -81.69 134.37 35.46 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.258 -179.867 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.415 ' HB3' ' CZ ' ' A' ' 78' ' ' PHE . 0.3 OUTLIER -143.32 129.73 20.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.378 179.958 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 43.3 t -85.55 142.94 12.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.34 -179.993 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.553 ' CZ ' HG11 ' A' ' 4' ' ' VAL . 51.5 m-85 -132.48 120.66 22.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.549 -179.866 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -105.36 163.72 12.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.257 179.83 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 53.79 57.45 6.04 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.271 179.992 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.63 ' O ' HG12 ' A' ' 81' ' ' VAL . 60.9 t -109.02 7.78 9.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.216 -179.965 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.487 HG23 ' O ' ' A' ' 81' ' ' VAL . 70.2 t -158.36 104.35 1.68 Allowed Pre-proline 0 CA--C 1.531 0.212 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 -179.932 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -74.93 178.46 7.22 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.499 2.132 . . . . 0.0 111.935 179.706 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -65.97 121.76 15.83 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.217 179.885 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 3.4 tttt 55.09 65.83 1.39 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.111 -179.823 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 32.6 p90 -49.58 143.23 7.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.755 -179.758 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 9.0 m -110.32 110.03 20.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.13 179.739 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 2.8 mp -49.18 121.1 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.542 -179.844 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 115.57 31.07 2.05 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 110.926 -0.869 . . . . 0.0 110.926 179.976 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.811 ' O ' HG23 ' A' ' 7' ' ' THR . . . -143.63 176.26 9.35 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.745 0.307 . . . . 0.0 110.253 179.834 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.528 HG23 ' O ' ' A' ' 6' ' ' PHE . 17.3 m -125.0 124.06 41.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.533 -179.901 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.525 ' CZ ' ' HB3' ' A' ' 90' ' ' ALA . 6.0 m-85 -124.2 129.54 50.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.272 179.87 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.917 ' HB1' ' HD2' ' A' ' 94' ' ' PRO . . . 178.01 179.24 0.23 Allowed Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.289 -179.988 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.917 ' HD2' ' HB1' ' A' ' 93' ' ' ALA . 48.7 Cg_endo . . . . . 0 C--O 1.249 1.072 0 C-N-CA 122.519 2.146 . . . . 0.0 111.959 -179.93 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.644 HG13 ' O ' ' A' ' 1' ' ' VAL . 7.6 p . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 . . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -74.1 150.28 42.61 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.508 2.138 . . . . 0.0 111.971 179.928 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -137.55 81.14 1.85 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.624 -179.756 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.484 ' CG1' ' CE1' ' A' ' 78' ' ' PHE . 1.7 p -153.72 163.7 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 121.176 0.512 . . . . 0.0 110.151 179.705 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.468 ' N ' HG22 ' A' ' 4' ' ' VAL . 0.2 OUTLIER -136.15 140.72 43.85 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.438 179.951 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 -105.8 165.91 10.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.965 179.754 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.4 m -160.03 103.49 1.48 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.819 0.343 . . . . 0.0 110.522 -179.823 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 61.1 t -60.04 93.99 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.17 179.771 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.689 ' HG3' HG11 ' A' ' 51' ' ' VAL . 2.4 mm-40 -49.8 165.33 0.08 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.609 -179.851 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.24 56.57 2.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.394 179.95 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -135.79 20.65 3.63 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 111.124 -0.79 . . . . 0.0 111.124 -179.909 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.2 p -74.7 108.46 7.47 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.949 0.405 . . . . 0.0 109.994 179.729 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 22.5 m-20 -92.2 -163.53 1.05 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.775 -179.506 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -55.5 -36.34 66.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.819 -179.706 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.455 ' HD3' ' ND1' ' A' ' 16' ' ' HIS . 0.1 OUTLIER -147.6 45.93 1.12 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.784 0.326 . . . . 0.0 110.582 -179.794 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.455 ' ND1' ' HD3' ' A' ' 15' ' ' LYS . 45.0 m80 -133.78 151.57 51.62 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.22 179.783 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.446 HD12 ' HA ' ' A' ' 17' ' ' LEU . 20.9 tp -137.28 92.54 2.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.462 -179.745 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.622 ' HB2' ' CG2' ' A' ' 53' ' ' THR . . . -87.91 123.13 32.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.298 179.885 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.658 HG23 HG23 ' A' ' 21' ' ' VAL . 27.2 m -121.02 144.76 28.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.555 -179.811 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.423 ' CD2' ' CG ' ' A' ' 22' ' ' LYS . 0.5 OUTLIER -91.38 83.35 5.44 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.28 179.77 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.658 HG23 HG23 ' A' ' 19' ' ' VAL . 24.4 t -89.44 100.3 10.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.543 -179.827 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.423 ' CG ' ' CD2' ' A' ' 20' ' ' LEU . 0.0 OUTLIER 174.9 135.7 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.353 179.859 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.504 ' CE2' ' HB2' ' A' ' 26' ' ' ASP . 0.7 OUTLIER -129.91 -173.29 2.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.1 179.874 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -40.62 -57.42 1.87 Allowed 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 120.795 0.331 . . . . 0.0 111.195 -179.783 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -89.22 -153.77 28.09 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 110.664 -0.974 . . . . 0.0 110.664 179.806 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.821 ' OD2' HG22 ' A' ' 70' ' ' THR . 28.1 t0 68.33 143.52 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.744 0.307 . . . . 0.0 110.408 179.983 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.685 ' O ' HG22 ' A' ' 27' ' ' THR . 86.4 m -119.33 13.44 12.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.062 179.863 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.405 ' O ' ' CG ' ' A' ' 71' ' ' GLU . 9.3 mtp 59.51 115.09 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.832 0.349 . . . . 0.0 110.594 179.732 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.785 ' HB3' ' O ' ' A' ' 69' ' ' LEU . . . -126.42 -57.17 1.39 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.13 179.81 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -157.46 166.69 32.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.147 179.789 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.621 HG21 ' CD1' ' A' ' 52' ' ' TRP . 38.5 t -152.41 148.27 14.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.448 -179.899 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.444 ' CB ' ' HA ' ' A' ' 43' ' ' ALA . 14.6 pt-20 -138.81 146.93 41.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.093 179.766 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.811 HD23 ' CG ' ' A' ' 54' ' ' PHE . 6.1 tp -128.86 138.3 51.96 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 120.923 0.392 . . . . 0.0 110.19 -179.093 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.541 ' N ' HD12 ' A' ' 33' ' ' LEU . 50.0 ttp85 -124.6 165.67 17.46 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.55 179.184 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -118.92 -83.07 0.65 Allowed 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 -179.975 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER 169.58 158.61 0.06 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.375 179.598 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 50.01 47.01 41.32 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 110.849 -0.901 . . . . 0.0 110.849 179.926 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 32.1 t -136.0 -174.93 3.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.817 0.341 . . . . 0.0 110.329 179.899 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -68.57 -63.57 1.03 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.471 -179.919 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -167.93 -173.87 2.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.343 -179.926 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.488 ' CE3' ' HB2' ' A' ' 34' ' ' ARG . 50.3 m95 -47.68 154.34 0.49 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.591 -179.943 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.436 HG22 ' O ' ' A' ' 33' ' ' LEU . 24.2 m -129.9 28.86 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.421 179.983 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.444 ' HA ' ' CB ' ' A' ' 32' ' ' GLU . . . 47.24 -175.34 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.131 179.555 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.401 ' HB2' ' O ' ' A' ' 31' ' ' VAL . 0.0 OUTLIER -112.94 -164.74 0.94 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.356 -179.97 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 25.7 m -146.52 104.97 3.81 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.477 -179.933 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.43 71.87 0.95 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.243 179.857 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -99.3 -34.49 5.05 Favored Glycine 0 CA--C 1.523 0.559 0 N-CA-C 110.813 -0.915 . . . . 0.0 110.813 -179.868 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.441 ' HG2' ' CG2' ' A' ' 51' ' ' VAL . 4.1 tp10 -80.5 130.11 34.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.808 0.337 . . . . 0.0 110.35 -179.916 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -78.39 78.38 1.62 Allowed Glycine 0 CA--C 1.522 0.53 0 N-CA-C 110.752 -0.939 . . . . 0.0 110.752 179.895 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 150.67 -32.01 1.0 Allowed Glycine 0 CA--C 1.522 0.502 0 N-CA-C 110.6 -1.0 . . . . 0.0 110.6 -179.959 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.689 HG11 ' HG3' ' A' ' 9' ' ' GLU . 17.5 m -145.81 -177.35 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.837 0.351 . . . . 0.0 110.369 -179.997 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . 0.621 ' CD1' HG21 ' A' ' 31' ' ' VAL . 7.5 m95 -102.97 141.15 36.26 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.584 -179.738 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.622 ' CG2' ' HB2' ' A' ' 18' ' ' ALA . 0.2 OUTLIER -124.22 152.22 43.18 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.942 179.7 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.811 ' CG ' HD23 ' A' ' 33' ' ' LEU . 80.6 t80 -117.39 161.65 19.21 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.423 -179.925 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -118.15 118.59 32.29 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.32 -179.993 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 40.2 m -111.48 164.24 13.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.449 -179.931 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -161.7 39.9 0.13 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.249 179.932 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -131.91 157.52 77.98 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.338 -179.946 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -71.61 -33.35 10.71 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.615 2.21 . . . . 0.0 112.2 -179.936 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -82.68 174.7 10.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.293 179.909 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 179.81 59.6 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.613 179.935 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -72.88 -139.95 0.37 Allowed Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.477 -1.049 . . . . 0.0 110.477 179.807 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -73.83 174.1 12.88 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.501 2.134 . . . . 0.0 111.699 179.698 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -135.52 177.08 8.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.957 0.408 . . . . 0.0 110.548 -179.937 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 -143.96 131.29 20.87 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.862 179.904 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -116.16 170.13 8.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.044 0.45 . . . . 0.0 110.884 -179.705 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.446 ' HG3' ' CH2' ' A' ' 41' ' ' TRP . 0.1 OUTLIER -172.54 80.75 0.05 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.049 -179.925 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.426 ' HA ' ' HA ' ' A' ' 31' ' ' VAL . 0.5 OUTLIER -81.57 167.02 19.72 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.191 0.52 . . . . 0.0 110.966 -179.594 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.785 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 6.8 mt -123.49 74.23 1.24 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.494 179.715 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.821 HG22 ' OD2' ' A' ' 26' ' ' ASP . 13.5 p -36.81 137.77 0.29 Allowed 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.696 -179.334 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.707 ' HG2' ' HB2' ' A' ' 29' ' ' ALA . 8.7 mm-40 -48.88 -46.48 42.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.822 -179.591 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.66 45.9 1.7 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.447 179.86 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -121.06 -110.17 2.17 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 110.863 -0.895 . . . . 0.0 110.863 -179.983 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.412 ' N ' ' OG1' ' A' ' 70' ' ' THR . 2.1 ptt? -171.67 152.69 3.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.831 0.348 . . . . 0.0 110.361 -179.905 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.522 ' HG3' HD23 ' A' ' 69' ' ' LEU . 0.0 OUTLIER -76.58 150.83 36.46 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.463 -179.942 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 55.0 m-20 -156.31 136.73 13.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.542 179.946 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.404 ' HA ' ' HG2' ' A' ' 67' ' ' ARG . 94.2 t -89.33 138.92 18.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.353 179.927 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.484 ' CE1' ' CG1' ' A' ' 4' ' ' VAL . 40.4 m-85 -126.81 134.87 50.46 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.793 -179.448 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -123.93 150.72 44.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.273 179.85 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 54.39 30.66 13.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.374 -179.904 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.437 ' HA ' ' HA ' ' A' ' 93' ' ' ALA . 54.8 t -53.71 -24.82 10.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.48 -179.925 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.439 ' CG1' ' HB3' ' A' ' 86' ' ' TYR . 59.3 t -134.34 132.3 20.95 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.579 -0.282 . . . . 0.0 110.535 179.897 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.447 ' CD ' ' CD1' ' A' ' 92' ' ' TYR . 49.5 Cg_endo -71.24 -171.48 0.61 Allowed 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.586 2.191 . . . . 0.0 111.996 179.744 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 21.3 pt-20 -85.23 129.92 34.71 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 179.29 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 59.33 50.66 7.51 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 -179.282 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.439 ' HB3' ' CG1' ' A' ' 82' ' ' VAL . 36.6 p90 -43.46 160.43 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.413 -179.407 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -130.92 104.26 7.04 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.925 179.751 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 3.0 mp -45.3 118.65 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.623 -179.798 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 118.42 36.7 0.9 Allowed Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.602 -0.999 . . . . 0.0 110.602 -179.821 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -149.32 153.34 37.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.768 0.318 . . . . 0.0 110.149 -179.96 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 92.4 m -103.63 93.62 5.02 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.727 -179.81 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.589 ' O ' ' HB3' ' A' ' 93' ' ' ALA . 40.1 m-85 -81.81 -153.76 0.11 Allowed 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 179.31 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.913 ' HB1' ' HD2' ' A' ' 94' ' ' PRO . . . 76.2 175.85 0.07 OUTLIER Pre-proline 0 N--CA 1.464 0.263 0 CA-C-O 120.689 0.281 . . . . 0.0 110.748 179.726 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.913 ' HD2' ' HB1' ' A' ' 93' ' ' ALA . 46.5 Cg_endo . . . . . 0 C--O 1.249 1.027 0 C-N-CA 122.523 2.148 . . . . 0.0 112.053 -179.988 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 2.6 m . . . . . 0 N--CA 1.489 1.524 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -76.41 147.88 29.36 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.566 2.178 . . . . 0.0 112.089 179.965 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 7.9 mtmm -127.04 81.15 2.0 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.402 179.988 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.586 HG21 ' CZ ' ' A' ' 78' ' ' PHE . 18.0 m -72.95 170.86 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.435 -179.979 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.413 HG23 ' O ' ' A' ' 4' ' ' VAL . 16.0 p -154.66 132.07 11.2 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.516 -179.97 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.528 ' O ' HG23 ' A' ' 91' ' ' THR . 13.6 m-85 -101.3 160.29 14.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.066 179.821 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.6 m -156.49 126.26 6.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.924 0.392 . . . . 0.0 110.683 -179.86 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.595 HG11 HG13 ' A' ' 88' ' ' ILE . 98.9 t -60.28 114.73 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.284 179.85 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.441 ' HB2' HG11 ' A' ' 51' ' ' VAL . 15.0 mm-40 -94.1 160.92 14.49 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.433 -179.91 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.9 ttmm -55.16 159.25 2.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.339 179.979 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 86.91 25.77 33.66 Favored Glycine 0 CA--C 1.523 0.539 0 N-CA-C 110.772 -0.931 . . . . 0.0 110.772 -179.968 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 58.3 m -94.84 120.3 34.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.813 0.34 . . . . 0.0 110.491 -179.891 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -119.38 -163.94 1.02 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.39 179.927 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -46.99 -61.89 1.66 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.245 -179.693 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.416 ' HG2' ' N ' ' A' ' 16' ' ' HIS . 0.8 OUTLIER -98.95 -28.28 13.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.058 -179.271 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.416 ' N ' ' HG2' ' A' ' 15' ' ' LYS . 1.7 m80 -65.02 123.66 20.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.833 0.349 . . . . 0.0 110.411 -179.818 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.482 HD22 ' HA ' ' A' ' 17' ' ' LEU . 0.3 OUTLIER -129.51 99.82 5.32 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.419 -179.953 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.588 ' HB1' HG11 ' A' ' 51' ' ' VAL . . . -95.88 130.93 42.69 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.128 179.83 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.68 ' O ' HG13 ' A' ' 51' ' ' VAL . 17.7 m -139.59 134.63 39.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.905 0.383 . . . . 0.0 110.796 -179.969 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -84.77 100.38 11.49 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.481 179.955 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.478 HG23 HG23 ' A' ' 19' ' ' VAL . 82.1 t -102.53 92.22 2.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.341 179.866 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.7 139.36 17.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.445 -179.925 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.425 ' CE1' HG12 ' A' ' 4' ' ' VAL . 2.1 p90 -155.0 168.02 28.41 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.257 179.929 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -74.17 125.06 27.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.417 -179.869 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 141.77 -91.35 0.18 Allowed Glycine 0 CA--C 1.523 0.555 0 N-CA-C 110.566 -1.014 . . . . 0.0 110.566 -179.934 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -72.93 -160.58 0.08 Allowed 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 179.805 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.683 ' O ' HG22 ' A' ' 27' ' ' THR . 33.5 m -144.14 31.67 1.24 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.637 179.975 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.416 ' O ' ' CG ' ' A' ' 71' ' ' GLU . 16.5 mtm 61.37 123.75 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.618 179.642 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.822 ' HB3' ' O ' ' A' ' 69' ' ' LEU . . . -124.86 -58.58 1.47 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.527 179.838 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -152.52 152.18 31.6 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.52 -179.958 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.765 HG21 ' CD1' ' A' ' 52' ' ' TRP . 27.9 t -141.76 155.8 20.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.191 179.746 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.429 ' CG ' ' HG3' ' A' ' 67' ' ' ARG . 0.9 OUTLIER -156.45 148.28 22.89 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.384 -179.784 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.765 HD12 ' H ' ' A' ' 34' ' ' ARG . 4.7 tp -111.4 148.94 31.97 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 -179.821 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.765 ' H ' HD12 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -97.77 -68.26 0.81 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.53 -179.818 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.439 ' CB ' ' O ' ' A' ' 34' ' ' ARG . 25.2 mt-10 88.8 74.94 0.01 OUTLIER 'General case' 0 CA--C 1.51 -0.58 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 -178.771 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -37.37 103.31 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.039 -0.982 . . . . 0.0 111.713 -178.097 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 107.13 37.07 2.38 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 110.413 -1.075 . . . . 0.0 110.413 -179.738 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.429 ' HB2' ' HB2' ' A' ' 35' ' ' GLU . 7.2 t -119.0 -157.5 0.69 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.676 0.274 . . . . 0.0 110.513 -179.641 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -111.25 66.41 0.63 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.855 0.359 . . . . 0.0 110.403 -179.837 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 76.39 160.06 0.22 Allowed 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.394 179.93 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.482 ' CZ3' ' HG2' ' A' ' 67' ' ' ARG . 82.4 m95 -51.18 156.79 1.03 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.566 -179.94 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.2 m -139.15 115.78 10.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.915 179.635 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -48.54 143.04 5.3 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.674 -179.651 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -73.26 -174.16 1.53 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.301 -179.959 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.412 ' O ' ' N ' ' A' ' 47' ' ' GLY . 59.1 m -145.53 120.81 10.22 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.096 179.887 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.42 ' O ' ' CG ' ' A' ' 46' ' ' LYS . 0.8 OUTLIER -68.67 64.4 0.11 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.412 -179.838 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.412 ' N ' ' O ' ' A' ' 45' ' ' THR . . . -72.6 -47.54 26.8 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 110.797 -0.921 . . . . 0.0 110.797 -179.981 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.469 ' CB ' ' HB ' ' A' ' 51' ' ' VAL . 0.5 OUTLIER -73.99 -174.34 1.84 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.866 0.365 . . . . 0.0 110.659 -179.814 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -82.79 -35.29 19.57 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 110.599 -1.0 . . . . 0.0 110.599 179.912 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -146.35 27.07 1.69 Allowed Glycine 0 CA--C 1.522 0.47 0 N-CA-C 110.117 -1.193 . . . . 0.0 110.117 179.69 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.68 HG13 ' O ' ' A' ' 19' ' ' VAL . 88.5 t -138.6 145.7 27.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.841 0.353 . . . . 0.0 110.084 -179.689 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . 0.765 ' CD1' HG21 ' A' ' 31' ' ' VAL . 4.2 m95 -94.55 114.37 26.34 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.513 -179.619 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.579 HG22 ' HB2' ' A' ' 18' ' ' ALA . 11.1 p -107.24 143.43 35.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.311 -179.937 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -126.44 150.86 48.41 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.446 179.925 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -108.39 95.47 5.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.355 -179.975 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -61.78 167.23 3.78 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.398 -179.967 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -105.79 -32.46 8.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.491 -179.955 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -111.45 153.52 44.13 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.432 -179.876 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -67.94 -32.37 28.88 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.899 2.399 . . . . 0.0 112.393 -179.934 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -77.53 128.07 33.56 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.673 -179.59 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 19.5 pt20 179.87 132.31 0.1 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.134 -179.943 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -138.79 -72.45 0.05 OUTLIER Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 -179.798 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -72.48 122.01 7.93 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.548 2.165 . . . . 0.0 112.006 179.837 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.596 ' HB3' HD13 ' A' ' 33' ' ' LEU . 45.1 m-85 -113.61 102.36 10.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.685 -179.689 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 52.2 m-20 -81.01 137.26 36.07 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 179.391 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -125.69 170.44 11.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.107 0.48 . . . . 0.0 111.077 -179.351 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.482 ' HG2' ' CZ3' ' A' ' 41' ' ' TRP . 0.0 OUTLIER -168.91 53.69 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.791 179.949 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.506 ' CZ ' HG11 ' A' ' 4' ' ' VAL . 0.2 OUTLIER -49.77 169.82 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.028 -179.56 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.822 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 6.9 mt -124.77 70.1 1.13 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.22 179.386 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 31.9 p -33.43 141.82 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.157 0.583 . . . . 0.0 112.241 -178.99 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.682 ' HG2' ' HB2' ' A' ' 29' ' ' ALA . 4.7 mm-40 -53.66 -60.11 3.73 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.745 -0.662 . . . . 0.0 110.455 -179.952 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 4.8 tmtt? -124.76 77.75 1.63 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.458 -179.973 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -170.55 -99.94 0.13 Allowed Glycine 0 CA--C 1.523 0.536 0 N-CA-C 110.764 -0.935 . . . . 0.0 110.764 179.901 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 179.29 173.56 0.81 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.864 0.364 . . . . 0.0 110.282 -179.938 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.19 -176.29 3.04 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.347 179.938 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.423 ' O ' ' CB ' ' A' ' 67' ' ' ARG . 2.7 t-20 -178.99 -173.7 0.31 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.016 179.942 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 93.0 t -128.31 127.32 67.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.887 0.375 . . . . 0.0 110.454 -179.884 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.586 ' CZ ' HG21 ' A' ' 4' ' ' VAL . 58.3 m-85 -112.64 123.24 49.86 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.887 179.741 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -113.89 151.85 31.6 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.781 -179.519 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 35.5 t0 60.26 24.0 13.4 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.762 179.834 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.654 HG22 ' HD3' ' A' ' 94' ' ' PRO . 25.4 t -55.73 -79.39 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.665 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.612 HG23 HG12 ' A' ' 81' ' ' VAL . 47.2 t -87.11 139.1 32.36 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.453 179.837 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.487 ' HD3' ' CG ' ' A' ' 92' ' ' TYR . 49.2 Cg_endo -71.76 -173.55 1.06 Allowed 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.624 2.216 . . . . 0.0 112.001 179.812 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 32.9 mp0 -64.12 -73.67 0.11 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.057 179.762 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -94.75 73.0 3.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.045 179.642 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.449 ' HB3' ' CG1' ' A' ' 82' ' ' VAL . 30.2 p90 -52.04 159.37 0.9 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.897 -179.574 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.74 109.99 12.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.094 179.747 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.595 HG13 HG11 ' A' ' 8' ' ' VAL . 3.3 mp -48.11 111.76 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.748 -179.769 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 110.56 55.0 0.53 Allowed Glycine 0 CA--C 1.523 0.538 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 179.995 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -175.75 131.78 0.26 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.82 0.343 . . . . 0.0 110.465 179.968 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.528 HG23 ' O ' ' A' ' 6' ' ' PHE . 35.5 m -83.16 144.58 29.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.159 179.917 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.487 ' CG ' ' HD3' ' A' ' 83' ' ' PRO . 71.9 m-85 -129.03 -83.79 0.57 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.691 -179.964 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.94 ' HB1' ' HD2' ' A' ' 94' ' ' PRO . . . 49.64 -179.01 0.01 OUTLIER Pre-proline 0 C--O 1.232 0.133 0 CA-C-O 120.624 0.249 . . . . 0.0 110.595 179.94 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.94 ' HD2' ' HB1' ' A' ' 93' ' ' ALA . 48.1 Cg_endo . . . . . 0 C--O 1.249 1.053 0 C-N-CA 122.481 2.121 . . . . 0.0 112.088 -179.902 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 4.0 m . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 110.128 -0.323 . . . . 0.0 110.128 . . . . . . . . . 0 0 . 1 . 031 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -77.06 159.22 33.95 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.588 2.192 . . . . 0.0 112.033 -179.904 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -139.62 97.47 3.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.38 179.984 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.651 ' O ' HG23 ' A' ' 5' ' ' THR . 34.2 m -66.21 -178.38 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.359 -179.937 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.651 HG23 ' O ' ' A' ' 4' ' ' VAL . 3.0 p -161.77 138.34 8.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.296 -179.996 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.614 ' O ' HG23 ' A' ' 91' ' ' THR . 23.4 m-85 -102.06 173.1 6.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.459 -179.757 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.451 HG23 ' O ' ' A' ' 90' ' ' ALA . 0.3 OUTLIER -165.96 102.92 0.66 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.287 -179.991 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.44 ' CG1' HG13 ' A' ' 88' ' ' ILE . 40.5 t -51.68 96.35 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.341 179.956 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.557 ' CD ' HD12 ' A' ' 20' ' ' LEU . 1.8 mm-40 -62.09 177.1 0.5 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.654 -179.737 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.8 tttt -80.63 60.34 3.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.409 -179.944 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -146.3 21.23 1.72 Allowed Glycine 0 CA--C 1.525 0.668 0 N-CA-C 111.022 -0.831 . . . . 0.0 111.022 179.974 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 25.6 m -110.32 114.58 28.15 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 110.121 -0.325 . . . . 0.0 110.121 179.921 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.419 ' OD1' ' N ' ' A' ' 14' ' ' GLU . 6.1 p30 -113.46 -49.13 2.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.612 -179.793 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.419 ' N ' ' OD1' ' A' ' 13' ' ' ASN . 9.6 mm-40 -154.15 -69.65 0.14 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.776 -179.792 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.433 ' N ' ' HD2' ' A' ' 15' ' ' LYS . 17.9 mmmt -91.25 -28.73 17.61 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.478 -179.478 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 9.5 m80 -76.36 128.59 35.14 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.764 -179.632 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.449 ' HA ' HD22 ' A' ' 17' ' ' LEU . 1.2 tm? -122.32 86.22 2.54 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.943 179.793 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.775 ' HB1' HG11 ' A' ' 51' ' ' VAL . . . -80.11 129.35 34.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.636 -179.596 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.658 ' O ' HG13 ' A' ' 51' ' ' VAL . 24.1 m -134.03 134.35 55.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.401 179.697 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.557 HD12 ' CD ' ' A' ' 9' ' ' GLU . 0.7 OUTLIER -89.36 87.47 7.12 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.377 -179.947 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.47 HG23 HG23 ' A' ' 19' ' ' VAL . 12.0 t -86.39 108.87 18.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.27 179.923 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.1 mtpt -179.67 176.39 0.79 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.226 179.95 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.442 ' CE2' HG12 ' A' ' 4' ' ' VAL . 20.1 p90 176.85 40.93 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.315 -179.963 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 55.63 174.77 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.353 179.974 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 70.74 -101.19 0.9 Allowed Glycine 0 CA--C 1.523 0.559 0 N-CA-C 110.635 -0.986 . . . . 0.0 110.635 -179.993 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -54.8 166.39 0.49 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.779 0.323 . . . . 0.0 110.359 179.934 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -115.0 -169.31 1.53 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.474 179.949 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.413 ' O ' ' CG ' ' A' ' 71' ' ' GLU . 13.4 mmt -115.21 127.45 55.52 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.637 -179.756 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.87 ' HB3' ' O ' ' A' ' 69' ' ' LEU . . . -118.03 -59.37 1.91 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.586 -179.904 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -150.44 153.06 35.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.215 -179.943 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.55 HG22 ' HB3' ' A' ' 68' ' ' PHE . 4.4 t -147.61 146.68 18.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.017 0.437 . . . . 0.0 110.773 -179.742 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.45 ' CB ' ' HA ' ' A' ' 43' ' ' ALA . 5.9 pt-20 -137.26 146.28 44.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.513 179.203 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.668 HD12 ' H ' ' A' ' 34' ' ' ARG . 9.8 tp -123.1 153.2 40.25 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-O 120.938 0.399 . . . . 0.0 110.033 -178.907 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.668 ' H ' HD12 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -145.66 162.73 36.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.678 179.574 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.405 ' O ' ' HB2' ' A' ' 36' ' ' HIS . 1.1 mt-10 -120.45 -86.11 0.65 Allowed 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 179.924 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.405 ' HB2' ' O ' ' A' ' 35' ' ' GLU . 0.8 OUTLIER -179.98 -40.62 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.803 0.335 . . . . 0.0 110.373 179.472 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -63.22 -56.83 17.97 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 110.781 -0.928 . . . . 0.0 110.781 -179.951 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.417 ' O ' ' CB ' ' A' ' 39' ' ' ASP . 1.5 t -55.03 -36.2 65.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.777 0.322 . . . . 0.0 110.356 -179.928 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.417 ' CB ' ' O ' ' A' ' 38' ' ' SER . 4.1 t70 81.6 -53.66 0.27 Allowed 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.489 -179.812 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -77.88 145.53 36.17 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.155 179.948 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.508 ' CE3' ' HB2' ' A' ' 34' ' ' ARG . 75.3 m95 -71.0 153.68 42.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.472 -179.864 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.6 HG21 ' CZ ' ' A' ' 54' ' ' PHE . 3.0 m -135.72 111.95 12.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.921 179.671 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.45 ' HA ' ' CB ' ' A' ' 32' ' ' GLU . . . -47.95 155.05 0.47 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.857 -179.479 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -76.42 -173.17 2.39 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.355 179.986 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 53.7 m -152.49 103.57 2.83 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.526 -179.943 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 7.9 ptpt -59.5 88.89 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.229 -0.442 . . . . 0.0 109.934 179.767 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -110.25 -28.46 4.08 Favored Glycine 0 CA--C 1.522 0.52 0 N-CA-C 111.239 -0.745 . . . . 0.0 111.239 -179.56 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.467 ' CB ' ' HB ' ' A' ' 51' ' ' VAL . 1.1 tp10 -72.09 -36.13 69.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.753 0.311 . . . . 0.0 110.698 -179.646 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 115.12 -37.46 3.49 Favored Glycine 0 CA--C 1.52 0.405 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 -179.115 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -138.02 21.32 3.17 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 178.631 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.775 HG11 ' HB1' ' A' ' 18' ' ' ALA . 52.6 t -155.44 144.61 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 -179.677 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . 0.495 ' NE1' HG21 ' A' ' 31' ' ' VAL . 3.0 m95 -91.51 110.42 21.74 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.968 0.413 . . . . 0.0 110.327 -179.749 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.461 ' CG2' ' HB2' ' A' ' 18' ' ' ALA . 1.1 p -101.81 142.17 33.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.468 -179.7 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.61 ' CG ' HD23 ' A' ' 33' ' ' LEU . 66.3 t80 -130.47 147.26 52.15 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.344 179.902 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 51.8 m-20 -89.04 101.17 13.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.431 -179.938 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.0 t -77.65 170.74 16.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.257 179.889 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -177.4 68.95 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.474 -179.912 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 179.49 118.61 0.21 Allowed Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.375 179.967 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -73.63 -2.43 12.17 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.475 2.117 . . . . 0.0 112.683 179.998 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 10.6 mp -67.05 74.91 0.12 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.727 0.298 . . . . 0.0 110.459 -179.943 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.423 ' HB2' ' HD3' ' A' ' 63' ' ' PRO . 57.7 mt-30 51.55 -170.06 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.177 179.998 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.492 ' N ' ' HD3' ' A' ' 63' ' ' PRO . . . -128.46 47.95 0.99 Allowed Glycine 0 CA--C 1.527 0.8 0 N-CA-C 111.589 -0.604 . . . . 0.0 111.589 -179.846 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.492 ' HD3' ' N ' ' A' ' 62' ' ' GLY . 51.8 Cg_endo -76.69 90.09 1.24 Allowed 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.389 2.06 . . . . 0.0 111.396 179.327 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.421 ' HB3' ' CD1' ' A' ' 33' ' ' LEU . 24.9 m-85 -92.28 160.51 15.1 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.272 0.558 . . . . 0.0 111.253 -179.238 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 5.0 m-80 -142.35 140.73 32.19 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.371 179.713 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.421 ' CZ ' HD13 ' A' ' 33' ' ' LEU . 79.0 m-85 -129.92 156.06 45.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.139 0.495 . . . . 0.0 111.545 -179.058 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.496 ' HD2' ' CZ2' ' A' ' 41' ' ' TRP . 1.8 mtp180 -156.38 61.96 0.55 Allowed 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.212 179.769 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.556 ' O ' HD23 ' A' ' 69' ' ' LEU . 0.7 OUTLIER -68.18 172.41 5.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.247 0.546 . . . . 0.0 110.856 -179.602 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.87 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 0.5 OUTLIER -131.09 76.05 1.7 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.47 -0.787 . . . . 0.0 109.293 179.728 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 2.7 p -35.4 136.9 0.19 Allowed 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 122.771 0.428 . . . . 0.0 111.813 -179.193 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.638 ' HG2' ' HB2' ' A' ' 29' ' ' ALA . 14.2 mt-10 -50.84 -28.95 10.54 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.582 -179.569 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.3 83.01 1.43 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.541 -179.847 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -177.05 -98.54 0.11 Allowed Glycine 0 CA--C 1.523 0.569 0 N-CA-C 110.846 -0.902 . . . . 0.0 110.846 179.864 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 179.3 -178.96 0.37 Allowed 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 110.201 -0.296 . . . . 0.0 110.201 -179.832 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.43 ' HG2' HD22 ' A' ' 69' ' ' LEU . 0.4 OUTLIER -93.4 179.9 5.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.873 0.368 . . . . 0.0 110.378 179.926 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 172.11 136.02 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.284 -179.988 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.457 HG12 ' N ' ' A' ' 78' ' ' PHE . 99.1 t -92.86 158.76 2.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.483 -179.986 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.457 ' CZ ' HG21 ' A' ' 4' ' ' VAL . 64.8 m-85 -143.25 108.22 4.94 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.12 179.94 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -91.17 147.91 22.73 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.663 -179.654 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 41.3 t0 51.51 52.2 15.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.797 179.742 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 74.9 t -68.72 -62.83 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 179.576 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.573 HG13 ' HD2' ' A' ' 83' ' ' PRO . 91.5 t -98.52 140.12 21.6 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.101 179.542 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.573 ' HD2' HG13 ' A' ' 82' ' ' VAL . 46.1 Cg_endo -69.74 -170.52 0.4 Allowed 'Trans proline' 0 N--CA 1.474 0.377 0 C-N-CA 122.638 2.225 . . . . 0.0 112.15 179.877 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 33.6 mp0 -77.35 -37.05 53.11 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.288 179.948 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -124.9 77.15 1.59 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.242 179.873 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.428 ' HB3' ' CG1' ' A' ' 82' ' ' VAL . 38.6 p90 -73.25 179.82 3.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.462 -179.871 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -157.69 120.56 3.91 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.305 -179.99 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.586 ' H ' HD12 ' A' ' 88' ' ' ILE . 4.0 mp -51.54 100.45 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.397 179.941 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 131.41 56.43 0.09 OUTLIER Glycine 0 CA--C 1.523 0.556 0 N-CA-C 110.703 -0.959 . . . . 0.0 110.703 -179.889 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.746 ' HB3' ' OH ' ' A' ' 92' ' ' TYR . . . -177.99 178.03 0.99 Allowed 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 110.253 -0.277 . . . . 0.0 110.253 179.981 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.614 HG23 ' O ' ' A' ' 6' ' ' PHE . 0.7 OUTLIER -111.8 146.24 37.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.889 0.376 . . . . 0.0 110.653 -179.839 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.746 ' OH ' ' HB3' ' A' ' 90' ' ' ALA . 8.6 m-85 -150.17 104.16 3.24 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.263 179.712 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.9 ' HB1' ' HD2' ' A' ' 94' ' ' PRO . . . 173.66 177.74 0.16 Allowed Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.461 179.968 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.9 ' HD2' ' HB1' ' A' ' 93' ' ' ALA . 50.4 Cg_endo . . . . . 0 C--O 1.249 1.026 0 C-N-CA 122.657 2.238 . . . . 0.0 112.211 -179.924 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.632 HG13 ' O ' ' A' ' 1' ' ' VAL . 7.7 p . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 . . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -75.38 145.09 29.78 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.667 2.245 . . . . 0.0 112.04 179.954 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 10.0 mttt -123.14 83.16 2.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.526 -179.853 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.575 HG11 ' CZ ' ' A' ' 78' ' ' PHE . 1.6 p -56.03 164.03 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.189 0.519 . . . . 0.0 110.204 179.894 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.476 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 9.1 p -142.17 128.65 20.15 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.411 179.966 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.55 ' CE2' ' CD2' ' A' ' 66' ' ' PHE . 8.0 m-85 -97.98 173.16 7.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.227 179.996 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.618 HG23 ' O ' ' A' ' 90' ' ' ALA . 12.9 m -165.37 117.79 1.16 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.469 -179.862 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.504 ' O ' HG23 ' A' ' 88' ' ' ILE . 20.6 t -59.11 94.57 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.269 179.946 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.737 ' HG3' HG11 ' A' ' 51' ' ' VAL . 0.1 OUTLIER -51.21 171.84 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.594 -179.893 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.2 ttmt -85.5 56.54 4.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.413 -179.99 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -147.63 25.36 1.5 Allowed Glycine 0 CA--C 1.524 0.622 0 N-CA-C 110.742 -0.943 . . . . 0.0 110.742 179.949 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -100.05 113.6 26.33 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.813 0.339 . . . . 0.0 110.216 179.939 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.407 ' OD1' ' N ' ' A' ' 14' ' ' GLU . 4.7 p30 -112.94 -51.4 2.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.533 -179.852 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.407 ' N ' ' OD1' ' A' ' 13' ' ' ASN . 0.5 OUTLIER -166.99 -64.98 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.755 -179.874 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.415 ' N ' ' HD2' ' A' ' 15' ' ' LYS . 10.9 mmmt -86.59 -27.11 24.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.54 -179.402 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 19.3 m80 -91.62 126.16 36.61 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.934 0.397 . . . . 0.0 110.849 -179.518 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.457 HD22 ' HA ' ' A' ' 17' ' ' LEU . 0.3 OUTLIER -116.81 89.63 3.15 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.627 179.425 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -83.51 126.05 32.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.762 -179.368 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.592 HG11 ' CZ ' ' A' ' 66' ' ' PHE . 19.8 m -113.55 -173.41 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.629 179.368 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.6 tt -141.04 59.21 1.53 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.256 179.679 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 28.0 t -55.86 116.54 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.428 -179.937 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.1 mttp -168.09 162.42 13.09 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.154 179.97 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -140.42 -63.67 0.48 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.225 -0.443 . . . . 0.0 109.979 -179.968 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -149.53 -47.25 0.14 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.318 179.981 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 170.22 74.84 0.04 OUTLIER Glycine 0 CA--C 1.524 0.601 0 N-CA-C 110.899 -0.88 . . . . 0.0 110.899 179.982 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -112.9 -168.31 1.3 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.767 0.318 . . . . 0.0 110.206 179.797 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.719 HG22 ' HG3' ' A' ' 71' ' ' GLU . 0.9 OUTLIER -113.45 137.78 51.04 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.094 179.984 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 7.8 mtt -101.62 129.57 47.77 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.872 -179.537 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.816 ' HB3' ' O ' ' A' ' 69' ' ' LEU . . . -112.68 -57.6 2.26 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.246 179.824 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.412 ' O ' ' CB ' ' A' ' 68' ' ' PHE . 0.7 OUTLIER -153.11 165.2 36.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.175 179.832 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.53 HG21 ' CD1' ' A' ' 52' ' ' TRP . 4.1 t -152.69 140.27 13.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.264 -0.426 . . . . 0.0 109.939 -179.969 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.454 ' CB ' ' HA ' ' A' ' 43' ' ' ALA . 1.5 pt-20 -137.34 137.34 38.8 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.968 0.413 . . . . 0.0 110.584 -179.701 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.563 HD12 ' CB ' ' A' ' 54' ' ' PHE . 1.6 mt -92.97 -178.52 4.83 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.587 -179.686 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.466 ' HB2' ' CZ3' ' A' ' 41' ' ' TRP . 0.7 OUTLIER -157.5 147.75 20.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.943 179.633 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -113.99 -14.36 12.43 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.957 -179.834 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 70.22 120.83 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.843 0.354 . . . . 0.0 110.31 -179.996 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 118.06 -45.27 1.29 Allowed Glycine 0 CA--C 1.522 0.481 0 N-CA-C 110.472 -1.051 . . . . 0.0 110.472 -179.753 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 20.7 t -63.24 -25.41 68.31 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.774 0.321 . . . . 0.0 110.314 179.778 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.1 t0 70.38 29.32 3.57 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.415 179.908 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -154.37 145.05 22.38 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.513 179.957 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.466 ' CZ3' ' HB2' ' A' ' 34' ' ' ARG . 83.8 m95 -88.14 145.66 25.81 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.036 179.8 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.768 HG21 ' CZ ' ' A' ' 54' ' ' PHE . 20.3 m -117.11 107.15 21.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.095 0.474 . . . . 0.0 110.33 -179.862 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.454 ' HA ' ' CB ' ' A' ' 32' ' ' GLU . . . -53.82 139.22 33.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.152 -179.782 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.86 -171.48 0.07 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.855 -179.644 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.422 ' O ' ' N ' ' A' ' 47' ' ' GLY . 86.7 m -143.55 97.65 3.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.217 179.858 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 13.5 ptmt -61.25 80.7 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.361 -179.883 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' A' ' 45' ' ' THR . . . -120.93 15.37 9.55 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 111.236 -0.745 . . . . 0.0 111.236 179.993 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.412 ' HG3' HG23 ' A' ' 51' ' ' VAL . 1.8 mm-40 -106.62 -33.24 7.71 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.847 0.356 . . . . 0.0 110.325 179.96 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 94.89 -36.79 3.63 Favored Glycine 0 CA--C 1.522 0.515 0 N-CA-C 110.667 -0.973 . . . . 0.0 110.667 179.973 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -110.92 -25.55 5.07 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 110.818 -0.913 . . . . 0.0 110.818 -179.877 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.737 HG11 ' HG3' ' A' ' 9' ' ' GLU . 15.5 m -140.66 -176.33 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.937 0.399 . . . . 0.0 110.591 -179.904 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . 0.53 ' CD1' HG21 ' A' ' 31' ' ' VAL . 9.5 m95 -108.58 142.28 39.26 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.726 -179.507 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -130.02 150.76 51.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.967 179.672 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.768 ' CZ ' HG21 ' A' ' 42' ' ' VAL . 65.8 t80 -136.18 153.57 51.21 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.884 0.373 . . . . 0.0 110.808 -179.825 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -95.56 96.46 9.07 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.212 179.831 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 31.3 p -50.71 121.62 6.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.562 -179.859 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -80.83 -26.83 36.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.099 179.721 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 23.8 pt-20 -118.32 144.88 35.95 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.18 179.883 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -67.07 -18.52 51.57 Favored 'Trans proline' 0 C--N 1.343 0.246 0 C-N-CA 122.765 2.31 . . . . 0.0 112.19 179.999 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.423 ' HA ' HD13 ' A' ' 60' ' ' LEU . 0.9 OUTLIER -71.94 118.21 14.51 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.426 179.975 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -101.19 54.14 0.84 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.242 179.86 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -73.15 -143.2 0.58 Allowed Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.715 -0.954 . . . . 0.0 110.715 -179.949 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.411 ' HB3' ' HA ' ' A' ' 80' ' ' ASP . 49.1 Cg_endo -77.27 106.16 2.18 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.614 2.209 . . . . 0.0 112.145 -179.856 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.501 ' HB3' HD21 ' A' ' 33' ' ' LEU . 16.4 m-85 -77.96 98.32 5.64 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.66 179.961 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.43 ' OD1' ' N ' ' A' ' 65' ' ' ASN . 0.4 OUTLIER -71.32 123.45 22.31 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 179.469 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.592 ' CZ ' HG11 ' A' ' 19' ' ' VAL . 2.7 m-85 -101.05 176.66 5.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.598 -179.55 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.858 ' HD2' HG22 ' A' ' 77' ' ' VAL . 1.7 mtp180 176.51 102.1 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.456 179.916 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.773 ' O ' HD23 ' A' ' 69' ' ' LEU . 0.8 OUTLIER -111.29 172.85 6.64 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.427 179.815 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.816 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 2.4 mt -128.88 65.98 1.43 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.376 179.684 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 29.0 p -31.5 143.87 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.246 0.619 . . . . 0.0 112.108 -179.302 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.719 ' HG3' HG22 ' A' ' 27' ' ' THR . 0.4 OUTLIER -68.29 -31.23 70.53 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.254 -179.716 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.5 tmtm? -141.03 56.24 1.56 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.47 179.994 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -145.48 -105.66 0.47 Allowed Glycine 0 CA--C 1.523 0.559 0 N-CA-C 110.622 -0.991 . . . . 0.0 110.622 179.9 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 10.6 ptm -178.47 -179.45 0.68 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.787 0.327 . . . . 0.0 110.205 -179.986 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.745 ' HD2' HD22 ' A' ' 69' ' ' LEU . 14.1 mmtm -90.82 158.19 16.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.14 179.871 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -175.25 135.71 0.35 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.801 -179.944 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.858 HG22 ' HD2' ' A' ' 67' ' ' ARG . 94.6 t -94.2 150.25 4.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.233 -0.44 . . . . 0.0 109.963 179.476 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.575 ' CZ ' HG11 ' A' ' 4' ' ' VAL . 71.2 m-85 -131.5 145.73 51.9 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.97 -179.203 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -139.62 162.19 35.7 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.006 179.76 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.411 ' HA ' ' HB3' ' A' ' 63' ' ' PRO . 0.1 OUTLIER 51.97 33.04 10.98 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.113 0.483 . . . . 0.0 109.839 -179.722 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.542 ' O ' HG12 ' A' ' 81' ' ' VAL . 87.6 t -78.41 -3.01 5.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.586 -179.406 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.445 HG23 ' O ' ' A' ' 81' ' ' VAL . 72.4 t -158.15 119.45 1.95 Allowed Pre-proline 0 CA--C 1.53 0.21 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 179.855 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.416 ' HD3' ' CG ' ' A' ' 92' ' ' TYR . 50.9 Cg_endo -75.66 169.64 21.88 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.458 2.105 . . . . 0.0 111.786 179.729 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -66.26 120.02 12.53 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 179.633 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 2.5 mtpt 67.24 58.85 0.54 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.224 -0.443 . . . . 0.0 109.997 -179.609 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 21.4 p90 -52.96 -175.16 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.741 -179.729 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 1.5 m -152.26 108.12 3.36 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.967 179.836 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.504 HG23 ' O ' ' A' ' 8' ' ' VAL . 3.3 mp -46.45 121.82 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.68 -179.86 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 113.73 29.59 2.83 Favored Glycine 0 CA--C 1.523 0.582 0 N-CA-C 110.736 -0.945 . . . . 0.0 110.736 -179.875 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.618 ' O ' HG23 ' A' ' 7' ' ' THR . . . -142.32 167.29 22.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.736 0.303 . . . . 0.0 110.443 -179.944 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 32.8 m -113.44 120.8 42.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.522 -179.968 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.471 ' O ' ' HB2' ' A' ' 93' ' ' ALA . 40.8 m-85 -125.62 123.55 39.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.394 179.954 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.919 ' HB1' ' HD2' ' A' ' 94' ' ' PRO . . . 174.56 178.45 0.17 Allowed Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.457 -179.981 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.919 ' HD2' ' HB1' ' A' ' 93' ' ' ALA . 49.8 Cg_endo . . . . . 0 C--O 1.25 1.083 0 C-N-CA 122.547 2.165 . . . . 0.0 112.112 -179.884 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 7.4 t . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 . . . . . . . . . 0 0 . 1 . 033 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -77.77 174.4 12.65 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.451 2.101 . . . . 0.0 112.063 -179.994 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 33.4 mmtm 44.97 86.84 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.07 179.497 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.524 ' CG1' ' CE1' ' A' ' 78' ' ' PHE . 2.1 p -106.26 163.42 4.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.336 0.588 . . . . 0.0 110.365 -179.968 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.486 ' N ' HG22 ' A' ' 4' ' ' VAL . 65.9 p -144.2 129.51 18.81 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.294 179.718 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.775 ' O ' HG23 ' A' ' 91' ' ' THR . 35.0 m-85 -89.29 -176.75 5.19 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.307 179.904 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -166.15 118.57 1.06 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.152 179.934 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.1 t -68.18 93.43 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.356 -179.899 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.605 ' O ' HG23 ' A' ' 88' ' ' ILE . 1.8 mm-40 -54.11 -178.45 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.303 -179.961 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.26 48.74 1.6 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.455 -179.839 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -112.3 -25.78 4.56 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 110.842 -0.903 . . . . 0.0 110.842 -179.992 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.1 m -50.82 120.97 5.28 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.826 0.346 . . . . 0.0 110.418 -179.982 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -114.13 -81.17 0.6 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.424 -179.912 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -106.78 -82.67 0.54 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.735 0.302 . . . . 0.0 110.41 -179.904 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.36 28.39 8.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.326 -179.995 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 8.9 m80 -104.08 167.39 9.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.325 -179.959 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.451 HD12 ' HA ' ' A' ' 17' ' ' LEU . 17.2 tp -154.13 88.79 1.25 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.452 -179.853 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.572 ' HB2' ' CG2' ' A' ' 53' ' ' THR . . . -81.37 109.62 16.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.454 -179.902 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.571 HG23 HG23 ' A' ' 21' ' ' VAL . 21.5 m -103.54 141.23 19.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.449 179.941 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -90.41 83.23 5.89 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.611 -179.99 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.571 HG23 HG23 ' A' ' 19' ' ' VAL . 16.2 t -79.32 90.61 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.348 179.866 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 176.08 157.29 0.24 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.982 -0.553 . . . . 0.0 109.95 -179.974 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.543 ' CE2' ' HB2' ' A' ' 26' ' ' ASP . 0.0 OUTLIER -113.89 -66.52 1.08 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.541 -179.751 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -153.45 -65.21 0.15 Allowed 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 111.808 0.299 . . . . 0.0 111.808 -179.395 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -106.36 -28.14 5.29 Favored Glycine 0 CA--C 1.525 0.702 0 C-N-CA 121.364 -0.446 . . . . 0.0 112.563 -178.372 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.543 ' HB2' ' CE2' ' A' ' 23' ' ' TYR . 16.8 t0 -42.29 152.02 0.1 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 117.277 0.539 . . . . 0.0 111.417 -179.363 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.402 HG22 ' H ' ' A' ' 28' ' ' MET . 0.2 OUTLIER -100.63 -174.67 2.7 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.731 -179.462 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.423 ' O ' ' CG ' ' A' ' 71' ' ' GLU . 34.7 mtm -123.17 126.07 46.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.336 -179.883 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.673 ' HB3' ' O ' ' A' ' 69' ' ' LEU . . . -118.97 -60.35 1.76 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.513 -179.706 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.7 ' HB3' HD12 ' A' ' 69' ' ' LEU . 0.6 OUTLIER -154.39 156.26 36.52 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.106 -179.937 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.474 ' HA ' ' HA ' ' A' ' 68' ' ' PHE . 0.7 OUTLIER -173.95 141.33 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.377 0.608 . . . . 0.0 110.271 -179.87 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.442 ' HG3' ' HB3' ' A' ' 41' ' ' TRP . 1.7 pm0 -141.18 169.48 17.53 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.059 -179.444 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.87 HD21 ' CE1' ' A' ' 66' ' ' PHE . 1.0 OUTLIER -117.3 174.34 6.19 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.157 0.503 . . . . 0.0 111.096 -179.479 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.43 ' NE ' ' HA ' ' A' ' 34' ' ' ARG . 0.5 OUTLIER -161.75 -176.69 5.41 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.486 179.562 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -129.92 -70.76 0.63 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.797 0.332 . . . . 0.0 110.424 179.928 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 58.2 t-80 -178.53 -50.02 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.344 179.972 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -121.02 25.69 7.02 Favored Glycine 0 CA--C 1.523 0.545 0 N-CA-C 110.733 -0.947 . . . . 0.0 110.733 179.87 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 2.7 m -70.97 -22.43 62.2 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.652 0.263 . . . . 0.0 110.593 179.931 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.4 t0 71.96 97.21 0.07 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.799 0.333 . . . . 0.0 110.326 -179.802 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 76.82 146.44 0.09 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.398 -179.961 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.513 ' CE3' ' HG2' ' A' ' 67' ' ' ARG . 35.5 m95 -79.83 160.95 25.91 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.54 -179.826 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.481 HG23 ' O ' ' A' ' 42' ' ' VAL . 32.1 m -132.16 122.18 47.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.179 179.832 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.428 ' HA ' ' HB3' ' A' ' 32' ' ' GLU . . . -46.51 130.44 11.1 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.8 -179.911 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.693 ' CE ' HD12 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -58.79 -167.51 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.22 -179.901 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 53.2 m -137.01 126.34 24.86 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.434 -179.946 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.66 67.16 6.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.231 -0.44 . . . . 0.0 109.987 179.726 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -96.86 -35.98 5.17 Favored Glycine 0 CA--C 1.522 0.503 0 N-CA-C 110.738 -0.945 . . . . 0.0 110.738 -179.772 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.449 ' HG2' ' CG2' ' A' ' 51' ' ' VAL . 31.8 tp10 -80.18 133.91 36.09 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.804 0.335 . . . . 0.0 110.369 179.915 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -79.36 88.39 1.21 Allowed Glycine 0 CA--C 1.523 0.587 0 N-CA-C 111.021 -0.831 . . . . 0.0 111.021 -179.794 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 129.81 -23.4 4.73 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 111.167 -0.773 . . . . 0.0 111.167 179.721 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.511 HG11 ' HG3' ' A' ' 9' ' ' GLU . 16.7 m -146.8 -175.56 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.933 0.397 . . . . 0.0 110.684 -179.756 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 8.4 m95 -103.22 144.61 31.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.462 -179.547 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.572 ' CG2' ' HB2' ' A' ' 18' ' ' ALA . 0.1 OUTLIER -132.57 145.15 50.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.546 -179.759 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -120.62 136.69 54.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.125 179.725 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 11.4 t0 -113.67 156.34 23.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.939 0.4 . . . . 0.0 110.765 -179.706 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -175.39 172.96 2.59 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.326 179.947 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -154.85 30.79 0.41 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.385 -179.97 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -75.64 157.36 84.25 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.473 -179.96 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -71.3 -34.52 9.73 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.67 2.247 . . . . 0.0 112.035 179.881 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 5.4 mt -81.37 167.3 19.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.356 -179.928 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 28.2 tt0 -172.53 111.39 0.25 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.476 -179.98 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -135.35 -143.26 4.71 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.597 -1.001 . . . . 0.0 110.597 179.975 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -77.32 171.84 17.02 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.546 2.164 . . . . 0.0 111.892 179.882 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -124.18 172.45 9.04 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.92 0.39 . . . . 0.0 110.511 -179.948 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.505 ' O ' HD23 ' A' ' 33' ' ' LEU . 5.3 m-80 -146.36 144.72 29.95 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.176 -179.982 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.87 ' CE1' HD21 ' A' ' 33' ' ' LEU . 39.3 m-85 -127.03 -177.12 3.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.019 0.437 . . . . 0.0 110.483 179.978 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.575 ' HB3' HG12 ' A' ' 77' ' ' VAL . 0.0 OUTLIER 176.78 72.66 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.799 179.76 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.831 ' O ' HD23 ' A' ' 69' ' ' LEU . 0.0 OUTLIER -71.01 -178.96 2.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.409 0.624 . . . . 0.0 111.626 -179.259 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.831 HD23 ' O ' ' A' ' 68' ' ' PHE . 9.1 mt -144.77 49.07 1.31 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.032 -0.985 . . . . 0.0 109.254 179.874 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.456 HG21 ' OD2' ' A' ' 26' ' ' ASP . 40.8 p -22.67 137.64 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.129 0.972 . . . . 0.0 112.891 -179.147 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.653 ' HG2' ' HB2' ' A' ' 29' ' ' ALA . 3.2 mm-40 -54.2 -25.27 21.97 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.533 -179.806 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.51 48.89 0.14 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.862 0.363 . . . . 0.0 110.547 -179.907 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.412 ' CA ' ' OG1' ' A' ' 70' ' ' THR . . . -128.34 -107.2 1.35 Allowed Glycine 0 CA--C 1.523 0.592 0 N-CA-C 110.707 -0.957 . . . . 0.0 110.707 179.915 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.409 ' N ' ' OG1' ' A' ' 70' ' ' THR . 66.0 mmm -139.13 171.28 14.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.832 0.349 . . . . 0.0 110.305 179.965 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.439 ' O ' ' CD ' ' A' ' 75' ' ' LYS . 0.0 OUTLIER -138.12 86.56 2.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.306 179.859 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -141.1 140.23 34.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.251 -179.971 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.575 HG12 ' HB3' ' A' ' 67' ' ' ARG . 17.9 m -66.61 -179.73 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.333 -179.958 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.524 ' CE1' ' CG1' ' A' ' 4' ' ' VAL . 66.1 m-85 -149.38 135.54 19.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.631 -179.831 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -119.21 158.99 24.89 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.395 -179.976 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 52.5 49.65 19.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.405 179.91 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.571 ' O ' HG12 ' A' ' 81' ' ' VAL . 80.9 t -90.89 -0.65 9.44 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.039 179.836 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.626 HG13 ' HB3' ' A' ' 86' ' ' TYR . 94.8 t -157.49 130.2 4.35 Favored Pre-proline 0 CA--C 1.527 0.093 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 179.667 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.501 ' HD3' ' CD1' ' A' ' 92' ' ' TYR . 49.7 Cg_endo -71.0 -167.09 0.25 Allowed 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.577 2.184 . . . . 0.0 112.06 179.767 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -68.78 -34.25 75.24 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.933 179.472 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -137.96 91.19 2.55 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.952 179.683 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.626 ' HB3' HG13 ' A' ' 82' ' ' VAL . 14.9 p90 -67.62 165.76 16.39 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.794 -179.65 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -141.34 115.24 9.15 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.064 179.844 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.605 HG23 ' O ' ' A' ' 9' ' ' GLU . 3.4 mp -46.58 131.08 3.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.762 -179.836 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 89.87 39.29 6.21 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 110.685 -0.966 . . . . 0.0 110.685 -179.905 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -146.81 155.93 42.73 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.865 0.364 . . . . 0.0 110.53 -179.918 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.775 HG23 ' O ' ' A' ' 6' ' ' PHE . 0.2 OUTLIER -106.42 142.22 36.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.258 179.954 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.501 ' CD1' ' HD3' ' A' ' 83' ' ' PRO . 73.3 m-85 -134.1 -86.48 0.41 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.762 -179.914 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.902 ' HB1' ' HD2' ' A' ' 94' ' ' PRO . . . 50.12 -179.05 0.01 OUTLIER Pre-proline 0 C--N 1.332 -0.154 0 CA-C-O 120.63 0.252 . . . . 0.0 110.547 179.923 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.902 ' HD2' ' HB1' ' A' ' 93' ' ' ALA . 47.9 Cg_endo . . . . . 0 C--O 1.249 1.054 0 C-N-CA 122.539 2.16 . . . . 0.0 112.064 -179.978 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 9.2 m . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 110.212 -0.292 . . . . 0.0 110.212 . . . . . . . . . 0 0 . 1 . 034 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -73.98 58.75 4.22 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.488 2.125 . . . . 0.0 112.045 179.943 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.28 30.59 7.14 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.361 179.913 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.779 HG21 ' CZ ' ' A' ' 78' ' ' PHE . 27.0 m -88.45 -176.03 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.087 179.85 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.587 HG23 ' O ' ' A' ' 4' ' ' VAL . 0.5 OUTLIER -167.04 146.92 5.44 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.364 179.971 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.491 ' H ' ' HB3' ' A' ' 93' ' ' ALA . 37.9 m-85 -118.78 158.13 26.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.22 179.905 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 53.2 m -150.73 104.71 3.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.35 -179.863 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.756 HG12 HD13 ' A' ' 88' ' ' ILE . 14.2 t -54.33 94.83 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.416 -179.905 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.83 ' HG3' HG11 ' A' ' 51' ' ' VAL . 4.7 mm-40 -69.33 162.89 26.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.286 -179.99 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.67 171.01 3.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.479 -179.967 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 86.67 19.59 56.06 Favored Glycine 0 CA--C 1.527 0.795 0 N-CA-C 111.103 -0.799 . . . . 0.0 111.103 -179.955 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.803 ' HB2' HD11 ' A' ' 88' ' ' ILE . 8.7 m -109.6 -159.76 0.69 Allowed 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 -179.936 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.409 ' HB2' ' O ' ' A' ' 12' ' ' SER . 10.2 m-80 66.79 -62.39 0.3 Allowed 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.153 179.556 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.402 ' N ' ' O ' ' A' ' 12' ' ' SER . 2.3 tt0 -43.44 -69.73 0.13 Allowed 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.76 0.314 . . . . 0.0 111.02 -179.555 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.432 ' HA ' ' CE ' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -156.29 25.9 0.35 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.388 179.965 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 55.2 m80 -149.77 165.46 32.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.081 0.467 . . . . 0.0 110.787 -179.572 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.479 HD22 ' HA ' ' A' ' 17' ' ' LEU . 0.4 OUTLIER -138.56 85.27 2.07 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.285 179.236 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.624 ' HB2' HG23 ' A' ' 53' ' ' THR . . . -78.2 153.42 31.99 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.985 -179.134 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.43 HG23 HG23 ' A' ' 21' ' ' VAL . 29.4 m -150.14 141.94 17.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.868 -0.606 . . . . 0.0 109.697 179.424 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -93.21 101.29 13.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.838 0.352 . . . . 0.0 110.621 -179.837 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.43 HG23 HG23 ' A' ' 19' ' ' VAL . 6.7 t -112.35 99.65 9.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.138 179.761 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.474 ' O ' ' CG ' ' A' ' 23' ' ' TYR . 24.7 mtpp -140.55 -72.88 0.35 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.671 -179.876 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.479 ' O ' ' CD2' ' A' ' 23' ' ' TYR . 29.7 p90 45.28 98.2 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.884 -179.667 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -46.82 116.1 1.24 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.835 -179.965 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 162.64 -42.32 0.35 Allowed Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.746 -0.942 . . . . 0.0 110.746 179.955 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -123.53 178.92 4.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.777 0.323 . . . . 0.0 110.378 -179.994 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.465 ' CB ' ' HB2' ' A' ' 71' ' ' GLU . 0.2 OUTLIER -103.85 -171.61 1.96 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.3 179.987 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.408 ' O ' ' HG3' ' A' ' 71' ' ' GLU . 6.1 mtt -117.4 118.83 33.28 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.819 -179.751 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.753 ' HB2' ' HA ' ' A' ' 71' ' ' GLU . . . -113.62 -62.33 1.61 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.109 179.57 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -165.0 165.1 20.39 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.767 -179.986 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.666 HG21 ' CD1' ' A' ' 52' ' ' TRP . 5.2 t -148.27 166.68 4.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.313 -179.896 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.482 ' N ' HG12 ' A' ' 31' ' ' VAL . 2.7 pt-20 -174.72 151.03 1.38 Allowed 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.416 -179.788 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.775 HD12 ' N ' ' A' ' 34' ' ' ARG . 3.0 pp -115.95 177.39 4.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.446 179.957 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.775 ' N ' HD12 ' A' ' 33' ' ' LEU . 2.7 ttm180 -120.2 -40.56 2.69 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.296 179.862 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.444 ' CB ' ' O ' ' A' ' 34' ' ' ARG . 3.8 tt0 87.43 32.97 0.02 OUTLIER 'General case' 0 CA--C 1.515 -0.384 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 -179.102 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.428 ' CE1' ' OE1' ' A' ' 61' ' ' GLN . 41.8 t-80 63.71 -74.03 0.04 OUTLIER 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 114.882 -1.054 . . . . 0.0 110.596 -180.0 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.421 ' N ' ' O ' ' A' ' 35' ' ' GLU . . . -136.49 103.69 0.45 Allowed Glycine 0 CA--C 1.523 0.534 0 N-CA-C 110.766 -0.934 . . . . 0.0 110.766 -179.987 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -139.87 -54.07 0.54 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.826 0.346 . . . . 0.0 110.252 179.907 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.7 p30 179.91 -45.66 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.321 -179.978 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -178.61 171.54 1.51 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.195 -179.964 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.508 ' CZ3' ' HG2' ' A' ' 67' ' ' ARG . 96.7 m95 -55.01 125.3 19.82 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.338 -179.993 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.466 HG23 ' HG ' ' A' ' 33' ' ' LEU . 4.4 m -106.91 116.93 51.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.128 179.861 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -48.83 126.03 11.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.505 -179.91 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.424 ' HE2' ' CE1' ' A' ' 66' ' ' PHE . 0.0 OUTLIER -55.79 -169.85 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.254 -179.929 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 33.8 m -141.13 95.69 2.88 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.425 -179.952 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.26 81.9 1.84 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.217 179.811 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -117.32 -17.85 5.58 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 111.404 -0.678 . . . . 0.0 111.404 -179.744 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.404 ' HB2' ' O ' ' A' ' 51' ' ' VAL . 0.1 OUTLIER -69.78 -32.65 71.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.774 0.321 . . . . 0.0 110.631 -179.766 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 97.4 -35.38 4.51 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 110.523 -1.031 . . . . 0.0 110.523 -179.839 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -113.86 -34.09 1.74 Allowed Glycine 0 CA--C 1.523 0.571 0 N-CA-C 110.458 -1.057 . . . . 0.0 110.458 179.912 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.83 HG11 ' HG3' ' A' ' 9' ' ' GLU . 23.9 m -123.78 172.75 10.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.808 0.337 . . . . 0.0 110.127 179.815 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . 0.666 ' CD1' HG21 ' A' ' 31' ' ' VAL . 8.8 m95 -105.06 133.8 49.24 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.529 -179.718 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.624 HG23 ' HB2' ' A' ' 18' ' ' ALA . 0.0 OUTLIER -119.79 -179.02 3.77 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.311 179.875 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.423 ' CD2' HD21 ' A' ' 33' ' ' LEU . 66.8 t80 -175.37 130.85 0.28 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.347 179.95 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 43.8 m-20 -68.91 117.29 10.39 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.359 -179.98 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 9.1 p -119.2 120.04 35.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.368 -179.994 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -100.93 -26.3 13.79 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.48 -179.921 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.402 ' O ' ' CG ' ' A' ' 58' ' ' GLU . 1.1 pt-20 -115.52 112.61 43.29 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.488 -179.872 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -70.7 -21.11 29.55 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.479 2.119 . . . . 0.0 111.891 179.655 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 44.73 -154.71 0.03 OUTLIER 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.854 179.584 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.428 ' OE1' ' CE1' ' A' ' 36' ' ' HIS . 0.0 OUTLIER -45.15 -31.9 1.61 Allowed 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.708 -0.224 . . . . 0.0 111.23 -179.644 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.499 ' N ' ' HD2' ' A' ' 63' ' ' PRO . . . 124.29 -41.98 1.64 Allowed Glycine 0 CA--C 1.531 1.058 0 C-N-CA 121.116 -0.564 . . . . 0.0 112.395 179.894 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.499 ' HD2' ' N ' ' A' ' 62' ' ' GLY . 45.2 Cg_endo -74.64 152.98 43.35 Favored 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 122.052 1.835 . . . . 0.0 112.811 -179.137 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.438 ' HD2' HG21 ' A' ' 82' ' ' VAL . 78.0 m-85 -126.77 101.61 6.68 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.318 179.832 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 20.7 m-20 -65.53 140.34 58.56 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 179.538 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.489 ' CE1' ' HB3' ' A' ' 33' ' ' LEU . 16.5 m-85 -128.96 176.58 7.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.235 0.54 . . . . 0.0 111.246 -179.34 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.508 ' HG2' ' CZ3' ' A' ' 41' ' ' TRP . 0.0 OUTLIER 176.91 89.17 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.447 179.878 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.676 ' CZ ' HG11 ' A' ' 4' ' ' VAL . 1.4 p90 -72.06 176.28 5.23 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.179 0.514 . . . . 0.0 110.874 -179.144 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.68 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 2.3 mt -130.12 61.12 1.59 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.031 179.715 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.407 ' OG1' ' N ' ' A' ' 74' ' ' MET . 0.6 OUTLIER -23.69 137.62 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.871 0.868 . . . . 0.0 113.011 -178.821 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.753 ' HA ' ' HB2' ' A' ' 29' ' ' ALA . 0.0 OUTLIER -48.41 -45.02 35.55 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.094 -179.533 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -145.37 38.32 1.15 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.279 179.973 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -114.57 -109.87 2.82 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.889 -0.884 . . . . 0.0 110.889 -179.952 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.407 ' N ' ' OG1' ' A' ' 70' ' ' THR . 20.8 mmt -154.41 -179.67 8.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.745 0.307 . . . . 0.0 110.183 179.909 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.439 ' HD3' ' N ' ' A' ' 75' ' ' LYS . 0.1 OUTLIER -115.85 100.74 8.21 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.996 0.427 . . . . 0.0 110.443 -179.888 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 49.0 t30 -115.9 152.86 32.61 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.241 179.895 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.517 HG12 ' N ' ' A' ' 78' ' ' PHE . 77.7 t -100.29 160.79 3.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.324 179.843 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.779 ' CZ ' HG21 ' A' ' 4' ' ' VAL . 64.9 m-85 -141.13 109.28 5.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.287 -179.907 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -95.77 159.66 14.87 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.496 -179.869 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 54.72 32.84 18.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.551 179.902 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.623 HG13 ' HB2' ' A' ' 93' ' ' ALA . 66.3 t -66.23 -54.68 24.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.286 179.901 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.626 HG13 ' HD2' ' A' ' 83' ' ' PRO . 76.2 t -101.1 142.45 24.64 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.02 179.95 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.626 ' HD2' HG13 ' A' ' 82' ' ' VAL . 43.5 Cg_endo -68.11 177.83 4.09 Favored 'Trans proline' 0 N--CA 1.475 0.42 0 C-N-CA 122.622 2.214 . . . . 0.0 112.287 179.915 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -59.31 -33.97 71.74 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.233 179.904 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.02 85.27 2.18 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.175 179.9 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.476 ' HB3' ' CG1' ' A' ' 82' ' ' VAL . 26.5 p90 -50.51 145.04 6.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.682 -179.751 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 4.2 m -136.08 111.45 9.14 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.304 179.841 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.803 HD11 ' HB2' ' A' ' 12' ' ' SER . 38.1 mm -50.49 110.19 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.49 -179.874 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 122.89 47.24 0.27 Allowed Glycine 0 CA--C 1.523 0.553 0 N-CA-C 110.819 -0.912 . . . . 0.0 110.819 179.918 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -160.0 159.02 31.61 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.774 0.321 . . . . 0.0 110.44 179.928 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 90.1 m -118.69 91.81 3.65 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.497 179.949 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.553 ' O ' ' HB3' ' A' ' 93' ' ' ALA . 32.9 m-85 -86.06 -156.71 0.3 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.154 179.847 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.877 ' HB1' ' HD2' ' A' ' 94' ' ' PRO . . . 76.19 173.6 0.09 OUTLIER Pre-proline 0 N--CA 1.463 0.179 0 CA-C-O 120.7 0.286 . . . . 0.0 110.307 -179.805 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.877 ' HD2' ' HB1' ' A' ' 93' ' ' ALA . 46.1 Cg_endo . . . . . 0 C--O 1.249 1.05 0 C-N-CA 122.582 2.188 . . . . 0.0 112.092 -179.908 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.569 HG13 ' O ' ' A' ' 1' ' ' VAL . 8.3 p . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 110.137 -0.32 . . . . 0.0 110.137 . . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -75.54 116.96 4.63 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.634 2.223 . . . . 0.0 112.165 -179.94 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.535 ' O ' HG22 ' A' ' 4' ' ' VAL . 81.7 mttt -146.45 29.38 1.04 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.346 179.971 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.731 ' O ' HG23 ' A' ' 5' ' ' THR . 23.0 m 44.59 -172.22 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.042 -179.804 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.731 HG23 ' O ' ' A' ' 4' ' ' VAL . 0.5 OUTLIER -174.02 136.8 0.53 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.521 -179.72 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.75 ' O ' HG23 ' A' ' 91' ' ' THR . 14.2 m-85 -105.17 172.13 6.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.01 179.857 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.406 ' HG1' HG23 ' A' ' 91' ' ' THR . 19.7 m -165.69 113.35 0.95 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.84 0.352 . . . . 0.0 110.447 -179.974 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 94.9 t -58.0 87.97 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.396 179.971 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.542 ' HG3' HG21 ' A' ' 51' ' ' VAL . 2.5 mm-40 -59.44 167.12 2.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.344 179.982 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.06 165.14 5.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.363 179.954 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 79.99 35.0 28.77 Favored Glycine 0 CA--C 1.523 0.582 0 N-CA-C 110.834 -0.906 . . . . 0.0 110.834 179.99 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 74.4 m -96.1 114.95 26.7 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.78 0.324 . . . . 0.0 110.369 -179.948 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -97.46 -168.85 1.75 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.213 179.998 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 67.8 mm-40 -69.24 -27.15 65.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.315 179.861 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.42 ' HG2' ' N ' ' A' ' 16' ' ' HIS . 0.0 OUTLIER -114.55 -30.65 6.46 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.641 -179.857 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.42 ' N ' ' HG2' ' A' ' 15' ' ' LYS . 2.0 m80 -70.59 151.28 45.17 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.851 0.357 . . . . 0.0 110.378 -179.902 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.507 HD22 ' HA ' ' A' ' 17' ' ' LEU . 0.3 OUTLIER -151.29 91.58 1.7 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.498 -179.965 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.626 ' HB1' HG11 ' A' ' 51' ' ' VAL . . . -89.31 136.19 33.16 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.868 179.675 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.746 ' O ' HG13 ' A' ' 51' ' ' VAL . 27.4 m -137.86 135.02 45.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.999 0.428 . . . . 0.0 110.847 -179.793 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -88.57 81.12 7.18 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.454 179.949 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.433 HG23 HG23 ' A' ' 19' ' ' VAL . 42.9 t -77.92 107.91 10.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.408 179.97 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -170.43 150.51 3.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.289 -179.986 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.485 ' CE1' HG12 ' A' ' 4' ' ' VAL . 8.4 p90 -166.78 31.4 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.493 -179.938 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 50.84 -167.78 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.513 179.959 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 63.45 -79.97 0.04 OUTLIER Glycine 0 CA--C 1.523 0.536 0 N-CA-C 110.796 -0.921 . . . . 0.0 110.796 179.88 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -71.63 179.54 3.02 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.678 0.275 . . . . 0.0 110.325 179.956 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -121.2 -174.1 2.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.389 -179.886 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.427 ' O ' ' CG ' ' A' ' 71' ' ' GLU . 22.6 mtm -114.99 122.35 45.97 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.677 -179.651 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.746 ' HB3' ' O ' ' A' ' 69' ' ' LEU . . . -120.02 -60.48 1.7 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.338 179.765 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.42 ' HB3' HD12 ' A' ' 69' ' ' LEU . 2.7 mt-10 -161.37 147.59 14.31 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.36 179.995 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.648 HG21 ' CD1' ' A' ' 52' ' ' TRP . 3.1 t -133.97 159.33 42.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.941 0.401 . . . . 0.0 110.596 179.987 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.424 ' OE2' ' N ' ' A' ' 32' ' ' GLU . 0.5 OUTLIER -150.04 147.79 28.24 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.148 -179.944 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.627 HD12 ' H ' ' A' ' 34' ' ' ARG . 12.0 tp -116.65 156.07 27.71 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 -179.603 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.627 ' H ' HD12 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -139.98 178.81 7.0 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.087 179.609 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -122.16 -79.91 0.62 Allowed 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 179.719 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -179.34 -38.42 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.349 179.487 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -130.28 22.87 4.67 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.884 -0.887 . . . . 0.0 110.884 179.937 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 8.2 t -77.34 -166.13 0.69 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.872 0.368 . . . . 0.0 110.304 179.959 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -87.2 52.99 2.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.143 179.868 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 69.71 178.61 0.25 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.251 -179.858 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.49 ' CZ3' ' HG2' ' A' ' 67' ' ' ARG . 97.2 m95 -50.47 139.08 16.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.629 -179.994 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.434 ' CG2' ' O ' ' A' ' 33' ' ' LEU . 4.6 m -125.89 111.33 26.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 109.743 -0.465 . . . . 0.0 109.743 179.531 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.41 ' HA ' ' HB3' ' A' ' 32' ' ' GLU . . . -44.45 138.15 3.35 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.116 -179.376 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -67.66 -171.73 0.22 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.89 -179.942 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.402 ' O ' ' N ' ' A' ' 47' ' ' GLY . 51.7 m -150.92 106.31 3.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.228 179.846 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 7.3 ptmt -62.77 80.99 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.495 -179.925 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.402 ' N ' ' O ' ' A' ' 45' ' ' THR . . . -98.74 -24.31 10.97 Favored Glycine 0 CA--C 1.523 0.555 0 N-CA-C 110.647 -0.981 . . . . 0.0 110.647 179.846 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.476 ' CB ' ' HB ' ' A' ' 51' ' ' VAL . 2.2 mm-40 -78.18 1.09 22.5 Favored 'General case' 0 CA--C 1.532 0.269 0 O-C-N 122.85 -0.206 . . . . 0.0 111.502 -179.891 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 67.93 17.29 69.41 Favored Glycine 0 CA--C 1.527 0.794 0 N-CA-C 111.13 -0.788 . . . . 0.0 111.13 -179.963 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 178.24 -38.57 0.08 OUTLIER Glycine 0 C--N 1.33 0.229 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 179.93 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.746 HG13 ' O ' ' A' ' 19' ' ' VAL . 22.2 t -101.24 150.3 5.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 179.227 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . 0.648 ' CD1' HG21 ' A' ' 31' ' ' VAL . 3.3 m95 -91.75 111.7 23.32 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.477 -179.543 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.552 HG22 ' HB2' ' A' ' 18' ' ' ALA . 15.0 p -107.73 150.13 27.33 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.494 -179.736 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 34.6 t80 -136.7 115.12 11.82 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.451 -179.996 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -66.8 162.27 21.88 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.289 179.974 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 6.3 t 65.09 127.04 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.705 179.849 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.424 ' O ' ' O ' ' A' ' 58' ' ' GLU . 5.7 tt0 -117.95 -15.93 9.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.955 179.885 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.424 ' O ' ' O ' ' A' ' 57' ' ' GLU . 2.2 pt-20 48.97 170.43 0.03 OUTLIER Pre-proline 0 N--CA 1.467 0.381 0 C-N-CA 123.213 0.605 . . . . 0.0 111.548 -179.94 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.41 ' CD ' ' HB2' ' A' ' 58' ' ' GLU . 38.3 Cg_endo -96.97 10.41 1.25 Allowed 'Trans proline' 0 N--CA 1.453 -0.877 0 C-N-CA 124.036 3.157 . . . . 0.0 112.961 -178.998 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.9 100.47 0.07 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.841 0.353 . . . . 0.0 110.512 -179.914 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -53.65 127.5 25.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.222 179.861 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 135.7 163.0 9.83 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.601 -0.999 . . . . 0.0 110.601 -179.806 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.439 ' CG ' ' HA ' ' A' ' 80' ' ' ASP . 49.9 Cg_endo -79.33 -171.95 1.39 Allowed 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.642 2.228 . . . . 0.0 112.091 -179.974 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 -97.16 171.64 8.32 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.85 0.357 . . . . 0.0 110.258 179.846 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -144.05 143.88 31.37 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.716 179.813 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 -131.28 177.75 7.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.201 0.524 . . . . 0.0 111.288 -179.466 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.49 ' HG2' ' CZ3' ' A' ' 41' ' ' TRP . 0.1 OUTLIER 175.7 67.28 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.265 -179.964 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -52.57 173.46 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.264 0.554 . . . . 0.0 111.143 -178.963 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.746 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 6.4 mt -128.68 55.91 1.68 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.126 179.595 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -26.73 137.87 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.736 0.815 . . . . 0.0 112.593 -178.915 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.578 ' N ' ' HB2' ' A' ' 29' ' ' ALA . 23.6 mt-10 -51.69 -51.75 53.58 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.25 -179.857 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 5.1 tptt -135.95 57.93 1.77 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.042 179.733 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -136.04 -96.64 0.49 Allowed Glycine 0 CA--C 1.523 0.592 0 N-CA-C 110.776 -0.93 . . . . 0.0 110.776 -179.823 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 1.9 ptt? 174.86 165.87 0.26 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.813 0.339 . . . . 0.0 110.515 -179.949 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.432 ' CD ' ' HA ' ' A' ' 69' ' ' LEU . 5.6 mmtp -94.13 137.9 32.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.005 -179.965 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 10.8 t30 -141.29 176.21 9.03 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.285 179.923 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 95.9 t -121.65 146.79 26.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.253 179.995 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -136.12 108.91 7.54 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.523 -179.904 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.402 ' O ' ' N ' ' A' ' 81' ' ' VAL . 54.4 m-20 -80.27 163.34 24.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.178 179.799 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.45 ' O ' ' HB ' ' A' ' 81' ' ' VAL . 1.1 m-20 58.94 -85.72 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.377 -179.813 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.887 HG12 HG23 ' A' ' 82' ' ' VAL . 55.6 t 68.55 -56.26 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 C-N-CA 123.432 0.693 . . . . 0.0 110.881 179.98 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.887 HG23 HG12 ' A' ' 81' ' ' VAL . 54.6 t -128.78 139.34 35.35 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.501 -179.894 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.516 ' HD2' HG13 ' A' ' 82' ' ' VAL . 46.2 Cg_endo -69.81 -170.32 0.39 Allowed 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.585 2.19 . . . . 0.0 112.066 179.699 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -87.07 -39.72 15.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.18 179.754 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -110.75 56.22 0.64 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.213 179.855 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 21.1 p90 -56.78 170.25 0.43 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.52 -179.838 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 26.6 m -151.35 121.16 7.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.149 179.907 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.429 ' H ' HD12 ' A' ' 88' ' ' ILE . 3.4 mp -50.58 111.29 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.388 -179.82 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 122.41 57.36 0.2 Allowed Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.655 -0.978 . . . . 0.0 110.655 -179.976 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.401 ' O ' HG23 ' A' ' 7' ' ' THR . . . -174.07 148.86 1.4 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.75 0.309 . . . . 0.0 110.378 -179.991 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.75 HG23 ' O ' ' A' ' 6' ' ' PHE . 50.9 m -106.97 93.88 4.8 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.6 -179.955 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.569 ' O ' ' HB3' ' A' ' 93' ' ' ALA . 44.0 m-85 -76.42 -155.67 0.06 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.145 -0.479 . . . . 0.0 109.761 179.549 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.89 ' HB1' ' HD2' ' A' ' 94' ' ' PRO . . . 75.65 172.95 0.09 OUTLIER Pre-proline 0 N--CA 1.464 0.227 0 CA-C-O 120.786 0.327 . . . . 0.0 110.811 179.773 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.89 ' HD2' ' HB1' ' A' ' 93' ' ' ALA . 46.9 Cg_endo . . . . . 0 C--O 1.25 1.08 0 C-N-CA 122.606 2.204 . . . . 0.0 111.965 179.884 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.653 HG13 ' O ' ' A' ' 1' ' ' VAL . 8.5 p . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 . . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -75.07 134.09 17.27 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.412 2.075 . . . . 0.0 112.188 -179.919 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.65 94.03 2.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.283 -179.904 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.518 ' CG1' ' CE1' ' A' ' 78' ' ' PHE . 1.9 p -63.89 163.24 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.285 0.564 . . . . 0.0 110.469 -179.811 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.478 ' N ' HG22 ' A' ' 4' ' ' VAL . 80.9 p -137.48 136.11 37.43 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.067 179.871 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.62 ' O ' HG23 ' A' ' 91' ' ' THR . 17.7 m-85 -97.0 -175.42 3.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.418 -179.81 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.407 ' HB ' ' HB2' ' A' ' 20' ' ' LEU . 2.5 m -167.15 95.53 0.48 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.237 -179.833 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.462 HG12 ' CD1' ' A' ' 88' ' ' ILE . 39.1 t -51.07 97.19 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.563 -179.879 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.492 ' HG3' HG11 ' A' ' 51' ' ' VAL . 4.4 mt-10 -61.92 174.52 0.83 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.443 -179.92 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.8 tttt -67.66 163.37 21.59 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.408 -179.977 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 74.27 25.74 70.03 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 179.883 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.475 ' CB ' HD11 ' A' ' 88' ' ' ILE . 0.5 OUTLIER -99.05 121.81 41.46 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.835 0.35 . . . . 0.0 110.431 -179.993 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -177.45 -175.03 0.52 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.427 179.99 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.41 ' O ' ' CB ' ' A' ' 15' ' ' LYS . 3.9 mt-10 -47.59 119.07 2.53 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.175 0.512 . . . . 0.0 110.834 -179.848 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.418 ' O ' ' CG ' ' A' ' 16' ' ' HIS . 0.8 OUTLIER 79.95 24.54 0.4 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.774 179.726 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.418 ' CG ' ' O ' ' A' ' 15' ' ' LYS . 3.2 m80 -174.04 111.75 0.17 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.829 0.347 . . . . 0.0 110.348 179.745 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.444 HD22 ' HA ' ' A' ' 17' ' ' LEU . 0.3 OUTLIER -128.93 101.19 5.97 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.489 -179.856 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -97.93 153.05 18.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.232 179.852 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.594 HG23 HG23 ' A' ' 21' ' ' VAL . 23.7 m -150.18 134.72 9.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.062 -179.7 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.581 HD22 ' CG ' ' A' ' 22' ' ' LYS . 0.5 OUTLIER -86.77 73.34 10.02 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.212 -0.449 . . . . 0.0 109.869 179.105 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.594 HG23 HG23 ' A' ' 19' ' ' VAL . 52.7 t -69.83 94.51 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.86 -179.468 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.581 ' CG ' HD22 ' A' ' 20' ' ' LEU . 0.0 OUTLIER 175.18 157.8 0.19 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.106 179.712 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.41 ' CE2' ' HB3' ' A' ' 26' ' ' ASP . 0.1 OUTLIER -127.08 -79.05 0.59 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.46 -179.981 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -99.49 -90.78 0.3 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.822 -179.814 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -139.68 32.83 2.19 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 111.132 -0.787 . . . . 0.0 111.132 -179.778 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.41 ' HB3' ' CE2' ' A' ' 23' ' ' TYR . 4.3 p30 -58.58 -171.11 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 179.727 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.454 ' HB ' ' CG ' ' A' ' 71' ' ' GLU . 0.9 OUTLIER -125.57 145.82 49.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.875 0.369 . . . . 0.0 110.37 179.987 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.411 ' O ' ' CG ' ' A' ' 71' ' ' GLU . 0.0 OUTLIER -98.7 129.39 45.16 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.662 -179.506 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.757 ' HB3' ' O ' ' A' ' 69' ' ' LEU . . . -120.47 -56.8 1.95 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.351 179.956 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -158.0 145.9 18.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.388 -179.982 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.888 HG21 ' CD1' ' A' ' 52' ' ' TRP . 2.4 t -135.68 140.38 44.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.141 179.995 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.463 ' CB ' ' HA ' ' A' ' 43' ' ' ALA . 4.4 pt-20 -139.14 141.39 38.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.858 0.361 . . . . 0.0 110.491 179.955 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.509 ' HG ' ' CE1' ' A' ' 66' ' ' PHE . 2.2 mt -113.0 174.61 5.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.94 -179.444 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.5 ' HB2' ' CZ3' ' A' ' 41' ' ' TRP . 1.5 ttp85 -149.61 -159.17 1.0 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.852 179.585 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -158.67 26.18 0.23 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.698 0.285 . . . . 0.0 110.759 179.887 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 49.4 25.88 1.45 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.726 179.752 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -129.73 -50.45 0.12 Allowed Glycine 0 CA--C 1.522 0.525 0 N-CA-C 110.706 -0.958 . . . . 0.0 110.706 -179.945 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -76.54 115.26 16.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.784 0.326 . . . . 0.0 110.425 -179.977 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -52.09 -25.83 9.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.361 -179.992 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.26 178.73 4.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.219 179.892 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.506 ' CH2' ' HG3' ' A' ' 67' ' ' ARG . 86.5 m95 -111.88 169.45 8.83 Favored 'General case' 0 CA--C 1.503 -0.862 0 CA-C-O 121.559 0.695 . . . . 0.0 110.876 -179.978 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.499 HG12 ' O ' ' A' ' 42' ' ' VAL . 1.0 OUTLIER -142.05 107.63 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.193 0 CA-C-N 114.63 -1.168 . . . . 0.0 109.769 -177.441 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.463 ' HA ' ' CB ' ' A' ' 32' ' ' GLU . . . -50.49 143.39 9.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.578 -179.445 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.463 ' HE2' ' CZ ' ' A' ' 66' ' ' PHE . 0.0 OUTLIER -63.14 -169.57 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.783 -179.765 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.405 ' O ' ' N ' ' A' ' 47' ' ' GLY . 46.0 m -135.35 110.18 8.72 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.03 179.811 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.77 66.45 0.09 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.566 -179.793 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.405 ' N ' ' O ' ' A' ' 45' ' ' THR . . . -83.35 -40.84 8.8 Favored Glycine 0 CA--C 1.522 0.522 0 N-CA-C 110.351 -1.1 . . . . 0.0 110.351 179.798 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -90.02 144.97 25.44 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 179.74 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -83.83 8.16 67.23 Favored Glycine 0 CA--C 1.528 0.903 0 N-CA-C 111.597 -0.601 . . . . 0.0 111.597 -179.896 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -127.44 -40.0 0.35 Allowed Glycine 0 CA--C 1.524 0.641 0 N-CA-C 110.978 -0.849 . . . . 0.0 110.978 -179.952 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.538 HG12 ' HA ' ' A' ' 20' ' ' LEU . 6.9 m -133.67 -176.5 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 121.088 0.47 . . . . 0.0 110.79 -179.605 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . 0.888 ' CD1' HG21 ' A' ' 31' ' ' VAL . 11.1 m95 -109.61 131.39 55.11 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.75 179.543 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 3.0 p -115.98 171.79 7.56 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.863 0.363 . . . . 0.0 110.318 -179.664 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 60.4 t80 -159.63 118.5 2.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.333 179.971 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -70.94 129.14 38.25 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.303 179.956 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 90.8 p -96.25 126.54 41.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.416 -179.949 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -136.58 36.95 2.67 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.394 179.984 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -138.04 156.61 73.97 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.324 179.854 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -72.45 -26.77 16.62 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.671 2.247 . . . . 0.0 112.216 -179.949 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.4 mt -79.5 126.61 31.08 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.541 -179.761 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -156.58 -178.37 7.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.358 -179.845 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 119.73 -106.25 1.2 Allowed Glycine 0 CA--C 1.526 0.725 0 N-CA-C 110.856 -0.898 . . . . 0.0 110.856 179.891 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -77.46 125.08 7.42 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.455 2.103 . . . . 0.0 111.972 179.991 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.414 ' CE2' ' HG ' ' A' ' 17' ' ' LEU . 42.6 m-85 -101.27 147.05 26.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.587 -179.869 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.448 ' O ' HD23 ' A' ' 33' ' ' LEU . 1.9 m-80 -120.69 131.19 54.43 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.618 179.511 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.509 ' CE1' ' HG ' ' A' ' 33' ' ' LEU . 19.8 m-85 -114.71 163.1 15.94 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.963 0.411 . . . . 0.0 111.47 -179.236 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.658 ' HD2' HG22 ' A' ' 77' ' ' VAL . 48.3 mtp180 -162.07 62.62 0.23 Allowed 'General case' 0 CA--C 1.52 -0.184 0 CA-C-N 115.353 -0.839 . . . . 0.0 109.807 179.014 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.967 ' O ' HD23 ' A' ' 69' ' ' LEU . 0.0 OUTLIER -67.09 -179.15 0.9 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.143 0.497 . . . . 0.0 110.828 -179.455 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.967 HD23 ' O ' ' A' ' 68' ' ' PHE . 5.7 mt -136.68 55.07 1.85 Allowed 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 179.321 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 18.5 p -29.02 137.95 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.543 0.737 . . . . 0.0 112.135 -178.904 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.678 ' HG2' ' HB2' ' A' ' 29' ' ' ALA . 8.0 mt-10 -51.22 -68.62 0.15 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.663 -179.24 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -106.29 68.45 0.76 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.781 0.324 . . . . 0.0 110.31 179.902 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -158.28 -104.58 0.21 Allowed Glycine 0 CA--C 1.523 0.587 0 N-CA-C 110.952 -0.859 . . . . 0.0 110.952 -179.972 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 13.3 ptm 174.26 179.38 0.11 Allowed 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 -179.838 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.25 175.68 6.85 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.87 0.367 . . . . 0.0 110.352 179.877 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 173.96 170.16 0.2 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.43 179.907 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.658 HG22 ' HD2' ' A' ' 67' ' ' ARG . 72.5 t -117.61 157.78 18.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.504 -179.987 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.518 ' CE1' ' CG1' ' A' ' 4' ' ' VAL . 41.3 m-85 -144.99 129.93 18.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.384 -179.932 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -118.85 147.03 44.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.319 179.942 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 59.13 45.45 14.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.455 179.862 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.503 ' O ' HG12 ' A' ' 81' ' ' VAL . 74.4 t -80.4 -3.91 6.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.073 179.893 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.437 HG23 ' C ' ' A' ' 81' ' ' VAL . 89.2 t -156.56 122.12 2.48 Favored Pre-proline 0 CA--C 1.528 0.117 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 179.654 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.431 ' HD3' ' CD1' ' A' ' 92' ' ' TYR . 50.8 Cg_endo -75.25 176.07 10.42 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.552 2.168 . . . . 0.0 112.129 -179.923 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -77.31 131.03 37.92 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 179.475 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 2.2 mmtt 59.92 40.75 18.68 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 -179.529 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 28.2 p90 -47.46 174.28 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.855 -179.681 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 10.9 m -129.36 129.66 45.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.242 179.987 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.475 HD11 ' CB ' ' A' ' 12' ' ' SER . 42.2 mm -66.51 115.3 4.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.337 179.981 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 119.45 37.34 0.79 Allowed Glycine 0 CA--C 1.523 0.573 0 N-CA-C 110.725 -0.95 . . . . 0.0 110.725 -179.917 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -147.67 172.57 13.85 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.808 0.337 . . . . 0.0 110.375 179.998 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.62 HG23 ' O ' ' A' ' 6' ' ' PHE . 87.9 m -114.83 126.16 54.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.422 -179.992 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.463 ' O ' ' HB2' ' A' ' 93' ' ' ALA . 54.6 m-85 -127.45 130.5 49.37 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.571 179.985 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.897 ' HB1' ' HD2' ' A' ' 94' ' ' PRO . . . 174.01 177.13 0.19 Allowed Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.435 179.713 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.897 ' HD2' ' HB1' ' A' ' 93' ' ' ALA . 49.4 Cg_endo . . . . . 0 C--O 1.25 1.094 0 C-N-CA 122.642 2.228 . . . . 0.0 112.071 -179.885 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 12.0 t . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 120.728 0.299 . . . . 0.0 110.232 . . . . . . . . . 0 0 . 1 . 037 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -77.05 167.57 24.82 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.587 2.191 . . . . 0.0 112.077 -179.972 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.86 59.35 0.99 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.367 -179.936 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.801 HG12 ' CE2' ' A' ' 23' ' ' TYR . 16.9 m -71.91 168.3 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.478 -179.967 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.427 ' HB ' ' CG2' ' A' ' 91' ' ' THR . 78.4 p -153.72 129.96 10.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.33 179.819 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.559 ' O ' HG23 ' A' ' 91' ' ' THR . 25.2 m-85 -93.44 165.46 12.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.41 -179.865 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -153.72 108.84 3.16 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.546 -179.883 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.442 ' CG1' HG13 ' A' ' 88' ' ' ILE . 92.0 t -57.79 114.26 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.12 179.759 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.65 ' CD ' HG11 ' A' ' 51' ' ' VAL . 1.8 mt-10 -84.36 159.11 20.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.61 -179.771 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.637 ' HA ' HG21 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -57.63 -25.81 60.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.48 -179.912 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -49.67 -26.4 7.73 Favored Glycine 0 CA--C 1.523 0.567 0 N-CA-C 110.8 -0.92 . . . . 0.0 110.8 -179.908 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.4 m -59.29 106.4 0.44 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.767 0.318 . . . . 0.0 110.289 179.961 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.434 ' O ' ' N ' ' A' ' 15' ' ' LYS . 10.8 p-10 -124.72 136.74 54.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.491 -179.962 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 53.34 -87.04 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.661 179.891 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.434 ' N ' ' O ' ' A' ' 13' ' ' ASN . 42.2 pttt -114.16 -27.39 7.67 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.659 0.266 . . . . 0.0 110.71 -179.963 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 8.9 m80 -49.36 134.19 19.01 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.533 179.947 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.477 HD22 ' HA ' ' A' ' 17' ' ' LEU . 0.2 OUTLIER -118.48 100.12 7.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.409 -179.88 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.583 ' HB2' ' CG2' ' A' ' 53' ' ' THR . . . -98.86 130.5 45.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.266 179.942 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.77 HG23 HG23 ' A' ' 21' ' ' VAL . 33.4 m -126.15 146.67 31.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.262 -179.914 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -96.66 70.97 2.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.307 -179.947 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.77 HG23 HG23 ' A' ' 19' ' ' VAL . 23.5 t -75.16 97.89 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.449 -179.877 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.02 146.39 9.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.405 179.975 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.801 ' CE2' HG12 ' A' ' 4' ' ' VAL . 17.0 p90 -173.16 140.03 0.84 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.455 -179.996 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -52.04 134.91 31.91 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.358 -179.98 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 126.78 -110.44 1.23 Allowed Glycine 0 CA--C 1.523 0.538 0 N-CA-C 110.684 -0.966 . . . . 0.0 110.684 179.993 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -67.01 145.85 54.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.781 0.324 . . . . 0.0 110.259 179.954 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.449 ' HB ' ' CG ' ' A' ' 71' ' ' GLU . 0.3 OUTLIER -80.87 -171.26 3.08 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.419 -179.884 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -117.92 124.63 48.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.567 -179.723 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.845 ' HB3' ' O ' ' A' ' 69' ' ' LEU . . . -114.54 -60.59 1.87 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.437 -179.783 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.559 ' OE2' ' HB1' ' A' ' 43' ' ' ALA . 0.5 OUTLIER -157.78 150.95 23.25 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.224 179.984 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 1.034 HG21 ' CD1' ' A' ' 52' ' ' TRP . 6.1 t -119.59 166.57 13.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.155 -179.899 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.468 ' N ' HG12 ' A' ' 31' ' ' VAL . 1.2 tp10 -153.08 140.06 19.21 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.017 0.437 . . . . 0.0 109.925 -179.416 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.708 HD12 ' N ' ' A' ' 34' ' ' ARG . 3.9 tp -134.3 142.62 47.34 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.182 -178.963 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.708 ' N ' HD12 ' A' ' 33' ' ' LEU . 6.7 tpm_? -127.73 -95.91 0.42 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.154 -0.475 . . . . 0.0 109.903 179.012 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.44 ' CB ' ' O ' ' A' ' 34' ' ' ARG . 0.0 OUTLIER 160.79 -83.51 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 120.763 0.316 . . . . 0.0 110.321 179.392 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 3.3 t60 177.88 -55.41 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.317 -179.868 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -59.36 -72.07 0.67 Allowed Glycine 0 CA--C 1.523 0.584 0 N-CA-C 110.639 -0.985 . . . . 0.0 110.639 179.955 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -58.05 122.03 12.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.819 0.342 . . . . 0.0 110.179 179.848 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 33.0 m-20 -83.26 6.71 18.64 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.312 -179.825 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -107.84 100.33 9.71 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 120.82 0.343 . . . . 0.0 110.54 -179.953 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.507 ' CZ3' ' HG2' ' A' ' 67' ' ' ARG . 68.7 m95 -59.4 155.32 15.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.072 179.733 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.506 HG21 ' CZ ' ' A' ' 54' ' ' PHE . 10.0 m -138.47 110.76 6.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-O 120.715 0.293 . . . . 0.0 110.307 179.98 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.559 ' HB1' ' OE2' ' A' ' 30' ' ' GLU . . . -45.68 149.75 0.57 Allowed 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.52 -179.8 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.403 ' HB2' ' HB ' ' A' ' 31' ' ' VAL . 0.0 OUTLIER -72.13 -170.55 0.62 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.916 0.388 . . . . 0.0 110.54 -179.722 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 68.8 m -138.88 126.04 21.37 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.409 -179.945 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 3.1 ptpt -94.56 91.32 6.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.564 -179.804 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -146.34 26.59 1.7 Allowed Glycine 0 CA--C 1.523 0.572 0 N-CA-C 110.81 -0.916 . . . . 0.0 110.81 179.963 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.493 ' OE2' HG21 ' A' ' 53' ' ' THR . 0.0 OUTLIER -106.45 174.52 5.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.836 0.351 . . . . 0.0 110.482 179.939 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -56.13 -29.44 56.02 Favored Glycine 0 CA--C 1.522 0.53 0 N-CA-C 110.487 -1.045 . . . . 0.0 110.487 179.787 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.437 ' O ' HG13 ' A' ' 51' ' ' VAL . . . 177.81 37.46 0.06 OUTLIER Glycine 0 CA--C 1.524 0.619 0 N-CA-C 110.861 -0.896 . . . . 0.0 110.861 179.965 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.65 HG11 ' CD ' ' A' ' 9' ' ' GLU . 13.1 m -154.78 177.87 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.828 0.347 . . . . 0.0 110.395 179.866 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . 1.034 ' CD1' HG21 ' A' ' 31' ' ' VAL . 5.4 m95 -103.92 144.92 30.87 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.379 -179.487 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.583 ' CG2' ' HB2' ' A' ' 18' ' ' ALA . 0.7 OUTLIER -137.15 157.91 45.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.382 -179.971 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.506 ' CZ ' HG21 ' A' ' 42' ' ' VAL . 78.2 t80 -148.95 155.39 40.77 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.49 -179.952 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -89.81 124.58 34.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.511 -179.89 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 94.0 p -120.56 103.56 9.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.273 179.937 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -110.3 -28.02 8.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.47 -179.906 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -59.55 125.63 80.19 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.458 -179.923 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -72.0 -11.73 27.6 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.519 2.146 . . . . 0.0 112.514 179.97 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -47.57 107.49 0.12 Allowed 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 120.901 0.381 . . . . 0.0 110.749 -179.732 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -76.05 118.89 19.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.345 179.929 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -179.65 170.85 42.39 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 -179.959 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.417 ' CB ' ' HA ' ' A' ' 80' ' ' ASP . 49.6 Cg_endo -79.02 151.63 24.04 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.597 2.198 . . . . 0.0 112.097 -179.893 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.571 ' HB3' HD13 ' A' ' 33' ' ' LEU . 29.4 m-85 -84.86 123.11 30.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.277 179.877 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 7.4 m-20 -95.28 134.46 38.03 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 179.516 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.424 ' CE2' ' HB2' ' A' ' 33' ' ' LEU . 51.8 m-85 -121.42 167.9 12.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.129 0.49 . . . . 0.0 111.045 -179.452 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.507 ' HG2' ' CZ3' ' A' ' 41' ' ' TRP . 0.3 OUTLIER -173.77 61.77 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.711 179.984 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.625 ' HZ ' HG11 ' A' ' 4' ' ' VAL . 1.7 p90 -56.78 174.11 0.17 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.99 -179.472 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.845 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 2.9 mt -121.54 72.14 1.0 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.221 179.515 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.401 ' OG1' ' N ' ' A' ' 74' ' ' MET . 62.3 p -35.84 136.17 0.27 Allowed 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.793 -179.241 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.681 ' HG2' ' HB2' ' A' ' 29' ' ' ALA . 14.8 mt-10 -49.96 -52.16 35.74 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.486 -179.861 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 6.3 tptp -129.21 71.67 1.44 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.529 -179.869 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -162.85 -103.71 0.18 Allowed Glycine 0 CA--C 1.522 0.528 0 N-CA-C 110.799 -0.92 . . . . 0.0 110.799 179.897 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.401 ' N ' ' OG1' ' A' ' 70' ' ' THR . 21.1 ptt? -179.21 -175.64 0.38 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.853 0.359 . . . . 0.0 110.292 179.988 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.553 ' HE3' HD22 ' A' ' 69' ' ' LEU . 0.0 OUTLIER -97.48 148.28 23.38 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.159 -179.69 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -152.62 123.09 7.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.192 179.854 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 98.4 t -81.65 143.73 11.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.526 -179.825 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.631 ' CZ ' HG21 ' A' ' 4' ' ' VAL . 53.9 m-85 -127.99 122.35 32.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.254 179.993 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -105.26 148.72 26.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.552 -179.699 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.417 ' HA ' ' CB ' ' A' ' 63' ' ' PRO . 1.0 OUTLIER 58.88 46.06 14.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.462 179.9 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.413 ' O ' ' HB3' ' A' ' 92' ' ' TYR . 90.1 t -77.0 -75.25 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.187 179.862 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.426 HG13 ' HD2' ' A' ' 83' ' ' PRO . 39.1 t -89.04 137.89 29.37 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.268 179.797 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.426 ' HD2' HG13 ' A' ' 82' ' ' VAL . 49.1 Cg_endo -73.17 -175.42 1.96 Allowed 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.5 2.133 . . . . 0.0 111.949 179.821 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -82.9 -31.18 27.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.135 179.738 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 6.0 tttp -117.45 51.56 1.02 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.255 179.846 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.403 ' HA ' ' HG2' ' A' ' 83' ' ' PRO . 48.8 p90 -52.56 159.61 1.02 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.55 -179.894 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -142.4 114.83 8.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.128 179.88 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.637 HG21 ' HA ' ' A' ' 10' ' ' LYS . 3.0 mp -49.83 100.16 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.466 -179.826 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 134.18 53.72 0.07 OUTLIER Glycine 0 CA--C 1.523 0.542 0 N-CA-C 110.602 -0.999 . . . . 0.0 110.602 -179.971 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.663 ' HB3' ' OH ' ' A' ' 92' ' ' TYR . . . -175.82 179.61 1.33 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.811 0.338 . . . . 0.0 110.359 179.99 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.559 HG23 ' O ' ' A' ' 6' ' ' PHE . 24.8 m -120.69 139.78 52.55 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.439 -179.83 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.663 ' OH ' ' HB3' ' A' ' 90' ' ' ALA . 7.1 m-85 -141.59 104.58 4.58 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.284 179.932 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.887 ' HB1' ' HD2' ' A' ' 94' ' ' PRO . . . 175.06 177.3 0.21 Allowed Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.301 -179.886 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.887 ' HD2' ' HB1' ' A' ' 93' ' ' ALA . 47.6 Cg_endo . . . . . 0 C--O 1.249 1.074 0 C-N-CA 122.486 2.124 . . . . 0.0 112.03 179.973 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.755 HG12 ' HE3' ' A' ' 3' ' ' LYS . 59.2 t . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 110.105 -0.332 . . . . 0.0 110.105 . . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -72.98 157.42 51.2 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.413 2.075 . . . . 0.0 111.952 179.8 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.755 ' HE3' HG12 ' A' ' 1' ' ' VAL . 10.4 mmtp -131.57 75.32 1.64 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.535 -179.737 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.507 ' CG1' ' CE1' ' A' ' 78' ' ' PHE . 2.0 p -65.25 163.25 2.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.172 0.511 . . . . 0.0 110.068 179.808 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.491 ' N ' HG22 ' A' ' 4' ' ' VAL . 3.9 p -147.78 131.07 16.53 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.384 -179.989 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.815 ' O ' HG23 ' A' ' 91' ' ' THR . 6.0 m-85 -96.46 174.73 6.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.287 -179.958 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.442 ' HB ' ' CB ' ' A' ' 20' ' ' LEU . 2.8 m -166.16 106.88 0.7 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.27 -179.813 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.71 ' O ' HG23 ' A' ' 88' ' ' ILE . 91.6 t -59.11 94.12 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.406 -179.85 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.799 ' HG3' HG11 ' A' ' 51' ' ' VAL . 15.4 mm-40 -56.02 158.86 3.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.236 179.899 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.494 ' HA ' HG21 ' A' ' 88' ' ' ILE . 1.9 ptmt -77.14 62.57 2.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.435 -179.948 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -154.95 27.32 0.64 Allowed Glycine 0 CA--C 1.523 0.593 0 N-CA-C 110.728 -0.949 . . . . 0.0 110.728 179.963 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 30.4 m -86.87 131.7 34.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.839 0.352 . . . . 0.0 110.358 -179.967 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -110.54 -159.71 0.69 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.143 -0.481 . . . . 0.0 109.986 179.872 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -47.83 -59.35 3.38 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.622 179.908 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.13 -25.07 9.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.588 -180.0 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 27.0 m80 -51.27 134.46 27.7 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.852 0.358 . . . . 0.0 110.421 -179.999 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.485 HD22 ' HA ' ' A' ' 17' ' ' LEU . 0.2 OUTLIER -127.05 98.03 5.17 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.371 -179.952 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.552 ' HB2' ' CG2' ' A' ' 53' ' ' THR . . . -94.4 127.85 40.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.213 179.929 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.761 HG23 HG23 ' A' ' 21' ' ' VAL . 22.7 m -128.0 148.15 32.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.317 -179.957 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.442 ' CB ' ' HB ' ' A' ' 7' ' ' THR . 0.9 OUTLIER -94.53 63.19 2.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.456 -179.936 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.761 HG23 HG23 ' A' ' 19' ' ' VAL . 22.8 t -65.66 100.49 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.292 179.969 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.39 152.26 21.83 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.313 -179.994 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 28.1 p90 179.23 157.49 0.56 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.367 -179.941 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -82.81 163.53 21.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.331 179.934 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 106.63 -49.09 0.9 Allowed Glycine 0 CA--C 1.523 0.57 0 N-CA-C 110.652 -0.979 . . . . 0.0 110.652 -179.963 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -130.44 -177.78 4.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.755 0.312 . . . . 0.0 110.171 179.906 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -126.68 162.87 24.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.514 -179.976 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.589 ' O ' ' HB2' ' A' ' 29' ' ' ALA . 0.0 OUTLIER -57.98 -160.84 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.316 179.92 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.755 ' HB2' ' N ' ' A' ' 71' ' ' GLU . . . 155.12 -63.71 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.291 0.637 . . . . 0.0 109.532 179.668 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 17.9 tt0 -148.7 161.53 41.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.061 179.8 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.465 HG21 ' CD1' ' A' ' 52' ' ' TRP . 10.7 t -155.11 150.18 11.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.234 179.911 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.436 ' CB ' ' HA ' ' A' ' 43' ' ' ALA . 1.4 pm0 -151.67 144.46 24.38 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.359 -179.955 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.726 HD12 ' H ' ' A' ' 34' ' ' ARG . 8.1 tp -112.96 151.14 30.92 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.486 -179.428 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.726 ' H ' HD12 ' A' ' 33' ' ' LEU . 4.7 ttp180 -117.2 -158.16 0.69 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.229 179.913 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 6.9 tm-20 -175.5 107.32 0.09 Allowed 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 -179.968 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -48.39 97.0 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.704 -179.434 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 161.67 -31.27 0.32 Allowed Glycine 0 CA--C 1.522 0.525 0 N-CA-C 110.468 -1.053 . . . . 0.0 110.468 179.859 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -117.87 145.26 44.73 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 179.937 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -94.95 21.45 7.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.778 -179.836 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 29.7 tp10 -130.38 113.52 14.44 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 -179.901 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.499 ' CZ2' ' HD2' ' A' ' 67' ' ' ARG . 63.7 m95 -63.72 172.99 1.89 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.162 179.707 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.419 ' CG2' ' O ' ' A' ' 33' ' ' LEU . 4.4 m -146.65 107.34 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.048 179.624 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.436 ' HA ' ' CB ' ' A' ' 32' ' ' GLU . . . -45.49 146.06 1.11 Allowed 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.679 -179.69 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.411 ' CE ' ' HB2' ' A' ' 54' ' ' PHE . 0.0 OUTLIER -68.56 -170.8 0.23 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.709 -179.712 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.403 ' HB ' ' O ' ' A' ' 53' ' ' THR . 92.8 m -145.34 107.19 4.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.436 -179.979 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -66.22 79.08 0.09 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.168 179.87 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -104.29 -22.93 8.32 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 111.056 -0.818 . . . . 0.0 111.056 -179.794 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.465 ' HG3' HG23 ' A' ' 53' ' ' THR . 0.1 OUTLIER -75.96 -178.62 4.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.979 0.419 . . . . 0.0 110.422 -179.939 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -111.79 38.95 3.05 Favored Glycine 0 CA--C 1.522 0.514 0 N-CA-C 110.244 -1.143 . . . . 0.0 110.244 179.579 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 165.39 -27.81 0.19 Allowed Glycine 0 CA--C 1.526 0.753 0 N-CA-C 111.311 -0.716 . . . . 0.0 111.311 -179.874 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.799 HG11 ' HG3' ' A' ' 9' ' ' GLU . 3.2 m -123.4 -176.3 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-O 120.884 0.373 . . . . 0.0 110.705 -179.726 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . 0.465 ' CD1' HG21 ' A' ' 31' ' ' VAL . 11.2 m95 -108.21 138.27 44.78 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.722 -179.661 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.552 ' CG2' ' HB2' ' A' ' 18' ' ' ALA . 2.9 p -130.64 137.86 49.81 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.768 179.549 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.411 ' HB2' ' CE ' ' A' ' 44' ' ' MET . 71.5 t80 -123.37 131.12 53.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.878 0.371 . . . . 0.0 110.753 -179.539 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -77.32 107.13 9.51 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.019 179.696 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.0 m -87.76 148.71 24.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.629 -179.693 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -122.97 -42.27 2.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.256 179.887 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -55.72 165.51 1.26 Allowed Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.404 179.987 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -94.32 5.32 2.64 Favored 'Trans proline' 0 N--CA 1.452 -0.934 0 C-N-CA 123.995 3.13 . . . . 0.0 113.015 -179.863 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -103.94 102.9 12.69 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.827 0.346 . . . . 0.0 110.355 179.918 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -122.82 75.13 1.25 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.453 -179.845 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -133.46 -101.03 0.74 Allowed Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.749 -0.94 . . . . 0.0 110.749 179.996 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -78.51 107.9 2.36 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.568 2.178 . . . . 0.0 112.049 -179.954 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 36.7 m-85 -93.42 166.42 12.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.391 -179.947 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.424 ' HB2' ' CB ' ' A' ' 34' ' ' ARG . 1.5 m-80 -133.86 147.41 51.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.018 179.785 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -140.55 175.07 9.9 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.031 0.443 . . . . 0.0 110.962 -179.718 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.499 ' HD2' ' CZ2' ' A' ' 41' ' ' TRP . 6.5 ptm180 -178.99 61.98 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.569 179.941 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.652 ' O ' HD23 ' A' ' 69' ' ' LEU . 0.3 OUTLIER -57.4 173.72 0.24 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.028 -179.223 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.723 HD22 ' HG2' ' A' ' 75' ' ' LYS . 2.9 mt -136.12 78.69 1.73 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.881 179.969 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 61.2 p -38.81 153.19 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.393 -179.646 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.755 ' N ' ' HB2' ' A' ' 29' ' ' ALA . 6.3 mt-10 -49.7 -33.97 17.44 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.388 -179.799 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.61 -36.08 82.69 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.354 -179.97 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 113.12 23.37 5.25 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 110.974 -0.851 . . . . 0.0 110.974 179.972 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -92.89 116.13 28.76 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.708 0.29 . . . . 0.0 110.307 179.902 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.723 ' HG2' HD22 ' A' ' 69' ' ' LEU . 3.1 mptt -113.46 173.72 6.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.35 -179.941 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 171.11 129.78 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.999 179.98 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 83.0 t -76.52 153.81 5.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.327 -179.994 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.507 ' CE1' ' CG1' ' A' ' 4' ' ' VAL . 87.1 m-85 -139.12 119.61 13.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.599 -179.879 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -106.03 152.22 23.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.095 179.812 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 11.0 t0 55.2 61.02 3.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.049 -179.751 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.482 ' O ' HG12 ' A' ' 81' ' ' VAL . 84.7 t -95.36 -8.19 9.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.234 -179.695 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.446 HG23 ' C ' ' A' ' 81' ' ' VAL . 57.3 t -156.33 132.07 5.68 Favored Pre-proline 0 C--N 1.332 -0.166 0 N-CA-C 110.406 -0.22 . . . . 0.0 110.406 179.872 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.509 ' HD3' ' CD1' ' A' ' 92' ' ' TYR . 50.0 Cg_endo -73.0 -176.09 2.23 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.507 2.138 . . . . 0.0 111.946 179.84 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -82.52 135.68 35.04 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 179.446 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 57.75 48.37 13.99 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 -179.466 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 48.8 p90 -43.28 156.36 0.05 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.414 -179.528 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 7.1 m -127.32 103.71 7.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.808 179.609 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.71 HG23 ' O ' ' A' ' 8' ' ' VAL . 2.5 mp -44.52 122.57 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.012 -179.632 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 117.43 35.37 1.1 Allowed Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.743 -0.943 . . . . 0.0 110.743 -179.935 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -155.74 142.35 18.73 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 110.222 -0.288 . . . . 0.0 110.222 179.978 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.815 HG23 ' O ' ' A' ' 6' ' ' PHE . 6.0 m -96.3 113.8 25.42 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.925 0.393 . . . . 0.0 110.716 -179.836 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.578 ' O ' ' HB3' ' A' ' 93' ' ' ALA . 33.0 m-85 -97.26 -153.58 0.42 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.788 179.751 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.869 ' HB1' ' HD2' ' A' ' 94' ' ' PRO . . . 78.42 173.78 0.08 OUTLIER Pre-proline 0 N--CA 1.465 0.305 0 CA-C-O 120.838 0.351 . . . . 0.0 110.722 179.808 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.869 ' HD2' ' HB1' ' A' ' 93' ' ' ALA . 48.1 Cg_endo . . . . . 0 C--O 1.249 1.053 0 C-N-CA 122.631 2.22 . . . . 0.0 112.079 179.958 . . . . . . . . 1 1 . 1 stop_ save_